PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ma, JL; Wang, XJ; Wang, YT; Zhao, YX; Gao, M; Li, XQ				Ma, Jinling; Wang, Xiujie; Wang, Yutang; Zhao, Yuexiang; Gao, Meng; Li, Xiaoqian			The Relationship between Glycated Hemoglobin and Complexity of Coronary Artery Lesions among Older Patients with Diabetes Mellitus	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; 1-YEAR CLINICAL-OUTCOMES; SIROLIMUS-ELUTING STENT; PREDICTS ALL-CAUSE; SYNTAX SCORE; CARDIOVASCULAR-DISEASE; GLYCOSYLATED HEMOGLOBIN; INTERVENTION; MORTALITY; RISK	Objectives: Glycated hemoglobin (HbA1c) is associated with an increased risk of cardiovascular disease. The aim of this study was to examine the relationship between HbA1c levels and the complexity of coronary artery lesions among the older patients with diabetes mellitus (DM). Methods: This retrospective study enrolled a total of 3805 consecutive type 2 DM patients aged 60 years and older who underwent their first elective coronary angiography and had their HbA1c levels measured at the Chinese PLA General Hospital between December 2005 and December 2012. The complexity of the coronary artery lesions was evaluated using the Syntax score, and the subjects were divided into three groups according to their HbA1c levels. Logistic regression and Pearson correlation were used to analyze the association between the measured HbA1c levels and Syntax score. Results: The mean age was 72.3 +/- 10.6 years. The higher HbA1c levels were significantly associated with higher Syntax score (p<0.001). The unadjusted correlation coefficient of HbA1c levels and the Syntax score was 0. 371 (p<0.001). In addition, the higher HbA1c categories were able to independently predict patients with intermediate or high Syntax score (Syntax score >= 23) after adjustment for age, sex, hypertension, smoking, dyslipidemia and creatinine levels in the logistic regression analysis. Conclusion: HbA1c is significantly associated with the complexity of coronary lesions among older patients with DM. A higher HbA1c value is an independent predictor of the prevalence of complex coronary lesions. Further prospective multicentre studies are needed to confirm this finding.	[Ma, Jinling; Wang, Yutang; Zhao, Yuexiang; Gao, Meng; Li, Xiaoqian] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China; [Wang, Xiujie] Zhaoyuan Peoples Hosp, Dept Radiol, Shandong, Peoples R China	Chinese People's Liberation Army General Hospital	Wang, YT (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China.	wangyutang301@163.com						Brewer N, 2008, DIABETES CARE, V31, P1144, DOI 10.2337/dc07-2374; Capodanno D, 2012, INT J CARDIOL, V159, P165, DOI 10.1016/j.ijcard.2012.01.049; Capodanno D, 2009, CIRC-CARDIOVASC INTE, V2, P302, DOI 10.1161/CIRCINTERVENTIONS.108.847137; Fillipon NML, 2012, CLIN CARDIOL, V35, P565, DOI 10.1002/clc.22028; Garg S, 2011, JACC-CARDIOVASC INTE, V4, P645, DOI 10.1016/j.jcin.2011.02.018; Garg S, 2011, JACC-CARDIOVASC INTE, V4, P432, DOI 10.1016/j.jcin.2011.01.008; Garg S, 2011, JACC-CARDIOVASC INTE, V4, P66, DOI 10.1016/j.jcin.2010.09.017; Gerstein HC, 2008, ARCH INTERN MED, V168, P1699, DOI 10.1001/archinte.168.15.1699; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Ikeda N, 2012, J ATHEROSCLER THROMB, V19, P1066, DOI 10.5551/jat.13722; Khaw KT, 2006, CURR OPIN LIPIDOL, V17, P637, DOI 10.1097/MOL.0b013e3280106b95; Lazzeri C, 2011, INT J CARDIOL, V151, P250, DOI 10.1016/j.ijcard.2011.06.077; Levitan EB, 2008, DIABETOLOGIA, V51, P267, DOI 10.1007/s00125-007-0882-y; Malmberg K, 2005, EUR HEART J, V26, P650, DOI 10.1093/eurheartj/ehi199; Martins RA, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-13; McNeely MJ, 2009, DIABETES CARE, V32, P1727, DOI 10.2337/dc09-0074; Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nishimura R, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-58; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Pacilli A, 2013, ATHEROSCLEROSIS, V228, P247, DOI 10.1016/j.atherosclerosis.2013.02.010; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pradhan AD, 2007, AM J MED, V120, P720, DOI 10.1016/j.amjmed.2007.03.022; Rizza S, 2010, ATHEROSCLEROSIS, V212, P316, DOI 10.1016/j.atherosclerosis.2010.05.017; Rohlfing C, 2002, CLIN CHEM, V48, P1116; Saely CH, 2008, ATHEROSCLEROSIS, V199, P317, DOI 10.1016/j.atherosclerosis.2007.11.020; Saleh N, 2012, DIABETOLOGIA, V55, P2109, DOI 10.1007/s00125-012-2565-6; Sarwar N, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000278; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Selvin E, 2008, ARCH INTERN MED, V168, P2070, DOI 10.1001/archinte.168.19.2070; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Serruys PW, 2010, J AM COLL CARDIOL, V55, P1093, DOI 10.1016/j.jacc.2009.11.049; Serruys PW, 2009, EUROINTERVENTION, V5, P50, DOI 10.4244/EIJV5I1A9; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Sianos Georgios, 2005, EuroIntervention, V1, P219; Silbernagel G, 2012, ATHEROSCLEROSIS, V221, P551, DOI 10.1016/j.atherosclerosis.2012.01.011; Silbernagel G, 2011, DIABETES CARE, V34, P1355, DOI 10.2337/dc10-2010; Singla A, 2012, J INTERV CARDIOL, V25, P262, DOI 10.1111/j.1540-8183.2011.00715.x; Valgimigli M, 2007, AM J CARDIOL, V99, P1072, DOI 10.1016/j.amjcard.2006.11.062; van Gaal WJ, 2009, INT J CARDIOL, V135, P60, DOI 10.1016/j.ijcard.2008.03.033; Wykrzykowska JJ, 2010, J AM COLL CARDIOL, V56, P272, DOI 10.1016/j.jacc.2010.03.044; Yun CH, 2009, ATHEROSCLEROSIS, V205, P481, DOI 10.1016/j.atherosclerosis.2009.01.015; Zhang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042551; Zhao M, 2013, INT J CARDIOL, V168, P3273, DOI 10.1016/j.ijcard.2013.04.136	46	10	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91972	10.1371/journal.pone.0091972	http://dx.doi.org/10.1371/journal.pone.0091972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658008	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300047
J	Martelli, D; Artoni, F; Monaco, V; Sabatini, AM; Micera, S				Martelli, Dario; Artoni, Fiorenzo; Monaco, Vito; Sabatini, Angelo Maria; Micera, Silvestro			Pre-Impact Fall Detection: Optimal Sensor Positioning Based on a Machine Learning Paradigm	PLOS ONE			English	Article							NEURONAL COORDINATION; RISK-FACTORS; MECHANISMS; PREVALENCE; PREVENTION; LOCOMOTION; RESPONSES; RECOVERY; SYSTEM	The aim of this study was to identify the best subset of body segments that provides for a rapid and reliable detection of the transition from steady walking to a slipping event. Fifteen healthy young subjects managed unexpected perturbations during walking. Whole-body 3D kinematics was recorded and a machine learning algorithm was developed to detect perturbation events. In particular, the linear acceleration of all the body segments was parsed by Independent Component Analysis and a Neural Network was used to classify walking from unexpected perturbations. The Mean Detection Time (MDT) was 3516123 ms with an Accuracy of 95.4%. The procedure was repeated with data related to different subsets of all body segments whose variability appeared strongly influenced by the perturbation-induced dynamic modifications. Accordingly, feet and hands accounted for most data information and the performance of the algorithm were slightly reduced using their combination. Results support the hypothesis that, in the framework of the proposed approach, the information conveyed by all the body segments is redundant to achieve effective fall detection, and suitable performance can be obtained by simply observing the kinematics of upper and lower distal extremities. Future studies are required to assess the extent to which such results can be reproduced in older adults and in different experimental conditions.	[Martelli, Dario; Artoni, Fiorenzo; Monaco, Vito; Sabatini, Angelo Maria; Micera, Silvestro] Scuola Superiore Santanna, BioRobot Inst, Pisa, Italy; [Micera, Silvestro] Swiss Fed Inst Technol Lausanne EPFL, Ctr Neuroprosthet, Translat Neural Engn Lab, Lausanne, Switzerland	Scuola Superiore Sant'Anna; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Monaco, V (corresponding author), Scuola Superiore Santanna, BioRobot Inst, Pisa, Italy.	v.monaco@sssup.it	artoni, firoenzo/K-8948-2016; MONACO, Vito/AAD-6610-2021; Micera, Silvestro/AAD-6630-2021; Artoni, Fiorenzo/ABB-9343-2020	artoni, firoenzo/0000-0002-0967-6643; Artoni, Fiorenzo/0000-0002-0967-6643; Martelli, Dario/0000-0002-1903-5372	Italian Ministry of Education and Research (MIUR); EC [GA 341 225929, ICT 287894, CIP-ICT-PSP-2011-5-297225]	Italian Ministry of Education and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); EC(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Italian Ministry of Education and Research (MIUR) through the relevant interest national project (PRIN) "A quantitative and multi factorial approach for estimating and preventing the risk of falls in the elderly people'' and by the following FP7 EC projects: CLONS "CLOsed-loop Neural prostheses for vestibular disorders'' (GA 341 225929); CYBERLEGs "The CYBERnetic LowEr-Limb CoGnitive Ortho-prosthesis'' (ICT 287894); I-DONT-FALL "Integrated prevention and Detection sOlutioNs Tailored to the population and Risk Factors associated with FALLs'' (CIP-ICT-PSP-2011-5-297225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Mostafa Y. S., 2012, AMLBOOK; Aziz O, 2011, IEEE T NEUR SYS REH, V19, P670, DOI 10.1109/TNSRE.2011.2162250; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; BERGER W, 1984, J PHYSIOL-LONDON, V357, P109, DOI 10.1113/jphysiol.1984.sp015492; Bourke AK, 2008, MED ENG PHYS, V30, P937, DOI 10.1016/j.medengphy.2007.12.003; Bourke AK, 2008, MED ENG PHYS, V30, P84, DOI 10.1016/j.medengphy.2006.12.001; Colombo R, 2008, NEUROREHAB NEURAL RE, V22, P50, DOI 10.1177/1545968307303401; Davidson ME, 2004, SYSTEM PROTECTION FA; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Dietz V, 2002, TRENDS NEUROSCI, V25, P462, DOI 10.1016/S0166-2236(02)02229-4; DIETZ V, 1987, J PHYSIOL-LONDON, V386, P149, DOI 10.1113/jphysiol.1987.sp016527; Dietz V, 2001, EUR J NEUROSCI, V14, P1906, DOI 10.1046/j.0953-816x.2001.01813.x; ENG JJ, 1994, EXP BRAIN RES, V102, P339; Grip H, 2003, IEEE T INF TECHNOL B, V7, P412, DOI 10.1109/TITB.2003.821322; Kangas M, 2008, GAIT POSTURE, V28, P285, DOI 10.1016/j.gaitpost.2008.01.003; Liu J, 2009, GAIT POSTURE, V30, P276, DOI 10.1016/j.gaitpost.2009.04.005; Lockhart TE, 2005, HUM FACTORS, V47, P708, DOI 10.1518/001872005775571014; Lockhart TE, 2006, FALL SENSING SYSTEMS; Lockhart TE, 2008, J ELECTROMYOGR KINES, V18, P205, DOI 10.1016/j.jelekin.2007.06.006; Luciani LB, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-51; Maki BE, 1996, J BIOMECH, V29, P343, DOI 10.1016/0021-9290(95)00053-4; Marigold DS, 2009, NEUROSCIENTIST, V15, P36, DOI 10.1177/1073858408322674; Martelli D., 2013, IEEE T BIOMED ENG; Masud T, 2001, AGE AGEING, V30, P3, DOI 10.1093/ageing/30.suppl_4.3; Miller WC, 2001, ARCH PHYS MED REHAB, V82, P1031, DOI 10.1053/apmr.2001.24295; Nyan MN, 2008, J BIOMECH, V41, P2297, DOI 10.1016/j.jbiomech.2008.03.042; Nyan MN, 2006, MED ENG PHYS, V28, P842, DOI 10.1016/j.medengphy.2005.11.008; Nyan MN, 2008, J BIOMECH, V41, P3475, DOI 10.1016/j.jbiomech.2008.08.009; Stolze H, 2004, J NEUROL, V251, P79, DOI 10.1007/s00415-004-0276-8; Vaughan CL, 2005, GAIT POSTURE, V21, P350, DOI 10.1016/j.gaitpost.2004.01.011; Wu G, 2000, J BIOMECH, V33, P1497, DOI 10.1016/S0021-9290(00)00117-2; Wu G, 2008, IEEE T NEUR SYS REH, V16, P178, DOI 10.1109/TNSRE.2007.916282; Zatsiorsky VM, 1990, CONT PROBLEMS BIOMEC, P272; Zhang F, 2011, IEEE T NEUR SYS REH, V19, P567, DOI 10.1109/TNSRE.2011.2161888; Zhao G, SENSORS BASEL, V12, P15338	35	17	17	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92037	10.1371/journal.pone.0092037	http://dx.doi.org/10.1371/journal.pone.0092037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658093	gold, Green Published, Green Submitted			2022-12-27	WOS:000333355300050
J	Minutolo, A; Conti, B; Grelli, S; Viscomi, C; Labbadia, G; Balsano, C				Minutolo, Antonella; Conti, Beatrice; Grelli, Sandro; Viscomi, Carmela; Labbadia, Giancarlo; Balsano, Clara			Lymphocytes as Liver Damage Mirror of HCV Related Adipogenesis Deregulation	PLOS ONE			English	Article							HEPATITIS-C VIRUS; KRUPPEL-LIKE FACTORS; INSULIN-RESISTANCE; VIRAL-HEPATITIS; GENE-EXPRESSION; UP-REGULATION; STEATOSIS; TWIST; ABNORMALITIES; REPLICATION	Hepatitis C virus infection leads to a wide spectrum of liver diseases ranging from mild chronic hepatitis to end-stage cirrhosis and hepatocellular carcinoma. An intriguing aspect of the HCV infection is its close connection with lipid metabolism playing an important role in the HCV life cycle and in its pathogenesis. HCV is known to be a hepatotropic virus; however, it can also infect peripheral blood mononuclear cells (PBMCs). The goal of the current investigation is to compare the adipogenesis profile of liver tissues to lymphocytes of HCV infected patients, in order to understand if PBMCs may reflect the alterations of intracellular pathways occurring during HCV-related liver steatosis. Using the Human Adipogenesis PCR Array, gene expression was analyzed in liver samples and PBMCs of chronic HCV+, HBV+ and Healthy Donors (HDs) patients. We observed a similar modulation of lipid metabolism in HCV+ and HBV+ liver tissues and lymphoid, cells suggesting that PBMCs reflect the liver adipogenesis deregulation related to infection, even if the two viruses have a different impact in the regulation of the adipogenesis mechanisms. In particular, some genes involved in lipid metabolism and inflammation, as well as in cell transformation, were up-regulated, in a similar way, in both HCV models analyzed. Interestingly, these genes were positively correlated to virological and hepatic functional parameters of HCV+ patients. On the contrary, HBV+ patients displayed a completely different profile. PBMCs of HCV+ patients seem to be useful model to study how HCV-related lipid metabolism deregulation occurs in liver. The obtained data suggest some molecules as new possible biomarkers of HCV-related liver damage progression.	[Minutolo, Antonella; Conti, Beatrice; Viscomi, Carmela; Balsano, Clara] Ex A Cesalpino Fdn, Francesco Balsano Fdn, Lab Mol Virol & Oncol, Rome, Italy; [Balsano, Clara] CNR, Natl Res Council, IBPM, Rome, Italy; [Grelli, Sandro] Tor Vergata Hosp, UOC Clin Microbiol, Rome, Italy; [Labbadia, Giancarlo] Sapienza Univ Rome, Umberto I Hosp, Dept Clin & Med Therapy, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); University of Rome Tor Vergata; Policlin Tor Vergata; Sapienza University Rome; University Hospital Sapienza Rome	Balsano, C (corresponding author), Ex A Cesalpino Fdn, Francesco Balsano Fdn, Lab Mol Virol & Oncol, Rome, Italy.	clara.balsano@cnr.it	MINUTOLO, ANTONELLA/AAA-1788-2020; Balsano, Clara/AAK-9870-2020; Grelli, Sandro/AAA-3279-2020	Balsano, Clara/0000-0002-9615-7031; GRELLI, SANDRO/0000-0003-1028-3203; minutolo, antonella/0000-0003-4784-4297	FIRB-Programma "Futuro in Ricerca'' [RBAP10MY35]; MIUR-Programma di ricerca di Rilevante Interesse Nazionale (PRIN) [2009YNERCE]	FIRB-Programma "Futuro in Ricerca''; MIUR-Programma di ricerca di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by FIRB-Programma "Futuro in Ricerca'' (prot. RBAP10MY35) and MIUR-Programma di ricerca di Rilevante Interesse Nazionale (PRIN) 2009 (prot. 2009YNERCE) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albecka A, 2012, HEPATOLOGY, V55, P998, DOI 10.1002/hep.25501; Alisi A, 2007, Dig Liver Dis, V39 Suppl 1, pS72, DOI 10.1016/S1590-8658(07)80015-6; Alisi A, 2008, J CELL PHYSIOL, V214, P396, DOI 10.1002/jcp.21211; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Cao ZX, 2010, BLOOD, V116, P4404, DOI 10.1182/blood-2010-05-285353; Roque-Cuellar MC, 2012, J MED VIROL, V84, P1727, DOI 10.1002/jmv.23345; Conti B, 2013, J HEPATOL, V58, P636, DOI 10.1016/j.jhep.2012.10.033; Corey KE, 2009, HEPATOLOGY, V50, P1030, DOI 10.1002/hep.23219; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Durazzo M, 2013, J ENDOCRINOL INVEST, V36, P600, DOI 10.3275/8883; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Hartling HJ, 2013, SCAND J IMMUNOL, V78, P378, DOI 10.1111/sji.12096; Hong YH, 2005, MOL CELL BIOCHEM, V276, P133, DOI 10.1007/s11010-005-3673-0; Katschke KJ, 2012, J BIOL CHEM, V287, P12886, DOI 10.1074/jbc.M112.345082; Khattab MA, 2012, J GASTROINTEST LIVER, V21, P59; Koga H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039981; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Lambert JE, 2013, HEPATOLOGY, V57, P1697, DOI 10.1002/hep.25990; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Mancone C, 2011, GUT, V60, P378, DOI 10.1136/gut.2010.211292; Mankouri J, 2010, P NATL ACAD SCI USA, V107, P11549, DOI 10.1073/pnas.0912426107; Mazumdar B, 2011, HEPATOLOGY, V54, P1149, DOI 10.1002/hep.24523; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Negro F, 2012, J VIRAL HEPATITIS, V19, P42, DOI 10.1111/j.1365-2893.2011.01523.x; Negro F, 2009, LIVER INT, V29, P26, DOI 10.1111/j.1478-3231.2008.01950.x; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Nkontchou G, 2010, J HEPATOL, V53, P827, DOI 10.1016/j.jhep.2010.04.035; Pham TNQ, 2013, J MED VIROL, V85, P441, DOI 10.1002/jmv.23481; Ploen D, 2013, J HEPATOL S, VS0168-8278; Roe B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023641; Sarhan MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062159; Sarhan MA, 2012, J GEN VIROL, V93, P2399, DOI 10.1099/vir.0.045393-0; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Scholtes C, 2012, HEPATOLOGY, V56, P39, DOI 10.1002/hep.25628; Tsedensodnom O, 2011, EXP CELL RES, V317, P920, DOI 10.1016/j.yexcr.2011.01.015; Wu CH, 2011, HEPATOLOGY, V54, P1966, DOI 10.1002/hep.24645; Wu ZN, 2013, DEV BIOL, V373, P235, DOI 10.1016/j.ydbio.2012.10.031; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zhang M, 2013, MED CHEM; Zhou J, 2011, HEPATOLOGY, V54, P109, DOI 10.1002/hep.24362	43	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92343	10.1371/journal.pone.0092343	http://dx.doi.org/10.1371/journal.pone.0092343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658135	gold, Green Published, Green Submitted			2022-12-27	WOS:000333355300074
J	Bell, JJ; Smith, D; Hannan, D; Haris, A; Jompa, J; Thomas, L				Bell, James J.; Smith, David; Hannan, Danielle; Haris, Abdul; Jompa, Jamaludin; Thomas, Luke			Resilience to Disturbance Despite Limited Dispersal and Self-Recruitment in Tropical Barrel Sponges: Implications for Conservation and Management	PLOS ONE			English	Article							POPULATION-STRUCTURE; XESTOSPONGIA-MUTA; CORAL-REEFS; ASSIGNMENT TESTS; CLIMATE-CHANGE; GENE FLOW; MARINE; PORIFERA; PROGRAM; CONNECTIVITY	While estimates of connectivity are important for effective management, few such estimates are available for reef invertebrates other than for corals. Barrel sponges are one of the largest and most conspicuous members of the coral reef fauna across the Indo-Pacific and given their large size, longevity and ability to process large volumes of water, they have a major role in reef functioning. Here we used a panel of microsatellite markers to characterise the genetic structure of two barrel sponge species, Xestospongia testudinaria and a currently undescribed Xestospongia species. We sampled across seven populations in the Wakatobi Marine National Park, SE Sulawesi (Indonesia) spanning a spatial scale of approximately 2 to 70 km, and present the first estimates of demographic connectivity for coral reef sponges. Genetic analyses showed high levels of genetic differentiation between all populations for both species, but contrasting patterns of genetic structuring for the two species. Autocorrelation analyses showed the likely dispersal distances of both species to be in the order of 60 and 140 m for Xestopongia sp. and Xestospongia testudinaria, respectively, which was supported by assignment tests that showed high levels of self-recruitment (>80%). We also found consistently high inbreeding coefficients across all populations for both species. Our study highlights the potential susceptibility of barrel sponges to environmental perturbations because they are generally long-lived, slow growing, have small population sizes and are likely to be reliant on self-recruitment. Surprisingly, despite these features we actually found the highest abundance of both barrel sponge species (although they were generally smaller) at a site that has been severely impacted by humans over the last fifty years. This suggests that barrel sponges exhibit environmental adaptation to declining environmental quality and has important implications for the management and conservation of these important reef species.	[Bell, James J.; Hannan, Danielle] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Smith, David] Univ Essex, Coral Reef Res Unit, Colchester CO4 3SQ, Essex, England; [Haris, Abdul; Jompa, Jamaludin] Hasanuddin Univ, Res & Dev Ctr Marine Coastal & Small Isl, Makassar, Indonesia; [Thomas, Luke] Univ Western Australia, Sch Plant Biol, Oceans Inst, Nedlands, WA 6009, Australia	Victoria University Wellington; University of Essex; Universitas Hasanuddin; University of Western Australia	Bell, JJ (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	james.bell@vuw.ac.nz	Jompa, Jamaluddin/AAD-9280-2021; haris, abdul/GPG-0863-2022	Jompa, Jamaluddin/0000-0001-9740-333X; haris, abdul/0000-0001-7535-4514; Bell, James/0000-0001-9996-945X; Smith, David/0000-0003-1886-8193	Victoria University of Wellington Research Fund	Victoria University of Wellington Research Fund	This work was funded by the Victoria University of Wellington Research Fund. The funders has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison GW, 2003, ECOL APPL, V13, pS8; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bell JJ, 2007, MAR ECOL PROG SER, V339, P73, DOI 10.3354/meps339073; Bell JJ, 2014, CONSERV GENET RESOUR, V6, P105, DOI 10.1007/s12686-013-0015-5; Bell JJ, 2013, GLOBAL CHANGE BIOL, V19, P2613, DOI 10.1111/gcb.12212; Bell JJ, 2005, P ROY SOC B-BIOL SCI, V272, P1067, DOI 10.1098/rspb.2005.3051; Bell JJ, 2004, J MAR BIOL ASSOC UK, V84, P581, DOI 10.1017/S0025315404009580h; Berry O, 2004, MOL ECOL, V13, P551, DOI 10.1046/j.1365-294X.2004.2081.x; Blanquer A, 2009, MAR ECOL PROG SER, V380, P95, DOI 10.3354/meps07931; Burke L., 2011, REEFS RISK REVISITED; Clifton J, 2010, ENVIRON SCI ENG TECH, P1; Cullen LC, 2010, ENVIRON SCI ENG TECH, P171; Duran S, 2004, MOL ECOL, V13, P511, DOI 10.1046/j.1365-294X.2004.2080.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FROMONT J, 1994, BIOCHEM SYST ECOL, V22, P735, DOI 10.1016/0305-1978(94)90059-0; FROMONT J, 1991, Beagle, V8, P73; FROMONT J, 1994, CORAL REEFS, V13, P119, DOI 10.1007/BF00300772; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; Horne JB, 2013, J HERED, V104, P532, DOI 10.1093/jhered/est021; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Knapp ISS, 2013, MAR POLLUT BULL, V66, P209, DOI 10.1016/j.marpolbul.2012.08.017; Lopez-Legentil S, 2009, CORAL REEFS, V28, P157, DOI 10.1007/s00338-008-0430-3; Lopez-Legentil S, 2008, MOL ECOL, V17, P1840, DOI 10.1111/j.1365-294X.2008.03667.x; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Maldonado M, 2006, CAN J ZOOL, V84, P175, DOI 10.1139/Z05-177; McMellor S, 2010, ENVIRON SCI ENG TECH, P11; McMurray SE, 2008, MAR BIOL, V155, P159, DOI 10.1007/s00227-008-1014-z; McMurray SE, 2010, ECOLOGY, V91, P560, DOI 10.1890/08-2060.1; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Powell AL, 2013, THESIS VICTORIA U WE; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Saenz-Agudelo P, 2009, MOL ECOL, V18, P1765, DOI 10.1111/j.1365-294X.2009.04109.x; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Swierts T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074396; Underwood JN, 2009, ECOL APPL, V19, P18, DOI 10.1890/07-1461.1; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whalan S, 2005, MAR BIOL, V146, P425, DOI 10.1007/s00227-004-1466-8; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1943, GENETICS, V28, P114; Wulff J, 2001, B MAR SCI, V69, P831	59	30	30	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91635	10.1371/journal.pone.0091635	http://dx.doi.org/10.1371/journal.pone.0091635			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651687	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000333352800044
J	Dubot-Peres, A; Tan, CYQ; de Chesse, R; Sibounheuang, B; Vongsouvath, M; Phommasone, K; Bessaud, M; Gazin, C; Thirion, L; Phetsouvanh, R; Newton, PN; de Lamballerie, X				Dubot-Peres, Audrey; Tan, Charlene Y. Q.; de Chesse, Reine; Sibounheuang, Bountoy; Vongsouvath, Manivanh; Phommasone, Koukeo; Bessaud, Mael; Gazin, Celine; Thirion, Laurence; Phetsouvanh, Rattanaphone; Newton, Paul N.; de Lamballerie, Xavier			SYBR Green Real-Time PCR for the Detection of All Enterovirus-A71 Genogroups	PLOS ONE			English	Article							ACUTE FLACCID PARALYSIS; MOUTH-DISEASE; RT-PCR; CLINICAL SPECIMENS; 71 INFECTION; MOLECULAR EPIDEMIOLOGY; HAND; FOOT; OUTBREAK; TAIWAN	Enterovirus A71 (EV-A71) has recently become an important public health threat, especially in South-East Asia, where it has caused massive outbreaks of Hand, Foot and Mouth disease every year, resulting in significant mortality. Rapid detection of EV-A71 early in outbreaks would facilitate implementation of prevention and control measures to limit spread. Real-time RTPCR is the technique of choice for the rapid diagnosis of EV-A71 infection and several systems have been developed to detect circulating strains. Although eight genogroups have been described globally, none of these PCR techniques detect all eight. We describe, for the first time, a SYBR Green real-time RT-PCR system validated to detect all 8 EV-A71 genogroups. This tool could permit the early detection and shift in genogroup circulation and the standardization of HFMD virological diagnosis, facilitating networking of laboratories working on EV-A71 in different regions.	[Dubot-Peres, Audrey; Tan, Charlene Y. Q.; de Chesse, Reine; Bessaud, Mael; Thirion, Laurence; de Lamballerie, Xavier] Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, Unite Mixte Rech Emergence Pathol Virales D 190, Marseille, France; [Dubot-Peres, Audrey; Sibounheuang, Bountoy; Vongsouvath, Manivanh; Phommasone, Koukeo; Phetsouvanh, Rattanaphone; Newton, Paul N.] Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Hospital Wellcome Trust Res Un, Viangchan, Laos; [Dubot-Peres, Audrey; Sibounheuang, Bountoy; Phommasone, Koukeo; Phetsouvanh, Rattanaphone; Newton, Paul N.] Univ Oxford, Churchill Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Gazin, Celine; de Lamballerie, Xavier] Univ Hosp, AP HM Timone, Inst Infect Dis & Trop Med, Lab Clin Microbiol, Marseille, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; University of Oxford; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Dubot-Peres, A (corresponding author), Aix Marseille Univ, IRD French Inst Res Dev, EHESP French Sch Publ Hlth, Unite Mixte Rech Emergence Pathol Virales D 190, Marseille, France.	audrey@tropmedres.ac	Bessaud, Maël/J-3961-2019	Bessaud, Maël/0000-0001-6758-9591; Laurence, THIRION/0000-0003-4301-2944; Newton, Paul/0000-0002-4608-6431	Wellcome Trust of Great Britain; Institut of Research for Development; Assistance Publique-Hopitaux de Marseille; Aix-Marseille University	Wellcome Trust of Great Britain(Wellcome Trust); Institut of Research for Development; Assistance Publique-Hopitaux de Marseille; Aix-Marseille University	Funded by the Wellcome Trust of Great Britain, Institut of Research for Development, Assistance Publique-Hopitaux de Marseille, Aix-Marseille University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Bessaud M, 2014, PLOS ONE IN PRESS; Bessaud M, 2012, J CLIN MICROBIOL, V50, P1650, DOI 10.1128/JCM.06657-11; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Brown BA, 2000, J CLIN VIROL, V16, P107, DOI 10.1016/S1386-6532(00)00065-2; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Cardosa MJ, 1999, LANCET, V354, P987, DOI 10.1016/S0140-6736(98)11032-2; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chang Luan-Yin, 2008, Pediatrics and Neonatology, V49, P103, DOI 10.1016/S1875-9572(08)60023-6; Chang LJ, 2008, J FORMOS MED ASSOC, V107, P589, DOI 10.1016/S0929-6646(08)60175-8; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Deshpande JM, 2003, CURR SCI INDIA, V84, P1350; Fan XL, 2013, VIRUS GENES, V46, P1, DOI 10.1007/s11262-012-0814-x; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Huang FL, 2002, CLIN INFECT DIS, V34, P1020, DOI 10.1086/339445; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; Jiang BF, 2012, J MED VIROL, V84, P1803, DOI 10.1002/jmv.23391; Komatsu H, 1999, PEDIATR NEUROL, V20, P17, DOI 10.1016/S0887-8994(98)00087-3; Lee MH, 2011, J MICROBIOL IMMUNOL, V44, P178, DOI 10.1016/j.jmii.2011.01.018; Mizuta K, 2005, J CLIN MICROBIOL, V43, P6171, DOI 10.1128/JCM.43.12.6171-6175.2005; Nguyen TTT, 2010, J VIROL METHODS, V170, P134, DOI 10.1016/j.jviromet.2010.09.017; Ni HX, 2012, J CLIN VIROL, V54, P342, DOI 10.1016/j.jcv.2012.04.021; Ninove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016142; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Rao CD, 2012, EMERG INFECT DIS, V18, P1833, DOI 10.3201/eid1811.111457; Sadeuh-Mba SA, 2013, J CLIN MICROBIOL, V51, P759, DOI 10.1128/JCM.02119-12; Singh S, 2002, J CLIN MICROBIOL, V40, P2823, DOI 10.1128/JCM.40.8.2823-2827.2002; Tan EL, 2006, MOL CELL PROBE, V20, P135, DOI 10.1016/j.mcp.2005.11.003; Tan EL, 2008, DIAGN MICR INFEC DIS, V61, P294, DOI 10.1016/j.diagmicrobio.2008.02.009; Tan EL, 2008, J CLIN VIROL, V42, P203, DOI 10.1016/j.jcv.2008.01.001; Tsao KC, 2002, J VIROL METHODS, V102, P9, DOI 10.1016/S0166-0934(01)00376-7; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Xiao XL, 2009, ARCH VIROL, V154, P121, DOI 10.1007/s00705-008-0266-8; Yan JJ, 2001, J MED VIROL, V65, P331, DOI 10.1002/jmv.2038; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	43	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e89963	10.1371/journal.pone.0089963	http://dx.doi.org/10.1371/journal.pone.0089963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651608	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800006
J	Ma, L; Ballantyne, C; Brautbar, A; Keinan, A				Ma, Li; Ballantyne, Christie; Brautbar, Ariel; Keinan, Alon			Analysis of Multiple Association Studies Provides Evidence of an Expression QTL Hub in Gene-Gene Interaction Network Affecting HDL Cholesterol Levels	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; MISSING HERITABILITY; COMBINATION THERAPY; FENOFIBRIC ACID; LOCI; EPISTASIS; VARIANTS; RISK; ATHEROSCLEROSIS; INDIVIDUALS	Epistasis has been suggested to underlie part of the missing heritability in genome-wide association studies. In this study, we first report an analysis of gene-gene interactions affecting HDL cholesterol (HDL-C) levels in a candidate gene study of 2,091 individuals with mixed dyslipidemia from a clinical trial. Two additional studies, the Atherosclerosis Risk in Communities study (ARIC; n = 9,713) and the Multi-Ethnic Study of Atherosclerosis (MESA; n = 2,685), were considered for replication. We identified a gene-gene interaction between rs1532085 and rs12980554 (P = 7.1x10(-7)) in their effect on HDL-C levels, which is significant after Bonferroni correction (P-c = 0.017) for the number of SNP pairs tested. The interaction successfully replicated in the ARIC study (P = 7.0x10(-4); P-c = 0.02). Rs1532085, an expression QTL (eQTL) of LIPC, is one of the two SNPs involved in another, well-replicated gene-gene interaction underlying HDL-C levels. To further investigate the role of this eQTL SNP in gene-gene interactions affecting HDL-C, we tested in the ARIC study for interaction between this SNP and any other SNP genome-wide. We found the eQTL to be involved in a few suggestive interactions, one of which significantly replicated in MESA. Importantly, these gene-gene interactions, involving only rs1532085, explain an additional 1.4% variation of HDL-C, on top of the 0.65% explained by rs1532085 alone. LIPC plays a key role in the lipid metabolism pathway and it, and rs1532085 in particular, has been associated with HDL-C and other lipid levels. Collectively, we discovered several novel gene-gene interactions, all involving an eQTL of LIPC, thus suggesting a hub role of LIPC in the gene-gene interaction network that regulates HDL-C levels, which in turn raises the hypothesis that LIPC's contribution is largely via interactions with other lipid metabolism related genes.	[Ma, Li; Keinan, Alon] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Ballantyne, Christie; Brautbar, Ariel] Baylor Coll Med, Dept Med, Sect Cardiovasc Res, Houston, TX 77030 USA; [Brautbar, Ariel] Marshfield Clin Fdn Med Res & Educ, Dept Med Genet, Marshfield, WI USA	Cornell University; Baylor College of Medicine; Marshfield Clinic	Brautbar, A (corresponding author), Baylor Coll Med, Dept Med, Sect Cardiovasc Res, Houston, TX 77030 USA.	brautbar@bcm.edu; ak735@cornell.edu	Ballantyne, Christie/A-6599-2008; ma, li/C-1585-2014	Keinan, Alon/0000-0002-9760-1122; Ballantyne, Christie/0000-0002-6432-1730	National Institutes of Health [R01HG006849]; Ellison Medical Foundation; Alfred P. Sloan Research Fellowship; Edward Mallinckrodt, Jr. Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); Edward Mallinckrodt, Jr. Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by National Institutes of Health Grant (R01HG006849). A.K. was also supported by The Ellison Medical Foundation, an Alfred P. Sloan Research Fellowship, and the Edward Mallinckrodt, Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselbergs FW, 2012, AM J HUM GENET, V91, P823, DOI 10.1016/j.ajhg.2012.08.032; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Brautbar A, 2012, J LIPID RES, V53, P556, DOI 10.1194/jlr.M020404; Brautbar A, 2011, ATHEROSCLEROSIS, V219, P737, DOI 10.1016/j.atherosclerosis.2011.08.015; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Folkersen L, 2010, CIRC-CARDIOVASC GENE, V3, P365, DOI 10.1161/CIRCGENETICS.110.948935; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-364; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Lu CQ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-407; Ma L, 2012, J LIPID RES; Ma L, 2012, PLOS GENETICS, V8; Ma L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-55; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Maxwell TJ, 2013, GENETICS; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raue U, 2012, J APPL PHYSIOL, V112, P1625, DOI 10.1152/japplphysiol.00435.2011; Ritchie MD, 2011, ANN HUM GENET, V75, P172, DOI 10.1111/j.1469-1809.2010.00630.x; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Santamarina-Fojo S, 1998, CURR OPIN LIPIDOL, V9, P211, DOI 10.1097/00041433-199806000-00005; Sun Y, 2012, HUM GENET, P1; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Toedter G, 2011, AM J GASTROENTEROL, V106, P1272, DOI 10.1038/ajg.2011.83; Turner SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019586; van Raalte DH, 2004, PHARM RES-DORDR, V21, P1531, DOI 10.1023/B:PHAM.0000041444.06122.8d; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wei W-H, 2012, EUROPEAN J HUMAN GEN; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	49	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92469	10.1371/journal.pone.0092469	http://dx.doi.org/10.1371/journal.pone.0092469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651390	Green Submitted, gold, Green Published			2022-12-27	WOS:000333352800115
J	Norling, R; Buron, BMD; Therkildsen, MH; Henriksen, BM; von Buchwald, C; Nielsen, MB				Norling, Rikke; Buron, Birgitte Marie Due; Therkildsen, Marianne Hamilton; Henriksen, Birthe Merete; von Buchwald, Christian; Nielsen, Michael Bachmann			Staging of Cervical Lymph Nodes in Oral Squamous Cell Carcinoma: Adding Ultrasound in Clinically Lymph Node Negative Patients May Improve Diagnostic Work-Up	PLOS ONE			English	Article							NECK DISSECTION; ASPIRATION-CYTOLOGY; IMAGING METHODS; IN-VITRO; HEAD; SONOGRAPHY; CT; GUIDELINES; CAVITY; LYMPHADENOPATHY	Introduction: Clinical staging of patients with oral squamous cell carcinoma (OSCC) is crucial for the choice of treatment. Computed tomography (CT) and/or magnetic resonance imaging (MRI) are typically recommended and used for staging of the cervical lymph nodes (LNs). Although ultrasonography (US) is a non-expensive, accessible and non-ionising imaging modality this method is not consistently used. This study aimed to investigate if addition of US of patients classified as clinically LN negative (cN0) by CT and/or MRI, increases the detection of LN metastases. Also, we aimed to identify which of the sonographic characteristics: echogenicity, border, shape, appearance of hilum and nodal blood-flow pattern best detect metastases in this patient group. Method: Fifty-one patients with OSCC classified as cN0 by CT/MRI were consecutively included and prospectively examined with US prior to sentinel node biopsy or selective neck dissection. Localisation, size and sonographic characteristics were registered for each LN and compared with the pathological findings. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated for different size measurements and sonographic characteristics. Results: We found that short axial diameter was the best size criterion for detection of metastases. However, the sonographic characteristics were better predictors than size and the presence at least four of the sonographic characteristics: hypo-echoic or heterogeneous appearance; irregular border; spherical shape; absence of nodal hilum; and peripheral nodal blood-flow resulted in a sensitivity of 43.8; specificity 91.4; PPV 70.0; and NPV 78.0. The number of patients with occult metastases decreased from 16 out of 51 (31%) to nine out of 51 (18%). Three patients (6%) were over-staged by US. Conclusion: The addition of US to the clinical work-up of patients with cN0 OSCC increases the detection of metastases, thus US potentially reduces the number of patients requiring a secondary neck surgery after sentinel node biopsy.	[Norling, Rikke; Buron, Birgitte Marie Due; Henriksen, Birthe Merete; Nielsen, Michael Bachmann] Copenhagen Univ Hosp, Rigshosp, Dept Radiol, Copenhagen, Denmark; [Therkildsen, Marianne Hamilton] Copenhagen Univ Hosp, Rigshosp, Dept Pathol, Copenhagen, Denmark; [von Buchwald, Christian] Copenhagen Univ Hosp, Rigshosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Norling, R (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Radiol, Copenhagen, Denmark.	Rikke.Norling@dadlnet.dk	von Buchwald, Christian/D-5336-2016; Nielsen, Michael Bachmann/U-2749-2018	von Buchwald, Christian/0000-0001-6753-8129; Nielsen, Michael Bachmann/0000-0002-9380-1688				AJCC, 2010, CANC STAGING MANUAL; Akoglu E, 2005, J OTOLARYNGOL, V34, P384, DOI 10.2310/7070.2005.34605; [Anonymous], 2009, TNM CLASSIFICATION M; Atula T, 1997, ACTA OTO-LARYNGOL, P223; Bhatia KSS, 2012, ULTRASOUND MED BIOL, V38, P195, DOI 10.1016/j.ultrasmedbio.2011.10.024; Bilde A, 2006, ACTA ONCOL, V45, P294, DOI 10.1080/02841860600592998; Christensen AF, 2006, ULTRASCHALL MED, V27, P360, DOI 10.1055/s-2005-858966; Cosgrove D, 2013, ULTRASCHALL MED, V34, P238, DOI 10.1055/s-0033-1335375; Danmarks statistik, 2013, FOLK; Devaney KO, 2007, AM J OTOLARYNG, V28, P271, DOI 10.1016/j.amjoto.2006.09.017; Dietrich CF, 2012, ULTRASCHALL MED, V33, P411, DOI 10.1055/s-0032-1325384; DSHHO, 2013, BEH OR PLAN KARC NAT; Gregoire V, 2003, RADIOTHER ONCOL, V69, P227, DOI 10.1016/j.radonc.2003.09.011; Gritzmann N, 2005, ULTRASCHALL MED, V26, P185, DOI 10.1055/s-2005-858271; Lai YS, 2013, LARYNGOSCOPE; Liao LJ, 2010, HEAD NECK-J SCI SPEC, V32, P594, DOI 10.1002/hed.21225; MAMELLE G, 1994, AM J SURG, V168, P494, DOI 10.1016/S0002-9610(05)80109-6; Mancuso AA, 2011, HEAD NECK RADIOLOGY; Nguyen A, 2013, LARYNGOSCOPE; NIELSEN MB, 1993, AM J ROENTGENOL, V161, P57, DOI 10.2214/ajr.161.1.8517321; Norling R, 2013, ACTA OTO-LARYNGOL, V133, P965, DOI 10.3109/00016489.2013.799290; Norling R, 2012, ACTA ONCOL, V51, P355, DOI 10.3109/0284186X.2011.640346; Piscaglia F, 2012, ULTRASCHALL MED, V33, P33, DOI 10.1055/s-0031-1281676; Rettenbacher T, 2010, ULTRASCHALL MED, V31, P344, DOI 10.1055/s-0029-1245584; Robbins KT, 2008, ARCH OTOLARYNGOL, V134, P536, DOI 10.1001/archotol.134.5.536; Schroeder U, 2008, ANN OTO RHINOL LARYN, V117, P854, DOI 10.1177/000348940811701111; Shoaib T, 1999, HEAD NECK-J SCI SPEC, V21, P728, DOI 10.1002/(SICI)1097-0347(199912)21:8<728::AID-HED8>3.0.CO;2-P; Stoeckli SJ, 2012, HEAD NECK-J SCI SPEC, V34, P469, DOI 10.1002/hed.21764; Stuckensen T, 2000, J CRANIO MAXILL SURG, V28, P319, DOI 10.1054/jcms.2000.0172; Sundhedsstyrelsen, 2012, PAKK HOV HALS KRAEFT; Thompson CF, 2013, EUR ARCH OTO-RHINO-L, V270, P2115, DOI 10.1007/s00405-012-2320-0; Trojanowska A, 2011, EUR J RADIOL; van den Brekel MWM, 1998, AM J NEURORADIOL, V19, P695; vandenBrekel MWM, 1996, LARYNGOSCOPE, V106, P987, DOI 10.1097/00005537-199608000-00014; VANDENBREKEL MWM, 1993, EUR ARCH OTO-RHINO-L, V250, P11, DOI 10.1007/BF00176941; Wendl CM, 2012, CLIN HEMORHEOL MICRO, V52, P153, DOI 10.3233/CH-2012-1593; Wensing BM, 2010, ORAL ONCOL, V46, P87, DOI 10.1016/j.oraloncology.2009.11.015; Wu CH, 2000, HEAD NECK-J SCI SPEC, V22, P223, DOI 10.1002/(SICI)1097-0347(200005)22:3<223::AID-HED3>3.0.CO;2-D; Yoon DY, 2009, EUR RADIOL, V19, P634, DOI 10.1007/s00330-008-1192-6	39	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90360	10.1371/journal.pone.0090360	http://dx.doi.org/10.1371/journal.pone.0090360			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651159	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800016
J	Oghabian, A; Kilpinen, S; Hautaniemi, S; Czeizler, E				Oghabian, Ali; Kilpinen, Sami; Hautaniemi, Sampsa; Czeizler, Elena			Biclustering Methods: Biological Relevance and Application in Gene Expression Analysis	PLOS ONE			English	Article							MICROARRAY DATA; ALGORITHMS	DNA microarray technologies are used extensively to profile the expression levels of thousands of genes under various conditions, yielding extremely large data-matrices. Thus, analyzing this information and extracting biologically relevant knowledge becomes a considerable challenge. A classical approach for tackling this challenge is to use clustering (also known as one-way clustering) methods where genes (or respectively samples) are grouped together based on the similarity of their expression profiles across the set of all samples (or respectively genes). An alternative approach is to develop biclustering methods to identify local patterns in the data. These methods extract subgroups of genes that are co-expressed across only a subset of samples and may feature important biological or medical implications. In this study we evaluate 13 biclustering and 2 clustering (k-means and hierarchical) methods. We use several approaches to compare their performance on two real gene expression data sets. For this purpose we apply four evaluation measures in our analysis: (1) we examine how well the considered (bi)clustering methods differentiate various sample types; (2) we evaluate how well the groups of genes discovered by the (bi)clustering methods are annotated with similar Gene Ontology categories; (3) we evaluate the capability of the methods to differentiate genes that are known to be specific to the particular sample types we study and (4) we compare the running time of the algorithms. In the end, we conclude that as long as the samples are well defined and annotated, the contamination of the samples is limited, and the samples are well replicated, biclustering methods such as Plaid and SAMBA are useful for discovering relevant subsets of genes and samples.	[Oghabian, Ali] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Kilpinen, Sami] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Hautaniemi, Sampsa] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Hautaniemi, Sampsa] Univ Helsinki, Genome Scale Biol Res Program, Helsinki, Finland; [Czeizler, Elena] Aalto Univ, Dept Comp Sci & Engn, Espoo, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Aalto University	Czeizler, E (corresponding author), Aalto Univ, Dept Comp Sci & Engn, Espoo, Finland.	elena.czeizler@aalto.fi	Hautaniemi, Sampsa/A-3122-2009; Hautaniemi, Sampsa/CAG-0362-2022	Hautaniemi, Sampsa/0000-0002-7749-2694; Hautaniemi, Sampsa/0000-0002-7749-2694; Kilpinen, Sami/0000-0003-3444-2539; Czeizler, Elena/0000-0003-4250-3979	Academy of Finland [125826]; Biocentrum Helsinki	Academy of Finland(Academy of Finland); Biocentrum Helsinki	These authors report the following sources of support or funding: Academy of Finland (project 125826, Center of Excellence in Cancer Genetics Research) (SH) and Biocentrum Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad W., 2007, VLDB WORKSH DAT MIN; Andreopoulos B, 2009, BRIEFINGS BIOINFORMA; [Anonymous], [No title captured]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Autio R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S24; Ayadi W, 2009, BIODATA MIN, V2, DOI 10.1186/1756-0381-2-9; Baldi P, 2004, HDB COMPUTATIONAL MO; Barkow S, 2006, BIOINFORMATICS, V22, P1282, DOI 10.1093/bioinformatics/btl099; Ben-Dor A, 2003, J COMPUT BIOL, V10, P373, DOI 10.1089/10665270360688075; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Busygin S, 2002, P 2 SIAM INT C DAT M; Busygin S, 2008, COMPUT OPER RES, V35, P2964, DOI 10.1016/j.cor.2007.01.005; Caldas J, 2010, LECT N BIOINFORMAT, V6044, P65, DOI 10.1007/978-3-642-12683-3_5; Caldas J, 2008, MACHINE LEARN SIGN P, P291, DOI 10.1109/MLSP.2008.4685495; Califano A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P75; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; den Bulcke TV, 2009, THESIS KATHOLIEKE U; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eren K, 2013, BRIEF BIOINFORM, V14, P279, DOI 10.1093/bib/bbs032; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Gu JJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S4; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HARTIGAN JA, 1972, J AM STAT ASSOC, V67, P123, DOI 10.2307/2284710; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Hochreiter S, 2010, BIOINFORMATICS, V26, P1520, DOI 10.1093/bioinformatics/btq227; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2004, BIOINFORMATICS; Kaiser S, 2008, TECHNICAL REPORT; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kluger Y, 2003, GENOME RES, V13, P703, DOI 10.1101/gr.648603; Lazzeroni L, 2002, STAT SINICA, V12, P61; Li Haifeng, 2006, Journal of Bioinformatics and Computational Biology, V4, P911, DOI 10.1142/S021972000600217X; Li L, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-8; Liu JZ, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P436; Liu JZ, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P187; Liu X, 2008, BMC BIOINFORMATICS, V9; Liu XW, 2007, BIOINFORMATICS, V23, P50, DOI 10.1093/bioinformatics/btl560; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Murali T M, 2003, Pac Symp Biocomput, P77; Nikkila J, 2002, NEURAL NETWORKS, V15, P953, DOI 10.1016/S0893-6080(02)00070-9; Okada Yoshifumi, 2007, IAENG International Journal of Computer Science, V34, P119; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Reiss DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-280; Santamaria R, 2007, LECT NOTES COMPUT SC, V4881, P780; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Sheng Q, 2003, BIOINFORMATICS, V19; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Sorensen T., 1948, BIOL SKAR, V5, P1; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Tang C, 2002, BIOINF BIOENG C 2001, P41; Teng L, 2008, J SIGNAL PROCESS SYS, V50, P267, DOI 10.1007/s11265-007-0121-2; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Turner H, 2005, COMPUT STAT DATA AN, V48, P235, DOI 10.1016/j.csda.2004.02.003; Wang H., 2002, P 2002 ACM SIGMOD IN, P394, DOI DOI 10.1145/564691.564737; Wang YK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-102; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wu Chang-Jiun, 2004, Genome Inform, V15, P239; Wu CJ, 2005, NUCLEIC ACIDS RES, V33, pW596, DOI 10.1093/nar/gki469; Xiao J, 2008, J COMPUT BIOL, V15, P1275, DOI 10.1089/cmb.2007.0219; Yang J, 2005, INT J ARTIF INTELL T, V14, P771, DOI 10.1142/S0218213005002387; Yoon S, 2005, IEEE ACM T COMPUT BI, V2, P339, DOI 10.1109/TCBB.2005.55	64	74	75	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90801	10.1371/journal.pone.0090801	http://dx.doi.org/10.1371/journal.pone.0090801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651574	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800025
J	van Rijn, VM; Mooij, SH; Mollers, M; Snijders, PJF; Speksnijder, AGCL; King, AJ; de Vries, HJC; van Eeden, A; van der Klis, FRM; de Melker, HE; van der Sande, MAB; van der Loeff, MFS				van Rijn, Vera M.; Mooij, Sofie H.; Mollers, Madelief; Snijders, Peter J. F.; Speksnijder, Arjen G. C. L.; King, Audrey J.; de Vries, Henry J. C.; van Eeden, Arne; van der Klis, Fiona R. M.; de Melker, Hester E.; van der Sande, Marianne A. B.; van der Loeff, Maarten F. Schim			Anal, Penile, and Oral High-Risk HPV Infections and HPV Seropositivity in HIV-Positive and HIV-Negative Men Who Have Sex with Men	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; VIRUS-LIKE PARTICLES; AGE-SPECIFIC PREVALENCE; NATURAL-HISTORY; CAPSID ANTIBODIES; CANCER INCIDENCE; HOMOSEXUAL-MEN; UNITED-STATES; TYPE-16; WOMEN	The effects of single or multiple concordant HPV infections at various anatomical sites on type-specific HPV seropositivity are currently unknown. In this cross-sectional study we assessed whether high-risk HPV infections at various anatomical sites (i.e., anal canal, penile shaft, and oral cavity), as well as concordant infections at multiple anatomical sites, were associated with type-specific seropositivity in HIV-positive and HIV-negative MSM. MSM aged >= 18 years were recruited in Amsterdam, the Netherlands (2010-2011). Baseline anal, penile, and oral samples were analyzed for HPV DNA and genotyped using a highly sensitive PCR and reverse line blot assay. Virus-like particle (VLP) based multiplex immunoassay was used to asses HPV-specific serum antibodies against L1 VLPs. The associations between HPV infections and type-specific seropositivity of seven high-risk HPV types (7-hrHPV: types 16, 18, 31, 33, 45, 52, 58) were estimated using logistic regression analyses with generalized estimating equations. We found that 86% of 306 HIV-positive MSM and 62% of 441 HIV-negative MSM were seropositive for at least one 7-hrHPV type. 69% of HIV-positive and 41% of HIV-negative MSM were infected with at least one 7-hrHPV type at the anus, penis, or oral cavity. In multivariable analyses, 7-hrHPV seropositivity was associated with type-specific anal (and not penile) 7-hrHPV infection, and did not significantly increase with a higher number of infected anatomical sites. Oral 7-hrHPV infection showed a positive, albeit non-significant, association with seropositivity. In conclusion, seropositivity among MSM appears to be largely associated with anal HPV infection, irrespective of additionally infected anatomical sites.	[van Rijn, Vera M.; Mollers, Madelief; King, Audrey J.; de Vries, Henry J. C.; van der Klis, Fiona R. M.; de Melker, Hester E.; van der Sande, Marianne A. B.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Mooij, Sofie H.; Speksnijder, Arjen G. C. L.; de Vries, Henry J. C.; van der Loeff, Maarten F. Schim] Publ Hlth Serv Amsterdam, Amsterdam, Netherlands; [Snijders, Peter J. F.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Mooij, Sofie H.; van der Loeff, Maarten F. Schim] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [van Eeden, Arne] Jan van Goyen Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [van der Sande, Marianne A. B.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Public Health Service Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	Mooij, SH (corresponding author), Publ Hlth Serv Amsterdam, Amsterdam, Netherlands.	somooij@ggd.amsterdam.nl	Speksnijder, Arjen/M-3406-2017; de Vries, Henry/K-5963-2012	Speksnijder, Arjen/0000-0002-1966-7265; de Vries, Henry/0000-0001-9784-547X; van der Sande, Marianne AB/0000-0002-4778-6739	Aids Fonds [2009029]; Public Health Service of Amsterdam; RIVM; Netherlands National Institute for Public Health and the Environment	Aids Fonds; Public Health Service of Amsterdam; RIVM; Netherlands National Institute for Public Health and the Environment	This study was funded through a grant from the Aids Fonds (grant number 2009029) and additional funding from the Public Health Service of Amsterdam and the RIVM. The Amsterdam Cohort Studies on HIV infection and AIDS, a collaboration between the Public Health Service of Amsterdam, the Academic Medical Center of the University of Amsterdam, Sanquin Blood Supply Foundation, and the University Medical Center Utrecht, are part of the Netherlands HIV Monitoring Foundation and financially supported by the Netherlands National Institute for Public Health and the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	af Geijersstam V, 1998, J INFECT DIS, V177, P1710, DOI 10.1086/517428; Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008; Carter JJ, 1996, J INFECT DIS, V174, P927, DOI 10.1093/infdis/174.5.927; Carter JJ, 2000, J INFECT DIS, V181, P1911, DOI 10.1086/315498; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; de Gruijl TD, 1999, J GEN VIROL, V80, P399, DOI 10.1099/0022-1317-80-2-399; Edelstein ZR, 2011, J INFECT DIS, V204, P209, DOI 10.1093/infdis/jir242; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Hagensee ME, 1997, J INFECT DIS, V176, P625, DOI 10.1086/514082; Heiligenberg M, 2013, J INFECT DIS, V208, P1081, DOI 10.1093/infdis/jit295; Ho GYF, 2004, CANCER EPIDEM BIOMAR, V13, P110, DOI 10.1158/1055-9965.EPI-03-0191; Hu YF, 2013, JAIDS-J ACQ IMM DEF, V64, P103, DOI 10.1097/QAI.0b013e31829b6298; Jansen IAV, 2011, AIDS, V25, P493, DOI 10.1097/QAD.0b013e328342fbe9; Johnson LG, 2004, CANCER-AM CANCER SOC, V101, P281, DOI 10.1002/cncr.20364; Kleter B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Kreimer AR, 2004, SEX TRANSM DIS, V31, P247, DOI 10.1097/01.OLQ.0000118425.49522.2C; Lu BB, 2012, CANCER EPIDEM BIOMAR, V21, P1542, DOI 10.1158/1055-9965.EPI-12-0483; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Mooij SH, 2013, CANCER EPIDEM BIOMAR, V22, P1698, DOI 10.1158/1055-9965.EPI-13-0460; Mooij SH, 2013, AIDS, V27, P2117, DOI 10.1097/QAD.0b013e328362395c; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Paaso AE, 2011, J GEN VIROL, V92, P2034, DOI 10.1099/vir.0.032011-0; Phanuphak N, 2013, JAIDS-J ACQ IMM DEF, V63, P472, DOI 10.1097/QAI.0b013e3182918a5a; Poynten IM, 2012, SEX TRANSM DIS, V39, P726, DOI 10.1097/OLQ.0b013e31825d5cb8; Scherpenisse M, 2012, VACCINE, V30, P6686, DOI 10.1016/j.vaccine.2012.08.068; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Silverberg MJ, 2006, CLIN VACCINE IMMUNOL, V13, P511, DOI 10.1128/CVI.13.4.511-519.2006; Sirera G, 2006, AIDS, V20, P1201, DOI 10.1097/01.aids.0000226963.10342.f4; Slavinsky J, 2001, INT J STD AIDS, V12, P516, DOI 10.1258/0956462011923615; Smith JS, 2011, J ADOLESCENT HEALTH, V48, P540, DOI 10.1016/j.jadohealth.2011.03.010; Svare EI, 1997, J INFECT DIS, V176, P876, DOI 10.1086/516505; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; van Aar F, 2013, AIDS, V27, P2921, DOI 10.1097/01.aids.0000432541.67409.3c; Vriend HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060696; WIDEROFF L, 1995, J INFECT DIS, V172, P1425, DOI 10.1093/infdis/172.6.1425; Xue XN, 2010, CANCER EPIDEM BIOMAR, V19, P159, DOI 10.1158/1055-9965.EPI-09-0546	39	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92208	10.1371/journal.pone.0092208	http://dx.doi.org/10.1371/journal.pone.0092208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651691	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800084
J	Bernardo, AD; Lopes, SMCD				Bernardo, Ana de Melo; Lopes, Susana M. Chuva de Sousa			The Involvement of the Proamnion in the Development of the Anterior Amnion Fold in the Chicken	PLOS ONE			English	Article							EMBRYO; IMPLANTATION; PROLIFERATION; EVOLUTION; CULTURE; VITRO; MODEL	The amnion was one of the most important evolutionary novelties in the animal kingdom, allowing independence of water for reproduction and subsequent exploration of terrestrial habitats, and is therefore an important structure to understand evolution. We have studied chicken amniogenesis using ex ovo culture systems and 3D-reconstructions of serially sectioned chicken embryos. We provide evidence for a transient depression of the head in the proamnion, forming a pouch, that positions the extraembryonic membranes dorsal to the head and that is fundamental for the correct formation of the amnion and chorion membranes. When this "sinking" process in the proamnion was blocked, the amnion/chorion did not form, even though the growth of the embryo per se seemed unaffected. Here, we give insight in the role of the proamnion in amniogenesis.	[Bernardo, Ana de Melo; Lopes, Susana M. Chuva de Sousa] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lopes, SMCD (corresponding author), Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands.	lopes@lumc.nl		de Melo Bernardo, Ana/0000-0002-7918-5911	European Commission [Leonardo da Vinci 2011-1-PT1-LEO02-08199]; Netherlands organization of Scientific Research (NWO) [ASPASIA 015.007.037]; Interuniversity Attraction Poles-Phase VII [IUAP/PAI P7/14]	European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Interuniversity Attraction Poles-Phase VII	This research was supported by the European Commission's Lifelong Learning Programme (Leonardo da Vinci 2011-1-PT1-LEO02-08199) to AMB and by the Netherlands organization of Scientific Research (NWO) (ASPASIA 015.007.037) and the Interuniversity Attraction Poles-Phase VII (IUAP/PAI P7/14) to AMB and SMCSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSTONE FB, 1948, J MORPHOL, V83, P359, DOI 10.1002/jmor.1050830303; Beneden E. Van, 1884, Arch. Biol., Vv, P369; Bernardo AD, 2012, BIOL OPEN, V1, P1146, DOI 10.1242/bio.20122592; Blomberg L, 2008, REPRODUCTION, V135, P181, DOI 10.1530/REP-07-0355; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Ferner K, 2011, RESP PHYSIOL NEUROBI, V178, P39, DOI 10.1016/j.resp.2011.03.029; Gilbert S.F., 2010, DEV BIOL; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hirota S., 1894, Journal Coll Japan, Vvi, P337; Larsen WJ, 2001, HUMAN EMBRYOLOGY, V3; Lee KY, 2004, REPRODUCTION, V128, P679, DOI 10.1530/rep.1.00340; Lillie FR, 1903, BIOL BULL-US, V5, P92, DOI 10.2307/1535515; Mess A, 2003, J EXP ZOOL PART A, V299A, P78, DOI 10.1002/jez.a.10292; MILLER SA, 1994, ANAT RECORD, V238, P225, DOI 10.1002/ar.1092380209; Mitsukuri K., 1891, Journal of the College of Science Japan, Viv, P1; Nagai H, 2011, GENESIS, V49, P46, DOI 10.1002/dvg.20690; Nakamura Y, 2007, POULTRY SCI, V86, P2182, DOI 10.1093/ps/86.10.2182; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; NICOLET G, 1963, EXPERIENTIA, V19, P165, DOI 10.1007/BF02171616; OVERTON J, 1989, CELL TISSUE RES, V257, P141; Patten DM, 1951, EARLY EMBRYOLOGY CHI; Pereira PNG, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-48; Pourquie O, 2004, MECH DEVELOP, V121, P1069, DOI 10.1016/j.mod.2004.05.002; RASWEILER JJ, 1979, J REPROD FERTIL, V56, P403; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Romanoff A., 1960, THE AVIAN EMBRYO, V1, P429; ROSENQUIST GC, 1971, DEV BIOL, V26, P323, DOI 10.1016/0012-1606(71)90131-X; Sheng GJ, 2010, INT J DEV BIOL, V54, P1033, DOI 10.1387/ijdb.103105gs; Shore T. W., 1889, Journal of Anatomy and Physiology, Vxxiv, P1; SMITH SM, 1994, DEV DYNAM, V200, P14, DOI 10.1002/aja.1002000103; Soukup V, 2013, J ANAT, V222, P79, DOI 10.1111/j.1469-7580.2012.01540.x; Stern CD, 1997, INT J DEV BIOL, V41, P379; Tipping N, 2011, ANAT REC, V294, P1143, DOI 10.1002/ar.21407; WATERMAN RE, 1980, ANAT RECORD, V197, P441, DOI 10.1002/ar.1091970408; [No title captured]	36	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92672	10.1371/journal.pone.0092672	http://dx.doi.org/10.1371/journal.pone.0092672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647352	Green Published, gold			2022-12-27	WOS:000333348500151
J	Bieg, M; Goetz, T; Lipnevich, AA				Bieg, Madeleine; Goetz, Thomas; Lipnevich, Anastasiya A.			What Students Think They Feel Differs from What They Really Feel - Academic Self-Concept Moderates the Discrepancy between Students' Trait and State Emotional Self-Reports	PLOS ONE			English	Article							EXPERIENCE; ACHIEVEMENT; PERSONALITY; BELIEF; RECALL; DOMAIN; BIAS	This study investigated whether there is a discrepancy pertaining to trait and state academic emotions and whether self-concept of ability moderates this discrepancy. A total of 225 secondary school students from two different countries enrolled in grades 8 and 11 (German sample; n = 94) and grade 9 (Swiss sample; n = 131) participated. Students' trait academic emotions of enjoyment, pride, anger, and anxiety in mathematics were assessed with a self-report questionnaire, whereas to assess their state academic emotions experience-sampling method was employed. The results revealed that students' scores on the trait assessment of emotions were generally higher than their scores on the state assessment. Further, as expected, students' academic self-concept in the domain of mathematics was shown to partly explain the discrepancy between scores on trait and state emotions. Our results indicate that there is a belief-driven discrepancy between what students think they feel (trait assessment) and what they really feel (state assessment). Implications with regard to the assessment of self-reported emotions in future studies and practical implications for the school context are discussed.	[Bieg, Madeleine; Goetz, Thomas] Univ Konstanz, Dept Empir Educ Res, Constance, Germany; [Bieg, Madeleine; Goetz, Thomas] Thurgau Univ Teacher Educ, Kreuzlingen, Switzerland; [Lipnevich, Anastasiya A.] CUNY, Queens Coll, Div Educ, New York, NY 10021 USA; [Lipnevich, Anastasiya A.] CUNY, Grad Ctr, New York, NY USA	University of Konstanz; City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System	Bieg, M (corresponding author), Univ Konstanz, Dept Empir Educ Res, Constance, Germany.	madeleine.bieg@uni-konstanz.de		Goetz, Thomas/0000-0002-8908-2166	Swiss National Science Foundation (SNSF) [100014_131713/1]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This research was supported by a grant from the Swiss National Science Foundation (SNSF) to the second author (Structure and Antecedents of Academic Emotions: Longitudinal Analyses on Habitual and State Emotions Across and Within School Domains; 100014_131713/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinis Herman, 2013, J MANAGE, V20, P1, DOI DOI 10.1177/0149206313478188.ANDREASSEN; Allen PA, 2008, HBK BEHAV NEUROSCI, V18, P115, DOI 10.1016/S1569-7339(08)00208-7; Barrett LF, 1997, PERS SOC PSYCHOL B, V23, P1100, DOI 10.1177/01461672972310010; Buehler R, 2001, PERS SOC PSYCHOL B, V27, P1480, DOI 10.1177/01461672012711009; Christensen TC, 2003, PERS SOC PSYCHOL B, V29, P51, DOI 10.1177/0146167202238371; Conner TS, 2012, PSYCHOSOM MED, V74, P327, DOI 10.1097/PSY.0b013e3182546f18; Durlak JA, 2011, CHILD DEV, V82, P405, DOI 10.1111/j.1467-8624.2010.01564.x; Eccles JS., 1985, GIFTED TALENTED DEV, P251; Efklides A, 2005, LEARN INSTR, V15, P377, DOI 10.1016/j.learninstruc.2005.07.006; Ellis A., 1999, J RATIONAL EMOTIVE C, V17, P69, DOI [DOI 10.1023/A:1023048830350, 10.1023/A:1023048830350]; Goetz T., 2013, INT GUIDE STUDENT AC, P192, DOI DOI 10.1037/0893-3200.10.3.243; Goetz T., 2003, LEARNING EMOTIONS IN; Goetz T, 2007, J EDUC PSYCHOL, V99, P715, DOI 10.1037/0022-0663.99.4.715; Goetz T, 2006, BRIT J EDUC PSYCHOL, V76, P289, DOI 10.1348/000709905X42860; Goetz T, 2013, PSYCHOL SCI, V24, P2079, DOI 10.1177/0956797613486989; Goetz T, 2010, MOTIV EMOTION, V34, P49, DOI 10.1007/s11031-009-9152-2; Gogol K, 2013, 14 C ED PSYCH GROUP; Guindon GE, 2012, INT J METH PSYCH RES, V21, P29, DOI 10.1002/mpr.1346; Hall NC, 2007, LEARN INDIVID DIFFER, V17, P280, DOI 10.1016/j.lindif.2007.04.002; Hektner JM, 2007, EXPERIENCE SAMPLING; Levine LJ, 2009, APPL COGNITIVE PSYCH, V23, P1059, DOI 10.1002/acp.1610; Linnenbrink EA, 2006, EDUC PSYCHOL REV, V18, P307, DOI 10.1007/s10648-006-9028-x; Linnenbrink-Garcia L, 2011, CONTEMP EDUC PSYCHOL, V36, P1, DOI 10.1016/j.cedpsych.2010.11.004; Ludtke Oliver., 2007, LEARNING ENVIRON RES, V9, P215, DOI [10.1007/s10984-006-9014-8, DOI 10.1007/S10984-006-9014-8]; MacCann C, 2012, J PSYCHOEDUC ASSESS, V30, P315, DOI 10.1177/0734282912449438; Marsh HW, 1990, 2 THEORETICAL EMPIRI; MCFARLAND C, 1989, J PERS SOC PSYCHOL, V57, P522, DOI 10.1037/0022-3514.57.3.522; Molenaar PCM, 2009, CURR DIR PSYCHOL SCI, V18, P112, DOI 10.1111/j.1467-8721.2009.01619.x; Mulligan K, 2012, EMOT REV, V4, P345, DOI 10.1177/1754073912445818; Naemi B, 2013, OXFORD HDB CHILD PSY; Nagengast B, 2012, J ED PSYCHOL; Nett UE, 2011, CONTEMP EDUC PSYCHOL, V36, P49, DOI 10.1016/j.cedpsych.2010.10.003; O'Mara AJ, 2006, EDUC PSYCHOL-US, V41, P181, DOI 10.1207/s15326985ep4103_4; Op't Eynde P., 2007, EMOTION ED EDS, P185, DOI DOI 10.1016/B978-012372545-5/50012-5; Partnership for 21st Century Skills, 2006, RES MATT 21 CENT SKI; Pekrun R, 2002, EDUC PSYCHOL-US, V37, P91, DOI 10.1207/S15326985EP3702_4; Pekrun R, 2006, EDUC PSYCHOL REV, V18, P315, DOI 10.1007/s10648-006-9029-9; Pekrun R, 2011, CONTEMP EDUC PSYCHOL, V36, P36, DOI 10.1016/j.cedpsych.2010.10.002; Peyton J, 2008, POSITIVE IMPACT SOCI; Porter LS, 2000, J SOC CLIN PSYCHOL, V19, P480, DOI 10.1521/jscp.2000.19.4.480; Raudenbush SW, 2009, HLM 6 08 HIERARCHICA; Robbins SB, 2009, J APPL PSYCHOL, V94, P1163, DOI 10.1037/a0015738; Robinson MD, 2002, PSYCHOL BULL, V128, P934, DOI 10.1037//0033-2909.128.6.934; Robinson MD, 2010, SELF IDENTITY, V9, P87, DOI 10.1080/15298860902728274; Safer MA, 2002, PERS SOC PSYCHOL B, V28, P1495, DOI 10.1177/014616702237577; Scherer K.R., 1984, APPROACHES EMOTION, P293; Schutz PA, 2002, EDUC PSYCHOL, V37, P67, DOI 10.1207/S15326985EP3702_1; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; van den Brink M, 2001, HEADACHE, V41, P11, DOI 10.1046/j.1526-4610.2001.111006011.x; Wanous JP, 1997, J APPL PSYCHOL, V82, P247, DOI 10.1037/0021-9010.82.2.247; Wigfield A., 2002, BIOL SOC BEHAV DEV S; Wilson TD, 2005, CURR DIR PSYCHOL SCI, V14, P131, DOI 10.1111/j.0963-7214.2005.00355.x; Wirtz D, 2003, PSYCHOL SCI, V14, P520, DOI 10.1111/1467-9280.03455	53	40	43	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92563	10.1371/journal.pone.0092563	http://dx.doi.org/10.1371/journal.pone.0092563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24647760	Green Published, gold			2022-12-27	WOS:000333348500144
J	Shcherbik, SV; Pearce, NC; Levine, ML; Klimov, AI; Villanueva, JM; Bousse, TL				Shcherbik, Svetlana V.; Pearce, Nicholas C.; Levine, Marnie L.; Klimov, Alexander I.; Villanueva, Julie M.; Bousse, Tatiana L.			Rapid Strategy for Screening by Pyrosequencing of Influenza Virus Reassortants - Candidates for Live Attenuated Vaccines	PLOS ONE			English	Article							GENOME COMPOSITION; INACTIVATED VACCINES; RESTRICTION ANALYSIS; WILD-TYPE; H3N2; PCR; EFFICACY; H1N1; RECOMBINANTS; RESISTANCE	Background: Live attenuated influenza vaccine viruses (LAIVs) can be generated by classical reassortment of gene segments between a cold adapted, temperature sensitive and attenuated Master Donor Virus (MDV) and a seasonal wild-type (wt) virus. The vaccine candidates contain hemagglutinin (HA) and neuraminidase (NA) genes derived from the circulating wt viruses and the remaining six genes derived from the MDV strains. Rapid, efficient selection of the viruses with 6: 2 genome compositions from the large number of genetically different viruses generated during reassortment is essential for the biannual production schedule of vaccine viruses. Methodology/Principal Findings: This manuscript describes a new approach for the genotypic analysis of LAIV reassortant virus clones based on pyrosequencing. LAIV candidate viruses were created by classical reassortment of seasonal influenza A (H3N2) (A/Victoria/361/2011, A/Ohio/02/2012, A/Texas/50/2012) or influenza A (H7N9) (A/Anhui/1/2013) wt viruses with the MDV A/Leningrad/134/17/57(H2N2). Using strain-specific pyrosequencing assays, mixed gene variations were detected in the allantoic progenies during the cloning procedure. The pyrosequencing analysis also allowed for estimation of the relative abundance of segment variants in mixed populations. This semi-quantitative approach was used for selecting specific clones for the subsequent cloning procedures. Conclusions/Significance: The present study demonstrates that pyrosequencing analysis is a useful technique for rapid and reliable genotyping of reassortants and intermediate clones during the preparation of LAIV candidates, and can expedite the selection of vaccine virus candidates.	[Shcherbik, Svetlana V.; Pearce, Nicholas C.; Levine, Marnie L.; Klimov, Alexander I.; Villanueva, Julie M.; Bousse, Tatiana L.] Ctr Dis Control & Prevent, Virol Surveillance & Diag Branch, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Shcherbik, Svetlana V.; Pearce, Nicholas C.; Levine, Marnie L.] Battelle Mem Inst, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Bousse, TL (corresponding author), Ctr Dis Control & Prevent, Virol Surveillance & Diag Branch, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	tbousse@cdc.gov		Pearce, Neil/0000-0002-9938-7852	U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (HHS BARDA)	U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (HHS BARDA)	The research study was supported by U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (HHS BARDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson ME, 2005, J CLIN VIROL, V33, P25, DOI 10.1016/j.jcv.2004.09.022; ALEKSANDROVA GI, 1977, VOP VIRUSOL+, P387; Alexandrova GIK, 1994, LIVE INFLUENZA VACCI; Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P67, DOI 10.1111/j.1750-2659.2010.00183.x; An WQ, 2009, CHINESE MED J-PEKING, V122, P2880, DOI 10.3760/cma.j.issn.0366-6999.2009.23.015; Arvia R, 2012, J VIROL METHODS, V184, P113, DOI 10.1016/j.jviromet.2012.05.018; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Cha TA, 1997, ANAL BIOCHEM, V252, P24, DOI 10.1006/abio.1997.2269; COUCH RB, 1993, ANN NY ACAD SCI, V685, P803, DOI 10.1111/j.1749-6632.1993.tb35946.x; COX NJ, 1979, VIROLOGY, V97, P190, DOI 10.1016/0042-6822(79)90386-6; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Deng YM, 2013, J CLIN VIROL, V58, P94, DOI 10.1016/j.jcv.2013.04.018; Deng YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023400; Desheva JA, 2006, VACCINE, V24, P6859, DOI 10.1016/j.vaccine.2006.06.023; Desheva Yu. A., 2007, Voprosy Virusologii, V52, P16; Deyde VM, 2009, ANTIVIR RES, V81, P16, DOI 10.1016/j.antiviral.2008.08.008; Duwe S, 2008, J VIROL METHODS, V153, P134, DOI 10.1016/j.jviromet.2008.07.017; Duwe SC, 2011, ANTIVIR RES, V89, P115, DOI 10.1016/j.antiviral.2010.11.001; EDWARDS KM, 1994, J INFECT DIS, V169, P68, DOI 10.1093/infdis/169.1.68; Elahi E, 2003, J VIROL METHODS, V109, P171, DOI 10.1016/S0166-0934(03)00068-5; Fulvini AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020823; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; GHENDON YZ, 1981, J GEN VIROL, V53, P215, DOI 10.1099/0022-1317-53-2-215; GHENDON YZ, 1984, INFECT IMMUN, V44, P730, DOI 10.1128/IAI.44.3.730-733.1984; Ha SH, 2006, J VIROL METHODS, V134, P154, DOI 10.1016/j.jviromet.2005.12.011; Kendal AP, 1997, EUR J EPIDEMIOL, V13, P591, DOI 10.1023/A:1007327505862; KENDAL AP, 1977, J GEN VIROL, V37, P145, DOI 10.1099/0022-1317-37-1-145; Kiseleva I V, 2011, Mol Gen Mikrobiol Virusol, P29; Kiseleva IV, 2011, VOP VIRUSOL+, V56, P28; Kiseleva I. V., 2007, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P40; KLIMOV AI, 1992, VIROLOGY, V186, P795, DOI 10.1016/0042-6822(92)90050-Y; KLIMOV AI, 1995, J VIROL METHODS, V52, P41, DOI 10.1016/0166-0934(94)00133-2; Lee EY, 2010, J VIROL METHODS, V165, P133, DOI 10.1016/j.jviromet.2009.10.022; Levine M, 2011, J CLIN MICROBIOL, V49, P1307, DOI 10.1128/JCM.02424-10; MEDVEDEVA TE, 1983, ACTA VIROL, V27, P311; Mello FCA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-96; Nichol KL, 2006, J INFECT DIS, V194, pS111, DOI 10.1086/507544; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Poon LLM, 2010, CLIN CHEM, V56, P1340, DOI 10.1373/clinchem.2010.149179; Rudenko L, 2011, VACCINE, V29, pA40, DOI 10.1016/j.vaccine.2011.04.122; Rudenko LG, 1996, B WORLD HEALTH ORGAN, V74, P77; Sakamoto S, 1996, J VIROL METHODS, V56, P161, DOI 10.1016/0166-0934(95)01909-X; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; SMORODINTSEN AA, 1965, IND MED SURG, V34, P53; TREANOR JJ, 1992, ANN INTERN MED, V117, P625, DOI 10.7326/0003-4819-117-8-625; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Vodeiko GM, 2003, VACCINE, V21, P3867, DOI 10.1016/S0264-410X(03)00312-8; Wareing MD, 2002, VACCINE, V20, P2082, DOI 10.1016/S0264-410X(02)00056-7; Watanabe T, 2013, NATURE; WHO, 2011, MAN LAB DIAGN VIR SU; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379	51	12	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92580	10.1371/journal.pone.0092580	http://dx.doi.org/10.1371/journal.pone.0092580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647786	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500147
J	Tamagnini, F; Scullion, S; Brown, JT; Randall, AD				Tamagnini, Francesco; Scullion, Sarah; Brown, Jonathan T.; Randall, Andrew D.			Low Concentrations of the Solvent Dimethyl Sulphoxide Alter Intrinsic Excitability Properties of Cortical and Hippocampal Pyramidal Cells	PLOS ONE			English	Article							NEUROTOXICITY; INFUSION; PLASTICITY	Dimethylsulfoxide (DMSO) is a widely used solvent in biology. It has many applications perhaps the most common of which is in aiding the preparation of drug solutions from hydrophobic chemical entities. Recent studies have suggested that this molecule may be able to induce apoptosis in neural tissues urging caution regarding its introduction into humans, for example as part of stem cell transplants. Here we have used in vitro electrophysiological methods applied to murine brain slices to examine whether a few hours treatment with 0.05% DMSO (a concentration regarded by many as innocuous) alters intrinsic excitability properties of neurones. We investigated pyramidal neurones in two distinct brain regions, namely area CA1 of the hippocampus and layer 2 of perirhinal cortex. In the former there was no effect on resting potential but input resistance was decreased by DMSO pre-treatment. In line with this action potential count for any level of depolarizing current stimulus was reduced by similar to 25% following DMSO treatment. I-h-mediated "sag" was also increased in CA1 pyramids and action potential waveform analysis demonstrated that DMSO treatment moved action potential threshold towards resting potential. In perirhinal cortex a decreased action potential output for various depolarizing current stimuli was also seen. In these cells action potential threshold was unaltered by DMSO but a significant increase in action potential width was apparent. These data indicate that pre-treatment with this widely employed solvent can elicit multifaceted neurophysiological changes in mammalian neurones at concentrations below those frequently encountered in the published literature.	[Tamagnini, Francesco; Scullion, Sarah; Brown, Jonathan T.; Randall, Andrew D.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Tamagnini, Francesco; Brown, Jonathan T.; Randall, Andrew D.] Univ Exeter, Inst Biomed & Clin Sci, Sch Med, Exeter, Devon, England	University of Bristol; University of Exeter	Randall, AD (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	A.D.Randall@Bristol.ac.uk		Brown, Jonathan T/0000-0001-5269-7661; Randall, Andrew/0000-0001-8852-3671; Tamagnini, Francesco/0000-0002-8741-5094	Medical Research Council (UK); Alzheimers Research UK [ARUK-SRF2012-6] Funding Source: researchfish; Medical Research Council [G1100623] Funding Source: researchfish; MRC [G1100623] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council (UK) who provided funds for staff salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Authier N, 2002, TOXICOL LETT, V132, P117, DOI 10.1016/S0378-4274(02)00052-8; Bliss T., 2007, HIPPOCAMPUS BOOK, P133; Brown JT, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.025; Brown JT, 2009, J PHYSIOL-LONDON, V587, P1265, DOI 10.1113/jphysiol.2008.167007; Chen YJ, 2012, ALCOHOL CLIN EXP RES, V36, P2036, DOI 10.1111/j.1530-0277.2012.01826.x; FOSSOM LH, 1985, NEUROTOXICOLOGY, V6, P17; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Hanslick JL, 2009, NEUROBIOL DIS, V34, P1, DOI 10.1016/j.nbd.2008.11.006; Higman MA, 2000, BONE MARROW TRANSPL, V26, P797, DOI 10.1038/sj.bmt.1702589; Hoyt R, 2000, BONE MARROW TRANSPL, V25, P1285, DOI 10.1038/sj.bmt.1702443; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Junior AM, 2008, BONE MARROW TRANSPL, V41, P95, DOI 10.1038/sj.bmt.1705883; Kealy J, 2011, PROG NEUROBIOL, V93, P522, DOI 10.1016/j.pneurobio.2011.03.002; KEUNG YK, 1994, BONE MARROW TRANSPL, V14, P363; Mueller LP, 2007, EUR J HAEMATOL, V78, P527, DOI 10.1111/j.1600-0609.2007.00851.x; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Navaroli VL, 2012, HIPPOCAMPUS, V22, P1392, DOI 10.1002/hipo.20975; Novarino G, 2004, J NEUROSCI, V24, P5322, DOI 10.1523/JNEUROSCI.1170-04.2004; Randall AD, 2012, NEUROBIOL AGING, V33, P2715, DOI 10.1016/j.neurobiolaging.2011.12.030; Renner S, 2011, FUTURE MED CHEM, V3, P751, DOI [10.4155/fmc.11.15, 10.4155/FMC.11.15]; STYLER MJ, 1992, BONE MARROW TRANSPL, V10, P435; Szabo I, 2010, FEBS LETT, V584, P2049, DOI 10.1016/j.febslet.2010.01.038; Tateno T, 2011, J NEUROPHYSIOL, V106, P1901, DOI 10.1152/jn.00162.2011; Windrum P, 2005, BONE MARROW TRANSPL, V36, P601, DOI 10.1038/sj.bmt.1705100; Windrum P, 2003, BONE MARROW TRANSPL, V31, P315, DOI 10.1038/sj.bmt.1703848; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008; Yu ZW, 1998, MOL MEMBR BIOL, V15, P59, DOI 10.3109/09687689809027519	27	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92557	10.1371/journal.pone.0092557	http://dx.doi.org/10.1371/journal.pone.0092557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647720	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000333348500143
J	Tang, DL; Lee, J; Muirhead, L; Li, TY; Qu, LR; Yu, J; Perera, F				Tang, Deliang; Lee, Joan; Muirhead, Loren; Li, Ting Yu; Qu, Lirong; Yu, Jie; Perera, Frederica			Molecular and Neurodevelopmental Benefits to Children of Closure of a Coal Burning Power Plant in China	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; NEUROTROPHIC FACTOR; PRENATAL EXPOSURE; BDNF; LTP; AIR; PHOSPHORYLATION; EXPRESSION; POLLUTANTS; PLASTICITY	Polycyclic aromatic hydrocarbons (PAH) are major toxic air pollutants released during incomplete combustion of coal. PAH emissions are especially problematic in China because of their reliance on coal-powered energy. The prenatal period is a window of susceptibility to neurotoxicants. To determine the health benefits of reducing air pollution related to coal-burning, we compared molecular biomarkers of exposure and preclinical effects in umbilical cord blood to neurodevelopmental outcomes from two successive birth cohorts enrolled before and after a highly polluting, coal-fired power plant in Tongliang County, China had ceased operation. Women and their newborns in the two successive cohorts were enrolled at the time of delivery. We measured PAH-DNA adducts, a biomarker of PAH-exposure and DNA damage, and brain-derived neurotrophic factor (BDNF), a protein involved in neuronal growth, in umbilical cord blood. At age two, children were tested using the Gesell Developmental Schedules (GDS). The two cohorts were compared with respect to levels of both biomarkers in cord blood as well as developmental quotient (DQ) scores across 5 domains. Lower levels of PAH-DNA adducts, higher concentrations of the mature BDNF protein (mBDNF) and higher DQ scores were seen in the 2005 cohort enrolled after closure of the power plant. In the two cohorts combined, PAH-DNA adducts were inversely associated with mBDNF as well as scores for motor (p = 0.05), adaptive (p = 0.022), and average (p = 0.014) DQ. BDNF levels were positively associated with motor (p = 0.018), social (p = 0.001), and average (p = 0.017) DQ scores. The findings indicate that the closure of a coal-burning plant resulted in the reduction of PAH-DNA adducts in newborns and increased mBDNF levels that in turn, were positively associated with neurocognitive development. They provide further evidence of the direct benefits to children's health as a result of the coal plant shut down, supporting clean energy and environmental policies in China and elsewhere.	[Tang, Deliang; Lee, Joan; Muirhead, Loren; Qu, Lirong; Yu, Jie; Perera, Frederica] Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA; [Li, Ting Yu] Chongqing Med Univ, Dept Pediat, Chongqing, Peoples R China	Columbia University; Chongqing Medical University	Tang, DL (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA.	dt14@columbia.edu		Perera, Frederica/0000-0002-1364-9250	Energy Foundation; Rockefeller Brothers Fund; Schmidt Foundation	Energy Foundation; Rockefeller Brothers Fund; Schmidt Foundation	This study was supported by the Energy Foundation, the Rockefeller Brothers Fund and the Schmidt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, WADE EC MOD CHIN WOR; Balkowiec A, 2002, J NEUROSCI, V22, P10399; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chow JC, 2006, J ENVIRON SCI HEAL A, V41, P517, DOI 10.1080/10934520600564253; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Edwards SC, 2010, ENVIRON HEALTH PERSP, V118, P1326, DOI 10.1289/ehp.0901070; Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000; Godschalk RWL, 2003, J BIOCHEM MOL BIOL, V36, P1; Gomez-Pinilla F, 2005, EXP NEUROL, V192, P235, DOI 10.1016/j.expneurol.2004.12.001; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Haapasalo A, 2002, J BIOL CHEM, V277, P43160, DOI 10.1074/jbc.M205202200; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hudon L, 1998, AM J OBSTET GYNECOL, V179, P858, DOI 10.1016/S0002-9378(98)70178-4; Jedrychowski Wieslaw, 2003, Int J Occup Med Environ Health, V16, P21; Kandel ER, 2004, BIOSCIENCE REP, V24, P475, DOI 10.1007/s10540-005-2742-7; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Li Z, 2012, TOXICOL SCI, V125, P233, DOI 10.1093/toxsci/kfr261; LIJINSKY W, 1991, MUTAT RES, V259, P251, DOI 10.1016/0165-1218(91)90121-2; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Millman A, 2008, PEDIATRICS, V122, P620, DOI 10.1542/peds.2007-3143; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Neeley EW, 2011, NEUROSCIENCE, V187, P24, DOI 10.1016/j.neuroscience.2011.03.065; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Perera F, 2012, ENVIRON RES, V114, P40, DOI 10.1016/j.envres.2011.12.011; Perera FP, 2004, ENVIRON HEALTH PERSP, V112, P1133, DOI 10.1289/ehp.6833; Perera F, 2008, ENVIRON HEALTH PERSP, V116, P1396, DOI 10.1289/ehp.11480; Perera FP, 2006, ENVIRON HEALTH PERSP, V114, P1287, DOI 10.1289/ehp.9084; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Sarsour K, 2011, J INT NEUROPSYCH SOC, V17, P120, DOI 10.1017/S1355617710001335; Sheng L, 2010, TOXICOL SCI, V118, P625, DOI 10.1093/toxsci/kfq304; Su TC, 2006, EUR J CARDIOV PREV R, V13, P849, DOI 10.1097/01.hjr.0000219116.25415.c4; Tang DL, 2008, ENVIRON HEALTH PERSP, V116, P674, DOI 10.1289/ehp.10471; Toledo-Rodriguez M, 2010, AM J MED GENET B, V153B, P1350, DOI 10.1002/ajmg.b.31109; Wormley DD, 2004, CELL MOL BIOL, V50, P715; Wormley DD, 2004, TOXICOL APPL PHARM, V197, P49, DOI 10.1016/j.taap.2004.01.016; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yeh CM, 2012, J PHYSIOL-LONDON, V590, P991, DOI 10.1113/jphysiol.2011.222042; Zhang JF, 2010, LANCET, V375, P1110, DOI 10.1016/S0140-6736(10)60062-1	42	36	37	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91966	10.1371/journal.pone.0091966	http://dx.doi.org/10.1371/journal.pone.0091966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647528	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500064
J	Vigil, JM; Strenth, C; Trujillo, T; Gangestad, SW				Vigil, Jacob M.; Strenth, Chance; Trujillo, Tiffany; Gangestad, Steven W.			Fluctuating Experimental Pain Sensitivities across the Menstrual Cycle Are Contingent on Women's Romantic Relationship Status	PLOS ONE			English	Article							SEX-DIFFERENCES; MODULATION; OXYTOCIN; PERCEPTION; HORMONES; PREFERENCES; ATTENTION; SPOUSE; MODEL; STIMULATION	We explored the social-signaling hypothesis that variability in exogenous pain sensitivities across the menstrual cycle is moderated by women's current romantic relationship status and hence the availability of a solicitous social partner for expressing pain behaviors in regular, isochronal ways. In two studies, we used the menstrual calendars of healthy women to provide a detailed approximation of the women's probability of conception based on their current cycle-day, along with relationship status, and cold pressor pain and ischemic pain sensitivities, respectively. In the first study (n = 135; 18-46 yrs., M-age = 23 yrs., 50% natural cycling), we found that naturally-cycling, pair-bonded women showed a positive correlation between the probability of conception and ischemic pain intensity (r = .45), associations not found for single women or hormonal contraceptive-users. A second study (n = 107; 19-29 yrs., M-age = 20 yrs., 56% natural cycling) showed a similar association between greater conception risk and higher cold-pressor pain intensity in naturally-cycling, pair-bonded women only (r = .63). The findings show that variability in exogenous pain sensitivities across different fertility phases of the menstrual cycle is contingent on basic elements of women's social environment and inversely correspond to variability in naturally occurring, perimenstrual symptoms. These findings have wide-ranging implications for: a) standardizing pain measurement protocols; b) understanding basic biopsychosocial pain-related processes; c) addressing clinical pain experiences in women; and d) understanding how pain influences, and is influenced by, social relationships.	[Vigil, Jacob M.; Strenth, Chance; Trujillo, Tiffany; Gangestad, Steven W.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	University of New Mexico	Vigil, JM (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	vigilJ@unm.edu		Gangestad, Steven/0000-0002-8879-4348; Strenth, Chance/0000-0002-8921-3525	Research Allocations Committee Grant from the University of New Mexico	Research Allocations Committee Grant from the University of New Mexico	The research was supported by a Research Allocations Committee Grant from the University of New Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER G, 1993, BIOL PSYCHIAT, V34, P687, DOI 10.1016/0006-3223(93)90041-B; AMICO JA, 1981, J CLIN ENDOCR METAB, V52, P988, DOI 10.1210/jcem-52-5-988; Anderberg UM, 2000, Z RHEUMATOL, V59, P373, DOI 10.1007/s003930070045; Bartley EJ, 2013, CLIN J PAIN, V29, P154, DOI 10.1097/AJP.0b013e31824c5edb; BLOCK AR, 1980, PAIN, V9, P243, DOI 10.1016/0304-3959(80)90011-1; Bressan P, 2008, PSYCHOL SCI, V19, P145, DOI 10.1111/j.1467-9280.2008.02060.x; Cano A, 2008, CLIN J PAIN, V24, P678, DOI 10.1097/AJP.0b013e31816753d8; Cano A, 2010, PAIN, V149, P9, DOI 10.1016/j.pain.2009.10.010; Chan SCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040215; Craig KD, 2010, J PAIN, V11, P101, DOI 10.1016/j.jpain.2009.08.008; Craig KD, 2009, CAN PSYCHOL, V50, P22, DOI 10.1037/a0014772; Davydov DM, 2007, J PSYCHOSOM RES, V62, P321, DOI 10.1016/j.jpsychores.2006.10.021; de Tommaso M, 2009, J HEADACHE PAIN, V10, P423, DOI 10.1007/s10194-009-0150-2; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Evans JJ, 2003, HUM REPROD, V18, P1428, DOI 10.1093/humrep/deg291; Fillingim RB, 2003, CLIN J PAIN, V19, P217, DOI 10.1097/00002508-200307000-00004; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; FLOR H, 1987, J PSYCHOSOM RES, V31, P251, DOI 10.1016/0022-3999(87)90082-1; French L, 2005, AM FAM PHYSICIAN, V71, P285; Gangestad SW, 1998, P ROY SOC B-BIOL SCI, V265, P927, DOI 10.1098/rspb.1998.0380; Garver-Apgar CE, 2008, EVOL HUM BEHAV, V29, P223, DOI 10.1016/j.evolhumbehav.2007.12.007; Gingnell M, 2012, HORM BEHAV, V62, P400, DOI 10.1016/j.yhbeh.2012.07.005; Iacovides S, 2013, J PAIN, V13, P973; Kallai I, 2004, PAIN, V112, P142, DOI 10.1016/j.pain.2004.08.008; Kerns RD, 2002, ANN BEHAV MED, V24, P100, DOI 10.1207/S15324796ABM2402_06; Kowalczyk WJ, 2010, J PAIN, V11, P330, DOI 10.1016/j.jpain.2009.08.004; Kuba T, 2005, BRAIN RES BULL, V66, P179, DOI 10.1016/j.brainresbull.2005.05.009; Lariviere C, 2013, CLIN J PAIN, V29, P265, DOI 10.1097/AJP.0b013e318250ed6f; Larson CM, 2013, HORM BEHAV, V63, P128, DOI 10.1016/j.yhbeh.2012.10.005; Lautenbacher S, 1999, PSYCHOSOM MED, V61, P822, DOI 10.1097/00006842-199911000-00015; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; LEVINE FM, 1991, PAIN, V44, P69, DOI 10.1016/0304-3959(91)90149-R; Lukaszewski AW, 2009, PERS INDIV DIFFER, V47, P191, DOI 10.1016/j.paid.2009.02.019; MacGregor EA, 2004, NEUROLOGY, V63, P351, DOI 10.1212/01.WNL.0000133134.68143.2E; Macrae CN, 2002, PSYCHOL SCI, V13, P532, DOI 10.1111/1467-9280.00493; McClelland LE, 2008, J BEHAV MED, V31, P413, DOI 10.1007/s10865-008-9163-6; Mitchell LA, 2004, J PAIN, V5, P233, DOI 10.1016/j.jpain.2004.03.004; Moseley GL, 2004, EXP BRAIN RES, V156, P64, DOI 10.1007/s00221-003-1766-0; Newton-John TRO, 2002, PAIN REV, V9, P7, DOI 10.1191/0968130202pr186ra; NORBECK JS, 1981, NURS RES, V30, P264; NORBECK JS, 1983, NURS RES, V32, P4; Okifuji A, 2006, J PAIN, V7, P851, DOI 10.1016/j.jpain.2006.04.005; Orbach-Zinger S, 2012, ANESTH ANALG, V114, P654, DOI 10.1213/ANE.0b013e318241f4f3; Ossewaarde L, 2013, HUM BRAIN MAPP, V34, P1187, DOI 10.1002/hbm.21502; Pawlowski B, 2005, BIOL PSYCHOL, V70, P38, DOI 10.1016/j.biopsycho.2005.02.002; Pud D, 2009, NEUROSCI LETT, V467, P237, DOI 10.1016/j.neulet.2009.10.048; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rezaii T, 2012, J PAIN, V13, P646, DOI 10.1016/j.jpain.2012.04.002; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Ring C, 2009, BIOL PSYCHOL, V81, P189, DOI 10.1016/j.biopsycho.2009.04.004; Romano JM, 1995, PAIN, V63, P353, DOI 10.1016/0304-3959(95)00062-3; Romano JM, 2000, BEHAV THER, V31, P415, DOI 10.1016/S0005-7894(00)80023-4; Romano JM, 2009, J BEHAV MED, V32, P558, DOI 10.1007/s10865-009-9234-3; Romans S, 2012, GENDER MED, V9, P361, DOI 10.1016/j.genm.2012.07.003; Roney JR, 2008, HORM BEHAV, V53, P14, DOI 10.1016/j.yhbeh.2007.09.008; Ruau D, 2012, J PAIN, V13, P228, DOI 10.1016/j.jpain.2011.11.002; Senior C, 2007, INT J PSYCHOPHYSIOL, V63, P186, DOI 10.1016/j.ijpsycho.2006.03.009; Stening K, 2007, AM J PHYSIOL-REG I, V293, pR1711, DOI 10.1152/ajpregu.00127.2007; Teepker M, 2010, NEUROPSYCHOBIOLOGY, V61, P131, DOI 10.1159/000279303; Tousignant-Laflamme Y, 2009, PAIN, V146, P47, DOI 10.1016/j.pain.2009.06.018; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Uryvaev YV, 1996, B EXP BIOL MED+, V122, P1071, DOI 10.1007/BF02447648; Van Damme S, 2004, PAIN, V111, P392, DOI 10.1016/j.pain.2004.07.022; Veldhuijzen DS, 2013, PAIN, V154, P548, DOI 10.1016/j.pain.2012.12.019; Vervoort T, 2008, PAIN, V138, P277, DOI 10.1016/j.pain.2007.12.013; Vetvik KG, 2010, J HEADACHE PAIN, V11, P87, DOI 10.1007/s10194-010-0197-0; Vigil JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078663; Vigil JM, 2011, PAIN, V152, P2125, DOI 10.1016/j.pain.2011.05.019; Vigil JM, 2009, BEHAV BRAIN SCI, V32, P375, DOI 10.1017/S0140525X09991075; Vigil JM, 2009, BEHAV BRAIN SCI, V32, P408, DOI 10.1017/S0140525X09990999; Vigil JM, WORLD J ANE IN PRESS; Vigil JM, PAIN RES MANAG; von Baeyer CL, 2005, J PAIN, V6, P218, DOI 10.1016/j.jpain.2005.01.349; Wang YL, 2013, NEUROPEPTIDES, V47, P93, DOI 10.1016/j.npep.2012.12.003; Wiech K, 2005, NEUROIMAGE, V27, P59, DOI 10.1016/j.neuroimage.2005.03.044; Wilcox AJ, 2001, CONTRACEPTION, V63, P211, DOI 10.1016/S0010-7824(01)00191-3	76	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91993	10.1371/journal.pone.0091993	http://dx.doi.org/10.1371/journal.pone.0091993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24647612	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500068
J	Gonzalo, V; Lozano, JJ; Alonso-Espinaco, V; Moreira, L; Munoz, J; Pellise, M; Castellvi-Bel, S; Bessa, X; Andreu, M; Xicola, RM; Llor, X; Ruiz-Ponte, C; Carracedo, A; Jover, R; Castells, A; Balaguer, F				Gonzalo, Victoria; Jose Lozano, Juan; Alonso-Espinaco, Virginia; Moreira, Leticia; Munoz, Jenifer; Pellise, Maria; Castellvi-Bel, Sergi; Bessa, Xavier; Andreu, Montserrat; Xicola, Rosa M.; Llor, Xavier; Ruiz-Ponte, Clara; Carracedo, Angel; Jover, Rodrigo; Castells, Antoni; Balaguer, Francesc		Spanish Gastroenterological Assoc	Multiple Sporadic Colorectal Cancers Display a Unique Methylation Phenotype	PLOS ONE			English	Article							CPG ISLAND METHYLATION; DNA METHYLATION; MICROSATELLITE INSTABILITY; HYPERPLASTIC POLYPOSIS; PROMOTER METHYLATION; MICE; PREDISPOSITION; TUMORIGENESIS; EXPRESSION; PROGNOSIS	Epigenetics are thought to play a major role in the carcinogenesis of multiple sporadic colorectal cancers (CRC). Previous studies have suggested concordant DNA hypermethylation between tumor pairs. However, only a few methylation markers have been analyzed. This study was aimed at describing the epigenetic signature of multiple CRC using a genome-scale DNA methylation profiling. We analyzed 12 patients with synchronous CRC and 29 age-, sex-, and tumor location-paired patients with solitary tumors from the EPICOLON II cohort. DNA methylation profiling was performed using the Illumina Infinium HM27 DNA methylation assay. The most significant results were validated by Methylight. Tumors samples were also analyzed for the CpG Island Methylator Phenotype (CIMP); KRAS and BRAF mutations and mismatch repair deficiency status. Functional annotation clustering was performed. We identified 102 CpG sites that showed significant DNA hypermethylation in multiple tumors with respect to the solitary counterparts (difference in beta value >= 0.1). Methylight assays validated the results for 4 selected genes (p = 0.0002). Eight out of 12(66.6%) multiple tumors were classified as CIMP-high, as compared to 5 out of 29(17.2%) solitary tumors (p = 0.004). Interestingly, 76 out of the 102 (74.5%) hypermethylated CpG sites found in multiple tumors were also seen in CIMP-high tumors. Functional analysis of hypermethylated genes found in multiple tumors showed enrichment of genes involved in different tumorigenic functions. In conclusion, multiple CRC are associated with a distinct methylation phenotype, with a close association between tumor multiplicity and CIMP-high. Our results may be important to unravel the underlying mechanism of tumor multiplicity.	[Gonzalo, Victoria; Alonso-Espinaco, Virginia; Moreira, Leticia; Munoz, Jenifer; Pellise, Maria; Castellvi-Bel, Sergi; Castells, Antoni; Balaguer, Francesc] Univ Barcelona, Dept Gastroenterol, Hosp Clin,IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Catalonia, Spain; [Jose Lozano, Juan] CIBERehd, Bioinformat Unit, Barcelona, Catalonia, Spain; [Bessa, Xavier; Andreu, Montserrat] Hosp del Mar, Dept Gastroenterol, Barcelona, Catalonia, Spain; [Xicola, Rosa M.; Llor, Xavier] Univ Illinois, Dept Med, Chicago, IL USA; [Xicola, Rosa M.; Llor, Xavier] Univ Illinois, Ctr Canc, Chicago, IL USA; [Ruiz-Ponte, Clara; Carracedo, Angel] Univ Compostela, Hosp Clin, Genom Med Grp, Galician Publ Fdn Genom Med FPGMX,CIBERER, Galicia, Spain; [Jover, Rodrigo] Hosp Gen Univ, Gastroenterol Unit, Alicante, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; General University Hospital of Alicante	Balaguer, F (corresponding author), Univ Barcelona, Dept Gastroenterol, Hosp Clin,IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Catalonia, Spain.	fprunes@clinic.cat	Rodrigo, Luis/A-6278-2010; Jover, Rodrigo/ABC-3258-2021; Ruiz-Ponte, Clara/I-3849-2015; Felis, Carmen Pinol/C-6397-2011; Carracedo, Angel/D-4257-2012; Bujanda, Luis/AAB-2485-2021; RIESTRA, SABINO/N-2897-2019; Andreu, Montserrat/D-9911-2015; Pellise, Maria/ABC-3246-2021; Enriquez-Navascues, Jose M/AAG-8632-2020; Moreira, Leticia/AAN-9863-2021; CUBIELLA, JOAQUIN/G-7692-2017; BALAGUER, FRANCESC/G-2389-2016; Castells, Antoni/ABC-1002-2021; Balaguer, Francesc/GPX-7801-2022; Carballo, Fernando/M-4668-2016	Rodrigo, Luis/0000-0003-1717-9345; Jover, Rodrigo/0000-0003-3742-3413; Ruiz-Ponte, Clara/0000-0002-2200-0162; Felis, Carmen Pinol/0000-0003-0626-1298; Carracedo, Angel/0000-0003-1085-8986; Bujanda, Luis/0000-0002-4353-9968; Andreu, Montserrat/0000-0003-4286-1098; Enriquez-Navascues, Jose M/0000-0002-6486-1489; Moreira, Leticia/0000-0002-4518-8591; CUBIELLA, JOAQUIN/0000-0002-9994-4831; Castells, Antoni/0000-0001-8431-2033; Lozano, Juan Jose/0000-0001-7613-3908; Carballo, Fernando/0000-0003-1152-1517; Alenda, Cristina/0000-0002-0560-1759; Poca Sans, Maria/0000-0002-0235-1395; Pinol, Virginia/0000-0003-3669-6989; ESTEVE, MARIA/0000-0002-3178-7008; Bessa Caserras, Xavier/0000-0003-4680-1228; Fernandez-Banares, Fernando/0000-0002-1489-504X; Castellvi-Bel, Sergi/0000-0003-1217-5097; Sanchez Hernandez, Eloy/0000-0003-2493-8303; Pellise, Maria/0000-0001-9739-4998; ESTEVE, MARIA/0000-0001-7716-0027; Balaguer, Francesc/0000-0002-0206-0539	Hospital Clinic of Barcelona; Ministerio de Economi-a y Competitividad [SAF 2007-64873, SAF2010-19273]; Fundacion Cientifica de la Asociacion Espanola contra el Cancer; Instituto de Salud Carlos III [PI10/00384]	Hospital Clinic of Barcelona; Ministerio de Economi-a y Competitividad(Spanish Government); Fundacion Cientifica de la Asociacion Espanola contra el Cancer; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants from the Hospital Clinic of Barcelona (Josep Font grant), Ministerio de Economi-a y Competitividad (SAF 2007-64873 and SAF2010-19273), Fundacion Cientifica de la Asociacion Espanola contra el Cancer, and Instituto de Salud Carlos III (PI10/00384). "Cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER). Union Europea. Una manera de hacer Europa''. CIBEREHD is funded by the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuli A, 2010, GASTROENTEROLOGY, V139, P788, DOI 10.1053/j.gastro.2010.05.072; Balaguer F, 2007, CLIN GASTROENTEROL H, V5, P379, DOI 10.1016/j.cgh.2006.12.025; Bardhan Kankana, 2013, Cancers (Basel), V5, P676, DOI 10.3390/cancers5020676; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Catalano V, 2011, HISTOPATHOLOGY, V58, P669, DOI 10.1111/j.1365-2559.2011.03818.x; Chan AOO, 2002, AM J PATHOL, V160, P529, DOI 10.1016/S0002-9440(10)64872-9; Chen HS, 2000, DIS COLON RECTUM, V43, P1093, DOI 10.1007/BF02236556; Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365; Giraldez MD, 2010, CLIN CANCER RES, V16, P5402, DOI 10.1158/1078-0432.CCR-10-1491; Dykes SL, 2003, CANCER-AM CANCER SOC, V98, P48, DOI 10.1002/cncr.11445; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Ferracin M, 2008, J PATHOL, V214, P594, DOI 10.1002/path.2318; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Giovannucci E, 2005, JNCI-J NATL CANCER I, V97, P1317, DOI 10.1093/jnci/dji305; Goel A, 2010, GASTROENTEROLOGY, V138, P1854, DOI 10.1053/j.gastro.2010.01.035; Gonzalo Victoria, 2008, Gastroenterol Hepatol, V31, P37; Gonzalo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008777; Gunderson Kevin L., 2009, V529, P197, DOI 10.1007/978-1-59745-538-1_13; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Joensuu EI, 2008, CANCER RES, V68, P4597, DOI 10.1158/0008-5472.CAN-07-6645; Kamiyama H, 2012, ONCOGENE, V31, P5029, DOI 10.1038/onc.2011.652; Kim YH, 2006, GENE CHROMOSOME CANC, V45, P781, DOI 10.1002/gcc.20341; Konishi K, 2009, CANCER PREV RES, V2, P814, DOI 10.1158/1940-6207.CAPR-09-0054; Latournerie M, 2008, BRIT J SURG, V95, P1528, DOI 10.1002/bjs.6382; Lawes DA, 2005, BRIT J CANCER, V93, P472, DOI 10.1038/sj.bjc.6602708; Lorenzi T, 2013, INT J CANC; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Minoo P, 2006, GUT, V55, DOI 10.1136/gut.2005.082859; Mullany SA, 2011, CLIN CANCER RES, V17, P427, DOI 10.1158/1078-0432.CCR-09-3069; Nosho K, 2009, GASTROENTEROLOGY, V137, P1609, DOI 10.1053/j.gastro.2009.08.002; Ogino S, 2006, MODERN PATHOL, V19, P1083, DOI 10.1038/modpathol.3800618; Pedroni M, 1999, INT J CANCER, V81, P1; Perez-Carbonell L, 2012, GUT, V61, P865, DOI 10.1136/gutjnl-2011-300041; Pinol V, 2004, DIS COLON RECTUM, V47, P1192, DOI 10.1007/s10350-004-0562-7; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Young J, 2006, CANCER EPIDEM BIOMAR, V15, P1778, DOI 10.1158/1055-9965.EPI-06-0164; Zauber P, 2013, J MOL DIAGN, V15, P652, DOI 10.1016/j.jmoldx.2013.03.009; Zuo XS, 2012, J NATL CANCER I, V104, P709, DOI 10.1093/jnci/djs187	42	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91033	10.1371/journal.pone.0091033	http://dx.doi.org/10.1371/journal.pone.0091033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643221	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900011
J	Goncalves-Souza, T; Diniz, JAF; Romero, GQ				Goncalves-Souza, Thiago; Felizola Diniz-Filho, Jose Alexandre; Romero, Gustavo Quevedo			Disentangling the Phylogenetic and Ecological Components of Spider Phenotypic Variation	PLOS ONE			English	Article							BODY-SIZE; HABITAT USE; EVOLUTION; PERFORMANCE; STRATEGIES; PATTERNS; LIFE; MASS	An understanding of how the degree of phylogenetic relatedness influences the ecological similarity among species is crucial to inferring the mechanisms governing the assembly of communities. We evaluated the relative importance of spider phylogenetic relationships and ecological niche (plant morphological variables) to the variation in spider body size and shape by comparing spiders at different scales: (i) between bromeliads and dicot plants (i. e., habitat scale) and (ii) among bromeliads with distinct architectural features (i. e., microhabitat scale). We partitioned the interspecific variation in body size and shape into phylogenetic (that express trait values as expected by phylogenetic relationships among species) and ecological components (that express trait values independent of phylogenetic relationships). At the habitat scale, bromeliad spiders were larger and flatter than spiders associated with the surrounding dicots. At this scale, plant morphology sorted out close related spiders. Our results showed that spider flatness is phylogenetically clustered at the habitat scale, whereas it is phylogenetically overdispersed at the microhabitat scale, although phylogenic signal is present in both scales. Taken together, these results suggest that whereas at the habitat scale selective colonization affect spider body size and shape, at fine scales both selective colonization and adaptive evolution determine spider body shape. By partitioning the phylogenetic and ecological components of phenotypic variation, we were able to disentangle the evolutionary history of distinct spider traits and show that plant architecture plays a role in the evolution of spider body size and shape. We also discussed the relevance in considering multiple scales when studying phylogenetic community structure.	[Goncalves-Souza, Thiago] Univ Estadual Paulista, Programa Posgrad Biol Anim, Dept Zool & Bot, Sao Jose Do Rio Preto, SP, Brazil; [Felizola Diniz-Filho, Jose Alexandre] Univ Fed Goias, Dept Ecol, Inst Ciencias Biol, Goiania, Go, Brazil; [Romero, Gustavo Quevedo] Univ Estadual Campinas, Dept Biol Anim, Inst Biol, Campinas, SP, Brazil	Universidade Estadual Paulista; Universidade Federal de Goias; Universidade de Sao Paulo; Universidade Estadual de Campinas	Goncalves-Souza, T (corresponding author), Univ Estadual Campinas, Dept Biol Anim, Inst Biol, Campinas, SP, Brazil.	tgoncalves.souza@gmail.com	Souza, Thiago Gonçalves/E-3813-2012; Diniz-Filho, José Alexandre Felizola/D-9405-2013; Romero, Gustavo Q/N-1896-2019; Romero, Gustavo Q/H-8974-2012	Souza, Thiago Gonçalves/0000-0001-8471-7479; Diniz-Filho, José Alexandre Felizola/0000-0002-0967-9684; Romero, Gustavo Q/0000-0003-3736-4759; Romero, Gustavo Q/0000-0003-3736-4759	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP; Conselho Nacional de Pesquisa/CNPq productivity fellowships	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa/CNPq productivity fellowships	GQR and TGS were funded by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP. JAFDF and GQR have been supported by Conselho Nacional de Pesquisa/CNPq productivity fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Atkinson David, 2007, P33, DOI 10.1017/CBO9780511611223.004; BENZING DH, 2000, BROMELIACEAE PROFILE; Bro-Jorgensen J, 2008, OIKOS, V117, P729, DOI 10.1111/j.0030-1299.2008.16069.x; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Desdevises Y, 2003, EVOLUTION, V57, P2647; Dias Sidclay Calaça, 2004, Rev. Bras. Zool., V21, P789, DOI 10.1590/S0101-81752004000400011; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Diniz JAF, 2012, ECOGRAPHY, V35, P239, DOI 10.1111/j.1600-0587.2011.06949.x; Diniz JAF, 2012, EVOLUTION, V66, P1079, DOI 10.1111/j.1558-5646.2011.01499.x; Diniz JAF, 2009, J BIOGEOGR, V36, P2222, DOI 10.1111/j.1365-2699.2009.02163.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Goncalves-Souza T, 2011, AUSTRAL ECOL, V36, P476, DOI 10.1111/j.1442-9993.2010.02177.x; Goodman BA, 2008, BIOL J LINN SOC, V94, P399, DOI 10.1111/j.1095-8312.2008.00988.x; Goodman BA, 2008, ECOLOGY, V89, P3462, DOI 10.1890/07-2093.1; Hare KM, 2009, HERPETOLOGICA, V65, P227, DOI 10.1655/08-032R2.1; HEDGES S B, 1989, Caribbean Journal of Science, V25, P123; Kelt DA, 1998, BIODIVERSITY DYNAMICS, P109; LIGHTON JRB, 1995, PHYSIOL ZOOL, V68, P43, DOI 10.1086/physzool.68.1.30163917; Moya-Larano J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001841; NORBERG RA, 1994, P ROY SOC B-BIOL SCI, V257, P227, DOI 10.1098/rspb.1994.0119; Piccoli GCO, 2011, HIST NATURAL ARANHA; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Polo V, 1999, J ANIM ECOL, V68, P324, DOI 10.1046/j.1365-2656.1999.00282.x; Remmel T, 2009, J ANIM ECOL, V78, P973, DOI 10.1111/j.1365-2656.2009.01566.x; Romero GQ, 2010, J ANIM ECOL, V79, P1122, DOI 10.1111/j.1365-2656.2010.01716.x; Romero GQ, 2008, ECOLOGY, V89, P3105, DOI 10.1890/08-0267.1; Sillett T. Scott, 1997, Ornithological Monographs, V48, P733; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Staggemeier VG, 2010, J ECOL, V98, P1409, DOI 10.1111/j.1365-2745.2010.01717.x; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Thomaz LD, 1997, BRENTWOOD BAY ME 193, P3; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1; Wendt T, 2008, PLANT SYST EVOL, V275, P31, DOI 10.1007/s00606-008-0054-7	35	15	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89314	10.1371/journal.pone.0089314	http://dx.doi.org/10.1371/journal.pone.0089314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24651264	gold, Green Submitted, Green Published			2022-12-27	WOS:000331711900123
J	Matsumoto, A; Mizuno, M; Hamada, N; Nozaki, Y; Jimbo, EF; Momoi, MY; Nagata, K; Yamagata, T				Matsumoto, Ayumi; Mizuno, Makoto; Hamada, Nanako; Nozaki, Yasuyuki; Jimbo, Eriko F.; Momoi, Mariko Y.; Nagata, Koh-ichi; Yamagata, Takanori			LIN7A Depletion Disrupts Cerebral Cortex Development, Contributing to Intellectual Disability in 12q21-Deletion Syndrome	PLOS ONE			English	Article							FACIO-CUTANEOUS SYNDROME; NEURONAL MIGRATION; INTERSTITIAL DELETION; MENTAL-RETARDATION; CANDIDATE REGION; BRAIN; PROTEIN; ELECTROPORATION; IDENTIFICATION; DOUBLECORTIN	Interstitial deletion of 12q21 has been reported in four cases, which share several common clinical features, including intellectual disability (ID), low-set ears, and minor cardiac abnormalities. Comparative genomic hybridization (CGH) analysis using the Agilent Human Genome CGH 180K array was performed with the genomic DNA from a two-year-old Japanese boy with these symptoms, as well as hypoplasia of the corpus callosum. Consequently, a 14 Mb deletion at 12q21.2-q21.33 (nt. 77 203 574-91 264 613 bp), which includes 72 genes, was detected. Of these, we focused on LIN7A, which encodes a scaffold protein that is important for synaptic function, as a possible responsible gene for ID, and we analyzed its role in cerebral cortex development. Western blotting analyses revealed that Lin-7A is expressed on embryonic day (E) 13.5, and gradually increases in the mouse brain during the embryonic stage. Biochemical fractionation resulted in the enrichment of Lin-7A in the presynaptic fraction. Suppression of Lin-7A expression by RNAi, using in utero electroporation on E14.5, delayed neuronal migration on postnatal day (P) 2, and Lin-7A-deficient neurons remained in the lower zone of the cortical plate and the intermediate zone. In addition, when Lin-7A was silenced in cortical neurons in one hemisphere, axonal growth in the contralateral hemisphere was delayed; development of these neurons was disrupted such that one half did not extend into the contralateral hemisphere after leaving the corpus callosum. Taken together, LIN7A is a candidate gene responsible for 12q21-deletion syndrome, and abnormal neuronal migration and interhemispheric axon development may contribute to ID and corpus callosum hypoplasia, respectively.	[Matsumoto, Ayumi; Nozaki, Yasuyuki; Jimbo, Eriko F.; Momoi, Mariko Y.; Yamagata, Takanori] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan; [Mizuno, Makoto; Hamada, Nanako; Nagata, Koh-ichi] Aichi Human Serv Ctr, Inst Dev Res, Dept Mol Neurobiol, Kasugai, Aichi, Japan	Jichi Medical University	Yamagata, T (corresponding author), Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan.	takanori@jichi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23390275]; MEXT; Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the grant from Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 23390275), MEXT-Supported Program for the Strategic Research Foundation at Private Universities 2011-2015 (Cooperative Basic and Clinical Research on Circadian Medicine). And also Grants-in-Aid for Scientific Research on Priority Area, Challenging Exploratory Research and Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and a grant from Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Brady AF, 1999, J MED GENET, V36, P939; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Corbo JC, 2002, J NEUROSCI, V22, P7548; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Humeau Y, 2009, J NEUROCHEM, V109, P1, DOI 10.1111/j.1471-4159.2009.05881.x; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Inaguma Y, 2014, EMBO MOL ME IN PRESS; Ito H, 2009, J NEUROCHEM, V108, P867, DOI 10.1111/j.1471-4159.2008.05849.x; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Klein OD, 2005, AM J MED GENET A, V138A, P349, DOI 10.1002/ajmg.a.30867; Lanktree M, 2008, AM J MED GENET B, V147B, P945, DOI 10.1002/ajmg.b.30723; Misawa H, 2001, J BIOL CHEM, V276, P9264, DOI 10.1074/jbc.M009334200; Mizutani Y, 2013, BIOL CHEM, V394, P281, DOI 10.1515/hsz-2012-0258; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Nishimura YV, 2012, MED MOL MORPHOL, V45, P1, DOI 10.1007/s00795-011-0557-0; Rauen KA, 2000, AM J MED GENET, V93, P219, DOI 10.1002/1096-8628(20000731)93:3<219::AID-AJMG12>3.0.CO;2-5; Rauen KA, 2002, AM J MED GENET, V110, P51, DOI 10.1002/ajmg.10478; Reiner O, 2009, MOL NEUROBIOL, V40, P1, DOI 10.1007/s12035-009-8065-0; Shinawi M, 2011, AM J MED GENET A, V155A, P1272, DOI 10.1002/ajmg.a.33878; Shinoda T, 2010, MOL BIOL CELL, V21, P1324, DOI 10.1091/mbc.E09-10-0869; Sudo K, 2006, NEUROSCI RES, V56, P347, DOI 10.1016/j.neures.2006.08.003; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; WISE SP, 1975, BRAIN RES, V90, P139, DOI 10.1016/0006-8993(75)90688-5; Zheng CY, 2011, NEUROSCIENTIST, V17, P493, DOI 10.1177/1073858410386384; Zhou J, 2013, P NATL ACAD SCI USA, V110, pE2714, DOI 10.1073/pnas.1310233110; Zucker B, 2010, J NEUROPATH EXP NEUR, V69, P880, DOI 10.1097/NEN.0b013e3181ed7a41	30	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92695	10.1371/journal.pone.0092695	http://dx.doi.org/10.1371/journal.pone.0092695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658322	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300117
J	Taha, MS; Nouri, K; Milroy, LG; Moll, JM; Herrmann, C; Brunsveld, L; Piekorz, RP; Ahmadian, MR				Taha, Mohamed S.; Nouri, Kazem; Milroy, Lech G.; Moll, Jens M.; Herrmann, Christian; Brunsveld, Luc; Piekorz, Roland P.; Ahmadian, Mohammad R.			Subcellular Fractionation and Localization Studies Reveal a Direct Interaction of the Fragile X Mental Retardation Protein (FMRP) with Nucleolin	PLOS ONE			English	Article							MESSENGER-RNA; INTRACELLULAR-LOCALIZATION; BINDING PROTEINS; CELL-CYCLE; IDENTIFICATION; NUCLEAR; POLYRIBOSOMES; ASSOCIATION; MITOCHONDRIA; TRANSLATION	Fragile X mental Retardation Protein (FMRP) is a well-known regulator of local translation of its mRNA targets in neurons. However, despite its ubiquitous expression, the role of FMRP remains ill-defined in other cell types. In this study we investigated the subcellular distribution of FMRP and its protein complexes in HeLa cells using confocal imaging as well as detergent-free fractionation and size exclusion protocols. We found FMRP localized exclusively to solid compartments, including cytosolic heavy and light membranes, mitochondria, nuclear membrane and nucleoli. Interestingly, FMRP was associated with nucleolin in both a high molecular weight ribosomal and translation-associated complex (>= 6 MDa) in the cytosol, and a low molecular weight complex (similar to 200 kDa) in the nucleoli. Consistently, we identified two functional nucleolar localization signals (NoLSs) in FMRP that are responsible for a strong nucleolar colocalization of the C-terminus of FMRP with nucleolin, and a direct interaction of the N-terminus of FMRP with the arginine-glycine-glycine (RGG) domain of nucleolin. Taken together, we propose a novel mechanism by which a transient nucleolar localization of FMRP underlies a strong nucleocytoplasmic translocation, most likely in a complex with nucleolin and possibly ribosomes, in order to regulate translation of its target mRNAs.	[Taha, Mohamed S.; Nouri, Kazem; Moll, Jens M.; Piekorz, Roland P.; Ahmadian, Mohammad R.] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Milroy, Lech G.; Brunsveld, Luc] Tech Univ Eindhoven, Biol Chem Lab, NL-5600 MB Eindhoven, Netherlands; [Milroy, Lech G.; Brunsveld, Luc] Tech Univ Eindhoven, Inst Complex Mol Syst, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Herrmann, Christian] Ruhr Univ Bochum, Dept Phys Chem 1, Bochum, Germany	Heinrich Heine University Dusseldorf; Eindhoven University of Technology; Eindhoven University of Technology; Ruhr University Bochum	Ahmadian, MR (corresponding author), Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	taha, mohamed/W-8321-2019	Nouri, Kazem/0000-0001-7787-1304; Taha, Mohamed/0000-0002-7121-9283; Brunsveld, Luc/0000-0001-5675-511X	German Academic Exchange Service (DAAD); International Graduate School of Protein Science and Technology (iGRASP); Strategic Research Fund (SFF) of the Heinrich-Heine University Dusseldorf [F-2012/79-6]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); International Graduate School of Protein Science and Technology (iGRASP); Strategic Research Fund (SFF) of the Heinrich-Heine University Dusseldorf	This work was supported in part by the German Academic Exchange Service (DAAD), the International Graduate School of Protein Science and Technology (iGRASP) and by the Strategic Research Fund (SFF) of the Heinrich-Heine University Dusseldorf (Grant F-2012/79-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2012, RNA BIOL, V9, P799, DOI 10.4161/rna.19718; Adams-Cioaba MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013559; Adinolfi S, 2003, BIOCHEMISTRY-US, V42, P10437, DOI 10.1021/bi034909g; Adjobo-Hermans MJW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-32; Bardoni B, 2003, EXP CELL RES, V289, P95, DOI 10.1016/S0014-4827(03)00222-2; Bardoni B, 2003, HUM MOL GENET, V12, P1689, DOI 10.1093/hmg/ddg181; Bardoni B, 1997, NEUROBIOL DIS, V4, P329, DOI 10.1006/nbdi.1997.0142; Bardoni B, 2001, BRAIN RES BULL, V56, P375, DOI 10.1016/S0361-9230(01)00647-5; Bardoni Barbara, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010751; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Blackwell E, 2010, HUM MOL GENET, V19, P1314, DOI 10.1093/hmg/ddq007; Brackett DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058296; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Callebaut C, 1996, VIROLOGY, V218, P181, DOI 10.1006/viro.1996.0178; Callebaut C, 1998, J BIOL CHEM, V273, P21988, DOI 10.1074/jbc.273.34.21988; Callebaut C, 1997, J BIOL CHEM, V272, P7159, DOI 10.1074/jbc.272.11.7159; Caudle WM, 2009, NEUROSCI LETT, V459, P11, DOI 10.1016/j.neulet.2009.04.060; Ceman S, 1999, MOL CELL BIOL, V19, P7925; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Ceman S, 2000, BIOCHEM BIOPH RES CO, V279, P904, DOI 10.1006/bbrc.2000.4035; Collins SC, 2010, AM J MED GENET A, V152A, P2512, DOI 10.1002/ajmg.a.33626; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Darnell JC, 2013, NAT NEUROSCI; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Davidovic L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003367; Dolzhanskaya N, 2006, J CELL SCI, V119, P1933, DOI 10.1242/jcs.02882; Dury AY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003890; Eberth Alexander, 2009, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1409s43; El Fatimy R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039338; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Galva C, 2012, J CELL SCI, V125, P6137, DOI 10.1242/jcs.114959; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Hoogeveen AT, 2002, MICROSC RES TECHNIQ, V57, P148, DOI 10.1002/jemt.10064; Huang L, 2011, J BIOL CHEM, V286, P24219, DOI 10.1074/jbc.M111.240259; Iacoangeli A, 2013, TRENDS BIOCHEM SCI, V38, P47, DOI 10.1016/j.tibs.2012.11.001; Jackson RS, 2007, CELL CYCLE, V6, P95, DOI 10.4161/cc.6.1.3665; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Kaplan ES, 2012, J NEUROCHEM, V123, P613, DOI 10.1111/j.1471-4159.2012.07936.x; Kim M, 2012, CURR PROTEIN PEPT SC, V13, P358, DOI 10.2174/138920312801619420; Kim M, 2009, MOL CELL BIOL, V29, P214, DOI 10.1128/MCB.01377-08; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; McLennan Y, 2011, CURR GENOMICS, V12, P216, DOI 10.2174/138920211795677886; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Ramos A, 2006, STRUCTURE, V14, P21, DOI 10.1016/j.str.2005.09.018; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; Ross-Inta C, 2010, BIOCHEM J, V429, P545, DOI 10.1042/BJ20091960; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; Scott MS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-317; Seidler NW, 2013, ADV EXP MED BIOL, V985, P61, DOI 10.1007/978-94-007-4716-6_3; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Sidorov MS, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-15; Sittler A, 1996, HUM MOL GENET, V5, P95, DOI 10.1093/hmg/5.1.95; Tajrishi Marjan M, 2011, Commun Integr Biol, V4, P267, DOI 10.4161/cib.4.3.14884; Tamanini F, 1996, HUM MOL GENET, V5, P809, DOI 10.1093/hmg/5.6.809; Tamanini F, 2000, HUM MOL GENET, V9, P1487, DOI 10.1093/hmg/9.10.1487; Tamanini F, 1999, BIOCHEM J, V343, P517, DOI 10.1042/0264-6021:3430517; Tamanini F, 1999, HUM MOL GENET, V8, P863, DOI 10.1093/hmg/8.5.863; Tisdale EJ, 2004, J BIOL CHEM, V279, P54046, DOI 10.1074/jbc.M409472200; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Villace P, 2004, NUCLEIC ACIDS RES, V32, P2411, DOI 10.1093/nar/gkh552; Wang T, 2012, CURR OPIN GENET DEV, V22, P256, DOI 10.1016/j.gde.2012.02.002; Willemsen R, 1996, BIOCHEM BIOPH RES CO, V225, P27, DOI 10.1006/bbrc.1996.1126; Wojcik F, 2012, J ORG CHEM, V77, P4226, DOI 10.1021/jo202561k; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Yao AY, 2011, HUM MOL GENET, V20, P51, DOI 10.1093/hmg/ddq431	76	41	46	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91465	10.1371/journal.pone.0091465	http://dx.doi.org/10.1371/journal.pone.0091465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658146	gold, Green Published			2022-12-27	WOS:000333355300033
J	Zhao, TJ; Sun, Q; del Rincon, SV; Lovato, A; Marques, M; Witcher, M				Zhao, Tiejun; Sun, Qiang; del Rincon, Sonia V.; Lovato, Amanda; Marques, Maud; Witcher, Michael			Gallotannin Imposes S Phase Arrest in Breast Cancer Cells and Suppresses the Growth of Triple-Negative Tumors In Vivo	PLOS ONE			English	Article							DNA-DAMAGE; TANNIC-ACID; CYCLIN D1; TGFBI; CHECKPOINT; EXPRESSION; PACLITAXEL; CHK2; ASSOCIATION; METASTASIS	Triple-negative breast cancers are associated with poor clinical outcomes and new therapeutic strategies are clearly needed. Gallotannin (Gltn) has been previously demonstrated to have potent anti-tumor properties against cholangiocarcinoma in mice, but little is known regarding its capacity to suppress tumor outgrowth in breast cancer models. We tested Gltn for potential growth inhibitory properties against a variety of breast cancer cell lines in vitro. In particular, triple-negative breast cancer cells display higher levels of sensitivity to Gltn. The loss of proliferative capacity in Gltn exposed cells is associated with slowed cell cycle progression and S phase arrest, dependent on Chk2 phosphorylation and further characterized by changes to proliferation related genes, such as cyclin D1 (CcnD1) as determined by Nanostring technology. Importantly, Gltn administered orally or via intraperitoneal (IP) injections greatly reduced tumor outgrowth of triple-negative breast cells from mammary fat pads without signs of toxicity. In conclusion, these data strongly suggest that Gltn represents a novel approach to treat triple-negative breast carcinomas.	[Witcher, Michael] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University	Witcher, M (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.	michael.witcher@mcgill.ca			Quebec Breast Cancer Foundation; Canadian Institute of Health Research; Weekend to End Womena(sic)(TM)s Cancer grants; Canadian Institute for Health research	Quebec Breast Cancer Foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Weekend to End Womena(sic)(TM)s Cancer grants; Canadian Institute for Health research(Canadian Institutes of Health Research (CIHR))	This work was supported by Quebec Breast Cancer Foundation, Canadian Institute of Health Research and Weekend to End Womena(sic)(TM) s Cancer grants to M. W. A. L. was supported by student fellowships from the Canadian Institute for Health research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Ahmed AA, 2011, CANCER RES, V71, P5806, DOI 10.1158/0008-5472.CAN-11-0025; Al-Halabi R, 2011, CANCER BIOL THER, V12, P59, DOI 10.4161/cbt.12.1.15715; ATHAR M, 1989, CANCER RES, V49, P5784; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Beeharry N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040342; BICHEL J, 1968, ACTA PHARMACOL TOX, V26, P41; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Casanova F, 2012, J CELL BIOCHEM, V113, P2586, DOI 10.1002/jcb.24134; Daenen LGM, 2011, CANCER RES, V71, P6976, DOI 10.1158/0008-5472.CAN-11-0627; de Lange J, 2012, CELL DEATH DIFFER, V19, P980, DOI 10.1038/cdd.2011.182; Duan JM, 2007, MOL CANCER THER, V6, P37, DOI 10.1158/1535-7163.MCT-05-0285; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Fathers C, 2012, CELL CYCLE, V11, P990, DOI 10.4161/cc.11.5.19482; Galanina N, 2011, CANCER J, V17, P96, DOI 10.1097/PPO.0b013e318212dee3; Gorogh T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-12; Han TD, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-183; Ibanez de Caceres I, 2010, ONCOGENE, V29, P1681, DOI 10.1038/onc.2009.454; Irigoyen M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-130; Joe AK, 2002, CLIN CANCER RES, V8, P893; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Juvekar A, 2012, CANCER DISCOV, V2, P1048, DOI 10.1158/2159-8290.CD-11-0336; Kurian AW, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2780; Lee HJ, 2011, CARCINOGENESIS, V32, P804, DOI 10.1093/carcin/bgr015; Li BY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-239; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Marienfeld C, 2003, HEPATOLOGY, V37, P1097, DOI 10.1053/jhep.2003.50192; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ng CP, 2004, J BIOL CHEM, V279, P8808, DOI 10.1074/jbc.M312215200; Pan Y, 2009, CANCER BIOL THER, V8, P1559, DOI 10.4161/cbt.8.16.8955; Ramnath N, 2005, CANCER CHEMOTH PHARM, V56, P447, DOI 10.1007/s00280-004-0951-6; Sareen D, 2007, MOL PHARMACOL, V72, P1466, DOI 10.1124/mol.107.039040; Segurado M, 2009, BIOL CELL, V101, P617, DOI 10.1042/BC20090053; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Sharpe R, 2011, CLIN CANCER RES, V17, P5275, DOI 10.1158/1078-0432.CCR-10-2727; Son HN, 2013, BBA-MOL CELL RES, V1833, P2378, DOI 10.1016/j.bbamcr.2013.06.012; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Touvier M, 2013, BREAST CANCER RES TR, V137, P225, DOI 10.1007/s10549-012-2323-y; Tumbarello DA, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-36; Tyagi A, 2011, CLIN CANCER RES, V17, P5402, DOI 10.1158/1078-0432.CCR-11-1072; Vassileva V, 2008, MOL CANCER THER, V7, P630, DOI 10.1158/1535-7163.MCT-07-2117; Velasco-Velazquez MA, 2011, FUTURE ONCOL, V7, P753, DOI [10.2217/FON.11.56, 10.2217/fon.11.56]; Wang J, 2004, J BIOL CHEM, V279, P39584, DOI 10.1074/jbc.M400015200; Wang LC, 2005, J BIOL CHEM, V280, P7634, DOI 10.1074/jbc.M413384200; Wang N, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-6; Wen GY, 2011, INT J ONCOL, V39, P1001, DOI 10.3892/ijo.2011.1097; Wu AH, 2011, MOL NUTR FOOD RES, V55, P921, DOI 10.1002/mnfr.201100006; Yamauchi K, 2008, CANCER RES, V68, P516, DOI 10.1158/0008-5472.CAN-07-3063; Zeng L, 2013, EXP CELL RES, V319, P2282, DOI 10.1016/j.yexcr.2013.06.011; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648	51	16	16	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92853	10.1371/journal.pone.0092853	http://dx.doi.org/10.1371/journal.pone.0092853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658335	Green Submitted, gold, Green Published			2022-12-27	WOS:000333355300134
J	Burger, EA; Sy, S; Nygard, M; Kristiansen, IS; Kim, JJ				Burger, Emily A.; Sy, Stephen; Nygard, Mari; Kristiansen, Ivar S.; Kim, Jane J.			Prevention of HPV-Related Cancers in Norway: Cost-Effectiveness of Expanding the HPV Vaccination Program to Include Pre-Adolescent Boys	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS-VACCINATION; QUALITY-OF-LIFE; CERVICAL-CANCER; GENITAL WARTS; YOUNG-WOMEN; TRANSMISSION; HEALTH; IMPACT; VACCINES; STATES	Background: Increasingly, countries have introduced female vaccination against human papillomavirus (HPV), causally linked to several cancers and genital warts, but few have recommended vaccination of boys. Declining vaccine prices and strong evidence of vaccine impact on reducing HPV-related conditions in both women and men prompt countries to reevaluate whether HPV vaccination of boys is warranted. Methods: A previously-published dynamic model of HPV transmission was empirically calibrated to Norway. Reductions in the incidence of HPV, including both direct and indirect benefits, were applied to a natural history model of cervical cancer, and to incidence-based models for other non-cervical HPV-related diseases. We calculated the health outcomes and costs of the different HPV-related conditions under a gender-neutral vaccination program compared to a female-only program. Results: Vaccine price had a decisive impact on results. For example, assuming 71% coverage, high vaccine efficacy and a reasonable vaccine tender price of $75 per dose, we found vaccinating both girls and boys fell below a commonly cited cost-effectiveness threshold in Norway ($83,000/quality-adjusted life year (QALY) gained) when including vaccine benefit for all HPV-related diseases. However, at the current market price, including boys would not be considered 'good value for money.' For settings with a lower cost-effectiveness threshold ($30,000/QALY), it would not be considered cost-effective to expand the current program to include boys, unless the vaccine price was less than $36/dose. Increasing vaccination coverage to 90% among girls was more effective and less costly than the benefits achieved by vaccinating both genders with 71% coverage. Conclusions: At the anticipated tender price, expanding the HPV vaccination program to boys may be cost-effective and may warrant a change in the current female-only vaccination policy in Norway. However, increasing coverage in girls is uniformly more effective and cost-effective than expanding vaccination coverage to boys and should be considered a priority.	[Burger, Emily A.; Kristiansen, Ivar S.] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway; [Sy, Stephen; Kim, Jane J.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci Boston, Cambridge, MA 02138 USA; [Nygard, Mari] Norway Dept Res, Canc Registry, Oslo, Norway	University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health	Burger, EA (corresponding author), Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway.	emily.burger@medisin.uio.no		Nygard, Mari/0000-0002-4100-4855	Norwegian Cancer Society [634201-2012]; U.S. National Cancer Institute of the National Institutes of Health [U54CA164336, R01CA160744]; NATIONAL CANCER INSTITUTE [R01CA160744, U54CA164336] Funding Source: NIH RePORTER	Norwegian Cancer Society(Norwegian Cancer Society); U.S. National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	EAB is supported in part by the Norwegian Cancer Society [634201-2012]; JJK is supported by the U.S. National Cancer Institute of the National Institutes of Health [U54CA164336, R01CA160744]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2032; [Anonymous], [No title captured]; Bishai D, 2000, ARCH OTOLARYNGOL, V126, P935, DOI 10.1001/archotol.126.8.935; Bogaards JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001147; Brill D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f924; Brisson M, 2011, J INFECT DIS, V204, P372, DOI 10.1093/infdis/jir285; Brown DR, 1999, J CLIN MICROBIOL, V37, P3316, DOI 10.1128/JCM.37.10.3316-3322.1999; Burger EA, 2012, BRIT J CANCER, V106, P1571, DOI 10.1038/bjc.2012.94; Cancer Registry of Norway, 2009, CANC NORW 2009 SPEC; Chesson HW, 2011, VACCINE, V29, P8443, DOI 10.1016/j.vaccine.2011.07.096; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Conway EL, 2012, SEX TRANSM INFECT, V88, P517, DOI 10.1136/sextrans-2011-050161; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; Elbasha EH, 2010, VACCINE, V28, P6858, DOI 10.1016/j.vaccine.2010.08.030; Federal Reserve, HIST RAT NORW KRON; French KM, 2007, BRIT J CANCER, V96, P514, DOI 10.1038/sj.bjc.6603575; Health Protection Agency, NUMB RAT AN WARTS DI; Hernandez BY, 2008, EMERG INFECT DIS, V14, P888, DOI 10.3201/eid1406.070616; Insinga RP, 2007, VACCINE, V26, P128, DOI 10.1016/j.vaccine.2007.10.056; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; Kim JJ, 2007, AM J EPIDEMIOL, V166, P137, DOI 10.1093/aje/kwm086; Kim JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3884; Klee M, 2000, GYNECOL ONCOL, V76, P14, DOI 10.1006/gyno.1999.5642; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Larsen TK, 2007, CANC NORWAY 2006 CAN; Leval A, 2013, JNCI-J NATL CANCER I, V105, P469, DOI 10.1093/jnci/djt032; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192; Mork J, 2012, MD AND GAP C 2012; Mork J, 2010, CANCER CAUSE CONTROL, V21, P1397, DOI 10.1007/s10552-010-9567-9; Norwegian Directorate of Health, 2012, EC EV HEALTHC GUID; Norwegian Directorate of Health, 2007, HLTH EFF SOC AN; Norwegian Institute of Public Health, 2012, ANN REP HPV VACC CHI; Norwegian Medicines Agency, 2010, PHARM ASS IP YERV TR; Norwegian Ministry of Health, PRIOR NEW REV GUID P; Olsen J, 2010, INT J TECHNOL ASSESS, V26, P183, DOI 10.1017/S0266462310000085; Omland T, 2012, LARYNGOSCOPE, V122, P1595, DOI 10.1002/lary.23327; Pedersen W, 2003, J NORWEGIAN MED SOC, V21, P3006; Rannestad T, 2008, PSYCHOL HEALTH, V23, P219; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Seto K, 2012, DRUGS, V72, P715, DOI 10.2165/11599470-000000000-00000; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222; Tjalma WA, 2013, INT J CANCER, V132, P854, DOI 10.1002/ijc.27713; Traeen B, 2003, REPORT SEXUAL BEHAV; Woodhall SC, 2011, SEX TRANSM INFECT, V87, P458, DOI 10.1136/sextrans-2011-050073; World Health Organization. ICO (Institut Catala d'Oncologia), INF CTR HUM PAP VIR; Zechmeister I, 2009, VACCINE, V27, P5133, DOI 10.1016/j.vaccine.2009.06.039	48	70	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e89974	10.1371/journal.pone.0089974	http://dx.doi.org/10.1371/journal.pone.0089974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651645	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800007
J	Nishimura, AL; Shum, C; Scotter, EL; Abdelgany, A; Sardone, V; Wright, J; Lee, YB; Chen, HJ; Bilican, B; Carrasco, M; Maniatis, T; Chandran, S; Rogelj, B; Gallo, JM; Shaw, CE				Nishimura, Agnes L.; Shum, Carole; Scotter, Emma L.; Abdelgany, Amr; Sardone, Valentina; Wright, Jamie; Lee, Youn-Bok; Chen, Han-Jou; Bilican, Bilada; Carrasco, Monica; Maniatis, Tom; Chandran, Siddharthan; Rogelj, Boris; Gallo, Jean-Marc; Shaw, Christopher E.			Allele-Specific Knockdown of ALS-Associated Mutant TDP-43 in Neural Stem Cells Derived from Induced Pluripotent Stem Cells	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; RNA INTERFERENCE; MUTATIONS; PROGRESSION; SOD1; EXPRESSION; NUCLEAR; MODEL; FUS	TDP-43 is found in cytoplasmic inclusions in 95% of amyotrophic lateral sclerosis (ALS) and 60% of frontotemporal lobar degeneration (FTLD). Approximately 4% of familial ALS is caused by mutations in TDP-43. The majority of these mutations are found in the glycine-rich domain, including the variant M337V, which is one of the most common mutations in TDP-43. In order to investigate the use of allele-specific RNA interference (RNAi) as a potential therapeutic tool, we designed and screened a set of siRNAs that specifically target TDP-43(M337V) mutation. Two siRNA specifically silenced the M337V mutation in HEK293T cells transfected with GFP-TDP-43(wt) or GFP-TDP-43(M337V) or TDP-43 C-terminal fragments counterparts. C-terminal TDP-43 transfected cells show an increase of cytosolic inclusions, which are decreased after allele-specific siRNA in M337V cells. We then investigated the effects of one of these allele-specific siRNAs in induced pluripotent stem cells (iPSCs) derived from an ALS patient carrying the M337V mutation. These lines showed a two-fold increase in cytosolic TDP-43 compared to the control. Following transfection with the allele-specific siRNA, cytosolic TDP-43 was reduced by 30% compared to cells transfected with a scrambled siRNA. We conclude that RNA interference can be used to selectively target the TDP-43(M337V) allele in mammalian and patient cells, thus demonstrating the potential for using RNA interference as a therapeutic tool for ALS.	[Nishimura, Agnes L.; Shum, Carole; Scotter, Emma L.; Abdelgany, Amr; Wright, Jamie; Lee, Youn-Bok; Chen, Han-Jou; Gallo, Jean-Marc; Shaw, Christopher E.] Kings Coll London, Dept Clin Neurosci, London, England; [Sardone, Valentina] Univ Pavia, Dept Publ Hlth Neurosci Expt & Forens Med, I-27100 Pavia, Italy; [Bilican, Bilada; Chandran, Siddharthan] Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Bilican, Bilada; Chandran, Siddharthan] Univ Edinburgh, Ctr Neurodegenerat, Edinburgh, Midlothian, Scotland; [Carrasco, Monica; Maniatis, Tom] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA; [Rogelj, Boris] Jozef Stefan Inst, Dept Biotechnol, Ljubljana, Slovenia	University of London; King's College London; University of Pavia; University of Edinburgh; University of Edinburgh; Columbia University; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Shaw, CE (corresponding author), Kings Coll London, Dept Clin Neurosci, London, England.	Christopher.Shaw@kcl.ac.uk	Rogelj, Boris/G-9252-2011; Scotter, Emma/C-4833-2012; Nishimura, Agnes L/B-2905-2011	Rogelj, Boris/0000-0003-3898-1943; Scotter, Emma/0000-0003-4064-3599; Gallo, Jean-Marc/0000-0003-0214-4545; Lee, Younbok/0000-0002-0479-9361; Nishimura, Agnes/0000-0001-5295-797X; Shaw, Christopher/0000-0003-0251-0146	Motor Neurone Disease Association UK; Wellcome Trust; Medical Research Council UK; Psychiatry Research Trust of the Institute of Psychiatry	Motor Neurone Disease Association UK; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Psychiatry Research Trust of the Institute of Psychiatry	This work was supported by grants from the Motor Neurone Disease Association UK, The Wellcome Trust, Medical Research Council UK, and The Psychiatry Research Trust of the Institute of Psychiatry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgany A, 2003, HUM MOL GENET, V12, P2637, DOI 10.1093/hmg/ddg280; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Che MX, 2011, FASEB J, V25, P2344, DOI 10.1096/fj.10-174482; Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950; de Ynigo-Mojado L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021352; Ding HL, 2003, AGING CELL, V2, P209, DOI 10.1046/j.1474-9728.2003.00054.x; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fiszer A, 2011, NUCLEIC ACIDS RES, V39, P5578, DOI 10.1093/nar/gkr156; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Maxwell MM, 2004, P NATL ACAD SCI USA, V101, P3178, DOI 10.1073/pnas.0308726100; Miller VM, 2004, NUCLEIC ACIDS RES, V32, P661, DOI 10.1093/nar/gkh208; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Rodriguez-Lebron E, 2009, MOL THER, V17, P1563, DOI 10.1038/mt.2009.123; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Scotter EL, 2008, J NEUROSCI METH, V171, P174, DOI 10.1016/j.jneumeth.2008.02.007; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tamaoka A, 2010, INTERNAL MED, V49, P331, DOI 10.2169/internalmedicine.49.2915; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Towne C, 2008, MOL THER, V16, P1018, DOI 10.1038/mt.2008.73; Tsai CP, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.009; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xu YF, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-73; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Zhang Y, 2009, J NEUROCHEM, V108, P82, DOI 10.1111/j.1471-4159.2008.05734.x	39	33	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91269	10.1371/journal.pone.0091269	http://dx.doi.org/10.1371/journal.pone.0091269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651281	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800035
J	Beaudry, JT; Krause, MA; Diakite, SAS; Fay, MP; Joshi, G; Diakite, M; White, NJ; Fairhurst, RM				Beaudry, Jeanette T.; Krause, Michael A.; Diakite, Seidina A. S.; Fay, Michael P.; Joshi, Gyan; Diakite, Mahamadou; White, Nicholas J.; Fairhurst, Rick M.			Ex-Vivo Cytoadherence Phenotypes of Plasmodium falciparum Strains from Malian Children with Hemoglobins A, S, and C	PLOS ONE			English	Article							INFECTED ERYTHROCYTES; SEVERE MALARIA; VAR GENES; PROTECTION; DISEASE; POPULATION; EXPRESSION; VARIANTS; DISPLAY	Sickle hemoglobin (Hb) S and HbC may protect against malaria by reducing the expression of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) on the surface of parasitized red blood cells (RBCs), thereby weakening their cytoadherence to microvascular endothelial cells (MVECs) and impairing their activation of MVECs to produce pathological responses. Therefore, we hypothesized that parasites causing malaria in HbAS or HbAC heterozygotes have overcome this protective mechanism by expressing PfEMP1 variants which mediate relatively strong binding to MVECs. To test this hypothesis, we performed 31 cytoadherence comparisons between parasites from HbAA and HbAS (or HbAC) Malian children with malaria. Ring-stage parasites from HbAA and HbAS (or HbAC) children were cultivated to trophozoites, purified, and then inoculated in parallel into the same wildtype uninfected RBCs. After one cycle of invasion and maturation to the trophozoite stage expressing PfEMP1, parasite strains were compared for binding to MVECs. In this assay, there were no significant differences in the binding of parasites from HbAS and HbAC children to MVECs compared to those from HbAA children (HbAS, fold-change = 1.46, 95% CI 0.97-2.19, p = 0.07; HbAC, fold-change = 1.19, 95% CI 0.77-1.84, p = 0.43). These data suggest that in-vitro reductions in cytoadherence by HbS and HbC may not be selecting for expression of high-avidity PfEMP1 variants in vivo. Future studies that identify PfEMP1 domains or amino-acid motifs which are selectively expressed in parasites from HbAS children may provide further insights into the mechanism of malaria protection by the sickle-cell trait.	[Beaudry, Jeanette T.; Krause, Michael A.; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Beaudry, Jeanette T.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Diakite, Seidina A. S.; Diakite, Mahamadou] Univ Bamako, Fac Med Pharm & Odontostomatol, Malaria Res & Training Ctr, Bamako, Mali; [Fay, Michael P.; Joshi, Gyan] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA; [White, Nicholas J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Dis Res Unit, Bangkok, Thailand	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford; University of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mahidol University	Fairhurst, RM (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rfairhurst@niaid.nih.gov	Fay, Michael P/A-2974-2008; White, Nick/AAC-6527-2019	Fay, Michael P/0000-0002-8643-9625; White, Nick/0000-0002-1897-1978; Diakite, Seidina A. S./0000-0003-1193-6501	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001000, ZIAAI001062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bull PC, 2000, J INFECT DIS, V182, P252, DOI 10.1086/315652; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; Bunn HF, 2013, BLOOD, V121, P20, DOI 10.1182/blood-2012-08-449397; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; DAVID PH, 1983, P NATL ACAD SCI-BIOL, V80, P5075, DOI 10.1073/pnas.80.16.5075; Fairhurst RM, 2012, MICROBES INFECT, V14, P851, DOI 10.1016/j.micinf.2012.05.006; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Kirchgatter K, 2002, MOL MED, V8, P16, DOI 10.1007/BF03401999; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Krause MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037214; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Taylor SM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003327; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313	31	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92185	10.1371/journal.pone.0092185	http://dx.doi.org/10.1371/journal.pone.0092185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647281	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500096
J	Chandy, SJ; Naik, GS; Charles, R; Jeyaseelan, V; Naumova, EN; Thomas, K; Lundborg, CS				Chandy, Sujith J.; Naik, Girish S.; Charles, Reni; Jeyaseelan, Visalakshi; Naumova, Elena N.; Thomas, Kurien; Lundborg, Cecilia Stalsby			The Impact of Policy Guidelines on Hospital Antibiotic Use over a Decade: A Segmented Time Series Analysis	PLOS ONE			English	Article							INFECTIOUS-DISEASES-SOCIETY; ANTIMICROBIAL RESISTANCE; INDIA; CARE; EPIDEMIOLOGY; INTERVENTION; SURVEILLANCE; REDUCTION; PNEUMONIA; OUTBREAK	Introduction: Antibiotic pressure contributes to rising antibiotic resistance. Policy guidelines encourage rational prescribing behavior, but effectiveness in containing antibiotic use needs further assessment. This study therefore assessed the patterns of antibiotic use over a decade and analyzed the impact of different modes of guideline development and dissemination on inpatient antibiotic use. Methods: Antibiotic use was calculated monthly as defined daily doses (DDD) per 100 bed days for nine antibiotic groups and overall. This time series compared trends in antibiotic use in five adjacent time periods identified as 'Segments,' divided based on differing modes of guideline development and implementation: Segment 1- Baseline prior to antibiotic guidelines development; Segment 2- During preparation of guidelines and booklet dissemination; Segment 3- Dormant period with no guidelines dissemination; Segment 4- Booklet dissemination of revised guidelines; Segment 5- Booklet dissemination of revised guidelines with intranet access. Regression analysis adapted for segmented time series and adjusted for seasonality assessed changes in antibiotic use trend. Results: Overall antibiotic use increased at a monthly rate of 0.95 (SE = 0.18), 0.21 (SE = 0.08) and 0.31 (SE = 0.06) for Segments 1, 2 and 3, stabilized in Segment 4 (0.05; SE = 0.10) and declined in Segment 5 (-0.37; SE = 0.11). Segments 1, 2 and 4 exhibited seasonal fluctuations. Pairwise segmented regression adjusted for seasonality revealed a significant drop in monthly antibiotic use of 0.401 (SE = 0.089; p<0.001) for Segment 5 compared to Segment 4. Most antibiotic groups showed similar trends to overall use. Conclusion: Use of overall and specific antibiotic groups showed varied patterns and seasonal fluctuations. Containment of rising overall antibiotic use was possible during periods of active guideline dissemination. Wider access through intranet facilitated significant decline in use. Stakeholders and policy makers are urged to develop guidelines, ensure active dissemination and enable accessibility through computer networks to contain antibiotic use and decrease antibiotic pressure.	[Chandy, Sujith J.; Lundborg, Cecilia Stalsby] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Chandy, Sujith J.; Naik, Girish S.] Christian Med Coll & Hosp, Dept Pharmacol & Clin Pharmacol, Vellore, Tamil Nadu, India; [Charles, Reni] Christian Med Coll & Hosp, Dept Pharm, Vellore, Tamil Nadu, India; [Jeyaseelan, Visalakshi] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India; [Naumova, Elena N.] Tufts Univ, Sch Engn, Dept Civil & Environm Engn, Medford, MA 02155 USA; [Naumova, Elena N.] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [Thomas, Kurien] Christian Med Coll & Hosp, Dept Med, Vellore, Tamil Nadu, India	Karolinska Institutet; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Tufts University; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore	Chandy, SJ (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	sjchandycmc@gmail.com	Naumova, Elena/AAP-3395-2020	Naumova, Elena/0000-0002-9562-4734; Naik, Girish S/0000-0002-2832-0001; Stalsby Lundborg, Cecilia/0000-0001-6525-1861	Erasmus Mundus External Cooperation Window Lot 15, India	Erasmus Mundus External Cooperation Window Lot 15, India	No specific funding was received for this study, but SJC received a scholarship from Erasmus Mundus External Cooperation Window Lot 15, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Amitabh V, 2012, LUNG INDIA, V29, P248, DOI 10.4103/0970-2113.99109; [Anonymous], 2008, ALTERN MED REV, V13, P165; Ansari F, 2003, J ANTIMICROB CHEMOTH, V52, P842, DOI 10.1093/jac/dkg459; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Das A, 2012, ACTA TROP, V121, P267, DOI 10.1016/j.actatropica.2011.11.008; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Dhillon PK, 2012, INT J EPIDEMIOL, V41, P847, DOI 10.1093/ije/dys046; Gagliotti C, 2011, EURO SURVEILL B EUR, VMar 16; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Goossens H, 2009, CLIN MICROBIOL INFEC, V15, P12, DOI 10.1111/j.1469-0691.2009.02725.x; Jagai JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038168; Joshi S, 2013, INDIAN J MED RES, V137, P363; Kaul S, 2007, Indian J Med Microbiol, V25, P230; Kaur J, 2013, J CLIN DIAGN RES, V7, P576, DOI 10.7860/JCDR/2013/4765.2831; Knobler SL, 2003, WHO GLOBAL STRATEGY; Kumar S, 2012, Indian J Community Med, V37, P158, DOI 10.4103/0970-0218.99914; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lofgren E, 2007, LECT NOTES COMPUT SC, V4506, P114; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mathai E, 2003, ANN NY ACAD SCI, V990, P359, DOI 10.1111/j.1749-6632.2003.tb07391.x; Mathai E, 2008, TROP MED INT HEALTH, V13, P41, DOI 10.1111/j.1365-3156.2007.01969.x; Meyer E, 2007, J ANTIMICROB CHEMOTH, V59, P1148, DOI 10.1093/jac/dkm088; Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698; Naumova EN, 2001, INT J EPIDEMIOL, V30, P1332, DOI 10.1093/ije/30.6.1332; Pagkalis S, 2011, DRUGS, V71, P2277, DOI 10.2165/11597020-000000000-00000; Pathak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038641; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Tangden T, 2011, J ANTIMICROB CHEMOTH, V66, P1161, DOI 10.1093/jac/dkr053; Thursky KA, 2006, INT J QUAL HEALTH C, V18, P224, DOI 10.1093/intqhc/mzi095; Williams A, 2011, J PHARM BIOALLIED SC, V3, P531, DOI 10.4103/0975-7406.90108; World Health Organization, TOP 10 CAUS DEATH	33	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92206	10.1371/journal.pone.0092206	http://dx.doi.org/10.1371/journal.pone.0092206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647339	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500097
J	Chao, JQ; Jin, J; Wang, D; Han, R; Zhu, RS; Zhu, YG; Li, SQ				Chao, Jinquan; Jin, Jie; Wang, Dong; Han, Ran; Zhu, Renshan; Zhu, Yingguo; Li, Shaoqing			Cytological and Transcriptional Dynamics Analysis of Host Plant Revealed Stage-Specific Biological Processes Related to Compatible Rice-Ustilaginoidea virens Interaction	PLOS ONE			English	Article							DISEASE RESISTANCE; ARABIDOPSIS-THALIANA; PROTEIN-KINASE; ORYZA-SATIVA; GENE; DEFENSE; PATHOGEN; PHOSPHORYLATION; EXPRESSION; STRATEGIES	Rice false smut, a fungal disease caused by Ustilaginoidea virens is becoming a severe detriment to rice production worldwide. However, little is known about the molecular response of rice to attacks by the smut pathogen. In this article, we define the initial infection process as having three stages: initial colonization on the pistil (stage 1, S1), amplification on the anther (stage 2, S2) and sporulation in the anther chambers (stage 3, S3). Based on the transcriptome of rice hosts in response to U. virens in two separate years, we identified 126, 204, and 580 specific regulated genes in their respective stages S1, S2, and S3, respectively, by excluding common expression patterns in other openly biotic/abiotic databases using bioinformatics. As the disease progresses, several stage-specific biological processes (BP) terms were distinctively enriched: "Phosphorylation" in stage S1, "PCD" in S2, and "Cell wall biogenesis" in S3, implying a concise signal cascade indicative of the tactics that smut pathogens use to control host rice cells during infection. 113 regulated genes were coexpressed among the three stages. They shared highly conserved promoter cis-element in the promoters in response to the regulation of WRKY and Myb for up-regulation, and ABA and Ca2+ for down regulation, indicating their potentially critical roles in signal transduction during rice-U. virens interaction. We further analyzed seven highly regulated unique genes; four were specific to pollen development, implying that pollen-related genes play critical roles in the establishment of rice susceptibility to U. virens. To my knowledge, this is the first report about probing of molecular response of rice to smut pathogen infection, which will greatly expand our understanding of the molecular events surrounding infection by rice false smut.	[Chao, Jinquan; Jin, Jie; Han, Ran; Zhu, Renshan; Zhu, Yingguo; Li, Shaoqing] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Wang, Dong] Univ Nebraska, Dept Stat, Lincoln, NE USA	Wuhan University; University of Nebraska System; University of Nebraska Lincoln	Li, SQ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	shaoqingli@whu.edu.cn			Transgenic Research and Development Program [2011ZX08001-004-002]; 863 Program [2011AA10A101]; Natural Science Foundation of China [31370363]	Transgenic Research and Development Program; 863 Program(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by the Transgenic Research and Development Program (2011ZX08001-004-002), 863 Program (2011AA10A101) and Natural Science Foundation (31370363) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashizawa T, 2012, J GEN PLANT PATHOL, V78, P255, DOI 10.1007/s10327-012-0389-3; Atia MMM, 2004, Z PFLANZENK PFLANZEN, V111, P71; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Baek KH, 2008, PLANT PATHOLOGY J, V24, P367, DOI 10.5423/PPJ.2008.24.4.367; Bittner-Eddy PD, 2000, PLANT J, V21, P177, DOI 10.1046/j.1365-313x.2000.00664.x; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Burdon JJ, 2009, SCIENCE, V324, P755, DOI 10.1126/science.1171663; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Ding XD, 2009, PLANT PHYSIOL, V149, P1478, DOI 10.1104/pp.108.128298; Diola V, 2013, FUNCT INTEGR GENOMIC, V13, P379, DOI 10.1007/s10142-013-0330-7; Divon HH, 2007, FEMS MICROBIOL LETT, V266, P65, DOI 10.1111/j.1574-6968.2006.00504.x; EBELL LF, 1969, PHYTOCHEMISTRY, V8, P227, DOI 10.1016/S0031-9422(00)85818-5; Ezcurra I, 1999, PLANT MOL BIOL, V40, P699, DOI 10.1023/A:1006206124512; Gao Li, 2013, Plant J, V75, P903, DOI 10.1111/tpj.12270; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grand X, 2012, PLANT BIOTECHNOL J, V10, P840, DOI 10.1111/j.1467-7652.2012.00703.x; Guo XiaoYi, 2012, Journal of Agricultural Science and Technology A, V2, P1211; Jiang CJ, 2010, MOL PLANT MICROBE IN, V23, P791, DOI 10.1094/MPMI-23-6-0791; Jin GH, 2013, J PLANT PHYSIOL, V170, P321, DOI 10.1016/j.jplph.2012.09.008; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; KOISO Y, 1994, J ANTIBIOT, V47, P765, DOI 10.7164/antibiotics.47.765; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kyndt T, 2012, J EXP BOT, V63, P2141, DOI 10.1093/jxb/err435; Leterrier M, 2005, PLANT PHYSIOL, V138, P2111, DOI 10.1104/pp.105.066225; Li H, 2009, PLANT MOL BIOL, V69, P337, DOI 10.1007/s11103-008-9430-5; Li YuSheng, 2011, Acta Agronomica Sinica, V37, P778, DOI 10.3724/SP.J.1006.2011.00788; Mao CZ, 2006, PLANT MOL BIOL, V61, P141, DOI 10.1007/s11103-005-6184-1; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-262; Qi YH, 2004, PLANTA, V219, P450, DOI 10.1007/s00425-004-1245-2; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Rea AC, 2010, J EXP BOT, V61, P1897, DOI 10.1093/jxb/erp393; RUFTY TW, 1983, PLANT PHYSIOL, V72, P474, DOI 10.1104/pp.72.2.474; Rush M C, 2000, Plant Dis, V84, P100, DOI 10.1094/PDIS.2000.84.1.100D; Schroud P., 2005, ARK AGR EXP STAT RES, V540, P143; Schulze-Lefert P, 2003, ANNU REV PHYTOPATHOL, V41, P641, DOI 10.1146/annurev.phyto.41.061002.083300; Seah S, 2001, THEOR APPL GENET, V102, P600, DOI 10.1007/s001220051686; Simoes I, 2004, EUR J BIOCHEM, V271, P2067, DOI 10.1111/j.1432-1033.2004.04136.x; Socquet-Juglard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054196; Sun XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076879; Tang YX, 2013, PLANT PATHOL, V62, P1, DOI 10.1111/j.1365-3059.2012.02629.x; TeBeest D, 2010, PHYTOPATHOLOGY, V100, P125; Tena G, 2011, CURR OPIN PLANT BIOL, V14, P519, DOI 10.1016/j.pbi.2011.05.006; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yap YK, 2005, PLANT PHYSIOL, V139, P127, DOI 10.1104/pp.105.065656; Yin YH, 2002, P NATL ACAD SCI USA, V99, P9090, DOI 10.1073/pnas.152330799; Yu DX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016818, 10.1371/journal.pone.0016079]; Zhang DB, 2011, J GENET GENOMICS, V38, P379, DOI 10.1016/j.jgg.2011.08.001; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang XW, 2012, PLANT CELL, V24, P5159, DOI 10.1105/tpc.112.105957; Zhu QH, 2013, GENE, V512, P259, DOI 10.1016/j.gene.2012.10.036	53	27	33	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91391	10.1371/journal.pone.0091391	http://dx.doi.org/10.1371/journal.pone.0091391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646527	Green Published, gold			2022-12-27	WOS:000333348500035
J	McCartney, JA; Stevens, NJ; O'Connor, PM				McCartney, Jacob A.; Stevens, Nancy J.; O'Connor, Patrick M.			The Earliest Colubroid-Dominated Snake Fauna from Africa: Perspectives from the Late Oligocene Nsungwe Formation of Southwestern Tanzania	PLOS ONE			English	Article							RUKWA RIFT BASIN; RED SANDSTONE GROUP; REVISED CLASSIFICATION; EARLY EOCENE; PHYLOGENY; SERPENTES; PALEOGENE; NUCLEAR; MIOCENE; MITOCHONDRIAL	The extant snake fauna has its roots in faunal upheaval occurring across the Paleogene - Neogene transition. On northern continents, this turnover is well established by the late early Miocene. However, this transition is poorly documented on southern landmasses, particularly on continental Africa, where no late Paleogene terrestrial snake assemblages are documented south of the equator. Here we describe a newly discovered snake fauna from the Late Oligocene Nsungwe Formation in the Rukwa Rift Basin of Tanzania. The fauna is small but diverse with eight identifiable morphotypes, comprised of three booids and five colubroids. This fauna includes Rukwanyoka holmani gen. et sp. nov., the oldest boid known from mainland Africa. It also provides the oldest fossil evidence for the African colubroid clade Elapidae. Colubroids dominate the fauna, comprising more than 75% of the recovered material. This is likely tied to local aridification and/or seasonality and mirrors the pattern of overturn in later snake faunas inhabiting the emerging grassland environments of Europe and North America. The early emergence of colubroid dominance in the Rukwa Rift Basin relative to northern continents suggests that the pattern of overturn that resulted in extant faunas happened in a more complex fashion on continental Africa than was previously realized, with African colubroids becoming at least locally important in the late Paleogene, either ahead of or as a consequence of the invasion of colubrids. The early occurrence of elapid snakes in the latest Oligocene of Africa suggests the clade rapidly spread from Asia to Africa, or arose in Africa, before invading Europe.	[McCartney, Jacob A.] SUNY Stony Brook, Hlth Sci Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA; [McCartney, Jacob A.; Stevens, Nancy J.; O'Connor, Patrick M.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [McCartney, Jacob A.; Stevens, Nancy J.; O'Connor, Patrick M.] Ohio Univ, Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Stevens, NJ (corresponding author), Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Irvine Hall, Athens, OH 45701 USA.	stevensn@ohio.edu	Stevens, Nancy J/E-6928-2013; OConnor, Patrick M/I-9383-2012	OConnor, Patrick M/0000-0002-6762-3806	National Geographic Society (CRE); LSB Leakey Foundation; Ohio University African Studies Program; Ohio University Research Council; Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee; National Science Foundation [EAR 0617561, EAR/IF 0933619, BCS 1127164]; Direct For Social, Behav & Economic Scie [1127164] Funding Source: National Science Foundation; Directorate For Geosciences [1349825] Funding Source: National Science Foundation	National Geographic Society (CRE)(National Geographic Society); LSB Leakey Foundation; Ohio University African Studies Program; Ohio University Research Council; Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee; National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Financial support was provided by: National Geographic Society (CRE), LSB Leakey Foundation, Ohio University African Studies Program, Ohio University Research Council, Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee, and the National Science Foundation (EAR 0617561; EAR/IF 0933619; BCS 1127164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2008, MOL PHYLOGENET EVOL, V46, P576, DOI 10.1016/j.ympev.2007.10.024; Andrews C. W., 1901, Geological Magazine (2), VDec. iv, P436; Andrews CW., 1924, GEOLOGICAL SURVEY NI, V7, P39; Andrews CW., 1906, DESCRIPTIVE CATALOGU; Antunes MT, 1964, NEOCRETACICO CENOZOI; Apesteguia S, 2006, NATURE, V440, P1037, DOI 10.1038/nature04413; AUFFENBERG W., 1959, BREVIORA MUS COMP ZOOL [HARVARD], V114, P1; Auffenberg W., 1958, American Museum Novitates, VNo. 1874, P1; AUFFENBERG WALTER, 1963, TULANE STUD ZOOL, V10, P131; Auge M, 1997, GEOLOGIE FRANCE, V1, P22; Auge Marc, 2006, Annales de Paleontologie, V92, P235, DOI 10.1016/j.annpal.2005.09.001; BAILON S, 1994, CIFEG OCCASIONAL PUB, V29, P129; BOGERT CHARLES M., 1964, SENCKENBERG BIOL, V45, P509; Bogert CM, 1941, B AM MUS NAT HIST, V57, P1; Boie F, 1827, ISIS OKEN, V20, P508; CUNDALL D, 1993, ZOOL J LINN SOC-LOND, V109, P275, DOI 10.1006/zjls.1993.1039; Depuret C., 1890, PALEONTOLOGIE, V3, P1; Dowling H. G., 1959, Copeia, V1953, P38; ESTES R, 1970, Forma et Functio, V3, P139; Feldmann RM, 2007, NEUES JAHRB GEOL P-A, V244, P71, DOI 10.1127/0077-7749/2007/0244-0071; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Gottfried M, 2007, J VERTEBR PALEONTOL, V27, p83A; Gower DJ, 2005, J ZOOL SYST EVOL RES, V43, P315, DOI 10.1111/j.1439-0469.2005.00315.x; Gray JE., 1825, ANN PHILOS, V2, P193; Guicking D, 2006, BIOL J LINN SOC, V87, P127, DOI 10.1111/j.1095-8312.2006.00561.x; Guo P, 2012, MOL PHYLOGENET EVOL, V63, P825, DOI 10.1016/j.ympev.2012.02.021; Head Jason J., 2007, Kirtlandia, V56, P177; Head JJ, 2005, J VERTEBR PALEONTOL, V25, P246, DOI 10.1671/0272-4634(2005)025[0246:FROSSF]2.0.CO;2; Hendey Q. B., 1969, S AFRICAN ARCHAEOLOG, V24, P96; Hoffstetter R., 1961, Bull Mus Hist nat Paris, V33, P326; Hoffstetter R., 1972, Annales Paleont (Vert), V58, P81; Hoffstetter R., 1969, P201; Hoffstetter R., 1939, ARCH MUS HIST NAT LY, V15, P1; HOFFSTETTER ROBERT, 1946, BULL MUS NATION HIST NAT [PARIS], V18, P132; Holman, 2000, FOSSIL SNAKES N AM O; Holman J.A., 1984, Journal of Vertebrate Paleontology, V3, P223; Holman J. Alan, 1999, Acta Zoologica Cracoviensia, V42, P447; Holman J. Alan, 1993, Tertiary Research, V14, P151; HOLMAN JA, 1977, HERPETOLOGICA, V33, P391; HOLMAN JA, 1977, HERPETOLOGICA, V33, P443; Ikeda Tadahiro, 2007, Current Herpetology, V26, P13, DOI 10.3105/1345-5834(2007)26[13:ACMSOT]2.0.CO;2; Ivanov M, 2002, ACTA PALAEONTOL POL, V47, P513; Ivanov Martin, 2001, Palaeontologische Zeitschrift, V74, P563; Ivanov Martin, 2000, Geodiversitas, V22, P559; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; Jacobs BF, 2004, PALAEOGEOGR PALAEOCL, V213, P115, DOI 10.1016/j.palaeo.2004.07.007; Kelly CMR, 2009, CLADISTICS, V25, P38, DOI 10.1111/j.1096-0031.2008.00237.x; Kelly CMR, 2011, MOL PHYLOGENET EVOL, V58, P415, DOI 10.1016/j.ympev.2010.11.010; Kluge A. G., 1991, MISCELLANEOUS PUBLIC, V178, P1; Kuch U, 2006, NATURWISSENSCHAFTEN, V93, P84, DOI 10.1007/s00114-005-0065-y; LaDuke T.C., 1991, CONTRIBUTIONS SCI NA, V424, P1, DOI [10.5962/p.226807, DOI 10.5962/P.226807]; Lawson R, 2005, MOL PHYLOGENET EVOL, V37, P581, DOI 10.1016/j.ympev.2005.07.016; Lawson R, 2004, J ZOOL, V263, P285, DOI 10.1017/S0952836904005278; Lee MSY, 2007, SYST BIODIVERS, V5, P371, DOI 10.1017/S1477200007002290; Lee MSY, 2002, BIOL REV, V77, P333, DOI 10.1017/S1464793102005924; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; List J. C., 1966, Illinois Biological Monographs, VNo. 36, P1; Madden CT, 1972, PALEOBIOS, V14, P1; MALNATE E V, 1972, Zoologische Mededelingen (Leiden), V47, P225; MCDOWELL S B, 1968, Journal of the Linnean Society of London Zoology, V47, P561; Meylan P.A., 1987, P78; Mlynarski M., 1982, Estudios Geologicos (Madrid), V38, P103; Nagy ZT, 2005, AFRICAN BIODIVERSITY: MOLECULES, ORGANISMS, ECOSYSTEMS, P221, DOI 10.1007/0-387-24320-8_20; Nopcsa F, 1923, PALAEONTOGRAPHICA, V55, P97; O'Connor PM, 2006, J AFR EARTH SCI, V44, P277, DOI 10.1016/j.jafrearsci.2005.11.022; Oppel M., 1811, ORDNUNGEN FAMILIEN G; Parmley Dennis, 2003, Acta Zoologica Cracoviensia, V46, P1; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Pyron RA, 2013, MOL PHYLOGENET EVOL, V66, P969, DOI 10.1016/j.ympev.2012.12.004; Pyron RA, 2012, EVOLUTION, V66, P163, DOI 10.1111/j.1558-5646.2011.01437.x; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; Rage, 1974, PALAEOVERTEBRATA, V6, P274; Rage J.C., 1973, Fossil Vertebr Afr, V3, P1; Rage J.-C., 1979, Bulletin de la Societe Geologique de France, V21, P329; Rage J.C., 1999, Palaeontologia Africana, V35, P85; RAGE J. C., 1984, SERPENTES HDB PALAOH, V11; RAGE J-C, 1981, Geobios (Villeurbanne), V14, P537, DOI 10.1016/S0016-6995(81)80127-1; RAGE J-C, 1988, Acta Zoologica Cracoviensia, V31, P457; RAGE J-C, 1987, P51; RAGE JC, 1983, CR ACAD SCI III-VIE, V296, P1029; Rage JC, 2005, CR PALEVOL, V4, P428, DOI 10.1016/j.crpv.2005.04.001; RAGE JC, 1975, CR ACAD SCI D NAT, V281, P515; Rage JC, 2003, GEODIVERSITAS, V25, P695; RAGE JC, 1992, CR ACAD SCI II, V314, P1085; Rage JC, 2008, ACTA PALAEONTOL POL, V53, P391, DOI 10.4202/app.2008.0303; Rage JC, 2013, ANN PALEONTOL, V99, P217, DOI 10.1016/j.annpal.2013.04.001; Rage Jean-Claude, 2003, Geological Survey of Namibia Memoir, V19, P43; Rage JC, 2010, GEOBIOS-LYON, V43, P253, DOI 10.1016/j.geobios.2009.08.002; Rasband W.S., 1997, IMAGEJ; Roberts EM, 2012, NAT GEOSCI, V5, P289, DOI [10.1038/ngeo1432, 10.1038/NGEO1432]; Roberts EM, 2004, CRETACEOUS RES, V25, P749, DOI 10.1016/j.cretres.2004.06.007; Roberts EM, 2010, J AFR EARTH SCI, V57, P179, DOI 10.1016/j.jafrearsci.2009.09.002; Sanders KL, 2010, MOL PHYLOGENET EVOL, V56, P857, DOI 10.1016/j.ympev.2010.04.031; SAVITZKY AH, 1980, EVOLUTION, V34, P1194, DOI 10.1111/j.1558-5646.1980.tb04065.x; Scanferla Agustin, 2013, PLoS ONE, V8, P1; Scanlon JD, 2006, NATURE, V439, P839, DOI 10.1038/nature04137; Scanlon JD, 2003, GEOBIOS-LYON, V36, P573, DOI 10.1016/S0016-6995(03)00056-1; Simons V, 2008, J VERTEBR PALEONTOL, V28, p143A; Smith KT, 2013, ZOOL ANZ, V252, P157, DOI 10.1016/j.jcz.2012.05.006; Sood MS, 1941, P INDIAN ACAD SCI B, V14, P191; Stevens N, 2006, J VERTEBR PALEONTOL, V26, p128A; Stevens NJ, 2009, J VERTEBR PALEONTOL, V29, P972, DOI 10.1671/039.029.0302; Stevens NJ, 2009, J VERTEBR PALEONTOL, V29, P631, DOI 10.1671/039.029.0219; Stevens NJ, 2005, J VERTEBR PALEONTOL, V25, P986, DOI 10.1671/0272-4634(2005)025[0986:AAPHFT]2.0.CO;2; Stevens NJ, 2006, J PALEONTOL, V80, P407, DOI 10.1666/0022-3360(2006)080[0407:MRPFTP]2.0.CO;2; Stevens NJ, 2010, J VERTEBR PALEONTOL, V30, p171A; Stevens NJ, 2013, NATURE, P1; Stevens NJ, 2008, E SIMONS SEARCH ORIG; SZYNDLAR Z, 1991, Estudios Geologicos (Madrid), V47, P103; SZYNDLAR Z, 1994, J VERTEBR PALEONTOL, V14, P24, DOI 10.1080/02724634.1994.10011536; Szyndlar Z, 2003, NONERYCINE BOOIDEA O; Szyndlar Zbigniew, 1996, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V240, P145; Szyndlar Z, 2012, B SOC GEOL FR, V183, P661, DOI 10.2113/gssgfbull.183.6.661; Szyndlar Zbigniew, 1993, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V192, P1; Szyndlar Z, 2009, PALAEONTOL Z, V83, P55, DOI 10.1007/s12542-009-0009-5; Tchernov E, 2000, SCIENCE, V287, P2010, DOI 10.1126/science.287.5460.2010; THIREAU MICHEL, 1967, BULL MUS NAT HIST NATUR, V39, P454; THOMAS H, 1991, B SOC GEOL FR, V162, P713; Tihen JA, 1964, SENCKENBERG BIOL, V45, P265; Underwood G., 1976, Linnean Soc Symp Ser, V3, P151; UNDERWOOD G, 1993, ZOOL J LINN SOC-LOND, V107, P3, DOI 10.1006/zjls.1993.1002; Vidal N, 2002, CR BIOL, V325, P977, DOI 10.1016/S1631-0691(02)01510-X; Vidal Nicolas, 2007, P27; Vidal N, 2007, CR BIOL, V330, P182, DOI 10.1016/j.crvi.2006.10.001; Vidal Nicolas, 2009, P390; WHISTLER DP, 1989, HERPETOLOGICA, V45, P350; Wiens JJ, 2008, SYST BIOL, V57, P420, DOI 10.1080/10635150802166053; Zaher Hussam, 2009, Pap. Avulsos Zool., V49, P115	128	40	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e90415	10.1371/journal.pone.0090415	http://dx.doi.org/10.1371/journal.pone.0090415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646522	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500014
J	Moreira, FC; Assumpcao, M; Hamoy, IG; Darnet, S; Burbano, R; Khayat, A; Goncalves, AN; Alencar, DO; Cruz, A; Magalhaes, L; Araujo, W; Silva, A; Santos, S; Demachki, S; Assumpcao, P; Ribeiro-dos-Santos, A				Moreira, Fabiano Cordeiro; Assumpcao, Monica; Hamoy, Igor G.; Darnet, Sylvain; Burbano, Rommel; Khayat, Andre; Goncalves, Andre Nicolau; Alencar, Dayse O.; Cruz, Aline; Magalhaes, Leandro; Araujo, Wilson, Jr.; Silva, Artur; Santos, Sidney; Demachki, Samia; Assumpcao, Paulo; Ribeiro-dos-Santos, Andrea			MiRNA Expression Profile for the Human Gastric Antrum Region Using Ultra-Deep Sequencing	PLOS ONE			English	Article							CANCER-CELL-LINES; MICRORNA TARGETS; SMALL RNAS; PROTEIN; ADHESION; FAMILY; APOPTOSIS; TISSUES; GENES; ROLES	Background: MicroRNAs are small non-coding nucleotide sequences that regulate gene expression. These structures are fundamental to several biological processes, including cell proliferation, development, differentiation and apoptosis. Identifying the expression profile of microRNAs in healthy human gastric antrum mucosa may help elucidate the miRNA regulatory mechanisms of the human stomach. Methodology/Principal Findings: A small RNA library of stomach antrum tissue was sequenced using high-throughput SOLiD sequencing technology. The total read count for the gastric mucosa antrum region was greater than 618,000. After filtering and aligning using with MirBase, 148 mature miRNAs were identified in the gastric antrum tissue, totaling 3,181 quality reads; 63.5% (2,021) of the reads were concentrated in the eight most highly expressed miRNAs (hsa-mir-145, hsa-mir-29a, hsa-mir-29c, hsa-mir-21, hsa-mir-451a, hsa-mir-192, hsa-mir-191 and hsa-mir-148a). RT-PCR validated the expression profiles of seven of these highly expressed miRNAs and confirmed the sequencing results obtained using the SOLiD platform. Conclusions/Significance: In comparison with other tissues, the antrum's expression profile was unique with respect to the most highly expressed miRNAs, suggesting that this expression profile is specific to stomach antrum tissue. The current study provides a starting point for a more comprehensive understanding of the role of miRNAs in the regulation of the molecular processes of the human stomach.	[Moreira, Fabiano Cordeiro; Assumpcao, Monica; Hamoy, Igor G.; Darnet, Sylvain; Burbano, Rommel; Khayat, Andre; Goncalves, Andre Nicolau; Alencar, Dayse O.; Cruz, Aline; Magalhaes, Leandro; Silva, Artur; Santos, Sidney; Assumpcao, Paulo; Ribeiro-dos-Santos, Andrea] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Hamoy, Igor G.] Univ Fed Rural Amazonia, Capanema, PA, Brazil; [Burbano, Rommel; Khayat, Andre; Santos, Sidney; Demachki, Samia; Ribeiro-dos-Santos, Andrea] Fed Univ Para, Nucleo Pesquisa Oncol, BR-66059 Belem, Para, Brazil; [Araujo, Wilson, Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Reg Hemoterapia, BR-14049 Ribeirao Preto, SP, Brazil; [Demachki, Samia] Fed Univ Para, Inst Ciencias Saude, BR-66059 Belem, Para, Brazil; [Assumpcao, Monica; Assumpcao, Paulo] Fed Univ Para, Hosp Univ Joao de Barros Barreto, BR-66059 Belem, Para, Brazil; [Cruz, Aline] Secretaria Estadual Saude Estado Para, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal Rural da Amazonia (UFRA); Universidade Federal do Para; Universidade de Sao Paulo; Universidade Federal do Para; Universidade Federal do Para	Ribeiro-dos-Santos, A (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	akelyufpa@gmail.com	Hamoy, Igor/S-5230-2019; Luiz Silva, Artur da Costa da/AAI-3516-2021; Burbano, Rommel R/C-4149-2012; Khayat, Andre/AAF-2415-2019; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Santos, Ândrea Ribeiro dos/B-6061-2013; DARNET, Sylvain Henri/G-4912-2012; Silva Jr, Wilson Araújo/E-9487-2011; Silva, Artur/E-1474-2014; CTC USP, CEPID 13 18/J-8951-2014; Aquime Goncalves, Andre Nicolau/Q-8326-2018; Moreira, Fabiano/I-2817-2015	Hamoy, Igor/0000-0002-7412-4263; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Burbano, Rommel R/0000-0002-4872-234X; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; DARNET, Sylvain Henri/0000-0001-6351-0903; Silva Jr, Wilson Araújo/0000-0001-9364-2886; Silva, Artur/0000-0002-4082-1132; Cruz Ramos, Aline MP/0000-0001-8812-2923; CTC USP, CEPID 13 18/0000-0002-7123-9524; Magalhaes, Leandro/0000-0002-2399-7769; Aquime Goncalves, Andre Nicolau/0000-0001-5264-8368; Moreira, Fabiano/0000-0002-2799-3546	CNPq/Brazil [162605/2011- 0]; CNPq/Produtividade; Governo do Para/SEDECT/FAPESPA; PROPESP/UFPA-FADESP	CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/Produtividade; Governo do Para/SEDECT/FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PROPESP/UFPA-FADESP	IGH is supported by Pos-Doc Junior (PDJ) fellowship from CNPq/Brazil (162605/2011- 0); ANDREA RIBEIRO-DOS-SANTOS supported by CNPq/Produtividade; SS supported by CNPq/Produtividade; ROMMEL BURBANO supported by CNPq/Produtividade; Governo do Para/SEDECT/FAPESPA, PROPESP/UFPA-FADESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2012, BIOCHEM BIOPH RES CO, V425, P908, DOI 10.1016/j.bbrc.2012.08.009; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Callahan JW, 2009, J PROTEOMICS, V72, P23, DOI 10.1016/j.jprot.2008.11.007; Cho WCS, 2009, EUR J CANCER, V45, P2197, DOI 10.1016/j.ejca.2009.04.039; Gao JL, 2012, MOL BIOL REP, V39, P8883, DOI 10.1007/s11033-012-1755-0; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grunewald TGP, 2009, TRANSL ONCOL, V2, P107, DOI 10.1593/tlo.09112; Gulmann C, 2004, WORLD J GASTROENTERO, V10, P17; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Howell GR, 2007, GENETICS, V175, P699, DOI 10.1534/genetics.106.065177; HUNTRISS JD, 1993, NUCLEIC ACIDS RES, V21, P4047, DOI 10.1093/nar/21.17.4047; ICHIYANAGI S, 1992, GASTROENTEROL JPN, V27, P559; Kim WJ, 2012, MOL CELL, V45, P587, DOI 10.1016/j.molcel.2011.12.025; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002690; Lock FE, 2010, ONCOGENE, V29, P4307, DOI 10.1038/onc.2010.192; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Merkerova M, 2010, STEM CELLS DEV, V19, P17, DOI 10.1089/scd.2009.0071; Mori T, 2012, FEBS LETT, V586, P1570, DOI 10.1016/j.febslet.2012.04.038; Philipps DL, 2008, DEV BIOL, V317, P72, DOI 10.1016/j.ydbio.2008.02.018; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Ribeiro-dos-Santos A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013205; Ricarte Filho Júlio C.M., 2006, Arq Bras Endocrinol Metab, V50, P1102, DOI 10.1590/S0004-27302006000600018; Saito Y, 2013, INT J CANCER, V132, P1751, DOI 10.1002/ijc.27862; Sanna MG, 2002, J BIOL CHEM, V277, P30454, DOI 10.1074/jbc.M203312200; Sherwood V, 2010, BIOCHEM J, V425, P303, DOI 10.1042/BJ20091318; Sun XJ, 2004, J BIOL CHEM, V279, P32839, DOI 10.1074/jbc.M402522200; Wang CM, 2011, BIOCHEM BIOPH RES CO, V411, P586, DOI 10.1016/j.bbrc.2011.06.191; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0	41	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92300	10.1371/journal.pone.0092300	http://dx.doi.org/10.1371/journal.pone.0092300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647245	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500109
J	O'Neill, S; Ferry, F; Murphy, S; Corry, C; Bolton, D; Devine, B; Ennis, E; Bunting, B				O'Neill, Siobhan; Ferry, Finola; Murphy, Sam; Corry, Colette; Bolton, David; Devine, Barney; Ennis, Edel; Bunting, Brendan			Patterns of Suicidal Ideation and Behavior in Northern Ireland and Associations with Conflict Related Trauma	PLOS ONE			English	Article							SELF-HARM; HEALTH	In this study, data from the World Mental Health Survey's Northern Ireland (NI) Study of Health and Stress (NISHS) was used to assess the associations between conflict- and non-conflict-related traumatic events and suicidal behaviour, controlling for age and gender and the effects of mental disorders in NI. DSM mental disorders and suicidal ideation, plans and attempts were assessed using the Composite International Diagnostic Interview (CIDI) in a multi-stage, clustered area probability household sample (N = 4,340, response rate 68.4%). The traumatic event categories were based on event types listed in the PTSD section of the CIDI. Suicidal ideation and attempts were more common in women than men, however, rates of suicide plans were similar for both genders. People with mood, anxiety and substance disorders were significantly more likely than those without to endorse suicidal ideation, plan or attempt. The highest odds ratios for all suicidal behaviors were for people with any mental disorder. However, the odds of seriously considering suicide were significantly higher for people with conflict and non-conflict-related traumatic events compared with people who had not experienced a traumatic event. The odds of having a suicide plan remain significantly higher for people with conflict- related traumatic events compared to those with only non-conflict-related events and no traumatic events. Finally, the odds of suicide attempt were significantly higher for people who have only non-conflict-related traumatic events compared with the other two categories. The results suggest that traumatic events associated with the NI conflict may be associated with suicidal ideation and plans, and this effect appears to be in addition to that explained by the presence of mental disorders. The reduced rates of suicide attempts among people who have had a conflict-related traumatic event may reflect a higher rate of single, fatal suicide attempts in this population.	[O'Neill, Siobhan; Ferry, Finola; Murphy, Sam; Corry, Colette; Ennis, Edel; Bunting, Brendan] Univ Ulster, Bamford Ctr Mental Hlth & Well Being, Coleraine BT52 1SA, Londonderry, North Ireland; [Bolton, David; Devine, Barney] Initiat Conflict Related Trauma, Enniskillen, Fermanagh, North Ireland	Ulster University	O'Neill, S (corresponding author), Univ Ulster, Bamford Ctr Mental Hlth & Well Being, Coleraine BT52 1SA, Londonderry, North Ireland.	sm.oneill@ulster.ac.uk		Ferry, Finola/0000-0003-1875-5180; Ennis, Edel/0000-0002-9677-0725; O'Neill, Siobhan/0000-0002-8786-2118; Bolton, David/0000-0001-9818-9590	research and development division of the Public Health Agency, Northern Ireland; Medical Research Council [MR/K023241/1] Funding Source: researchfish; MRC [MR/K023241/1] Funding Source: UKRI	research and development division of the Public Health Agency, Northern Ireland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the research and development division of the Public Health Agency, Northern Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MENT MENT; [Anonymous], 2008, WHO WORLD MENTAL HLT; Bunting BP, 2012, PSYCHOL MED, V42, P1727, DOI 10.1017/S0033291711002510; Bunting B, 2013, SOC PSYCH PSYCH EPID, V48, P81, DOI 10.1007/s00127-012-0518-5; Bunting BP, 2013, J TRAUMA STRESS, V26, P134, DOI 10.1002/jts.21766; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Cooper J, 2002, SOC PSYCH PSYCH EPID, V37, P271, DOI 10.1007/s001270200019; Department of Health Social Services and Public Safety, 2006, PROT LIF SHAR VIS NO; Durkheim E., 2002, SUICIDE STUDY SOCIOL; Haw C, 2008, J AFFECT DISORDERS, V109, P139, DOI 10.1016/j.jad.2007.12.224; Heeringa S. G., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P14; Joiner T. E., 2005, WHY PEOPLE DIE SUICI; Karam EG, 2008, PLOS MED, V5, P579, DOI 10.1371/journal.pmed.0050061; McDaid D, 2010, INJURY PREV, V16, pA257, DOI 10.1136/ip.2010.029215.916; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2012, PERSPECTIVES WHO WOR, P148; O'Connor R, 2011, BR J PSYCH, V200, P330; O'Connor RC, 2011, CRISIS, V32, P295, DOI 10.1027/0227-5910/a000120; Pitman A, 2012, LANCET, V379, P2383, DOI 10.1016/S0140-6736(12)60731-4; Selby EA, 2010, CLIN PSYCHOL REV, V30, P298, DOI 10.1016/j.cpr.2009.12.004; StataCorp, 2007, STAT SOFTW REL 10 0; Stein DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010574; Stein DJ, 2012, SUICIDE GLOBAL PERSP, P131; Tomlinson MW, 2012, INT SOCIOL, V27, P464, DOI 10.1177/0268580912443579; Turecki G, 2005, J PSYCHIATR NEUROSCI, V30, P398; World Health Organization, 1992, ICD 10 CLASSIFICATIO	26	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91532	10.1371/journal.pone.0091532	http://dx.doi.org/10.1371/journal.pone.0091532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24646627	gold, Green Published			2022-12-27	WOS:000333348500037
J	Rico, E; Oliva, C; Gutierrez, KJ; Alzate, JF; Genes, CM; Moreno, D; Casanova, E; Gigante, A; Perez-Perez, MJ; Camarasa, MJ; Clos, J; Gago, F; Jimenez-Ruiz, A				Rico, Eva; Oliva, Cristina; Jesus Gutierrez, Kilian; Fernando Alzate, Juan; Mario Genes, Carlos; Moreno, David; Casanova, Elena; Gigante, Alba; Perez-Perez, Maria-Jesus; Camarasa, Maria-Jose; Clos, Joachim; Gago, Federico; Jimenez-Ruiz, Antonio			Leishmania infantum EndoG Is an Endo/Exo-Nuclease Essential for Parasite Survival	PLOS ONE			English	Article							MITOCHONDRIAL ENDONUCLEASE-G; PROGRAMMED CELL-DEATH; PURIFICATION; APOPTOSIS	EndoG, a member of the DNA/RNA non-specific beta beta alpha-metal family of nucleases, has been demonstrated to be present in many organisms, including Trypanosomatids. This nuclease participates in the apoptotic program in these parasites by migrating from the mitochondrion to the nucleus, where it takes part in the degradation of genomic DNA that characterizes this process. We now demonstrate that Leishmania infantum EndoG (LiEndoG) is an endo-exonuclease that has a preferential 59 exonuclease activity on linear DNA. Regardless of its role during apoptotic cell death, this enzyme seems to be necessary during normal development of the parasites as indicated by the reduced growth rates observed in LiEndoG hemi-knockouts and their poor infectivity in differentiated THP-1 cells. The pro-life role of this protein is also corroborated by the higher survival rates of parasites that over-express this protein after treatment with the LiEndoG inhibitor Lei49. Taken together, our results demonstrate that this enzyme plays essential roles in both survival and death of Leishmania parasites.	[Rico, Eva; Oliva, Cristina; Jesus Gutierrez, Kilian; Mario Genes, Carlos; Moreno, David; Jimenez-Ruiz, Antonio] Univ Alcala de Henares, CSIC, Dept Biol Sistemas, Unidad Asociada, Madrid, Spain; [Fernando Alzate, Juan] Univ Antioquia, Fac Med, Dept Microbiol & Parasitol, Medellin, Colombia; [Casanova, Elena; Gigante, Alba; Perez-Perez, Maria-Jesus; Camarasa, Maria-Jose] IQM CSIC, Madrid, Spain; [Clos, Joachim] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Gago, Federico] CSIC, Unidad Asociada, Dept Ciencias Biomed, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Alcala; Universidad de Antioquia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Medica (IQM); Bernhard Nocht Institut fur Tropenmedizin; Consejo Superior de Investigaciones Cientificas (CSIC)	Jimenez-Ruiz, A (corresponding author), Univ Alcala de Henares, CSIC, Dept Biol Sistemas, Unidad Asociada, Madrid, Spain.	antonio.jimenez@uah.es	Jimenez-Ruiz, Antonio/K-2991-2014; Oliva, Cristina/AAI-9548-2020; Alzate, Juan F./AFD-6646-2022; Camarasa, María-José/N-8845-2019; Perez-Perez, Maria-Jesus/O-4580-2014; Camarasa, María-José/B-6340-2015; Gago, Federico/H-1004-2015; Gago, Federico/AAS-3992-2020; Moreno, David/J-2969-2012	Jimenez-Ruiz, Antonio/0000-0001-8238-3081; Alzate, Juan F./0000-0003-2578-4609; Camarasa, María-José/0000-0002-4978-6468; Perez-Perez, Maria-Jesus/0000-0003-1336-7760; Camarasa, María-José/0000-0002-4978-6468; Gago, Federico/0000-0002-3071-4878; Gago, Federico/0000-0002-3071-4878; Moreno, David/0000-0002-7017-4095; Gigante, Alba/0000-0003-2606-665X; Genes, Carlos/0000-0001-5449-3355	Spanish MEC/MICINN [SAF2009-13914-C02]; Comunidad de Madrid [S-2010/BMD-2457]; Junta de Comunidades de Castilla la Mancha [POII10-0180-7897]	Spanish MEC/MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Junta de Comunidades de Castilla la Mancha(Junta de Comunidades de Castilla-La Mancha)	Sources of funding: Spanish MEC/MICINN Project SAF2009-13914-C02; Comunidad de Madrid Project BIPEDD-2-CM ref S-2010/BMD-2457; Junta de Comunidades de Castilla la Mancha Project POII10-0180-7897. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzate JF, 2006, APOPTOSIS, V11, P161, DOI 10.1007/s10495-006-4570-z; BERNARDI A, 1975, EUR J BIOCHEM, V52, P451, DOI 10.1111/j.1432-1033.1975.tb04013.x; BERNARDI G, 1973, NATURE-NEW BIOL, V246, P36, DOI 10.1038/newbio246036a0; Bosedasgupta S, 2008, CELL DEATH DIFFER; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Casanova E, 2013, CHEMMEDCHEM, V8, P1161, DOI 10.1002/cmdc.201300129; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; CUMMINGS OW, 1987, J BIOL CHEM, V262, P2005; Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169; DAKE E, 1988, J BIOL CHEM, V263, P7691; FRASER MJ, 1989, J BIOL CHEM, V264, P13093; Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050; Loll B, 2009, NUCLEIC ACIDS RES, V37, P7312, DOI 10.1093/nar/gkp770; Low RL, 2003, MITOCHONDRION, V2, P225, DOI 10.1016/S1567-7249(02)00104-6; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Plano D, 2011, EUR J MED CHEM, V46, P3315, DOI 10.1016/j.ejmech.2011.04.054; Quijada L, 2003, MOL BIOCHEM PARASIT, V130, P139, DOI 10.1016/S0166-6851(03)00159-2; Rico E, 2009, MOL BIOCHEM PARASIT, V163, P28, DOI 10.1016/j.molbiopara.2008.09.007; RUIZCARRILLO A, 1987, EMBO J, V6, P401, DOI 10.1002/j.1460-2075.1987.tb04769.x; Schafer P, 2004, J MOL BIOL, V338, P217, DOI 10.1016/j.jmb.2004.02.069; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Yokoyama WM, 2006, CURR PROTOC IMMUNOL; ZASSENHAUS HP, 1994, CURR GENET, V25, P142, DOI 10.1007/BF00309540	23	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89526	10.1371/journal.pone.0089526	http://dx.doi.org/10.1371/journal.pone.0089526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24651293	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000052
J	Presslauer, S; Milosavljevic, D; Huebl, W; Parigger, S; Schneider-Koch, G; Bruecke, T				Presslauer, Stefan; Milosavljevic, Dejan; Huebl, Wolfgang; Parigger, Silvia; Schneider-Koch, Gabriele; Bruecke, Thomas			Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS	PLOS ONE			English	Article							CEREBROSPINAL-FLUID ANALYSIS; MULTIPLE-SCLEROSIS; OLIGOCLONAL BANDS; DIFFERENTIAL-DIAGNOSIS; IMMUNE-RESPONSE; CSF; IGG; CRITERIA; ABSENCE	Background: Quantification of kappa free light chains (KFLC) in cerebrospinal fluid shows high diagnostic sensitivity in multiple sclerosis and clinically isolated syndrome patients. However, a clearly defined threshold value is still missing and a possible prognostic value of the KFLC levels in these patients remains undefined. Methods: Results of KFLC quantification in 420 controls were used to set an upper limit of normal KFLC concentration in CSF under different blood-CSF-barrier conditions. Additionally, KFLC values of MS and CIS patients were assessed and results were evaluated with reference to the patients corresponding disease courses. Results: The calculated upper limit of normal KFLC-concentration covers 98% of these control patients. Using this cut-off, plasma cell activity in CSF can be detected in 97% of MS patients and in 97% of CIS patients. However, there is no evidence that the extent of KFLC elevation provides prognostic value in MS and CIS patients in this study. Conclusion: KFLC determination should become a first line screen in the diagnostic algorithms of MS and CIS. The extent of elevation of intrathecal KFLC has no prognostic value on the disease course in MS and CIS patients.	[Presslauer, Stefan; Parigger, Silvia; Schneider-Koch, Gabriele; Bruecke, Thomas] Wilhelminenspital Stadt Wien, Dept Neurol, Vienna, Austria; [Milosavljevic, Dejan; Huebl, Wolfgang] Wilhelminenspital Stadt Wien, Dept Lab Med, Vienna, Austria	Wilhelminenspital; Wilhelminenspital	Presslauer, S (corresponding author), Wilhelminenspital Stadt Wien, Dept Neurol, Vienna, Austria.	presslauer@gmx.at						Annunziata P, 2006, J NEUROL SCI, V244, P97, DOI 10.1016/j.jns.2006.01.004; Desplat-Jego S, 2005, J CLIN IMMUNOL, V25, P338, DOI 10.1007/s10875-005-5371-9; Dobson R, 2013, J NEUROL NEUROSUR PS, V84, P909, DOI 10.1136/jnnp-2012-304695; Freedman MS, 2005, ARCH NEUROL-CHICAGO, V62, P865, DOI 10.1001/archneur.62.6.865; Goffette S, 2004, J NEUROL NEUROSUR PS, V75, P308, DOI 10.1136/jnnp.2003.010710; Gout O, 2011, MULT SCLER, V17, P164, DOI 10.1177/1352458510385506; Imrell K, 2006, NEUROLOGY, V67, P1062, DOI 10.1212/01.wnl.0000237343.93389.35; Joseph FG, 2009, J NEUROL NEUROSUR PS, V80, P292, DOI 10.1136/jnnp.2008.150896; Ignacio RJ, 2010, J NEUROL, V257, P1188, DOI 10.1007/s00415-010-5490-y; Kaplan B, 2010, J NEUROIMMUNOL, V229, P263, DOI 10.1016/j.jneuroim.2010.09.002; Katzmann JA, 2002, CLIN CHEM, V48, P1437; Krakauer M, 1998, ACTA NEUROL SCAND, V98, P161, DOI 10.1111/j.1600-0404.1998.tb07287.x; LEFVERT AK, 1985, ANN NEUROL, V17, P13, DOI 10.1002/ana.410170105; Link H, 2006, J NEUROIMMUNOL, V180, P17, DOI 10.1016/j.jneuroim.2006.07.006; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MCLEAN BN, 1990, BRAIN, V113, P1269, DOI 10.1093/brain/113.5.1269; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Presslauer S, 2008, J NEUROL, V255, P1508, DOI 10.1007/s00415-008-0954-z; Reiber H, 1998, MULT SCLER, V4, P111, DOI 10.1177/135245859800400304; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Rinker John R 2nd, 2006, Neurology, V67, P1288, DOI 10.1212/01.wnl.0000238107.31364.21; Rudick R A, 1995, Mult Scler, V1, P150; RUDICK RA, 1989, NEUROLOGY, V39, P964, DOI 10.1212/WNL.39.7.964; Schaffler N, 2011, ACTA NEUROL SCAND, V124, P151, DOI 10.1111/j.1600-0404.2010.01454.x; Siritho S, 2009, J NEUROL SCI, V279, P21, DOI 10.1016/j.jns.2008.12.029; STENDAHLBRODIN L, 1980, J NEUROL NEUROSUR PS, V43, P102, DOI 10.1136/jnnp.43.2.102; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; Tintore M, 2013, ECTRIMS 2013 OCT 03; Villar LM, 2005, ARCH NEUROL-CHICAGO, V62, P574, DOI 10.1001/archneur.62.4.574; Villar LM, 2012, CLIN CHIM ACTA, V413, P1813, DOI 10.1016/j.cca.2012.07.007; Zeman AZJ, 1996, J NEUROL NEUROSUR PS, V60, P27, DOI 10.1136/jnnp.60.1.27; Zipoli V, 2009, MULT SCLER J, V15, P472, DOI 10.1177/1352458508100502	34	56	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89945	10.1371/journal.pone.0089945	http://dx.doi.org/10.1371/journal.pone.0089945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24651567	Green Submitted, gold, Green Published			2022-12-27	WOS:000332385900102
J	Carter, R; Mouralidarane, A; Soeda, J; Ray, S; Pombo, J; Saraswati, R; Novelli, M; Fusai, G; Rappa, F; Saracino, C; Pazienza, V; Poston, L; Taylor, PD; Vinciguerra, M; Oben, JA				Carter, Rebeca; Mouralidarane, Angelina; Soeda, Junpei; Ray, Shuvra; Pombo, Joaquim; Saraswati, Ruma; Novelli, Marco; Fusai, Giuseppe; Rappa, Francesca; Saracino, Chiara; Pazienza, Valerio; Poston, Lucilla; Taylor, Paul D.; Vinciguerra, Manlio; Oben, Jude A.			Non-Alcoholic Fatty Pancreas Disease Pathogenesis: A Role for Developmental Programming and Altered Circadian Rhythms	PLOS ONE			English	Article							BODY-MASS INDEX; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; OFFSPRING HYPERPHAGIA; METABOLIC SYNDROME; CANCER; MODEL; METAANALYSIS; ADIPOSITY; PREGNANCY	Objectives: Emerging evidence suggests that maternal obesity (MO) predisposes offspring to obesity and the recently described non-alcoholic fatty pancreas disease (NAFPD) but involved mechanisms remain unclear. Using a pathophysiologically relevant murine model, we here investigated a role for the biological clock -molecular core circadian genes (CCG) in the generation of NAFPD. Design: Female C57BL6 mice were fed an obesogenic diet (OD) or standard chow (SC) for 6 weeks, prior to pregnancy and throughout gestation and lactation: resulting offspring were subsequently weaned onto either OD (Ob_Ob and Con_Ob) or standard chow (Ob_Con and Con_Con) for 6 months. Biochemical, pro-inflammatory and pro-fibrogenic markers associated with NAFPD were then evaluated and CCG mRNA expression in the pancreas determined. Results: Offspring of obese dams weaned on to OD (Ob_Ob) had significantly increased (p<0.05): bodyweight, pancreatic triglycerides, macrovesicular pancreatic fatty-infiltration, and pancreatic mRNA expression of TNF-alpha, IL-6, alpha-SMA, TGF-beta and increased collagen compared to offspring of control dams weaned on to control chow (Con_Con). Analyses of CCG expression demonstrated a phase shift in CLOCK (-4.818, p<0.01), REV-ERB-alpha (-1.4, p<0.05) and Per2 (3.27, p<0.05) in association with decreased amplitude in BMAL-1 (-0.914, p<0.05) and PER2 (1.18, p<0.005) in Ob_Ob compared to Con_Con. 2-way ANOVA revealed significant interaction between MO and post-weaning OD in expression of CLOCK (p<0.005), PER1 (p<0.005) and PER2 (p<0.05) whilst MO alone influenced the observed rhythmic variance in expression of all 5 measured CCG. Conclusions: Fetal and neonatal exposure to a maternal obesogenic environment interacts with a post-natal hyper-calorific environment to induce offspring NAFPD through mechanisms involving perturbations in CCG expression.	[Carter, Rebeca; Mouralidarane, Angelina; Soeda, Junpei; Ray, Shuvra; Vinciguerra, Manlio; Oben, Jude A.] UCL, Royal Free Hosp, Inst Liver & Digest Hlth, London, England; [Ray, Shuvra; Oben, Jude A.] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London, England; [Pombo, Joaquim; Saraswati, Ruma; Poston, Lucilla; Taylor, Paul D.] Kings Coll London, Div Womens Hlth, London WC2R 2LS, England; [Pombo, Joaquim; Saraswati, Ruma; Poston, Lucilla] Kings Hlth Partners, London, England; [Saraswati, Ruma; Novelli, Marco] UCL, Dept Pathol, London, England; [Fusai, Giuseppe] UCL, Royal Free Hosp, Hepatobiliary & Liver Transplant Unit, London, England; [Rappa, Francesca] Univ Palermo, Sect Human Anat, Dept Expt Biomed & Clin Neurosci, Palermo, Italy; [Rappa, Francesca; Vinciguerra, Manlio] Euromediterranean Inst Sci & Technol IEMEST, Palermo, Italy; [Pazienza, Valerio; Vinciguerra, Manlio] IRCCS Casa Sollievo Sofferenza, Gastroenterol Unit, Dept Med Sci, San Giovanni Rotondo, Italy	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Palermo; IRCCS Casa Sollievo Della Sofferenza	Oben, JA (corresponding author), UCL, Royal Free Hosp, Inst Liver & Digest Hlth, London, England.	j.oben@ucl.ac.uk	OBEN, JUDE A/K-4331-2013; Francesca, Rappa/ADW-8431-2022; Soeda, Junpei/AAC-4816-2020; Pazienza, Valerio/K-5073-2012; Vinciguerra, Manlio/N-1309-2015	Pazienza, Valerio/0000-0002-3492-1153; Vinciguerra, Manlio/0000-0002-1768-3894; Poston, Lucilla/0000-0003-1100-2821; Taylor, Paul David/0000-0002-4740-4307; Oben, Jude/0000-0003-3350-8356; Soeda, Junpei/0000-0003-3753-0999; rappa, francesca/0000-0001-6610-5268	Wellcome Trust; MFAG - AIRC; Italian Ministry of Health [RC1303GA49]; Biotechnology and Biological Sciences Research Council [BB/H008845/1] Funding Source: researchfish; BBSRC [BB/H008845/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MFAG - AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JAO is supported by the Wellcome Trust. MV is supported by a MFAG - AIRC grant. VP is supported by a grant of the Italian Ministry of Health (RC1303GA49). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; Benegiamo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060527; Bracci PM, 2012, MOL CARCINOGEN, V51, P53, DOI 10.1002/mc.20778; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Clement S, 2011, HEPATOLOGY, V54, P38, DOI 10.1002/hep.24340; Deblon N, 2012, BRIT J PHARMACOL, V165, P2325, DOI 10.1111/j.1476-5381.2011.01716.x; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Grabiec K, 2012, POSTEP HIG MED DOSW, V66, P1, DOI 10.5604/973505; Hinde K, 2010, AM J PRIMATOL, V72, P522, DOI 10.1002/ajp.20806; Hurt Ryan T, 2011, JPEN J Parenter Enteral Nutr, V35, p4S, DOI 10.1177/0148607111415110; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kohsaka A, 2007, TRENDS ENDOCRIN MET, V18, P4, DOI 10.1016/j.tem.2006.11.005; Lamia KA, 2010, NATURE, V466, P571, DOI 10.1038/466571a; Larsson SC, 2007, INT J CANCER, V120, P1993, DOI 10.1002/ijc.22535; Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]; Mathur Abhishek, 2007, HPB (Oxford), V9, P312, DOI 10.1080/13651820701504157; Matthews PA, 2011, J PHYSIOL-LONDON, V589, P3969, DOI 10.1113/jphysiol.2011.212324; Mazzoccoli G, 2012, CHRONOBIOL INT, V29, P227, DOI 10.3109/07420528.2012.658127; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Norman JE, 2011, P NUTR SOC, V70, P450, DOI 10.1017/S0029665111003077; Oben JA, 2010, BIOCHEM BIOPH RES CO, V394, P24, DOI 10.1016/j.bbrc.2010.02.057; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Organization WH, 2012, OB OV; Orozco-Solis R, 2011, INT J OBESITY, V35, P990, DOI 10.1038/ijo.2010.223; Orozco-Solis R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013537; Patel AV, 2005, CANCER EPIDEM BIOMAR, V14, P459, DOI 10.1158/1055-9965.EPI-04-0583; Peaston AE, 2006, MAMM GENOME, V17, P365, DOI 10.1007/s00335-005-0180-2; Pitt Henry A, 2007, HPB (Oxford), V9, P92, DOI 10.1080/13651820701286177; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Smits MM, 2011, NAT REV GASTRO HEPAT, V8, P169, DOI 10.1038/nrgastro.2011.4; Suter M, 2011, FASEB J, V25, P714, DOI 10.1096/fj.10-172080; Tevy MF, 2013, TRENDS ENDOCRIN MET, V24, P229, DOI 10.1016/j.tem.2012.12.002; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Varcoe TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053800; Veyrat-Durebex C, 2009, AM J PHYSIOL-ENDOC M, V296, pE1120, DOI 10.1152/ajpendo.90592.2008; Vinciguerra M, 2013, CLIN EXP MED; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169	42	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e89505	10.1371/journal.pone.0089505	http://dx.doi.org/10.1371/journal.pone.0089505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24657938	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300006
J	Gong, XW; Li, JB; Lu, QC; Liang, PJ; Zhang, PM				Gong, Xin-Wei; Li, Jing-Bo; Lu, Qin-Chi; Liang, Pei-Ji; Zhang, Pu-Ming			Effective Connectivity of Hippocampal Neural Network and Its Alteration in Mg2+-Free Epilepsy Model	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; PARTIAL DIRECTED COHERENCE; EPILEPTIFORM DISCHARGES; BRAIN NETWORKS; ORGANIZATION; TOPOLOGY; SEIZURE; LOCALIZATION; PROPAGATION; DYNAMICS	Understanding the connectivity of the brain neural network and its evolution in epileptiform discharges is meaningful in the epilepsy researches and treatments. In the present study, epileptiform discharges were induced in rat hippocampal slices perfused with Mg2+-free artificial cerebrospinal fluid. The effective connectivity of the hippocampal neural network was studied by comparing the normal and epileptiform discharges recorded by a microelectrode array. The neural network connectivity was constructed by using partial directed coherence and analyzed by graph theory. The transition of the hippocampal network topology from control to epileptiform discharges was demonstrated. Firstly, differences existed in both the averaged in- and out-degree between nodes in the pyramidal cell layer and the granule cell layer, which indicated an information flow from the pyramidal cell layer to the granule cell layer during epileptiform discharges, whereas no consistent information flow was observed in control. Secondly, the neural network showed different small-worldness in the early, middle and late stages of the epileptiform discharges, whereas the control network did not show the small-world property. Thirdly, the network connectivity began to change earlier than the appearance of epileptiform discharges and lasted several seconds after the epileptiform discharges disappeared. These results revealed the important network bases underlying the transition from normal to epileptiform discharges in hippocampal slices. Additionally, this work indicated that the network analysis might provide a useful tool to evaluate the neural network and help to improve the prediction of seizures.	[Gong, Xin-Wei; Liang, Pei-Ji; Zhang, Pu-Ming] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Li, Jing-Bo; Lu, Qin-Chi] Shanghai Jiao Tong Univ, Ren Ji Hosp, Dept Neurol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, PM (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	pmzhang@sjtu.edu.cn			Key Basic Research Project of Science and Technology Commission of Shanghai [13DJ1400303]; Natural Science Foundation of Shanghai [12ZR1413800]; Shanghai Jiao Tong University Fund for Interdisciplinary Research for Medical Applications [YG2012ZD08]; Seed Fund of Ren Ji Hospital [RJZZ13-005]	Key Basic Research Project of Science and Technology Commission of Shanghai; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Jiao Tong University Fund for Interdisciplinary Research for Medical Applications; Seed Fund of Ren Ji Hospital	This work was supported by the Key Basic Research Project of Science and Technology Commission of Shanghai (13DJ1400303), the Natural Science Foundation of Shanghai (12ZR1413800), the Shanghai Jiao Tong University Fund for Interdisciplinary Research for Medical Applications (YG2012ZD08), and the Seed Fund of Ren Ji Hospital (RJZZ13-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andersen P., 2007, HIPPOCAMPUS BOOK; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Bartolomei F, 2013, CLIN NEUROPHYSIOL; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bertram EH, 2013, EXP NEUROL, V244, P67, DOI 10.1016/j.expneurol.2012.01.028; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Daniel S, 2012, SPECTRAL GRAPH THEOR, P495; Ding L, 2007, NEUROIMAGE, V34, P575, DOI 10.1016/j.neuroimage.2006.09.042; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Dolan KT, 2001, PHYS REV E, V64; Douw L, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00174; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Feldt S, 2011, TRENDS NEUROSCI, V34, P225, DOI 10.1016/j.tins.2011.02.007; Friston KJ, 1995, HUM BRAIN MAPP, V3, P56, DOI 10.1002/hbm.460030106; Gandica Y, 2010, PHYSICA A, V389, P4172, DOI 10.1016/j.physa.2010.05.043; Gong XW, 2010, PROG BIOCHEM BIOPHYS, V37, P1240, DOI 10.3724/SP.J.1206.2010.00065; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; Hill AJ, 2010, J NEUROSCI METH, V185, P246, DOI 10.1016/j.jneumeth.2009.10.007; Kass RE, 2003, NETWORK-COMP NEURAL, V14, P5, DOI 10.1088/0954-898X/14/1/301; Korzeniewska A, 1997, J NEUROSCI METH, V73, P49, DOI 10.1016/S0165-0270(96)02212-1; Kramer MA, 2008, EPILEPSY RES, V79, P173, DOI 10.1016/j.eplepsyres.2008.02.002; Kramer MA, 2012, NEUROSCIENTIST, V18, P360, DOI 10.1177/1073858411422754; [李静波 Li Jingbo], 2012, [生物物理学报, Acta Biophysica Sinica], V28, P119; Liao W., 2010, PLOS ONE, V5; Liu JS, 2013, NEUROSCI BULL, V29, P28, DOI 10.1007/s12264-013-1304-4; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; MORF M, 1978, IEEE T GEOSCI REMOTE, V16, P85, DOI 10.1109/TGE.1978.294569; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Sameshima K, 1999, J NEUROSCI METH, V94, P93, DOI 10.1016/S0165-0270(99)00128-4; Scharfman HE, 2007, PROG BRAIN RES, V163, P627, DOI 10.1016/S0079-6123(07)63034-9; Srinivas KV, 2007, EUR J NEUROSCI, V25, P3276, DOI 10.1111/j.1460-9568.2007.05559.x; Stam CJ, 2012, CLIN NEUROPHYSIOL, V123, P1067, DOI 10.1016/j.clinph.2012.01.011; Steidl EM, 2006, BRAIN RES, V1096, P70, DOI 10.1016/j.brainres.2006.04.034; Tassi L, 2009, EPILEPTIC DISORD, V11, P281, DOI 10.1684/epd.2009.0279; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; WESTERHOFF CHA, 1995, PFLUG ARCH EUR J PHY, V430, P238, DOI 10.1007/BF00374655; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Wilke C, 2010, EPILEPSIA, V51, P564, DOI 10.1111/j.1528-1167.2009.02329.x; Wu HH, 2006, LECT NOTES COMPUT SC, V3973, P573; Yang F, 2010, NEURAL REGEN RES, V5, P1548, DOI 10.3969/j.issn.1673-5374.2010.20.004; Zhang W, 2012, J NEUROSCI, V32, P1183, DOI 10.1523/JNEUROSCI.5342-11.2012; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	52	27	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92961	10.1371/journal.pone.0092961	http://dx.doi.org/10.1371/journal.pone.0092961			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658094	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300148
J	Grewal, DS; Chou, J; Rollins, SD; Fawzi, AA				Grewal, Dilraj S.; Chou, Jonathan; Rollins, Stuart D.; Fawzi, Amani A.			A Pilot Quantitative Study of Topographic Correlation between Reticular Pseudodrusen and the Choroidal Vasculature Using En Face Optical Coherence Tomography	PLOS ONE			English	Article							SUBRETINAL DRUSENOID DEPOSITS; MACULAR DEGENERATION; HIGH-PENETRATION; PREVALENCE; COMPLEMENT; CHORIOCAPILLARIS; ASSOCIATION; HYPOTHESIS; IMAGE; RPE	Purpose: To analyze the topographic correlation between reticular pseudodrusen (RPD) visualized on infrared reflectance (IR) and choroidal vasculature using en-face volumetric spectral-domain optical coherence tomography (SD-OCT). Methods: A masked observer marked individual RPD on IR images using ImageJ (NIH, Bethesda, MD). Using the macular volume scan (Cirrus, Carl Zeiss Meditec Inc, Dublin, CA), the RPE slab function was used to generate a C-scan of the most superficial choroidal vasculature. An independent masked grader created a topographic binary map of the choroidal vasculature by thresholding the en-face image, which was overlaid onto the IR map of RPD. For each IR image, ImageJ was used to generate a random set of dots as "control lesions''. Results: 17 eyes of 11 patients (78 +/- 13.7 years) with RPD were analyzed. The average number of RPD lesions identified on IR images was 414 +/- 71.5, of which 49.6 +/- 4.3% were located overlying the choroidal vasculature, compared to 45.4 +/- 4.0% in controls (p = 0.014). 50.4 +/- 4.3% of lesions overlay the choroidal stroma, of which 76.5 +/- 3.1% were <= 3 pixels from the choroidal vessels. The percentage of RPD lesions located within <= 3 pixels from the choroidal vasculature was significantly greater than the percentage located >= 7 pixels away. (p<0.0001). Compared to controls (71.6 +/- 3.8%), RPD were more likely to be located <= 3 pixels away from choroidal vessels (p = 0.014). In contrast, control lesions were more likely to be >= 7 pixels away from choroidal vessels than RPD (9.1 +/- 1.9% vs. 4.8 +/- 1.2%, respectively, p = 0.002). Conclusions: Our analysis shows that RPD lesions follow the underlying choroidal vasculature. Approximately half the RPD directly overlay the choroidal vessels and the majority of the remaining lesions were <= 3 pixels (<= 30microns) from the vessel edge, supporting the hypothesis that RPD maybe related to pathologic changes at the choroidal level.	[Grewal, Dilraj S.; Chou, Jonathan; Rollins, Stuart D.; Fawzi, Amani A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Fawzi, AA (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	afawzimd@gmail.com	fawzi, amani/AAA-9199-2021	fawzi, amani/0000-0002-9568-3558; Grewal, Dilraj/0000-0002-2229-5343	Research to Prevent Blindness (RPB, NY); RPB student research grant;  [NIH-EY021470]; NATIONAL EYE INSTITUTE [R01EY021470] Funding Source: NIH RePORTER	Research to Prevent Blindness (RPB, NY)(Research to Prevent Blindness (RPB)); RPB student research grant; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by NIH-EY021470 (AAF), unrestricted funds to the Department of Ophthalmology from Research to Prevent Blindness (RPB, NY), and RPB student research grant (JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alten F, 2013, INVESTIGATIVE OPHTHA; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Arnold JJ, 1997, AM J OPHTHALMOL, V124, P344, DOI 10.1016/S0002-9394(14)70826-8; ARNOLD JJ, 1995, RETINA-J RET VIT DIS, V15, P183, DOI 10.1097/00006982-199515030-00001; Cohen SY, 2007, BRIT J OPHTHALMOL, V91, P354, DOI 10.1136/bjo.2006.101022; Curcio CA, 2013, RETINA-J RET VIT DIS, V33, P265, DOI 10.1097/IAE.0b013e31827e25e0; FRIEDMAN E, 1963, ARCH OPHTHALMOL-CHIC, V69, P220; Gehrs KM, 2010, ARCH OPHTHALMOL-CHIC, V128, P349, DOI 10.1001/archophthalmol.2010.18; Hageman GS, 1999, MOL VIS, V5; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Jaillon F, 2011, BIOMED OPT EXPRESS, V2, P1147, DOI 10.1364/BOE.2.001147; Klein R, 2008, AM J OPHTHALMOL, V145, P317, DOI 10.1016/j.ajo.2007.09.008; Kortvely E, 2010, INVEST OPHTH VIS SCI, V51, P79, DOI 10.1167/iovs.09-3850; Leng T, 2009, RETINA-J RET VIT DIS, V29, P988, DOI 10.1097/IAE.0b013e3181ae7113; Lengyel I, 2004, INVEST OPHTH VIS SCI, V45, P2886, DOI 10.1167/iovs.03-1083; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; MIMOUN G, 1990, J FR OPHTALMOL, V13, P511; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; Puche N, 2013, RETINA-J RET VIT DIS, V33, P998, DOI 10.1097/IAE.0b013e31827b6483; Pumariega NM, 2011, OPHTHALMOLOGY, V118, P1619, DOI 10.1016/j.ophtha.2011.01.029; Querques G, 2013, RETINA; Querques G, 2011, RETINA-J RET VIT DIS, V31, P518, DOI 10.1097/IAE.0b013e3181f04974; Querques G, 2012, INVEST OPHTH VIS SCI, V53, P1258, DOI 10.1167/iovs.11-8907; Rudolf M, 2008, EXP EYE RES, V87, P402, DOI 10.1016/j.exer.2008.07.010; Sarks J, 2011, BRIT J OPHTHALMOL, V95, P979, DOI 10.1136/bjo.2010.194977; Sarks SH, 1999, BRIT J OPHTHALMOL, V83, P358, DOI 10.1136/bjo.83.3.358; Schmitz-Valckenberg S, 2011, INVEST OPHTH VIS SCI, V52, P5009, DOI 10.1167/iovs.11-7235; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwartz DM, 2013, OPHTHALMOLOGY; Smith RT, 2011, ARCH OPHTHALMOL-CHIC, V129, P1061, DOI 10.1001/archophthalmol.2011.212; Smith RT, 2009, AM J OPHTHALMOL, V148, P733, DOI 10.1016/j.ajo.2009.06.028; Sohrab M, 2013, MED HYPOTHESIS DISCO, V2, P69; Sohrab M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048631; Sohrab MA, 2011, INVEST OPHTH VIS SCI, V52, P5743, DOI 10.1167/iovs.10-6942; Spaide RF, 2010, RETINA-J RET VIT DIS, V30, P1441, DOI 10.1097/IAE.0b013e3181ee5ce8; Ueda-Arakawa N, 2013, AM J OPHTHALMOL, V155, P260, DOI 10.1016/j.ajo.2012.08.011; Yasuno Y, 2009, INVEST OPHTH VIS SCI, V50, P405, DOI 10.1167/iovs.08-2272; Zweifel SA, 2011, RETINA-J RET VIT DIS, V31, P229, DOI 10.1097/IAE.0b013e3181f049bd; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P1775, DOI 10.1016/j.ophtha.2010.01.027; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P303, DOI 10.1016/j.ophtha.2009.07.014	41	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92841	10.1371/journal.pone.0092841	http://dx.doi.org/10.1371/journal.pone.0092841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658298	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300133
J	Chen, DP; Ma, YY; Wang, XQ; Yu, SQ; Li, L; Dai, B; Mao, ZG; Sun, LJ; Xu, CG; Rong, S; Tang, MJ; Zhao, HB; Liu, HC; Serra, AL; Graf, N; Liu, SY; Wuthrich, RP; Mei, CL				Chen, Dongping; Ma, Yiyi; Wang, Xueqi; Yu, Shengqiang; Li, Lin; Dai, Bing; Mao, Zhiguo; Sun, Lijun; Xu, Chenggang; Rong, Shu; Tang, Mengjun; Zhao, Hongbo; Liu, Hongchao; Serra, Andreas L.; Graf, Nicole; Liu, Shiyuan; Wuethrich, Rudolf P.; Mei, Changlin			Clinical Characteristics and Disease Predictors of a Large Chinese Cohort of Patients with Autosomal Dominant Polycystic Kidney Disease	PLOS ONE			English	Article							STAGE RENAL-DISEASE; SINGLE-CENTER; VOLUME; PROGRESSION; ADPKD; IDENTIFICATION; EXPERIENCE; RISK; PKD1	Objective: Autosomal dominant polycystic kidney disease (ADPKD) is a relentlessly progressing form of chronic kidney disease for which there is no cure. The aim of this study was to characterize Chinese patients with ADPKD and to identify the factors which predict cyst growth and renal functional deterioration. Methods: To analyze disease predicting factors we performed a prospective longitudinal observational study in a cohort of 541 Chinese patients with ADPKD and an eGFR >= 30 ml/min/1.73 m(2). Patients were followed clinically and radiologically with sequential abdominal magnetic resonance imaging (MRI). Clinical characteristics and laboratory data were related to changes in estimated glomerular filtration rate (eGFR) and total kidney volume (TKV). A linear regression model was developed to analyze the factors which determine eGFR and TKV changes. Results: The age range of this unselected cohort ranged from 4 to 77 years. Median follow-up time was 14.3 +/- 10.6 months. Although inter-individual differences in eGFR and TKV were large, there was a consistent link between these two parameters. Baseline log(10)-transformed TKV and urinary protein/creatinine ratio were identified as the major predictors for a faster eGFR decline and were associated with a higher TKV growth rate. Interestingly, a lower thrombocyte count correlated significantly with lower eGFR (r = 0.222) and higher TKV (r = 0.134). Conclusions: This large cohort of Chinese patients with ADPKD provides unique epidemiological data for comparison with other cohorts of different ethnicity. In Chinese patients we identified a lower thrombocyte count as a significant predictor of disease progression. These results are important for the design of future clinical trials to retard polycystic kidney disease progression.	[Chen, Dongping; Ma, Yiyi; Wang, Xueqi; Yu, Shengqiang; Li, Lin; Dai, Bing; Mao, Zhiguo; Sun, Lijun; Xu, Chenggang; Rong, Shu; Tang, Mengjun; Mei, Changlin] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Nephrol, Kidney Inst, Shanghai, Peoples R China; [Zhao, Hongbo; Liu, Hongchao; Liu, Shiyuan] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Radiol, Shanghai, Peoples R China; [Serra, Andreas L.; Wuethrich, Rudolf P.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Graf, Nicole] Graf Biostat, Winterthur, Switzerland	Naval Medical University; Naval Medical University; University of Zurich; University Zurich Hospital	Wuthrich, RP (corresponding author), Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland.	wuethrich@usz.ch; chlmei1954@126.com	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X; Ma, yiyi/0000-0002-0772-957X	Institutional Partnership Grant from the Sino Swiss Science & Technology Cooperation (SSSTC) Program; National High Technology Reseach Development (863) Project of China [2007AA02Z3Z1]; National Natural Science Foundation of China [30570867, 30771016, 30971368]; National Natural Science Foundation of China for Young Scientists [81000281, 81100482]; Shanghai Key Clinical Disciplines Construction Project; Key Scientific and Technological Project of Shanghai Committee of Science and Technology [11431920800]	Institutional Partnership Grant from the Sino Swiss Science & Technology Cooperation (SSSTC) Program; National High Technology Reseach Development (863) Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China for Young Scientists(National Natural Science Foundation of China (NSFC)); Shanghai Key Clinical Disciplines Construction Project; Key Scientific and Technological Project of Shanghai Committee of Science and Technology	This work was supported by an Institutional Partnership Grant from the Sino Swiss Science & Technology Cooperation (SSSTC) Program, National High Technology Reseach Development (863) Project of China (2007AA02Z3Z1), National Natural Science Foundation of China (30570867, 30771016, 30971368), National Natural Science Foundation of China for Young Scientists (81000281, 81100482), Shanghai Key Clinical Disciplines Construction Project, Key Scientific and Technological Project of Shanghai Committee of Science and Technology (11431920800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audrezet MP, 2012, HUM MUTAT, V33, P1239, DOI 10.1002/humu.22103; BATH PMW, 1995, PLATELETS, V6, P336, DOI 10.3109/09537109509078468; Chapman AB, 2003, KIDNEY INT, V64, P1035, DOI 10.1046/j.1523-1755.2003.00185.x; CHAPMAN AB, 1994, J AM SOC NEPHROL, V5, P1349; Chapman AB, 2012, CLIN J AM SOC NEPHRO, V7, P479, DOI 10.2215/CJN.09500911; Choukroun G, 1995, J AM SOC NEPHROL, V6, P1634; Cornec-Le Gall E, 2013, J AM SOC NEPHROL, V24, P1006, DOI 10.1681/ASN.2012070650; FRANZ KA, 1983, KIDNEY INT, V23, P526, DOI 10.1038/ki.1983.51; Grantham J, 2008, KIDNEY INT, V73, P108, DOI 10.1038/sj.ki.5002624; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Helal I, 2013, NEPHROL DIAL TRANSPL, V28, P380, DOI 10.1093/ndt/gfs417; Johnson AM, 1997, J AM SOC NEPHROL, V8, P1560; King BF, 2000, J AM SOC NEPHROL, V11, P1505, DOI 10.1681/ASN.V1181505; Kistler AD, 2009, KIDNEY INT, V75, P235, DOI 10.1038/ki.2008.558; Meijer E, 2010, AM J KIDNEY DIS, V56, P883, DOI 10.1053/j.ajkd.2010.06.023; Neumann HPH, 2013, NEPHROL DIAL TRANSPL, V28, P1472, DOI 10.1093/ndt/gfs551; Orskov B, 2012, NEPHROL DIAL TRANSPL, V27, P1607, DOI 10.1093/ndt/gfr467; Ozkok A, 2013, CLIN EXP NEPHROL, V17, P345, DOI 10.1007/s10157-012-0706-3; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Rossetti S, 2012, J AM SOC NEPHROL, V23, P915, DOI 10.1681/ASN.2011101032; SIMON HB, 1955, JAMA-J AM MED ASSOC, V159, P657, DOI 10.1001/jama.1955.02960240023006; Sise C, 2000, KIDNEY INT, V58, P2492, DOI 10.1046/j.1523-1755.2000.00433.x; Thong KM, 2013, QJM-INT J MED, V106, P639, DOI 10.1093/qjmed/hct082; Tokiwa S, 2011, CLIN EXP NEPHROL, V15, P539, DOI 10.1007/s10157-011-0428-y; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2011, CLIN J AM SOC NEPHRO, V6, P640, DOI 10.2215/CJN.03250410; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161	28	23	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92232	10.1371/journal.pone.0092232	http://dx.doi.org/10.1371/journal.pone.0092232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651850	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000333352800087
J	Meggyes, M; Miko, E; Polgar, B; Bogar, B; Farkas, B; Illes, Z; Szereday, L				Meggyes, Matyas; Miko, Eva; Polgar, Beata; Bogar, Barbara; Farkas, Balint; Illes, Zsolt; Szereday, Laszlo			Peripheral Blood TIM-3 Positive NK and CD8+T Cells throughout Pregnancy: TIM-3/Galectin-9 Interaction and Its Possible Role during Pregnancy	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; T-HELPER TYPE-1; INNATE IMMUNE CELLS; GALECTIN-9; TOLERANCE; AUTOIMMUNE; LIGAND; INTERFACE; INDUCTION; RESPONSES	Problem: The T-cell immunoglobulin and mucin domain (TIM) family is a relatively newly described group of molecules with a conserved structure and important immunological functions. Identification of Galectin-9 as a ligand for TIM-3 has established the Galectin-9/TIM-3 pathway as an important negative regulator of Th1 immunity and tolerance induction. Data about the TIM-3/Gal-9 pathway in the pathogenesis of human diseases is emerging, but their possible role during human pregnancy is not precisely known. The aim of our study was to investigate the number, phenotype and functional activity of TIM-3+ peripheral blood mononuclear cells during healthy human pregnancy. Methods of Study: 57 healthy pregnant women [first trimester (n = 16); second trimester (n = 19); third trimester (n = 22)] and 30 non-pregnant controls were enrolled in the study. We measured the surface expression of TIM-3 by cytotoxic T cells, NK cells and NK cell subsets as well as Galectin-9 expression by regulatory T cells by flow cytometry. We analyzed the cytokine production and cytotoxicity of TIM3+ and TIM3-CD8 T and NK cells obtained from non-pregnant and healthy pregnant women at different stages of pregnancy by flow cytometry. Serum Galectin-9 levels were measured by ELISA. Results: Our results show that the numbers of peripheral NK and cytotoxic T cells and their TIM-3 expression do not change between the first, second and third trimesters of pregnancy. Compared to non-pregnant individuals, regulatory T cells show higher level of Galectin-9 expression as pregnancy proceeds, which is in line with the level of Galectin-9 in the patients sera. Cytotoxic T cells, NK cells and NK cell subsets expressing TIM-3 molecule show altered cytokine production and cytotoxicity during pregnancy compared to non-pregnant individuals. Conclusion: Our results indicate that Galectin-9 expressing regulatory T cells, TIM-3+ cytotoxic T cells and NK cells could play an important role in the maintenance of healthy pregnancy.	[Meggyes, Matyas; Miko, Eva; Polgar, Beata; Bogar, Barbara; Szereday, Laszlo] Univ Pecs, Ctr Clin, Dept Med Microbiol & Immunol, Pecs, Hungary; [Meggyes, Matyas; Miko, Eva; Polgar, Beata; Szereday, Laszlo] Janos Szentagothai Res Ctr, Pecs, Hungary; [Farkas, Balint] Univ Pecs, Ctr Clin, Dept Obstet & Gynaecol, Pecs, Hungary; [Illes, Zsolt] Odense Univ Hosp, Dept Neurol, DK-5000 Odense, Denmark; [Illes, Zsolt] Univ Southern Denmark, Inst Clin Res, Odense, Denmark	University of Pecs; University of Pecs; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Szereday, L (corresponding author), Univ Pecs, Ctr Clin, Dept Med Microbiol & Immunol, Pecs, Hungary.	szereday.laszlo@pte.hu	Szereday, Laszlo/AAR-5741-2021; Liu, FU-TONG/A-5749-2019; Farkas, Balint/AAF-9137-2019	Szereday, Laszlo/0000-0002-1208-2969; Liu, FU-TONG/0000-0002-3354-1001; Farkas, Balint/0000-0003-0638-2057; Illes, Zsolt/0000-0001-9655-0450	Hungarian National Research Fund [OTKA K104960]; Pecs University Research Fund [PTE-AOK-KA-2013/21, 34039/KA-OTKA/11-19, 11-14]; Social Renewal Operational Programme [TAMOP-4.2.1. B-10/2/KONV-2010-0002, TAMOP-4.2.2/B-10/1-2010-0029, TAMOP-4.2.2.A-11/1/KONV-2012-0053, TAMOP 4.2.4. A/2-11-1-2012-0001]; Hungarian Academy of Sciences	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Pecs University Research Fund; Social Renewal Operational Programme; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by grants from Hungarian National Research Fund (OTKA K104960), Pecs University Research Fund (PTE-AOK-KA-2013/21, 34039/KA-OTKA/11-19 and 11-14), Social Renewal Operational Programme (TAMOP-4.2.1.B-10/2/KONV-2010-0002, TAMOP-4.2.2/B-10/1-2010-0029, TAMOP-4.2.2.A-11/1/KONV-2012-0053. and TAMOP 4.2.4. A/2-11-1-2012-0001) and the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences to L. Szereday. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blidner AG, 2013, AM J REPROD IMMUNOL, V69, P369, DOI 10.1111/aji.12090; Borzychowski AM, 2005, EUR J IMMUNOL, V35, P3054, DOI 10.1002/eji.200425929; Chabtini L, 2013, J IMMUNOL, V190, P88, DOI 10.4049/jimmunol.1202176; Chaouat G, 2007, SEMIN IMMUNOPATHOL, V29, P95, DOI 10.1007/s00281-007-0069-0; de Weyer PSV, 2006, BIOCHEM BIOPH RES CO, V351, P571, DOI 10.1016/j.bbrc.2006.10.079; Golden-Mason L, 2013, J VIROL, V87, P4835, DOI 10.1128/JVI.01085-12; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Kwak-Kim J, 2008, AM J REPROD IMMUNOL, V59, P388, DOI 10.1111/j.1600-0897.2008.00596.x; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; LIN H, 1993, J IMMUNOL, V151, P4562; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Miko E, 2010, REPROD BIOMED ONLINE, V21, P750, DOI 10.1016/j.rbmo.2010.07.012; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Naka EL, 2009, INT IMMUNOPHARMACOL, V9, P658, DOI 10.1016/j.intimp.2008.11.013; Oomizu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048574; Popovici RM, 2005, J CLIN ENDOCR METAB, V90, P6170, DOI 10.1210/jc.2004-2529; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sacks GP, 2003, CLIN EXP IMMUNOL, V131, P490, DOI 10.1046/j.1365-2249.2003.02082.x; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Shimizu Y, 2008, ENDOCR J, V55, P879, DOI 10.1507/endocrj.K08E-111; Southcombe J, 2010, J REPROD IMMUNOL, V87, P52, DOI 10.1016/j.jri.2010.07.003; Than NG, 2012, TRENDS ENDOCRIN MET, V23, P23, DOI 10.1016/j.tem.2011.09.003; von Wolff M, 2005, MOL HUM REPROD, V11, P189, DOI 10.1093/molehr/gah144; Wiersma VR, 2013, MED RES REV, V33, pE102, DOI 10.1002/med.20249; Zhao J, 2009, J IMMUNOL, V182, P6618, DOI 10.4049/jimmunol.0803876; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	30	55	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92371	10.1371/journal.pone.0092371	http://dx.doi.org/10.1371/journal.pone.0092371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651720	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000333352800104
J	Sanches, TLM; Cunha, LD; Silva, GK; Guedes, PMM; Silva, JS; Zamboni, DS				Sanches, Tiago L. M.; Cunha, Larissa D.; Silva, Grace K.; Guedes, Paulo M. M.; Silva, Joao Santana; Zamboni, Dario S.			The Use of a Heterogeneously Controlled Mouse Population Reveals a Significant Correlation of Acute Phase Parasitemia with Mortality in Chagas Disease	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; IFN-GAMMA; REDUCES PARASITEMIA; GENETIC-CONTROL; RESISTANT MICE; SUSCEPTIBILITY; HOST; STRAINS; INTERLEUKIN-12; PATHOLOGY	Chagas disease develops upon infection with the protozoan parasite Trypanosoma cruzi and undergoes an acute phase characterized by massive parasite replication and the presence of parasites in the blood. This condition is known as acute phase parasitemia. This initial stage may result in a cure, in the development of the chronic stages of the disease or in the death of the infected host. Despite intensive investigation related to the characterization of the acute and chronic phases of the disease, the cause-effect relationship of acute phase parasitemia to the outcome of the disease is still poorly understood. In this study, we artificially generated a heterogeneously controlled mouse population by intercrossing F1 mice obtained from a parental breeding of highly susceptible A/J with highly resistant C57BL/6 mouse strains. This F2 population was infected and used to assess the correlation of acute phase parasitemia with the longevity of the animals. We used nonparametric statistical analyses and found a significant association between parasitemia and mortality. If males and females were evaluated separately, we found that the former were more susceptible to death, although parasitemia was similar in males and females. In females, we found a strong negative correlation between parasitemia and longevity. In males, however, additional factors independent of parasitemia may favor mouse mortality during the development of the disease. The correlations of acute phase parasitemia with mortality reported in this study may facilitate an appropriate prognostic approach to the disease in humans. Moreover, these results illustrate the complexity of the mammalian genetic traits that regulate host resistance during Chagas disease.	[Sanches, Tiago L. M.; Cunha, Larissa D.; Zamboni, Dario S.] Univ Sao Paulo, Med Sch Ribeirao Preto, FMRP USP, Dept Cell Biol, Sao Paulo, Brazil; [Silva, Grace K.; Guedes, Paulo M. M.; Silva, Joao Santana] Univ Sao Paulo, Med Sch Ribeirao Preto, FMRP USP, Dept Biochem & Immunol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Zamboni, DS (corresponding author), Univ Sao Paulo, Med Sch Ribeirao Preto, FMRP USP, Dept Cell Biol, Sao Paulo, Brazil.	dszamboni@fmrp.usp.br	Silva, Joao/A-4484-2008; Zamboni, Dario S/D-3024-2012; Cunha, Larissa D/I-4204-2012; Guedes, Paulo/Y-2546-2018; Silva, Grace/E-7673-2012	Silva, Joao/0000-0002-3410-3927; Zamboni, Dario S/0000-0002-7856-7512; Silva, Grace/0000-0001-6417-4243; Dias da Cunha, Larissa/0000-0002-1290-0263; Matta Guedes, Paulo Marcos/0000-0002-4564-6791	Instituto Nacional de Ciencia e Tecnologia em Vacinas (INCTV/CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/50959-4, 2013/08216-2]; Fundacao de Amparo ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); FAPESP	Instituto Nacional de Ciencia e Tecnologia em Vacinas (INCTV/CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Instituto Nacional de Ciencia e Tecnologia em Vacinas (INCTV/CNPq), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Grants 2010/50959-4 and 2013/08216-2) and Fundacao de Amparo ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA). TLMS, GKS and LDC are supported by fellowships from FAPESP. DSZ and JSS are CNPq Research Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsohn IA, 1996, EXP PARASITOL, V84, P231, DOI 10.1006/expr.1996.0109; Aleixo Denise Lessa, 2012, BMC Res Notes, V5, P352, DOI 10.1186/1756-0500-5-352; Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; Andersson J, 2003, IMMUNOL LETT, V86, P207, DOI 10.1016/S0165-2478(03)00019-1; Andrade LO, 2002, EXP PARASITOL, V100, P269, DOI 10.1016/S0014-4894(02)00024-3; Andrade Sonia G., 1997, Revista da Sociedade Brasileira de Medicina Tropical, V30, P27, DOI 10.1590/S0037-86821997000100006; [Anonymous], 2012, WHO TECHN REP SER; Arantes JM, 2007, EXP PARASITOL, V117, P43, DOI 10.1016/j.exppara.2007.03.006; Arantes JM, 2011, EXP PARASITOL, V128, P401, DOI 10.1016/j.exppara.2011.05.011; Barretto A C, 1993, Arq Bras Cardiol, V60, P225; Chessler ADC, 2011, INFECT IMMUN, V79, P2112, DOI 10.1128/IAI.01176-10; Clapcott SJ, 2000, PARASITE IMMUNOL, V22, P259, DOI 10.1046/j.1365-3024.2000.00308.x; Coura JR, 2012, REV SOC BRAS MED TRO, V45, P286, DOI 10.1590/S0037-86822012000300002; Coura JR, 2010, ACTA TROP, V115, P5, DOI 10.1016/j.actatropica.2010.03.008; da Costa SCG, 2002, HISTOL HISTOPATHOL, V17, P837, DOI 10.14670/HH-17.837; Da Silva APG, 2003, IMMUNOLOGY, V108, P230, DOI 10.1046/j.1365-2567.2003.01571.x; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Engman DM, 2002, ACTA TROP, V81, P123, DOI 10.1016/S0001-706X(01)00202-9; ESPINOSA R, 1985, INT J CARDIOL, V8, P45, DOI 10.1016/0167-5273(85)90262-1; Garzoni LR, 2004, INT J ANTIMICROB AG, V23, P286, DOI 10.1016/j.ijantimicag.2003.07.019; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Graefe SEB, 2003, GENES IMMUN, V4, P321, DOI 10.1038/sj.gene.6363972; Graefe SEB, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000057; Guedes PMM, 2010, BRIT J PHARMACOL, V160, P270, DOI 10.1111/j.1476-5381.2009.00576.x; Kayama H, 2010, MICROBES INFECT, V12, P511, DOI 10.1016/j.micinf.2010.03.005; Laroque A, 2012, GENES IMMUN, V13, P155, DOI 10.1038/gene.2011.67; Macedo Andra M, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004118; Marinho CRF, 2009, MICROBES INFECT, V11, P1037, DOI 10.1016/j.micinf.2009.07.011; Marinho CRF, 2004, INFECT IMMUN, V72, P2350, DOI 10.1128/IAI.72.4.2350-2357.2004; Martins GA, 2004, MICROBES INFECT, V6, P1133, DOI 10.1016/j.micinf.2004.07.002; MINOPRIO P, 1991, INT IMMUNOL, V3, P427, DOI 10.1093/intimm/3.5.427; MINOPRIO P, 1993, J IMMUNOL, V151, P4200; Nagajyothi F, 2012, PARASITOL RES, V110, P2491, DOI 10.1007/s00436-011-2790-9; Nava-Castro K, 2012, ANN NY ACAD SCI, V1262, P16, DOI 10.1111/j.1749-6632.2012.06632.x; Paiva CN, 2009, J LEUKOCYTE BIOL, V86, P1239, DOI 10.1189/jlb.0309187; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; RIVERAVANDERPAS MT, 1983, ACTA TROP, V40, P5; Roberts CW, 2001, CLIN MICROBIOL REV, V14, P476, DOI 10.1128/CMR.14.3.476-488.2001; Roberts LJ, 1999, EUR J IMMUNOL, V29, P3047, DOI 10.1002/(SICI)1521-4141(199909)29:09&lt;3047::AID-IMMU3047&gt;3.0.CO;2-L; Rodrigues CM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000846; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Silva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053766; Silva GK, 2010, J IMMUNOL, V184, P1148, DOI 10.4049/jimmunol.0902254; TANOWITZ HB, 1992, CLIN MICROBIOL REV, V5, P400, DOI 10.1128/CMR.5.4.400-419.1992; Vago AR, 2000, AM J PATHOL, V156, P1805, DOI 10.1016/S0002-9440(10)65052-3; Valdez RH, 2012, ANTIMICROB AGENTS CH, V56, P507, DOI 10.1128/AAC.05575-11; Vasconcelos RHT, 2012, CYTOKINE, V59, P203, DOI 10.1016/j.cyto.2012.04.035; Wallace A, 2001, BIOL RES, V34, P83; WRIGHTSMAN R, 1982, INFECT IMMUN, V36, P637, DOI 10.1128/IAI.36.2.637-644.1982; Yoshida N, 2008, PARASITOL INT, V57, P105, DOI 10.1016/j.parint.2007.12.008	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91640	10.1371/journal.pone.0091640	http://dx.doi.org/10.1371/journal.pone.0091640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651711	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800045
J	Ward, JD; Mullaney, B; Schiller, BJ; He, LD; Petnic, SE; Couillault, C; Pujol, N; Bernal, TU; Van Gilst, MR; Ashrafi, K; Ewbank, JJ; Yamamoto, KR				Ward, Jordan D.; Mullaney, Brendan; Schiller, Benjamin J.; He, Le D.; Petnic, Sarah E.; Couillault, Carole; Pujol, Nathalie; Bernal, Teresita U.; Van Gilst, Marc R.; Ashrafi, Kaveh; Ewbank, Jonathan J.; Yamamoto, Keith R.			Defects in the C. elegans acyl-CoA Synthase, acs-3, and Nuclear Hormone Receptor, nhr-25, Cause Sensitivity to Distinct, but Overlapping Stresses	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE EXPRESSION; CAENORHABDITIS-ELEGANS; CUTICLE SURFACE; INNATE IMMUNITY; DEVELOPMENTAL AGE; OSMOTIC-STRESS; SOMATIC GONAD; PROTEIN; GENES; EPIDERMIS	Metazoan transcription factors control distinct networks of genes in specific tissues, yet understanding how these networks are integrated into physiology, development, and homeostasis remains challenging. Inactivation of the nuclear hormone receptor nhr-25 ameliorates developmental and metabolic phenotypes associated with loss of function of an acyl-CoA synthetase gene, acs-3. ACS-3 activity prevents aberrantly high NHR-25 activity. Here, we investigated this relationship further by examining gene expression patterns following acs-3 and nhr-25 inactivation. Unexpectedly, we found that the acs-3 mutation or nhr-25 RNAi resulted in similar transcriptomes with enrichment in innate immunity and stress response gene expression. Mutants of either gene exhibited distinct sensitivities to pathogens and environmental stresses. Only nhr-25 was required for wild-type levels of resistance to the bacterial pathogen P. aeruginosa and only acs-3 was required for wild-type levels of resistance to osmotic stress and the oxidative stress generator, juglone. Inactivation of either acs-3 or nhr-25 compromised lifespan and resistance to the fungal pathogen D. coniospora. Double mutants exhibited more severe defects in the lifespan and P. aeruginosa assays, but were similar to the single mutants in other assays. Finally, acs-3 mutants displayed defects in their epidermal surface barrier, potentially accounting for the observed sensitivities. Together, these data indicate that inactivation of either acs-3 or nhr-25 causes stress sensitivity and increased expression of innate immunity/stress genes, most likely by different mechanisms. Elevated expression of these immune/stress genes appears to abrogate the transcriptional signatures relevant to metabolism and development.	[Ward, Jordan D.; Schiller, Benjamin J.; Petnic, Sarah E.; Bernal, Teresita U.; Yamamoto, Keith R.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Mullaney, Brendan; Ashrafi, Kaveh] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [He, Le D.; Couillault, Carole; Pujol, Nathalie; Ewbank, Jonathan J.] UM2 Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France; [He, Le D.; Couillault, Carole; Pujol, Nathalie; Ewbank, Jonathan J.] INSERM, F-13258 Marseille, France; [He, Le D.; Couillault, Carole; Pujol, Nathalie; Ewbank, Jonathan J.] CNRS, UMR7280, Marseille, France; [Van Gilst, Marc R.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Fred Hutchinson Cancer Center	Ward, JD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	jordan.ward@ucsf.edu	Ward, Jordan/H-3444-2019; Pujol, Nathalie/K-3880-2012; Ewbank, Jonathan J/G-4948-2010	Ward, Jordan/0000-0001-9870-8936; Pujol, Nathalie/0000-0001-8889-3197; Ewbank, Jonathan J/0000-0002-1257-6862	Terry Fox Foundation [700046]; Canadian Institutes of Health Research [234765]; NIH [CA20535]; NSF [MCB-1157767]; National Institute of Environmental Health Sciences [ES021412-01]; Program in Breakthrough Biomedical Research; INSERM; CNRS; French ANR; Direct For Biological Sciences [1157767] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R37CA020535, R01CA020535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021412] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Terry Fox Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Program in Breakthrough Biomedical Research; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); French ANR(French National Research Agency (ANR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	JDW was supported by postdoctoral fellowships from the Terry Fox Foundation (award #700046) and the Canadian Institutes of Health Research (award #234765). Research support was from the NIH (CA20535) and NSF (MCB-1157767) to KRY, the National Institute of Environmental Health Sciences (ES021412-01) and the Program in Breakthrough Biomedical Research to KA. JE is funded by institutional grants from INSERM and the CNRS, and program grants from the French ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antebi A, 2000, GENE DEV, V14, P1512; Antebi A, 1998, DEVELOPMENT, V125, P1191; Asahina M, 2000, GENES CELLS, V5, P711, DOI 10.1046/j.1365-2443.2000.00361.x; Asahina M, 2006, DEV CELL, V11, P203, DOI 10.1016/j.devcel.2006.06.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; BLAXTER ML, 1992, PARASITOL TODAY, V8, P243, DOI 10.1016/0169-4758(92)90126-M; BLAXTER ML, 1993, J BIOL CHEM, V268, P6600; BLUM J, 1983, ARCH BIOCHEM BIOPHYS, V222, P35, DOI 10.1016/0003-9861(83)90499-X; BRENNER S, 1974, GENETICS, V77, P71; Cezairliyan B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003101; Chen Z, 2004, MOL CELL BIOL, V24, P7345, DOI 10.1128/MCB.24.17.7345-7358.2004; Chisholm AD, 2012, WIRES DEV BIOL, V1, P879, DOI 10.1002/wdev.77; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Dierking K, 2011, CELL HOST MICROBE, V9, P425, DOI 10.1016/j.chom.2011.04.011; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gissendanner CR, 2000, DEV BIOL, V221, P259, DOI 10.1006/dbio.2000.9679; Gomez F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-300; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Hada K, 2010, DEV BIOL, V344, P1100, DOI 10.1016/j.ydbio.2010.05.508; Hansen M, 2007, WESTERN HUM REV, V61, P6; Hartwig K, 2009, GENES NUTR, V4, P59, DOI 10.1007/s12263-009-0113-x; Hayes GD, 2006, DEVELOPMENT, V133, P4631, DOI 10.1242/dev.02655; HIMMELHOCH S, 1979, J NEMATOL, V11, P358; HIMMELHOCH S, 1983, EXP PARASITOL, V55, P299, DOI 10.1016/0014-4894(83)90026-7; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; JANSSON HB, 1986, J NEMATOL, V18, P570; Kage-Nakadai E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008857; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Lamitina ST, 2004, AM J PHYSIOL-CELL PH, V286, pC785, DOI 10.1152/ajpcell.00381.2003; Lee KZ, 2010, VIRULENCE, V1, P113, DOI 10.4161/viru.1.3.10974; Li Y, 2011, BMB REP, V44, P285, DOI 10.5483/BMBRep.2011.44.4.285; Meli VS, 2010, MOL BIOL CELL, V21, P1648, DOI 10.1091/mbc.E08-07-0708; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Miyabayashi T, 1999, DEV BIOL, V215, P314, DOI 10.1006/dbio.1999.9470; Monsalve GC, 2011, CURR BIOL, V21, P2033, DOI 10.1016/j.cub.2011.10.054; Moribe H, 2004, J CELL SCI, V117, P5209, DOI 10.1242/jcs.01403; Mullaney BC, 2010, CELL METAB, V12, P398, DOI 10.1016/j.cmet.2010.08.013; Partridge FA, 2008, DEV BIOL, V317, P549, DOI 10.1016/j.ydbio.2008.02.060; Pathare PP, 2012, PLOS GENET, V8, P333, DOI 10.1371/journal.pgen.1002645; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Silhankova M, 2005, J CELL SCI, V118, P223, DOI 10.1242/jcs.01609; Simeckova K, 2007, FOLIA BIOL-PRAGUE, V53, P85; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Sutphin George L, 2009, J Vis Exp, DOI 10.3791/1152; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Taubert S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000021; Taubert S, 2011, MOL CELL ENDOCRINOL, V334, P49, DOI 10.1016/j.mce.2010.04.021; Tong A, 2009, P NATL ACAD SCI USA, V106, P1457, DOI 10.1073/pnas.0809339106; Ward JD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003992; Wheeler JM, 2006, GENETICS, V174, P1327, DOI 10.1534/genetics.106.059089; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525; Ziegler K, 2009, CELL HOST MICROBE, V5, P341, DOI 10.1016/j.chom.2009.03.006; ZUCKERMAN BM, 1979, EXP PARASITOL, V47, P419, DOI 10.1016/0014-4894(79)90095-X; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	67	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92552	10.1371/journal.pone.0092552	http://dx.doi.org/10.1371/journal.pone.0092552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651852	Green Published, gold			2022-12-27	WOS:000333352800127
J	Abel, EV; Kim, EJ; Wu, JJ; Hynes, M; Bednar, F; Proctor, E; Wang, LD; Dziubinski, ML; Simeone, DM				Abel, Ethan V.; Kim, Edward J.; Wu, Jingjiang; Hynes, Mark; Bednar, Filip; Proctor, Erica; Wang, Lidong; Dziubinski, Michele L.; Simeone, Diane M.			The Notch Pathway Is Important in Maintaining the Cancer Stem Cell Population in Pancreatic Cancer	PLOS ONE			English	Article							PROSPECTIVE IDENTIFICATION; BREAST-CANCER; TUMOR; DIFFERENTIATION; CLEAVAGE	Background: Pancreatic cancer stem cells (CSCs) represent a small subpopulation of pancreatic cancer cells that have the capacity to initiate and propagate tumor formation. However, the mechanisms by which pancreatic CSCs are maintained are not well understood or characterized. Methods: Expression of Notch receptors, ligands, and Notch signaling target genes was quantitated in the CSC and non-CSC populations from 8 primary human pancreatic xenografts. A gamma secretase inhibitor (GSI) that inhibits the Notch pathway and a shRNA targeting the Notch target gene Hes1 were used to assess the role of the Notch pathway in CSC population maintenance and pancreatic tumor growth. Results: Notch pathway components were found to be upregulated in pancreatic CSCs. Inhibition of the Notch pathway using either a gamma secretase inhibitor or Hes1 shRNA in pancreatic cancer cells reduced the percentage of CSCs and tumorsphere formation. Conversely, activation of the Notch pathway with an exogenous Notch peptide ligand increased the percentage of CSCs as well as tumorsphere formation. In vivo treatment of orthotopic pancreatic tumors in NOD/SCID mice with GSI blocked tumor growth and reduced the CSC population. Conclusion: The Notch signaling pathway is important in maintaining the pancreatic CSC population and is a potential therapeutic target in pancreatic cancer.	[Abel, Ethan V.; Wu, Jingjiang; Hynes, Mark; Bednar, Filip; Proctor, Erica; Wang, Lidong; Dziubinski, Michele L.; Simeone, Diane M.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Kim, Edward J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Simeone, Diane M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Simeone, Diane M.] Univ Michigan, Dept Translat Oncol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Simeone, DM (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.	simeone@umich.edu	Kim, Edward/W-2366-2019		Randy Pausch Family AACR-PANCAN Innovation Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER	Randy Pausch Family AACR-PANCAN Innovation Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Randy Pausch Family AACR-PANCAN Innovation Award (DMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Hald J, 2003, DEV BIOL, V260, P426, DOI 10.1016/S0012-1606(03)00326-9; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Ishibashi S, 2004, J NEUROSCI RES, V78, P215, DOI 10.1002/jnr.20246; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Parisi M J, 1998, Cell Res, V8, P15; Schreck KC, 2010, CLIN CANCER RES, V16, P6060, DOI 10.1158/1078-0432.CCR-10-1624; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tolcher AW, 2012, J CLIN ONCOL, V30, P2348, DOI 10.1200/JCO.2011.36.8282; Wang ZW, 2011, ANTICANCER RES, V31, P1105; Yabuuchi S, 2013, CANCER LETT, V335, P41, DOI 10.1016/j.canlet.2013.01.054; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yen WC, 2012, CLIN CANCER RES, V18, P5374, DOI 10.1158/1078-0432.CCR-12-0736; Zhang XP, 2008, MOL CELL BIOCHEM, V307, P101, DOI 10.1007/s11010-007-9589-0	33	109	118	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91983	10.1371/journal.pone.0091983	http://dx.doi.org/10.1371/journal.pone.0091983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647545	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500065
J	Dong, XP; Hao, YT; Wei, YC; Yin, QW; Du, JJ; Zhao, XG				Dong, Xiaopeng; Hao, Yingtao; Wei, Yucheng; Yin, Qiuwei; Du, Jiajun; Zhao, Xiaogang			Response to First-Line Chemotherapy in Patients with Non-Small Cell Lung Cancer According to RRM1 Expression	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; PHASE-III TRIAL; GEMCITABINE; ERCC1; CISPLATIN; RESISTANCE; SURVIVAL; PLATINUM; EFFICACY; REPAIR	Background: The response to cytotoxic chemotherapy varies greatly in patients with advanced non-small cell lung cancer (NSCLC), and molecular markers may be useful in determining a preferable therapeutic approach for individual patients. This retrospective study was performed to evaluate the predictive value of ribonucleotide reductase regulatory subunit M1 (RRM1) on the therapeutic efficacy of platinum-based chemotherapy in patients with NSCLC. Methods: Patients with advanced NSCLC who received platinum doublet chemotherapy (n = 229) were included in this retrospective study, and their clinical outcomes were analyzed according to RRM1 expression. Results: In patients receiving gemcitabine-based therapy, the disease control rate (DCR) and progression-free survival (PFS) of patients with RRM1-negative tumors were significantly higher than in patients with RRMI-positive tumors (P=0.041 and P=0.01, respectively), and multivariate analysis showed that RRM1 expression was an independent prognostic factor (P=0.013). No similar differences were found in patients receiving docetaxel-or vinorelbine-based therapy. In RRM1-positive patients, the DCRs for docetaxel and vinorelbine were higher than for gemcitabine (P=0.047 and P=0.047, respectively), and docetaxel and vinorelbine showed a longer PFS than gemcitabine-based chemotherapy (P=0.012 and P=0.007). No similar differences were found among patients with RRM1-negative tumors. Conclusions: Negative RRM1 expression in advanced NSCLC is associated with a higher response rate to gemcitabine-based chemotherapy. In patients with RRM1-positive tumors, docetaxel and vinorelbine showed a higher therapeutic efficacy than gemcitabine-based therapy. Additional prospective studies are needed to investigate the predictive meaning of RRM1 in the response to chemotherapy.	[Dong, Xiaopeng; Hao, Yingtao; Zhao, Xiaogang] Shandong Univ, Hosp 2, Dept Thorac Surg, Jinan 250100, Peoples R China; [Wei, Yucheng] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Thorac Surg, Qingdao 266071, Peoples R China; [Yin, Qiuwei] Shandong Univ, Qilu Hosp, Dept Thorac Surg, Jinan 250100, Peoples R China; [Du, Jiajun] Shandong Prov Hosp, Dept Thorac Surg, Jinan, Peoples R China	Shandong University; Qingdao University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Zhao, XG (corresponding author), Shandong Univ, Hosp 2, Dept Thorac Surg, Jinan 250100, Peoples R China.	dxp3260@sohu.com						Bepler G, 2008, J THORAC ONCOL, V3, P1112, DOI 10.1097/JTO.0b013e3181874936; Bepler G, 2006, J CLIN ONCOL, V24, P4731, DOI 10.1200/JCO.2006.06.1101; Bepler G, 2013, J CLIN ONCOL, V31, P2404, DOI 10.1200/JCO.2012.46.9783; Bergman AM, 2005, CANCER RES, V65, P9510, DOI 10.1158/0008-5472.CAN-05-0989; Ceppi P, 2006, ANN ONCOL, V17, P1818, DOI 10.1093/annonc/mdl300; Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; Gong WY, 2012, LUNG CANCER, V75, P374, DOI 10.1016/j.lungcan.2011.08.003; Kelly K, 2001, J CLIN ONCOL, V19, P3210, DOI 10.1200/JCO.2001.19.13.3210; Oguri T, 2006, MOL CANCER THER, V5, P1800, DOI 10.1158/1535-7163.MCT-06-0025; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Papadaki C, 2012, J THORAC ONCOL, V7, P663, DOI 10.1097/JTO.0b013e318244bdd4; Park JH, 2012, LUNG CANCER, V77, P433, DOI 10.1016/j.lungcan.2012.03.020; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Reynolds C, 2009, J CLIN ONCOL, V27, P5808, DOI 10.1200/JCO.2009.21.9766; Rosell R, 2004, CLIN CANCER RES, V10, P1318, DOI 10.1158/1078-0432.CCR-03-0156; Roth JA, 2011, CLIN LUNG CANCER, V12, P393, DOI 10.1016/j.cllc.2011.04.005; Scagliotti GV, 2002, J CLIN ONCOL, V20, P4285, DOI 10.1200/JCO.2002.02.068; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Simon GR, 2007, INT J BIOCHEM CELL B, V39, P1318, DOI 10.1016/j.biocel.2007.05.006; Simon GR, 2012, CANCER-AM CANCER SOC, V118, P2525, DOI 10.1002/cncr.26522; Simon GR, 2008, FUTURE ONCOL, V4, P51, DOI 10.2217/14796694.4.1.51; Souglakos J, 2008, BRIT J CANCER, V98, P1710, DOI 10.1038/sj.bjc.6604344; Sun JM, 2011, J THORAC ONCOL, V6, P1392, DOI 10.1097/JTO.0b013e3182208ea8	23	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92320	10.1371/journal.pone.0092320	http://dx.doi.org/10.1371/journal.pone.0092320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647522	gold, Green Submitted, Green Published			2022-12-27	WOS:000333348500115
J	Missios, S; Bekelis, K				Missios, Symeon; Bekelis, Kimon			The Association of Unfavorable Outcomes with the Intensity of Neurosurgical Care in the United States	PLOS ONE			English	Article							REGIONAL-VARIATIONS; MORTALITY; QUALITY; VOLUME	Object: There is wide regional variability in the volume of procedures performed for similar surgical patients throughout the United States. We investigated the association of the intensity of neurosurgical care (defined as the average annual number of neurosurgical procedures per capita) with mortality, length of stay (LOS), and rate of unfavorable discharge for inpatients after neurosurgical procedures. Methods: We performed a retrospective cohort study involving the 202,518 patients who underwent cranial neurosurgical procedures from 2005-2010 and were registered in the National Inpatient Sample (NIS) database. Regression techniques were used to investigate the association of the average intensity of neurosurgical care with the average mortality, LOS, and rate of unfavorable discharge. Results: The inpatient neurosurgical mortality, rate of unfavorable discharge, and average LOS varied significantly among several states. In a multivariate analysis male gender, coverage by Medicaid, and minority racial status were associated with increased mortality, rate of unfavorable discharge, and LOS. The opposite was true for coverage by private insurance, higher income, fewer comorbidities and small hospital size. There was no correlation of the intensity of neurosurgical care with the mortality (Pearson's r = 20.18, P = 0.29), rate of unfavorable discharge (Pearson's r = 0.08, P = 0.62), and LOS of cranial neurosurgical procedures (Pearson's r = 20.21, P = 0.22). Conclusions: We observed significant disparities in mortality, LOS, and rate of unfavorable discharge for cranial neurosurgical procedures in the United States. Increased intensity of neurosurgical care was not associated with improved outcomes.	[Missios, Symeon] Cleveland Clin, Dept Neurosurg, Cleveland, OH 44106 USA; [Bekelis, Kimon] Dartmouth Hitchcock Med Ctr, Neurosurg Sect, Lebanon, NH 03766 USA	Cleveland Clinic Foundation; Dartmouth College	Bekelis, K (corresponding author), Dartmouth Hitchcock Med Ctr, Neurosurg Sect, Lebanon, NH 03766 USA.	kbekelis@gmail.com	Bekelis, Kimon/Y-3402-2019					Baicker K, 2004, HLTH AFF MILLWOOD S; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; CHARLSON ME, 1987, ARCH INTERN MED, V147, P2155, DOI 10.1001/archinte.147.12.2155; Fisher ES, 2011, NEW ENGL J MED, V365, P2445, DOI 10.1056/NEJMp1112442; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2003, PERSPECT BIOL MED, V46, P69, DOI 10.1353/pbm.2003.0004; Fisher ES, 2004, HLTH AFF MILLWOOD S; Fisher ES, 2010, JAMA-J AM MED ASSOC, V304, P17115; Goodney PP, 2013, J VASC SURG, V57, P1471, DOI 10.1016/j.jvs.2012.11.068; Ong MK, 2009, CIRC-CARDIOVASC QUAL, V2, P548, DOI 10.1161/CIRCOUTCOMES.108.825612; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Romley JA, 2011, ANN INTERN MED, V154, P160, DOI 10.7326/0003-4819-154-3-201102010-00005; Rothberg MB, 2010, HEALTH AFFAIR, V29, P1523, DOI 10.1377/hlthaff.2009.0287; Silber JH, 2010, HEALTH SERV RES, V45, P1872, DOI 10.1111/j.1475-6773.2010.01180.x; Skinner J, 2005, CIRCULATION, V112, P2634, DOI 10.1161/CIRCULATIONAHA.105.543231; Skinner JS, 2006, HEALTH AFFAIR, V25, pW34, DOI 10.1377/hlthaff.25.w34; Steiner Claudia, 2002, Eff Clin Pract, V5, P143; Yasaitis L, 2009, HEALTH AFFAIR, V28, pW566, DOI 10.1377/hlthaff.28.4.w566	20	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92057	10.1371/journal.pone.0092057	http://dx.doi.org/10.1371/journal.pone.0092057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24647225	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500076
J	Narayan, EJ; Graham, C; McCallum, H; Hero, JM				Narayan, Edward J.; Graham, Clara; McCallum, Hamish; Hero, Jean-Marc			Over-Wintering Tadpoles of Mixophyes fasciolatus Act as Reservoir Host for Batrachochytrium dendrobatidis	PLOS ONE			English	Article							WILD FROGS; CHYTRIDIOMYCOSIS; DISEASE; PATHOGEN; DECLINE; TRANSMISSION; PREVALENCE; TIME; SUSCEPTIBILITY; POPULATIONS	Batrachochytrium dendrobatidis (Bd), a cutaneous amphibian fungus that causes the lethal disease chytridiomycosis, has been implicated as a cause of many amphibian declines. Bd can tolerate low temperatures with an optimum thermal range from 17-24 degrees C. It has been shown that Bd infection may result in species extinction, avoiding the transmission threshold presented by density dependent transmission theory. Prevalence of Bd during autumn and winter has been shown to be as low as 0% in some species. It is currently unclear how Bd persists in field conditions and what processes result in carry-over between seasons. It has been hypothesised that overwintering tadpoles may host Bd between breeding seasons. The Great Barred Frog (Mixophyes fasciolatus) is a common, stable and widespread species in Queensland, Australia, and is known to carry Bd. Investigation into Bd infection of different life stages of M. fasciolatus during seasonally low prevalence may potentially reveal persistence and carry-over methods between seasons. Metamorphs, juveniles, and adults were swabbed for Bd infection over three months (between March and May, 2011) at 5 sites of varying altitude (66 m-790 m). A total of 93 swabs were analysed using Polymerase Chain Reaction (PCR) real-time analysis. PCR analysis showed 6 positive (1 excluded), 4 equivocal and 83 negative results for infection with Bd. Equivocal results were assumed to be negative using the precautionary principle. The 5 positive results consisted of 4 emerging (Gosner stage 43-45) metamorphs and 1 adult M. fasciolatus. Fisher's exact test on prevalence showed that the prevalence was significantly different between life stages. All positive results were sampled at high altitudes (790 m); however prevalence was not significantly different between altitudes. Infection of emerging metamorphs suggests that individuals were infected as tadpoles. We hypothesise that M. fasciolatus tadpoles carry Bd through seasons. Thus, Mixophyes fasciolatus may act as disease reservoirs at multiple life stages.	[Narayan, Edward J.; Graham, Clara; McCallum, Hamish; Hero, Jean-Marc] Griffith Univ, Sch Environm, Environm Futures Res Inst, Nathan, Qld 4111, Australia	Griffith University	Narayan, EJ (corresponding author), Griffith Univ, Sch Environm, Environm Futures Res Inst, Gold Coast Campus, Nathan, Qld 4111, Australia.	e.narayan@ga.griffith.edu.au	McCallum, Hamish/E-1638-2013; Narayan, Edward/E-8238-2016	McCallum, Hamish/0000-0002-3493-0412; Narayan, Edward/0000-0003-2719-0900	Griffith University Environmental Futures Centre	Griffith University Environmental Futures Centre	This research was supported by the Griffith University Environmental Futures Centre, as part of CG's honours thesis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen D, 2010, GLOBAL BD MAPPING PR; Anstis M., 2007, TADPOLES S E AUSTR G; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger S, 2005, HORM BEHAV, V47, P419, DOI 10.1016/j.yhbeh.2004.11.011; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Daszak P, 2004, HERPETOL J, V14, P201; Davis A. K., 2010, Comparative Clinical Pathology, V19, P49, DOI 10.1007/s00580-009-0914-8; Fellers GM, 2001, COPEIA, P945, DOI 10.1643/0045-8511(2001)001[0945:OCITMY]2.0.CO;2; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Graham CM, 2013, GEN COMP ENDOCR, V191, P24, DOI 10.1016/j.ygcen.2013.05.012; Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499; HERO J-M, 1989, Herpetological Review, V20, P66; Hero Jean-Marc, 2006, Pacific Conservation Biology, V12, P313; Hero JM, 2004, HERPETOL J, V14, P175; Hero JM, 2005, J ZOOL, V267, P221, DOI 10.1017/S0952836905007296; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Kindermann C, 2012, COMP BIOCHEM PHYS A, V162, P171, DOI 10.1016/j.cbpa.2012.02.018; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; Kriger KM, 2006, DIS AQUAT ORGAN, V71, P141, DOI 10.3354/dao071141; Kriger KM, 2006, ECOHEALTH, V3, P171, DOI 10.1007/s10393-006-0027-7; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059499; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McDonald K, 1999, REV DECLINING FROGS, P14; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; Narayan EJ, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot011; Parris KM, 2002, WILDLIFE RES, V29, P469, DOI 10.1071/WR01107; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Rachowicz LJ, 2007, J ANIM ECOL, V76, P711, DOI 10.1111/j.1365-2656.2007.01256.x; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stratford Danial S., 2010, Australian Zoologist, V35, P189; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Symonds EP, 2007, J WILDLIFE DIS, V43, P48, DOI 10.7589/0090-3558-43.1.48; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Woodhams DC, 2006, J WILDLIFE DIS, V42, P207, DOI 10.7589/0090-3558-42.2.207	48	12	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92499	10.1371/journal.pone.0092499	http://dx.doi.org/10.1371/journal.pone.0092499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647532	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500137
J	Otis, JS; Niccoli, S; Hawdon, N; Sarvas, JL; Frye, MA; Chicco, AJ; Lees, SJ				Otis, Jeffrey S.; Niccoli, Sarah; Hawdon, Nicole; Sarvas, Jessica L.; Frye, Melinda A.; Chicco, Adam J.; Lees, Simon J.			Pro-Inflammatory Mediation of Myoblast Proliferation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; SATELLITE CELL-PROLIFERATION; HUMAN SKELETAL-MUSCLE; PROINFLAMMATORY CYTOKINE EXPRESSION; LEUKEMIA INHIBITORY FACTOR; STIMULATES IL-6 PRODUCTION; PROTEIN-KINASE-C; TNF-ALPHA; GENE-EXPRESSION	Skeletal muscle satellite cell function is largely dictated by the surrounding environment following injury. Immune cell infiltration dominates the extracellular space in the injured area, resulting in increased cytokine concentrations. While increased pro-inflammatory cytokine expression has been previously established in the first 3 days following injury, less is known about the time course of cytokine expression and the specific mechanisms of cytokine induced myoblast function. Therefore, the expression of IL-1 beta and IL-6 at several time points following injury, and their effects on myoblast proliferation, were examined. In order to do this, skeletal muscle was injured using barium chloride in mice and tissue was collected 1, 5, 10, and 28 days following injury. Mechanisms of cytokine induced proliferation were determined in cell culture using both primary and C2C12 myoblasts. It was found that there is a similar to 20-fold increase in IL-1 beta ( p <= 0.05) and IL-6 ( p = 0.06) expression 5 days following injury. IL-1b increased proliferation of both primary and C2C12 cells similar to 25%. IL-1 beta stimulation also resulted in increased NF-kappa B activity, likely contributing to the increased proliferation. These data demonstrate for the first time that IL-1 beta alone can increase the mitogenic activity of primary skeletal muscle satellite cells and offer insight into the mechanisms dictating satellite cell function following injury.	[Niccoli, Sarah; Hawdon, Nicole; Sarvas, Jessica L.; Lees, Simon J.] Northern Ontario Sch Med, Div Med Sci, Thunder Bay, ON, Canada; [Sarvas, Jessica L.; Lees, Simon J.] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Chicco, Adam J.; Lees, Simon J.] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA; [Frye, Melinda A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Otis, Jeffrey S.] Georgia State Univ, Dept Kinesiol & Hlth, Atlanta, GA 30303 USA	Northern Ontario School of Medicine; Lakehead University; Colorado State University; Colorado State University; University System of Georgia; Georgia State University	Lees, SJ (corresponding author), Northern Ontario Sch Med, Div Med Sci, Thunder Bay, ON, Canada.	simon.lees@nosm.ca			National Institutes of Health (National Institute on Aging [R03 AG-034352]; National Institute of Alcohol Abuse and Alcoholism [K01 017190]; Northern Ontario Heritage Fund Corporation; NATIONAL INSTITUTE ON AGING [R03AG034352] Funding Source: NIH RePORTER	National Institutes of Health (National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Northern Ontario Heritage Fund Corporation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institutes of Health (National Institute on Aging R03 AG-034352, P. I., Simon J. Lees; National Institute of Alcohol Abuse and Alcoholism K01 017190, P. I., Jeffrey S. Otis) and the Northern Ontario Heritage Fund Corporation (P. I., Simon J. Lees). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; ALMEKINDERS LC, 1986, AM J SPORT MED, V14, P303, DOI 10.1177/036354658601400411; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Baeuerle PA, 1998, CURR BIOL, V8, pR19, DOI 10.1016/S0960-9822(98)70010-7; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; BARLOW Y, 1992, BRIT MED BULL, V48, P698, DOI 10.1093/oxfordjournals.bmb.a072572; Berger A, 2000, BRIT MED J, V321, P424, DOI 10.1136/bmj.321.7258.424; BETHEA JR, 1992, J CELL PHYSIOL, V152, P264, DOI 10.1002/jcp.1041520207; Boyd JH, 2006, INFECT IMMUN, V74, P6829, DOI 10.1128/IAI.00286-06; CANTINI M, 1995, BIOCHEM BIOPH RES CO, V216, P49, DOI 10.1006/bbrc.1995.2590; Catanzaro R, 2012, J BIOL REG HOMEOS AG, V26, P337; Chabaud M, 1998, J IMMUNOL, V161, P409; Chevrel G, 2005, ANN RHEUM DIS, V64, P1257, DOI 10.1136/ard.2004.032359; Clary CR, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-30; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Collins RA, 2001, J HISTOCHEM CYTOCHEM, V49, P989, DOI 10.1177/002215540104900807; Cornelison DDW, 2008, J CELL BIOCHEM, V105, P663, DOI 10.1002/jcb.21892; Cumberbatch M, 2006, J EXP MED, V203, P953, DOI 10.1084/jem.20052367; de Almeida P, 2013, LASERS MED SCI; Dekeyser GJ, 2013, REGEN MED RES, V1, DOI 10.1186/2050-490X-1-2; Dumke BR, 2011, AM J PHYSL CELL PHYS; ELIAS JA, 1990, J IMMUNOL, V145, P161; FIELDING RA, 1993, AM J PHYSIOL, V265, pR166, DOI 10.1152/ajpregu.1993.265.1.R166; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Frost RA, 2003, AM J PHYSIOL-REG I, V285, pR1153, DOI 10.1152/ajpregu.00164.2003; Frost RA, 2002, AM J PHYSIOL-REG I, V283, pR698, DOI 10.1152/ajpregu.00039.2002; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Hamada K, 2004, FASEB J, V18, P264, DOI 10.1096/fj.03-1286fje; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Isumi Y, 1999, FEBS LETT, V463, P110, DOI 10.1016/S0014-5793(99)01615-4; Jove M, 2006, ENDOCRINOLOGY, V147, P552, DOI 10.1210/en.2005-0440; Jove M, 2005, ENDOCRINOLOGY, V146, P3087, DOI 10.1210/en.2004-1560; Jozsi AC, 2000, MECH AGEING DEV, V120, P45, DOI 10.1016/S0047-6374(00)00178-0; Jump SS, 2009, EXP PHYSIOL, V94, P739, DOI 10.1113/expphysiol.2008.046136; Kafoury Ramzi M, 2005, Int J Environ Res Public Health, V2, P107, DOI 10.3390/ijerph2005010107; KHAN I, 1995, GASTROENTEROLOGY, V108, P1720, DOI 10.1016/0016-5085(95)90133-7; Knofler M, 1997, FEBS LETT, V405, P213, DOI 10.1016/S0014-5793(97)00190-7; Krause MP, 2013, ACTA PHYSIOL, V208, P180, DOI 10.1111/apha.12099; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Lee JG, 2013, BIOL CELL, V105, P175, DOI 10.1111/boc.201200077; Lee TS, 2006, WORLD J GASTROENTERO, V12, P716, DOI 10.3748/wjg.v12.i5.716; Lees SJ, 2008, CELL PROLIFERAT, V41, P193, DOI 10.1111/j.1365-2184.2008.00512.x; Lees SJ, 2009, AGING CELL, V8, P26, DOI 10.1111/j.1474-9726.2008.00445.x; Lees SJ, 2006, AM J PHYSIOL-CELL PH, V290, pC609, DOI 10.1152/ajpcell.00408.2005; Lees SJ, 2008, AMJPHYSIOL CELL PHYS; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Li W, 2009, AM J PHYSIOL-CELL PH, V297, pC706, DOI 10.1152/ajpcell.00626.2008; Li YP, 2003, FASEB J, V17, P1048, DOI 10.1096/fj.02-0759com; LIBBY P, 1988, J CLIN INVEST, V81, P487, DOI 10.1172/JCI113346; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579; Luo GJ, 2003, AM J PHYSIOL-REG I, V284, pR1249, DOI 10.1152/ajpregu.00490.2002; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MCGEE DW, 1993, J IMMUNOL, V151, P970; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; Mendias CL, 2004, MUSCLE NERVE, V30, P497, DOI 10.1002/mus.20102; Merrick MA, 2002, J ATHL TRAINING, V37, P209; Mikkelsen UR, 2009, J APPL PHYSIOL, V107, P1600, DOI 10.1152/japplphysiol.00707.2009; MISHRA DK, 1995, J BONE JOINT SURG AM, V77, P1510, DOI 10.2106/00004623-199510000-00005; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nozaki M, 2012, MUSCLE NERVE, V46, P70, DOI 10.1002/mus.23280; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; Onozaki K, 2013, YAKUGAKU ZASSHI, V133, P645, DOI 10.1248/yakushi.13-00064; Otis Jeffrey S, 2008, AIDS Res Ther, V5, P8, DOI 10.1186/1742-6405-5-8; Otis JS, 2007, MUSCLE NERVE, V36, P842, DOI 10.1002/mus.20883; Otis JS, 2010, ALCOHOL ALCOHOLISM, V45, P495, DOI 10.1093/alcalc/agq066; Otis JS, 2009, ALCOHOL CLIN EXP RES, V33, P1450, DOI 10.1111/j.1530-0277.2009.00975.x; Ozes ON, 1999, NATURE, V401, P82; Parikh AA, 1997, SHOCK, V8, P249, DOI 10.1097/00024382-199710000-00003; Parise G, 2008, MUSCLE NERVE, V37, P611, DOI 10.1002/mus.20995; Peake J, 2010, AM J PHYSIOL-REG I, V298, pR1485, DOI 10.1152/ajpregu.00467.2009; Prelovsek O, 2006, AM J PHYSIOL-REG I, V291, pR1651, DOI 10.1152/ajpregu.00020.2006; Przybyla B, 2006, EXP GERONTOL, V41, P320, DOI 10.1016/j.exger.2005.12.007; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rathbone CR, 2008, MUSCLE NERVE, V37, P84, DOI 10.1002/mus.20897; Rathbone CR, 2009, EUR J CELL BIOL, V88, P35, DOI 10.1016/j.ejcb.2008.08.003; Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schertzer JD, 2006, GENE THER, V13, P1657, DOI 10.1038/sj.gt.3302817; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; SIRONI M, 1989, J IMMUNOL, V142, P549; Soltow QA, 2010, J MUSCLE RES CELL M, V31, P215, DOI 10.1007/s10974-010-9227-4; Spangelo BL, 2000, ANN NY ACAD SCI, V917, P597; Sung MS, 2012, INFLAMMATION, V35, P1585, DOI 10.1007/s10753-012-9473-2; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; TIDBALL JG, 1995, MED SCI SPORT EXER, V27, P1022, DOI 10.1249/00005768-199507000-00011; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; Trendelenburg AU, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-3; Trenerry MK, 2008, REJUV RES, V11, P717, DOI 10.1089/rej.2007.0643; Turner NA, 2009, AM J PHYSIOL-HEART C, V297, pH1117, DOI 10.1152/ajpheart.00372.2009; Wang X, 2008, CELL MOL NEUROBIOL, V28, P113, DOI 10.1007/s10571-007-9247-9; Warren GL, 2004, FASEB J, V18, P413, DOI 10.1096/fj.04-2421fje; Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zhan M, 2007, J CELL SCI, V120, P692, DOI 10.1242/jcs.03372; Zhang CC, 2013, J BIOL CHEM, V288, P1489, DOI 10.1074/jbc.M112.419788	100	65	67	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92363	10.1371/journal.pone.0092363	http://dx.doi.org/10.1371/journal.pone.0092363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647690	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500122
J	Rahman, MM; Alkhouri, H; Tang, F; Che, WC; Ge, Q; Ammit, AJ				Rahman, Md. Mostafizur; Alkhouri, Hatem; Tang, Francesca; Che, Wenchi; Ge, Qi; Ammit, Alaina J.			Sphingosine 1-Phosphate Induces Neutrophil Chemoattractant IL-8: Repression by Steroids	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; NF-KAPPA-B; P38 MAPK; UP-REGULATION; TNF-ALPHA; CELLS; ASTHMA; SECRETION; CYTOKINES; RANTES	The bioactive sphingolipid sphingosine 1-phosphate (S1P) is found in increased amounts in the airways of asthmatics. S1P can regulate airway smooth muscle functions associated with asthmatic inflammation and remodeling, including cytokine secretion. To date however, whether S1P induces secretion of an important chemokine responsible for neutrophilia in airway inflammation - IL-8 - was unexplored. The aim of this study was to investigate whether S1P induces IL-8 gene expression and secretion to enhance neutrophil chemotaxis in vitro, as well as examine the molecular mechanisms responsible for repression by the corticosteroid dexamethasone. We show that S1P upregulates IL-8 secretion from ASM cells and enhance neutrophil chemotaxis in vitro. The corticosteroid dexamethasone significantly represses IL-8 mRNA expression and protein secretion in a concentration- and time-dependent manner. Additionally, we reveal that S1P-induced IL-8 secretion is p38 MAPK and ERK-dependent and that these key phosphoproteins act on the downstream effector mitogen-and stress-activated kinase 1 (MSK1) to control secretion of the neutrophil chemoattractant cytokine IL-8. The functional relevance of this in vitro data was demonstrated by neutrophil chemotaxis assays where S1P-induced effects can be significantly attenuated by pretreatment with dexamethasone, pharmacological inhibition of p38 MAPK- or ERK-mediated pathways, or by knocking down MSK-1 with siRNA. Taken together, our study reveals the molecular pathways responsible for IL-8 secretion from ASM cells in response to S1P and indicates ways in which the impact on IL-8-driven neutrophilia may be lessened.	[Rahman, Md. Mostafizur; Alkhouri, Hatem; Che, Wenchi; Ammit, Alaina J.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Tang, Francesca; Ge, Qi] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Woolcock Institute of Medical Research	Ammit, AJ (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	alaina.ammit@sydney.edu.au	Alkhouri, Hatem/AAG-3390-2021; Ge, Qi/D-3988-2013; Tang, Francesca/H-4833-2016	Alkhouri, Hatem/0000-0002-5569-704X; Ammit, Alaina/0000-0003-0555-2544	Endeavour Postgraduate Award; National Health and Medical Research Council of Australia	Endeavour Postgraduate Award; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by an Endeavour Postgraduate Award (to MMR) and funded by project grants from the National Health and Medical Research Council of Australia (to AJA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammit AJ, 2001, FASEB J, V15, P1212, DOI 10.1096/fj.00-0742fje; Ammit AJ, 2002, AM J RESP CELL MOL, V26, P465, DOI 10.1165/ajrcmb.26.4.4681; Ammit AJ, 1997, AM J RESP CRIT CARE, V155, P1123, DOI 10.1164/ajrccm.155.3.9116997; Amrani Y, 2001, MOL PHARMACOL, V60, P646; Amrani Y, 1999, J IMMUNOL, V163, P2128; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Baines KJ, 2009, EXP LUNG RES, V35, P554, DOI 10.1080/01902140902777490; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; BROIDE DH, 1992, J ALLERGY CLIN IMMUN, V89, P958, DOI 10.1016/0091-6749(92)90218-Q; Catley MC, 2006, MOL PHARMACOL, V70, P697, DOI 10.1124/mol.106.023150; Che W, 2013, AM J RESP CELL MOL B; Che WC, 2012, BBA-MOL CELL RES, V1823, P1658, DOI 10.1016/j.bbamcr.2012.06.011; Henness S, 2006, AM J PHYSIOL-LUNG C, V290, pL1283, DOI 10.1152/ajplung.00367.2005; Issa R, 2006, AM J PHYSIOL-LUNG C, V291, pL66, DOI 10.1152/ajplung.00384.2005; John M, 1997, J IMMUNOL, V158, P1841; Johnson PRA, 1995, PULM PHARMACOL, V8, P43, DOI 10.1006/pulp.1995.1006; Jolly PS, 2002, MOL IMMUNOL, V38, P1239, DOI 10.1016/S0161-5890(02)00070-6; Kaur M, 2013, J PHARMACOL EXP THER, V347, P173, DOI 10.1124/jpet.112.201855; Lai WQ, 2011, BIOSCIENCE REP, V31, P145, DOI 10.1042/BSR20100087; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Manetsch M, 2012, BRIT J PHARMACOL, V166, P2049, DOI 10.1111/j.1476-5381.2012.01923.x; Manetsch M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059635; Manetsch M, 2012, AM J PHYSIOL-LUNG C, V302, pL838, DOI 10.1152/ajplung.00317.2011; Manetsch M, 2012, CELL SIGNAL, V24, P907, DOI 10.1016/j.cellsig.2011.12.013; Milara J, 2009, EUR J PHARMACOL, V609, P132, DOI 10.1016/j.ejphar.2009.03.012; Moutzouris JP, 2010, BBA-MOL CELL RES, V1803, P416, DOI 10.1016/j.bbamcr.2009.12.007; Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010; Newcomb DC, CURRENT OPINION IMMU; Olivera A, 2011, ADV EXP MED BIOL, V716, P123, DOI 10.1007/978-1-4419-9533-9_8; Quante T, 2008, AM J RESP CELL MOL, V39, P208, DOI 10.1165/rcmb.2007-0014OC; Simpson JL, 2013, EUROPEAN RESP J; Simpson JL, 2007, THORAX, V62, P211, DOI 10.1136/thx.2006.061358; Simpson JL, 2009, PHARMACOL THERAPEUT, V124, P86, DOI 10.1016/j.pharmthera.2009.06.004; Yang Yang, 2011, Ther Adv Respir Dis, V5, P325, DOI 10.1177/1753465811406772; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	35	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92466	10.1371/journal.pone.0092466	http://dx.doi.org/10.1371/journal.pone.0092466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647471	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500135
J	Shi, L; Chen, XS; Tang, WY; Li, ZY; Liu, J; Gao, F; Sang, JL				Shi, Lei; Chen, Xuesi; Tang, Wenying; Li, Zhenyi; Liu, Jin; Gao, Feng; Sang, Jianli			Combination of FACS and Homologous Recombination for the Generation of Stable and High-Expression Engineered Cell Lines	PLOS ONE			English	Article							TRANSGENE EXPRESSION; CHO-CELLS; STRATEGIES; EFFICIENT; PROTEINS	Traditionally, cell line generation requires several months and involves screening of over several hundred cell clones for high productivity before dozens are selected as candidate cell lines. Here, we have designed a new strategy for the generation of stable and high-expression cell lines by combining homologous recombination (HR) and fluorescence-activated cell sorting (FACS). High expression was indicated by the expression of secreted green fluorescent protein (SEGFP). Parental cell lines with the highest expression of SEGFP were then selected by FACS and identified by stability analysis. Consequently, HR vectors were constructed using the cassette for SEGFP as the HR region. After transfecting the HR vector, the cells with negative SEGFP expression were enriched by FACS. The complete exchange between SEGFP and target gene (TNFR-Fc) cassettes was demonstrated by DNA analysis. Compared with the traditional method, by integrating the cassette containing the gene of interest into the pre-selected site, the highest producing cells secreted a more than 8-fold higher titer of target protein. Hence, this new strategy can be applied to isolated stable cell lines with desirable expression of any gene of interest. The stable cell lines can rapidly produce proteins for researching protein structure and function and are even applicable in drug discovery.	[Shi, Lei; Chen, Xuesi; Liu, Jin; Gao, Feng; Sang, Jianli] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China; [Shi, Lei; Tang, Wenying; Li, Zhenyi; Gao, Feng] AutekBio Inc, R&D Dept, Beijing, Peoples R China	Beijing Normal University	Gao, F (corresponding author), Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China.	feng_gao@autekbio.com; jlsang@bnu.edu.cn	Chen, Xuesi/ABB-5039-2020		National "Twelfth Five-Year Plan" from the Ministry of Health [2011ZX09506-007]	National "Twelfth Five-Year Plan" from the Ministry of Health	This work was supported by The National "Twelfth Five-Year Plan" from the Ministry of Health (2011ZX09506-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bort JAH, 2010, BIOTECHNOL J, V5, P1090, DOI 10.1002/biot.201000095; Deer JR, 2004, BIOTECHNOL PROGR, V20, P880, DOI 10.1021/bp034383r; Dorai H, 2012, BIOTECHNOL BIOENG, V109, P1016, DOI 10.1002/bit.24367; Dreesen IAJ, 2011, BIOTECHNOL BIOENG, V108, P853, DOI 10.1002/bit.22990; Grandjean M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr436; Hacker DL, 2009, BIOTECHNOL ADV, V27, P1023, DOI 10.1016/j.biotechadv.2009.05.008; HASTY P, 1991, MOL CELL BIOL, V11, P5586, DOI 10.1128/MCB.11.11.5586; Huang Y, 2007, J IMMUNOL METHODS, V322, P28, DOI 10.1016/j.jim.2007.01.022; IMARC Group, 2012, SKUIMRC4880703; Jayapal KR, 2007, CHEM ENG PROG, V103, P40; Khoo SHG, 2009, BIOTECHNOL BIOENG, V102, P188, DOI 10.1002/bit.22041; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Koduri RK, 2001, GENE, V280, P87, DOI 10.1016/S0378-1119(01)00772-7; Kwaks THJ, 2006, TRENDS BIOTECHNOL, V24, P137, DOI 10.1016/j.tibtech.2006.01.007; Kwaks THJ, 2003, NAT BIOTECHNOL, V21, P553, DOI 10.1038/nbt814; Matasci M., 2008, DRUG DISCOV TODAY TE, V5, pe37, DOI DOI 10.1016/J.DDTEC.2008.12.003; Mattanovich D, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-12; Nair Ayyappan R, 2011, BMC Res Notes, V4, P178, DOI 10.1186/1756-0500-4-178; Peng J, 2005, RETARGETING PRESET R; Pichler J, 2011, BIOTECHNOL BIOENG, V108, P386, DOI 10.1002/bit.22946; Pichler J, 2009, J BIOTECHNOL, V141, P80, DOI 10.1016/j.jbiotec.2009.03.001; Porter AJ, 2010, BIOTECHNOL PROGR, V26, P1446, DOI 10.1002/btpr.442; Qiao JH, 2009, J MOL BIOL, V390, P579, DOI 10.1016/j.jmb.2009.05.012; Seth G, 2007, CURR OPIN BIOTECH, V18, P557, DOI 10.1016/j.copbio.2007.10.012; Sleiman RJ, 2008, BIOTECHNOL BIOENG, V99, P578, DOI 10.1002/bit.21612; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Wilke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027829; Yanez RJ, 1999, SOMAT CELL MOLEC GEN, V25, P27, DOI 10.1023/B:SCAM.0000007137.28557.73	28	4	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91712	10.1371/journal.pone.0091712	http://dx.doi.org/10.1371/journal.pone.0091712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646904	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500046
J	Walters, BJ; Lin, WW; Diao, SY; Brimble, M; Iconaru, LI; Dearman, J; Goktug, A; Chen, TS; Zuo, J				Walters, Brandon J.; Lin, Wenwei; Diao, Shiyong; Brimble, Mark; Iconaru, Luigi I.; Dearman, Jennifer; Goktug, Asli; Chen, Taosheng; Zuo, Jian			High-Throughput Screening Reveals Alsterpaullone, 2-Cyanoethyl as a Potent p27(Kip1) Transcriptional Inhibitor	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; CELL-CYCLE; HAIR-CELLS; STEM-CELLS; CANCER; EXPRESSION; GENE; COCHLEA; ORGAN; CORTI	p27(Kip1) is a cell cycle inhibitor that prevents cyclin dependent kinase (CDK)/cyclin complexes from phosphorylating their targets. p27(Kip1) is a known tumor suppressor, as the germline loss of p27(Kip1) results in sporadic pituitary formation in aged rodents, and its presence in human cancers is indicative of a poor prognosis. In addition to its role in cancer, loss of p27(Kip1) results in regenerative phenotypes in some tissues and maintenance of stem cell pluripotency, suggesting that p27(Kip1) inhibitors could be beneficial for tissue regeneration. Because p27(Kip1) is an intrinsically disordered protein, identifying direct inhibitors of the p27(Kip1) protein is difficult. Therefore, we pursued a high-throughput screening strategy to identify novel p27(Kip1) transcriptional inhibitors. We utilized a luciferase reporter plasmid driven by the p27(Kip1) promoter to transiently transfect HeLa cells and used cyclohexamide as a positive control for non-specific inhibition. We screened a "bioactive'' library consisting of 8,904 (4,359 unique) compounds, of which 830 are Food and Drug Administration (FDA) approved. From this screen, we successfully identified 111 primary hits with inhibitory effect against the promoter of p27(Kip1). These hits were further refined using a battery of secondary screens. Here we report four novel p27(Kip1) transcriptional inhibitors, and further demonstrate that our most potent hit compound (IC50 = 200 nM) Alsterpaullone 2-cyanoethyl, inhibits p27(Kip1) transcription by preventing FoxO3a from binding to the p27(Kip1) promoter. This screen represents one of the first attempts to identify inhibitors of p27(Kip1) and may prove useful for future tissue regeneration studies.	[Walters, Brandon J.; Diao, Shiyong; Brimble, Mark; Iconaru, Luigi I.; Dearman, Jennifer; Zuo, Jian] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Lin, Wenwei; Goktug, Asli; Chen, Taosheng] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Brimble, Mark] Univ Bath, Bath BA2 7AY, Avon, England	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Bath	Zuo, J (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jian.zuo@stjude.org	Chen, Taosheng/I-6351-2013; Lin, Wenwei/D-9241-2018	Chen, Taosheng/0000-0001-6420-3809; Lin, Wenwei/0000-0001-8754-6150; Brimble, Mark/0000-0001-7182-9818; Walters, Brandon/0000-0002-8073-6573	Office of Naval Research [N000140911014, N000141210191, N000141210775]; National Institutes of Health [DC06471, GM086415, CA21765]; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; The Hartwell Individual Biomedical Research Award; HHF emerging research grant; Garwood Fellowship; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006471, R21DC013879] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); The Hartwell Individual Biomedical Research Award; HHF emerging research grant; Garwood Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the Office of Naval Research: N000140911014, N000141210191, and N000141210775 (JZ); National Institutes of Health: DC06471 (JZ), GM086415 (TC), and CA21765 (St. Jude); The American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; JZ is a recipient of The Hartwell Individual Biomedical Research Award; BW is a recipient of the HHF emerging research grant; LI is a recipient of the Garwood Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertagnolli MM, 2009, CLIN CANCER RES, V15, P2116, DOI 10.1158/1078-0432.CCR-08-2674; Bottini C, 2009, INT J ONCOL, V34, P69, DOI 10.3892/ijo_00000130; Chang BL, 2004, CANCER RES, V64, P1997, DOI 10.1158/0008-5472.CAN-03-2340; Chen P, 1999, DEVELOPMENT, V126, P1581; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Duronio RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008904; Herbst J, 2009, ASSAY DRUG DEV TECHN, V7, P294, DOI 10.1089/adt.2008.184; Karnezis AN, 2001, J CLIN INVEST, V108, P383, DOI 10.1172/JCI11933; Lee YS, 2006, DEVELOPMENT, V133, P2817, DOI 10.1242/dev.02453; Leonardi R, 2010, CHEM BIOL, V17, P892, DOI 10.1016/j.chembiol.2010.06.006; Lin WW, 2008, J BIOL CHEM, V283, P30650, DOI 10.1074/jbc.M806132200; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Liu ZY, 2012, J NEUROSCI, V32, P10530, DOI 10.1523/JNEUROSCI.0686-12.2012; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Maass JC, 2013, JARO-J ASSOC RES OTO, V14, P495, DOI 10.1007/s10162-013-0383-2; Mantela J, 2005, DEVELOPMENT, V132, P2377, DOI 10.1242/dev.01834; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Menchon C, 2011, CELL CYCLE, V10, P1435, DOI 10.4161/cc.10.9.15421; Minami S, 1997, FEBS LETT, V411, P1, DOI 10.1016/S0014-5793(97)00660-1; Minoda R, 2007, HEARING RES, V232, P44, DOI 10.1016/j.heares.2007.06.005; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Oesterle EC, 2011, CELL CYCLE, V10, P1237, DOI 10.4161/cc.10.8.15301; Pellegata NS, 2006, P NATL ACAD SCI USA, V103, P15558, DOI 10.1073/pnas.0603877103; Rabbani F, 2007, BJU INT, V100, P259, DOI 10.1111/j.1464-410X.2007.06927.x; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Tolle N, 2011, CURR TOP MED CHEM, V11, P1320, DOI 10.2174/156802611795589601; Trapp J, 2006, J MED CHEM, V49, P7307, DOI 10.1021/jm060118b; Vrijens K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059045; Walters BJ, 2013, HEARING RES, V297, P68, DOI 10.1016/j.heares.2012.11.009; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Zaharevitz DW, 1999, CANCER RES, V59, P2566; Zhang SW, 2013, J CELL BIOCHEM, V114, P354, DOI 10.1002/jcb.24371	38	12	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91173	10.1371/journal.pone.0091173	http://dx.doi.org/10.1371/journal.pone.0091173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646893	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500025
J	Zhou, WP; Hui, DF; Shen, WJ				Zhou, Weiping; Hui, Dafeng; Shen, Weijun			Effects of Soil Moisture on the Temperature Sensitivity of Soil Heterotrophic Respiration: A Laboratory Incubation Study	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; ECOSYSTEM RESPIRATION; MICROBIAL COMMUNITIES; EXTRACTION METHOD; WATER-CONTENT; DECOMPOSITION; RESPONSES; BIOMASS; CO2; PATTERNS	The temperature sensitivity (Q(10)) of soil heterotrophic respiration (Rh) is an important ecological model parameter and may vary with temperature and moisture. While Q(10) generally decreases with increasing temperature, the moisture effects on Q(10) have been controversial. To address this, we conducted a 90-day laboratory incubation experiment using a subtropical forest soil with a full factorial combination of five moisture levels (20%, 40%, 60%, 80%, and 100% water holding capacity - WHC) and five temperature levels (10, 17, 24, 31, and 38 degrees C). Under each moisture treatment, R-h was measured several times for each temperature treatment to derive Q(10) based on the exponential relationships between R-h and temperature. Microbial biomass carbon (MBC), microbial community structure and soil nutrients were also measured several times to detect their potential contributions to the moisture-induced Q(10) variation. We found that Q(10) was significantly lower at lower moisture levels (60%, 40% and 20% WHC) than at higher moisture level (80% WHC) during the early stage of the incubation, but became significantly higher at 20% WHC than at 60% WHC and not significantly different from the other three moisture levels during the late stage of incubation. In contrast, soil R-h had the highest value at 60% WHC and the lowest at 20% WHC throughout the whole incubation period. Variations of Q(10) were significantly associated with MBC during the early stages of incubation, but with the fungi-to-bacteria ratio during the later stages, suggesting that changes in microbial biomass and community structure are related to the moisture-induced Q(10) changes. This study implies that global warming's impacts on soil CO2 emission may depend upon soil moisture conditions. With the same temperature rise, wetter soils may emit more CO2 into the atmosphere via heterotrophic respiration.	[Zhou, Weiping; Shen, Weijun] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Zhou, Weiping] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tennessee State University	Shen, WJ (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	shenweij@scbg.ac.cn	Shen, Weijun/G-2942-2010	Shen, Weijun/0000-0001-7574-8839; Hui, Dafeng/0000-0002-5284-2897	Natural Science Foundation of China [31130011, 31290222]; Natural Science Foundation of Guangdong Province, China [S2012020011084]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This study was financially supported by the Natural Science Foundation of China (31130011 and 31290222), and the Natural Science Foundation of Guangdong Province, China (S2012020011084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo CBM, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001006; Billings SA, 2013, GLOBAL CHANGE BIOL, V19, P90, DOI 10.1111/gcb.12029; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; CARLYLE JC, 1988, J ECOL, V76, P654, DOI 10.2307/2260565; Chen DM, 2009, FOREST ECOL MANAG, V257, P2088, DOI 10.1016/j.foreco.2009.02.018; Christ MJ, 1996, SOIL BIOL BIOCHEM, V28, P1191, DOI 10.1016/0038-0717(96)00120-4; Conant RT, 2008, ECOLOGY, V89, P2384, DOI 10.1890/08-0137.1; Cook FJ, 2008, SOIL BIOL BIOCHEM, V40, P1013, DOI 10.1016/j.soilbio.2007.12.012; Craine JM, 2011, SOIL BIOL BIOCHEM, V43, P455, DOI 10.1016/j.soilbio.2010.10.011; Craine JM, 2010, NAT GEOSCI, V3, P854, DOI [10.1038/ngeo1009, 10.1038/NGEO1009]; Yuste JC, 2010, BIOGEOCHEMISTRY, V98, P127, DOI 10.1007/s10533-009-9381-1; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Deng Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041493, 10.1371/journal.pone.0038737]; DORICH RA, 1983, SOIL SCI SOC AM J, V47, P833, DOI 10.2136/sssaj1983.03615995004700040042x; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Gray SB, 2011, SOIL SCI SOC AM J, V75, P2217, DOI 10.2136/sssaj2011.0135; Guggenberger G, 1999, SOIL SCI SOC AM J, V63, P1188, DOI 10.2136/sssaj1999.6351188x; Hamdi S, 2013, SOIL BIOL BIOCHEM, V58, P115, DOI 10.1016/j.soilbio.2012.11.012; He ZL, 1997, BIOL FERT SOILS, V24, P421, DOI 10.1007/s003740050267; HOLLAND EA, 1987, ECOLOGY, V68, P425, DOI 10.2307/1939274; Huang WJ, 2013, PLANT SOIL, V364, P181, DOI 10.1007/s11104-012-1355-8; Hui DF, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002297; Jassal RS, 2008, GLOBAL CHANGE BIOL, V14, P1305, DOI 10.1111/j.1365-2486.2008.01573.x; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P33, DOI 10.1016/0038-0717(95)00101-8; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; Li ZA, 2001, PLANT SOIL, V229, P105, DOI 10.1023/A:1004832013143; LINN DM, 1984, SOIL SCI SOC AM J, V48, P794, DOI 10.2136/sssaj1984.03615995004800040019x; Lundquist EJ, 1999, SOIL BIOL BIOCHEM, V31, P1031, DOI 10.1016/S0038-0717(99)00017-6; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Moyano FE, 2012, BIOGEOSCIENCES, V9, P1173, DOI 10.5194/bg-9-1173-2012; Moyano FE, 2013, SOIL BIOL BIOCHEM, V59, P72, DOI 10.1016/j.soilbio.2013.01.002; NAKAS JP, 1979, APPL ENVIRON MICROB, V38, P454, DOI 10.1128/AEM.38.3.454-460.1979; OBERBAUER SF, 1992, OECOLOGIA, V92, P568, DOI 10.1007/BF00317851; ORCHARD VA, 1983, SOIL BIOL BIOCHEM, V15, P447, DOI 10.1016/0038-0717(83)90010-X; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1754, DOI 10.1111/j.1365-2486.2005.001010.x; Reichstein M, 2002, FUNCT ECOL, V16, P27, DOI 10.1046/j.0269-8463.2001.00597.x; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Richardson J, 2012, SOIL BIOL BIOCHEM, V46, P89, DOI 10.1016/j.soilbio.2011.11.008; SCHNURER J, 1986, MICROBIAL ECOL, V12, P217, DOI 10.1007/BF02011206; Shen WJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000685; Shen WJ, 2009, GLOBAL CHANGE BIOL, V15, P2274, DOI 10.1111/j.1365-2486.2009.01857.x; Solomon S., 2007, CONTRIBUTION WORKING, P996; Song MH, 2010, EUR J SOIL BIOL, V46, P375, DOI 10.1016/j.ejsobi.2010.09.003; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Tuomi M, 2008, ECOL MODEL, V211, P182, DOI 10.1016/j.ecolmodel.2007.09.003; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang CK, 2006, GLOBAL CHANGE BIOL, V12, P2103, DOI 10.1111/j.1365-2486.2006.01234.x; Wang GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053914; Williams MA, 2007, SOIL BIOL BIOCHEM, V39, P2750, DOI 10.1016/j.soilbio.2007.05.025; Xu LK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002281; Yu XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028397; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x; Yuste JC, 2004, GLOBAL CHANGE BIOL, V10, P161, DOI 10.1111/j.1529-8817.2003.00727.x; Zak DR, 1996, ECOL APPL, V6, P257, DOI 10.2307/2269568; Zhou T, 2009, SCI CHINA SER C, V52, P982, DOI 10.1007/s11427-009-0125-1	64	63	67	3	191	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92531	10.1371/journal.pone.0092531	http://dx.doi.org/10.1371/journal.pone.0092531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647610	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500140
J	Fa, M; Staniszewski, A; Saeed, F; Francis, YI; Arancio, O				Fa, Mauro; Staniszewski, Agnieszka; Saeed, Faisal; Francis, Yitshak I.; Arancio, Ottavio			Dynamin 1 Is Required for Memory Formation	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; RELEASE PROBABILITY; TRANSMITTER RELEASE; AMYLOID-BETA; ENDOCYTOSIS; ISOFORMS; INHIBITION; CALMODULIN; MODULATION	Dynamin 1-3 isoforms are known to be involved in endocytotic processes occurring during synaptic transmission. No data has directly linked dynamins yet with normal animal behavior. Here we show that dynamin pharmacologic inhibition markedly impairs hippocampal-dependent associative memory. Memory loss was associated with changes in synaptic function occurring during repetitive stimulation that is thought to be linked with memory induction. Synaptic fatigue was accentuated by dynamin inhibition. Moreover, dynamin inhibition markedly reduced long-term potentiation, post-tetanic potentiation, and neurotransmitter released during repetitive stimulation. Most importantly, the effect of dynamin inhibition onto memory and synaptic plasticity was due to a specific involvement of the dynamin 1 isoform, as demonstrated through a genetic approach with siRNA against this isoform to temporally block it. Taken together, these findings identify dynamin 1 as a key protein for modulation of memory and release evoked by repetitive activity.	[Fa, Mauro; Staniszewski, Agnieszka; Saeed, Faisal; Francis, Yitshak I.; Arancio, Ottavio] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA	Columbia University	Arancio, O (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	oa1@columbia.edu	arancio, ottavio/AAB-7959-2019; Fa, Mauro/F-5515-2011; Fà, Mauro/AAH-2749-2020	Fa, Mauro/0000-0002-8348-0382; Fà, Mauro/0000-0002-8348-0382; Saeed, Faisal/0000-0003-1194-2792; arancio, ottavio/0000-0001-6335-164X	NIH [R01NS049442]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH # R01NS049442. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcio B, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-37; Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; Armbruster M, 2013, ELIFE, V2, DOI 10.7554/eLife.00845; Bartolome-Martin D, 2012, J CELL SCI, V125, P422, DOI 10.1242/jcs.090878; Bayazitov IT, 2007, J NEUROSCI, V27, P11510, DOI 10.1523/JNEUROSCI.3077-07.2007; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Casoli T, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.012; Casse F, 2012, J NEUROSCI, V32, P5186, DOI 10.1523/JNEUROSCI.5296-11.2012; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; Davidson TJ, 2004, J NEUROSCI, V24, P10040, DOI 10.1523/JNEUROSCI.3643-04.2004; DeAndrade MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035518; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Guo CH, 2010, BEHAV GENET, V40, P680, DOI 10.1007/s10519-010-9374-9; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Hou QL, 2004, EUR J NEUROSCI, V20, P1593, DOI 10.1111/j.1460-9568.2004.03600.x; Hua YF, 2013, NEURON, V80, P343, DOI 10.1016/j.neuron.2013.08.010; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Kamal A, 2011, BRAIN RES, V1410, P33, DOI 10.1016/j.brainres.2011.06.059; Kasuya J, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.011.2009; Kramar EA, 2004, J NEUROSCI, V24, P5151, DOI 10.1523/JNEUROSCI.0800-04.2004; Liu YW, 2011, P NATL ACAD SCI USA, V108, pE234, DOI 10.1073/pnas.1102710108; Lou XL, 2008, P NATL ACAD SCI USA, V105, P17555, DOI 10.1073/pnas.0809621105; Lu JZ, 2008, BIOCHEM BIOPH RES CO, V371, P315, DOI 10.1016/j.bbrc.2008.04.077; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Neher E, 2001, J NEUROSCI, V21, P9638, DOI 10.1523/JNEUROSCI.21-24-09638.2001; Neher Erwin, 2010, Front Synaptic Neurosci, V2, P144, DOI 10.3389/fnsyn.2010.00144; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Otis T, 1996, J NEUROSCI, V16, P7496; Owen GR, 2012, CELL MOL NEUROBIOL, V32, P919, DOI 10.1007/s10571-012-9836-0; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; Virmani T, 2006, J NEUROSCI, V26, P2197, DOI 10.1523/JNEUROSCI.4500-05.2006; Wu XS, 2009, J NEUROSCI, V29, P11038, DOI 10.1523/JNEUROSCI.2367-09.2009; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Yao J, 2012, NAT NEUROSCI, V15, P243, DOI 10.1038/nn.3013; Yao LJ, 2012, P NATL ACAD SCI USA, V109, P291, DOI 10.1073/pnas.1100608109; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	55	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91954	10.1371/journal.pone.0091954	http://dx.doi.org/10.1371/journal.pone.0091954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643165	gold, Green Submitted, Green Published			2022-12-27	WOS:000333259900050
J	Zhou, XY; Yu, YY; Li, YH; Wu, JJ; Zhang, XJ; Guo, XW; Wang, WM				Zhou, Xiaoyun; Yu, Yongyao; Li, Yanhe; Wu, Junjie; Zhang, Xiujie; Guo, Xianwu; Wang, Weimin			Comparative Analysis of Mitochondrial Genomes in Distinct Nuclear Ploidy Loach Misgurnus anguillicaudatus and Its Implications for Polyploidy Evolution	PLOS ONE			English	Article							COMPLETE MITOGENOME SEQUENCE; TRANSFER-RNA GENES; CYTOCHROME-B GENE; PHYLOGENETIC ANALYSIS; NATURAL OCCURRENCE; HUBEI PROVINCE; DNA SEQUENCE; 1ST RECORD; TELEOSTEI; DIVERSITY	Misgurnus anguillicaudatus has several natural ploidy types. To investigate whether nuclear polyploidy have an impact on mitochondrial DNA (mtDNA), the complete mitochondrial genomes (mitogenomes) of five distinct ploidy M. anguillicaudatus (natural diploid, triploid, tetraploid, pentaploid and hexaploid), which were collected in central China, were sequenced and analyzed. The five mitogenomes share the same gene arrangement and have similar gene size, base composition and codon usage pattern. The most variable regions of the mitogenome were the protein-coding genes, especially the ND4L (5.39% mutation rate). Most variations occurred in tetraploids. The phylogenetic tree showed that the tetraploid M. anguillicaudatus separated early from other ploidy loaches. Meanwhile, the mitogenomes from pentaploids, and hexaploids have the closest phylogenetic relations, but far from that of tetraploids, implying that pentaploids and hexaploids could not be formed from tetraploids, possibly from the diploids and triploids. The genus Misgurnus species were divided into two divergent inter-genus clades, and the five ploidy M. anguillicaudatus were monophyletic, which support the hypotheses about the mitochondrial introgression in loach species.	[Zhou, Xiaoyun; Yu, Yongyao; Li, Yanhe; Wu, Junjie; Zhang, Xiujie; Wang, Weimin] Huazhong Agr Univ, Freshwater Aquaculture Collaborat Innovat Ctr Hub, Minist Agr, Coll Fisheries,Key Lab Freshwater Anim Breeding, Wuhan, Peoples R China; [Guo, Xianwu] Inst Politecn Nacl, Lab Biomed Mol, Ctr Biotecnol Genom, Colonia Narciso Mendoza, Tamaulipas, Mexico	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Instituto Politecnico Nacional - Mexico	Wang, WM (corresponding author), Huazhong Agr Univ, Freshwater Aquaculture Collaborat Innovat Ctr Hub, Minist Agr, Coll Fisheries,Key Lab Freshwater Anim Breeding, Wuhan, Peoples R China.	wangwm@mail.hzau.edu.cn	Guo, Xianwu/D-6709-2018	Li, Yanhe/0000-0001-6451-4527	National Natural Science Foundation of China [31001103, 31372180]; Fundamental Research Funds for the Central Universities [2011PY137]; Ph.D. Programs Foundation of the Ministry of Education of China [20100146120012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China)	This research was supported by the National Natural Science Foundation of China (Program No. 31001103 and 31372180) and the Fundamental Research Funds for the Central Universities (Program No. 2011PY137). This research is also a component of the Ph.D. Programs Foundation of the Ministry of Education of China (Program No. 20100146120012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas K, 2009, J FISH BIOL, V75, P435, DOI 10.1111/j.1095-8649.2009.02320.x; Adams KL, 2007, J HERED, V98, P136, DOI 10.1093/jhered/esl061; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arai K, 2003, FOLIA BIOL-KRAKOW, V51, P107; Blank HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000047; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Broughton RE, 2001, GENOME RES, V11, P1958, DOI 10.1101/gr.156801; Brown W.M., 1985, MOL EVOLUTIONARY GEN, P399; Catanese G, 2008, DNA SEQUENCE, V19, P159, DOI 10.1080/10425170701207117; CHANG ZJ, 2000, J HENAN NORMAL U NAT, V28, P71; Chen J.-x., 1984, Acta Zootaxonomica Sinica, V9, P201; Cheng YZ, 2012, GENET MOL BIOL, V35, P191, DOI 10.1590/S1415-47572012005000006; Choleva L, 2012, EVOLUTION, V66, P2191, DOI 10.1111/j.1558-5646.2012.01589.x; CLAYTON DA, 1991, TRENDS BIOCHEM SCI, V16, P107, DOI 10.1016/0968-0004(91)90043-U; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Cui L, 2013, FOLIA ZOOL, V62, P14; DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116; Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, pG914, DOI 10.1152/ajpgi.00402.2011; Gao ZX, 2007, COMP BIOCHEM PHYS A, V147, P1001, DOI 10.1016/j.cbpa.2007.03.006; Gattermann N, 2004, NUCLEOS NUCLEOT NUCL, V23, P1275, DOI 10.1081/NCN-200027545; Guo XH, 2006, GENETICS, V172, P1745, DOI 10.1534/genetics.105.049841; He AY, 2011, MOL BIOL REP, V38, P2015, DOI 10.1007/s11033-010-0324-7; He SP, 2008, MOL PHYLOGENET EVOL, V47, P419, DOI 10.1016/j.ympev.2007.10.012; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inoue JG, 2001, FISHERIES SCI, V67, P118, DOI 10.1046/j.1444-2906.2001.00207.x; Janko K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045384; Kartavtsev YP, 2007, GENE, V396, P13, DOI 10.1016/j.gene.2007.01.027; Kitagawa T, 2011, FOLIA ZOOL, V60, P343; Koizumi Noriyuki, 2009, Transactions of the Japanese Society of Irrigation Drainage and Rural Engineering, V77, P7; KUMAZAWA Y, 1993, J MOL EVOL, V37, P380, DOI 10.1007/BF00178868; LEE WJ, 1995, J MOL EVOL, V41, P54; Li SF, 2009, J FISH BIOL, V74, P1787, DOI 10.1111/j.1095-8649.2009.02258.x; Li T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055381; Li YJ, 2008, NIPPON SUISAN GAKK, V74, P177, DOI 10.2331/suisan.74.177; Li YH, 2011, INDIAN J EXP BIOL, V49, P953; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lou Yun-Dong, 1997, Journal of Fisheries of China, V21, P82; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukens LN, 2006, PLANT PHYSIOL, V140, P336, DOI 10.1104/pp.105.066308; MA G, 1996, J GANSU SCI, V8, P77; Mabuchi K, 2006, AQUACULTURE, V257, P68, DOI 10.1016/j.aquaculture.2006.03.040; MAYFIELD JE, 1978, CHROMOSOMA, V67, P157, DOI 10.1007/BF00293173; Meyer Axel, 1993, Biochemistry and Molecular Biology of Fishes, V2, P1; Miya M, 1999, MAR BIOTECHNOL, V1, P416, DOI 10.1007/PL00011798; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; Morishima K, 1999, FISH GENET BREED SCI, V28, P113; Morishima K, 2008, GENETICA, V132, P159, DOI 10.1007/s10709-007-9158-1; Nalbant TT, 1998, ITAL J ZOOL, V65, P109, DOI 10.1080/11250009809386803; Nei M., 2000, MOL EVOLUTION PHYLOG; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Peng ZG, 2006, GENE, V376, P290, DOI 10.1016/j.gene.2006.04.014; POGLAZOVA MN, 1991, MICROBIOLOGY+, V60, P623; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qin CG, 2002, J NUTR BIOCHEM, V13, P592, DOI 10.1016/S0955-2863(02)00193-6; Randi E, 1998, J MOL EVOL, V47, P449, DOI 10.1007/PL00006402; Ruokonen M, 2002, MOL PHYLOGENET EVOL, V23, P422, DOI 10.1016/S1055-7903(02)00021-0; SACCONE C, 1991, J MOL EVOL, V33, P83, DOI 10.1007/BF02100199; Saitoh K, 2010, MOL PHYLOGENET EVOL, V56, P1001, DOI 10.1016/j.ympev.2010.04.021; Sbisa E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Slechtova V, 2008, MOL PHYLOGENET EVOL, V47, P812, DOI 10.1016/j.ympev.2007.12.018; Small RL, 1999, MOL BIOL EVOL, V16, P491, DOI 10.1093/oxfordjournals.molbev.a026131; SOUTHERN SO, 1988, J MOL EVOL, V28, P32, DOI 10.1007/BF02143495; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang QY, 2006, MOL PHYLOGENET EVOL, V39, P347, DOI 10.1016/j.ympev.2005.08.007; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang CH, 2012, MOL BIOL REP, V39, P6337, DOI 10.1007/s11033-012-1455-9; Wang JJ, 2012, MITOCHONDR DNA, V23, P366, DOI 10.3109/19401736.2012.696628; WANG JP, 1993, J HEBEI U, V13, P51; Wang XY, 2013, MITOCHONDR DNA, V24, P1, DOI 10.3109/19401736.2012.710222; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yan JP, 2010, FISH PHYSIOL BIOCHEM, V36, P263, DOI 10.1007/s10695-008-9251-0; Yin Jie, 2005, Acta Hydrobiologica Sinica, V29, P469; Yu X. Z., 1989, CHROMOSOMES CHINESE; Yue GH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-242; Zeng LG, 2012, MITOCHONDR DNA, V23, P187, DOI 10.3109/19401736.2012.668893; Zhang QQ, 1999, ICHTHYOL RES, V46, P153, DOI 10.1007/BF02675433; Zhou XY, 2008, J APPL ICHTHYOL, V24, P664, DOI 10.1111/j.1439-0426.2008.01116.x; Zhu ZY, 2008, AQUACULTURE, V276, P44, DOI 10.1016/j.aquaculture.2008.02.008	82	16	19	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92033	10.1371/journal.pone.0092033	http://dx.doi.org/10.1371/journal.pone.0092033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643051	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900066
J	Bae, SE; Wright, IK; Wyse, C; Samson-Desvignes, N; Le Blanc, P; Laroche, S; Hazlerigg, DG; Johnston, JD				Bae, Sung-Eun; Wright, Ian K.; Wyse, Cathy; Samson-Desvignes, Nathalie; Le Blanc, Pascale; Laroche, Serge; Hazlerigg, David G.; Johnston, Jonathan D.			Regulation of Pituitary MT1 Melatonin Receptor Expression by Gonadotrophin-Releasing Hormone (GnRH) and Early Growth Response Factor-1 (Egr-1): In Vivo and In Vitro Studies	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; LUTEINIZING-HORMONE; PARS TUBERALIS; MULTIPLE PITUITARY; MESSENGER-RNA; HUMAN PUBERTY; TRANSCRIPTION; MICE; INHIBITION; LINEAGE	Melatonin receptor expression exhibits profound developmental changes through poorly understood mechanisms. In mammals, a current model suggests that pubertal reactivation of gonadotrophin-releasing hormone (GnRH) secretion down-regulates MT1 melatonin receptors in pituitary gonadotroph cells, via the induction of early growth response factor-1 (EGR-1). Here we have examined this model by testing the hypotheses that inhibition of Mt1 expression by GnRH occurs directly in gonadotroph cells, can be reversed in adulthood by blockade of GnRH receptors, and requires EGR-1. We first confirmed the endogenous expression of Mt1 mRNA in the alpha T3-1 gonadotroph cell line. Stimulation of these cells with a GnRH agonist resulted in a rapid increase of Egr-1 mRNA expression, which peaked after 30-60 minutes, and a more prolonged elevation of nuclear EGR-1 immunoreactivity. Moreover, the GnRH agonist significantly decreased Mt1 mRNA. We then treated adult male rats with the GnRH antagonist cetrorelix or saline. After 4 weeks of daily injections, cetrorelix significantly reduced serum LH concentration and testis weight, with histological analysis confirming absence of spermatogenesis. Despite the successful inhibition of GnRH signalling, pituitary Mt1 expression was unchanged. Next we studied the proximal region of the rat Mt1 promoter. Consistent with previous work, over-expression of the transcription factor PITX-1 increased Mt1-luciferase reporter activity; this effect was dependent on the presence of consensus PITX-1 promoter binding regions. Over-expression of EGR-1 inhibited PITX-1-stimulated activity, even following mutation of the consensus EGR-1 binding site. Finally, we studied Egr1(-/-) mice and observed no difference in pituitary Mt1 expression between Egr1(-/-) and wild-type litter mates. This work demonstrates that GnRH receptor activation directly down-regulates Mt1 expression in gonadotroph cells. However, pituitary Mt1 expression in adults is unaltered by blockade of GnRH signalling or absence of EGR-1. Our data therefore suggest that melatonin receptor regulation by GnRH is not reversible in adulthood and doesn't require EGR-1.	[Bae, Sung-Eun; Wright, Ian K.; Johnston, Jonathan D.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Wyse, Cathy; Hazlerigg, David G.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Wyse, Cathy] Univ Glasgow, Sch Vet Med, Glasgow, Lanark, Scotland; [Samson-Desvignes, Nathalie; Le Blanc, Pascale; Laroche, Serge] Univ Paris 11, CNRS, Ctr Neurosci Paris Sud, Orsay, France; [Hazlerigg, David G.] Univ Tromso, Fac Biosci Fisheries & Econ, Dept Arctic & Marine Biol, Tromso, Norway	University of Surrey; University of Aberdeen; University of Glasgow; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UiT The Arctic University of Tromso	Johnston, JD (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England.	j.johnston@surrey.ac.uk	Johnston, Jonathan D/H-6363-2011; Johnston, Jonathan/AAS-6969-2021	Johnston, Jonathan D/0000-0001-8083-9794; Desvignes, Nathalie/0000-0002-4243-0733	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F020309/1]; BBSRC [BB/F020309/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F020309/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC; grant BB/F020309/1; http://www.bbsrc.ac.uk/home/home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett P, 1996, MOL ENDOCRINOL, V10, P892, DOI 10.1210/me.10.7.892; Crowley SJ, 2012, DEV PSYCHOBIOL, V54, P468, DOI 10.1002/dev.20605; Davis FC, 1997, J BIOL RHYTHM, V12, P498, DOI 10.1177/074873049701200603; de Holanda FS, 2011, GYNECOL ENDOCRINOL, V27, P519, DOI 10.3109/09513590.2010.501888; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Fortin J, 2010, CELL SIGNAL, V22, P936, DOI 10.1016/j.cellsig.2010.01.019; Hansson ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046001; HORN F, 1991, MOL ENDOCRINOL, V5, P347, DOI 10.1210/mend-5-3-347; Ishii H, 2009, NEUROENDOCRINOLOGY, V90, P251, DOI 10.1159/000231993; Johnston JD, 2006, J NEUROENDOCRINOL, V18, P50, DOI 10.1111/j.1365-2826.2005.01389.x; Johnston JD, 2006, ENDOCRINOLOGY, V147, P959, DOI 10.1210/en.2005-1100; Johnston JD, 2003, J NEUROENDOCRINOL, V15, P405, DOI 10.1046/j.1365-2826.2003.00972.x; Johnston JD, 2003, P NATL ACAD SCI USA, V100, P2831, DOI 10.1073/pnas.0436184100; Johnston JD, 2007, MOL CELL ENDOCRINOL, V268, P59, DOI 10.1016/j.mce.2007.01.015; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Liu J, 2001, INT J ONCOL, V18, P863; MARTIN JE, 1979, ENDOCRINOLOGY, V105, P1007, DOI 10.1210/endo-105-4-1007; MARTIN JE, 1976, SCIENCE, V191, P301, DOI 10.1126/science.1108199; MARTIN JE, 1980, NEUROENDOCRINOLOGY, V31, P13, DOI 10.1159/000123044; Otway DT, 2009, CHRONOBIOL INT, V26, P1340, DOI 10.3109/07420520903412368; REITER RJ, 1993, EXPERIENTIA, V49, P654, DOI 10.1007/BF01923947; Reiter RJ, 2010, PROG BRAIN RES, V181, P127, DOI 10.1016/S0079-6123(08)81008-4; SILMAN RE, 1979, NATURE, V282, P301, DOI 10.1038/282301a0; Srinivasan V, 2009, GYNECOL ENDOCRINOL, V25, P779, DOI 10.3109/09513590903159649; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Torres-Farfan C, 2011, ENDOCRINOLOGY, V152, P1891, DOI 10.1210/en.2010-1260; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Tourtellotte WG, 2000, MOL CELL BIOL, V20, P5261, DOI 10.1128/MCB.20.14.5261-5268.2000; Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567; van Geijlswijk IM, 2011, PSYCHOPHARMACOLOGY, V216, P111, DOI 10.1007/s00213-011-2202-y; Vanecek J, 1999, REV REPROD, V4, P67, DOI 10.1530/revreprod/4.2.67; Veyrac A, 2013, P NATL ACAD SCI USA, V110, P7062, DOI 10.1073/pnas.1220558110; Wagner GC, 2007, EUR J NEUROSCI, V25, P485, DOI 10.1111/j.1460-9568.2006.05291.x; WINDLE JJ, 1990, MOL ENDOCRINOL, V4, P597, DOI 10.1210/mend-4-4-597; Zeman M, 2009, J HYPERTENS, V27, pS21, DOI 10.1097/01.hjh.0000358833.41181.f6; Zhang F, 2003, J BIOL CHEM, V278, P44246, DOI 10.1074/jbc.M305564200	36	12	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90056	10.1371/journal.pone.0090056	http://dx.doi.org/10.1371/journal.pone.0090056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658054	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000333355300010
J	Cousin, MA; Ebbert, JO; Wiinamaki, AR; Urban, MD; Argue, DP; Ekker, SC; Klee, EW				Cousin, Margot A.; Ebbert, Jon O.; Wiinamaki, Amanda R.; Urban, Mark D.; Argue, David P.; Ekker, Stephen C.; Klee, Eric W.			Larval Zebrafish Model for FDA-Approved Drug Repositioning for Tobacco Dependence Treatment	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; RECEPTOR PARTIAL AGONIST; ORAL TOPIRAMATE; MEDICATION DEVELOPMENT; INDUCED REINSTATEMENT; DOPAMINE SYSTEM; NICOTINE; ALCOHOL; COCAINE; APOMORPHINE	Cigarette smoking remains the most preventable cause of death and excess health care costs in the United States, and is a leading cause of death among alcoholics. Long-term tobacco abstinence rates are low, and pharmacotherapeutic options are limited. Repositioning medications approved by the U. S. Food and Drug Administration (FDA) may efficiently provide clinicians with new treatment options. We developed a drug-repositioning paradigm using larval zebrafish locomotion and established predictive clinical validity using FDA-approved smoking cessation therapeutics. We evaluated 39 physician-vetted medications for nicotine-induced locomotor activation blockade. We further evaluated candidate medications for altered ethanol response, as well as in combination with varenicline for nicotine-response attenuation. Six medications specifically inhibited the nicotine response. Among this set, apomorphine and topiramate blocked both nicotine and ethanol responses. Both positively interact with varenicline in the Bliss Independence test, indicating potential synergistic interactions suggesting these are candidates for translation into Phase II clinical trials for smoking cessation.	[Cousin, Margot A.; Ebbert, Jon O.; Wiinamaki, Amanda R.; Urban, Mark D.; Argue, David P.; Ekker, Stephen C.; Klee, Eric W.] Mayo Clin, Mayo Addict Res Ctr, Rochester, MN 55905 USA; [Cousin, Margot A.; Ekker, Stephen C.; Klee, Eric W.] Mayo Clin, Ctr Clin & Translat Sci, Rochester, MN USA; [Ebbert, Jon O.] Mayo Clin, Nicotine Dependence Ctr, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Klee, EW (corresponding author), Mayo Clin, Mayo Addict Res Ctr, Rochester, MN 55905 USA.	klee.eric@mayo.edu	Cousin, Margot/AAD-4591-2019	Cousin, Margot/0000-0002-6119-9346; Ekker, Stephen/0000-0003-0726-4212	Eagles Foundation; Mayo Foundation; Mayo Clinic Cancer Center; Mayo Clinic CTSA [UL1TR000135]; National Institutes of Health (NIH) [DA034475, DA14546, KL2 TR000136]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000136, UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA034475, R01DA014546] Funding Source: NIH RePORTER	Eagles Foundation; Mayo Foundation; Mayo Clinic Cancer Center; Mayo Clinic CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Eagles Foundation, Mayo Foundation, Mayo Clinic Cancer Center, Mayo Clinic CTSA UL1TR000135, National Institutes of Health (NIH) DA034475 to MAC, DA14546 to SCE, and KL2 TR000136 to EWK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; BACOPOULOS NG, 1979, PSYCHOPHARMACOLOGY, V60, P195, DOI 10.1007/BF00432293; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Bang PI, 2002, J NEUROSCI METH, V118, P177, DOI 10.1016/S0165-0270(02)00118-8; BEIL H, 1977, BRIT J ADDICT, V72, P129; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Bernardi RE, 2009, LEARN MEMORY, V16, P777, DOI 10.1101/lm.1648509; Best JD, 2008, NEUROPSYCHOPHARMACOL, V33, P1206, DOI 10.1038/sj.npp.1301489; Brennan CH, 2011, REV NEUROSCIENCE, V22, P37, DOI 10.1515/RNS.2011.006; Brunerova L, 2012, PSYCHIAT RES, V198, P297, DOI 10.1016/j.psychres.2011.09.022; Buckley CE, 2010, NEUROPHARMACOLOGY, V59, P149, DOI 10.1016/j.neuropharm.2010.04.014; Cachat J, 2010, BEHAV BRAIN RES, V208, P371, DOI 10.1016/j.bbr.2009.12.004; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P599, DOI 10.1080/10408440802026315; Carey RJ, 2004, BRAIN RES, V1019, P134, DOI 10.1016/j.brainres.2004.05.091; Cecchi M, 2007, NEUROPSYCHOPHARMACOL, V32, P589, DOI 10.1038/sj.npp.1301140; Charlet K, 2013, CURR TOP BEHAV NEURO, V13, P461, DOI 10.1007/7854_2011_130; CLARKE PBS, 1983, BRIT J PHARMACOL, V78, P329, DOI 10.1111/j.1476-5381.1983.tb09398.x; Ebbert JO, 2014, JAMA-J AM MED ASSOC, V311, P155, DOI 10.1001/jama.2013.283185; Ebbert JO, 2009, NICOTINE TOB RES, V11, P234, DOI 10.1093/ntr/ntn031; Faessel HM, 2010, CLIN PHARMACOKINET, V49, P799, DOI 10.2165/11537850-000000000-00000; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; FIORE MC, 2000, TREATING TOBACCO USE; Goldoni M, 2007, TOXICOL IN VITRO, V21, P759, DOI 10.1016/j.tiv.2007.03.003; Gonzalez Lorie A, 2009, Mol Cell Pharmacol, V1, P180; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x; Hajak G, 2003, ADDICTION, V98, P1371, DOI 10.1046/j.1360-0443.2003.00491.x; HALVORSEN KAL, 1978, INT J ADDICT, V13, P475, DOI 10.3109/10826087809045262; Hurt RD, 1996, JAMA-J AM MED ASSOC, V275, P1097, DOI 10.1001/jama.275.14.1097; Irons TD, 2013, PHARMACOL BIOCHEM BE, V103, P792, DOI 10.1016/j.pbb.2012.12.010; JENSEN SB, 1977, BRIT J ADDICT, V72, P325; Jerlhag E, 2011, DRUG ALCOHOL DEPEN, V117, P126, DOI 10.1016/j.drugalcdep.2011.01.010; Johnson BA, 2005, ARCH INTERN MED, V165, P1600, DOI 10.1001/archinte.165.14.1600; Johnson BA, 2004, ARCH GEN PSYCHIAT, V61, P905, DOI 10.1001/archpsyc.61.9.905; Johnson BA, 2003, LANCET, V361, P1677, DOI 10.1016/S0140-6736(03)13370-3; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Kayir H, 2009, SYNAPSE, V63, P15, DOI 10.1002/syn.20576; Kedikian X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069453; Kenna George A, 2009, Curr Drug Abuse Rev, V2, P135; Khazaal Y, 2006, PSYCHIAT CLIN NEUROS, V60, P384, DOI 10.1111/j.1440-1819.2006.01518.x; Kily LJM, 2008, J EXP BIOL, V211, P1623, DOI 10.1242/jeb.014399; Klee EW, 2012, HUM GENET, V131, P977, DOI 10.1007/s00439-011-1128-0; Klee EW, 2011, NICOTINE TOB RES, V13, P301, DOI 10.1093/ntr/ntr010; Kokel D, 2012, TRENDS BIOTECHNOL, V30, P421, DOI 10.1016/j.tibtech.2012.05.001; Kokel David, 2008, Briefings in Functional Genomics & Proteomics, V7, P483, DOI 10.1093/bfgp/eln040; Lerman C, 2007, NAT REV DRUG DISCOV, V6, P746, DOI 10.1038/nrd2361; Lobina Carla, 2011, Front Psychiatry, V2, P76, DOI 10.3389/fpsyt.2011.00076; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; Mantsch JR, 2010, NEUROPSYCHOPHARMACOL, V35, P2165, DOI 10.1038/npp.2010.86; Mathur P, 2010, NEUROBIOL DIS, V40, P66, DOI 10.1016/j.nbd.2010.05.016; McKee SA, 2009, ADDICT BIOL, V14, P99, DOI 10.1111/j.1369-1600.2008.00135.x; MEREU G, 1987, EUR J PHARMACOL, V141, P395, DOI 10.1016/0014-2999(87)90556-5; Miller N, 2013, BEHAV BRAIN RES, V240, P192, DOI 10.1016/j.bbr.2012.11.033; Morgan G, 2010, AM J HEALTH BEHAV, V34, P267, DOI 10.5993/AJHB.34.3.2; Neelkantan N, 2013, ACS CHEM NEUROSCI, V4, P1137, DOI 10.1021/cn400090q; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Obach RS, 2006, DRUG METAB DISPOS, V34, P121, DOI 10.1124/dmd.105.006767; Ou HC, 2009, JARO-J ASSOC RES OTO, V10, P191, DOI 10.1007/s10162-009-0158-y; Parker MO, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00065; Petzold AM, 2009, P NATL ACAD SCI USA, V106, P18662, DOI 10.1073/pnas.0908247106; Prober DA, 2008, J NEUROSCI, V28, P10102, DOI 10.1523/JNEUROSCI.2740-08.2008; Radke AK, 2012, NEUROPSYCHOPHARMACOL, V37, P2405, DOI 10.1038/npp.2012.97; Rauhut AS, 2003, PSYCHOPHARMACOLOGY, V169, P1, DOI 10.1007/s00213-003-1450-x; Regan KS, 2011, J EXP BIOL, V214, P2560, DOI 10.1242/jeb.056333; Rovira M, 2011, P NATL ACAD SCI USA, V108, P19264, DOI 10.1073/pnas.1113081108; Rudoy CA, 2007, PROG NEURO-PSYCHOPH, V31, P1119, DOI 10.1016/j.pnpbp.2007.04.005; Rudoy CA, 2009, NEUROPSYCHOPHARMACOL, V34, P1135, DOI 10.1038/npp.2008.102; Shakarchi K, 2013, J EXP BIOL, V216, P869, DOI 10.1242/jeb.079657; Shen RY, 2007, BIOL PSYCHIAT, V61, P93, DOI 10.1016/j.biopsych.2006.03.018; Soderpalm B, 2013, CURR TOP BEHAV NEURO, V13, P127, DOI 10.1007/7854_2011_170; Sparks JA, 1999, PSYCHOPHARMACOLOGY, V141, P145, DOI 10.1007/s002130050818; Stewart A, 2011, REV NEUROSCIENCE, V22, P95, DOI 10.1515/RNS.2011.011; STROMBOM U, 1977, PSYCHOPHARMACOLOGY, V51, P293, DOI 10.1007/BF00431639; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Vranjkovic O, 2012, J PHARMACOL EXP THER, V342, P541, DOI 10.1124/jpet.112.193615; Wafford KA, 2005, CURR OPIN PHARMACOL, V5, P47, DOI 10.1016/j.coph.2004.08.006; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Zacny JP, 2012, DRUG ALCOHOL DEPEN, V120, P229, DOI 10.1016/j.drugalcdep.2011.07.006; Zarrindast MR, 2010, NEUROSCI LETT, V475, P156, DOI 10.1016/j.neulet.2010.03.069; Zhao T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048911	82	26	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90467	10.1371/journal.pone.0090467	http://dx.doi.org/10.1371/journal.pone.0090467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658307	gold, Green Submitted, Green Published			2022-12-27	WOS:000333355300017
J	Kiessling, S; Sollars, PJ; Pickard, GE				Kiessling, Silke; Sollars, Patricia J.; Pickard, Gary E.			Light Stimulates the Mouse Adrenal through a Retinohypothalamic Pathway Independent of an Effect on the Clock in the Suprachiasmatic Nucleus	PLOS ONE			English	Article							ACUTE REGULATORY PROTEIN; CIRCADIAN CLOCK; GENE-EXPRESSION; DEFICIENT MICE; GOLDEN-HAMSTER; TIME; RAT; GLUCOCORTICOIDS; MPER2; TRACT	The brain's master circadian pacemaker resides within the hypothalamic suprachiasmatic nucleus (SCN). SCN clock neurons are entrained to the day/night cycle via the retinohypothalamic tract and the SCN provides temporal information to the central nervous system and to peripheral organs that function as secondary oscillators. The SCN clock-cell network is thought to be the hypothalamic link between the retina and descending autonomic circuits to peripheral organs such as the adrenal gland, thereby entraining those organs to the day/night cycle. However, there are at least three different routes or mechanisms by which retinal signals transmitted to the hypothalamus may be conveyed to peripheral organs: 1) via retinal input to SCN clock neurons; 2) via retinal input to non-clock neurons in the SCN; or 3) via retinal input to hypothalamic regions neighboring the SCN. It is very well documented that light-induced responses of the SCN clock (i.e., clock gene expression, neural activity, and behavioral phase shifts) occur primarily during the subjective night. Thus to determine the role of the SCN clock in transmitting photic signals to descending autonomic circuits, we compared the phase dependency of light-evoked responses in the SCN and a peripheral oscillator, the adrenal gland. We observed light-evoked clock gene expression in the mouse adrenal throughout the subjective day and subjective night. Light also induced adrenal corticosterone secretion during both the subjective day and subjective night. The irradiance threshold for light-evoked adrenal responses was greater during the subjective day compared to the subjective night. These results suggest that retinohypothalamic signals may be relayed to the adrenal clock during the subjective day by a retinal pathway or cellular mechanism that is independent of an effect of light on the SCN neural clock network and thus may be important for the temporal integration of physiology and metabolism.	[Kiessling, Silke; Sollars, Patricia J.; Pickard, Gary E.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA; [Kiessling, Silke] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Pickard, Gary E.] Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; McGill University; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center	Pickard, GE (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA.	gpickard2@unl.edu	Kiessling, Silke/AAZ-3854-2020	Kiessling, Silke/0000-0002-6293-6328	NIH [R01NS077003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077003] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grant R01NS077003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Malek ZA, 2001, CELL MOL LIFE SCI, V58, P434, DOI 10.1007/PL00000868; Abizaid A, 2004, EUR J NEUROSCI, V20, P2767, DOI 10.1111/j.1460-9568.2004.03737.x; Abraham D, 2006, J BIOL RHYTHM, V21, P169, DOI 10.1177/0748730406288040; Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Bae K, 2007, J BIOL RHYTHM, V22, P85, DOI 10.1177/0748730406296718; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bittman EL, 2003, AM J PHYSIOL-REG I, V285, pR561, DOI 10.1152/ajpregu.00783.2002; BLOCK GD, 1993, INT REV CYTOL, V146, P83, DOI 10.1016/S0074-7696(08)60381-2; BORNSTEIN SR, 1990, ENDOCRINOLOGY, V127, P900, DOI 10.1210/endo-127-2-900; Brown TM, 2011, J PHYSIOL-LONDON, V589, P1173, DOI 10.1113/jphysiol.2010.199877; Buijs RM, 1999, EUR J NEUROSCI, V11, P1535, DOI 10.1046/j.1460-9568.1999.00575.x; Canteras NS, 2011, BRAIN RES REV, V65, P150, DOI 10.1016/j.brainresrev.2010.09.006; CASCIO CS, 1987, BRAIN RES, V423, P173, DOI 10.1016/0006-8993(87)90837-7; Diekman CO, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003196; Dragich JM, 2010, EUR J NEUROSCI, V31, P864, DOI 10.1111/j.1460-9568.2010.07119.x; EADE NR, 1958, BRIT J PHARM CHEMOTH, V13, P390; Engeland WC, 2005, ENDOCRINE, V28, P325, DOI 10.1385/ENDO:28:3:325; Gooley Joshua J., 2003, Journal of Neuroscience, V23, P7093; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; HENDRICKSON AE, 1972, Z ZELLFORSCH MIK ANA, V135, P1, DOI 10.1007/BF00307084; HOLLAND WC, 1956, BRIT J PHARM CHEMOTH, V11, P449, DOI 10.1111/j.1476-5381.1956.tb00015.x; Irwin RP, 2007, J NEUROSCI, V27, P11748, DOI 10.1523/JNEUROSCI.1840-07.2007; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Jakubcakova V, 2007, NEURON, V54, P831, DOI 10.1016/j.neuron.2007.04.031; JOHNSON RF, 1988, BRAIN RES, V462, P301, DOI 10.1016/0006-8993(88)90558-6; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kino T, 2011, ENDOCR DEV, V20, P116, DOI 10.1159/000321232; KLEIN DC, 1979, BRAIN RES, V174, P245, DOI 10.1016/0006-8993(79)90848-5; LEVINE JD, 1991, J COMP NEUROL, V306, P344, DOI 10.1002/cne.903060210; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; Loh DH, 2008, NEUROENDOCRINOLOGY, V88, P246, DOI 10.1159/000140676; Meijer JH, 1998, J NEUROSCI, V18, P9078; Miller WL, 2007, BBA-MOL CELL BIOL L, V1771, P663, DOI 10.1016/j.bbalip.2007.02.012; Mohawk JA, 2007, PHYSIOL BEHAV, V92, P800, DOI 10.1016/j.physbeh.2007.06.009; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Morin LP, 2013, EXP NEUROL, V243, P4, DOI 10.1016/j.expneurol.2012.06.026; Mutoh T, 2003, J PHYSIOL-LONDON, V547, P317, DOI 10.1113/jphysiol.2002.028001; Nakamura TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028726; NIIJIMA A, 1993, PHYSIOL BEHAV, V54, P555, DOI 10.1016/0031-9384(93)90249-F; NIIJIMA A, 1992, J AUTONOM NERV SYST, V40, P155, DOI 10.1016/0165-1838(92)90026-D; Oishi K, 2002, MOL BRAIN RES, V109, P11, DOI 10.1016/S0169-328X(02)00457-6; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Ota T, 2012, MOL CELL ENDOCRINOL, V349, P30, DOI 10.1016/j.mce.2011.08.010; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Pendergast JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030254; Pendergast JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008552; Pezuk P, 2012, ENDOCRINOLOGY, V153, P4775, DOI 10.1210/en.2012-1486; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PICKARD GE, 1982, J COMP NEUROL, V211, P65, DOI 10.1002/cne.902110107; PICKARD GE, 1981, J COMP NEUROL, V196, P155, DOI 10.1002/cne.901960111; Pickard GE, 2008, THE SENSES VISION, P537; Pittendrigh CS., 1981, HDB BEHAV NEUROBIOLO, V4, P94; Ruan GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038985; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Schrader JA, 2010, NEUROSCIENCE, V171, P513, DOI 10.1016/j.neuroscience.2010.08.057; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Sujino M, 2012, ENDOCRINOLOGY, V153, P2277, DOI 10.1210/en.2011-1794; van der Veen DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047692; Yan L, 1999, NEUROSCIENCE, V94, P141, DOI 10.1016/S0306-4522(99)00223-7; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zheng B, 1999, CELL, V105, P683	71	48	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92959	10.1371/journal.pone.0092959	http://dx.doi.org/10.1371/journal.pone.0092959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658072	Green Published, gold			2022-12-27	WOS:000333355300147
J	Liu, AR; Chen, S; Cai, SX; Dong, L; Liu, L; Yang, Y; Guo, FM; Lu, XM; He, HL; Chen, QH; Hu, SL; Qiu, HB				Liu, Airan; Chen, Song; Cai, Shixia; Dong, Liang; Liu, Le; Yang, Yi; Guo, Fengmei; Lu, Xiaomin; He, Hongli; Chen, Qihong; Hu, Shuling; Qiu, Haibo			Wnt5a through Noncanonical Wnt/JNK or Wnt/PKC Signaling Contributes to the Differentiation of Mesenchymal Stem Cells into Type II Alveolar Epithelial Cells In Vitro	PLOS ONE			English	Article							INDUCED LUNG INJURY; PROGENITOR CELLS; PROMOTES PROLIFERATION; MYOCARDIAL-INFARCTION; TRANSCRIPTION FACTORS; DEPENDENT PATHWAY; IMPROVES SURVIVAL; OXIDATIVE STRESS; STROMAL CELLS; MIGRATION	The differentiation of mesenchymal stem cells (MSCs) into type II alveolar epithelial (AT II) cells is critical for reepithelization and recovery in acute respiratory distress syndrome (ARDS), and Wnt signaling was considered to be the underlying mechanisms. In our previous study, we found that canonical Wnt pathway promoted the differentiation of MSCs into AT II cells, however the role of the noncanonical Wnt pathway in this process is unclear. It was disclosed in this study that noncanonical Wnt signaling in mouse bone marrow-derived MSCs (mMSCs) was activated during the differentiation of mMSCs into AT II cells in a modified co-culture system with murine lung epithelial-12 cells and small airway growth media. The levels of surfactant protein (SP) C, SPB and SPD, the specific markers of AT II cells, increased in mMSCs when Wnt5a was added to activate noncanonical Wnt signaling, while pretreatment with JNK or PKC inhibitors reversed the promotion of Wnt5a. The differentiation rate of mMSCs also depends on their abilities to accumulate and survive in inflammatory tissue. We found that the Wnt5a supplement promoted the vertical and horizontal migration of mMSCs, ameliorated the cell death and the reduction of Bcl-2/Bax induced by H2O2. The effect of Wnt5a on the migration of mMSCs and their survival after H2O2 exposure were partially inhibited with PKC or JNK blockers. In conclusion, Wnt5a through Wnt/JNK signaling alone or both Wnt/JNK and Wnt/PKC signaling promoted the differentiation of mMSCs into AT II cells and the migration of mMSCs; through Wnt/PKC signaling, Wnt5a increased the survival of mMSCs after H2O2 exposure in vitro.	[Liu, Airan; Cai, Shixia; Dong, Liang; Liu, Le; Yang, Yi; Guo, Fengmei; Lu, Xiaomin; He, Hongli; Chen, Qihong; Hu, Shuling; Qiu, Haibo] Southeast Univ, Zhongda Hosp, Sch Med, Dept Crit Care Med, Nanjing, Jiangsu, Peoples R China; [Chen, Song] China Pharmaceut Univ, Sch Life Sci & Technol, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China	Southeast University - China; China Pharmaceutical University	Qiu, HB (corresponding author), Southeast Univ, Zhongda Hosp, Sch Med, Dept Crit Care Med, Nanjing, Jiangsu, Peoples R China.	haiboq2000@gmail.com	Qiu, Haibo/AAS-9047-2021; Chen, QH/GXH-3158-2022	Qiu, Haibo/0000-0001-8589-4717; 	national natural science foundation of China [81070049, 81300060, 81170057, Bk2010399, BK2011600]; Ministry of Education China [2010009212006]	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education China(Ministry of Education, China)	This work was co-financed by three national natural science foundations of China (No. 81070049, 81300060, 81170057 URL:http://isisn.nsfc.gov.cn/egrantweb/), two natural science foundations of the Jiangsu province (No. Bk2010399, BK2011600 URL: http://210.73.128.90/XMSB/Eve_Login.jsp) and the new teacher fund for doctor station sponsored by the Ministry of Education China (No. 2010009212006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartis D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057393; Berger MJ, 2006, CYTOTHERAPY, V8, P480, DOI 10.1080/14653240600941549; Bergwitz C, 2001, BBA-MOL CELL RES, V1538, P129, DOI 10.1016/S0167-4889(00)00123-3; Bluwstein A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.15; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Caelles C, 1997, GENE DEV, V11, P3351, DOI 10.1101/gad.11.24.3351; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Cheng CW, 2008, BIOCHEM BIOPH RES CO, V365, P285, DOI 10.1016/j.bbrc.2007.10.166; Copland IB, 2009, STEM CELLS, V27, P467, DOI 10.1634/stemcells.2008-0520; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Flaherty MP, 2008, CIRCULATION, V117, P2241, DOI 10.1161/CIRCULATIONAHA.107.741066; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hara T, 1998, BIOCHEM BIOPH RES CO, V244, P41, DOI 10.1006/bbrc.1998.8210; He ZS, 2011, STEM CELLS DEV, V20, P1771, DOI 10.1089/scd.2010.0380; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jin Z, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-480; Karow M, 2009, J CELL MOL MED, V13, P2506, DOI 10.1111/j.1582-4934.2008.00619.x; Koyanagi M, 2005, J BIOL CHEM, V280, P16838, DOI 10.1074/jbc.M500323200; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Lang WH, 2004, CELL SIGNAL, V16, P457, DOI 10.1016/j.cellsig.2003.09.002; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Liebermann DA, 1998, INT J ONCOL, V12, P685; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Liu AR, 2013, J CELL PHYSIOL, V228, P1270, DOI 10.1002/jcp.24282; Loscertales M, 2008, DEVELOPMENT, V135, P1365, DOI 10.1242/dev.010504; Ma N, 2011, CELL BIOL INT, V35, P1261, DOI 10.1042/CBI20110026; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Matthay Michael A, 2005, Proc Am Thorac Soc, V2, P206, DOI 10.1513/pats.200501-009AC; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Muller-Ehmsen J, 2006, J MOL CELL CARDIOL, V41, P876, DOI 10.1016/j.yjmcc.2006.07.023; Onizuka T, 2012, J MOL CELL CARDIOL, V52, P650, DOI 10.1016/j.yjmcc.2011.11.010; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Qiu WM, 2011, BIOCHEM BIOPH RES CO, V413, P98, DOI 10.1016/j.bbrc.2011.08.061; Rackley CR, 2012, J CLIN INVEST, V122, P2724, DOI 10.1172/JCI60519; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Ring L, 2014, CELL SIGNAL, V26, P260, DOI 10.1016/j.cellsig.2013.11.021; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Serikov VB, 2007, ANAT REC, V290, P1033, DOI 10.1002/ar.20574; Shang YC, 2007, ACTA PHARMACOL SIN, V28, P1761, DOI 10.1111/j.1745-7254.2007.00671.x; Shi MD, 2013, CELL BIOCHEM BIOPHYS, V66, P161, DOI 10.1007/s12013-012-9465-8; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; van Amerongen R, 2012, DEV BIOL, V369, P101, DOI 10.1016/j.ydbio.2012.06.020; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wang LM, 2002, NEPHRON, V91, P142, DOI 10.1159/000057616; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Ward PA, 2010, ANN NY ACAD SCI, V1203, P53, DOI 10.1111/j.1749-6632.2010.05552.x; Yamada M, 2004, J IMMUNOL, V172, P1266, DOI 10.4049/jimmunol.172.2.1266; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yang YJ, 2008, EUR HEART J, V29, P1578, DOI 10.1093/eurheartj/ehn167; Yoon SO, 2001, FASEB J, V15, P111, DOI 10.1096/fj.01-0398fje; Yu JM, 2006, MOL CELL BIOCHEM, V288, P17, DOI 10.1007/s11010-005-9113-3; Yuzugullu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-90; Zhang JY, 2008, CELL MOL LIFE SCI, V65, P1435, DOI 10.1007/s00018-008-8047-9; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zhao F, 2008, TRANSPL P, V40, P1700, DOI 10.1016/j.transproceed.2008.01.080; Zhao Y, 2010, MOL CARCINOGEN, V49, P760, DOI 10.1002/mc.20651; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037823; Zhuang Y, 2009, CHINESE MED J-PEKING, V122, P183, DOI 10.3760/cma.j.issn.0366-6999.2009.02.014	67	34	39	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90229	10.1371/journal.pone.0090229	http://dx.doi.org/10.1371/journal.pone.0090229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658098	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300012
J	Morgan, JL; Svenson, KL; Lake, JP; Zhang, WD; Stearns, TM; Marion, MA; Peters, LL; Paigen, B; Donahue, LR				Morgan, Judith L.; Svenson, Karen L.; Lake, Jeffrey P.; Zhang, Weidong; Stearns, Timothy M.; Marion, Michael A.; Peters, Luanne L.; Paigen, Beverly; Donahue, Leah Rae			Effects of Housing Density in Five Inbred Strains of Mice	PLOS ONE			English	Article							CAGE FLOOR SPACE; LABORATORY MICE; HEART-RATE; C57BL/6J; AGGRESSION; RESPONSES; BEHAVIOR; DISEASE; WEIGHT; BALB/C	To evaluate the effect of increased mouse density in a cage, mice were housed at the density recommended by the 1996 Guide for the Care and Use of Laboratory Animals and at densities that were approximately 2, 2.6, and 3 times greater. Five strains of mice (129S1/SvImJ, A/J, BALB/cByJ, C57BL/6J, and DBA/2J) were evaluated throughout 3- and 8-month timeframes for health and well-being, including mortality, cardiac measures, plasma cholesterol, body weight, bone mineral density, organ weights, hematology, behavioral observations, and open field and light-dark tests. For 22 of the 27 traits measured, increased housing density had no significant effect. Kidney weight, adrenal weight, and heart rate decreased as mice were housed more densely, and some of the decreases were statistically significant. Reduced kidney weight, adrenal weight, and heart rate are not considered to be negative outcomes and may even indicate reduced stress. However, all measurements of these three traits were within normal physiological ranges. Percent fat increased slightly in strains 129S1/SvImJ, A/J, and DBA/2J, but did not increase in strains BALB/cByJ, and C57BL/6J. These results indicate that mice can be housed at higher densities than those currently recommended.	[Morgan, Judith L.; Svenson, Karen L.; Lake, Jeffrey P.; Zhang, Weidong; Stearns, Timothy M.; Marion, Michael A.; Peters, Luanne L.; Paigen, Beverly; Donahue, Leah Rae] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Donahue, LR (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	leahrae.donahue@jax.org		Stearns, Timothy/0000-0002-5533-6076; Peters, Luanne/0000-0002-0784-0534	National Heart, Lung, and Blood Institute [HL66611, HL077796]; Howard Hughes Medical Institute; Jackson Laboratory; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066611, R37HL077796, R01HL077796] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Jackson Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was made possible by grants HL66611 and HL077796 from the National Heart, Lung, and Blood Institute www.nhlbi.nih.gov/) to BP; funding from the Howard Hughes Medical Institute (www.hhmi.org/) to LRD; and institutional funds from The Jackson Laboratory (www.jax.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellei P.M., 2011, REV NEUROCI NCI, V19, P591, DOI [10.34024/rnc.2011.v19.8323, DOI 10.34024/RNC.2011.V19.8323]; Bernberg E, 2009, ATHEROSCLEROSIS, V204, P90, DOI 10.1016/j.atherosclerosis.2008.08.013; BRAYTON AR, 1974, J ENDOCRINOL, V61, pR48; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; Davidson LP, 2007, COMPARATIVE MED, V57, P355; Di Curzio DL, 2010, ADRENAL GLAND WEIGHT; Foltz C, 2007, LAB ANIMAL, V36, P40, DOI 10.1038/laban1107-40; Fullwood Steven, 1998, ILAR J, V39, P29; Gilmore AJ, 2008, LAB ANIM-UK, V42, P140, DOI 10.1258/la.2007.06030e; Gonder JC, 2007, ILAR J, V48, P29, DOI 10.1093/ilar.48.1.29; Grewal IS, 1997, AUTOIMMUNITY, V26, P209, DOI 10.3109/08916939709008026; HIMMSHAGEN J, 1992, P SOC EXP BIOL MED, V200, P502; Horn MJ, 2012, J AM ASSOC LAB ANIM, V51, P781; KARP JD, 1993, BRAIN BEHAV IMMUN, V7, P326, DOI 10.1006/brbi.1993.1032; Kingston SG, 1996, PHYSIOL BEHAV, V60, P145, DOI 10.1016/0031-9384(95)02241-4; Laber K, 2008, J AM ASSOC LAB ANIM, V47, P16; LES EP, 1968, LAB ANIM CARE, V18, P623; McGlone JJ, 2001, CONTEMP TOP LAB ANIM, V40, P21; Meijer MK, 2009, J APPL ANIM WELF SCI, V12, P293, DOI 10.1080/10888700902955849; Naidu S, 1995, J Gravit Physiol, V2, pP140; National Research Council, 2012, GUIDE CARE USE LAB A; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; Nicholson A, 2009, J AM ASSOC LAB ANIM, V48, P740; O'Malley J, 2008, J AM ASSOC LAB ANIM, V47, P9; ORTIZ R, 1985, PHYSIOL BEHAV, V34, P857, DOI 10.1016/0031-9384(85)90003-4; ORTIZ R, 1984, EXPERIENTIA, V40, P1428, DOI 10.1007/BF01951927; Paigen B, 2012, J ANIM SCI, V90, P5182, DOI 10.2527/jas.2012-5417; PETERS A, 1990, LAB ANIM, V24, P273, DOI 10.1258/002367790780866227; Peters LL, 2002, PHYSIOL GENOMICS, V11, P185, DOI 10.1152/physiolgenomics.00077.2002; R Development CoreTeam, 2012, R LANG ENV STAT COMP; Reed DR, 2009, SURVEY ADIPOSE DEPOT; Schmidt MV, 2010, HORM BEHAV, V57, P415, DOI 10.1016/j.yhbeh.2010.01.010; Smith AL, 2005, COMPARATIVE MED, V55, P368; Smith AL, 2005, ILAR J, V46, P140, DOI 10.1093/ilar.46.2.140; Smith AL, 2004, COMPARATIVE MED, V54, P656; Sterlemann V, 2008, HORM BEHAV, V53, P386, DOI 10.1016/j.yhbeh.2007.11.001; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; Svenson KL, 2003, J APPL PHYSIOL, V94, P1650, DOI 10.1152/japplphysiol.01029.2003; Van Loo PLP, 2007, LAB ANIM-UK, V41, P441, DOI 10.1258/002367707782314328; Van Loo PLP, 2003, LAB ANIM-UK, V37, P300, DOI 10.1258/002367703322389870; Van Loo PLP, 2001, PHYSIOL BEHAV, V72, P675, DOI 10.1016/S0031-9384(01)00425-5; Van Loo PLR, 2005, LAB ANIM-UK, V39, P58, DOI 10.1258/0023677052886501; Xing SQ, 2009, AM J PHYSIOL-HEART C, V296, pH1907, DOI 10.1152/ajpheart.00681.2008	43	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90012	10.1371/journal.pone.0090012	http://dx.doi.org/10.1371/journal.pone.0090012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658028	Green Published, gold			2022-12-27	WOS:000333355300009
J	Kong, YY; Wang, DF; Shi, L; Hui, SCN; Chu, WCW				Kong, Youyong; Wang, Defeng; Shi, Lin; Hui, Steve C. N.; Chu, Winnie C. W.			Adaptive Distance Metric Learning for Diffusion Tensor Image Segmentation	PLOS ONE			English	Article							LEVEL SET METHOD; DTI SEGMENTATION; THALAMIC NUCLEI; BRAIN; CONNECTIVITY; TRACTOGRAPHY; MRI; INFORMATION; MAPS	High quality segmentation of diffusion tensor images (DTI) is of key interest in biomedical research and clinical application. In previous studies, most efforts have been made to construct predefined metrics for different DTI segmentation tasks. These methods require adequate prior knowledge and tuning parameters. To overcome these disadvantages, we proposed to automatically learn an adaptive distance metric by a graph based semi-supervised learning model for DTI segmentation. An original discriminative distance vector was first formulated by combining both geometry and orientation distances derived from diffusion tensors. The kernel metric over the original distance and labels of all voxels were then simultaneously optimized in a graph based semi-supervised learning approach. Finally, the optimization task was efficiently solved with an iterative gradient descent method to achieve the optimal solution. With our approach, an adaptive distance metric could be available for each specific segmentation task. Experiments on synthetic and real brain DTI datasets were performed to demonstrate the effectiveness and robustness of the proposed distance metric learning approach. The performance of our approach was compared with three classical metrics in the graph based semi-supervised learning framework.	[Kong, Youyong; Wang, Defeng; Shi, Lin; Hui, Steve C. N.; Chu, Winnie C. W.] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China; [Kong, Youyong; Wang, Defeng; Shi, Lin; Hui, Steve C. N.; Chu, Winnie C. W.] Chinese Univ Hong Kong, Res Ctr Med Image Comp, Shatin, Hong Kong, Peoples R China; [Wang, Defeng; Chu, Winnie C. W.] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Wang, Defeng] Chinese Univ Hong Kong, Dept Biomed Engn, Shatin, Hong Kong, Peoples R China; [Wang, Defeng] Chinese Univ Hong Kong, Shun Hing Inst Adv Engn, Shatin, Hong Kong, Peoples R China; [Shi, Lin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Wang, DF (corresponding author), Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China.	dfwang@cuhk.edu.hk; winniechu@cuhk.edu.hk	Chu, Winnie CW/F-8449-2014; Shi, Lin/K-5241-2014; Hui, Steve CN/Q-3715-2016; Hui, Steve/AAF-6195-2021	Chu, Winnie CW/0000-0003-4962-4132; Shi, Lin/0000-0003-2318-4669; Hui, Steve CN/0000-0002-1523-4040; Hui, Steve/0000-0002-1523-4040	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 411811, 475711, 416712, 473012, 462611, SEG_CUHK02]; National Natural Science Foundation of China [81271653, 81201157]; Shenzhen Science and Technology Innovation Committee [JCYJ20120619152326449, JC201005250030A]; Shun Hing Institute of Advanced Engineering [BME-p2-13/BME-CUHK]; Chinese University of Hong Kong; Fondation Yves Cotrel pour la Recherche en Pathologie Rechidienne-Institut de France	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Innovation Committee; Shun Hing Institute of Advanced Engineering; Chinese University of Hong Kong(Chinese University of Hong Kong); Fondation Yves Cotrel pour la Recherche en Pathologie Rechidienne-Institut de France	The work described in this paper was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No.: CUHK 411811, 475711, 416712, 473012, 462611, SEG_CUHK02), grants from the National Natural Science Foundation of China (Project No. 81271653 and 81201157), grants from Shenzhen Science and Technology Innovation Committee (Project No. JCYJ20120619152326449 and JC201005250030A), a grant from BME-p2-13/BME-CUHK of the Shun Hing Institute of Advanced Engineering, The Chinese University of Hong Kong, and a grant from Fondation Yves Cotrel pour la Recherche en Pathologie Rechidienne-Institut de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbeek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081895; Arsigny V, 2006, MAGN RESON MED, V56, P411, DOI 10.1002/mrm.20965; Awate SP, 2007, IEEE T MED IMAGING, V26, P1525, DOI 10.1109/TMI.2007.907301; Bao LJ, 2009, PHYS MED BIOL, V54, P1435, DOI 10.1088/0031-9155/54/6/004; Barbieri S, 2012, NEUROIMAGE, V60, P1025, DOI 10.1016/j.neuroimage.2012.01.076; Barbieri S, 2011, NEUROIMAGE, V55, P532, DOI 10.1016/j.neuroimage.2010.12.069; Boggs PT, 1996, ANN OPER RES, V62, P419, DOI 10.1007/BF02206825; Choe AS, 2012, NMR BIOMED, V25, P900, DOI 10.1002/nbm.1810; de Luis-Garcia R, 2013, IEEE ENG MED BIO, P503, DOI 10.1109/EMBC.2013.6609547; Deng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063385; Deng Y, 2013, IEEE T NEUR NET LEAR, V24, P383, DOI 10.1109/TNNLS.2012.2235082; Deng Y, 2012, IEEE J-STSP, V6, P566, DOI 10.1109/JSTSP.2012.2195472; Deng Y, 2011, IEEE T IMAGE PROCESS, V20, P2329, DOI 10.1109/TIP.2011.2109729; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gahm JK, 2013, I S BIOMED IMAGING, P504; Gao YR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082782, 10.1371/journal.pone.0075065]; Gu YF, 2013, IEEE J-STARS, V6, P1109, DOI 10.1109/JSTARS.2013.2243112; Guggenberger R, 2013, EUR J RADIOL, V82, pE590, DOI 10.1016/j.ejrad.2013.05.011; Guo WH, 2008, PHILOS T R SOC A, V366, P2279, DOI 10.1098/rsta.2008.0042; Han D, 2009, IEEE ENG MED BIO, P5653, DOI 10.1109/IEMBS.2009.5333767; Hao X, 2014, MED IMAGE ANAL, V18, P161, DOI 10.1016/j.media.2013.10.007; Hui ES, 2010, NEUROIMAGE, V49, P2366, DOI 10.1016/j.neuroimage.2009.10.022; Jbabdi S, 2012, MAGN RESON MED, V68, P1846, DOI 10.1002/mrm.24204; Jia YQ, 2008, IEEE IMAGE PROC, P3204, DOI 10.1109/ICIP.2008.4712477; Jiang N, 2011, IEEE T IMAGE PROCESS, V20, P2288, DOI 10.1109/TIP.2011.2114895; Jin R, 2009, PROC CVPR IEEE, P896, DOI 10.1109/CVPRW.2009.5206684; Jonasson L, 2007, SIGNAL PROCESS, V87, P309, DOI 10.1016/j.sigpro.2005.12.017; Jou RJ, 2011, AM J NEURORADIOL, V32, P1607, DOI 10.3174/ajnr.A2558; Kim KI, 2005, IEEE T PATTERN ANAL, V27, P1351, DOI 10.1109/TPAMI.2005.181; Kong Y, 2011, 3D DIFFUSION TENSOR, P1602; Kong Y, 2014, AM J NEUROR IN PRESS; Lemaire JJ, 2007, NEUROIMAGE, V37, pS109, DOI 10.1016/j.neuroimage.2007.05.055; Li CM, 2011, IEEE T IMAGE PROCESS, V20, P2007, DOI 10.1109/TIP.2011.2146190; Liu B, 2010, IEEE T SYST MAN CY B, V40, P973, DOI 10.1109/TSMCB.2009.2034632; Liu TM, 2007, NEUROIMAGE, V38, P114, DOI 10.1016/j.neuroimage.2007.07.002; Malcolm J, 2007, IEEE I CONF COMP VIS, P2726; Mang SC, 2012, MAGN RESON MED, V67, P118, DOI 10.1002/mrm.22996; Morgan VL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006660; Rathore RKS, 2011, MAGN RESON IMAGING, V29, P1088, DOI 10.1016/j.mri.2011.04.014; Sajjadi SA, 2013, BRAIN, V136, P2253, DOI 10.1093/brain/awt118; Saygin ZM, 2011, NEUROIMAGE, V56, P1353, DOI 10.1016/j.neuroimage.2011.03.006; Schmithorst VJ, 2007, BEHAV BRAIN SCI, V30, P169, DOI 10.1017/S0140525X0700129X; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Unrath A, 2008, NEUROSCI LETT, V434, P322, DOI 10.1016/j.neulet.2008.02.013; Wang DF, 2012, J NEUROSCI METH, V209, P371, DOI 10.1016/j.jneumeth.2012.06.026; Wang Q, 2010, AM J NEURORADIOL, V31, P516, DOI 10.3174/ajnr.A1862; Wang ZZ, 2005, IEEE T MED IMAGING, V24, P1267, DOI 10.1109/TMI.2005.854516; Weldeselassie YT, 2007, SPIE MED IMAGING, V6512; Wiegell MR, 2003, NEUROIMAGE, V19, P391, DOI 10.1016/S1053-8119(03)00044-2; Wiltshire K, 2010, CAN J NEUROL SCI, V37, P595, DOI 10.1017/S0317167100010751; Wu YC, 2011, NEUROIMAGE, V54, P1840, DOI 10.1016/j.neuroimage.2010.09.067; Xiang SM, 2008, PATTERN RECOGN, V41, P3600, DOI 10.1016/j.patcog.2008.05.018; Yang L, 2010, IEEE T PATTERN ANAL, V32, P30, DOI 10.1109/TPAMI.2008.273; Yang W, 2012, MED PHYS, V39, P6929, DOI 10.1118/1.4754305; Yap PT, 2010, IEEE T MED IMAGING, V29, P1192, DOI 10.1109/TMI.2010.2043680; Yassa MA, 2010, P NATL ACAD SCI USA, V107, P12687, DOI 10.1073/pnas.1002113107; Yeung DY, 2007, IEEE T NEURAL NETWOR, V18, P141, DOI 10.1109/TNN.2006.883723; Zhou DY, 2004, ADV NEUR IN, V16, P321; Ziyan U, 2006, LECT NOTES COMPUT SC, V4191, P807	59	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92069	10.1371/journal.pone.0092069	http://dx.doi.org/10.1371/journal.pone.0092069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651858	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800067
J	Liu, LL; Qu, JQ; Zhou, XL; Liu, XF; Zhang, ZB; Wang, XM; Liu, T; Liu, GM				Liu, Longlong; Qu, Jieqiong; Zhou, Xilong; Liu, Xuefeng; Zhang, Zhaobao; Wang, Xumin; Liu, Tao; Liu, Guiming			Discovery of a Strongly-Interrelated Gene Network in Corals under Constant Darkness by Correlation Analysis after Wavelet Transform on Complex Network Model	PLOS ONE			English	Article							EXPRESSION PROFILES; REEF; DYNAMICS	Coral reefs occupy a relatively small portion of sea area, yet serve as a crucial source of biodiversity by establishing harmonious ecosystems with marine plants and animals. Previous researches mainly focused on screening several key genes induced by stress. Here we proposed a novel method-correlation analysis after wavelet transform of complex network model, to explore the effect of light on gene expression in the coral Acropora millepora based on microarray data. In this method, wavelet transform and the conception of complex network were adopted, and 50 key genes with large differences were finally captured, including both annotated genes and novel genes without accurate annotation. These results shed light on our understanding of coral's response toward light changes and the genome-wide interaction among genes under the control of biorhythm, and hence help us to better protect the coral reef ecosystems. Further studies are needed to explore how functional connections are related to structural connections, and how connectivity arises from the interactions within and between different systems. The method introduced in this study for analyzing microarray data will allow researchers to explore genome-wide interaction network with their own dataset and understand the relevant biological processes.	[Liu, Longlong; Qu, Jieqiong; Zhou, Xilong; Liu, Xuefeng; Liu, Tao] Ocean Univ China, Qingdao, Shandong, Peoples R China; [Wang, Xumin; Liu, Guiming] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Zhang, Zhaobao] Shandong Univ Tradit Chinese Med, Coll Pharm, Jinan, Peoples R China	Ocean University of China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Shandong University of Traditional Chinese Medicine	Liu, GM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	liugm@big.ac.cn	Qu, Jieqiong/AAA-4288-2019; wang, xumin/HII-8627-2022	Qu, Jieqiong/0000-0003-0915-1342; Zhang, Zhaobao/0000-0003-2422-9566	Chinese National Natural Science Funds [40906097]	Chinese National Natural Science Funds(National Natural Science Foundation of China (NSFC))	This research was supported by the Chinese National Natural Science Funds (grant no. 40906097). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Aronson RB, 2000, LIMNOL OCEANOGR, V45, P251, DOI 10.4319/lo.2000.45.1.0251; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Besser J, 2007, GENE EXPR PATTERNS, V7, P511, DOI 10.1016/j.modgep.2006.10.007; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Deuker L, 2009, NEUROIMAGE, V47, P1460, DOI 10.1016/j.neuroimage.2009.05.035; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; Fukamachi S, 2007, J MOL EVOL, V65, P359, DOI 10.1007/s00239-007-9035-7; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Gui LM, 2013, DEV CELL, V25, P43, DOI 10.1016/j.devcel.2013.02.008; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Ke BX, 2012, P NATL ACAD SCI USA, V109, P6165, DOI 10.1073/pnas.1113987109; Kim S, 2000, J BIOMED OPT, V5, P411, DOI 10.1117/1.1289142; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Mercado-Pimentel ME, 2007, DEV BIOL, V304, P420, DOI 10.1016/j.ydbio.2006.12.038; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mueller RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-492; Neigel J, 2007, CORAL REEFS, V26, P487, DOI 10.1007/s00338-007-0248-4; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-435; Shono H, 2000, COMPUT BIOL MED, V30, P237, DOI 10.1016/S0010-4825(00)00010-X; SPUDICH JL, 1980, J CELL BIOL, V85, P136, DOI 10.1083/jcb.85.1.136; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Wang S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r126; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Zeng S, 2002, GENE, V294, P45, DOI 10.1016/S0378-1119(02)00791-6	36	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92434	10.1371/journal.pone.0092434	http://dx.doi.org/10.1371/journal.pone.0092434			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651851	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800106
J	Marmelat, V; Torre, K; Beek, PJ; Daffertshofer, A				Marmelat, Vivien; Torre, Kjerstin; Beek, Peter J.; Daffertshofer, Andreas			Persistent Fluctuations in Stride Intervals under Fractal Auditory Stimulation	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; HUMAN GAIT; DYNAMICS; VARIABILITY; COMPLEXITY; SYNCHRONIZATION; REASSESSMENT; PHYSIOLOGY; STABILITY; BEHAVIOR	Stride sequences of healthy gait are characterized by persistent long-range correlations, which become anti-persistent in the presence of an isochronous metronome. The latter phenomenon is of particular interest because auditory cueing is generally considered to reduce stride variability and may hence be beneficial for stabilizing gait. Complex systems tend to match their correlation structure when synchronizing. In gait training, can one capitalize on this tendency by using a fractal metronome rather than an isochronous one? We examined whether auditory cues with fractal variations in inter-beat intervals yield similar fractal inter-stride interval variability as isochronous auditory cueing in two complementary experiments. In Experiment 1, participants walked on a treadmill while being paced by either an isochronous or a fractal metronome with different variation strengths between beats in order to test whether participants managed to synchronize with a fractal metronome and to determine the necessary amount of variability for participants to switch from anti-persistent to persistent inter-stride intervals. Participants did synchronize with the metronome despite its fractal randomness. The corresponding coefficient of variation of inter-beat intervals was fixed in Experiment 2, in which participants walked on a treadmill while being paced by non-isochronous metronomes with different scaling exponents. As expected, inter-stride intervals showed persistent correlations similar to self-paced walking only when cueing contained persistent correlations. Our results open up a new window to optimize rhythmic auditory cueing for gait stabilization by integrating fractal fluctuations in the inter-beat intervals.	[Marmelat, Vivien; Torre, Kjerstin] Univ Montpellier I, EuroMov, Movement Hlth Lab, Montpellier, France; [Marmelat, Vivien; Beek, Peter J.; Daffertshofer, Andreas] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Beek, Peter J.] Brunel Univ, Sch Sport & Educ, Uxbridge UB8 3PH, Middx, England	Universite de Montpellier; Vrije Universiteit Amsterdam; Brunel University	Daffertshofer, A (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	a.daffertshofer@vu.nl		Daffertshofer, Andreas/0000-0001-9107-3552; Beek, Peter/0000-0002-0917-8548	SKILLS of the Commission of the European Community [035005]; Netherlands Organisation for Scientific Research (NWO) [400-08-127]	SKILLS of the Commission of the European Community; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by SKILLS, an Integrated Project (FP6-IST Contract #035005) of the Commission of the European Community. Andreas Daffertshofer received financial support from the Netherlands Organisation for Scientific Research (NWO grant #400-08-127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006626; Damouras S, 2010, GAIT POSTURE, V31, P336, DOI 10.1016/j.gaitpost.2009.12.002; Delignieres D, 2006, J MATH PSYCHOL, V50, P525, DOI 10.1016/j.jmp.2006.07.004; Delignieres D, 2014, PHYSICA A, V394, P47, DOI 10.1016/j.physa.2013.09.037; Delignieres D, 2009, J APPL PHYSIOL, V106, P1272, DOI 10.1152/japplphysiol.90757.2008; Dingwell JB, 2010, GAIT POSTURE, V32, P348, DOI 10.1016/j.gaitpost.2010.06.004; Ehrle N, 2005, BRAIN COGNITION, V58, P133, DOI 10.1016/j.bandc.2004.09.014; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldberger Ary L, 2006, Proc Am Thorac Soc, V3, P467, DOI 10.1513/pats.200603-028MS; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045, DOI 10.1152/jappl.2000.88.6.2045; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; Kaipust JP, 2013, ANN BIOMED ENG, V41, P1595, DOI 10.1007/s10439-012-0654-9; Lim I, 2005, CLIN REHABIL, V19, P695, DOI 10.1191/0269215505cr906oa; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Madison G, 2001, J EXP PSYCHOL HUMAN, V27, P411, DOI 10.1037/0096-1523.27.2.411; Marmelat V, 2012, EXP BRAIN RES, V222, P137, DOI 10.1007/s00221-012-3202-9; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Roerdink M, 2008, J BIOMECH, V41, P2628, DOI 10.1016/j.jbiomech.2008.06.023; Stephen DG, 2008, PHYSICA A, V387, P5271, DOI 10.1016/j.physa.2008.05.015; Stephen DG, 2011, CHAOS SOLITON FRACT, V44, P160, DOI 10.1016/j.chaos.2011.01.005; Terrier P, 2005, HUM MOVEMENT SCI, V24, P97, DOI 10.1016/j.humov.2005.03.002; Terrier P, 2012, HUM MOVEMENT SCI, V31, P1585, DOI 10.1016/j.humov.2012.05.004; Terrier P, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-12; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Van Orden GC, 2003, J EXP PSYCHOL GEN, V132, P331, DOI 10.1037/0096-3445.132.3.331; Werner G, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00015; Weron R, 2002, PHYSICA A, V312, P285, DOI 10.1016/S0378-4371(02)00961-5	33	51	51	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91949	10.1371/journal.pone.0091949	http://dx.doi.org/10.1371/journal.pone.0091949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651455	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800057
J	Post, S; Heijink, IH; Petersen, AH; de Bruin, HG; van Oosterhout, AJM; Nawijn, MC				Post, Sijranke; Heijink, Irene H.; Petersen, Arjen H.; de Bruin, Harold G.; van Oosterhout, Antoon J. M.; Nawijn, Martijn C.			Protease-Activated Receptor-2 Activation Contributes to House Dust Mite-Induced IgE Responses in Mice	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; NF-KAPPA-B; BRONCHIAL EPITHELIAL-CELLS; DEPENDENT ACTIVATION; GERMAN-COCKROACH; INHALED ANTIGEN; ASTHMA; SENSITIZATION; EXPRESSION; EXPOSURE	Aeroallergens such as house dust mite (HDM), cockroach, and grass or tree pollen are innocuous substances that can induce allergic sensitization upon inhalation. The serine proteases present in these allergens are thought to activate the protease-activated receptor (PAR)-2, on the airway epithelium, thereby potentially inducing allergic sensitization at the expense of inhalation tolerance. We hypothesized that the proteolytic activity of allergens may play an important factor in the allergenicity to house dust mite and is essential to overcome airway tolerance. Here, we aimed to investigate the role of PAR-2 activation in allergic sensitization and HDM-induced allergic airway inflammation. In our study, Par-2 deficient mice were treated with two different HDM extracts containing high and low serine protease activities twice a week for a period of 5 weeks. We determined airway inflammation through quantification of percentages of mononuclear cells, eosinophils and neutrophils in the bronchial alveolar lavage fluid and measured total IgE and HDM-specific IgE and IgG1 levels in serum. Furthermore, Th2 and pro-inflammatory cytokines including IL-5, IL-13, Eotaxin-1, IL-17, KC, Chemokine (C-C motif) ligand 17 (CCL17) and thymic stromal lymphopoietin (TSLP), were measured in lung tissue homogenates. We observed that independent of the serine protease content, HDM was able to induce elevated levels of eosinophils and neutrophils in the airways of both wild-type (WT) and Par-2 deficient mice. Furthermore, we show that induction of pro-inflammatory cytokines by HDM exposure is independent of Par-2 activation. In contrast, serine protease activity of HDM does contribute to enhanced levels of total IgE, but not HDM-specific IgE. We conclude that, while Par-2 activation contributes to the development of IgE responses, it is largely dispensable for the HDM-induced induction of pro-inflammatory cytokines and airway inflammation in an experimental mouse model of HDM-driven allergic airway disease.	[Post, Sijranke; Heijink, Irene H.; Petersen, Arjen H.; de Bruin, Harold G.; van Oosterhout, Antoon J. M.; Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Lab Allergol & Pulm Dis, Groningen, Netherlands; [Post, Sijranke; Heijink, Irene H.; de Bruin, Harold G.; van Oosterhout, Antoon J. M.; Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Heijink, Irene H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Nawijn, MC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Lab Allergol & Pulm Dis, Groningen, Netherlands.	m.c.nawijn@umcg.nl		Nawijn, Martijn/0000-0003-3372-6521	Dutch Lung Foundation [NAF 3.2.07.019]; Foundation Dutch Asthma Control [SAB2011/016]	Dutch Lung Foundation; Foundation Dutch Asthma Control	This study was supported by grants from the Dutch Lung Foundation (NAF 3.2.07.019) and the Foundation Dutch Asthma Control (Stichting Astma bestrijding SAB2011/016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; Alcorn JF, 2010, AM J PHYSIOL-LUNG C, V298, pL57, DOI 10.1152/ajplung.00037.2009; Arizmendi NG, 2011, ALLERGY ASTHMA CL IM, V7, DOI 10.1186/1710-1492-7-22; Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; Barlow JL, 2011, CLIN EXP ALLERGY, V41, P1447, DOI 10.1111/j.1365-2222.2011.03806.x; Boitano S, 2011, AM J PHYSIOL-LUNG C, V300, pL605, DOI 10.1152/ajplung.00359.2010; Cocks TM, 1999, NATURE, V398, P156, DOI 10.1038/18223; Day SB, 2012, J INNATE IMMUN, V4, P100, DOI 10.1159/000329132; Ebeling C, 2005, J ALLERGY CLIN IMMUN, V115, P623, DOI 10.1016/j.jaci.2004.11.042; Ebeling C, 2007, J IMMUNOL, V179, P2910, DOI 10.4049/jimmunol.179.5.2910; Gough L, 2003, CLIN EXP ALLERGY, V33, P1159, DOI 10.1046/j.1365-2222.2003.01716.x; Gregory LG, 2009, CLIN EXP ALLERGY, V39, P1597, DOI 10.1111/j.1365-2222.2009.03302.x; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Heijink IH, 2007, J IMMUNOL, V178, P7678, DOI 10.4049/jimmunol.178.12.7678; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; HOLT PG, 1981, IMMUNOLOGY, V42, P409; Jeon SK, 2008, J INVEST DERMATOL, V128, P1930, DOI 10.1038/jid.2008.13; Kauffman H. F., 2006, CLIN MOL ALLERGY, V4, P1; Knight DA, 2001, J ALLERGY CLIN IMMUN, V108, P797, DOI 10.1067/mai.2001.119025; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lewkowich IP, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-122; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nathan AT, 2009, J ALLERGY CLIN IMMUN, V123, P612, DOI 10.1016/j.jaci.2008.12.006; Nelson RP, 1996, J ALLERGY CLIN IMMUN, V98, P258, DOI 10.1016/S0091-6749(96)70148-3; Osterlund C, 2009, CLIN EXP ALLERGY, V39, P1199, DOI 10.1111/j.1365-2222.2009.03284.x; Page K, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-62; Post S, 2012, THORAX, V67, P488, DOI 10.1136/thoraxjnl-2011-200606; Rallabhandi P, 2008, J BIOL CHEM, V283, P24314, DOI 10.1074/jbc.M804800200; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Tully JE, 2013, J IMMUNOL, V191, P5811, DOI 10.4049/jimmunol.1301329; Vieira RP, 2011, AM J RESP CRIT CARE, V184, P215, DOI 10.1164/rccm.201011-1762OC; Walsh ER, 2008, J EXP MED, V205, P1285, DOI 10.1084/jem.20071836; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183	36	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91206	10.1371/journal.pone.0091206	http://dx.doi.org/10.1371/journal.pone.0091206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651123	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800033
J	Wang, C; Grohme, MA; Mali, B; Schill, RO; Frohme, M				Wang, Chong; Grohme, Markus A.; Mali, Brahim; Schill, Ralph O.; Frohme, Marcus			Towards Decrypting Cryptobiosis-Analyzing Anhydrobiosis in the Tardigrade Milnesium tardigradum Using Transcriptome Sequencing	PLOS ONE			English	Article							DESICCATION TOLERANCE; HEAT-SHOCK; MOLECULAR-MECHANISMS; CRYSTALLIN PROTEIN; GENE-EXPRESSION; MESSENGER-RNA; DNA; TREHALOSE; RESISTANCE; INDUCTION	Background: Many tardigrade species are capable of anhydrobiosis; however, mechanisms underlying their extreme desiccation resistance remain elusive. This study attempts to quantify the anhydrobiotic transcriptome of the limnoterrestrial tardigrade Milnesium tardigradum. Results: A prerequisite for differential gene expression analysis was the generation of a reference hybrid transcriptome atlas by assembly of Sanger, 454 and Illumina sequence data. The final assembly yielded 79,064 contigs (>100 bp) after removal of ribosomal RNAs. Around 50% of them could be annotated by SwissProt and NCBI non-redundant protein sequences. Analysis using CEGMA predicted 232 (93.5%) out of the 248 highly conserved eukaryotic genes in the assembly. We used this reference transcriptome for mapping and quantifying the expression of transcripts regulated under anhdydrobiosis in a time-series during dehydration and rehydration. 834 of the transcripts were found to be differentially expressed in a single stage (dehydration/inactive tun/rehydration) and 184 were overlapping in two stages while 74 were differentially expressed in all three stages. We have found interesting patterns of differentially expressed transcripts that are in concordance with a common hypothesis of metabolic shutdown during anhydrobiosis. This included down-regulation of several proteins of the DNA replication and translational machinery and protein degradation. Among others, heat shock proteins Hsp27 and Hsp30c were up-regulated in response to dehydration and rehydration. In addition, we observed up-regulation of ployubiquitin-B upon rehydration together with a higher expression level of several DNA repair proteins during rehydration than in the dehydration stage. Conclusions: Most of the transcripts identified to be differentially expressed had distinct cellular function. Our data suggest a concerted molecular adaptation in M. tardigradum that permits extreme forms of ametabolic states such as anhydrobiosis. It is temping to surmise that the desiccation tolerance of tradigrades can be achieved by a constitutive cellular protection system, probably in conjunction with other mechanisms such as rehydration-induced cellular repair.	[Wang, Chong; Grohme, Markus A.; Mali, Brahim; Frohme, Marcus] Tech Univ Appl Sci Wildau, Wildau, Germany; [Schill, Ralph O.] Univ Stuttgart, Inst Biol, D-70174 Stuttgart, Germany	University of Applied Sciences Wildau; University of Stuttgart	Wang, C (corresponding author), Tech Univ Appl Sci Wildau, Wildau, Germany.	cwang@th-wildau.de	Frohme, Marcus/HCH-4031-2022; Grohme, Markus/ABH-4373-2020	Grohme, Markus/0000-0002-4250-5600	German Federal Ministry of Education and Research, BMBF, as part of FUNCRYPTA [FKY 0313838E]	German Federal Ministry of Education and Research, BMBF, as part of FUNCRYPTA	This work was supported by the German Federal Ministry of Education and Research, BMBF, as part of FUNCRYPTA (FKY 0313838E). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-69; Altiero T, 2012, J LIMNOL, V71, P211, DOI 10.4081/jlimnol.2012.e22; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barker MS, 2010, EVOL BIOINFORM, V6, P143, DOI 10.4137/EBO.S5861; Beisser D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-72; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bewley J. D., 1992, Water and life: comparative analysis of water relationships at the organismic, cellular and molecular level., P141; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Browne JA, 2004, EUKARYOT CELL, V3, P966, DOI 10.1128/EC.3.4.966-975.2004; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Clegg JS, 2005, INTEGR COMP BIOL, V45, P715, DOI 10.1093/icb/45.5.715; Cornette R, 2010, J BIOL CHEM, V285, P35889, DOI 10.1074/jbc.M110.150623; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Eyres I, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-148; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Forster F, 2012, BIOINFORM BIOL INSIG, V6, P69, DOI 10.4137/BBI.S9150; Forster F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-469; Gagyi-Palffy Andrea, 2011, ELBA Bioflux, V3, P13; Gechev TS, 2013, CELL MOL LIFE SCI, V70, P689, DOI 10.1007/s00018-012-1155-6; Ghisolfi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043628; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Goyal K, 2005, INTEGR COMP BIOL, V45, P702, DOI 10.1093/icb/45.5.702; Grohme MA, 2011, J ZOOL SYST EVOL RES, V49, P127, DOI 10.1111/j.1439-0469.2010.00610.x; Gusev O, 2011, CELL STRESS CHAPERON, V16, P81, DOI 10.1007/s12192-010-0223-9; Hayward SAL, 2004, J EXP BIOL, V207, P963, DOI 10.1242/jeb.00842; Heikkila JJ, 2004, J CELL BIOCHEM, V93, P672, DOI 10.1002/jcb.20237; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Hengherr S, 2009, PHYSIOL BIOCHEM ZOOL, V82, P749, DOI 10.1086/605954; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Garcia AH, 2011, J BIOSCIENCES, V36, P939, DOI 10.1007/s12038-011-9107-0; Higo A, 2007, MICROBIOL-SGM, V153, P3685, DOI 10.1099/mic.0.2007/009233-0; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Humann JL, 2009, APPL ENVIRON MICROB, V75, P446, DOI 10.1128/AEM.02207-08; Jonsson I., 2014, OPEN ZOOL J, V3, P1, DOI [10.2174/1874336601003010001, DOI 10.2174/1874336601003010001]; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2007, COMP BIOCHEM PHYS B, V146, P456, DOI 10.1016/j.cbpb.2006.10.111; Katoh H, 2004, MICROB ECOL, V47, P164, DOI 10.1007/s00248-003-1043-6; KOSTER KL, 1988, PLANT PHYSIOL, V88, P829, DOI 10.1104/pp.88.3.829; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Lapinski J, 2003, FEBS LETT, V553, P387, DOI 10.1016/S0014-5793(03)01062-7; Leek JT, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-150; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li ZY, 2012, BRIEF FUNCT GENOMICS, V11, P25, DOI 10.1093/bfgp/elr035; Liang P, 1997, J BIOL CHEM, V272, P19051, DOI 10.1074/jbc.272.30.19051; Liang P, 1997, EUR J BIOCHEM, V243, P225, DOI 10.1111/j.1432-1033.1997.0225a.x; Liu XN, 2003, AM J BOT, V90, P526, DOI 10.3732/ajb.90.4.526; Lopez MD, 2008, RNA, V14, P1, DOI 10.1261/rna.782308; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; MacManes MD, 2013, PEERJ, V1, DOI 10.7717/peerj.113; Malde K, 2006, BIOINFORMATICS, V22, P2232, DOI 10.1093/bioinformatics/btl368; Mali B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-168; MANNIRONI C, 1989, NUCLEIC ACIDS RES, V17, P9113, DOI 10.1093/nar/17.22.9113; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Martinez-Barnetche J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-207; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mizrahi T, 2010, CELL STRESS CHAPERON, V15, P351, DOI 10.1007/s12192-009-0150-9; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-673; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Niedringhaus TP, 2011, ANAL CHEM, V83, P4327, DOI 10.1021/ac2010857; O'Mahony PJ, 1999, PLANT MOL BIOL, V41, P657, DOI 10.1023/A:1006330623364; Ono F, 2008, J PHYS CHEM SOLIDS, V69, P2297, DOI 10.1016/j.jpcs.2008.04.019; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rebecchi L, 2007, ISJ-INVERT SURVIV J, V4, P65; Rebecchi L, 2009, J EXP BIOL, V212, P4033, DOI 10.1242/jeb.033266; Ren XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051188; Reuner A, 2010, CELL STRESS CHAPERON, V15, P423, DOI 10.1007/s12192-009-0158-1; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Salmela L, 2010, BIOINFORMATICS, V26, P1284, DOI 10.1093/bioinformatics/btq151; Schill RO, 2004, J EXP BIOL, V207, P1607, DOI 10.1242/jeb.00935; Schokraie E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009502; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Shirkey B, 2003, NUCLEIC ACIDS RES, V31, P2995, DOI 10.1093/nar/gkg404; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Singh J, 2005, APPL ENVIRON MICROB, V71, P8752, DOI 10.1128/AEM.71.12.8752-8763.2005; Tunnacliffe A, 2005, HYDROBIOLOGIA, V546, P315, DOI 10.1007/s10750-005-4239-6; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Tyson Trevor, 2012, BMC Research Notes, V5, P68, DOI 10.1186/1756-0500-5-68; Welnicz W, 2011, J INSECT PHYSIOL, V57, P577, DOI 10.1016/j.jinsphys.2011.03.019; Willsie JK, 2001, J EXP BIOL, V204, P2339; Wolkers WF, 2002, COMP BIOCHEM PHYS A, V131, P535, DOI 10.1016/S1095-6433(01)00505-0; Yamaguchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044209; Yang XA, 2010, BIOINFORMATICS, V26, P2526, DOI 10.1093/bioinformatics/btq468; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	100	34	35	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92663	10.1371/journal.pone.0092663	http://dx.doi.org/10.1371/journal.pone.0092663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651535	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800139
J	Guzman, C; Bagga, M; Kaur, A; Westermarck, J; Abankwa, D				Guzman, Camilo; Bagga, Manish; Kaur, Amanpreet; Westermarck, Jukka; Abankwa, Daniel			ColonyArea: An ImageJ Plugin to Automatically Quantify Colony Formation in Clonogenic Assays	PLOS ONE			English	Article							MAMMALIAN-CELL COLONIES; EPIDERMAL-GROWTH-FACTOR; HUMAN KERATINOCYTES; PROTEIN-KINASE; INHIBITORS; APOPTOSIS; ARREST; LINE	The clonogenic or colony formation assay is a widely used method to study the number and size of cancer cell colonies that remain after irradiation or cytotoxic agent administration and serves as a measure for the anti-proliferative effect of these treatments. Alternatively, this assay is used to quantitate the transforming potential of cancer associated genes and chemical agents. Therefore, there is a need for a simplified and standardized analysis of colony formation assays for both routine laboratory use and for parallelized automated analysis. Here we describe the freely available ImageJ-plugin "ColonyArea", which is optimized for rapid and quantitative analysis of focus formation assays conducted in 6- to 24-well dishes. ColonyArea processes image data of multi-well dishes, by separating, concentrically cropping and background correcting well images individually, before colony formation is quantitated. Instead of counting the number of colonies, ColonyArea determines the percentage of area covered by crystal violet stained cell colonies, also taking the intensity of the staining and therefore cell density into account. We demonstrate that these parameters alone or in combination allow for robust quantification of IC50 values of the cytotoxic effect of two staurosporines, UCN-01 and staurosporine (STS) on human glioblastoma cells (T98G). The relation between the potencies of the two compounds compared very well with that obtained from an absorbance based method to quantify colony growth and to published data. The ColonyArea ImageJ plugin provides a simple and efficient analysis routine to quantitate assay data of one of the most commonly used cellular assays. The bundle is freely available for download as supporting information. We expect that ColonyArea will be of broad utility for cancer biologists, as well as clinical radiation scientists.	[Guzman, Camilo; Bagga, Manish; Kaur, Amanpreet; Westermarck, Jukka; Abankwa, Daniel] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Guzman, Camilo; Bagga, Manish; Kaur, Amanpreet; Westermarck, Jukka; Abankwa, Daniel] Abo Akad Univ, Turku, Finland; [Kaur, Amanpreet; Westermarck, Jukka] Univ Turku, Dept Pathol, Turku, Finland; [Kaur, Amanpreet] Univ Turku, Turku Doctoral Program Biomed Sci, Turku, Finland	University of Turku; Abo Akademi University; University of Turku; University of Turku	Abankwa, D (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.	daniel.abankwa@btk.fi	Westermarck, Jukka/AAL-6464-2020	Westermarck, Jukka/0000-0001-7478-3018; Kaur, Amanpreet/0000-0003-2824-5272; Abankwa, Daniel/0000-0003-2769-0745	Academy of Finland; Sigrid Juselius Foundation; Cancer Society of Finland; Marie-Curie Reintegration Grant; Foundation of the Finnish Cancer Institute; Cancer Foundation Finland sr [130067] Funding Source: researchfish	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Marie-Curie Reintegration Grant(European Commission); Foundation of the Finnish Cancer Institute; Cancer Foundation Finland sr	This work was supported by the Academy of Finland fellowship grant, the Sigrid Juselius Foundation, the Cancer Society of Finland and the Marie-Curie Reintegration Grant to DA. JW was supported by funding from the Foundation of the Finnish Cancer Institute and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Barber PR, 2001, PHYS MED BIOL, V46, P63, DOI 10.1088/0031-9155/46/1/305; BETTGER WJ, 1981, P NATL ACAD SCI-BIOL, V78, P5588, DOI 10.1073/pnas.78.9.5588; Booden MA, 2005, CELL BIOL 4 VOLUME S, V3, P345; Cai ZL, 2011, INT J RADIAT BIOL, V87, P1135, DOI 10.3109/09553002.2011.622033; Cheng CM, 2011, MOL CELL BIOL, V31, P983, DOI 10.1128/MCB.00137-10; Courage C, 1996, BRIT J CANCER, V74, P1199, DOI 10.1038/bjc.1996.517; COURAGE C, 1995, BRIT J CANCER, V71, P697, DOI 10.1038/bjc.1995.137; Dahle J, 2004, CYTOM PART A, V60A, P182, DOI 10.1002/cyto.a.20038; FALLON RJ, 1990, BIOCHEM BIOPH RES CO, V170, P1191, DOI 10.1016/0006-291X(90)90519-S; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gani OABSM, 2010, NAT PROD REP, V27, P489, DOI 10.1039/b923848b; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Ichinose M, 2002, CANCER RES, V62, P1433; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Marshall ME, 2011, CLIN CANCER RES, V17, P5016, DOI 10.1158/1078-0432.CCR-11-0050; Niemela M, 2012, ONCOGENE, V31, P4266, DOI 10.1038/onc.2011.599; Nygardas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064200; PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653; Ritz C, 2005, J STAT SOFTW, V12, P1; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Xu XZ, 1999, ONCOGENE, V18, P5554, DOI 10.1038/sj.onc.1203091; Yamasaki F, 2003, CANCER CHEMOTH PHARM, V51, P271, DOI 10.1007/s00280-002-0562-z; Yamasaki F, 2007, PATHOBIOLOGY, V74, P22, DOI 10.1159/000101048; ZYZAK LL, 1994, CELL GROWTH DIFFER, V5, P537	26	334	335	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92444	10.1371/journal.pone.0092444	http://dx.doi.org/10.1371/journal.pone.0092444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647355	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500132
J	Tenge, VR; Knowles, J; Johnson, JL				Tenge, Victoria R.; Knowles, Jared; Johnson, Jill L.			The Ribosomal Biogenesis Protein Utp21 Interacts with Hsp90 and Has Differing Requirements for Hsp90-Associated Proteins	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; SMALL-SUBUNIT PROCESSOME; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONE; HEAT-SHOCK; IN-VIVO; TETRATRICOPEPTIDE REPEAT; CELLULAR FUNCTIONS; STEROID-RECEPTOR; CLIENT PROTEINS	The molecular chaperone Hsp90 buffers the effects of genetic variation by assisting the stabilization and folding of multiple clients critical for cell signaling and growth. We identified an interaction of Hsp90 and associated proteins with the essential nucleolar protein, Utp21, part of a large complex required for biogenesis of the small ribosomal subunit. The utp21-S602F mutation, which causes minor defects in otherwise wild-type yeast, exhibited severe or lethal growth defects when combined with mutations in Hsp90 or co-chaperones. WT Utp21 and Utp21-S602F exhibited similar interactions with Hsp90, and steady-state levels of WT Utp21 were reduced upon Hsp90 mutation or inhibition. Mutations in the human homolog of UTP21, WDR36, have been associated with adult-onset primary open-angle glaucoma, a leading cause of blindness worldwide. Three different mutant forms of Utp21 analogous to glaucoma-associated WDR36 mutations exhibit reduced levels in yeast cells expressing mutations in Hsp90 or associated chaperones, suggesting that Hsp90 and co-chaperones buffer the effects of those mutations.	[Johnson, Jill L.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; Univ Idaho, Ctr Reprod Biol, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho	Johnson, JL (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	jilljohn@uidaho.edu		Tenge, Victoria/0000-0002-9429-7161	National Science Foundation [MCB-0744522]; INBRE Program, NIH [P20 RR016454, P20 GM103408]; Div Of Molecular and Cellular Bioscience [0744522] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); INBRE Program, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was primarily funded by a grant to JLJ from the National Science Foundation, MCB-0744522. JK was a Brigham Young University-Idaho Summer Research intern supported by the INBRE Program, NIH Grant Nos. P20 RR016454 (National Center for Research Resources) and P20 GM103408 (National Institute of General Medical Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; Chi ZL, 2010, HUM MOL GENET, V19, P3806, DOI 10.1093/hmg/ddq299; Dosil M, 2004, J BIOL CHEM, V279, P37385, DOI 10.1074/jbc.M404909200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; Fan BJ, 2009, MOL VIS, V15, P646; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 2007, ARCH OPHTHALMOL-CHIC, V125, P434, DOI 10.1001/archopht.125.3.434-b; Flom G, 2006, GENETICS, V172, P41, DOI 10.1534/genetics.105.045815; Flom G, 2005, CURR GENET, V47, P368, DOI 10.1007/s00294-005-0580-6; Flom GA, 2012, CURR GENET, V58, P149, DOI 10.1007/s00294-012-0373-7; Flom GA, 2008, MOL BIOL CELL, V19, P5249, DOI 10.1091/mbc.E08-04-0435; Footz T, 2011, MOL VIS, V17, P1957; Footz TK, 2009, HUM MOL GENET, V18, P1276, DOI 10.1093/hmg/ddp027; Franzosa EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028211; Gallenberger M, 2011, HUM MOL GENET, V20, P422, DOI 10.1093/hmg/ddq478; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hauser MA, 2006, INVEST OPHTH VIS SCI, V47, P2542, DOI 10.1167/iovs.05-1476; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Johnson JL, 2007, MOL CELL BIOL, V27, P768, DOI 10.1128/MCB.01034-06; Johnson JL, 2000, MOL CELL BIOL, V20, P3027, DOI 10.1128/MCB.20.9.3027-3036.2000; Koga F, 2009, ANTICANCER RES, V29, P797; Lee P, 2004, MOL BIOL CELL, V15, P1785, DOI 10.1091/mbc.E03-07-0480; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Longshaw VM, 2004, J CELL SCI, V117, P701, DOI 10.1242/jcs.00905; Mandal AK, 2010, MOL BIOL CELL, V21, P1439, DOI 10.1091/mbc.E09-09-0779; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Phizicky E, 2003, NATURE, V422, P208, DOI 10.1038/nature01512; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; SIKORSKI RS, 1989, GENETICS, V122, P19; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Wegele H, 2006, J MOL BIOL, V356, P802, DOI 10.1016/j.jmb.2005.12.008; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; Zuehlke AD, 2012, GENETICS, V191, P805, DOI 10.1534/genetics.112.140319	61	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92569	10.1371/journal.pone.0092569	http://dx.doi.org/10.1371/journal.pone.0092569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647762	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500145
J	Wang, KY				Wang, Kuo-Ying			How Change of Public Transportation Usage Reveals Fear of the SARS Virus in a City	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; PANDEMIC INFLUENZA; STRATEGIES; OUTBREAK	The outbreaks of the severe acute respiratory syndrome (SARS) epidemic in 2003 resulted in unprecedented impacts on people's daily life. One of the most significant impacts to people is the fear of contacting the SARS virus while engaging daily routine activity. Here we use data from daily underground ridership in Taipei City and daily reported new SARS cases in Taiwan to model the dynamics of the public fear of the SARS virus during the wax and wane of the SARS period. We found that for each reported new SARS case there is an immediate loss of about 1200 underground ridership (the fresh fear). These daily loss rates dissipate to the following days with an e-folding time of about 28 days, reflecting the public perception on the risk of contacting SARS virus when traveling with the underground system (the residual fear). About 50% of daily ridership was lost during the peak of the 2003 SARS period, compared with the loss of 80% daily ridership during the closure of the underground system after Typhoon Nari, the loss of 50-70% ridership due to the closure of the governmental offices and schools during typhoon periods, and the loss of 60% daily ridership during Chinese New Year holidays.	Natl Cent Univ, Dept Atmospher Sci, Chungli 32054, Taiwan	National Central University	Wang, KY (corresponding author), Natl Cent Univ, Dept Atmospher Sci, Chungli 32054, Taiwan.	kuoying@mail.atm.ncu.edu.tw			National Central University	National Central University	This work was funded by National Central University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beech H, 2003, TIME, V161; Cauchemez S, 2006, EMERG INFECT DIS, V12, P110; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P680; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P461; Chen YC, 2004, EMERG INFECT DIS, V10, P782, DOI 10.3201/eid1005.030579; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Dye C, 2003, SCIENCE, V300, P1884, DOI 10.1126/science.1086925; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396; Hsieh YH, 2005, EMERG INFECT DIS, V11, P278, DOI 10.3201/eid1102.040190; Hsieh YH, 2004, EMERG INFECT DIS, V10, P201, DOI 10.3201/eid1002.030515; Hsueh Po-Ren, 2005, Journal of Microbiology Immunology and Infection, V38, P82; Liu JT, 2005, HEALTH ECON, V14, P83, DOI 10.1002/hec.911; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Mamelund SE, 2004, POPULATION, V59, P269, DOI 10.2307/3654955; Moussaid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084592; Normile D, 2013, SCIENCE, V339, P1269, DOI [10.1126/science.339.6125.1269, 10.1126/science.339.6125.1272]; Nuttall I, 2013, SCIENCE, V339, P1287, DOI 10.1126/science.1236434; Perrin A, 2003, TIME, V161, P3; Twu SJ, 2003, EMERG INFECT DIS, V9, P718; Wang KY, 2004, WATER AIR SOIL POLL, V156, P29, DOI 10.1023/B:WATE.0000036788.41409.5b; Wayne RP, 1993, CHEM ATMOSPHERE; World Health Organization (WHO), 2003, SUMM PROB SARS CAS O; Zhou GF, 2003, EMERG INFECT DIS, V9, P1608	28	42	42	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89405	10.1371/journal.pone.0089405	http://dx.doi.org/10.1371/journal.pone.0089405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647278	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500005
J	Wang, W; Zhang, B				Wang, Wen; Zhang, Bo			Statins for the Prevention of Stroke: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; REDUCTASE INHIBITORS; DIABETES-MELLITUS; CHOLESTEROL; ATORVASTATIN; PRAVASTATIN; EVENTS; ROSUVASTATIN; ISCHEMIA	Background: Stroke is a frequently encountered clinical event that has a detrimental impact on the quality of life. Evidence has increasingly shown that statins can substantially reduce the risk of coronary heart disease. However, it remains to be determined whether statins are definitively effective in preventing stroke. Methods: We systematically searched the PubMed, Embase, and Central databases for studies that compared the effects of statins and placebo in patients at high risk for stroke. The outcome measures were overall incidence of stroke, incidence of fatal stroke, and incidence of hemorrhagic stroke. Results: Eighteen randomized controlled trials satisfied all the inclusion criteria for the meta-analysis. The analysis revealed that statins reduced the overall incidence of stroke than placebo (odds ratio [OR]: 0.80; 95% confidence interval [CI]: 0.74-0.87; P<0.00001). In particular, statins showed efficacy in reducing the incidence of fatal stroke (OR: 0.90; 95% CI: 0.67-1.21; P = 0.47) and hemorrhagic stroke (OR: 0.87; 95% CI: 0.60-1.25; P = 0.45). On the contrary, they were found to increase the overall incidence of stroke (OR: 1.12; 95% CI: 0.89-1.41; P = 0.32) and fatal stroke (OR: 1.37; 95% CI: 0.93-2.03; P = 0.11) in renal transplant recipients and patients undergoing regular hemodialysis. Conclusion: The results of this analysis suggest that statins may be beneficial in reducing the overall incidence of stroke and they may decrease the risk of fatal stroke and hemorrhagic stroke. However, statins should be used with caution in patients with a history of renal transplantation, regular hemodialysis, transient ischemic attack, or stroke. Further analyses should focus on multicentre, double-blind, placebo-controlled randomized trials with data stratification according to the nature of primary diseases and dose-effect relationship, to clarify the benefits of statins in protection against stroke.	[Wang, Wen; Zhang, Bo] Dalian Med Univ, Affiliated Hosp 1, Dept Neurosurg, Dalian, Peoples R China	Dalian Medical University	Zhang, B (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Neurosurg, Dalian, Peoples R China.	zhangbodl@126.com						Abedini S, 2009, TRANSPLANTATION, V87, P112, DOI 10.1097/TP.0b013e31818bfce8; Amarenco P, 2004, LANCET NEUROL, V3, P271, DOI 10.1016/S1474-4422(04)00734-3; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Athyros VG, 2002, CURR MED RES OPIN, V18, P220, DOI 10.1185/030079902125000787; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Calabro P, 2005, CURR OPIN CARDIOL, V20, P541, DOI 10.1097/01.hco.0000181482.99067.bf; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Everett BM, 2010, CIRCULATION, V121, P143, DOI 10.1161/CIRCULATIONAHA.109.874834; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Goldstein LB, 2008, NEUROLOGY, V70, P2364, DOI 10.1212/01.wnl.0000296277.63350.77; Grundy SM, 1997, ARCH INTERN MED, V157, P1177, DOI 10.1001/archinte.157.11.1177; Hitman GA, 2007, DIABETIC MED, V24, P1313, DOI 10.1111/j.1464-5491.2007.02268.x; Kent DM, 2006, NEW ENGL J MED, V355, P613, DOI 10.1056/NEJMe068146; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.2337/dc05-2415; Koren MJ, 2004, J AM COLL CARDIOL, V44, P1772, DOI 10.1016/j.jacc.2004.07.053; Lakhan Shaheen E, 2010, Int Arch Med, V3, P22, DOI 10.1186/1755-7682-3-22; Mohr JP, 1997, STROKE, V28, P1501; Moonis M, 2005, STROKE, V36, P1298, DOI 10.1161/01.STR.0000165920.67784.58; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; PEDERSEN TR, 1994, LANCET, V344, P1383; Plehn JF, 1999, CIRCULATION, V99, P216, DOI 10.1161/01.CIR.99.2.216; Robinson JG, 2005, J AM COLL CARDIOL, V46, P1855, DOI 10.1016/j.jacc.2005.05.085; Rysz J, 2009, EXPERT OPIN THER TAR, V13, P541, DOI [10.1517/14728220902882130 , 10.1517/14728220902882130]; Sever PS, 2008, EUR HEART J, V29, P499, DOI 10.1093/eurheartj/ehm583; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Vaughan CJ, 1999, STROKE, V30, P1969, DOI 10.1161/01.STR.30.9.1969; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Waters DD, 2002, CIRCULATION, V106, P1690, DOI 10.1161/01.CIR.0000031568.40630.1C; White HD, 2000, NEW ENGL J MED, V343, P317, DOI 10.1056/NEJM200008033430502; Willey JZ, 2010, ARCH NEUROL-CHICAGO, V67, P1062, DOI 10.1001/archneurol.2010.199	34	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92388	10.1371/journal.pone.0092388	http://dx.doi.org/10.1371/journal.pone.0092388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643199	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900129
J	David, MA; Jones, KH; Inzana, JA; Zuscik, MJ; Awad, HA; Mooney, RA				David, Michael A.; Jones, Khyrie H.; Inzana, Jason A.; Zuscik, Michael J.; Awad, Hani A.; Mooney, Robert A.			Tendon Repair Is Compromised in a High Fat Diet-Induced Mouse Model of Obesity and Type 2 Diabetes	PLOS ONE			English	Article							FLEXOR; CELLS; TENDINOPATHY; ADHESIONS; COLLAGEN; BIOLOGY; INJURY	Introduction: The obesity epidemic has resulted in a large increase in type 2 diabetes (T2D). While some secondary complications of T2D are well recognized and their cellular and molecular mechanisms are defined, the impact of T2D on the musculoskeletal system is less understood. Clinical evidence suggests that tendon strength and repair are compromised. Here, a mouse model of obesity and T2D recapitulates the deleterious effects of this condition on tendon repair. Methods: Male C57BL/6J mice at 5 weeks of age were placed on a high fat (HF)(60% kcal) or low fat (10% kcal) diet for 12 weeks. The flexor digitorum longus (FDL) tendon was then injured by puncturing it with a beveled needle. Progression of FDL tendon healing was assessed through biomechanical and histological analysis at 0, 7, 14 and 28 days post-injury. Results: HF-fed mice displayed increased body weight and elevated fasting glucose levels, both consistent with T2D. No differences in biomechanical properties of the uninjured FDL tendon were observed after 12 weeks on HF versus lean diets, but decreased maximum force in uninjured tendons from HF-fed mice was observed at 24 weeks. Following puncture injury, tendons from HF-fed mice displayed impaired biomechanical properties at day 28 post injury. In support of defective repair in the HF-fed mice, histological examination of the injury site showed a smaller area of repair and lower cell content in the repair area of HF-fed mice. Insulin receptors were expressed in most cells at the injury site regardless of diet. Discussion: The HF-diet mouse model of obesity and T2D reproduces the impaired tendon healing that is observed in this patient population. The exact mechanism is unknown, but we hypothesize that a cellular defect, perhaps involving insulin resistance, leads to decreased proliferation or recruitment to the injury site, and ultimately contributes to defective tendon healing.	[David, Michael A.; Jones, Khyrie H.; Mooney, Robert A.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [David, Michael A.; Inzana, Jason A.; Awad, Hani A.] Univ Rochester, Dept Biomed Engn, Rochester, NY USA; [Zuscik, Michael J.; Awad, Hani A.; Mooney, Robert A.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Mooney, RA (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA.	Robert_Mooney@urmc.rochester.edu	Awad, Hani A/G-6976-2014; Mostafa, Taymour/H-6834-2019	Awad, Hani A/0000-0003-2197-2610; Mostafa, Taymour/0000-0003-3627-0662; Zuscik, Michael/0000-0003-0461-8708; Inzana, Jason/0000-0002-5221-273X	NIH [P50 AR054041]; AO Trauma Research Fund; NIAMS/NIH [P30 AR061307, R01AR056696]; NSF [2012116002]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056696, P50AR054041, P30AR061307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AO Trauma Research Fund; NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by the following: NIH P50 AR054041, AO Trauma Research Fund, NIAMS/NIH P30 AR061307, NIAMS/NIH R01AR056696, and NSF graduate research fellowship 2012116002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2013, RHEUMATOLOGY, V52, P599, DOI 10.1093/rheumatology/kes395; Akturk M, 2007, EXP CLIN ENDOCR DIAB, V115, P92, DOI 10.1055/s-2007-955097; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Aydeniz A, 2008, J INT MED RES, V36, P505, DOI 10.1177/147323000803600315; Bedi A, 2010, J SHOULDER ELB SURG, V19, P978, DOI 10.1016/j.jse.2009.11.045; Bloomgarden ZT, 2000, DIABETES CARE, V23, P118, DOI 10.2337/diacare.23.1.118; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Branford OA, 2008, PLAST RECONSTR SURG, V121, P781, DOI 10.1097/01.prs.0000299373.25294.65; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chbinou N, 2004, AM J PHYSIOL-REG I, V286, pR952, DOI 10.1152/ajpregu.00536.2003; Chen AL, 2003, J SHOULDER ELB SURG, V12, P416, DOI 10.1016/S1058-2746(03)00172-1; Chuen FS, 2004, J HISTOCHEM CYTOCHEM, V52, P1151, DOI 10.1369/jhc.3A6232.2004; Clement ND, 2010, J BONE JOINT SURG BR, V92B, P1112, DOI 10.1302/0301-620X.92B8.23571; DiDomenico LA, 2008, J FOOT ANKLE SURG, V47, P463, DOI 10.1053/j.jfas.2008.05.007; Elfar JC, 2008, J BONE JOINT SURG AM, V90A, P1644, DOI 10.2106/JBJS.G.00557; Gaida JE, 2008, DISABIL REHABIL, V30, P1555, DOI 10.1080/09638280701786864; GARNER WL, 1989, PLAST RECONSTR SURG, V83, P875, DOI 10.1097/00006534-198905000-00018; GELBERMAN RH, 1986, J HAND SURG-AM, V11A, P106, DOI 10.1016/S0363-5023(86)80115-0; Hasslund S, 2008, J ORTHOP RES, V26, P824, DOI 10.1002/jor.20531; Huang ES, 2009, DIABETES CARE, V32, P2225, DOI 10.2337/dc09-0459; James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007; Loiselle AE, 2009, J ORTHOP RES, V27, P833, DOI 10.1002/jor.20769; Palmes D, 2002, J ORTHOPAED RES, V20, P939, DOI 10.1016/S0736-0266(02)00032-3; Ramchurn N, 2009, EUR J INTERN MED, V20, P718, DOI 10.1016/j.ejim.2009.08.001; Ramirez LC, 1998, J DIABETES COMPLICAT, V12, P337, DOI 10.1016/S1056-8727(98)00024-5; Reddy GK, 2004, EXP DIABESITY RES, V5, P143, DOI 10.1080/15438600490277860; Rosenbloom AL, 1996, ENDOCRIN METAB CLIN, V25, P473, DOI 10.1016/S0889-8529(05)70335-2; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; TANAKA S, 1988, J MOL BIOL, V203, P495, DOI 10.1016/0022-2836(88)90015-0; Taylor R, 2012, DIABETES, V61, P778, DOI 10.2337/db12-0073; VLASSARA H, 1994, LAB INVEST, V70, P138; Voleti PB, 2012, ANNU REV BIOMED ENG, V14, P47, DOI 10.1146/annurev-bioeng-071811-150122; WOJCIAK B, 1993, CLIN EXP IMMUNOL, V93, P108; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	37	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91234	10.1371/journal.pone.0091234	http://dx.doi.org/10.1371/journal.pone.0091234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658034	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300028
J	Pei, N; Jie, FL; Luo, J; Wan, RQ; Zhang, YL; Chen, XL; Liang, ZB; Du, HY; Li, A; Chen, BH; Zhang, Y; Sumners, C; Li, JL; Gu, WW; Li, HW				Pei, Nana; Jie, Feilong; Luo, Jie; Wan, Renqiang; Zhang, Yanling; Chen, Xinglu; Liang, Zhibing; Du, Hongyan; Li, Andrew; Chen, Baihong; Zhang, Yi; Sumners, Colin; Li, Jinlong; Gu, Weiwang; Li, Hongwei			Gene Expression Profiling Associated with Angiotensin II Type 2 Receptor-Induced Apoptosis in Human Prostate Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TRAIL-INDUCED APOPTOSIS; MEDIATED APOPTOSIS; LIGAND TRAIL; DEATH; INHIBITION; FAMILY; HRK; PROLIFERATION; GROWTH	Increased expression of angiotensin II type 2 receptor (AT2R) induces apoptosis in numerous tumor cell lines, with either Angiotensin II-dependent or Angiotensin II-independent regulation, but its molecular mechanism remains poorly understood. Here, we used PCR Array analysis to determine the gene and microRNA expression profiles in human prostate cancer cell lines transduced with AT2R recombinant adenovirus. Our results demonstrated that AT2R over expression leads to up-regulation of 6 apoptosis-related genes (TRAIL-R2, BAG3, BNIPI, HRK, Gadd45a, TP53BP2), 2 cytokine genes (IL6 and IL8) and 1 microRNA, and down-regulation of 1 apoptosis-related gene TNFSF10 and 2 cytokine genes (BMP6, BMP7) in transduced DU145 cells. HRK was identified as an up-regulated gene in AT2R-transduced PC-3 cells by real-time RT-PCR. Next, we utilized siRNAs to silence the up-regulated genes to further determine their roles on AT2R overexpression mediated apoptosis. The results showed downregulation of Gadd45a reduced the apoptotic effect by similar to 30% in DU145 cells, downregulation of HRK reduced AT2R-mediated apoptosis by more than 50% in PC-3 cells, while downregulation of TRAIL-R2 enhanced AT2R-mediated apoptosis more than 4 times in DU145 cells. We also found that the effects on AT2R-mediated apoptosis caused by downregulation of Gadd45a, TRAIL-R2 and HRK were independent in activation of p38 MAPK, p44/42 MAPK and p53. Taken together, our results demonstrated that TRAIL-R2, Gadd45a and HRK may be novel target genes for further study of the mechanism of AT2R-mediated apoptosis in prostate cancer cells.	[Pei, Nana; Jie, Feilong; Luo, Jie; Zhang, Yanling; Chen, Xinglu; Liang, Zhibing; Du, Hongyan; Chen, Baihong; Li, Jinlong; Li, Hongwei] Southern Med Univ, Sch Biotechnol, Guangzhou, Guangdong, Peoples R China; [Wan, Renqiang] Guangdong No 2 Prov Peoples Hosp, Dept Otolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China; [Li, Andrew] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Zhang, Yi] Univ Florida, Dept Pharmacol, Gainesville, FL 32610 USA; [Sumners, Colin] Univ Florida, Dept Physiol & Funct Gen, Gainesville, FL USA; [Gu, Weiwang] Southern Med Univ, Inst Comparat Med, Guangzhou, Guangdong, Peoples R China; [Gu, Weiwang] Southern Med Univ, Ctr Lab Animals, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Southern Medical University - China; Southern Medical University - China	Li, JL (corresponding author), Southern Med Univ, Sch Biotechnol, Guangzhou, Guangdong, Peoples R China.	lijinlong75@126.com; guww100@163.com; hongwei1@yahoo.com		Sumners, Colin/0000-0002-9689-2255	National Natural Science Foundation of China [81072113]; National 863 High Technique Development Projects of China [2012AA02A403]; State Key Laboratory of Pathogen and Biosecurity Program [SKLPBS1103]; Chinese government [2011A091000022, 2010B060500001, 2011B060300028, 2011B060300014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 High Technique Development Projects of China(National High Technology Research and Development Program of China); State Key Laboratory of Pathogen and Biosecurity Program; Chinese government	This work was supported by National Natural Science Foundation of China Grant 81072113 (H.L.), National 863 High Technique Development Projects of China Grant 2012AA02A403 (H.L.), State Key Laboratory of Pathogen and Biosecurity Program SKLPBS1103 (H.L.), as well as by awards 2011A091000022, 2010B060500001, 2011B060300028 and 2011B060300014 to W. G. from the Chinese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedecs K, 1997, BIOCHEM J, V325, P449, DOI 10.1042/bj3250449; Bhaskaran M, 2003, AM J PHYSIOL-RENAL, V284, pF955, DOI 10.1152/ajprenal.00246.2002; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chow L, 2008, PROSTATE, V68, P651, DOI 10.1002/pros.20738; Crawford ED, 2009, UROLOGY, V73, P4, DOI 10.1016/j.urology.2009.03.001; Cretu Alexandra, 2009, Cancer Ther, V7, P268; Cui TX, 2002, MOL ENDOCRINOL, V16, P2113, DOI 10.1210/me.2001-0284; Ding GH, 2002, AM J PHYSIOL-RENAL, V283, pF173, DOI 10.1152/ajprenal.00240.2001; Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; FORNACE AJ, 1992, ANN NY ACAD SCI, V663, P139, DOI 10.1111/j.1749-6632.1992.tb38657.x; Ghosh AP, 2009, J NEUROPATH EXP NEUR, V68, P747, DOI 10.1097/NEN.0b013e3181a9d524; GRADY EF, 1991, J CLIN INVEST, V88, P921, DOI 10.1172/JCI115395; Greene MI, 2000, ONCOGENE REV, V19, P2984; Griffith TS, 2000, J IMMUNOL, V165, P2886, DOI 10.4049/jimmunol.165.5.2886; Griffith TS, 1998, CURR OPIN IMMUNOL, V10, P559, DOI 10.1016/S0952-7915(98)80224-0; Haselmann V, 2014, GASTROENTEROLOGY, V146, P278, DOI 10.1053/j.gastro.2013.10.009; Horiuchi M, 1997, J BIOL CHEM, V272, P19022, DOI 10.1074/jbc.272.30.19022; Inoue K, 2000, CANCER RES, V60, P2290; Kalinec GM, 2005, P NATL ACAD SCI USA, V102, P16019, DOI 10.1073/pnas.0508053102; Kawabata A, 2012, CANCER RES, V72, P2057, DOI 10.1158/0008-5472.CAN-11-3634; Keane MM, 1999, CANCER RES, V59, P734; Klose A, 2011, NEOPLASIA, V13, P276, DOI 10.1593/neo.101540; Koyama S, 2002, J CANCER RES CLIN, V128, P73, DOI 10.1007/s004320100292; Li HW, 2009, MOL CANCER THER, V8, P3255, DOI 10.1158/1535-7163.MCT-09-0237; Li HW, 2005, BIOCHEM BIOPH RES CO, V336, P29, DOI 10.1016/j.bbrc.2005.08.035; Liebermann DA, 1998, ONCOGENE, V17, P3319, DOI 10.1038/sj.onc.1202574; Liebermann DA, 2011, CELL CYCLE, V10, P3428, DOI 10.4161/cc.10.20.17528; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Marcus JS, 2003, GLIA, V41, P152, DOI 10.1002/glia.10168; MATSUSHIMA K, 1992, CHEM IMMUNOL, V51, P236; Miura S, 2005, J BIOL CHEM, V280, P18237, DOI 10.1074/jbc.M500639200; Miura SI, 2000, EMBO J, V19, P4026, DOI 10.1093/emboj/19.15.4026; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Nakamura M, 2005, ACTA NEUROPATHOL, V110, P402, DOI 10.1007/s00401-005-1065-x; Nakamura M, 2008, ONCOGENE, V27, pS105, DOI 10.1038/onc.2009.48; Nimmanapalli R, 2001, CANCER RES, V61, P759; Nouet S, 2004, J BIOL CHEM, V279, P28989, DOI 10.1074/jbc.M403880200; Palacios C, 2013, CURR PHARM DES; Qiu Y, 1998, NATURE, V393, P83, DOI 10.1038/30012; Sanz C, 2002, HAEMATOLOGICA, V87, P903; Shenoy UV, 1999, ENDOCRINOLOGY, V140, P500, DOI 10.1210/en.140.1.500; Srivastava SK, 2011, CARCINOGENESIS, V32, P1832, DOI 10.1093/carcin/bgr223; STOLL M, 1995, J CLIN INVEST, V95, P651, DOI 10.1172/JCI117710; Szliszka E, 2012, INT J MOL SCI, V13, P15343, DOI 10.3390/ijms131115343; Szliszka E, 2013, UROL ONCOL-SEMIN ORI, V31, P331, DOI 10.1016/j.urolonc.2011.01.019; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Wach S, 2001, ONCOGENE, V20, P7761, DOI 10.1038/sj.onc.1204962; Wakabayashi T, 2002, NEUROSCI LETT, V318, P77, DOI 10.1016/S0304-3940(01)02487-9; Wang M, 2008, J PATHOL, V215, P13, DOI 10.1002/path.2333; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yamada T, 1996, P NATL ACAD SCI USA, V93, P156, DOI 10.1073/pnas.93.1.156; Yang F, 2013, J BIOL CHEM, V288, P6552, DOI 10.1074/jbc.M112.418335; Young JE, 2009, J NEUROSCI, V29, P1987, DOI 10.1523/JNEUROSCI.4072-08.2009; Zhang XD, 1999, CANCER RES, V59, P2747	60	11	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92253	10.1371/journal.pone.0092253	http://dx.doi.org/10.1371/journal.pone.0092253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658029	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300067
J	Allen, RJ; Soares, MA; Haberman, ID; Szpalski, C; Schachar, J; Lin, CD; Nguyen, PD; Saadeh, PB; Warren, SM				Allen, Robert J., Jr.; Soares, Marc A.; Haberman, Ilyse D.; Szpalski, Caroline; Schachar, Jeffrey; Lin, Clarence D.; Nguyen, Phuong D.; Saadeh, Pierre B.; Warren, Stephen M.			Combination Therapy Accelerates Diabetic Wound Closure	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; QUALITY-OF-LIFE; GROWTH-FACTOR; MYOCARDIAL-INFARCTION; MOBILIZATION; STEM; NEOVASCULARIZATION; COMPLICATIONS; CXCR4; VASCULOGENESIS	Background: Non-healing foot ulcers are the most common cause of non-traumatic amputation and hospitalization amongst diabetics in the developed world. Impaired wound neovascularization perpetuates a cycle of dysfunctional tissue repair and regeneration. Evidence implicates defective mobilization of marrow-derived progenitor cells (PCs) as a fundamental cause of impaired diabetic neovascularization. Currently, there are no FDA-approved therapies to address this defect. Here we report an endogenous PC strategy to improve diabetic wound neovascularization and closure through a combination therapy of AMD3100, which mobilizes marrow-derived PCs by competitively binding to the cell surface CXCR4 receptor, and PDGF-BB, which is a protein known to enhance cell growth, progenitor cell migration and angiogenesis. Methods and Results: Wounded mice were assigned to 1 of 5 experimental arms (n = 8/arm): saline treated wild-type, saline treated diabetic, AMD3100 treated diabetic, PDGF-BB treated diabetic, and AMD3100/PDGF-BB treated diabetic. Circulating PC number and wound vascularity were analyzed for each group (n = 8/group). Cellular function was assessed in the presence of AMD3100. Using a validated preclinical model of type II diabetic wound healing, we show that AMD3100 therapy (10 mg/kg; i.p. daily) alone can rescue diabetes-specific defects in PC mobilization, but cannot restore normal wound neovascularization. Through further investigation, we demonstrate an acquired trafficking-defect within AMD3100-treated diabetic PCs that can be rescued by PDGF-BB (2 mg; topical) supplementation within the wound environment. Finally, we determine that combination therapy restores diabetic wound neovascularization and accelerates time to wound closure by 40%. Conclusions: Combination AMD3100 and PDGF-BB therapy synergistically improves BM PC mobilization and trafficking, resulting in significantly improved diabetic wound closure and neovascularization. The success of this endogenous, cell-based strategy to improve diabetic wound healing using FDA-approved therapies is inherently translatable.	[Allen, Robert J., Jr.; Soares, Marc A.; Haberman, Ilyse D.; Szpalski, Caroline; Schachar, Jeffrey; Lin, Clarence D.; Nguyen, Phuong D.; Saadeh, Pierre B.; Warren, Stephen M.] NYU, Inst Reconstruct Plast Surg, Langone Med Ctr, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Warren, SM (corresponding author), NYU, Inst Reconstruct Plast Surg, Langone Med Ctr, New York, NY 10016 USA.	stephen.warren.md@gmail.com		Haberman, Ilyse/0000-0002-3289-4788; Saadeh, Pierre/0000-0001-9818-8598	NIMHD NIH HHS [L60 MD003100] Funding Source: Medline	NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Armstrong DG, 2008, J FOOT ANKLE SURG, V47, P278, DOI 10.1053/j.jfas.2008.02.015; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bernardi S, 2012, EXP DIABETES RES, DOI 10.1155/2012/872504; Boutoille D, 2008, FOOT ANKLE INT, V29, P1074, DOI 10.3113/FAI.2008.1074; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Capla JM, 2007, PLAST RECONSTR SURG, V119, P59, DOI 10.1097/01.prs.0000244830.16906.3f; Cashen Amanda F, 2007, Future Oncol, V3, P19, DOI 10.2217/14796694.3.1.19; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chan RK, 2006, J BURN CARE RES, V27, P202, DOI 10.1097/01.BCR.0000202898.11277.58; Cheng CF, 2011, J CLIN INVEST, V121, P4348, DOI 10.1172/JCI46475; Cross KJ, 2003, SURG CLIN N AM, V83, P531, DOI 10.1016/S0039-6109(02)00202-5; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Davidson EH, 2011, PLAST RECONSTR SURG, V128, P406, DOI 10.1097/PRS.0b013e31821e6e2e; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fiorina P, 2010, CELL TRANSPLANT, V19, P1369, DOI 10.3727/096368910X514288; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Jarajapu YPR, 2010, CIRC RES, V106, P854, DOI 10.1161/CIRCRESAHA.109.213140; Kao HK, 2011, ANN SURG, V254, P1066, DOI 10.1097/SLA.0b013e3182251559; KOLLURU GK, 2012, INT J VASC MED, DOI DOI 10.1155/2012/918267; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Lee E, 2010, INVEST OPHTH VIS SCI, V51, P3666, DOI 10.1167/iovs.09-3802; Lin CD, 2008, PLAST RECONSTR SURG, V122, P1341, DOI 10.1097/PRS.0b013e318188217b; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Marrotte EJ, 2010, J CLIN INVEST, V120, P4207, DOI 10.1172/JCI36858; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Miyajima S, 2006, DIABETES RES CLIN PR, V71, P272, DOI 10.1016/j.diabres.2005.07.005; Nagai MK, 2002, EXPERT OPIN BIOL TH, V2, P211, DOI 10.1517/14712598.2.2.211; Nishimura Y, 2012, J INVEST DERMATOL, V132, P711, DOI 10.1038/jid.2011.356; Petersen M, 2003, DIABETES CARE, V26, P917; Robson MC, 1998, AM J SURG, V176, p80S, DOI 10.1016/S0002-9610(98)00186-X; Roncalli J, 2011, J AM COLL CARDIOL, V57, P2444, DOI 10.1016/j.jacc.2010.11.069; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Schwartz A, 2004, CYTOM PART B-CLIN CY, V57B, P1, DOI 10.1002/cyto.b.10066; Sciaccaluga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073426; Suriano R, 2008, CANCER RES, V68, P6038, DOI 10.1158/0008-5472.CAN-08-1009; Tanaka R, 2014, CELL TRANSPLANT, V23, P167, DOI 10.3727/096368912X658007; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Tepper OM, 2010, DIABETES, V59, P1974, DOI 10.2337/db09-0185; Theiss HD, 2011, STEM CELL RES, V7, P244, DOI 10.1016/j.scr.2011.05.003; Wang XX, 2011, PLAST RECONSTR SURG, V128, P395, DOI 10.1097/PRS.0b013e31821e6e10	46	22	22	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92667	10.1371/journal.pone.0092667	http://dx.doi.org/10.1371/journal.pone.0092667			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651576	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800140
J	Biere, L; Donal, E; Terrien, G; Furber, A; Martin, L; Prunier, F				Biere, Loic; Donal, Erwan; Terrien, Gwenola; Furber, Alain; Martin, Ludovic; Prunier, Fabrice			Left Ventricular Function in a Large Cohort of Pseudoxanthoma Elasticum Patients	PLOS ONE			English	Article							DIASTOLIC FUNCTION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; DYSFUNCTION; AGE	Objective: Pseudoxanthoma elasticum (PXE) is a rare autosomal recessive disorder characterized by the mineralization and fragmentation of elastic fibers in the skin, retina, and vascular walls. While there is no doubt that peripheral arterial disease is associated with PXE, several other cardiac complications have been linked with PXE, mainly based on case reports. It remains unclear, whether cardiac systolic or diastolic function impairment is a common complication of PXE. Methods: This study conducted systematic assessment of left ventricular systolic and diastolic function via standard echocardiography and two-dimensional strain imaging, in a large cohort of asymptomatic PXE patients (n = 75) and matched healthy controls (n = 30). Results: PXE and controls did not differ in terms of any of the diastolic parameters tested: E-wave (82617 cm/s vs. 82613 cm/s, p = 0.890), E deceleration time (191.7 +/- 55.6 ms vs. 190.0 +/- 35.9 ms, p = 0.879), and E/Em ratio (7.1 +/- 2.3 vs. 7.0 +/- 1.8, p = 0.829). In addition, no significant differences were observed between PXE and control in terms of left ventricular volumes and ejection fraction, as well as global, basal, mid, and apex longitudinal strains. Conclusions: These findings revealed that preclinical cardiac dysfunction is uncommon in a large population of asymptomatic PXE patients.	[Biere, Loic; Terrien, Gwenola; Furber, Alain; Martin, Ludovic; Prunier, Fabrice] LUNAM Univ, Angers, France; [Biere, Loic; Terrien, Gwenola; Furber, Alain; Prunier, Fabrice] Univ Angers, CHU Angers, Lab Cardioprotect Remodelage & Thrombose, Serv Cardiol, Angers, France; [Donal, Erwan] CHU Rennes, Serv Cardiol, Rennes, France; [Donal, Erwan] CIC IT 804, Rennes, France; [Donal, Erwan] INSERM, Lab Traitement Signal & Image, U1099, Rennes, France; [Furber, Alain; Martin, Ludovic; Prunier, Fabrice] CHU Angers, Ctr Consultat PXE, Angers, France; [Martin, Ludovic] Univ Angers, CNRS 6214, UMR INSERM 1083, Angers, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Prunier, F (corresponding author), LUNAM Univ, Angers, France.	FaPrunier@chu-angers.fr	Prunier, Fabrice/A-5210-2011; Martin, Ludovic/K-2674-2015; donal, erwan/ABC-9736-2020		PXE France; CHU d'Angers	PXE France; CHU d'Angers	This work received financial grant support from PXE France and CHU d'Angers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campens L, 2013, ARTERIOSCLER THROMB, V33; De Sutter J, 2005, AM J CARDIOL, V95, P1020, DOI 10.1016/j.amjcard.2005.01.021; KLEIN AL, 1994, MAYO CLIN PROC, V69, P212, DOI 10.1016/S0025-6196(12)61059-3; Kuznetsova T, 2009, CIRC-HEART FAIL, V2, P105, DOI 10.1161/CIRCHEARTFAILURE.108.822627; Lafitte S, 2009, EUR J ECHOCARDIOGR, V10, P414, DOI 10.1093/ejechocard/jen299; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEBWOHL M, 1994, J AM ACAD DERMATOL, V30, P103, DOI 10.1016/S0190-9622(08)81894-4; Leftheriotis Georges, 2013, Frontiers in Genetics, V4, P4, DOI 10.3389/fgene.2013.00004; Leftheriotis G, 2011, J VASC SURG, V54, P1390, DOI 10.1016/j.jvs.2011.04.041; Leitman M, 2004, J AM SOC ECHOCARDIOG, V17, P1021, DOI 10.1016/j.echo.2004.06.019; Miki K, 2007, MED MOL MORPHOL, V40, P172, DOI 10.1007/s00795-007-0368-5; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; NAVARROLOPEZ F, 1980, CHEST, V78, P113, DOI 10.1378/chest.78.1.113; Neldner K H, 1988, Clin Dermatol, V6, P1; Nguyen LD, 2006, AM J CARDIOL, V97, P1535, DOI 10.1016/j.amjcard.2005.11.091; Prunier F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068700; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Vanakker Olivier M, 2008, Hum Mutat, V29, P205, DOI 10.1002/humu.9514	18	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90364	10.1371/journal.pone.0090364	http://dx.doi.org/10.1371/journal.pone.0090364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651258	Green Published, gold			2022-12-27	WOS:000333352800017
J	Buti, E; Mesquita, D; Araujo, SJ				Buti, Elisenda; Mesquita, Duarte; Araujo, Sofia J.			Hedgehog Is a Positive Regulator of FGF Signalling during Embryonic Tracheal Cell Migration	PLOS ONE			English	Article							SONIC HEDGEHOG; FEEDBACK LOOP; BRANCHING MORPHOGENESIS; TRANSCRIPTION FACTORS; DROSOPHILA SEGMENT; GENE-EXPRESSION; GROWTH; EGR; BRANCHLESS; HOMOLOG	Cell migration is a widespread and complex process that is crucial for morphogenesis and for the underlying invasion and metastasis of human cancers. During migration, cells are steered toward target sites by guidance molecules that induce cell direction and movement through complex intracellular mechanisms. The spatio-temporal regulation of the expression of these guidance molecules is of extreme importance for both normal morphogenesis and human disease. One way to achieve this precise regulation is by combinatorial inputs of different transcription factors. Here we used Drosophila melanogaster mutants with migration defects in the ganglionic branches of the tracheal system to further clarify guidance regulation during cell migration. By studying the cellular consequences of overactivated Hh signalling, using ptc mutants, we found that Hh positively regulates Bnl/FGF levels during embryonic stages. Our results show that Hh modulates cell migration non-autonomously in the tissues surrounding the action of its activity. We further demonstrate that the Hh signalling pathway regulates bnl expression via Stripe (Sr), a zinc-finger transcription factor with homology to the Early Growth Response (EGR) family of vertebrate transcription factors. We propose that Hh modulates embryonic cell migration by participating in the spatio-temporal regulation of bnl expression in a permissive mode. By doing so, we provide a molecular link between the activation of Hh signalling and increased chemotactic responses during cell migration.	[Buti, Elisenda; Mesquita, Duarte; Araujo, Sofia J.] CSIC, IBMB, Inst Mol Biol Barcelona, Dept Dev Biol, Barcelona, Spain; [Buti, Elisenda; Mesquita, Duarte; Araujo, Sofia J.] Inst Res Biomed IRB Barcelona, Cell & Dev Biol Programme, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Araujo, SJ (corresponding author), CSIC, IBMB, Inst Mol Biol Barcelona, Dept Dev Biol, Barcelona, Spain.	sarbmc@ibmb.csic.es	Araújo, Sofia J/J-5681-2014	Araújo, Sofia J/0000-0002-4749-8913	Spanish Ministerio de Ciencia y Innovacion [RYC-2007-00417, BFU-2006-01935, BFU-2009-07629]; FPI fellowship; Leonardo da Vinci fellowship; Spanish Ministerio de Ciencia y Innovacion	Spanish Ministerio de Ciencia y Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FPI fellowship(Spanish Government); Leonardo da Vinci fellowship; Spanish Ministerio de Ciencia y Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by the Spanish Ministerio de Ciencia y Innovacion (RYC-2007-00417, BFU-2006-01935, BFU-2009-07629). E. B. was supported by a FPI fellowship and D. M. by a Leonardo da Vinci fellowship. S.J.A. holds a Ramon y Cajal Researcher position granted by the Spanish Ministerio de Ciencia y Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFOLTER M, 1994, DEVELOPMENT, V120, P3105; AFFOLTER M, 1994, DEVELOPMENT, V120, P743; Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Araujo SJ, 2011, J CELL SCI; Araujo SJ, 2007, DEVELOPMENT, V134, P3665, DOI 10.1242/dev.007328; Aza-Blanc P, 1999, TRENDS GENET, V15, P458, DOI 10.1016/S0168-9525(99)01869-7; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Barrett AL, 2008, DEV BIOL, V317, P234, DOI 10.1016/j.ydbio.2008.02.025; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Biehs B, 2010, DEVELOPMENT, V137, P3887, DOI 10.1242/dev.055871; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; BRAND AH, 1993, DEVELOPMENT, V118, P401; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Campos-Ortega AJ, 1985, EMBRYONIC DEV DROSOP, P10; Casali A, 2004, NATURE, V431, P76, DOI 10.1038/nature02835; Caussinus E, 2008, CURR BIOL, V18, P1727, DOI 10.1016/j.cub.2008.10.062; Chen CK, 1998, DEVELOPMENT, V125, P4959; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Choy SW, 2012, VITAM HORM, V88, P1, DOI 10.1016/B978-0-12-394622-5.00001-8; Christiansen AE, 2013, CELL DEATH DIFFER, V20, P302, DOI 10.1038/cdd.2012.126; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Dorfman R, 2002, DEV BIOL, V252, P119, DOI 10.1006/dbio.2002.0836; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Englund C, 1999, DEVELOPMENT, V126, P1505; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Frommer G, 1996, EMBO J, V15, P1642, DOI 10.1002/j.1460-2075.1996.tb00509.x; Geisbrecht ER, 2013, DEV DYN; Gervais L, 2011, DEVELOPMENT, V138, P1269, DOI 10.1242/dev.059188; Ghabrial AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002087; Glazer L, 2001, DEVELOPMENT, V128, P1599; Guillemin K, 1996, DEVELOPMENT, V122, P1353; HIDALGO A, 1990, DEVELOPMENT, V110, P291; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; Imam F, 1999, GENETICS; Ingham PW, 2011, NATURE REV GENETICS; Kato K, 2004, DEVELOPMENT, V131, P5253, DOI 10.1242/dev.01404; Khaliullina H, 2009, DEVELOPMENT; Klambt C, 1992, GENES DEV; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; LEE JC, 1995, P NATL ACAD SCI USA, V92, P10344, DOI 10.1073/pnas.92.22.10344; Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912; Lin CW, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003423; Merabet S, 2005, EMBO REP, V6, P762, DOI 10.1038/sj.embor.7400462; Miyake A, 2005, DEV BIOL, V288, P259, DOI 10.1016/j.ydbio.2005.09.042; Nussbaumer U, 2000, MECH DEVELOP, V96, P27, DOI 10.1016/S0925-4773(00)00373-7; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Piepenburg O, 2000, MOL CELL, V6, P203, DOI 10.1016/S1097-2765(00)00022-8; Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; SUKHATME VP, 1990, J AM SOC NEPHROL, V1, P859; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; Vincent S, 1997, DEVELOPMENT, V124, P2741; Vorbruggen G, 1997, P NATL ACAD SCI USA, V94, P8606, DOI 10.1073/pnas.94.16.8606; Zhan YY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014134; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	66	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92682	10.1371/journal.pone.0092682	http://dx.doi.org/10.1371/journal.pone.0092682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651658	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800142
J	Cardoso, JCR; Felix, RC; Power, DM				Cardoso, Joao C. R.; Felix, Rute C.; Power, Deborah M.			Nematode and Arthropod Genomes Provide New Insights into the Evolution of Class 2 B1 GPCRs	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CYCLASE-ACTIVATING POLYPEPTIDE; HORMONE-RELEASING-HORMONE; PARATHYROID-HORMONE; FUNCTIONAL-CHARACTERIZATION; CAENORHABDITIS-ELEGANS; PHYLOGENETIC ANALYSIS; DIURETIC HORMONES; SECRETIN RECEPTOR; FAMILY	Nematodes and arthropods are the most speciose animal groups and possess Class 2 B1 G-protein coupled receptors (GPCRs). Existing models of invertebrate Class 2 B1 GPCR evolution are mainly centered on Caenorhabditis elegans and Drosophila melanogaster and a few other nematode and arthropod representatives. The present study reevaluates the evolution of metazoan Class 2 B1 GPCRs and orthologues by exploring the receptors in several nematode and arthropod genomes and comparing them to the human receptors. Three novel receptor phylogenetic clusters were identified and designated cluster A, cluster B and PDF-R-related cluster. Clusters A and B were identified in several nematode and arthropod genomes but were absent from D. melanogaster and Culicidae genomes, whereas the majority of the members of the PDF-R-related cluster were from nematodes. Cluster A receptors were nematode and arthropod-specific but shared a conserved gene environment with human receptor loci. Cluster B members were orthologous to human GCGR, PTHR and Secretin members with which they probably shared a common origin. PDF-R and PDF-R related clusters were present in representatives of both nematodes and arthropods. The results of comparative analysis of GPCR evolution and diversity in protostomes confirm previous notions that C. elegans and D. melanogaster genomes are not good representatives of nematode and arthropod phyla. We hypothesize that at least four ancestral Class 2 B1 genes emerged early in the metazoan radiation, which after the protostome-deuterostome split underwent distinct selective pressures that resulted in duplication and deletion events that originated the current Class 2 B1 GPCRs in nematode and arthropod genomes.	[Cardoso, Joao C. R.; Felix, Rute C.; Power, Deborah M.] Ctr Marine Sci, Faro, Portugal		Cardoso, JCR (corresponding author), Ctr Marine Sci, Faro, Portugal.	jccardo@ualg.pt	Félix, Rute/AAC-2912-2020; Power, Deborah M/D-3333-2011; Félix, Rute C/M-6164-2013; dos Reis Cardoso, Joao Carlos/M-4151-2013	Félix, Rute/0000-0002-4144-3452; Power, Deborah M/0000-0003-1366-0246; Félix, Rute C/0000-0002-4144-3452; dos Reis Cardoso, Joao Carlos/0000-0001-7890-0170	Portuguese Foundation for Science and Technology (FCT) [PTDC/BIA-BCM/114395/2009]; European Regional Development Fund through COMPETE; FCT [PEst-C/MAR/LA0015/2011, SFRH/BPD/89811/2012]; auxiliary research contract FCT Pluriannual funds	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Regional Development Fund through COMPETE; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); auxiliary research contract FCT Pluriannual funds	This work was supported by the Portuguese Foundation for Science and Technology (FCT) project PTDC/BIA-BCM/114395/2009, by the European Regional Development Fund through COMPETE and FCT under the project "PEst-C/MAR/LA0015/2011." RCF is in receipt of an FCT grant (SFRH/BPD/89811/2012) and JCRC is supported by auxiliary research contract FCT Pluriannual funds attributed to CCMAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti G, 2006, J BIOL CHEM, V281, P24193, DOI 10.1074/jbc.M603528200; Asmann YW, 2000, MOL PHARMACOL, V58, P911, DOI 10.1124/mol.58.5.911; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P325; Cabrero P, 2002, J EXP BIOL, V205, P3799; Cardoso JCR, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-108; Cardoso Joao C R, 2012, Front Endocrinol (Lausanne), V3, P157, DOI 10.3389/fendo.2012.00157; Cardoso JCR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-135; Coast GM, 2002, ADV INSECT PHYSIOL, V29, P279, DOI 10.1016/S0065-2806(02)29004-9; Coghlan Avril, 2005, P1; Couvineau A, 2012, CURR DRUG TARGETS, V13, P103, DOI 10.2174/138945012798868434; DeAlmeida VI, 1998, MOL ENDOCRINOL, V12, P750, DOI 10.1210/me.12.5.750; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Dobolyi Arpad, 2012, Front Endocrinol (Lausanne), V3, P121, DOI 10.3389/fendo.2012.00121; Dong MQ, 2002, RECEPTOR CHANNEL, V8, P189, DOI 10.1080/10606820213686; Donnelly D, 1997, FEBS LETT, V409, P431, DOI 10.1016/S0014-5793(97)00546-2; Drozdowski L, 2009, WORLD J GASTROENTERO, V15, P385, DOI 10.3748/wjg.15.385; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Frooninckx Lotte, 2012, Front Endocrinol (Lausanne), V3, P167, DOI 10.3389/fendo.2012.00167; Furuya K, 2000, P NATL ACAD SCI USA, V97, P6469, DOI 10.1073/pnas.97.12.6469; Gensure RC, 2005, BIOCHEM BIOPH RES CO, V328, P666, DOI 10.1016/j.bbrc.2004.11.069; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Harmar AJ, 2001, GENOME BIOL, V2; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hector CE, 2009, J EXP BIOL, V212, P3142, DOI 10.1242/jeb.033175; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hwang JI, 2013, MOL BIOL EVOL; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; Janssen Donny, 2013, Front Endocrinol (Lausanne), V4, P28, DOI 10.3389/fendo.2013.00028; Janssen T, 2008, J BIOL CHEM, V283, P15241, DOI 10.1074/jbc.M709060200; Jee C, 2013, GENES BRAIN BEHAV, V12, P250, DOI 10.1111/j.1601-183X.2012.00829.x; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; Johnson EC, 2004, J EXP BIOL, V207, P743, DOI 10.1242/jeb.00818; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Kokkoris Stelios, 2012, Front Endocrinol (Lausanne), V3, P135, DOI 10.3389/fendo.2012.00135; Korner Meike, 2012, Front Endocrinol (Lausanne), V3, P158, DOI 10.3389/fendo.2012.00158; Laburthe M, 1996, ANN NY ACAD SCI, V805, P94; Laburthe M, 2002, RECEPTOR CHANNEL, V8, P137, DOI 10.1080/10606820290005191; Laburthe M, 2007, PEPTIDES, V28, P1631, DOI 10.1016/j.peptides.2007.04.026; Lam IPY, 2008, INT REV CYTOL, V265, P159, DOI 10.1016/S0074-7696(07)65004-9; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Li CJ, 2013, GENE, V519, P1, DOI 10.1016/j.gene.2013.01.061; Li YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028269; Meelkop E, 2011, PROG NEUROBIOL, V93, P125, DOI 10.1016/j.pneurobio.2010.10.004; Meelkop E, 2012, MOL CELL ENDOCRINOL, V361, P232, DOI 10.1016/j.mce.2012.05.001; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Mertens I, 2007, PEPTIDES, V28, P1775, DOI 10.1016/j.peptides.2007.05.005; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Naot D, 2008, BONE, V43, P813, DOI 10.1016/j.bone.2008.07.003; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nery LEM, 1997, COMP BIOCHEM PHYS A, V118, P1135, DOI 10.1016/S0300-9629(97)00045-5; Ng SYL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044691; Nordstrom KJV, 2009, MOL BIOL EVOL, V26, P71, DOI 10.1093/molbev/msn228; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Pinheiro PLC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-110; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rota-Stabelli O, 2013, CURR BIOL, V23, P392, DOI 10.1016/j.cub.2013.01.026; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savard J, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-7; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Skaer NJV, 2002, J EXP BIOL, V205, P1869; Sommer RJ, 2011, ANNU REV GENET, V45, P1, DOI 10.1146/annurev-genet-110410-132417; Taghert PH, 2003, ADV GENET, V49, P1, DOI 10.1016/S0065-2660(03)01001-0; Talsma AD, 2012, P NATL ACAD SCI USA, V109, P12177, DOI 10.1073/pnas.1200247109; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Witherspoon DJ, 2003, J MOL EVOL, V56, P751, DOI 10.1007/s00239-002-2450-x; Wyder S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r242; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zamanian M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-596; Zandawala M, 2012, INSECT BIOCHEM MOLEC, V42, P816, DOI 10.1016/j.ibmb.2012.06.006	86	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92220	10.1371/journal.pone.0092220	http://dx.doi.org/10.1371/journal.pone.0092220			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651821	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800086
J	Charney, ND; Castorino, JJ; Dobro, MJ; Steely, SL				Charney, Noah D.; Castorino, John J.; Dobro, Megan J.; Steely, Sarah L.			Embryo Development inside Female Salamander (Ambystoma jeffersonianum-laterale) Prior to Egg Laying	PLOS ONE			English	Article							SPERM STORAGE; UNISEXUAL SALAMANDERS; RETENTION; EVOLUTION; AMPHIBIANS; PEDOMORPHOSIS; PLASTICITY; VIVIPARITY; ADVANTAGE	The length of embryo retention prior to oviposition is a critical evolutionary trait. In all oviparous salamanders, which include the vast majority of species in the order, fertilization is thought to occur at the time of egg laying. Embryos then enter the first cleavage stage several hours after being deposited. This pattern holds for previously studied individuals in the Ambystoma jeffersonianum-laterale complex. Here, we document an instance in which a female Ambystoma jeffersonianum-laterale was carrying embryos internally that had already reached stage 10 of development. Development likely began several days prior to the start of migration to the breeding pond. This is the first such record for any egg-laying salamander, and suggests a degree of plasticity in the timing of fertilization and development not previously recognized. Further work is needed to ascertain the prevalence, mechanics, and evolutionary significance of this phenomenon.	[Charney, Noah D.; Castorino, John J.; Dobro, Megan J.; Steely, Sarah L.] Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA		Charney, ND (corresponding author), Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA.	noah@alumni.amherst.edu		Dobro, Megan/0000-0002-6464-3932				Andrews RM, 1997, J ZOOL, V243, P579, DOI 10.1111/j.1469-7998.1997.tb02803.x; Bogart JP, 2007, GENOME, V50, P119, DOI 10.1139/G06-152; Boisseau C, 1975, P94; Briegleb W., 1962, Zeitschrift fuer Morphologie und Oekologie der Tiere, V51, P271, DOI 10.1007/BF00407657; Bruce RC, 2003, REPROD BIOL PHYLOGEN, V1; Buckley D, 2007, EVOL DEV, V9, P105, DOI 10.1111/j.1525-142X.2006.00141.x; Buskirk JV, 2009, ECOL MONOGR, V79, P681; Charney ND, 2013, J HERPETOLO IN PRESS; Charney ND, 2012, EVOLUTION, V66, P1387, DOI 10.1111/j.1558-5646.2011.01523.x; Clarke SF, 1879, DEV AMBLYSTOMA PUNCT, V1, P105; Denoel M, 2005, BIOL REV, V80, P663, DOI 10.1017/S1464793105006858; Duellman W. E., 1986, BIOL AMPHIBIANS; Exbrayat J. M., 2006, REPROD BIOL PHYLOGEN, V5; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Greven H., 2003, REPROD BIOL PHYLOGEN, V1; Harrison R.G, 1969, ORG DEV EMBRYO, V1, P44; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Kupfer A, 2006, ZOOL ANZ, V244, P223, DOI 10.1016/j.jcz.2005.12.001; Larson A, 2003, REPROD BIOL PHYLOGEN, V1; Laurin M, 1999, ANN SCI NAT ZOOL, V20, P99, DOI 10.1016/S0003-4339(00)86974-9; NEWMAN RA, 1992, BIOSCIENCE, V42, P671, DOI 10.2307/1312173; Petranka J.W, 1998, SALAMANDERS US CANAD; POLLACK HN, 1993, GLOBAL PLANET CHANGE, V7, P173, DOI 10.1016/0921-8181(93)90048-S; SCHRECKENBERG GM, 1975, DEV BIOL, V42, P391, DOI 10.1016/0012-1606(75)90343-7; SEVER DM, 1995, J MORPHOL, V223, P35, DOI 10.1002/jmor.1052230106; Sever DM, 1998, J EXP ZOOL, V282, P460, DOI 10.1002/(SICI)1097-010X(199811/12)282:4/5<460::AID-JEZ5>3.0.CO;2-O; Sever DM, 2003, REPROD BIOL PHYLOGEN, V2; Tennessen JA, 2003, MOL ECOL, V12, P1567, DOI 10.1046/j.1365-294X.2003.01830.x; TOMPA AS, 1979, J MOLLUS STUD, V45, P155, DOI 10.1093/oxfordjournals.mollus.a065489; Wake MH, 1998, J EXP ZOOL, V282, P477; WAKE MH, 1993, J EXP ZOOL, V266, P394, DOI 10.1002/jez.1402660507; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P111, DOI 10.1093/icb/icr046; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037	33	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91919	10.1371/journal.pone.0091919	http://dx.doi.org/10.1371/journal.pone.0091919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651275	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800054
J	Fulcher, BD; Phillips, AJK; Postnova, S; Robinson, PA				Fulcher, Ben D.; Phillips, Andrew J. K.; Postnova, Svetlana; Robinson, Peter A.			A Physiologically Based Model of Orexinergic Stabilization of Sleep and Wake	PLOS ONE			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; COERULEUS-NORADRENERGIC SYSTEM; VENTROLATERAL PREOPTIC NUCLEUS; ASCENDING AROUSAL SYSTEM; CIRCADIAN-RHYTHMS; QUANTITATIVE MODEL; ACTIVE NEURONS; HYPOCRETIN/OREXIN NEURONS; NARCOLEPSY-CATAPLEXY; MATHEMATICAL-MODEL	The orexinergic neurons of the lateral hypothalamus (Orx) are essential for regulating sleep-wake dynamics, and their loss causes narcolepsy, a disorder characterized by severe instability of sleep and wake states. However, the mechanisms through which Orx stabilize sleep and wake are not well understood. In this work, an explanation of the stabilizing effects of Orx is presented using a quantitative model of important physiological connections between Orx and the sleep-wake switch. In addition to Orx and the sleep-wake switch, which is composed of mutually inhibitory wake-active monoaminergic neurons in brainstem and hypothalamus (MA) and the sleep-active ventrolateral preoptic neurons of the hypothalamus (VLPO), the model also includes the circadian and homeostatic sleep drives. It is shown that Orx stabilizes prolonged waking episodes via its excitatory input to MA and by relaying a circadian input to MA, thus sustaining MA firing activity during the circadian day. During sleep, both Orx and MA are inhibited by the VLPO, and the subsequent reduction in Orx input to the MA indirectly stabilizes sustained sleep episodes. Simulating a loss of Orx, the model produces dynamics resembling narcolepsy, including frequent transitions between states, reduced waking arousal levels, and a normal daily amount of total sleep. The model predicts a change in sleep timing with differences in orexin levels, with higher orexin levels delaying the normal sleep episode, suggesting that individual differences in Orx signaling may contribute to chronotype. Dynamics resembling sleep inertia also emerge from the model as a gradual sleep-to-wake transition on a timescale that varies with that of Orx dynamics. The quantitative, physiologically based model developed in this work thus provides a new explanation of how Orx stabilizes prolonged episodes of sleep and wake, and makes a range of experimentally testable predictions, including a role for Orx in chronotype and sleep inertia.	[Fulcher, Ben D.; Postnova, Svetlana; Robinson, Peter A.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Phillips, Andrew J. K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Sleep Med, Boston, MA 02115 USA; [Postnova, Svetlana; Robinson, Peter A.] Univ Sydney, Ctr Integrated Res & Understanding Sleep, Sydney, NSW 2006, Australia; [Postnova, Svetlana; Robinson, Peter A.] Univ Sydney, Brain Dynam Ctr, Sydney, NSW 2006, Australia; [Robinson, Peter A.] Univ Sydney, Cooperat Res Ctr Alertness Safety & Prod, Sydney, NSW 2006, Australia	University of Sydney; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Sydney; University of Sydney; University of Sydney	Fulcher, BD (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	ben.d.fulcher@gmail.com	Fulcher, Ben/H-8733-2019	Fulcher, Ben/0000-0002-3003-4055; Robinson, Peter/0000-0002-5050-9804; Postnova, Svetlana/0000-0002-1224-0779; Phillips, Andrew/0000-0003-1156-7056	Australian Research Council; National Health and Medical Research Council, Westmead Millennium Institute; National Space Biomedical Research Institute through NASA NCC [9-58]	Australian Research Council(Australian Research Council); National Health and Medical Research Council, Westmead Millennium Institute; National Space Biomedical Research Institute through NASA NCC	This work was supported by the Australian Research Council, the National Health and Medical Research Council, Westmead Millennium Institute, and the National Space Biomedical Research Institute through NASA NCC 9-58. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1995, ARCH ITAL BIOL, V134, P109; ACHERMANN P, 1994, BIOL CYBERN, V71, P115, DOI 10.1007/BF00197314; Akerstedt T, 2002, SLEEP MED REV, V6, P267, DOI 10.1053/smrv.2001.0202; Alexandre C, 2013, CURR OPIN NEUROBIOL, V23, P752, DOI 10.1016/j.conb.2013.04.008; Anaclet C, 2012, J NEUROSCI, V32, P17970, DOI 10.1523/JNEUROSCI.0620-12.2012; Andlauer O, 2012, SLEEP, V35, P1247, DOI 10.5665/sleep.2080; Aran A, 2010, SLEEP, V33, P1457, DOI 10.1093/sleep/33.11.1457; ASTONJONES G, 1991, PROG BRAIN RES, V88, P501; Behn CGD, 2008, J NEUROPHYSIOL, V99, P3090, DOI 10.1152/jn.01243.2007; Behn CGD, 2007, J NEUROPHYSIOL, V97, P3828, DOI 10.1152/jn.01184.2006; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; BROUGHTON R, 1986, SLEEP, V9, P205, DOI 10.1093/sleep/9.1.205; Burgess CR, 2012, J NEUROSCI, V32, P12305, DOI 10.1523/JNEUROSCI.2630-12.2012; Carrier J, 1997, J SLEEP RES, V6, P230, DOI 10.1111/j.1365-2869.1997.00230.x; Carter ME, 2012, P NATL ACAD SCI USA, V109, pE2635, DOI 10.1073/pnas.1202526109; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chou TC, 2003, J NEUROSCI, V23, P10691; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; DANTZ B, 1994, ELECTROEN CLIN NEURO, V90, P24, DOI 10.1016/0013-4694(94)90110-4; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dworak M, 2007, NEUROSCIENCE, V150, P789, DOI 10.1016/j.neuroscience.2007.09.062; Eriksson KS, 2001, J NEUROSCI, V21, P9273, DOI 10.1523/JNEUROSCI.21-23-09273.2001; Freeman WJ, 1975, MASS ACTION NERVOUS; Fulcher BD, 2010, J THEOR BIOL, V264, P407, DOI 10.1016/j.jtbi.2010.02.028; Fulcher BD, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051920; Gallopin T, 2004, SLEEP, V27, P19; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Grivel J, 2005, J NEUROSCI, V25, P4127, DOI 10.1523/JNEUROSCI.0666-05.2005; Gundel A., 2007, SOMNOLOGIE SCHLAFFOR, V11, P148, DOI [10.1007/s11818-007-0312-x, DOI 10.1007/S11818-007-0312-X]; Horvath TL, 1999, J COMP NEUROL, V415, P145; Hungs M, 2001, BIOESSAYS, V23, P397, DOI 10.1002/bies.1058; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; Jewett ME, 1999, SLEEP, V22, P171, DOI 10.1093/sleep/22.2.171; John J, 2004, NEURON, V42, P619, DOI 10.1016/S0896-6273(04)00247-8; JONES BE, 2000, PRINCIPLES PRACTICE, P134; KAITIN KI, 1986, SLEEP, V9, P116, DOI 10.1093/sleep/9.1.116; Kantor S, 2009, SLEEP, V32, P1127, DOI 10.1093/sleep/32.9.1127; Kessler BA, 2011, NEUROSCIENCE, V178, P82, DOI 10.1016/j.neuroscience.2011.01.031; Kloeden PE, 2010, NUMERICAL SOLUTION S, V23; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Kukkonen JP, 2002, AM J PHYSIOL-CELL PH, V283, pC1567, DOI 10.1152/ajpcell.00055.2002; Kumar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042059; Lazarus M, 2013, CURR OPIN NEUROBIOL, V23, P780, DOI 10.1016/j.conb.2013.02.001; Liu RJ, 2002, J NEUROSCI, V22, P9453; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; Mallis MM, 2004, AVIAT SPACE ENVIR MD, V75, pA4; Mieda M, 2004, J NEUROSCI, V24, P10493, DOI 10.1523/JNEUROSCI.3171-04.2004; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; Morairty S, 2004, NEUROSCIENCE, V123, P451, DOI 10.1016/j.neuroscience.2003.08.066; Nobili L, 1996, NEUROPHYSIOL CLIN, V26, P51, DOI 10.1016/0987-7053(96)81534-6; Ohno K, 2008, FRONT NEUROENDOCRIN, V29, P70, DOI 10.1016/j.yfrne.2007.08.001; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Phillips AJK, 2007, J BIOL RHYTHM, V22, P167, DOI 10.1177/0748730406297512; Phillips AJK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003213; Phillips AJK, 2013, J THEOR BIOL, V319, P75, DOI 10.1016/j.jtbi.2012.11.029; Phillips AJK, 2010, J BIOL RHYTHM, V25, P217, DOI 10.1177/0748730410369208; Phillips AJK, 2008, J THEOR BIOL, V255, P413, DOI 10.1016/j.jtbi.2008.08.022; Phillips AJK, 2011, J BIOL RHYTHM, V26, P441, DOI 10.1177/0748730411414163; Phillips AJK, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000826; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Postnova S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053379; Postnova S, 2009, J BIOL RHYTHM, V24, P523, DOI 10.1177/0748730409346655; Puckeridge M, 2011, J THEOR BIOL, V273, P44, DOI 10.1016/j.jtbi.2010.12.018; Rempe MJ, 2010, J MATH BIOL, V60, P615, DOI 10.1007/s00285-009-0276-5; Robinson PA, 1997, PHYS REV E, V56, P826, DOI 10.1103/PhysRevE.56.826; Robinson PA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041924; Sakurai T, 2005, NEURON, V46, P297, DOI 10.1016/j.neuron.2005.03.010; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Scammell TE, 2005, NAT NEUROSCI, V8, P1286, DOI 10.1038/nn1005-1286; Scammell TE, 2003, ANN NEUROL, V53, P154, DOI 10.1002/ana.10444; Selbach O, 2006, CHRONOBIOL INT, V23, P63, DOI 10.1080/07420520500545961; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Silber MH, 2002, SLEEP, V25, P197, DOI 10.1093/sleep/25.2.197; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Sun H, 2013, SLEEP, V36, P259, DOI 10.5665/sleep.2386; Takahashi K, 2008, NEUROSCIENCE, V153, P860, DOI 10.1016/j.neuroscience.2008.02.058; Tamakawa Y, 2006, J NEUROPHYSIOL, V95, P2055, DOI 10.1152/jn.00575.2005; Tassi P, 2000, SLEEP MED REV, V4, P341, DOI 10.1053/smrv.2000.0098; Thakkar MM, 2008, NEUROSCIENCE, V153, P875, DOI 10.1016/j.neuroscience.2008.01.017; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thannickal TC, 2009, SLEEP, V32, P993, DOI 10.1093/sleep/32.8.993; WEBSTER RA, 2002, NEUROTRANSMITTERS DR; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859	97	29	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91982	10.1371/journal.pone.0091982	http://dx.doi.org/10.1371/journal.pone.0091982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651580	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800061
J	Liu, C; Li, XX; Gao, W; Liu, W; Liu, DS				Liu, Cui; Li, Xing-Xia; Gao, Wei; Liu, Wen; Liu, De-Shan			Progranulin-Derived Atsttrin Directly Binds to TNFRSF25 (DR3) and Inhibits TNF-Like Ligand 1A (TL1A) Activity	PLOS ONE			English	Article							NECROSIS-FACTOR TNF; T-CELL; GROWTH-FACTOR; DEATH RECEPTOR; FAMILY; SUPERFAMILY; MOUSE; THERAPIES; CYTOKINE; IMMUNITY	Atsttrin, a progranulin (PGRN)-derived molecule composed of three TNFR-binding domains of PGRN, binds to TNF receptors (TNFR) and is therapeutic against inflammatory arthritis. Here we screened the associations of Atsttrin and other members in TNFR subfamily, which led to the discovery of TNFRSF25 (DR3) as an additional Atsttrin-interacting member in TNFR family. Similar to TNFR1 and TNFR2, DR3 also directly bound to Atsttrin. The first three cysteine-rich domains (CRD) in the extracellular portion of DR3 were required for this interaction. Atsttrin inhibited the interaction between DR3 and its TNF-Like Ligand 1A (TL1A). In addition, Atsttrin inhibited TL1A-stimulated target gene expressions and neutralized TL1A-enhanced osteoclastogenesis in vitro. Furthermore, Atsttrin ameliorated the pathology in dextran sulfate sodium induced colitis. Taken together, these findings not only provide the new insights into Atsttrin's therapeutic action in inflammatory arthritis, but may also present Atsttrin as a novel biological agent for treating various types of diseases associated with TL1A/DR3 pathway.	[Liu, Cui; Li, Xing-Xia] Shandong Univ, Qilu Hosp, Dept Pediat Surg, Jinan 250100, Peoples R China; [Gao, Wei] Shandong Univ, Qilu Hosp, Dept Nursing, Jinan 250100, Peoples R China; [Liu, Wen] Taishan Med Univ, Dept Biotechnol, Tai An, Shandong, Peoples R China; [Liu, De-Shan] Shandong Univ, Dept Tradit Chinese Med, Qilu Hosp, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Liu, DS (corresponding author), Shandong Univ, Dept Tradit Chinese Med, Qilu Hosp, Jinan 250100, Peoples R China.	dsliu168@gmail.com			National Natural Science Foundation of China [81173250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 81173250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; Borysenko CW, 2005, BIOCHEM BIOPH RES CO, V328, P794, DOI 10.1016/j.bbrc.2005.01.017; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Buchan SL, 2012, EUR J IMMUNOL, V42, P580, DOI 10.1002/eji.201041950; Bull MJ, 2008, J EXP MED, V205, P2457, DOI 10.1084/jem.20072378; Cavallini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060136; Cha SS, 1999, IMMUNITY, V11, P253, DOI 10.1016/S1074-7613(00)80100-4; Chen X, 2013, J NEUROSCI, V33, P9202, DOI 10.1523/JNEUROSCI.5336-12.2013; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Croft M, 2012, TRENDS IMMUNOL, V33, P144, DOI 10.1016/j.it.2011.10.004; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Egashira Y, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-105; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Furst DE, 2010, CLIN EXP RHEUMATOL, V28, pS5; Guo ZL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/540794; Haritunians T, 2010, INFLAMM BOWEL DIS, V16, P1830, DOI 10.1002/ibd.21293; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; Hwang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076679; Jian JL, 2013, FEBS LETT, V587, P3428, DOI 10.1016/j.febslet.2013.09.024; Jian JL, 2013, J LEUKOCYTE BIOL, V93, P199, DOI 10.1189/jlb.0812429; Kawase R, 2013, CARDIOVASC RES, V100, P125, DOI 10.1093/cvr/cvt178; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kim S, 2005, J IMMUNOL METHODS, V298, P1, DOI 10.1016/j.jim.2004.12.019; Latiano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022688; Lee SE, 2010, DERMATOL SIN, V28, P1; Liu CJ, 2012, PHARMACOL THERAPEUT, V133, P124, DOI 10.1016/j.pharmthera.2011.10.003; Liu CJ, 2011, FEBS LETT, V585, P3675, DOI 10.1016/j.febslet.2011.04.065; Magis C, 2012, TRENDS BIOCHEM SCI, V37, P353, DOI 10.1016/j.tibs.2012.06.002; McLaren JE, 2010, J IMMUNOL, V184, P5827, DOI 10.4049/jimmunol.0903782; Meylan F, 2011, MUCOSAL IMMUNOL, V4, P172, DOI 10.1038/mi.2010.67; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Meylan F, 2011, IMMUNOL REV, V244, P188, DOI 10.1111/j.1600-065X.2011.01068.x; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Newman SJ, 2000, BRAIN RES, V857, P131, DOI 10.1016/S0006-8993(99)02417-8; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Prehn JL, 2007, J IMMUNOL, V178, P4033, DOI 10.4049/jimmunol.178.7.4033; Rasheed Z, 2008, CURR RHEUMATOL REV, V4, P246, DOI 10.2174/157339708786263915; Screaton GR, 1997, P NATL ACAD SCI USA, V94, P4615, DOI 10.1073/pnas.94.9.4615; Sfikakis PP, 2011, CLIN IMMUNOL, V141, P231, DOI 10.1016/j.clim.2011.09.005; Shih DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016090; Slebioda TJ, 2011, EUR J IMMUNOL, V41, P2606, DOI 10.1002/eji.201141477; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tan KB, 1997, GENE, V204, P35, DOI 10.1016/S0378-1119(97)00509-X; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Thurner L, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4406; Tremelling M, 2008, INFLAMM BOWEL DIS, V14, P733, DOI 10.1002/ibd.20399; Twohig JP, 2010, J NEUROSCI, V30, P3782, DOI 10.1523/JNEUROSCI.1928-09.2010; Vezina A, 2014, CANCER LETT, V345, P100, DOI 10.1016/j.canlet.2013.11.021; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645; Zhao YP, 2013, FEBS LETT, V587, P1805, DOI 10.1016/j.febslet.2013.04.037; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	54	46	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92743	10.1371/journal.pone.0092743	http://dx.doi.org/10.1371/journal.pone.0092743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651300	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800152
J	Mayneris-Perxachs, J; Sala-Vila, A; Chisaguano, M; Castellote, AI; Estruch, R; Covas, MI; Fito, M; Salas-Salvado, J; Martinez-Gonzalez, MA; Lamuela-Raventos, R; Ros, E; Lopez-Sabater, MC				Mayneris-Perxachs, Jordi; Sala-Vila, Aleix; Chisaguano, Maribel; Castellote, Ana I.; Estruch, Ramon; Isabel Covas, Maria; Fito, Montserrat; Salas-Salvado, Jordi; Martinez-Gonzalez, Miguel A.; Lamuela-Raventos, Rosa; Ros, Emilio; Carmen Lopez-Sabater, M.		PREDIMED Study Investigators	Effects of 1-Year Intervention with a Mediterranean Diet on Plasma Fatty Acid Composition and Metabolic Syndrome in a Population at High Cardiovascular Risk	PLOS ONE			English	Article							ESTIMATED DESATURASE ACTIVITIES; INSULIN SENSITIVITY; WEIGHT-LOSS; OBESITY; BLOOD; NUTS; MEN; PATTERNS; DISEASE; PROFILE	Background & Aims: Metabolic syndrome (MetS) has become an important public concern due to its increasing prevalence. An altered fatty acid composition has been associated with MetS, but the Mediterranean diet has been shown to have a protective effect. The aim of the present study was to analyze the influence of a Mediterranean dietary pattern, as assessed by the biomarkers of food supplied, on the plasma fatty acid composition and its relation with MetS after 1 year of intervention. Methods: A total of 424 subjects were randomly selected from the PREDIMED randomized dietary trial after completing a 1-year intervention program. Participants aged 55 to 80 years and at high risk of cardiovascular disease were randomly assigned to three dietary interventions: Mediterranean diet supplemented with virgin olive oil or nuts, or a low-fat diet. Results: After 1 year of intervention participants in the virgin olive oil group showed significantly increased plasma concentrations of palmitic and oleic acids, but reduced proportions of margaric, stearic, and linoleic acids. In turn, subjects in the nut group showed significantly increased levels of palmitic, linoleic, and a-linolenic acids, but reduced proportions of myristic, margaric, palmitoleic, and dihommo-c-linoleic acids. Increases in the biomarkers of foods supplied to the Mediterranean diet groups, i.e., oleic and a-linolenic acids, were beneficially associated with the incidence, reversion and prevalence of MetS. No weight changes were observed among participants. Conclusions: The nut and olive oil diets induced a fatty acid composition that has been shown to be beneficial in the face of MetS. Therefore, a Mediterranean diet rich in fats of vegetable origin may be a useful tool for the management of MetS without the need for concerns over weight gain due to its high fat content.	[Mayneris-Perxachs, Jordi; Chisaguano, Maribel; Castellote, Ana I.; Lamuela-Raventos, Rosa; Carmen Lopez-Sabater, M.] Univ Barcelona, Dept Nutr & Food Sci XARTA INSA, Fac Pharm, Barcelona, Spain; [Sala-Vila, Aleix; Ros, Emilio] Hosp Clin Barcelona, Biomed Res Inst August Pi & Sunyer IDIBAPS, Lipid Clin, Endocrinol & Nutr Serv, Barcelona, Spain; [Estruch, Ramon] Hosp Clin Barcelona, Dept Internal Med, Barcelona, Spain; [Isabel Covas, Maria; Fito, Montserrat] Municipal Inst Med Res, Cardiovasc Epidemiol Unit, Barcelona, Spain; [Salas-Salvado, Jordi] Univ Rovira & Virgili, Fac Med, IISPV, Human Nutr Unit, E-43201 Reus, Spain; [Martinez-Gonzalez, Miguel A.] Univ Navarra, Sch Med, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Sala-Vila, Aleix; Chisaguano, Maribel; Castellote, Ana I.; Estruch, Ramon; Isabel Covas, Maria; Fito, Montserrat; Salas-Salvado, Jordi; Martinez-Gonzalez, Miguel A.; Lamuela-Raventos, Rosa; Ros, Emilio; Carmen Lopez-Sabater, M.] Physiopathol Obes & Nutr CIBEROBN, Madrid, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Lopez-Sabater, MC (corresponding author), Univ Barcelona, Dept Nutr & Food Sci XARTA INSA, Fac Pharm, Barcelona, Spain.	mclopez@ub.edu	Algorta, Jaime/CAF-7793-2022; Casas, Rosa/ABD-1915-2020; Guasch-Ferre, Marta/H-6680-2019; Sanchez-Villegas, Almudena/T-6733-2019; Mayneris-Perxachs, Jordi/B-2589-2018; Salas-Salvado, Jordi/C-7229-2017; IBIS, ATENCION PRIMARIA/I-3524-2016; Estruch, Ramon/AAZ-3723-2020; Fito, Montserrat/C-1822-2012; Lapetra, Jose/F-2552-2015; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Mayneris-Perxachs, Jordi/AAG-7724-2020; ZAZPE, ITZIAR/B-1970-2017; Toledo, Estefania/H-6211-2014; Lamuela-Raventos, Rosa M/F-3986-2016	Algorta, Jaime/0000-0002-7042-5675; Casas, Rosa/0000-0002-0211-9166; Guasch-Ferre, Marta/0000-0001-8525-1404; Sanchez-Villegas, Almudena/0000-0001-7733-9238; Mayneris-Perxachs, Jordi/0000-0003-3788-3815; Salas-Salvado, Jordi/0000-0003-2700-7459; Fito, Montserrat/0000-0002-1817-483X; Mayneris-Perxachs, Jordi/0000-0003-3788-3815; Basora, Josep/0000-0003-0278-1149; Ros, Emilio/0000-0002-2573-1294; Diaz-Lopez, Andres/0000-0002-7500-5629; Fernandez-Ballart, Joan D./0000-0002-1320-6484; ZAZPE, ITZIAR/0000-0002-8787-2981; Toledo, Estefania/0000-0002-6263-4434; Lamuela-Raventos, Rosa M/0000-0002-1287-4560; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808	Ministerio de Ciencia e Innovacion [AGL2008-04124, AGL2009-09730]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This research was supported by national grants from the "Ministerio de Ciencia e Innovacion" (AGL2008-04124 and AGL2009-09730). CIBEROBN, CIBERESP and RETIC Alimentacion Saludable are initiative from the ISCIII, Government of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete I, 2010, NUTR REV, V68, P214, DOI 10.1111/j.1753-4887.2010.00280.x; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Baxter AJ, 2006, ASIA PAC J CLIN NUTR, V15, P134; Bondia-Pons I, 2007, EUR J CLIN NUTR, V61, P1345, DOI 10.1038/sj.ejcn.1602662; Bondia-Pons I, 2004, J CHROMATOGR B, V809, P339, DOI 10.1016/j.jchromb.2004.07.002; Brynes AE, 2000, AM J CLIN NUTR, V72, P1111; Buckland G, 2008, OBES REV, V9, P582, DOI 10.1111/j.1467-789X.2008.00503.x; Cicerale S, 2009, CRIT REV FOOD SCI, V49, P218, DOI 10.1080/10408390701856223; Colette C, 2003, INT J OBESITY, V27, P648, DOI 10.1038/sj.ijo.0802299; Corpeleijn E, 2006, DIABETOLOGIA, V49, P2392, DOI 10.1007/s00125-006-0383-4; Desroches S, 2007, APPL PHYSIOL NUTR ME, V32, P23, DOI [10.1139/H06-095, 10.1139/h06-095]; Erkkila A, 2008, PROG LIPID RES, V47, P172, DOI 10.1016/j.plipres.2008.01.004; Esposito K, 2010, METAB SYNDR RELAT D, V8, P197, DOI 10.1089/met.2009.0095; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Jones PJH, 2008, METABOLISM, V57, P1198, DOI 10.1016/j.metabol.2008.04.012; Lopez-Miranda J, 2010, NUTR METAB CARDIOVAS, V20, P284, DOI 10.1016/j.numecd.2009.12.007; Martinez-Gonzalez M.A., 2010, INT J EPIDEMIOL, V41, P377, DOI DOI 10.1093/ije/dyq250; Mattes RD, 2010, ASIA PAC J CLIN NUTR, V19, P137; Perez-Lopez FR, 2009, MATURITAS, V64, P67, DOI 10.1016/j.maturitas.2009.07.013; Raatz SK, 2001, J NUTR, V131, P231; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Richard C, 2011, NUTR METAB CARDIOVAS, V21, P628, DOI 10.1016/j.numecd.2010.01.012; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Sabate J, 2010, ASIA PAC J CLIN NUTR, V19, P131; Sabate J, 2009, AM J CLIN NUTR, V89, pS1643, DOI 10.3945/ajcn.2009.26736Q; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Simonsen NR, 1998, AM J CLIN NUTR, V68, P134, DOI 10.1093/ajcn/68.1.134; Vessby B, 2002, ANN NY ACAD SCI, V967, P183; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Warensjo E, 2008, NUTR METAB CARDIOVAS, V18, P683, DOI 10.1016/j.numecd.2007.11.002; Warensjo E, 2006, AM J CLIN NUTR, V84, P442	37	48	50	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e85202	10.1371/journal.pone.0085202	http://dx.doi.org/10.1371/journal.pone.0085202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651160	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800002
J	Qi, Y; Duhachek-Muggy, S; Li, H; Zolkiewska, A				Qi, Yue; Duhachek-Muggy, Sara; Li, Hui; Zolkiewska, Anna			Phenotypic Diversity of Breast Cancer-Related Mutations in Metalloproteinase-Disintegrin ADAM12	PLOS ONE			English	Article							I-TASSER; HB-EGF; CARCINOMAS; EXPRESSION; INCREASES; MIGRATION; SERVER; NOTCH	Six different somatic missense mutations in the human ADAM12 gene have been identified so far in breast cancer. Five of these mutations involve highly conserved residues in the extracellular domain of the transmembrane ADAM12-L protein. Two of these extracellular mutations, D301H and G479E, have been previously characterized in the context of mouse ADAM12. Three other mutations, T596A, R612Q, and G668A, have been reported more recently, and their effects on ADAM12-L protein structure/function are not known. Here, we show that ADAM12-L bearing the G668A mutation is largely retained in the endoplasmic reticulum in its nascent, full-length form, with an intact N-terminal pro-domain. The T596A and R612Q mutants are efficiently trafficked to the cell surface and proteolytically processed to remove their pro-domains. However, the T596A mutant shows decreased catalytic activity at the cell surface, while the R612Q mutant is fully active and comparable to the wild-type ADAM12-L. The D301H and G479E mutants, consistent with the corresponding D299H and G477E mutants of mouse ADAM12 described earlier, are not proteolytically processed and do not exhibit catalytic activity at the cell surface. Among all six breast cancer-associated mutations in ADAM12-L, mutations that preserve the activity R612Q and L792F - occur in triple-negative breast cancers, while loss-of-function mutations - D301H, G479E, T596A, and G668A - are found in non-triple negative cancers. This apparent association between the catalytic activity of the mutants and the type of breast cancer supports a previously postulated role of an active ADAM12-L in the triple negative breast cancer disease.	[Qi, Yue; Duhachek-Muggy, Sara; Li, Hui; Zolkiewska, Anna] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA	Kansas State University	Zolkiewska, A (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	zolkiea@ksu.edu		Li, Hui/0000-0002-4114-8349	NIH [R15CA151065, R01CA172222]; Terry C. Johnson Center for Basic Cancer Research at KSU; NATIONAL CANCER INSTITUTE [R15CA151065, R01CA172222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry C. Johnson Center for Basic Cancer Research at KSU; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants R15CA151065 and R01CA172222, and Innovative Research Award from Terry C. Johnson Center for Basic Cancer Research at KSU. This is contribution 13-310-J from Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Ben T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2904; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; Creighton CJ, 2012, BIOL-TARGETS THER, V6, P289, DOI 10.2147/BTT.S29923; Diaz B, 2013, J CELL BIOL, V201, P279, DOI 10.1083/jcb.201209151; Dillon LW, 2013, HUM MOL GENET, V22, P1443, DOI 10.1093/hmg/dds561; Dyczynska E, 2008, INT J CANCER, V122, P2634, DOI 10.1002/ijc.23405; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Frohlich C, 2013, BIOCHEM J, V452, P97, DOI 10.1042/BJ20121558; Harsha A, 2008, J MOL MED, V86, P961, DOI 10.1007/s00109-008-0353-z; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Huang J, 2005, MOL BIOL CELL, V16, P4982, DOI 10.1091/mbc.E05-03-0258; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Jiao X, 2012, GENE CHROMOSOME CANC, V51, P480, DOI 10.1002/gcc.21935; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Li H, 2013, BREAST CANCER RES TR, V139, P691, DOI 10.1007/s10549-013-2602-2; Li H, 2012, BREAST CANCER RES TR, V135, P759, DOI 10.1007/s10549-012-2220-4; Liu HL, 2009, J BIOL CHEM, V284, P29077, DOI 10.1074/jbc.M109.014258; Mitsui Y, 2006, CANCER RES, V66, P9913, DOI 10.1158/0008-5472.CAN-06-0377; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Rao VH, 2012, ONCOGENE, V31, P2888, DOI 10.1038/onc.2011.460; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Roy R, 2011, J BIOL CHEM, V286, P20758, DOI 10.1074/jbc.M110.216036; Roy R, 2012, BREAST CANCER RES TR, V131, P731, DOI 10.1007/s10549-011-1431-4; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stautz D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037628; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	37	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92536	10.1371/journal.pone.0092536	http://dx.doi.org/10.1371/journal.pone.0092536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651654	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800123
J	Shigemizu, D; Abe, T; Morizono, T; Johnson, TA; Boroevich, KA; Hirakawa, Y; Ninomiya, T; Kiyohara, Y; Kubo, M; Nakamura, Y; Maeda, S; Tsunoda, T				Shigemizu, Daichi; Abe, Testuo; Morizono, Takashi; Johnson, Todd A.; Boroevich, Keith A.; Hirakawa, Yoichiro; Ninomiya, Toshiharu; Kiyohara, Yutaka; Kubo, Michiaki; Nakamura, Yusuke; Maeda, Shiro; Tsunoda, Tatsuhiko			The Construction of Risk Prediction Models Using GWAS Data and Its Application to a Type 2 Diabetes Prospective Cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISM; DETECTING GENE-GENE; POPULATION; SUSCEPTIBILITY; REGRESSION; MELLITUS; IMPACT; TESTS	Recent genome-wide association studies (GWAS) have identified several novel single nucleotide polymorphisms (SNPs) associated with type 2 diabetes (T2D). Various models using clinical and/or genetic risk factors have been developed for T2D risk prediction. However, analysis considering algorithms for genetic risk factor detection and regression methods for model construction in combination with interactions of risk factors has not been investigated. Here, using genotype data of 7,360 Japanese individuals, we investigated risk prediction models, considering the algorithms, regression methods and interactions. The best model identified was based on a Bayes factor approach and the lasso method. Using nine SNPs and clinical factors, this method achieved an area under a receiver operating characteristic curve (AUC) of 0.8057 on an independent test set. With the addition of a pair of interaction factors, the model was further improved (p-value 0.0011, AUC 0.8085). Application of our model to prospective cohort data showed significantly better outcome in disease-free survival, according to the log-rank trend test comparing Kaplan-Meier survival curves (p value2.09 x 10(-11)). While the major contribution was from clinical factors rather than the genetic factors, consideration of genetic risk factors contributed to an observable, though small, increase in predictive ability. This is the first report to apply risk prediction models constructed from GWAS data to a T2D prospective cohort. Our study shows our model to be effective in prospective prediction and has the potential to contribute to practical clinical use in T2D.	[Shigemizu, Daichi; Abe, Testuo; Morizono, Takashi; Johnson, Todd A.; Boroevich, Keith A.; Tsunoda, Tatsuhiko] RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Hirakawa, Yoichiro; Ninomiya, Toshiharu; Kiyohara, Yutaka] Kyushu Univ, Dept Environm Med, Grad Sch Med Sci, Fukuoka 812, Japan; [Ninomiya, Toshiharu] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Maeda, Shiro] RIKEN, Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan	RIKEN; Kyushu University; Kyushu University; RIKEN; University of Tokyo; RIKEN	Tsunoda, T (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan.	tsunoda@src.riken.jp	Tsunoda, Tatsuhiko/K-2061-2014; Kubo, Michiaki/N-7947-2015; Johnson, Todd Andrew/ABG-4704-2021; Johnson, Todd/Q-9944-2019	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Johnson, Todd Andrew/0000-0003-3377-6692; Johnson, Todd/0000-0003-3377-6692; Boroevich, Keith/0000-0001-7095-7332	Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Banerji B, 1990, Ann Soc Belg Med Trop, V70 Suppl 1, P15; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Cule E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-372; Doi Y, 2012, DIABETIC MED, V29, P107, DOI 10.1111/j.1464-5491.2011.03376.x; Doi Y, 2008, J CLIN ENDOCR METAB, V93, P3425, DOI 10.1210/jc.2007-2819; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gulcher J, 2009, NEW ENGL J MED, V360, P1360; Horikawa Y, 2008, J CLIN ENDOCR METAB, V93, P3136, DOI 10.1210/jc.2008-0452; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Imamura M, 2012, HUM MOL GENET, V21, P3042, DOI 10.1093/hmg/dds113; Jia HX, 2011, ARCH MED RES, V42, P361, DOI 10.1016/j.arcmed.2011.08.001; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Kooperberg C, 2010, GENET EPIDEMIOL, V34, P643, DOI 10.1002/gepi.20509; Larkin M, 2001, LANCET, V358, P565, DOI 10.1016/S0140-6736(01)05751-8; Lu Qing, 2009, BMC Proc, V3 Suppl 7, pS49; Lukacs K, 2012, DIABETOLOGIA, V55, P689, DOI 10.1007/s00125-011-2378-z; Ma LJ, 2010, DIABETES, V59, P2837, DOI 10.2337/db09-1604; McCarthy MI, 2011, DIABETIC MED, V28, P132, DOI 10.1111/j.1464-5491.2010.03194.x; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; OHMURA T, 1993, DIABETOLOGIA, V36, P1198, DOI 10.1007/BF00401066; Ohshige T, 2010, DIABETES CARE, V33, P842, DOI 10.2337/dc09-1933; Pan W, 2011, HUM HERED, V72, P98, DOI 10.1159/000330632; Park SH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S13; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sparso T, 2009, DIABETOLOGIA, V52, P1308, DOI 10.1007/s00125-009-1362-3; Team RDC, 2009, R LANG ENV STAT COMP; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wei Z, 2013, AM J HUM GENET; Willems SM, 2011, CURR DIABETES REP, V11, P511, DOI 10.1007/s11892-011-0235-6; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; ZOU H, 2005, J R STAT SOC B, V67	42	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92549	10.1371/journal.pone.0092549	http://dx.doi.org/10.1371/journal.pone.0092549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651836	gold, Green Submitted, Green Published			2022-12-27	WOS:000333352800126
J	Stellmann, JP; Neuhaus, A; Lederer, C; Daumer, M; Heesen, C				Stellmann, Jan-Patrick; Neuhaus, Anneke; Lederer, Christian; Daumer, Martin; Heesen, Christoph			Validating Predictors of Disease Progression in a Large Cohort of Primary-Progressive Multiple Sclerosis Based on a Systematic Literature Review	PLOS ONE			English	Review							NATURAL-HISTORY; DOUBLE-BLIND; DISABILITY; MS; MULTICENTER; TRIALS; ONSET; TIME	Background: New agents with neuroprotective or neuroregenerative potential might be explored in primary-progressive Multiple Sclerosis (PPMS) - the MS disease course with leading neurodegenerative pathology. Identification of patients with a high short-term risk for progression may minimize study duration and sample size. Cohort studies reported several variables as predictors of EDSS disability progression but findings were partially contradictory. Objective: To analyse the impact of published predictors on EDSS disease progression in a large cohort of PPMS patients. Methods: A systematic literature research was performed to identify predictors for disease progression in PPMS. Individual case data from the Sylvia Lawry Centre (SLC) and the Hamburg MS patient database (HAPIMS) was pooled for a retrospective validation of these predictors on the annualized EDSS change. Results: The systematic literature analysis revealed heterogeneous data from 3 prospective and 5 retrospective natural history cohort studies. Age at onset, gender, type of first symptoms and early EDSS changes were available for validation. Our pooled cohort of 597 PPMS patients (54% female) had a mean follow-up of 4.4 years and mean change of EDSS of 0.35 per year based on 2503 EDSS assessments. There was no significant association between the investigated variables and the EDSS-change. Conclusion: None of the analysed variables were predictive for the disease progression measured by the annualized EDSS change. Whether PPMS is still unpredictable or our results may be due to limitations of cohort assessments or selection of predictors cannot be answered. Large systematic prospective studies with new endpoints are needed.	[Stellmann, Jan-Patrick; Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, Hamburg, Germany; [Neuhaus, Anneke; Lederer, Christian; Daumer, Martin] Sylvia Lawry Ctr Multiple Sclerosis Res, Munich, Germany; [Neuhaus, Anneke; Daumer, Martin] Trium Anal Online GmbH, Munich, Germany; [Stellmann, Jan-Patrick; Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Stellmann, JP (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, Hamburg, Germany.	j.stellmann@uke.uni-hamburg.de	Stellmann, Jan-Patrick/ABA-7132-2020	Stellmann, Jan-Patrick/0000-0003-2565-2833	NEU2 consortium; Federal Ministry of Education and Research (BMBF) [Fo0315610-0315620]	NEU2 consortium; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was funded by the NEU2 consortium, which is supported by the Federal Ministry of Education and Research (BMBF) (Fo0315610-0315620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson PB, 1999, ARCH NEUROL-CHICAGO, V56, P1138, DOI 10.1001/archneur.56.9.1138; [Anonymous], 2012, GUID CLIN INV MED PR; Antel J, 2012, ACTA NEUROPATHOL, V123, P627, DOI 10.1007/s00401-012-0953-0; Bosma LVAE, 2013, MULT SCLER J, V19, P326, DOI 10.1177/1352458512454346; Bosma LVAE, 2012, MULT SCLER J, V18, P345, DOI 10.1177/1352458511419880; Calabrese M, 2012, BRAIN, V135, P2952, DOI 10.1093/brain/aws246; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; Cottrell DA, 1999, BRAIN, V122, P641, DOI 10.1093/brain/122.4.641; Cottrell DA, 1999, BRAIN, V122, P625, DOI 10.1093/brain/122.4.625; Denney DR, 2008, J NEUROL SCI, V267, P129, DOI 10.1016/j.jns.2007.10.007; Ebers GC, 2008, NEUROLOGY, V71, P624, DOI 10.1212/01.wnl.0000313034.46883.16; Ebers GC, 2004, MULT SCLER J, V10, pS8, DOI 10.1191/1352458504ms1025oa; Ebers GC, 2011, NEUROLOGY, V76, P1025, DOI 10.1212/WNL.0b013e31820a9674; EMA, 2013, EUR MED AG NEWS EV W; Fox Robert J, 2012, Mult Scler, V18, P1534, DOI 10.1177/1352458512458169; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Heesen C, 2008, MULT SCLER, V14, P988, DOI 10.1177/1352458508088916; Khaleeli Z, 2010, MULT SCLER J, V16, P317, DOI 10.1177/1352458509358090; Khaleeli Z, 2008, ANN NEUROL, V63, P790, DOI 10.1002/ana.21375; Koch M, 2009, NEUROLOGY, V73, P1996, DOI 10.1212/WNL.0b013e3181c5b47f; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; Miller DH, 2004, MULT SCLER J, V10, pS56, DOI 10.1191/1352458504ms1031oa; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Montalban X, 2009, MULT SCLER J, V15, P1195, DOI 10.1177/1352458509106937; Neuhaus A, 2006, J NEUROL, V253, P58; Pohlau D, 2007, MULT SCLER J, V13, P1107, DOI 10.1177/1352458507078400; R Core Team, 2021, R LANGUAGE ENV STAT; Rice GPA, 2011, MOST; Rodrigues DN, 2011, ARQ NEURO-PSIQUIAT, V69, P590, DOI 10.1590/S0004-282X2011000500004; Rovaris M, 2006, BRAIN, V129, P2628, DOI 10.1093/brain/awl222; Sola P, 2011, MULT SCLER J, V17, P303, DOI 10.1177/1352458510386996; Tremlett H, 2005, NEUROLOGY, V65, P1919, DOI 10.1212/01.wnl.0000188880.17038.1d; Vukusic S, 2003, J NEUROL SCI, V206, P153, DOI 10.1016/S0022-510X(02)00427-6; Weinshenker BG, 1996, NEUROLOGY, V46, P1613, DOI 10.1212/WNL.46.6.1613; Wolinsky JS, 2007, ANN NEUROL, V61, P14, DOI 10.1002/ana.21079; Zhang J, 2011, ECTRIMS	37	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92761	10.1371/journal.pone.0092761	http://dx.doi.org/10.1371/journal.pone.0092761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651401	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800154
J	Visser, TAW				Visser, Troy A. W.			Evidence for Deficits in the Temporal Attention Span of Poor Readers	PLOS ONE			English	Article							WORKING-MEMORY DEFICITS; SHORT-TERM-MEMORY; VISUAL-ATTENTION; DEVELOPMENTAL DYSLEXIA; RESOURCE DEPLETION; PROCESSING DEFICITS; READING-DISABILITY; BLINK; SEQUENCES; PERCEPTION	Background: While poor reading is often associated with phonological deficits, many studies suggest that visual processing might also be impaired. In particular, recent research has indicated that poor readers show impaired spatial visual attention spans in partial and whole report tasks. Given the similarities between competition-based accounts for reduced visual attention span and similar explanations for impairments in sequential object processing, the present work examined whether poor readers show deficits in their "temporal attention span" - that is, their ability to rapidly and accurately process sequences of consecutive target items. Methodology/Principal Findings: Poor and normal readers monitored a sequential stream of visual items for two (TT condition) or three (TTT condition) consecutive target digits. Target identification was examined using both unconditional and conditional measures of accuracy in order to gauge the overall likelihood of identifying a target and the likelihood of identifying a target given successful identification of previous items. Compared to normal readers, poor readers showed small but consistent deficits in identification across targets whether unconditional or conditional accuracy was used. Additionally, in the TTT condition, final-target conditional accuracy was poorer than unconditional accuracy, particularly for poor readers, suggesting a substantial cost arising from processing the previous two targets that was not present in normal readers. Conclusions/Significance: Mirroring the differences found between poor and normal readers in spatial visual attention span, the present findings suggest two principal differences between the temporal attention spans of poor and normal readers. First, the consistent pattern of reduced performance across targets suggests increased competition amongst items within the same span for poor readers. Second, the steeper decline in final target performance amongst poor readers in the TTT condition suggests a reduction in the extent of their temporal attention span.	Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia	University of Western Australia	Visser, TAW (corresponding author), Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia.	taw.visser@gmail.com		Visser, Troy/0000-0003-3960-2263	Australian Research Council [DP120102313]	Australian Research Council(Australian Research Council)	This research was funded by an Australian Research Council Discovery Grant (DP120102313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERBACH E, 1961, AT&T TECH J, V40, P309, DOI 10.1002/j.1538-7305.1961.tb03987.x; Bacon AM, 2013, MEMORY, V21, P189, DOI 10.1080/09658211.2012.718789; Borsting E, 1996, VISION RES, V36, P1047, DOI 10.1016/0042-6989(95)00199-9; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; BRANNAN JR, 1987, PERCEPT PSYCHOPHYS, V41, P23, DOI 10.3758/BF03208209; Buchholz J, 2007, VISION RES, V47, P1292, DOI 10.1016/j.visres.2006.11.028; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Cestnick L, 2001, BRAIN COGNITION, V46, P319, DOI 10.1006/brcg.2000.1273; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; de Jong PF, 1998, J EXP CHILD PSYCHOL, V70, P75, DOI 10.1006/jecp.1998.2451; Dell'Acqua R, 2007, J EXP PSYCHOL HUMAN, V33, P593, DOI 10.1037/0096-1523.33.3.593; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Dubois M, 2010, CORTEX, V46, P717, DOI 10.1016/j.cortex.2009.11.002; Dux PE, 2008, PSYCHON B REV, V15, P809, DOI 10.3758/PBR.15.4.809; Dux PE, 2009, PSYCHON B REV, V16, P219, DOI 10.3758/PBR.16.1.219; Facoetti A, 2003, COGNITIVE BRAIN RES, V16, P185, DOI 10.1016/S0926-6410(02)00270-7; Facoetti A, 2001, EXP BRAIN RES, V138, P46, DOI 10.1007/s002210100700; Ferlazzo F, 2007, EXP PSYCHOL, V54, P89, DOI 10.1027/1618-3169.54.2.89; Fluss J, 2008, ARCH PEDIATR, V15, P1058; Frith U, 1997, DYSLEXIA: BIOLOGY, COGNITION AND INTERVENTION, P1; Hari R, 1999, NEUROSCI LETT, V271, P202, DOI 10.1016/S0304-3940(99)00547-9; Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; Hawelka S, 2005, VISION RES, V45, P855, DOI 10.1016/j.visres.2004.10.007; Kaufman A. S., 2004, KAUFMANN BRIEF INTEL, VSecond; La Roque CL, 2009, VISION RES, V49, P96, DOI 10.1016/j.visres.2008.09.027; Laasonen M, 2012, BRAIN COGNITION, V80, P311, DOI 10.1016/j.bandc.2012.08.002; Lacroix Guy L, 2005, Brain Cogn, V57, P115; Lallier M, 2010, CORTEX, V46, P231, DOI 10.1016/j.cortex.2009.03.014; Lassus-Sangosse D, 2008, VISION RES, V48, P979, DOI 10.1016/j.visres.2008.01.025; Lobier M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058097; Lum JAG, 2007, BRAIN COGNITION, V63, P287, DOI 10.1016/j.bandc.2006.09.010; Marendaz C, 1996, ANN PSYCHOL, V96, P193; McAnally KI, 2000, J DEV PHYS DISABIL, V12, P145, DOI 10.1023/A:1009459622805; McLean GMT, 2010, CORTEX, V46, P1317, DOI 10.1016/j.cortex.2010.06.010; Olivers CNL, 2008, VIS COGN, V16, P785, DOI 10.1080/13506280701428658; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Potter MC, 2002, J EXP PSYCHOL HUMAN, V28, P1149, DOI 10.1037//0096-1523.28.5.1149; Potter MC, 1998, J EXP PSYCHOL LEARN, V24, P979, DOI 10.1037/0278-7393.24.4.979; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Rashotte, 1999, TOWRE 2 TEST WORD RE; RAYMOND JE, 1995, J EXP PSYCHOL HUMAN, V21, P653, DOI 10.1037/0096-1523.21.3.653; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; RAYNER K, 1989, COGNITIVE NEUROPSYCH, V6, P357, DOI 10.1080/02643298908253288; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Slaghuis WL, 2006, VISION RES, V46, P3291, DOI 10.1016/j.visres.2006.05.009; SLAGHUIS WL, 1993, CORTEX, V29, P601, DOI 10.1016/S0010-9452(13)80284-5; Snowling M J, 2001, Dyslexia, V7, P37; SPERLING G, 1995, PSYCHOL REV, V102, P503, DOI 10.1037/0033-295X.102.3.503; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Stenneken P, 2011, NEUROPSYCHOLOGIA, V49, P3454, DOI 10.1016/j.neuropsychologia.2011.08.021; Swanson HL, 2009, J LEARN DISABIL-US, V42, P260, DOI 10.1177/0022219409331958; Tang MF, 2013, PSYCHON B R IN PRESS; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Valdois S., 2003, READ WRIT, V16, P541, DOI DOI 10.1023/A:1025501406971; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; Visser TA, 2004, PERCEPT PSYCHOPHYS, V66, P1418, DOI 10.3758/BF03195008; Visser TAW, 1999, PSYCHOL BULL, V125, P458, DOI 10.1037/0033-2909.125.4.458; Visser TAW, 2004, VISION RES, V44, P2521, DOI 10.1016/j.visres.2004.05.010; Visser TAW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033265; Visser TAW, 2011, J EXP PSYCHOL HUMAN, V37, P1527, DOI 10.1037/a0023508; Visser TAW, 2009, PSYCHOL RES-PSYCH FO, V73, P327, DOI 10.1007/s00426-008-0155-5; Wang SM, 2013, J EXP CHILD PSYCHOL, V115, P188, DOI 10.1016/j.jecp.2012.11.015	65	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91278	10.1371/journal.pone.0091278	http://dx.doi.org/10.1371/journal.pone.0091278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651313	gold, Green Published			2022-12-27	WOS:000333352800036
J	Chitalia, N; Ismail, T; Tooth, L; Boa, F; Hampson, G; Goldsmith, D; Kaski, JC; Banerjee, D				Chitalia, Nihil; Ismail, Tuan; Tooth, Laura; Boa, Frances; Hampson, Geeta; Goldsmith, David; Kaski, Juan Carlos; Banerjee, Debasish			Impact of Vitamin D Supplementation on Arterial Vasomotion, Stiffness and Endothelial Biomarkers in Chronic Kidney Disease Patients	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; GROWTH-FACTOR 23; CARDIOVASCULAR EVENTS; VASCULAR HEALTH; D REPLACEMENT; D-RECEPTOR; CORONARY; DYSFUNCTION; POPULATION; MORTALITY	Background: Cardiovascular events are frequent and vascular endothelial function is abnormal in patients with chronic kidney disease (CKD). We demonstrated endothelial dysfunction with vitamin D deficiency in CKD patients; however the impact of cholecalciferol supplementation on vascular stiffness and vasomotor function, endothelial and bone biomarkers in CKD patients with low 25-hydroxy vitamin D [25(OH)D] is unknown, which this study investigated. Methods: We assessed non-diabetic patients with CKD stage 3/4, age 17-80 years and serum 25(OH)D <75 nmol/L. Brachial artery Flow Mediated Dilation (FMD), Pulse Wave Velocity (PWV), Augmentation Index (AI) and circulating blood biomarkers were evaluated at baseline and at 16 weeks. Oral 300,000 units cholecalciferol was administered at baseline and 8-weeks. Results: Clinical characteristics of 26 patients were: age 50 +/- 14 (mean +/- 1SD) years, eGFR 41 +/- 11 ml/min/1.73 m(2), males 73%, dyslipidaemia 36%, smokers 23% and hypertensives 87%. At 16-week serum 25(OH)D and calcium increased (43 +/- 16 to 84 +/- 29 nmol/L, p < 0.001 and 2.37 +/- 0.09 to 2.42 +/- 0.09 mmol/L; p = 0.004, respectively) and parathyroid hormone decreased (10.8 +/- 8.6 to 7.4 +/- 4.4; p = 0.001). FMD improved from 3.1 +/- 3.3% to 6.1 +/- 3.7%, p = 0.001. Endothelial biomarker concentrations decreased: E-Selectin from 5666 +/- 2123 to 5256 +/- 2058 pg/mL; p = 0.032, ICAM-1, 3.45 +/- 0.01 to 3.10 +/- 1.04 ng/mL; p = 0.038 and VCAM-1, 54 +/- 33 to 42 +/- 33 ng/mL; p = 0.006. eGFR, BP, PWV, AI, hsCRP, von Willebrand factor and Fibroblast Growth Factor-23, remained unchanged. Conclusion: This study demonstrates for the first time improvement of endothelial vasomotor and secretory functions with vitamin D in CKD patients without significant adverse effects on arterial stiffness, serum calcium or FGF-23.	[Chitalia, Nihil; Banerjee, Debasish] St Georges Healthcare NHS Trust, Renal & Transplantat Unit, London, England; [Chitalia, Nihil; Ismail, Tuan; Kaski, Juan Carlos; Banerjee, Debasish] Univ London, Cardiovasc Res Ctr, London, England; [Tooth, Laura; Boa, Frances] St Georges Healthcare NHS Trust, London, England; [Hampson, Geeta; Goldsmith, David] NHS Fdn Trust, Renal Dept, London, England; [Hampson, Geeta; Goldsmith, David] NHS Fdn Trust, Dept Clin Chem, London, England	St Georges University London; University of London; St Georges University London; Oxford University Hospitals NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust	Banerjee, D (corresponding author), St Georges Healthcare NHS Trust, Renal & Transplantat Unit, London, England.	Debasish.Banerjee@stgeorges.nhs.uk	Goldsmith, David J A/H-6965-2018; Banerjee, Debasish/G-8292-2019; Banerjee, Debasish/P-7861-2019	Goldsmith, David J A/0000-0002-4349-9193; Banerjee, Debasish/0000-0002-6863-2325; Banerjee, Debasish/0000-0002-6863-2325	St Georges Hospital Charity	St Georges Hospital Charity	This study was partially funded by the St Georges Hospital Charity (http://www.givingtogeorges.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding received for this study.	Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; ANDERSON TJ, 1995, J AM COLL CARDIOL, V26, P1235, DOI 10.1016/0735-1097(95)00327-4; Bae JH, 2001, ATHEROSCLEROSIS, V158, P165, DOI 10.1016/S0021-9150(01)00408-7; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Borges ACR, 1999, HYPERTENSION, V34, P897, DOI 10.1161/01.HYP.34.4.897; Chandra Prakash, 2008, Endocr Pract, V14, P10; Chitalia N, 2012, ATHEROSCLEROSIS, V220, P265, DOI 10.1016/j.atherosclerosis.2011.10.023; Deanfield J, 2005, J HYPERTENS, V23, P7, DOI 10.1097/00004872-200501000-00004; DESCAMPSLATSCHA B, 1994, SEMIN NEPHROL, V14, P253; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Drechsler C, 2011, NEPHROL DIAL TRANSPL, V26, P1024, DOI 10.1093/ndt/gfq606; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Fraser WD, 2013, CALCIFIED TISSUE INT, V92, P118, DOI 10.1007/s00223-012-9693-3; Froicu M, 2003, MOL ENDOCRINOL, V17, P2386, DOI 10.1210/me.2003-0281; Gepner AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036617; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2010, CLIN J AM SOC NEPHRO, V5, P1710, DOI 10.2215/CJN.02640310; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Harris RA, 2011, AM J HYPERTENS, V24, P557, DOI 10.1038/ajh.2011.12; HERBELIN A, 1991, KIDNEY INT, V39, P954, DOI 10.1038/ki.1991.120; Kanbay M, 2011, CLIN J AM SOC NEPHRO, V6, P1887, DOI 10.2215/CJN.11451210; Kestenbaum B, 2011, J AM COLL CARDIOL, V58, P1433, DOI 10.1016/j.jacc.2011.03.069; Leventis P, 2009, SCAND J RHEUMATOL, V38, P149, DOI 10.1080/03009740802419081; Lou YR, 2010, J STEROID BIOCHEM, V118, P162, DOI 10.1016/j.jsbmb.2009.11.011; Muller K, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 1, APRIL 1996, V1, P68; Pilz S, 2011, NEPHROL DIAL TRANSPL, V26, P3603, DOI 10.1093/ndt/gfr076; PROCSAL DA, 1975, J BIOL CHEM, V250, P8382; Recio-Mayoral A, 2011, ATHEROSCLEROSIS, V216, P446, DOI 10.1016/j.atherosclerosis.2011.02.017; Shab-Bidar S, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-125; Sidhu JS, 2004, AM J CARDIOL, V94, P151, DOI 10.1016/j.amjcard.2004.03.051; Sidhu JS, 2002, HEART, V88, P289, DOI 10.1136/heart.88.3.289; Sokol SI, 2012, VASC MED, V17, P394, DOI 10.1177/1358863X12466709; Stam F, 2006, J AM SOC NEPHROL, V17, P537, DOI 10.1681/ASN.2005080834; Suessenbacher A, 2006, VASC MED, V11, P239, DOI 10.1177/1358863x06075006; Sugden JA, 2008, DIABETIC MED, V25, P320, DOI 10.1111/j.1464-5491.2007.02360.x; Timimi FK, 1998, J AM COLL CARDIOL, V31, P552, DOI 10.1016/S0735-1097(97)00536-6; Tonelli M, 2012, LANCET, V380, P807, DOI 10.1016/S0140-6736(12)60572-8; Turner C, 2013, J CLIN ENDOCR METAB; Uzum AK, 2010, EUR J ENDOCRINOL, V163, P825, DOI 10.1530/EJE-10-0591; Witham MD, 2012, NUTR METAB CARDIOVAS, V22, P864, DOI 10.1016/j.numecd.2010.11.001; Witham MD, 2010, DIABETOLOGIA, V53, P2112, DOI 10.1007/s00125-010-1838-1; Witham MD, 2012, INT J CARDIOL; Wolf M, 2011, J AM SOC NEPHROL, V22, P956, DOI 10.1681/ASN.2010080894; Wong MSK, 2010, AM J PHYSIOL-HEART C, V299, pH1226, DOI 10.1152/ajpheart.00288.2010; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801; Yilmaz MI, 2011, NEPHROL DIAL TRANSPL, V26, P3537, DOI 10.1093/ndt/gfr081	47	76	82	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91363	10.1371/journal.pone.0091363	http://dx.doi.org/10.1371/journal.pone.0091363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646518	Green Accepted, gold, Green Published			2022-12-27	WOS:000333348500032
J	Dobrowolska, JA; Kasten, T; Huang, YF; Benzinger, TLS; Sigurdson, W; Ovod, V; Morris, JC; Bateman, RJ				Dobrowolska, Justyna A.; Kasten, Tom; Huang, Yafei; Benzinger, Tammie L. S.; Sigurdson, Wendy; Ovod, Vitaliy; Morris, John C.; Bateman, Randall J.			Diurnal Patterns of Soluble Amyloid Precursor Protein Metabolites in the Human Central Nervous System	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; BETA-SECRETASE; CEREBROSPINAL-FLUID; ALPHA-SECRETASE; ALZHEIMERS-DISEASE; DEMENTIA; DYNAMICS; CLEAVAGE; BRAIN; REDUCTION	The amyloid-beta (A beta) protein is diurnally regulated in both the cerebrospinal fluid and blood in healthy adults; circadian amplitudes decrease with aging and the presence of cerebral A beta deposits. The cause of the A beta diurnal pattern is poorly understood. One hypothesis is that the Amyloid Precursor Protein (APP) is diurnally regulated, leading to APP product diurnal patterns. APP in the central nervous system is processed either via the beta-pathway (amyloidogenic), generating soluble APP-beta (sAPP beta) and A beta, or the alpha-pathway (non-amyloidogenic), releasing soluble APP-alpha (sAPP alpha). To elucidate the potential contributions of APP to the A beta diurnal pattern and the balance of the alpha- and beta- pathways in APP processing, we measured APP proteolytic products over 36 hours in human cerebrospinal fluid from cognitively normal and Alzheimer's disease participants. We found diurnal patterns in sAPP alpha, sAPP beta, A beta(40), and A beta(42), which diminish with increased age, that support the hypothesis that APP is diurnally regulated in the human central nervous system and thus results in A beta diurnal patterns. We also found that the four APP metabolites were positively correlated in all participants without cerebral A beta deposits. This positive correlation suggests that the a-and b-APP pathways are non-competitive under normal physiologic conditions where APP availability may be the limiting factor that determines sAPP alpha and sAPP beta production. However, in participants with cerebral A beta deposits, there was no correlation of A beta to sAPP metabolites, suggesting that normal physiologic regulation of cerebrospinal fluid A beta is impaired in the presence of amyloidosis. Lastly, we found that the ratio of sAPP beta to sAPP alpha was significantly higher in participants with cerebral A beta deposits versus those without deposits. Therefore, the sAPP beta to sAPP alpha ratio may be a useful biomarker for cerebral amyloidosis.	[Dobrowolska, Justyna A.; Kasten, Tom; Huang, Yafei; Ovod, Vitaliy; Morris, John C.; Bateman, Randall J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Morris, John C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Benzinger, Tammie L. S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Sigurdson, Wendy; Morris, John C.; Bateman, Randall J.] Washington Univ, Sch Med, Charles F & Joanne Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Bateman, Randall J.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bateman, RJ (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	batemanr@wustl.edu	Benzinger, Tammie/L-6104-2013; Zakaria, Justyna Dobrowolska/L-7283-2019	Benzinger, Tammie/0000-0002-8114-0552; Zakaria, Justyna Dobrowolska/0000-0003-1718-147X; Bateman, Randall/0000-0002-7729-1702	US National Institutes of Health [K08 AG027091-01, K23 03094601, R-01-NS065667, P50 AG5681-22, P01 AG03991-22]; Washington University Clinical & Translational Science Award [UL1 RR024992]; Betty and Steve Schmid; Knight Initiative for Alzheimer Research; James and Elizabeth McDonnell Fund for Alzheimer Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG042791, P01AG003991, P50AG005681, U19AG032438, K08AG027091, U01AG032438, UF1AG032438, P01AG026276] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Clinical & Translational Science Award; Betty and Steve Schmid; Knight Initiative for Alzheimer Research; James and Elizabeth McDonnell Fund for Alzheimer Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the US National Institutes of Health (K08 AG027091-01, K23 03094601, R-01-NS065667, P50 AG5681-22, and P01 AG03991-22), Washington University Clinical & Translational Science Award UL1 RR024992, grants from an anonymous foundation, a gift from Betty and Steve Schmid, The Knight Initiative for Alzheimer Research, The James and Elizabeth McDonnell Fund for Alzheimer Research, and a research grant from Eli Lilly for the purchase of antibodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The donors have no competing interests in relation to this work. The authors are not aware of any competing interests. The identity of the donors is not relevant to the editors' or reviewers' assessment of the validity of the manuscript. There was no involvement of any tobacco company in this research, neither through funding of the research costs, nor by funding of the authors' salaries.	Alexopoulos P, 2012, ALZHEIMERS DEMENT, V8, P304, DOI 10.1016/j.jalz.2011.04.009; Andreasen N, 1999, ARCH NEUROL-CHICAGO, V56, P673, DOI 10.1001/archneur.56.6.673; Bateman RJ, 2007, NEUROLOGY, V68, P666, DOI 10.1212/01.wnl.0000256043.50901.e3; Brinkmalm G, 2013, BRAIN RES, V1513, P117, DOI 10.1016/j.brainres.2013.03.019; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gabelle A, 2010, BRAIN RES, V1357, P175, DOI 10.1016/j.brainres.2010.08.022; Galasko D, 1998, ARCH NEUROL-CHICAGO, V55, P937, DOI 10.1001/archneur.55.7.937; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GANDY SE, 1992, NEUROBIOL AGING, V13, P601, DOI 10.1016/0197-4580(92)90063-4; Haimov I, 1997, SLEEP, V20, P294, DOI 10.1093/sleep/20.4.294; Holtzman DM, 2011, SCI TRANSL MED, V3; Huang YF, 2012, ARCH NEUROL-CHICAGO, V69, P1591, DOI 10.1001/archneurol.2012.18107; Huang YF, 2012, ARCH NEUROL-CHICAGO, V69, P51, DOI 10.1001/archneurol.2011.235; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; Kim M, 2009, HUM MOL GENET, V18, P3987, DOI 10.1093/hmg/ddp323; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Lewczuk P, 2010, MOL PSYCHIATR, V15, P138, DOI 10.1038/mp.2008.84; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; May PC, 2011, J NEUROSCI, V31, P16507, DOI 10.1523/JNEUROSCI.3647-11.2011; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Olsson A, 2003, EXP NEUROL, V183, P74, DOI 10.1016/S0014-4886(03)00027-X; Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291; Sankaranarayanan S, 2008, J PHARMACOL EXP THER, V324, P957, DOI 10.1124/jpet.107.130039; Savage MJ, 1998, J NEUROSCI, V18, P1743; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Tranah GJ, 2011, ANN NEUROL, V70, P722, DOI 10.1002/ana.22468; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	36	40	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89998	10.1371/journal.pone.0089998	http://dx.doi.org/10.1371/journal.pone.0089998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646516	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500012
J	Lodha, A; Sauve, R; Bhandari, V; Tang, S; Christianson, H; Bhandari, A; Amin, H; Singhal, N				Lodha, Abhay; Sauve, Reg; Bhandari, Vineet; Tang, Selphee; Christianson, Heather; Bhandari, Anita; Amin, Harish; Singhal, Nalini			Need for Supplemental Oxygen at Discharge in Infants with Bronchopulmonary Dysplasia Is Not Associated with Worse Neurodevelopmental Outcomes at 3 Years Corrected Age	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; EXTREMELY PRETERM INFANTS; CHRONIC LUNG-DISEASE; LANGUAGE OUTCOMES; THERAPY; CHILDREN; DEFINITION; HEALTH; GROWTH; DESATURATION	Objectives: To determine if chronic oxygen dependency (discharge home on supplemental oxygen) in children with bronchopulmonary dysplasia (BPD; defined as requirement for supplemental O-2 at 36 weeks postmenstrual age) predicts neurodevelopmental disability rates and growth outcomes at 36 months corrected age (CA). Study Design: Longitudinal cohort study. Setting: Southern Alberta regional center located at high altitude. Participants: Preterm infants weighing <= 1250 grams with no BPD, BPD, and BPD with chronic oxygen dependency. Main outcome measures: Neurodevelopmental and growth outcomes. Results: Of 1563 preterm infants admitted from 1995-2007, 1212 survived. Complete follow-up data were available for 1030 (85%) children. Children in BPD and BPD with chronic oxygen dependency groups had significantly lower birth weights, gestational ages, prolonged mechanical ventilation and oxygen supplementation and received more postnatal steroids, compared to those without BPD. Children with BPD and BPD with chronic oxygen dependency were more likely to be below the 5th centile in weight and height compared to those without BPD but there was little difference between the BPD and BPD with chronic oxygen dependency groups. After controlling for confounding variables, children who had BPD and BPD with chronic oxygen dependency had higher odds of neurodevelopmental disability compared to those without BPD [OR (odds ratio) 1.9 (95% CI 1.1 to 3.5) and OR 1.8 (1.1 to 2.9), respectively], with no significant difference between BPD and BPD with chronic oxygen dependency [OR 0.9 (95% CI 0.6 to 1.5)]. Conclusions: BPD and BPD with chronic oxygen dependency in children predicts abnormal neurodevelopmental outcomes at 36 months CA. However, the neurodevelopmental disability rates were not significantly higher in BPD with chronic oxygen dependency children compared to children with BPD only. Compared to those without BPD, growth is impaired in children with BPD and BPD with chronic oxygen dependency, but no difference between the latter two groups.	[Lodha, Abhay; Sauve, Reg; Amin, Harish; Singhal, Nalini] Alberta Childrens Prov Gen Hosp, Peter Lougheed Ctr, Foothills Med Ctr, Dept Pediat, Calgary, AB, Canada; [Lodha, Abhay; Sauve, Reg; Christianson, Heather] Univ Calgary, Calgary, AB, Canada; [Lodha, Abhay; Sauve, Reg; Tang, Selphee; Christianson, Heather; Amin, Harish; Singhal, Nalini] Alberta Hlth Serv, Calgary, AB, Canada; [Lodha, Abhay; Sauve, Reg; Singhal, Nalini] Alberta Childrens Prov Gen Hosp, Inst Child & Maternal Hlth, Calgary, AB, Canada; [Bhandari, Vineet] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Bhandari, Anita] Connecticut Childrens Med Ctr, Dept Pediat Pulmonol, Hartford, CT USA	Alberta Childrens Hospital; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; Alberta Childrens Hospital; University of Calgary; Yale University; Connecticut Children's Medical Center	Lodha, A (corresponding author), Alberta Childrens Prov Gen Hosp, Peter Lougheed Ctr, Foothills Med Ctr, Dept Pediat, Calgary, AB, Canada.	aklodha@ucalgary.ca	Bhandari, Vineet/AAS-3365-2020		University of Calgary and Department of Pediatrics	University of Calgary and Department of Pediatrics	This work was supported by the University of Calgary and Department of Pediatrics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJ, 2006, SEMIN PERINATOL, V30, P227, DOI 10.1053/j.semperi.2006.05.010; [Anonymous], 2001, PAEDIAT CHILD HLTH, V6, P39; Bancalari E, 2005, EARLY HUM DEV, V81, P171, DOI 10.1016/j.earlhumdev.2004.12.005; Bhandari A, 2009, PEDIATRICS, V123, P1562, DOI 10.1542/peds.2008-1962; Bhandari V, 2013, SEMIN PERINATOL, V37, P108, DOI 10.1053/j.semperi.2013.01.007; Bhandari V, 2010, SEMIN FETAL NEONAT M, V15, P223, DOI 10.1016/j.siny.2010.03.009; Bhandari V, 2009, PEDIATRICS, V124, P517, DOI 10.1542/peds.2008-1302; Bizzarro MJ, 2013, J PERINATOL; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Botet F, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-63; Britton JR, 2012, J PERINATOL, V32, P880, DOI 10.1038/jp.2012.6; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Chess PR, 2006, SEMIN PERINATOL, V30, P171, DOI 10.1053/j.semperi.2006.05.003; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Ehrenkranz RA, 2005, PEDIATRICS, V116, P1353, DOI 10.1542/peds.2005-0249; Ehrenkranz RA, 2011, PEDIATR RES, V69, P522, DOI 10.1203/PDR.0b013e318217f4f1; Fitzgerald DA, 2008, MED J AUSTRALIA, V189, P578, DOI 10.5694/j.1326-5377.2008.tb02186.x; Hennessy EM, 2008, ARCH DIS CHILD, V93, P1037, DOI 10.1136/adc.2008.140830; Jeng SF, 2008, DEV MED CHILD NEUROL, V50, P51, DOI 10.1111/j.1469-8749.2007.02011.x; Karagianni P, 2011, PEDIATR NEUROL, V44, P40, DOI 10.1016/j.pediatrneurol.2010.07.008; Kuczmarski RJ, 2000, ADV DATA, V8, P1; Lagatta JM, 2013, J PEDIAT; Lagatta J, 2012, J PEDIATR-US, V160, P232, DOI 10.1016/j.jpeds.2011.08.033; Laughon M, 2009, PEDIATRICS, V124, P637, DOI 10.1542/peds.2008-2874; Lee SK, 2012, AM J PERINATOL; Lewis BA, 2002, J COMMUN DISORD, V35, P393, DOI 10.1016/S0021-9924(02)00085-0; Lodha A, 2011, POSTGRAD MED J, V87, P175, DOI 10.1136/pgmj.2010.107532; LUCHI JM, 1991, AM J DIS CHILD, V145, P813; Madden J, 2010, J PERINATOL, V30, P103, DOI 10.1038/jp.2009.142; Majnemer A, 2000, DEV MED CHILD NEUROL, V42, P53; Moon NM, 2007, EARLY HUM DEV, V83, P209, DOI 10.1016/j.earlhumdev.2006.05.015; Natarajan G, 2012, EARLY HUM DEV, V88, P509, DOI 10.1016/j.earlhumdev.2011.12.013; Nesterenko TH, 2008, AM J PERINAT, V25, P251, DOI 10.1055/s-2008-1075038; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Russman B S, 1989, Curr Probl Pediatr, V19, P65; SAUVE RS, 1989, CLIN PEDIATR, V28, P113, DOI 10.1177/000992288902800301; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Schmidt B, 2007, NEW ENGL J MED, V357, P1893, DOI 10.1056/NEJMoa073679; Schmidt B, 2013, JAMA-J AM MED ASSOC, V309, P2111, DOI 10.1001/jama.2013.5555; Sedowofia K, 2008, NEONATOLOGY, V94, P113, DOI 10.1159/000119721; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Shepherd EG, 2012, J PERINATOL, V32, P33, DOI 10.1038/jp.2011.45; Short EJ, 2003, PEDIATRICS, V112, pE359, DOI 10.1542/peds.112.5.e359; Short EJ, 2007, ARCH PEDIAT ADOL MED, V161, P1082, DOI 10.1001/archpedi.161.11.1082; SINGER L, 1992, PEDIATRICS, V90, P380; Singer LT, 2001, J DEV BEHAV PEDIATR, V22, P19, DOI 10.1097/00004703-200102000-00003; Sola A, 2007, ACTA PAEDIATR, V96, P801, DOI 10.1111/j.1651-2227.2007.00287.x; Stenson BJ, 2013, NEW ENGL J MED, V368, P2094, DOI 10.1056/NEJMoa1302298; Trittmann JK, 2013, EUR J PEDIATR, V172, P1173, DOI 10.1007/s00431-013-2016-5; Trittmann JK, 2013, EUR J PEDIAT; Van Marter LJ, 2011, ARCH DIS CHILD-FETAL, V96, pF20, DOI 10.1136/adc.2010.183012; Van Marter LJ, 2000, PEDIATRICS, V105, P1194, DOI 10.1542/peds.105.6.1194; Vohr BR, 2004, PEDIATRICS, V113, P781, DOI 10.1542/peds.113.4.781; Wang LY, 2010, PEDIATR PULM, V45, P165, DOI 10.1002/ppul.21171; WHITEHEAD J, 1993, STAT MED, V12, P2257, DOI 10.1002/sim.4780122404; Zanardo V, 2001, EARLY HUM DEV, V65, P39, DOI 10.1016/S0378-3782(01)00190-6	56	29	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e90843	10.1371/journal.pone.0090843	http://dx.doi.org/10.1371/journal.pone.0090843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646665	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500018
J	Pucci, F; Dhanani, M; Dehouck, Y; Rooman, M				Pucci, Fabrizio; Dhanani, Malik; Dehouck, Yves; Rooman, Marianne			Protein Thermostability Prediction within Homologous Families Using Temperature-Dependent Statistical Potentials	PLOS ONE			English	Article							THERMAL-STABILITY; STRUCTURAL ENTROPY; SALT BRIDGES; EVOLUTION; ENZYMES	The ability to rationally modify targeted physical and biological features of a protein of interest holds promise in numerous academic and industrial applications and paves the way towards de novo protein design. In particular, bioprocesses that utilize the remarkable properties of enzymes would often benefit from mutants that remain active at temperatures that are either higher or lower than the physiological temperature, while maintaining the biological activity. Many in silico methods have been developed in recent years for predicting the thermodynamic stability of mutant proteins, but very few have focused on thermostability. To bridge this gap, we developed an algorithm for predicting the best descriptor of thermostability, namely the melting temperature T-m, from the protein's sequence and structure. Our method is applicable when the T-m of proteins homologous to the target protein are known. It is based on the design of several temperature-dependent statistical potentials, derived from datasets consisting of either mesostable or thermostable proteins. Linear combinations of these potentials have been shown to yield an estimation of the protein folding free energies at low and high temperatures, and the difference of these energies, a prediction of the melting temperature. This particular construction, that distinguishes between the interactions that contribute more than others to the stability at high temperatures and those that are more stabilizing at low T, gives better performances compared to the standard approach based on T-independent potentials which predict the thermal resistance from the thermodynamic stability. Our method has been tested on 45 proteins of known T-m that belong to 11 homologous families. The standard deviation between experimental and predicted T-m's is equal to 13.6 degrees C in cross validation, and decreases to 8.3 degrees C if the 6 worst predicted proteins are excluded. Possible extensions of our approach are discussed.	[Pucci, Fabrizio; Dhanani, Malik; Dehouck, Yves; Rooman, Marianne] Univ Libre Bruxelles, Dept BioModeling BioInformat & BioProc, Brussels, Belgium	Universite Libre de Bruxelles	Pucci, F (corresponding author), Univ Libre Bruxelles, Dept BioModeling BioInformat & BioProc, Brussels, Belgium.	fapucci@ulb.ac.be; mrooman@ulb.ac.be		Dehouck, Yves/0000-0002-7401-104X	FRFC project of the Belgian fund for scientific research (FNRS)	FRFC project of the Belgian fund for scientific research (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by FRFC project of the Belgian fund for scientific research (FNRS). FP is Postdoctoral Fellow, YD Postdoctoral Researcher, and MR Research Director at the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalde M, 2006, TRENDS BIOTECHNOL, V24, P281, DOI 10.1016/j.tibtech.2006.04.002; Bae E, 2008, P NATL ACAD SCI USA, V105, P9594, DOI 10.1073/pnas.0800938105; Berezovsky IN, 2007, PLOS COMPUT BIOL, V3, P498, DOI 10.1371/journal.pcbi.0030052; Berezovsky IN, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035002; Bruins ME, 2001, APPL BIOCHEM BIOTECH, V90, P155, DOI 10.1385/ABAB:90:2:155; Chakravarty S, 2002, BIOCHEMISTRY-US, V41, P8152, DOI 10.1021/bi025523t; Chan CH, 2004, PROTEINS, V57, P684, DOI 10.1002/prot.20263; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; Dehouck Y, 2006, BIOPHYS J, V90, P4010, DOI 10.1529/biophysj.105.079434; Dehouck Y, 2008, PROTEIN ENG DES SEL, V21, P275, DOI 10.1093/protein/gzn001; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Eijsink VGH, 2005, BIOMOL ENG, V22, P21, DOI 10.1016/j.bioeng.2004.12.003; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; Folch B, 2008, J CHEM INF MODEL, V48, P119, DOI 10.1021/ci700237g; Folch B, 2010, BIOPHYS J, V98, P667, DOI 10.1016/j.bpj.2009.10.050; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Gromiha MM, 1999, BIOPHYS CHEM, V82, P51, DOI 10.1016/S0301-4622(99)00103-9; Gromiha MM, 2001, BIOPHYS CHEM, V91, P71, DOI 10.1016/S0301-4622(01)00154-5; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Ku TH, 2009, COMPUT BIOL CHEM, V33, P445, DOI 10.1016/j.compbiolchem.2009.10.002; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Kumar S, 2001, BIOCHEMISTRY-US, V40, P14152, DOI 10.1021/bi0106383; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Li YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047247; Ma BG, 2010, STRUCTURE, V18, P819, DOI 10.1016/j.str.2010.04.004; Mora M, 2010, J MOL MED, V88, P143, DOI 10.1007/s00109-009-0574-9; NOJIMA H, 1978, J MOL BIOL, V122, P33, DOI 10.1016/0022-2836(78)90106-7; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; ROOMAN MJ, 1991, J MOL BIOL, V221, P961, DOI 10.1016/0022-2836(91)80186-X; Seeliger D, 2010, BIOPHYS J, V98, P2309, DOI 10.1016/j.bpj.2010.01.051; Shah PS, 2007, J MOL BIOL, V372, P1, DOI 10.1016/j.jmb.2007.06.032; Suhre K, 2003, J BIOL CHEM, V278, P17198, DOI 10.1074/jbc.M301327200; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wijma HJ, 2013, CURRENT OPINION STRU, V23, P17	45	34	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91659	10.1371/journal.pone.0091659	http://dx.doi.org/10.1371/journal.pone.0091659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646884	Green Submitted, gold, Green Published			2022-12-27	WOS:000333348500044
J	Stadnicka-Michalak, J; Tanneberger, K; Schirmer, K; Ashauer, R				Stadnicka-Michalak, Julita; Tanneberger, Katrin; Schirmer, Kristin; Ashauer, Roman			Measured and Modeled Toxicokinetics in Cultured Fish Cells and Application to In Vitro - In Vivo Toxicity Extrapolation	PLOS ONE			English	Article							3 WATERBORNE CHLOROETHANES; ORGANIC-CHEMICALS; RAINBOW-TROUT; ECOTOXICOLOGY; QSARS; LINE	Effect concentrations in the toxicity assessment of chemicals with fish and fish cells are generally based on external exposure concentrations. External concentrations as dose metrics, may, however, hamper interpretation and extrapolation of toxicological effects because it is the internal concentration that gives rise to the biological effective dose. Thus, we need to understand the relationship between the external and internal concentrations of chemicals. The objectives of this study were to: (i) elucidate the time-course of the concentration of chemicals with a wide range of physicochemical properties in the compartments of an in vitro test system, (ii) derive a predictive model for toxicokinetics in the in vitro test system, (iii) test the hypothesis that internal effect concentrations in fish (in vivo) and fish cell lines (in vitro) correlate, and (iv) develop a quantitative in vitro to in vivo toxicity extrapolation method for fish acute toxicity. To achieve these goals, time-dependent amounts of organic chemicals were measured in medium, cells (RTgill-W1) and the plastic of exposure wells. Then, the relation between uptake, elimination rate constants, and log K-OW was investigated for cells in order to develop a toxicokinetic model. This model was used to predict internal effect concentrations in cells, which were compared with internal effect concentrations in fish gills predicted by a Physiologically Based Toxicokinetic model. Our model could predict concentrations of non-volatile organic chemicals with log K-OW between 0.5 and 7 in cells. The correlation of the log ratio of internal effect concentrations in fish gills and the fish gill cell line with the log K-OW was significant (r>0.85, p = 0.0008, F-test). This ratio can be predicted from the log K-OW of the chemical (77% of variance explained), comprising a promising model to predict lethal effects on fish based on in vitro data.	[Stadnicka-Michalak, Julita; Tanneberger, Katrin; Schirmer, Kristin; Ashauer, Roman] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland; [Stadnicka-Michalak, Julita; Schirmer, Kristin] ETH, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Stadnicka-Michalak, Julita; Schirmer, Kristin] EPF Lausanne, Sch Architecture Civil & Environm Engn, Lausanne, Switzerland; [Tanneberger, Katrin] Ecosens AG, Wallisellen, Switzerland; [Ashauer, Roman] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of York - UK	Stadnicka-Michalak, J (corresponding author), Eawag, Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland.	julita.stadnicka@gmail.com	SCHIRMER, KRISTIN/AAG-2332-2019; morantes, silvana/S-3841-2018; Ashauer, Roman/E-6640-2010	morantes, silvana/0000-0001-6628-4526; Ashauer, Roman/0000-0002-9579-8793	European Union [PITN-GA-2009-238148]	European Union(European Commission)	This research is financially supported by the European Union under the 7th Framework Programme ( project acronym CREAM, contract number PITN-GA-2009-238148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, MULTIMEDIA ENV MODEL, DOI DOI 10.1201/9781420032543; Arnot JA, 2006, ENVIRON REV, V14, P257, DOI 10.1139/a06-005; Ashauer R, 2010, J ENVIRON MONITOR, V12, P2056, DOI 10.1039/c0em00234h; Bernhard MJ, 2005, ENVIRON TOXICOL CHEM, V24, P1738, DOI 10.1897/04-234R.1; Bertelsen SL, 1998, EVALUATION LOG KOW T; Bols NC, 2005, BIOCH MOLEC, V6, P43; BOLS NC, 1994, J FISH DIS, V17, P601, DOI 10.1111/j.1365-2761.1994.tb00258.x; Cowan-Ellsberry CE, 2008, CHEMOSPHERE, V70, P1804, DOI 10.1016/j.chemosphere.2007.08.030; Debruyn AMH, 2007, ENVIRON TOXICOL CHEM, V26, P1803, DOI 10.1897/07-016R.1; Endo S, 2013, ENV SCI TECHNOLOGY; Escher Beate I., 2011, Integrated Environmental Assessment and Management, V7, P28, DOI 10.1002/ieam.100; Escher BI, 2002, ENVIRON SCI TECHNOL, V36, P4201, DOI 10.1021/es015848h; FOCUS, 2006, SANCO100582005 FOCUS, P434; Gulden M, 2005, AQUAT TOXICOL, V72, P327, DOI 10.1016/j.aquatox.2005.02.002; Gulden M, 2001, TOXICOL IN VITRO, V15, P233, DOI 10.1016/S0887-2333(01)00008-X; Hestermann EV, 2000, TOXICOL SCI, V53, P316, DOI 10.1093/toxsci/53.2.316; Hoffman D, 2005, PHARM STAT, V4, P15, DOI 10.1002/pst.147; Jager T, 2009, ECOTOXICOLOGY, V18, P187, DOI 10.1007/s10646-008-0271-4; Johnson I, 2009, PROPOSED EQS WATER F, P60; Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q; Kramer NI, 2012, CHEM RES TOXICOL, V25, P436, DOI 10.1021/tx200479k; Kramer NI, 2010, CHEM RES TOXICOL, V23, P1806, DOI 10.1021/tx1002595; Kramer NI, 2009, TOXICOL IN VITRO, V23, P1372, DOI 10.1016/j.tiv.2009.07.029; Li ZH, 2010, COMP BIOCHEM PHYS C, V152, P392, DOI 10.1016/j.cbpc.2010.06.006; MCCARTY LS, 1993, ENVIRON SCI TECHNOL, V27, P1719, DOI 10.1021/es00046a001; Meador JP, 2008, J ENVIRON MONITOR, V10, P1486, DOI 10.1039/b814041n; Nichols JW, 2007, ENVIRON TOXICOL CHEM, V26, P1304, DOI 10.1897/06-259R.1; NICHOLS JW, 1993, AQUAT TOXICOL, V27, P83, DOI 10.1016/0166-445X(93)90049-7; NICHOLS JW, 1991, TOXICOL APPL PHARM, V110, P374, DOI 10.1016/0041-008X(91)90040-L; NICHOLS JW, 1990, TOXICOL APPL PHARM, V106, P433, DOI 10.1016/0041-008X(90)90338-U; OECD, 2019, FISH AC TOX TEST OEC, V2, DOI [10.1787/9789264069961-en, DOI 10.1787/9789264069961-EN]; Ramos EU, 1997, ENVIRON SCI POLLUT R, V4, P83, DOI 10.1007/BF02986285; Rubach Mascha N., 2011, Integrated Environmental Assessment and Management, V7, P172, DOI 10.1002/ieam.105; Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514; Schirmer K, 1997, TOXICOL IN VITRO, V11, P107, DOI 10.1016/S0887-2333(97)00002-7; Schirmer K, 2006, TOXICOLOGY, V224, P163, DOI 10.1016/j.tox.2006.04.042; Schirmer K, 2008, AQUAT TOXICOL, V90, P128, DOI 10.1016/j.aquatox.2008.08.005; Schreiber R, 2008, ENVIRON TOXICOL CHEM, V27, P1676, DOI 10.1897/07-504; Smith KEC, 2010, AQUAT TOXICOL, V98, P15, DOI 10.1016/j.aquatox.2010.01.007; Stadnicka J, 2012, ENVIRON SCI TECHNOL, V46, P3273, DOI 10.1021/es2043728; Tanneberger K, 2013, ENVIRON SCI TECHNOL, V47, P1110, DOI 10.1021/es303505z; Tanneberger K, 2010, ENVIRON SCI TECHNOL, V44, P4775, DOI 10.1021/es100045y; Van Leeuwen C.J., 2007, RISK ASSESSMENT CHEM, P686	43	54	54	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92303	10.1371/journal.pone.0092303	http://dx.doi.org/10.1371/journal.pone.0092303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647349	gold, Green Submitted, Green Published			2022-12-27	WOS:000333348500111
J	van der Plas, MJA; Andersen, AS; Nazir, S; van Tilburg, NH; Oestergaard, PR; Krogfelt, KA; van Dissel, JT; Hensbergen, PJ; Bertina, RM; Nibbering, PH				van der Plas, Mariena J. A.; Andersen, Anders S.; Nazir, Sheresma; van Tilburg, Nico H.; Oestergaard, Peter R.; Krogfelt, Karen A.; van Dissel, Jaap T.; Hensbergen, Paul J.; Bertina, Rogier M.; Nibbering, Peter H.			A Novel Serine Protease Secreted by Medicinal Maggots Enhances Plasminogen Activator-Induced Fibrinolysis	PLOS ONE			English	Article							PRO-INFLAMMATORY RESPONSES; LUCILIA-SERICATA; IN-VITRO; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; DENATURED PROTEINS; DERMAL FIBROBLASTS; SURGICAL MAGGOTS; CHRONIC WOUNDS; LEG ULCERS	Maggots of the blowfly Lucilia sericata are used for the treatment of chronic wounds. As haemostatic processes play an important role in wound healing, this study focused on the effects of maggot secretions on coagulation and fibrinolysis. The results showed that maggot secretions enhance plasminogen activator-induced formation of plasmin and fibrinolysis in a dose-and time-dependent manner. By contrast, coagulation was not affected by secretions. Biochemical studies indicated that a novel serine protease within secretions, designated Sericase, cleaved plasminogen to several fragments. Recombinant Sericase degraded plasminogen leading amongst others to the formation of the mini-plasminogen like fragment Val454-plasminogen. In addition, the presence of a non-proteolytic cofactor in secretions was discovered, which plays a role in the enhancement of plasminogen activator-induced fibrinolysis by Sericase. We conclude from our in vitro studies that the novel serine protease Sericase, with the aid of a non-proteolytic cofactor, enhances plasminogen activator-induced fibrinolysis.	[van der Plas, Mariena J. A.; Nazir, Sheresma; van Dissel, Jaap T.; Nibbering, Peter H.] Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands; [van der Plas, Mariena J. A.] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands; [Andersen, Anders S.; Krogfelt, Karen A.] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark; [Andersen, Anders S.; Oestergaard, Peter R.] Novozymes AS, Bagsvaerd, Denmark; [Andersen, Anders S.] Bispebjerg Hosp, Copenhagen Wound Healing Ctr, DK-2400 Copenhagen, Denmark; [van Tilburg, Nico H.; Bertina, Rogier M.] Leiden Univ, Dept Thrombosis & Hemostasis, Med Ctr, Leiden, Netherlands; [Hensbergen, Paul J.] Leiden Univ, Ctr Prote & Metabol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Statens Serum Institut; Novozymes; University of Copenhagen; Bispebjerg Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Plas, MJA (corresponding author), Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden.	mjavanderplas@gmail.com	van der Plas, Mariena/GYV-3702-2022; Krogfelt, Karen Angeliki/P-2430-2018; Bertina, Rogier/AGQ-5246-2022; Krogfelt, Karen Angeliki A/O-8145-2016	Krogfelt, Karen Angeliki A/0000-0001-7536-3453; van der Plas, Mariena/0000-0002-3233-2881; Hensbergen, Paul/0000-0002-3193-5445	University of Copenhagen, Faculty of Health Sciences; Danish Research Council for Technology and Production [274-05-0435]	University of Copenhagen, Faculty of Health Sciences; Danish Research Council for Technology and Production	Anders Schou Andersen was supported by a clinical PhD scholarship from the University of Copenhagen, Faculty of Health Sciences. The TAST project was financed by a material grant from The Danish Research Council for Technology and Production 274-05-0435 to Professor Karen A. Krogfelt, Statens Serum Institute, Copenhagen, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirbasli M, 2005, INT J CLIN PRACT, V59, P102, DOI 10.1111/j.1742-1241.2005.00379.x; Agren Magnus S, 2007, Int J Low Extrem Wounds, V6, P82, DOI 10.1177/1534734607301394; Andersen A, 2008, 18 EUR TISS REP SOC; Andersen AS, 2010, J ANTIMICROB CHEMOTH, V65, P1646, DOI 10.1093/jac/dkq165; Andersen AS, 2009, MICROBIOLOGY, V156, P400; Becker F, 2004, J MICROBIOL METH, V57, P123, DOI 10.1016/j.mimet.2003.12.002; Brown A, 2012, MED VET ENTOMOL, V26, P432, DOI 10.1111/j.1365-2915.2012.01029.x; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Chambers L, 2003, BRIT J DERMATOL, V148, P14, DOI 10.1046/j.1365-2133.2003.04935.x; Chen WYJ, 2007, WOUND REPAIR REGEN, V15, P434, DOI 10.1111/j.1524-475X.2007.00250.x; CHRISTENSEN U, 1979, BIOCHIM BIOPHYS ACTA, V567, P472, DOI 10.1016/0005-2744(79)90133-5; Church John C T, 2005, Int J Low Extrem Wounds, V4, P59, DOI 10.1177/153473460500400110; Clark RAF, 2001, ANN NY ACAD SCI, V936, P355; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Fine A, 1934, J BONE JOINT SURG, V16, P572; FREDENBURGH JC, 1992, J BIOL CHEM, V267, P26150; Frishman D, 2001, BIOINFORMATICS, V17, P44, DOI 10.1093/bioinformatics/17.1.44; Greiling D, 1997, J CELL SCI, V110, P861; Horobin AJ, 2006, J INVEST DERMATOL, V126, P1410, DOI 10.1038/sj.jid.5700256; Horobin AJ, 2005, WOUND REPAIR REGEN, V13, P422, DOI 10.1111/j.1067-1927.2005.130410.x; Jukema GN, 2002, CLIN INFECT DIS, V35, P1566, DOI 10.1086/344904; Kastl SP, 2006, J THROMB HAEMOST, V4, P1790, DOI 10.1111/j.1538-7836.2006.02046.x; Kim PY, 2012, J BIOL CHEM, V287, P4652, DOI 10.1074/jbc.M111.317719; Lasne D, 2006, CAN J ANAESTH, V53, pS2, DOI 10.1007/BF03022247; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Lerant I, 2000, BBA-PROTEIN STRUCT M, V1480, P311, DOI 10.1016/S0167-4838(00)00083-2; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; MACHOVICH R, 1989, BIOCHEMISTRY-US, V28, P4517, DOI 10.1021/bi00436a059; Machovich R, 1997, ARCH BIOCHEM BIOPHYS, V344, P343, DOI 10.1006/abbi.1997.0221; MOROZ LA, 1981, BLOOD, V58, P97; Mumcuoglu KY, 1998, DIABETES CARE, V21, P2030, DOI 10.2337/diacare.21.11.2030; Namias N, 2000, J BURN CARE REHABIL, V21, P254, DOI 10.1097/00004630-200021030-00012; RADCLIFFE R, 1981, ARCH BIOCHEM BIOPHYS, V211, P750, DOI 10.1016/0003-9861(81)90512-9; Robinson W, 1933, J BONE JOINT SURG, V15, P409; Schmidtchen A, 2003, ACTA DERM-VENEREOL, V83, P310, DOI 10.1080/00015550310016689; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; SHERMAN RA, 1988, MED VET ENTOMOL, V2, P225, DOI 10.1111/j.1365-2915.1988.tb00188.x; Skurk T, 2004, INT J OBESITY, V28, P1357, DOI 10.1038/sj.ijo.0802778; Steen Hanno, 2002, Sci STKE, V2002, ppl16, DOI 10.1126/stke.2002.154.pl16; Steenvoorde P, 2005, Int J Low Extrem Wounds, V4, P57, DOI 10.1177/153473460500400109; Steffensen B, 2001, CRIT REV ORAL BIOL M, V12, P373, DOI 10.1177/10454411010120050201; Subramaniam K, 2008, INT WOUND J, V5, P79, DOI 10.1111/j.1742-481X.2007.00336.x; Telford G, 2012, MED VET ENTOMOL, V26, P291, DOI 10.1111/j.1365-2915.2011.01000.x; Telford G, 2010, BRIT J DERMATOL, V163, P523, DOI 10.1111/j.1365-2133.2010.09854.x; van der Plas MJA, 2009, DIABETOLOGIA, V52, P1962, DOI 10.1007/s00125-009-1432-6; van der Plas MJA, 2008, J ANTIMICROB CHEMOTH, V61, P117, DOI 10.1093/jac/dkm407; van der Plas MJA, 2007, MICROBES INFECT, V9, P507, DOI 10.1016/j.micinf.2007.01.008; van der Plas MJA, 2010, J ANTIMICROB CHEMOTH, V65, P917, DOI 10.1093/jac/dkq042; van der Plas MJA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008071; VISTNES LM, 1981, SURGERY, V90, P835; Walter MC, 2009, NUCLEIC ACIDS RES, V37, pD408, DOI 10.1093/nar/gkn749; Weil Grover C., 1933, AM J SURG, V19, P36; Whitney JD, 2005, NURS CLIN N AM, V40, P191, DOI 10.1016/j.cnur.2004.09.002; Woeldike HF, 1989, PRODUCTION PROTEINS; Wysocki AB, 1999, WOUND REPAIR REGEN, V7, P154, DOI 10.1046/j.1524-475X.1999.00154.x; Zollner TM, 1997, BRIT J DERMATOL, V136, P341, DOI 10.1046/j.1365-2133.1997.5601515.x	56	12	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92096	10.1371/journal.pone.0092096	http://dx.doi.org/10.1371/journal.pone.0092096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647546	gold, Green Submitted, Green Published			2022-12-27	WOS:000333348500084
J	Stefan, N; Sun, Q; Fritsche, A; Machann, J; Schick, F; Gerst, F; Jeppesen, C; Joost, HG; Hu, FB; Boeing, H; Ullrich, S; Haring, HU; Schulze, MB				Stefan, Norbert; Sun, Qi; Fritsche, Andreas; Machann, Juergen; Schick, Fritz; Gerst, Felicia; Jeppesen, Charlotte; Joost, Hans-Georg; Hu, Frank B.; Boeing, Heiner; Ullrich, Susanne; Haering, Hans-Ulrich; Schulze, Matthias B.			Impact of the Adipokine Adiponectin and the Hepatokine Fetuin-A on the Development of Type 2 Diabetes: Prospective Cohort- and Cross-Sectional Phenotyping Studies	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; METABOLICALLY BENIGN; RISK; EXPRESSION; PATHOPHYSIOLOGY; POLYMORPHISMS; ASSOCIATION; MECHANISMS	Background: Among adipokines and hepatokines, adiponectin and fetuin-A were consistently found to predict the incidence of type 2 diabetes, both by regulating insulin sensitivity. Objective: To determine to what extent circulating adiponectin and fetuin-A are independently associated with incident type 2 diabetes in humans, and the major mechanisms involved. Methods: Relationships with incident diabetes were tested in two cohort studies: within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study (628 cases) and the Nurses' Health Study (NHS; 470 cases). Relationships with body fat compartments, insulin sensitivity and insulin secretion were studied in the Tubingen Lifestyle Intervention Program (TULIP; N = 358). Results: Circulating adiponectin and fetuin-A, independently of several confounders and of each other, associated with risk of diabetes in EPIC-Potsdam (RR for 1 SD: adiponectin: 0.45 [95% CI 0.37-0.54], fetuin-A: 1.18 [1.05-1.32]) and the NHS (0.51 [0.42-0.62], 1.35 [1.16-1.58]). Obesity measures considerably attenuated the association of adiponectin, but not of fetuin-A. Subjects with low adiponectin and concomitantly high fetuin-A had the highest risk. Whereas both proteins were independently (both p < 1.8x10(-7)) associated with insulin sensitivity, circulating fetuin-A (r = -0.37, p = 0.0004), but not adiponectin, associated with insulin secretion in subjects with impaired glucose tolerance. Conclusions: We provide novel information that adiponectin and fetuin-A independently of each other associate with the diabetes risk. Furthermore, we suggest that they are involved in the development of type 2 diabetes via different mechanisms, possibly by mediating effects of their source tissues, expanded adipose tissue and nonalcoholic fatty liver.	[Stefan, Norbert; Fritsche, Andreas; Gerst, Felicia; Ullrich, Susanne; Haering, Hans-Ulrich] Univ Tubingen Hosp, Dept Internal Med 4, Tubingen, Germany; [Stefan, Norbert; Fritsche, Andreas; Gerst, Felicia; Ullrich, Susanne; Haering, Hans-Ulrich] Inst Diabet Res & Metab Dis, Tubingen, Germany; [Stefan, Norbert; Fritsche, Andreas; Machann, Juergen; Gerst, Felicia; Jeppesen, Charlotte; Joost, Hans-Georg; Ullrich, Susanne; Haering, Hans-Ulrich; Schulze, Matthias B.] DZD, Munich, Germany; [Sun, Qi; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sun, Qi; Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Sun, Qi; Hu, Frank B.] Harvard Univ, Sch Med, Boston, MA USA; [Machann, Juergen; Schick, Fritz] Univ Tubingen Hosp, Sect Expt Radiol, Tubingen, Germany; [Jeppesen, Charlotte; Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany; [Joost, Hans-Georg] German Inst Human Nutr Potsdam Rehbrucke, Dept Pharmacol, Nuthetal, Germany; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Harvard University; Harvard T.H. Chan School of Public Health; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Stefan, N (corresponding author), Univ Tubingen Hosp, Dept Internal Med 4, Tubingen, Germany.	norbert.stefan@med.uni-tuebingen.de	Schulze, Matthias B/AAH-6906-2021; Joost, Hans-Georg/J-4462-2013	Schulze, Matthias B/0000-0002-0830-5277; Joost, Hans-Georg/0000-0002-5860-606X; Schick, Fritz/0000-0002-4231-3406; Stefan, Norbert/0000-0002-2186-9595	Federal Ministry of Science, Germany [01 EA 9401]; European Union [SOC 95201408 05F02]; German Cancer Aid [70-2488-Ha I]; European Community [SOC 98200769 05F02]; National Institutes of Health [CA87969, CA4449, DK58845, DK58785, P30 DK46200]; National Heart, Lung, and Blood Institute [K99HL098459]; Pilot and Feasibility program; Boston Obesity Nutrition Research Center [DK46200]; German Research Foundation (DFG) [KFO 114, STE 1096/3-1]; German Federal Ministry of Education and Research; Diabetes Stiftung [270-07-10]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL098459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058785, P30DK046200, R56DK058785, R01DK058845] Funding Source: NIH RePORTER	Federal Ministry of Science, Germany; European Union(European Commission); German Cancer Aid(Deutsche Krebshilfe); European Community(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pilot and Feasibility program; Boston Obesity Nutrition Research Center; German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Diabetes Stiftung; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The recruitment phase of the EPIC-Potsdam Study was supported by the Federal Ministry of Science, Germany (01 EA 9401) and the European Union (SOC 95201408 05F02). The follow-up of the EPIC-Potsdam Study was supported by the German Cancer Aid (70-2488-Ha I) and the European Community (SOC 98200769 05F02). The NHS was supported by research grants (CA87969, CA4449, DK58845, DK58785, and P30 DK46200) from the National Institutes of Health. Q.S. was supported by a career development award K99HL098459 from the National Heart, Lung, and Blood Institute and a Pilot and Feasibility program sponsored by the Boston Obesity Nutrition Research Center (DK46200). The TULIP was supported by grants from the German Research Foundation (DFG; KFO 114, and a Heisenberg-Professorship to NS: STE 1096/3-1). The study was also supported by the German Federal Ministry of Education and Research to the German Center for Diabetes Research (DZD eV) and a grant from the Diabetes Stiftung (270-07-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBERGER P, 1989, CELL, V58, P631, DOI 10.1016/0092-8674(89)90098-6; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Dasgupta S, 2010, BIOCHEM J, V429, P451, DOI 10.1042/BJ20100330; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Fisher E, 2009, CIRC-CARDIOVASC GENE, V2, P607, DOI 10.1161/CIRCGENETICS.109.870410; Gastaldelli A, 2007, GASTROENTEROLOGY, V133, P496, DOI 10.1053/j.gastro.2007.04.068; Gavin JR, 1997, DIABETES CARE, V20, P1183; Haukeland JW, 2012, EUR J ENDOCRINOL, V166, P503, DOI 10.1530/EJE-11-0864; Heinrichsdorff J, 2012, NAT MED, V18, P1182, DOI 10.1038/nm.2869; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; Islam Md Shahidul, 2012, Methods Mol Biol, V933, P161, DOI 10.1007/978-1-62703-068-7_10; Ix JH, 2008, JAMA-J AM MED ASSOC, V300, P182, DOI 10.1001/jama.300.2.182; Ix JH, 2012, CIRCULATION, V125, P2316, DOI 10.1161/CIRCULATIONAHA.111.072751; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Ou HY, 2012, ENDOCRINOLOGY, V153, P2974, DOI 10.1210/en.2011-2043; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Perseghin G, 2011, DIABETES CARE, V34, pS367, DOI 10.2337/dc11-s249; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Rees DA, 2012, DIABETIC MED, V22, P359; Reinehr T, 2008, J CLIN ENDOCR METAB, V93, P4479, DOI 10.1210/jc.2008-1505; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Staiger K, 2005, J CLIN ENDOCR METAB, V90, P6707, DOI 10.1210/jc.2005-0467; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Stefan N, 2013, NAT MED, V19, P394, DOI 10.1038/nm.3116; Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258; Stefan N, 2011, DIABETES, V60, P2011, DOI 10.2337/db11-0231; Sun Q, 2013, DIABETES, V62, P49, DOI 10.2337/db12-0372; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Weikert C, 2008, CIRCULATION, V118, P2555, DOI 10.1161/CIRCULATIONAHA.108.814418	38	57	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92238	10.1371/journal.pone.0092238	http://dx.doi.org/10.1371/journal.pone.0092238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643166	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900109
J	Thompson, MC; Wheeler, KK; Shi, JX; Smith, GA; Xiang, HY				Thompson, Meghan C.; Wheeler, Krista K.; Shi, Junxin; Smith, Gary A.; Xiang, Huiyun			An Evaluation of Comparability between NEISS and ICD-9-CM Injury Coding	PLOS ONE			English	Article							SURVEILLANCE SYSTEM	Objective: To evaluate the National Electronic Injury Surveillance System's (NEISS) comparability with a data source that uses ICD-9-CM coding. Methods: A sample of NEISS cases from a children's hospital in 2008 was selected, and cases were linked with their original medical record. Medical records were reviewed and an ICD-9-CM code was assigned to each case. Cases in the NEISS sample that were non-injuries by ICD-9-CM standards were identified. A bridging matrix between the NEISS and ICD-9-CM injury coding systems, by type of injury classification, was proposed and evaluated. Results: Of the 2,890 cases reviewed, 13.32% (n = 385) were non-injuries according to the ICD-9-CM diagnosis. Using the proposed matrix, the comparability of the NEISS with ICD-9-CM coding was favorable among injury cases (k = 0.87, 95% CI: 0.85-0.88). The distribution of injury types among the entire sample was similar for the two systems, with percentage differences >= 1% for only open wounds or amputation, poisoning, and other or unspecified injury types. Conclusions: There is potential for conducting comparable injury research using NEISS and ICD-9-CM data. Due to the inclusion of some non-injuries in the NEISS and some differences in type of injury definitions between NEISS and ICD-9-CM coding, best practice for studies using NEISS data obtained from the CPSC should include manual review of case narratives. Use of the standardized injury and injury type definitions presented in this study will facilitate more accurate comparisons in injury research.	[Thompson, Meghan C.; Wheeler, Krista K.; Shi, Junxin; Smith, Gary A.; Xiang, Huiyun] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA; [Thompson, Meghan C.; Smith, Gary A.; Xiang, Huiyun] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Xiang, HY (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA.	Huiyun.Xiang@nationwidechildrens.org	Xiang, Huiyun/E-4335-2011	Thompson, Meghan/0000-0003-1462-4802	National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, United States Department of Health and Human Services [1R49CE000241-01]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE000241] Funding Source: NIH RePORTER	National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, United States Department of Health and Human Services; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was funded by the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, United States Department of Health and Human Services (Grant No.: 1R49CE000241-01). The views expressed here are solely the responsibility of the authors and do not necessarily reflect the official views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; [Anonymous], 2009, ACC ICD 9 CM COD 5 0; [Anonymous], 2013, ICD 10; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Buck CJ, 2009, 2009 ICD 9 CM, V1; Centers for Disease Control and Prevention, 2003, WEB BAS INJ STAT QUE; CHRISTOFFEL KK, 1992, PEDIATRICS, V89, P1027; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Division of Hazard and Injury Systems U.S. Consumer Product Safety Commission, 2000, NEISS NAT EL INJ SUR; German R R, 2001, MMWR Recomm Rep, V50, P1; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Gilchrist Julie, 2012, Morbidity and Mortality Weekly Report, V61, P270; Halpin J, 2009, INJURY PREV, V15, P328, DOI 10.1136/ip.2009.021691; Harris VA, 2011, PEDIATRICS, V128, P455, DOI 10.1542/peds.2010-2687; Holder Y., 2001, INJURY SURVEILLANCE; Horan JM, 2003, EPIDEMIOL REV, V25, P24, DOI 10.1093/epirev/mxg010; Israeli Center for Trauma and Emergency Medicine Research Gertner Institute Sheba Medical Center, BAR INJ DIAGN MATR C BAR INJ DIAGN MATR C; Jhung MA, 2007, MED CARE, V45, pS96, DOI 10.1097/MLR.0b013e318041f737; Lawrence BA., 2011, MED WORK LOSS COST E; Lawrence BA, 2000, INJURY CONTROL SAFET, V7, P97; McDonald A K, 1996, Inj Prev, V2, P77, DOI 10.1136/ip.2.1.77; Miller TR., 1995, DATABOOK NONFATAL IN; Quinlan KP, 1999, ANN EMERG MED, V34, P637, DOI 10.1016/S0196-0644(99)70166-6; Schroeder T, 2013, STATISTICIAN; Spicer R.S., 2010, FINAL REPORT NATL HI; U.S. Consumer Product Safety Commission, 2012, NEISS COD MAN ALL TR; U.S. Consumer Product Safety Commission, 2012, NEISS COD MAN; United States Department of Health and Human Services Centers for Disease Control and Prevention National Center for Injury Prevention and Control and United States Consumer Product Safety Commission, 2009, NAT EL INJ SURV SYST; Weiss H B, 1996, Inj Prev, V2, P61, DOI 10.1136/ip.2.1.61; Xiang H, 2006, INJURY PREV, V12, P8, DOI 10.1136/ip.2005.010033; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034	31	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92052	10.1371/journal.pone.0092052	http://dx.doi.org/10.1371/journal.pone.0092052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658100	gold, Green Published			2022-12-27	WOS:000333355300051
J	Barciszewska, AM; Nowak, S; Naskret-Barciszewska, MZ				Barciszewska, Anna-Maria; Nowak, Stanislaw; Naskret-Barciszewska, Miroslawa Z.			The Degree of Global DNA Hypomethylation in Peripheral Blood Correlates with That in Matched Tumor Tissues in Several Neoplasia	PLOS ONE			English	Article							METHYLATION; DEMETHYLATION; CANCER; CLASSIFICATION; EPIGENOME; BIOLOGY; CELLS	There are no good blood and serum biomarkers for detection, follow up, or prognosis of brain tumors. However, they are needed for more detailed tumor classification, better prognosis estimation and selection of an efficient therapeutic strategy. The aim of this study was to use the epigenetic changes in DNA of peripheral blood samples as a molecular marker to diagnose brain tumors as well as other diseases. We have applied a very precise thin-layer chromatography (TLC) analysis of the global amount of 5-methylcytosine (m(5)C) in DNA from brain tumors, colon and breast cancer tissues and peripheral blood samples of the same patients. The m(5)C level in tissue DNA from different brain tumor types, expressed as R coefficient, changes within the range of 0.2-1.6 and overlaps with R of that of blood samples. It negatively correlates with the WHO malignancy grade. The global DNA hypomethylation quantitative measure in blood, demonstrates a big potential for development of non-invasive applications for detection of a low and a high grade brain tumors. We have also used this approach to analyze patients with breast and colon cancers. In all these cases the m(5)C amount in DNA cancer tissue match with data of blood. This study is the first to demonstrate the potential role of global m(5)C content in blood DNA for early detection of brain tumors and others diseases. So, genomic DNA hypomethylation is a promising marker for prognosis of various neoplasms as well as other pathologies.	[Barciszewska, Anna-Maria; Nowak, Stanislaw] Poznan Univ Med Sci, Dept Neurosurg & Neurotraumatol, Poznan, Poland; [Naskret-Barciszewska, Miroslawa Z.] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland	Poznan University of Medical Sciences; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Barciszewska, AM (corresponding author), Poznan Univ Med Sci, Dept Neurosurg & Neurotraumatol, Poznan, Poland.	abarcisz@man.poznan.pl	Barciszewska, Anna-Maria/J-5978-2018	Barciszewska, Anna-Maria/0000-0002-7179-1474	Polish Ministry of Science and Higher Education [N N401 066338, N N403 219637]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported within the Polish Ministry of Science and Higher Education projects Nr N N401 066338 to AMB and MZNB and Nr N N403 219637 to AMB, SN and MZNB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli R, 2011, FREE RADICAL BIO MED, V50, P254, DOI 10.1016/j.freeradbiomed.2010.11.009; Barciszewska AM, 2007, IUBMB LIFE, V59, P765, DOI 10.1080/15216540701697412; Barciszewska AM, 2009, THERAPEUTIC RIBONUCLEIC ACIDS IN BRAIN TUMORS, P141, DOI 10.1007/978-3-642-00475-9_7; Barciszewska MZ, 2007, BIOGERONTOLOGY, V8, P673, DOI 10.1007/s10522-007-9109-3; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Fouse SD, 2010, EPIGENOMICS-UK, V2, P105, DOI 10.2217/EPI.09.35; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Fueyo J, 2011, ARCH NEUROL-CHICAGO, V68, P303, DOI 10.1001/archneurol.2010.293; Gong ZZ, 2011, CELL RES, V21, P1649, DOI 10.1038/cr.2011.140; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Iwamoto K, 2011, GENOME RES, V21, P688, DOI 10.1101/gr.112755.110; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Klug M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r63; Langevin SM, 2012, EPIGENETICS-US, V7, P291, DOI 10.4161/epi.7.3.19134; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nagarajan RP, 2009, SEMIN CANCER BIOL, V19, P188, DOI 10.1016/j.semcancer.2009.02.005; Nelson HH, 2011, ENVIRON HEALTH PERSP, V119, P1528, DOI 10.1289/ehp.1103423; Niedzwiecki MM, 2013, EPIGENETICS-US, V8, P730, DOI 10.4161/epi.25012; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Rajendran G, 2011, J NEURO-ONCOL, V104, P483, DOI 10.1007/s11060-010-0520-2; Smolarek I, 2010, MED SCI MONITOR, V16, pCR149; Stieber D, 2011, EXPERT OPIN THER TAR, V15, P1227, DOI 10.1517/14728222.2011.588211; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Ullah MF, 2009, CANCER TREAT REV, V35, P193, DOI 10.1016/j.ctrv.2008.10.004; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Volle CB, 2012, BIOCHEMISTRY-US, V51, P52, DOI 10.1021/bi201552s; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zukiel R, 2004, MOL CANCER RES, V2, P196	33	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92599	10.1371/journal.pone.0092599	http://dx.doi.org/10.1371/journal.pone.0092599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651295	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800132
J	Cox, JC; Sadiraj, V; Schmidt, U				Cox, James C.; Sadiraj, Vjollca; Schmidt, Ulrich			Asymmetrically Dominated Choice Problems, the Isolation Hypothesis and Random Incentive Mechanisms	PLOS ONE			English	Article							DECISION; RISK	This paper presents an experimental study of the random incentive mechanisms which are a standard procedure in economic and psychological experiments. Random incentive mechanisms have several advantages but are incentive-compatible only if responses to the single tasks are independent. This is true if either the independence axiom of expected utility theory or the isolation hypothesis of prospect theory holds. We present a simple test of this in the context of choice under risk. In the baseline (one task) treatment we observe risk behavior in a given choice problem. We show that by integrating a second, asymmetrically dominated choice problem in a random incentive mechanism risk behavior can be manipulated systematically. This implies that the isolation hypothesis is violated and the random incentive mechanism does not elicit true preferences in our example.	[Cox, James C.; Sadiraj, Vjollca] Georgia State Univ, Andrew Young Sch Policy Studies, Atlanta, GA 30303 USA; [Schmidt, Ulrich] Kiel Inst World Econ, Kiel, Germany; [Schmidt, Ulrich] Univ Kiel, Dept Econ, Kiel, Germany	University System of Georgia; Georgia State University; Institut fur Weltwirtschaft an der Universitat Kiel (IFW); University of Kiel	Schmidt, U (corresponding author), Kiel Inst World Econ, Kiel, Germany.	ulrich.schmidt@ifw-kiel.de						Anderson S, 2007, APPL ECON, V39, P675, DOI 10.1080/00036840500462046; Baltussen G., 2009, WORKING PAPER; Beattie J, 1997, J RISK UNCERTAINTY, V14, P155, DOI 10.1023/A:1007721327452; Bhargava M, 2000, J CONSUM PSYCHOL, V9, P167, DOI 10.1207/S15327663JCP0903_4; Birnbaum MH, 2008, PSYCHOL REV, V115, P463, DOI 10.1037/0033-295X.115.2.463; Camerer C. F., 1989, J RISK UNCERTAINTY, V2, P61, DOI DOI 10.1007/BF00055711; CONLISK J, 1989, AM ECON REV, V79, P392; Costa-Gomes MA, 2008, REV ECON STUD, V75, P729, DOI 10.1111/j.1467-937X.2008.00498.x; Cubitt R., 2001, J ECON METHODOL, V8, P385, DOI DOI 10.1080/13501780110103748; Cubitt R. P., 1998, Experimental Economics, V1, P115, DOI 10.1023/A:1026435508449; Heinemann F, 2009, REV ECON STUD, V76, P181, DOI 10.1111/j.1467-937X.2008.00512.x; Hey JD, 2005, EXP ECON, V8, P233, DOI 10.1007/s10683-005-1465-8; Hey JD, 2005, APPL ECON, V37, P9, DOI 10.1080/0003684042000286124; HOLT CA, 1986, AM ECON REV, V76, P508; Hsee CK, 1998, J CONSUM RES, V25, P175, DOI 10.1086/209534; HUBER J, 1982, J CONSUM RES, V9, P90, DOI 10.1086/208899; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Laury S., 2005, SOCIAL SCI RES NETWO, DOI [10.2139/ssrn.894271, DOI 10.2139/SSRN.894271]; Lee JW, 2008, J RISK UNCERTAINTY, V36, P19, DOI 10.1007/s11166-007-9028-3; Offerman T, 2009, REV ECON STUD, V76, P1461, DOI 10.1111/j.1467-937X.2009.00557.x; Regenwetter M, 2011, PSYCHOL REV, V118, P42, DOI 10.1037/a0021150; SIMONSON I, 1992, J MARKETING RES, V29, P281, DOI 10.2307/3172740; STARMER C, 1991, AM ECON REV, V81, P971	23	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90742	10.1371/journal.pone.0090742	http://dx.doi.org/10.1371/journal.pone.0090742			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651486	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800022
J	Quesnelle, PE; Lindsay, KE; Fahrig, L				Quesnelle, Pauline E.; Lindsay, Kathryn E.; Fahrig, Lenore			Low Reproductive Rate Predicts Species Sensitivity to Habitat Loss: A Meta-Analysis of Wetland Vertebrates	PLOS ONE			English	Article							HOME-RANGE SIZE; PATCH ISOLATION METRICS; DISPERSAL DISTANCE; EXPERIMENTAL TRANSLOCATIONS; FRAGMENTED LANDSCAPES; MOVEMENT PATTERNS; SPATIAL ECOLOGY; ANIMAL MOVEMENT; BIRD MOVEMENTS; FOREST	We tested the hypotheses that species with greater mobility and/or higher reproductive rates are less sensitive to habitat loss than species with lower mobility and/or reproductive rates by conducting a meta-analysis of wetland vertebrate responses to wetland habitat loss. We combined data from 90 studies conducted worldwide that quantified the relationship between wetland amount in a landscape and population abundance of at least one wetland species to determine if mobility (indexed as home range size and body length) and annual reproductive rate influence species responses to wetland loss. When analyzed across all taxa, animals with higher reproductive rates were less sensitive to wetland loss. Surprisingly, we did not find an effect of mobility on response to wetland loss. Overall, wetland mammals and birds were more sensitive to wetland loss than were reptiles and amphibians. Our results suggest that dispersal between habitat patches is less important than species' reproductive rates for population persistence in fragmented landscapes. This implies that immigration and colonization rate is most strongly related to reproduction, which determines the total number of potential colonists.	[Quesnelle, Pauline E.; Lindsay, Kathryn E.; Fahrig, Lenore] Carleton Univ, Ottawa Carleton Inst Biol, Geomat & Landscape Ecol Res Lab, Ottawa, ON K1S 5B6, Canada; [Lindsay, Kathryn E.] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada	Carleton University; University of Ottawa; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada	Quesnelle, PE (corresponding author), Carleton Univ, Ottawa Carleton Inst Biol, Geomat & Landscape Ecol Res Lab, Ottawa, ON K1S 5B6, Canada.	pauline.quesnelle@glel.carleton.ca	Fahrig, Lenore/C-6494-2012	Fahrig, Lenore/0000-0002-3841-0342; Lindsay, Kathryn/0000-0001-8763-1937	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation/Ontario Innovation Fund Grant	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation/Ontario Innovation Fund Grant(Canada Foundation for Innovation)	This study was supported by a Natural Sciences and Engineering Research Council of Canada scholarship to P.E.Q and a Canada Foundation for Innovation/Ontario Innovation Fund Grant to K.E.L and L.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; Attum O, 2007, J ZOOL, V271, P134, DOI 10.1111/j.1469-7998.2006.00178.x; Baguette M, 2000, J APPL ECOL, V37, P100, DOI 10.1046/j.1365-2664.2000.00478.x; Bender DJ, 2005, ECOLOGY, V86, P1023, DOI 10.1890/03-0769; Bender DJ, 2003, LANDSCAPE ECOL, V18, P17, DOI 10.1023/A:1022937226820; Blomquist SM, 2009, HERPETOL CONSERV BIO, V4, P142; Borenstein M, 2009, INTRO META ANAL; Bowman J, 2003, CAN J ZOOL, V81, P195, DOI 10.1139/Z02-237; Bowman J, 2002, ECOLOGY, V83, P2049, DOI 10.2307/3071786; Bowne DR, 2004, LANDSCAPE ECOL, V19, P1, DOI 10.1023/B:LAND.0000018357.45262.b9; Cardador L, 2009, IBIS, V151, P766, DOI 10.1111/j.1474-919X.2009.00963.x; Cosentino BJ, 2010, LANDSCAPE ECOL, V25, P1589, DOI 10.1007/s10980-010-9529-3; deVries HH, 1996, OECOLOGIA, V107, P332, DOI 10.1007/BF00328449; Eigenbrod F, 2011, BIOL CONSERV, V144, P298, DOI 10.1016/j.biocon.2010.09.007; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Gibbs JP, 1998, LANDSCAPE ECOL, V13, P263, DOI 10.1023/A:1008056424692; Gobeil JF, 2002, OIKOS, V98, P447, DOI 10.1034/j.1600-0706.2002.980309.x; Guerry AD, 2002, CONSERV BIOL, V16, P745, DOI 10.1046/j.1523-1739.2002.00557.x; Gurevitch Jessica, 1993, P378; Hadley AS, 2009, BIOL LETTERS, V5, P207, DOI 10.1098/rsbl.2008.0691; Hanski I, 1994, BIOL CONSERV, V15, P250; Heard GW, 2012, BIOL CONSERV, V148, P156, DOI 10.1016/j.biocon.2012.01.018; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Hinam HL, 2008, BIOL CONSERV, V141, P524, DOI 10.1016/j.biocon.2007.11.011; Holland GJ, 2009, BIODIVERS CONSERV, V18, P2997, DOI 10.1007/s10531-009-9621-7; Holland Jeffrey D., 2005, Journal of Insect Conservation, V9, P109, DOI 10.1007/s10841-005-0612-z; Houlahan JE, 2003, CAN J FISH AQUAT SCI, V60, P1078, DOI [10.1139/f03-095, 10.1139/F03-095]; Hullett CR, 2003, COMMUN MONOGR, V70, P52, DOI 10.1080/715114664; Jackson HB, 2012, LANDSCAPE ECOL, V27, P929, DOI 10.1007/s10980-012-9757-9; Jenkins DG, 2007, GLOBAL ECOL BIOGEOGR, V16, P415, DOI 10.1111/j.1466-8238.2007.00312.x; Jennions MD., 2013, HDB META ANAL ECOLOG, P207, DOI [10.23943/princeton/9780691137285.003.0014, DOI 10.23943/PRINCETON/9780691137285.003.0014, DOI 10.1515/9781400846184-016]; Kennedy CM, 2010, BIOL CONSERV, V143, P2136, DOI 10.1016/j.biocon.2010.05.025; Lajeunesse M.J., 2013, HDB METAANALYSIS ECO, P195, DOI DOI 10.1515/9781400846184-015; Lemckert Francis L., 2004, Applied Herpetology, V1, P165, DOI 10.1163/157075403323012179; Leon-Cortes JL, 2003, OIKOS, V102, P449, DOI 10.1034/j.1600-0706.2003.12129.x; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; MARTIN AH, 2012, NY TIMES BK REV 0415, P22; Meyer CFJ, 2008, J APPL ECOL, V45, P381, DOI 10.1111/j.1365-2664.2007.01389.x; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING WE; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.2307/3071919; Neuschulz EL, 2013, ANIM CONSERV, V16, P170, DOI 10.1111/j.1469-1795.2012.00582.x; Newbold T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2131; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Ockinger E, 2009, BASIC APPL ECOL, V10, P573, DOI [10.1016/j.baac.2008.12.002, 10.1016/j.baae.2008.12.002]; Perry G, 2002, ECOLOGY, V83, P1870, DOI 10.2307/3071771; Pope SE, 2000, ECOLOGY, V81, P2498; Prugh LR, 2009, ECOL APPL, V19, P1300, DOI 10.1890/08-1524.1; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Quesnelle PE, 2013, BIOL CONSERV, V160, P200, DOI 10.1016/j.biocon.2013.01.020; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ranius T, 2010, ECOGRAPHY, V33, P971, DOI 10.1111/j.1600-0587.2009.06363.x; Rehm EM, 2007, WILSON J ORNITHOL, V119, P648, DOI 10.1676/06-060.1; Roe JH, 2008, AUSTRAL ECOL, V33, P1045, DOI 10.1111/j.1442-9993.2008.01877.x; Row JR, 2006, COPEIA, P797, DOI 10.1643/0045-8511(2006)6[797:KANAEO]2.0.CO;2; Rucker G, 2009, STAT MED, V28, P721, DOI 10.1002/sim.3511; Rytwinski T, 2012, BIOL CONSERV, V147, P87, DOI 10.1016/j.biocon.2011.11.023; Schooley RL, 2006, J MAMMAL, V87, P495, DOI 10.1644/05-MAMM-A-249R1.1; Schooley RL, 2009, ECOL APPL, V19, P1708, DOI 10.1890/08-2169.1; Semlitsch RD, 2008, J WILDLIFE MANAGE, V72, P260, DOI 10.2193/2007-082; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Skidds DE, 2007, J HERPETOL, V41, P439, DOI 10.1670/0022-1511(2007)41[439:HCOREI]2.0.CO;2; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Swihart RK, 2003, DIVERS DISTRIB, V9, P1, DOI 10.1046/j.1472-4642.2003.00158.x; Thomas CD, 2000, P ROY SOC B-BIOL SCI, V267, P139, DOI 10.1098/rspb.2000.0978; Thornton D, 2011, ECOL APPL, V21, P817, DOI 10.1890/10-0549.1; Thornton DH, 2011, LANDSCAPE ECOL, V26, P7, DOI 10.1007/s10980-010-9549-z; Tischendorf L, 2003, LANDSCAPE ECOL, V18, P41, DOI 10.1023/A:1022908109982; Tscharntke T, 2002, ECOL RES, V17, P229, DOI 10.1046/j.1440-1703.2002.00482.x; Uezu A, 2005, BIOL CONSERV, V123, P507, DOI 10.1016/j.biocon.2005.01.001; Van Buskirk J, 2005, ECOLOGY, V86, P1936, DOI 10.1890/04-1237; Van Houtan KS, 2007, ECOL LETT, V10, P219, DOI 10.1111/j.1461-0248.2007.01004.x; Vance MD, 2003, ECOLOGY, V84, P2643, DOI 10.1890/02-0159; Vetter D, 2011, ECOGRAPHY, V34, P1, DOI 10.1111/j.1600-0587.2010.06453.x; Veysey JS, 2011, LANDSCAPE ECOL, V26, P661, DOI 10.1007/s10980-011-9590-6; Vie J-C, 2009, WILDLIFE CHANGING WO; Wang Y, 2009, ANIM CONSERV, V12, P329, DOI 10.1111/j.1469-1795.2009.00257.x; With KA, 1999, CONSERV BIOL, V13, P314, DOI 10.1046/j.1523-1739.1999.013002314.x	82	25	27	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90926	10.1371/journal.pone.0090926	http://dx.doi.org/10.1371/journal.pone.0090926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651675	gold, Green Published			2022-12-27	WOS:000333352800027
J	Sano, M; Sasaki, T; Hirakawa, S; Sakabe, J; Ogawa, M; Baba, S; Zaima, N; Tanaka, H; Inuzuka, K; Yamamoto, N; Setou, M; Sato, K; Konno, H; Unno, N				Sano, Masaki; Sasaki, Takeshi; Hirakawa, Satoshi; Sakabe, Junichi; Ogawa, Mikako; Baba, Satoshi; Zaima, Nobuhiro; Tanaka, Hiroki; Inuzuka, Kazunori; Yamamoto, Naoto; Setou, Mitsutoshi; Sato, Kohji; Konno, Hiroyuki; Unno, Naoki			Lymphangiogenesis and Angiogenesis in Abdominal Aortic Aneurysm	PLOS ONE			English	Article							MACROPHAGE RECRUITMENT; MICROVESSEL DENSITY; BREAST-CANCER; UP-REGULATION; ATHEROSCLEROSIS; INFLAMMATION; PATHOGENESIS; PODOPLANIN; TUMORS; CELLS	The pathogenesis of abdominal aortic aneurysm (AAA) is characterized to be inflammation-associated degeneration of vascular wall. Neovascularization is regularly found in human AAA and considered to play critical roles in the development and rupture of AAA. However, little is known about lymphangiogenesis in AAA. The purpose of this study was to demonstrate both angiogenesis and lymphangiogenesis in AAA. Abdominal aortic tissue was harvested either from autopsy (control group) and during open-repair surgery for AAA (AAA group). Adventitial lymphatic vasa vasorum was observed in both groups, but seemed to be no significant morphological changes in AAA. Immunohistochemical studies identified infiltration of lymphatic vessel endothelial hyaluronan receptor (LYVE) -1, vascular endothelial growth factor (VEGF)-C, and matrix metalloproteinase (MMP)-9-positive macrophages and podoplanin and Prox-1-positive microvessels in the intima/media in AAA wall, where hypoxia-inducible factors (HIF)-1 alpha was expressed. VEGF-C and MMP-9 were not expressed in macrophages infiltrating in the adventitia. Intraoperative indocyanine green fluorescence lymphography revealed lymph stasis in intima/medial in AAA. Fluorescence microscopy of the collected samples also confirmed the accumulation of lymph in the intima/media but not in adventitia. These results demonstrate that infiltration of macrophages in intima/media is associated with lymphangiogenesis and angiogenesis in AAA. Lymph-drainage appeared to be insufficient in the AAA wall.	[Sano, Masaki; Tanaka, Hiroki; Inuzuka, Kazunori; Yamamoto, Naoto; Unno, Naoki] Med Photon Res Ctr, Appl Med Photon Lab, Div Vasc Surg, Hamamatsu, Shizuoka, Japan; [Sasaki, Takeshi; Sato, Kohji] Med Photon Res Ctr, Appl Med Photon Lab, Dept Anat & Neurosci, Hamamatsu, Shizuoka, Japan; [Hirakawa, Satoshi; Sakabe, Junichi] Med Photon Res Ctr, Appl Med Photon Lab, Dept Dermatol, Hamamatsu, Shizuoka, Japan; [Ogawa, Mikako] Med Photon Res Ctr, Appl Med Photon Lab, Dept Mol Imaging, Hamamatsu, Shizuoka, Japan; [Baba, Satoshi] Hamamatsu Univ Sch Med, Dept Diagnost Pathol, Hamamatsu, Shizuoka 4313192, Japan; [Zaima, Nobuhiro; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan; [Sano, Masaki; Tanaka, Hiroki; Inuzuka, Kazunori; Yamamoto, Naoto; Konno, Hiroyuki; Unno, Naoki] Hamamatsu Univ Sch Med, Dept Surg 2, Hamamatsu, Shizuoka 4313192, Japan; [Zaima, Nobuhiro] Kinki Univ, Dept Appl Biol Chem, Osaka, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Kindai University (Kinki University)	Unno, N (corresponding author), Med Photon Res Ctr, Appl Med Photon Lab, Div Vasc Surg, Hamamatsu, Shizuoka, Japan.	unno@hama-med.ac.jp		Sakabe, Jun-Ichi/0000-0002-8237-0472	Japan Society for the Promotion of Science (JSPS) [22591400]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101090, R01GM088847] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24689049, 23390289] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported partly by a Grant-in-Aid for Scientific Research (C) (22591400) (to N.U.) from Japan Society for the Promotion of Science (JSPS) for purchasing reagents or analysis tools. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Choi I, 2013, ANGIOGENESIS, V16, P29, DOI 10.1007/s10456-012-9297-6; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Danese S, 2006, GASTROENTEROLOGY, V130, P2060, DOI 10.1053/j.gastro.2006.03.054; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Drozdz K, 2012, LYMPHOLOGY, V45, P26; Fenyo IM, 2013, IMMUNOBIOLOGY, V218, P1376, DOI 10.1016/j.imbio.2013.06.005; FOX SB, 1995, J PATHOL, V177, P275, DOI 10.1002/path.1711770310; Hatakeyama K, 2012, THROMB RES; HOLMES DR, 1995, J VASC SURG, V21, P761, DOI 10.1016/S0741-5214(05)80007-2; James JM, 2013, DEVELOPMENT, V140, P3903, DOI 10.1242/dev.095026; Kajimoto K, 2009, ATHEROSCLEROSIS, V206, P505, DOI 10.1016/j.atherosclerosis.2009.03.028; Kaneko H, 2011, CARDIOVASC RES, V91, P358, DOI 10.1093/cvr/cvr080; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Miwa K, 2005, GENE THER, V12, P1109, DOI 10.1038/sj.gt.3302496; Nakayama Y, 2007, ANTICANCER RES, V27, P619; Ordonez NG, 2012, ADV ANAT PATHOL, V19, P281, DOI 10.1097/PAP.0b013e3182691c2a; Rizas KD, 2009, CARDIOL REV, V17, P201, DOI 10.1097/CRD.0b013e3181b04698; ROSS R, 1976, NEW ENGL J MED, V295, P420, DOI 10.1056/NEJM197608192950805; ROSS R, 1976, NEW ENGL J MED, V295, P369, DOI 10.1056/NEJM197608122950707; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schoppmann SF, 2001, ANTICANCER RES, V21, P2351; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sharma R, 2008, ANN NY ACAD SCI, V1131, P13, DOI 10.1196/annals.1413.002; Shi VY, 2012, MICROCIRCULATION, V19, P567, DOI 10.1111/j.1549-8719.2012.00189.x; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Sugaya M, 2012, J INVEST DERMATOL, V132, P667, DOI 10.1038/jid.2011.349; Suzuki Y, 2012, KIDNEY INT, V81, P865, DOI 10.1038/ki.2011.464; Swedenborg J, 2011, ARTERIOSCL THROM VAS, V31, P734, DOI 10.1161/ATVBAHA.110.213157; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tanaka H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057398; Thairu N, 2011, ANGIOGENESIS, V14, P223, DOI 10.1007/s10456-011-9208-2; Unno N, 2008, EUR J VASC ENDOVASC, V36, P230, DOI 10.1016/j.ejvs.2008.04.013; Unno N, 2013, SURG TODAY; Vermeulen PB, 1996, EUR J CANCER, V32A, P2474, DOI 10.1016/S0959-8049(96)00379-6; Vijaynagar B, 2013, EUR J CLIN INVEST, V43, P758, DOI 10.1111/eci.12103; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WOLPE SD, 1988, J EXP MED, V167, P570, DOI 10.1084/jem.167.2.570; Xu XS, 2009, INT J CARDIOL, V134, P426, DOI 10.1016/j.ijcard.2007.12.098; Zampell JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049940; Zampell JC, 2012, PLAST RECONSTR SURG, V129, P825, DOI 10.1097/PRS.0b013e3182450b2d; Zhou Q, 2011, ARTHRITIS RHEUM-US, V63, P2318, DOI 10.1002/art.30421	52	34	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e89830	10.1371/journal.pone.0089830	http://dx.doi.org/10.1371/journal.pone.0089830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651519	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800005
J	Wierenga, C; Bischoff-Grethe, A; Melrose, AJ; Grenesko-Stevens, E; Irvine, Z; Wagner, A; Simmons, A; Matthews, S; Yau, WYW; Fennema-Notestine, C; Kaye, WH				Wierenga, Christina; Bischoff-Grethe, Amanda; Melrose, A. James; Grenesko-Stevens, Emily; Irvine, Zoe; Wagner, Angela; Simmons, Alan; Matthews, Scott; Yau, Wai-Ying Wendy; Fennema-Notestine, Christine; Kaye, Walter H.			Altered BOLD Response during Inhibitory and Error Processing in Adolescents with Anorexia Nervosa	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL FLEXIBILITY; SET-SHIFTING ABILITY; ANTERIOR CINGULATE; EATING-DISORDERS; BRAIN ACTIVATION; NO-GO; TASK; MODEL; CHILDHOOD; RECOVERY	Background: Individuals with anorexia nervosa (AN) are often cognitively rigid and behaviorally over-controlled. We previously showed that adult females recovered from AN relative to healthy comparison females had less prefrontal activation during an inhibition task, which suggested a functional brain correlate of altered inhibitory processing in individuals recovered from AN. However, the degree to which these functional brain alterations are related to disease state and whether error processing is altered in AN individuals is unknown. Methodology/Principal Findings: In the current study, ill adolescent AN females (n = 11) and matched healthy comparison adolescents (CA) with no history of an eating disorder (n = 12) performed a validated stop signal task (SST) during functional magnetic resonance imaging (fMRI) to explore differences in error and inhibitory processing. The groups did not differ on sociodemographic variables or on SST performance. During inhibitory processing, a significant group x difficulty (hard, easy) interaction was detected in the right dorsal anterior cingulate cortex (ACC), right middle frontal gyrus (MFG), and left posterior cingulate cortex (PCC), which was characterized by less activation in AN compared to CA participants during hard trials. During error processing, a significant group x accuracy (successful inhibit, failed inhibit) interaction in bilateral MFG and right PCC was observed, which was characterized by less activation in AN compared to CA participants during error (i.e., failed inhibit) trials. Conclusion/Significance: Consistent with our prior findings in recovered AN, ill AN adolescents, relative to CA, showed less inhibition-related activation within the dorsal ACC, MFG and PCC as inhibitory demand increased. In addition, ill AN adolescents, relative to CA, also showed reduced activation to errors in the bilateral MFG and left PCC. These findings suggest that altered prefrontal and cingulate activation during inhibitory and error processing may represent a behavioral characteristic in AN that is independent of the state of recovery.	[Wierenga, Christina; Bischoff-Grethe, Amanda; Melrose, A. James; Grenesko-Stevens, Emily; Irvine, Zoe; Wagner, Angela; Simmons, Alan; Matthews, Scott; Yau, Wai-Ying Wendy; Fennema-Notestine, Christine; Kaye, Walter H.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Simmons, Alan; Matthews, Scott] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Fennema-Notestine, Christine] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Bischoff-Grethe, A (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	agrethe@ucsd.edu	Wierenga, Christina/N-3019-2017; Simmons, Alan N/A-9815-2008	Wierenga, Christina/0000-0002-4843-1809; Simmons, Alan N/0000-0003-3963-2112; Fennema-Notestine, Christine/0000-0002-6527-6361	National Institutes of Health [R21-MH086017, R01-MH042984-17A1, R01-MH042984-18S1]; Price Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH042984, R21MH086017, R01MH092793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Price Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by National Institutes of Health grants R21-MH086017, R01-MH042984-17A1, R01-MH042984-18S1, and the Price Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 2012, COG NEUROPSYCHI 0717; Anguera JA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00649; Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Attia E, 2005, BIOL PSYCHIAT, V57, P674, DOI 10.1016/j.biopsych.2004.11.045; Badgaiyan RD, 1998, NEUROIMAGE, V7, P255, DOI 10.1006/nimg.1998.0326; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; BEATON GH, 1979, AM J CLIN NUTR, V32, P2546, DOI 10.1093/ajcn/32.12.2546; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Boutelle KN, 1998, OBES RES, V6, P219, DOI 10.1002/j.1550-8528.1998.tb00340.x; Brooks SJ, 2012, CONSCIOUS COGN, V21, P751, DOI 10.1016/j.concog.2012.02.006; Brooks SJ, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-76; Buhren K, 2012, J NEURAL TRANSM, V119, P1047, DOI 10.1007/s00702-012-0821-z; Bulik CM, 2007, INT J EAT DISORDER, V40, P310, DOI 10.1002/eat.20367; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Casey BJ, 2011, J RES ADOLESCENCE, V21, P21, DOI 10.1111/j.1532-7795.2010.00712.x; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dietz WH, 1998, PEDIATRICS, V101, P518; Dixon LB, 2006, J NUTR, V136, P3054, DOI 10.1093/jn/136.12.3054; Ferro AM, 2005, INT J EAT DISORDER, V38, P323, DOI 10.1002/eat.20203; First M. D., 1996, USERS GUIDE STRUCTUR; Fitzpatrick KK, 2012, INT J EAT DISORDER, V45, P909, DOI 10.1002/eat.22027; Frank GK, 2005, BIOL PSYCHIAT, V58, P908, DOI 10.1016/j.biopsych.2005.05.003; Friederich HC, 2011, CURR TOP BEHAV NEURO, V6, P111, DOI 10.1007/7854_2010_83; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Halmi KA, 2012, INT J EAT DISORDER, V45, P800, DOI 10.1002/eat.22019; Harnishfeger KK, 1996, J EXP CHILD PSYCHOL, V62, P292, DOI 10.1006/jecp.1996.0032; Heaton KH, 2003, WISCONSIN CARD SORTI; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; HERZOG DB, 1992, J CLIN PSYCHIAT, V53, P147; Holliday J, 2005, AM J PSYCHIAT, V162, P2269, DOI 10.1176/appi.ajp.162.12.2269; Jenkinson M., 2004, 10 INT C FUNCT MAPP; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Jimerson DC, 1996, PSYCHIAT CLIN N AM, V19, P739, DOI 10.1016/S0193-953X(05)70378-6; Kaye WH, 2013, BIOL PSYCHIAT, V73, P836, DOI 10.1016/j.biopsych.2013.01.002; Kaye WH, 2013, TRENDS NEUROSCI, V36, P110, DOI 10.1016/j.tins.2013.01.003; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; Keel PK, 1999, ARCH GEN PSYCHIAT, V56, P63, DOI 10.1001/archpsyc.56.1.63; Klein DA, 2003, INT REV PSYCHIATR, V15, P205, DOI 10.1080/0954026031000136839; Knutson B, 2007, ANN NY ACAD SCI, V1104, P54, DOI 10.1196/annals.1390.020; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Kullman S, 2013, SOC COGN AFFECT NEUR; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lampard AM, 2011, EAT BEHAV, V12, P90, DOI 10.1016/j.eatbeh.2010.11.004; Lock J, 2005, INT J EAT DISORDER, V37, pS64, DOI 10.1002/eat.20122; Lock J, 2011, AM J PSYCHIAT, V168, P55, DOI 10.1176/appi.ajp.2010.10010056; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Marsh R, 2006, HUM BRAIN MAPP, V27, P848, DOI 10.1002/hbm.20225; Marsh R, 2011, AM J PSYCHIAT, V168, P1210, DOI 10.1176/appi.ajp.2011.11010094; Matthews SC, 2005, NEUROREPORT, V16, P755, DOI 10.1097/00001756-200505120-00020; McAnarney ER, 2011, J ADOLESCENT HEALTH, V49, P99, DOI 10.1016/j.jadohealth.2010.11.259; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Nakazato M, 2009, PSYCHOL MED, V39, P1029, DOI 10.1017/S0033291708004108; Nakazato M, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-29; National Institute for Health and Clinical Excellence (NICE), 2004, COR INT TREATM MAN A; Oberndorfer TA, 2011, INT J EAT DISORDER, V44, P1, DOI 10.1002/eat.20750; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Pieters GLM, 2007, BRAIN COGNITION, V63, P42, DOI 10.1016/j.bandc.2006.07.009; Pinheiro J, 2020, R PACKAGE VERSION 31; Roberts ME, 2007, PSYCHOL MED, V37, P1075, DOI 10.1017/S0033291707009877; Robertson G, 2006, WIDE RANGE ACHIEVEME; Sarrar L, 2011, PSYCHONEUROENDOCRINO, V36, P1396, DOI 10.1016/j.psyneuen.2011.03.014; Sato Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061108; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Shott ME, 2012, NEUROPSYCHOLOGY, V26, P191, DOI 10.1037/a0026771; Stedal K, 2012, EUR EAT DISORD REV, V20, P175, DOI 10.1002/erv.1160; Steinglass JE, 2006, J INT NEUROPSYCH SOC, V12, P431, DOI 10.1017/S1355617706060528; Steinglass JE, 2012, J INT NEUROPSYCH SOC, V18, P773, DOI 10.1017/S1355617712000446; Suskauer SJ, 2008, J AM ACAD CHILD PSY, V47, P1141, DOI 10.1097/CHI.0b013e3181825b1f; Tchanturia K, 2004, J PSYCHIATR RES, V38, P545, DOI 10.1016/j.jpsychires.2004.03.001; Tchanturia K, 2002, Eat Weight Disord, V7, P312; Tchanturia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028331; Vogt BA, 2005, J COMP NEUROL, V485, P218, DOI 10.1002/cne.20512; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Wagner A, 2006, INT J EAT DISORDER, V39, P276, DOI 10.1002/eat.20251; Walton ME, 2003, J NEUROSCI, V23, P6475; Wartenburger I, 2009, NEUROIMAGE, V48, P291, DOI 10.1016/j.neuroimage.2009.06.025; Watanabe J, 2002, NEUROIMAGE, V17, P1207, DOI 10.1006/nimg.2002.1198; Wecshler D, 1999, WECHSLER ABBREVIATED; Woolley J, 2008, BRIT J PSYCHIAT, V192, P25, DOI 10.1192/bjp.bp.107.036558; Yang TT, 2009, NEUROREPORT, V20, P440, DOI 10.1097/WNR.0b013e3283262e10; Yucel M, 2003, J PSYCHIATR NEUROSCI, V28, P350; Zastrow A, 2009, AM J PSYCHIAT, V166, P608, DOI 10.1176/appi.ajp.2008.08050775; Zheng D, 2008, J COGNITIVE NEUROSCI, V20, P1434, DOI 10.1162/jocn.2008.20100	88	51	51	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92017	10.1371/journal.pone.0092017	http://dx.doi.org/10.1371/journal.pone.0092017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651705	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800064
J	Yucebas, SC; Son, YA				Yucebas, Sait Can; Son, Yesim Aydin			A Prostate Cancer Model Build by a Novel SVM-ID3 Hybrid Feature Selection Method Using Both Genotyping and Phenotype Data from dbGaP	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUPPORT VECTOR MACHINES; BODY-MASS INDEX; RISK; CLASSIFICATION; METAANALYSIS; DIAGNOSIS; GENETICS; DENSITY; ANTIGEN	Through Genome Wide Association Studies (GWAS) many Single Nucleotide Polymorphism (SNP)-complex disease relations can be investigated. The output of GWAS can be high in amount and high dimensional, also relations between SNPs, phenotypes and diseases are most likely to be nonlinear. In order to handle high volume-high dimensional data and to be able to find the nonlinear relations we have utilized data mining approaches and a hybrid feature selection model of support vector machine and decision tree has been designed. The designed model is tested on prostate cancer data and for the first time combined genotype and phenotype information is used to increase the diagnostic performance. We were able to select phenotypic features such as ethnicity and body mass index, and SNPs those map to specific genes such as CRR9, TERT. The performance results of the proposed hybrid model, on prostate cancer dataset, with 90.92% of sensitivity and 0.91 of area under ROC curve, shows the potential of the approach for prediction and early detection of the prostate cancer.	[Yucebas, Sait Can; Son, Yesim Aydin] Middle E Tech Univ, Grad Sch Informat, Dept Med Informat, TR-06531 Ankara, Turkey; [Son, Yesim Aydin] Middle E Tech Univ, Grad Sch Informat, Bioinformat Grad Program, TR-06531 Ankara, Turkey	Middle East Technical University; Middle East Technical University	Son, YA (corresponding author), Middle E Tech Univ, Grad Sch Informat, Dept Med Informat, TR-06531 Ankara, Turkey.	yesim.aydinson@gmail.com	SON, Yesim AYDIN/F-5879-2011; Son, Yesim Aydin/AAF-8696-2019; Yucebas, Sait/O-7341-2019	SON, Yesim AYDIN/0000-0002-8118-4272; Son, Yesim Aydin/0000-0002-8118-4272; Yucebas, Sait Can/0000-0002-1030-3545	NATIONAL CANCER INSTITUTE [RC2CA148085, U01CA136792, U01CA098758, R37CA054281, P01CA033619, R01CA063464] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004726] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA63464, R37CA54281, P01CA33619, RC2 CA148085, U01CA136792, U01CA98758] Funding Source: Medline; NHGRI NIH HHS [U01HG004726, U01HG004789-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abeel T, 2010, BIOINFORMATICS, V26, P392, DOI 10.1093/bioinformatics/btp630; Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Aguiar V., 2010, SOFT COMPUTING METHO, P219; Aksoy Y, 2003, ANN CLIN LAB SCI, V33, P320; Anunciacao O, 2010, ADV INTEL SOFT COMPU, V74, P43, DOI 10.1007/978-3-642-13214-8_6; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; BRETTON PR, 1994, CANCER, V74, P2991, DOI 10.1002/1097-0142(19941201)74:11<2991::AID-CNCR2820741116>3.0.CO;2-R; Caplan A, 2002, AM J CLIN PATHOL, V117, P104, DOI DOI 10.1309/C4UN-12LK-43HP-JXY3; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Frohlich H, 2005, IEEE IJCNN, P1431; Gerstenblith MR, 2010, PIGM CELL MELANOMA R, V23, P587, DOI 10.1111/j.1755-148X.2010.00730.x; Giovannucci E, 2003, J NATL CANCER I, V95, P1240, DOI 10.1093/jnci/djg009; Graczyk M, 2009, LECT NOTES ARTIF INT, V5796, P800; He JY, 2006, IEEE T NANOBIOSCI, V5, P46, DOI 10.1109/TNB.2005.864021; HIATT RA, 1994, CANCER CAUSE CONTROL, V5, P66, DOI 10.1007/BF01830728; Hoffman Richard M, 2002, BMC Fam Pract, V3, P19, DOI 10.1186/1471-2296-3-19; Hoffman RM, 2001, JNCI-J NATL CANCER I, V93, P388, DOI 10.1093/jnci/93.5.388; Huang J, 2004, P NATL ACAD SCI USA, V101, P10529, DOI 10.1073/pnas.0403794101; Huang LC, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-81; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kleinmann N, 2012, NAT REV UROL, V9, P258, DOI 10.1038/nrurol.2012.56; Lee JC, 2011, BRIEF FUNCT GENOMICS, V10, P71, DOI 10.1093/bfgp/elr009; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Listgarten J, 2004, CLIN CANCER RES, V10, P2725, DOI 10.1158/1078-0432.CCR-1115-03; Mooney MA, 2012, IEEE ACM T COMPUT BI, V9, P899, DOI 10.1109/TCBB.2011.145; Mourad R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-16; Musani SK, 2007, HUM HERED, V63, P67, DOI 10.1159/000099179; OESTERLING JE, 1991, J UROLOGY, V145, P907, DOI 10.1016/S0022-5347(17)38491-4; Reddy MVPL, 2011, GENES IMMUN, V12, P208, DOI 10.1038/gene.2010.70; Ritchie MD, 2007, APPL SOFT COMPUT, V7, P471, DOI 10.1016/j.asoc.2006.01.013; Rokach L, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P165, DOI 10.1007/0-387-25465-X_9; Scholkopf B., 2004, MIT PRESS SERIES COM; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tsuji S, 2010, HUM MOL GENET, V19, pR65, DOI 10.1093/hmg/ddq162; Ullah AZD, 2012, NUCLEIC ACIDS RES, V40, pW65, DOI 10.1093/nar/gks364; Wu KP, 2009, PATTERN RECOGN, V42, P710, DOI 10.1016/j.patcog.2008.08.030; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	41	9	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91404	10.1371/journal.pone.0091404	http://dx.doi.org/10.1371/journal.pone.0091404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651484	Green Published, gold			2022-12-27	WOS:000333352800040
J	Chen, HJ; Wang, Y; Zhu, XQ; Li, PC; Teng, GJ				Chen, Hua-Jun; Wang, Yu; Zhu, Xi-Qi; Li, Pei-Cheng; Teng, Gao-Jun			Classification of Cirrhotic Patients with or without Minimal Hepatic Encephalopathy and Healthy Subjects Using Resting-State Attention-Related Network Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; INHIBITORY CONTROL TEST; FUNCTIONAL MRI; ALZHEIMERS-DISEASE; HUMAN BRAIN; IMPAIRMENT; DIAGNOSIS; ABNORMALITIES; DYSFUNCTION	Background: Attention deficit is an early and key characteristic of minimal hepatic encephalopathy (MHE) and has been used as indicator for MHE detection. The aim of this study is to classify the cirrhotic patients with or without MHE (NMHE) and healthy controls (HC) using the resting-state attention-related brain network analysis. Methods and Findings: Resting-state fMRI was administrated to 20 MHE patients, 21 NMHE patients, and 17 HCs. Three attention-related networks, including dorsal attention network (DAN), ventral attention network (VAN), and default mode network (DMN), were obtained by independent component analysis. One-way analysis of covariance was performed to determine the regions of interest (ROIs) showing significant functional connectivity (FC) change. With FC strength of ROIs as indicators, Linear Discriminant Analysis (LDA) was conducted to differentiate MHE from HC or NMHE. Across three groups, significant FC differences were found within DAN (left superior/inferior parietal lobule and right inferior parietal lobule), VAN (right superior parietal lobule), and DMN (bilateral posterior cingulate gyrus and precuneus, and left inferior parietal lobule). With FC strength of ROIs from three networks as indicators, LDA yielded 94.6% classification accuracy between MHE and HC (100% sensitivity and 88.2% specificity) and 85.4% classification accuracy between MHE and NMHE (90.0% sensitivity and 81.0% specificity). Conclusions: Our results suggest that the resting-state attention-related brain network analysis can be useful in classification of subjects with MHE, NMHE, and HC and may provide a new insight into MHE detection.	[Chen, Hua-Jun; Wang, Yu; Zhu, Xi-Qi; Li, Pei-Cheng; Teng, Gao-Jun] Southeast Univ, Jiangsu Key Lab Mol & Funct Imaging, Dept Radiol, Zhongda Hosp,Med Sch, Nanjing, Jiangsu, Peoples R China; [Zhu, Xi-Qi] Southeast Univ, Dept Radiol, Hosp Nanjing 2, Sch Med, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Teng, GJ (corresponding author), Southeast Univ, Jiangsu Key Lab Mol & Funct Imaging, Dept Radiol, Zhongda Hosp,Med Sch, Nanjing, Jiangsu, Peoples R China.	gjteng@vip.sina.com	xiqi, zhu/GLU-8790-2022		National Basic Research Program of China (973 Program) [2013CB733800, 2013CB733803]; National Natural Science Foundation of China [30910103905]; Scientific Research Foundation of Graduate School of Southeast University [YBJJ1243]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Graduate School of Southeast University	This work was supported by grants from the National Basic Research Program of China (973 Program: No. 2013CB733800, No. 2013CB733803), National Natural Science Foundation of China (No. 30910103905), and Scientific Research Foundation of Graduate School of Southeast University (No. YBJJ1243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio P, 2005, METAB BRAIN DIS, V20, P115, DOI 10.1007/s11011-005-4149-3; Bajaj JS, 2008, GASTROENTEROLOGY, V135, P1591, DOI 10.1053/j.gastro.2008.07.021; Bajaj JS, 2008, HEPATOLOGY, V47, P596, DOI 10.1002/hep.22032; Bajaj JS, 2007, AM J GASTROENTEROL, V102, P754, DOI 10.1111/j.1572-0241.2007.01048.x; Bajaj JS, 2013, HEPATOLOGY, V58, P1122, DOI 10.1002/hep.26309; Bajaj JS, 2012, HEPATOLOGY, V55, P1164, DOI 10.1002/hep.25507; Bajaj JS, 2009, HEPATOLOGY, V50, P2014, DOI 10.1002/hep.23216; Bao ZJ, 2007, WORLD J GASTROENTERO, V13, P3003, DOI 10.3748/wjg.v13.i21.3003; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chen G, 2011, RADIOLOGY, V259, P213, DOI 10.1148/radiol.10100734; Chen HJ, 2013, RADIOLOGY, V266, P261, DOI 10.1148/radiol.12120026; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Felipo V, 2012, HEPATOLOGY, V55, P530, DOI 10.1002/hep.24704; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Guevara M, 2011, J HEPATOL, V55, P564, DOI 10.1016/j.jhep.2010.12.008; Hsu TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035266; Li R, 2012, HUM BRAIN MAPP, V33, P1076, DOI 10.1002/hbm.21269; Li R, 2011, NEUROIMAGE, V56, P1035, DOI 10.1016/j.neuroimage.2011.03.010; Li YY, 2004, WORLD J GASTROENTERO, V10, P2397; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Lin WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036986; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Ni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042016; Prasad S, 2007, HEPATOLOGY, V45, P549, DOI 10.1002/hep.21533; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041376; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Qi RF, 2012, RADIOLOGY, V264, P187, DOI 10.1148/radiol.12111429; Romero-Gomez M, 2004, HEPATOLOGY, V39, P939, DOI 10.1002/hep.20152; Schomerus H, 2001, METAB BRAIN DIS, V16, P37, DOI 10.1023/A:1011610427843; Sharma P, 2007, J HEPATOL, V47, P67, DOI 10.1016/j.jhep.2007.02.022; Wein C, 2004, HEPATOLOGY, V39, P739, DOI 10.1002/hep.20095; Weissenborn K, 2005, METAB BRAIN DIS, V20, P359, DOI 10.1007/s11011-005-7919-z; Weissenborn K, 2001, METAB BRAIN DIS, V16, P13, DOI 10.1023/A:1011654210096; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Xuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030570; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zhang LJ, 2007, ACTA RADIOL, V48, P577, DOI 10.1080/02841850701308378; Zhang LJ, 2012, RADIOLOGY, V265, P528, DOI 10.1148/radiol.12120185; Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042824; Zhang LJ, 2012, HUM BRAIN MAPP, V33, P1384, DOI 10.1002/hbm.21295; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zhong B, 2001, Zhonghua Nei Ke Za Zhi, V40, P13; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029	46	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89684	10.1371/journal.pone.0089684	http://dx.doi.org/10.1371/journal.pone.0089684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647353	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500007
J	Chester, ET; Matthews, TG; Howson, TJ; Johnston, K; Mackie, JK; Strachan, SR; Robson, BJ				Chester, Edwin T.; Matthews, Ty G.; Howson, Travis J.; Johnston, Kerrylyn; Mackie, Jonathon K.; Strachan, Scott R.; Robson, Belinda J.			Constraints upon the Response of Fish and Crayfish to Environmental Flow Releases in a Regulated Headwater Stream Network	PLOS ONE			English	Article							MACULATUS JENYNS 1842; FRESH-WATER FISH; GALAXIAS-MACULATUS; PROCAMBARUS-CLARKII; INVASIVE CRAYFISH; CLIMATE-CHANGE; LIFE-HISTORY; DROUGHT; RIVER; RECOLONIZATION	In dry climate zones, headwater streams are often regulated for water extraction causing intermittency in perennial streams and prolonged drying in intermittent streams. Regulation thereby reduces aquatic habitat downstream of weirs that also form barriers to migration by stream fauna. Environmental flow releases may restore streamflow in rivers, but are rarely applied to headwaters. We sampled fish and crayfish in four regulated headwater streams before and after the release of summer-autumn environmental flows, and in four nearby unregulated streams, to determine whether their abundances increased in response to flow releases. Historical data of fish and crayfish occurrence spanning a 30 year period was compared with contemporary data (electrofishing surveys, Victoria Range, Australia; summer 2008 to summer 2010) to assess the longer-term effects of regulation and drought. Although fish were recorded in regulated streams before 1996, they were not recorded in the present study upstream or downstream of weirs despite recent flow releases. Crayfish (Geocharax sp. nov. 1) remained in the regulated streams throughout the study, but did not become more abundant in response to flow releases. In contrast, native fish (Gadopsis marmoratus, Galaxias oliros, Galaxias maculatus) and crayfish remained present in unregulated streams, despite prolonged drought conditions during 2006-2010, and the assemblages of each of these streams remained essentially unchanged over the 30 year period. Flow release volumes may have been too small or have operated for an insufficient time to allow fish to recolonise regulated streams. Barriers to dispersal may also be preventing recolonisation. Indefinite continuation of annual flow releases, that prevent the unnatural cessation of flow caused by weirs, may eventually facilitate upstream movement of fish and crayfish in regulated channels; but other human-made dispersal barriers downstream need to be identified and ameliorated, to allow native fish to fulfil their life cycles in these headwater streams.	[Chester, Edwin T.; Strachan, Scott R.; Robson, Belinda J.] Murdoch Univ, Perth, WA, Australia; [Matthews, Ty G.; Howson, Travis J.; Mackie, Jonathon K.] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Johnston, Kerrylyn] Murdoch Univ, Marine & Freshwater Res Lab, Perth, WA, Australia	Murdoch University; Deakin University; Murdoch University	Robson, BJ (corresponding author), Murdoch Univ, Perth, WA, Australia.	b.robson@murdoch.edu.au	Matthews, Ty/G-1677-2013	Robson, Belinda/0000-0002-9215-3666	Glenelg-Hopkins Catchment Management Authority; Wannon Water	Glenelg-Hopkins Catchment Management Authority; Wannon Water	This research was funded by the Glenelg-Hopkins Catchment Management Authority (www.ghcma.vic.gov.au) and Wannon Water (www.wannonwater.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G.R., 2002, FIELD GUIDE FRESHWAT; Barbee NC, 2011, MAR FRESHWATER RES, V62, P790, DOI 10.1071/MF10284; Barriga JP, 2007, J APPL ICHTHYOL, V23, P128, DOI 10.1111/j.1439-0426.2006.00820.x; Beatty S., 2013, NOVEL METHODS MANAGI; Bond NR, 2008, HYDROBIOLOGIA, V600, P3, DOI 10.1007/s10750-008-9326-z; Bond N, 2011, MAR FRESHWATER RES, V62, P1043, DOI 10.1071/MF10286; Bond N, 2010, FRESHWATER BIOL, V55, P1997, DOI 10.1111/j.1365-2427.2010.02421.x; Chapman A, 2006, ENVIRON BIOL FISH, V77, P21, DOI 10.1007/s10641-006-9051-2; Chessman BC, 2010, FRESHWATER BIOL, V55, P1780, DOI 10.1111/j.1365-2427.2010.02403.x; Chester ET, 2011, FRESHWATER BIOL, V56, P2094, DOI 10.1111/j.1365-2427.2011.02644.x; Coleman RA, 2010, CONSERV GENET, V11, P1911, DOI 10.1007/s10592-010-0082-z; Creed RP, 2004, J N AM BENTHOL SOC, V23, P224, DOI 10.1899/0887-3593(2004)023&lt;0224:EEBCIA&gt;2.0.CO;2; Dexter T, 2013, AUSTRAL ECO IN PRESS; Doehring K, 2011, MAR FRESHWATER RES, V62, P38, DOI 10.1071/MF10101; Dorn NJ, 2008, HYDROBIOLOGIA, V605, P209, DOI 10.1007/s10750-008-9355-7; Englund G, 1999, OIKOS, V87, P48, DOI 10.2307/3546995; Feurich R, 2012, ECOL ENG, V47, P1, DOI 10.1016/j.ecoleng.2012.06.013; Finn DS, 2011, J N AM BENTHOL SOC, V30, P963, DOI 10.1899/11-012.1; Flinders CA, 2003, AM MIDL NAT, V149, P134, DOI 10.1674/0003-0031(2003)149[0134:EOSPOC]2.0.CO;2; GARVEY JE, 1994, ECOLOGY, V75, P532, DOI 10.2307/1939556; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Gherardi F, 2000, ARCH HYDROBIOL, V150, P153; Gorley C.K., 2006, GETTING STARTED PRIM; Harris JH, 2013, ECOLOGY OF AUSTRALIAN FRESHWATER FISHES, P223; Hitt NP, 2012, OIKOS, V121, P127, DOI 10.1111/j.1600-0706.2011.19482.x; Howson TJ, 2012, ECOL ENG, V40, P144, DOI 10.1016/j.ecoleng.2011.12.007; JACKSON P D, 1983, Proceedings of the Royal Society of Victoria, V95, P39; JACKSON PD, 1978, AUST J MAR FRESH RES, V29, P293; JACKSON PD, 1978, AUST J MAR FRESH RES, V29, P725, DOI 10.1071/MF9780725; Johnston K., 2010, Freshwater Crayfish, V17, P245; Johnston K, 2011, AUSTRAL ECOL, V36, P269, DOI 10.1111/j.1442-9993.2010.02147.x; Kerby JL, 2005, BIOL CONSERV, V126, P402, DOI 10.1016/j.biocon.2005.06.020; King AJ, 2013, ECOLOGY OF AUSTRALIAN FRESHWATER FISHES, P159; Koster WM, 2008, ECOL FRESHW FISH, V17, P146, DOI 10.1111/j.1600-0633.2007.00269.x; Lassalle G, 2009, FRESHWATER BIOL, V54, P587, DOI 10.1111/j.1365-2427.2008.02135.x; Laurenson LJB, 2012, J FISH BIOL, V81, P1085, DOI 10.1111/j.1095-8649.2012.03383.x; Lind PR, 2007, RIVER RES APPL, V23, P933, DOI 10.1002/rra.1016; Mackie JK, 2013, ECOL ENG, V53, P100, DOI 10.1016/j.ecoleng.2012.12.018; Matthews WJ, 2003, FRESHWATER BIOL, V48, P1232, DOI 10.1046/j.1365-2427.2003.01087.x; McMaster D, 2008, MAR FRESHWATER RES, V59, P177, DOI 10.1071/MF07140; Miller Adam D., 2004, Memoirs of Museum Victoria, V61, P121; Morrongiello JR, 2011, MAR FRESHWATER RES, V62, P1082, DOI 10.1071/MF10308; Murchie KJ, 2008, RIVER RES APPL, V24, P197, DOI 10.1002/rra.1058; Raadik TA, 2011, SYSTEMATIC REVISION; Raadik TA, 1996, AQUATIC FAUNA SURVEY; Robson BJ, 2010, MAR FRESHWATER RES, V61, P778, DOI 10.1071/MF09073; Robson BJ, 2013, HYDROBIOLOGIA, V719, P77, DOI 10.1007/s10750-012-1371-y; Robson BJ, 2011, ECOL ENG, V37, P1379, DOI 10.1016/j.ecoleng.2011.03.015; Robson BJ, 2008, FRESHWATER BIOL, V53, P2385, DOI 10.1111/j.1365-2427.2008.02061.x; Schultz MB, 2007, INVERTEBR SYST, V21, P569, DOI 10.1071/IS07019; STEIN RA, 1977, ECOLOGY, V58, P1237, DOI 10.2307/1935078; Urbina MA, 2011, PHYSIOL BEHAV, V103, P240, DOI 10.1016/j.physbeh.2011.02.009	52	16	16	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91925	10.1371/journal.pone.0091925	http://dx.doi.org/10.1371/journal.pone.0091925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647407	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500061
J	Norberg, P; Bergstrom, M; Hermansson, M				Norberg, Peter; Bergstrom, Maria; Hermansson, Malte			Complete Nucleotide Sequence and Analysis of Two Conjugative Broad Host Range Plasmids from a Marine Microbial Biofilm	PLOS ONE			English	Article							RESISTANCE INCP-1 PLASMID; COMPLETE GENOME SEQUENCE; HORIZONTAL GENE-TRANSFER; ANTIMICROBIAL RESISTANCE; BACTERIAL COMMUNITIES; SEDIMENT BACTERIA; ESCHERICHIA-COLI; TRANSPOSONS; RECOMBINATION; DIVERSITY	The complete nucleotide sequence of plasmids pMCBF1 and pMCBF6 was determined and analyzed. pMCBF1 and pMCBF6 form a novel clade within the IncP-1 plasmid family designated IncP-1 sigma. The plasmids were exogenously isolated earlier from a marine biofilm. pMCBF1 (62 689 base pairs; bp) and pMCBF6 (66 729 bp) have identical backbones, but differ in their mercury resistance transposons. pMCBF1 carries Tn5053 and pMCBF6 carries Tn5058. Both are flanked by 5 bp direct repeats, typical of replicative transposition. Both insertions are in the vicinity of a resolvase gene in the backbone, supporting the idea that both transposons are "res-site hunters'' that preferably insert close to and use external resolvase functions. The similarity of the backbones indicates recent insertion of the two transposons and the ongoing dynamics of plasmid evolution in marine biofilms. Both plasmids also carry the insertion sequence ISPst1, albeit without flanking repeats. ISPs1is located in an unusual site within the control region of the plasmid. In contrast to most known IncP-1 plasmids the pMCBF1/pMCBF6 backbone has no insert between the replication initiation gene (trfA) and the vegetative replication origin (oriV). One pMCBF1/pMCBF6 block of about 2.5 kilo bases (kb) has no similarity with known sequences in the databases. Furthermore, insertion of three genes with similarity to the multidrug efflux pump operon mexEF and a gene from the NodT family of the tripartite multi-drug resistance-nodulation-division (RND) system in Pseudomonas aeruginosa was found. They do not seem to confer antibiotic resistance to the hosts of pMCBF1/pMCBF6, but the presence of RND on promiscuous plasmids may have serious implications for the spread of antibiotic multi-resistance.	[Norberg, Peter] Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden; [Bergstrom, Maria; Hermansson, Malte] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Hermansson, M (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	malte.hermansson@cmb.gu.se			Swedish Research Council [2002-214]; University of Gothenburg	Swedish Research Council(Swedish Research CouncilEuropean Commission); University of Gothenburg	Financial support for this study was provided by The Swedish Research Council (contract no. 2002-214), to M. H. and by the University of Gothenburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl MI, 2007, PLASMID, V58, P31, DOI 10.1016/j.plasmid.2006.11.007; BAYA AM, 1986, APPL ENVIRON MICROB, V51, P1285, DOI 10.1128/AEM.51.6.1285-1292.1986; Bolognese F, 1999, APPL ENVIRON MICROB, V65, P1876; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Cook MA, 2001, MICROBIOL-SGM, V147, P2089, DOI 10.1099/00221287-147-8-2089; COUTURIER M, 1988, MICROBIOL REV, V52, P375, DOI 10.1128/MMBR.52.3.375-395.1988; Dahlberg C, 1997, APPL ENVIRON MICROB, V63, P4692, DOI 10.1128/AEM.63.12.4692-4697.1997; Dahlberg C, 1998, APPL ENVIRON MICROB, V64, P2670; Dahlberg C, 1998, MOL BIOL EVOL, V15, P385, DOI 10.1093/oxfordjournals.molbev.a025935; del Castillo CS, 2013, INT J ANTIMICROB AG, V42, P10, DOI 10.1016/j.ijantimicag.2013.02.027; Haines AS, 2006, MICROBIOL-SGM, V152, P2689, DOI 10.1099/mic.0.28941-0; HERMANSSON M, 1987, APPL ENVIRON MICROB, V53, P2338, DOI 10.1128/AEM.53.10.2338-2342.1987; Heuer H, 2012, FEMS MICROBIOL REV, V36, P1083, DOI 10.1111/j.1574-6976.2012.00337.x; Holmes EC, 1999, EVOLUTION OF HIV, P177; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kholodii G, 2002, MICROBIOL-SGM, V148, P3569, DOI 10.1099/00221287-148-11-3569; KHOLODII GY, 1995, MOL MICROBIOL, V17, P1189, DOI 10.1111/j.1365-2958.1995.mmi_17061189.x; KHOLODII GY, 1993, J MOL BIOL, V230, P1103, DOI 10.1006/jmbi.1993.1228; Kirzhner V, 2007, J MOL EVOL, V64, P448, DOI 10.1007/s00239-006-0178-8; KOBAYASHI N, 1994, MICROBIOL-SGM, V140, P289, DOI 10.1099/13500872-140-2-289; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lopez-Perez M, 2013, GENOME BIOL EVOL, V5, P1220, DOI 10.1093/gbe/evt089; Ma Y, 2011, ENVIRON MICROBIOL, V14, P453; Maniatis T., 1982, MOL CLONING LAB MANU; Martinez B, 2001, J BACTERIOL, V183, P5684, DOI 10.1128/JB.183.19.5684-5697.2001; MCCLURE NC, 1989, APPL ENVIRON MICROB, V55, P2627, DOI 10.1128/AEM.55.10.2627-2634.1989; Minakhina S, 1999, MOL MICROBIOL, V33, P1059, DOI 10.1046/j.1365-2958.1999.01548.x; Mindlin S, 2005, RES MICROBIOL, V156, P994, DOI 10.1016/j.resmic.2005.05.011; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Norberg P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1267; Oliveira CS, 2012, PLASMID, V67, P252, DOI 10.1016/j.plasmid.2011.11.002; Oliveira CS, 2013, PLASMID, V70, P412, DOI 10.1016/j.plasmid.2013.06.002; Oosterkamp MJ, 2011, J BACTERIOL, V193, P5028, DOI 10.1128/JB.00365-11; Osborn AM, 2000, FEMS MICROBIOL LETT, V186, P203, DOI 10.1111/j.1574-6968.2000.tb09105.x; Palenik B, 2009, ENVIRON MICROBIOL, V11, P349, DOI 10.1111/j.1462-2920.2008.01772.x; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Petersen J, 2013, APPL MICROBIOL BIOT, V97, P2805, DOI 10.1007/s00253-013-4746-8; Phelan RW, 2011, APPL ENVIRON MICROB, V77, P327, DOI 10.1128/AEM.01239-10; Pinyon JL, 2011, MICROB DRUG RESIST, V17, P339, DOI 10.1089/mdr.2010.0196; Poole K, 2001, CURR OPIN MICROBIOL, V4, P500, DOI 10.1016/S1369-5274(00)00242-3; Pradella S, 2010, ARCH MICROBIOL, V192, P115, DOI 10.1007/s00203-009-0535-2; Ren Y, 2010, J BACTERIOL, V192, P2463, DOI 10.1128/JB.00067-10; Schierup MH, 2000, GENETICS, V156, P879; Schierup MH, 2000, MOL BIOL EVOL, V17, P1578, DOI 10.1093/oxfordjournals.molbev.a026256; SINGER M, 1989, MICROBIOL REV, V53, P1; SIZEMORE RK, 1977, ANTIMICROB AGENTS CH, V12, P373, DOI 10.1128/AAC.12.3.373; SLATKIN M, 1991, GENETICS, V129, P555; Smalla K, 2002, FEMS MICROBIOL ECOL, V42, P165, DOI 10.1111/j.1574-6941.2002.tb01006.x; SMITH CA, 1993, J GEN MICROBIOL, V139, P1761, DOI 10.1099/00221287-139-8-1761; Sobecky PA, 1997, APPL ENVIRON MICROB, V63, P888, DOI 10.1128/AEM.63.3.888-895.1997; Sobecky PA, 1998, APPL ENVIRON MICROB, V64, P2822; Sobecky Patricia A., 2009, V532, P435, DOI 10.1007/978-1-60327-853-9_25; Tauch A, 2003, MOL GENET GENOMICS, V268, P570, DOI 10.1007/s00438-002-0785-z; Thomas CM, 2000, HORIZONTAL GENE POOL; Thorsted PA, 1998, J MOL BIOL, V282, P969, DOI 10.1006/jmbi.1998.2060; Tralau T, 2001, APPL ENVIRON MICROB, V67, P1508, DOI 10.1128/AEM.67.4.1508-1516.2001; van Elsas JD, 1998, APPL ENVIRON MICROB, V64, P880; Vedler E, 2004, J BACTERIOL, V186, P7161, DOI 10.1128/JB.186.21.7161-7174.2004; Villeneuve C, 2012, J BACTERIOL, V194, P4126, DOI 10.1128/JB.00726-12; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Yang J, 2013, MICROB ECOL, V65, P975, DOI 10.1007/s00248-013-0187-2; Zhong ZP, 2003, PLASMID, V49, P233, DOI 10.1016/S0147-619X(03)00014-3; Zhong ZP, 2001, APPL ENVIRON MICROB, V67, P5771, DOI 10.1128/AEM.67.12.5771-5779.2001	64	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92321	10.1371/journal.pone.0092321	http://dx.doi.org/10.1371/journal.pone.0092321			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647540	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500116
J	Pirastu, N; Kooyman, M; Traglia, M; Robino, A; Willems, SM; Pistis, G; d'Adamo, P; Amin, N; d'Eustacchio, A; Navarini, L; Sala, C; Karssen, LC; van Duijn, C; Toniolo, D; Gasparini, P				Pirastu, Nicola; Kooyman, Maarten; Traglia, Michela; Robino, Antonietta; Willems, Sara M.; Pistis, Giorgio; d'Adamo, Pio; Amin, Najaf; d'Eustacchio, Angela; Navarini, Luciano; Sala, Cinzia; Karssen, Lennart C.; van Duijn, Cornelia; Toniolo, Daniela; Gasparini, Paolo			Association Analysis of Bitter Receptor Genes in Five Isolated Populations Identifies a Significant Correlation between TAS2R43 Variants and Coffee Liking	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TYPE-2 DIABETES-MELLITUS; TASTE RECEPTORS; CAFFEINE; RISK; CONSUMPTION; FOOD; DISEASE; TWINS; SENSITIVITY	Coffee, one of the most popular beverages in the world, contains many different physiologically active compounds with a potential impact on people's health. Despite the recent attention given to the genetic basis of its consumption, very little has been done in understanding genes influencing coffee preference among different individuals. Given its markedly bitter taste, we decided to verify if bitter receptor genes (TAS2Rs) variants affect coffee liking. In this light, 4066 people from different parts of Europe and Central Asia filled in a field questionnaire on coffee liking. They have been consequently recruited and included in the study. Eighty-eight SNPs covering the 25 TAS2R genes were selected from the available imputed ones and used to run association analysis for coffee liking. A significant association was detected with three SNP: one synonymous and two functional variants (W35S and H212R) on the TAS2R43 gene. Both variants have been shown to greatly reduce in vitro protein activity. Surprisingly the wild type allele, which corresponds to the functional form of the protein, is associated to higher liking of coffee. Since the hTAS2R43 receptor is sensible to caffeine, we verified if the detected variants produced differences in caffeine bitter perception on a subsample of people coming from the FVG cohort. We found a significant association between differences in caffeine perception and the H212R variant but not with the W35S, which suggests that the effect of the TAS2R43 gene on coffee liking is mediated by caffeine and in particular by the H212R variant. No other significant association was found with other TAS2R genes. In conclusion, the present study opens new perspectives in the understanding of coffee liking. Further studies are needed to clarify the role of the TAS2R43 gene in coffee hedonics and to identify which other genes and pathways are involved in its genetics.	[Pirastu, Nicola; Robino, Antonietta; d'Adamo, Pio; d'Eustacchio, Angela; Gasparini, Paolo] Ist Ricovero & Cura Carattere Sci Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Pirastu, Nicola; Robino, Antonietta; d'Adamo, Pio; Gasparini, Paolo] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Kooyman, Maarten; Willems, Sara M.; Amin, Najaf; Karssen, Lennart C.; van Duijn, Cornelia] Erasmus MC, Genet Epidemiol Unit, Dept Epidemiol, Rotterdam, Netherlands; [Navarini, Luciano] Illycaffe Spa, Trieste, Italy; [van Duijn, Cornelia] Leiden Univ, Med Ctr, Ctr Med Syst Biol, Leiden, Netherlands; [Traglia, Michela; Pistis, Giorgio; Sala, Cinzia; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy	IRCCS Burlo Garofolo; University of Trieste; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Pirastu, N (corresponding author), Ist Ricovero & Cura Carattere Sci Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.	nicola.pirastu@burlo.trieste.it	d'Adamo, Adamo Pio/G-4064-2011; Sala, Cinzia Felicita/AAN-1900-2020; Pirastu, Nicola/AHB-6226-2022; Toniolo, Daniela/AAE-2969-2019; Gasparini, Paolo/B-6173-2014; Traglia, Michela/AAX-5816-2020; Robino, Antonietta/K-9398-2016	d'Adamo, Adamo Pio/0000-0001-9367-4909; Toniolo, Daniela/0000-0001-9545-6032; Pirastu, Nicola/0000-0002-5363-3886; Kooyman, Maarten/0000-0002-9023-5617; s, hema/0000-0002-3440-9475; Van Duijn, Cornelia/0000-0002-2374-9204; Amin, Najaf/0000-0002-8944-1771; Karssen, Lennart C./0000-0002-1959-342X; Robino, Antonietta/0000-0003-2152-2353; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Gasparini, Paolo/0000-0002-0859-0856	Region Friuli Venezia Giulia [35\09]; Italian Ministry of health; POR-FESR Regione Autonoma Friuli Venezia Giulia, Italy; European Commission [018947 (LSHG-CT-2006-01947)]; European Community by the European Commission [HEALTH-F4-2007-201413, QLG2-CT-2002-01254]; Netherlands Organisation for Scientific Research; Russian Foundation for Basic Research [NWO-RFBR 047.017.043]; Netherlands Scientific Organization [NWO 480-05-003]; BBMRI-NL, a Research Infrastructure; Dutch Government [NWO 184.021.007]	Region Friuli Venezia Giulia(Regione Friuli Venezia Giulia); Italian Ministry of health(Ministry of Health, Italy); POR-FESR Regione Autonoma Friuli Venezia Giulia, Italy; European Commission(European CommissionEuropean Commission Joint Research Centre); European Community by the European Commission; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Netherlands Scientific Organization; BBMRI-NL, a Research Infrastructure; Dutch Government	The SR study has been funded by the Region Friuli Venezia Giulia grant number 35\09 Linea 2 "Sulle tracce di Marco Polo: geni, gusto e loro implicazioni sulla salute lungo la Via della Seta". The INGI-FVG study was funded through the Italian Ministry of health. This work is part of a joint project with illycaffe' s.p.a. within the framework of the "Nutrigenomica e consumo di caffe' : effetti fisiologici, genetica del gusto e genetica della pianta" project partially supported by the POR-FESR 2007-2013 Regione Autonoma Friuli Venezia Giulia, Italy. The VB study was founded trough Fondazione Compagnia di San Paolo, Torino, Fondazione Cariplo, Milano and Health Ministry (Progetto Finalizzato and Italian Centre for Disease Prevention and Control). The ERF study as a part of EUROSPAN (European Special Populations Research Network) was supported by European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947) and also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F4-2007-201413 by the European Commission under the programme "Quality of Life and Management of the Living Resources" of 5th Framework Programme (no. QLG2-CT-2002-01254). High-throughput analysis of the ERF data was supported by joint grant from Netherlands Organisation for Scientific Research and the Russian Foundation for Basic Research (NWO-RFBR 047.017.043). Statistical analyses were partly carried out on the Genetic Cluster Computer (http://www.geneticcluster.org) which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003 PI: Posthuma) along with a supplement from the Dutch Brain Foundation and the VU University Amsterdam. This research was financially supported by BBMRI-NL, a Research Infrastructure financed by the Dutch Government (NWO 184.021.007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amin N, 2012, MOL PSYCHIATR, V17, P1116, DOI 10.1038/mp.2011.101; Aulchenko YS, 2004, EUR J HUM GENET, V12, P527, DOI 10.1038/sj.ejhg.5201188; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Belonogova NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065395; Carlsson S, 2004, INT J EPIDEMIOL, V33, P616, DOI 10.1093/ije/dyh185; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Coetzee H, 1996, FOOD QUAL PREFER, V7, P81, DOI 10.1016/0950-3293(95)00039-9; CONTERIO F, 1962, HEREDITY, V17, P347, DOI 10.1038/hdy.1962.36; Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dorea JG, 2005, BRIT J NUTR, V93, P773, DOI 10.1079/BJN20051370; Dragana V, 2013, HEAR BALANC IN PRESS; Drewnowski A, 1998, ANN NY ACAD SCI, V855, P797, DOI 10.1111/j.1749-6632.1998.tb10661.x; Duffy VB, 2007, J AM DIET ASSOC, V107, P237, DOI 10.1016/j.jada.2006.11.005; Duffy VB, 2009, ANN NY ACAD SCI, V1170, P558, DOI 10.1111/j.1749-6632.2009.04593.x; Farah A, 2012, COFFEE EMERGING HLTH, P1; Genick UK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027745; Girotto G, 2011, J MED GENET, V48, P369, DOI 10.1136/jmg.2010.088310; GOLDSTEIN A, 1965, J PHARMACOL EXP THER, V149, P156; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Griffiths RR, 2000, ARCH FAM MED, V9, P727, DOI 10.1001/archfami.9.8.727; Grigg D., 2002, GeoJournal, V57, P283, DOI 10.1023/B:GEJO.0000007249.91153.c3; Hayes JE, 2011, CHEM SENSES, V36, P311, DOI 10.1093/chemse/bjq132; Heath A C, 1998, Twin Res, V1, P176, DOI 10.1375/twin.1.4.176; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kleemola P, 2000, ARCH INTERN MED, V160, P3393, DOI 10.1001/archinte.160.22.3393; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Lanier SA, 2005, PHYSIOL BEHAV, V83, P821, DOI 10.1016/j.physbeh.2004.10.004; Ledda M, 2013, HUM MOL GENET; Lim J-W, 2012, EMERGING HLTH EFFECT, P111, DOI [10.1002/9781119949893.ch6, DOI 10.1002/9781119949893.CH6]; Lindsay J, 2012, EMERGING HLTH EFFECT, P97, DOI [10.1002/9781119949893.ch5, DOI 10.1002/9781119949893.CH5]; Luciano M, 2005, ADDICTION, V100, P1510, DOI 10.1111/j.1360-0443.2005.01223.x; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Nkondjock A., 2012, Coffee: emerging health effects and disease prevention, P197; Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x; Pronin AN, 2007, CURR BIOL, V17, P1403, DOI 10.1016/j.cub.2007.07.046; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; ROBERTSON D, 1984, AM J MED, V77, P54, DOI 10.1016/0002-9343(84)90435-2; Roudnitzky N, 2011, HUM MOL GENET, V20, P3437, DOI 10.1093/hmg/ddr252; Sacerdote C, 2007, AM J EPIDEMIOL, V166, P576, DOI 10.1093/aje/kwm113; SCHIFFMAN SS, 1985, PHARMACOL BIOCHEM BE, V22, P195, DOI 10.1016/0091-3057(85)90377-6; Thurstone L., 1955, J FOOD SCI, V20, P512, DOI DOI 10.1111/J.1365-2621.1955.TB16862.X; Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213; Umemura T, 2006, AM J CARDIOL, V98, P1538, DOI 10.1016/j.amjcard.2006.06.058; van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X; Vink JM, 2009, TWIN RES HUM GENET, V12, P127, DOI 10.1375/twin.12.2.127; Yeomans MR, 2007, PHYSIOL BEHAV, V92, P831, DOI 10.1016/j.physbeh.2007.06.006; Yeomans MR, 2012, PHYSIOL BEHAV, V106, P345, DOI 10.1016/j.physbeh.2012.03.013	50	29	32	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92065	10.1371/journal.pone.0092065	http://dx.doi.org/10.1371/journal.pone.0092065			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647340	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500078
J	Kalajzic, AC; Vidacek, NS; Huzak, M; Ivankovic, M; Rubelj, I				Kalajzic, Andrea Cukusic; Vidacek, Nikolina Skrobot; Huzak, Miljenko; Ivankovic, Milena; Rubelj, Ivica			Telomere Q-PNA-FISH - Reliable Results from Stochastic Signals	PLOS ONE			English	Article							NORMAL HUMAN FIBROBLASTS; HUMAN-CELLS; LENGTH; SENESCENCE; LIFE; ACCUMULATION; HUMANS; CHROMOSOMES; STRESS	Structural and functional analysis of telomeres is very important for understanding basic biological functions such as genome stability, cell growth control, senescence and aging. Recently, serious concerns have been raised regarding the reliability of current telomere measurement methods such as Southern blot and quantitative polymerase chain reaction. Since telomere length is associated with age related pathologies, including cardiovascular disease and cancer, both at the individual and population level, accurate interpretation of measured results is a necessity. The telomere Q-PNA-FISH technique has been widely used in these studies as well as in commercial analysis for the general population. A hallmark of telomere Q-PNA-FISH is the wide variation among telomere signals which has a major impact on obtained results. In the present study we introduce a specific mathematical and statistical analysis of sister telomere signals during cell culture senescence which enabled us to identify high regularity in their variations. This phenomenon explains the reproducibility of results observed in numerous telomere studies when the Q-PNA-FISH technique is used. In addition, we discuss the molecular mechanisms which probably underlie the observed telomere behavior.	[Kalajzic, Andrea Cukusic; Vidacek, Nikolina Skrobot; Ivankovic, Milena; Rubelj, Ivica] Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia; [Huzak, Miljenko] Univ Zagreb, Dept Math, Zagreb 41000, Croatia	Rudjer Boskovic Institute; University of Zagreb	Rubelj, I (corresponding author), Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia.	rubelj@irb.hr	Cukusic Kalajzic, Andrea/D-6223-2017	Cukusic Kalajzic, Andrea/0000-0002-3085-3181	Croatian Ministry of Sciences, Education and Sports [098-0982913-2768, 037-0372790-2800]	Croatian Ministry of Sciences, Education and Sports	Croatian Ministry of Sciences, Education and Sports [098-0982913-2768 to I. R., 037-0372790-2800 to M. H.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Bekaert S, 2002, CYTOMETRY, V48, P34, DOI 10.1002/cyto.10105; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Canela A, 2007, P NATL ACAD SCI USA, V104, P5300, DOI 10.1073/pnas.0609367104; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Gilson E, 2007, CELL CYCLE, V6, P2486, DOI 10.4161/cc.6.20.4798; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Graakjaer J, 2006, ANN NY ACAD SCI, V1067, P311, DOI 10.1196/annals.1354.042; Graakjaer J, 2004, AGING CELL, V3, P97, DOI 10.1111/j.1474-9728.2004.00093.x; Harley CB, 2011, REJUV RES, V14, P45, DOI 10.1089/rej.2010.1085; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Huffman KE, 2000, J BIOL CHEM, V275, P19719, DOI 10.1074/jbc.M002843200; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Krejci K, 1998, CHROMOSOMA, V107, P198, DOI 10.1007/s004120050297; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Londono-Vallejo JA, 2001, NUCLEIC ACIDS RES, V29, P3164, DOI 10.1093/nar/29.15.3164; Martens UM, 2000, EXP CELL RES, V256, P291, DOI 10.1006/excr.2000.4823; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; Rubelj I, 1999, J THEOR BIOL, V197, P425, DOI 10.1006/jtbi.1998.0886; Rubelj I, 2000, MECH AGEING DEV, V112, P233, DOI 10.1016/S0047-6374(99)00090-1; Steenstrup T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt370; Vera E, 2012, AGING-US, V4, P379, DOI 10.18632/aging.100462; Vidacek NS, 2010, EXP GERONTOL, V45, P235, DOI 10.1016/j.exger.2010.01.009; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Young JI, 2001, J BIOL CHEM, V276, P19610, DOI 10.1074/jbc.M009470200	33	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92559	10.1371/journal.pone.0092559	http://dx.doi.org/10.1371/journal.pone.0092559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643066	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900146
J	Brzostek, A; Szulc, I; Klink, M; Brzezinska, M; Sulowska, Z; Dziadek, J				Brzostek, Anna; Szulc, Izabela; Klink, Magdalena; Brzezinska, Marta; Sulowska, Zofia; Dziadek, Jaroslaw			Either Non-Homologous Ends Joining or Homologous Recombination Is Required to Repair Double-Strand Breaks in the Genome of Macrophage-Internalized Mycobacterium tuberculosis	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-REPAIR; GENETIC REQUIREMENTS; RECA PROTEIN; SURVIVAL; PATHWAYS; PATHOGENESIS; MUTANT; DAMAGE; MECHANISMS	The intracellular pathogen Mycobacterium tuberculosis (Mtb) is constantly exposed to a multitude of hostile conditions and is confronted by a variety of potentially DNA-damaging assaults in vivo, primarily from host-generated antimicrobial toxic radicals. Exposure to reactive nitrogen species and/or reactive oxygen species causes different types of DNA damage, including oxidation, depurination, methylation and deamination, that can result in single-or double-strand breaks (DSBs). These breaks affect the integrity of the whole genome and, when left unrepaired, can lead to cell death. Here, we investigated the role of the DSB repair pathways, homologous recombination (HR) and non-homologous ends joining (NHEJ), in the survival of Mtb inside macrophages. To this end, we constructed Mtb strains defective for HR (Delta recA), NHEJ [Delta(ku,ligD)], or both DSB repair systems [Delta(ku,ligD,recA)]. Experiments using these strains revealed that either HR or NHEJ is sufficient for the survival and propagation of tubercle bacilli inside macrophages. Inhibition of nitric oxide or superoxide anion production with L-NIL or apocynin, respectively, enabled the Delta(ku,ligD,recA) mutant strain lacking both systems to survive intracellularly. Complementation of the Delta(ku,ligD,recA) mutant with an intact recA or ku-ligD rescued the ability of Mtb to propagate inside macrophages.	[Brzostek, Anna; Szulc, Izabela; Klink, Magdalena; Brzezinska, Marta; Sulowska, Zofia; Dziadek, Jaroslaw] Polish Acad Sci, Inst Med Biol, Lodz, Poland	Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Dziadek, J (corresponding author), Polish Acad Sci, Inst Med Biol, Lodz, Poland.	jdziadek@cbm.pan.pl	Klink, Magdalena/U-1953-2019	Dziadek, Jaroslaw/0000-0003-1427-884X; Szulc-Kielbik, Izabela/0000-0003-1290-697X; Klink, Magdalena/0000-0002-9870-7391	European Regional Development Fund [POIG.01.01.02-10-107/09]	European Regional Development Fund(European Commission)	This research was financed by a grant from the European Regional Development Fund (POIG.01.01.02-10-107/09) under the Operational Programme Innovative Economy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Aranda J, 2011, J BACTERIOL, V193, P3740, DOI 10.1128/JB.00389-11; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; Brzezinska M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-43; Brzostek A, 2007, FEMS MICROBIOL LETT, V275, P106, DOI 10.1111/j.1574-6968.2007.00865.x; Brzostek A, 2013, J STEROID BIOCHEM, V134, P1, DOI 10.1016/j.jsbmb.2012.09.028; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; BUCHMEIER NA, 1993, MOL MICROBIOL, V7, P933, DOI 10.1111/j.1365-2958.1993.tb01184.x; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Cadet J, 2012, CANCER LETT, V327, P5, DOI 10.1016/j.canlet.2012.04.005; Carpenter EP, 2007, EMBO J, V26, P1363, DOI 10.1038/sj.emboj.7601593; Cuccui J, 2007, INFECT IMMUN, V75, P1186, DOI 10.1128/IAI.01240-06; Darwin KH, 2005, INFECT IMMUN, V73, P4581, DOI 10.1128/IAI.73.8.4581-4587.2005; Davies BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001295; Della M, 2004, SCIENCE, V306, P683, DOI 10.1126/science.1099824; Dos Vultos T, 2009, FEMS MICROBIOL REV, V33, P471, DOI 10.1111/j.1574-6976.2009.00170.x; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Dziadek J, 2002, J BACTERIOL, V184, P3848, DOI 10.1128/JB.184.14.3848-3855.2002; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Fletcher HM, 1997, INFECT IMMUN, V65, P4592, DOI 10.1128/IAI.65.11.4592-4597.1997; Fu LM, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/23054; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Gorna AE, 2010, CLIN SCI, V119, P187, DOI 10.1042/CS20100041; Gupta R, 2011, MOL MICROBIOL, V79, P316, DOI 10.1111/j.1365-2958.2010.07463.x; Houghton J, 2012, J BACTERIOL, V194, P2916, DOI 10.1128/JB.06654-11; Korycka-Machala M, 2006, FEMS MICROBIOL LETT, V258, P83, DOI 10.1111/j.1574-6968.2006.00199.x; KOWALCZYKOWSKI SC, 1994, EXPERIENTIA, V50, P204, DOI 10.1007/BF01924003; KOWALCZYKOWSKI SC, 1991, BIOCHIMIE, V73, P289, DOI 10.1016/0300-9084(91)90216-N; Kurthkoti K, 2012, MECH AGEING DEV, V133, P138, DOI 10.1016/j.mad.2011.09.003; Mertens K, 2008, MOL MICROBIOL, V69, P1411, DOI 10.1111/j.1365-2958.2008.06373.x; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pitcher RS, 2007, ANNU REV MICROBIOL, V61, P259, DOI 10.1146/annurev.micro.61.080706.093354; Pitcher RS, 2007, DNA REPAIR, V6, P1271, DOI 10.1016/j.dnarep.2007.02.009; Pitcher RS, 2005, J MOL BIOL, V351, P531, DOI 10.1016/j.jmb.2005.06.038; Raja A, 2004, INDIAN J MED RES, V120, P213; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Richardson AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000451; Sander P, 2001, INFECT IMMUN, V69, P3562, DOI 10.1128/IAI.69.6.3562-3568.2001; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; Wojcik EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051064; Yang Chul-Su, 2009, Immune Netw, V9, P46, DOI 10.4110/in.2009.9.2.46; Yeager CM, 2001, APPL ENVIRON MICROB, V67, P5384, DOI 10.1128/AEM.67.12.5384-5391.2001	49	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92799	10.1371/journal.pone.0092799	http://dx.doi.org/10.1371/journal.pone.0092799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658131	Green Submitted, gold, Green Published			2022-12-27	WOS:000333355300130
J	Huang, LQ; Yu, ZH; Zhang, T; Zhao, XP; Huang, G				Huang, Liangqian; Yu, Zhenhai; Zhang, Teng; Zhao, Xiaoping; Huang, Gang			HSP40 Interacts with Pyruvate Kinase M2 and Regulates Glycolysis and Cell Proliferation in Tumor Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CANCER; PKM2; GROWTH; ISOFORM; TARGETS; HSP70; CYCLE; BETA; DNAJ	Pyruvate kinase M2 (PKM2) is predominantly expressed in cancers, which is considered as a key regulator of the Warburg effect. In this study, HSP40 was identified as a novel binding partner of PKM2. HSP40-PKM2 association destabilized PKM2 protein through HSC70. In the presence of HSP40, PKM2 protein level and PKM2-mediated PDK1 expression were down-regulated. Moreover, HSP40 was involved in regulating glucose metabolism on PKM2 dependent way and at the mean time had an effect on mitochondrial oxygen respiration. In line with inhibition effect of HSP40 on glycolysis, the growth of cancer cells was inhibited by HSP40. Our data provided a new regulation mechanism of PKM2, which suggested a new therapeutic target for cancer therapy.	[Huang, Liangqian; Huang, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Huang, Liangqian; Huang, Gang] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Huang, Liangqian; Zhang, Teng; Zhao, Xiaoping; Huang, Gang] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China; [Yu, Zhenhai; Huang, Gang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, G (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China.	huang2802@163.com			"973'' Project [2012CB932604]; New Drug Discovery Project [2012ZX09506-001-005]; Shanghai Leading Academic Discipline Project [S30203]; National Natural Science Foundation of China [81071180, 81001008, 81372195]; Shanghai Pujiang Program [13PJ1406000]; Science and Technology Commission of Shanghai Municipality [134119a5600]	"973'' Project(National Basic Research Program of China); New Drug Discovery Project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The study was supported by research grants from "973'' Project (No. 2012CB932604), New Drug Discovery Project (No. 2012ZX09506-001-005), Shanghai Leading Academic Discipline Project (No. S30203), National Natural Science Foundation of China (No. 81071180,81001008 & 81372195), Shanghai Pujiang Program (No. 13PJ1406000) and Science and Technology Commission of Shanghai Municipality (No. 134119a5600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Chen J, 2012, CANCER LETT, V316, P204, DOI 10.1016/j.canlet.2011.10.039; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Gao XL, 2013, J BIOL CHEM, V288, P15971, DOI 10.1074/jbc.M112.448753; Guo CX, 2013, BIOORG MED CHEM LETT, V23, P3358, DOI 10.1016/j.bmcl.2013.03.090; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Jo SR, 2012, J NEUROSCI, V32, P8491, DOI 10.1523/JNEUROSCI.6514-11.2012; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Mitra A, 2009, CLIN EXP METASTAS, V26, P559, DOI 10.1007/s10585-009-9255-x; Mitra A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1874; Newington JT, 2012, J BIOL CHEM, V287, P37245, DOI 10.1074/jbc.M112.366195; Ohtsuka K, 2000, INT J HYPERTHER, V16, P231, DOI 10.1080/026567300285259; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; QI M, 2013, BIOCHIM BIOPHYS ACTA, V1839, P62; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Soo ETL, 2008, IN VIVO, V22, P311; Sterrenberg JN, 2011, CANCER LETT, V312, P129, DOI 10.1016/j.canlet.2011.08.019; Wang CC, 2006, CANCER RES, V66, P6756, DOI 10.1158/0008-5472.CAN-06-0185; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu SF, 2013, ACTA BIOCH BIOPH SIN, V45, P27, DOI 10.1093/abbs/gms106; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; YU L, 2012, ONCOLOGY LETT; Yu Z., 2013, J BIOL CHEM; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462	37	27	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92949	10.1371/journal.pone.0092949	http://dx.doi.org/10.1371/journal.pone.0092949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658033	gold, Green Submitted, Green Published			2022-12-27	WOS:000333355300146
J	Lee, JY; Hong, WJ; Majeti, R; Stearns, T				Lee, Joanna Y.; Hong, Wan-Jen; Majeti, Ravindra; Stearns, Tim			Centrosome-Kinase Fusions Promote Oncogenic Signaling and Disrupt Centrosome Function in Myeloproliferative Neoplasms	PLOS ONE			English	Article							BCR-ABL ONCOPROTEIN; TYROSINE KINASE; T(6/8) TRANSLOCATION; PRIMARY CILIUM; STEM-CELLS; FOP; PROTEINS; DISORDER; DISEASE; GENE	Chromosomal translocations observed in myeloproliferative neoplasms (MPNs) frequently fuse genes that encode centrosome proteins and tyrosine kinases. This causes constitutive activation of the kinase resulting in aberrant, proliferative signaling. The function of centrosome proteins in these fusions is not well understood. Among others, kinase centrosome localization and constitutive kinase dimerization are possible consequences of centrosome protein-kinase fusions. To test the relative contributions of localization and dimerization on kinase signaling, we targeted inducibly dimerizable FGFR1 to the centrosome and other subcellular locations and generated a mutant of the FOP-FGFR1 MPN fusion defective in centrosome localization. Expression in mammalian cells followed by western blot analysis revealed a significant decrease in kinase signaling upon loss of FOP-FGFR1 centrosome localization. Kinase dimerization alone resulted in phosphorylation of the FGFR1 signaling target PLC gamma, however levels comparable to FOP-FGFR1 required subcellular targeting in addition to kinase dimerization. Expression of MPN fusion proteins also resulted in centrosome disruption in epithelial cells and transformed patient cells. Primary human MPN cells showed masses of modified tubulin that colocalized with centrin, Smoothened (Smo), IFT88, and Arl13b. This is distinct from acute myeloid leukemia (AML) cells, which are not associated with centrosome-kinase fusions and had normal centrosomes. Our results suggest that effective proliferative MPN signaling requires both subcellular localization and dimerization of MPN kinases, both of which may be provided by centrosome protein fusion partners. Furthermore, centrosome disruption may contribute to the MPN transformation phenotype.	[Lee, Joanna Y.; Stearns, Tim] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Hong, Wan-Jen; Majeti, Ravindra] Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Hong, Wan-Jen; Majeti, Ravindra] Stanford Univ, Sch Med, Inst Canc, Stanford, CA 94305 USA; [Hong, Wan-Jen; Majeti, Ravindra] Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Stearns, Tim] Stanford Sch Med, Dept Genet, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Stearns, T (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	stearns@stanford.edu		Majeti, Ravindra/0000-0002-5814-0984; Stearns, Tim/0000-0002-0671-6582	NIH Cell and Molecular Biology Training Grant; ARCS Foundation Award; NIH Grant [GM52022]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052022] Funding Source: NIH RePORTER	NIH Cell and Molecular Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCS Foundation Award; NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH Cell and Molecular Biology Training Grant to J.Y.L. (http://www.nigms.nih.gov/Training/InstPredoc/PredocTrainingDescription.htm), an ARCS Foundation Award to J.Y.L. (https://www.arcsfoundation.org), and NIH Grant GM52022 to T.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochtler T, 2012, LEUKEMIA, V26, P728, DOI 10.1038/leu.2011.283; Christensen ST, 2012, J PATHOL, V226, P172, DOI 10.1002/path.3004; Cross NCP, 2008, ACTA HAEMATOL-BASEL, V119, P199, DOI 10.1159/000140631; de la Roche M, 2013, SCIENCE, V342, P1247, DOI 10.1126/science.1244689; Delaval B, 2005, LEUKEMIA, V19, P1739, DOI 10.1038/sj.leu.2403926; Delaval B, 2005, CANCER RES, V65, P7231, DOI 10.1158/0008-5472.CAN-04-4167; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Giehl M, 2005, LEUKEMIA, V19, P1192, DOI 10.1038/sj.leu.2403779; Gilliland DG, 2002, SEMIN HEMATOL, V39, P6, DOI 10.1053/shem.2002.36921; Gillingham AK, 2000, EMBO REP, V1, P524; Guasch G, 2004, BLOOD, V103, P309, DOI 10.1182/blood-2003-05-1690; Guasch G, 2001, MOL CELL BIOL, V21, P8129, DOI 10.1128/MCB.21.23.8129-8142.2001; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Kazmierczak B, 2010, IET SYST BIOL, V4, P348, DOI 10.1049/iet-syb.2010.0002; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Lee JY, 2013, PLOS ONE IN PRESS; Lelievre H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-30; Mahjoub MR, 2012, CURR BIOL, V22, P1628, DOI 10.1016/j.cub.2012.06.057; Matsuda M, 2001, J CELL BIOL, V153, P599, DOI 10.1083/jcb.153.3.599; MCWHIRTER JR, 1993, EMBO J, V12, P1533, DOI 10.1002/j.1460-2075.1993.tb05797.x; Michaud EJ, 2006, CANCER RES, V66, P6463, DOI 10.1158/0008-5472.CAN-06-0462; Mikolajka A, 2006, J MOL BIOL, V359, P863, DOI 10.1016/j.jmb.2006.03.070; NEGOESCU A, 1994, J HISTOCHEM CYTOCHEM, V42, P433, DOI 10.1177/42.3.7508473; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Popovici C, 1999, BLOOD, V93, P1381, DOI 10.1182/blood.V93.4.1381.404k30_1381_1389; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosnet O, 2007, HAEMATOLOGICA, V92, P728, DOI 10.3324/haematol.11387; Tefferi A, 2009, CANCER-AM CANCER SOC, V115, P3842, DOI 10.1002/cncr.24440; TOWLER DA, 1987, J BIOL CHEM, V262, P1030; Walz C, 2007, HAEMATOLOGICA, V92, P163, DOI 10.3324/haematol.10980; Xiao S, 2000, BLOOD, V96, P699; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zhao X, 2002, NAT STRUCT BIOL, V9, P117	42	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92641	10.1371/journal.pone.0092641	http://dx.doi.org/10.1371/journal.pone.0092641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658090	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300109
J	Liu, Y; Liu, Y; Su, LL; Jiang, SJ				Liu, Yao; Liu, Yi; Su, Lili; Jiang, Shu-Juan			Recipient-Related Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ISHLT WORKING GROUP; IDIOPATHIC PULMONARY-FIBROSIS; INHALED NITRIC-OXIDE; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; REPERFUSION INJURY; SURVIVAL; FAILURE; DEFINITION; PRESSURE	Background: Primary graft dysfunction (PGD) is the main cause of early morbidity and mortality after lung transplantation. Previous studies have yielded conflicting results for PGD risk factors. Herein, we carried out a systematic review and meta-analysis of published literature to identify recipient-related clinical risk factors associated with PGD development. Method: A systematic search of electronic databases (PubMed, Embase, Web of Science, Cochrane CENTRAL, and Scopus) for studies published from 1970 to 2013 was performed. Cohort, case-control, or cross-sectional studies that examined recipient-related risk factors of PGD were included. The odds ratios (ORs) or mean differences (MDs) were calculated using random-effects models Result: Thirteen studies involving 10042 recipients met final inclusion criteria. From the pooled analyses, female gender (OR 1.38, 95% CI 1.09 to 1.75), African American (OR 1.82, 95% CI 1.36 to 2.45), idiopathic pulmonary fibrosis (IPF) (OR 1.78, 95% CI 1.49 to 2.13), sarcoidosis (OR 4.25, 95% CI 1.09 to 16.52), primary pulmonary hypertension (PPH) (OR 3.73, 95% CI 2.16 to 6.46), elevated BMI (BMI >= 25 kg/m(2)) (OR 1.83, 95% CI 1.26 to 2.64), and use of cardiopulmonary bypass (CPB) (OR 2.29, 95% CI 1.43 to 3.65) were significantly associated with increased risk of PGD. Age, cystic fibrosis, secondary pulmonary hypertension (SPH), intra-operative inhaled nitric oxide (NO), or lung transplant type (single or bilateral) were not significantly associated with PGD development (all P>0.05). Moreover, a nearly 4 fold increased risk of short-term mortality was observed in patients with PGD (OR 3.95, 95% CI 2.80 to 5.57). Conclusions: Our analysis identified several recipient related risk factors for development of PGD. The identification of higher-risk recipients and further research into the underlying mechanisms may lead to selective therapies aimed at reducing this reperfusion injury.	[Liu, Yao; Liu, Yi; Su, Lili; Jiang, Shu-Juan] Shandong Univ, Prov Hosp Affiliated, Dept Resp Med, Jinan 250100, Shandong, Peoples R China	Shandong University	Jiang, SJ (corresponding author), Shandong Univ, Prov Hosp Affiliated, Dept Resp Med, Jinan 250100, Shandong, Peoples R China.	doctorliuyao@126.com			National Natural Science Foundation of China [81301790]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the research grant from National Natural Science Foundation of China (No. 81301790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADATIA I, 1994, ANN THORAC SURG, V57, P1311, DOI 10.1016/0003-4975(94)91382-X; AEBA R, 1994, ANN THORAC SURG, V57, P715, DOI 10.1016/0003-4975(94)90573-8; Allen JG, 2012, ANN THORAC SURG, V93, P1843, DOI 10.1016/j.athoracsur.2012.02.041; Alvarez A, 2013, INTERACT CARDIOV TH, V16, P426, DOI 10.1093/icvts/ivs570; Arcasoy SM, 1999, NEW ENGL J MED, V340, P1081, DOI 10.1056/NEJM199904083401406; Barr ML, 2005, J HEART LUNG TRANSPL, V24, P1468, DOI 10.1016/j.healun.2005.02.019; Bellmeyer A, 2007, AM J RESP CRIT CARE, V175, P587, DOI 10.1164/rccm.200603-312OC; Burton CM, 2007, EUR J CARDIO-THORAC, V31, P75, DOI 10.1016/j.ejcts.2006.10.024; BUTLER J, 1993, ANN THORAC SURG, V55, P552, DOI 10.1016/0003-4975(93)91048-R; Christie JD, 2009, AM J RESP CRIT CARE, V180, P1010, DOI 10.1164/rccm.200901-0118OC; Christie JD, 2005, J HEART LUNG TRANSPL, V24, P1454, DOI 10.1016/j.healun.2004.11.049; Christie JD, 2005, J HEART LUNG TRANSPL, V24, P1451, DOI 10.1016/j.healun.2005.03.004; Christie JD, 2005, AM J RESP CRIT CARE, V171, P1312, DOI 10.1164/rccm.200409-1243OC; Christie JD, 2003, CHEST, V124, P1232, DOI 10.1378/chest.124.4.1232; de Perrot M, 2005, J HEART LUNG TRANSPL, V24, P1460, DOI 10.1016/j.healun.2005.02.017; Diamond JM, 2013, AM J RESP CRIT CARE, V187, P527, DOI 10.1164/rccm.201210-1865OC; Fang A, 2011, CHEST, V139, P782, DOI 10.1378/chest.09-2806; Felten ML, 2012, EUR J CARDIO-THORAC, V41, P686, DOI 10.1093/ejcts/ezr019; Gammie JS, 1998, J THORAC CARDIOV SUR, V115, P990, DOI 10.1016/S0022-5223(98)70396-4; Garat C, 1997, AM J RESP CRIT CARE, V155, P1957, DOI 10.1164/ajrccm.155.6.9196102; Halldorsson AO, 2000, ANN THORAC SURG, V69, P198, DOI 10.1016/S0003-4975(99)01104-2; Higgins J., 2009, COCHRANE HDB SYSTEMA; Hooper WC, 1999, CHEST, V116, P880, DOI 10.1378/chest.116.4.880; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Jain M, 2011, AM J RESP CRIT CARE, V183, P1490, DOI 10.1164/rccm.201009-1409OC; Jones DS, 1999, CLIN PHARMACOL THER, V65, P408, DOI 10.1016/S0009-9236(99)70135-9; Kanasky WF, 2002, CHEST, V121, P401, DOI 10.1378/chest.121.2.401; Khalil N, 2004, CAN MED ASSOC J, V171, P153, DOI 10.1503/cmaj.1030055; King RC, 2000, ANN THORAC SURG, V69, P1681, DOI 10.1016/S0003-4975(00)01425-9; Krenn K, 2007, AM J TRANSPLANT, V7, P700, DOI 10.1111/j.1600-6143.2006.01673.x; Kuntz CL, 2009, CLIN TRANSPLANT, V23, P819, DOI 10.1111/j.1399-0012.2008.00951.x; Lederer DJ, 2011, AM J RESP CRIT CARE, V184, P1055, DOI 10.1164/rccm.201104-0728OC; Lee JC, 2010, SEMIN RESP CRIT CARE, V31, P161, DOI 10.1055/s-0030-1249111; MACDONALD P, 1995, J THORAC CARDIOV SUR, V110, P861, DOI 10.1016/S0022-5223(95)70125-7; Madill J, 2001, J HEART LUNG TRANSPL, V20, P288, DOI 10.1016/S1053-2498(00)00315-6; Mangialardi RJ, 2000, CRIT CARE MED, V28, P3137, DOI 10.1097/00003246-200009000-00001; Mason DP, 2007, ANN THORAC SURG, V84, P1121, DOI 10.1016/j.athoracsur.2007.04.096; Medoff BD, 2009, AM J RESP CELL MOL, V41, P397, DOI 10.1165/rcmb.2008-0415OC; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Pierre AF, 1998, J THORAC CARDIOV SUR, V116, P932, DOI 10.1016/S0022-5223(98)70043-1; Samano MN, 2012, TRANSPL P, V44, P2462, DOI 10.1016/j.transproceed.2012.07.134; Shah RJ, 2012, TRANSL RES, V160, P435, DOI 10.1016/j.trsl.2012.08.003; Shargall Y, 2005, J HEART LUNG TRANSPL, V24, P1489, DOI 10.1016/j.healun.2005.03.011; Shigemura N, 2013, TRANSPLANTATION, V95, P513, DOI 10.1097/TP.0b013e3182751f1f; Simpson E, 1997, ANNU REV IMMUNOL, V15, P39, DOI 10.1146/annurev.immunol.15.1.39; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Summer R, 2008, AM J PHYSIOL-LUNG C, V294, pL1035, DOI 10.1152/ajplung.00397.2007; Sweezey N, 1998, AM J PHYSIOL-CELL PH, V274, pC379, DOI 10.1152/ajpcell.1998.274.2.C379; Thabut G, 2003, J THORAC CARDIOV SUR, V126, P469, DOI 10.1016/S0022-5223(03)00600-7; Thabut G, 2002, CHEST, V121, P1876, DOI 10.1378/chest.121.6.1876; Wahidi MM, 2002, CHEST, V121, P2072, DOI 10.1378/chest.121.6.2072; Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676; Wang YP, 2006, J HEART LUNG TRANSPL, V25, P533, DOI 10.1016/j.healun.2005.12.004; Webert KE, 2003, TRANSFUS MED REV, V17, P252, DOI 10.1016/S0887-7963(03)00039-7; Wells G, 2006, NEWCASTLE OTTAWA SCA; Whitson BA, 2006, J THORAC CARDIOV SUR, V131, P73, DOI 10.1016/j.jtcvs.2005.08.039	56	48	53	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92773	10.1371/journal.pone.0092773	http://dx.doi.org/10.1371/journal.pone.0092773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658073	gold, Green Submitted, Green Published			2022-12-27	WOS:000333355300127
J	Riedel, G; Rudrich, U; Fekete-Drimusz, N; Manns, MP; Vondran, FWR; Bock, M				Riedel, Gesa; Ruedrich, Urda; Fekete-Drimusz, Nora; Manns, Michael P.; Vondran, Florian W. R.; Bock, Michael			An Extended Delta CT-Method Facilitating Normalisation with Multiple Reference Genes Suited for Quantitative RT-PCR Analyses of Human Hepatocyte-Like Cells	PLOS ONE			English	Article							HOUSEKEEPING GENE; DIFFERENTIATION; IDENTIFICATION; EXPRESSION; CULTURE; TARGET	Reference genes (RG) as sample internal controls for gene transcript level analyses by quantitative RT-PCR (RT-qPCR) must be stably expressed within the experimental range. A variety of in vitro cell culture settings with primary human hepatocytes, and Huh-7 and HepG2 cell lines, were used to determine candidate RG expression stability in RT-qPCR analyses. Employing GeNorm, BestKeeper and Normfinder algorithms, this study identifies PSMB6, MDH1 and some more RG as sufficiently unregulated, thus expressed at stable levels, in hepatocyte-like cells in vitro. Inclusion of multiple RG, quenching occasional regulations of single RG, greatly stabilises gene expression level calculations from RT-qPCR data. To further enhance validity and reproducibility of relative RT-qPCR quantifications, the Delta CT calculation can be extended (e-Delta CT) by replacing the CT of a single RG in Delta CT with an averaged CT-value from multiple RG. The use of two or three RG here identified suited for human hepatocyte-like cells - for normalisation with the straightforward e-Delta CT calculation, should improve reproducibility and robustness of comparative RT-qPCR-based gene expression analyses.	[Riedel, Gesa; Ruedrich, Urda; Fekete-Drimusz, Nora; Bock, Michael] Hannover Med Sch, REBIRTH Res Grp Hepat Cell Therapy, Hannover, Germany; [Riedel, Gesa; Ruedrich, Urda; Fekete-Drimusz, Nora; Manns, Michael P.; Bock, Michael] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Vondran, Florian W. R.] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Bock, M (corresponding author), Hannover Med Sch, REBIRTH Res Grp Hepat Cell Therapy, Hannover, Germany.	bock.michael@mh-hannover.de		Bock, Michael/0000-0001-9673-4903	REBIRTH-Cluster of Excellence (Deutsche Forschungsgemeinschaft); German Centre for Infection Research (DZIF, TTU Hepatitis); Else Kroner-Fresenius-Stiftung (FWRV) [2010_A49]	REBIRTH-Cluster of Excellence (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Centre for Infection Research (DZIF, TTU Hepatitis); Else Kroner-Fresenius-Stiftung (FWRV)	This work was funded by the REBIRTH-Cluster of Excellence (Deutsche Forschungsgemeinschaft), the German Centre for Infection Research (DZIF, TTU Hepatitis) and the Else Kroner-Fresenius-Stiftung (FWRV; 2010_A49). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Koyama T, 2009, TISSUE ENG PT A, V15, P1099, DOI 10.1089/ten.tea.2008.0242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sivaganesan M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-120; Stern-Straeter J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-66; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Tostoes RM, 2012, HEPATOLOGY, V55, P1227, DOI 10.1002/hep.24760; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vondran FWR, 2008, ARTIF ORGANS, V32, P205, DOI 10.1111/j.1525-1594.2007.00524.x; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; Yamashita Y, 2003, INT J CANCER, V103, P572, DOI 10.1002/ijc.10699; Yang Xianxian, 2012, BMC Res Notes, V5, P222, DOI 10.1186/1756-0500-5-222	20	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e93031	10.1371/journal.pone.0093031	http://dx.doi.org/10.1371/journal.pone.0093031			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658132	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300152
J	Di Gaetano, C; Fiorito, G; Ortu, MF; Rosa, F; Guarrera, S; Pardini, B; Cusi, D; Frau, F; Barlassina, C; Troffa, C; Argiolas, G; Zaninello, R; Fresu, G; Glorioso, N; Piazza, A; Matullo, G				Di Gaetano, Cornelia; Fiorito, Giovanni; Ortu, Maria Francesca; Rosa, Fabio; Guarrera, Simonetta; Pardini, Barbara; Cusi, Daniele; Frau, Francesca; Barlassina, Cristina; Troffa, Chiara; Argiolas, Giuseppe; Zaninello, Roberta; Fresu, Giovanni; Glorioso, Nicola; Piazza, Alberto; Matullo, Giuseppe			Sardinians Genetic Background Explained by Runs of Homozygosity and Genomic Regions under Positive Selection	PLOS ONE			English	Article							MEDITERRANEAN ISLANDS CORSICA; POPULATION; HISTORY; MTDNA; ASSOCIATION; PATTERNS; MODEL; AREA; SET	The peculiar position of Sardinia in the Mediterranean sea has rendered its population an interesting biogeographical isolate. The aim of this study was to investigate the genetic population structure, as well as to estimate Runs of Homozygosity and regions under positive selection, using about 1.2 million single nucleotide polymorphisms genotyped in 1077 Sardinian individuals. Using four different methods - fixation index, inflation factor, principal component analysis and ancestry estimation - we were able to highlight, as expected for a genetic isolate, the high internal homogeneity of the island. Sardinians showed a higher percentage of genome covered by RoHs>0.5 Mb (F-RoH%0.5) when compared to peninsular Italians, with the only exception of the area surrounding Alghero. We furthermore identified 9 genomic regions showing signs of positive selection and, we re-captured many previously inferred signals. Other regions harbor novel candidate genes for positive selection, like TMEM252, or regions containing long non coding RNA. With the present study we confirmed the high genetic homogeneity of Sardinia that may be explained by the shared ancestry combined with the action of evolutionary forces.	[Di Gaetano, Cornelia; Fiorito, Giovanni; Piazza, Alberto; Matullo, Giuseppe] Univ Turin, Dept Med Sci, Turin, Italy; [Di Gaetano, Cornelia; Fiorito, Giovanni; Rosa, Fabio; Guarrera, Simonetta; Pardini, Barbara; Piazza, Alberto; Matullo, Giuseppe] HuGeF Human Genet Fdn, Turin, Italy; [Ortu, Maria Francesca; Frau, Francesca; Troffa, Chiara; Argiolas, Giuseppe; Zaninello, Roberta; Fresu, Giovanni; Glorioso, Nicola] Univ Sassari, AOU, Hypertens & Related Dis Ctr, I-07100 Sassari, Italy; [Cusi, Daniele; Frau, Francesca; Barlassina, Cristina] Univ Milan, Dept Hlth Sci, Milan, Italy; [Cusi, Daniele; Frau, Francesca; Barlassina, Cristina] Filarete Fdn, Genom & Bioinformat Unit, Milan, Italy	University of Turin; University of Sassari; University of Milan	Di Gaetano, C (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	cornelia.digaetano@unito.it; giuseppe.matullo@unito.it	Matullo, Giuseppe/K-6383-2016; Pardini, Barbara/ABI-2295-2020; Guarrera, Simonetta/AAB-8482-2022; Di Gaetano, Cornelia/AAA-5477-2019; Rosa, Fabio/AGI-6840-2022; Pardini, Barbara/K-9451-2016	Matullo, Giuseppe/0000-0003-0674-7757; Pardini, Barbara/0000-0001-9571-4257; Di Gaetano, Cornelia/0000-0001-8938-7093; Rosa, Fabio/0000-0002-8335-4482; Pardini, Barbara/0000-0001-9571-4257; Barlassina, Cristina/0000-0001-7407-2697; Fiorito, Giovanni/0000-0002-7651-5452; Piazza, Alberto/0000-0002-2355-4183	Human Genetic Foundation (HuGeF); Compagnia di San Paolo of Turin; HYPERGENES project; Seventh Framework Programme [FP7 - HEALTH-F4-2007-201550]; InterOmics an Italian Flagship project; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Consiglio Nazionale delle Ricerche (CNR) [PB.05]	Human Genetic Foundation (HuGeF); Compagnia di San Paolo of Turin(Compagnia di San Paolo); HYPERGENES project; Seventh Framework Programme(European Commission); InterOmics an Italian Flagship project; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Consiglio Nazionale delle Ricerche (CNR)(Consiglio Nazionale delle Ricerche (CNR))	The Human Genetic Foundation (HuGeF) and the Compagnia di San Paolo of Turin (to M.G.) were the main supporter of this project. This study used data from the following grants: HYPERGENES project (funded by the Seventh Framework Programme FP7 - HEALTH-F4-2007-201550) and InterOmics an Italian Flagship project (funded b 1 y Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) and Consiglio Nazionale delle Ricerche (CNR) Project PB.05 (to C.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Angius A, 2002, HUM GENET, V111, P9, DOI 10.1007/s00439-002-0753-z; BARBUJANI G, 1995, P NATL ACAD SCI USA, V92, P9171, DOI 10.1073/pnas.92.20.9171; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Calo C M, 1998, Anthropol Anz, V56, P227; Calo CM, 2003, COLLEGIUM ANTROPOL, V27, P105; Capelli C, 2006, ANN HUM GENET, V70, P207, DOI 10.1111/j.1529-8817.2005.00224.x; Cappello N, 1996, ANN HUM GENET, V60, P125, DOI 10.1111/j.1469-1809.1996.tb01183.x; Caramelli D, 2007, HUM GENET, V122, P327, DOI 10.1007/s00439-007-0403-6; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Contini M., 1989, GEOLINGUISTIQUE, V4, P129; Contini M, 1979, B I PHONETIQUE GRENO, V8, P57; Contu D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001430; Contu L, 1998, TISSUE ANTIGENS, V52, P452, DOI 10.1111/j.1399-0039.1998.tb03072.x; D'Amore G, 2010, HOMO, V61, P385, DOI 10.1016/j.jchb.2010.09.002; Development Core Team R R, 2009, LANG ENV STAT COMP; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di Gaetano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043759; Falchi A, 2006, J HUM GENET, V51, P9, DOI 10.1007/s10038-005-0324-y; Francalacci P, 2003, AM J PHYS ANTHROPOL, V121, P270, DOI 10.1002/ajpa.10265; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Fraumene C, 2006, MOL BIOL EVOL, V23, P2101, DOI 10.1093/molbev/msl084; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gilad Y, 2003, AM J HUM GENET, V73, P489, DOI 10.1086/378132; Gompert Z, 2011, GENETICS, V187, P903, DOI 10.1534/genetics.110.124693; Grimaldi MC, 2001, TISSUE ANTIGENS, V58, P281, DOI 10.1034/j.1399-0039.2001.580501.x; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; HUDSON RR, 1992, GENETICS, V132, P583; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; Lampis R, 2000, HUM MOL GENET, V9, P2959, DOI 10.1093/hmg/9.20.2959; Malaspina P, 2000, ANN HUM GENET, V64, P395, DOI 10.1046/j.1469-1809.2000.6450395.x; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; MORAL P, 1994, AM J PHYS ANTHROPOL, V93, P441, DOI 10.1002/ajpa.1330930405; Morelli L, 2000, HUM BIOL, V72, P585; Naitza S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002480; Pardo LM, 2012, EUR J HUM GENET, V20, P956, DOI 10.1038/ejhg.2012.22; PIAZZA A, 1988, ANN HUM GENET, V52, P203, DOI 10.1111/j.1469-1809.1988.tb01098.x; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Piras IS, 2012, EUR J HUM GENET; Pistis G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004654; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rendine S, 1997, ANN HUM GENET, V61, P411; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Salvi E, 2011, HYPERTENSION; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scozzari R, 2001, HUM IMMUNOL, V62, P871, DOI 10.1016/S0198-8859(01)00286-5; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sutin AR, 2011, J BEHAV MED; Terracciano A, 2010, MOL PSYCHIATR, V15, P647, DOI 10.1038/mp.2008.113; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; VONA G, 1997, INT J ANTHR, V12, P71, DOI DOI 10.1007/BF02447890; VONA G, 1992, INT J ANTHR, V7, P25; Wagner M. L., 1941, HIST LAUTLEHRE SARDI; Zei G, 2003, EUR J HUM GENET, V11, P802, DOI 10.1038/sj.ejhg.5201040; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	60	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91237	10.1371/journal.pone.0091237	http://dx.doi.org/10.1371/journal.pone.0091237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651212	gold, Green Published			2022-12-27	WOS:000333352800034
J	Hill, J; Kayentao, K; Toure, M; Diarwara, S; Bruce, J; Smedley, J; Doumbo, OK; ter Kuile, FO; Webster, J				Hill, Jenny; Kayentao, Kassoum; Toure, Mahamoudou; Diarwara, Sory; Bruce, Jane; Smedley, James; Doumbo, Ogobara K.; ter Kuile, Feiko O.; Webster, Jayne			Effectiveness of Antenatal Clinics to Deliver Intermittent Preventive Treatment and Insecticide Treated Nets for the Control of Malaria in Pregnancy in Mali: A Household Survey	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE; PRESUMPTIVE TREATMENT; WOMEN; METAANALYSIS; TANZANIA; COVERAGE; THERAPY; AFRICA	Background: WHO recommends intermittent-preventive-treatment (IPTp) with sulphadoxine-pyrimethamine (SP) and insecticide-treated-nets (ITNs) to prevent malaria in pregnancy in sub-Saharan Africa, however uptake remains unacceptably low. We evaluated the effectiveness of antenatal clinics (ANC) to deliver two doses of IPTp and ITNs to pregnant women in Segou district, Mali. Methods: We used household data to assess the systems effectiveness of ANC to deliver IPTp and ITNs to pregnant women and used logistic regression to identify predictors of ANC attendance, receipt of IPTp and ITN use during pregnancy, and the impact on community effectiveness. Results: Of 81% of recently pregnant women who made at least one ANC visit, 59% of these attended during the eligible gestational age for IPTp. Of these, 82% reported receiving one dose of SP and 91% attended ANC again, of whom 66% received a second dose, resulting in a cumulative effectiveness for 2-dose IPTp of 29%, most of whom used an ITN (90%). Cumulative effectiveness of 2-dose SP by directly observed therapy (DOT) was very low (6%). ITN use was 92%, and ANC was the main source (81%). Reported and ANC-card data showed some doses of SP are given to women in their first trimester. Women were less likely to receive two doses by DOT if they were married (OR 0.10; CI 0.03, 0.40), or lived <5 km from the health facility (OR 0.34; CI 0.14, 0.83). A high household person-LLIN ratio predicted low ITN use in pregnant women (OR 0.16; CI 0.04, 0.55). Conclusion: Our findings suggest poor adherence by health workers to provision of IPTp by eligible gestational age and DOT, contributing to low effectiveness of this strategy in this setting. ITN delivery and use among women was substantially higher. Efforts to improve health worker adherence to IPTp guidelines are needed to improve service delivery of IPTp.	[Hill, Jenny; Kayentao, Kassoum; Smedley, James; ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Kayentao, Kassoum; Toure, Mahamoudou; Diarwara, Sory; Doumbo, Ogobara K.] Univ Sci Tech & Technol Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Bruce, Jane; Webster, Jayne] London Sch Hyg & Trop Med, Dis Control Dept, London WC1, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Science & Technology of Bamako; University of London; London School of Hygiene & Tropical Medicine	Hill, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England.	j.hill@liv.ac.uk	Kuile, Feiko ter/ABD-6681-2020; Hill, Jenny/C-3839-2017	Kuile, Feiko ter/0000-0003-3663-5617; Hill, Jenny/0000-0003-1588-485X; Webster, Jayne/0000-0002-0498-8883	Malaria in Pregnancy (MiP) Consortium; Bill & Melinda Gates Foundation	Malaria in Pregnancy (MiP) Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Malaria in Pregnancy (MiP) Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1991, NEPHRON, V59, P522, DOI 10.1159/000186630; [Anonymous], 2011, ROLL BACK MALARIA PA; [Anonymous], 2004, STRATEGIC FRAMEWORK; Baiden F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028944; Cellule de Planification et de Statistique Ministere de la Sante Direction Nationale de la Statistique et de I'Informatique Ministere de I'Economie dlledC Bamako Mali, 2007, ENQ DEM SANT MAL 200; CHANDRAMOHAN D, 2007, TROP MED INT HEALTH, V12, P1; Chico RM, 2011, TROP MED INT HLTH; Countdown to 2015, 2010, TRACK PROGR MAT NEWB; Diala C, 2012, BARRIERS UPTAKE MALA; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Gikandi PW, 2008, TROP MED INT HEALTH, V13, P208, DOI 10.1111/j.1365-3156.2007.01992.x; Gross K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-140; Guyatt HL, 2004, TROP MED INT HEALTH, V9, P255, DOI 10.1046/j.1365-3156.2003.01193.x; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Hill J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001488; Hill J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064913; Iliyasu Z, 2012, PATHOG GLOB HEALTH, V106, P323, DOI 10.1179/2047773212Y.0000000037; Kayentao K, 2013, JAMA-J AM MED ASSOC, V309, P594, DOI 10.1001/jama.2012.216231; Marchant T, 2010, CAN MED ASSOC J, V182, P152, DOI 10.1503/cmaj.090268; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Paintain LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024035; Programme National de Lutte Contre le Paludisme MInistere de al Sante Organisation Mondiale de la Sante, 2006, POL NAT LUTT PAL MAL; Ridde V, 2004, Sante Publique, V16, P37; Roll Back Malaria MEASURE Evaluation USAID UNICEF World Health Organization, 2009, RBMWG2009TP1 USAID U; Sangare LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015066; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-18; Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; van Eijk AM, 2013, LANCET INFECT DIS, V13, P1029, DOI 10.1016/S1473-3099(13)70199-3; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Webster J, 2011, THESIS LONDON SCH HY; Webster J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065437; Webster J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067520; Webster J, 2010, AM J TROP MED HYG, V82, P672, DOI 10.4269/ajtmh.2010.09-0473; World Health Organisation, 2006, MAL PREGN GUID MEAS; World Health Organization, 2012, UPD WHO POL REC OCT; Worrall E, 2007, LANCET INFECT DIS, V7, P156, DOI 10.1016/S1473-3099(07)70027-0	40	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92102	10.1371/journal.pone.0092102	http://dx.doi.org/10.1371/journal.pone.0092102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651078	Green Accepted, gold, Green Published			2022-12-27	WOS:000333352800070
J	Toshner, M; Dunmore, BJ; McKinney, EF; Southwood, M; Caruso, P; Upton, PD; Waters, JP; Ormiston, ML; Skepper, JN; Nash, G; Rana, AA; Morrell, NW				Toshner, Mark; Dunmore, Benjamin J.; McKinney, Eoin F.; Southwood, Mark; Caruso, Paola; Upton, Paul D.; Waters, John P.; Ormiston, Mark L.; Skepper, Jeremy N.; Nash, Gerard; Rana, Amer A.; Morrell, Nicholas W.			Transcript Analysis Reveals a Specific HOX Signature Associated with Positional Identity of Human Endothelial Cells	PLOS ONE			English	Article							GENE-EXPRESSION; EXTRACELLULAR-MATRIX; PROGENITOR CELLS; HOMEOBOX GENES; IN-VITRO; CANCER; DIFFERENTIATION; MORPHOGENESIS; COMMITMENT; DIVERSITY	The endothelial cell has a remarkable ability for sub-specialisation, adapted to the needs of a variety of vascular beds. The role of developmental programming versus the tissue contextual environment for this specialization is not well understood. Here we describe a hierarchy of expression of HOX genes associated with endothelial cell origin and location. In initial microarray studies, differential gene expression was examined in two endothelial cell lines: blood derived outgrowth endothelial cells (BOECs) and pulmonary artery endothelial cells. This suggested shared and differential patterns of HOX gene expression between the two endothelial lines. For example, this included a cluster on chromosome 2 of HOXD1, HOXD3, HOXD4, HOXD8 and HOXD9 that was expressed at a higher level in BOECs. Quantative PCR confirmed the higher expression of these HOXs in BOECs, a pattern that was shared by a variety of microvascular endothelial cell lines. Subsequently, we analysed publically available microarrays from a variety of adult cell and tissue types using the whole "HOX transcriptome" of all 39 HOX genes. Using hierarchical clustering analysis the HOX transcriptome was able to discriminate endothelial cells from 61 diverse human cell lines of various origins. In a separate publically available microarray dataset of 53 human endothelial cell lines, the HOX transcriptome additionally organized endothelial cells related to their organ or tissue of origin. Human tissue staining for HOXD8 and HOXD9 confirmed endothelial expression and also supported increased microvascular expression of these HOXs. Together these observations suggest a significant involvement of HOX genes in endothelial cell positional identity.	[Toshner, Mark; Dunmore, Benjamin J.; McKinney, Eoin F.; Caruso, Paola; Upton, Paul D.; Waters, John P.; Ormiston, Mark L.; Rana, Amer A.; Morrell, Nicholas W.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Toshner, Mark; Southwood, Mark] Papworth Hosp, Cambridge CB3 8RE, England; [Skepper, Jeremy N.] Univ Cambridge, Dept Neurosci & Physiol, Cambridge CB2 2QQ, England; [Nash, Gerard] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Papworth Hospital; University of Cambridge; University of Birmingham	Morrell, NW (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England.	nwm23@cam.ac.uk	wei, wei/HHR-8613-2022; Nash, Gerard B/E-4182-2010; Manganotti, Paolo/L-1763-2018	Nash, Gerard B/0000-0002-5935-2831; Manganotti, Paolo/0000-0001-5305-6268; Morrell, Nicholas/0000-0001-5700-9792; Toshner, Mark/0000-0002-3969-6143; Ormiston, Mark/0000-0003-0907-1940; McKinney, Eoin/0000-0003-3516-3072; southwood, mark/0000-0002-3493-9599	Academy of Medical Sciences; British Heart Foundation; Cambridge Cardiovascular Consortium; Cambridge National Institutes of Health Research Biomedical Research Centre; MRC [G0800784, MR/K020919/1, G1000847] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL5-Toshner] Funding Source: researchfish; British Heart Foundation [FS/13/19/29931, PG/12/54/29734, FS/12/39/29653, PG/11/10/28724, PG/10/35/28339, SP/12/12/29836, RG/13/4/30107] Funding Source: researchfish; Kidney Research UK [TF13/2010] Funding Source: researchfish; Medical Research Council [MR/K020919/1, G0800784, G1000847] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10174] Funding Source: researchfish	Academy of Medical Sciences(Academy of Medical Sciences (AMS)); British Heart Foundation(British Heart Foundation); Cambridge Cardiovascular Consortium; Cambridge National Institutes of Health Research Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); British Heart Foundation(British Heart Foundation); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by grants from the Academy of Medical Sciences and the British Heart Foundation, and supported by the Cambridge Cardiovascular Consortium and Cambridge National Institutes of Health Research Biomedical Research Centre. The authors would like to acknowledge the contribution of Phil Stone who organized the leucocyte migration assays, and sadly died during the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez DF, 2008, AM J PHYSIOL-LUNG C, V294, pL419, DOI 10.1152/ajplung.00314.2007; Amali AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058857; Belotti D, 1998, LAB INVEST, V78, P1291; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Diehl F, 2007, BLOOD, V109, P1472, DOI 10.1182/blood-2006-08-039651; Garry DJ, 2006, CELL, V127, P1101, DOI 10.1016/j.cell.2006.11.031; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Hansen SL, 2006, J CRANIOFAC SURG, V17, P767, DOI 10.1097/00001665-200607000-00031; Harada K, 2009, J CELL SCI, V122, P3923, DOI 10.1242/jcs.052324; Jeong MS, 2009, J MICROBIOL BIOTECHN, V19, P1557, DOI 10.4014/jmb.0905.05021; Kusuma S, 2012, FASEB J, V26, P4925, DOI 10.1096/fj.12-209296; Lee HJ, 2011, EXP LUNG RES, V37, P344, DOI 10.3109/01902148.2011.577267; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; MANOHAR CF, 1993, BIOCHEM MOL BIOL INT, V30, P733; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Murthi P, 2008, PLACENTA, V29, P624, DOI 10.1016/j.placenta.2008.04.006; Ormiston ML, 2012, CIRCULATION; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pitera JE, 2001, MECH DEVELOP, V109, P377, DOI 10.1016/S0925-4773(01)00530-5; RAINGER GE, 1995, AM J PHYSIOL-HEART C, V269, pH1398, DOI 10.1152/ajpheart.1995.269.4.H1398; REDLINE RW, 1992, GENOMICS, V13, P425, DOI 10.1016/0888-7543(92)90263-R; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rinn JL, 2008, GENE DEV, V22, P303, DOI 10.1101/gad.1610508; Rossig L, 2005, J EXP MED, V201, P1825, DOI 10.1084/jem.20042097; Storti P, 2011, LEUKEMIA, V25, P527, DOI 10.1038/leu.2010.270; Takahashi Y, 2004, EXP CELL RES, V293, P144, DOI 10.1016/j.yexcr.2003.09.024; Toshner M, 2009, AM J RESP CRIT CARE, V180, P780, DOI 10.1164/rccm.200810-1662OC; Wang H, 2006, CIRC RES, V98, P1331, DOI 10.1161/01.RES.0000220650.26555.1d; Wang KC, 2009, TRENDS CELL BIOL, V19, P268, DOI 10.1016/j.tcb.2009.03.007; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Winnik S, 2009, CARDIOVASC RES, V83, P558, DOI 10.1093/cvr/cvp133; Wu YX, 2003, MOL CELL BIOL, V23, P5680, DOI 10.1128/MCB.23.16.5680-5691.2003; Zhong JP, 2003, J CLIN INVEST, V112, P30, DOI 10.1172/JCI200317034; Zhu SK, 2013, CIRC RES, V112, P152, DOI 10.1161/CIRCRESAHA.112.280016; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	40	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91334	10.1371/journal.pone.0091334	http://dx.doi.org/10.1371/journal.pone.0091334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651450	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800038
J	Wu, CY; Wang, C; Guan, XC; Liu, YX; Li, DM; Zhou, XJ; Zhang, YN; Chen, X; Wang, JJ; Zen, K; Zhang, CY; Zhang, CN				Wu, Caiyun; Wang, Cheng; Guan, Xiaocui; Liu, Yuxiu; Li, Demin; Zhou, Xiaojun; Zhang, Yanni; Chen, Xi; Wang, Junjun; Zen, Ke; Zhang, Chen-Yu; Zhang, Chunni			Diagnostic and Prognostic Implications of a Serum miRNA Panel in Oesophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILE; CIRCULATING MICRORNAS; POTENTIAL BIOMARKER; CLINICAL IMPACT; CANCER; PLASMA	Background and Aim: Circulating microRNAs (miRNAs) are potential biomarkers for cancer detection; however, little is known about their prognostic impact on oesophageal squamous cell carcinoma (ESCC). The current study aims to uncover novel miRNAs for prognostic biomarkers in ESCC patients. Patients and Methods: We initially screened the expression of 754 serum miRNAs using TaqMan Low Density Array in two pooled samples respectively from 28 ESCC and 28 normal controls. Markedly upregulated miRNAs in ESCC and some miRNAs reported to be differently expressed in ESCC tissue were then validated individually by RT-qPCR in another 83 patients and 83 controls arranged in two phases. The changes of the selected miRNAs during the esophagectomy and their prognostic value were examined. Results: Seven serum miRNAs were found to be significantly higher in ESCC than in controls; namely, miR-25, miR-100, miR-193-3p, miR-194, miR-223, miR-337-5p and miR-483-5p (P<0.0001), and the area under the receiver-operating-characteristic (ROC) curve (AUC) for the seven-miRNA panel was 0.83 (95% CI 0.75-0.90). Most of these miRNAs declined markedly in postoperative samples versus preoperative samples (P<0.05). Moreover, high level of miR-25 was significantly correlated with shorter overall survival in patients (P = 0.027). Cox regression analysis identified lymph node metastasis, miR-25 and miR-100 as the independent risk factors for overall survival (hazard ratio (HR) 2.98 [1.36-6.55], P = 0.006; HR 3.84 [1.02-14.41], P = 0.029; HR 4.18 [1.21-14.50], P = 0.024, respectively). Conclusion: The seven serum miRNAs could potentially serve as novel biomarkers for ESCC; moreover, specific miRNAs such as miR-25 and miR-100 can predict poor survival in ESCC.	[Wu, Caiyun; Wang, Cheng; Guan, Xiaocui; Wang, Junjun; Zhang, Chunni] Nanjing Univ, Jinling Hosp, Sch Life Sci, Dept Clin Lab, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Cheng; Chen, Xi; Zen, Ke; Zhang, Chen-Yu; Zhang, Chunni] Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Yuxiu] Nanjing Univ, Jinling Hosp, Sch Clin, Coll Med,Dept Sci Res Management, Nanjing 210008, Jiangsu, Peoples R China; [Li, Demin] Nanjing Univ, Jinling Hosp, Sch Clin, Coll Med,Dept Cardiothorac Surg, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Xiaojun] Nanjing Univ, Jinling Hosp, Sch Clin, Coll Med,Dept Pathol, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Yanni] Canc Hosp Xuzhou, Dept Med Oncol, Xuzhou, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University	Zen, K (corresponding author), Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	kzen@nju.edu.cn; cyzhang@nju.edu.cn; zchunni27@hotmail.com	Wang, Cheng/O-7206-2016	Wang, Cheng/0000-0002-1834-2119; Zhang, Chunni/0000-0002-7329-7162	National Basic Research Program of China (973 Program) [2014CB542300]; National Natural Science Foundation of China [81171661, 81301511, 81271904]; Natural Science Foundation of Jiangsu Province [BK2011013]; Medical Scientific Research Foundation of Nanjing Military Command [12Z28]; Research Special Fund for Public Welfare Industry of Health [201302018]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Medical Scientific Research Foundation of Nanjing Military Command; Research Special Fund for Public Welfare Industry of Health	This work was supported by grants from the National Basic Research Program of China (973 Program) (no. 2014CB542300), the National Natural Science Foundation of China (Nos. 81171661, 81301511 and 81271904), Natural Science Foundation of Jiangsu Province (no. BK2011013), Medical Scientific Research Foundation of Nanjing Military Command (no. 12Z28) and the Research Special Fund for Public Welfare Industry of Health (no. 201302018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosman F., 2010, WHO CLASSIFICATION T, V4th; Chabre O, 2013, ENDOCR-RELAT CANCER, V20, P579, DOI 10.1530/ERC-13-0051; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070914, 10.1371/journal.pone.0079652]; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gu J, 2013, CURR PHARM DESIGN, V19, P1292; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Hirajima S, 2013, BRIT J CANCER, V108, P1822, DOI 10.1038/bjc.2013.148; Hiyama T, 2007, INT J CANCER, V121, P1643, DOI 10.1002/ijc.23044; Hu ZB, 2012, CARCINOGENESIS, V33, P828, DOI 10.1093/carcin/bgs030; Komatsu S, 2011, BRIT J CANCER, V105, P104, DOI 10.1038/bjc.2011.198; Kurashige J, 2012, J SURG ONCOL, V106, P188, DOI 10.1002/jso.23064; Liu R, 2012, CLIN CHEM, V58, P610, DOI 10.1373/clinchem.2011.172767; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Luo Y, 2013, CLIN CHEM, V59, P658, DOI 10.1373/clinchem.2012.195297; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ruol A, 2008, ARCH SURG-CHICAGO, V144, P247; Selth LA, 2013, BRIT J CANCER, V109, P641, DOI 10.1038/bjc.2013.369; Sun J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0411-9; Takeshita N, 2013, BRIT J CANCER, V108, P644, DOI 10.1038/bjc.2013.8; Tanaka Y, 2013, CANCER-AM CANCER SOC, V119, P1159, DOI 10.1002/cncr.27895; Wang Y, 2013, J APPL TOXI IN PRESS; Xu XH, 2012, BIOCHEM BIOPH RES CO, V421, P640, DOI 10.1016/j.bbrc.2012.03.048; Yang CH, 2013, INT J CANCER, V132, P116, DOI 10.1002/ijc.27657; Yong FL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-280; Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553; Zhang TF, 2013, MOL CARCINOGEN, V52, P581, DOI 10.1002/mc.21880; Zhang TF, 2011, CLIN SCI, V121, P437, DOI 10.1042/CS20110207	29	78	81	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92292	10.1371/journal.pone.0092292	http://dx.doi.org/10.1371/journal.pone.0092292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651474	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800097
J	Balestrino, F; Puggioli, A; Gilles, JRL; Bellini, R				Balestrino, Fabrizio; Puggioli, Arianna; Gilles, Jeremie R. L.; Bellini, Romeo			Validation of a New Larval Rearing Unit for Aedes albopictus (Diptera: Culicidae) Mass Rearing	PLOS ONE			English	Article							STERILE INSECT TECHNIQUE; ANOPHELES-ARABIENSIS; BORNE DISEASES; MOSQUITOS; SEPARATION; COMPETITION; AEGYPTI; PUPAE; DEVICE; REPLACEMENT	The mosquito larval rearing unit developed at the Insect Pest Control Laboratory (IPCL) of the FAO/IAEA Joint Division was evaluated for its potential use for Aedes albopictus (Skuse, 1895) mass rearing in support of the development of a sterile insect technique (SIT) package for this species. The use of the mass rearing trays and rack did not adversely affect larval development, pupation and survival rates and allowed the management of large larval rearing colonies with reduced space requirements in comparison with classical individual trays. The effects of larval density, water temperature and diet composition on pupal production and size differentiation for sex separation efficacy were analyzed for individual mass rearing trays as well as multiple trays stacked within the dedicated rack unit. Best results were obtained using eighteen thousand larvae per tray at a density of 3 larvae per ml of deionized water at a temperature of 28 degrees C on a diet consisting of 50% tuna meal, 36% bovine liver powder, 14% brewer's yeast and, as an additive, 0.2 gr of Vitamin Mix per 100 ml of diet solution. Pupae were harvested on the sixth day from larval introduction at L-1 stage and males were separated out by the use of a 1400 mu m sieve with 99.0% accuracy with a recovery rate of ca. 25% of the total available males. With the use of this larval rearing unit, an average production of 100,000 male pupae per week can be achieved in just 2 square meter of laboratory space. Compared to previous laboratory rearing method, the same pupal production and sex separation efficacy could only be achieved by use of ca. 200 plastic trays which required the space of two 5 square meter climatic-controlled rooms.	[Balestrino, Fabrizio; Gilles, Jeremie R. L.] IAEA, Div Nucl Tech Food & Agr, Int Atom Energy Agcy FAO IAEA, Insect Pest Control Lab,Joint Food & Agr Org, A-1400 Vienna, Austria; [Puggioli, Arianna; Bellini, Romeo] Ctr Agr Ambiente CAA G Nicoli, Med & Vet Entomol Dept, Crevalcore, Italy	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency	Balestrino, F (corresponding author), IAEA, Div Nucl Tech Food & Agr, Int Atom Energy Agcy FAO IAEA, Insect Pest Control Lab,Joint Food & Agr Org, A-1400 Vienna, Austria.	fabriziobalestrino@hotmail.com			Emilia-Romagna Regional Bureau - Public Health Department; FP7 Infrastructure project "INFRAVEC'' Research capacity for the implementation of genetic control of mosquitoes [228421]	Emilia-Romagna Regional Bureau - Public Health Department(Regione Emilia Romagna); FP7 Infrastructure project "INFRAVEC'' Research capacity for the implementation of genetic control of mosquitoes	This work was supported by grants from the Emilia-Romagna Regional Bureau - Public Health Department and from the FP7 Infrastructure project "INFRAVEC'' Research capacity for the implementation of genetic control of mosquitoes, grant 228421. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; ANSARI MA, 1977, INDIAN J MED RES, V65, P91; Balestrino F, 2012, J MED ENTOMOL, V49, P595, DOI 10.1603/ME11188; Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272; Balestrino F, 2013, J MED ENTOM IN PRESS, V51; Balestrino F, 2011, J AM MOSQUITO CONTR, V27, P227, DOI 10.2987/10-6085.1; BAR-ZEEV MICHA, 1958, BULL ENT RES, V49, P157, DOI 10.1017/S0007485300053499; Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x; Bellini R., 2007, P505, DOI 10.1007/978-1-4020-6059-5_47; Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048; Bellini R., 2005, THESIS U BOLOGNA ITA; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; Briegel H, 2003, J VECTOR ECOL, V28, P1; Briegel H, 2001, J MED ENTOMOL, V38, P566, DOI 10.1603/0022-2585-38.4.566; CHAMBERS GM, 1990, J AM MOSQUITO CONTR, V6, P394; Damiens D, 2012, J MED ENTOMOL, V49, P1001, DOI 10.1603/ME11289; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; FAY R. W., 1959, MOSQUITO NEWS, V19, P144; FOCKS DA, 1980, J MED ENTOMOL, V17, P567, DOI 10.1093/jmedent/17.6.567; FOLGER HT, 1946, PHYSIOL ZOOL, V19, P190, DOI 10.1086/physzool.19.2.30151892; Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Ikeshoji T., 1981, Japanese Journal of Sanitary Zoology, V32, P7; Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2; KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; LOWE RE, 1981, MOSQ NEWS, V41, P634; MCCRAY EM, 1961, J ECON ENTOMOL, V54, P819, DOI 10.1093/jee/54.4.819; Medici A, 2011, J ECON ENTOMOL, V104, P266, DOI 10.1603/EC10108; Mellanby K., 1958, Entomologia Experimentalis et Applicata, V1, P153, DOI 10.1007/BF00291058; MOORE CG, 1972, ANN ENTOMOL SOC AM, V65, P915, DOI 10.1093/aesa/65.4.915; MORI A, 1979, Tropical Medicine, V21, P85; OMARDEEN T. A., 1957, BULL ENT RES, V48, P349, DOI 10.1017/S0007485300047180; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Puggioli A, 2013, J MED ENTOMOL, V50, P819, DOI 10.1603/ME13011; SHARMA VP, 1972, B WORLD HEALTH ORGAN, V47, P429; SHUEY JA, 1987, J AM MOSQUITO CONTR, V3, P65; Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40; THOMAS IM, 1950, AUST J SCI RES SER B, V3, P113, DOI 10.1071/BI9500113; Timmermann S. E., 1993, Bulletin of the Society for Vector Ecology, V18, P174; WHO/TDR, 2010, PLANN M 1 TECHN CONS; Wilke AB, 2009, ASIA PACIFIC J MOL B, V17, P65; Wyss JH, 2000, ANN NY ACAD SCI, V916, P186, DOI 10.1111/j.1749-6632.2000.tb05289.x; Yamada H, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-197	45	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91914	10.1371/journal.pone.0091914	http://dx.doi.org/10.1371/journal.pone.0091914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647347	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500059
J	Bartels, DJP; van Laarhoven, AIM; Haverkamp, EA; Wilder-Smith, OH; Donders, ART; van Middendorp, H; van de Kerkhof, PCM; Evers, AWM				Bartels, Danielle J. P.; van Laarhoven, Antoinette I. M.; Haverkamp, Elise A.; Wilder-Smith, Oliver H.; Donders, A. Rogier T.; van Middendorp, Henriet; van de Kerkhof, Peter C. M.; Evers, Andrea W. M.			Role of Conditioning and Verbal Suggestion in Placebo and Nocebo Effects on Itch	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; MOTION SICKNESS; DAILY STRESSORS; ANALGESIA; PAIN; EXPECTATIONS; PERSONALITY; VALIDATION; EXPECTANCY; PSORIASIS	Placebo and nocebo effects are known to play a key role in treatment effects in a wide variety of conditions. These effects have frequently been investigated with regard to pain and also in other physical sensations, but have hardly been investigated with regard to itch. In addition, neither in pain nor in any other physical sensation, the single and combined contribution of the expectancy mechanisms of conditioning and verbal suggestion have ever been investigated in both placebo and nocebo effects within one design. For the first time, the role of verbal suggestion and conditioning in placebo and nocebo effects on itch was experimentally investigated. Expectations about itch stimuli were induced in healthy subjects by verbal suggestion, conditioning, or a combination of both procedures, and compared with a control group without expectation induction. Itch was induced electrically by means of quantitative sensory testing. Significant placebo and nocebo effects were induced in the group in which combined procedures of conditioning and verbal suggestion were applied in comparison with the control group. The conditioning and verbal suggestion procedures applied individually did not induce significant placebo and nocebo effects when compared with the control group. The results of this study extend existing evidence on different physical sensations, like pain, by showing that also for itch, the combination of conditioning and verbal suggestion is most promising in inducing both placebo and nocebo effects. More research on placebo and nocebo effects at a perceptive and neurobiological level is warranted to further elucidate the common and specific mechanisms underlying placebo and nocebo effects on itch and other physical sensations.	[Bartels, Danielle J. P.; van Laarhoven, Antoinette I. M.; van Middendorp, Henriet; Evers, Andrea W. M.] Leiden Univ, Inst Psychol, Unit Hlth Med & Neuropsychol, Leiden, Netherlands; [Bartels, Danielle J. P.; van Laarhoven, Antoinette I. M.; Haverkamp, Elise A.; van Middendorp, Henriet; Evers, Andrea W. M.] Radboud Univ Nijmegen, Dept Med Psychol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Wilder-Smith, Oliver H.] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, NL-6525 ED Nijmegen, Netherlands; [Donders, A. Rogier T.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands; [van de Kerkhof, Peter C. M.] Radboud Univ Nijmegen, Dept Dermatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Leiden University; Leiden University - Excl LUMC; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Bartels, DJP (corresponding author), Leiden Univ, Inst Psychol, Unit Hlth Med & Neuropsychol, Leiden, Netherlands.	D.Bartels@fsw.leidenuniv.nl	Evers, Andrea/GWV-9705-2022; van Middendorp, Henriet/B-8300-2013; Evers, Andrea/U-8983-2019; Wilder-Smith, Oliver H.G./E-7541-2012; van de Kerkhof, P.C.M./H-8059-2014; Evers, A.W.M./L-4299-2015; Donders, A.R.T./L-4277-2015	Evers, Andrea/0000-0002-0090-5091; Wilder-Smith, Oliver H.G./0000-0003-4390-2381; Donders, A.R.T./0000-0002-0484-1419; van Laarhoven, Antoinette/0000-0001-6932-9283; van Middendorp, Henriet/0000-0003-4575-0895	Netherlands Organization for Scientific Research (NOW)	Netherlands Organization for Scientific Research (NOW)(Netherlands Organization for Scientific Research (NWO))	This work is financed by the Netherlands Organization for Scientific Research (NOW, http://www.nwo.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Atlas LY, 2012, NEUROSCI LETT, V520, P140, DOI 10.1016/j.neulet.2012.03.039; Benedetti F, 2011, PATIENT EDUC COUNS, V84, P413, DOI 10.1016/j.pec.2011.04.034; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; Benedetti F, 2008, ANNU REV PHARMACOL, V48, P33, DOI 10.1146/annurev.pharmtox.48.113006.094711; Brouwer D, 2008, PSYCHOL ASSESSMENT, V20, P310, DOI 10.1037/1040-3590.20.3.310; Colloca L, 2008, PAIN, V136, P211, DOI 10.1016/j.pain.2008.02.006; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Colloca L, 2013, PAIN, V154, P511, DOI 10.1016/j.pain.2013.02.002; Colloca L, 2011, PSYCHOSOM MED, V73, P598, DOI 10.1097/PSY.0b013e3182294a50; Colloca L, 2010, PAIN, V151, P430, DOI 10.1016/j.pain.2010.08.007; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Evers AWM, 2010, BRIT J DERMATOL, V163, P986, DOI 10.1111/j.1365-2133.2010.09984.x; Eysenck HJ, 1975, EPQ EYSENCK PERSONAL; Geers AL, 2005, J PSYCHOSOM RES, V58, P121, DOI 10.1016/j.jpsychores.2004.08.011; Geers AL, 2007, J PSYCHOSOM RES, V62, P563, DOI 10.1016/j.jpsychores.2006.12.005; Holle H, 2012, P NATL ACAD SCI USA, V109, P19816, DOI 10.1073/pnas.1216160109; Horing B, 2013, PSYCHOSOM MED, V75, P497, DOI 10.1097/PSY.0b013e3182915ee7; Ikoma A, 2005, PAIN, V113, P148, DOI 10.1016/j.pain.2004.10.003; Jensen KB, 2012, P NATL ACAD SCI USA, V109, P15959, DOI 10.1073/pnas.1202056109; Klinger R, 2007, PAIN, V128, P31, DOI 10.1016/j.pain.2006.08.025; Klosterhalfen S, 2000, PSYCHOSOM MED, V62, P671, DOI 10.1097/00006842-200009000-00011; Lee HF, 2012, PAIN, V153, P1301, DOI 10.1016/j.pain.2012.03.018; Martin-Pichora Andrea L, 2011, J Pain Res, V4, P67, DOI 10.2147/JPR.S15966; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Mitchell LA, 2004, J PAIN, V5, P233, DOI 10.1016/j.jpain.2004.03.004; Morton DL, 2009, PAIN, V146, P194, DOI 10.1016/j.pain.2009.07.026; Musial F, 2007, WORLD J GASTROENTERO, V13, P3425, DOI 10.3748/wjg.v13.i25.3425; Niemeier V., 2000, DERMATOL PSYCHOSOM, V1, P15, DOI [10.1159/000057993, DOI 10.1159/000057993]; Papoiu A D P, 2011, Br J Dermatol, V164, P1299, DOI 10.1111/j.1365-2133.2011.10318.x; Pecina M, 2013, NEUROPSYCHOPHARMACOL, V38, P639, DOI 10.1038/npp.2012.227; Pollo A, 2008, EUR J NEUROSCI, V28, P379, DOI 10.1111/j.1460-9568.2008.06344.x; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schneider G, 2006, CLIN EXP DERMATOL, V31, P762, DOI 10.1111/j.1365-2230.2006.02211.x; Scholz O, 1994, Z KLIN PSYCHOL-FORSC, V23, P127; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; van Laarhoven AIM, 2012, BRIT J DERMATOL, V167, P262, DOI 10.1111/j.1365-2133.2012.10933.x; van Laarhoven AIM, 2011, PAIN, V152, P1486, DOI 10.1016/j.pain.2011.01.043; Verhoeven EWM, 2009, BRIT J DERMATOL, V161, P295, DOI 10.1111/j.1365-2133.2009.09194.x; Verhoeven EWM, 2008, ACTA DERM-VENEREOL, V88, P211, DOI 10.2340/00015555-0452; Verhoeven EWM, 2009, J INVEST DERMATOL, V129, P2075, DOI 10.1038/jid.2008.460; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	86	87	2	172	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91727	10.1371/journal.pone.0091727	http://dx.doi.org/10.1371/journal.pone.0091727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24646924	gold, Green Submitted, Green Published			2022-12-27	WOS:000333348500049
J	Liao, YX; Shen, WF; Kong, GM; Lv, HN; Tao, WH; Bo, P				Liao, Yuexia; Shen, Weigan; Kong, Guimei; Lv, Houning; Tao, Wenhua; Bo, Ping			Apigenin Induces the Apoptosis and Regulates MAPK Signaling Pathways in Mouse Macrophage ANA-1 Cells	PLOS ONE			English	Article							INFLAMMATION; FLAVONOIDS; KINASE; P38	Apigenin is a naturally occurring plant flavonoid that possesses antioxidant, anti-cancer and anti-inflammatory properties. However, there are few reports has been done on the ability of apigenin to induce apoptosis in macrophages. In this study, mouse macrophage ANA-1 cells were incubated with different concentrations of apigenin. The cell viability was determined by an MTT assay. The cell apoptosis were analyzed by flow cytometric analysis. Apoptosis were also analyzed using a TUNEL assay and a DNA ladder. The level of intracellular ROS was detected using a dichlorofluorescein -diacetate probe. The expression levels of apoptosis-related proteins were detected by western blot analysis. The results showed that apigenin decreased the viability of ANA-1 cells and induced apoptosis in a dose-and time-dependent manner. Apigenin increased the level of intracellular ROS, downregulated the expression of Bcl-2 and upregulated the expression of caspase-3 and caspase-8 in ANA-1 cells. Furthermore, apigenin downregulated the expression of phospho-ERK and phospho-JNK, upregulated the expression of phospho-p38 and had no significant effect on the expression of Bax, ERK, JNK and p38. The results suggested that apigenin induced cell apoptosis in mouse macrophage ANA-1 cells may via increasing intracellular ROS, regulating the MAPK pathway, and then inhibiting Bcl-2 expression.	[Liao, Yuexia; Kong, Guimei; Tao, Wenhua; Bo, Ping] Yangzhou Univ, Sch Med, Dept Chinese Med Integrated Western Med, Yangzhou, Peoples R China; [Shen, Weigan] Yangzhou Univ, Sch Med, Dept Cell Biol, Yangzhou, Peoples R China; [Lv, Houning] Yangzhou Univ, Sch Med, Dept Med, Yangzhou, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University	Bo, P (corresponding author), Yangzhou Univ, Sch Med, Dept Chinese Med Integrated Western Med, Yangzhou, Peoples R China.	yangzboping@163.com			National Natural Science Foundation of China [30873343]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 30873343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Blanchette J, 2009, IMMUNOLOGY, V127, P123, DOI 10.1111/j.1365-2567.2008.02929.x; Bolego C, 2013, ARTERIOSCL THROM VAS, V33, P1127, DOI 10.1161/ATVBAHA.113.301328; Cao XC, 2013, CHINESE J CANCER RES, V25, P212, DOI 10.3978/j.issn.1000-9604.2013.04.01; Chakrabarti M, 2013, J MOL NEUROSCI; Cohen-Saidon C, 2006, BLOOD, V107, P1413, DOI 10.1182/blood-2005-07-2648; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; de Grey ADNJ, 2006, FREE RADICAL RES, V40, P1244, DOI 10.1080/10715760600913176; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Funakoshi-Tago M, 2011, INT IMMUNOPHARMACOL, V11, P1150, DOI 10.1016/j.intimp.2011.03.012; Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008; Han JY, 2012, BIOL PHARM BULL, V35, P1440, DOI 10.1248/bpb.b110686; Hristodorov D, 2012, TOXINS, V4, P676, DOI 10.3390/toxins4090676; Kang OH, 2011, IMMUNOPHARM IMMUNOT, V33, P473, DOI 10.3109/08923973.2010.538851; Kharbanda S, 2000, MOL CELL BIOL, V20, P4979, DOI 10.1128/MCB.20.14.4979-4989.2000; Kim SH, 2013, MOL CELL ENDOCRINOL, V369, P130, DOI 10.1016/j.mce.2013.01.012; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Liu GW, 2013, J CELL PHYSIOL, V228, P502, DOI 10.1002/jcp.24157; Lordan S, 2008, BRIT J NUTR, V100, P287, DOI 10.1017/S0007114507898643; Mafuvadze B, 2012, HORM CANCER-US, V3, P160, DOI 10.1007/s12672-012-0114-x; Milisav I, 2012, INT J MOL SCI, V13, P10771, DOI 10.3390/ijms130910771; Mounho BJ, 1999, TOXICOL APPL PHARM, V159, P125, DOI 10.1006/taap.1999.8740; Orrenius S, 2011, TOXICOL SCI, V119, P3, DOI 10.1093/toxsci/kfq268; Park WH, 2013, ONCOL LETT, V5, P1633, DOI 10.3892/ol.2013.1216; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Sagaert X, 2012, VIRCHOWS ARCH, V460, P555, DOI 10.1007/s00428-012-1244-9; Sawatzky DA, 2006, AM J PATHOL, V168, P33, DOI 10.2353/ajpath.2006.050058; Shukla S, 2007, CELL CYCLE, V6, P1102, DOI 10.4161/cc.6.9.4146; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Tang X, 2012, IMMUNOLOGY; Taylor CA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-35; Tong X, 2013, ANTICANCER AGENTS ME; Verma G, 2012, J CELL PHYSIOL, V227, P1791, DOI 10.1002/jcp.22903; Wang J, 2012, INFLAMMATION, V35, P1466, DOI 10.1007/s10753-012-9460-7; Wang LL, 2012, TOXICOL LETT, V209, P193, DOI 10.1016/j.toxlet.2011.12.014; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Yoon O, 2012, ONCOL LETT, V4, P1033, DOI 10.3892/ol.2012.834	39	27	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92007	10.1371/journal.pone.0092007	http://dx.doi.org/10.1371/journal.pone.0092007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646936	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500070
J	Lim, R; Morwood, CJ; Barker, G; Lappas, M				Lim, Ratana; Morwood, Carrington J.; Barker, Gillian; Lappas, Martha			Effect of Silibinin in Reducing Inflammatory Pathways in In Vitro and In Vivo Models of Infection-Induced Preterm Birth	PLOS ONE			English	Article							FACTOR-KAPPA-B; HUMAN FETAL MEMBRANES; PROLABOR MEDIATORS; MILK THISTLE; PROINFLAMMATORY CYTOKINES; PREMATURE RUPTURE; HUMAN PLACENTA; MYELOID CELLS; HUMAN LABOR; EXPRESSION	Infection-induced preterm birth is the largest cause of infant death and of neurological disabilities in survivors. Silibinin, from milk thistle, exerts potent anti-inflammatory activities in non-gestational tissues. The aims of this study were to determine the effect of silibinin on pro-inflammatory mediators in (i) human fetal membranes and myometrium treated with bacterial endotoxin lipopolysaccharide (LPS) or the pro-inflammatory cytokine IL-1 beta, and (ii) in preterm fetal membranes with active infection. The effect of silibinin on infection induced inflammation and brain injury in pregnant mice was also assessed. Fetal membranes and myometrium (tissue explants and primary cells) were treated with 200 mu M silibinin in the presence or absence of 10 mu g/ml LPS or 1 ng/ml IL-1 beta. C57BL/6 mice were injected with 70 mg/kg silibinin with or without 50 mu g LPS on embryonic day 16. Fetal brains were collected after 6 h. In human fetal membranes, silibinin significantly decreased LPS-stimulated expression of IL-6 and IL-8, COX-2, and prostaglandins PGE(2) and PGF(2 alpha). In primary amnion and myometrial cells, silibinin also decreased IL-1 beta-induced MMP-9 expression. Preterm fetal membranes with active infection treated with silibinin showed a decrease in IL-6, IL-8 and MMP-9 expression. Fetal brains from mice treated with silibinin showed a significant decrease in LPS-induced IL-8 and ninjurin, a marker of brain injury. Our study demonstrates that silibinin can reduce infection and inflammation-induced pro-labour mediators in human fetal membranes and myometrium. Excitingly, the in vivo results indicate a protective effect of silibinin on infection-induced brain injury in a mouse model of preterm birth.	[Lim, Ratana; Morwood, Carrington J.; Barker, Gillian; Lappas, Martha] Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia; [Lim, Ratana; Morwood, Carrington J.; Barker, Gillian; Lappas, Martha] Univ Melbourne, Obstet Nutr & Endocrinol Grp, Dept Obstet & Gynaecol, Melbourne, Vic 3010, Australia	University of Melbourne	Lappas, M (corresponding author), Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia.	mlappas@unimelb.edu.au			National Health and Medical Research Council (NHMRC) [1047025]; University of Melbourne; Austin Hospital Medical Research Foundation (AMRF); Medical Research Foundation for Women and Babies; Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Research Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne); Austin Hospital Medical Research Foundation (AMRF); Medical Research Foundation for Women and Babies; Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Research Foundation	Associate Professor Martha Lappas was in recipient of a National Health and Medical Research Council (NHMRC) Career Development Award (grant no. 1047025). Dr. Ratana Lim was, in part, supported by an early career researcher grant from the University of Melbourne. This work was supported by the Austin Hospital Medical Research Foundation (AMRF), Medical Research Foundation for Women and Babies, and the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovici A, 2012, OBSTET GYN CLIN N AM, V39, P77, DOI 10.1016/j.ogc.2011.12.003; Agarwal R, 2006, ANTICANCER RES, V26, P4457; Ahn BJ, 2009, BIOCHEM BIOPH RES CO, V387, P321, DOI 10.1016/j.bbrc.2009.07.019; Alfirevic Z, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6531; Au AY, 2011, J VET PHARMACOL THER, V34, P120, DOI 10.1111/j.1365-2885.2010.01200.x; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; BENNETT PR, 1987, AM J OBSTET GYNECOL, V156, P649, DOI 10.1016/0002-9378(87)90070-6; Bhupathiraju SN, 2013, AM J CLIN NUTR; Brantsaeter AL, 2009, J NUTR, V139, P1162, DOI 10.3945/jn.109.104968; Burd I, 2010, J NEUROSCI RES, V88, P1872, DOI 10.1002/jnr.22368; Carlson SE, 2013, AM J CLIN NUTR, V97, P808, DOI 10.3945/ajcn.112.050021; Chawanpaiboon Saifon, 2012, Journal of the Medical Association of Thailand, V95, P636; Cho SJ, 2013, P NATL ACAD SCI USA, V110, P9362, DOI 10.1073/pnas.1221242110; Choi YH, 2012, BIOCHEM BIOPH RES CO, V427, P450, DOI 10.1016/j.bbrc.2012.07.112; Cristofalo R, 2013, FREE RADICAL RES, V47, P268, DOI 10.3109/10715762.2013.765951; Dammann O, 2002, MENT RETARD DEV D R, V8, P46, DOI 10.1002/mrdd.10005; Deep G, 2007, INTEGR CANCER THER, V6, P130, DOI 10.1177/1534735407301441; Denison FC, 1998, HUM REPROD, V13, P3560, DOI 10.1093/humrep/13.12.3560; Dodd JM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004947.pub3; Elovitz MA, 2011, INT J DEV NEUROSCI, V29, P663, DOI 10.1016/j.ijdevneu.2011.02.011; Endoh Y, 2009, J IMMUNOL, V182, P2258, DOI 10.4049/jimmunol.0802683; Galinsky R, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/412831; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gross G, 2000, AM J PHYSIOL-REG I, V278, pR1415, DOI 10.1152/ajpregu.2000.278.6.R1415; Hackett ES, 2013, J VET INTERN MED, V27, P10, DOI 10.1111/jvim.12002; Helmer H, 2002, J SOC GYNECOL INVEST, V9, P15, DOI 10.1016/S1071-5576(01)00142-3; Hoh C, 2006, CLIN CANCER RES, V12, P2944, DOI 10.1158/1078-0432.CCR-05-2724; Ifergan I, 2011, ANN NEUROL, V70, P751, DOI 10.1002/ana.22519; Giorgi VSI, 2012, J REPROD IMMUNOL, V95, P67, DOI 10.1016/j.jri.2012.06.004; Kaga N, 1996, AM J OBSTET GYNECOL, V174, P754, DOI 10.1016/S0002-9378(96)70460-X; Kang JS, 2004, BIOCHEM PHARMACOL, V67, P175, DOI 10.1016/j.bcp.2003.08.032; Kaukola T, 2006, PEDIATR RES, V59, P478, DOI 10.1203/01.pdr.0000182596.66175.ee; Kaur M, 2009, MOL CANCER THER, V8, P2366, DOI 10.1158/1535-7163.MCT-09-0304; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Kim BR, 2013, INFLAMM RES; Kovacevic Z, 2011, CURR TOP MED CHEM, V11, P483, DOI 10.2174/156802611794785190; Ladas EJ, 2003, J ALTERN COMPLEM MED, V9, P411, DOI 10.1089/107555303765551633; Lappas M, 2007, PLACENTA, V28, P543, DOI 10.1016/j.placenta.2006.05.011; Lappas M, 2004, J CLIN ENDOCR METAB, V89, P2365, DOI 10.1210/jc.2003-031385; Lappas M, 2011, PLACENTA, V32, P1016, DOI 10.1016/j.placenta.2011.09.011; Lappas M, 2002, BIOL REPROD, V67, P668, DOI 10.1095/biolreprod67.2.668; Lappas M, 2013, J REPROD IMMUNOL, V99, P24, DOI 10.1016/j.jri.2013.04.005; Lappas M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110056; Lee PR, 2003, AM J OBSTET GYNECOL, V189, P261, DOI 10.1067/mob.2003.485; Lee Y, 2003, MOL HUM REPROD, V9, P213, DOI 10.1093/molehr/gag026; Li JF, 2010, J BRACHIAL PLEX PERI, V5, DOI 10.1186/1749-7221-5-18; Lim R, 2013, REPROD SCI, V20, P957, DOI 10.1177/1933719112472741; Lim R, 2013, MOL HUM REPROD, V19, P451, DOI 10.1093/molehr/gat015; Lim R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108126; Lim R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105163; Liu WW, 2013, FEBS J, V280, P4572, DOI 10.1111/febs.12426; Lu P, 2009, BRIT J PHARMACOL, V157, P1270, DOI 10.1111/j.1476-5381.2009.00295.x; Mateen S, 2010, MOL CARCINOGEN, V49, P247, DOI 10.1002/mc.20595; McClure J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041832; MEISS R, 1982, AGENTS ACTIONS, V12, P254; Menon R, 2007, BEST PRACT RES CL OB, V21, P467, DOI 10.1016/j.bpobgyn.2007.01.008; Myhre R, 2013, J NUTR, V143, P1100, DOI 10.3945/jn.112.173229; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Park SW, 2010, J PHARMACOL EXP THER, V333, P736, DOI 10.1124/jpet.110.166884; Parrish MR, 2013, J PERINATOL, V33, P593, DOI 10.1038/jp.2013.18; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Pedersen L, 2011, J PHYSIOL-LONDON, V589, P1409, DOI 10.1113/jphysiol.2010.200733; Raina K, 2013, MOL CARCINOGEN, V52, P195, DOI 10.1002/mc.21843; Rauk PN, 2000, AM J REPROD IMMUNOL, V43, P152, DOI 10.1111/j.8755-8920.2000.430304.x; Redline RW, 2007, PEDIATR DEVEL PATHOL, V10, P282, DOI 10.2350/06-12-0203.1; Roos C, 2013, JAMA-J AM MED ASSOC, V309, P41, DOI 10.1001/jama.2012.153817; Salim R, 2012, OBSTET GYNECOL, V120, P1323, DOI [10.1097/AOG.0b013e3182755dff, http://10.1097/AOG.0b013e3182755dff]; Sebastian BM, 2011, J BIOL CHEM, V286, P35989, DOI 10.1074/jbc.M111.254201; Sennstrom MB, 2000, MOL HUM REPROD, V6, P375, DOI 10.1093/molehr/6.4.375; Singh RP, 2002, CANCER RES, V62, P3063; Sparey C, 1999, J CLIN ENDOCR METAB, V84, P1705, DOI 10.1210/jc.84.5.1705; Suppiej A, 2009, EARLY HUM DEV, V85, P187, DOI 10.1016/j.earlhumdev.2008.09.410; Tamayo C, 2007, INTEGR CANCER THER, V6, P146, DOI 10.1177/1534735407301942; Vadillo-Ortega F, 2005, BJOG-INT J OBSTET GY, V112, P19, DOI 10.1111/j.1471-0528.2005.00579.x; Wall C, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/485201; Wang Q, 2012, J ASIAN NAT PROD RES, V14, P688, DOI 10.1080/10286020.2012.685725; Wang QO, 2011, PHARMACOL BIOCHEM BE, V98, P140, DOI 10.1016/j.pbb.2010.12.006; Xu P, 2002, J CLIN ENDOCR METAB, V87, P1353, DOI 10.1210/jc.87.3.1353; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680; Young A, 2002, BIOL REPROD, V66, P445, DOI 10.1095/biolreprod66.2.445	83	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92505	10.1371/journal.pone.0092505	http://dx.doi.org/10.1371/journal.pone.0092505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647589	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500139
J	Sanner, H; Schwartz, T; Flato, B; Vistnes, M; Christensen, G; Sjaastad, I				Sanner, Helga; Schwartz, Thomas; Flato, Berit; Vistnes, Maria; Christensen, Geir; Sjaastad, Ivar			Increased Levels of Eotaxin and MCP-1 in Juvenile Dermatomyositis Median 16.8 Years after Disease Onset; Associations with Disease Activity, Duration and Organ Damage	PLOS ONE			English	Article							IDIOPATHIC INFLAMMATORY MYOPATHIES; PROGNOSTIC-FACTORS; CHEMOKINES; CHILDREN; CHEMOATTRACTANT; INTERLEUKIN-18; ANTAGONIST; CYTOKINES; ARTHRITIS; FIBROSIS	Objective: To compare cytokine profiles in patients with juvenile dermatomyositis (JDM) after medium to long-term follow-up with matched controls, and to examine associations between cytokine levels and disease activity, disease duration and organ damage. Methods: Fifty-four JDM patients were examined median 16.8 years (2-38) after disease onset (follow-up) and compared with 54 sex- and age-matched controls. Cytokine concentrations in serum were quantified by Luminex technology. In patients, disease activity score (DAS), myositis damage index (MDI) and other disease parameters were collected by chart review (early parameters) and clinical examination (follow-up). Results: Serum levels of eotaxin, monocyte chemoattractant protein-1 (MCP-1) and interferon-inducible protein 10 (IP-10) were elevated in JDM patients compared to controls (31.5%, 37.2% and 43.2% respectively, all p<0.05). Patients with active (n = 28), but not inactive disease (n = 26) had a higher level of MCP-1 than their respective controls. Levels of eotaxin and MCP-1 correlated with disease duration (r = 0.47 and r = 0.64, both p<0.001) and age in patients, but not with age in controls. At follow-up, MDI was associated with MCP-1(standardized beta = 0.43, p = 0.002) after adjusting for disease duration and gender. High MDI 1 year post-diagnosis predicted high levels of eotaxin and MCP-1 at follow-up (standardized beta = 0.24 and 0.29, both p<0.05) after adjusting for disease duration and gender. Conclusion: Patients with JDM had higher eotaxin, MCP-1 and IP-10 than controls. High eotaxin and MCP-1 at follow-up was predicted by early disease parameters, and MCP-1 was associated with organ damage at follow-up, highlighting a role of these chemokines in JDM.	[Sanner, Helga; Flato, Berit] Univ Oslo, Rikshosp, Oslo Univ Hosp, Rheumatol Sect, N-0027 Oslo, Norway; [Sanner, Helga] Univ Oslo, Rikshosp, Oslo Univ Hosp, Norwegian Competence Ctr Pediat & Adolescent Rheu, N-0027 Oslo, Norway; [Schwartz, Thomas; Vistnes, Maria; Christensen, Geir; Sjaastad, Ivar] Oslo Univ Hosp Ulleval, Expt Med Res Inst, Oslo, Norway; [Schwartz, Thomas; Vistnes, Maria; Christensen, Geir; Sjaastad, Ivar] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Schwartz, Thomas; Vistnes, Maria; Christensen, Geir; Sjaastad, Ivar] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Schwartz, Thomas; Flato, Berit] Univ Oslo, Inst Clin Med, Oslo, Norway; [Sjaastad, Ivar] Oslo Univ Hosp Ulleval, Dept Cardiol, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Schwartz, T (corresponding author), Oslo Univ Hosp Ulleval, Expt Med Res Inst, Oslo, Norway.	thomas.schwartz@medisin.uio.no		Vistnes, Maria/0000-0002-6243-0626				Baechler EC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3531; Bilgic H, 2009, ARTHRITIS RHEUM-US, V60, P3436, DOI 10.1002/art.24936; Bode RK, 2003, ARTHRIT RHEUM-ARTHR, V49, P7, DOI 10.1002/art.10924; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; de Jager W, 2007, ANN RHEUM DIS, V66, P589, DOI 10.1136/ard.2006.061853; De Paepe B, 2009, CURR OPIN RHEUMATOL, V21, P610, DOI 10.1097/BOR.0b013e3283317b31; FELDMAN BM, 1995, J RHEUMATOL, V22, P326; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Fujii H, 2011, ARTHRITIS RHEUM-US, V63, P96, DOI 10.1002/art.30106; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Gono T, 2010, RHEUMATOLOGY, V49, P1878, DOI 10.1093/rheumatology/keq196; Huaux F, 2005, AM J PATHOL, V167, P1485, DOI 10.1016/S0002-9440(10)61235-7; Isenberg DA, 2004, RHEUMATOLOGY, V43, P49, DOI 10.1093/rheumatology/keg427; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Lazarevic D, 2013, ANN RHEUM DIS, V72, P686, DOI 10.1136/annrheumdis-2012-201483; Martinelli R, 2001, J BIOL CHEM, V276, P42957, DOI 10.1074/jbc.M103933200; Mathiesen PR, 2010, CLIN EXP RHEUMATOL, V28, P782; McCann LJ, 2006, RHEUMATOLOGY, V45, P1255, DOI 10.1093/rheumatology/kel099; Mielnik P, 2012, RHEUMATOL INT, V32, P639, DOI 10.1007/s00296-010-1692-y; Morokata T, 2006, J PHARMACOL EXP THER, V317, P244, DOI 10.1124/jpet.105.097048; Niewold TB, 2009, ARTHRITIS RHEUM, V60, P1815, DOI 10.1002/art.24555; OPPENHEIM JJ, 2001, CYTOKINE REFERENCE, P3; Pachman LM, 2006, J PEDIATR-US, V148, P247, DOI 10.1016/j.jpeds.2005.10.032; Ravelli A, 2010, ARTHRIT CARE RES, V62, P63, DOI 10.1002/acr.20015; Sanner H, 2014, RHEUMATOLOG IN PRESS; Sanner H, 2011, ANN RHEUM DIS, V70, P86, DOI 10.1136/ard.2010.131433; Sanner H, 2010, ARTHRIT CARE RES, V62, P1103, DOI 10.1002/acr.20203; Sanner H, 2009, RHEUMATOLOGY, V48, P1541, DOI 10.1093/rheumatology/kep302; Schwartz T, 2013, ANN RHEUM DIS, DOI [10.1136/annrheumdis-2013-, DOI 10.1136/ANNRHEUMDIS-2013-]; Schwartz T, 2011, ANN RHEUM DIS, V70, P766, DOI 10.1136/ard.2010.137968; Sultan SM, 2002, RHEUMATOLOGY, V41, P22, DOI 10.1093/rheumatology/41.1.22; Szodoray P, 2010, RHEUMATOLOGY, V49, P1867, DOI 10.1093/rheumatology/keq151; Tacke F, 2007, J GASTROEN HEPATOL, V22, P1256, DOI 10.1111/j.1440-1746.2006.04621.x; Tucci M, 2006, CLIN EXP IMMUNOL, V146, P21, DOI 10.1111/j.1365-2249.2006.03180.x; Vergunst CE, 2008, ARTHRITIS RHEUM-US, V58, P1931, DOI 10.1002/art.23591; Vistnes M, 2010, J APPL PHYSIOL, V108, P1357, DOI 10.1152/japplphysiol.01084.2009; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006; Zong M, 2011, NAT REV RHEUMATOL, V7, P297, DOI 10.1038/nrrheum.2011.39; Zweifel M, 2010, TRANSPL P, V42, P2763, DOI 10.1016/j.transproceed.2010.05.152	39	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92171	10.1371/journal.pone.0092171	http://dx.doi.org/10.1371/journal.pone.0092171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647150	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500094
J	Xu, W; Chen, H; He, CL; Wang, Q				Xu, Wen; Chen, Hui; He, Chen-Liu; Wang, Qiang			Deep Sequencing-Based Identification of Small Regulatory RNAs in Synechocystis sp PCC 6803	PLOS ONE			English	Article							SMALL NONCODING RNAS; PLASMID COPY NUMBER; ANTISENSE-RNA; 6S RNA; GENE-EXPRESSION; PHOTOSYSTEM-I; P RNA; STRAIN; LIGHT; PREDICTION	Synechocystis sp. PCC 6803 is a genetically tractable model organism for photosynthesis research. The genome of Synechocystis sp. PCC 6803 consists of a circular chromosome and seven plasmids. The importance of small regulatory RNAs (sRNAs) as mediators of a number of cellular processes in bacteria has begun to be recognized. However, little is known regarding sRNAs in Synechocystis sp. PCC 6803. To provide a comprehensive overview of sRNAs in this model organism, the sRNAs of Synechocystis sp. PCC 6803 were analyzed using deep sequencing, and 7,951,189 reads were obtained. High quality mapping reads (6,127,890) were mapped onto the genome and assembled into 16,192 transcribed regions (clusters) based on read overlap. A total number of 5211 putative sRNAs were revealed from the genome and the 4 megaplasmids, and 27 of these molecules, including four from plasmids, were confirmed by RT-PCR. In addition, possible target genes regulated by all of the putative sRNAs identified in this study were predicted by IntaRNA and analyzed for functional categorization and biological pathways, which provided evidence that sRNAs are indeed involved in many different metabolic pathways, including basic metabolic pathways, such as glycolysis/gluconeogenesis, the citrate cycle, fatty acid metabolism and adaptations to environmentally stress-induced changes. The information from this study provides a valuable reservoir for understanding the sRNA-mediated regulation of the complex physiology and metabolic processes of cyanobacteria.	[Xu, Wen; Chen, Hui; He, Chen-Liu; Wang, Qiang] Chinese Acad Sci, Key Lab Algal Biol, Inst Hydrobiol, Wuhan, Hubei Province, Peoples R China; [Xu, Wen] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, Q (corresponding author), Chinese Acad Sci, Key Lab Algal Biol, Inst Hydrobiol, Wuhan, Hubei Province, Peoples R China.	wangqiang@ihb.ac.cn	Chen, Hui/T-4383-2019; Wang, Qiang/P-7806-2016	Wang, Qiang/0000-0002-7388-4703	National Program on Key Basic Research Project [2011CB200902]; National Natural Science Foundation of China [31270094]	National Program on Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported jointly by the National Program on Key Basic Research Project (2011CB200902) and the National Natural Science Foundation of China (31270094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo P, 2012, RNA, V18, P530, DOI 10.1261/rna.027359.111; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Axmann IM, 2007, GENE, V406, P69, DOI 10.1016/j.gene.2007.06.011; Axmann IM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r73; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; Coornaert A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003156; CSISZAR K, 1987, GENE, V60, P29, DOI 10.1016/0378-1119(87)90210-1; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; Eisenhut M, 2012, J BIOL CHEM, V287, P33153, DOI 10.1074/jbc.M112.391755; Flaherty BL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-332; Fujimori T, 2005, J BIOL CHEM, V280, P22191, DOI 10.1074/jbc.M500369200; Georg J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.63; Gogol EB, 2011, P NATL ACAD SCI USA, V108, P12875, DOI 10.1073/pnas.1109379108; Hernandez JA, 2010, J PLANT PHYSIOL, V167, P430, DOI 10.1016/j.jplph.2009.10.009; Hess WR, 1998, FEBS LETT, V431, P138, DOI 10.1016/S0014-5793(98)00729-7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HY, 2009, NUCLEIC ACIDS RES, V37, pD150, DOI 10.1093/nar/gkn852; Ikeuchi M, 1996, Tanpakushitsu Kakusan Koso, V41, P2579; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Iwai M, 2004, PLANT CELL PHYSIOL, V45, P1809, DOI 10.1093/pcp/pch207; Johansen J, 2008, J MOL BIOL, V383, P1, DOI 10.1016/j.jmb.2008.06.058; Jorgensen MG, 2012, MOL MICROBIOL, V84, P36, DOI 10.1111/j.1365-2958.2012.07976.x; Kurpiel PM, 2012, J ANTIMICROB CHEMOTH, V67, P339, DOI 10.1093/jac/dkr479; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; Lee EJ, 2010, MOL MICROBIOL, V76, P1020, DOI 10.1111/j.1365-2958.2010.07161.x; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2013, NUCLEIC ACIDS RES, V41, pD233, DOI 10.1093/nar/gks1264; Mandin P, 2010, EMBO J, V29, P3094, DOI 10.1038/emboj.2010.179; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Okibe N, 2010, MICROBIOL-SGM, V156, P3609, DOI 10.1099/mic.0.043745-0; Park SY, 2010, CELL, V142, P737, DOI 10.1016/j.cell.2010.07.046; Pellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032723; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Quintana N, 2011, APPL MICROBIOL BIOT, V91, P471, DOI 10.1007/s00253-011-3394-0; Raghavan R, 2011, GENOME RES, V21, P1487, DOI 10.1101/gr.119370.110; Sakurai I, 2012, PLANT PHYSIOL, V160, P1000, DOI 10.1104/pp.112.202127; Schluter JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-245; Schon A, 2002, INT J SYST EVOL MICR, V52, P1383, DOI 10.1099/ijs.0.01983-0; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Steglich C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000173; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Thomason MK, 2012, MOL MICROBIOL, V84, P17, DOI 10.1111/j.1365-2958.2012.07965.x; Tous C, 2001, J BIOL CHEM, V276, P29059, DOI 10.1074/jbc.M103418200; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; VIOQUE A, 1992, NUCLEIC ACIDS RES, V20, P6331, DOI 10.1093/nar/20.23.6331; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Voss B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-375; Voss B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060224; Voss B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-123; Wang Q, 2008, PLANT PHYSIOL, V147, P1239, DOI 10.1104/pp.108.121087; Wassarman KM, 2007, MOL MICROBIOL, V65, P1425, DOI 10.1111/j.1365-2958.2007.05894.x; Wassarman KM, 2002, CELL, V109, P141, DOI 10.1016/S0092-8674(02)00717-1; Watanabe T, 1997, FEBS LETT, V416, P302, DOI 10.1016/S0014-5793(97)01237-4; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weaver KE, 2007, CURR OPIN MICROBIOL, V10, P110, DOI 10.1016/j.mib.2007.03.002; Wilms I, 2011, MOL MICROBIOL, V80, P492, DOI 10.1111/j.1365-2958.2011.07589.x	67	17	18	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92711	10.1371/journal.pone.0092711	http://dx.doi.org/10.1371/journal.pone.0092711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647397	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500152
J	He, L; Ren, RJ; Yang, HL; Hardin, C; Reyes, L; Reynaud, J; Gardiner, SK; Fortune, B; Demirel, S; Burgoyne, CF				He, Lin; Ren, Ruojin; Yang, Hongli; Hardin, Christy; Reyes, Luke; Reynaud, Juan; Gardiner, Stuart K.; Fortune, Brad; Demirel, Shaban; Burgoyne, Claude F.			Anatomic vs. Acquired Image Frame Discordance in Spectral Domain Optical Coherence Tomography Minimum Rim Measurements	PLOS ONE			English	Article							NERVE-FIBER LAYER; SCANNING LASER POLARIMETRY; DISC MARGIN ANATOMY; OPEN-ANGLE GLAUCOMA; VISUAL-FIELD; SUSPECTED GLAUCOMA; HEAD; DAMAGE; EYES; VARIABILITY	Purpose: To quantify the effects of using the fovea to Bruch's membrane opening (FoBMO) axis as the nasal-temporal midline for 30 degrees sectoral (clock-hour) spectral domain optical coherence tomography (SDOCT) optic nerve head (ONH) minimum rim width (MRW) and area (MRA) calculations. Methods: The internal limiting membrane and BMO were delineated within 24 radial ONH B-scans in 222 eyes of 222 participants with ocular hypertension and glaucoma. For each eye the fovea was marked within the infrared reflectance image, the FoBMO angle (theta) relative to the acquired image frame (AIF) horizontal was calculated, the ONH was divided into 30 degrees sectors using a FoBMO or AIF nasal/temporal axis, and SDOCT MRW and MRA were quantified within each FoBMO vs. AIF sector. For each sector, focal rim loss was calculated as the MRW and MRA gradients (i.e. the difference between the value for that sector and the one clockwise to it divided by 30 degrees). Sectoral FoBMO vs. AIF discordance was calculated as the difference between the FoBMO and AIF values for each sector. Generalized estimating equations were used to predict the eyes and sectors of maximum FoBMO vs. AIF discordance. Results: The mean FoBMO angle was -6.6 +/- 4.2 degrees (range: -17 degrees to +7 degrees). FoBMO vs. AIF discordance in sectoral mean MRW and MRA was significant for 7 of 12 and 6 of 12 sectors, respectively (p < 0.05, Wilcoxon test, Bonferroni correction). Eye-specific, FoBMO vs. AIF sectoral discordance was predicted by sectoral rim gradient (p < 0.001) and FoBMO angle (p < 0.001) and achieved maximum values of 83% for MRW and 101% for MRA. Conclusions: Using the FoBMO axis as the nasal-temporal axis to regionalize the ONH rather than a line parallel to the AIF horizontal axis significantly influences clock-hour SDOCT rim values. This effect is greatest in eyes with large FoBMO angles and sectors with focal rim loss.	[He, Lin; Ren, Ruojin; Yang, Hongli; Hardin, Christy; Reyes, Luke; Reynaud, Juan; Burgoyne, Claude F.] Legacy Hlth, Opt Nerve Head Res Lab, Portland, OR 97232 USA; [Yang, Hongli; Reynaud, Juan; Gardiner, Stuart K.; Fortune, Brad; Demirel, Shaban; Burgoyne, Claude F.] Legacy Hlth, Discoveries Sight Res Labs, Devers Eye Inst, Portland, OR USA	Legacy Health; Devers Eye Institute; Legacy Health	Burgoyne, CF (corresponding author), Legacy Hlth, Opt Nerve Head Res Lab, Portland, OR 97232 USA.	cfburgoyne@deverseye.org	Yang, Aliza/HGU-3681-2022; Gardiner, Stuart/I-7279-2013	Gardiner, Stuart/0000-0002-9139-4943; Burgoyne, Claude/0000-0002-2765-4739; Demirel, Shaban/0000-0003-3855-6461; Yang, Hongli/0000-0002-3636-9219; Fortune, Brad/0000-0003-0284-5173	National Institutes of Health [R01-EY021281, R01-EY019674]; Legacy Good Samaritan Foundation; Heidelberg Engineering; Alcon Research Institute; Sears Medical Trust; NATIONAL EYE INSTITUTE [R01EY021281, R01EY019674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Legacy Good Samaritan Foundation; Heidelberg Engineering; Alcon Research Institute(Novartis); Sears Medical Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health Grants R01-EY021281 (CFB) and R01-EY019674 (SD), Legacy Good Samaritan Foundation, unrestricted research support from Heidelberg Engineering, the Alcon Research Institute and the Sears Medical Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen PJ, 1996, GLAUCOMAS, V1, P617; ARMALY MF, 1967, ARCH OPHTHALMOL-CHIC, V78, P35, DOI 10.1001/archopht.1967.00980030037007; BALAZSI AG, 1984, ARCH OPHTHALMOL-CHIC, V102, P1011, DOI 10.1001/archopht.1984.01040030813022; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; CAPRIOLI J, 1988, OPHTHALMOLOGY, V95, P723; Chauhan BC, 2013, AM J OPHTHALMOL, V156, P218, DOI 10.1016/j.ajo.2013.04.016; Chauhan BC, 2013, OPHTHALMOLOGY, V120, P535, DOI 10.1016/j.ophtha.2012.09.055; Chen Teresa C, 2009, Trans Am Ophthalmol Soc, V107, P254; Downs JC, 2007, INVEST OPHTH VIS SCI, V48, P3195, DOI 10.1167/iovs.07-0021; Essock EA, 2003, ARCH OPHTHALMOL-CHIC, V121, P1238, DOI 10.1001/archopht.121.9.1238; Gardiner SK, 2005, INVEST OPHTH VIS SCI, V46, P3712, DOI 10.1167/iovs.05-0266; Gardiner SK, 2013, AM J OPHTHA IN PRESS; Gardiner SK, 2012, INVEST OPHTH VIS SCI, V53, P3598, DOI 10.1167/iovs.11-9065; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Harizman N, 2006, ARCH OPHTHALMOL-CHIC, V124, P1579, DOI 10.1001/archopht.124.11.1579; Harwerth RS, 2010, PROG RETIN EYE RES, V29, P249, DOI 10.1016/j.preteyeres.2010.02.001; He L, 2014, INVEST OPHTH VIS SCI, V55, P574, DOI 10.1167/iovs.13-13245; Helb HM, 2010, ACTA OPHTHALMOL, V88, P842, DOI 10.1111/j.1755-3768.2009.01602.x; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; Hood DC, 2013, INVEST OPHTH VIS SCI, V54, P7338, DOI 10.1167/iovs.13-12680; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Hu ZH, 2010, INVEST OPHTH VIS SCI, V51, P5708, DOI 10.1167/iovs.09-4838; Jansonius NM, 2009, VISION RES, V49, P2157, DOI 10.1016/j.visres.2009.04.029; JONAS JB, 1989, OPHTHALMOLOGY, V96, P627; Medeiros FA, 2003, BRIT J OPHTHALMOL, V87, P413, DOI 10.1136/bjo.87.4.413; Moghimi S, 2012, INVEST OPHTHALMOL VI; Patel NB, 2012, OPTOMETRY VISION SCI, V89, pE652, DOI 10.1097/OPX.0b013e318238c34e; Povazay B, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2773736; Reis ASC, 2012, INVEST OPHTH VIS SCI, V53, P1852, DOI 10.1167/iovs.11-9309; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Schiefer U, 2003, ARCH OPHTHALMOL-CHIC, V121, P458, DOI 10.1001/archopht.121.4.458; Sharma A, 2011, OPHTHALMOLOGY, V118, P1348, DOI 10.1016/j.ophtha.2010.12.008; Spry PGD, 2005, J GLAUCOMA, V14, P11, DOI 10.1097/01.ijg.0000145813.46848.b8; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P1206, DOI 10.1167/iovs.10-5599; Strouthidis NG, 2010, INVEST OPHTH VIS SCI, V51, P1464, DOI 10.1167/iovs.09-3984; Turpin A, 2009, INVEST OPHTH VIS SCI, V50, P3249, DOI 10.1167/iovs.08-2492; Valverde-Megias A, 2013, INVEST OPHTH VIS SCI, V54, P5771, DOI 10.1167/iovs.13-12440; Wyatt HJ, 2007, VISION RES, V47, P925, DOI 10.1016/j.visres.2006.12.012; Yang HL, 2012, INVEST OPHTH VIS SCI, V53, P394, DOI 10.1167/iovs.11-8244	39	44	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92225	10.1371/journal.pone.0092225	http://dx.doi.org/10.1371/journal.pone.0092225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643069	gold, Green Submitted, Green Published			2022-12-27	WOS:000333259900107
J	Fancsalszky, L; Monostori, E; Farkas, Z; Pourkarimi, E; Masoudi, N; Hargitai, B; Bosnar, MH; Dezeljin, M; Zsakai, A; Vellai, T; Mehta, A; Takacs-Vellai, K				Fancsalszky, Luca; Monostori, Eszter; Farkas, Zsolt; Pourkarimi, Ehsan; Masoudi, Neda; Hargitai, Balazs; Bosnar, Maja Herak; Dezeljin, Martina; Zsakai, Annamaria; Vellai, Tibor; Mehta, Anil; Takacs-Vellai, Krisztina			NDK-1, the Homolog of NM23-H1/H2 Regulates Cell Migration and Apoptotic Engulfment in C. elegans	PLOS ONE			English	Article							NUCLEOSIDE-DIPHOSPHATE KINASE; METASTASIS SUPPRESSOR NM23-H1; RNA INTERFERENCE; GENE NM23; AWD; DIFFERENTIATION; PHAGOCYTOSIS; EXPRESSION; CLEARANCE; INTEGRINS	Abnormal regulation of cell migration and altered rearrangement of cytoskeleton are characteristic of metastatic cells. The first described suppressor of metastatic processes is NM23-H1, which displays NDPK (nucleoside-diphosphate kinase) activity. To better understand the role of nm23 genes in cell migration, we investigated the function of NDK-1, the sole Caenorhabditis elegans homolog of group I NDPKs in distal tip cell (DTC) migration. Dorsal phase of DTC migration is regulated by integrin mediated signaling. We find that ndk-1 loss of function mutants show defects in this phase. Epistasis analysis using mutants of the alpha-integrin ina-1 and the downstream functioning motility-promoting signaling module (referred to as CED-10 pathway) placed NDK-1 downstream of CED-10/Rac. As DTC migration and engulfment of apoptotic corpses are analogous processes, both partially regulated by the CED-10 pathway, we investigated defects of apoptosis in ndk-1 mutants. Embryos and germ cells defective for NDK-1 showed an accumulation of apoptotic cell corpses. Furthermore, NDK-1::GFP is expressed in gonadal sheath cells, specialized cells for engulfment and clearence of apoptotic corpses in germ line, which indicates a role for NDK-1 in apoptotic corpse removal. In addition to the CED-10 pathway, engulfment in the worm is also mediated by the CED-1 pathway. abl-1/Abl and abi-1/Abi, which function in parallel to both CED-10/CED-1 pathways, also regulate engulfment and DTC migration. ndk-1(-); abi-1(-) double mutant embryos display an additive phenotype (e.g. enhanced number of apoptotic corpses) which suggests that ndk-1 acts in parallel to abi-1. Corpse number in ndk-1(-); ced-10(-) double mutants, however, is similar to ced-10(-) single mutants, suggesting that ndk-1 acts downstream of ced-10 during engulfment. In addition, NDK-1 shows a genetic interaction with DYN-1/dynamin, a downstream component of the CED-1 pathway. In summary, we propose that NDK-1/NDPK might represent a converging point of CED-10 and CED-1 pathways in the process of cytoskeleton rearrangement.	[Fancsalszky, Luca; Monostori, Eszter; Farkas, Zsolt; Pourkarimi, Ehsan; Masoudi, Neda; Hargitai, Balazs; Vellai, Tibor; Takacs-Vellai, Krisztina] Eotvos Lorand Univ, Dept Genet, Budapest, Hungary; [Bosnar, Maja Herak; Dezeljin, Martina] Rudjer Boskovic Inst, Div Mol Med, Mol Oncol Lab, Zagreb, Croatia; [Zsakai, Annamaria] Eotvos Lorand Univ, Dept Biol Anthropol, Budapest, Hungary; [Mehta, Anil] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland	Eotvos Lorand University; Rudjer Boskovic Institute; Eotvos Lorand University; University of Dundee	Takacs-Vellai, K (corresponding author), Eotvos Lorand Univ, Dept Genet, Budapest, Hungary.	takacsve@gmail.com	Farkas, Zsolt/AAF-9966-2020; Vellai, Tibor/AAG-2154-2020; Zsakai, Annamaria/AAE-8639-2020; Takacs-Vellai, Krisztina/AAF-9062-2020; Bosnar, Maja Herak/AAN-6122-2020	Farkas, Zsolt/0000-0001-8531-8912; Zsakai, Annamaria/0000-0001-8880-2056; Takacs-Vellai, Krisztina/0000-0002-4472-0363; Pourkarimi, Ehsan/0000-0001-9598-3465	OTKA Hungarian Scientific Research Fund [PD75477]; Wellcome Trust [069150]; OTKA grants [NK78012, K109349]; Janos Bolyai Scholarship of the Hungarian Academy of Sciences	OTKA Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Wellcome Trust(Wellcome TrustEuropean Commission); OTKA grants(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the OTKA Hungarian Scientific Research Fund PD75477 to K.T.-V. A.M. is supported by the Wellcome Trust [069150]. T.V. is supported by OTKA grants NK78012 and K109349. K.T.-V. is a grantee of the Janos Bolyai Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL of OTKA: http://www.otka.hu/en, URL of Janos Bolyai scholarship: http://mta.hu/cikkek/?node_id=22421, Wellcome Trust: http://www.wellcome.ac.uk/.	Annesley SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026024; Baillat G, 2002, J BIOL CHEM, V277, P18961, DOI 10.1074/jbc.M108818200; Besant PG, 2003, INT J BIOCHEM CELL B, V35, P297, DOI 10.1016/S1357-2725(02)00257-1; Blelloch R, 1999, CURR OPIN CELL BIOL, V11, P608, DOI 10.1016/S0955-0674(99)00028-9; Boissan M, 2010, CANCER RES, V70, P7710, DOI 10.1158/0008-5472.CAN-10-1887; BRENNER S, 1974, GENETICS, V77, P71; Choudhuri T, 2010, CANCER BIOL THER, V9, P1065, DOI 10.4161/cbt.9.12.11995; Cram EJ, 2006, J CELL SCI, V119, P4811, DOI 10.1242/jcs.03274; Dammai V, 2003, GENE DEV, V17, P2812, DOI 10.1101/gad.1096903; Desvignes T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-256; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fournier HN, 2003, J BIOENERG BIOMEMBR, V35, P81, DOI 10.1023/A:1023450008347; Gartner A., 2008, GERMLINE SURVIVAL AP; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu TY, 2010, CURR BIOL, V20, P477, DOI 10.1016/j.cub.2010.01.062; Hurwitz ME, 2009, PLOS BIOL, V7, P876, DOI 10.1371/journal.pbio.1000099; Kang Y, 2007, BIOCHEM BIOPH RES CO, V359, P76, DOI 10.1016/j.bbrc.2007.05.090; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Lee M, 2005, BBA-GEN SUBJECTS, V1723, P248, DOI 10.1016/j.bbagen.2005.01.003; Lee M, 2001, J BIOL CHEM, V276, P36404, DOI 10.1074/jbc.M105795200; Lehmann R, 2001, CURR OPIN GENET DEV, V11, P457, DOI 10.1016/S0959-437X(00)00217-3; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Ma DQ, 2004, J BIOL CHEM, V279, P18073, DOI 10.1074/jbc.M400185200; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Marino N, 2011, N-S ARCH PHARMACOL, V384, P351, DOI 10.1007/s00210-011-0646-6; Masoudi N, 2013, DEVELOPMENT, V140, P3486, DOI 10.1242/dev.094011; Meighan CM, 2007, GENE DEV, V21, P1615, DOI 10.1101/gad.1534807; Miyamoto M, 2009, MOL CELL BIOCHEM, V329, P175, DOI 10.1007/s11010-009-0106-5; Montell DJ, 1999, DEVELOPMENT, V126, P3035; Nallamothu G, 2008, MOL CELL BIOL, V28, P1964, DOI 10.1128/MCB.01743-07; Nallamothu G, 2009, MOL CELL BIOCHEM, V329, P35, DOI 10.1007/s11010-009-0112-7; Negroni A, 2000, CELL DEATH DIFFER, V7, P843, DOI 10.1038/sj.cdd.4400720; Palmieri D, 2005, JNCI-J NATL CANCER I, V97, P632, DOI 10.1093/jnci/dji111; Perina D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-87; Postel EH, 1996, P NATL ACAD SCI USA, V93, P6892, DOI 10.1073/pnas.93.14.6892; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; She SY, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-93; Shen Q, 2013, DEVELOPMENT, V140, P3230, DOI 10.1242/dev.093732; Steeg PS, 2003, CANCER LETT, V190, P1, DOI 10.1016/S0304-3835(02)00499-8; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sun J, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008769, 10.1371/journal.pone.0011351]; Timmons Lisa, 2006, V351, P109; VENTURELLI D, 1995, P NATL ACAD SCI USA, V92, P7435, DOI 10.1073/pnas.92.16.7435; Volm M, 1998, CLIN EXP METASTAS, V16, P595, DOI 10.1023/A:1006588601683; Woolworth JA, 2009, MOL CELL BIOL, V29, P4679, DOI 10.1128/MCB.00297-09; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhang QB, 2011, INT J CANCER, V128, P40, DOI 10.1002/ijc.25307	52	18	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92687	10.1371/journal.pone.0092687	http://dx.doi.org/10.1371/journal.pone.0092687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658123	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000333355300113
J	Paino, T; Sarasquete, ME; Paiva, B; Krzeminski, P; San-Segundo, L; Corchete, LA; Redondo, A; Garayoa, M; Garcia-Sanz, R; Gutierrez, NC; Ocio, EM; San-Miguel, JF				Paino, Teresa; Sarasquete, Maria E.; Paiva, Bruno; Krzeminski, Patryk; San-Segundo, Laura; Corchete, Luis A.; Redondo, Alba; Garayoa, Mercedes; Garcia-Sanz, Ramon; Gutierrez, Norma C.; Ocio, Enrique M.; San-Miguel, Jesus F.			Phenotypic, Genomic and Functional Characterization Reveals No Differences between CD138(++) and CD138(low) Subpopulations in Multiple Myeloma Cell Lines	PLOS ONE			English	Article							CANCER STEM-CELLS; PLASMA-CELLS; BONE-MARROW; CLONOGENIC CELLS; DRUG-RESISTANCE; TUMOR-CELLS; PROGENITORS; LEUKEMIA; CAPACITY; GROWTH	Despite recent advances in the treatment of multiple myeloma (MM), it remains an incurable disease potentially due to the presence of resistant myeloma cancer stem cells (MM-CSC). Although the presence of clonogenic cells in MM was described three decades ago, the phenotype of MM-CSC is still controversial, especially with respect to the expression of syndecan-1 (CD138). Here, we demonstrate the presence of two subpopulations - CD138(++) (95-99%) and CD138(low) (1-5%) - in eight MM cell lines. To find out possible stem-cell-like features, we have phenotypically, genomic and functionally characterized the two subpopulations. Our results show that the minor CD138(low) subpopulation is morphologically identical to the CD138(++) fraction and does not represent a more immature B-cell compartment (with lack of CD19, CD20 and CD27 expression). Moreover, both subpopulations have similar gene expression and genomic profiles. Importantly, both CD138(++) and CD138(low) subpopulations have similar sensitivity to bortezomib, melphalan and doxorubicin. Finally, serial engraftment in CB17-SCID mice shows that CD138(++) as well as CD138(low) cells have self-renewal potential and they are phenotypically interconvertible. Overall, our results differ from previously published data in MM cell lines which attribute a B-cell phenotype to MM-CSC. Future characterization of clonal plasma cell subpopulations in MM patients' samples will guarantee the discovery of more reliable markers able to discriminate true clonogenic myeloma cells.	[Paino, Teresa; Krzeminski, Patryk; San-Segundo, Laura; Garayoa, Mercedes; Ocio, Enrique M.] Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain; [Sarasquete, Maria E.; Corchete, Luis A.; Redondo, Alba; Garcia-Sanz, Ramon; Gutierrez, Norma C.; Ocio, Enrique M.] Hosp Univ Salamanca, Salamanca, Spain; [Paino, Teresa; Sarasquete, Maria E.; Krzeminski, Patryk; San-Segundo, Laura; Garayoa, Mercedes; Garcia-Sanz, Ramon; Gutierrez, Norma C.; Ocio, Enrique M.] Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain; [Paiva, Bruno; San-Miguel, Jesus F.] Univ Navarra Clin, CIMA, Pamplona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Navarra	Ocio, EM (corresponding author), Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain.	emocio@usal.es	San-Segundo, Laura/E-6441-2018; San-Miguel, Jesús F./V-8977-2018; Sánchez, Luis Antonio Corchete/D-1336-2018; Krzeminski, Patryk/AAH-3956-2021; Paiva, Bruno/AAB-8881-2021; Krzeminski, Patryk/J-3262-2016; Garcia-Sanz, Ramon/B-7986-2017; Garayoa, Mercedes/O-6039-2017; sarasquete, Maria E/U-8063-2018	San-Segundo, Laura/0000-0003-2391-5935; San-Miguel, Jesús F./0000-0002-9183-4857; Sánchez, Luis Antonio Corchete/0000-0003-4577-8599; Paiva, Bruno/0000-0003-1977-3815; Garcia-Sanz, Ramon/0000-0003-4120-2787; Garayoa, Mercedes/0000-0003-2194-2841; sarasquete, Maria E/0000-0001-7335-3657; Gutierrez, Norma/0000-0001-5834-9510; Ocio, Enrique M./0000-0002-5765-0085	Cooperative Research Thematic Network (RTICs) [RD06/0020/0006]; Junta de Castilla y Leon. Consejeria de Sanidad [GRS 391/B/09]; Ministerio de Ciencia e Innovacion [PS09/01897]; Fundacion Memoria D. Samuel Solorzano Barruso [FS/2-2010]; Asociacion Espanola Contra el Cancer (AECC) [GCB120981SAN]	Cooperative Research Thematic Network (RTICs); Junta de Castilla y Leon. Consejeria de Sanidad(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Memoria D. Samuel Solorzano Barruso; Asociacion Espanola Contra el Cancer (AECC)	This work was supported by the Cooperative Research Thematic Network (RTICs; RD06/0020/0006), the "Junta de Castilla y Leon. Consejeria de Sanidad" (GRS 391/B/09), the "Ministerio de Ciencia e Innovacion" (PS09/01897), the "Fundacion Memoria D. Samuel Solorzano Barruso" (FS/2-2010) and Asociacion Espanola Contra el Cancer (AECC)(GCB120981SAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharadwaj S, 2013, STEM CELLS, V31, P1840, DOI 10.1002/stem.1424; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boucher K, 2012, CLIN CANCER RES, V18, P6155, DOI 10.1158/1078-0432.CCR-12-0531; Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Carvajal-Vergara X, 2005, BLOOD, V105, P4492, DOI 10.1182/blood-2004-08-2985; Chaidos A, 2013, BLOOD, V121, P318, DOI 10.1182/blood-2012-06-436220; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen Q, 2005, BLOOD, V106, P698, DOI 10.1182/blood-2004-11-4286; Chilosi M, 1999, MODERN PATHOL, V12, P1101; Chiron D, 2012, BRIT J HAEMATOL, V156, P679, DOI 10.1111/j.1365-2141.2011.08904.x; Christensen JH, 2012, HAEMATOL-HEMATOL J, V97, pE18, DOI 10.3324/haematol.2011.043125; Dick J E, 1996, Curr Opin Hematol, V3, P405; Fuhler GM, 2010, EXP CELL RES, V316, P1816, DOI 10.1016/j.yexcr.2010.03.013; Greenstein S, 2003, EXP HEMATOL, V31, P271, DOI 10.1016/S0301-472X(03)00023-7; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Guteerrez NC, 2005, LEUKEMIA, V19, P402, DOI 10.1038/sj.leu.2403625; HAMBURGER A, 1977, J CLIN INVEST, V60, P846, DOI 10.1172/JCI108839; Hosen N, 2012, LEUKEMIA, V26, P2135, DOI 10.1038/leu.2012.80; Jacak J, 2013, J BIOTECHNOL, V164, P525, DOI 10.1016/j.jbiotec.2013.01.027; Jakubikova J, 2011, BLOOD, V117, P4409, DOI 10.1182/blood-2010-02-267344; Jego G, 1999, BLOOD, V94, P701, DOI 10.1182/blood.V94.2.701.414k16_701_712; Jego G, 2001, BLOOD, V97, P1817, DOI 10.1182/blood.V97.6.1817; Kim D, 2012, LEUKEMIA, V26, P2530, DOI 10.1038/leu.2012.140; Kukreja A, 2006, J EXP MED, V203, P1859, DOI 10.1084/jem.20052136; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Luo YC, 2012, STEM CELLS, V30, P2100, DOI 10.1002/stem.1193; Ma MH, 2003, CLIN CANCER RES, V9, P1136; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Ocio EM, 2009, BLOOD, V113, P3781, DOI 10.1182/blood-2008-09-177774; PAINO T, 2013, HAEMATOLOGICA, V97, P1110; Paino T, 2013, HAEMATOL-HEMATOL J, V98, DOI 10.3324/haematol.2012.077727; Paino T, 2012, HAEMATOL-HEMATOL J, V97, P1110, DOI 10.3324/haematol.2011.057372; Paiva B, 2011, LEUKEMIA, V25, P697, DOI 10.1038/leu.2010.320; Pilarski LM, 2000, BLOOD, V95, P1056, DOI 10.1182/blood.V95.3.1056.003k26_1056_1065; Reid S, 2010, INT J LAB HEMATOL, V32, pE190, DOI 10.1111/j.1751-553X.2010.01222.x; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; San-Miguel JF, 2011, HAEMATOL-HEMATOL J, V96, P1246, DOI 10.3324/haematol.2011.051169; Sanz-Rodriguez F, 1999, BRIT J HAEMATOL, V107, P825, DOI 10.1046/j.1365-2141.1999.01762.x; Spisek R, 2007, J EXP MED, V204, P831, DOI 10.1084/jem.20062387; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Van Valckenborgh E, 2012, LEUKEMIA, V26, P1436, DOI 10.1038/leu.2011.373; Wei A, 2003, J CLIN PATHOL, V56, P406, DOI 10.1136/jcp.56.6.406; Wijdenes J, 1996, BRIT J HAEMATOL, V94, P318, DOI 10.1046/j.1365-2141.1996.d01-1811.x; Wulf GG, 2001, BLOOD, V98, P1166, DOI 10.1182/blood.V98.4.1166; Yaccoby S, 2005, CLIN CANCER RES, V11, P7599, DOI 10.1158/1078-0432.CCR-05-0523; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	51	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92378	10.1371/journal.pone.0092378	http://dx.doi.org/10.1371/journal.pone.0092378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658332	gold, Green Submitted, Green Published			2022-12-27	WOS:000333355300078
J	Pang, XM; Xu, J; Chang, Y; Tang, D; Zheng, Y; Liu, YH; Sun, YM				Pang, Xiaomei; Xu, Jing; Chang, Yi; Tang, Di; Zheng, Ya; Liu, Yanhua; Sun, Yiming			Mismatch Negativity of Sad Syllables Is Absent in Patients with Major Depressive Disorder	PLOS ONE			English	Article							ATTENTIVE CHANGE DETECTION; FACIAL EXPRESSIONS; UNIPOLAR DEPRESSION; DEVIANCE DETECTION; DYSFUNCTION; DEFICITS; MEMORY; SCHIZOPHRENIA; MMN; INFORMATION	Background: Major depressive disorder (MDD) is an important and highly prevalent mental disorder characterized by anhedonia and a lack of interest in everyday activities. Additionally, patients with MDD appear to have deficits in various cognitive abilities. Although a number of studies investigating the central auditory processing of low-level sound features in patients with MDD have demonstrated that this population exhibits impairments in automatic processing, the influence of emotional voice processing has yet to be addressed. To explore the automatic processing of emotional prosodies in patients with MDD, we analyzed the ability to detect automatic changes using event-related potentials (ERPs). Method: This study included 18 patients with MDD and 22 age-and sex-matched healthy controls. Subjects were instructed to watch a silent movie but to ignore the afferent acoustic emotional prosodies presented to both ears while continuous electroencephalographic activity was synchronously recorded. Prosodies included meaningless syllables, such as "dada'' spoken with happy, angry, sad, or neutral tones. The mean amplitudes of the ERPs elicited by emotional stimuli and the peak latency of the emotional differential waveforms were analyzed. Results: The sad MMN was absent in patients with MDD, whereas the happy and angry MMN components were similar across groups. The abnormal sad emotional MMN component was not significantly correlated with the HRSD-17 and HAMA scores, respectively. Conclusion: The data indicate that patients with MDD are impaired in their ability to automatically process sad prosody, whereas their ability to process happy and angry prosodies remains normal. The dysfunctional sad emotion-related MMN in patients with MDD were not correlated with depression symptoms. The blunted MMN of sad prosodies could be considered a trait of MDD.	[Pang, Xiaomei; Xu, Jing; Chang, Yi; Tang, Di; Liu, Yanhua; Sun, Yiming] Dalian Med Univ, Affiliated Hosp 1, Dept Neurol & Psychiat, Dalian, Liaoning Provin, Peoples R China; [Pang, Xiaomei; Xu, Jing; Tang, Di] Dalian Med Univ, Res Inst Integrated Tradit & Western Med, Dalian, Liaoning Provin, Peoples R China; [Zheng, Ya] Dalian Med Univ, Dept Psychol, Dalian, Liaoning Provin, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University	Xu, J (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Neurol & Psychiat, Dalian, Liaoning Provin, Peoples R China.	xujing_doc@aliyun.com; changyidalian@gmail.com	liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022	Zheng, Ya/0000-0002-7469-5955	Natural Science Foundation of China [81101113, 81171412, 30970759]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Natural Science Foundation of China (81101113, 81171412 and 30970759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso MR, 1999, NEUROPSYCHOLOGY, V13, P557, DOI 10.1037/0894-4105.13.4.557; Bearden CE, 2006, PSYCHIAT RES, V142, P139, DOI 10.1016/j.psychres.2005.08.010; Bourke C, 2010, AUST NZ J PSYCHIAT, V44, P681, DOI 10.3109/00048674.2010.496359; Bruder GE, 2009, PSYCHIAT RES, V170, P218, DOI 10.1016/j.psychres.2008.10.023; Bruck C, 2011, PHYS LIFE REV, V8, P383, DOI 10.1016/j.plrev.2011.10.002; Buyukdura JS, 2011, PROG NEURO-PSYCHOPH, V35, P395, DOI 10.1016/j.pnpbp.2010.10.019; Chang Y, 2010, NEUROSCI LETT, V472, P33, DOI 10.1016/j.neulet.2010.01.050; Dai Q, 2012, CLIN NEUROPHYSIOL, V123, P2172, DOI 10.1016/j.clinph.2012.04.018; Devrim-Ucok M, 2008, EUR ARCH PSY CLIN N, V258, P179, DOI 10.1007/s00406-007-0772-9; Egeland J, 2003, ACTA PSYCHIAT SCAND, V108, P276, DOI 10.1034/j.1600-0447.2003.00146.x; ElMassioui F, 1996, NEUROREPORT, V7, P2483; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; First M.B., 2016, STRUCTURED CLIN INTE; Fossati P, 2002, ENCEPHALE, V28, P97; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Hammar A, 2003, SCAND J PSYCHOL, V44, P409, DOI 10.1046/j.1467-9450.2003.00361.x; He W, 2010, PROG NEURO-PSYCHOPH, V34, P366, DOI 10.1016/j.pnpbp.2009.12.021; Jacobsen T, 2003, CLIN NEUROPHYSIOL, V114, P1133, DOI 10.1016/S1388-2457(03)00043-9; Kahkonen S, 2007, J PSYCHIATR NEUROSCI, V32, P316; Lepisto T, 2004, CLIN NEUROPHYSIOL, V115, P620, DOI 10.1016/j.clinph.2003.10.020; Leppanen JM, 2004, PSYCHIAT RES, V128, P123, DOI 10.1016/j.psychres.2004.05.020; Leung S, 2010, PSYCHOPHARMACOLOGY, V208, P233, DOI 10.1007/s00213-009-1723-0; Lieder F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002911; Lim SL, 2005, J ABNORM PSYCHOL, V114, P50, DOI 10.1037/0021-843X.114.1.50; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; Merriam EP, 1999, AM J PSYCHIAT, V156, P780; Oranje B, 2008, INT J NEUROPSYCHOPH, V11, P453, DOI 10.1017/S1461145707008176; Paavilainen P, 2013, INT J PSYCHOPHYSIOL, V88, P109, DOI 10.1016/j.ijpsycho.2013.03.015; Paelecke-Habermann Y, 2005, J AFFECT DISORDERS, V89, P125, DOI 10.1016/j.jad.2005.09.006; Paradiso S, 1997, J NERV MENT DIS, V185, P748, DOI 10.1097/00005053-199712000-00005; Pelosi L, 2000, CLIN NEUROPHYSIOL, V111, P1531, DOI 10.1016/S1388-2457(00)00354-0; Preiss M, 2009, PSYCHIAT RES, V169, P235, DOI 10.1016/j.psychres.2008.06.042; Pringle A, 2013, J PSYCHOPHARMACOL, V27, P719, DOI 10.1177/0269881112474523; Purcell R, 1997, PSYCHOL MED, V27, P1277, DOI 10.1017/S0033291797005448; Qiao ZX, 2013, PSYCHIAT RES-NEUROIM, V211, P78, DOI 10.1016/j.pscychresns.2012.07.006; Qiu XH, 2011, NEUROSCI LETT, V491, P53, DOI 10.1016/j.neulet.2011.01.006; Ridout N, 2003, COGNITION EMOTION, V17, P101, DOI 10.1080/02699930302272; Schatzberg AF, 2000, AM J PSYCHIAT, V157, P1095, DOI 10.1176/appi.ajp.157.7.1095; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; SCHROGER E, 1995, NEUROSCI LETT, V193, P185, DOI 10.1016/0304-3940(95)11696-T; Shestyuk AY, 2005, BIOL PSYCHIAT, V57, P1089, DOI 10.1016/j.biopsych.2005.02.013; Stuhrmann A, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-10; Takei Y, 2009, PSYCHOPHYSIOLOGY, V46, P52, DOI 10.1111/j.1469-8986.2008.00748.x; Thonnessen H, 2010, NEUROIMAGE, V50, P250, DOI 10.1016/j.neuroimage.2009.11.082; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Umbricht D, 2003, NEUROPSYCHOPHARMACOL, V28, P170, DOI 10.1038/sj.npp.1300005; Umbricht D, 2003, BIOL PSYCHIAT, V53, P1120, DOI 10.1016/S0006-3223(02)01642-6; Weierich MR, 2010, NEUROIMAGE, V49, P2871, DOI 10.1016/j.neuroimage.2009.09.047; Weiland-Fiedler P, 2004, J AFFECT DISORDERS, V82, P253, DOI 10.1016/j.jad.2003.10.009; Wienberg M, 2010, J PSYCHOPHARMACOL, V24, P1183, DOI 10.1177/0269881109102606; Winkler I, 1998, NEUROREPORT, V9, P3809, DOI 10.1097/00001756-199812010-00008; Winkler I, 2012, INT J PSYCHOPHYSIOL, V83, P132, DOI 10.1016/j.ijpsycho.2011.10.001; Xu Q, 2013, BRAIN TOPOGR, V26, P488, DOI 10.1007/s10548-013-0275-0	53	17	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91995	10.1371/journal.pone.0091995	http://dx.doi.org/10.1371/journal.pone.0091995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6GL	24658084	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300049
J	Sugimoto, K; Senda, M; Kasai, D; Fukuda, M; Masai, E; Senda, T				Sugimoto, Keisuke; Senda, Miki; Kasai, Daisuke; Fukuda, Masao; Masai, Eiji; Senda, Toshiya			Molecular Mechanism of Strict Substrate Specificity of an Extradiol Dioxygenase, DesB, Derived from Sphingobium sp SYK-6	PLOS ONE			English	Article							CRYSTAL-STRUCTURES; 2,3-DIHYDROXYBIPHENYL 1,2-DIOXYGENASE; CATABOLIC PATHWAYS; LIGNIN; CRYSTALLIZATION; LIGAB; GENE	DesB, which is derived from Sphingobium sp. SYK-6, is a type II extradiol dioxygenase that catalyzes a ring opening reaction of gallate. While typical extradiol dioxygenases show broad substrate specificity, DesB has strict substrate specificity for gallate. The substrate specificity of DesB seems to be required for the efficient growth of S. sp. SYK-6 using lignin-derived aromatic compounds. Since direct coordination of hydroxyl groups of the substrate to the non-heme iron in the active site is a critical step for the catalytic reaction of the extradiol dioxygenases, the mechanism of the substrate recognition and coordination of DesB was analyzed by biochemical and crystallographic methods. Our study demonstrated that the direct coordination between the non-heme iron and hydroxyl groups of the substrate requires a large shift of the Fe (II) ion in the active site. Mutational analysis revealed that His124 and His192 in the active site are essential to the catalytic reaction of DesB. His124, which interacts with OH (4) of the bound gallate, seems to contribute to proper positioning of the substrate in the active site. His192, which is located close to OH (3) of the gallate, is likely to serve as the catalytic base. Glu377' interacts with OH (5) of the gallate and seems to play a critical role in the substrate specificity. Our biochemical and structural study showed the substrate recognition and catalytic mechanisms of DesB.	[Sugimoto, Keisuke] Asahikawa Natl Coll Technol, Dept Chem Mat, Asahikawa, Hokkaido, Japan; [Senda, Miki; Senda, Toshiya] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Photon Factory, Struct Biol Res Ctr, Tsukuba, Ibaraki, Japan; [Kasai, Daisuke; Fukuda, Masao; Masai, Eiji] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 94021, Japan	High Energy Accelerator Research Organization (KEK); Nagaoka University of Technology	Senda, T (corresponding author), High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Photon Factory, Struct Biol Res Ctr, Tsukuba, Ibaraki, Japan.	toshiya.senda@kek.jp		Senda, Toshiya/0000-0002-5153-928X; Masai, Eiji/0000-0001-9194-7483	Ministry of Education, Science, and Culture, Japan [22121005]; New Energy and Industrial Technology Development Organization (NEDO) [P08005]	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (22121005 TS) from the Ministry of Education, Science, and Culture, Japan (http://www.mext.go.jp/english/). This work was also supported by the New Energy and Industrial Technology Development Organization (NEDO) (http://www.nedo.go.jp/english/index.html) (P08005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barry KP, 2013, BIOCHEMISTRY-US, V52, P6724, DOI 10.1021/bi400665t; Eltis LD, 1996, J BACTERIOL, V178, P5930, DOI 10.1128/jb.178.20.5930-5937.1996; Emerson JP, 2008, P NATL ACAD SCI USA, V105, P7347, DOI 10.1073/pnas.0711179105; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fielding AJ, 2011, J BIOL INORG CHEM, V16, P341, DOI 10.1007/s00775-010-0732-0; HAN S, 1995, SCIENCE, V270, P976, DOI 10.1126/science.270.5238.976; Jackson TA, 2004, ACCOUNTS CHEM RES, V37, P461, DOI 10.1021/ar030272h; Ju KS, 2011, MOL MICROBIOL, V82, P355, DOI 10.1111/j.1365-2958.2011.07817.x; Kasai D, 2005, J BACTERIOL, V187, P5067, DOI 10.1128/JB.187.15.5067-5074.2005; Kasai D, 2004, J BACTERIOL, V186, P4951, DOI 10.1128/JB.186.15.4951-4959.2004; KATAYAMA Y, 1988, FEBS LETT, V233, P129, DOI 10.1016/0014-5793(88)81369-3; Kovaleva EG, 2007, SCIENCE, V316, P453, DOI 10.1126/science.1134697; Lipscomb JD, 2008, CURR OPIN STRUC BIOL, V18, P644, DOI 10.1016/j.sbi.2008.11.001; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; Mendel S, 2004, BIOCHEMISTRY-US, V43, P13390, DOI 10.1021/bi048518t; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Sato N, 2002, J MOL BIOL, V321, P621, DOI 10.1016/S0022-2836(02)00673-3; Senda M, 2007, ACTA CRYSTALLOGR F, V63, P311, DOI 10.1107/S1744309107009992; Senda T, 1996, J MOL BIOL, V255, P735, DOI 10.1006/jmbi.1996.0060; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Sugimoto K, 1999, STRUCTURE, V7, P953, DOI 10.1016/S0969-2126(99)80122-1; Sugimoto K, 2009, ACTA CRYSTALLOGR F, V65, P1171, DOI 10.1107/S1744309109041086; Uragami Y, 2001, J INORG BIOCHEM, V83, P269, DOI 10.1016/S0162-0134(00)00172-0; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaillancourt FH, 1998, J BIOL CHEM, V273, P34887, DOI 10.1074/jbc.273.52.34887; Vaillancourt FH, 2002, J AM CHEM SOC, V124, P2485, DOI 10.1021/ja0174682; Vance CK, 1998, J AM CHEM SOC, V120, P461, DOI 10.1021/ja972060j; Vetting MW, 2004, J BACTERIOL, V186, P1945, DOI 10.1128/JB.186.7.1945-1958.2004	30	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92249	10.1371/journal.pone.0092249	http://dx.doi.org/10.1371/journal.pone.0092249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24657997	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300066
J	Theysohn, JM; Kraff, O; Eilers, K; Andrade, D; Gerwig, M; Timmann, D; Schmitt, F; Ladd, ME; Ladd, SC; Bitz, AK				Theysohn, Jens M.; Kraff, Oliver; Eilers, Kristina; Andrade, Dorian; Gerwig, Marcus; Timmann, Dagmar; Schmitt, Franz; Ladd, Mark E.; Ladd, Susanne C.; Bitz, Andreas K.			Vestibular Effects of a 7 Tesla MRI Examination Compared to 1.5 T and 0 T in Healthy Volunteers	PLOS ONE			English	Article							STATIC MAGNETIC-FIELDS; STRAY FIELDS; CROSSOVER; EXPOSURE; VERTIGO; SYSTEMS; SAFETY	Ultra-high-field MRI (7 Tesla (T) and above) elicits more temporary side-effects compared to 1.5 T and 3 T, e. g. dizziness or "postural instability'' even after exiting the scanner. The current study aims to assess quantitatively vestibular performance before and after exposure to different MRI scenarios at 7 T, 1.5 T and 0 T. Sway path and body axis rotation (Unterberger's stepping test) were quantitatively recorded in a total of 46 volunteers before, 2 minutes after, and 15 minutes after different exposure scenarios: 7 T head MRI (n = 27), 7 T no RF (n = 22), 7 T only B-0 (n = 20), 7 T in & out B-0 (n = 20), 1.5 T no RF (n = 20), 0 T (n = 15). All exposure scenarios lasted 30 minutes except for brief one minute exposure in 7 T in & out B-0. Both measures were documented utilizing a 3D ultrasound system. During sway path evaluation, the experiment was repeated with eyes both open and closed. Sway paths for all long-lasting 7 T scenarios (normal, no RF, only B-0) with eyes closed were significantly prolonged 2 minutes after exiting the scanner, normalizing after 15 minutes. Brief exposure to 7 T B-0 or 30 minutes exposure to 1.5 T or 0 T did not show significant changes. End positions after Unterberger's stepping test were significantly changed counter-clockwise after all 7 T scenarios, including the brief in & out B-0 exposure. Shorter exposure resulted in a smaller alteration angle. In contrast to sway path, reversal of changes in body axis rotation was incomplete after 15 minutes. 1.5 T caused no rotational changes. The results show that exposure to the 7 Tesla static magnetic field causes only a temporary dysfunction or "over-compensation'' of the vestibular system not measurable at 1.5 or 0 Tesla. Radiofrequency fields, gradient switching, and orthostatic dysregulation do not seem to play a role.	[Theysohn, Jens M.; Kraff, Oliver; Eilers, Kristina; Andrade, Dorian; Ladd, Mark E.; Ladd, Susanne C.; Bitz, Andreas K.] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Theysohn, Jens M.; Kraff, Oliver; Eilers, Kristina; Andrade, Dorian; Ladd, Susanne C.] Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Gerwig, Marcus; Timmann, Dagmar] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Schmitt, Franz] Siemens Healthcare Sect, Erlangen, Germany; [Ladd, Mark E.; Bitz, Andreas K.] German Canc Res Ctr, Div Med Phys Radiol E020, Heidelberg, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Siemens AG; Helmholtz Association; German Cancer Research Center (DKFZ)	Theysohn, JM (corresponding author), Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany.	jens.theysohn@uni-due.de	Kraff, Oliver/AAE-2238-2020	Kraff, Oliver/0000-0002-6006-8934; Ladd, Mark/0000-0002-4128-9440	University Duisburg-Essen; German Research Foundation (DFG)	University Duisburg-Essen; German Research Foundation (DFG)(German Research Foundation (DFG))	The authors kindly thank the University Duisburg-Essen and the German Research Foundation (DFG) for their assumption of publication costs of this article. The authors have no other support or funding to report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakeres DW, 2005, PROG BIOPHYS MOL BIO, V87, P255, DOI 10.1016/j.pbiomolbio.2004.08.012; Chakeres DW, 2003, J MAGN RESON IMAGING, V18, P346, DOI 10.1002/jmri.10367; Chakeres DW, 2003, J MAGN RESON IMAGING, V18, P342, DOI 10.1002/jmri.10366; Davalos-Bichara M, 2013, NORMATIVE RESULTS HL; de Vocht F, 2007, BIOELECTROMAGNETICS, V28, P247, DOI 10.1002/bem.20311; Faraldo-Garcia A, 2012, EUR ARCH OTO-RHINO-L, V269, P673, DOI 10.1007/s00405-011-1707-7; *FDA, 2003, GUID IND FDA STAFF C; Fetter M., 2010, NEUROREHABILITATION, V383, P398; Glover PM, 2007, BIOELECTROMAGNETICS, V28, P349, DOI 10.1002/bem.20316; Heilmaier C, 2011, BIOELECTROMAGNETICS, V32, P610, DOI 10.1002/bem.20680; Heinrich A, 2013, RADIOLOGY, V266, P236, DOI 10.1148/radiol.12112172; IEC, 2010, MED EL EQ 2; Kangarlu A, 1999, MAGN RESON IMAGING, V17, P1407, DOI 10.1016/S0730-725X(99)00086-7; Kangarlu A, 2004, RADIOLOGE, V44, P19, DOI 10.1007/s00117-003-0993-5; Kangarlu A, 2000, CONCEPT MAGNETIC RES, V12, P321; MCROBBIE D, 1984, CLIN PHYS PHYSIOL M, V5, P67, DOI 10.1088/0143-0815/5/2/002; Mian OS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078748; MIRKA A, 1990, NEUROL CLIN, V8, P351, DOI 10.1016/S0733-8619(18)30360-8; Roberts DC, 2011, CURR BIOL, V21, P1635, DOI 10.1016/j.cub.2011.08.029; Robitaille PML, 1998, NMR BIOMED, V11, P263, DOI 10.1002/(SICI)1099-1492(199810)11:6<263::AID-NBM549>3.0.CO;2-0; Saunders R, 1983, NUCL MAGN RESON, P383; Schenck JF, 2005, PROG BIOPHYS MOL BIO, V87, P185, DOI 10.1016/j.pbiomolbio.2004.08.009; SCHENCK JF, 1992, MED PHYS, V19, P1089, DOI 10.1118/1.596827; Schenck JF, 2000, J MAGN RESON IMAGING, V12, P2, DOI 10.1002/1522-2586(200007)12:1<2::AID-JMRI2>3.0.CO;2-V; Schild H, 2005, ROFO-FORTSCHR RONTG, V177, P621, DOI 10.1055/s-2005-858048; TENFORDE TS, 1992, ANNU REV PUBL HEALTH, V13, P173, DOI 10.1146/annurev.publhealth.13.1.173; Theysohn JM, 2008, MAGN RESON MATER PHY, V21, P63, DOI 10.1007/s10334-007-0095-x; Thormann M, 2013, EUR J RADIOL, V82, P768, DOI 10.1016/j.ejrad.2011.08.001; van Nierop LE, 2013, MAGN RESON MED, V70, P232, DOI 10.1002/mrm.24454; Versluis MJ, 2013, J MAGN RESON IMAGING, V38, P722, DOI 10.1002/jmri.23904; Vogt FM, 2004, RADIOLOGY, V233, P548, DOI 10.1148/radiol.2332030428	31	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92104	10.1371/journal.pone.0092104	http://dx.doi.org/10.1371/journal.pone.0092104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658179	gold, Green Submitted, Green Published			2022-12-27	WOS:000333355300054
J	Cao, HH; Zhang, M; Zhao, H; Zhang, Y; Wang, XX; Guo, SS; Zhang, ZF; Liu, TX				Cao, He-He; Zhang, Meng; Zhao, Hui; Zhang, Yi; Wang, Xing-Xing; Guo, Shan-Shan; Zhang, Zhan-Feng; Liu, Tong-Xian			Deciphering the Mechanism of beta-Aminobutyric Acid-Induced Resistance in Wheat to the Grain Aphid, Sitobion avenae	PLOS ONE			English	Article							PLANT DEFENSE; ARABIDOPSIS; GROWTH; ACCUMULATION; POTENTIATION; TOLERANCE; BEHAVIOR; TOMATO	The non-protein amino acid beta-aminobutyric acid (BABA) can induce plant resistance to a broad spectrum of biotic and abiotic stresses. However, BABA-induced plant resistance to insects is less well-studied, especially its underlying mechanism. In this research, we applied BABA to wheat seedlings and tested its effects on Sitobion avenae (F.). When applied as a soil drench, BABA significantly reduced weights of S. avenae, whereas foliar spray and seed treatment had no such effects. BABA-mediated suppression of S. avenae growth was dose dependent and lasted at least for 7 days. The aminobutyric acid concentration in phloem sap of BABA-treated plants was higher and increased with BABA concentrations applied. Moreover, after 10 days of treatment, the aminobutyric acid content in BABA-treated plants was still higher than that in control treatment. Sitobion avenae could not discriminate artificial diet containing BABA from standard diet, indicating that BABA itself is not a deterrent to this aphid. Also S. avenae did not show preference for control plants or BABA-treated plants. Consistent with choice test results, S. avenae had similar feeding activities on control and BABA-treated plants, suggesting that BABA did not induce antifeedants in wheat seedlings. In addition, aminobutyric acid concentration in S. avenae feeding on BABA-treated plants was significantly higher than those feeding on control plants. Sitobion avenae growth rate was reduced on the artificial diet containing BABA, indicating that BABA had direct toxic effects on this aphid species. These results suggest that BABA application reduced S. avenae performance on wheat seedlings and the mechanism is possibly due to direct toxicity of high BABA contents in plant phloem.	[Cao, He-He; Zhang, Meng; Zhao, Hui; Zhang, Yi; Wang, Xing-Xing; Guo, Shan-Shan; Zhang, Zhan-Feng; Liu, Tong-Xian] Northwest A&F Univ, Minist Agr, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Cao, He-He; Zhang, Meng; Zhao, Hui; Zhang, Yi; Wang, Xing-Xing; Guo, Shan-Shan; Zhang, Zhan-Feng; Liu, Tong-Xian] Northwest A&F Univ, Minist Agr, Key Lab Crop Pest Management Losses Plateau, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Liu, TX (corresponding author), Northwest A&F Univ, Minist Agr, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Liu, TX (corresponding author), Northwest A&F Univ, Minist Agr, Key Lab Crop Pest Management Losses Plateau, Yangling, Shaanxi, Peoples R China.	txliu@nwsuaf.edu.cn			National Basic Research Program of China (973 Projects) [2012CB114105]; Special Fund for Agro-Scientific Research in the Public Interest [201103022]; China Agriculture Research System [CARS-25-B-06]	National Basic Research Program of China (973 Projects)(National Basic Research Program of China); Special Fund for Agro-Scientific Research in the Public Interest; China Agriculture Research System	Funding of this research was partially supported by each of the following grants: the National Basic Research Program of China (973 Projects No. 2012CB114105), Special Fund for Agro-Scientific Research in the Public Interest (201103022), China Agriculture Research System (CARS-25-B-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUCLAIR JACQUES L., 1965, ANN ENTOMOL SOC AMER, V58, P855, DOI 10.1093/aesa/58.6.855; Cao HH, 2014, INSECT SCI, V21, P47, DOI 10.1111/1744-7917.12023; COHEN Y, 1994, PHYSIOL MOL PLANT P, V45, P441, DOI 10.1016/S0885-5765(05)80041-4; Du YL, 2012, J EXP BOT, V63, P4849, DOI 10.1093/jxb/ers164; Hamiduzzaman MM, 2005, MOL PLANT MICROBE IN, V18, P819, DOI 10.1094/MPMI-18-0819; Hodge S, 2006, ANN APPL BIOL, V148, P223, DOI 10.1111/j.1744-7348.2006.00061.x; Hodge S, 2005, B ENTOMOL RES, V95, P449, DOI 10.1079/BER2005375; Hosie AM, 1997, TRENDS NEUROSCI, V20, P578, DOI 10.1016/S0166-2236(97)01127-2; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Hubner CA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00177; Jakab G, 2005, PLANT PHYSIOL, V139, P267, DOI 10.1104/pp.105.065698; Jakab G, 2001, EUR J PLANT PATHOL, V107, P29, DOI 10.1023/A:1008730721037; Justyna PG, 2013, ACTA PHYSIOL PLANT, V35, P1735, DOI 10.1007/s11738-013-1215-z; Liu XM, 2010, PLANT PHYSIOL, V152, P985, DOI 10.1104/pp.109.150656; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Oka Y, 1999, PHYTOPATHOLOGY, V89, P1138, DOI 10.1094/PHYTO.1999.89.12.1138; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; PRADO E, 1994, ENTOMOL EXP APPL, V72, P157, DOI 10.1007/BF02383550; Ramputh AL, 1996, PLANT PHYSIOL, V111, P1349, DOI 10.1104/pp.111.4.1349; Sarria E, 2009, COMPUT ELECTRON AGR, V67, P35, DOI 10.1016/j.compag.2009.02.006; Sasek V, 2012, EUR J PLANT PATHOL, V133, P279, DOI 10.1007/s10658-011-9897-9; SCHMIEDEN V, 1995, MOL PHARMACOL, V48, P919; Siegrist J, 2000, PHYSIOL MOL PLANT P, V56, P95, DOI 10.1006/pmpp.1999.0255; Singh P, 2010, PLANT SIGNAL BEHAV, V5, P878, DOI 10.4161/psb.5.7.11903; Tiwari S, 2013, B ENTOMOL RES, V103, P592, DOI 10.1017/S0007485313000229; TJALLINGII WF, 1978, ENTOMOL EXP APPL, V24, P721, DOI 10.1007/BF02385128; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; Ton J, 2005, PLANT CELL, V17, P987, DOI 10.1105/tpc.104.029728; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; URQUHART AA, 1981, PLANT PHYSIOL, V68, P750, DOI 10.1104/pp.68.3.750; van Emden H, 2007, APHIDS AS CROP PESTS, pXXI; Will T, 2006, J EXP BOT, V57, P729, DOI 10.1093/jxb/erj089; Wu CC, 2010, J EXP BOT, V61, P995, DOI 10.1093/jxb/erp363; Zhang HT, 2009, PLANT-DERIVED NATURAL PRODUCTS: SYNTHESIS, FUNCTION, AND APPLICATION, P181, DOI 10.1007/978-0-387-85498-4_8; Zimmerli L, 2000, P NATL ACAD SCI USA, V97, P12920, DOI 10.1073/pnas.230416897; Zimmerli L, 2008, PLANT J, V53, P144, DOI 10.1111/j.1365-313X.2007.03343.x	36	24	27	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91768	10.1371/journal.pone.0091768	http://dx.doi.org/10.1371/journal.pone.0091768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651046	Green Submitted, gold, Green Published			2022-12-27	WOS:000333352800049
J	Chiang, WH; Huang, WC; Shen, MY; Wang, CH; Huang, YF; Lin, SC; Chern, CS; Chiu, HC				Chiang, Wen-Hsuan; Huang, Wen-Chia; Shen, Ming-Yin; Wang, Che-Hsu; Huang, Yi-Fong; Lin, Sung-Chyr; Chern, Chorng-Shyan; Chiu, Hsin-Cheng			Dual-Layered Nanogel-Coated Hollow Lipid/Polypeptide Conjugate Assemblies for Potential pH-Triggered Intracellular Drug Release	PLOS ONE			English	Article							POLYMER-CAGED NANOBINS; TRANSMEMBRANE CHANNELS; RAFT POLYMERIZATION; STRUCTURAL-CHANGES; DELIVERY PLATFORM; IN-VIVO; MICELLES; VESICLES; NANOPARTICLES; COPOLYMERS	To achieve effective intracellular anticancer drug delivery, the polymeric vesicles supplemented with the pH-responsive outlayered gels as a delivery system of doxorubicin (DOX) were developed from self-assembly of the lipid/polypeptide adduct, distearin grafted poly(gamma-glutamic acid) (poly(gamma-GA)), followed by sequential deposition of chitosan and poly(gamma-GA-co-gamma-glutamyl oxysuccinimide)-g-monomethoxy poly(ethylene glycol) in combination with in situ covalent cross-linking on assembly surfaces. The resultant gel-caged polymeric vesicles (GCPVs) showed superior performance in regulating drug release in response to the external pH change. Under typical physiological conditions (pH 7.4 and 37 degrees C) at which the gamma-GA/DOX ionic pairings remained mostly undisturbed, the dense outlayered gels of GCPVs significantly reduced the premature leakage of the uncomplexed payload. With the environmental pH being reduced from pH 7.4 to 4.7, the drug liberation was appreciably promoted by the massive disruption of the ionic gamma-GA/DOX complexes along with the significant swelling of nanogel layers upon the increased protonation of chitosan chain segments. After being internalized by HeLa cells via endocytosis, GCPVs exhibited cytotoxic effect comparable to free DOX achieved by rapidly releasing the payload in intracellular acidic endosomes and lysosomes. This strongly implies the great promise of such unique GCPVs as an intracellular drug delivery carrier for potential anticancer treatment.	[Chiang, Wen-Hsuan; Huang, Wen-Chia; Shen, Ming-Yin; Wang, Che-Hsu; Chiu, Hsin-Cheng] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Shen, Ming-Yin] Natl Taiwan Univ Hosp, Dept Surg, Hsinchu Branch, Hsinchu, Taiwan; [Huang, Yi-Fong; Lin, Sung-Chyr] Natl Chung Hsing Univ, Dept Chem Engn, Taichung 40227, Taiwan; [Chern, Chorng-Shyan] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei, Taiwan	National Tsing Hua University; National Taiwan University; National Taiwan University Hospital; National Chung Hsing University; National Taiwan University of Science & Technology	Chiu, HC (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	hscchiu@mx.nthu.edu.tw		Chiu, Hsin-Cheng/0000-0001-5509-2107; Chiang, Wen-Hsuan/0000-0002-2022-0858	National Tsing Hua University [102N2733E1, 101N2716E1]; National Taiwan Hospital-Hsinchu Branch [HCH-101-17, NTHU-HCH100-03]	National Tsing Hua University; National Taiwan Hospital-Hsinchu Branch	This work is financially supported by the National Tsing Hua University (102N2733E1 and 101N2716E1) and National Taiwan Hospital-Hsinchu Branch (HCH-101-17 and NTHU-HCH100-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ahmady ZS, 2012, ACS NANO, V6, P9335, DOI 10.1021/nn302148p; Bae HH, 2012, J MICROBIOL BIOTECHN, V22, P1782, DOI 10.4014/jmb.1208.08031; Blanazs A, 2009, MACROMOL RAPID COMM, V30, P267, DOI 10.1002/marc.200800713; Broz P, 2006, NANO LETT, V6, P2349, DOI 10.1021/nl0619305; Chen ZW, 2013, BIOMATERIALS, V34, P1364, DOI 10.1016/j.biomaterials.2012.10.060; Chiang WH, 2012, LANGMUIR, V28, P15056, DOI 10.1021/la302903v; Chiang WH, 2009, MACROMOLECULES, V42, P3611, DOI 10.1021/ma900263j; Chiu HC, 2008, ANGEW CHEM INT EDIT, V47, P1875, DOI 10.1002/anie.200704078; Cuomo F, 2010, LANGMUIR, V26, P10555, DOI 10.1021/la100584b; Dai J, 2011, ANGEW CHEM INT EDIT, V50, P9404, DOI 10.1002/anie.201103806; Dou HJ, 2003, ANGEW CHEM INT EDIT, V42, P1516, DOI 10.1002/anie.200250254; Du JZ, 2011, J AM CHEM SOC, V133, P17560, DOI 10.1021/ja207150n; ElBayoumi TA, 2010, METHODS MOL BIOL, V605, P1, DOI 10.1007/978-1-60327-360-2_1; Han SY, 2011, J MATER CHEM, V21, P7996, DOI 10.1039/c1jm10466g; Hsu YH, 2005, MACROMOLECULES, V38, P9757, DOI 10.1021/ma0512713; Hsu YH, 2006, LANGMUIR, V22, P6764, DOI 10.1021/la060229d; Huang WC, 2012, ADV FUNCT MATER, V22, P2267, DOI 10.1002/adfm.201103117; Huang YF, 2011, CHEM COMMUN, V47, P10978, DOI 10.1039/c1cc14793e; Jung SH, 2009, INT J PHARMACEUT, V382, P254, DOI 10.1016/j.ijpharm.2009.08.002; Lee HJ, 2010, CHEM COMMUN, V46, P377, DOI 10.1039/b913732g; Lee SM, 2010, ANGEW CHEM INT EDIT, V49, P9960, DOI 10.1002/anie.201004867; Lee SM, 2009, J AM CHEM SOC, V131, P9311, DOI 10.1021/ja9017336; Li J, 2012, BIOMATERIALS, V33, P2310, DOI 10.1016/j.biomaterials.2011.11.022; Li YL, 2009, ANGEW CHEM INT EDIT, V48, P9914, DOI 10.1002/anie.200904260; Manocha B, 2010, J NANOMATER, V2010, DOI 10.1155/2010/780171; Miyata K, 2011, REACT FUNCT POLYM, V71, P227, DOI 10.1016/j.reactfunctpolym.2010.10.009; Ning SH, 2011, SOFT MATTER, V7, P9394, DOI 10.1039/c1sm05814b; Osaka T, 2009, COLLOID SURFACE B, V71, P325, DOI 10.1016/j.colsurfb.2009.03.004; Park JH, 2008, PROG POLYM SCI, V33, P113, DOI 10.1016/j.progpolymsci.2007.09.003; Poon Z, 2011, ACS NANO, V5, P4284, DOI 10.1021/nn200876f; Rapoport N, 2007, PROG POLYM SCI, V32, P962, DOI 10.1016/j.progpolymsci.2007.05.009; Samad Abdus, 2007, Current Drug Delivery, V4, P297, DOI 10.2174/156720107782151269; Smith AE, 2010, MACROMOLECULES, V43, P1210, DOI 10.1021/ma902378k; Sun PJ, 2011, J CONTROL RELEASE, V155, P96, DOI 10.1016/j.jconrel.2010.11.005; Sun QQ, 2011, J MATER CHEM, V21, P15316, DOI 10.1039/c1jm12404h; Tang RP, 2011, J CONTROL RELEASE, V151, P18, DOI 10.1016/j.jconrel.2010.12.005; Wan WM, 2009, MACROMOLECULES, V42, P4950, DOI 10.1021/ma901014m; Wang DL, 2011, BIOMACROMOLECULES, V12, P1370, DOI 10.1021/bm200155t; Wang WW, 2012, ADV MATER, V24, P115, DOI 10.1002/adma.201104066; Zhang L, 2011, BIOMATERIALS, V32, P4604, DOI 10.1016/j.biomaterials.2011.02.064; Zhang WL, 2010, BIOMACROMOLECULES, V11, P1331, DOI 10.1021/bm100116g; Zheng C, 2011, MACROMOL BIOSCI, V11, P338, DOI 10.1002/mabi.201000333	42	18	19	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92268	10.1371/journal.pone.0092268	http://dx.doi.org/10.1371/journal.pone.0092268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651156	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800091
J	Cortopassi, WA; Penna-Coutinho, J; Aguiar, ACC; Pimentel, AS; Buarque, CD; Costa, PRR; Alves, BRM; Franca, TCC; Krettli, AU				Cortopassi, Wilian A.; Penna-Coutinho, Julia; Aguiar, Anna C. C.; Pimentel, Andre S.; Buarque, Camilla D.; Costa, Paulo R. R.; Alves, Bruna R. M.; Franca, Tanos C. C.; Krettli, Antoniana U.			Theoretical and Experimental Studies of New Modified Isoflavonoids as Potential Inhibitors of Topoisomerase I from Plasmodium falciparum	PLOS ONE			English	Article							MALIGNANT CELL-LINES; ANTINEOPLASIC ACTIVITY; ANTIMALARIAL ACTIVITY; MALARIA; PTEROCARPANQUINONE; RESISTANCE; DOCKING; VITRO; CAMPTOTHECIN; SENSITIVITY	DNA topoisomerase I from Plasmodium falciparum (PfTopoI), a potential selective target for chemotherapy and drug development against malaria, is used here, together with human Topo I (HssTopoI), for docking, molecular dynamics (MD) studies and experimental assays. Six synthetic isoflavonoid derivatives and the known PfTopoI inhibitors camptothecin and topotecan were evaluated in parallel. Theoretical results suggest that these compounds dock in the binding site of camptothecin and topotecan inside both enzymes and that LQB223 binds selectively in PfTopoI. In vitro tests against P. falciparum blood parasites corroborated the theoretical findings. The selectivity index (SI) of LQB223 >= 98 suggests that this molecule is the most promising in the group of compounds tested. In vivo experiments in mice infected with P. berghei showed that LQB223 has an antimalarial activity similar to that of chloroquine.	[Cortopassi, Wilian A.; Pimentel, Andre S.; Buarque, Camilla D.; Alves, Bruna R. M.] Pontificia Univ Catolica Rio de Janeiro, Dept Quim, Rio De Janeiro, Brazil; [Cortopassi, Wilian A.; Franca, Tanos C. C.] Inst Mil Engn, Lab Modelagem Aplicada Def Quim & Biol, Rio De Janeiro, Brazil; [Penna-Coutinho, Julia; Aguiar, Anna C. C.; Krettli, Antoniana U.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil; [Penna-Coutinho, Julia; Aguiar, Anna C. C.; Krettli, Antoniana U.] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Costa, Paulo R. R.] Nucleo Pesquisas Prod Nat, Lab Quim Bioorgan, Rio De Janeiro, Brazil	Pontificia Universidade Catolica do Rio de Janeiro; Instituto Militar de Engenharia (IME); Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Krettli, AU (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil.	akrettli@cpqrr.fiocruz.br	Pimentel, Andre/B-1278-2010; Aguiar, Anna Caroline/J-6970-2015; BUARQUE, CAMILLA DJENNE/AAZ-1268-2020; Costa, Paulo Roberto Ribeiro/F-1153-2013; Costa, Paulo Roberto Ribeiro/AAH-4777-2021; Cortopassi, Wilian/P-3136-2014; França, Tanos Celmar Costa/I-9519-2012	Pimentel, Andre/0000-0002-1301-0561; Aguiar, Anna Caroline/0000-0003-0139-8279; BUARQUE, CAMILLA DJENNE/0000-0002-2639-2220; Costa, Paulo Roberto Ribeiro/0000-0001-9541-1707; Costa, Paulo Roberto Ribeiro/0000-0001-9541-1707; Cortopassi, Wilian/0000-0001-8038-7847; França, Tanos Celmar Costa/0000-0002-6048-8103	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [304557/2012-9]; Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ) [E-26/102.993/2012]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Funding provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-304557/2012-9 and Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ)-E-26/102.993/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar ACC, 2012, MEM I OSWALDO CRUZ, V107, P831, DOI 10.1590/S0074-02762012000700001; Bacelar TD, 2013, ANTI-CANCER DRUG, V24, P73, DOI 10.1097/CAD.0b013e3283592da8; Barbara A, 2013, PLOS ONE, V8; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bezivin C, 2003, PHYTOMEDICINE, V10, P499, DOI 10.1078/094471103322331458; Bodley AL, 1998, BIOCHEM PHARMACOL, V55, P709, DOI 10.1016/S0006-2952(97)00556-X; Buarque CD, 2011, BIOORGAN MED CHEM, V19, P6885, DOI 10.1016/j.bmc.2011.09.025; CARVALHO LH, 1991, BRAZ J MED BIOL RES, V24, P1113; Cortopassi WA, 2012, MOL SIMULAT, V38, P1132, DOI 10.1080/08927022.2012.696113; Costa P.R.R., 2010, Patent, Patent No. [WO2010054452-A1, 2010054452]; Davies M, 2009, J MED CHEM, V52, P2683, DOI 10.1021/jm800963t; de Andrade-Neto VF, 2004, BIOORG MED CHEM LETT, V14, P1145, DOI 10.1016/j.bmcl.2003.12.069; de Madureira MD, 2002, J ETHNOPHARMACOL, V81, P23, DOI 10.1016/S0378-8741(02)00005-3; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Drwal MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025150; Frisch G. W., 2013, GAUSSIAN 09; Hess B, 2009, ABSTR PAP AM CHEM S, V237; Kasam V, 2007, J CHEM INF MODEL, V47, P1818, DOI 10.1021/ci600451t; Kontoyianni M, 2004, J MED CHEM, V47, P558, DOI 10.1021/jm0302997; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Leach AR, 2006, J MED CHEM, V49, P5851, DOI 10.1021/jm060999m; Lin Jessica T, 2010, Curr Infect Dis Rep, V12, P165, DOI 10.1007/s11908-010-0099-y; Netto CD, 2010, BIOORGAN MED CHEM, V18, P1610, DOI 10.1016/j.bmc.2009.12.073; Noedl H, 2002, EXP PARASITOL, V102, P157, DOI 10.1016/S0014-4894(03)00051-1; ODUOLA AMJ, 1988, EXP PARASITOL, V67, P354, DOI 10.1016/0014-4894(88)90082-3; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Penna-Coutinho J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021237; PETERS W, 1965, EXP PARASITOL, V17, P80, DOI 10.1016/0014-4894(65)90012-3; Portes JD, 2012, VET PARASITOL, V186, P261, DOI 10.1016/j.vetpar.2011.11.008; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Reguera RM, 2006, BBA-GENE STRUCT EXPR, V1759, P117, DOI 10.1016/j.bbaexp.2006.03.006; Ribeiro GA, 2013, J ANTIMICROB CHEMOTH, V68, P789, DOI 10.1093/jac/dks498; RIECKMANN KH, 1978, LANCET, V1, P22; Roy A, 2011, MOL BIOL INT, V2011; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Webb MR, 2004, BIOCHEM J, V384, P527, DOI 10.1042/BJ20040474; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1	47	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91191	10.1371/journal.pone.0091191	http://dx.doi.org/10.1371/journal.pone.0091191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651068	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800032
J	Drillon, G; Carbone, A; Fischer, G				Drillon, Guenola; Carbone, Alessandra; Fischer, Gilles			SynChro: A Fast and Easy Tool to Reconstruct and Visualize Synteny Blocks along Eukaryotic Chromosomes	PLOS ONE			English	Article							HOMOLOGY; ARABIDOPSIS; REGIONS; REARRANGEMENTS; ADHORE	Reconstructing synteny blocks is an essential step in comparative genomics studies. Different methods were already developed to answer various needs such as genome (re-)annotation, identification of duplicated regions and whole genome duplication events or estimation of rearrangement rates. We present SynChro, a tool that reconstructs synteny blocks between pairwise comparisons of multiple genomes. SynChro is based on a simple algorithm that computes Reciprocal Best-Hits (RBH) to reconstruct the backbones of the synteny blocks and then automatically completes these blocks with non-RBH syntenic homologs. This approach has two main advantages: (i) synteny block reconstruction is fast (feasible on a desk computer for large eukaryotic genomes such as human) and (ii) synteny block reconstruction is straightforward as all steps are integrated (no need to run Blast or TribeMCL prior to reconstruction) and there is only one parameter to set up, the synteny block stringency Delta. Benchmarks on three pairwise comparisons of genomes, representing three different levels of synteny conservation (Human/Mouse, Human/Zebra Finch and Human/Zebrafish) show that Synchro runs faster and performs at least as well as two other commonly used and more sophisticated tools (MCScanX and i-ADHoRe). In addition, SynChro provides the user with a rich set of graphical outputs including dotplots, chromosome paintings and detailed synteny maps to visualize synteny blocks with all homology relationships and synteny breakpoints with all included genetic features. SynChro is freely available under the BSD license at http://www.lcqb.upmc.fr/CHROnicle/SynChro.html.	[Drillon, Guenola; Carbone, Alessandra; Fischer, Gilles] Sorbonne Univ, Univ Paris 06, UMR 7238, Paris, France; [Drillon, Guenola; Carbone, Alessandra; Fischer, Gilles] CNRS, UMR7238, Paris, France; [Carbone, Alessandra] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Universitaire de France	Fischer, G (corresponding author), Sorbonne Univ, Univ Paris 06, UMR 7238, Paris, France.	Gilles.Fischer@upmc.fr	Fischer, Gilles/Q-4603-2019; Fischer, Gilles/G-6654-2016	Fischer, Gilles/0000-0001-5732-2682; Carbone, Alessandra/0000-0003-2098-5743	Agence Nationale de la Recherche ('GB-3G') [ANR-10-BLAN-1606-01]; CNRS	Agence Nationale de la Recherche ('GB-3G')(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Agence Nationale de la Recherche ('GB-3G', ANR-10-BLAN-1606-01, http://www.agence-nationale-recherche.fr/) and by an ATIP grant from the CNRS (http://www.cnrs.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cannon SB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r68; Dong XJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r86; Drillon G, 2013, J LOGIC COMPUT, V23, P815, DOI 10.1093/logcom/exr047; Drillon G, 2011, CR BIOL, V334, P629, DOI 10.1016/j.crvi.2011.05.011; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Hampson S, 2003, GENOME RES, V13, P999, DOI 10.1101/gr.814403; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Ma J, 2006, GENOME RES, V16, P1557, DOI 10.1101/gr.5383506; Ng MP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-192; Pan XK, 2005, BIOINFORMATICS, V21, P3461, DOI 10.1093/bioinformatics/bti555; Proost S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr955; Simillion C, 2004, GENOME RES, V14, P1095, DOI 10.1101/gr.2179004; Sinha AU, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-82; Soderlund C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr123; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Vandepoele K, 2002, GENOME RES, V12, P1792, DOI 10.1101/gr.400202; Wang XY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-447; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Xinghuo Z., 2008, P 11 INT C EXT DAT T, P656	22	56	56	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92621	10.1371/journal.pone.0092621	http://dx.doi.org/10.1371/journal.pone.0092621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651407	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800134
J	Khan, MH; Meghvansi, MK; Gupta, R; Veer, V; Singh, L; Kalita, MC				Khan, Mohammad Haneef; Meghvansi, Mukesh K.; Gupta, Rajeev; Veer, Vijay; Singh, Lokendra; Kalita, Mohan C.			Foliar Spray with Vermiwash Modifies the Arbuscular Mycorrhizal Dependency and Nutrient Stoichiometry of Bhut Jolokia (Capsicum assamicum)	PLOS ONE			English	Article							COMPOST TEA; NAGA CHILLI; GROWTH-RATE; PLANT; FUNGI; SOIL; RESPONSES; YIELD; L.; NUTRITION	Vermiwash (VW), a liquid extract obtained from vermicomposting beds, is used as an organic fertilizer for crop plants. The current study investigated the effect of a vermiwash foliar spray on the response of bhut jolokia (Capsicum assamicum) exposed to two different arbuscular mycorrhizal fungi (AMF: Rhizophagus irregularis, RI and G. mosseae, GM) in acidic soil under naturally ventilated greenhouse conditions. The VW spray significantly influenced the growth of plants receiving the dual treatment of AMF+VW. Plant growth was more prominent in the GM+VW treatment group than that in the RI+VW treatment group. The plant-AMF interactions in relation to growth and nutrient requirements were also significantly influenced by the application of VW. Interestingly, the VW treatment appeared to contribute more N to plants when compared to that under the AMF treatment, which led to changes in the C: N: P stoichiometry in plant shoots. Furthermore, the increased potassium dependency, as observed in the case of the dual treatments, suggests the significance of such treatments for improving crop conditions under salt stress. Overall, our study shows that the VW foliar spray modifies the response of a crop to inoculations of different AMF with regard to growth and nutrient utilization, which has implications for the selection of an efficient combination of nutrient source for improving crop growth.	[Khan, Mohammad Haneef; Meghvansi, Mukesh K.; Gupta, Rajeev; Veer, Vijay] Def Res & Dev Org, Def Res Lab, Tezpur, Assam, India; [Singh, Lokendra] Def Res & Dev Org, Directorate Gen Life Sci, New Delhi, India; [Kalita, Mohan C.] Gauhati Univ, Dept Biotechnol & Bioengn, Gauhati, Assam, India	Defence Research & Development Organisation (DRDO); Defence Research Laboratory (DRL); Defence Research & Development Organisation (DRDO); Gauhati University	Meghvansi, MK (corresponding author), Def Res & Dev Org, Def Res Lab, Post Bag 2, Tezpur, Assam, India.	mk_meghvansi@yahoo.co.in		Khan, Mohammad Haneef/0000-0001-9603-7593	Defence Research & Development Organisation (DRDO), New Delhi, India	Defence Research & Development Organisation (DRDO), New Delhi, India(Defence Research & Development Organisation (DRDO))	This study was funded by Defence Research & Development Organisation (DRDO), New Delhi, India from operating funds rather than grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Alloush GA, 2001, COMMUN SOIL SCI PLAN, V32, P231, DOI 10.1081/CSS-100103004; Ansari AA, 2010, AFR J AGR RES, V5, P1794; Arancon N. Q., 2007, BioCycle, V48, P51; Arthur GD, 2001, ENVIRON EXP BOT, V45, P55, DOI 10.1016/S0098-8472(00)00080-0; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Chen MM, 2010, PLANT SOIL, V326, P21, DOI 10.1007/s11104-009-9982-4; Doubkova P, 2012, SOIL BIOL BIOCHEM, V44, P56, DOI 10.1016/j.soilbio.2011.09.011; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Garcia Martinez Ignacio, 2002, Crop Research (Hisar), V24, P323; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gosling P, 2006, AGR ECOSYST ENVIRON, V113, P17, DOI 10.1016/j.agee.2005.09.009; Guo W, 2013, APPL SOIL ECOL, V72, P85, DOI 10.1016/j.apsoil.2013.06.001; Hanway J.J., 1952, IOWA AGR, V57, P1, DOI DOI 10.12691/AJWR-7-1-5; Haytova D., 2013, Annual Review and Research in Biology, V3, P455; Hessen DO, 2007, FUNCT ECOL, V21, P956, DOI 10.1111/j.1365-2435.2007.01306.x; Holloway Peter J., 1993, Pesticide Science, V37, P203, DOI 10.1002/ps.2780370214; Ismail SA, 1997, VERMICOLOGY BIOL EAR; Jackson ML, 2005, SOIL CHEM ANAL ADV C; Johnson NC, 2010, NEW PHYTOL, V185, P631, DOI 10.1111/j.1469-8137.2009.03110.x; Jordan NR, 2000, WEED RES, V40, P397, DOI 10.1046/j.1365-3180.2000.00207.x; Khorshidi M., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V5, P1191; Kuepper G, 2003, FOLIAR FERTILIZATION; Kyle M, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.1; Leon-Anzueto E, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue6-fulltext-9; Medina A, 2010, J SOIL SCI PLANT NUT, V10, P354, DOI 10.4067/S0718-95162010000100009; Medina A, 2010, APPL SOIL ECOL, V44, P181, DOI 10.1016/j.apsoil.2009.12.004; Meghvansi MK, 2012, J CROP IMPROV, V26, P520, DOI 10.1080/15427528.2012.657293; Meghvansi MK, 2010, J ETHNOPHARMACOL, V132, P1, DOI 10.1016/j.jep.2010.08.034; Meghvansi MK, 2008, EUR J SOIL BIOL, V44, P316, DOI 10.1016/j.ejsobi.2008.03.003; Milleret R, 2009, PLANT SOIL, V316, P1, DOI 10.1007/s11104-008-9753-7; Muthukumar T, 2002, J AGRON CROP SCI, V188, P123, DOI 10.1046/j.1439-037X.2002.00544.x; Naidu Y, 2013, SCI HORTIC-AMSTERDAM, V159, P33, DOI 10.1016/j.scienta.2013.04.024; Peng S., 1992, International Rice Research Newsletter, V17, P19; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; PLENCHETTE C, 1983, PLANT SOIL, V70, P199, DOI 10.1007/BF02374780; Porras-Soriano A, 2009, J PLANT PHYSIOL, V166, P1350, DOI 10.1016/j.jplph.2009.02.010; Scheuerell S, 2002, COMPOST SCI UTIL, V10, P313; Schonherr J, 2000, PLANTA, V212, P112, DOI 10.1007/s004250000373; Sensoy S, 2007, SCI HORTIC-AMSTERDAM, V113, P92, DOI 10.1016/j.scienta.2007.01.023; Sharma P. K., 1980, Journal of the Indian Society of Soil Science, V28, P450; Siddiqui Y, 2008, CROP PROT, V27, P385, DOI 10.1016/j.cropro.2007.07.002; Siddiqui Y, 2011, SCI HORTIC-AMSTERDAM, V130, P289, DOI 10.1016/j.scienta.2011.05.043; Singh RK, 2011, AFR J MICROBIOL RES, V5, P5004, DOI 10.5897/AJMR11.628; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; STERNER RW, 1995, LINKING SPECIES & ECOSYSTEMS, P240; Tandon HLS., 1993, METHODS ANAL SOILS P; Thomas JMG, 2003, CROP SCI, V43, P1548, DOI 10.2135/cropsci2003.1548; van der Heijden MGA, 2002, ECOL STU AN, V157, P243; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; Vrede T, 2004, ECOLOGY, V85, P1217, DOI 10.1890/02-0249; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Willis A, 2013, CRIT REV PLANT SCI, V32, P1, DOI 10.1080/07352689.2012.683375; Wilson GWT, 1998, AM J BOT, V85, P1732, DOI 10.2307/2446507; Zhang F, 2004, PLANT SOIL, V260, P89, DOI 10.1023/B:PLSO.0000030192.15621.20	58	24	24	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92318	10.1371/journal.pone.0092318	http://dx.doi.org/10.1371/journal.pone.0092318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651577	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800100
J	Liu, L; Chen, H; Wang, MM; Zhao, Y; Cai, GH; Qi, XS; Han, GH				Liu, Lei; Chen, Hui; Wang, Mengmeng; Zhao, Yan; Cai, Guohong; Qi, Xingshun; Han, Guohong			Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CONCURRENT TRANSARTERIAL CHEMOEMBOLIZATION; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; DRUG-ELUTING BEADS; HEPATOCELLULAR-CARCINOMA; PHASE-III; CANCER; MULTICENTER; MANAGEMENT; EFFICACY	Background and Aim: A large number of studies have tried to combine sorafenib with TACE for patients with unresectable hepatocellular carcinoma (HCC) and the results were controversial. We conducted this systematic review and meta-analysis to evaluate the safety and efficacy of combination therapy of sorafenib and TACE in the management of unresectable HCC. Methods: MEDLINE, PsycINFO, Scopus, EMBASE, and the Cochrane Library were searched from January 1990 to October 2013 and these databases were searched for appropriate studies combining TACE and sorafenib in treatment of HCC. Two authors independently reviewed the databases and extracted the data and disagreements were resolved by discussion. Effective value and safety were analyzed. Effective value included disease control rate (DCR), time to progression (TTP) and overall survival (OS). Results: 17 studies were included in the study. In the 10 noncomparative studies, DCR ranged from 18.4 to 91.2%. Median TTP ranged from 7.1 to 9.0 months, and median OS ranged from 12 to 27 months. In the 7 comparative studies, the hazard ratio (HR) for TTP was found to be 0.76 (95% CI 0.66-0.89; P<0.001) with low heterogeneity among studies (P = 0.243; I-2 = 25.5%). However, the HR for OS was found to be 0.81 (95% CI 0.65-1.01; P = 0.061) with low heterogeneity among studies (P = 0.259; I-2 = 25.4%). The common toxicities included fatigue, diarrhea, nausea, hand foot skin reaction (HFSR), hematological events, hepatotoxicity, alopecia, hepatotoxicity, hypertension and rash/desquamation. AEs are generally manageable with dose reductions. Conclusions: Combination therapy may bring benefits for unresectable HCC patients in terms of TTP but not OS. Further well-designed randomized controlled studies are needed to confirm the efficacy of combination therapy.	[Liu, Lei; Chen, Hui; Qi, Xingshun; Han, Guohong] Fourth Mil Med Univ, Xijing Hosp, Xijing Hosp Digest Dis, Dept Digest Intervent Radiol, Xian 710032, Shaanxi, Peoples R China; [Zhao, Yan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Gastroenterol, Xian 710049, Shaanxi, Peoples R China; [Cai, Guohong] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Dept Anat Histol & Embryol, Xian 710032, Shaanxi, Peoples R China; [Wang, Mengmeng] Fourth Mil Med Univ, Sch Mil Prevent Med, Dept Hlth Serv, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Xi'an Jiaotong University; Air Force Military Medical University; Air Force Military Medical University	Han, GH (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Xijing Hosp Digest Dis, Dept Digest Intervent Radiol, Xian 710032, Shaanxi, Peoples R China.	guohhan@126.com	Qi, Xingshun/M-7063-2013	Qi, Xingshun/0000-0002-9448-6739; Liu, Lei/0000-0002-3570-2219				Bai W, 2013, J DIGEST DIS, V14, P181, DOI 10.1111/1751-2980.12038; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Cabrera R, 2011, ALIMENT PHARM THER, V34, P205, DOI 10.1111/j.1365-2036.2011.04697.x; Choi GH, 2013, RADIOLOGY, V269, P602, DOI 10.1148/radiol.13130150; Chung YH, 2013, INT J CANCER, V132, P2448, DOI 10.1002/ijc.27925; Dufour JF, 2010, ONCOLOGIST, V15, P1198, DOI 10.1634/theoncologist.2010-0180; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Erhardt A, 2009, HEPATOLOGY S1080A, V50, pA1675; Faloppi L, 2011, CANCER TREAT REV, V37, P169, DOI 10.1016/j.ctrv.2010.08.001; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Higgins J., 2009, COCHRANE HDB SYSTEMA; Hoffmann K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-349; Huang YH, 2013, CHINESE MED J-PEKING, V126, P385, DOI 10.3760/cma.j.issn.0366-6999.20113067; Kudo M, 2011, EUR J CANCER, V47, P2117, DOI 10.1016/j.ejca.2011.05.007; Lee JH, 2011, 46 ANN M EUR ASS STU; Lencioni R, 2012, J CLIN ONCOGENE, V30; Li X, 2004, WORLD J GASTROENTERO, V10, P2878; Martin RC II, 2010, ASCO GASTR CANC S JA; Martin R, 2012, HEPATO-GASTROENTEROL, V59, P255, DOI 10.5754/hge10240; Muhammad A, 2013, WORLD J HEPATOL, V5, P364, DOI 10.4254/wjh.v5.i7.364; Park JW, 2013, LIVER INT, V33, P327, DOI 10.1111/liv.12083; Park JW, 2012, J HEPATOL, V56, P1336, DOI 10.1016/j.jhep.2012.01.006; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pawlik TM, 2011, J CLIN ONCOL, V29, P3960, DOI 10.1200/JCO.2011.37.1021; Qu XD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-263; Raoul JL, 2011, CANCER TREAT REV, V37, P212, DOI 10.1016/j.ctrv.2010.07.006; Sansonno D, 2012, ONCOLOGIST, V17, P359, DOI 10.1634/theoncologist.2011-0313; Sieghart W, 2012, EUR RADIOL, V22, P1214, DOI 10.1007/s00330-011-2368-z; Weintraub JL, 2013, J VASC INTERV RADIOL, V24, P1123, DOI 10.1016/j.jvir.2013.01.494; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Zhao Y, 2013, ANN ONCOL, V24, P1786, DOI 10.1093/annonc/mdt072	33	76	83	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91124	10.1371/journal.pone.0091124	http://dx.doi.org/10.1371/journal.pone.0091124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651044	gold, Green Submitted, Green Published			2022-12-27	WOS:000333352800031
J	McMahon, CR; Howe, H; van den Hoff, J; Alderman, R; Brolsma, H; Hindell, MA				McMahon, Clive R.; Howe, Hamish; van den Hoff, John; Alderman, Rachael; Brolsma, Henk; Hindell, Mark A.			Satellites, the All-Seeing Eyes in the Sky: Counting Elephant Seals from Space	PLOS ONE			English	Article							BIODIVERSITY LOSS; MIROUNGA-LEONINA; SOUTHERN; TRENDS; TIME	Regular censuses are fundamental for the management of animal populations but, are logistically challenging for species living in remote regions. The advent of readily accessible, high resolution satellite images of earth mean that it is possible to resolve relatively small (0.6 m) objects, sufficient to discern large animals. To illustrate how these advances can be used to count animals in remote regions, individual elephant seals (Mirounga leonina) were counted using satellite imagery. We used an image taken on 10/10/2011 to count elephant seals (n = 1790 +/- 306 (95%CL)) on the isthmus of Macquarie Island, an estimate which overlapped with concurrent ground counts (n = 1991). The number of individuals per harem estimated using the two approaches were highly correlated, with a slope close to one and the estimated intercept also encompassing zero. This proof of concept opens the way for satellites to be used as a standard censusing technique for inaccessible and cryptically coloured species. Quantifying the population trends of higher order predators provides an especially informative and tractable indicator of ecosystem health.	[McMahon, Clive R.; Howe, Hamish; Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [van den Hoff, John; Brolsma, Henk] Australian Antarctic Div, Kingston, Tas, Australia; [Alderman, Rachael] Dept Primary Ind Water & Environm, Threatened Species & Marine Sect, Hobart, Tas, Australia	University of Tasmania; Australian Antarctic Division	McMahon, CR (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	clive.mcmahon@utas.edu.au	McMahon, Clive R/D-5713-2013	McMahon, Clive R/0000-0001-5241-8917; Hindell, Mark/0000-0002-7823-7185				Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; Fretwell PT, 2009, GLOBAL ECOL BIOGEOGR, V18, P543, DOI 10.1111/j.1466-8238.2009.00467.x; Gutro R, 2005, SATELLITE DATA TRACK; HINDELL MA, 1987, J ZOOL, V213, P365, DOI 10.1111/j.1469-7998.1987.tb03712.x; Hindell MA, 2003, MARINE MAMMALS HUMAN; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Horning N., 2010, REMOTE SENSING ECOLO; Hughes BJ, 2011, WILDLIFE BIOL, V17, P210, DOI 10.2981/10-106; Laliberte AS, 2003, WILDLIFE SOC B, V31, P362; LaRue MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060568; LaRue MA, 2011, POLAR BIOL, V34, P1727, DOI 10.1007/s00300-011-1023-0; Lynch HJ, 2012, POLAR BIOL, V35, P963, DOI 10.1007/s00300-011-1138-3; McMahon CR, 2009, OECOLOGIA, V159, P69, DOI 10.1007/s00442-008-1205-9; McMahon CR, 2005, MAMMAL REV, V35, P82, DOI 10.1111/j.1365-2907.2005.00055.x; McMahon CR, 2004, BEHAV ECOL SOCIOBIOL, V55, P349, DOI 10.1007/s00265-003-0721-1; Naveen R, 2012, POLAR BIOL, V35, P1879, DOI 10.1007/s00300-012-1230-3; Platonov NG, 2013, BIOL BULL+, V40, P197, DOI 10.1134/S1062359013020106; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Trathan PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014738; van den Hoff J, 2007, POLAR BIOL, V30, P1275, DOI 10.1007/s00300-007-0288-9; Yang Z, 2012, EVALUATING HIGH RESO	22	50	54	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92613	10.1371/journal.pone.0092613	http://dx.doi.org/10.1371/journal.pone.0092613			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651378	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800133
J	Pohar, J; Pirher, N; Bencina, M; Mancek-Keber, M; Jerala, R				Pohar, Jelka; Pirher, Nina; Bencina, Mojca; Mancek-Keber, Mateja; Jerala, Roman			The Ectodomain of TLR3 Receptor Is Required for Its Plasma Membrane Translocation	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; NUCLEIC-ACID; INTRACELLULAR COMPARTMENTS; EPITHELIAL-CELLS; SENSING TLRS; CPG-DNA; LOCALIZATION; RECOGNITION; PROTEIN	Toll-like receptor 3 (TLR3) is a dsRNA sensing receptor that is localized in the cellular compartments but also at the plasma membrane. Overexpression of UNC93B1 promoted localization of TLR3, but not other nucleic acid sensing TLRs, to the plasma membrane. Here we show that UNC93B1 itself is localized at the plasma membrane. We investigated the role of different domains of TLR3 on cell signaling by preparing chimeric receptors between TLR3 and TLR9 where each of the transmembrane segments or cytosolic domains has been exchanged. While the ectodomain completely governs ligand specificity and the cytosolic TIR domain determines the engagement of the signaling adapters as well as the potentiation of receptor activation by UNC93B1, the ectodomain but not transmembrane segment or cytosolic domain determines plasma membrane localization of TLR3. Nevertheless, TLR3 receptor and ligand endocytosis as well as endosomal acidification are important for the robust signaling of TLR3.	[Pohar, Jelka; Pirher, Nina; Bencina, Mojca; Mancek-Keber, Mateja; Jerala, Roman] Natl Inst Chem, Ljubljana, Slovenia; [Bencina, Mojca; Mancek-Keber, Mateja; Jerala, Roman] EN FIST Ctr Excellence, Ljubljana, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia; University of Ljubljana	Jerala, R (corresponding author), Natl Inst Chem, Hajdrihova 19, Ljubljana, Slovenia.	roman.jerala@ki.si		Pohar, Jelka/0000-0002-7616-164X	Slovenian Research Agency; International Centre for Genetic Engineering and Biotechnology (CRP-ICGEB) [CRP/SLO08-01]; EN-FIST Centre of Excellence; European Union	Slovenian Research Agency(Slovenian Research Agency - Slovenia); International Centre for Genetic Engineering and Biotechnology (CRP-ICGEB); EN-FIST Centre of Excellence; European Union(European Commission)	This work was supported by the project and program grant from the Slovenian Research Agency (http://www.arrs.gov.si/en/dobrodoslica.asp), International Centre for Genetic Engineering and Biotechnology (CRP-ICGEB research grant - project no. CRP/SLO08-01; http://www.icgeb.org/home.html) and EN-FIST Centre of Excellence (http://enfist.si/En/) financed in part by the European Union structural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrade WA, 2013, CELL HOST MICROBE, V13, P42, DOI 10.1016/j.chom.2012.12.003; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Chaturvedi A, 2009, TRAFFIC, V10, P621, DOI 10.1111/j.1600-0854.2009.00899.x; Chuang TH, 2002, J LEUKOCYTE BIOL, V71, P538; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Deane JA, 2006, J IMMUNOL, V177, P6573, DOI 10.4049/jimmunol.177.10.6573; Eaton-Bassiri A, 2004, INFECT IMMUN, V72, P7202, DOI 10.1128/IAI.72.12.7202-7211.2004; Ewaschuk JB, 2007, INFECT IMMUN, V75, P2572, DOI 10.1128/IAI.01662-06; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; Funami K, 2007, J IMMUNOL, V179, P6867, DOI 10.4049/jimmunol.179.10.6867; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Itoh K, 2008, J IMMUNOL, V181, P5522, DOI 10.4049/jimmunol.181.8.5522; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kajita E, 2006, BIOCHEM BIOPH RES CO, V343, P578, DOI 10.1016/j.bbrc.2006.03.014; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim J, 2013, J IMMUNOL, V190, P5287, DOI 10.4049/jimmunol.1202767; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Leifer CA, 2006, J BIOL CHEM, V281, P35585, DOI 10.1074/jbc.M607511200; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Menager P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000315; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Pegu A, 2008, J IMMUNOL, V180, P3399, DOI 10.4049/jimmunol.180.5.3399; Pifer R, 2011, J BIOL CHEM, V286, P3307, DOI 10.1074/jbc.M110.171025; Pirher N, 2008, NAT STRUCT MOL BIOL, V15, P761, DOI 10.1038/nsmb.1453; Pohar J, 2013, J BIOL CHEM, V288, P442, DOI 10.1074/jbc.M112.413922; Qi RS, 2012, J BIOL CHEM, V287, P32617, DOI 10.1074/jbc.M112.387803; Qi RS, 2010, J BIOL CHEM, V285, P36635, DOI 10.1074/jbc.M110.144402; Singh D, 2013, J BIOL CHEM, V288, P8258, DOI 10.1074/jbc.M112.440883; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Ueta M, 2005, BIOCHEM BIOPH RES CO, V331, P285, DOI 10.1016/j.bbrc.2005.02.196; Watanabe A, 2011, J BIOL CHEM, V286, P10702, DOI 10.1074/jbc.M110.185793; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	53	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92391	10.1371/journal.pone.0092391	http://dx.doi.org/10.1371/journal.pone.0092391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651829	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800105
J	Qu, B; Gu, YH; Shen, J; Qin, JZ; Bao, JQ; Hu, Y; Zeng, WX; Dong, WZ				Qu, Bin; Gu, Yihua; Shen, Jian; Qin, Jinzhou; Bao, Jianqiang; Hu, Yuan; Zeng, Wenxian; Dong, Wuzi			Trehalose Maintains Vitality of Mouse Epididymal Epithelial Cells and Mediates Gene Transfer	PLOS ONE			English	Article							IN-VITRO; SPERM; MEMBRANE; CULTURE; CAPUT; COCULTURE; INJECTION; DELIVERY; FLUIDITY; LINE	In the present study, trehalose was utilized to improve primary culture of mouse epididymal epithelial cells in vitro, and to enhance naked DNA delivery in epididymis in vivo. During the six-day culture, the proliferation activity of the cells in the medium with addition of trehalose was higher than that of those cells cultured in absence of trehalose (p<0.01). To determine the optimal concentration for cell proliferation, a series of trehalose concentrations (0, 60, 120, 180 mM) were tested, and the result indicated that the cell in the medium with 120 mM trehalose showed the highest proliferation potential. The epididymis epithelial cells were cultured in the medium containing 120 mM trehalose upon 16th passage, and they continued expressing markers of epididymal epithelial cell, such as rE-RABP, AR and ER-beta. Our study also indicated that trehalose concentrations of 120-240 mM, especially 180 mM, could effectively enhance DNA delivery into the mouse epididymis epithelial cell in vitro. Moreover, trehalose could induce in vivo expression of exogenous DNA in epididymal epithelial cells and help to internalize plasmid into sperm, which did not influence motility of sperm when the mixture of trehalose (180 mM) and DNA was injected into epididymal lumen through efferent tubule. This study suggested that trehalose, as an effective and safer reagent, could be employed potentially to maintain vitality of mouse epididymal epthetial cells during long-term culture in vitro and to mediate in vitro and in vivo gene transfer.	[Qu, Bin; Shen, Jian; Qin, Jinzhou; Hu, Yuan; Zeng, Wenxian; Dong, Wuzi] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Gu, Yihua] Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China; [Bao, Jianqiang] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA	Northwest A&F University - China; Nevada System of Higher Education (NSHE); University of Nevada Reno	Dong, WZ (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	dongyangluyi@126.com	Bao, Jianqiang/T-7299-2019; Bao, Jianqiang/G-9184-2016; Zeng, Wen/GPS-8058-2022	Bao, Jianqiang/0000-0003-1248-2687; 	National Natural Science Foundation of China [C170104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. C170104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagla EME, 2003, BIOL REPROD, V69, P1245, DOI 10.1095/biolreprod.103.017889; Bassols J, 2004, THERIOGENOLOGY, V62, P929, DOI 10.1016/j.theriogenology.2003.12.015; Bongso A, 1996, HUM REPROD, V11, P1451; Britan A, 2004, MOL CELL ENDOCRINOL, V224, P41, DOI 10.1016/j.mce.2004.06.010; Chen YC, 1998, TISSUE CELL, V30, P1, DOI 10.1016/S0040-8166(98)80002-5; Companyo M, 2007, BBA-BIOMEMBRANES, V1768, P2246, DOI 10.1016/j.bbamem.2007.06.011; Du JY, 2009, BIOL REPROD, V80, P13, DOI 10.1095/biolreprod.108.068346; Dufresne J, 2005, ENDOCRINOLOGY, V146, P4710, DOI 10.1210/en.2004-1634; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Esponda P, 2011, ZYGOTE, V19, P287, DOI 10.1017/S0967199410000523; Gao X, 2007, AAPS J, V9, pE92, DOI 10.1208/aapsj0901009; Hall JC, 1997, BIOCHEM MOL BIOL INT, V42, P833, DOI 10.1080/15216549700203271; Hamzeh M, 2009, J ANDROL, V30, P200, DOI 10.2164/jandrol.108.006171; Hermo L., 2002, EPIDIDYMIS MOL CLIN, P81, DOI [10.1007/978-1-4615-0679-9_5, DOI 10.1007/978-1-4615-0679-9_5]; HIRATA T, 1994, SURGERY, V115, P102; Kaneko T, 2009, CRYOBIOLOGY, V59, P59, DOI 10.1016/j.cryobiol.2009.04.006; Kang Mo K, 2007, Methods Mol Biol, V371, P151; McGinnis LK, 2005, BIOL REPROD, V73, P627, DOI 10.1095/biolreprod.105.042291; MOORE HDM, 1986, J REPROD FERTIL, V78, P327, DOI 10.1530/jrf.0.0780327; Moore HDM, 1998, J REPROD FERTIL, P23; Oliver A. E., 2004, CELL PRESERV TECHNOL, V2, P35, DOI DOI 10.1089/153834404322708745; OLSON GE, 1983, J ANDROL, V4, P347; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sasnoor LM, 2005, TRANSPLANTATION, V80, P1251, DOI 10.1097/01.tp.0000169028.01327.90; Sato M, 2002, MOL REPROD DEV, V61, P49, DOI 10.1002/mrd.1130; Saxena A, 2012, BIOTECHNIQUES, V52, P381, DOI 10.2144/0000113878; Seki T, 2010, J BIOL CHEM, V285, P33252, DOI 10.1074/jbc.M110.146704; Tabuchi Y, 2005, BIOCHEM BIOPH RES CO, V329, P812, DOI 10.1016/j.bbrc.2005.02.066; Tang CH, 2009, J GENE MED, V11, P250, DOI 10.1002/jgm.1295; Tseng WC, 2007, J GENE MED, V9, P659, DOI 10.1002/jgm.1063; Wang Z, 2000, Shi Yan Sheng Wu Xue Bao, V33, P129; Woelders H, 1997, CRYOBIOLOGY, V35, P93, DOI 10.1006/cryo.1997.2028; Wolkers WF, 2003, BBA-BIOMEMBRANES, V1612, P154, DOI 10.1016/S0005-2736(03)00114-7; Yamashiro H, 2007, ANIM REPROD SCI, V102, P165, DOI 10.1016/j.anireprosci.2007.02.026; Zhao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054645; Zhao Y, 2011, CELL MOL LIFE SCI, V68, P697, DOI 10.1007/s00018-010-0478-4; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106	38	6	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92483	10.1371/journal.pone.0092483	http://dx.doi.org/10.1371/journal.pone.0092483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651491	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800118
J	Dusek, RJ; Hallgrimsson, GT; Ip, HS; Jonsson, JE; Sreevatsan, S; Nashold, SW; TeSlaa, JL; Enomoto, S; Halpin, RA; Lin, XD; Fedorova, N; Stockwell, TB; Dugan, VG; Wentworth, DE; Hall, JS				Dusek, Robert J.; Hallgrimsson, Gunnar T.; Ip, Hon S.; Jonsson, Jon E.; Sreevatsan, Srinand; Nashold, Sean W.; TeSlaa, Joshua L.; Enomoto, Shinichiro; Halpin, Rebecca A.; Lin, Xudong; Fedorova, Nadia; Stockwell, Timothy B.; Dugan, Vivien G.; Wentworth, David E.; Hall, Jeffrey S.			North Atlantic Migratory Bird Flyways Provide Routes for Intercontinental Movement of Avian Influenza Viruses	PLOS ONE			English	Article							A VIRUS; SPRING MIGRATION; WILD WATERFOWL; LINEAGE; EVOLUTION; GENES; GULLS; PERFORMANCE; OUTBREAK; SEQUENCE	Avian influenza virus (AIV) in wild birds has been of increasing interest over the last decade due to the emergence of AIVs that cause significant disease and mortality in both poultry and humans. While research clearly demonstrates that AIVs can move across the Pacific or Atlantic Ocean, there has been no data to support the mechanism of how this occurs. In spring and autumn of 2010 and autumn of 2011 we obtained cloacal swab samples from 1078 waterfowl, gulls, and shorebirds of various species in southwest and west Iceland and tested them for AIV. From these, we isolated and fully sequenced the genomes of 29 AIVs from wild caught gulls (Charadriiformes) and waterfowl (Anseriformes) in Iceland. We detected viruses that were entirely (8 of 8 genomic segments) of American lineage, viruses that were entirely of Eurasian lineage, and viruses with mixed American-Eurasian lineage. Prior to this work only 2 AIVs had been reported from wild birds in Iceland and only the sequence from one segment was available in GenBank. This is the first report of finding AIVs of entirely American lineage and Eurasian lineage, as well as reassortant viruses, together in the same geographic location. Our study demonstrates the importance of the North Atlantic as a corridor for the movement of AIVs between Europe and North America.	[Dusek, Robert J.; Ip, Hon S.; Nashold, Sean W.; TeSlaa, Joshua L.; Hall, Jeffrey S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA; [Hallgrimsson, Gunnar T.] Southwest Iceland Nat Res Inst, Sandgeroi, Iceland; [Jonsson, Jon E.] Univ Iceland, Snaefellsnes Res Ctr, Stykkisholmur, Iceland; [Sreevatsan, Srinand; Enomoto, Shinichiro] Univ Minnesota, Coll Vet Med, Vet & Biomed Sci Dept, St Paul, MN 55108 USA; [Halpin, Rebecca A.; Lin, Xudong; Fedorova, Nadia; Stockwell, Timothy B.; Dugan, Vivien G.; Wentworth, David E.] J Craig Venter Inst, Rockville, MD USA	United States Department of the Interior; United States Geological Survey; University of Iceland; University of Minnesota System; University of Minnesota Twin Cities; J. Craig Venter Institute	Dusek, RJ (corresponding author), US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA.	rdusek@usgs.gov	Jónsson, Jón Einar/K-7482-2015; Hallgrimsson, Gunnar Thor/M-3105-2015; Sreevatsan, Srinand/V-6808-2019	Jónsson, Jón Einar/0000-0003-1198-786X; Hallgrimsson, Gunnar Thor/0000-0002-3697-9148; Sreevatsan, Srinand/0000-0002-5162-2403; Stockwell, Timothy/0000-0002-3595-4539; TeSlaa, Joshua/0000-0001-7802-3454; Dusek, Robert/0000-0001-6177-7479; Ip, Hon/0000-0003-4844-7533; Hall, Jeffrey/0000-0001-5599-2826; Wentworth, David/0000-0002-5190-980X; Nashold, Sean/0000-0002-8869-6633	United States Geological Service; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services [HHSN266200700007C, HHSN272200900007C]	United States Geological Service; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been funded by the United States Geological Service and with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services under Contract Nos. HHSN266200700007C and HHSN272200900007C. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahl J, 2009, VIROLOGY, V390, P289, DOI 10.1016/j.virol.2009.05.002; Boere CG, 2006, WATERBIRDS WORLD, P40; Buscaglia C, 2012, AVIAN DIS, V56, P1017, DOI 10.1637/10147-040712-Reg.1; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Docherty D.E., 1988, Journal of Tissue Culture Methods, V11, P165, DOI 10.1007/BF01404270; Dohna HZ, 2009, EMERG INFECT DIS, V15, P1040, DOI 10.3201/eid1507.090245; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Escorcia M, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-57; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ghedin E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/infdis/jiq040; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; GORMAN OT, 1991, J VIROL, V65, P3704, DOI 10.1128/JVI.65.7.3704-3714.1991; GUDMUNDSSON GA, 1992, ARDEA, V80, P315; GUDMUNDSSON GA, 1995, P ROY SOC B-BIOL SCI, V261, P73, DOI 10.1098/rspb.1995.0119; GUDMUNDSSON GA, 1993, IBIS, V135, P166, DOI 10.1111/j.1474-919X.1993.tb02828.x; Hall JS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-179; Hallgrimsson GT, 2012, J ORNITHOL, V153, P603, DOI 10.1007/s10336-012-0816-4; Hallgrimsson Gunnar Thor, 2011, Marine Ornithology, V39, P137; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Lam TTY, 2012, ECOL LETT, V15, P24, DOI 10.1111/j.1461-0248.2011.01703.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LATORREMARGALEF N, 2008, P ROY SOC LOND B BIO, V276, P1029; Lebarbenchon C, 2009, J MOL GENET MED, V3, P121, DOI DOI 10.4172/1747-0862.1000023; LUDWIG S, 1991, VIROLOGY, V183, P566, DOI 10.1016/0042-6822(91)90985-K; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Olsen K.M., 2003, GULLS EUROPE ASIA N; Pereda AJ, 2008, VIROLOGY, V378, P363, DOI 10.1016/j.virol.2008.06.010; Ratanakorn P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049939; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; Senne DA, 2010, AVIAN DIS, V54, P179, DOI 10.1637/8921-050809-Review.1; Sharshov K, 2010, EMERG INFECT DIS, V16, P349, DOI 10.3201/eid1602.090974; Shi WF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014454; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2007, J VIROL, V81, P11612, DOI 10.1128/JVI.01368-07; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Vijaykrishna D, 2013, J VIROL, V87, P10182, DOI 10.1128/JVI.03437-12; WEBSTER RG, 1981, VIROLOGY, V113, P712, DOI 10.1016/0042-6822(81)90200-2; Wille M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020664; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1; Woolcock Peter R., 2008, V436, P35, DOI 10.1007/978-1-59745-279-3_6; Zhou Bin, 2012, Methods Mol Biol, V865, P175, DOI 10.1007/978-1-61779-621-0_11; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09; Zohari S, 2009, VIROL J, V5, DOI 10.1186/1743-422X-5-147	51	58	58	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92075	10.1371/journal.pone.0092075	http://dx.doi.org/10.1371/journal.pone.0092075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647410	Green Submitted, gold, Green Published			2022-12-27	WOS:000333348500080
J	Kosinska, MK; Liebisch, G; Lochnit, G; Wilhelm, J; Klein, H; Kaesser, U; Lasczkowski, G; Rickert, M; Schmitz, G; Steinmeyer, J				Kosinska, Marta Krystyna; Liebisch, Gerhard; Lochnit, Guenter; Wilhelm, Jochen; Klein, Heiko; Kaesser, Ulrich; Lasczkowski, Gabriele; Rickert, Markus; Schmitz, Gerd; Steinmeyer, Juergen			Sphingolipids in Human Synovial Fluid - A Lipidomic Study	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; RABBIT ARTICULAR-CARTILAGE; NECROSIS-FACTOR-ALPHA; LYSOPHOSPHATIDIC ACID; RHEUMATOID-ARTHRITIS; MATRIX-METALLOPROTEINASE; HUMAN PLASMA; CERAMIDE; APOPTOSIS; CARDIOLIPIN	Articular synovial fluid (SF) is a complex mixture of components that regulate nutrition, communication, shock absorption, and lubrication. Alterations in its composition can be pathogenic. This lipidomic investigation aims to quantify the composition of sphingolipids (sphingomyelins, ceramides, and hexosyl- and dihexosylceramides) and minor glycerophospholipid species, including (lyso)phosphatidic acid, (lyso)phosphatidylglycerol, and bis(monoacylglycero)phosphate species, in the SF of knee joints from unaffected controls and from patients with early (eOA) and late (lOA) stages of osteoarthritis (OA), and rheumatoid arthritis (RA). SF without cells and cellular debris from 9 postmortem donors (control), 18 RA, 17 eOA, and 13 lOA patients were extracted to measure lipid species using electrospray ionization tandem mass spectrometry - directly or coupled with hydrophilic interaction liquid chromatography. We provide a novel, detailed overview of sphingolipid and minor glycerophospholipid species in human SF. A total of 41, 48, and 50 lipid species were significantly increased in eOA, lOA, and RA SF, respectively when compared with normal SF. The level of 21 lipid species differed in eOA SF versus SF from lOA, an observation that can be used to develop biomarkers. Sphingolipids can alter synovial inflammation and the repair responses of damaged joints. Thus, our lipidomic study provides the foundation for studying the biosynthesis and function of lipid species in health and most prevalent joint diseases.	[Kosinska, Marta Krystyna; Klein, Heiko; Rickert, Markus; Steinmeyer, Juergen] Univ Giessen, Dept Orthoped, D-35390 Giessen, Germany; [Liebisch, Gerhard; Schmitz, Gerd] Univ Hosp Regensburg, Dept Clin Chem & Lab Med, Regensburg, Germany; [Lochnit, Guenter] Univ Giessen, Dept Biochem, D-35390 Giessen, Germany; [Wilhelm, Jochen] Univ Giessen, Med Clin 2 4, D-35390 Giessen, Germany; [Kaesser, Ulrich] Krankenhaus Balser Stiftung, Internist Praxiszentrum, Giessen, Germany; [Lasczkowski, Gabriele] Univ Giessen, Inst Forens Med, D-35390 Giessen, Germany	Justus Liebig University Giessen; University of Regensburg; Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Steinmeyer, J (corresponding author), Univ Giessen, Dept Orthoped, D-35390 Giessen, Germany.	juergen.steinmeyer@ortho.med.uni-giessen.de	Liebisch, Gerhard/G-6130-2010; Wilhelm, Jochen/AAX-4302-2021; Rickert, Markus/D-8731-2017	Liebisch, Gerhard/0000-0003-4886-0811; Wilhelm, Jochen/0000-0001-5544-9647; Rickert, Markus/0000-0001-7681-9918; Steinmeyer, Juergen/0000-0002-4053-503X	DRB foundation; "LipidomicNet'' project; European Union [202272]	DRB foundation; "LipidomicNet'' project; European Union(European Commission)	This work was supported in part by a grant of the DRB foundation and by the "LipidomicNet'' project, funded within the Seventh Framework Programme of the European Union (Grant agreement number 202272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agassandian M, 2013, BBA-MOL CELL BIOL L, V1831, P612, DOI 10.1016/j.bbalip.2012.09.010; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bellamy N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005321.pub2; Berckmans RJ, 2005, ARTHRITIS RES THER, V7, pR536, DOI 10.1186/ar1706; Colosimo M, 2000, BONE MARROW TRANSPL, V25, P549, DOI 10.1038/sj.bmt.1702166; Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9; Drobnik W, 2003, J LIPID RES, V44, P754, DOI 10.1194/jlr.M200401-JLR200; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Gerritsen ME, 1998, AM J PATHOL, V152, P505; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Hullin-Matsuda F, 2009, PROSTAG LEUKOTR ESS, V81, P313, DOI 10.1016/j.plefa.2009.09.006; Hurst-Kennedy J, 2009, BBA-MOL CELL RES, V1793, P836, DOI 10.1016/j.bbamcr.2009.01.020; Ichinose Y, 1998, J LAB CLIN MED, V131, P410, DOI 10.1016/S0022-2143(98)90141-X; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kim MK, 2005, BIOCHEM PHARMACOL, V70, P1764, DOI 10.1016/j.bcp.2005.09.015; Kosinska MK, 2013, ARTHRITIS RHEUM-US, V65, P2323, DOI 10.1002/art.38053; Kraus VB, 2002, ARTHRITIS RHEUM-US, V46, P420, DOI 10.1002/art.10124; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Lee JY, 2011, ANAL BIOANAL CHEM, V400, P2953, DOI 10.1007/s00216-011-4958-7; Liebisch G, 1999, J LIPID RES, V40, P1539; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Luberto C, 2002, NEUROCHEM RES, V27, P609, DOI 10.1023/A:1020267831851; Ludwig TE, 2012, ARTHRITIS RHEUM-US, V64, P3963, DOI 10.1002/art.34674; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Masuda I, 2013, OSTEOARTHR CARTILAGE, V21, pS296, DOI 10.1016/j.joca.2013.02.622; Meikle PJ, 2008, BIOCHEM J, V411, P71, DOI 10.1042/BJ20071043; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Mizushima N, 1998, ANN RHEUM DIS, V57, P495, DOI 10.1136/ard.57.8.495; Niemela PS, 2006, BIOPHYS J, V90, P851, DOI 10.1529/biophysj.105.067371; Orosa B, 2012, ARTHRITIS RHEUM-US, V64, P2460, DOI 10.1002/art.34443; OUTERBRIDGE RE, 1961, J BONE JOINT SURG BR, V43, P752; PRUZANSKI W, 1988, J RHEUMATOL, V15, P1351; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Sabatini M, 2001, BIOCHEM BIOPH RES CO, V283, P1105, DOI 10.1006/bbrc.2001.4920; Sabatini M, 2000, BIOCHEM BIOPH RES CO, V267, P438, DOI 10.1006/bbrc.1999.1983; Scherer M, 2010, ANAL CHEM, V82, P8794, DOI 10.1021/ac1021826; Scherer M, 2010, J LIPID RES, V51, P2001, DOI 10.1194/jlr.D005322; Scherer M, 2009, CLIN CHEM, V55, P1218, DOI 10.1373/clinchem.2008.113779; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Song HY, 2010, BBA-MOL CELL BIOL L, V1801, P23, DOI 10.1016/j.bbalip.2009.08.011; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Tetlow LC, 2001, ARTHRITIS RHEUM-US, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C; Tokumura A, 2002, BBA-MOL CELL BIOL L, V1582, P18, DOI 10.1016/S1388-1981(02)00133-6; Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095; Yin HY, 2012, FREE RADICAL RES, V46, P959, DOI 10.3109/10715762.2012.676642	49	62	62	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91769	10.1371/journal.pone.0091769	http://dx.doi.org/10.1371/journal.pone.0091769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646942	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500051
J	Paulander, W; Wang, Y; Folkesson, A; Charbon, G; Lobner-Olesen, A; Ingmer, H				Paulander, Wilhelm; Wang, Ying; Folkesson, Anders; Charbon, Godefroid; Lobner-Olesen, Anders; Ingmer, Hanne			Bactericidal Antibiotics Increase Hydroxyphenyl Fluorescein Signal by Altering Cell Morphology	PLOS ONE			English	Article							DEATH; RESISTANCE; DIVISION; CLUSTER	It was recently proposed that for bactericidal antibiotics a common killing mechanism contributes to lethality involving indirect stimulation of hydroxyl radical (OH center dot) formation. Flow cytometric detection of OH center dot by hydroxyphenyl fluorescein (HPF) probe oxidation was used to support this hypothesis. Here we show that increased HPF signals in antibiotics-exposed bacterial cells are explained by fluorescence associated with increased cell size, and do not reflect reactive oxygen species (ROS) concentration. Independently of antibiotics, increased fluorescence was seen for elongated cells expressing the oxidative insensitive green fluorescent protein (GFP). Although our data question the role of ROS in lethality of antibiotics other research approaches point to important interplays between basic bacterial metabolism and antibiotic susceptibility. To underpin such relationships, methods for detecting bacterial metabolites at a cellular level are needed.	[Paulander, Wilhelm; Wang, Ying; Ingmer, Hanne] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Folkesson, Anders] Tech Univ Denmark, Dept Microbial Ecol & Anim Hlth, Frederiksberg C, Denmark; [Charbon, Godefroid; Lobner-Olesen, Anders] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; University of Copenhagen	Paulander, W (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg C, Denmark.	wp@sund.ku.dk	charbon, godefroid/D-3040-2011; Løbner-Olesen, Anders/K-4344-2014	charbon, godefroid/0000-0003-4792-1889; Løbner-Olesen, Anders/0000-0002-0344-6417; Ingmer, Hanne/0000-0002-8350-5631; Folkesson, Anders/0000-0002-2175-830X	Danish Research Council of Independent Research [274-08-0531, 09-069656]; Ung Elitforskarpris [09-076146]; Lundbeck Foundation; Danish Council for Strategic Research; Novo Nordisk Foundation; Lundbeck Foundation [R100-2011-9542] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0001802] Funding Source: researchfish	Danish Research Council of Independent Research; Ung Elitforskarpris; Lundbeck Foundation(Lundbeckfonden); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	HI is supported by grants from the Danish Research Council of Independent Research (274-08-0531); WP is supported by grants from the Danish Research Council of Independent Research (09-069656) and Ung Elitforskarpris (09-076146); GC and ALO are supported by the Lundbeck Foundation; and ALO is supported by the Danish Research Council of Independent Research, the Danish Council for Strategic Research and the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chittezham Thomas V, 2013, MBIO, V20, P4; Dwyer DJ, 2012, MOL CELL, V46, P561, DOI 10.1016/j.molcel.2012.04.027; Ezraty B, 2013, SCIENCE, V340, P1583, DOI 10.1126/science.1238328; FLETCHER G, 1978, J BACTERIOL, V133, P91, DOI 10.1128/JB.133.1.91-100.1978; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Gottfredsson M, 1998, ANTIMICROB AGENTS CH, V42, P1005, DOI 10.1128/AAC.42.5.1005; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Mahoney TF, 2013, J BACTERIOL, V195, P1869, DOI 10.1128/JB.02197-12; MASON DJ, 1995, ANTIMICROB AGENTS CH, V39, P2752, DOI 10.1128/AAC.39.12.2752; Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x; Renggli S, 2013, J BACTERIOL, V195, P4067, DOI 10.1128/JB.00393-13; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999	19	24	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92231	10.1371/journal.pone.0092231	http://dx.doi.org/10.1371/journal.pone.0092231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647480	Green Published, gold			2022-12-27	WOS:000333348500101
J	Mazurier, N; Parain, K; Parlier, D; Pretto, S; Hamdache, J; Vernier, P; Locker, M; Bellefroid, E; Perron, M				Mazurier, Nicolas; Parain, Karine; Parlier, Damien; Pretto, Silvia; Hamdache, Johanna; Vernier, Philippe; Locker, Morgane; Bellefroid, Eric; Perron, Muriel			Ascl1 as a Novel Player in the Ptf1a Transcriptional Network for GABAergic Cell Specification in the Retina	PLOS ONE			English	Article							GLYCINERGIC AMACRINE CELLS; DEVELOPING NERVOUS-SYSTEM; PRONEURAL GENES; FATE SPECIFICATION; XENOPUS-EMBRYOS; ACHAETE-SCUTE; VERTEBRATE RETINA; BHLH GENES; NEURONAL DIFFERENTIATION; SEROTONERGIC NEURONS	In contrast with the wealth of data involving bHLH and homeodomain transcription factors in retinal cell type determination, the molecular bases underlying neurotransmitter subtype specification is far less understood. Using both gain and loss of function analyses in Xenopus, we investigated the putative implication of the bHLH factor Ascl1 in this process. We found that in addition to its previously characterized proneural function, Ascl1 also contributes to the specification of the GABAergic phenotype. We showed that it is necessary for retinal GABAergic cell genesis and sufficient in overexpression experiments to bias a subset of retinal precursor cells towards a GABAergic fate. We also analysed the relationships between Ascl1 and a set of other bHLH factors using an in vivo ectopic neurogenic assay. We demonstrated that Ascl1 has unique features as a GABAergic inducer and is epistatic over factors endowed with glutamatergic potentialities such as Neurog2, NeuroD1 or Atoh7. This functional specificity is conferred by the basic DNA binding domain of Ascl1 and involves a specific genetic network, distinct from that underlying its previously demonstrated effects on catecholaminergic differentiation. Our data show that GABAergic inducing activity of Ascl1 requires the direct transcriptional regulation of Ptf1a, providing therefore a new piece of the network governing neurotransmitter subtype specification during retinogenesis.	[Mazurier, Nicolas; Parain, Karine; Pretto, Silvia; Hamdache, Johanna; Locker, Morgane; Perron, Muriel] Univ Paris 11, UPR Ctr Natl Rech Sci Neurobiol & Dev 3294, Orsay, France; [Parlier, Damien; Bellefroid, Eric] ULB IBMM, Lab Embryol Mol, Gosselies, Belgium; [Vernier, Philippe] Inst Alfred Fessard, UPR Ctr Natl Rech Sci Neurobiol & Dev 3294, Gif Sur Yvette, France	UDICE-French Research Universities; Universite Paris Saclay; Universite Libre de Bruxelles	Perron, M (corresponding author), Univ Paris 11, UPR Ctr Natl Rech Sci Neurobiol & Dev 3294, Orsay, France.	muriel.perron@u-psud.fr	Perron, Muriel/F-6795-2019	Perron, Muriel/0000-0002-1558-8236	Agence Nationale de la Recherche [056054]; Centre national de la recherche scientifique, University Paris-Sud, Retina France; ARC [1108]; Belgian Fonds de la Recherche Scientifique [FRFC 3.4635.06]; Belgian Queen Elisabeth Medical Foundation; Federation Wallonie-Bruxelles;  [IFR144]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre national de la recherche scientifique, University Paris-Sud, Retina France; ARC(Australian Research Council); Belgian Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Belgian Queen Elisabeth Medical Foundation; Federation Wallonie-Bruxelles; 	NM is a Neuropole de Recherche Francilien fellow; DP is a Belgian Fonds pour la formation A A la Recherche dans l'Industrie et dans l'Agriculture fellow. This research was supported by grants to MP from the Agence Nationale de la Recherche (056054), Centre national de la recherche scientifique, University Paris-Sud, Retina France, ARC (1108), IFR144 and to EB from the Belgian Fonds de la Recherche Scientifique (FRFC 3.4635.06), the Belgian Queen Elisabeth Medical Foundation, the Federation Wallonie-Bruxelles (Action de Recherche Concertee) and the Walloon Region Excellence Programme ("CIBLES"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R, 2008, BRAIN RES, V1192, P134, DOI 10.1016/j.brainres.2007.03.044; Afelik S, 2006, GENE DEV, V20, P1441, DOI 10.1101/gad.378706; Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Amato MA, 2005, J COMP NEUROL, V481, P331, DOI 10.1002/cne.20387; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Brzezinski JA, 2011, DEVELOPMENT, V138, P3519, DOI 10.1242/dev.064006; Casarosa S, 1999, DEVELOPMENT, V126, P525; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chitnis A, 1996, DEVELOPMENT, V122, P2295; Dullin JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-110; Duquette PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013232; Farah MH, 2006, BRAIN RES REV, V52, P264, DOI 10.1016/j.brainresrev.2006.04.002; Feng L, 2006, DEVELOPMENT, V133, P4815, DOI 10.1242/dev.02664; Feng L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-36; FERREIRO B, 1993, MECH DEVELOP, V40, P25, DOI 10.1016/0925-4773(93)90085-C; Fode C, 2000, GENE DEV, V14, P67; Fujitani Y, 2006, DEVELOPMENT, V133, P4439, DOI 10.1242/dev.02598; Gammill LS, 1997, DEVELOPMENT, V124, P471; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Henke RM, 2009, DEVELOPMENT, V136, P2945, DOI 10.1242/dev.035352; Henke RM, 2009, DEV BIOL, V328, P529, DOI 10.1016/j.ydbio.2009.01.007; Hirsch MR, 1998, DEVELOPMENT, V125, P599; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; Howard MJ, 2005, DEV BIOL, V277, P271, DOI 10.1016/j.ydbio.2004.09.034; Hufnagel RB, 2010, DEV BIOL, V340, P490, DOI 10.1016/j.ydbio.2010.02.002; Jacob J, 2013, DIS MODEL MECH; Jasoni CL, 1996, J COMP NEUROL, V369, P319; JASONI CL, 1994, DEVELOPMENT, V120, P769; Jiang HS, 2009, J NEUROSCI, V29, P10449, DOI 10.1523/JNEUROSCI.3048-09.2009; Jo AY, 2007, EXP CELL RES, V313, P4066, DOI 10.1016/j.yexcr.2007.08.026; Jusuf PR, 2011, J NEUROSCI, V31, P2549, DOI 10.1523/JNEUROSCI.4713-10.2011; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Lang B, 2010, NEUROPHARMACOLOGY, V58, P215, DOI 10.1016/j.neuropharm.2009.07.003; Lea Robert, 2012, Methods Mol Biol, V917, P431, DOI 10.1007/978-1-61779-992-1_24; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lelievre EC, 2011, DEV BIOL, V358, P296, DOI 10.1016/j.ydbio.2011.07.033; Li M, 2006, J COMP NEUROL, V495, P645, DOI 10.1002/cne.20900; Lo LC, 1998, DEVELOPMENT, V125, P609; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Mao WM, 2009, DEV NEUROBIOL, V69, P88, DOI 10.1002/dneu.20693; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Meredith DM, 2009, J NEUROSCI, V29, P11139, DOI 10.1523/JNEUROSCI.2303-09.2009; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Mizuguchi R, 2006, NAT NEUROSCI, V9, P770, DOI 10.1038/nn1706; Mo ZQ, 2004, DEVELOPMENT, V131, P1607, DOI 10.1242/dev.01071; Morikawa Y, 2007, DEV BIOL, V307, P114, DOI 10.1016/j.ydbio.2007.04.027; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; Nakhai H, 2007, DEVELOPMENT, V134, P1151, DOI 10.1242/dev.02781; Nelson BR, 2009, DEV DYNAM, V238, P2163, DOI 10.1002/dvdy.21848; Nieuwkoop P D, 1967, Acta Biotheor, V17, P178, DOI 10.1007/BF01601987; Ohnuma S, 2002, METHODS, V28, P411, DOI 10.1016/S1046-2023(02)00260-8; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Osorio J, 2010, J COMP NEUROL, V518, P851, DOI 10.1002/cne.22247; Parain K, 2012, DEV NEUROBIOL, V72, P491, DOI 10.1002/dneu.20973; Park CH, 2006, J CELL SCI, V119, P2310, DOI 10.1242/jcs.02955; Parlier D, 2008, DEV DYNAM, V237, P2147, DOI 10.1002/dvdy.21621; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Pattyn A, 2004, NAT NEUROSCI, V7, P589, DOI 10.1038/nn1247; Peltopuro P, 2010, DEV BIOL, V343, P63, DOI 10.1016/j.ydbio.2010.04.015; Perron M, 1999, P NATL ACAD SCI USA, V96, P14996, DOI 10.1073/pnas.96.26.14996; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; Powell LM, 2008, CURR OPIN GENET DEV, V18, P411, DOI 10.1016/j.gde.2008.07.012; Roybon L, 2009, EUR J NEUROSCI, V29, P232, DOI 10.1111/j.1460-9568.2008.06595.x; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Souopgui J, 2007, INT J DEV BIOL, V51, P339, DOI 10.1387/ijdb.062235js; Suga A, 2009, DEV BIOL, V330, P318, DOI 10.1016/j.ydbio.2009.04.002; Taelman V, 2004, DEV BIOL, V276, P47, DOI 10.1016/j.ydbio.2004.08.019; Talikka M, 2002, DEV BIOL, V247, P137, DOI 10.1006/dbio.2002.0677; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Tomita K, 1996, GENES CELLS, V1, P765, DOI 10.1111/j.1365-2443.1996.tb00016.x; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Wang JCC, 2005, DEV BIOL, V285, P101, DOI 10.1016/j.ydbio.2005.05.041; Wilkinson G, 2013, NEUROSCIENCE, V253, P256, DOI 10.1016/j.neuroscience.2013.08.029; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Zaghloul NA, 2007, MOL VIS, V13, P86; Zordan P, 2008, DEV DYNAM, V237, P1726, DOI 10.1002/dvdy.21571	82	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92113	10.1371/journal.pone.0092113	http://dx.doi.org/10.1371/journal.pone.0092113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643195	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900089
J	Perrineau, MM; Gross, J; Zelzion, E; Price, DC; Levitan, O; Boyd, J; Bhattacharya, D				Perrineau, Marie-Mathilde; Gross, Jeferson; Zelzion, Ehud; Price, Dana C.; Levitan, Orly; Boyd, Jeffrey; Bhattacharya, Debashish			Using Natural Selection to Explore the Adaptive Potential of Chlamydomonas reinhardtii	PLOS ONE			English	Article							ELECTRON-TRANSPORT; ESCHERICHIA-COLI; CIRCADIAN CLOCK; MUTATION-RATE; EXPRESSION; MECHANISM; EVOLUTION; REVEALS; REPAIR; ALGAE	Improving feedstock is critical to facilitate the commercial utilization of algae, in particular in open pond systems where, due to the presence of competitors and pests, high algal growth rates and stress tolerance are beneficial. Here we raised laboratory cultures of the model alga Chlamydomonas reinhardtii under serial dilution to explore the potential of crop improvement using natural selection. The alga was evolved for 1,880 generations in liquid medium under continuous light (EL population). At the end of the experiment, EL cells had a growth rate that was 35% greater than the progenitor population (PL). The removal of acetate from the medium demonstrated that EL growth enhancement largely relied on efficient usage of this organic carbon source. Genome re-sequencing uncovered 1,937 polymorphic DNA regions in the EL population with 149 single nucleotide polymorphisms resulting in amino acid substitutions. Transcriptome analysis showed, in the EL population, significant up regulation of genes involved in protein synthesis, the cell cycle and cellular respiration, whereas the DNA repair pathway and photosynthesis were down regulated. Like other algae, EL cells accumulated neutral lipids under nitrogen depletion. Our work demonstrates transcriptome and genome-wide impacts of natural selection on algal cells and points to a useful strategy for strain improvement.	[Perrineau, Marie-Mathilde; Gross, Jeferson; Zelzion, Ehud; Price, Dana C.; Bhattacharya, Debashish] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA; [Levitan, Orly; Bhattacharya, Debashish] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Boyd, Jeffrey] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Bhattacharya, D (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA.	bhattacharya@aesop.rutgers.edu	Perrineau, Marie-Mathilde/J-4459-2014	Perrineau, Marie-Mathilde/0000-0002-1772-7009; Boyd, Jeffrey/0000-0001-7721-3926; Levitan, Orly/0000-0001-5248-8501	Department of Energy [DE-EE0003373/001]; Rutgers University	Department of Energy(United States Department of Energy (DOE)); Rutgers University	This work was supported by a grant from the Department of Energy (DE-EE0003373/001) and by financial support from Rutgers University for the SEBS Genome Cooperative (http://dblab.rutgers.edu/genome_cooperative/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen SL, 2010, BIOESSAYS, V32, P1058, DOI 10.1002/bies.201000087; [Anonymous], 2007, PRINCIPLES PLANT GEN; Bailis JM, 2008, MOL CELL BIOL, V28, P1724, DOI 10.1128/MCB.01717-07; Bec B, 2008, LIMNOL OCEANOGR, V53, P863, DOI 10.4319/lo.2008.53.2.0863; Bell G, 2013, EVOLUTION, V67, P468, DOI 10.1111/j.1558-5646.2012.01782.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; Brueggeman AJ, 2012, PLANT CELL, V24, P1860, DOI 10.1105/tpc.111.093435; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Collins S, 2004, NATURE, V431, P566, DOI 10.1038/nature02945; Collins S, 2011, EVOL BIOL, V38, P3, DOI 10.1007/s11692-010-9106-3; Demirbas A, 2011, ENERG CONVERS MANAGE, V52, P163, DOI 10.1016/j.enconman.2010.06.055; Dittami SM, 2012, PLANT J, V71, P366, DOI 10.1111/j.1365-313X.2012.04982.x; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Fang W, 2012, PLANT CELL, V24, P1876, DOI 10.1105/tpc.112.097949; FETT JP, 1994, PLANT PHYSIOL, V106, P103, DOI 10.1104/pp.106.1.103; Gokhale A, 2009, J CELL BIOL, V186, P817, DOI 10.1083/jcb.200906168; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Govender T, 2012, BIORESOURCE TECHNOL, V114, P507, DOI 10.1016/j.biortech.2012.03.024; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Gu Zhenglong, 2009, Genome Biol, V10, P304, DOI 10.1186/gb-2009-10-3-304; Hannon M, 2010, BIOFUELS-UK, V1, P763, DOI 10.4155/BFS.10.44; Harris JM, 2013, WORKING PAPER; Heifetz PB, 2000, PLANT PHYSIOL, V122, P1439, DOI 10.1104/pp.122.4.1439; Huesemann MH, 2009, APPL BIOCHEM BIOTECH, V157, P507, DOI 10.1007/s12010-008-8298-9; Jeong BR, 2002, P NATL ACAD SCI USA, V99, P1076, DOI 10.1073/pnas.022392999; Johnson X, 2013, EUKARYOT CELL, V12, P776, DOI 10.1128/EC.00318-12; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Lee K., 2001, BIOTECHNOL BIOPROC E, V6, P194, DOI [DOI 10.1007/BF02932550, 10.1007/BF02932550]; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Liang DT, 1999, J CELL SCI, V112, P559; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohbeck KT, 2013, EVOLUTION, V67, P1892, DOI 10.1111/j.1558-5646.2012.01812.x; Luck M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.401604; Maki K, 2011, J BIOL CHEM, V286, P41701, DOI 10.1074/jbc.M111.285619; Maranon E, 2013, ECOL LETT, V16, P371, DOI 10.1111/ele.12052; Matsuo M, 1998, PLANT CELL PHYSIOL, V39, P263, DOI 10.1093/oxfordjournals.pcp.a029366; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Mittag M, 2005, PLANT PHYSIOL, V137, P399, DOI 10.1104/pp.104.052415; Ness RW, 2012, GENETICS, V192, P1447, DOI 10.1534/genetics.112.145078; Nishihama R, 2013, CURR OPIN PLANT BIOL, V16, P630, DOI 10.1016/j.pbi.2013.07.006; Niwa Y, 2013, P NATL ACAD SCI USA, V110, P13666, DOI 10.1073/pnas.1220004110; Page MD, 2012, PLANT CELL, V24, P2649, DOI 10.1105/tpc.112.098962; Reisdorph NA, 2004, PLANT PHYSIOL, V134, P1546, DOI 10.1104/pp.103.031930; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Russell GE, 1978, PLANT BREEDING PEST; Santosa V, 2013, J BIOL CHEM, V288, P6864, DOI 10.1074/jbc.M112.432393; Sheehan J., 1998, TP58024190 NREL; Snow AA, 2012, BIOSCIENCE, V62, P765, DOI 10.1525/bio.2012.62.8.9; Sung W, 2012, P NATL ACAD SCI USA, V109, P18488, DOI 10.1073/pnas.1216223109; Vlcek D, 2008, CURR GENET, V53, P1, DOI 10.1007/s00294-007-0163-9; Zhila NO, 2005, RUSS J PLANT PHYSL+, V52, P311, DOI 10.1007/s11183-005-0047-0	55	29	29	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92533	10.1371/journal.pone.0092533	http://dx.doi.org/10.1371/journal.pone.0092533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658261	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300094
J	Zeytuni, N; Uebe, R; Maes, M; Davidov, G; Baram, M; Raschdorf, O; Nadav-Tsubery, M; Kolusheva, S; Bitton, R; Goobes, G; Friedler, A; Miller, Y; Schuler, D; Zarivach, R				Zeytuni, Natalie; Uebe, Rene; Maes, Michal; Davidov, Geula; Baram, Michal; Raschdorf, Oliver; Nadav-Tsubery, Merav; Kolusheva, Sofiya; Bitton, Ronit; Goobes, Gil; Friedler, Assaf; Miller, Yifat; Schueler, Dirk; Zarivach, Raz			Cation Diffusion Facilitators Transport Initiation and Regulation Is Mediated by Cation Induced Conformational Changes of the Cytoplasmic Domain	PLOS ONE			English	Article							PARTICLE MESH EWALD; MAGNETOSPIRILLUM-GRYPHISWALDENSE; MAGNETOSOME FORMATION; PROTEIN; FAMILY; MEMBRANE; BINDING; HYPERMANGANESEMIA; POLYCYTHEMIA; HOMEOSTASIS	Cation diffusion facilitators (CDF) are part of a highly conserved protein family that maintains cellular divalent cation homeostasis in all domains of life. CDF's were shown to be involved in several human diseases, such as Type-II diabetes and neurodegenerative diseases. In this work, we employed a multi-disciplinary approach to study the activation mechanism of the CDF protein family. For this we used MamM, one of the main ion transporters of magnetosomes - bacterial organelles that enable magnetotactic bacteria to orientate along geomagnetic fields. Our results reveal that the cytosolic domain of MamM forms a stable dimer that undergoes distinct conformational changes upon divalent cation binding. MamM conformational change is associated with three metal binding sites that were identified and characterized. Altogether, our results provide a novel auto-regulation mode of action model in which the cytosolic domain's conformational changes upon ligand binding allows the priming of the CDF into its transport mode.	[Zeytuni, Natalie; Davidov, Geula; Zarivach, Raz] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Zeytuni, Natalie; Davidov, Geula; Zarivach, Raz] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Uebe, Rene; Raschdorf, Oliver; Schueler, Dirk] Univ Munich, Dept Biol 1, Martinsried, Germany; [Maes, Michal; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Baram, Michal] Ben Gurion Univ Negev, Dept Chem, Beer Sheva, Israel; [Baram, Michal; Kolusheva, Sofiya; Bitton, Ronit; Miller, Yifat] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel; [Nadav-Tsubery, Merav; Goobes, Gil] Bar Ilan Univ, Dept Chem, Ramat Gan, Israel; [Bitton, Ronit; Miller, Yifat] Ben Gurion Univ Negev, Dept Chem Engn, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; University of Munich; Hebrew University of Jerusalem; Ben Gurion University; Ben Gurion University; Bar Ilan University; Ben Gurion University	Zarivach, R (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	zarivach@bgu.ac.il	Zeytuni, Natalie/AAP-7850-2021; ZARIVACH, RAZ/F-1671-2012	ZARIVACH, RAZ/0000-0001-6543-0296; Raschdorf, Oliver/0000-0003-1558-059X; Kolusheva, Sofiya/0000-0002-4406-2241; Davidov, Geula/0000-0001-5153-4940; Zeytuni, Natalie/0000-0002-5708-4095; Bitton, Ronit/0000-0001-9601-9926; Schuler, Dirk/0000-0002-2327-0762; Maes, Michal/0000-0002-7406-3982	GIF (German-Israeli Foundation for Scientific Research and Development); European Cooperation in Science and Technology (COST action) [CM0902]; Israeli Ministry of Science and Technology; Deutsche Forschungsgemeinschaft [SCHU 1080/13-1]; European Union [NMP4-SL-2010-245542-Bio2MaN4MRI]; European Research Council under the European Community/ERC [203413]; FP7-PEOPLE-2011-CIG [303741]	GIF (German-Israeli Foundation for Scientific Research and Development)(German-Israeli Foundation for Scientific Research and Development); European Cooperation in Science and Technology (COST action)(European Cooperation in Science and Technology (COST)); Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); European Research Council under the European Community/ERC(European Research Council (ERC)); FP7-PEOPLE-2011-CIG	This research was supported by grants from the GIF (German-Israeli Foundation for Scientific Research and Development), the European Cooperation in Science and Technology (COST action CM0902), the Israeli Ministry of Science and Technology, the Deutsche Forschungsgemeinschaft (grant SCHU 1080/13-1) and the FP7 of the European Union (collaborative grant NMP4-SL-2010-245542-Bio2MaN4MRI). AF is supported by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no 203413. YM is supported by the FP7-PEOPLE-2011-CIG, research grant no. 303741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Anton A, 1999, J BACTERIOL, V181, P6876, DOI 10.1128/JB.181.22.6876-6881.1999; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barraud P, 2012, J BIOMOL NMR, V53, P93, DOI 10.1007/s10858-012-9625-6; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cherezov V, 2008, STRUCTURE, V16, P1378, DOI 10.1016/j.str.2008.05.014; Coudray N, 2013, P NATL ACAD SCI US; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Etzion Y, 2008, J CARDIOVASC ELECTR, V19, P157, DOI 10.1111/j.1540-8167.2007.01008.x; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Fu RQ, 2004, J MAGN RESON, V168, P8, DOI 10.1016/j.jmr.2004.01.012; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guinier A, 1955, J POLYM SCI, V1, P268; Haney CJ, 2005, J IND MICROBIOL BIOT, V32, P215, DOI 10.1007/s10295-005-0224-3; Higuchi T, 2009, PROTEINS, V76, P768, DOI 10.1002/prot.22444; Jiang F, 2012, BIOMED ENVIRON SCI, V25, P23, DOI 10.3967/0895-3988.2012.01.004; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Katzmann E, 2010, MOL MICROBIOL, V77, P208, DOI 10.1111/j.1365-2958.2010.07202.x; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Mahoney MW, 2001, J CHEM PHYS, V115, P10758, DOI 10.1063/1.1418243; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Munkelt D, 2004, J BACTERIOL, V186, P8036, DOI 10.1128/JB.186.23.8036-8043.2004; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Patel AB, 2005, J MOL BIOL, V347, P803, DOI 10.1016/j.jmb.2005.01.069; Patrushev N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033211; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Persans MW, 2001, P NATL ACAD SCI USA, V98, P9995, DOI 10.1073/pnas.171039798; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Schuler D, 2004, ARCH MICROBIOL, V181, P1, DOI 10.1007/s00203-003-0631-7; SCHULER D, 1995, FEMS MICROBIOL LETT, V132, P139, DOI 10.1016/0378-1097(95)00300-T; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Uebe R, 2011, MOL MICROBIOL, V82, P818, DOI 10.1111/j.1365-2958.2011.07863.x; Uebe R, 2010, J BACTERIOL, V192, P4192, DOI 10.1128/JB.00319-10; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200; Zeytuni N, 2012, ACTA CRYSTALLOGR F, V68, P927, DOI 10.1107/S1744309112025638; Zeytuni N, 2011, P NATL ACAD SCI USA, V108, pE480, DOI 10.1073/pnas.1103367108	53	33	35	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92141	10.1371/journal.pone.0092141	http://dx.doi.org/10.1371/journal.pone.0092141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658343	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300057
J	Dessein, PH; Tsang, L; Norton, GR; Woodiwiss, AJ; Solomon, A				Dessein, Patrick H.; Tsang, Linda; Norton, Gavin R.; Woodiwiss, Angela J.; Solomon, Ahmed			Retinol Binding Protein 4 Concentrations Relate to Enhanced Atherosclerosis in Obese Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE; ENDOTHELIAL ACTIVATION; METABOLIC-SYNDROME; CAUCASIAN WOMEN; AFRICAN BLACK; RETINOL-BINDING-PROTEIN-4; DISEASE; CLASSIFICATION; ADIPONECTIN	Background: Retinol binding protein 4 (RBP) enhances metabolic risk and atherogenesis. Whether RBP4 contributes to cardiovascular risk in rheumatoid arthritis (RA) is unknown. Methods: We assessed RBP4 concentrations and those of endothelial activation molecules including E-selectin, vascular cell adhesion molecule-1, intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 by ELISA, and the common carotid artery intima-media thickness (cIMT) and carotid artery plaque by ultrasound in 217 (112 black and 105 white) patients with RA. Relationships were identified in potential confounder and mediator adjusted mixed regression models. Results: RBP4 concentrations were associated with systolic and mean blood pressure, and those of glucose and E-selectin (partial R = -0.207 (p = 0.003), -0.195 (p = 0.006), -0.155 (p = 0.03) and -0.191 (p = 0.007), respectively in all patients); these RBP4-cardiovascular risk relations were mostly reproduced in patients with but not without adverse traditional or non-traditional cardiovascular risk profiles. RBP4 concentrations were not associated with atherosclerosis in all patients, but related independently to cIMT (partial R = 0.297, p = 0.03) and plaque (OR (95% CI) = 2.95 (1.31-6.68), p = 0.008) in those with generalized obesity, as well as with plaque in those with abdominal obesity (OR (95% CI) = 1.95 (1.12-3.42), p = 0.01). Conclusion: In the present study, RBP4 concentrations were inversely associated with metabolic risk and endothelial activation in RA. This requires further investigation. RBP4 concentrations were related to enhanced atherosclerosis in patients with generalized or/and abdominal obesity.	[Dessein, Patrick H.; Norton, Gavin R.; Woodiwiss, Angela J.] Univ Witwatersrand, Sch Physiol, Fac Hlth Sci, Cardiovasc Pathophysiol & Genom Res Unit, Johannesburg, South Africa; [Tsang, Linda] Milpk Hosp, Johannesburg, South Africa; [Solomon, Ahmed] Univ Witwatersrand, Charlotte Maxeke Johannesburg Acad Hosp, Fac Hlth Sci, Dept Rheumatol, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand	Dessein, PH (corresponding author), Univ Witwatersrand, Sch Physiol, Fac Hlth Sci, Cardiovasc Pathophysiol & Genom Res Unit, Johannesburg, South Africa.	Dessein@telkomsa.net	Dessein, Patrick/AAL-2986-2020	Norton, Gavin/0000-0001-6416-6104	South African Medical Research Council [MRC2008_DES]; National Research Foundation	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation	The study was supported by the South African Medical Research Council, grant number MRC2008_DES, and the National Research Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manauscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Balagopal P, 2007, J CLIN ENDOCR METAB, V92, P1971, DOI 10.1210/jc.2006-2712; Bobbert T, 2010, ATHEROSCLEROSIS, V213, P549, DOI 10.1016/j.atherosclerosis.2010.07.063; Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789; Corrales A, 2013, ANN RHEUM DIS, DOI [10.1136/annrheumdis-2012-203101, DOI 10.1136/ANNRHEUMDIS-2012-203101]]; Craig RL, 2007, MOL GENET METAB, V90, P338, DOI 10.1016/j.ymgme.2006.11.003; Crowson CS, 2011, ANN RHEUM DIS, V70, P719, DOI 10.1136/ard.2010.145482; Dessein PH, 2013, CLIN EXP RHEUMATOL, V31, P53; Dessein Patrick H, 2007, BMC Cardiovasc Disord, V7, P31, DOI 10.1186/1471-2261-7-31; Dessein PH, 2005, J RHEUMATOL, V32, P435; Dessein PH, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4308; Dessein PH, 2013, ANN RHEUM DIS, V72, P1743, DOI 10.1136/annrheumdis-2013-203911; Dessein PH, 2013, ANN RHEUM DIS, V72, P1586, DOI 10.1136/annrheumdis-2013-203587; Dessein PH, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/461849; Dessein PH, 2009, J RHEUMATOL, V36, P1357, DOI 10.3899/jrheum.090288; Dessein PH, 2006, J RHEUMATOL, V33, P201; Dessein PH, 2004, ANN RHEUM DIS, V63, P170, DOI 10.1089/105072504323150750; Dessein PH, 2005, ARTHRITIS RES THER, V7, pR634, DOI 10.1186/ar1717; Dessein PH, 2014, RHEUMATOL I IN PRESS; Dessein PH, 2014, ARTHRITIS R IN PRESS; Dessein PH, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/510243; Farjo KM, 2012, MOL CELL BIOL, V32, P5103, DOI 10.1128/MCB.00820-12; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Frommer KW, 2010, ARTHRITIS RHEUM-US, V62, P2886, DOI 10.1002/art.27616; Gabriel SE, 2012, CURR OPIN RHEUMATOL, V24, P171, DOI 10.1097/BOR.0b013e32834ff2fd; Garcia-Bermudez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077695; Genre F, 2014, ANN RHEUM DIS, V73, P941, DOI 10.1136/annrheumdis-2013-204484; Gepner AD, 2006, J AM SOC ECHOCARDIOG, V19, P223, DOI 10.1016/j.echo.2005.09.006; Graham TE, 2007, DIABETOLOGIA, V50, P814, DOI 10.1007/s00125-006-0557-0; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Gulfe A, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-41; Hahn BH, 2010, LUPUS, V19, P913, DOI 10.1177/0961203310364397; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kotnik P, 2011, EUR J ENDOCRINOL, V165, P703, DOI 10.1530/EJE-11-0431; Kremers HM, 2008, ARTHRITIS RHEUM-US, V58, P2268, DOI 10.1002/art.23650; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Mallat Z, 2009, J CLIN ENDOCR METAB, V94, P255, DOI 10.1210/jc.2008-0253; Myasoedova E, 2011, J RHEUMATOL, V38, P983, DOI 10.3899/jrheum.101133; Sattar N, 2008, J CLIN ENDOCR METAB, V93, P3299, DOI 10.1210/jc.2008-1435; Sodergren A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3116; Solomon A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3784; Stefan N, 2007, DIABETES CARE, V30, P1173, DOI 10.2337/dc06-2342; Steyn NP, 2008, PUBLIC HEALTH NUTR, V11, P307, DOI 10.1017/S136898000700033X; Takashima N, 2006, NEW ENGL J MED, V355, P1392; Tong KM, 2008, CELL SIGNAL, V20, P1478, DOI 10.1016/j.cellsig.2008.04.003; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; von Eynatten M, 2007, DIABETOLOGIA, V50, P1930, DOI 10.1007/s00125-007-0743-8; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	52	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92739	10.1371/journal.pone.0092739	http://dx.doi.org/10.1371/journal.pone.0092739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651174	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800150
J	Jiang, Q; Wang, F; Li, MY; Ma, J; Tan, GF; Xiong, AS				Jiang, Qian; Wang, Feng; Li, Meng-Yao; Ma, Jing; Tan, Guo-Fei; Xiong, Ai-Sheng			Selection of Suitable Reference Genes for qPCR Normalization under Abiotic Stresses in Oenanthe javanica (BI.) DC	PLOS ONE			English	Article							EXPRESSION ANALYSIS; HEAT-STRESS; IDENTIFICATION; TOLERANT; MODEL; SALT; VALIDATION; PERSICARIN; MANNITOL; PATHWAY	Accurate normalization of gene expression data is an absolute prerequisite to obtain reliable results in qPCR analysis. Oenanthe javanica, an aquatic perennial herb, belongs to the Oenanthe genus in Apiaceae family, with known medicinal properties. In the current study, O. javanica was subjected to hormone stimuli (gibberellin, salicylic acid, methyl jasmonate, and abscisic acid) and abiotic stresses (heat, cold, salt, and drought), and the expression of nine candidate reference genes (eIF-4 alpha, ACT7, TIP41, GAPDH, SAND, EF-1 alpha, PP2A, TBP, and TUB) was evaluated. Stability of the genes was assessed using geNorm, NormFinder and BestKeeper. All the genes presented distinct expression profiles under the experimental conditions analyzed. Under abiotic stress conditions, ACT7 and PP2A genes displayed the maximum stability; PP2A and SAND were the most stable genes under hormone stimuli. Even though PP2A gene was most stable across all the samples, individual analysis revealed changes in expression profile. To further validate the suitability of the reference genes identified in this study, the expression level of M6PR gene under salt treatment was studied. Based on our data, we propose that it is essential to normalize the target gene expression with specific reference genes under different experimental conditions for most accurate results. To our knowledge, this is the first systematic analysis for reference genes under abiotic stress and hormone stimuli conditions in O. javanica. This will be beneficial for future studies on O. javanica and other plants in Apiaceae family at molecular level.	[Jiang, Qian; Wang, Feng; Li, Meng-Yao; Ma, Jing; Tan, Guo-Fei; Xiong, Ai-Sheng] Nanjing Agr Univ, Key Lab Biol & Germplasm Enhancement Hort Crops E, State Key Lab Crop Genet & Germplasm Enhancement, Minist Agr,Coll Hort, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Xiong, AS (corresponding author), Nanjing Agr Univ, Key Lab Biol & Germplasm Enhancement Hort Crops E, State Key Lab Crop Genet & Germplasm Enhancement, Minist Agr,Coll Hort, Nanjing, Jiangsu, Peoples R China.	Xiongaisheng@njau.edu.cn		Jiang, Qian/0000-0002-2877-1179; Xiong, Ai-Sheng/0000-0002-7900-5001	National Natural Science Foundation of China [31272175]; New Century Excellent Talents in University [NCET-11-0670]; Jiangsu Natural Science Foundation [BK20130027]; Graduate Educated Innovation Project of Jiangsu Province [CXZZ13_0297]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Shuangchuang Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Graduate Educated Innovation Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Shuangchuang Project	The research was supported by the National Natural Science Foundation of China (31272175); New Century Excellent Talents in University (NCET-11-0670); Jiangsu Natural Science Foundation (BK20130027); Graduate Educated Innovation Project of Jiangsu Province (CXZZ13_0297); Priority Academic Program Development of Jiangsu Higher Education Institutions and Jiangsu Shuangchuang Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attala MN, 2013, PLANT MOL BIOL; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chan ZL, 2012, GENOMICS, V100, P110, DOI 10.1016/j.ygeno.2012.06.004; Chan ZL, 2011, J EXP BOT, V62, P4787, DOI 10.1093/jxb/err130; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Carvalho K, 2013, MOL BIOTECHNOL, V53, P315, DOI 10.1007/s12033-012-9529-4; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Galli V, 2013, PLANT CELL REP, V32, P1869, DOI 10.1007/s00299-013-1499-x; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Han YQ, 2008, J ETHNOPHARMACOL, V118, P148, DOI 10.1016/j.jep.2008.03.024; Humbeck K, 2003, J EXP BOT, V54, P375, DOI [10.1093/jxb/54.381.375, 10.1093/jxb/erg012]; Ji G, 1990, Zhongguo Zhong Yao Za Zhi, V15, P429; Kim JY, 2009, BMB REP, V42, P482, DOI 10.5483/BMBRep.2009.42.8.482; Kim JE, 2011, CANCER PREV RES, V4, P582, DOI 10.1158/1940-6207.CAPR-11-0032; Kozera B, 2013, J APPL GENET; Ku SK, 2013, THROMB RES, V132, pE58, DOI 10.1016/j.thromres.2013.05.004; Ku SK, 2013, FOOD CHEM TOXICOL, V53, P197, DOI 10.1016/j.fct.2012.11.040; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Lilly ST, 2011, MOL PLANT MICROBE IN, V24, P294, DOI 10.1094/MPMI-10-10-0236; Ma CJ, 2010, PHYTOTHER RES, V24, P913, DOI 10.1002/ptr.3065; Ma G, 2007, CHEM-BIOL INTERACT, V167, P153, DOI 10.1016/j.cbi.2007.02.006; Manickavelu A, 2010, DNA RES, V17, P211, DOI 10.1093/dnares/dsq009; Monteiro F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072998; Nakashima A, 2013, FEBS LETT, V587, P2924, DOI 10.1016/j.febslet.2013.07.027; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Park HJ, 2013, INT J MOL SCI, V14, P11871, DOI 10.3390/ijms140611871; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; REN X, 2010, PLANT J; Staneloni RJ, 2008, MOL PLANT, V1, P75, DOI 10.1093/mp/ssm007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Yang XB, 2000, ACTA PHARMACOL SIN, V21, P239; Zhifang G, 2003, PLANT CELL ENVIRON, V26, P275, DOI 10.1046/j.1365-3040.2003.00958.x; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]	43	41	51	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92262	10.1371/journal.pone.0092262	http://dx.doi.org/10.1371/journal.pone.0092262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651080	gold, Green Submitted, Green Published			2022-12-27	WOS:000333352800089
J	Shao, ML; Lu, XM; Cong, WT; Xing, X; Tan, Y; Li, YQ; Li, XK; Jin, LT; Wang, XJ; Dong, JC; Jin, SZ; Zhang, C; Cai, L				Shao, Minglong; Lu, Xuemian; Cong, Weitao; Xing, Xiao; Tan, Yi; Li, Yunqian; Li, Xiaokun; Jin, Litai; Wang, Xiaojie; Dong, Juancong; Jin, Shunzi; Zhang, Chi; Cai, Lu			Multiple Low-Dose Radiation Prevents Type 2 Diabetes-Induced Renal Damage through Attenuation of Dyslipidemia and Insulin Resistance and Subsequent Renal Inflammation and Oxidative Stress	PLOS ONE			English	Article							INDUCED DNA-DAMAGE; BREAST-CANCER PATIENTS; APOPTOTIC CELL-DEATH; AKT ACTIVATION; KIDNEY-DISEASE; POTENTIAL ROLE; NEPHROPATHY; OBESITY; PROLIFERATION; LIPOTOXICITY	Background: Dyslipidemia and lipotoxicity-induced insulin resistance, inflammation and oxidative stress are the key pathogeneses of renal damage in type 2 diabetes. Increasing evidence shows that whole-body low dose radiation (LDR) plays a critical role in attenuating insulin resistance, inflammation and oxidative stress. Objective: The aims of the present study were to investigate whether LDR can prevent type 2 diabetes-induced renal damage and the underlying mechanisms. Methods: Mice were fed with a high-fat diet (HFD, 40% of calories from fat) for 12 weeks to induce obesity followed by a single intraperitoneal injection of streptozotocin (STZ, 50 mg/kg) to develop a type 2 diabetic mouse model. The mice were exposed to LDR at different doses (25, 50 and 75 mGy) for 4 or 8 weeks along with HFD treatment. At each time-point, the kidney weight, renal function, blood glucose level and insulin resistance were examined. The pathological changes, renal lipid profiles, inflammation, oxidative stress and fibrosis were also measured. Results: HFD/STZ-induced type 2 diabetic mice exhibited severe pathological changes in the kidney and renal dysfunction. Exposure of the mice to LDR for 4 weeks, especially at 50 and 75 mGy, significantly improved lipid profiles, insulin sensitivity and protein kinase B activation, meanwhile, attenuated inflammation and oxidative stress in the diabetic kidney. The LDR-induced anti-oxidative effect was associated with up-regulation of renal nuclear factor E2-related factor-2 (Nrf-2) expression and function. However, the above beneficial effects were weakened once LDR treatment was extended to 8 weeks. Conclusion: These results suggest that LDR exposure significantly prevented type 2 diabetes-induced kidney injury characterized by renal dysfunction and pathological changes. The protective mechanisms of LDR are complicated but may be mainly attributed to the attenuation of dyslipidemia and the subsequent lipotoxicity-induced insulin resistance, inflammation and oxidative stress.	[Shao, Minglong; Xing, Xiao; Dong, Juancong; Jin, Shunzi] Jilin Univ, Sch Publ Hlth, Changchun 130023, Peoples R China; [Shao, Minglong; Cong, Weitao; Tan, Yi; Li, Xiaokun; Jin, Litai; Zhang, Chi; Cai, Lu] Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Peoples R China; [Shao, Minglong; Lu, Xuemian; Zhang, Chi] Wenzhou Med Univ, Affiliated Hosp 3, Chinese Amer Res Inst Diabet Complicat, Ruian Ctr, Wenzhou, Peoples R China; [Cong, Weitao; Li, Xiaokun; Jin, Litai; Wang, Xiaojie] Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China; [Xing, Xiao] Changchun Inst Food & Drug Control, Changchun, Peoples R China; [Tan, Yi; Cai, Lu] Univ Louisville, Dept Pediat, Kosair Childrens Hosp Res Inst, Louisville, KY 40292 USA; [Li, Yunqian] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun 130023, Peoples R China	Jilin University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; University of Louisville; Jilin University	Jin, SZ (corresponding author), Jilin Univ, Sch Publ Hlth, Changchun 130023, Peoples R China.	jinsz@jlu.edu.cn; zhangchi515@126.com	DONG, JUANCONG/GRS-2303-2022; Cai, Lu/AAG-9920-2019		National Science Foundation of China [81000294, 81370917]; Wenzhou Medical University [QTJ13005]; National Institutes of Health [1 R01 DK091338-01A1]; Wenzhou Medical University; Zhejiang Provincial Natural Science Foundation [LQ12H07002, LQ13H020005]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091338] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Medical University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenzhou Medical University; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by a Young Scientist Award from the National Science Foundation of China (81000294, to CZ); the National Science Foundation of China (81370917, to CZ); the Research Development Fund of Wenzhou Medical University (QTJ13005, to CZ); the National Institutes of Health (1 R01 DK091338-01A1, to LC); a Start-up Fund for the Chinese-American Research Institute for Diabetic Complications from Wenzhou Medical University (to XL and LC); and the Zhejiang Provincial Natural Science Foundation (LQ12H07002, to WTC; LQ13H020005, to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2008, PHYSIOL BEHAV, V94, P8, DOI 10.1016/j.physbeh.2007.11.016; Athyros VG, 2010, EXPERT OPIN PHARMACO, V11, P723, DOI 10.1517/14656560903575654; Aunapuu M, 2004, ANN ANAT, V186, P277, DOI 10.1016/S0940-9602(04)80017-7; Bagby SP, 2007, KIDNEY INT, V71, P1199, DOI 10.1038/sj.ki.5002286; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Bobulescu IA, 2010, CURR OPIN NEPHROL HY, V19, P393, DOI 10.1097/MNH.0b013e32833aa4ac; Bonnet F, 2000, DIABETES METAB, V26, P254; Burrows NR, 2008, ADV CHRONIC KIDNEY D, V15, P147, DOI 10.1053/j.ackd.2008.01.002; Cai L, 1999, HUM EXP TOXICOL, V18, P419, DOI 10.1191/096032799678840291; Calabrese EJ, 2013, BIOGERONTOLOGY, V14, P365, DOI 10.1007/s10522-013-9436-5; Cui WP, 2013, AM J PHYSIOL-ENDOC M, V304, pE87, DOI 10.1152/ajpendo.00430.2012; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Franceschini N, 2012, KIDNEY INT, V82, P220, DOI 10.1038/ki.2012.107; Gaipl US, 2009, AUTOIMMUNITY, V42, P340, DOI 10.1080/08916930902831233; Gilbert ER, 2011, EXP DIABETES RES, DOI 10.1155/2011/416254; Gum RJ, 2003, DIABETES, V52, P21, DOI 10.2337/diabetes.52.1.21; Harjai KJ, 1999, ANN INTERN MED, V131, P376, DOI 10.7326/0003-4819-131-5-199909070-00009; Heerspink Hiddo J Lambers, 2011, Rev Diabet Stud, V8, P392, DOI 10.1900/RDS.2011.8.392; Hellman B, 2005, EXP ONCOL, V27, P102; Hirano T, 1999, KIDNEY INT, V56, pS22; Iseki K, 2008, INTERNAL MED, V47, P681, DOI 10.2169/internalmedicine.47.0906; Ji H, 2005, AM J PHYSIOL-HEART C, V288, pH43, DOI 10.1152/ajpheart.00630.2004; Jisieike-Onuigbo NN, 2011, NIGER J CLIN PRACT, V14, P171, DOI 10.4103/1119-3077.84009; Karihtala P, 2007, APMIS, V115, P81, DOI 10.1111/j.1600-0463.2007.apm_514.x; Kim CS, 2007, MOL CELLS, V24, P424; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; Lee S, 2009, AM J PHYSIOL-HEART C, V297, pH569, DOI 10.1152/ajpheart.00293.2009; Li B, 2012, EXP DIABETES RES, DOI 10.1155/2012/216512; Lin JL, 2008, DIABETES CARE, V31, P2338, DOI 10.2337/dc08-0277; Liu GW, 2007, CRIT REV TOXICOL, V37, P587, DOI 10.1080/10408440701493061; Luo J, 1998, METABOLISM, V47, P663, DOI 10.1016/S0026-0495(98)90027-0; Mantovani Giovanni, 2003, Journal of Environmental Pathology Toxicology and Oncology, V22, P17, DOI 10.1615/JEnvPathToxOncol.v22.i1.20; Marney AM, 2007, CLIN SCI, V113, P267, DOI 10.1042/CS20070123; Matheny RW, 2010, CELL DEATH DIFFER, V17, P677, DOI 10.1038/cdd.2009.150; McKay GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058472; Meguro S, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/687867; Miller AW, 2001, AM J PHYSIOL-HEART C, V281, pH1524, DOI 10.1152/ajpheart.2001.281.4.H1524; Murea M, 2010, CLIN J AM SOC NEPHRO, V5, P2373, DOI 10.2215/CJN.08160910; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Palyvoda O, 2002, ANTICANCER RES, V22, P1721; Pathak CM, 2007, J RADIAT RES, V48, P113, DOI 10.1269/jrr.06063; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Pinar B, 2007, RADIAT RES, V168, P415, DOI 10.1667/RR0746.1; Piqueras L, 2007, ARTERIOSCL THROM VAS, V27, P63, DOI 10.1161/01.ATV.0000250972.83623.61; Popanda O, 2003, INT J RADIAT ONCOL, V55, P1216, DOI 10.1016/S0360-3016(02)04415-2; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; Rivero A, 2009, CLIN SCI, V116, P479, DOI 10.1042/CS20080394; Rutledge JC, 2010, NAT REV NEPHROL, V6, P361, DOI 10.1038/nrneph.2010.59; San Miguel Symone M, 2011, Compend Contin Educ Dent, V32, pE10; Skrha J, 2003, ACTA DIABETOL, V40, pS324, DOI 10.1007/s00592-003-0113-z; Soetikno V, 2011, MOL NUTR FOOD RES, V55, P1655, DOI 10.1002/mnfr.201100080; Song Y, 2004, EXP MOL PATHOL, V76, P66, DOI 10.1016/j.yexmp.2003.08.002; Srinivasan K, 2007, INDIAN J MED RES, V125, P451; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Toblli JE, 2009, NEPHROL DIAL TRANSPL, V24, P2384, DOI 10.1093/ndt/gfp103; Ton ALY, 2007, SEMIN NEPHROL, V27, P130, DOI 10.1016/j.semnephrol.2007.01.006; van Kleef EM, 2000, INT J RADIAT BIOL, V76, P641, DOI 10.1080/095530000138303; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; Xing X, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/291087; Yang RL, 2008, J CLIN BIOCHEM NUTR, V43, P154, DOI 10.3164/jcbn.2008044; Zhang C, 2009, AM J PHYSIOL-ENDOC M, V297, pE1366, DOI 10.1152/ajpendo.00478.2009; Zhao HG, 2010, TOXICOL LETT, V192, P356, DOI 10.1016/j.toxlet.2009.11.011; Zhao WY, 2006, AM J PHYSIOL-HEART C, V291, pH336, DOI 10.1152/ajpheart.01307.2005; Zhao YG, 2011, TOXICOL LETT, V200, P100, DOI 10.1016/j.toxlet.2010.11.001	67	51	53	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92574	10.1371/journal.pone.0092574	http://dx.doi.org/10.1371/journal.pone.0092574			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651118	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800129
J	Vidal, N; Zaldua, N; D'Anatro, A; Naya, DE				Vidal, Nicolas; Zaldua, Natalia; D'Anatro, Alejandro; Naya, Daniel E.			Are the Most Plastic Species the Most Abundant Ones? An Assessment Using a Fish Assemblage	PLOS ONE			English	Article							CLIMATE-CHANGE; PHENOTYPIC PLASTICITY; DIGESTIVE FLEXIBILITY; IMPACTS; MODELS; HYPOTHESIS; MORPHOLOGY; PHYSIOLOGY; EVOLUTION; COMMUNITY	Few studies have evaluated phenotypic plasticity at the community level, considering, for example, plastic responses in an entire species assemblage. In addition, none of these studies have addressed the relationship between phenotypic plasticity and community structure. Within this context, here we assessed the magnitude of seasonal changes in digestive traits (seasonal flexibility), and of changes during short-term fasting (flexibility during fasting), occurring in an entire fish assemblage, comprising ten species, four trophic levels, and a 37-fold range in body mass. In addition, we analyzed the relationship between estimates of digestive flexibility and three basic assemblage structure attributes, i.e., species trophic position, body size, and relative abundance. We found that: (1) Seasonal digestive flexibility was not related with species trophic position or with body size; (2) Digestive flexibility during fasting tended to be inversely correlated with body size, as expected from scaling relationships; (3) Digestive flexibility, both seasonal and during fasting, was positively correlated with species relative abundance. In conclusion, the present study identified two trends in digestive flexibility in relation to assemblage structure, which represents an encouraging departure point in the search of general patterns in phenotypic plasticity at the local community scale.	[Vidal, Nicolas; Zaldua, Natalia; D'Anatro, Alejandro; Naya, Daniel E.] Univ Republica, Fac Ciencias, Dept Ecol & Evoluc, Montevideo, Uruguay	Universidad de la Republica, Uruguay	Naya, DE (corresponding author), Univ Republica, Fac Ciencias, Dept Ecol & Evoluc, Montevideo, Uruguay.	dnaya@fcien.edu.uy			ANII (Uruguay); SDC (China-Denmark); PEDECIBA (Uruguay); CSIC (Uruguay)	ANII (Uruguay); SDC (China-Denmark); PEDECIBA (Uruguay); CSIC (Uruguay)	Funded by ANII (Uruguay) and SDC (China-Denmark) to NV, PEDECIBA (Uruguay) to NZ, ANII (Uruguay) to AD, and CSIC (Uruguay) to DEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Kirigin AJ, 2013, OECOLOGIA, V173, P745, DOI 10.1007/s00442-013-2682-z; [Anonymous], 2011, ECOLOGICAL NICHES GE; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Clauss M, 2007, COMP BIOCHEM PHYS A, V148, P249, DOI 10.1016/j.cbpa.2007.05.024; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Firn J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035870; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; Gianoli E, 2012, BIOL J LINN SOC, V105, P1, DOI 10.1111/j.1095-8312.2011.01793.x; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Gurevitch J., 2001, ANAL ECOLOGICAL EXPT, P347; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; HUME ID, 1989, PHYSIOL ZOOL, V62, P1145, DOI 10.1086/physzool.62.6.30156206; Karasov WH, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P87; KARASOV WH, 1983, AM J PHYSIOL, V245, pG443, DOI 10.1152/ajpgi.1983.245.4.G443; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; Konarzewski M, 2013, J COMP PHYSIOL B, V183, P27, DOI 10.1007/s00360-012-0698-z; Molina-Montenegro MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047620; Naya DE, 2008, AM NAT, V172, pE122, DOI 10.1086/590957; Naya DE, 2007, EVOL ECOL RES, V9, P1363; Peacor SD, 2012, P ROY SOC B-BIOL SCI, V279, P122, DOI 10.1098/rspb.2011.0606; Pennisi E, 2005, SCIENCE, V307, P1896, DOI 10.1126/science.307.5717.1896; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Piersma T., 2010, FLEXIBLE PHENOTYPE B; Pigliucci M., 2001, SYN ECO EVO; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Richter-Boix A, 2006, EVOL ECOL RES, V8, P1139; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Starck JM, 2005, PHYSL ECOLOGICAL ADA; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Teixeira de Mello F., 2011, PECES AGUA DULCE URU; Teixeira-de Mello F, 2012, HYDROBIOLOGIA, V684, P143, DOI 10.1007/s10750-011-0979-7; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; Touchon JC, 2011, J ANIM ECOL, V80, P79, DOI 10.1111/j.1365-2656.2010.01765.x; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; West-Eberhard Mary Jane, 2003, pi; WESTOBY M, 1995, J ECOL, V83, P531, DOI 10.2307/2261605; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Zaldua N, 2014, COMP BIOCHEM PHYS A, V169, P7, DOI 10.1016/j.cbpa.2013.12.006	45	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92446	10.1371/journal.pone.0092446	http://dx.doi.org/10.1371/journal.pone.0092446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651865	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800107
J	Wei, ZH; Chen, H; Zhang, C; Ye, BC				Wei, Zi-Han; Chen, Huan; Zhang, Chang; Ye, Bang-Ce			FRET-Based System for Probing Protein-Protein Interactions between sigma(R) and RsrA from Streptomyces Coelicolor in Response to the Redox Environment	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; DISULFIDE BOND FORMATION; NF-KAPPA-B; OXIDATIVE STRESS; FLUORESCENT PROTEINS; ORGANIC HYDROPEROXIDES; BACILLUS-SUBTILIS; LIVING CELLS; ZINC; IDENTIFICATION	Protein-protein interactions between sigma factor sigma(R) and its corresponding zinc-binding anti-sigma (ZAS) protein RsrA trigger the thioredoxin system for maintaining cellular redox homeostasis in S. coelicolor. RsrA bound to zinc associates with sigma(R), inhibiting its transcriptional activity in a reducing environment. During disulfide stress it forms intramolecular disulfide bonds, leading to zinc release and dissociation from sigma(R), which initiates transcription to produce reductase and thioredoxin. We designed a fluorescence resonance energy transfer (FRET) based system for monitoring protein-protein interactions between sigma(R) and RsrA to further understand how this redox switch regulates the thioredoxin system in S. coelicolor in response to its redox environment, especially various reactive oxygen species (ROS) derived from different metabolic pathways, and clarify the different response mechanisms between Zn-RsrA and apo-RsrA. By the use of the FRET approach described here, we showed that zinc protected thiols in RsrA and causes the sigma(R)-RsrA complex to form a more compact structure. This system was also utilized to detect changes in redox status induced by ROS and diamide in real time in E. coli cells.	[Wei, Zi-Han; Chen, Huan; Zhang, Chang; Ye, Bang-Ce] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	East China University of Science & Technology	Ye, BC (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	bcye@ecust.edu.cn			China NSF [21276079]; SRFDP [20120074110009]; Chinese Ministry of Education [313019]; Fundamental Research Funds for the Central Universities	China NSF(National Natural Science Foundation of China (NSFC)); SRFDP(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Chinese Ministry of Education(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the China NSF (21276079), SRFDP (no. 20120074110009), the Key Grant Project (no. 313019) of the Chinese Ministry of Education, and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2006, ACS CHEM BIOL, V1, P371, DOI 10.1021/cb600202f; Aslund F, 1999, CELL, V96, P751, DOI 10.1016/S0092-8674(00)80584-X; Bae JB, 2004, J MOL BIOL, V335, P425, DOI 10.1016/j.jmb.2003.10.065; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; Bill A, 2011, J AM CHEM SOC, V133, P8372, DOI 10.1021/ja202513s; DiPilato LM, 2010, CURR OPIN CHEM BIOL, V14, P37, DOI 10.1016/j.cbpa.2009.10.012; Dittmer PJ, 2009, J BIOL CHEM, V284, P16289, DOI 10.1074/jbc.M900501200; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; Ewald JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028245; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Gaballa A, 2002, MOL MICROBIOL, V45, P997, DOI 10.1046/j.1365-2958.2002.03068.x; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Herbig AF, 2001, MOL MICROBIOL, V41, P849, DOI 10.1046/j.1365-2958.2001.02543.x; Hoppe AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064760; Ibraheem A, 2010, CURR OPIN CHEM BIOL, V14, P30, DOI 10.1016/j.cbpa.2009.09.033; Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292; Kim MS, 2009, MOL MICROBIOL, V73, P815, DOI 10.1111/j.1365-2958.2009.06824.x; Kolossov VL, 2008, EXP BIOL MED, V233, P238, DOI 10.3181/0707-RM-192; Li W, 2003, J MOL BIOL, V333, P461, DOI 10.1016/j.jmb.2003.08.038; Li W, 2002, J MOL BIOL, V323, P225, DOI 10.1016/S0022-2836(02)00948-8; Maret W, 2005, J TRACE ELEM MED BIO, V19, P7, DOI 10.1016/j.jtemb.2005.02.003; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Miyawaki A, 2011, ANNU REV BIOCHEM, V80, P357, DOI 10.1146/annurev-biochem-072909-094736; Najumudeen AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066425; Oushiki D, 2010, J AM CHEM SOC, V132, P2795, DOI 10.1021/ja910090v; Paget MSB, 1998, EMBO J, V17, P5776, DOI 10.1093/emboj/17.19.5776; Paget MSB, 2001, MOL MICROBIOL, V42, P1007, DOI 10.1046/j.1365-2958.2001.02675.x; Paige JS, 2012, SCIENCE, V335, P1194, DOI 10.1126/science.1218298; Park JH, 2008, MOL MICROBIOL, V68, P861, DOI 10.1111/j.1365-2958.2008.06191.x; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Shcherbakova D., 2012, ANGEW CHEM INT EDIT, V51, P2; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; Whitby PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050588; White R, 2004, METHODS MOL BIOL NIT, P215; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Wilkins MR, 2007, PROTEOME RES CONCEPT, P169; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zdanowski K, 2006, BIOCHEMISTRY-US, V45, P8294, DOI 10.1021/bi060711v; Zhang C, 2014, BIOSENS BIOELECTRON, V54, P15, DOI 10.1016/j.bios.2013.10.038; Zhang C, 2013, BIOTECHNOL J, V8, P1280, DOI 10.1002/biot.201300001; Zhang C, 2013, APPL MICROBIOL BIOT, V97, P8307, DOI 10.1007/s00253-013-5121-5; Zhang YX, 2012, FREE RADICAL BIO MED, V53, P1531, DOI 10.1016/j.freeradbiomed.2012.07.010; Zhao BS, 2010, J AM CHEM SOC, V132, P17065, DOI 10.1021/ja1071114	47	6	6	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92330	10.1371/journal.pone.0092330	http://dx.doi.org/10.1371/journal.pone.0092330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651617	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800101
J	Zhang, WC; Zhao, FR; Chen, J; Chen, WX				Zhang, Wen-Chao; Zhao, Feng-Rong; Chen, Juan; Chen, Wei-Xian			Meta-Analysis: Diagnostic Accuracy of Antinuclear Antibodies, Smooth Muscle Antibodies and Antibodies to a Soluble Liver Antigen/Liver Pancreas in Autoimmune Hepatitis	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; CHRONIC ACTIVE HEPATITIS; OVERLAP SYNDROME; F-ACTIN; SCLEROSING CHOLANGITIS; INITIAL PRESENTATION; ANTIACTIN ANTIBODY; MEDICAL PROGRESS; RISK-FACTORS; AUTOANTIBODIES	Background: Antinuclear antibodies (ANA), smooth muscle antibodies (SMA) and antibodies to a soluble liver antigen/liver pancreas (anti-SLA/LP) are useful markers that can help clinicians to diagnose and classify autoimmune hepatitis (AIH). Objectives: To determine whether ANA, SMA and anti-SLA/LP help to accurately diagnose patients with AIH. Search strategy: The PubMed, CNKI, WANFANG, and SinoMed databases were accessed to retrieve studies published in English and Chinese. Studies published up to October 2013 were reviewed. Selection criteria: Studies on the diagnostic value of ANA, SMA or anti-SLA/LP in the diagnosis of known or suspected AIH were included. Data collection and analysis: Two authors evaluated studies independently and rated their methodological quality using quality assessment of diagnostic accuracy studies (QUADAS) tools; relevant data were abstracted. The random-effects method was used to summarize sensitivities, specificities, positive and negative likelihood ratios, and diagnostic odds ratios (DORs) from all 29 studies. Results: The pooled sensitivity, specificity, positive and negative likelihood ratios, and DOR for ANA were 0.650 (95% confidence interval [CI], 0.619 to 0.680), 0.751 (95% CI, 0.737 to 0.764), 3.030 (95% CI, 2.349 to 3.910), 0.464 (95% CI, 0.356 to 0.604), and 7.380 (95% CI, 4.344 to 12.539), respectively. For SMA, the values were 0.593 (95% CI, 0.564 to 0.621), 0.926 (95% CI, 0.917 to 0.934), 11.740 (95% CI, 7.379 to 18.678), 0.449 (95% CI, 0.367 to 0.549), and 31.553 (95% CI, 17.147 to 58.060), respectively. Finally, for anti-SLA/LP, the values were 0.194 (95% CI, 0.168 to 0.222), 0.989 (95% CI, 0.985 to 0.993), 11.089 (95% CI, 7.601 to 16.177), 0.839 (95% CI, 0.777 to 0.905), and 16.867 (95% CI, 10.956 to 25.967), respectively. Authors' conclusions: ANA provided moderate sensitivity and specificity, while SMA gave moderate sensitivity and high specificity, and anti-SLA/LP exhibited low sensitivity and high specificity. All three antibodies were limited by their unsatisfactory sensitivities and lack of consistency.	[Zhang, Wen-Chao; Chen, Wei-Xian] Chongqing Med Univ, Affiliated Hosp 2, Dept Lab Med, Chongqing, Peoples R China; [Zhao, Feng-Rong] Youyang Peoples Hosp, Dept Obstet & Gynaecol, Chongqing, Peoples R China; [Chen, Juan] Chongqing Med Univ, Affiliated Hosp 2, Inst Viral Hepatitis, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Chen, WX (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Lab Med, Chongqing, Peoples R China.	chenweixian75@163.com			National Natural Science Foundation of China [81171628]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81171628), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Obeidy E, 2006, IRAQI J GASTROENTERO, V1, P49; Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Baeres M, 2002, GUT, V51, P259, DOI 10.1136/gut.51.2.259; Ballot E, 2000, J HEPATOL, V33, P208, DOI 10.1016/S0168-8278(00)80361-X; Bittencourt PL, 1998, AM J GASTROENTEROL, V93, P1394, DOI 10.1111/j.1572-0241.1998.1394a.x; Bostrom EA, 2011, SCAND J IMMUNOL, V74, P463, DOI 10.1111/j.1365-3083.2011.02592.x; BOTTAZZO GF, 1976, J CLIN PATHOL, V29, P403, DOI 10.1136/jcp.29.5.403; Cancado ELR, 1996, HEPATOLOGY, V23, P1098; Cassani F, 1997, HEPATOLOGY, V26, P561, DOI 10.1002/hep.510260305; Chazouilleres O, 2006, J HEPATOL, V44, P400, DOI 10.1016/j.jhep.2005.10.017; Chazouilleres O, 1998, HEPATOLOGY, V28, P296, DOI 10.1002/hep.510280203; COOK GC, 1971, Q J MED, V40, P159, DOI 10.1093/oxfordjournals.qjmed.a067264; Czaja A J, 2005, Minerva Gastroenterol Dietol, V51, P313; CZAJA AJ, 1995, DIGEST DIS SCI, V40, P435, DOI 10.1007/BF02065434; Czaja AJ, 2006, J HEPATOL, V44, P251, DOI 10.1016/j.jhep.2005.11.037; Czaja AJ, 2005, HEPATOLOGY, V41, P207, DOI 10.1002/hep.20539; Czaja AJ, 2004, LIVER INT, V24, P322, DOI 10.1111/j.1478-3231.2004.0924.x; Czaja AJ, 2004, AUTOIMMUNITY, V37, P195, DOI 10.1080/08916930410001702469; Czaja AJ, 2002, HEPATOLOGY, V36, P479, DOI 10.1053/jhep.2002.34944; Czaja AJ, 2001, GASTROENTEROLOGY, V120, P239, DOI 10.1053/gast.2001.20223; Czaja AJ, 2002, AUTOIMMUNITY, V35, P475, DOI 10.1080/0891693021000054101; CZAJA AJ, 1995, AM J GASTROENTEROL, V90, P1206; Czaja AJ, 2002, AM J GASTROENTEROL, V97, P2051; CZAJA AJ, 1993, GASTROENTEROLOGY, V105, P1522, DOI 10.1016/0016-5085(93)90160-E; Czaja AJ, 2002, AM J GASTROENTEROL, V97, P413; Czaja AJ, 2001, HEPATOLOGY, V34, P659, DOI 10.1053/jhep.2001.27562; Czaja AJ, 1996, ANN INTERN MED, V125, P588, DOI 10.7326/0003-4819-125-7-199610010-00009; Czaja AJ, 2001, DIGEST DIS SCI, V46, P140, DOI 10.1023/A:1005670111068; CZAJA AJ, 1994, GASTROENTEROLOGY, V107, P200, DOI 10.1016/0016-5085(94)90078-7; Czaja AJ, 1998, DIGEST DIS SCI, V43, P2149, DOI 10.1023/A:1018836004279; Czaja AJ, 2000, IMMUNOL REV, V174, P250, DOI 10.1034/j.1600-0528.2002.017401.x; Deng JW, 2010, CHIN EXP LAB MED, V2, P147; DONALDSON PT, 1991, HEPATOLOGY, V13, P701, DOI 10.1016/0270-9139(91)92567-R; Efe C, 2013, LIVER INT, V33, P190, DOI 10.1111/liv.12022; FAINBOIM L, 1994, HUM IMMUNOL, V41, P146, DOI 10.1016/0198-8859(94)90008-6; Feld JJ, 2005, HEPATOLOGY, V42, P53, DOI 10.1002/hep.20732; Floreani A, 2005, AM J GASTROENTEROL, V100, P1516, DOI 10.1111/j.1572-0241.2005.41841.x; Frenzel C, 2006, AM J GASTROENTEROL, V101, P2731, DOI 10.1111/j.1572-0241.2006.00830.x; GABBIANI G, 1973, AM J PATHOL, V72, P473; GELPI C, 1992, P NATL ACAD SCI USA, V89, P9739, DOI 10.1073/pnas.89.20.9739; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Granito A, 2006, J CLIN PATHOL, V59, P280, DOI 10.1136/jcp.2005.027367; Gregorio GV, 1997, HEPATOLOGY, V25, P541, DOI 10.1002/hep.510250308; Gupta R, 2001, J GASTROEN HEPATOL, V16, P1144, DOI 10.1046/j.1440-1746.2001.02602.x; Hargraves M, 1948, MAYO CLIN P, V27, P25; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; HOLBOROW EJ, 1963, BMJ-BRIT MED J, P656, DOI 10.1136/bmj.1.5331.656; HOMBERG JC, 1987, HEPATOLOGY, V7, P1333, DOI 10.1002/hep.1840070626; Homburger HA, 1998, ARCH PATHOL LAB MED, V122, P993; Hu CJ, 2011, DIGEST DIS SCI, V56, P3357, DOI 10.1007/s10620-011-1756-1; Ichai P, 2007, LIVER TRANSPLANT, V13, P996, DOI 10.1002/lt.21036; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; JOHNSON GD, 1965, LANCET, V2, P878; JOHNSON PJ, 1993, HEPATOLOGY, V18, P998, DOI 10.1002/hep.1840180435; Joshi S, 2002, HEPATOLOGY, V35, P409, DOI 10.1053/jhep.2002.30902; Kessler WR, 2004, CLIN GASTROENTEROL H, V2, P625, DOI 10.1016/S1542-3565(04)00246-0; Kinoshita H, 1999, LIVER, V19, P122, DOI 10.1111/j.1478-3231.1999.tb00021.x; Kogan J, 2002, J CLIN GASTROENTEROL, V35, P75, DOI 10.1097/00004836-200207000-00016; Krawitt EL, 2006, NEW ENGL J MED, V354, P54, DOI 10.1056/NEJMra050408; Krawitt EL, 1996, NEW ENGL J MED, V334, P897, DOI 10.1056/NEJM199604043341406; Li XC, 2006, J BHU NAT SCI, V6, P538; LIDMAN K, 1976, CLIN EXP IMMUNOL, V24, P266; Lim KN, 2001, AM J GASTROENTEROL, V96, P3390, DOI 10.1111/j.1572-0241.2001.05272.x; Lohse AW, 1999, HEPATOLOGY, V29, P1078, DOI 10.1002/hep.510290409; Long H, 2012, CHIN J TRAUMA DISABI, V12, P131; LUDWIG J, 1984, LIVER, V4, P105; Lv S, 2006, SHANDONG J MED, V25, P82; Ma Y, 2002, HEPATOLOGY, V35, P658, DOI 10.1053/jhep.2002.32092; MA Y, 2001, J HEPATOL S1, V34, P212; Ma YX, 2012, J MED, V12, P1030; MACKAY IR, 1956, LANCET, V271, P1323; MACKAY IR, 1959, LANCET, V1, P65; MACKAY IR, 1965, ANN NY ACAD SCI, V124, P767, DOI 10.1111/j.1749-6632.1965.tb19000.x; MACKAY IR, 1972, LANCET, V2, P793; MACKAY IR, 1980, GASTROENTEROLOGY, V79, P95; MANNS M, 1987, LANCET, V1, P292; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; MANNS MP, 1989, J CLIN INVEST, V83, P1066, DOI 10.1172/JCI113949; McNair ANB, 1998, AM J GASTROENTEROL, V93, P777; MIESCHER P, 1954, EXPERIENTIA, V10, P252, DOI 10.1007/BF02157392; Miyakawa H, 2003, J AUTOIMMUN, V21, P77, DOI 10.1016/S0896-8411(03)00084-2; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Muratori P, 2002, AUTOIMMUNITY, V35, P497, DOI 10.1080/0891693021000054066; MURRAYLYON IM, 1973, LANCET, V1, P735; Nishioka M, 1997, J GASTROEN HEPATOL, V12, P862, DOI 10.1111/j.1440-1746.1997.tb00384.x; Nishioka M, 1992, IMMUNOLOGY LIVER, P193; Onozuka Y, 1994, JAP HEPATOL, V35, P834; Qiu DK, 2011, J HEPATOL, V54, P340, DOI 10.1016/j.jhep.2010.06.032; SEKI T, 1992, GASTROENTEROLOGY, V103, P1041, DOI 10.1016/0016-5085(92)90041-V; SOLOWAY RD, 1972, GASTROENTEROLOGY, V63, P820; STECHEMESSER E, 1993, HEPATOLOGY, V18, P1; Stengel D, 2003, J MED SCREEN, V10, P47, DOI 10.1258/096914103321610806; Strassburg CP, 1996, J HEPATOL, V25, P859, DOI 10.1016/S0168-8278(96)80290-X; Tan Li-ming, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P463; Tan LiMing, 2013, Chinese Journal of Immunology, V29, P839; [谭立明 TAN Liming], 2009, [免疫学杂志, Immunological Journal], V25, P697; Tan LM, 2012, CHIN J IMMUNOL, V12, P1061; Tan LM, 2006, WORLD J GASTROENTERO, V14, P2801; URIBE M, 1984, J CLIN GASTROENTEROL, V6, P331; van Buuren HR, 2000, J HEPATOL, V33, P543, DOI 10.1034/j.1600-0641.2000.033004543.x; Vergani D, 2004, J HEPATOL, V41, P677, DOI 10.1016/j.jhep.2004.08.002; Vergani Diego, 2002, Clin Liver Dis, V6, P727, DOI 10.1016/S1089-3261(02)00018-1; Villalta D, 2008, AUTOIMMUNITY, V41, P105, DOI 10.1080/08916930701619896; Vitozzi S, 2004, AUTOIMMUNITY, V37, P217, DOI 10.1080/08916930410001686260; Werner M, 2008, SCAND J GASTROENTERO, V43, P1232, DOI 10.1080/00365520802130183; Wesierska-Gadek J, 1998, GASTROENTEROLOGY, V114, P329, DOI 10.1016/S0016-5085(98)70485-8; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; WHITTINGHAM S, 1966, GASTROENTEROLOGY, V51, P499; Wies I, 2000, LANCET, V355, P1510, DOI 10.1016/S0140-6736(00)02166-8; Zeng XT., 2013, J HUBEI U MED, V32, P6; Zhang BC, 2004, CHIN J LAB MED, V3, P166; Zhang JL, 2007, GUANGDONG J MED, V12, P1962; Zhang L, 2012, CHIN LAB MED CLIN, V10, P1258; Zhang TS, 2008, CHIN J EVID BASED ME, V2, P97	114	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92267	10.1371/journal.pone.0092267	http://dx.doi.org/10.1371/journal.pone.0092267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651126	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800090
J	Gross, KM; Schote, AB; Schneider, KK; Schulz, A; Meyer, J				Gross, Katharina M.; Schote, Andrea B.; Schneider, Katja Kerstin; Schulz, Andre; Meyer, Jobst			Elevated Social Stress Levels and Depressive Symptoms in Primary Hyperhidrosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; PALMAR HYPERHIDROSIS; FOCAL HYPERHIDROSIS; HORMONE; ANXIETY; TIME	Primary hyperhidrosis is defined as excessive sweating of certain body areas without physiological reasons. Hyperhidrotic individuals report a high psychological strain and an impairment of their quality of life. Thus, the aim of the study is to investigate the relation between hyperhidrosis and different psychological as well as physiological aspects of chronic stress as a co-factor for the etiology of depression. In this study, forty hyperhidrotic subjects were compared to forty age-and sex-matched healthy control subjects. The Trier Inventory of Chronic Stress ('Trierer Inventar zum chronischen Stress': TICS), the Beck Depression Inventory (BDI-II) and the Screening for Somatoform Disorders (SOMS-2) were used to examine the correlation between primary hyperhidrosis and stress as well as accompanying depressive and somatic symptoms. The cortisol awakening response of each subject was analyzed as a physiological stress correlate. In hyperhidrotics, we found a significant lack of social recognition as well as significantly more depressive symptoms compared to the control subjects. A subgroup of patients with axillary hyperhidrosis had the highest impact on these increased issues of chronic stress, pointing to a higher embarrassment in these subjects. Especially in social situations, hyperhidrotics showed higher stress levels, whereby a vicious circle of stress and sweating is triggered. However, the cortisol awakening response did not significantly differ between hyperhidrotics and controls. Moreover, affected persons suffer from more depressive symptoms, which may be caused by feelings of shame and a lack of self-confidence. This initial study provides an impetus for further investigation to reveal a causative relationship between hyperhidrosis and its psychological concomitants.	[Gross, Katharina M.; Schote, Andrea B.; Meyer, Jobst] Univ Trier, Inst Psychobiol, Dept Neurobehav Genet, Trier, Germany; [Schneider, Katja Kerstin] Univ Trier, Dept Psychol, Trier, Germany; [Schulz, Andre] Univ Luxembourg, Res Unit INSIDE, Walferdange, Luxembourg; [Schulz, Andre] Univ Trier, Inst Psychobiol, Dept Clin Psychophysiol, Trier, Germany	Universitat Trier; Universitat Trier; University of Luxembourg; Universitat Trier	Meyer, J (corresponding author), Univ Trier, Inst Psychobiol, Dept Neurobehav Genet, Trier, Germany.	meyerjo@uni-trier.de	Schulz, André/AAC-5576-2021	Schulz, André/0000-0002-9381-2651	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [GRK 1389]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	JM and ABS were supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), grant GRK 1389. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAR R, 1977, ANN SURG, V186, P34, DOI 10.1097/00000658-197707000-00006; Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; Beck AT., 1996, MANUAL BECK DEPRESSI; Becker P., 2004, TRIERER INVENTAR ZUM; Benson RA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6800; BYRNE J, 1990, BRIT J SURG, V77, P1046, DOI 10.1002/bjs.1800770931; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Clow A, 2010, NEUROSCI BIOBEHAV R, V35, P97, DOI 10.1016/j.neubiorev.2009.12.011; Cohen J.E., 1988, STAT POWER ANAL BEHA; DRESSENDORFER RA, 1992, J STEROID BIOCHEM, V43, P683, DOI 10.1016/0960-0760(92)90294-S; DRUMMOND PD, 1987, BRAIN, V110, P793, DOI 10.1093/brain/110.3.793; Eisenach JH, 2005, MAYO CLIN PROC, V80, P657, DOI 10.4065/80.5.657; Erikson E.H., 1968, IDENTITY YOUTH CRISI; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; Genazzani AR, 2007, CLIMACTERIC, V10, P11, DOI 10.1080/13697130601114891; Hamm H, 2006, DERMATOLOGY, V212, P343, DOI 10.1159/000092285; Hautzinger M., 2009, BDI 2 BECK DEPRESSIO; HELLHAMMER DH, 1993, PSYCHOTHER PSYCHOSOM, V60, P8, DOI 10.1159/000288675; Higashimoto I, 2006, AM J MED GENET A, V140A, P567, DOI 10.1002/ajmg.a.31127; Iwase S, 1997, J AUTONOM NERV SYST, V64, P65, DOI 10.1016/S0165-1838(97)00014-3; Kaufmann H, 2003, CLIN AUTON RES, V13, P96, DOI 10.1007/s10286-003-0082-x; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kopelman D, 1996, J VASC SURG, V24, P194, DOI 10.1016/S0741-5214(96)70093-9; Lee HH, 2012, KOREAN J PAIN, V25, P28, DOI 10.3344/kjp.2012.25.1.28; OGAWA T, 1975, JPN J PHYSIOL, V25, P525; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; REINAUER S, 1993, BRIT J DERMATOL, V129, P166, DOI 10.1111/j.1365-2133.1993.tb03521.x; Rief W., 2008, SOMS SCREENING SOMAT; Ro KM, 2002, J VASC SURG, V35, P382, DOI 10.1067/mva.2002.119507; Ruchinskas RA, 2002, BRIT J DERMATOL, V147, P733, DOI 10.1046/j.1365-2133.2002.04857.x; Ruchinskas R, 2007, DERMATOLOGY, V214, P195, DOI 10.1159/000099581; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; SHIH CJ, 1983, J AUTONOM NERV SYST, V8, P33, DOI 10.1016/0165-1838(83)90021-8; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Slominski Andrzej T, 2012, Adv Anat Embryol Cell Biol, V212, P1; Sonntag M, 2004, ZFA Z F R ALLGEMEINM, V80, P289, DOI [10.1055/s-2004-822835, DOI 10.1055/S-2004-822835]; Strutton DR, 2004, J AM ACAD DERMATOL, V51, P241, DOI 10.1016/j.jaad.2003.12.040; Weber A, 2005, BRIT J DERMATOL, V152, P342, DOI 10.1111/J.1365-2133.2004.06334.X; Wilke K., 2007, International Journal of Cosmetic Science, V29, P169, DOI 10.1111/j.1467-2494.2007.00387.x; Wolosker N, 2012, J VASC SURG, V55, P154, DOI 10.1016/j.jvs.2011.07.097	42	34	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92412	10.1371/journal.pone.0092412	http://dx.doi.org/10.1371/journal.pone.0092412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647796	gold, Green Submitted, Green Published			2022-12-27	WOS:000333348500127
J	Hansel, A; Steinbach, D; Greinke, C; Schmitz, M; Eiselt, J; Scheungraber, C; Gajda, M; Hoyer, H; Runnebaum, IB; Durst, M				Hansel, Alfred; Steinbach, Daniel; Greinke, Christiane; Schmitz, Martina; Eiselt, Juliane; Scheungraber, Cornelia; Gajda, Mieczyslaw; Hoyer, Heike; Runnebaum, Ingo B.; Duerst, Matthias			A Promising DNA Methylation Signature for the Triage of High-Risk Human Papillomavirus DNA-Positive Women	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; SIGNALING PATHWAY; CANCER CELLS; FOLLOW-UP; PCR; HYPERMETHYLATION; POPULATION; COLPOSCOPY; CARCINOMAS; BIOMARKERS	High-risk human papillomavirus (hrHPV)-DNA testing is frequently performed parallel to cytology for the detection of high-grade dysplasia and cervical cancer particularly in women above 30 years of age. Although highly sensitive, hrHPV testing cannot distinguish between HPV-positive women with or without clinically relevant lesions. However, in principle discrimination is possible on the basis of DNA methylation markers. In order to identify novel DNA regions which allow an effective triage of hrHPV-positive cases, hypermethylated DNA enriched from cervical cancers was compared with that from cervical scrapes of HPV16-positive cases with no evidence for disease by CpG island microarray hybridization. The most promising marker regions were validated by quantitative methylation-specific PCR (qMSP) using DNA from archived cervical tissues and cervical scrapes. The performance of these markers was then determined in an independent set of 217 hrHPV-positive cervical scrapes from outpatients with histopathological verification. A methylation signature comprising the 59 regions of the genes DLX1, ITGA4, RXFP3, SOX17 and ZNF671 specific for CIN3 and cervical cancer (termed CIN3+) was identified and validated. A high detection rate of CIN3+ was obtained if at least 2 of the 5 markers were methylated. In the subsequent cross-sectional study all cervical carcinomas (n = 19) and 56% (13/23) of CIN3 were identified by this algorithm. Only 10% (11/105) of hrHPV-positive women without histological evidence of cervical disease were scored positive by the methylation assay. Of note is that the detection rate of CIN3 differed between age groups. Eight of nine CIN3 were detected among women >= 30 years of age but only five of fourteen among,30 year old group (p = 0.03). The specificity for CIN3+ in the older age group was 76.6% (95% CI 65.6-85.5%). Clinical validation studies are required to determine the usefulness of these novel markers for triage after primary hrHPV testing in a cervical cancer screening setting.	[Hansel, Alfred; Steinbach, Daniel; Greinke, Christiane; Schmitz, Martina; Eiselt, Juliane; Scheungraber, Cornelia; Runnebaum, Ingo B.; Duerst, Matthias] Jena Univ Hosp, Dept Gynaecol, Jena, Germany; [Hoyer, Heike] Jena Univ Hosp, IMSID, Jena, Germany; [Gajda, Mieczyslaw] Jena Univ Hosp, Inst Pathol, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Durst, M (corresponding author), Jena Univ Hosp, Dept Gynaecol, Jena, Germany.	matthias.duerst@med.uni-jena.de		Steinbach, Daniel/0000-0002-0276-3701	European Commission [LSHC-CT-2005-018704]; Bundesministerium fur Wirtschaft und Technologie [03 EFT 5T06]	European Commission(European CommissionEuropean Commission Joint Research Centre); Bundesministerium fur Wirtschaft und Technologie(Federal Ministry for Economic Affairs and Energy (BMWi))	This work was supported in part by a grant to MD from the European Commission (LSHC-CT-2005-018704) and a grant to AH from the Bundesministerium fur Wirtschaft und Technologie (03 EFT 5T06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai E, 2012, CARCINOGENESIS, V33, P1487, DOI 10.1093/carcin/bgs177; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Bierkens M, 2013, INT J CANCER, V133, P1293, DOI 10.1002/ijc.28138; Brandsma JL, 2009, VIROLOGY, V389, P100, DOI 10.1016/j.virol.2009.03.029; Bulkmans NWJ, LANCET, V370, P1764; Chiba S, 2003, P NATL ACAD SCI USA, V100, P15577, DOI 10.1073/pnas.2536757100; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Cuzick J, 2010, CANCER PREV RES, V3, P689, DOI 10.1158/1940-6207.CAPR-10-0096; Eijsink JJH, 2012, INT J CANCER, V130, P1861, DOI 10.1002/ijc.26326; GLOBOCAN, 2012, GLOBOCAN 2012 EST CA; Hafner N, 2011, GYNECOL ONCOL, V121, P224, DOI 10.1016/j.ygyno.2010.11.018; Hesselink AT, 2011, CLIN CANCER RES, V17, P2459, DOI 10.1158/1078-0432.CCR-10-2548; Huang YW, 2010, GYNECOL ONCOL, V117, P239, DOI 10.1016/j.ygyno.2010.02.006; Jacobs MV, 1997, J CLIN MICROBIOL, V35, P791, DOI 10.1128/JCM.35.3.791-795.1997; Jia Y, 2012, J MOL DIAGN, V14, P577, DOI 10.1016/j.jmoldx.2012.06.004; Kahn SL, 2008, CANCER CYTOPATHOL, V114, P57, DOI 10.1002/cncr.23258; Kalantari M, 2004, J VIROL, V78, P12762, DOI 10.1128/JVI.78.23.12762-12772.2004; Kristensen LS, 2009, CLIN CHEM, V55, P1471, DOI 10.1373/clinchem.2008.121962; Lechner M, 2010, ADV GENET, V70, P247, DOI [10.1016/S0065-2660(10)70009-2, 10.1016/B978-0-12-380866-0.60009-5]; Lendvai A, 2012, EPIGENETICS-US, V7, P1268, DOI 10.4161/epi.22301; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Mirabello L, 2012, JNCI-J NATL CANCER I, V104, P556, DOI 10.1093/jnci/djs135; Overmeer RM, 2011, INT J CANCER, V129, P2218, DOI 10.1002/ijc.25890; Overmeer RM, 2009, J PATHOL, V219, P327, DOI 10.1002/path.2598; Park J, 2004, ONCOGENE, V23, P3474, DOI 10.1038/sj.onc.1207470; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Schmitz M, 2009, J CLIN VIROL, V44, P302, DOI 10.1016/j.jcv.2009.01.006; Schneider A, 2000, INT J CANCER, V89, P529, DOI 10.1002/1097-0215(20001120)89:6&lt;529::AID-IJC11&gt;3.0.CO;2-G; Tong Wei-Gang, 2010, Epigenetics, V5, P499; Wentzensen N, 2009, GYNECOL ONCOL, V112, P293, DOI 10.1016/j.ygyno.2008.10.012; Wentzensen N, 2012, JNCI-J NATL CANCER I, V104, P1738, DOI 10.1093/jnci/djs425; Wentzensen N, 2012, CLIN CANCER RES, V18, P4154, DOI 10.1158/1078-0432.CCR-12-0270; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8; Wu XW, 2010, CANCER RES, V70, P2718, DOI 10.1158/0008-5472.CAN-09-3631	36	48	53	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91905	10.1371/journal.pone.0091905	http://dx.doi.org/10.1371/journal.pone.0091905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647315	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500058
J	Yuan, ZB; Chen, J; Chen, DW; Xu, G; Xia, MJ; Xu, Y; Gao, YQ				Yuan, Zhibin; Chen, Jian; Chen, Dewei; Xu, Gang; Xia, Minjie; Xu, Yong; Gao, Yuqi			Megakaryocytic Leukemia 1 (MKL1) Regulates Hypoxia Induced Pulmonary Hypertension in Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CLASS-II TRANSACTIVATOR; ARTERIAL-HYPERTENSION; COL1A2 TRANSCRIPTION; NITRIC-OXIDE; TGF-BETA; ACTIVATION; EXPRESSION; INDUCTION; GENE	Hypoxia induced pulmonary hypertension (HPH) represents a complex pathology that involves active vascular remodeling, loss of vascular tone, enhanced pulmonary inflammation, and increased deposition of extracellular matrix proteins. Megakaryocytic leukemia 1 (MKL1) is a transcriptional regulator known to influence cellular response to stress signals in the vasculature. We report here that in response to chronic hypobaric hypoxia, MKL1 expression was up-regulated in the lungs in rats. Short hairpin RNA (shRNA) mediated depletion of MKL1 significantly ameliorated the elevation of pulmonary arterial pressure in vivo with a marked alleviation of vascular remodeling. MKL1 silencing also restored the expression of NO, a key vasoactive molecule necessary for the maintenance of vascular tone. In addition, hypoxia induced pulmonary inflammation was dampened in the absence of MKL1 as evidenced by normalized levels of pro-inflammatory cytokines and chemokines as well as reduced infiltration of pro-inflammatory immune cells in the lungs. Of note, MKL1 knockdown attenuated fibrogenesis in the lungs as indicated by picrosirius red staining. Finally, we demonstrate that MKL1 mediated transcriptional activation of type I collagen genes in smooth muscle cells under hypoxic conditions. In conclusion, we data highlight a previously unidentified role for MKL1 in the pathogenesis of HPH and as such lay down groundwork for future investigation and drug development.	[Yuan, Zhibin; Chen, Jian; Chen, Dewei; Xu, Gang; Gao, Yuqi] Third Mil Med Univ, Coll High Altitude Mil Med, Dept Pathophysiol & High Altitude Physiol, Chongqing, Peoples R China; [Yuan, Zhibin; Chen, Jian; Chen, Dewei; Xu, Gang; Gao, Yuqi] Third Mil Med Univ, Key Lab High Altitude Med, Minist Educ, Chongqing, Peoples R China; [Yuan, Zhibin; Chen, Jian; Chen, Dewei; Xu, Gang; Gao, Yuqi] Third Mil Med Univ, PLA, Key Lab High Altitude Med, Chongqing, Peoples R China; [Xia, Minjie; Xu, Yong] Nanjing Med Univ, Dept Pathophysiol, Key Lab Cardiovasc Dis, Nanjing, Jiangsu, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Nanjing Medical University	Xu, Y (corresponding author), Nanjing Med Univ, Dept Pathophysiol, Key Lab Cardiovasc Dis, Nanjing, Jiangsu, Peoples R China.	yxu2005@gmail.com; gyq@mail.tmmu.edu.cn		chen, jian/0000-0003-0258-9878	National Basic Science Research "973" Program of China [2012CB518201, 2012CB517503]; Program for New Century Excellent Talents in University of China [NCET-11-0991]; Natural Science Foundation of China [81100041, 31270805]; Natural Science Foundation of Jiangsu Province [BK2012043]; Ministry of Education [212059]; Postdoctoral Research Grant of China [20100471771]	National Basic Science Research "973" Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Ministry of Education; Postdoctoral Research Grant of China	This study was supported, in part, by the National Basic Science Research "973" Program of China (2012CB518201, 2012CB517503), the Program for New Century Excellent Talents in University of China (NCET-11-0991), Natural Science Foundation of China (81100041, 31270805), Natural Science Foundation of Jiangsu Province (BK2012043), the Ministry of Education (212059), and the Postdoctoral Research Grant of China (20100471771). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; BelAiba RS, 2006, CIRC RES, V98, P828, DOI 10.1161/01.RES.0000210539.54861.27; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Berkenbosch JW, 2000, AM J PHYSIOL-LUNG C, V278, pL276, DOI 10.1152/ajplung.2000.278.2.L276; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; CHANG SW, 1994, J APPL PHYSIOL, V77, P2817, DOI 10.1152/jappl.1994.77.6.2817; Chaouat A, 2009, CHEST, V136, P678, DOI 10.1378/chest.08-2420; CROUCH EC, 1989, AM REV RESPIR DIS, V140, P1045, DOI 10.1164/ajrccm/140.4.1045; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; DURMOWICZ AG, 1994, AM J PATHOL, V145, P1411; Fang F, 2011, CIRC RES, V108, P797, DOI 10.1161/CIRCRESAHA.111.240655; Fang MM, 2009, NUCLEIC ACIDS RES, V37, P4393, DOI 10.1093/nar/gkp398; Hanaoka M, 1998, CIRCULATION, V97, P1124, DOI 10.1161/01.CIR.97.12.1124; Jeong JK, 2012, BIOCHEM BIOPH RES CO, V429, P93, DOI 10.1016/j.bbrc.2012.10.086; Ko Eun A, 2010, Drug Discov Today Dis Models, V7, P123; Koizume S, 2012, NUCLEIC ACIDS RES, V40, P5389, DOI 10.1093/nar/gks201; Kong XC, 2009, J MOL CELL CARDIOL, V46, P748, DOI 10.1016/j.yjmcc.2009.01.011; Kong XC, 2009, J MOL CELL CARDIOL, V46, P292, DOI 10.1016/j.yjmcc.2008.10.023; Kubo K, 1998, RESP PHYSIOL, V111, P301, DOI 10.1016/S0034-5687(98)00006-1; Kuwahara K, 2010, MOL CELL BIOL, V30, P4134, DOI 10.1128/MCB.00154-10; Lee SM, 2010, J BIOL CHEM, V285, P22036, DOI 10.1074/jbc.M110.108878; Li J, 2012, DEVELOPMENT, V139, P3531, DOI 10.1242/dev.082222; Li M, 2011, J IMMUNOL, V187, P2711, DOI 10.4049/jimmunol.1100479; Luchsinger LL, 2011, J BIOL CHEM; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; POIANI GJ, 1992, CIRC RES, V70, P912, DOI 10.1161/01.RES.70.5.912; Prie S, 1997, J PHARMACOL EXP THER, V282, P1312; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Raiesdana A, 2006, ANN MED, V38, P95, DOI 10.1080/07853890600622143; Raychaudhuri B, 1999, AM J RESP CELL MOL, V21, P311, DOI 10.1165/ajrcmb.21.3.3611; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Stenmark KR, 2005, J APPL PHYSIOL, V98, P715, DOI 10.1152/japplphysiol.00840.2004; STENMARK KR, 1991, AM J PHYSIOL, V261, P97, DOI 10.1152/ajplung.1991.261.4.L97; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Tian W, 2012, HEPATOLOGY; Tsai BM, 2004, AM J PHYSIOL-LUNG C, V287, pL1215, DOI 10.1152/ajplung.00179.2004; Vergadi E, 2011, CIRCULATION, V123, P1986, DOI 10.1161/CIRCULATIONAHA.110.978627; VORABERGER G, 1991, J IMMUNOL, V147, P2777; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Xia J, 2012, BIOCHEM BIOPH RES CO, V428, P264, DOI 10.1016/j.bbrc.2012.10.043; Xu Y, 2011, AM J RESP CELL MOL, V44, P898, DOI 10.1165/rcmb.2009-0416OC; Zhao L, 2001, CIRCULATION, V104, P424, DOI 10.1161/hc2901.093117	44	8	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e83895	10.1371/journal.pone.0083895	http://dx.doi.org/10.1371/journal.pone.0083895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647044	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500001
J	Wang, Y; Yin, JY; Li, XP; Chen, J; Qian, CY; Zheng, Y; Fu, YL; Chen, ZY; Zhou, HH; Liu, ZQ				Wang, Ying; Yin, Ji-Ye; Li, Xiang-Ping; Chen, Juan; Qian, Chen-Yue; Zheng, Yi; Fu, Yi-Lan; Chen, Zi-Yu; Zhou, Hong-Hao; Liu, Zhao-Qian			The Association of Transporter Genes Polymorphisms and Lung Cancer Chemotherapy Response	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTER; MOLECULAR-MECHANISMS; PLATINUM RESISTANCE; TISSUE DISTRIBUTION; MESSENGER-RNA; CISPLATIN; EXPRESSION; TUMORS; PROTEIN; NEPHROTOXICITY	Lung cancer is one of the most common cancers and is the leading cause of death worldwide. Platinum-based chemotherapy is the main treatment method in lung cancer patients. Our previous studies indicated that single nucleotide polymorphisms (SNPs) in some transporter genes played important role in platinum-based chemotherapy efficacy. The aim of this study was to investigate the association of SNPs in transporter genes and platinum-based chemotherapy efficacy. The main polymorphisms on transporters OCT2, LRP, AQP2, AQP9 and TMEM205 genes were genotyped in 338 lung cancer patients. The rs195854 in genotypic model, rs896412 in genotypic and recessive models for all subjects showed significant association with chemotherapy response. In stratification analysis, TMEM205 rs896412, OCT2 rs1869641 and rs195854, AQP9 rs1516400 and AQP2 rs7314734 showed significant relation to chemotherapy response. In conclusion, the genetic polymorphisms in OCT2, AQP2, AQP9 and TMEM205 may contribute to chemotherapy response in lung cancer patients.	[Wang, Ying; Yin, Ji-Ye; Li, Xiang-Ping; Chen, Juan; Qian, Chen-Yue; Zheng, Yi; Zhou, Hong-Hao; Liu, Zhao-Qian] Cent South Univ, Hunan Key Lab Pharmacogenet, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China; [Fu, Yi-Lan; Chen, Zi-Yu] Cent South Univ, Affiliated Canc Hosp, XiangYa Sch Med, Changsha, Hunan, Peoples R China	Central South University; Central South University	Liu, ZQ (corresponding author), Cent South Univ, Hunan Key Lab Pharmacogenet, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China.	liuzhaoqian63@126.com	li, xiang/GWM-6319-2022; Yin, Ji-Ye/AAE-6794-2020	Yin, Ji-Ye/0000-0002-1244-5045; Liu, Zhaoqian/0000-0003-0428-3928	National High-tech R&D Program of China 863 Program [2012AA02A517]; National Natural Science Foundation of China [81173129, 81373490, 81202595]; Program for the Special Scientific Research Foundation of Doctor Disciplines in University of Ministry of Education of China [20110162110034]; Hunan Provincial Natural Science Foundation of China [12JJ7006]	National High-tech R&D Program of China 863 Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for the Special Scientific Research Foundation of Doctor Disciplines in University of Ministry of Education of China; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	This work was supported in part by National High-tech R&D Program of China 863 Program Grant 2012AA02A517 (ZYC)(http://www.863.gov.cn/), National Natural Science Foundation of China Grants 81173129 and 81373490 (ZYC), and 81202595 (JY)(http://scholarmate.nsfc.gov.cn/scm/), Program for the Special Scientific Research Foundation of Doctor Disciplines in University of Ministry of Education of China Grant 20110162110034 (ZYC), Hunan Provincial Natural Science Foundation of China Grant 12JJ7006 (ZYC)(http://www.hnst.gov.cn/zxgz/zkjj/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnouti Y, 2006, DRUG METAB DISPOS, V34, P477, DOI 10.1121/dmd.105.006932; Campa D, 2012, INT J CANCER, V131, P2920, DOI 10.1002/ijc.27567; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; Efferth T, 2005, PHARMACOL THERAPEUT, V107, P155, DOI 10.1016/j.pharmthera.2005.02.005; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Eymin B, 2001, ONCOGENE, V20, P1678, DOI 10.1038/sj.onc.1204242; Eymin B, 2003, ONCOGENE, V22, P1822, DOI 10.1038/sj.onc.1206303; Filipski KK, 2008, CLIN CANCER RES, V14, P3875, DOI 10.1158/1078-0432.CCR-07-4793; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fujita T, 2006, J PHARM SCI-US, V95, P25, DOI 10.1002/jps.20536; Groves CE, 2006, J PHARMACOL EXP THER, V316, P743, DOI 10.1124/jpet.105.094979; Gupta A, 2009, BIOSCI TRENDS, V3, P191; Hall MD, 2008, ANNU REV PHARMACOL, V48, P495, DOI 10.1146/annurev.pharmtox.48.080907.180426; Hida T, 1998, CANCER RES, V58, P3761; Innocenti F, 2009, J CLIN ONCOL, V27, P2604, DOI 10.1200/JCO.2008.20.6300; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kishore BK, 2000, KIDNEY INT, V58, P701, DOI 10.1046/j.1523-1755.2000.00216.x; Knepper MA, 1996, KIDNEY INT, V49, P1712, DOI 10.1038/ki.1996.253; Langer CJ, 2002, JNCI-J NATL CANCER I, V94, P173; Lilenbaum RC, 2005, J CLIN ONCOL, V23, P190, DOI 10.1200/JCO.2005.07.172; Ludwig T, 2004, KIDNEY INT, V66, P196, DOI 10.1111/j.1523-1755.2004.00720.x; Miao ZF, 2009, TOXICOL IN VITRO, V23, P209, DOI 10.1016/j.tiv.2008.11.011; Onuki N, 1999, CANCER, V85, P600, DOI 10.1002/(SICI)1097-0142(19990201)85:3<600::AID-CNCR10>3.0.CO;2-W; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pham DK, 2006, J CLIN ONCOL, V24, P1700, DOI 10.1200/JCO.2005.04.3224; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; ROWE JM, 1995, BLOOD, V86, P457, DOI 10.1182/blood.V86.2.457.bloodjournal862457; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Shen DW, 2012, PHARM RES-DORDR, V29, P643, DOI 10.1007/s11095-011-0562-y; Shen DW, 2010, J CELL PHYSIOL, V225, P822, DOI 10.1002/jcp.22287; Slitt AL, 2002, DRUG METAB DISPOS, V30, P212, DOI 10.1124/dmd.30.2.212; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Wang W, 2004, ONCOL REP, V12, P1365; Wernyj RP, 2004, DRUG RESIST UPDATE, V7, P227, DOI 10.1016/j.drup.2004.08.002; Wright SH, 2004, PHYSIOL REV, V84, P987, DOI 10.1152/physrev.00040.2003; Xu XJ, 2012, CLIN EXP PHARMACOL P, V39, P786, DOI 10.1111/j.1440-1681.2012.05741.x; Xu XJ, 2012, LUNG CANCER, V77, P438, DOI 10.1016/j.lungcan.2012.03.023; Zolk O, 2009, DRUG METAB DISPOS, V37, P1312, DOI 10.1124/dmd.108.023762	39	6	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91967	10.1371/journal.pone.0091967	http://dx.doi.org/10.1371/journal.pone.0091967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643204	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900051
J	Contreras-Vallejos, E; Utreras, E; Borquez, DA; Prochazkova, M; Terse, A; Jaffe, H; Toledo, A; Arruti, C; Pant, HC; Kulkarni, AB; Gonzalez-Billault, C				Contreras-Vallejos, Erick; Utreras, Elias; Borquez, Daniel A.; Prochazkova, Michaela; Terse, Anita; Jaffe, Howard; Toledo, Andrea; Arruti, Cristina; Pant, Harish C.; Kulkarni, Ashok B.; Gonzalez-Billault, Christian			Searching for Novel Cdk5 Substrates in Brain by Comparative Phosphoproteomics of Wild Type and Cdk5(-/-) Mice	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; ACTIVATED PROTEIN-KINASE; MONOCLONAL-ANTIBODY; C SUBSTRATE; PHOSPHORYLATION; MARCKS; EXPRESSION; IDENTIFICATION; DOUBLECORTIN; NEURONS	Protein phosphorylation is the most common post-translational modification that regulates several pivotal functions in cells. Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/threonine kinase which is mostly active in the nervous system. It regulates several biological processes such as neuronal migration, cytoskeletal dynamics, axonal guidance and synaptic plasticity among others. In search for novel substrates of Cdk5 in the brain we performed quantitative phosphoproteomics analysis, isolating phosphoproteins from whole brain derived from E18.5 Cdk5(+/+) and Cdk5(-/-) embryos, using an Immobilized Metal-Ion Affinity Chromatography (IMAC), which specifically binds to phosphorylated proteins. The isolated phosphoproteins were eluted and isotopically labeled for relative and absolute quantitation (iTRAQ) and mass spectrometry identification. We found 40 proteins that showed decreased phosphorylation at Cdk5(-/-) brains. In addition, out of these 40 hypophosphorylated proteins we characterized two proteins, : MARCKS (Myristoylated Alanine-Rich protein Kinase C substrate) and Grin1 (G protein regulated inducer of neurite outgrowth 1). MARCKS is known to be phosphorylated by Cdk5 in chick neural cells while Grin1 has not been reported to be phosphorylated by Cdk5. When these proteins were overexpressed in N2A neuroblastoma cell line along with p35, serine phosphorylation in their Cdk5 motifs was found to be increased. In contrast, treatments with roscovitine, the Cdk5 inhibitor, resulted in an opposite effect on serine phosphorylation in N2A cells and primary hippocampal neurons transfected with MARCKS. In summary, the results presented here identify Grin 1 as novel Cdk5 substrate and confirm previously identified MARCKS as a a bona fide Cdk5 substrate.	[Contreras-Vallejos, Erick; Utreras, Elias; Borquez, Daniel A.; Gonzalez-Billault, Christian] Univ Chile, Dept Biol, Lab Cellular & Neuronal Dynam, Fac Sci, Santiago, Chile; [Prochazkova, Michaela; Terse, Anita; Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, Funct Genom Sect, NIH, Bethesda, MD 20892 USA; [Jaffe, Howard] NINDS, Prot & Peptide Facil, NIH, Bethesda, MD 20892 USA; [Toledo, Andrea; Arruti, Cristina] Univ Repub, Fac Ciencias, Dept Biol Celular & Mol, Secci Biol Celular,Lab Cultivo Tejidos, Montevideo, Uruguay; [Pant, Harish C.] NINDS, Neurochem Lab, NIH, Bethesda, MD 20892 USA	Universidad de Chile; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Universidad de la Republica, Uruguay; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Kulkarni, AB (corresponding author), Natl Inst Dent & Craniofacial Res, Funct Genom Sect, NIH, Bethesda, MD 20892 USA.	ak40m@nih.gov; chrgonza@uchile.cl	Utreras, Elias/I-1038-2013; Gonzalez-Billault, Christian/P-2393-2019; Gonzalez-Billault, Christian/K-9622-2013	Utreras, Elias/0000-0002-1004-0466; Gonzalez-Billault, Christian/0000-0003-0335-1482; Toledo, Andrea/0000-0002-8310-8636	Fondecyt [1095089, ACT1114, PAI 79100009, 11110136]; Divisions of Intramural Research, National Institute of Dental and Craniofacial Research; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America;  [CONICYT-24120958];  [MECESUP-UCH7013]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003104] Funding Source: NIH RePORTER	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Divisions of Intramural Research, National Institute of Dental and Craniofacial Research; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America; ; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by CONICYT-24120958 and MECESUP-UCH7013 (EC) Fondecyt 1095089 and ACT1114 (to CG-B), PAI 79100009 and Fondecyt 11110136 (EU), and the Divisions of Intramural Research, National Institute of Dental and Craniofacial Research (ABK) and the National Institute of Neurological Disorders and Stroke (HCP), National Institutes of Health, Bethesda, Maryland, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arif A, 2012, BIOCHEM PHARMACOL, V84, P985, DOI 10.1016/j.bcp.2012.06.027; Bernasconi F, 2006, NEUROSIGNALS, V15, P180, DOI 10.1159/000096734; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Borquez DA, 2013, GENOMICS, V101, P221, DOI 10.1016/j.ygeno.2013.01.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Chen LT, 1999, J BIOL CHEM, V274, P26931, DOI 10.1074/jbc.274.38.26931; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Connell-Crowley L, 2000, CURR BIOL, V10, P599, DOI 10.1016/S0960-9822(00)00487-5; Contreras-Vallejos E, 2012, CELL SIGNAL, V24, P44, DOI 10.1016/j.cellsig.2011.08.022; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dosemeci A, 2010, BIOCHEM BIOPH RES CO, V391, P78, DOI 10.1016/j.bbrc.2009.10.167; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gatlin JC, 2006, MOL BIOL CELL, V17, P5115, DOI 10.1091/mbc.E05-12-1183; Gillardon F, 2005, J CELL BIOCHEM, V95, P817, DOI 10.1002/jcb.20463; Gillardon F, 2005, PROTEOMICS, V5, P1299, DOI 10.1002/pmic.200400992; Gonzalez-Billault C, 2000, HISTOL HISTOPATHOL, V15, P1177, DOI 10.14670/HH-15.1177; Goswami T, 2012, PROTEOMICS, V12, P2185, DOI 10.1002/pmic.201200003; GRAFF JM, 1989, MOL ENDOCRINOL, V3, P1903, DOI 10.1210/mend-3-11-1903; Graham ME, 2004, BIOCHEM J, V381, P471, DOI 10.1042/BJ20040324; Hahn CM, 2005, NEUROSCIENCE, V134, P449, DOI 10.1016/j.neuroscience.2005.04.020; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hawash Ammar H., 2007, Biotechnology Journal, V2, P941, DOI 10.1002/biot.200700093; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Henriquez DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053123; Hernandez F, 2013, J ALZHEIMERS DIS, V33, pS141, DOI 10.3233/JAD-2012-129025; Horiuchi Y, 2006, GENES CELLS, V11, P1393, DOI 10.1111/j.1365-2443.2006.01027.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Iida N, 2004, METHOD ENZYMOL, V390, P475; Jimenez-Mateos EM, 2005, J NEUROSCI RES, V80, P350, DOI 10.1002/jnr.20453; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Liu CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S25; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Luttrell DK, 2003, ASSAY DRUG DEV TECHN, V1, P327, DOI 10.1089/15406580360545143; Manenti S, 1999, BIOCHEM J, V340, P775, DOI 10.1042/0264-6021:3400775; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mosevitsky MI, 2005, INT REV CYTOL, V245, P245, DOI 10.1016/S0074-7696(05)45007-X; Nakata H, 2005, MOL PHARMACOL, V67, P695, DOI 10.1124/mol.104.003913; Nordman JC, 2012, J CELL SCI, V125, P5502, DOI 10.1242/jcs.110379; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Palmer RH, 1996, FEBS LETT, V378, P281, DOI 10.1016/0014-5793(95)01454-3; Pant AC, 1997, BRAIN RES, V765, P259, DOI 10.1016/S0006-8993(97)00561-1; Pigino G, 1997, J CELL SCI, V110, P257; Qin HX, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-73; Rudrabhatla P, 2010, FASEB J, V24, P4396, DOI 10.1096/fj.10-157859; Scarlett CO, 2003, DEV BRAIN RES, V144, P25, DOI 10.1016/S0165-3806(03)00155-x; Schnack C, 2008, PROTEOMICS, V8, P1980, DOI 10.1002/pmic.200701063; Sharma P, 2002, J BIOL CHEM, V277, P528, DOI 10.1074/jbc.M109324200; Solomonia RO, 2008, EXP BRAIN RES, V188, P323, DOI 10.1007/s00221-008-1428-3; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Sun KH, 2009, MOL BIOL CELL, V20, P4611, DOI 10.1091/mbc.E09-05-0433; Tanaka H, 2012, DEV BIOL, V370, P223, DOI 10.1016/j.ydbio.2012.07.032; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; TANIGUCHI H, 1994, J BIOL CHEM, V269, P18299; Terada M, 1998, J NEUROCHEM, V71, P2600; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Toledo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062863; Toledo A, 2009, BIOCHEM BIOPH RES CO, V383, P353, DOI 10.1016/j.bbrc.2009.04.029; Trivedi N, 2005, J CELL SCI, V118, P993, DOI 10.1242/jcs.01697; Tseng HC, 2005, CHEM BIOL, V12, P769, DOI 10.1016/j.chembiol.2005.05.012; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Utreras E, 2009, NEUROSCIENCE, V161, P978, DOI 10.1016/j.neuroscience.2009.04.002; Utreras E, 2012, J BIOL CHEM, V287, P16917, DOI 10.1074/jbc.M111.329979; Utreras Elias, 2009, Drug Discov Today Ther Strateg, V6, P105, DOI 10.1016/j.ddstr.2009.04.004; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; WU WCS, 1982, P NATL ACAD SCI-BIOL, V79, P5249, DOI 10.1073/pnas.79.17.5249; Zolessi FR, 2004, J PROTEOME RES, V3, P84, DOI 10.1021/pr034066f; Zolessi FR, 1999, BIOCHEM BIOPH RES CO, V257, P480, DOI 10.1006/bbrc.1999.0490; Zolessi FR, 2001, DEV BRAIN RES, V130, P257, DOI 10.1016/S0165-3806(01)00251-6	72	26	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90363	10.1371/journal.pone.0090363	http://dx.doi.org/10.1371/journal.pone.0090363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658276	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300016
J	Wu, HH; Yin, JB; Zhang, T; Cui, YY; Dong, YL; Chen, GZ; Wang, W				Wu, Huang-Hui; Yin, Jun-Bin; Zhang, Ting; Cui, Yuan-Yuan; Dong, Yu-Lin; Chen, Guo-Zhong; Wang, Wen			Inhibiting Spinal Neuron-Astrocytic Activation Correlates with Synergistic Analgesia of Dexmedetomidine and Ropivacaine	PLOS ONE			English	Article							NEUROPATHIC PAIN; NERVE LIGATION; MECHANICAL ALLODYNIA; CAUSES NEUROTOXICITY; GLIAL ACTIVATION; JNK ACTIVATION; RAT MODEL; KETAMINE; CELLS; CORD	Background: This study aims to identify that intrathecal (i.t.) injection of dexmedetomidine (Dex) and ropivacaine (Ropi) induces synergistic analgesia on chronic inflammatory pain and is accompanied with corresponding "neuron-astrocytic" alterations. Methods: Male, adult Sprague-Dawley rats were randomly divided into sham, control and i.t. medication groups. The analgesia profiles of i.t. Dex, Ropi, and their combination detected by Hargreaves heat test were investigated on the subcutaneous (s.c.) injection of complete Freund adjuvant (CFA) induced chronic pain in rat and their synergistic analgesia was confirmed by using isobolographic analysis. During consecutive daily administration, pain behavior was daily recorded, and immunohistochemical staining was applied to investigate the number of Fos-immunoreactive (Fos-ir) neurons on hour 2 and day 1, 3 and 7, and the expression of glial fibrillary acidic protein (GFAP) within the spinal dorsal horn (SDH) on day 1, 3, 5 and 7 after s.c. injection of CFA, respectively, and then Western blot to examine spinal GFAP and beta-actin levels on day 3 and 7. Results: i.t. Dex or Ropi displayed a short-term analgesia in a dose-dependent manner, and consecutive daily administrations of their combination showed synergistic analgesia and remarkably down-regulated neuronal and astrocytic activations indicated by decreases in the number of Fos-ir neurons and the GFAP expression within the SDH, respectively. Conclusion: i.t. co-delivery of Dex and Ropi shows synergistic analgesia on the chronic inflammatory pain, in which spinal "neuron-astrocytic activation" mechanism may play an important role.	[Wu, Huang-Hui; Chen, Guo-Zhong] Fuzhou Gen Hosp Nanjing Mil Reg, Dept Anesthesiol, Fuzhou, Peoples R China; [Yin, Jun-Bin; Zhang, Ting; Cui, Yuan-Yuan; Dong, Yu-Lin; Wang, Wen] Fourth Mil Med Univ, Preclin Sch Med, Dept Anat Histol & Embryol, Xian 710032, Peoples R China; [Yin, Jun-Bin; Zhang, Ting; Cui, Yuan-Yuan; Dong, Yu-Lin; Wang, Wen] Fourth Mil Med Univ, Preclin Sch Med, KK Leung Brain Res Ctr, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Chen, GZ (corresponding author), Fuzhou Gen Hosp Nanjing Mil Reg, Dept Anesthesiol, Fuzhou, Peoples R China.	cgzssq2000@sina.com; wangwen@fmmu.edu.cn			NSFC [31070976, 81271230]; Fourth Military Medical University	NSFC(National Natural Science Foundation of China (NSFC)); Fourth Military Medical University	This work is partly supported by the NSFC (31070976, 81271230) and intramural grant of the Fourth Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT FV, 1984, BRAIN RES, V295, P77, DOI 10.1016/0006-8993(84)90817-5; Al-Mustafa MM, 2009, SAUDI MED J, V30, P365; Bai L, 2012, PAIN PHYSICIAN, V15, P311; BOURGOIN S, 1993, NEUROPHARMACOLOGY, V32, P633, DOI 10.1016/0028-3908(93)90076-F; Bruzzone A, 2008, BRIT J PHARMACOL, V155, P494, DOI 10.1038/bjp.2008.278; Chichorro JG, 2004, BRIT J PHARMACOL, V141, P1175, DOI 10.1038/sj.bjp.0705724; Dadure C, 2012, PEDIATR ANESTH, V22, P93, DOI 10.1111/j.1460-9592.2011.03730.x; Gandhi Kishor, 2012, Anesthesiol Clin, V30, pe1; GOLDMAN JA, 1958, BRIT J ANAESTH, V30, P377, DOI 10.1093/bja/30.8.377; Grosu Irina, 2010, F1000 Med Rep, V2, P90, DOI 10.3410/M2-90; Guo BL, 2013, MITOCHONDRION, V13, P292, DOI 10.1016/j.mito.2013.03.007; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Gupta R, 2011, INDIAN J ANAESTH, V55, P347, DOI 10.4103/0019-5049.84841; Gupta Rajni, 2011, J Anaesthesiol Clin Pharmacol, V27, P339, DOI 10.4103/0970-9185.83678; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Harsten A, 2013, BRIT J ANAESTHESIA; HOLZ GG, 1989, J NEUROSCI, V9, P657; Huang R, 2000, BRAIN RES, V873, P297, DOI 10.1016/S0006-8993(00)02525-7; Ihmsen H, 2012, ANAESTHESIST, V61, P1059, DOI 10.1007/s00101-012-2114-1; Jones L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009234.pub2; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kanazi GE, 2006, ACTA ANAESTH SCAND, V50, P222, DOI 10.1111/j.1399-6576.2006.00919.x; Katsura H, 2008, GLIA, V56, P723, DOI 10.1002/glia.20648; Kimura M, 2012, NEUROSCI LETT, V529, P70, DOI 10.1016/j.neulet.2012.08.008; Li SS, 2013, CNS NEUROSCI THER, V19, P364, DOI 10.1111/cns.12100; Li XH, 2001, J PHARMACOL EXP THER, V299, P939; Liang LL, 2013, BRAIN RES, V1513, P17, DOI 10.1016/j.brainres.2013.04.003; Liu L, 2012, BRAIN RES, V1427, P1, DOI 10.1016/j.brainres.2011.08.019; Mei XP, 2011, NEUROSIGNALS, V19, P44, DOI 10.1159/000324293; Mei XP, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-6; Mei XP, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-50; Mei XP, 2009, J NEUROCHEM, V109, P1691, DOI 10.1111/j.1471-4159.2009.06087.x; Mohamed AA, 2012, PAIN PHYSICIAN, V15, P339; Mori K, 2002, NEUROPHARMACOLOGY, V43, P1026, DOI 10.1016/S0028-3908(02)00211-3; Nishimori M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005059.pub3; Oka M, 2006, BIOCHEM BIOPH RES CO, V341, P874, DOI 10.1016/j.bbrc.2006.01.039; Perrott DH, 2008, CURR OPIN ANESTHESIO, V21, P480, DOI 10.1097/ACO.0b013e3283063499; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sanders RD, 2010, ACTA ANAESTH SCAND, V54, P710, DOI 10.1111/j.1399-6576.2009.02177.x; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shukla Deepika, 2011, J Anaesthesiol Clin Pharmacol, V27, P495, DOI 10.4103/0970-9185.86594; Simmons SW, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003401.pub3; Sites BD, 2012, REGION ANESTH PAIN M, V37, P478, DOI 10.1097/AAP.0b013e31825cb3d6; Solanki SL, 2013, ANAESTH INTENS CARE, V41, P51, DOI 10.1177/0310057X1304100110; Stone LS, 1998, J NEUROSCI, V18, P5928; Sun YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076603; Sun ZH, 2012, ANAESTH INTENS CARE, V40, P825, DOI 10.1177/0310057X1204000427; Sun ZH, 2012, MOL MED REP, V6, P1455, DOI 10.3892/mmr.2012.1115; Suter MR, 2007, NEURON GLIA BIOL, V3, P255, DOI 10.1017/S1740925X08000100; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Thorlin T, 1998, NEUROPHARMACOLOGY, V37, P299, DOI 10.1016/S0028-3908(98)00026-4; Toda S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-2; Wang W, 2008, ANAT REC, V291, P513, DOI 10.1002/ar.20673; Wang W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006973; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Werdehausen R, 2009, BRIT J ANAESTH, V103, P711, DOI 10.1093/bja/aep236; Wirkner K, 2007, CEREB CORTEX, V17, P621, DOI 10.1093/cercor/bhk012; Xu B, 2010, CLIN EXP PHARMACOL P, V37, pe158, DOI 10.1111/j.1440-1681.2010.05426.x; Yan M, 2011, NEUROCHEM INT, V58, P549, DOI 10.1016/j.neuint.2011.01.013; Yaster M, 2011, ANESTHESIOLOGY, V114, P412, DOI 10.1097/ALN.0b013e318205df50; Yuan X, 2013, EUROPEAN J ANAESTHES; Zhang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055556; Zhong Z, 2009, ANAESTH INTENS CARE, V37, P929, DOI 10.1177/0310057X0903700612; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	66	14	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92374	10.1371/journal.pone.0092374	http://dx.doi.org/10.1371/journal.pone.0092374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658263	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300076
J	Yousuf, S; Duan, ML; Moen, EL; Cross-Knorr, S; Brilliant, K; Bonavida, B; LaValle, T; Yeung, KC; Al-Mulla, F; Chin, EG; Chatterjee, D				Yousuf, Saad; Duan, Meili; Moen, Erika L.; Cross-Knorr, Sam; Brilliant, Kate; Bonavida, Benjamin; LaValle, Theresa; Yeung, Kam C.; Al-Mulla, Fahd; Chin, Eugene; Chatterjee, Devasis			Raf Kinase Inhibitor Protein (RKIP) Blocks Signal Transducer and Activator of Transcription 3 (STAT3) Activation in Breast and Prostate Cancer	PLOS ONE			English	Article							CONSTITUTIVE ACTIVATION; EPITHELIAL-CELLS; MOLECULAR TARGETS; MYELOMA CELLS; ANTITUMOR-ACTIVITY; COLORECTAL-CANCER; TUMOR PROGRESSION; INDUCED APOPTOSIS; PLASMA-MEMBRANES; MULTIPLE-MYELOMA	Raf kinase inhibitor protein (RKIP) is a member of the phosphatidylethanolamine-binding-protein (PEBP) family that modulates the action of many kinases involved in cellular growth, apoptosis, epithelial to mesenchymal transition, motility, invasion and metastasis. Previously, we described an inverse association between RKIP and signal transducers and activators of transcription 3 (STAT3) expression in gastric adenocarcinoma patients. In this study, we elucidated the mechanism by which RKIP regulates STAT3 activity in breast and prostate cancer cell lines. RKIP over expression inhibited c-Src autophosphorylation and activation, as well as IL-6-, JAK1 and 2-, and activated Raf-mediated STAT3 tyrosine and serine phosphorylation and subsequent activation. In MDA-231 breast cancer cells that stably over express RKIP, IL-6 treatment blocked STAT3 phosphorylation and transcriptional activation. Conversely, in RKIP knockdown MDA-231 cells: STAT3 phosphorylation and activation increased in comparison to parental MDA-231 cells. RKIP over expression resulted in constitutive physical interaction with STAT3 and blocked c-Src and STAT3 association. The treatment of DU145 prostate, but not PC3 prostate or MDA-231 breast, cancer cell lines with ENMD-1198 or MKC-1 dramatically increased expression of RKIP. Overexpression of RKIP sensitized PC3 and MDA-231 cells to MTI-induced apoptosis. Moreover, MTI treatment resulted in a decrease in Src-mediated STAT3 tyrosine phosphorylation and activation, an effect that was significantly enhanced by RKIP over expression. In stable RKIP over expressing MDA-231 cells, tumor xenograft growth induced by activated STAT3 is inhibited. RKIP synergizes with MTIs to induce apoptosis and inhibit STAT3 activation of breast and prostate cancer cells. RKIP plays a critical role in opposing the effects of pro-oncogenic STAT3 activation.	[Yousuf, Saad; Duan, Meili; Moen, Erika L.; Cross-Knorr, Sam; Brilliant, Kate; Chin, Eugene; Chatterjee, Devasis] Brown Univ, Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Yousuf, Saad; Duan, Meili; Moen, Erika L.; Cross-Knorr, Sam; Brilliant, Kate; Chin, Eugene; Chatterjee, Devasis] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Duan, Meili] Capital Med Univ, Beijing Friendship Hosp, Dept Crit Care Med, Beijing, Peoples R China; [Bonavida, Benjamin] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA USA; [LaValle, Theresa] Kolltan Pharmaceut Inc, New Haven, CT USA; [Yeung, Kam C.] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43606 USA; [Al-Mulla, Fahd] Kuwait Univ, Fac Med, Dept Pathol, Safat, Kuwait; [Chin, Eugene] Brown Univ, Rhode Isl Hosp, Dept Surg Res, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Capital Medical University; University of California System; University of California Los Angeles; University System of Ohio; University of Toledo; Kuwait University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Chatterjee, D (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA.	Devasis_Chatterjee@brown.edu	Al-Mulla, Fahd/E-2068-2015	Al-Mulla, Fahd/0000-0001-5409-3829; Moen, Erika/0000-0002-9800-8742	U.S. Army Medical Breast Cancer Research Program under Materiel Command [W81XWH-07-1-0556, W81XWH-08-1-0516]; National Institute of General Medical Sciences of the National Institutes of Health [P20GM103421]; National Center for Research Resources (NCRR) [P20 RR 017695, 1R01 CA102128-01A2]; NATIONAL CANCER INSTITUTE [R01CA102128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103421] Funding Source: NIH RePORTER	U.S. Army Medical Breast Cancer Research Program under Materiel Command; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. Army Medical Breast Cancer Research Program under Materiel Command W81XWH-07-1-0556 and W81XWH-08-1-0516 (DC). Research reported in this publication was also supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM103421. The previous segment of this project was supported by the National Center for Research Resources (NCRR) under P20 RR 017695 (DC) and 1R01 CA102128-01A2 (EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mulla F, 2006, J CLIN ONCOL, V24, P5672, DOI 10.1200/JCO.2006.07.5499; Al-Mulla F, 2013, J CELL PHYSIOL, V228, P1688, DOI 10.1002/jcp.24335; al-Mulla F, 2011, MOL BIOSYST, V7, P928, DOI 10.1039/c0mb00208a; Al-Mulla F, 2011, CANCER RES, V71, P1334, DOI 10.1158/0008-5472.CAN-10-3102; Alas S, 2003, CLIN CANCER RES, V9, P316; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Barton BE, 2004, MOL CANCER THER, V3, P11; Beach S, 2008, ONCOGENE, V27, P2243, DOI 10.1038/sj.onc.1210860; Behera R, 2010, CARCINOGENESIS, V31, P192, DOI 10.1093/carcin/bgp289; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Blaskovich MA, 2003, CANCER RES, V63, P1270; Buettner R, 2002, CLIN CANCER RES, V8, P945; Burke PA ZX, 2007, AACR NCI EORTC INT B, VB290; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chatterjee D, 2004, J BIOL CHEM, V279, P17515, DOI 10.1074/jbc.M313816200; Chatterjee D, 1996, ANN NY ACAD SCI, V803, P143, DOI 10.1111/j.1749-6632.1996.tb26383.x; Chatterjee D, 2001, CANCER RES, V61, P7148; Chatterjee D, 2008, CLIN CANCER RES, V14, P2994, DOI 10.1158/1078-0432.CCR-07-4496; Chauhan D, 2003, BLOOD, V101, P3606, DOI 10.1182/blood-2002-10-3146; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; Clifton JG, 2007, J CHROMATOGR B, V849, P293, DOI 10.1016/j.jchromb.2006.08.047; Constancio-Lund SS, 2009, MOL CARCINOGEN, V48, P156, DOI 10.1002/mc.20466; CUSHMAN M, 1995, J MED CHEM, V38, P2041, DOI 10.1021/jm00012a003; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Darnowski JW, 2006, J BIOL CHEM, V281, P17707, DOI 10.1074/jbc.M600088200; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Deng JX, 2007, CURR CANCER DRUG TAR, V7, P91, DOI 10.2174/156800907780006922; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Duhe RJ, 2001, CELL BIOCHEM BIOPHYS, V34, P17, DOI 10.1385/CBB:34:1:17; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Fernandes A, 1999, INT J CANCER, V83, P564, DOI 10.1002/(SICI)1097-0215(19991112)83:4<564::AID-IJC20>3.0.CO;2-Q; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Gao B, 2001, FEBS LETT, V488, P179, DOI 10.1016/S0014-5793(00)02430-3; GAO SP, 2006, SCI STKE; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Germain D, 2007, CLIN CANCER RES, V13, P5665, DOI 10.1158/1078-0432.CCR-06-2491; Grandis JR, 2000, LARYNGOSCOPE, V110, P868, DOI 10.1097/00005537-200005000-00016; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Haldar S, 1996, CANCER RES, V56, P1253; Heim MH, 1999, J RECEPT SIGNAL TR R, V19, P75, DOI 10.3109/10799899909036638; Iancu C, 2000, CANCER RES, V60, P3537; Josic D, 2005, ELECTROPHORESIS, V26, P2809, DOI 10.1002/elps.200500060; Karni R, 1999, ONCOGENE, V18, P4654, DOI 10.1038/sj.onc.1202835; Keller ET, 2004, CANCER LETT, V207, P131, DOI 10.1016/j.canlet.2004.02.006; LaVallee TM, 2008, MOL CANCER THER, V7, P1472, DOI 10.1158/1535-7163.MCT-08-0107; LaVallee TM BP, 2007, P AM ASSOC CANC RES, V48, P498; Lawson EL, 2006, ELECTROPHORESIS, V27, P2747, DOI 10.1002/elps.200600059; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lin TS, 2000, ONCOGENE, V19, P2496, DOI 10.1038/sj.onc.1203486; Minoo P, 2007, AM J CLIN PATHOL, V127, P820, DOI 10.1309/5D7MM22DAVGDT1R8; Nam S, 2005, P NATL ACAD SCI USA, V102, P5998, DOI 10.1073/pnas.0409467102; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez, 1998, Oncologist, V3, P373; Puthier D, 1999, EUR J IMMUNOL, V29, P3945, DOI 10.1002/(SICI)1521-4141(199912)29:12<3945::AID-IMMU3945>3.0.CO;2-O; ROTH BJ, 1993, CANCER, V72, P2457, DOI 10.1002/1097-0142(19931015)72:8<2457::AID-CNCR2820720825>3.0.CO;2-Z; Schuierer MM, 2004, CANCER RES, V64, P5186, DOI 10.1158/0008-5472.CAN-03-3861; Severin FF, 1997, NATURE, V388, P888, DOI 10.1038/42270; Shim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067604; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Slupsky JR, 1999, CURR BIOL, V9, P971, DOI 10.1016/S0960-9822(99)80426-6; SPEICHER LA, 1992, CANCER RES, V52, P4433; SUMANTRAN VN, 1995, CANCER RES, V55, P2507; Turkson J, 2004, MOL CANCER THER, V3, P261; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; WeberNordt RM, 1996, BLOOD, V88, P809; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yuan ZL, 2004, MOL CELL BIOL, V24, P9390, DOI 10.1128/MCB.24.21.9390-9400.2004; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	76	40	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92478	10.1371/journal.pone.0092478	http://dx.doi.org/10.1371/journal.pone.0092478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658061	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300088
J	Bailey, AL; Lauck, M; Weiler, A; Sibley, SD; Dinis, JM; Bergman, Z; Nelson, CW; Correll, M; Gleicher, M; Hyeroba, D; Tumukunde, A; Weny, G; Chapman, C; Kuhn, JH; Hughes, AL; Friedrich, TC; Goldberg, TL; O'Connor, DH				Bailey, Adam L.; Lauck, Michael; Weiler, Andrea; Sibley, Samuel D.; Dinis, Jorge M.; Bergman, Zachary; Nelson, Chase W.; Correll, Michael; Gleicher, Michael; Hyeroba, David; Tumukunde, Alex; Weny, Geoffrey; Chapman, Colin; Kuhn, Jens H.; Hughes, Austin L.; Friedrich, Thomas C.; Goldberg, Tony L.; O'Connor, David H.			High Genetic Diversity and Adaptive Potential of Two Simian Hemorrhagic Fever Viruses in a Wild Primate Population	PLOS ONE			English	Article							RESPIRATORY-SYNDROME-VIRUS; DEHYDROGENASE-ELEVATING VIRUS; N-LINKED GLYCOSYLATION; NEUTRALIZATION EPITOPE; ANTIBODY NEUTRALIZATION; MOLECULAR-BIOLOGY; GP5; IDENTIFICATION; GLYCOPROTEIN; EMERGENCE	Key biological properties such as high genetic diversity and high evolutionary rate enhance the potential of certain RNA viruses to adapt and emerge. Identifying viruses with these properties in their natural hosts could dramatically improve disease forecasting and surveillance. Recently, we discovered two novel members of the viral family Arteriviridae: simian hemorrhagic fever virus (SHFV)-krc1 and SHFV-krc2, infecting a single wild red colobus (Procolobus rufomitratus tephrosceles) in Kibale National Park, Uganda. Nearly nothing is known about the biological properties of SHFVs in nature, although the SHFV type strain, SHFV-LVR, has caused devastating outbreaks of viral hemorrhagic fever in captive macaques. Here we detected SHFV-krc1 and SHFV-krc2 in 40% and 47% of 60 wild red colobus tested, respectively. We found viral loads in excess of 10(6)-10(7) RNA copies per milliliter of blood plasma for each of these viruses. SHFV-krc1 and SHFV-krc2 also showed high genetic diversity at both the inter-and intra-host levels. Analyses of synonymous and non-synonymous nucleotide diversity across viral genomes revealed patterns suggestive of positive selection in SHFV open reading frames (ORF) 5 (SHFV-krc2 only) and 7 (SHFV-krc1 and SHFV-krc2). Thus, these viruses share several important properties with some of the most rapidly evolving, emergent RNA viruses.	[Bailey, Adam L.; Lauck, Michael; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Bailey, Adam L.; Lauck, Michael; Weiler, Andrea; Sibley, Samuel D.; Bergman, Zachary; Friedrich, Thomas C.; Goldberg, Tony L.; O'Connor, David H.] Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Weiler, Andrea; Sibley, Samuel D.; Dinis, Jorge M.; Bergman, Zachary; Friedrich, Thomas C.; Goldberg, Tony L.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Nelson, Chase W.; Hughes, Austin L.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Correll, Michael; Gleicher, Michael] Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA; [Hyeroba, David; Tumukunde, Alex; Weny, Geoffrey; Chapman, Colin] Makerere Univ, Kampala, Uganda; [Chapman, Colin] McGill Univ, Dept Anthropol, Montreal, PQ, Canada; [Chapman, Colin] McGill Univ, Sch Environm, Montreal, PQ, Canada; [Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Wisconsin System; University of Wisconsin Madison; Makerere University; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	O'Connor, DH (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.	dhoconno@wisc.edu	Kuhn, Jens H./B-7615-2011; Chapman, Colin/S-1911-2019	Kuhn, Jens H./0000-0002-7800-6045; Chapman, Colin/0000-0002-8827-8140; Friedrich, Thomas/0000-0001-9831-6895; Nelson, Chase/0000-0001-6287-1598; o'connor, david/0000-0003-2139-470X; Sibley, Samuel/0000-0002-6754-3187; Bergman, Zachary/0000-0002-2924-2965	US Department of Health and Human Services [HHSN272200700016I]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077376, R01AI098420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081061, T32GM008692] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER; Div Of Information & Intelligent Systems [1162037] Funding Source: National Science Foundation	US Department of Health and Human Services; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	Jens H. Kuhn is employed by a commercial company, Tunnell Government Services, Inc. Tunnell is a subcontractor to Battelle Memorial Institute, which is the primary contractor to NIH to run the NIH facility "Integrated Research Facility at Fort Detrick". As the authors pointed out in the disclaimer, Tunnell's involvement with Battelle, and Battelle's involvement with NIH is stipulated in US Department of Health and Human Services contract HHSN272200700016I. All work performed by Jens H. Kuhn (and all other Tunnell IRF employees) is property of the US government under the contract. Jens H. Kuhn therefore has no competing interests. The affiliation with Tunnell/Battelle does not alter Jens H. Kuhn's adherence to all PLOS ONE policies on sharing data and materials. To be completely clear, this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN AM, 1968, AM J TROP MED HYG, V17, P413, DOI 10.4269/ajtmh.1968.17.413; Ansari IH, 2006, J VIROL, V80, P3994, DOI 10.1128/JVI.80.8.3994-4004.2006; Apetrei C, 2004, FRONT BIOSCI-LANDMRK, V9, P225, DOI 10.2741/1154; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Balasuriya UBR, 1997, VIROLOGY, V232, P114, DOI 10.1006/viro.1997.8551; Borderia AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010319; BRIERLEY I, 1995, J GEN VIROL, V76, P1885, DOI 10.1099/0022-1317-76-8-1885; Chapman CA, 1996, INT J PRIMATOL, V17, P31, DOI 10.1007/BF02696157; Chen ZY, 2000, VIROLOGY, V266, P88, DOI 10.1006/viro.1999.0050; Chen ZY, 1999, J NEUROVIROL, V5, P200, DOI 10.3109/13550289909022003; de Lima M, 2009, VIROLOGY, V390, P31, DOI 10.1016/j.virol.2009.04.017; de Oliveira T, 2004, GENETICS, V167, P1047, DOI 10.1534/genetics.103.018135; Dokland T, 2010, VIRUS RES, V154, P86, DOI 10.1016/j.virusres.2010.07.029; Duran JP, 1997, VIRUS GENES, V14, P19, DOI 10.1023/A:1007931322271; Faaberg KS, 1997, VIROLOGY, V227, P245, DOI 10.1006/viro.1996.8310; Fang Y, 2012, P NATL ACAD SCI USA, V109, pE2920, DOI 10.1073/pnas.1211145109; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Goldberg TL, 2012, CONSERVATION MED APP; Gonin P, 1998, ARCH VIROL, V143, P1927, DOI 10.1007/s007050050430; GRAVELL M, 1986, P SOC EXP BIOL MED, V181, P112; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hedges JF, 1999, VIROLOGY, V264, P92, DOI 10.1006/viro.1999.9982; Hofmann K., 1993, BIOL CHEM HOPPE SEYL, V374; Holmes E., 2009, EVOLUTION EMERGENCE; Holmes EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000505; Hughes AL, 2001, J VIROL, V75, P7966, DOI 10.1128/JVI.75.17.7966-7972.2001; Johnson RF, 2011, VIROLOGY, V421, P129, DOI 10.1016/j.virol.2011.09.016; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kimura M., 1983, NEUTRAL THEORY MOL E; King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAPIN B. A., 1967, VOP VIRUSOL, V12, P168; Lauck M, 2013, J VIROL, V87, P688, DOI 10.1128/JVI.02433-12; Lauck M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019056; LONDON WT, 1977, NATURE, V268, P344, DOI 10.1038/268344a0; Lu ZC, 2012, VIROLOGY, V432, P99, DOI 10.1016/j.virol.2012.05.022; Mardassi H, 1998, J VIROL, V72, P6298, DOI 10.1128/JVI.72.8.6298-6306.1998; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ni JQ, 2012, J VET DIAGN INVEST, V24, P349, DOI 10.1177/1040638711434111; NOVELLA IS, 1995, P NATL ACAD SCI USA, V92, P5841, DOI 10.1073/pnas.92.13.5841; Ostrowski M, 2002, J VIROL, V76, P4241, DOI 10.1128/JVI.76.9.4241-4250.2002; PALMER AE, 1968, AM J TROP MED HYG, V17, P404, DOI 10.4269/ajtmh.1968.17.404; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plagemann PGW, 2004, VET IMMUNOL IMMUNOP, V102, P263, DOI 10.1016/j.vetimm.2004.09.011; Plagemann PGW, 2002, ARCH VIROL, V147, P2327, DOI 10.1007/s00705-002-0887-2; Plagemann PGW, 2001, VIROLOGY, V290, P11, DOI 10.1006/viro.2001.1139; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Struhsaker T, 2008, IUCN 2013 IUCN RED L; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAURASO NM, 1968, AM J TROP MED HYG, V17, P422, DOI 10.4269/ajtmh.1968.17.422; Tian DB, 2012, J VIROL, V86, P3701, DOI 10.1128/JVI.06836-11; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Van Breedam W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000730; van Marle G, 1999, P NATL ACAD SCI USA, V96, P12056, DOI 10.1073/pnas.96.21.12056; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Vu HLX, 2011, J VIROL, V85, P5555, DOI 10.1128/JVI.00189-11; Wasserman MD, 2013, INT J PRIMATOL, V34, P1020, DOI 10.1007/s10764-013-9711-y; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wieringa R, 2002, J VIROL, V76, P10829, DOI 10.1128/JVI.76.21.10829-10840.2002; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354; Wright CF, 2011, J VIROL, V85, P2266, DOI 10.1128/JVI.01396-10; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	68	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90714	10.1371/journal.pone.0090714	http://dx.doi.org/10.1371/journal.pone.0090714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651479	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800021
J	Gao, YL; Reitz, SR; Wei, QB; Yu, WY; Zhang, Z; Lei, ZR				Gao, Yulin; Reitz, Stuart R.; Wei, Qingbo; Yu, Wenyan; Zhang, Zhi; Lei, Zhongren			Local Crop Planting Systems Enhance Insecticide-Mediated Displacement of Two Invasive Leafminer Fly	PLOS ONE			English	Article							DIGLYPHUS-ISAEA HYMENOPTERA; LIRIOMYZA-TRIFOLII DIPTERA; AGROMYZIDAE; SATIVAE; SUSCEPTIBILITY; HUIDOBRENSIS; EULOPHIDAE; PARASITISM; ABAMECTIN	Liriomyza sativae and L. trifolii are highly invasive leafminer pests of vegetable crops that have invaded southern China in recent years. Liriomyza sativae was the first of these species to invade China, but it is now being displaced by L. trifolii. The rate and extent of this displacement vary across southern China. In Hainan, monocultures of highly valuable cowpea are planted and treated extensively with insecticides in attempts to control leafminer damage. In Guangdong, cowpea fields are interspersed with other less valuable crops, such as towel gourd (Luffa cylindrica), which receive significantly fewer insecticide applications than cowpea. To determine how differences in cropping systems influence the Liriomyza species composition, we conducted field trials in 2011 and 2012 in Guangdong where both species were present. We replicated conditions in Hainan by planting cowpea monocultures that were isolated from other agricultural fields, and we replicated conditions in Guangdong by planting cowpea in a mixed crop environment with towel gourd planted in neighboring plots. We then compared leafminer populations in cowpea treated with the insecticide avermectin and untreated cowpea. We also monitored leafminer populations in the untreated towel gourd. Untreated cowpea and towel gourd had comparatively low proportions of L. trifolii, which remained relatively stable over the course of each season. Avermectin applications led to increases in the proportions of L. trifolii, and after three weekly applications populations were >95% L. trifolii in both crop systems. However, the rate of change and persistence of L. trifolii in the mixed crop system were less than in the monocrop. These results indicate that L. trifolii is much less susceptible to avermectin than is L. sativae. Further, L. sativae was able to persist in the untreated towel gourd, which probably enabled it to recolonize treated cowpea.	[Gao, Yulin; Wei, Qingbo; Yu, Wenyan; Zhang, Zhi; Lei, Zhongren] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Reitz, Stuart R.] Oregon State Univ, Dept Crop & Soil Sci, Ontario, OR USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Oregon State University	Gao, YL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	ylgao@ippcaas.cn; leizr@sina.com	Gao, Yu/HGE-1937-2022; Reitz, Stuart/AAC-4467-2019		National Key Basic Research Program [2009CB119004]; China Agriculture Research System [CARS-25-B-07]	National Key Basic Research Program(National Basic Research Program of China); China Agriculture Research System	This work was supported in part by the National Key Basic Research Program (973 Projects Grant 2009CB119004) and the China Agriculture Research System (CARS-25-B-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, BIOL INVASIONS, V10, P951, DOI 10.1007/s10530-007-9173-2; Chen XX, 2003, BIOCONTROL, V48, P515, DOI 10.1023/A:1025726813462; Gao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036622; Gao YL, 2011, J ECON ENTOMOL, V104, P1771, DOI 10.1603/EC11206; JOHNSON MW, 1987, J ECON ENTOMOL, V80, P56, DOI 10.1093/jee/80.1.56; KANG L, 1996, ECOLOGY SUSTAINABLE; Kaspi R, 2005, BIOL CONTROL, V35, P172, DOI 10.1016/j.biocontrol.2005.07.021; [雷仲仁 Lei Zhongren], 2007, [植物保护, Plant Protection], V33, P37; Lei ZR, 2005, BIOL MANAGEMENT INVA, P177; MASON GA, 1987, J ECON ENTOMOL, V80, P1262, DOI 10.1093/jee/80.6.1262; Mujica N, 2011, ENVIRON ENTOMOL, V40, P217, DOI 10.1603/EN10170; Musundire R, 2012, J ECON ENTOMOL, V105, P161, DOI 10.1603/EC10420; OATMAN E R, 1976, Journal of Economic Entomology, V69, P667, DOI 10.1093/jee/69.5.667; PALUMBO JC, 1994, J ECON ENTOMOL, V87, P1070, DOI 10.1093/jee/87.4.1070; PARRELLA M P, 1985, Journal of Agricultural Entomology, V2, P234; PARRELLA MP, 1987, ANNU REV ENTOMOL, V32, P201, DOI 10.1146/annurev.en.32.010187.001221; Purcell Mary F., 1995, Proceedings of the Hawaiian Entomological Society, V32, P45; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; Reitz SR, 2013, INSECTICIDES DEV SAF; Tokumaru S, 2005, JPN J APPL ENTOMOL Z, V49, P1, DOI 10.1303/jjaez.2005.1; Weintraub PG, 2001, CROP PROT, V20, P207, DOI 10.1016/S0261-2194(00)00128-9; Zehnder G. W., 1984, California Agriculture, V38, P7; ZEHNDER GW, 1984, ENVIRON ENTOMOL, V13, P492, DOI 10.1093/ee/13.2.492; Zhang WenJun, 2011, Proceedings of the International Academy of Ecology and Environmental Sciences, V1, P125; Zhong PingSheng, 2010, Guangxi Agricultural Sciences, V41, P338	25	14	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92625	10.1371/journal.pone.0092625	http://dx.doi.org/10.1371/journal.pone.0092625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651465	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800135
J	Kooistra, SM; Norgaard, LCR; Lees, MJ; Steinhauer, C; Johansen, JV; Helin, K				Kooistra, Susanne Marije; Norgaard, Lise Christine Rudkjaer; Lees, Michael James; Steinhauer, Cornelia; Johansen, Jens Vilstrup; Helin, Kristian			A Screen Identifies the Oncogenic Micro-RNA miR-378a-5p as a Negative Regulator of Oncogene-Induced Senescence	PLOS ONE			English	Article							DEMETHYLASE JMJD3 CONTRIBUTES; ORAL-CANCER CELLS; TUMOR-SUPPRESSOR; DOWN-REGULATION; CELLULAR SENESCENCE; CYCLE ARREST; EXPRESSION; GENE; PROLIFERATION; ANGIOGENESIS	Oncogene-induced senescence (OIS) can occur in response to hyperactive oncogenic signals and is believed to be a fail-safe mechanism protecting against tumorigenesis. To identify new factors involved in OIS, we performed a screen for microRNAs that can overcome or inhibit OIS in human diploid fibroblasts. This screen led to the identification of miR-378a-5p and in addition several other miRNAs that have previously been shown to play a role in senescence. We show that ectopic expression of miR-378a-5p reduces the expression of several senescence markers, including p16(INK4A) and senescence-associated beta-galactosidase. Moreover, cells with ectopic expression of miR-378a-5p retain proliferative capacity even in the presence of an activated Braf oncogene. Finally, we identified several miR-378a-5p targets in diploid fibroblasts that might explain the mechanism by which the microRNA can delay OIS. We speculate that miR-378a-5p might positively influence tumor formation by delaying OIS, which is consistent with a known pro-oncogenic function of this microRNA.	[Kooistra, Susanne Marije; Norgaard, Lise Christine Rudkjaer; Lees, Michael James; Steinhauer, Cornelia; Johansen, Jens Vilstrup; Helin, Kristian] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Kooistra, Susanne Marije; Norgaard, Lise Christine Rudkjaer; Lees, Michael James; Steinhauer, Cornelia; Helin, Kristian] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark; [Johansen, Jens Vilstrup] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Danish Stem Cell Ctr DanStem, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Helin, K (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark.	kristian.helin@bric.ku.dk	Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022	Helin, Kristian/0000-0003-1975-6097; Steinhauer, Cornelia/0000-0002-5390-4893; Vilstrup Johansen, Jens/0000-0001-7094-6801	Netherlands Organisation for Scientific Research (NWO); Danish National Advanced Technology Foundation; Novo Nordisk Foundation; Lundbeck Foundation; Excellence program of the University of Copenhagen	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Danish National Advanced Technology Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Excellence program of the University of Copenhagen	SMK was supported by a postdoctoral fellowship from the Netherlands Organisation for Scientific Research (NWO). The work in the Helin laboratory was supported by, the Danish National Advanced Technology Foundation, the Novo Nordisk Foundation, the Lundbeck Foundation, and the Excellence program of the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2012, AGEING RES REV, V11, P491, DOI 10.1016/j.arr.2012.01.003; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Bishop CL, 2010, MOL CELL, V40, P533, DOI 10.1016/j.molcel.2010.10.027; Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chandler H, 2013, CURR OPIN CELL BIOL, V25, P765, DOI 10.1016/j.ceb.2013.07.005; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chen YJ, 2011, HEAD NECK-J SCI SPEC, V33, P257, DOI 10.1002/hed.21442; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Deng ZQ, 2013, J BIOL CHEM, V288, P319, DOI 10.1074/jbc.M112.418830; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Fang L, 2012, CELL CYCLE, V11, P4352, DOI 10.4161/cc.22670; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Gambaro K, 2013, MOL ONCOL, V7, P513, DOI 10.1016/j.molonc.2012.12.006; Gorospe M, 2011, TRENDS GENET, V27, P233, DOI 10.1016/j.tig.2011.03.005; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kang L, 2008, PATHOL INT, V58, P334, DOI 10.1111/j.1440-1827.2008.02233.x; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Li QC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048278; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Roychoudhury P, 2007, MOL CARCINOGEN, V46, P198, DOI 10.1002/mc.20265; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sharp TV, 2008, P NATL ACAD SCI USA, V105, P19932, DOI 10.1073/pnas.0805003105; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Wu QP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044579; Ying MY, 2011, STEM CELLS, V29, P20, DOI 10.1002/stem.561	44	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91034	10.1371/journal.pone.0091034	http://dx.doi.org/10.1371/journal.pone.0091034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651706	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800028
J	Lu, W; Tamura, T; Song, JN; Akutsu, T				Lu, Wei; Tamura, Takeyuki; Song, Jiangning; Akutsu, Tatsuya			Integer Programming-Based Method for Designing Synthetic Metabolic Networks by Minimum Reaction Insertion in a Boolean Model	PLOS ONE			English	Article							ESCHERICHIA-COLI; ROBUSTNESS; PREDICTION; PATHWAYS; TARGETS	In this paper, we consider the Minimum Reaction Insertion (MRI) problem for finding the minimum number of additional reactions from a reference metabolic network to a host metabolic network so that a target compound becomes producible in the revised host metabolic network in a Boolean model. Although a similar problem for larger networks is solvable in a flux balance analysis (FBA)-based model, the solution of the FBA-based model tends to include more reactions than that of the Boolean model. However, solving MRI using the Boolean model is computationally more expensive than using the FBA-based model since the Boolean model needs more integer variables. Therefore, in this study, to solve MRI for larger networks in the Boolean model, we have developed an efficient Integer Programming formalization method in which the number of integer variables is reduced by the notion of feedback vertex set and minimal valid assignment. As a result of computer experiments conducted using the data of metabolic networks of E. coli and reference networks downloaded from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database, we have found that the developed method can appropriately solve MRI in the Boolean model and is applicable to large scale-networks for which an exhaustive search does not work. We have also compared the developed method with the existing connectivity-based methods and FBA-based methods, and show the difference between the solutions of our method and the existing methods. A theoretical analysis of MRI is also conducted, and the NP-completeness of MRI is proved in the Boolean model. Our developed software is available at "http://sunflower.kuicr.kyoto-u.ac.jp/similar to rogi/minRect/minRect.html."	[Lu, Wei; Tamura, Takeyuki; Akutsu, Tatsuya] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto, Japan; [Song, Jiangning] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin, Peoples R China	Kyoto University; Monash University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Tamura, T (corresponding author), Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto, Japan.	tamura@kuicr.kyoto-u.ac.jp; takutsu@kuicr.kyoto-u.ac.jp	Tamura, Takeyuki/ABI-2627-2020; Song, Jiangning/F-9787-2010	Song, Jiangning/0000-0001-8031-9086; Akutsu, Tatsuya/0000-0001-9763-797X	JSPS, Japan [25730005, 25250028, 22240009]; Chinese Academy of Sciences (CAS); Chinese Academy of Sciences Visiting Professorship for Senior International Scientists, China	JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Chinese Academy of Sciences Visiting Professorship for Senior International Scientists, China	TT was partially supported by JSPS, Japan (Grant-in-Aid for Young Scientists (B) 25730005 and Grant-in-Aid for Scientific Research (A) 25250028). JS is an Australian National Health and Medical Research Council (NHMRC) Peter Doherty Fellow and a recipient of the Hundred Talents Program of the Chinese Academy of Sciences (CAS). TA was partly supported by the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists, China, and Grant-in-Aid #22240009 from JSPS, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Ara K, 2007, BIOTECHNOL APPL BIOC, V46, P169, DOI 10.1042/BA20060111; Bro C, 2006, METAB ENG, V8, P102, DOI 10.1016/j.ymben.2005.09.007; Cho A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-35; de Boer AL, 2003, CURR OPIN CHEM BIOL, V7, P273, DOI 10.1016/S1367-5931(03)00023-1; Ellis LBM, 2006, NUCLEIC ACIDS RES, V34, pD517, DOI 10.1093/nar/gkj076; Gonzalez-Lergier J, 2005, J AM CHEM SOC, V127, P9930, DOI 10.1021/ja051586y; Handorf T, 2005, J MOL EVOL, V61, P498, DOI 10.1007/s00239-005-0027-1; Hatzimanikatis V, 2005, BIOINFORMATICS, V21, P1603, DOI 10.1093/bioinformatics/bti213; Haus UU, 2008, J COMPUT BIOL, V15, P259, DOI 10.1089/cmb.2007.0229; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Hou BK, 2003, J CHEM INF COMP SCI, V43, P1051, DOI 10.1021/ci034018f; Hou BK, 2004, J IND MICROBIOL BIOT, V31, P261, DOI 10.1007/s10295-004-0144-7; IBM, 2022, IBM ILOG CPLEX OPT; Jin GX, 2011, BIOINFORMATICS, V27, pI310, DOI 10.1093/bioinformatics/btr202; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KARMARKAR N, 1984, COMBINATORICA, V4, P373, DOI 10.1007/BF02579150; Lee D, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.027101; Lee JH, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-2; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Lemke N, 2004, BIOINFORMATICS, V20, P115, DOI 10.1093/bioinformatics/btg386; Li Z, 2009, IET SYST BIOL, V3, P523, DOI 10.1049/iet-syb.2008.0166; Mijts BN, 2003, CURR OPIN BIOTECH, V14, P597, DOI 10.1016/j.copbio.2003.09.009; Mizoguchi H, 2007, BIOTECHNOL APPL BIOC, V46, P157, DOI 10.1042/BA200650107; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; Prather KLJ, 2008, CURR OPIN BIOTECH, V19, P468, DOI 10.1016/j.copbio.2008.07.009; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Schrijver A., 1998, THEORY LINEAR INTEGE; Smart AG, 2008, P NATL ACAD SCI USA, V105, P13223, DOI 10.1073/pnas.0803571105; Soh KC, 2010, TRENDS BIOTECHNOL, V28, P501, DOI 10.1016/j.tibtech.2010.07.002; Sridhar Padmavati, 2008, Pac Symp Biocomput, P291; Suthers PF, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000285; Takemoto K, 2013, PHYSICA A, V392, P5525, DOI 10.1016/j.physa.2013.07.003; Tamura Takeyuki, 2010, International Journal of Knowledge Discovery in Bioinformatics, V1, P14, DOI 10.4018/jkdb.2010100202; Zhenping L, 2007, BIOINFORMATICS, V23, P1631, DOI 10.1093/bioinformatics/btm156	36	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92637	10.1371/journal.pone.0092637	http://dx.doi.org/10.1371/journal.pone.0092637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651476	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800136
J	Rasschaert, F; Telfer, B; Lessitala, F; Decroo, T; Remartinez, D; Biot, M; Candrinho, B; Mbofana, F; Van Damme, W				Rasschaert, Freya; Telfer, Barbara; Lessitala, Faustino; Decroo, Tom; Remartinez, Daniel; Biot, Marc; Candrinho, Baltazar; Mbofana, Francisco; Van Damme, Wim			A Qualitative Assessment of a Community Antiretroviral Therapy Group Model in Tete, Mozambique	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SELF-MANAGEMENT; PATIENT RETENTION; TREATMENT PROGRAM; HEALTH-SERVICES; HIV TREATMENT; CARE; ADHERENCE; COUNTRIES; PEOPLE	Background: To improve retention on ART, Medecins Sans Frontieres, the Ministry of Health and patients piloted a community-based antiretroviral distribution and adherence monitoring model through Community ART Groups (CAG) in Tete, Mozambique. By December 2012, almost 6000 patients on ART had formed groups of whom 95.7% were retained in care. We conducted a qualitative study to evaluate the relevance, dynamic and impact of the CAG model on patients, their communities and the healthcare system. Methods: Between October 2011 and May 2012, we conducted 16 focus group discussions and 24 in-depth interviews with the major stakeholders involved in the CAG model. Audio-recorded data were transcribed verbatim and analysed using a grounded theory approach. Results: Six key themes emerged from the data: 1) Barriers to access HIV care, 2) CAG functioning and actors involved, 3) Benefits for CAG members, 4) Impacts of CAG beyond the group members, 5) Setbacks, and 6) Acceptance and future expectations of the CAG model. The model provides cost and time savings, certainty of ART access and mutual peer support resulting in better adherence to treatment. Through the active role of patients, HIV information could be conveyed to the broader community, leading to an increased uptake of services and positive transformation of the identity of people living with HIV. Potential pitfalls included limited access to CAG for those most vulnerable to defaulting, some inequity to patients in individual ART care and a high dependency on counsellors. Conclusion: The CAG model resulted in active patient involvement and empowerment, and the creation of a supportive environment improving the ART retention. It also sparked a reorientation of healthcare services towards the community and strengthened community actions. Successful implementation and scalability requires (a) the acceptance of patients as partners in health, (b) adequate resources, and (c) a well-functioning monitoring and management system.	[Rasschaert, Freya; Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Telfer, Barbara; Lessitala, Faustino; Decroo, Tom] Med Sans Frontieres Tete, Tete, Mozambique; [Remartinez, Daniel] Med Sans Frontieres Maputo, Maputo, Mozambique; [Biot, Marc] Med Sans Frontieres Brussels, Brussels, Belgium; [Candrinho, Baltazar] Minist Hlth Tete, Tete, Mozambique; [Mbofana, Francisco] Minist Hlth Maputo, Maputo, Mozambique	Institute of Tropical Medicine (ITM)	Rasschaert, F (corresponding author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	frasschaert@itg.be	Decroo, Tom/AAV-7208-2020; Van Damme, Wim/F-7404-2011	Decroo, Tom/0000-0002-1205-1484; Van Damme, Wim/0000-0002-6344-3007	MSF - Operational Centre Brussels	MSF - Operational Centre Brussels	The study was funded by proper funds (money collected through donations of the general population in mainly European countries) of the MSF - Operational Centre Brussels. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfani F, 2012, 6217 WPS WORLD BANK; [Anonymous], SOC SCI MED, V64, P1549; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bailey J, 2008, FAM PRACT, V25, P127, DOI 10.1093/fampra/cmn003; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Bernard H. R., 2017, RES METHODS ANTHR; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Caluwaerts C, 2009, INT HEALTH, V1, P97, DOI 10.1016/j.inhe.2009.03.002; Curtis S, 2000, SOC SCI MED, V50, P1001, DOI 10.1016/S0277-9536(99)00350-0; Decroo T, 2013, INT STD RES IN PRESS; Decroo T, 2013, INT HEALTH, V5, P169, DOI 10.1093/inthealth/iht016; Decroo T, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/749718; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Decroo T, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-6; Foddy W. H., 1993, CONSTRUCTING QUESTIO, DOI 10.1017/CBO9780511518201; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Genberg BL, 2009, SOC SCI MED, V68, P2279, DOI 10.1016/j.socscimed.2009.04.005; Gifford AL, 2002, JAIDS-J ACQ IMM DEF, V31, pS163, DOI 10.1097/00126334-200212153-00016; Groh K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-650; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; HAYS RB, 1993, AIDS, V7, P425, DOI 10.1097/00002030-199303000-00019; Hennink M., 2020, QUALITATIVE RES METH; Hermann K, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-31; INS INE & ICF Macro, 2010, INQ NAC PREV RISC CO; Instituto Nacional de Estatistica de Mozambique, 2008, PREL REP MULT IND CL; Kipp W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040902; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Kober K, 2011, EXPERT PATIENTS AIDS; Lambdin BH, 2011, JAIDS-J ACQ IMM DEF, V57, pE33, DOI 10.1097/QAI.0b013e3182167e90; Lorig K, 2000, SELF MANAGEMENT ED C; Mak WWS, 2007, SOC SCI MED, V64, P1549, DOI 10.1016/j.socscimed.2006.12.003; Manjate F, 2009, NYAU COMO PRESERVACA; Maxwell J., 2004, QUALITATIVE RES DESI, DOI DOI 10.1177/1094428106290193; Ministry of Health Mozambique, 2012, PROGR TRAT ANT TARV; Ministry of Health of Mozambique, 2010, INQ NAC PREV RISC CO; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Posse M, 2009, AIDS PATIENT CARE ST, V23, P867, DOI 10.1089/apc.2009.0050; Rice E, 2009, AIDS BEHAV, V13, P1253, DOI 10.1007/s10461-009-9554-x; Rifkin S. B., 1986, Health Policy and Planning, V1, P240, DOI 10.1093/heapol/1.3.240; Ssali SN, 2010, AIDS PATIENT CARE ST, V24, P675, DOI 10.1089/apc.2010.0062; Swendeman D, 2009, AIDS CARE, V21, P1321, DOI 10.1080/09540120902803158; Thompson AGH, 2007, SOC SCI MED, V64, P1297, DOI 10.1016/j.socscimed.2006.11.002; Ulin P.R., 2005, QUAL METHODS PUBL HL, P71; Van Damme W, 2008, SOC SCI MED, V66, P2108, DOI 10.1016/j.socscimed.2008.01.043; van Olmen J, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-38; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; WHO UNAIDS UNICEF, 2012, GLOB HIV AIDS RESP E; World Health Organization, 2009, WHO COUNTR COOP STRA; Wouters E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-194	52	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91544	10.1371/journal.pone.0091544	http://dx.doi.org/10.1371/journal.pone.0091544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651523	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800042
J	Watanabe, K; Biesinger, J; Salmans, ML; Roberts, BS; Arthur, WT; Cleary, M; Andersen, B; Xie, XH; Dai, X				Watanabe, Kazuhide; Biesinger, Jacob; Salmans, Michael L.; Roberts, Brian S.; Arthur, William T.; Cleary, Michele; Andersen, Bogi; Xie, Xiaohui; Dai, Xing			Integrative ChIP-seq/Microarray Analysis Identifies a CTNNB1 Target Signature Enriched in Intestinal Stem Cells and Colon Cancer	PLOS ONE			English	Article							CHROMATIN OCCUPANCY; WNT; DNA; ACTIVATION; METHYLATION; PATHWAY; GENES; SET	Background: Deregulation of canonical Wnt/CTNNB1 (beta-catenin) pathway is one of the earliest events in the pathogenesis of colon cancer. Mutations in APC or CTNNB1 are highly frequent in colon cancer and cause aberrant stabilization of CTNNB1, which activates the transcription of Wnt target genes by binding to chromatin via the TCF/LEF transcription factors. Here we report an integrative analysis of genome-wide chromatin occupancy of CTNNB1 by chromatin immunoprecipitation coupled with high-throughput sequencing (ChIP-seq) and gene expression profiling by microarray analysis upon RNAi-mediated knockdown of CTNNB1 in colon cancer cells. Results: We observed 3629 CTNNB1 binding peaks across the genome and a significant correlation between CTNNB1 binding and knockdown-induced gene expression change. Our integrative analysis led to the discovery of a direct Wnt target signature composed of 162 genes. Gene ontology analysis of this signature revealed a significant enrichment of Wnt pathway genes, suggesting multiple feedback regulations of the pathway. We provide evidence that this gene signature partially overlaps with the Lgr(5+) intestinal stem cell signature, and is significantly enriched in normal intestinal stem cells as well as in clinical colorectal cancer samples. Interestingly, while the expression of the CTNNB1 target gene set does not correlate with survival, elevated expression of negative feedback regulators within the signature predicts better prognosis. Conclusion: Our data provide a genome-wide view of chromatin occupancy and gene regulation of Wnt/CTNNB1 signaling in colon cancer cells.	[Watanabe, Kazuhide; Salmans, Michael L.; Andersen, Bogi; Dai, Xing] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92717 USA; [Biesinger, Jacob; Xie, Xiaohui; Dai, Xing] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92717 USA; [Biesinger, Jacob; Xie, Xiaohui] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92717 USA; [Roberts, Brian S.; Arthur, William T.; Cleary, Michele] Merck & Co Inc, Rosetta Inpharmat LLC, Seattle, WA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Merck & Company	Dai, X (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92717 USA.	xdai@uci.edu	Watanabe, Kazuhide/C-9667-2017	Watanabe, Kazuhide/0000-0002-5331-0593; Dai, Xing/0000-0001-8134-1365; Xie, Xiaohui/0000-0002-5479-6345; Biesinger, W Jacob B/0000-0003-0172-525X	Susan G. Komen grant [KG110897]; U.S. Department of Defense BCRP Postdoctoral Fellowship [W81XWH-10-1-0383]; National Institutes of Health [R01HG006870]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044882] Funding Source: NIH RePORTER	Susan G. Komen grant(Susan G. Komen Breast Cancer Foundation); U.S. Department of Defense BCRP Postdoctoral Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding from Susan G. Komen grant KG110897 (XD), a U.S. Department of Defense BCRP Postdoctoral Fellowship (K.W. W81XWH-10-1-0383), and National Institutes of Health grant R01HG006870 (to XX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Biechele TL, 2009, COLD SPRING HARB PRO, V2009; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Flowers GP, 2012, DEVELOPMENT, V139, P2416, DOI 10.1242/dev.063206; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Hoverter NP, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.139pe43; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Jessen S, 2008, BIOESSAYS, V30, P448, DOI 10.1002/bies.20757; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Karolchik D, 2011, CURR PROTOC HUM GENE; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; King TD, 2006, EXP CELL RES, V312, P3693, DOI 10.1016/j.yexcr.2006.08.010; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Lin GX, 2006, NAT BIOTECHNOL, V24, P1476, DOI 10.1038/nbt1206-1476; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mokry M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015092; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Munoz J, 2012, EMBO J; Najdi Rani, 2011, J Carcinog, V10, P5, DOI 10.4103/1477-3163.78111; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	52	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92317	10.1371/journal.pone.0092317	http://dx.doi.org/10.1371/journal.pone.0092317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651522	gold, Green Published			2022-12-27	WOS:000333352800099
J	Chen, J; Li, T; Liu, QL; Jiao, HY; Yang, WJ; Liu, XX; Huo, ZH				Chen, Jing; Li, Tao; Liu, Qilun; Jiao, Haiyan; Yang, Wenjun; Liu, Xiaoxia; Huo, Zhenghao			Clinical and Prognostic Significance of HIF-1 alpha, PTEN, CD44v6, and Survivin for Gastric Cancer: A Meta-Analysis	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; EXPRESSION; ANGIOGENESIS; METASTASIS; RESISTANCE; CARCINOMA; INSIGHTS; GROWTH; MARKER; TUMORS	Purpose: This study was to quantitatively summarize published data for evaluating the clinical and prognostic significance of four proteins involved in hypoxia-inducible factor-1 (HIF-1 alpha) regulation of the metastasis cascade. Methods: Searches were performed using the MEDLINE, EMBASE, Cochrane Library, and Chinese Biomedicine databases without any language restrictions. Studies were pooled and either the summary risk ratio (RR) or odds ratio (OR) was calculated. Potential sources of heterogeneity were sought out via subgroup and sensitivity analyses, and publication bias was also performed. Results: Seventeen studies evaluated HIF-1 alpha, 20 studies evaluated phosphatase and tensin homolog (PTEN), 20 studies evaluated Survivin, and 16 studies evaluated CD44v6. Our results showed that increased HIF-1 alpha expression was linked to a poor 5-year overall survival (RR = 1.508; 95% confidence interval (CI) 1.318-1.725; P<0.001). Decreased survival was heavily influenced by advanced tumor invasion (OR = 3.050; 95% CI 2.067-4.501; P<0.001), lymph node metastasis (1415 patients; OR = 3.486, 95% CI 2.737-4.440; P<0.001), distant metastasis (OR = 6.635; 95% CI 1.855-23.738; P = 0.004), vascular invasion (OR = 2.368; 95% CI 1.725-3.252; P<0.001), dedifferentiation (OR = 2.112; 95% CI 1.410-3.163; P<0.001), tumor size (OR = 1.921; 95% CI 1.395-2.647; P<0.001), and a higher TNM stage (OR = 2.762; 95% CI 1.941-3.942; P<0.001). Similarly, aberrant expression of PTEN, CD44v6, and Survivin were also observed in tumors that correlated with poor OS. The higher ORs of death at 5 years were 1.637 (95% CI = 1.452-1.845; P<0.001), 1.901 (95% CI = 1.432-2.525; P<0.001), and 1.627 (95% CI = 1.384-1.913; P<0.001), respectively, with an OR>2 for the main stratified meta-analyses of clinical factors. Conclusions: Our findings indicate that HIF-1 alpha/PTEN/CD44v6/Survivin, as measured by immunohistochemistry, can be used to predict the prognosis and potential for invasion and metastasis in Asian patients with gastric cancer. The development of strategies against this subset of proteins could lead to new therapeutic approaches.	[Chen, Jing; Jiao, Haiyan; Yang, Wenjun; Liu, Xiaoxia; Huo, Zhenghao] Ningxia Med Univ, Dept Med Genet & Cell Biol, Yinchuan, Peoples R China; [Chen, Jing; Jiao, Haiyan; Yang, Wenjun; Liu, Xiaoxia; Huo, Zhenghao] Ningxia Med Univ, Minist Educ, Lab Fertil Preservat & Maintenance, Yinchuan, Peoples R China; [Li, Tao; Liu, Qilun] Ningxia Med Univ, Gen Hosp, Dept Oncol, Yinchuan, Peoples R China	Ningxia Medical University; Ningxia Medical University; Ningxia Medical University	Huo, ZH (corresponding author), Ningxia Med Univ, Dept Med Genet & Cell Biol, Yinchuan, Peoples R China.	huozh58@163.com		Yang, Wenjun/0000-0001-5671-1344	National Natural Science Foundation of China [81260339, 81301886]; Fundamental Research Funds for Ningxia Medical University [XT2012009, XQ2012014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Ningxia Medical University	This work is supported by the grants from National Natural Science Foundation of China (81260339 and 81301886) and Fundamental Research Funds for Ningxia Medical University (XT2012009 and XQ2012014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2012, MOL CANCER THER, V11, P277, DOI 10.1158/1535-7163.MCT-11-0648; Chen J, 2011, J CANCER RES CLIN, V137, P1799, DOI 10.1007/s00432-011-1057-2; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayes DF, 2001, J MAMMARY GLAND BIOL, V6, P375, DOI 10.1023/A:1014778713034; Hill RP, 2009, SEMIN RADIAT ONCOL, V19, P106, DOI 10.1016/j.semradonc.2008.12.002; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Krieg A, 2013, MOL BIOL REP, V40, P5501, DOI 10.1007/s11033-013-2650-z; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Krishnamachary B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044078; Lanvin O, 2013, EUR J CANC; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Liu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071930; Lou-Qian Zhang, 2013, PLoS One, V8, pe54970, DOI 10.1371/journal.pone.0054970; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Meza-Junco J, 2012, BIOL-TARGETS THER, V6, P137, DOI 10.2147/BTT.S23917; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Ocana A, 2013, JNCI-J NATL CANCER I, V105, P266, DOI 10.1093/jnci/djs501; Park JH, 2011, ONCOGENE, V30, P4578, DOI 10.1038/onc.2011.174; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shah MA, 2011, CLIN CANCER RES, V17, P2693, DOI 10.1158/1078-0432.CCR-10-2203; Shin HR, 2012, JPN J CLIN ONCOL, V42, P867, DOI 10.1093/jjco/hys077; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Sun XP, 2014, FEBS J, V281, P115, DOI 10.1111/febs.12577; Tsai YP, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-102; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Zhang ZG, 2013, ASIAN PAC J CANCER P, V14, P4195, DOI 10.7314/APJCP.2013.14.7.4195; Zhao TF, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-159; Zheng SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065753; Zhu CL, 2013, MOL BIOL REP, V40, P6055, DOI 10.1007/s11033-013-2715-z	36	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91842	10.1371/journal.pone.0091842	http://dx.doi.org/10.1371/journal.pone.0091842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647137	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500055
J	Chyu, KY; Lio, WM; Dimayuga, PC; Zhou, JC; Zhao, XN; Yano, J; Trinidad, P; Honjo, T; Cercek, B; Shah, PK				Chyu, Kuang-Yuh; Lio, Wai Man; Dimayuga, Paul C.; Zhou, Jianchang; Zhao, Xiaoning; Yano, Juliana; Trinidad, Portia; Honjo, Tomoyuki; Cercek, Bojan; Shah, Prediman K.			Cholesterol Lowering Modulates T Cell Function In Vivo and In Vitro	PLOS ONE			English	Article							INCREASES COLLAGEN CONTENT; LOW-DENSITY LIPOPROTEINS; HYPERCHOLESTEROLEMIA LEADS; ATHEROSCLEROTIC LESIONS; PROLIFERATION; RESPONSES; DIET; STATINS; PLAQUES; LDL	Background: The lipid milleu exacerbates the inflammatory response in atherosclerosis but its effect on T cell mediated immune response has not been fully elucidated. We hypothesized that lipid lowering would modulate T cell mediated immune function. Methods and Results: T cells isolated from human PBMC or splenic T cells from apoE-/- mouse had higher proliferative response to T cell receptor (TCR) ligation in medium supplemented with 10% fetal bovine serum (FBS) compared to medium with 10% delipidated FBS. The differences in proliferation were associated with changes in lipid rafts, cellular cholesterol content, IL-10 secretion and subsequent activation of signaling molecule activated by TCR ligation. Immune biomarkers were also assessed in vivo using male apoE-/- mice fed atherogenic diet (AD) starting at 7 weeks of age. At 25 weeks of age, a sub-group was switched to normal diet (ND) whereas the rest remained on AD until euthanasia at 29 weeks of age. Dietary change resulted in a lower circulating level of cholesterol, reduced plaque size and inflammatory phenotype of plaques. These changes were associated with reduced intracellular IL-10 and IL-12 expression in CD4(+) and CD8(+) T cells. Conclusion: Our results show that lipid lowering reduces T cell proliferation and function, supporting the notion that lipid lowering modulates T cell function in vivo and in vitro.	[Chyu, Kuang-Yuh; Lio, Wai Man; Dimayuga, Paul C.; Zhou, Jianchang; Zhao, Xiaoning; Yano, Juliana; Trinidad, Portia; Honjo, Tomoyuki; Cercek, Bojan; Shah, Prediman K.] Cedars Sinai Med Ctr, Div Cardiol, Oppenheimer Atherosclerosis Res Ctr, Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Chyu, KY (corresponding author), Cedars Sinai Med Ctr, Div Cardiol, Oppenheimer Atherosclerosis Res Ctr, Cedars Sinai Heart Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	Chyuk@cshs.org			Heart Foundation; Spielberg Cardiovascular Research Fund; Skirball Foundation	Heart Foundation; Spielberg Cardiovascular Research Fund; Skirball Foundation	This study is supported by the Heart Foundation, the Spielberg Cardiovascular Research Fund and the Skirball Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa M, 1998, CIRC RES, V83, P1015, DOI 10.1161/01.RES.83.10.1015; Aikawa M, 1999, CIRCULATION, V100, P1215, DOI 10.1161/01.CIR.100.11.1215; Aikawa M, 1998, CIRCULATION, V97, P2433, DOI 10.1161/01.CIR.97.24.2433; Armstrong AJ, 2010, J IMMUNOL, V184, P173, DOI 10.4049/jimmunol.0902372; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; CARUZZO C, 1995, ANGIOLOGY, V46, P269, DOI 10.1177/000331979504600401; Chyu KY, 2004, ATHEROSCLEROSIS, V176, P27, DOI 10.1016/j.atherosclerosis.2004.04.016; Cipollone F, 2003, CIRCULATION, V107, P1479, DOI 10.1161/01.CIR.0000056530.03783.81; Crisby M, 2001, CIRCULATION, V103, P926, DOI 10.1161/01.cir.103.7.926; CUTHBERT JA, 1984, P NATL ACAD SCI-BIOL, V81, P4539, DOI 10.1073/pnas.81.14.4539; CUTHBERT JA, 1986, J BIOL CHEM, V261, P3620; CUTHBERT JA, 1987, J BIOL CHEM, V262, P7808; Farmer J A, 2000, Curr Atheroscler Rep, V2, P208, DOI 10.1007/s11883-000-0022-3; Fulop T, 2001, MECH AGEING DEV, V122, P1413, DOI 10.1016/S0047-6374(01)00274-3; Gotto AM, 2001, CURR OPIN LIPIDOL, V12, P391, DOI 10.1097/00041433-200108000-00004; Graham LS, 2010, J BONE MINER RES, V25, P2460, DOI 10.1002/jbmr.148; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Maganto-Garcia E, 2011, CIRCULATION, V124, P185, DOI 10.1161/CIRCULATIONAHA.110.006411; Mays ME, 2008, CURR ATHEROSCLER REP, V10, P45, DOI 10.1007/s11883-008-0008-0; MULLER CP, 1984, CYTOMETRY, V5, P42, DOI 10.1002/cyto.990050108; Nix M, 2000, CELL DEATH DIFFER, V7, P413, DOI 10.1038/sj.cdd.4400666; ORNISH D, 1990, LANCET, V336, P129, DOI 10.1016/0140-6736(90)91656-U; Pasterkamp G, 2010, EXPERT REV CARDIOVAS, V8, P1235, DOI 10.1586/ERC.10.107; Robertson AKL, 2004, SCAND J IMMUNOL, V59, P285, DOI 10.1111/j.0300-9475.2004.01403.x; Surls J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038733; WATTS GF, 1992, LANCET, V339, P563, DOI 10.1016/0140-6736(92)90863-X; Wilhelm AJ, 2009, ARTERIOSCL THROM VAS, V29, P843, DOI 10.1161/ATVBAHA.108.183442; Zhao XQ, 2001, ARTERIOSCL THROM VAS, V21, P1623, DOI 10.1161/hq1001.098463; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216; Zhou XH, 2009, ATHEROSCLEROSIS, V204, P381, DOI 10.1016/j.atherosclerosis.2008.10.017	30	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92095	10.1371/journal.pone.0092095	http://dx.doi.org/10.1371/journal.pone.0092095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647529	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500083
J	Grimaldi-Bensouda, L; Begaud, B; Rossignol, M; Avouac, B; Lert, F; Rouillon, F; Benichou, J; Massol, J; Duru, G; Magnier, AM; Abenhaim, L; Guillemot, D				Grimaldi-Bensouda, Lamiae; Begaud, Bernard; Rossignol, Michel; Avouac, Bernard; Lert, France; Rouillon, Frederic; Benichou, Jacques; Massol, Jacques; Duru, Gerard; Magnier, Anne-Marie; Abenhaim, Lucien; Guillemot, Didier			Management of Upper Respiratory Tract Infections by Different Medical Practices, Including Homeopathy, and Consumption of Antibiotics in Primary Care: The EPI3 Cohort Study in France 2007-2008	PLOS ONE			English	Article							CONSULTATION RATES	Background: Prescribing of antibiotics for upper respiratory tract infections (URTI) varies substantially in primary care. Objectives: To describe and compare antibiotic and antipyretic/anti-inflammatory drugs use, URTI symptoms' resolution and occurrence of potentially-associated infections in patients seeking care from general practitioners (GPs) who exclusively prescribe conventional medications (GP-CM), regularly prescribe homeopathy within a mixed practice (GP-Mx), or are certified homeopathic GPs (GP-Ho). Method: The EPI3 survey was a nationwide population-based study of a representative sample of 825 GPs and their patients in France (2007-2008). GP recruitment was stratified by self-declared homeopathic prescribing preferences. Adults and children with confirmed URTI were asked to participate in a standardized telephone interview at inclusion, one-, three- and twelve-month follow up. Study outcomes included medication consumption, URTI symptoms' resolution and potentially-associated infections (sinusitis or otitis media/externa) as reported by patients. Analyses included calibration to account for non-respondents and groups were compared using multivate analyses adjusting for baseline differences with a propensity score. Results: 518 adults and children with URTI (79.3% rhinopharyngitis) were included (36.9% response rate comparable between groups). As opposed to GP-CM patients, patients in the GP-Ho group showed significantly lower consumption of antibiotics (Odds ratio (OR) = 0.43, 95% confidence interval (CI): 0.27-0.68) and antipyretic/anti-inflammatory drugs (OR = 0.54, 95% CI: 0.38-0.76) with similar evolution in related symptoms (OR = 1.16, 95% CI: 0.64-2.10). An excess of potentially-associated infections (OR = 1.70, 95% CI: 0.90-3.20) was observed in the GP-Ho group (not statistically significant). No difference was found between GP-CM and GP-Mx patients. Conclusion: Patients who chose to consult GPs certified in homeopathy used less antibiotics and antipyretic/antiinflammatory drugs for URTI than those seen by GPs prescribing conventional medications. No difference was observed in patients consulting GPs within mixed-practice. A non-statistically significant excess was estimated through modelling for associated infections in the GP-Ho group and needs to be further studied.	[Grimaldi-Bensouda, Lamiae; Avouac, Bernard] LA SER, Paris, France; [Grimaldi-Bensouda, Lamiae] Inst Pasteur, Pharmacoepidemiol & Infect Dis Res Grp, Paris, France; [Begaud, Bernard] Univ Bordeaux Segalen, INSERM, U657, Bordeaux, France; [Rossignol, Michel] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Rossignol, Michel] LA SER Ctr Risk Res, Montreal, PQ, Canada; [Lert, France] INSERM, Ctr Epidemiol & Populat Hlth, U1018, Villejuif, France; [Rouillon, Frederic] Univ Paris 05, St Anne Hosp, Paris, France; [Benichou, Jacques] Univ Bordeaux 2, Dept Pharmacol, INSERM, Tondu Hosp Case 41,U657, F-33076 Bordeaux, France; [Benichou, Jacques] Univ Hosp Rouen, Dept Biostat, Rouen, France; [Massol, Jacques] Univ Franche Comte, Fac Med, F-25030 Besancon, France; [Duru, Gerard] Cyklad Grp, Rillieux La Pape, France; [Magnier, Anne-Marie] Univ Paris 06, Fac Med, Paris, France; [Abenhaim, Lucien] Univ London London Sch Hyg & Trop Med, Dept Epidemiol, London WC1E 7HT, England; [Abenhaim, Lucien] LA SER Europe Ltd, London, England; [Guillemot, Didier] Inst Pasteur, Paris, France; [Guillemot, Didier] Univ Paris Ile France Ouest, Fac Med, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU de Rouen; Universite de Franche-Comte; CHU Besancon; UDICE-French Research Universities; Sorbonne Universite; University of London; London School of Hygiene & Tropical Medicine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Grimaldi-Bensouda, L (corresponding author), LA SER, Paris, France.	Lamiae.grimaldi@la-ser.com	Guillemot, Didier/AAN-3051-2020	Guillemot, Didier/0000-0002-8497-1765; Grimaldi-Bensouda, Lamiae/0000-0003-1952-5467	Laboratoires Boiron, France	Laboratoires Boiron, France	This study was funded by Laboratoires Boiron, France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altunc U, 2007, MAYO CLIN PROC, V82, P69; Ashworth M, 2005, BRIT J GEN PRACT, V55, P603; Chahwakilian P, 2011, J ANTIMICROB CHEMOTH, V66, P2872, DOI 10.1093/jac/dkr387; Costelloe Ceire, 2010, BMJ, V340, pc2096, DOI 10.1136/bmj.c2096; Davey Peter, 2010, Expert Rev Clin Pharmacol, V3, P667, DOI 10.1586/ecp.10.46; de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467; DEVILLE JC, 1992, J AM STAT ASSOC, V87, P376, DOI 10.2307/2290268; Dommergues MA, 2012, SCAND J INFECT DIS, V44, P495, DOI 10.3109/00365548.2012.669840; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P423, DOI 10.1093/jac/dkl183; Filipetto Frank A, 2008, Patient Prefer Adherence, V2, P35; Grimaldi-Bensouda L, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000215; Grimaldi-Bensouda L, 2012, PHARMACOEPIDEM DR S, V21, P753, DOI 10.1002/pds.3194; Haidvogl Max, 2007, BMC Complement Altern Med, V7, P7, DOI 10.1186/1472-6882-7-7; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Jain Asha, 2003, Homeopathy, V92, P71, DOI 10.1016/S1475-4916(03)00004-3; Kirkby R, 2010, HOMEOPATHY, V99, P69, DOI 10.1016/j.homp.2009.09.001; Kooreman P, 2012, EUR J HEALTH ECON, V13, P769, DOI 10.1007/s10198-011-0330-2; Labarthe G., 2004, DREES ETUDES RESULTA, V315, P1; Lamiae GB, 2010, PHARMACOEPIDEM DR S, V19, P591, DOI 10.1002/pds.1952; Pulcini C, 2013, EUR J PUBLIC HEALTH, V23, P262, DOI 10.1093/eurpub/cks100; Rossi E, 2009, HOMEOPATHY, V98, P2, DOI 10.1016/j.homp.2008.11.005; Smith SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001831.pub4; Trichard M, 2005, Homeopathy, V94, P3, DOI 10.1016/j.homp.2004.11.021; Vincent S, 2013, J ALTERN COMPLEM MED, V19, P146, DOI 10.1089/acm.2011.0706; Welschen I, 2004, FAM PRACT, V21, P234, DOI 10.1093/fampra/cmh303; Williams-Piehota PA, 2011, ALTERN THER HEALTH M, V17, P22; World Health Organization, 1977, STAT CLASS DIS CAUS	27	32	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89990	10.1371/journal.pone.0089990	http://dx.doi.org/10.1371/journal.pone.0089990			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646513	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500011
J	Raji, CA; Tarzwell, R; Pavel, D; Schneider, H; Uszler, M; Thornton, J; van Lierop, M; Cohen, P; Amen, DG; Henderson, T				Raji, Cyrus A.; Tarzwell, Robert; Pavel, Dan; Schneider, Howard; Uszler, Michael; Thornton, John; van Lierop, Muriel; Cohen, Phil; Amen, Daniel G.; Henderson, Theodore			Clinical Utility of SPECT Neuroimaging in the Diagnosis and Treatment of Traumatic Brain Injury: A Systematic Review	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; EMISSION COMPUTED-TOMOGRAPHY; HYPERBARIC-OXYGEN THERAPY; POST-CONCUSSION SYNDROME; CLOSED-HEAD-INJURY; COGNITIVE REHABILITATION THERAPY; TECHNETIUM-99M-HMPAO SPECT; PHASE-I; PSYCHIATRIC-ILLNESS; OUTCOME PREDICTION	Purpose: This systematic review evaluated the clinical utility of single photon emission computed tomography (SPECT) in traumatic brain injury (TBI). Methods: After defining a PICO Statement (Population, Intervention, Comparison and Outcome Statement), PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) criteria were applied to identify 1600 articles. After screening, 374 articles were eligible for review. Inclusion for review was focus on SPECT in the setting of mild, moderate, or severe TBI with cerebral lobar specificity of SPECT findings. Other inclusion criteria were comparison modalities in the same subjects and articles in English. Foreign language articles, SPECT studies that did not include comparison modalities, and case reports were not included for review. Results: We identified 19 longitudinal and 52 cross-sectional studies meeting inclusion criteria. Three longitudinal studies examined diagnostic predictive value. The first showed positive predictive value increases from initial SPECT scan shortly after trauma to one year follow up scans, from 59% to 95%. Subsequent work replicated these results in a larger cohort. Longitudinal and cross sectional studies demonstrated SPECT lesion localization not detected by CT or MRI. The most commonly abnormal regions revealed by SPECT in cross-sectional studies were frontal (94%) and temporal (77%) lobes. SPECT was found to outperform both CT and MRI in both acute and chronic imaging of TBI, particularly mild TBI. It was also found to have a near 100% negative predictive value. Conclusions: This review demonstrates Level IIA evidence (at least one non-randomized controlled trial) for the value of SPECT in TBI. Given its advantages over CT and MRI in the detection of mild TBI in numerous studies of adequate quality, and given its excellent negative predictive value, it may be an important second test in settings where CT or MRI are negative after a closed head injury with post-injury neurological or psychiatric symptoms.	[Raji, Cyrus A.] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA; [Henderson, Theodore] Synapt Space, Denver, CO USA; [Tarzwell, Robert] Univ British Columbia, Sch Med, Vancouver, BC V5Z 1M9, Canada; [Pavel, Dan] PathFinder Brain SPECT, Deerfield, IL USA; [Schneider, Howard] Sheppard Associates, Toronto, ON, Canada; [Uszler, Michael] St Johns Hlth Ctr, Santa Monica, CA USA; [Thornton, John] Rossiter Thornton Associates, Toronto, ON, Canada; [van Lierop, Muriel; Cohen, Phil] Lions Gate Hosp, Vancouver, BC, Canada; [Amen, Daniel G.] Amen Clin Inc, Newport Beach, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of British Columbia	Henderson, T (corresponding author), Synapt Space, Denver, CO USA.	thesynapticspace7@gmail.com	Schneider, Howard/GXG-5503-2022	Schneider, Howard/0000-0001-8052-6448				Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Abe M, 2003, SURG NEUROL, V59, P464, DOI 10.1016/S0090-3019(03)00078-8; Abu-Judeh H H, 2000, Nucl Med Rev Cent East Eur, V3, P5; Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; Agarwal D, 2005, J NEUROSURG PEDIAT, V102, P167; Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Amorim BJ, 2011, ARQ NEURO-PSIQUIAT, V69, P682, DOI 10.1590/S0004-282X2011000500020; Anderson RJ, 2008, MOL INTERV, V8, P204, DOI 10.1124/mi.8.5.2; Armistead-Jehle P, 2012, J NEUROTRAUM, V29, P2513, DOI 10.1089/neu.2012.2400; Assadi M, 2007, HELL J NUCL MED, V10, P183; Audenaert Kurt, 2003, Med Sci Monit, V9, pMT112; BARCLAY L, 1985, BIOL PSYCHIAT, V20, P146, DOI 10.1016/0006-3223(85)90074-5; Barrett KF, 2004, UNDERSEA HYPERBAR M, V31, P395; BAVETTA S, 1994, NUCL MED COMMUN, V15, P961, DOI 10.1097/00006231-199412000-00007; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Beuthien-Baumann B, 2003, NUCL MED COMMUN, V24, P643, DOI 10.1097/00006231-200306000-00005; Bicik I, 1998, NEUROLOGY, V51, P345, DOI 10.1212/WNL.51.2.345; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Center DaVBI, 2013, DOD WORLDW NUMB TBI; Chen Y, 2013, J NEUROPSYCH CLIN N, V25, P103, DOI 10.1176/appi.neuropsych.12030058; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048298; CHOKSEY MS, 1991, J NEUROL NEUROSUR PS, V54, P6, DOI 10.1136/jnnp.54.1.6; CUSUMANO S, 1992, ELECTROEN CLIN NEURO, V84, P499, DOI 10.1016/0168-5597(92)90039-E; Davis P C, 2000, Radiology, V215 Suppl, P507; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Devous Sr MD, 2005, FUNCTIONAL CEREBRAL, P16; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; DUCOURS JL, 1990, NUCL MED COMMUN, V11, P361, DOI 10.1097/00006231-199005000-00003; Eftekhari Mohammad, 2005, BMC Nucl Med, V5, P6, DOI 10.1186/1471-2385-5-6; Emanuelson IM, 1997, DEV MED CHILD NEUROL, V39, P502; Emmerling MR, 2000, ANN NY ACAD SCI, V903, P118, DOI 10.1111/j.1749-6632.2000.tb06357.x; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2009, J HEAD TRAUMA REHAB, V24, P272, DOI 10.1097/HTR.0b013e3181a66342; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Goethals I, 2004, J NEUROTRAUM, V21, P1059, DOI 10.1089/0897715041651051; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Goshen E, 1996, NUCL MED COMMUN, V17, P418, DOI 10.1097/00006231-199605000-00011; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; GRAY BG, 1992, J NUCL MED, V33, P52; Habert MO, 2011, NEUROBIOL AGING, V32, P15, DOI 10.1016/j.neurobiolaging.2009.01.013; Harch PG, 2012, J NEUROTRAUM, V29, P2516, DOI 10.1089/neu.2012.2608; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Hashimoto K, 2009, J REHABIL MED, V41, P661, DOI 10.2340/16501977-0388; Hattori N, 2009, J NUCL MED, V50, P1054, DOI 10.2967/jnumed.108.060368; Henderson TP, 2012, RELIG STUD REV, V38, P17, DOI 10.1111/j.1748-0922.2011.01578_5.x; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; ICHISE M, 1994, J NUCL MED, V35, P217; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Ito H, 1997, Ann Nucl Med, V11, P167; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; Jellinger KA, 2004, J NEUROL NEUROSUR PS, V75, P511; Jeyaraj JA, 2013, BRAIN INJURY, V27, P1338, DOI 10.3109/02699052.2013.823650; Jian X, 2009, BRAIN INJURY, V23, P445, DOI 10.1080/02699050902838157; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Juni JE, 2009, SOC NUCL MED PROCEDU; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kauppinen T, 2002, NUCL MED COMMUN, V23, P1065, DOI 10.1097/00006231-200211000-00005; KEMP PM, 1995, J NEUROL NEUROSUR PS, V59, P368, DOI 10.1136/jnnp.59.4.368; Kesler SR, 2000, BRAIN INJURY, V14, P851; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kim Sunhee, 2011, Int J Mol Imaging, V2011, P813028, DOI 10.1155/2011/813028; Kinuya K, 2004, NUCL MED COMMUN, V25, P333, DOI 10.1097/00006231-200404000-00004; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Laatsch L, 1999, BRAIN INJURY, V13, P555, DOI 10.1080/026990599121304; Laatsch L, 1997, BRAIN INJURY, V11, P851; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; LAURIN NR, 1989, J NUCL MED, V30, P1627; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lewis DH, 2006, J NEUROIMAGING, V16, P272, DOI 10.1111/j.1552-6569.2006.00034.x; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; LOUTFI ISSA, 1995, INVEST RADIOL, V30, P588, DOI 10.1097/00004424-199510000-00004; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Mann NM, 2006, CLIN NUCL MED, V31, P458, DOI 10.1097/01.rlu.0000227010.72925.6d; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Metting Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064461; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; NAGAMACHI S, 1995, NUCL MED COMMUN, V16, P17, DOI 10.1097/00006231-199501000-00006; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; Nobili F, 2008, J NEUROL, V255, P1344, DOI 10.1007/s00415-008-0897-4; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; Office CB, 2012, VET HLTH ADM TREATME, P18; Okamoto T, 2007, EUR J NEUROL, V14, P540, DOI 10.1111/j.1468-1331.2007.01742.x; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; REID RH, 1990, CLIN NUCL MED, V15, P383, DOI 10.1097/00003072-199006000-00003; Rockhill CM, 2010, BRAIN INJURY, V24, P1051, DOI 10.3109/02699052.2010.494586; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; ROPER SN, 1991, J NUCL MED, V32, P1684; Rupright J, 1996, ARCH PHYS MED REHAB, V77, P1205, DOI 10.1016/S0003-9993(96)90150-1; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; Sataloff RT, 1996, AM J OTOL, V17, P909; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; Shiina G, 1998, AM J NEURORADIOL, V19, P297; Shimizu S, 2005, DEMENT GERIATR COGN, V20, P25, DOI 10.1159/000085070; Shin YB, 2006, BRAIN INJURY, V20, P661, DOI 10.1080/02699050600677071; SILVERMAN IE, 1993, J NUCL MED, V34, P1447; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taber Katherine H, 2013, J Neuropsychiatry Clin Neurosci, V25, P1, DOI 10.1176/appi.neuropsych.12120401; Umile EM, 1998, BRAIN INJURY, V12, P577; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Website C, 2012, INJ PREV CONTR TRAUM; Wiedmann KD, 1989, NEUROPSYCHOLOGY, V3, P267, DOI 10.1037//0894-4105.3.4.267; Wong SBC, 2006, PROG BRAIN RES, V157, P173, DOI 10.1016/S0079-6123(06)57011-6; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P7, DOI 10.2176/nmc.33.7; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	130	58	59	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91088	10.1371/journal.pone.0091088	http://dx.doi.org/10.1371/journal.pone.0091088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646878	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500023
J	Cordero, JG; Juarez, ML; Gonzalez-Y-Merchand, JA; Barron, LC; Castaneda, BG				Garcia Cordero, Julio; Leon Juarez, Moises; Gonzalez-Y-Merchand, Jorge A.; Cedillo Barron, Leticia; Gutierrez Castaneda, Benito			Caveolin-1 in Lipid Rafts Interacts with Dengue Virus NS3 during Polyprotein Processing and Replication in HMEC-1 Cells	PLOS ONE			English	Article							RICH MEMBRANE MICRODOMAINS; NF-KAPPA-B; RNA REPLICATION; PROTEIN INTERACTIONS; MONOCLONAL-ANTIBODY; ANCHORED PROTEINS; IMMUNE-RESPONSE; CHOLESTEROL; ENTRY; FLAVIVIRUS	Lipid rafts are ordered microdomains within cellular membranes that are rich in cholesterol and sphingolipids. Caveolin (Cav-1) and flotillin (Flt-1) are markers of lipid rafts, which serve as an organizing center for biological phenomena and cellular signaling. Lipid rafts involvement in dengue virus (DENV) processing, replication, and assembly remains poorly characterized. Here, we investigated the role of lipid rafts after DENV endocytosis in human microvascular endothelial cells (HMEC-1). The non-structural viral proteins NS3 and NS2B, but not NS5, were associated with detergent-resistant membranes. In sucrose gradients, both NS3 and NS2B proteins appeared in Cav-1 and Flt-1 rich fractions. Additionally, double immunofluorescence staining of DENV-infected HMEC-1 cells showed that NS3 and NS2B, but not NS5, colocalized with Cav-1 and Flt-1. Furthermore, in HMEC-1cells transfected with NS3 protease, shown a strong overlap between NS3 and Cav-1, similar to that in DENV-infected cells. In contrast, double-stranded viral RNA (dsRNA) overlapped weakly with Cav-1 and Flt-1. Given these results, we investigated whether Cav-1 directly interacted with NS3. Cav-1 and NS3 co-immunoprecipitated, indicating that they resided within the same complex. Furthermore, when cellular cholesterol was depleted by methyl-beta cyclodextrin treatment after DENV entrance, lipid rafts were disrupted, NS3 protein level was reduced, besides Cav-1 and NS3 were displaced to fractions 9 and 10 in sucrose gradient analysis, and we observed a dramatically reduction of DENV particles release. These data demonstrate the essential role of caveolar cholesterol-rich lipid raft microdomains in DENV polyprotein processing and replication during the late stages of the DENV life cycle.	[Garcia Cordero, Julio; Leon Juarez, Moises; Cedillo Barron, Leticia] IPN, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City 07738, DF, Mexico; [Garcia Cordero, Julio; Gonzalez-Y-Merchand, Jorge A.] IPN, Escuela Nacl Ciencias Biol, Dept Microbiol, Mexico City 07738, DF, Mexico; [Gutierrez Castaneda, Benito] Univ Autonoma Mexico, Fac Estudios Super, Lab Inmunol, Tlalnepantla Estado Mexi, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Barron, LC (corresponding author), IPN, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City 07738, DF, Mexico.	lcedillo@civestav.mx; benitogc@yahoo.com.mx	Juarez, Moises Leon/AAI-1958-2019	Leon Juarez, Moises/0000-0002-5726-5953	National Council for Science and Technology (CONACyT) [CB-2010-01/0154270]	National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the National Council for Science and Technology (CONACyT) Grant CB-2010-01/0154270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; Bartenschlager R, 2008, FUTURE MICROBIOL, V3, P155, DOI 10.2217/17460913.3.2.155; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Bustos-Arriaga J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001420; Carter GC, 2009, VIROLOGY, V386, P192, DOI 10.1016/j.virol.2008.12.031; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997; Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213; Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3; Garcia-Cordero J, 2005, HYBRIDOMA, V24, P160, DOI 10.1089/hyb.2005.24.160; Garcia-Cordero J, 2014, IMMUNOL INVEST, V43, P28, DOI 10.3109/08820139.2013.833622; Gayen S, 2012, BIOCHEM BIOPH RES CO, V423, P799, DOI 10.1016/j.bbrc.2012.06.043; Hailstones D, 1998, J LIPID RES, V39, P369; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Huang JH, 2007, J BIOL CHEM, V282, P6143, DOI 10.1074/jbc.M607701200; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; Jury EC, 2007, SEMIN CELL DEV BIOL, V18, P608, DOI 10.1016/j.semcdb.2007.08.002; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Lin SS, 2010, J VIROL, V84, P9487, DOI 10.1128/JVI.00763-10; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Lorizate M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004820; Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08; Metzner C, 2008, VIROLOGY, V382, P125, DOI 10.1016/j.virol.2008.09.014; Moreland NJ, 2012, J VIROL METHODS, V179, P97, DOI 10.1016/j.jviromet.2011.10.006; MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985; Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928; Puerta-Guardo H, 2010, J GEN VIROL, V91, P394, DOI 10.1099/vir.0.015420-0; Radyukhin V, 2008, ARCH VIROL, V153, P1977, DOI 10.1007/s00705-008-0214-7; Ravid D, 2010, J VIROL, V84, P9749, DOI 10.1128/JVI.01079-10; Reeves VL, 2012, ADV EXP MED BIOL, V729, P3, DOI 10.1007/978-1-4614-1222-9_1; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Simmons GE, 2012, VIROLOGY, V432, P110, DOI 10.1016/j.virol.2012.05.016; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Urcuqui-Inchima S, 2010, ADV VIRUS RES, V77, P1, DOI 10.1016/S0065-3527(10)77001-9; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; Ochoa MV, 2009, ARCH VIROL, V154, P919, DOI 10.1007/s00705-009-0396-7; Wang XM, 2011, J VIROL, V85, P5483, DOI 10.1128/JVI.00254-11; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007	45	29	29	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e90704	10.1371/journal.pone.0090704	http://dx.doi.org/10.1371/journal.pone.0090704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643062	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900007
J	Li, ZJ; Zhang, Y; Ying, XJ; Song, JM; Zhang, RX; Li, Z; Chen, HL; Ye, PJ; Shen, Y; Pan, WH; Chen, ZL				Li, Zhenjun; Zhang, Yan; Ying, Xiaojiang; Song, Junmin; Zhang, Ruoxin; Li, Zhen; Chen, Hongliang; Ye, Pingjiang; Shen, Yi; Pan, Weihuo; Chen, Zhiliang			The Association between RAD23B Ala249Val Polymorphism and Cancer Susceptibility: Evidence from a Meta-Analysis	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-REPAIR; GENETIC POLYMORPHISMS; BREAST-CANCER; PATHWAY GENES; LUNG-CANCER; C PROTEIN; XPC GENE; RISK; SMOKING	Background: A number of studies have investigated associations of genetic variation in RAD23B Ala249Val (rs1805329 C>T) with cancer susceptibility; however, the findings are inconsistent. We performed a meta-analysis to acquire a more precise estimation of the relationship. Method: We searched literatures from PubMed, Embase and Web of Science. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to estimate the association between Ala249Val polymorphism and cancer risk. Results: A total of 23 studies consisting of 10837 cases and 13971 controls were included in this meta-analysis. Overall, no significant associations were found between RAD23B Ala249Val polymorphism and cancer risk (Val/Val vs. Ala/Ala: OR = 0.97, 95% CI = 0.75-1.25; Ala/Val vs. Ala/Ala: OR = 1.08, 95% CI = 0.96-1.22; recessive model: OR = 0.93, 95% CI = 0.76-1.14 and dominant model: OR = 1.07, 95% CI = 0.94-1.20). We did not find any significant associations in the further stratification analyses by cancer type, ethnicity and source of control. Conclusions: Despite some limitations, this meta-analysis indicates that it is unlikely that the RAD23B 249Val/Val polymorphism may contribute to the individual susceptibility to cancer risk. However, further advanced designed studies with larger sample size and different ethnicities should be conducted to confirm our results.	[Li, Zhenjun; Ying, Xiaojiang; Chen, Hongliang; Ye, Pingjiang; Shen, Yi; Pan, Weihuo; Chen, Zhiliang] Zhejiang Univ, Shaoxing Hosp, Shaoxing Peoples Hosp, Dept Colorectal Surg, Shaoxing, Zhejiang, Peoples R China; [Zhang, Yan] Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Med Oncol, Suzhou, Jiangsu, Peoples R China; [Song, Junmin; Li, Zhen] Zhengzhou Univ, Affiliated Hosp 1, Dept Colorectal Surg, Zhengzhou 450052, Henan, Peoples R China; [Zhang, Ruoxin] Barts & London Queen Marys Sch Med & Dent, Dept Clin Pharmacol, London, England	Zhejiang University; Jiangsu University; Zhengzhou University; University of London; Queen Mary University London	Ying, XJ (corresponding author), Zhejiang Univ, Shaoxing Hosp, Shaoxing Peoples Hosp, Dept Colorectal Surg, Shaoxing, Zhejiang, Peoples R China.	mdyingxj@126.com; docsongjm@163.com			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi R, 2009, INT J CANCER, V125, P1431, DOI 10.1002/ijc.24442; Chang JS, 2008, INT J CANCER, V123, P2095, DOI 10.1002/ijc.23801; Chen M, 2007, CARCINOGENESIS, V28, P2160, DOI 10.1093/carcin/bgm167; Dai QS, 2013, GENE, V528, P335, DOI 10.1016/j.gene.2013.06.092; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Ezzati M, 2005, INT J CANCER, V116, P963, DOI 10.1002/ijc.21100; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Garcia-Closas M, 2006, CANCER EPIDEM BIOMAR, V15, P536, DOI 10.1158/1055-9965.EPI-05-0749; Geacintov NE, 2002, BIOPOLYMERS, V65, P202, DOI 10.1002/bip.10239; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; He J, 2013, INT J CANCER, V133, P1765, DOI 10.1002/ijc.28089; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hoffmann D, 1997, J TOXICOL ENV HEALTH, V50, P307, DOI 10.1080/009841097160393; Hsieh HC, 2005, BIOCHEM BIOPH RES CO, V335, P181, DOI 10.1016/j.bbrc.2005.07.067; Huang WY, 2006, CANCER EPIDEM BIOMAR, V15, P306, DOI 10.1158/1055-9965.EPI-05-0751; Ibarrola-Villava M, 2011, EUR J CANCER, V47, P2618, DOI 10.1016/j.ejca.2011.05.011; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Landi S, 2006, CANCER RES, V66, P11062, DOI 10.1158/0008-5472.CAN-06-1039; Leibeling D, 2006, J MOL HISTOL, V37, P225, DOI 10.1007/s10735-006-9041-x; Lin J, 2008, CARCINOGENESIS, V29, P2112, DOI 10.1093/carcin/bgn189; MANTEL N, 1959, J NATL CANCER I, V22, P719; McKean-Cowdin R, 2009, CANCER EPIDEM BIOMAR, V18, P1118, DOI 10.1158/1055-9965.EPI-08-1078; Mechanic LE, 2006, CARCINOGENESIS, V27, P1377, DOI 10.1093/carcin/bgi330; Michiels S, 2009, CARCINOGENESIS, V30, P763, DOI 10.1093/carcin/bgp046; Millikan RC, 2006, CARCINOGENESIS, V27, P610, DOI 10.1093/carcin/bgi252; Pan J, 2009, CARCINOGENESIS, V30, P785, DOI 10.1093/carcin/bgp058; Perez-Mayoral J, 2013, MOL CARCINOGEN, V52, P127, DOI 10.1002/mc.22056; Rajaraman P, 2010, NEURO-ONCOLOGY, V12, P37, DOI 10.1093/neuonc/nop012; Santos LS, 2013, ONCOL REP, V30, P2458, DOI 10.3892/or.2013.2702; Shen M, 2005, INT J CANCER, V116, P768, DOI 10.1002/ijc.21117; Shen M, 2006, HUM GENET, V119, P659, DOI 10.1007/s00439-006-0177-2; Shen MR, 1998, CANCER RES, V58, P604; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Thoma BS, 2005, NUCLEIC ACIDS RES, V33, P2993, DOI 10.1093/nar/gki610; Tomoda T, 2012, J GASTROEN HEPATOL, V27, P797, DOI 10.1111/j.1440-1746.2011.06948.x; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang Y, 2007, CLIN CANCER RES, V13, P3753, DOI 10.1158/1078-0432.CCR-06-1911; Wu XF, 2006, AM J HUM GENET, V78, P464, DOI 10.1086/500848; Yin ZB, 2014, TUMOR BIOL, V35, P1609, DOI 10.1007/s13277-013-1222-0; Zhang MD, 2008, CANCER EPIDEM BIOMAR, V17, P2123, DOI 10.1158/1055-9965.EPI-07-2735	43	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91922	10.1371/journal.pone.0091922	http://dx.doi.org/10.1371/journal.pone.0091922			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643114	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900049
J	Zhang, J; Ren, RM; Luo, XF; Fan, P; Liu, XH; Liang, SS; Ma, L; Yu, P; Bai, H				Zhang, Juan; Ren, Rongmei; Luo, Xuefeng; Fan, Ping; Liu, Xinghui; Liang, Shanshan; Ma, Lei; Yu, Ping; Bai, Huai			A Small Physiological Electric Field Mediated Responses of Extravillous Trophoblasts Derived from HTR8/SVneo Cells: Involvement of Activation of Focal Adhesion Kinase Signaling	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; EXPRESSION; MIGRATION; MOTILITY; STIMULATION; OVEREXPRESSION; KERATINOCYTES; PREECLAMPSIA; FIBRONECTIN; ORIENTATION	Moderate invasion of trophoblast cells into endometrium is essential for the placental development and normal pregnancy. Electric field (EF)-induced effects on cellular behaviors have been observed in many cell types. This study was to investigate the effect of physiological direct current EF (dc EF) on cellular responses such as elongation, orientation and motility of trophoblast cells. Immortalized first trimester extravillous trophoblast cells (HTR-8/SVneo) were exposed to the dc EF at physiological magnitude. Cell images were recorded and analyzed by image analyzer. Cell lysates were used to detect protein expression by Western blot. Cultured in the dc EFs the cells showed elongation, orientation and enhanced migration rate compared with non-EF stimulated cells at field strengths of 100 mV/mm to 200 mV/mm. EF exposure increased focal adhesion kinase (FAK) phosphorylation in a time-dependent manner and increased expression levels of MMP-2. Pharmacological inhibition of FAK impaired the EF-induced responses including motility and abrogated the elevation of MMP-2 expression. However, the expression levels of integrins like integrin alpha 1, alpha 5, alpha V and beta 1 were not affected by EF stimulation. Our results demonstrate the importance of FAK activation in migration/motility of trophobalst cells driven by EFs. In addition, it raises the feasibility of using applied EFs to promote placentation through effects on trophoblast cells.	[Zhang, Juan; Ren, Rongmei; Luo, Xuefeng; Fan, Ping; Liang, Shanshan; Ma, Lei; Bai, Huai] Sichuan Univ, Lab Genet Dis & Perinatal Med, West China Univ Hosp 2, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Juan; Ren, Rongmei; Luo, Xuefeng; Fan, Ping; Liang, Shanshan; Ma, Lei; Bai, Huai] Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, West China Univ Hosp 2, Minist Educ, Chengdu 610064, Sichuan, Peoples R China; [Liu, Xinghui] Sichuan Univ, Dept Obstet & Gynecol, West China Univ Hosp 2, Chengdu 610064, Sichuan, Peoples R China; [Yu, Ping] Sichuan Univ, Lab Cell & Gene Therapy, West China Univ Hosp 2, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Bai, H (corresponding author), Sichuan Univ, Lab Genet Dis & Perinatal Med, West China Univ Hosp 2, Chengdu 610064, Sichuan, Peoples R China.	baihuai60@aliyun.com	LUO, XUEFENG/AAX-3762-2021		National Natural Science Foundation of China [30872774, 81271733]; Sichuan Province Science and Research foundation of China [2012SZ0011]; National Basic Research Program of China (973 program) [2007CB948101]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0935]; West China Second University Hospital of Sichuan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province Science and Research foundation of China; National Basic Research Program of China (973 program)(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); West China Second University Hospital of Sichuan University	This work was supported by grants from the National Natural Science Foundation of China 30872774 (HB) and 81271733 (HB), Sichuan Province Science and Research foundation of China 2012SZ0011 (HB), National Basic Research Program of China (973 program, No. 2007CB948101), Program for Changjiang Scholars and Innovative Research Team in University IRT0935, and Research Seed Fund from West China Second University Hospital of Sichuan University (HB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Androulidaki A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-30; Bai H, 2004, ARTERIOSCL THROM VAS, V24, P1234, DOI 10.1161/01.ATV.0000131265.76828.8a; Bai H, 2011, CYTOKINE, V55, P110, DOI 10.1016/j.cyto.2011.03.003; Bai XW, 2007, AM J PHYSIOL-CELL PH, V293, pC1539, DOI 10.1152/ajpcell.00089.2007; Ball E, 2006, J PATHOL, V208, P535, DOI 10.1002/path.1927; BARKER AT, 1982, AM J PHYSIOL, V242, pR358, DOI 10.1152/ajpregu.1982.242.3.R358; Benaitreau D, 2010, J ENDOCRINOL, V207, P45, DOI 10.1677/JOE-10-0170; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Cary LA, 1996, J CELL SCI, V109, P1787; Cary Leslie A., 1999, Frontiers in Bioscience, V4, pD102, DOI 10.2741/Cary; Chang MM, 2011, BIOCHEM MOL BIOL EDU, V39, P291, DOI 10.1002/bmb.20501; Chao PHG, 2000, J BIOMECH ENG-T ASME, V122, P261, DOI 10.1115/1.429661; CHIANG MC, 1992, EXP EYE RES, V54, P999, DOI 10.1016/0014-4835(92)90164-N; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Djamgoz MBA, 2001, J CELL SCI, V114, P2697; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; FELDINGHABERMANN B, 1992, J CLIN INVEST, V89, P2018, DOI 10.1172/JCI115811; FERRIER J, 1986, J CELL PHYSIOL, V129, P283, DOI 10.1002/jcp.1041290303; Finkelstein E, 2004, J CELL SCI, V117, P1533, DOI 10.1242/jcs.00986; Fitzgerald JS, 2005, INT J BIOCHEM CELL B, V37, P2284, DOI 10.1016/j.biocel.2005.02.025; Fox GL, 1999, P NATL ACAD SCI USA, V96, P14978, DOI 10.1073/pnas.96.26.14978; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; GATES RE, 1994, CELL GROWTH DIFFER, V5, P891; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Huppertz B, 1998, CELL TISSUE RES, V291, P133; ILLC D, 1995, NATURE, V377, P539; Johnsen GM, 2011, PLACENTA, V32, P626, DOI 10.1016/j.placenta.2011.06.009; Jovanovic M, 2010, REPRODUCTION, V139, P789, DOI 10.1530/REP-09-0341; Kadyrov M, 2003, PLACENTA, V24, P540, DOI 10.1053/plac.2002.0946; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Levin M, 2007, TRENDS CELL BIOL, V17, P261, DOI 10.1016/j.tcb.2007.04.007; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; McCaig CD, 1997, BIOESSAYS, V19, P819, DOI 10.1002/bies.950190912; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; McCaig CD, 2009, J CELL SCI, V122, P4267, DOI 10.1242/jcs.023564; Meng XT, 2011, EXP NEUROL, V227, P210, DOI 10.1016/j.expneurol.2010.11.002; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nishimura KY, 1996, J CELL SCI, V109, P199; OWENS LV, 1995, CANCER RES, V55, P2752; Qiu Q, 2004, REPRODUCTION, V128, P355, DOI 10.1530/rep.1.00234; ROBINSON KR, 1996, NERVE GROWTH GUIDANC, P131; Ruan YC, 2012, NAT MED, V18, P1112, DOI 10.1038/nm.2771; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Sta Iglesia Drina D., 1998, Wound Repair and Regeneration, V6, P531; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Zhao M, 1999, MOL BIOL CELL, V10, P1259, DOI 10.1091/mbc.10.4.1259; Zhao M, 1996, J CELL SCI, V109, P1405; Zhao M, 2004, J CELL SCI, V117, P397, DOI 10.1242/jcs.00868	51	11	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92252	10.1371/journal.pone.0092252	http://dx.doi.org/10.1371/journal.pone.0092252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643246	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900111
J	Zhang, XN; Zhang, ZQ; Dai, FH; Shi, BS; Chen, L; Zhang, XX; Zang, GQ; Zhang, JM; Chen, XR; Qian, FX; Hu, YW; Yuan, ZH				Zhang, Xiaonan; Zhang, Zhanqing; Dai, Fahui; Shi, Bisheng; Chen, Liang; Zhang, Xinxin; Zang, Guoqing; Zhang, Jiming; Chen, Xiaorong; Qian, Fangxing; Hu, Yunwen; Yuan, Zhenghong			Comparison of Circulating, Hepatocyte Specific Messenger RNA and microRNA as Biomarkers for Chronic Hepatitis B and C	PLOS ONE			English	Article							CANCER; SERUM; BLOOD; DIAGNOSIS; INJURY	Circulating microRNAs have been widely recognized as a novel category of biomarker in a variety of physiological and pathological conditions. Other reports revealed that fragments of organ specific messenger RNAs are also detectable in serum/plasma and can be utilized as sensitive indicators of liver pathology and cancer. In order to assess the sensitivity and reliability of these two class of RNAs as marker of hepatitis B or C induced chronic liver disease, we collected plasma samples from 156 chronic hepatitis B or C patients (HBV active n = 112, HBV carrier n = 19, hepatitis C n = 25) and 22 healthy donors and quantified their circulating mRNA for albumin, HP (haptoglobin), CYP2E1 (cytochrome P450, family 2, subfamily E) and ApoA2 (Apolipoprotein A2) in conjunction with microRNA-122, a well established marker for acute and chronic liver injury. We found that plasma microRNA-122 level is significantly elevated in patients with active HBV but not in HBV carriers. Furthermore, microRNA-122 is not elevated in HCV patients even though their median serum alanine aminotransferase (sALT) was three fold of the healthy donors. Nevertheless, circulating mRNAs, especially albumin mRNA, showed much more sensitivity in distinguishing active hepatitis B, hepatitis B carrier or HCV patients from healthy control. Correlation and multiple linear regression analysis suggested that circulating mRNAs and miRNAs are much more related to HBsAg titre than to sALT. Immunoprecipitation of HBsAg in HBV patients' plasma resulted in enrichment of albumin and HP mRNA suggesting that fragments of liver specific transcripts can be encapsidated into HBsAg particles. Taken together, our results suggest that hepatocyte specific transcripts in plasma like albumin mRNA showed greater sensitivity and specificity in differentiating HBV or HCV induced chronic liver disease than microRNA-122. Circulating mRNA fragments merit more attention in the quest of next generation biomarkers for various maladies.	[Zhang, Xiaonan; Dai, Fahui; Shi, Bisheng; Hu, Yunwen; Yuan, Zhenghong] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Zhang, Zhanqing; Chen, Liang] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Viral Hepatitis, Shanghai 200433, Peoples R China; [Zhang, Xinxin] Shanghai Jiao Tong Univ, Ruijin Hosp, Inst Infect & Resp Dis, Sch Med, Shanghai, Peoples R China; [Zang, Guoqing] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Shanghai, Peoples R China; [Zhang, Jiming] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Chen, Xiaorong] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Chinese Tradit Med, Shanghai 200433, Peoples R China; [Qian, Fangxing] Shanghai Changning Ctr Hosp, Dept Infect Dis, Shanghai, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Fudan University	Yuan, ZH (corresponding author), Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	zhyuan@shaphc.org		Zhang, Xiaonan/0000-0002-1286-7280; zhang, zhanqing/0000-0001-7709-9027	National Science and Technology Major Project of China [2012ZX10002007-001]; National Natural Science Foundation [81201278]; National Health and Family Planning Commission [201302010]	National Science and Technology Major Project of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Health and Family Planning Commission	This work was supported by National Science and Technology Major Project of China (Grant No. 2012ZX10002007-001), National Natural Science Foundation (Grant No. 81201278) and National Health and Family Planning Commission (Grant No. 201302010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arataki K, 2013, J MED VIROL, V85, P789, DOI 10.1002/jmv.23540; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Chan RWY, 2010, CLIN CHEM, V56, P82, DOI 10.1373/clinchem.2009.133355; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li Y, 2006, J CLIN ONCOL, V24, P1754, DOI 10.1200/JCO.2005.03.7598; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miyamoto M, 2008, TOXICOL SCI, V106, P538, DOI 10.1093/toxsci/kfn188; Novellino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031952; Pinzani P, 2010, METHODS, V50, P302, DOI 10.1016/j.ymeth.2010.02.004; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wetmore BA, 2010, HEPATOLOGY, V51, P2127, DOI 10.1002/hep.23574; Wong SCC, 2004, CLIN CANCER RES, V10, P1613, DOI 10.1158/1078-0432.CCR-1168-3; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	18	27	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92112	10.1371/journal.pone.0092112	http://dx.doi.org/10.1371/journal.pone.0092112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643113	gold, Green Submitted, Green Published			2022-12-27	WOS:000333259900088
J	Chang, CC; Sue, YM; Yang, NJ; Lee, YH; Juan, SH				Chang, Chih-Cheng; Sue, Yuh-Mou; Yang, Nian-Jie; Lee, Yi-Hsuan; Juan, Shu-Hui			3-Methylcholanthrene, an AhR Agonist, Caused Cell-Cycle Arrest by Histone Deacetylation through a RhoA-Dependent Recruitment of HDAC1 and pRb2 to E2F1 Complex	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; VASCULAR ENDOTHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; RETINOBLASTOMA PROTEIN; PHOSPHATIDYLINOSITOL 3-KINASE; MOLECULAR-MECHANISMS; TUMOR-SUPPRESSOR; DIOXIN RECEPTOR; EXPRESSION; TRANSCRIPTION	We previously showed that treating vascular endothelial cells with 3-methylcholanthrene (3MC) caused cell-cycle arrest in the Go/G1 phase; this resulted from the induction of p21 and p27 and a decreased level and activity of the cyclin-dependent kinase, Cdk2. We further investigated the molecular mechanisms that modulate cell-cycle regulatory proteins through the aryl-hydrocarbon receptor (AhR)/Ras homolog gene family, member A (RhoA) dependent epigenetic modification of histone. AhR/RhoA activation mediated by 3MC was essential for the upregulation of retinoblastoma 2 (pRb2) and histone deacetylase 1 (HDAC1), whereas their nuclear translocation was primarily modulated by RhoA activation. The combination of increased phosphatase and tensin homolog (PTEN) activity and decreased phosphatidylinositide 3-kinase (PI3K) activation by 3MC led to the inactivation of the Ras-cRaf pathway, which contributed to pRb2 hypophosphorylation. Increased HDAC1/pRb2 recruitment to the E2F1 complex decreased E2F1-transactivational activity and H3/H4 deacetylation, resulting in the downregulation of cell-cycle regulatory proteins (Cdk2/4 and Cyclin D3/E). Co-immunoprecipitation and electrophoretic mobility shift assay (EMSA) results showed that simvastatin prevented the 3MC-increased binding activities of E2F1 proteins in their promoter regions. Additionally, RhoA inhibitors (statins) reversed the effect of 3MC in inhibiting DNA synthesis by decreasing the nuclear translocation of pRb2/HDAC1, leading to a recovery of the levels of cell-cycle regulatory proteins. In summary, 3MC decreased cell proliferation by the epigenetic modification of histone through an AhR/RhoA-dependent mechanism that can be rescued by statins.	[Chang, Chih-Cheng; Yang, Nian-Jie; Juan, Shu-Hui] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan; [Chang, Chih-Cheng; Yang, Nian-Jie; Juan, Shu-Hui] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Sue, Yuh-Mou] Taipei Med Univ, Wan Fang Hosp, Dept Nephrol, Taipei, Taiwan; [Lee, Yi-Hsuan] Natl Yang Ming Univ, Inst Physiol, Taipei 112, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Yang Ming Chiao Tung University	Juan, SH (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan.	juansh@tmu.edu.tw		Lee, Yi-Hsuan/0000-0002-3213-827X	National Science Council of Taiwan [NSC100-2320-B-038-016-MY2[2-2], NSC102-2320-B-038-030-MY3]; Taipei Medical University-associated Wan Fang Hospital [100TMU-WFH-06, 101TMU-WFH-09]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University-associated Wan Fang Hospital	This study was sponsored by grants from the National Science Council of Taiwan (NSC100-2320-B-038-016-MY2[2-2] and NSC102-2320-B-038-030-MY3) and the Taipei Medical University-associated Wan Fang Hospital (100TMU-WFH-06 and 101TMU-WFH-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; Chang CC, 2012, AM J PATHOL, V181, P211, DOI 10.1016/j.ajpath.2012.03.032; Chang CC, 2009, CELL MOL LIFE SCI, V66, P3193, DOI 10.1007/s00018-009-0102-7; Claudio PP, 2001, CANCER RES, V61, P462; Davis RK, 2008, DRUG NEWS PERSPECT, V21, P331, DOI 10.1358/dnp.2008.21.6.1246832; DeGregori J, 2006, MOL CELL BIOL, V26, P1165, DOI 10.1128/MCB.26.4.1165-1169.2006; DENISON MS, 1995, J BIOL CHEM, V270, P18175, DOI 10.1074/jbc.270.31.18175; Dudler T, 1996, J BIOL CHEM, V271, P11541, DOI 10.1074/jbc.271.19.11541; Elferink CJ, 2001, MOL PHARMACOL, V59, P664, DOI 10.1124/mol.59.4.664; Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444; Garrison PM, 2000, ARCH BIOCHEM BIOPHYS, V374, P161, DOI 10.1006/abbi.1999.1620; Ge NL, 1998, J BIOL CHEM, V273, P22708, DOI 10.1074/jbc.273.35.22708; Gomez-Duran A, 2008, J MOL BIOL, V380, P1, DOI 10.1016/j.jmb.2008.04.056; Gu JG, 1998, J CELL BIOL, V143, P1375, DOI 10.1083/jcb.143.5.1375; Juan SH, 2006, EUR J PHARMACOL, V530, P1, DOI 10.1016/j.ejphar.2005.11.023; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; LAM EWF, 1995, GENE, V160, P277, DOI 10.1016/0378-1119(95)00184-8; Latchney SE, 2011, STEM CELLS DEV, V20, P313, DOI 10.1089/scd.2009.0529; LEES E, 1995, CURR OPIN CELL BIOL, V7, P773, DOI 10.1016/0955-0674(95)80060-3; Lin H, 2008, J CELL PHYSIOL, V214, P434, DOI 10.1002/jcp.21214; Ma Q, 1997, J BIOL CHEM, V272, P8878; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Mulero-Navarro S, 2005, J BIOL CHEM, V280, P28731, DOI 10.1074/jbc.M504538200; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Pang PH, 2008, J CELL PHYSIOL, V215, P161, DOI 10.1002/jcp.21299; Paramio JM, 1999, ONCOGENE, V18, P7462, DOI 10.1038/sj.onc.1203151; Pierre S, 2011, BIOCHEM PHARMACOL, V81, P304, DOI 10.1016/j.bcp.2010.10.003; Puga A, 2000, J BIOL CHEM, V275, P2943, DOI 10.1074/jbc.275.4.2943; Puga A, 2011, TOXICOL SCI, V120, P256, DOI 10.1093/toxsci/kfq393; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shih CM, 2004, EUR J PHARMACOL, V496, P41, DOI 10.1016/j.ejphar.2004.06.016; Wang S, 1998, MOL CELL BIOL, V18, P7487, DOI 10.1128/MCB.18.12.7487; Weiss C, 1996, EXP CELL RES, V226, P154, DOI 10.1006/excr.1996.0214; Xu J, 2000, STROKE, V31, P1744, DOI 10.1161/01.STR.31.7.1744; Zhang HS, 2001, ONCOGENE, V20, P3134, DOI 10.1038/sj.onc.1204338	36	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92793	10.1371/journal.pone.0092793	http://dx.doi.org/10.1371/journal.pone.0092793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658119	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300129
J	Ma, R; Cui, Z; Hu, SY; Jia, XY; Yang, R; Zheng, X; Ao, J; Liu, G; Liao, YH; Zhao, MH				Ma, Rui; Cui, Zhao; Hu, Shui-Yi; Jia, Xiao-Yu; Yang, Rui; Zheng, Xin; Ao, Jie; Liu, Gang; Liao, Yun-Hua; Zhao, Ming-Hui			The Alternative Pathway of Complement Activation May Be Involved in the Renal Damage of Human Anti-Glomerular Basement Membrane Disease	PLOS ONE			English	Article							PROPERDIN BINDS; MICE; GLOMERULONEPHRITIS; NEPHRITIS; C3; CELLS; DEFICIENCY; ARTHRITIS; ANTIBODY; DEPOSIT	Linear deposition of IgG and complement 3 (C3) along glomerular basement membrane (GBM) is generally revealed in the kidneys of human anti-GBM disease. Our recent studies demonstrated the pathogenic role of complement activation in renal damage of this disease. However, the pathways of complement activation were still paradoxical. In this study, renal biopsy tissues from 10 patients with anti-GBM disease were used to investigate the pathways of complement activation by detecting the deposition of various complement components, including C1q, factor B, factor P (properdin), mannose-binding lectin (MBL), C3d, C4d and C5b-9, using immunohistochemistry and immunofluorescence. We found that C1q, factor B, properdin, C3d, C4d and C5b-9 were detected in all the glomeruli of our patients, along GBM with a linear and/or granular staining pattern. Furthermore, C1q, factor B and properdin co-localized well with C5b-9. The properdin also co-localized well with C3d. However, the deposition of MBL was diffusive in mesangium, GBM, Bowman's capsule and within crescents and was not co-localized with C5b-9 but partially co-localized with C4d. The intensity of factor B deposition (3.3 vs. 1.2, P<0.001) and C5b-9 deposition (3.2 vs. 1.6, P<0.001) was significantly stronger in the glomeruli with crescent formation, compared with the glomeruli without crescents. The complement system is overall activated via both the alternative pathway and classical pathway in the kidneys of human anti-GBM disease. The alternative pathway might play an important role in complement activation induced renal damage.	[Ma, Rui; Cui, Zhao; Hu, Shui-Yi; Jia, Xiao-Yu; Yang, Rui; Zheng, Xin; Ao, Jie; Liu, Gang; Zhao, Ming-Hui] Peking Univ, Hosp 1, Inst Nephrol,Key Lab Renal Dis, Dept Med,Renal Div,Minist Educ China,Key Lab Chro, Beijing 100871, Peoples R China; [Ma, Rui; Liao, Yun-Hua] Guangxi Med Univ, Affiliated Hosp 1, Dept Med, Div Renal, Nanning, Guangxi Zhuang, Peoples R China; [Zhao, Ming-Hui] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Ministry of Education, China; Peking University; Guangxi Medical University	Cui, Z (corresponding author), Peking Univ, Hosp 1, Inst Nephrol,Key Lab Renal Dis, Dept Med,Renal Div,Minist Educ China,Key Lab Chro, Beijing 100871, Peoples R China.	cuizhao@bjmu.edu.cn	Cui, Zhao/ABZ-9262-2022	Cui, Zhao/0000-0002-5837-1926	Chinese 973 project [2012CB517702]; Natural Science Fund of China [81321064]; National Natural Science Fund of China [81370801]	Chinese 973 project(National Basic Research Program of China); Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant of Chinese 973 project (No. 2012CB517702), a grant from Natural Science Fund of China to the Innovation Research Group (81321064) and a grant of National Natural Science Fund of China (81370801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cui Z, 2005, NEPHRON CLIN PRACT, V99, pC49, DOI 10.1159/000083133; Daha M, 1989, BEHRING I MITT, V84, P42; Elliott MK, 2004, KIDNEY INT, V65, P129, DOI 10.1111/j.1523-1755.2004.00371.x; Fischer EG, 2006, AM J CLIN PATHOL, V125, P445, DOI 10.1309/NPTP-4UKV-7JU3-ELMQ; Gaarkeuken H, 2008, AM J PHYSIOL-RENAL, V295, pF1397, DOI 10.1152/ajprenal.90313.2008; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Hebert MJ, 1998, NEPHROL DIAL TRANSPL, V13, P2799, DOI 10.1093/ndt/13.11.2799; Hietala MA, 2002, J IMMUNOL, V169, P454, DOI 10.4049/jimmunol.169.1.454; Hisano S, 2005, AM J KIDNEY DIS, V45, P295, DOI 10.1053/j.ajkd.2004.10.020; Hisano S, 2007, PATHOL INT, V57, P351, DOI 10.1111/j.1440-1827.2007.02107.x; Holers VM, 2002, J EXP MED, V195, P211, DOI 10.1084/jem.200116116; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Kluth DC, 1999, J AM SOC NEPHROL, V10, P2446; Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2; Lerner RA, 1999, J AM SOC NEPHROL, V10, P1389; Ma R, 2013, J CLIN IMMUNOL, V33, P172, DOI 10.1007/s10875-012-9772-2; Otten MA, 2009, J IMMUNOL, V183, P3980, DOI 10.4049/jimmunol.0901301; Roos A, 2006, J AM SOC NEPHROL, V17, P1724, DOI 10.1681/ASN.2005090923; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; SCHULZE M, 1993, AM J PATHOL, V142, P179; Segelmark M, 2003, NEPHRON CLIN PRACT, V94, pC59, DOI 10.1159/000072022; Sheerin NS, 1997, CLIN EXP IMMUNOL, V110, P403, DOI 10.1046/j.1365-2249.1997.4261438.x; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Trouw LA, 2004, J CLIN INVEST, V114, P679, DOI 10.1172/JCI200421075; Xing GQ, 2009, J CLIN IMMUNOL, V29, P282, DOI 10.1007/s10875-008-9268-2; Xu W, 2008, J IMMUNOL, V180, P7613, DOI 10.4049/jimmunol.180.11.7613	28	27	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91250	10.1371/journal.pone.0091250	http://dx.doi.org/10.1371/journal.pone.0091250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658070	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300029
J	Ruan, M; Zhang, Z; Li, SY; Yan, M; Liu, SW; Yang, WJ; Wang, LZ; Zhang, CP				Ruan, Min; Zhang, Zun; Li, Siyi; Yan, Min; Liu, Shengwen; Yang, Wenjun; Wang, Lizheng; Zhang, Chenping			Activation of Toll-Like Receptor-9 Promotes Cellular Migration via Up-Regulating MMP-2 Expression in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							NF-KAPPA-B; MATRIX METALLOPROTEINASES; SIGNALING PATHWAYS; INNATE IMMUNITY; CANCER; INVASION; METASTASIS; SUPPRESSES; SITE	Purpose: Activation of Toll like receptors (TLRs) signaling has been implicated in promoting malignant cell invasion and metastatic potential. Previously we demonstrated that increased TLR-9 expression predicted poor survival in oral cancer patients. The objective of this study is to further investigate the roles and potential molecular mechanisms of TLR-9 signaling in human oral cancer cell invasion. Methods: Cell migration, invasion and protein expression were detected by wound healing assay, Transwell chambers model and western blot. The secretion and activity levels of metalloproteinases-2/9 were quantified by ELISA and Gelatin zymography. EMSA and ChIP assays were employed to detect the activity of AP-1signal pathway. TLR-9 siRNA transfection was used to regulate the expression and activity of TLR-9 in oral cancer cell line HB cells. Result: The results of both wound healing assay and in vitro Transwell assay revealed that activation of TLR-9 induced dose- and time-dependent migration and invasion of HB cells. An increased expression, secretion and activity of MMP-2 were observed upon the treatment of CpG-ODN. The TLR-9 signaling-mediated MMP-2 expression appeared to be a consequence of AP-1 activation, because that their DNA binding activity was enhanced by CpG-ODN treatment. All these influences were efficiently repressed by the knockdown of TLR-9 through siRNA or pretreatment of an AP-1 inhibitor. Conclusion: Activation of TLR-9 signaling could promote human oral cancer HB cells invasion with the induction of MMP-2 presentation by attenuating AP-1 binding activity, suggesting a novel anti-metastatic application for TLR-9 targeted therapy in oral cancer in the future.	[Ruan, Min; Li, Siyi; Yan, Min; Liu, Shengwen; Yang, Wenjun; Zhang, Chenping] Shanghai Jiao Tong Univ, Peoples Hosp 9, Coll Stomatol,Shanghai Key Lab Stomatol, Sch Med,Dept Oral & Maxillofacial Head & Neck On, Shanghai 200030, Peoples R China; [Zhang, Zun] Tongji Univ, Shanghai East Hosp, Dept Stomatol, Shanghai 200092, Peoples R China; [Wang, Lizheng] Shanghai Jiao Tong Univ, Peoples Hosp 9, Coll Stomatol, Sch Med,Dept Oral Pathol,Shanghai Key Lab Stomato, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Tongji University; Shanghai Jiao Tong University	Ruan, M (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Coll Stomatol,Shanghai Key Lab Stomatol, Sch Med,Dept Oral & Maxillofacial Head & Neck On, Shanghai 200030, Peoples R China.	doctorruanmin@hotmail.com		Ruan, Min/0000-0002-1789-7518	National Natural Science Foundation of China [81102049]; Natural Science Foundation of Shanghai [11ZR1420600]; Shanghai Leading Academic Discipline Project [S30206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This study was supported by Project of National Natural Science Foundation of China (Grant No. 81102049) (URL: http://www.nsfc.gov.cn/Portal0/default152.htm); the Natural Science Foundation of Shanghai (Grant No. 11ZR1420600) to MR (URL: http://www.stcsm.gov.cn/); and Shanghai Leading Academic Discipline Project (Project Number: S30206) to CZ (URL: http://www.shec.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; Chen R, 2007, AM J REPROD IMMUNOL, V57, P93, DOI 10.1111/j.1600-0897.2006.00441.x; de Vicente JC, 2005, ORAL ONCOL, V41, P283, DOI 10.1016/j.oraloncology.2004.08.013; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ferlay J, 2010, IARC CANC BASE, V10; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Guo HY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-77; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hsieh YS, 2007, CARCINOGENESIS, V28, P977, DOI 10.1093/carcin/bgl221; Hua D, 2009, MOL IMMUNOL, V46, P2876, DOI 10.1016/j.molimm.2009.06.016; Ilvesaro JM, 2007, PROSTATE, V67, P774, DOI 10.1002/pros.20562; Katayama A, 2004, CLIN CANCER RES, V10, P634, DOI 10.1158/1078-0432.CCR-0864-02; Katomongkolgit R, 2008, ORAL ONCOL, V44, P587, DOI 10.1016/j.oraloncology.2007.08.005; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Killeen SD, 2009, BRIT J CANCER, V100, P1589, DOI 10.1038/sj.bjc.6604942; KUSUKAWA J, 1993, AM J CLIN PATHOL, V99, P18, DOI 10.1093/ajcp/99.1.18; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Merrell MA, 2006, MOL CANCER RES, V4, P437, DOI 10.1158/1541-7786.MCR-06-0007; Myoung H, 2002, CANCER LETT, V185, P201, DOI 10.1016/S0304-3835(02)00281-1; O'Neill LAJ, 2002, CURR TOP MICROBIOL, V270, P47; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Ruan Min, 2008, Phytotherapy Research, V22, P407, DOI 10.1002/ptr.2340; Ruan M, 2012, CANCER SCI, V103, P1938, DOI 10.1111/j.1349-7006.2012.02394.x; Ruan M, 2011, ARCH ORAL BIOL, V56, P877, DOI 10.1016/j.archoralbio.2011.01.010; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Toualbi-Abed K, 2008, CARCINOGENESIS, V29, P536, DOI 10.1093/carcin/bgm293; Xie WJ, 2009, BIOCHEM BIOPH RES CO, V379, P1027, DOI 10.1016/j.bbrc.2009.01.009; Yang XC, 2013, EUR REV MED PHARMACO, V17, P1669; Zhong LP, 2008, ARCH ORAL BIOL, V53, P443, DOI 10.1016/j.archoralbio.2007.12.002	35	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92748	10.1371/journal.pone.0092748	http://dx.doi.org/10.1371/journal.pone.0092748			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658023	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300126
J	Abdiche, YN; Miles, A; Eckman, J; Foletti, D; Van Blarcom, TJ; Yeung, YA; Pons, J; Rajpal, A				Abdiche, Yasmina Noubia; Miles, Adam; Eckman, Josh; Foletti, Davide; Van Blarcom, Thomas J.; Yeung, Yik Andy; Pons, Jaume; Rajpal, Arvind			High-Throughput Epitope Binning Assays on Label-Free Array-Based Biosensors Can Yield Exquisite Epitope Discrimination That Facilitates the Selection of Monoclonal Antibodies with Functional Activity	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; HUMAN HEMOGLOBIN; IDENTIFICATION; RECEPTOR; MIXTURE; PROTEON; DOMAIN	Here, we demonstrate how array-based label-free biosensors can be applied to the multiplexed interaction analysis of large panels of analyte/ligand pairs, such as the epitope binning of monoclonal antibodies (mAbs). In this application, the larger the number of mAbs that are analyzed for cross-blocking in a pairwise and combinatorial manner against their specific antigen, the higher the probability of discriminating their epitopes. Since cross-blocking of two mAbs is necessary but not sufficient for them to bind an identical epitope, high-resolution epitope binning analysis determined by high-throughput experiments can enable the identification of mAbs with similar but unique epitopes. We demonstrate that a mAb's epitope and functional activity are correlated, thereby strengthening the relevance of epitope binning data to the discovery of therapeutic mAbs. We evaluated two state-of-the-art label-free biosensors that enable the parallel analysis of 96 unique analyte/ligand interactions and nearly ten thousand total interactions per unattended run. The IBIS-MX96 is a microarray-based surface plasmon resonance imager (SPRi) integrated with continuous flow microspotting technology whereas the Octet-HTX is equipped with disposable fiber optic sensors that use biolayer interferometry (BLI) detection. We compared their throughput, versatility, ease of sample preparation, and sample consumption in the context of epitope binning assays. We conclude that the main advantages of the SPRi technology are its exceptionally low sample consumption, facile sample preparation, and unparalleled unattended throughput. In contrast, the BLI technology is highly flexible because it allows for the simultaneous interaction analysis of 96 independent analyte/ligand pairs, ad hoc sensor replacement and on-line reloading of an analyte- or ligand-array. Thus, the complementary use of these two platforms can expedite applications that are relevant to the discovery of therapeutic mAbs, depending upon the sample availability, and the number and diversity of the interactions being studied.	[Abdiche, Yasmina Noubia; Foletti, Davide; Van Blarcom, Thomas J.; Yeung, Yik Andy; Pons, Jaume; Rajpal, Arvind] Rinat Pfizer Inc, San Francisco, CA 94080 USA; [Miles, Adam; Eckman, Josh] Wasatch Microfluid, Salt Lake City, UT USA	Pfizer	Abdiche, YN (corresponding author), Rinat Pfizer Inc, San Francisco, CA 94080 USA.	yasmina.abdiche@pfizer.com			Rinat-Pfizer Inc.	Rinat-Pfizer Inc.(Pfizer)	The study was funded by Rinat-Pfizer Inc. The authors designed the experiments, collected and analyzed the data, and wrote the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche YN, 2012, J IMMUNOL METHODS, V382, P101, DOI 10.1016/j.jim.2012.05.010; Abdiche YN, 2011, ANAL BIOCHEM, V411, P139, DOI 10.1016/j.ab.2010.12.020; Abdiche YN, 2009, ANAL BIOCHEM, V386, P172, DOI 10.1016/j.ab.2008.11.038; Aldaz-Carroll L, 2005, VIROLOGY, V341, P59, DOI 10.1016/j.virol.2005.07.006; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Eddings MA, 2008, ANAL BIOCHEM, V382, P55, DOI 10.1016/j.ab.2008.07.031; El-Manzalawy Yasser, 2010, Immunome Res, V6 Suppl 2, pS2, DOI 10.1186/1745-7580-6-S2-S2; Emde A, 2011, ONCOGENE, V30, P1631, DOI 10.1038/onc.2010.547; Gesellchen Frank, 2005, V305, P17; Jamnani FR, 2012, EXP CELL RES, V318, P1112, DOI 10.1016/j.yexcr.2012.03.004; Klein C, 2013, MABS-AUSTIN, V5, P22, DOI 10.4161/mabs.22771; Koefoed K, 2011, MABS-AUSTIN, V3, P584, DOI 10.4161/mabs.3.6.17955; Krummenacher C, 2000, J VIROL, V74, P10863, DOI 10.1128/JVI.74.23.10863-10872.2000; Markovitz RC, 2013, BLOOD, V121, P2785, DOI 10.1182/blood-2012-09-456582; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Rich RL, 2007, ANAL BIOCHEM, V361, P1, DOI 10.1016/j.ab.2006.10.040; Robak T, 2012, BLOOD, V120, P3670, DOI 10.1182/blood-2012-06-438804; Song HY, 2012, LANGMUIR, V28, P997, DOI 10.1021/la202734f; Spangler JB, 2012, J MOL BIOL, V422, P532, DOI 10.1016/j.jmb.2012.06.014; Sun GY, 2008, J CHROMATOGR B, V867, P1, DOI 10.1016/j.jchromb.2008.02.014; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06	22	73	77	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92451	10.1371/journal.pone.0092451	http://dx.doi.org/10.1371/journal.pone.0092451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651868	gold, Green Submitted, Green Published			2022-12-27	WOS:000333352800108
J	Lu, T; Huang, J; Zeng, FG				Lu, Thomas; Huang, Juan; Zeng, Fan-Gang			Accurate Guitar Tuning by Cochlear Implant Musicians	PLOS ONE			English	Article							MODULATION TRANSFER-FUNCTIONS; EVOKED-POTENTIALS; PERCEPTION; PITCH; RECOGNITION; REFLECTS; CHILDREN; HEARING; LIMITS	Modern cochlear implant (CI) users understand speech but find difficulty in music appreciation due to poor pitch perception. Still, some deaf musicians continue to perform with their CI. Here we show unexpected results that CI musicians can reliably tune a guitar by CI alone and, under controlled conditions, match simultaneously presented tones to <0.5 Hz. One subject had normal contralateral hearing and produced more accurate tuning with CI than his normal ear. To understand these counterintuitive findings, we presented tones sequentially and found that tuning error was larger at similar to 30 Hz for both subjects. A third subject, a non-musician CI user with normal contralateral hearing, showed similar trends in performance between CI and normal hearing ears but with less precision. This difference, along with electric analysis, showed that accurate tuning was achieved by listening to beats rather than discriminating pitch, effectively turning a spectral task into a temporal discrimination task.	[Lu, Thomas; Zeng, Fan-Gang] Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Irvine, CA 92697 USA; [Huang, Juan] Johns Hopkins Univ, Mind Brain Inst, Baltimore, MD USA	University of California System; University of California Irvine; Johns Hopkins University	Lu, T (corresponding author), Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Irvine, CA 92697 USA.	telu@uci.edu			NIH [2RO1 DC008858, P30 DC008369]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008858, P30DC008369] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was carried out at University of California, Irvine with support from NIH Grants 2RO1 DC008858 and P30 DC008369. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACON SP, 1985, AUDIOLOGY, V24, P117; Baumann S, 2008, J COGNITIVE NEUROSCI, V20, P2238, DOI 10.1162/jocn.2008.20157; Chen JKC, 2010, PEDIATRICS, V125, pE793, DOI 10.1542/peds.2008-3620; Fu QJ, 2008, HEARING RES, V242, P198, DOI 10.1016/j.heares.2007.11.010; GFELLER K, 1991, J SPEECH HEAR RES, V34, P916, DOI 10.1044/jshr.3404.916; Gfeller Kate, 2002, Cochlear Implants Int, V3, P29, DOI 10.1179/cim.2002.3.1.29; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; HINOJOSA R, 1980, ARCH OTOLARYNGOL, V106, P193; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Kishon-Rabin Liat, 2001, Journal of Basic and Clinical Physiology and Pharmacology, V12, P125; Kong YY, 2004, EAR HEARING, V25, P173, DOI 10.1097/01.AUD.0000120365.97792.2F; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; McDermott Hugh J, 2004, Trends Amplif, V8, P49, DOI 10.1177/108471380400800203; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Mitani C, 2007, EAR HEARING, V28, p29S, DOI 10.1097/AUD.0b013e318031547a; Olszewski Carol, 2005, Cochlear Implants Int, V6, P123, DOI 10.1179/cim.2005.6.3.123; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Pijl S, 1997, EAR HEARING, V18, P364, DOI 10.1097/00003446-199710000-00002; Sandmann P, 2010, CLIN NEUROPHYSIOL; Sandmann P, 2009, BRAIN, V132, P1967, DOI 10.1093/brain/awp034; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; SHANNON RV, 1992, J ACOUST SOC AM, V91, P2156, DOI 10.1121/1.403807; SHANNON RV, 1983, HEARING RES, V12, P1, DOI 10.1016/0378-5955(83)90115-6; SPIEGEL MF, 1984, J ACOUST SOC AM, V76, P1690, DOI 10.1121/1.391605; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zeng Fan-Gang, 2008, IEEE Rev Biomed Eng, V1, P115, DOI 10.1109/RBME.2008.2008250; Zeng FG, 2002, HEARING RES, V174, P101, DOI 10.1016/S0378-5955(02)00644-5	31	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92454	10.1371/journal.pone.0092454	http://dx.doi.org/10.1371/journal.pone.0092454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651081	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800109
J	Sun, XD; Li, J; Dong, FN; Dong, JT				Sun, Xiaodong; Li, Jie; Dong, Frederick N.; Dong, Jin-Tang			Characterization of Nuclear Localization and SUMOylation of the ATBF1 Transcription Factor in Epithelial Cells	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; TUMOR-SUPPRESSOR; PROTEIN; BINDING; EXPRESSION; UBIQUITIN; MOTIF; GENE; PML; DIFFERENTIATION	ATBF1/ZFHX3 is a large transcription factor that functions in development, tumorigenesis and other biological processes. ATBF1 is normally localized in the nucleus, but is often mislocalized in the cytoplasm in cancer cells. The mechanism underlying the mislocalization of ATBF1 is unknown. In this study, we analyzed the nuclear localization of ATBF1, and found that ectopically expressed ATBF1 formed nuclear body (NB)-like dots in the nucleus, some of which indeed physically associated with promyelocytic leukemia (PML) NBs. We also defined a 3-amino acid motif, KRK2615-2617, as the nuclear localization signal (NLS) for ATBF1. Interestingly, diffusely distributed nuclear SUMO1 proteins were sequestered into ATBF1 dots, which could be related to ATBF1's physical association with PML NBs, known SUMOylation hotspots. Furthermore, ATBF1 itself was SUMOylated. ATBF1 SUMOylation occurred at more than 3 lysine residues including K-2349, K-2806 and K-3258 and was nuclear specific. Finally, the PIAS3 SUMO1 E3 ligase, which interacts with ATBF1 directly, diminished rather than enhanced ATBF1 SUMOylation, preventing the co-localization of ATBF1 with SUMO1 in the nucleus. These findings suggest that nuclear localization and SUMOylation are important for the transcription factor function of ATBF1, and that ATBF1 could cooperate with PML NBs to regulate protein SUMOylation in different biological processes.	[Sun, Xiaodong; Li, Jie; Dong, Frederick N.; Dong, Jin-Tang] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University	Dong, JT (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA.	j.dong@emory.edu	Li, Jie/K-8812-2015	Dong, Jin-Tang/0000-0003-2349-5782	National Cancer Institute, National Institutes of Health [R01CA121459]; NATIONAL CANCER INSTITUTE [R01CA121459] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R01CA121459 from the National Cancer Institute, National Institutes of Health, http://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Brand Peter, 2010, PMC Biophys, V3, P3, DOI 10.1186/1757-5036-3-3; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Cho YG, 2007, CLIN CANCER RES, V13, P4355, DOI 10.1158/1078-0432.CCR-07-0619; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Dahle O, 2004, EXP CELL RES, V297, P118, DOI 10.1016/j.yexcr.2004.03.014; Delaune A, 2008, J NEUROCHEM, V104, P89, DOI 10.1111/j.1471-4159.2007.05019.x; Dong XY, 2012, BIOCHEM J, V444, P581, DOI 10.1042/BJ20111890; Dong XY, 2010, J BIOL CHEM, V285, P32801, DOI 10.1074/jbc.M110.128330; Evdokimov E, 2008, J CELL SCI, V121, P4106, DOI 10.1242/jcs.038570; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Ishii Y, 2003, J COMP NEUROL, V465, P57, DOI 10.1002/cne.10807; Jang MS, 2002, BIOCHEM BIOPH RES CO, V295, P495, DOI 10.1016/S0006-291X(02)00699-X; Jung CG, 2005, DEVELOPMENT, V132, P5137, DOI 10.1242/dev.02098; Jung CG, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-47; Kaspar P, 1999, J BIOL CHEM, V274, P14422, DOI 10.1074/jbc.274.20.14422; Kataoka H, 2000, BIOCHEM BIOPH RES CO, V267, P91, DOI 10.1006/bbrc.1999.1911; Kim CJ, 2008, HISTOPATHOLOGY, V52, P552, DOI 10.1111/j.1365-2559.2008.02980.x; Kim TS, 2010, DIS MODEL MECH, V3, P752, DOI 10.1242/dmm.004689; Kocer B, 2004, DIGEST DIS SCI, V49, P954, DOI 10.1023/B:DDAS.0000034554.96191.66; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Li M, 2013, BIOCHEM BIOPH RES CO, V430, P358, DOI 10.1016/j.bbrc.2012.11.009; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049841; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Mabuchi M, 2010, BIOCHEM BIOPH RES CO, V398, P321, DOI 10.1016/j.bbrc.2010.06.090; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MIURA Y, 1995, J BIOL CHEM, V270, P26840, DOI 10.1074/jbc.270.45.26840; Mori Y, 2007, INT J CANCER, V121, P241, DOI 10.1002/ijc.22654; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054; Qi Y, 2008, P NATL ACAD SCI USA, V105, P2481, DOI 10.1073/pnas.0712196105; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Sun XD, 2007, J CANCER RES CLIN, V133, P103, DOI 10.1007/s00432-006-0148-y; Sun XD, 2013, HEAD NECK-J SCI SPEC, V35, P1007, DOI 10.1002/hed.23077; Sun XD, 2012, GENESIS, V50, P819, DOI 10.1002/dvg.22041; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; Watanabe M, 1996, MOL BRAIN RES, V42, P344, DOI 10.1016/S0169-328X(96)00204-5; Xu JY, 2006, PROSTATE, V66, P1082, DOI 10.1002/pros.20430; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204; Zhang S, 2012, BIOCHEM BIOPH RES CO, V427, P537, DOI 10.1016/j.bbrc.2012.09.092; Zhang ZH, 2005, CLIN CANCER RES, V11, P193; Zimber A, 2004, CELL SIGNAL, V16, P1085, DOI 10.1016/j.cellsig.2004.03.020	50	18	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92746	10.1371/journal.pone.0092746	http://dx.doi.org/10.1371/journal.pone.0092746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651376	gold, Green Submitted, Green Published			2022-12-27	WOS:000333352800153
J	Carrolo, M; Pinto, FR; Melo-Cristino, J; Ramirez, M				Carrolo, Margarida; Pinto, Francisco Rodrigues; Melo-Cristino, Jose; Ramirez, Mario			Pherotype Influences Biofilm Growth and Recombination in Streptococcus pneumoniae	PLOS ONE			English	Article							GENETIC-TRANSFORMATION; NATURAL COMPETENCE; FRATRICIDE; DNA; IDENTIFICATION; PHEROMONE; MECHANISM; PNEUMOCOCCUS; INDUCTION; CHILDREN	In Streptococcus pneumoniae the competence-stimulating peptide (CSP), encoded by the comC gene, controls competence development and influences biofilm growth. We explored the influence of pherotype, defined by the two major comC allelic variants (comC1 and comC2), on biofilm development and recombination efficiency. Among isolates recovered from human infections those presenting comC1 show a higher capacity to form in vitro biofilms. The influence of pherotype on biofilm growth was confirmed by experiments with isogenic strains differing in their comC alleles. Biofilm architecture evaluated by confocal laser scanning microscopy showed that strains carrying comC1 form biofilms that are denser and thicker than those carrying the comC2 allele. Isogenic strains carrying the comC1 allele yielded more transformants than those carrying the comC2 allele in both planktonic and biofilm growth. Transformation assays with comC knockout strains show that ComD1 needs lower doses of the signaling peptide to reach the same biological outcomes. In contrast to mixed planktonic growth, within mixed biofilms inter-pherotype genetic exchange is less frequent than that occurring between bacteria of the same pherotype. Since biofilms are a major bacterial lifestyle, these observations may explain the genetic differentiation between populations with different pherotypes reported previously. Considering that biofilms have been associated with colonization our results suggest that strains carrying the comC1 allele may be more transmissible and more efficient at persisting in carriage. Both effects may help explain the higher prevalence of the comC1 allele in the pneumococcal population.	[Carrolo, Margarida; Melo-Cristino, Jose; Ramirez, Mario] Univ Lisbon, Inst Microbiol, Fac Med, P-1699 Lisbon, Portugal; [Carrolo, Margarida; Melo-Cristino, Jose; Ramirez, Mario] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal; [Pinto, Francisco Rodrigues] Univ Lisbon, Fac Ciencias, Ctr Quim & Bioquim, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Ramirez, M (corresponding author), Univ Lisbon, Inst Microbiol, Fac Med, P-1699 Lisbon, Portugal.	ramirez@fm.ul.pt	Ramirez, Mario/B-4993-2008; Carrolo, Margarida/AAM-2938-2020; Pinto, Francisco/A-7443-2008; Melo-Cristino, Jose A G/H-3726-2013	Ramirez, Mario/0000-0002-4084-6233; Pinto, Francisco/0000-0002-4217-0054; Melo-Cristino, Jose A G/0000-0001-8643-1722; Carrolo, Margarida/0000-0002-6866-9515	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/35854/2007, SFRH/BPD/79310/2011, PTDC/SAU-ESA/64888/2006, PTDC/BIA-MIC/119709/2010, PTDC/EBB-EBI/113824/2009]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	Margarida Carrolo is supported research grants from Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BD/35854/2007 and SFRH/BPD/79310/2011). This work was partially supported by Fundacao para a Ciencia e Tecnologia, Portugal (PTDC/SAU-ESA/64888/2006, PTDC/BIA-MIC/119709/2010 and PTDC/EBB-EBI/113824/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Berg KH, 2012, APPL ENVIRON MICROB, V78, P3515, DOI 10.1128/AEM.00098-12; Brugger SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011638; Carrolo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015678; Carrolo M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-191; Claverys JP, 2007, NAT REV MICROBIOL, V5, P219, DOI 10.1038/nrmicro1613; Claverys JP, 2007, MOL MICROBIOL, V64, P1423, DOI 10.1111/j.1365-2958.2007.05757.x; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Cook LC, 2014, FEMS MICROBIOL REV, V38, P473, DOI 10.1111/1574-6976.12046; Cornejo OE, 2010, MOL BIOL EVOL, V27, P694, DOI 10.1093/molbev/msp287; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Domenech M, 2013, INFECT IMMUN, V81, P2606, DOI 10.1128/IAI.00491-13; Evans BA, 2013, ISME J, V7, P791, DOI 10.1038/ismej.2012.170; Feil EJ, 2000, GENETICS, V154, P1439; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; Halfmann A, 2007, FEMS MICROBIOL LETT, V268, P217, DOI 10.1111/j.1574-6968.2006.00584.x; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Havarstein LS, 2006, MOL MICROBIOL, V59, P1297, DOI 10.1111/j.1365-2958.2005.05021.x; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Iannelli F, 2005, FEMS MICROBIOL LETT, V252, P321, DOI 10.1016/j.femsle.2005.09.008; Johnsborg O, 2008, MOL MICROBIOL, V69, P245, DOI 10.1111/j.1365-2958.2008.06288.x; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Li YH, 2002, J BACTERIOL, V184, P2699, DOI 10.1128/JB.184.10.2699-2708.2002; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Marks LR, 2012, INFECT IMMUN, V80, P2744, DOI 10.1128/IAI.00488-12; Marks LR, 2012, MBIO, V3, DOI [10.1128/mBio.00200-12, DOI 10.1128/MBI0.00200-12]; MORRISON DA, 1983, J BACTERIOL, V156, P281, DOI 10.1128/JB.156.1.281-290.1983; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Neil RB, 2009, MICROBES INFECT, V11, P281, DOI 10.1016/j.micinf.2008.12.001; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Perry JA, 2009, FEMS MICROBIOL LETT, V299, P261, DOI 10.1111/j.1574-6968.2009.01758.x; Petersen FC, 2004, J BACTERIOL, V186, P6327, DOI 10.1128/JB.186.18.6327-6331.2004; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Piotrowski A, 2009, J BACTERIOL, V191, P3359, DOI 10.1128/JB.01750-08; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Ramirez M, 1997, MICROB DRUG RESIST, V3, P39, DOI 10.1089/mdr.1997.3.39; Serrano I, 2005, J CLIN MICROBIOL, V43, P1706, DOI 10.1128/JCM.43.4.1706-1715.2005; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Suntharalingam P, 2005, TRENDS MICROBIOL, V13, P3, DOI 10.1016/j.tim.2004.11.009; Tetz GV, 2009, ANTIMICROB AGENTS CH, V53, P1204, DOI 10.1128/AAC.00471-08; Thomas VC, 2009, MOL MICROBIOL, V72, P1022, DOI 10.1111/j.1365-2958.2009.06703.x; Tikhomirova A, 2013, PATHOG DIS, V69, P114, DOI 10.1111/2049-632X.12073; TOMASZ A, 1965, NATURE, V208, P155, DOI 10.1038/208155a0; Tortosa P, 1999, CURR OPIN MICROBIOL, V2, P588, DOI 10.1016/S1369-5274(99)00026-0; Trappetti C, 2011, INFECT IMMUN, V79, P4550, DOI 10.1128/IAI.05644-11; Valente C, 2012, MICROB DRUG RESIST, V18, P550, DOI 10.1089/mdr.2011.0228; Vestrheim DF, 2011, INFECT GENET EVOL, V11, P1703, DOI 10.1016/j.meegid.2011.07.003; Wei H, 2012, APPL ENVIRON MICROB, V78, P5897, DOI 10.1128/AEM.01343-12	49	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92138	10.1371/journal.pone.0092138	http://dx.doi.org/10.1371/journal.pone.0092138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646937	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500089
J	Dalla Costa, E; Minero, M; Lebelt, D; Stucke, D; Canali, E; Leach, MC				Dalla Costa, Emanuela; Minero, Michela; Lebelt, Dirk; Stucke, Diana; Canali, Elisabetta; Leach, Matthew C.			Development of the Horse Grimace Scale (HGS) as a Pain Assessment Tool in Horses Undergoing Routine Castration	PLOS ONE			English	Article							FACIAL EXPRESSIONS; EQUINE CASTRATION; YOUNG HORSES; POSTOPERATIVE PAIN; ANALGESIA; PHENYLBUTAZONE; BUTORPHANOL; RELIABILITY; RESPONSES; SURGERY	Background: The assessment of pain is critical for the welfare of horses, in particular when pain is induced by common management procedures such as castration. Existing pain assessment methods have several limitations, which reduce the applicability in everyday life. Assessment of facial expression changes, as a novel means of pain scoring, may offer numerous advantages and overcome some of these limitations. The objective of this study was to develop and validate a standardised pain scale based on facial expressions in horses (Horse Grimace Scale [HGS]). Methodology/Principal Findings: Forty stallions were assigned to one of two treatments and all animals underwent routine surgical castration under general anaesthesia. Group A (n = 19) received a single injection of Flunixin immediately before anaesthesia. Group B (n = 21) received Flunixin immediately before anaesthesia and then again, as an oral administration, six hours after the surgery. In addition, six horses were used as anaesthesia controls (C). These animals underwent non-invasive, indolent procedures, received the same treatment as group A, but did not undergo surgical procedures that could be accompanied with surgical pain. Changes in behaviour, composite pain scale (CPS) scores and horse grimace scale (HGS) scores were assessed before and 8-hours post-procedure. Only horses undergoing castration (Groups A and B) showed significantly greater HGS and CPS scores at 8-hours post compared to pre operatively. Further, maintenance behaviours such as explorative behaviour and alertness were also reduced. No difference was observed between the two analgesic treatment groups. Conclusions: The Horse Grimace Scale potentially offers an effective and reliable method of assessing pain following routine castration in horses. However, auxiliary studies are required to evaluate different painful conditions and analgesic schedules.	[Dalla Costa, Emanuela; Minero, Michela; Canali, Elisabetta] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy; [Lebelt, Dirk; Stucke, Diana] Havelland Equine Hosp, Pferdeklin Havelland, Beetzsee Brielow, Germany; [Leach, Matthew C.] Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Milan; Newcastle University - UK	Dalla Costa, E (corresponding author), Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy.	emanuela.dallacosta@unimi.it	Costa, Emanuela Dalla/G-9746-2017; Lebelt, Dirk/ABC-4048-2020; Minero, Michela/G-9001-2017; canali, elisabetta/G-8897-2017	Costa, Emanuela Dalla/0000-0002-5037-3759; Minero, Michela/0000-0001-8285-5501; canali, elisabetta/0000-0002-4962-5955	EU	EU(European Commission)	The authors would like to thank the EU VII Framework program (FP7-KBBE-2010-4) for financing the Animal Welfare Indicators (AWIN) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley FH, 2005, EQUINE VET J, V37, P565, DOI 10.2746/042516405775314826; Ashraf AB, 2009, IMAGE VISION COMPUT, V27, P1788, DOI 10.1016/j.imavis.2009.05.007; Bidwell LA, 2007, VET ANAESTH ANALG, V34, P23, DOI 10.1111/j.1467-2995.2005.00283.x; Bussieres G, 2008, RES VET SCI, V85, P294, DOI 10.1016/j.rvsc.2007.10.011; Canadian Veterinary Medical Association, 2006, CASTR HORS DONK MUL; Capner C, 2001, VET REC, V149, P252; Dalla Costa E, 2010, P 46 C INT SOC APPL, P235; di Perrotolo Maud Scotto, 2010, STAL, V36, P49; Eager R, 2002, PRELIMINARY INVESTIG; Ekman P., 2002, FACIAL ACTION CODING; England GCW, 1996, BRIT VET J, V152, P641, DOI 10.1016/S0007-1935(96)80118-7; Erber R, 2012, VET J, V191, P171, DOI 10.1016/j.tvjl.2011.08.008; European Horse Network, 2010, KEY FIG; Figueiredo J. P., 2005, International Journal of Applied Research in Veterinary Medicine, V3, P249; Flecknell P, 2001, VET REC, V149, P252; Graubner C, 2011, VET J, V188, P178, DOI 10.1016/j.tvjl.2010.04.029; GRUNAU RVE, 1987, PAIN, V28, P395, DOI 10.1016/0304-3959(87)90073-X; Hall CW, 1983, VET ANESTHESIA; Heleski MC, 2012, CODE PRACTICE CARE H; JOHNSON CB, 1993, VET REC, V133, P336, DOI 10.1136/vr.133.14.336; Jones R, 2001, VET REC, V149, P252; Jordan A, 2011, INT J GERIATR PSYCH, V26, P118, DOI 10.1002/gps.2489; Keating SCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044437; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035656; Leach MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0013347; Love EJ, 2009, EQUINE VET EDUC, V21, P46, DOI 10.2746/095777309X390290; Love EJ, 2009, EQUINE VET J, V41, P552, DOI 10.2746/042516409X391024; Maassen E, 2009, PFERDEHEILKUNDE, V25, P451, DOI 10.21836/PEM20090502; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Mcdonnell SM, 2003, EQUID ETHOGRAM; McGreevy P, 2004, EQUINE BEHAV; Molony V, 1997, J ANIM SCI, V75, P266; Moya SL, 2008, APPL ANIM BEHAV SCI, V111, P133, DOI 10.1016/j.applanim.2007.05.019; MUIR WW, 1982, AM J VET RES, V43, P1756; National Equine Welfare Council (NEWC), 2009, EQ IND WELF GUID COM; Price J, 2005, RES VET SCI, V78, P277, DOI 10.1016/j.rvsc.2004.09.009; Price J, 2003, VET ANAESTH ANALG, V30, P124, DOI 10.1046/j.1467-2995.2003.00139.x; Pritchett LC, 2003, APPL ANIM BEHAV SCI, V80, P31, DOI 10.1016/S0168-1591(02)00205-8; Sanz MG, 2009, JAVMA-J AM VET MED A, V235, P1194, DOI 10.2460/javma.235.10.1194; Searle D, 1999, AUST VET J, V77, P428, DOI 10.1111/j.1751-0813.1999.tb12083.x; Sondergaard E, 2003, APPL ANIM BEHAV SCI, V84, P265, DOI 10.1016/j.applanim.2003.08.011; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Taylor PM, 2002, VET CLIN N AM-EQUINE, V18, P1, DOI 10.1016/S0749-0739(02)00009-3; van Loon JPAM, 2010, J EQUINE VET SCI, V30, P641, DOI 10.1016/j.jevs.2010.09.011; Vinuela-Fernandez I, 2011, VET J, V188, P171, DOI 10.1016/j.tvjl.2010.05.011; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080	47	273	274	5	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92281	10.1371/journal.pone.0092281	http://dx.doi.org/10.1371/journal.pone.0092281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647606	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500106
J	Dierselhuis, MP; Jankowska-Gan, E; Blokland, E; Pool, J; Burlingham, WJ; van Halteren, AGS; Goulmy, E				Dierselhuis, Miranda P.; Jankowska-Gan, Ewa; Blokland, Els; Pool, Jos; Burlingham, William J.; van Halteren, Astrid G. S.; Goulmy, Els			HY Immune Tolerance Is Common in Women without Male Offspring	PLOS ONE			English	Article							REGULATORY T-CELLS; ALLOGRAFT ACCEPTANCE; PREGNANCY; MICROCHIMERISM; LONG; SEX; LYMPHOCYTES; RECIPIENTS; CHIMERISM; BLOOD	Background: Sex difference is an established risk factor for hematopoietic stem cell transplantation (HSCT)-related complications like graft versus host disease (GVHD). CD8(pos) cytotoxic T cells specific for Y chromosome-encoded minor Histocompatibility antigens (HY) play an important role therein. Prior to HSC donation, female donors may encounter HY antigens through fetomaternal or transmaternal cell flow, potentially leading to the induction of HY-specific cytotoxic or regulatory immune responses. Whether HY priming occurs independent of parity, and whether HY priming is dependent on the presence of male microchimerism, is as yet unknown. Methods: We investigated the presence of HY-specific regulatory T cells (Treg) and male microchimerism in 45 healthy women with a fully documented pregnancy and family history. HY peptide-induced linked suppression, a commonly reported functional feature of CD4(pos) and CD8(pos) Treg, was measured by trans vivo Delayed Type Hypersensitivity testing. As source of HY antigens, male microchimerism was analyzed by real-time PCR and defined by the presence of male DNA in at least one purified leukocyte cell type. Results: HLA class I or class II restricted HY-specific Treg were detected in 26/42 (62%) women eligible for analysis. The prevalence of HY-specific Treg was significantly higher in women who had never given birth to sons than in women with male offspring (p = 0.004). Male microchimerism could be detected in 24 out of 45 (53%) women but did not correlate with the presence of HY specific Treg. Conclusions: HY-specific Treg in women with male offspring have been described previously. Here we show for the first time that, in fact, HY specific Treg are more common in nulliparous women and in parous women with female offspring. Their presence is independent of the presence of male microchimerism. Whether HY-specific Treg presence in female stem cell grafts might decrease the GVHD incidence in male HSCT recipients needs to be investigated.	[Dierselhuis, Miranda P.; Blokland, Els; Pool, Jos; Goulmy, Els] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Jankowska-Gan, Ewa; Burlingham, William J.] Univ Wisconsin, Dept Surg, Madison, WI USA; [van Halteren, Astrid G. S.] Leiden Univ, Med Ctr, Immunol Lab, Dept Pediat WAKZ, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Wisconsin System; University of Wisconsin Madison; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Halteren, AGS (corresponding author), Leiden Univ, Med Ctr, Immunol Lab, Dept Pediat WAKZ, Leiden, Netherlands.	a.g.s.van_Halteren@lumc.nl			Netherlands Organization for Scientific Research (NWO Spinoza award); Macropa Foundation; National Blood Foundation; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO Spinoza award)(Netherlands Organization for Scientific Research (NWO)); Macropa Foundation; National Blood Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was financially supported by the Netherlands Organization for Scientific Research (NWO Spinoza award; http://www.nwo.nl/onderzoek-enresultaten/programmas/spinozapremie), the Macropa Foundation (www.macropa.com) and the National Blood Foundation (www.sanquin.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga H, 2001, TRANSFUSION, V41, P1524, DOI 10.1046/j.1537-2995.2001.41121524.x; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Bucher C, 2007, BLOOD, V110, P468, DOI 10.1182/blood-2007-02-076257; Burlingham WJ, 2007, AM J TRANSPLANT, V7, P466, DOI 10.1111/j.1600-6143.2006.01627.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai JC, 2004, J EXP MED, V199, P1017, DOI 10.1084/jem.20031012; de Bellefon Laurent Meric, 2010, Chimerism, V1, P56, DOI 10.4161/chim.1.2.14294; Dierselhuis MP, 2012, BLOOD, V120, P505, DOI 10.1182/blood-2012-02-410571; Drabbels JJM, 2011, BLOOD, V118, pE149, DOI 10.1182/blood-2011-06-362053; Dutta Partha, 2010, Chimerism, V1, P2, DOI 10.4161/chim.1.1.12667; Evans PC, 1999, BLOOD, V93, P2033, DOI 10.1182/blood.V93.6.2033.406k18_2033_2037; Fehse B, 2001, J HEMATOTH STEM CELL, V10, P419, DOI 10.1089/152581601750289028; Gammill HS, 2010, INT J DEV BIOL, V54, P531, DOI 10.1387/ijdb.082767hg; Jankowska-Gan E, 2002, HUM IMMUNOL, V63, P862, DOI 10.1016/S0198-8859(02)00450-0; Jankowska-Gan E, 2013, JOVE-J VIS EXP, DOI 10.3791/4454; Kim YH, 2012, BIOL BLOOD MARROW TR, V18, P381, DOI 10.1016/j.bbmt.2011.10.038; Koopmans M, 2005, AM J TRANSPLANT, V5, P1495, DOI 10.1111/j.1600-6143.2005.00858.x; Lissauer D, 2012, J IMMUNOL, V189, P1072, DOI 10.4049/jimmunol.1200544; Loren AW, 2006, BIOL BLOOD MARROW TR, V12, P758, DOI 10.1016/j.bbmt.2006.03.015; Mutis T, 1999, NAT MED, V5, P839, DOI 10.1038/10563; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; Olson BM, 2012, J IMMUNOL, V189, P5590, DOI 10.4049/jimmunol.1201744; Piper KP, 2007, BIOL REPROD, V76, P96, DOI 10.1095/biolreprod.106.055426; Quayle AJ, 1997, J INFECT DIS, V176, P960, DOI 10.1086/516541; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Spierings Eric, 2012, Methods Mol Biol, V882, P509, DOI 10.1007/978-1-61779-842-9_29; van Halteren AGS, 2009, BLOOD, V114, P2263, DOI 10.1182/blood-2009-01-200410; VanBuskirk AM, 1998, TRANSPLANTATION, V65, P1115, DOI 10.1097/00007890-199804270-00017; VanBuskirk AM, 2000, J CLIN INVEST, V106, P145, DOI 10.1172/JCI9171; Verdijk RM, 2004, BLOOD, V103, P1961, DOI 10.1182/blood-2003-05-1625; Yan Z, 2005, AM J MED, V118, P899, DOI 10.1016/j.amjmed.2005.03.037	31	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91274	10.1371/journal.pone.0091274	http://dx.doi.org/10.1371/journal.pone.0091274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646895	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500026
J	Ng, K; Higurashi, M; Uemiya, N; Qian, Y				Keith Ng; Higurashi, Masakazu; Uemiya, Nahoko; Qian, Yi			Secondary Histomorphological Changes in Cerebral Arteries of Normotensive and Hypertensive Rats following a Carotid-Jugular Fistula Induction	PLOS ONE			English	Article							BLOOD-FLOW; ARTERIOVENOUS-MALFORMATIONS; MECHANICAL-PROPERTIES; AGE; RUPTURE; MODELS; YOUNG; SIZE	Haemodynamic changes in cerebral circulation are associated with the natural ageing process and associated pathology, leading to the development of incapacitating neurological and neurovascular diseases. Due to inherent biological limitations, current literatures mostly aimed at studying the correlation descriptively or quantifying the relationship in vitro or using computational models. In this paper, a model of a carotid-jugular fistula in the rat was used to create a haemodynamic insult to the intracranial arterial circulation and subsequent venous drainage. An arterial-venous (AV) fistula was created in 12 rats, 6 of which are normotensive Wistar-Kyoto strain (WKY) and the rest spontaneously hypertensive strain (SHR) with an additional 6 in each strains designed as controls without previous surgery. After 4 weeks of convalescence, all 24 rats were euthanised and their cerebral circulation was examined histomorphologically. We confirmed an intrinsic morphological difference between normotensive WKY and hypertensive SHR and found a modest but significant arterial shrinkage in both strains induced with AV fistula. We also reported that alterations in blood flow are also associated with marked extracellular matrix changes. We concluded that the model was suitable for studying the relative contributions of altering haemodynamic patterns and venous drainage on cerebrovascular changes. We also found that hypertension modulated cerebral vascular changes in addition to disrupted blood flow.	[Keith Ng; Qian, Yi] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Higurashi, Masakazu] Yokohama Minami Kyousai Hosp, Dept Neurosurg, Yokohama, Kanagawa, Japan; [Uemiya, Nahoko] Saitama Med Univ, Dept Endovasc Neurosurg, Saitama, Japan	Macquarie University; Saitama Medical University	Qian, Y (corresponding author), Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia.	yi.qian@mq.edu.au			Australian Research Council [DP110102985]; Macquarie University	Australian Research Council(Australian Research Council); Macquarie University	This work was supported by research grants from the Australian Research Council DP110102985. Dr Ng is supported by the Macquarie University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bailey EL, 2011, NEUROPATH APPL NEURO, V37, P711, DOI 10.1111/j.1365-2990.2011.01170.x; Bailey EL, 2009, STROKE, V40, pE451, DOI 10.1161/STROKEAHA.108.528430; BAUMBACH GL, 1991, CIRC RES, V68, P338, DOI 10.1161/01.RES.68.2.338; BAUMBACH GL, 1993, HYPERTENSION, V21, P816, DOI 10.1161/01.HYP.21.6.816; Chen J, 2012, CHINESE MED J-PEKING, V125, P1303, DOI 10.3760/cma.j.issn.0366-6999.2012.07.021; COX RH, 1977, AM J PHYSIOL, V233, pH256, DOI 10.1152/ajpheart.1977.233.2.H256; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; de la Torre JC, 1999, ACTA NEUROPATHOL, V98, P1, DOI 10.1007/s004010051044; Eldawoody H, 2009, BRAIN RES, V1300, P159, DOI 10.1016/j.brainres.2009.08.099; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Hainsworth AH, 2012, J NEUROL SCI, V322, P237, DOI 10.1016/j.jns.2012.05.046; HAJDU MA, 1990, CIRC RES, V66, P1747, DOI 10.1161/01.RES.66.6.1747; HAJDU MA, 1991, HYPERTENSION, V18, P15; HAJDU MA, 1994, AM J PHYSIOL, V266, pH1027, DOI 10.1152/ajpheart.1994.266.3.H1027; Huttunen T, 2010, NEUROSURGERY, V66, P631, DOI 10.1227/01.NEU.0000367634.89384.4B; Illies T, 2012, STROKE, V43, P2910, DOI 10.1161/STROKEAHA.112.669945; INGEBRIGTSEN R, 1965, Acta Chir Scand, V129, P156; Jimenez-Altayo F, 2007, AM J PHYSIOL-HEART C, V293, pH628, DOI 10.1152/ajpheart.00165.2007; JOHANSSON BB, 1985, J CARDIOVASC PHARM, V7, pS90, DOI 10.1097/00005344-198507002-00017; Joutel A, 2010, J CLIN INVEST, V120, P433, DOI 10.1172/JCI39733; Kolega J, 2011, J VASC RES, V48, P429, DOI 10.1159/000324840; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Laurant P, 2004, CAN J PHYSIOL PHARM, V82, P269, DOI 10.1139/Y04-026; LEE RMKW, 1995, PHARMACOL THERAPEUT, V66, P149, DOI 10.1016/0163-7258(94)00071-A; LINVILLE DG, 1991, NEUROBIOL AGING, V12, P503, DOI 10.1016/0197-4580(91)90080-4; Lv XL, 2011, WORLD NEUROSURG, V76, P455, DOI 10.1016/j.wneu.2011.04.015; Moftakhar P, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.2.FOCUS09317; MORGAN MK, 1989, BRAIN RES, V496, P241, DOI 10.1016/0006-8993(89)91071-8; Prosenz P, 1971, STROKE, V2, P279, DOI 10.1161/01.STR.2.3.279; Rahman M, 2010, STROKE, V41, P916, DOI 10.1161/STROKEAHA.109.574244; Raymond J, 2013, AM J NEURORADIOL, V34, P346, DOI 10.3174/ajnr.A3407; Sammons V, 2011, J CLIN NEUROSCI, V18, P165, DOI 10.1016/j.jocn.2010.04.045; Schultz SK, 1999, NEUROREPORT, V10, P2493, DOI 10.1097/00001756-199908200-00011; STEHBENS WE, 1963, ARCH NEUROL-CHICAGO, V8, P272, DOI 10.1001/archneur.1963.00460030056005; TACHIBANA H, 1984, AM J ROENTGENOL, V142, P1027, DOI 10.2214/ajr.142.5.1027; WARSHAW DM, 1979, CIRC RES, V45, P250, DOI 10.1161/01.RES.45.2.250	37	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92433	10.1371/journal.pone.0092433	http://dx.doi.org/10.1371/journal.pone.0092433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647348	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500131
J	Zhang, L; Wang, H; Zou, JW; Rogers, WE; Siemann, E				Zhang, Ling; Wang, Hong; Zou, Jianwen; Rogers, William E.; Siemann, Evan			Non-Native Plant Litter Enhances Soil Carbon Dioxide Emissions in an Invaded Annual Grassland	PLOS ONE			English	Article							LEAF-LITTER; DECOMPOSITION DYNAMICS; NITROGEN; RESPIRATION; AVAILABILITY; INVASIONS; ECOSYSTEM; RELEASE; BALANCE; PURE	Litter decomposition is a fundamental ecosystem process in which breakdown and decay of plant detritus releases carbon and nutrients. Invasive exotic plants may produce litter that differs from native plant litter in quality and quantity. Such differences may impact litter decomposition and soil respiration in ways that depend on whether exotic and native plant litters decompose in mixtures. However, few field experiments have examined how exotic plants affect soil respiration via litter decomposition. Here, we conducted an in situ study of litter decomposition of an annual native grass (Eragrostis pilosa), a perennial exotic forb (Alternanthera philoxeroides), and their mixtures in an annual grassland in China to examine potential invasion effects on soil respiration. Alternanthera litter decomposed faster than Eragrostis litter when each was incubated separately. Mass loss in litter mixes was more rapid than predicted from rates in single species bags (only 35% of predicted mass remained at 8 months) showing synergistic effects. Notably, exotic plant litter decomposition rate was unchanged but native plant litter decomposition rate was accelerated in mixtures (decay constant k = 0.20 month(-1)) compared to in isolation (k = 0.10 month(-1)). On average, every litter type increased soil respiration compared to bare soil from which litter was removed. However, the increases were larger for mixed litter (1.82 times) than for Alternanthera litter (1.58 times) or Eragrostis litter (1.30 times). Carbon released as CO2 relative to litter carbon input was also higher for mixed litter (3.34) than for Alternathera litter (2.29) or Eragrostis litter (1.19). Our results indicated that exotic Alternanthera produces rapidly decomposing litter which also accelerates the decomposition of native plant litter in litter mixtures and enhances soil respiration rates. Thus, this exotic invasive plant species will likely accelerate carbon cycling and increase soil respiration even at intermediate stages of invasion in these annual grasslands.	[Zhang, Ling; Wang, Hong; Zou, Jianwen; Siemann, Evan] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Zhang, Ling; Siemann, Evan] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX USA; [Zou, Jianwen] Cornell Univ, Dept Hort, Ithaca, NY USA; [Rogers, William E.] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX USA	Nanjing Agricultural University; Rice University; Cornell University; Texas A&M University System; Texas A&M University College Station	Zou, JW (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.	jwzou21@njau.edu.cn; siemann@rice.edu	huang, yao/GWR-5388-2022; ZOU, JIANWEN/B-3059-2012	ZOU, JIANWEN/0000-0003-4689-9237	NSFC [41225003]; Ministry of Education 111 project [B12009]; US-NSF [DEB 0820560]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); China Scholarship Council; Direct For Biological Sciences [0820560] Funding Source: National Science Foundation	NSFC(National Natural Science Foundation of China (NSFC)); Ministry of Education 111 project(Ministry of Education, China - 111 Project); US-NSF(National Science Foundation (NSF)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); China Scholarship Council(China Scholarship Council); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the NSFC (41225003), the Ministry of Education 111 project (B12009), US-NSF (DEB 0820560), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and the China Scholarship Council (for providing funding support to LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, ECOLOGY, V78, P244, DOI 10.1890/0012-9658(1997)078[0244:NAPMCO]2.0.CO;2; Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; Ashton IW, 2005, ECOL APPL, V15, P1263, DOI 10.1890/04-0741; Barlocher Felix, 2005, P37, DOI 10.1007/1-4020-3466-0_6; Bassett IE, 2010, NEW ZEAL J ECOL, V34, P324; Berger TW, 2010, SOIL BIOL BIOCHEM, V42, P986, DOI 10.1016/j.soilbio.2010.02.020; Berglund SL, 2012, OIKOS, V121, P1112, DOI 10.1111/j.1600-0706.2011.19787.x; Briones MJI, 1996, SOIL BIOL BIOCHEM, V28, P1381, DOI 10.1016/S0038-0717(96)00158-7; CHAPMAN K, 1988, AGR ECOSYST ENVIRON, V24, P33, DOI 10.1016/0167-8809(88)90054-0; Chapman SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062671; Chen BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066289; CROSSLEY DA, 1962, ECOLOGY, V43, P571, DOI 10.2307/1933396; Ehrenfeld JG, 2001, ECOL APPL, V11, P1287, DOI 10.2307/3060920; Feng YL, 2007, OECOLOGIA, V153, P501, DOI 10.1007/s00442-007-0759-2; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Frey SD, 2003, SOIL BIOL BIOCHEM, V35, P1001, DOI 10.1016/S0038-0717(03)00155-X; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hickman JE, 2013, OECOLOGIA, V173, P319, DOI 10.1007/s00442-013-2607-x; Holdredge C, 2011, BIOL INVASIONS, V13, P423, DOI 10.1007/s10530-010-9836-2; HORNER JD, 1988, AM NAT, V132, P869, DOI 10.1086/284894; Kainulainen P, 2002, SOIL BIOL BIOCHEM, V34, P37, DOI 10.1016/S0038-0717(01)00147-X; Kourtev PS, 2003, SOIL BIOL BIOCHEM, V35, P895, DOI 10.1016/S0038-0717(03)00120-2; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Lecerf A, 2011, ECOLOGY, V92, P160, DOI 10.1890/10-0315.1; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; McLaren JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023702; McTiernan KB, 1997, OIKOS, V78, P527, DOI 10.2307/3545614; Meisner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031596; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Rodgers VL, 2008, OECOLOGIA, V157, P459, DOI 10.1007/s00442-008-1089-8; Rubino M, 2010, SOIL BIOL BIOCHEM, V42, P1009, DOI 10.1016/j.soilbio.2010.02.018; Sayer EJ, 2011, NAT CLIM CHANGE, V1, P304, DOI 10.1038/NCLIMATE1190; Sayer EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001299; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Siemann E, 2003, J ECOL, V91, P923, DOI 10.1046/j.1365-2745.2003.00822.x; Weber E, 2008, BIOL INVASIONS, V10, P1411, DOI 10.1007/s10530-008-9216-3; WIEDER RK, 1982, ECOLOGY, V63, P1636, DOI 10.2307/1940104; Zeid M, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: MILLETS AND GRASSES, P135, DOI 10.1007/978-3-642-14255-0_8; Zou JW, 2004, CHINESE SCI BULL, V49, P381, DOI 10.1360/03wd0270; Zuo SP, 2012, WEED BIOL MANAG, V12, P123, DOI 10.1111/j.1445-6664.2012.00443.x	46	29	30	11	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92301	10.1371/journal.pone.0092301	http://dx.doi.org/10.1371/journal.pone.0092301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647312	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500110
J	Feasey, NA; Houston, A; Mukaka, M; Komrower, D; Mwalukomo, T; Tenthani, L; Jahn, A; Moore, M; Peters, RPH; Gordon, MA; Everett, DB; French, N; van Oosterhout, JJ; Allain, TJ; Heyderman, RS				Feasey, Nicholas A.; Houston, Angela; Mukaka, Mavuto; Komrower, Dan; Mwalukomo, Thandie; Tenthani, Lyson; Jahn, Andreas; Moore, Mike; Peters, Remco P. H.; Gordon, Melita A.; Everett, Dean B.; French, Neil; van Oosterhout, Joep J.; Allain, Theresa J.; Heyderman, Robert S.			A Reduction in Adult Blood Stream Infection and Case Fatality at a Large African Hospital following Antiretroviral Therapy Roll-Out	PLOS ONE			English	Article							COTRIMOXAZOLE PROPHYLAXIS; SALMONELLA BACTEREMIA; HIV; MALAWI; MORTALITY; RESISTANCE; TUBERCULOSIS; PREVALENCE; CHILDREN; PROGRAM	Introduction: Blood-stream infection (BSI) is one of the principle determinants of the morbidity and mortality associated with advanced HIV infection, especially in sub-Saharan Africa. Over the last 10 years, there has been rapid roll-out of antiretroviral therapy (ART) and cotrimoxazole prophylactic therapy (CPT) in many high HIV prevalence African countries. Methods: A prospective cohort of adults with suspected BSI presenting to Queen's Hospital, Malawi was recruited between 2009 and 2010 to describe causes of and outcomes from BSI. Comparison was made with a cohort pre-dating ART roll-out to investigate whether and how ART and CPT have affected BSI. Malawian census and Ministry of Health ART data were used to estimate minimum incidence of BSI in Blantyre district. Results: 2,007 patients were recruited, 90% were HIV infected. Since 1997/8, culture-confirmed BSI has fallen from 16% of suspected cases to 10% (p < 0.001) and case fatality rate from confirmed BSI has fallen from 40% to 14% (p < 0.001). Minimum incidence of BSI was estimated at 0.03/1000 years in HIV uninfected vs. 2.16/1000 years in HIV infected adults. Compared to HIV seronegative patients, the estimated incidence rate-ratio for BSI was 80 (95% CI: 46-139) in HIV-infected/untreated adults, 568 (95% CI: 302-1069) during the first 3 months of ART and 30 (95% CI: 16-59) after 3 months of ART. Conclusions: Following ART roll-out, the incidence of BSI has fallen and clinical outcomes have improved markedly. Nonetheless, BSI incidence remains high in the first 3 months of ART despite CPT. Further interventions to reduce BSI-associated mortality in the first 3 months of ART require urgent evaluation.	[Feasey, Nicholas A.; Mukaka, Mavuto; Mwalukomo, Thandie; Moore, Mike; Everett, Dean B.; van Oosterhout, Joep J.; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Feasey, Nicholas A.; Houston, Angela; Komrower, Dan; Mwalukomo, Thandie; Allain, Theresa J.; Heyderman, Robert S.] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [Feasey, Nicholas A.; Moore, Mike; Heyderman, Robert S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Tenthani, Lyson; Jahn, Andreas] Minist Hlth, Dept HIV & AIDS, Lilongwe, Malawi; [Tenthani, Lyson] I TECH Lilongwe, Lilongwe, Malawi; [Jahn, Andreas] Univ Washington, Dept Global Hlth, I TECH, Seattle, WA 98195 USA; [Peters, Remco P. H.] Anova Hlth Inst, Johannesburg, South Africa; [Peters, Remco P. H.] Anova Hlth Inst, Tzaneen, South Africa; [Gordon, Melita A.; Everett, Dean B.; French, Neil] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [van Oosterhout, Joep J.] Dignitas Int, Blantyre, Malawi	University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Washington; University of Washington Seattle; University of Liverpool	Feasey, NA (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	nfeasey@liverpool.ac.uk	Jahn, Andreas/ABB-7796-2020; Gordon, Melita/F-5563-2012	Jahn, Andreas/0000-0003-4645-1600; Heyderman, Robert/0000-0003-4573-449X; Peters, Remco Petrus Hendricus/0000-0003-2124-7275; French, Neil/0000-0003-4814-8293; Everett, Dean/0000-0002-8458-6779; Feasey, Nicholas/0000-0003-4041-1405; Gordon, Melita/0000-0002-0629-0884	Wellcome Trust [WT092152MA, 084679/Z/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust: Nicholas Feasey is supported by Wellcome Trust Research Fellowship WT092152MA and MLW is supported by Wellcome Trust Core Award 084679/Z/08/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Wellcome Trust URL: www.wellcome.ac.uk	[Anonymous], 2011, MAL DHS 2010 PREL RE; Arthur G, 2001, CLIN INFECT DIS, V33, P248, DOI 10.1086/321820; Barrow GI, 1993, COWAN STEELES MANUAL; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; BSAC, 2009, METH ANT SUSC TEST V; Chihana M, 2012, TROP MED INT HEALTH, V17, pe74, DOI 10.1111/j.1365-3156.2012.02929.x; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Everett DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017765; Feasey NA, 2013, J CLIN MICROBIOL, V51, P2311, DOI 10.1128/JCM.00330-13; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; Glennie SJ, 2013, CLIN INFECT DIS, V56, P291, DOI 10.1093/cid/cis842; Gordon MA, 2001, J INFECTION, V42, P44, DOI 10.1053/jinf.2000.0779; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Hung CC, 2007, CLIN INFECT DIS, V45, pE60, DOI 10.1086/520681; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Lewis DK, 2003, T ROY SOC TROP MED H, V97, P91, DOI 10.1016/S0035-9203(03)90035-6; Malawi MoHo, 2010, Q HIV PROGRAMME REPO; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Monique van Lettow AA, 2012, PLOS1 IN PRESS; Mwagomba B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010452; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; PETIT PLC, 1995, E AFR MED J, V72, P116; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Roca-Feltrer A, 2012, EMERG INFECT DIS, V18, P272, DOI 10.3201/eid1802.111008; Ssali FN, 1998, J ACQ IMMUN DEF SYND, V19, P484, DOI 10.1097/00042560-199812150-00007; UNAIDS, 2010, MAL HIV AIDS MON EV; Wadonda-Kabondo N, 2012, CLIN INFECT DIS, V54, pS362, DOI 10.1093/cid/cir987; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; WHO, 2011, WHONMHMNM111	33	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92226	10.1371/journal.pone.0092226	http://dx.doi.org/10.1371/journal.pone.0092226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643091	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000333259900108
J	Jia, X; Miao, ZQ; Li, W; Zhang, LC; Feng, CC; He, YH; Bi, XM; Wang, LQ; Du, YW; Hou, M; Hao, DP; Xiao, Y; Chen, LN; Li, KN				Jia, Xu; Miao, Zhengqiang; Li, Wan; Zhang, Liangcai; Feng, Chenchen; He, Yuehan; Bi, Xiaoman; Wang, Liqiang; Du, Youwen; Hou, Min; Hao, Dapeng; Xiao, Yun; Chen, Lina; Li, Kongning			Cancer-Risk Module Identification and Module-Based Disease Risk Evaluation: A Case Study on Lung Cancer	PLOS ONE			English	Article							GENE COEXPRESSION NETWORK; QUALITY-OF-LIFE; DIFFERENTIAL COEXPRESSION; BIOLOGICAL PROCESSES; MULTIPLE GENES; EXPRESSION; INFORMATION; ACTIVATION; MICROARRAY; GROWTH	Gene expression profiles have drawn broad attention in deciphering the pathogenesis of human cancers. Cancer-related gene modules could be identified in co-expression networks and be applied to facilitate cancer research and clinical diagnosis. In this paper, a new method was proposed to identify lung cancer-risk modules and evaluate the module-based disease risks of samples. The results showed that thirty one cancer-risk modules were closely related to the lung cancer genes at the functional level and interactional level, indicating that these modules and genes might synergistically lead to the occurrence of lung cancer. Our method was proved to have good robustness by evaluating the disease risk of samples in eight cancer expression profiles (four for lung cancer and four for other cancers), and had better performance than the WGCNA method. This method could provide assistance to the diagnosis and treatment of cancers and a new clue for explaining cancer mechanisms.	[Jia, Xu; Miao, Zhengqiang; Li, Wan; Zhang, Liangcai; Feng, Chenchen; He, Yuehan; Bi, Xiaoman; Wang, Liqiang; Du, Youwen; Hou, Min; Hao, Dapeng; Xiao, Yun; Chen, Lina; Li, Kongning] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Hei Longjiang P, Peoples R China	Harbin Medical University	Chen, LN (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Hei Longjiang P, Peoples R China.	chenlina@ems.hrbmu.edu.cn; kongningli@hotmail.com	Bi, Xiaoman/AAA-6462-2022; Xiao, Yun/A-8359-2013; Zhang, Liang/GWM-6088-2022; Zhang, Liangcai/AAD-4415-2020	Chen, Lina/0000-0002-4576-6814; Bi, Xiaoman/0000-0003-4464-5014; Li, Wan/0000-0002-9797-0315	National Natural Science Foundation of China [61272388, 31301040]; Oversea Scholars Project; Education Department of Heilongjiang Province [1155H012]; Master Innovation Funds of Heilongjiang Province [YJSCX2012-209HLJ, YJSCX2012-224HLJ]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Oversea Scholars Project; Education Department of Heilongjiang Province; Master Innovation Funds of Heilongjiang Province	Funding provided by the National Natural Science Foundation of China (No. 61272388 and No. 31301040); Oversea Scholars Project funded by Education Department of Heilongjiang Province (NO. 1155H012); and the Master Innovation Funds of Heilongjiang Province (No. YJSCX2012-209HLJ and YJSCX2012-224HLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Cho SB, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-109; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; de Jong S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039498; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Dewey FE, 2011, CIRC-CARDIOVASC GENE, V4, P26, DOI 10.1161/CIRCGENETICS.110.941757; Dinu I, 2009, BRIEF BIOINFORM, V10, P24, DOI 10.1093/bib/bbn042; Dong LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004895; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Fang G, 2010, BIOCOMPUT-PAC SYM, P145; Hollen PJ, 1996, SEMIN ONCOL, V23, P31; Hong Shengjun, 2011, International Journal of Computational Biology and Drug Design, V4, P147, DOI 10.1504/IJCBDD.2011.041008; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ivliev AE, 2010, CANCER RES, V70, P10060, DOI 10.1158/0008-5472.CAN-10-2465; Kendall RL, 1999, J BIOL CHEM, V274, P6453, DOI 10.1074/jbc.274.10.6453; Kettunen E, 2004, CANCER GENET CYTOGEN, V149, P98, DOI 10.1016/s0165-4608(03)00300-5; Kona FR, 2012, BREAST CANCER RES TR, V135, P495, DOI 10.1007/s10549-012-2107-4; Kreiman G, 2004, NUCLEIC ACIDS RES, V32, P2889, DOI 10.1093/nar/gkh614; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lattimore BS, 2005, COMPUT BIOL CHEM, V29, P354, DOI 10.1016/j.compbiolchem.2005.07.002; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; MARCHANDISE FXP, 1989, EUR RESPIR J, V2, P623; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Min JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002505; Ogata Y, 2010, BIOINFORMATICS, V26, P1267, DOI 10.1093/bioinformatics/btq121; Okabe H, 2001, CANCER RES, V61, P2129; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Pittman J, 2004, P NATL ACAD SCI USA, V101, P8431, DOI 10.1073/pnas.0401736101; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Purmann A, 2007, GENOMICS, V89, P580, DOI 10.1016/j.ygeno.2007.01.010; Reimand J, 2008, NUCLEIC ACIDS RES, V36, pW452, DOI 10.1093/nar/gkn230; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Roth JA, 1996, NAT MED, V2, P985, DOI 10.1038/nm0996-985; Rusiniak ME, 2012, ONCOGENE, V31, P4034, DOI 10.1038/onc.2011.566; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shakhnovich Boris E, 2004, Genome Inform, V15, P221; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Taniwaki M, 2007, CLIN CANCER RES, V13, P6624, DOI 10.1158/1078-0432.CCR-07-1328; Teschendorff AE, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-604; Tesson BM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-497; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wang Guiping, 2010, Zhongguo Fei Ai Za Zhi, V13, P282, DOI 10.3779/j.issn.1009-3419.2010.04.02; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Watson M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-509; West M, 2006, GENOME RES, V16, P559, DOI 10.1101/gr.3851306; Zaykin DV, 2011, J EVOLUTION BIOL, V24, P1836, DOI 10.1111/j.1420-9101.2011.02297.x; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang LC, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-38; Zhang YQ, 2012, INT J CANCER, V131, P83, DOI 10.1002/ijc.26346; Zochbauer-Muller S, 2001, CANCER RES, V61, P249	66	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92395	10.1371/journal.pone.0092395	http://dx.doi.org/10.1371/journal.pone.0092395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643254	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900131
J	Legare, F; Borduas, F; Freitas, A; Jacques, A; Godin, G; Luconi, F; Grimshaw, J				Legare, France; Borduas, Francine; Freitas, Adriana; Jacques, Andre; Godin, Gaston; Luconi, Francesca; Grimshaw, Jeremy		CPD-KT Team	Development of a Simple 12-Item Theory-Based Instrument to Assess the Impact of Continuing Professional Development on Clinical Behavioral Intentions	PLOS ONE			English	Article							PLANNED BEHAVIOR; SUBJECTIVE NORMS; NURSES INTENTIONS; KNOWLEDGE TRANSLATION; HEALTH-PROFESSIONALS; HAND HYGIENE; CARE; ATTITUDES; EDUCATION; DETERMINANTS	Background: Decision-makers in organizations providing continuing professional development (CPD) have identified the need for routine assessment of its impact on practice. We sought to develop a theory-based instrument for evaluating the impact of CPD activities on health professionals' clinical behavioral intentions. Methods and Findings: Our multipronged study had four phases. 1) We systematically reviewed the literature for instruments that used socio-cognitive theories to assess healthcare professionals' clinically-oriented behavioral intentions and/or behaviors; we extracted items relating to the theoretical constructs of an integrated model of healthcare professionals' behaviors and removed duplicates. 2) A committee of researchers and CPD decision-makers selected a pool of items relevant to CPD. 3) An international group of experts (n = 70) reached consensus on the most relevant items using electronic Delphi surveys. 4) We created a preliminary instrument with the items found most relevant and assessed its factorial validity, internal consistency and reliability (weighted kappa) over a two-week period among 138 physicians attending a CPD activity. Out of 72 potentially relevant instruments, 47 were analyzed. Of the 1218 items extracted from these, 16% were discarded as improperly phrased and 70% discarded as duplicates. Mapping the remaining items onto the constructs of the integrated model of healthcare professionals' behaviors yielded a minimum of 18 and a maximum of 275 items per construct. The partnership committee retained 61 items covering all seven constructs. Two iterations of the Delphi process produced consensus on a provisional 40-item questionnaire. Exploratory factorial analysis following test-retest resulted in a 12-item questionnaire. Cronbach's coefficients for the constructs varied from 0.77 to 0.85. Conclusion: A 12-item theory-based instrument for assessing the impact of CPD activities on health professionals' clinical behavioral intentions showed adequate validity and reliability. Further studies could assess its responsiveness to behavior change following CPD activities and its capacity to predict health professionals' clinical performance.	[Legare, France; Freitas, Adriana] CHUQ Res Ctr CRCHUQ, Publ Hlth & Practice Changing Res Grp, Quebec City, PQ, Canada; [Borduas, Francine] Univ Laval, Fac Med, Off Vice Dean Educ & Continuing Profess Dev, Quebec City, PQ G1K 7P4, Canada; [Jacques, Andre] Coll Med Quebec, Practice Enhancement Div, Montreal, PQ, Canada; [Godin, Gaston] Univ Laval, Fac Nursing, Quebec City, PQ, Canada; [Luconi, Francesca] McGill Univ, Fac Med, Continuing Hlth Profess Educ Off, Montreal, PQ, Canada; [Grimshaw, Jeremy] Univ Ottawa, Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Grimshaw, Jeremy] Univ Ottawa, Dept Med, Ottawa, ON, Canada	Laval University; Laval University; McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Legare, F (corresponding author), CHUQ Res Ctr CRCHUQ, Publ Hlth & Practice Changing Res Grp, Quebec City, PQ, Canada.	France.Legare@mfa.ulaval.ca		Legare, France/0000-0002-2296-6696	Canadian Institutes of Health Research (CIHR) [200911PHE-216868-PHE-CFBA-19158]; Ministere de la Sante et des Services Sociaux du Quebec (MSSS), QC, Canada; Consortium pedagogique - Secteur DPC; Faculty of Medicine; Universite Laval, Quebec, QC, Canada; Practice Enhancement Division; College des medecins du Quebec, Montreal, QC, Canada; Federation des medecins specialistes du Quebec, Montreal, QC, Canada; Faculty of Medicine and Health Sciences; Universite de Sherbrooke, Sherbrooke, QC, Canada; Universite de Montreal, QC, Canada; Centre for Continuing Health Professional Education, McGill University, Montreal, QC, Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ministere de la Sante et des Services Sociaux du Quebec (MSSS), QC, Canada; Consortium pedagogique - Secteur DPC; Faculty of Medicine; Universite Laval, Quebec, QC, Canada; Practice Enhancement Division; College des medecins du Quebec, Montreal, QC, Canada; Federation des medecins specialistes du Quebec, Montreal, QC, Canada; Faculty of Medicine and Health Sciences; Universite de Sherbrooke, Sherbrooke, QC, Canada; Universite de Montreal, QC, Canada; Centre for Continuing Health Professional Education, McGill University, Montreal, QC, Canada	This study was funded by a Partnership for Health System Improvement grant from the Canadian Institutes of Health Research (CIHR; 2010-2013; grant # 200911PHE-216868-PHE-CFBA-19158) and by the Ministere de la Sante et des Services Sociaux du Quebec (MSSS), QC, Canada. FL, GG and JMG hold Canada Research Chairs. The following CME organizations provided funding for this study: Consortium pedagogique - Secteur DPC, Faculty of Medicine, Universite Laval, Quebec, QC, Canada; Practice Enhancement Division, College des medecins du Quebec, Montreal, QC, Canada; Federation des medecins specialistes du Quebec, Montreal, QC, Canada; Faculty of Medicine and Health Sciences, Universite de Sherbrooke, Sherbrooke, QC, Canada; Universite de Montreal, QC, Canada; and Centre for Continuing Health Professional Education, McGill University, Montreal, QC, Canada. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript' on the online submission form.	Accreditation Council for Continuing Medical Education, 2012, ACCME ANN REP DAT 20; Agency for Health Research and Quality, 2001, TRANSL RES PRACT TRI; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Askelson NM, 2010, WOMEN HEALTH, V50, P144, DOI 10.1080/03630241003705094; Ben Natan M, 2009, INT J NURS PRACT, V15, P566, DOI 10.1111/j.1440-172X.2009.01799.x; Bercher D, 2008, ATTITUDES PARAMEDICS; Bernaix L W, 2000, J Hum Lact, V16, P201, DOI 10.1177/089033440001600304; Bernaix LW, 2008, JOGNN-J OBST GYN NEO, V37, P436, DOI 10.1111/j.1552-6909.2008.00261.x; Bonetti D, 2005, SOC SCI MED, V60, P2135, DOI 10.1016/j.socscimed.2004.08.072; Bonetti D, 2006, SOC SCI MED, V63, P1889, DOI 10.1016/j.socscimed.2006.04.005; Bonetti D, 2009, PSYCHOL HEALTH, V24, P843, DOI 10.1080/08870440802108918; Campbell EG, 2009, JAMA-J AM MED ASSOC, V302, P1807, DOI 10.1001/jama.2009.1560; Casper ES, 2008, PSYCHIAT SERV, V59, P747, DOI 10.1176/appi.ps.59.7.747; Casper ES, 2007, PSYCHIAT SERV, V58, P1324, DOI 10.1176/appi.ps.58.10.1324; Centre de developpement professionnel continu de la Faculte de medecine de l'Universite Laval College des medecins du Quebec et Centre de Recherche du CHU de Quebec, 2011, FOR ECH TRANSF CONN; Chau PYK, 2001, DECISION SCI, V32, P699, DOI 10.1111/j.1540-5915.2001.tb00978.x; Crawford TE, 1998, FACTORS INFLUENCING; Daneault S, 2004, CAN J PUBLIC HEALTH, V95, P151, DOI 10.1007/BF03405785; DiIorio C, 1997, J Neurosci Nurs, V29, P50; Eccles MP, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-26; Eccles MP, 2009, INT J BEHAV MED, V16, P377, DOI 10.1007/s12529-008-9023-3; Edwards H E, 2001, Nurs Health Sci, V3, P149, DOI 10.1046/j.1442-2018.2001.00080.x; Ellery J, 2007, AM J HEALTH BEHAV, V31, P312, DOI 10.5993/AJHB.31.3.8; Elwyn G, 2001, PATIENT EDUC COUNS, V43, P5, DOI 10.1016/S0738-3991(00)00149-X; Farris K, 1995, J SOCIAL ADM PHARM, V12, P64; Farris KB, 1999, SOC SCI MED, V49, P55, DOI 10.1016/S0277-9536(99)00078-7; Faulkner G, 2001, AM J HEALTH PROMOT, V16, P98, DOI 10.4278/0890-1171-16.2.98; Federation of Medical Regulatory authorities of Canada, 2008, POS STAT 2008; Feng JY, 2005, RES NURS HEALTH, V28, P337, DOI 10.1002/nur.20087; Fields S, 2008, ROLE THEORY PLANNED; Foy R, 2005, INT J QUAL HEALTH C, V17, P147, DOI 10.1093/intqhc/mzi017; Foy R, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-31; Frank J, 2005, CANMEDS PHYS COMPETE; Gagnon MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-8; Gagnon MP, 2003, INT J MED INFORM, V71, P103, DOI 10.1016/S1386-5056(03)00094-7; Gilomen-Study G, 1998, PREDICTING MANAGED C; Godin G, 2000, AM J INFECT CONTROL, V28, P359, DOI 10.1067/mic.2000.107594; Godin G, 1999, COMMUNITY DENT ORAL, V27, P221, DOI 10.1111/j.1600-0528.1999.tb02014.x; Godin G, 2007, BEHAV MED, V33, P67, DOI 10.3200/BMED.33.2.67-79; Godin G, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-36; Green Helen, 2008, Ment Health Fam Med, V5, P213; Hanbury A, 2009, BRIT J HEALTH PSYCH, V14, P505, DOI 10.1348/135910708X369558; Harbour VJ, 2009, USING THEORY PLANNED; HARRELL GD, 1974, J MARKETING RES, V11, P269, DOI 10.2307/3151142; Herbert Kathleen E, 2006, Res Social Adm Pharm, V2, P299, DOI 10.1016/j.sapharm.2006.02.008; Hoppe CRG, 1999, PREDICTING HLTH PROF; Hsu CC, 2007, PRACTICAL ASSESSMENT, V12, P7; Hu PJ, 1999, J MANAGE INFORM SYST, V16, P91, DOI 10.1080/07421222.1999.11518247; Jenner E. A., 2002, PSYCHOL HEALTH MED, V7, P311, DOI DOI 10.1080/13548500220139412; Jurgens DW, 1996, NURSES INTENTIONS AD; Khanna R, 2009, RES SOC ADMIN PHARM, V5, P170, DOI 10.1016/j.sapharm.2008.06.006; Kirkpatrick D. L., 1998, EVALUATING TRAINING; Kittisopee T, 2001, INFLUENCES PERSONALI; Lambert BL, 1997, SOC SCI MED, V45, P1767, DOI 10.1016/S0277-9536(97)00108-1; Landis JR, 1977, BIOMETRICS, V33, P16, DOI DOI 10.2307/2529310; Lavoie M, 1999, J APPL SOC PSYCHOL, V29, P772, DOI 10.1111/j.1559-1816.1999.tb02023.x; Legare F, 2007, HEALTH EXPECT, V10, P364, DOI 10.1111/j.1369-7625.2007.00465.x; Legare France, 2005, BMC Med Inform Decis Mak, V5, P31, DOI 10.1186/1472-6947-5-31; Legare F, 2011, J CONTIN EDUC HEALTH, V31, P181, DOI 10.1002/chp.20125; Legare F, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-17; Liabsuetrakul T, 2003, SOC SCI MED, V57, P1665, DOI 10.1016/S0277-9536(02)00550-6; Marrone SR, 2008, J TRANSCULT NURS, V19, P8, DOI 10.1177/1043659607309143; MASON HL, 1983, PATIENT COUNS HEALTH, V4, P190, DOI 10.1016/S0738-3991(83)80004-4; Maue SK, 2004, AM J MANAG CARE, V10, P383; Millstein SG, 1996, HEALTH PSYCHOL, V15, P398, DOI 10.1037/0278-6133.15.5.398; O'Boyle CA, 2001, AM J INFECT CONTROL, V29, P352, DOI 10.1067/mic.2001.18405; Payant L, 2006, FACTORS RELATED CHIL; Pessoa-Silva CL, 2005, INFECT CONT HOSP EP, V26, P305, DOI 10.1086/502544; Pielak KL, 2010, J ADV NURS, V66, P1602, DOI 10.1111/j.1365-2648.2010.05326.x; Pradel FG, 2007, J AM PHARM ASSOC, V47, P737, DOI 10.1331/JAPhA.2007.06138; Puffer S, 2004, J ADV NURS, V47, P500, DOI 10.1111/j.1365-2648.2004.03129.x; Quinn R, 1996, ATTITUDE SUBJECTIVE; Ramsay CR, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-71; Renfroe D H, 1990, Sch Inq Nurs Pract, V4, P47; Ryu S, 2003, EXPERT SYST APPL, V25, P113, DOI 10.1016/S0957-4174(03)00011-3; Saillour-Glenisson F, 2003, REV EPIDEMIOL SANTE, V51, P65; Sauls DJ, 2007, NURS RES, V56, P117, DOI 10.1097/01.NNR.0000263972.54619.4a; Shoham S, 2008, CIN-COMPUT INFORM NU, V26, P106, DOI 10.1097/01.NCN.0000304777.48155.e3; Ten Wolde GB, 2008, PHARM WORLD SCI, V30, P336, DOI 10.1007/s11096-007-9183-2; TESSARO I, 1994, PUBLIC HEALTH NURS, V11, P273, DOI 10.1111/j.1525-1446.1994.tb00423.x; Tian J, 2010, ACAD MED, V85, P1518, DOI 10.1097/ACM.0b013e3181eac3fb; Triandis H.C., 1980, NEBRASKA S MOTIVATIO, P195, DOI DOI 10.1016/S0969-4765(04)00066-9; Vermette L, 1996, AIDS CARE, V8, P479, DOI 10.1080/09540129650125669; Walker A, 2004, FAM PRACT, V21, P670, DOI 10.1093/fampra/cmh615; Wallace KG, 1997, CANCER NURS, V20, P34, DOI 10.1097/00002820-199702000-00005; Walsh AM, 2005, J ADV NURS, V49, P453, DOI 10.1111/j.1365-2648.2004.03318.x; Watson P. W. B., 2001, PSYCHOL HEALTH MED, V6, P399; Werner P, 2001, J ADV NURS, V35, P784, DOI 10.1046/j.1365-2648.2001.01911.x; Wilson C, 1998, APPPL THEORY PLANNED	89	51	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91013	10.1371/journal.pone.0091013	http://dx.doi.org/10.1371/journal.pone.0091013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24643173	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900010
J	Li, YL; Zheng, J; Li, QS				Li Yunlan; Zheng Juan; Li Qingshan			Antitumor Activity of Di-n-Butyl-(2,6-Difluorobenzohydroxamato) Tin(IV) against Human Gastric Carcinoma SGC-7901 Cells via G2/M Cell Cycle Arrest and Cell Apoptosis	PLOS ONE			English	Article							ACTIVATION; PHOSPHORYLATION; CHECKPOINTS; MECHANISMS; PATHWAY; PHASE; P53	Di-n-butyl-(2,6-difluorobenzohydroxamato) Tin(IV) (DBDFT), a potential antitumor agent against malignancies, exhibited high activities both in vitro and in vivo. Flow cytometric analysis showed that treatment with DBDFT against Human Gastric Carcinoma (SGC-7901) cells induced a concentration and time-dependent cell accumulation in the G2/M phase of the cell cycle with a parallel depletion of the percentage of cells in G0/G1, the cell apoptosis was observed by characteristic morphological changes and AnnexinV/PI dual-immunofluorescence staining. Fluorescence quantitative FQ-PCR and western blot results showed that G2/M-phase arrest was correlated with up-regulation of cyclin dependent kinase inhibitor p21, Chk2 and CyclinB1, whereas the expressions of other G2/M regulatory check-point protein, Cdc2, and feedback loop protein Cdc25C were obviously down-regulated in a p53-independent manner after the SGC-7901 cells were treated with DBDFT (2.5, 5.0, 7.5 mu mol.L-1) compared with the control. Furthermore, the up-regulation of Bax and down-regulation of Bcl-2 as well as the activation of caspase-3 were observed, which indicated that DBDFT treatment triggered the mitochondrial apoptotic pathway with an increase of Bax/Bcl-2 ratios, resulting in mitochondrial membrane potential loss and caspase-9 activation in DBDFT treated SGC-7901 cells. In summary, the results illustrated the involvement of multiple signaling pathways targeted by DBDFT in mediating G2/M cell cycle arrest and apoptosis in SGC-7901 cells, which suggested that DBDFT might have therapeutic potential against gastric carcinoma as an effective compound.	[Li Yunlan; Zheng Juan; Li Qingshan] Shanxi Med Univ, Sch Pharmaceut Sci, Taiyuan, Peoples R China	Shanxi Medical University	Li, YL (corresponding author), Shanxi Med Univ, Sch Pharmaceut Sci, Taiyuan, Peoples R China.	liyunlanrr@163.com; qingshanl@yahoo.com			National Natural Science Foundation of China [30973603]; State Key Science and Technology of China [2009ZX09103-104]; Shanxi Foundation for overseas returned [2010-54]; science and technology activities [201368]; Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province; Shanxi Province Foundation Science for Youths; Foundation for the Younth Doctor from Shanxi Medical University; Program for the Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Science and Technology of China; Shanxi Foundation for overseas returned; science and technology activities; Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province; Shanxi Province Foundation Science for Youths; Foundation for the Younth Doctor from Shanxi Medical University; Program for the Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi province	This research was supported by the National Natural Science Foundation of China (No. 30973603), the "Innovative Drug Development'' State Key Science and Technology of China (No. 2009ZX09103-104), the Shanxi Foundation for overseas returned (No. 2010-54) and preferred project supported by the science and technology activities (No. 201368), the Program for the Top Young and Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi Province and by Shanxi Province Foundation Science for Youths, the Foundation for the Younth Doctor from Shanxi Medical University in 2008 and Program for the Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi province(2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Baul TSB, 2008, J INORG BIOCHEM, V102, P1719, DOI 10.1016/j.jinorgbio.2008.05.001; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen YL, 2006, BIOCHEM PHARMACOL, V72, P308, DOI 10.1016/j.bcp.2006.04.031; De Souza CPC, 2000, EXP CELL RES, V257, P11, DOI 10.1006/excr.2000.4872; Deep G, 2006, ONCOGENE, V25, P1053, DOI 10.1038/sj.onc.1209146; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Gielen M, 2003, J BRAZIL CHEM SOC, V14, P870, DOI 10.1590/S0103-50532003000600003; Gielen M, 1997, Met Based Drugs, V4, P193, DOI 10.1155/MBD.1997.193; Grivicich I, 2005, ONCOL RES, V15, P385, DOI 10.3727/096504005776449680; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Ho John W., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P131, DOI 10.2174/1568011053174819; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Li QS, 2004, CHEM-EUR J, V10, P1456, DOI 10.1002/chem.200305266; Li YL, 2010, MOL CARCINOGEN, V49, P566, DOI 10.1002/mc.20623; Lian FR, 1998, NUTR CANCER, V31, P184, DOI 10.1080/01635589809514701; LIEBERMANN DA, 1995, ONCOGENE, V11, P199; McShea A, 2000, J BIOL CHEM, V275, P23181, DOI 10.1074/jbc.M001772200; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; RUSSO T, 1995, J BIOL CHEM, V270, P29386, DOI 10.1074/jbc.270.49.29386; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shin SY, 2010, CANCER LETT, V287, P231, DOI 10.1016/j.canlet.2009.06.019; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Tabassum S, 2006, J ORGANOMET CHEM, V691, P1761, DOI 10.1016/j.jorganchem.2005.12.033; Tang L, 2012, TOXICOL LETT, V213, P167, DOI 10.1016/j.toxlet.2012.06.008; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; WANG XW, 2001, NUCLEIC ACIDS RES, V29, P2020; Yin H, 1999, CHEM RES, V4, P54; Yu J, 2007, CARCINOGENESIS, V28, P632, DOI 10.1093/carcin/bgl168; Yunlan L, 1997, J INORGANIC BIOCH, V102, P1731; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; 尚先梅, 2008, [中国科学. B辑, 化学, Science in China. Series B, Chemistry], V38, P429	36	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e90793	10.1371/journal.pone.0090793	http://dx.doi.org/10.1371/journal.pone.0090793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643073	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900008
J	Liu, RH; Jin, PP; Yu, LQ; Wang, Y; Han, LP; Shi, T; Li, X				Liu, Ruohai; Jin, Pengpeng; Yu, Liqun; Wang, Ying; Han, Liping; Shi, Tong; Li, Xu			Impaired Mitochondrial Dynamics and Bioenergetics in Diabetic Skeletal Muscle	PLOS ONE			English	Article							INSULIN-RESISTANCE; MITOFUSIN 2; FUSION; FISSION; TRANSMISSION; CONTRIBUTES; PGC-1-ALPHA; DYSFUNCTION; METABOLISM; ACTIVATION	In most cells, mitochondria are highly dynamic organelles that constantly fuse, divide and move. These processes allow mitochondria to redistribute in a cell and exchange contents among the mitochondrial population, and subsequently repair damaged mitochondria. However, most studies on mitochondrial dynamics have been performed on cultured cell lines and neurons, and little is known about whether mitochondria are dynamic organelles in vivo, especially in the highly specialized and differentiated adult skeletal muscle cells. Using mitochondrial matrix-targeted photoactivatable green fluorescent protein (mtPAGFP) and electroporation methods combined with confocal microscopy, we found that mitochondria are dynamic in skeletal muscle in vivo, which enables mitochondria exchange contents within the whole mitochondrial population through nanotunneling-mediated mitochondrial fusion. Mitochondrial network promotes rapid transfer of mtPAGFP within the cell. More importantly, the dynamic behavior was impaired in high-fat diet (HFD)-induced obese mice, accompanying with disturbed mitochondrial respiratory function and decreased ATP content in skeletal muscle. We further found that proteins controlling mitochondrial fusion MFN1 and MFN2 but not Opa1 were decreased and proteins governing mitochondrial fission Fis1 and Drp1 were increased in skeletal muscle of HFD-induced mice when compared to normal diet-fed mice. Altogether, we conclude that mitochondria are dynamic organelles in vivo in skeletal muscle, and it is essential in maintaining mitochondrial respiration and bioenergetics.	[Liu, Ruohai; Shi, Tong] Wenzhou Med Univ, Affiliated Hosp 2, Dept Anaesthesia, Wenzhou, Peoples R China; [Jin, Pengpeng; Yu, Liqun; Wang, Ying; Han, Liping; Li, Xu] Wenzhou Med Univ, Renji Coll, Dept Physiol, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Li, X (corresponding author), Wenzhou Med Univ, Renji Coll, Dept Physiol, Wenzhou, Peoples R China.	lixu0577@126.com			National Nature Science Foundation of China [81100138]; Wenzhou Science and Technology Bureau [Y20100212, Y20090230]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Science and Technology Bureau	This work was supported by grants from National Nature Science Foundation of China (No. 81100138) and Wenzhou Science and Technology Bureau (NO.Y20100212 and Y20090230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Caffin F, 2013, J PHYSIOL-LONDON, V591, P6017, DOI 10.1113/jphysiol.2013.263079; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen Le, 2011, Congest Heart Fail, V17, P257; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Eisenberg BR, 2010, COMPREHENSIVE PHYSL, P73; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; Gan KX, 2013, WORLD J GASTROENTERO, V19, P1572, DOI 10.3748/wjg.v19.i10.1572; Garcia-Cazarin ML, 2011, JOVE-J VIS EXP, DOI 10.3791/2452; GOLDSPINK G, 1964, NATURE, V204, P1095, DOI 10.1038/2041095a0; Grandemange S, 2009, SEMIN CANCER BIOL, V19, P50, DOI 10.1016/j.semcancer.2008.12.001; Holloway GP, 2008, AM J PHYSIOL-ENDOC M, V294, pE1060, DOI 10.1152/ajpendo.00726.2007; Huang XH, 2013, P NATL ACAD SCI USA, V110, P2846, DOI 10.1073/pnas.1300741110; Hernandez-Alvarez MI, 2010, DIABETES CARE, V33, P645, DOI 10.2337/dc09-1305; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Kanzaki Y, 2010, CIRCULATION, V121, P831, DOI 10.1161/CIR.0b013e3181d22e2d; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Liesa M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003613; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Matsumoto-Ida M, 2006, CIRCULATION, V114, P1497, DOI 10.1161/CIRCULATIONAHA.106.628834; OGATA T, 1985, CELL TISSUE RES, V242, P461; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Redpath CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069165; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Sciote J J, 2000, J Orthod, V27, P15, DOI 10.1093/ortho/27.1.15; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; SKULACHEV VP, 1990, J MEMBRANE BIOL, V114, P97, DOI 10.1007/BF01869092; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Vendelin M, 2005, AM J PHYSIOL-CELL PH, V288, pC757, DOI 10.1152/ajpcell.00281.2004; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yi JX, 2011, J BIOL CHEM, V286, P32436, DOI 10.1074/jbc.M110.217711; Zhao J, 2012, ONCOGENE; Zorzano A, 2010, BBA-BIOENERGETICS, V1797, P1028, DOI 10.1016/j.bbabio.2010.02.017; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004; Zorzano Antonio, 2009, Archives of Physiology and Biochemistry, V115, P1, DOI 10.1080/13813450802676335	44	91	95	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92810	10.1371/journal.pone.0092810	http://dx.doi.org/10.1371/journal.pone.0092810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658162	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300131
J	Prasad, V; Rho, J; Selvaraj, S; Cheung, M; Vandross, A; Ho, N				Prasad, Vinay; Rho, Jason; Selvaraj, Senthil; Cheung, Mike; Vandross, Andrae; Ho, Nancy			Can a Resident's Publication Record Predict Fellowship Publications?	PLOS ONE			English	Article							MEDICAL-SCHOOL; APPLICANTS; BEHAVIOR; SURGERY	Background: Internal medicine fellowship programs have an incentive to select fellows who will ultimately publish. Whether an applicant's publication record predicts long term publishing remains unknown. Methods: Using records of fellowship bound internal medicine residents, we analyzed whether publications at time of fellowship application predict publications more than 3 years (2 years into fellowship) and up to 7 years after fellowship match. We calculate the sensitivity, specificity, positive and negative predictive values and likelihood ratios for every cutoff number of application publications, and plot a receiver operator characteristic curve of this test. Results: Of 307 fellowship bound residents, 126 (41%) published at least one article 3 to 7 years after matching, and 181 (59%) of residents do not publish in this time period. The area under the receiver operator characteristic curve is 0.59. No cutoff value for application publications possessed adequate test characteristics. Conclusion: The number of publications an applicant has at time of fellowship application is a poor predictor of who publishes in the long term. These findings do not validate the practice of using application publications as a tool for selecting fellows.	[Prasad, Vinay] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Rho, Jason; Cheung, Mike] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Selvaraj, Senthil] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Vandross, Andrae] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Ho, Nancy] Univ Maryland, Dept Med, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northwestern University; Harvard University; Brigham & Women's Hospital; Yale University; University System of Maryland; University of Maryland Baltimore	Prasad, V (corresponding author), NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA.	vinayak.prasad@nih.gov		Prasad, Vinayak/0000-0002-6110-8221; Selvaraj, Senthil/0000-0001-8418-7623				ACGME, 2007, ACGME PROGR REQ GRAD; Crowley RW, 2012, NEUROSURGERY, V70, P1024, DOI 10.1227/NEU.0b013e3182367143; Ioannidis JPA, 2012, JAMA-J AM MED ASSOC, V308, P575, DOI 10.1001/jama.2012.8144; Ioannidis JPA, 2010, JAMA-J AM MED ASSOC, V303, P1646, DOI 10.1001/jama.2010.503; Kanna B, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-42; Lawton MT, 2007, NEUROSURGERY, V60, P934, DOI 10.1227/01.NEU.0000255445.51989.33; Papadakis MA, 2005, NEW ENGL J MED, V353, P2673, DOI 10.1056/NEJMsa052596; Prasad V, 2012, AM J MED, V125, P939, DOI 10.1016/j.amjmed.2012.05.014; Prasad V, 2011, TEACH LEARN MED, V23, P337, DOI 10.1080/10401334.2011.611780; Prasad V, 2011, ACAD MED, V86, P2, DOI 10.1097/ACM.0b013e3181ff64ac; Stain SC, 2013, JAMA SURG, V148, P413, DOI 10.1001/jamasurg.2013.180; Yang G, 2011, J UROLOGY, V185, P642, DOI 10.1016/j.juro.2010.09.097	12	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90140	10.1371/journal.pone.0090140	http://dx.doi.org/10.1371/journal.pone.0090140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658088	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300011
J	Bar-On, L; Aertbelien, E; Molenaers, G; Desloovere, K				Bar-On, Lynn; Aertbelien, Erwin; Molenaers, Guy; Desloovere, Kaat			Muscle Activation Patterns When Passively Stretching Spastic Lower Limb Muscles of Children with Cerebral Palsy	PLOS ONE			English	Article							TOXIN TYPE-A; REFLEX THRESHOLD; PATHOPHYSIOLOGY; RECOMMENDATIONS; RELIABILITY; MOVEMENT; PARESIS; ONSET; CATCH	The definition of spasticity as a velocity-dependent activation of the tonic stretch reflex during a stretch to a passive muscle is the most widely accepted. However, other mechanisms are also thought to contribute to pathological muscle activity and, in patients post-stroke and spinal cord injury can result in different activation patterns. In the lower-limbs of children with spastic cerebral palsy (CP) these distinct activation patterns have not yet been thoroughly explored. The aim of the study was to apply an instrumented assessment to quantify different muscle activation patterns in four lower-limb muscles of children with CP. Fifty-four children with CP were included (males/females n = 35/19; 10.8 +/- 3.8 yrs; bilateral/unilateral involvement n = 32/22; Gross Motor Functional Classification Score I-IV) of whom ten were retested to evaluate intra-rater reliability. With the subject relaxed, single-joint, sagittal-plane movements of the hip, knee, and ankle were performed to stretch the lower-limb muscles at three increasing velocities. Muscle activity and joint motion were synchronously recorded using inertial sensors and electromyography (EMG) from the adductors, medial hamstrings, rectus femoris, and gastrocnemius. Muscles were visually categorised into activation patterns using average, normalized root mean square EMG (RMS-EMG) compared across increasing position zones and velocities. Based on the visual categorisation, quantitative parameters were defined using stretch-reflex thresholds and normalized RMS-EMG. These parameters were compared between muscles with different activation patterns. All patterns were dominated by high velocity-dependent muscle activation, but in more than half, low velocity-dependent activation was also observed. Muscle activation patterns were found to be both muscle-and subject-specific (p<0.01). The intra-rater reliability of all quantitative parameters was moderate to good. Comparing RMS-EMG between incremental position zones during low velocity stretches was found to be the most sensitive in categorizing muscles into activation patterns (p<0.01). Future studies should investigate whether muscles with different patterns react differently to treatment.	[Bar-On, Lynn; Molenaers, Guy; Desloovere, Kaat] Univ Hosp Leuven, Clin Mot Anal Lab, Leuven, Belgium; [Bar-On, Lynn; Desloovere, Kaat] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Aertbelien, Erwin] Katholieke Univ Leuven, Dept Mech Engn, Leuven, Belgium; [Molenaers, Guy] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Molenaers, Guy] Univ Hosp Leuven, Dept Orthopaed, Leuven, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven	Bar-On, L (corresponding author), Univ Hosp Leuven, Clin Mot Anal Lab, Leuven, Belgium.	Lynn.1.bar-on@uzleuven.be	Aertbeliën, Erwin/L-5547-2018; Bar-On, Lynn/GLT-6281-2022; Desloovere, Kaat/F-3240-2014	Aertbeliën, Erwin/0000-0002-4514-0934; Bar-On, Lynn/0000-0003-4793-2860; Desloovere, Kaat/0000-0002-8507-5276	Doctoral Scholarships Committee for International Collaboration with non EER-countries (DBOF) of the University of Leuven, Belgium; Flemish agency for Innovation by Science and Technology (IWT-TBM) [060799]	Doctoral Scholarships Committee for International Collaboration with non EER-countries (DBOF) of the University of Leuven, Belgium; Flemish agency for Innovation by Science and Technology (IWT-TBM)	Lynn Bar-On is supported by a grant from the Doctoral Scholarships Committee for International Collaboration with non EER-countries (DBOF) of the University of Leuven, Belgium. This work was further supported by a grant for Applied Biomedical Research from the Flemish agency for Innovation by Science and Technology (IWT-TBM: grant number 060799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-On L, 2013, GAIT POSTURE, V38, P141, DOI 10.1016/j.gaitpost.2012.11.003; Bar-On L, 2014, ARCH PHYS MED REHAB, V95, P515, DOI 10.1016/j.apmr.2013.08.010; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Boyd RN, 1999, EUR J NEUROL, V6, pS23, DOI 10.1111/j.1468-1331.1999.tb00031.x; Burke D, 2013, NEUROLOGY, V80, pS20, DOI 10.1212/WNL.0b013e31827624a7; Calota A, 2008, CLIN NEUROPHYSIOL, V119, P2329, DOI 10.1016/j.clinph.2008.07.215; Calota A, 2009, TOP STROKE REHABIL, V16, P177, DOI 10.1310/tsr1603-177; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Desloovere K, 2012, EUR J PAEDIATR NEURO, V16, P229, DOI 10.1016/j.ejpn.2010.09.006; Dietz V, 2007, LANCET NEUROL, V6, P725, DOI 10.1016/S1474-4422(07)70193-X; Fleuren JFM, 2010, J NEUROL NEUROSUR PS, V81, P46, DOI 10.1136/jnnp.2009.177071; Gage JR., 2009, IDENTIFICATION TREAT; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; Graham HK, 2000, GAIT POSTURE, V11, P67, DOI 10.1016/S0966-6362(99)00054-5; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hislop HJ, 1995, DANIELS WORTHINGS MU; Hornby TG, 2003, J NEUROPHYSIOL, V89, P416, DOI 10.1152/jn.00979.2001; Jobin A, 2000, DEV MED CHILD NEUROL, V42, P531, DOI 10.1017/S0012162200001018; Kamper DG, 2001, ANN BIOMED ENG, V29, P1122, DOI 10.1114/1.1424918; KATZ JN, 1992, MED CARE, V30, P917, DOI 10.1097/00005650-199210000-00004; LANCE JW, 1980, NEUROLOGY, V30, P1303, DOI 10.1212/WNL.30.12.1303; Lebiedowska MK, 2009, J NEUROSCI METH, V179, P323, DOI 10.1016/j.jneumeth.2009.02.005; Lee AS, 2007, J BIOMECH, V40, P3521, DOI 10.1016/j.jbiomech.2007.05.012; LEVIN MF, 1994, BRAIN RES, V657, P23, DOI 10.1016/0006-8993(94)90949-0; Li S, 2006, MUSCLE NERVE, V33, P183, DOI 10.1002/mus.20453; Lieber RL, 2004, MUSCLE NERVE, V29, P615, DOI 10.1002/mus.20059; Lieber RL, 2010, SKELETAL MUSCLE STRU; Malhotra S, 2008, CLIN REHABIL, V22, P1105, DOI 10.1177/0269215508095089; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; McPherson JG, 2008, J NEUROPHYSIOL, V100, P3236, DOI 10.1152/jn.90563.2008; Meinders M, 1996, ARCH PHYS MED REHAB, V77, P487, DOI 10.1016/S0003-9993(96)90038-6; Morrell DS, 2002, RADIOGRAPHICS, V22, P257, DOI 10.1148/radiographics.22.2.g02mr19257; Musampa NK, 2007, EXP BRAIN RES, V181, P579, DOI 10.1007/s00221-007-0956-6; Pandyan AD, 2006, DISABIL REHABIL, V28, P579, DOI 10.1080/09638280500242390; RAUCH HE, 1965, AIAA J, V3, P1445, DOI 10.2514/3.3166; Sheean G, 2008, UPPER MOTOR NEURONE SYNDROME AND SPASTICITY: CLINICAL MANAGEMENT AND NEUROPHYSIOLOGY, 2ND EDITION, P9, DOI 10.1017/CBO9780511544866.003; Staude G, 1999, MED ENG PHYS, V21, P449, DOI 10.1016/S1350-4533(99)00067-3; THILMANN AF, 1991, BRAIN, V114, P233; van den Noort JC, 2010, ARCH PHYS MED REHAB, V91, P615, DOI 10.1016/j.apmr.2009.12.022; van der Salm A, 2005, ARCH PHYS MED REHAB, V86, P1991, DOI 10.1016/j.apmr.2005.04.023; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wu YN, 2010, DEV MED CHILD NEUROL, V52, P563, DOI 10.1111/j.1469-8749.2009.03602.x	43	19	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91759	10.1371/journal.pone.0091759	http://dx.doi.org/10.1371/journal.pone.0091759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651860	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000333352800048
J	Bond, CE; Nancarrow, DJ; Wockner, LF; Wallace, L; Montgomery, GW; Leggett, BA; Whitehall, VLJ				Bond, Catherine E.; Nancarrow, Derek J.; Wockner, Leesa F.; Wallace, Leanne; Montgomery, Grant W.; Leggett, Barbara A.; Whitehall, Vicki L. J.			Microsatellite Stable Colorectal Cancers Stratified by the BRAF V600E Mutation Show Distinct Patterns of Chromosomal Instability	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; COPY-NUMBER ALTERATIONS; GENOMIC INSTABILITY; ANEUPLOIDY; PROGNOSIS; HETEROZYGOSITY; ASSOCIATION; ABERRATIONS; LANDSCAPE; MECHANISM	The BRAF (V600E) mutation in colorectal cancers that are microsatellite stable (MSS) confers a poor patient prognosis, whereas BRAF mutant microsatellite-unstable (MSI) colorectal cancers have an excellent prognosis. BRAF wild type cancers are typically MSS and display chromosomal instability (CIN). CIN has not been extensively studied on a genome-wide basis in relation to BRAF mutational status in colorectal cancer. BRAF mutant/MSS (BRAFmut/MSS) cancers (n = 33) and BRAF mutant/MSI (BRAFmut/MSI) cancers (n = 30) were compared for presence of copy number aberrations (CNAs) indicative of CIN, with BRAF wild type/MSS (BRAFwt/MSS) cancers (n = 18) using Illumina CytoSNP-12 arrays. BRAFmut/MSS and BRAF-wt/MSS cancers showed comparable numbers of CNAs/cancer at 32.8 and 29.8 respectively. However, there were differences in patterns of CNA length between MSS cohorts, with BRAFmut/MSS cancers having significantly greater proportions of focal CNAs compared to BRAFwt/MSS cancers (p<0.0001); whereas whole chromosomal arm CNAs were more common in BRAFwt/MSS cancers (p<0.0001). This related to a reduced average CNA length in BRAFmut/MSS compared to BRAFwt/MSS cancers (20.7 Mb vs 33.4 Mb; p<0.0001); and a smaller average percent of CIN affected genomes in BRAFmut/MSS compared to BRAFwt/MSS cancers (23.9% vs 34.9% respectively). BRAFmut/MSI cancers were confirmed to have low CNA rates (5.4/cancer) and minimal CIN-affected genomes (average of 4.5%) compared to MSS cohorts (p<0.0001). BRAFmut/MSS cancers had more frequent deletion CNAs compared to BRAFwt/MSS cancers on 6p and 17q at loci not typically correlated with colorectal cancer, and greater amplification CNAs on 8q and 18q compared to BRAFwt/MSS cancers. These results indicate that comparable rates of CIN occur between MSS subgroups, however significant differences in their patterns of instability exist, with BRAFmut/MSS cancers showing a 'focal pattern' and BRAFwt/MSS cancers having a 'whole arm pattern' of CIN. This and the genomic loci more frequently affected in BRAFmut/MSS cancers provides further evidence of the biological distinctions of this important cancer subgroup.	[Bond, Catherine E.; Leggett, Barbara A.; Whitehall, Vicki L. J.] QIMR Berghofer Med Res Inst, Conjoint Gastroenterol Lab, Brisbane, Qld, Australia; [Bond, Catherine E.; Leggett, Barbara A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Nancarrow, Derek J.] QIMR Berghofer Med Res Inst, Canc Control Grp, Brisbane, Qld, Australia; [Nancarrow, Derek J.] QIMR Berghofer Med Res Inst, Oncogen Grp, Brisbane, Qld, Australia; [Wockner, Leesa F.] QIMR Berghofer Med Res Inst, Canc & Populat Studies Grp, Brisbane, Qld, Australia; [Wallace, Leanne; Montgomery, Grant W.] QIMR Berghofer Med Res Inst, Mol Epidemiol Grp, Brisbane, Qld, Australia; [Leggett, Barbara A.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Whitehall, Vicki L. J.] Pathol Queensland, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Bond, CE (corresponding author), QIMR Berghofer Med Res Inst, Conjoint Gastroenterol Lab, Brisbane, Qld, Australia.	catherine.bond@qimrberghofer.edu.au	Montgomery, Grant W/B-7148-2008; Whitehall, Vicki L/B-6262-2013; Leggett, Barbara A/D-3579-2011; Whitehall, Vicki/E-5414-2019; WALLACE, Leanne/V-2097-2018	Montgomery, Grant W/0000-0002-4140-8139; Whitehall, Vicki L/0000-0002-8285-2391; Leggett, Barbara/0000-0003-2062-7380; WALLACE, Leanne/0000-0003-4310-7572; Wockner, Leesa/0000-0002-8921-9265; Bond, Catherine/0000-0002-9615-5300	National Health and Medical Research Council grant (NHMRC) [1050455]; Australian Postgraduate Award; Cancer Australia grant [552449]	National Health and Medical Research Council grant (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Cancer Australia grant	This research was supported by a National Health and Medical Research Council grant (NHMRC #1050455) and an Australian Postgraduate Award. DN was supported by a Cancer Australia grant #552449. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2011, INT J CANCER, V129, P1848, DOI 10.1002/ijc.25841; Antelo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045357; Beggs AD, 2013, ONCOGENE, V32, P5333, DOI 10.1038/onc.2012.584; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Belaguli NS, 2010, NEOPLASIA, V12, P856, DOI 10.1593/neo.10224; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bond CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047483; Bond CE, 2012, INT J CANCER, V130, P1567, DOI 10.1002/ijc.26175; Chang SC, 2006, INT J CANCER, V118, P1721, DOI 10.1002/ijc.21563; Cheng YW, 2008, CLIN CANCER RES, V14, P6005, DOI 10.1158/1078-0432.CCR-08-0216; Deng GR, 2006, INT J CANCER, V118, P2999, DOI 10.1002/ijc.21740; Duijf PHG, 2013, ONCOGENE, V32, P4727, DOI 10.1038/onc.2012.616; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Dyrso T, 2011, CANCER GENET-NY, V204, P84, DOI 10.1016/j.cancergencyto.2010.08.019; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fudenberg G, 2011, NAT BIOTECHNOL, V29, P1109, DOI 10.1038/nbt.2049; Gaasenbeek M, 2006, CANCER RES, V66, P3471, DOI 10.1158/0008-5472.CAN-05-3285; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hirsch D, 2013, CANCER RES, V73, P1454, DOI 10.1158/0008-5472.CAN-12-0928; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Janssen A, 2013, ONCOGENE, V32, P4459, DOI 10.1038/onc.2012.576; Jasmine F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031968; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Kakar S, 2008, ARCH PATHOL LAB MED, V132, P958, DOI 10.1043/1543-2165(2008)132[958:CCCIMP]2.0.CO;2; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TM, 2013, GENOME RES, V23, P217, DOI 10.1101/gr.140301.112; Knez K, 2012, SMALL, V8, P868, DOI 10.1002/smll.201102209; Koinuma K, 2004, INT J CANCER, V108, P237, DOI 10.1002/ijc.11523; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Kozlowska J, 2012, TUMOR BIOL, V33, P1015, DOI 10.1007/s13277-012-0334-2; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; LOTHE RA, 1993, CANCER RES, V53, P5849; Martinez C, 2010, CELL CYCLE, V9, P2275, DOI 10.4161/cc.9.12.11865; Melcher R, 2011, CARCINOGENESIS, V32, P636, DOI 10.1093/carcin/bgr011; Mosesso P, MUTAT RES, V701, P86; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nancarrow DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001093; Nancarrow DJ, 2008, CANCER RES, V68, P4163, DOI 10.1158/0008-5472.CAN-07-6710; Obe G, 2010, CYTOGENET GENOME RES, V128, P8, DOI 10.1159/000303328; Ogino S, 2011, CLIN CANC RES; Ogino S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-72; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Roylance R, 2006, ONCOGENE, V25, P6544, DOI 10.1038/sj.onc.1209659; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Sawada T, 2013, GENE CHROMOSOME CANC, V52, P140, DOI 10.1002/gcc.22013; Sinicrope FA, 2006, GASTROENTEROLOGY, V131, P729, DOI 10.1053/j.gastro.2006.06.005; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; Thompson SL, 2011, CHROMOSOME RES, V19, P433, DOI 10.1007/s10577-010-9179-y; Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200; Walther A, 2008, GUT, V57, P941, DOI 10.1136/gut.2007.135004; Watanabe T, 2012, J CLIN ONCOL; Weaver BA, 2008, CANCER CELL, V14, P431, DOI 10.1016/j.ccr.2008.11.011; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Whitehall VLJ, 2012, INT J CANCER, V131, P813, DOI 10.1002/ijc.26440; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Xie T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042001, 10.1371/journal.pone.0047577]	62	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91739	10.1371/journal.pone.0091739	http://dx.doi.org/10.1371/journal.pone.0091739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651849	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800047
J	Moutai, T; Yamana, H; Nojima, T; Kitamura, D				Moutai, Tatsuya; Yamana, Hideyuki; Nojima, Takuya; Kitamura, Daisuke			A Novel and Effective Cancer Immunotherapy Mouse Model Using Antigen-Specific B Cells Selected In Vitro	PLOS ONE			English	Article							GERMINAL CENTER SELECTION; MONOCLONAL-ANTIBODIES; MEMORY B; THERAPEUTIC ANTIBODIES; APOPTOSIS; ISOTYPE	Immunotherapies such as adoptive transfer of T cells or natural killer cells, or monoclonal antibody (MoAb) treatment have recently been recognized as effective means to treat cancer patients. However, adoptive transfer of B cells or plasma cells producing tumor-specific antibodies has not been applied as a therapy because long-term culture and selective expansion of antigen-specific B cells has been technically very difficult. Here, we describe a novel cancer immunotherapy that uses B-cell adoptive transfer. We demonstrate that germinal-center-like B cells (iGB cells) induced in vitro from mouse naive B cells become plasma cells and produce IgG antibodies for more than a month in the bone marrow of non-irradiated recipient mice. When transferred into mice, iGB cells producing antibody against a surrogate tumor antigen suppressed lung metastasis and growth of mouse melanoma cells expressing the same antigen and prolonged survival of the recipients. In addition, we have developed a novel culture system called FAIS to selectively expand antigen-specific iGB cells utilizing the fact that iGB cells are sensitive to Fas-induced cell death unless their antigen receptors are ligated by membrane-bound antigens. The selected iGB cells efficiently suppressed lung metastasis of melanoma cells in the adoptive immunotherapy model. As human blood B cells can be propagated as iGB cells using culture conditions similar to the mouse iGB cell cultures, our data suggest that it will be possible to treat cancer-bearing patients by the adoptive transfer of cancer-antigen-specific iGB cells selected in vitro. This new adoptive immunotherapy should be an alternative to the laborious development of MoAb drugs against cancers for which no effective treatments currently exist.	[Moutai, Tatsuya; Yamana, Hideyuki; Nojima, Takuya; Kitamura, Daisuke] Tokyo Univ Sci, Div Mol Biol, Res Inst Biomed Sci RIBS, Noda, Chiba 278, Japan	Tokyo University of Science	Kitamura, D (corresponding author), Tokyo Univ Sci, Div Mol Biol, Res Inst Biomed Sci RIBS, Noda, Chiba 278, Japan.	kitamura@rs.noda.tus.ac.jp			Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS) [22390097]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [22021042]; Grants-in-Aid for Scientific Research [12J08179] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Takeda Science Foundation, Grants-in-Aid for Scientific Research (B) (22390097) from Japan Society for the Promotion of Science (JSPS) and Grants-in-Aid for Scientific Research on Priority Areas (22021042) from The Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (to DK), and by Grants-in-Aid for JSPS Fellows (to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Becker P. D., 2010, PLOS ONE, V5; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; DENKERS EY, 1985, J IMMUNOL, V135, P2183; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HERLYN D, 1982, P NATL ACAD SCI-BIOL, V79, P4761, DOI 10.1073/pnas.79.15.4761; HU F, 1964, CANCER RES, V24, P1634; Iannello A, 2005, CANCER METAST REV, V24, P487, DOI 10.1007/s10555-005-6192-2; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; KAMINSKI MS, 1986, J IMMUNOL, V136, P1123; Klee GG, 2000, ARCH PATHOL LAB MED, V124, P921; Kubota T, 2009, CANCER SCI, V100, P1566, DOI 10.1111/j.1349-7006.2009.01222.x; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lee S, 2012, CURR ONCOL REP, V14, P468, DOI 10.1007/s11912-012-0257-5; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Oda M, 2010, ARCH BIOCHEM BIOPHYS, V494, P145, DOI 10.1016/j.abb.2009.11.024; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; Schadendorf D, 2009, ANN ONCOL, V20, P41, DOI 10.1093/annonc/mdp253; Scheeren FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017189; Scott Andrew M, 2012, Cancer Immun, V12, P14; SETO M, 1983, CANCER RES, V43, P4768; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744	36	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92732	10.1371/journal.pone.0092732	http://dx.doi.org/10.1371/journal.pone.0092732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647439	Green Submitted, gold, Green Published			2022-12-27	WOS:000333348500153
J	Muller, PA; Dhamne, SC; Vahabzadeh-Hagh, AM; Pascual-Leone, A; Jensen, FE; Rotenberg, A				Muller, Paul A.; Dhamne, Sameer C.; Vahabzadeh-Hagh, Andrew M.; Pascual-Leone, Alvaro; Jensen, Frances E.; Rotenberg, Alexander			Suppression of Motor Cortical Excitability in Anesthetized Rats by Low Frequency Repetitive Transcranial Magnetic Stimulation	PLOS ONE			English	Article							LONG-TERM DEPRESSION; VALERIC ACID APV; CORTICOSPINAL EXCITABILITY; CORTEX EXCITABILITY; STATUS EPILEPTICUS; NMDA RECEPTORS; ELECTRIC-FIELD; MODULATION; INHIBITION; RTMS	Repetitive transcranial magnetic stimulation (rTMS) is a widely-used method for modulating cortical excitability in humans, by mechanisms thought to involve use-dependent synaptic plasticity. For example, when low frequency rTMS (LF rTMS) is applied over the motor cortex, in humans, it predictably leads to a suppression of the motor evoked potential (MEP), presumably reflecting long-term depression (LTD) - like mechanisms. Yet how closely such rTMS effects actually match LTD is unknown. We therefore sought to (1) reproduce cortico-spinal depression by LF rTMS in rats, (2) establish a reliable animal model for rTMS effects that may enable mechanistic studies, and (3) test whether LTD-like properties are evident in the rat LF rTMS setup. Lateralized MEPs were obtained from anesthetized Long-Evans rats. To test frequency-dependence of LF rTMS, rats underwent rTMS at one of three frequencies, 0.25, 0.5, or 1 Hz. We next tested the dependence of rTMS effects on N-methyl-D-aspartate glutamate receptor (NMDAR), by application of two NMDAR antagonists. We find that 1 Hz rTMS preferentially depresses unilateral MEP in rats, and that this LTD-like effect is blocked by NMDAR antagonists. These are the first electrophysiological data showing depression of cortical excitability following LF rTMS in rats, and the first to demonstrate dependence of this form of cortical plasticity on the NMDAR. We also note that our report is the first to show that the capacity for LTD-type cortical suppression by rTMS is present under barbiturate anesthesia, suggesting that future neuromodulatory rTMS applications under anesthesia may be considered.	[Muller, Paul A.; Dhamne, Sameer C.; Vahabzadeh-Hagh, Andrew M.; Rotenberg, Alexander] Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA; [Vahabzadeh-Hagh, Andrew M.; Pascual-Leone, Alvaro; Rotenberg, Alexander] Harvard Univ, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Pascual-Leone, Alvaro] Univ Autonoma Barcelona, Inst Univ Neurorehabilitacio Guttmann, Badalona, Spain; [Jensen, Frances E.] Univ Penn Hlth Syst, Perelman Sch Med, Dept Neurol, Philadelphia, PA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Autonomous University of Barcelona; University of Pennsylvania; Pennsylvania Medicine	Rotenberg, A (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA.	alexander.rotenberg@childrens.harvard.edu	Pascual-Leone, Alvaro/AAC-5101-2019	Pascual-Leone, Alvaro/0000-0001-8975-0382; Muller, Paul/0000-0002-1957-4763	Boston Children's Hospital Translational Research Program; NIH [K08 NS055895, 5R01NS031718]; IDDRC [P30-HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS055895, R01NS031718] Funding Source: NIH RePORTER	Boston Children's Hospital Translational Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IDDRC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Boston Children's Hospital Translational Research Program (AR), NIH K08 NS055895 (AR), NIH 5R01NS031718 (FEJ), IDDRC P30-HD18655 (AR, FEJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin-Abidin S, 2008, EXP BRAIN RES, V188, P249, DOI 10.1007/s00221-008-1356-2; Benali A, 2011, J NEUROSCI, V31, P1193, DOI 10.1523/JNEUROSCI.1379-10.2011; Bouras R, 2003, HIPPOCAMPUS, V13, P780, DOI 10.1002/hipo.10124; Brasil-Neto JP, 2004, ARQ NEURO-PSIQUIAT, V62, P21, DOI 10.1590/S0004-282X2004000100004; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Cincotta M, 2003, CLIN NEUROPHYSIOL, V114, P1827, DOI 10.1016/S1388-2457(03)00181-0; de Olmos S, 2009, NEUROSCIENCE, V164, P1347, DOI 10.1016/j.neuroscience.2009.09.022; Dragasevic N, 2002, MOVEMENT DISORD, V17, P528, DOI 10.1002/mds.10109; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Fitzgerald PB, 2005, NEUROREPORT, V16, P1525, DOI 10.1097/01.wnr.0000177005.14108.f1; Fregni Felipe, 2005, Curr Psychiatry Rep, V7, P381, DOI 10.1007/s11920-005-0041-4; Funke K, 2011, J PHYSIOL-LONDON, V589, P4423, DOI 10.1113/jphysiol.2011.206573; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Ghiglieri V, 2012, EXP NEUROL, V236, P395, DOI 10.1016/j.expneurol.2012.04.020; Guerrini L, 1997, J NEUROSCI, V17, P6057; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Kent S, 1996, DEV BRAIN RES, V94, P1, DOI 10.1016/0165-3806(96)00023-5; Khedr EM, 2007, CLIN NEUROPHYSIOL, V118, P140, DOI 10.1016/j.clinph.2006.09.006; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Kobayashi M, 2010, RESTOR NEUROL NEUROS, V28, P437, DOI 10.3233/RNN-2010-0562; Kourrich S., 2008, NEURAL PLAST, V2008; Lai MC, 2009, PEDIATR RES, V66, P441, DOI 10.1203/PDR.0b013e3181b337d2; Lee SL, 2008, OTOLARYNG HEAD NECK, V138, P398, DOI 10.1016/j.otohns.2007.11.035; Liu AL, 2013, SEIZURE-EUR J EPILEP, V22, P893, DOI 10.1016/j.seizure.2013.06.014; LOEB C, 1990, EPILEPSY RES, V6, P249, DOI 10.1016/0920-1211(90)90080-F; Loeb C, 1993, Seizure, V2, P309, DOI 10.1016/S1059-1311(05)80146-3; Maeda F, 2000, CLIN NEUROPHYSIOL, V111, P800, DOI 10.1016/S1388-2457(99)00323-5; ManahanVaughan D, 1997, J NEUROSCI, V17, P3303; McGuire M, 2008, J APPL PHYSIOL, V105, P942, DOI 10.1152/japplphysiol.01274.2006; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; Muller PA, 2012, BRAIN STIMUL, V5, P320, DOI 10.1016/j.brs.2011.05.003; Nakano M, 2004, EUR J NEUROSCI, V19, P2881, DOI 10.1111/j.0953-816X.2004.03390.x; Padberg F, 2009, EXP NEUROL, V219, P2, DOI 10.1016/j.expneurol.2009.04.020; Patrizi F, 2006, THESCIENTIFICWORLDJO, V6, P472, DOI 10.1100/tsw.2006.98; Peinemann A, 2004, CLIN NEUROPHYSIOL, V115, P1519, DOI 10.1016/j.clinph.2004.02.005; Pell GS, 2011, PROG NEUROBIOL, V93, P59, DOI 10.1016/j.pneurobio.2010.10.003; Rizzo V, 2004, J PHYSIOL-LONDON, V554, P483, DOI 10.1113/jphysiol.2003.048777; Rodriguez-Moreno A, 2008, NAT NEUROSCI, V11, P744, DOI 10.1038/nn.2125; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Rosen AC, 2009, CURR PAIN HEADACHE R, V13, P12, DOI 10.1007/s11916-009-0004-2; Rotenberg A, 2010, CLIN NEUROPHYSIOL, V121, P104, DOI 10.1016/j.clinph.2009.09.008; Rotenberg A, 2010, BRAIN TOPOGR, V22, P257, DOI 10.1007/s10548-009-0116-3; Rotenberg A, 2009, EPILEPSY BEHAV, V14, P253, DOI 10.1016/j.yebeh.2008.09.007; Rotenberg A, 2008, CLIN NEUROPHYSIOL, V119, P2697, DOI 10.1016/j.clinph.2008.09.003; Siegelbaum S A, 1991, Curr Opin Neurobiol, V1, P113, DOI 10.1016/0959-4388(91)90018-3; Sokhadze EM, 2009, J AUTISM DEV DISORD, V39, P619, DOI 10.1007/s10803-008-0662-7; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Sun W, 2012, EPILEPSIA, V53, P1782, DOI 10.1111/j.1528-1167.2012.03626.x; Thordstein M, 2012, EPILEPSY BEHAV, V25, P468, DOI 10.1016/j.yebeh.2012.07.026; Ting JT, 2013, BEHAV BRAIN RES, V255, P3, DOI 10.1016/j.bbr.2013.02.037; TOFTS PS, 1991, ELECTROEN CLIN NEURO, V81, P238, DOI 10.1016/0168-5597(91)90077-B; Tostes JG, 2013, NEUROSCIENCE, V255, P212, DOI 10.1016/j.neuroscience.2013.09.064; Vahabzadeh-Hagh AM, 2012, NEUROMODULATION, V15, P296, DOI 10.1111/j.1525-1403.2012.00482.x; Vahabzadeh-Hagh AM, 2011, J NEUROPHYSIOL, V105, P615, DOI 10.1152/jn.00660.2010; Wang F, 2010, J MOL NEUROSCI, V41, P145, DOI 10.1007/s12031-009-9311-7; Wankerl K, 2010, J NEUROSCI, V30, P6197, DOI 10.1523/JNEUROSCI.4673-09.2010; Watanabe K, 2007, BRAIN RES, V1166, P20, DOI 10.1016/j.brainres.2007.06.049; WHISHAW IQ, 1977, PHYSIOL BEHAV, V19, P719, DOI 10.1016/0031-9384(77)90304-3; Wohrl R, 2007, EUR J NEUROSCI, V25, P251, DOI 10.1111/j.1460-9568.2006.05274.x; Zheng JB, 2005, P ANN INT IEEE EMBS, P1529	63	48	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91065	10.1371/journal.pone.0091065	http://dx.doi.org/10.1371/journal.pone.0091065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646791	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500021
J	Richards, M; Phoon, CW; Goh, GTW; Seng, EK; Guo, XM; Tan, CMF; Chan, WK; Lee, JMK				Richards, Mark; Phoon, Chee Wee; Goh, Gwendoline Tze Wei; Seng, Eng Khuan; Guo, Xu Ming; Tan, Cherine Mei Fong; Chan, Woon-Khiong; Lee, Joel Mun Kin			A New Class of Pluripotent Stem Cell Cytotoxic Small Molecules	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; REGENERATIVE MEDICINE; TERATOMA FORMATION; SUICIDE GENE; TUMORIGENICITY; ANTIBODY; STRESS	A major concern in Pluripotent Stem Cell (PSC)-derived cell replacement therapy is the risk of teratoma formation from contaminating undifferentiated cells. Removal of undifferentiated cells from differentiated cultures is an essential step before PSC-based cell therapies can be safely deployed in a clinical setting. We report a group of novel small molecules that are cytotoxic to PSCs. Our data indicates that these molecules are specific and potent in their activity allowing rapid eradication of undifferentiated cells. Experiments utilizing mixed PSC and primary human neuronal and cardiomyocyte cultures demonstrate that up to a 6-fold enrichment for specialized cells can be obtained without adversely affecting cell viability and function. Several structural variants were synthesized to identify key functional groups and to improve specificity and efficacy. Comparative microarray analysis and ensuing RNA knockdown studies revealed involvement of the PERK/ATF4/DDIT3 ER stress pathway. Surprisingly, cell death following ER stress induction was associated with a concomitant decrease in endogenous ROS levels in PSCs. Undifferentiated cells treated with these molecules preceding transplantation fail to form teratomas in SCID mice. Furthermore, these molecules remain non-toxic and non-teratogenic to zebrafish embryos suggesting that they may be safely used in vivo.	[Richards, Mark; Phoon, Chee Wee; Seng, Eng Khuan; Guo, Xu Ming; Tan, Cherine Mei Fong; Lee, Joel Mun Kin] Nanyang Polytech, Sch Chem & Life Sci, Singapore, Singapore; [Goh, Gwendoline Tze Wei] Singapore Eye Res Inst, Singapore, Singapore; [Chan, Woon-Khiong] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Lee, Joel Mun Kin] Newcastle Univ, Food & Human Nutr Programme Singapore, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Nanyang Polytechnic; National University of Singapore; Singapore National Eye Center; National University of Singapore; Newcastle University - UK	Richards, M (corresponding author), Nanyang Polytech, Sch Chem & Life Sci, Singapore, Singapore.	mark_richards@nyp.gov.sg; dbscwk@nus.edu.sg	Khiong, Chan Woon/A-8064-2008	Khiong, Chan Woon/0000-0001-7395-7506; Seng, Eng Khuan/0000-0001-9980-6431	Singapore Ministry of Education Innovation Fund [MOE IF-2008-1-043]	Singapore Ministry of Education Innovation Fund(Ministry of Education, Singapore)	This research was supported by the Singapore Ministry of Education Innovation Fund grant MOE IF-2008-1-043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021076; Ben-David U, 2013, CELL STEM CELL, V12, P167, DOI 10.1016/j.stem.2012.11.015; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Bongso A, 2008, J CELL BIOCHEM, V105, P1352, DOI 10.1002/jcb.21957; Cheng FY, 2012, BIOMATERIALS, V33, P3195, DOI 10.1016/j.biomaterials.2012.01.023; Fong CY, 2009, STEM CELL REV REP, V5, P72, DOI 10.1007/s12015-009-9054-4; Fong CY, 2010, J CELL BIOCHEM, V111, P769, DOI 10.1002/jcb.22775; Fu X, 2011, REGEN MED, V6, P327, DOI [10.2217/RME.11.18, 10.2217/rme.11.18]; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; Geens M, 2007, HUM REPROD, V22, P733, DOI 10.1093/humrep/del418; Gropp M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045532; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Jung YJ, 2012, STEM CELLS, V30, P42, DOI 10.1002/stem.727; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Scadden David, 2012, Cell Stem Cell, V10, P149, DOI 10.1016/j.stem.2012.01.010; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tan HL, 2009, STEM CELLS, V27, P1792, DOI 10.1002/stem.109; Tang C, 2011, SEMIN IMMUNOPATHOL, V33, P563, DOI 10.1007/s00281-011-0269-5; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497	26	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e85039	10.1371/journal.pone.0085039	http://dx.doi.org/10.1371/journal.pone.0085039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647085	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500002
J	Tougard, C; Folly, J; Berrebi, P				Tougard, Christelle; Folly, Joy; Berrebi, Patrick			New Light on the Evolutionary History of the Common Goby (Pomatoschistus microps) with an Emphasis on Colonization Processes in the Mediterranean Sea	PLOS ONE			English	Article							POPULATION-GROWTH; DIFFERENTIAL DISTRIBUTION; HOLOCENE EVOLUTION; DNA-SEQUENCES; P-MARMORATUS; GENE FLOW; PHYLOGEOGRAPHY; TELEOSTEI; LAGOON; REGION	Through the study of the phylogeographic structure and demographic history of the common goby, Pomatoschistus microps, the influence of Quaternary climatic changes on the evolutionary history of coastal and marine fishes is investigated. Because of its sedentary life cycle in Mediterranean lagoons, it is also a good model to study more specifically if the formation of lagoons during the Holocene had an impact on population structure and demography. Mitochondrial sequences of Northeastern Atlantic and Western Mediterranean specimens were used for phylogenetic reconstructions as well as divergence time estimates, demographic history and population structure analyses. Pomatoschistus microps was a highly supported monophyletic clade including four lineages. It may have appeared 77,000 yr ago, and the divergence of its lineages likely occured shortly thereafter (between 61,000 and 54,000 yr). Most lineages had polytomic topologies, low nucleotide diversity and demographic analyses providing evidence of population expansion. Each lineage was characterized by a large number of private haplotypes. Most haplotypes found in Mediterranean localities were endemic, and one was dominant. Complex reticulated relationships connecting North European, Atlantic and Mediterranean haplotypes were observed. Moderate to high population structure was underlined. Contrary to previous published studies, no significant differentiation was observed between Atlantic and Mediterranean populations, indicating that the Gibraltar Strait is not a phylogeographic break for P. microps. Indeed, molecular dating combined with the tree topologies, phylogeographic and demographic analyses as well as high haplotype diversity underline a recent and rapid population divergence during the last glacial. However, population structure indicates that differentiation is an ongoing process. From an ancestral population trapped in the Atlantic, this goby colonized first northern Europe and later the Mediterranean Sea. Shared haplotypes could have dispersed in the western Mediterranean basin before the lagoon formation, while most private haplotypes, evidencing a recent isolation, probably diverged in lagoons after their closure.	[Tougard, Christelle; Folly, Joy; Berrebi, Patrick] CNRS, UMR 5554, Inst Sci Evolut Montpellier, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Tougard, C (corresponding author), CNRS, UMR 5554, Inst Sci Evolut Montpellier, Montpellier, France.	Christelle.Tougard@univ-montp2.fr			French Government (CNRS); French Government (UM2)	French Government (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French Government (UM2)	This work was funded by the French Government (CNRS and UM2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARKHIPOV SA, 1995, BOREAS, V24, P196; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bargelloni L, 2005, MOL PHYLOGENET EVOL, V36, P523, DOI 10.1016/j.ympev.2005.04.017; Bargelloni L, 2003, J EVOLUTION BIOL, V16, P1149, DOI 10.1046/j.1420-9101.2003.00620.x; Bennett KD, 2008, QUATERNARY SCI REV, V27, P2449, DOI 10.1016/j.quascirev.2008.08.019; Berrebi P, 2005, ESTUAR COAST SHELF S, V65, P708, DOI 10.1016/j.ecss.2005.07.008; Berrebi P, 2009, FOLIA ZOOL, V58, P123; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Boissin E, 2011, BIOL J LINN SOC, V102, P175, DOI 10.1111/j.1095-8312.2010.01565.x; Bouchereau JL, 1998, OCEANOL ACTA, V21, P503, DOI 10.1016/S0399-1784(98)80034-0; Boudouresque C.-F, 2004, TRAV SCI PARC NATL P, V20, P97; Cavazza W, 2003, EPISODES, V26, P160, DOI 10.18814/epiiugs/2003/v26i3/002; COLL M, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0011842; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Demboski JR, 2001, MOL ECOL, V10, P1227, DOI 10.1046/j.1365-294X.2001.01260.x; Durand JD, 2012, MOL PHYLOGENET EVOL, V64, P73, DOI 10.1016/j.ympev.2012.03.006; Emeis KC, 2000, PALAEOGEOGR PALAEOCL, V158, P259, DOI 10.1016/S0031-0182(00)00053-5; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Garcia CF, 2012, J COASTAL RES, V28, P1617, DOI 10.2112/JCOASTRES-D-11-00007.1; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Frigola J, 2008, QUATERN INT, V181, P88, DOI 10.1016/j.quaint.2007.06.016; Fu YX, 1997, GENETICS, V147, P915; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gysels ES, 2004, BIOL J LINN SOC, V83, P561, DOI 10.1111/j.1095-8312.2004.00411.x; Gysels ES, 2004, MOL ECOL, V13, P403, DOI 10.1046/j.1365-294X.2003.02087.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HEALEY MC, 1972, J NAT HIST, V6, P133, DOI 10.1080/00222937200770121; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; HSU KJ, 1973, NATURE, V242, P240, DOI 10.1038/242240a0; Huyse T, 2004, MOL PHYLOGENET EVOL, V32, P324, DOI 10.1016/j.ympev.2003.11.007; JONES D., 1966, HYDROBIOLOGIA, V27, P515, DOI 10.1007/BF00042710; Karanth KP, 2003, CURR SCI INDIA, V85, P1276; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Krijgsman W, 2002, EARTH PLANET SC LETT, V205, P1, DOI 10.1016/S0012-821X(02)01008-7; Lambeck K, 2000, EARTH PLANET SC LETT, V175, P203, DOI 10.1016/S0012-821X(99)00289-7; Landini W, 2005, QUATERN INT, V140, P64, DOI 10.1016/j.quaint.2005.05.019; Larmuseau MHD, 2009, J BIOGEOGR, V36, P1138, DOI 10.1111/j.1365-2699.2008.02072.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lucchi MR, 2006, SEDIMENT GEOL, V183, P1, DOI 10.1016/j.sedgeo.2005.09.003; Mazzini I, 1999, MAR MICROPALEONTOL, V37, P289, DOI 10.1016/S0377-8398(99)00023-7; Mejri R, 2011, MOL PHYLOGENET EVOL, V58, P395, DOI 10.1016/j.ympev.2010.12.001; Mejri R, 2009, MOL PHYLOGENET EVOL, V53, P596, DOI 10.1016/j.ympev.2009.04.018; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Miller P.J., 1986, P1019; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nylander JAA., 2004, BIOINFORMATICS; Pampoulie C, 1999, THESIS U MONTPELLIER; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poulos SE, 2009, Z GEOMORPHOL, V53, P151, DOI 10.1127/0372-8854/2009/0053S1-0151; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Raynal O, 2010, B SOC GEOL FR, V181, P211, DOI 10.2113/gssgfbull.181.2.211; Rigal F, 2008, SCI MAR, V72, P469; Robinson-Rechavi M, 2000, BIOINFORMATICS, V16, P296, DOI 10.1093/bioinformatics/16.3.296; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rouchy JM, 2006, SEDIMENT GEOL, V188, P35, DOI 10.1016/j.sedgeo.2006.02.005; Sabatier P, 2010, B SOC GEOL FR, V181, P27, DOI 10.2113/gssgfbull.181.1.27; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Simonovic PD, 1999, J FISH BIOL, V54, P533; SLATKIN M, 1991, GENETICS, V129, P555; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang QY, 2006, MOL PHYLOGENET EVOL, V39, P347, DOI 10.1016/j.ympev.2005.08.007; Vanhove MPM, 2012, BIOL J LINN SOC, V105, P73, DOI 10.1111/j.1095-8312.2011.01781.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WILSON RCL, 2000, GREAT ICE AGE CLIMAT; YANG ZB, 1994, J MOL EVOL, V39, P105; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389	79	11	11	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91576	10.1371/journal.pone.0091576	http://dx.doi.org/10.1371/journal.pone.0091576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646724	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500040
J	Ward, BK; Tan, GXJ; Roberts, DC; Della Santina, CC; Zee, DS; Carey, JP				Ward, Bryan K.; Tan, Grace X-J; Roberts, Dale C.; Della Santina, Charles C.; Zee, David S.; Carey, John P.			Strong Static Magnetic Fields Elicit Swimming Behaviors Consistent with Direct Vestibular Stimulation in Adult Zebrafish	PLOS ONE			English	Article							VESTIBULOOCULAR REFLEX; LATERAL-LINE; VERTEBRATE MAGNETORECEPTOR; VELOCITY STORAGE; INNER-EAR; FISH; GENTAMICIN; QUANTIFICATION; NEUROBIOLOGY; CHINCHILLA	Zebrafish (Danio rerio) offer advantages as model animals for studies of inner ear development, genetics and ototoxicity. However, traditional assessment of vestibular function in this species using the vestibulo-ocular reflex requires agar-immobilization of individual fish and specialized video, which are difficult and labor-intensive. We report that using a static magnetic field to directly stimulate the zebrafish labyrinth results in an efficient, quantitative behavioral assay in free-swimming fish. We recently observed that humans have sustained nystagmus in high strength magnetic fields, and we attributed this observation to magnetohydrodynamic forces acting on the labyrinths. Here, fish were individually introduced into the center of a vertical 11.7T magnetic field bore for 2-minute intervals, and their movements were tracked. To assess for heading preference relative to a magnetic field, fish were also placed in a horizontally oriented 4.7T magnet in infrared (IR) light. A sub-population was tested again in the magnet after gentamicin bath to ablate lateral line hair cell function. Free-swimming adult zebrafish exhibited markedly altered swimming behavior while in strong static magnetic fields, independent of vision or lateral line function. Two-thirds of fish showed increased swimming velocity or consistent looping/rolling behavior throughout exposure to a strong, vertically oriented magnetic field. Fish also demonstrated altered swimming behavior in a strong horizontally oriented field, demonstrating in most cases preferred swimming direction with respect to the field. These findings could be adapted for 'high-throughput' investigations of the effects of environmental manipulations as well as for changes that occur during development on vestibular function in zebrafish.	[Ward, Bryan K.; Della Santina, Charles C.; Zee, David S.; Carey, John P.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Roberts, Dale C.; Zee, David S.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Tan, Grace X-J] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Della Santina, Charles C.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Zee, David S.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Zee, David S.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ward, BK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	bward15@jhmi.edu	Ward, Bryan/AAM-7721-2020; Ward, Bryan/M-2306-2018	Ward, Bryan/0000-0001-5201-6117; Tan, Grace/0000-0002-7606-193X	NIDCD [T32DC0000027]; Zebrafish International Resource Center (ZIRC); NIH-NCRR [P40 RR012546]; Johns Hopkins Center for Hearing and Balance histology core [P30 DC005211];  [R21DC011919]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005211, R21DC011919, T32DC000027] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Zebrafish International Resource Center (ZIRC); NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Johns Hopkins Center for Hearing and Balance histology core; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was made possible by R21DC011919 and salary support for BW from NIDCD T32DC0000027. The authors would like to especially thank contributors to the Vestibular NeuroEngineering Lab Research Fund, the Lloyd B. Minor Vestibular Research Fund, and the Cinquegrana Fund. Additional support was provided by the Zebrafish International Resource Center (ZIRC), which is supported by the NIH-NCRR P40 RR012546 and the Johns Hopkins Center for Hearing and Balance histology core P30 DC005211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anken RH, 1998, ADV SPACE RES-SERIES, V22, P277, DOI 10.1016/S0273-1177(98)80020-3; BARLOW HB, 1947, AM J PHYSIOL, V148, P372, DOI 10.1152/ajplegacy.1947.148.2.372; Beck JC, 2004, J NEUROPHYSIOL, V92, P3546, DOI 10.1152/jn.00311.2004; Bianco IH, 2012, CURR BIOL, V22, P1285, DOI 10.1016/j.cub.2012.05.026; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Chen CC, 2013, J PHYSL; Diebel CE, 2000, NATURE, V406, P299, DOI 10.1038/35018561; Eder SHK, 2012, P NATL ACAD SCI USA, V109, P12022, DOI 10.1073/pnas.1205653109; EMRAN F, 2008, J VIS EXP; Faucher K, 2008, HEARING RES, V240, P12, DOI 10.1016/j.heares.2008.03.007; Glover PM, 2007, BIOELECTROMAGNETICS, V28, P349, DOI 10.1002/bem.20316; Hirvonen TP, 2005, J NEUROPHYSIOL, V93, P643, DOI 10.1152/jn.00160.2004; Houpt TA, 2013, AM J PHYSL REGUL INT; Houpt TA, 2012, PHYSIOL BEHAV, V105, P388, DOI 10.1016/j.physbeh.2011.08.030; Ijiri K, 2000, ADV SPACE RES-SERIES, V25, P1997, DOI 10.1016/S0273-1177(99)01005-4; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; KATZ E, 1991, EXP BRAIN RES, V87, P505, DOI 10.1007/BF00227076; Lopez I, 1997, INT J DEV NEUROSCI, V15, P447, DOI 10.1016/S0736-5748(96)00103-7; Mo W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-110; Montgomery JC, 1997, NATURE, V389, P960, DOI 10.1038/40135; Moore A, 2009, J FISH BIOL, V74, P1629, DOI 10.1111/j.1095-8649.2009.02197.x; MOORE A, 1990, PHILOS T ROY SOC B, V329, P11, DOI 10.1098/rstb.1990.0145; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; PASTOR AM, 1992, J NEUROPHYSIOL, V68, P2003, DOI 10.1152/jn.1992.68.6.2003; Rahmann H, 2000, ADV SPACE RES-SERIES, V25, P1985, DOI 10.1016/S0273-1177(99)01007-8; RAPHAN T, 1979, EXP BRAIN RES, V35, P229; Roberts DC, 2011, CURR BIOL; ROBINSON DA, 1977, EXP BRAIN RES, V30, P447; Schonleber J, 2004, ADV SPACE RES-SERIES, V33, P1416, DOI 10.1016/j.asr.2003.12.006; Shcherbakov D, 2005, CURR BIOL, V15, pR161, DOI 10.1016/j.cub.2005.02.039; Takebe A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00727; Van Trump WJ, 2010, HEARING RES, V261, P42, DOI 10.1016/j.heares.2010.01.001; von Baumgarten R J, 1979, Life Sci Space Res, V17, P161; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wilson JM, 2009, J AM ASSOC LAB ANIM, V48, P785; Wu LQ, 2012, SCIENCE, V336, P1054, DOI 10.1126/science.1216567; Wu LQ, 2011, CURR BIOL, V21, P418, DOI 10.1016/j.cub.2011.01.058	38	20	22	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92109	10.1371/journal.pone.0092109	http://dx.doi.org/10.1371/journal.pone.0092109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647586	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500086
J	Wen, B; Combes, V; Bonhoure, A; Weksler, BB; Couraud, PO; Grau, GER				Wen, Beryl; Combes, Valery; Bonhoure, Amandine; Weksler, Babette B.; Couraud, Pierre-Olivier; Grau, Georges E. R.			Endotoxin-Induced Monocytic Microparticles Have Contrasting Effects on Endothelial Inflammatory Responses	PLOS ONE			English	Article							CIRCULATING MICROPARTICLES; PROCOAGULANT ACTIVITY; VASCULAR HOMEOSTASIS; ADHESION MOLECULES; SEPTIC SHOCK; VE-CADHERIN; SEPSIS; CELLS; PERMEABILITY; CYTOKINES	Septic shock is a severe disease state characterised by the body's life threatening response to infection. Complex interactions between endothelial cells and circulating monocytes are responsible for microvasculature dysfunction contributing to the pathogenesis of this syndrome. Here, we intended to determine whether microparticles derived from activated monocytes contribute towards inflammatory processes and notably vascular permeability. We found that endotoxin stimulation of human monocytes enhances the release of microparticles of varying phenotypes and mRNA contents. Elevated numbers of LPS-induced monocytic microparticles (mMP) expressed CD54 and contained higher levels of transcripts for pro-inflammatory cytokines such as TNF, IL-6 and IL-8. Using a prothrombin time assay, a greater reduction in plasma coagulation time was observed with LPS-induced mMP than with non-stimulated mMP. Co-incubation of mMP with the human brain endothelial cell line hCMEC/D3 triggered their time-dependent uptake and significantly enhanced endothelial microparticle release. Unexpectedly, mMP also modified signalling pathways by diminishing pSrc (tyr416) expression and promoted endothelial monolayer tightness, as demonstrated by endothelial impedance and permeability assays. Altogether, these data strongly suggest that LPS-induced mMP have contrasting effects on the intercellular communication network and display a dual potential: enhanced pro-inflammatory and procoagulant properties, together with protective function of the endothelium.	[Wen, Beryl; Combes, Valery; Bonhoure, Amandine; Grau, Georges E. R.] Univ Sydney, Sydney Med Sch, Vasc Immunol Unit, Camperdown, NSW, Australia; [Wen, Beryl; Combes, Valery; Bonhoure, Amandine; Grau, Georges E. R.] Univ Sydney, Bosch Inst, Camperdown, NSW, Australia; [Weksler, Babette B.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Couraud, Pierre-Olivier] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Couraud, Pierre-Olivier] CNRS, UMR 8104, Paris, France; [Couraud, Pierre-Olivier] Univ Paris 05, Sorbonne Paris Cite, Paris, France	University of Sydney; University of Sydney; Cornell University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Wen, B (corresponding author), Univ Sydney, Sydney Med Sch, Vasc Immunol Unit, Camperdown, NSW, Australia.	beryl.wen@sydney.edu.au	Grau, Georges/AGR-7139-2022	Grau, Georges/0000-0002-0442-0462; Combes, Valery/0000-0003-2178-3596	National Health Medical Research Council [570771, 571014, 1009914, 1028241]; Rebecca L. Cooper Medical Research Foundation; University of Sydney; Al Kerr Bequest, Sydney Medical School	National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Medical Research Foundation; University of Sydney(University of Sydney); Al Kerr Bequest, Sydney Medical School	This work was supported by grants from the National Health Medical Research Council # 570771, 571014, 1009914, 1028241 and the Rebecca L. Cooper Medical Research Foundation. The support of the University of Sydney Bridging Support Grant and funding from the Al Kerr Bequest, Sydney Medical School is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Amabile N, 2008, AM J RESP CRIT CARE, V177, P1268, DOI 10.1164/rccm.200710-1458OC; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Bernimoulin M, 2009, J THROMB HAEMOST, V7, P1019, DOI 10.1111/j.1538-7836.2009.03434.x; Borrelli E, 1996, CRIT CARE MED, V24, P392, DOI 10.1097/00003246-199603000-00006; Bozza FA, 2010, J CEREBR BLOOD F MET, V30, P440, DOI 10.1038/jcbfm.2009.215; Brown GT, 2011, J IMMUNOLOGY; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Connor DE, 2009, BLOOD COAGUL FIBRIN, V20, P558, DOI 10.1097/MBC.0b013e32832ee915; Dean WL, 2009, THROMB HAEMOSTASIS, V102, P711, DOI 10.1160/TH09-04-243; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Densmore JC, 2006, SHOCK, V26, P464, DOI 10.1097/01.shk.0000228791.10550.36; Diehl P, 2012, CARDIOVASC RES, V93, P633, DOI 10.1093/cvr/cvs007; Dwyer J, 2011, ONCOGENE, V30, P190, DOI 10.1038/onc.2010.411; Essayagh S, 2007, THROMB HAEMOSTASIS, V98, P831, DOI 10.1160/TH07-02-0082; FINGERLE G, 1993, BLOOD, V82, P3170; Gilleron J, 2008, J CELL SCI, V121, P4069, DOI 10.1242/jcs.033373; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Gorbunova EE, 2011, J VIROL, V85, P2296, DOI 10.1128/JVI.02319-10; Habersberger J, 2012, CARDIOVASC RES, V96, P64, DOI 10.1093/cvr/cvs237; Hillenbrand A, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-26; Hollenberg SM, 2007, CRIT CARE, V11, DOI 10.1186/cc6190; Hu GC, 2009, MICROVASC RES, V77, P21, DOI 10.1016/j.mvr.2008.10.002; Jaiswal R, 2011, FASEB J; Jaiswal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061515; Jimenez JJ, 2005, MULT SCLER J, V11, P310, DOI 10.1191/1352458505ms1184oa; Kanazawa S, 2003, LUNG CANCER-J IASLC, V39, P145, DOI 10.1016/S0169-5002(02)00441-5; Lou J, 1996, EUR J IMMUNOL, V26, P3107, DOI 10.1002/eji.1830261242; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Marceau F, 2010, INT IMMUNOPHARMACOL, V10, P1344, DOI 10.1016/j.intimp.2010.08.016; Mastronardi ML, 2010, FUNDAMENTAL CLIN PHA; Mfonkeu JBP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013415; Morel O, 2006, ARTERIOSCL THROM VAS, V26, P2594, DOI 10.1161/01.ATV.0000246775.14471.26; Morel O, 2009, HAEMATOL-HEMATOL J, V94, P313, DOI 10.3324/haematol.2009.003657; Mostefai HA, 2008, AM J RESP CRIT CARE, V178, P1148, DOI 10.1164/rccm.200712-1835OC; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Oehmcke S, 2011, CELLULAR MICROBIOLOG; Ogata N, 2006, DIABETES RES CLIN PR, V73, P241, DOI 10.1016/j.diabres.2006.01.014; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; PINE RW, 1983, ARCH SURG-CHICAGO, V118, P242; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; SATTA N, 1994, J IMMUNOL, V153, P3245; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; SPRUNG CL, 1990, CRIT CARE MED, V18, P801, DOI 10.1097/00003246-199008000-00001; Sundararajan V, 2005, CRIT CARE MED, V33, P71, DOI 10.1097/01.CCM.0000150027.98160.80; Trappenburg MC, 2011, NEPHROLOGY DIALYSIS; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Walters SB, 2013, J IMMUNOL, V190, P669, DOI 10.4049/jimmunol.1201856; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; WARKENTIN TE, 1994, BLOOD, V84, P3691, DOI 10.1182/blood.V84.11.3691.bloodjournal84113691; Wassmer SC, 2011, CELL MICROBIOL, V13, P198, DOI 10.1111/j.1462-5822.2010.01528.x; Wassmer SC, 2006, INFECT IMMUN, V74, P645, DOI 10.1128/IAI.74.1.645-653.2006; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Weksler BB, 2005, FASEB J; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x; YOUNG GB, 1990, CLIN INVEST MED, V13, P297; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	61	32	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91597	10.1371/journal.pone.0091597	http://dx.doi.org/10.1371/journal.pone.0091597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646764	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500041
J	Exline, MC; Justiniano, S; Hollyfield, JL; Berhe, F; Besecker, BY; Das, S; Wewers, MD; Sarkar, A				Exline, Matthew C.; Justiniano, Steven; Hollyfield, Jennifer L.; Berhe, Freweine; Besecker, Beth Y.; Das, Srabani; Wewers, Mark D.; Sarkar, Anasuya			Microvesicular Caspase-1 Mediates Lymphocyte Apoptosis in Sepsis	PLOS ONE			English	Article							CELL-DEATH; IL-1-BETA-CONVERTING ENZYME; MEMBRANE MICROPARTICLES; IMPROVES SURVIVAL; MICE DEFICIENT; UNITED-STATES; ACTIVATION; INTERLEUKIN-1-BETA; INFLAMMASOME; IL-1-BETA	Objective: Immune dysregulation during sepsis is poorly understood, however, lymphocyte apoptosis has been shown to correlate with poor outcomes in septic patients. The inflammasome, a molecular complex which includes caspase-1, is essential to the innate immune response to infection and also important in sepsis induced apoptosis. Our group has recently demonstrated that endotoxin-stimulated monocytes release microvesicles (MVs) containing caspase-1 that are capable of inducing apoptosis. We sought to determine if MVs containing caspase-1 are being released into the blood during human sepsis and induce apoptosis.. Design: Single-center cohort study Measurements: 50 critically ill patients were screened within 24 hours of admission to the intensive care unit and classified as either a septic or a critically ill control. Circulatory MVs were isolated and analyzed for the presence of caspase-1 and the ability to induce lymphocyte apoptosis. Patients remaining in the ICU for 48 hours had repeated measurement of caspase-1 activity on ICU day 3. Main Results: Septic patients had higher microvesicular caspase-1 activity 0.05 (0.04, 0.07) AFU versus 0.0 AFU (0, 0.02) (p < 0.001) on day 1 and this persisted on day 3, 0.12 (0.1, 0.2) versus 0.02 (0, 0.1) (p < 0.001). MVs isolated from septic patients on day 1 were able to induce apoptosis in healthy donor lymphocytes compared with critically ill control patients (17.8 +/- 9.2% versus 4.3 +/- 2.6% apoptotic cells, p < 0.001) and depletion of MVs greatly diminished this apoptotic signal. Inhibition of caspase-1 or the disruption of MV integrity abolished the ability to induce apoptosis. Conclusion: These findings suggest that microvesicular caspase-1 is important in the host response to sepsis, at least in part, via its ability to induce lymphocyte apoptosis. The ability of microvesicles to induce apoptosis requires active caspase-1 and intact microvesicles.	[Exline, Matthew C.; Justiniano, Steven; Hollyfield, Jennifer L.; Berhe, Freweine; Besecker, Beth Y.; Das, Srabani; Wewers, Mark D.; Sarkar, Anasuya] Ohio State Univ, Davis Heart & Lung Res Inst, Pulm Allergy Crit Care & Sleep Med Div, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Sarkar, A (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Pulm Allergy Crit Care & Sleep Med Div, Wexner Med Ctr, Columbus, OH 43210 USA.	anasuya.sarkar@osumc.edu	Wewers, Mark/AAB-6202-2021		NHLBI NIH HHS [R01 HL124325] Funding Source: Medline; NIGMS NIH HHS [K23 GM107624] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM107624] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Brabant D, 2011, BIOCHEM BIOPH RES CO, V412, P260, DOI 10.1016/j.bbrc.2011.07.080; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Distler JHW, 2006, AUTOIMMUNITY, V39, P683, DOI 10.1080/08916930601061538; Elliott JM, 2009, J BIOL CHEM, V284, P6546, DOI 10.1074/jbc.M806121200; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fahy RJ, 1999, J IMMUNOL, V163, P1755; Fahy RJ, 2008, AM J RESP CRIT CARE, V177, P983, DOI 10.1164/rccm.200703-418OC; Fantuzzi G, 1996, J IMMUNOL, V157, P291; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; Grobmyer SR, 1999, MOL MED, V5, P585, DOI 10.1007/BF03402071; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1999, J IMMUNOL, V162, P4148; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Huber LC, 2007, APOPTOSIS, V12, P363, DOI 10.1007/s10495-006-0622-7; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Joshi VD, 2002, INFECT IMMUN, V70, P6896, DOI 10.1128/IAI.70.12.6896-6903.2002; Kim HJ, 2004, J IMMUNOL, V172, P4948, DOI 10.4049/jimmunol.172.8.4948; Kumar A, 2005, J BIOL CHEM, V280, P42619, DOI 10.1074/jbc.M508416200; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Li P, 1997, J CELL BIOCHEM, V64, P27, DOI 10.1002/(SICI)1097-4644(199701)64:1<27::AID-JCB5>3.0.CO;2-1; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2006, CELL DEATH DIFFER; McKechnie NM, 2006, EXP EYE RES, V83, P304, DOI 10.1016/j.exer.2005.11.028; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Monick MM, 2003, ANNU REV PHYSIOL, V65, P643, DOI 10.1146/annurev.physiol.65.092101.142440; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; Scott AM, 2006, CELL DEATH DIFFER; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Vaki I, J LEUKOC BIOL, V89, P343; Vaki I, 2011, J LEUKOCYTE BIOL, V89, P343, DOI 10.1189/jlb.0410232; van der Velden AWM, 2003, J IMMUNOL, V171, P6742, DOI 10.4049/jimmunol.171.12.6742; Wang W, 2005, AM J PHYSIOL-RENAL, V288, pF997, DOI 10.1152/ajprenal.00130.2004; Watanabe JJ, 2003, J BIOL CHEM, V278, P33161, DOI 10.1074/jbc.M305321200; Wewers MD, 2004, P NATL ACAD SCI USA, V101, P10241, DOI 10.1073/pnas.0403971101; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	61	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e90968	10.1371/journal.pone.0090968	http://dx.doi.org/10.1371/journal.pone.0090968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643116	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900009
J	Gurushidze, M; Hensel, G; Hiekel, S; Schedel, S; Valkov, V; Kumlehn, J				Gurushidze, Maia; Hensel, Goetz; Hiekel, Stefan; Schedel, Sindy; Valkov, Vladimir; Kumlehn, Jochen			True-Breeding Targeted Gene Knock-Out in Barley Using Designer TALE-Nuclease in Haploid Cells	PLOS ONE			English	Article							HORDEUM-VULGARE L.; DNA-BINDING SPECIFICITY; GENOME; TRANSFORMATION; VECTORS; MARKER	Transcription activator-like effector nucleases (TALENs) are customizable fusion proteins able to cleave virtually any genomic DNA sequence of choice, and thereby to generate site-directed genetic modifications in a wide range of cells and organisms. In the present study, we expressed TALENs in pollen-derived, regenerable cells to establish the generation of instantly true-breeding mutant plants. A gfp-specific TALEN pair was expressed via Agrobacterium-mediated transformation in embryogenic pollen of transgenic barley harboring a functional copy of gfp. Thanks to the haploid nature of the target cells, knock-out mutations were readily detected, and homozygous primary mutant plants obtained following genome duplication. In all, 22% of the TALEN transgenics proved knocked out with respect to gfp, and the loss of function could be ascribed to the deletions of between four and 36 nucleotides in length. The altered gfp alleles were transmitted normally through meiosis, and the knock-out phenotype was consistently shown by the offspring of two independent mutants. Thus, here we describe the efficient production of TALEN-mediated gene knock-outs in barley that are instantaneously homozygous and non-chimeric in regard to the site-directed mutations induced. This TALEN approach has broad applicability for both elucidating gene function and tailoring the phenotype of barley and other crop species.	[Gurushidze, Maia; Hensel, Goetz; Hiekel, Stefan; Schedel, Sindy; Valkov, Vladimir; Kumlehn, Jochen] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany; [Valkov, Vladimir] Inst Genet & Biophys, Naples, Italy	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Gurushidze, M (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany.	maiko@ipk-gatersleben.de	Hensel, Goetz/ABA-8238-2020; Kumlehn, Jochen/AAF-8241-2020; Hensel, G./F-9957-2010; Valkov, Vladimir Totev/M-4753-2017	Hensel, Goetz/0000-0002-5539-3097; Kumlehn, Jochen/0000-0001-7080-7983; Hensel, G./0000-0002-5539-3097; Valkov, Vladimir Totev/0000-0002-3811-0913; Chamas (nee Schedel), Sindy/0000-0003-2765-0719; Hiekel, Stefan/0000-0001-7649-3989	German Federal Ministry of Education and Research [FKZ 0315965]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was made financially possible through a grant number FKZ 0315965 from the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Christian M, 2013, G3-GENES GENOM GENET, V3, P1697, DOI 10.1534/g3.113.007104; Fang YD, 2002, J PLANT PHYSIOL, V159, P1131, DOI 10.1078/0176-1617-00707; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Gonzalez-Melendi P, 2005, PLANTA, V222, P47, DOI 10.1007/s00425-005-1515-7; Hensel Goetz, 2009, Int J Plant Genomics, V2009, P835608, DOI 10.1155/2009/835608; Kasha KJ, 2001, J EXP BOT, V52, P1227, DOI 10.1093/jexbot/52.359.1227; Kim Y, 2013, NAT METHODS, V10, P185, DOI [10.1038/nmeth.2364, 10.1038/NMETH.2364]; Komari T, 1996, PLANT J, V10, P165, DOI 10.1046/j.1365-313X.1996.10010165.x; Kumlehn J, 2006, PLANT BIOTECHNOL J, V4, P251, DOI 10.1111/j.1467-7652.2005.00178.x; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Maluszynski M., 2003, DOUBLED HAPLOID PROD; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Pallotta MA, 2000, THEOR APPL GENET, V101, P1100, DOI 10.1007/s001220051585; Puchta H, 2013, PLANT J, DOI 101111/tpj12338; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; THIEBAUT J, 1978, CAN J GENET CYTOL, V20, P513, DOI 10.1139/g78-060; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Wah DA, 1997, NATURE, V388, P97, DOI 10.1038/40446; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179	35	68	76	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92046	10.1371/journal.pone.0092046	http://dx.doi.org/10.1371/journal.pone.0092046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643227	Green Submitted, gold, Green Published			2022-12-27	WOS:000333259900071
J	Beauregard, F; de Blois, S				Beauregard, Frieda; de Blois, Sylvie			Beyond a Climate-Centric View of Plant Distribution: Edaphic Variables Add Value to Distribution Models	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; HUMUS FORMS; SAMPLE-SIZE; PREDICTIONS; ABUNDANCE; FOREST; UNCERTAINTIES; PERFORMANCE; DIVERSITY; ACCURACY	Both climatic and edaphic conditions determine plant distribution, however many species distribution models do not include edaphic variables especially over large geographical extent. Using an exceptional database of vegetation plots (n = 4839) covering an extent of similar to 55000 km(2), we tested whether the inclusion of fine scale edaphic variables would improve model predictions of plant distribution compared to models using only climate predictors. We also tested how well these edaphic variables could predict distribution on their own, to evaluate the assumption that at large extents, distribution is governed largely by climate. We also hypothesized that the relative contribution of edaphic and climatic data would vary among species depending on their growth forms and biogeographical attributes within the study area. We modelled 128 native plant species from diverse taxa using four statistical model types and three sets of abiotic predictors: climate, edaphic, and edaphic-climate. Model predictive accuracy and variable importance were compared among these models and for species' characteristics describing growth form, range boundaries within the study area, and prevalence. For many species both the climate-only and edaphic-only models performed well, however the edaphic-climate models generally performed best. The three sets of predictors differed in the spatial information provided about habitat suitability, with climate models able to distinguish range edges, but edaphic models able to better distinguish within-range variation. Model predictive accuracy was generally lower for species without a range boundary within the study area and for common species, but these effects were buffered by including both edaphic and climatic predictors. The relative importance of edaphic and climatic variables varied with growth forms, with trees being more related to climate whereas lower growth forms were more related to edaphic conditions. Our study identifies the potential for non-climate aspects of the environment to pose a constraint to range expansion under climate change.	[Beauregard, Frieda; de Blois, Sylvie] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada; [de Blois, Sylvie] McGill Univ, McGill Sch Environm, Ste Anne De Bellevue, PQ, Canada	McGill University; McGill University	de Blois, S (corresponding author), McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada.	sylvie.deblois@mcgill.ca			Fonds de Recherche du Quebec - Natures et Technologies; Natural Sciences and Engineering Research Council of Canada	Fonds de Recherche du Quebec - Natures et Technologies; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors acknowledge funding from the Fonds de Recherche du Quebec - Natures et Technologies (www.fqrnt.gouv.qc.ca) to F. Beauregard and from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) to S. de Blois. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda SC, 2011, ECOGRAPHY, V34, P31, DOI 10.1111/j.1600-0587.2010.06134.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Attorre F, 2011, APPL VEG SCI, V14, P242, DOI 10.1111/j.1654-109X.2010.01114.x; Austin MP, 2011, J BIOGEOGR, V38, P9, DOI 10.1111/j.1365-2699.2010.02415.x; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Berteaux Dominique, 2010, Diversity, V2, P1181, DOI 10.3390/d2111181; Bertrand R, 2012, GLOBAL CHANGE BIOL, V18, P2648, DOI 10.1111/j.1365-2486.2012.02679.x; Chambers D, 2013, FOREST ECOL MANAG, V291, P20, DOI 10.1016/j.foreco.2012.10.046; COTE B, 1994, CAN J FOREST RES, V24, P192, DOI 10.1139/x94-027; Coudun C, 2006, J BIOGEOGR, V33, P1750, DOI 10.1111/j.1365-2699.2005.01443.x; de Blois S, 2001, LANDSCAPE ECOL, V16, P421, DOI 10.1023/A:1017548003345; Dengler J, 2011, J VEG SCI, V22, P582, DOI 10.1111/j.1654-1103.2011.01265.x; Dubuis A, 2013, J VEG SCI, V24, P593, DOI 10.1111/jvs.12002; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2009, MAPPING SPECIES DIST; Gosselin Jocelyn, 2012, Biodiversity Ecol, V4, P432, DOI 10.7809/b-e.00219; Hanspach J, 2010, PERSPECT PLANT ECOL, V12, P219, DOI 10.1016/j.ppees.2010.04.002; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hutchinson M. F., 2002, ANUSPLIN VERSION 4 2; Jones CC, 2010, ECOL APPL, V20, P311, DOI 10.1890/08-2261.1; Lafleur B, 2010, ENVIRON REV, V18, P279, DOI 10.1139/A10-013; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Marage D, 2009, GLOBAL ECOL BIOGEOGR, V18, P88, DOI 10.1111/j.1466-8238.2008.00428.x; Mateo RG, 2010, DIVERS DISTRIB, V16, P84, DOI 10.1111/j.1472-4642.2009.00617.x; McKenney DW, 2011, GLOBAL CHANGE BIOL, V17, P2720, DOI 10.1111/j.1365-2486.2011.02413.x; Nelson BD., 2001, STAT DATA ANAL DATA; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Philips D. W., 1991, CANADA PRECIPITATION; Ponge JF, 2003, SOIL BIOL BIOCHEM, V35, P935, DOI 10.1016/S0038-0717(03)00149-4; Rehfeldt G.E, 2006, SPLINE MODEL CLIMATE; Rousseau C., 1974, GEOGRAPHIE FLORISTIQ; Rupprecht F, 2011, J VEG SCI, V22, P647, DOI 10.1111/j.1654-1103.2011.01269.x; Saucier J. P., 2003, VEGETATION ZONES BIO; Saucier J.P., 1994, POINT OBSERVATION EC; Sormunen H, 2011, POLAR BIOL, V34, P883, DOI 10.1007/s00300-010-0945-2; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Syphard AD, 2009, ECOGRAPHY, V32, P907, DOI 10.1111/j.1600-0587.2009.05883.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2013, J VEG SCI, V24, P591, DOI 10.1111/jvs.12076; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Wang TL, 2012, FOREST ECOL MANAG, V279, P128, DOI 10.1016/j.foreco.2012.05.034; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Young NE, 2012, ENVIRON MONIT ASSESS, V184, P5439, DOI 10.1007/s10661-011-2351-9	48	55	57	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92642	10.1371/journal.pone.0092642	http://dx.doi.org/10.1371/journal.pone.0092642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658097	Green Submitted, gold, Green Published			2022-12-27	WOS:000333355300110
J	Ma, X; Wang, S; Do, T; Song, XQ; Inaba, M; Nishimoto, Y; Liu, LP; Gao, Y; Mao, Y; Li, H; McDowell, W; Park, J; Malanowski, K; Peak, A; Perera, A; Li, H; Gaudenz, K; Haug, J; Yamashita, Y; Lin, HF; Ni, JQ; Xie, T				Ma, Xing; Wang, Su; Do, Trieu; Song, Xiaoqing; Inaba, Mayu; Nishimoto, Yoshiya; Liu, Lu-ping; Gao, Yuan; Mao, Ying; Li, Hui; McDowell, William; Park, Jungeun; Malanowski, Kate; Peak, Allison; Perera, Anoja; Li, Hua; Gaudenz, Karin; Haug, Jeff; Yamashita, Yukiko; Lin, Haifan; Ni, Jian-quan; Xie, Ting			Piwi Is Required in Multiple Cell Types to Control Germline Stem Cell Lineage Development in the Drosophila Ovary	PLOS ONE			English	Article							PRIMARY PIRNA BIOGENESIS; BAG-OF-MARBLES; SELF-RENEWAL; TRANSGENIC RNAI; ASYMMETRIC DIVISION; NICHE CELLS; GENE; PATHWAY; GENOME; DIFFERENTIATION	The piRNA pathway plays an important role in maintaining genome stability in the germ line by silencing transposable elements (TEs) from fly to mammals. As a highly conserved piRNA pathway component, Piwi is widely expressed in both germ cells and somatic cells in the Drosophila ovary and is required for piRNA production in both cell types. In addition to its known role in somatic cap cells to maintain germline stem cells (GSCs), this study has demonstrated that Piwi has novel functions in somatic cells and germ cells of the Drosophila ovary to promote germ cell differentiation. Piwi knockdown in escort cells causes a reduction in escort cell (EC) number and accumulation of undifferentiated germ cells, some of which show active BMP signaling, indicating that Piwi is required to maintain ECs and promote germ cell differentiation. Simultaneous knockdown of dpp, encoding a BMP, in ECs can partially rescue the germ cell differentiation defect, indicating that Piwi is required in ECs to repress dpp. Consistent with its key role in piRNA production, TE transcripts increase significantly and DNA damage is also elevated in the piwi knockdown somatic cells. Germ cell-specific knockdown of piwi surprisingly causes depletion of germ cells before adulthood, suggesting that Piwi might control primordial germ cell maintenance or GSC establishment. Finally, Piwi inactivation in the germ line of the adult ovary leads to gradual GSC loss and germ cell differentiation defects, indicating the intrinsic role of Piwi in adult GSC maintenance and differentiation. This study has revealed new germline requirement of Piwi in controlling GSC maintenance and lineage differentiation as well as its new somatic function in promoting germ cell differentiation. Therefore, Piwi is required in multiple cell types to control GSC lineage development in the Drosophila ovary.	[Ma, Xing; Wang, Su; Do, Trieu; Song, Xiaoqing; Nishimoto, Yoshiya; McDowell, William; Park, Jungeun; Malanowski, Kate; Peak, Allison; Perera, Anoja; Li, Hua; Gaudenz, Karin; Haug, Jeff; Xie, Ting] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Ma, Xing; Wang, Su; Xie, Ting] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS USA; [Inaba, Mayu; Yamashita, Yukiko] Univ Michigan, Ctr Stem Cell Biol, Inst Life Sci, Ann Arbor, MI 48109 USA; [Liu, Lu-ping; Gao, Yuan; Mao, Ying; Li, Hui; Ni, Jian-quan] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Lin, Haifan] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Michigan System; University of Michigan; Tsinghua University; Yale University	Xie, T (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	tgx@stowers.org	Ma, Xing/S-8690-2018	Yamashita, Yukiko/0000-0001-5541-0216	National Institutes of Health [2R01 GM64428]; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (2R01 GM64428) and the Stowers Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2008, COLD SH Q B, V73, P283, DOI 10.1101/sqb.2008.73.058; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Casanueva MO, 2004, DEVELOPMENT, V131, P1881, DOI 10.1242/dev.01076; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Eliazer S, 2011, P NATL ACAD SCI USA, V108, P7064, DOI 10.1073/pnas.1015874108; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gong WJ, 2005, PLOS GENET, V1, P589, DOI 10.1371/journal.pgen.0010067; Guo Z, 2009, DEVELOPMENT, V136, P3627, DOI 10.1242/dev.036939; Haase AD, 2010, GENE DEV, V24, P2499, DOI 10.1101/gad.1968110; Handler D, 2011, EMBO J, V30, P3977, DOI 10.1038/emboj.2011.308; Harris AN, 2001, DEVELOPMENT, V128, P2823; Hayashi Y, 2009, J CELL BIOL, V187, P473, DOI 10.1083/jcb.200904118; Huang XA, 2013, DEV CELL, V24, P502, DOI 10.1016/j.devcel.2013.01.023; Jin ZG, 2013, CURR BIOL, V23, P1442, DOI 10.1016/j.cub.2013.06.021; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; Kirilly D, 2011, DEVELOPMENT, V138, P5087, DOI 10.1242/dev.067850; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Lin H, 1994, DEVELOPMENT, V4, P947; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000740; Malone CD, 2009, COLD SH Q B, V74, P225, DOI 10.1101/sqb.2009.74.052; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Qi H, 2011, J BIOL CHEM, V286, P3789, DOI 10.1074/jbc.M110.193888; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Rangan P, 2011, CURR BIOL, V21, P1373, DOI 10.1016/j.cub.2011.06.057; Rojas-Rios P, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001298; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Schulz C, 2002, DEVELOPMENT, V129, P4523; Shen R, 2009, P NATL ACAD SCI USA, V106, P11623, DOI 10.1073/pnas.0903325106; Siomi MC, 2010, SEMIN CELL DEV BIOL, V21, P754, DOI 10.1016/j.semcdb.2010.01.011; Smulders-Srinivasan TK, 2010, GENETICS, V186, P573, DOI 10.1534/genetics.110.119081; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Szakmary A, 2009, J CELL BIOL, V185, P613, DOI 10.1083/jcb.200903034; Van Doren M, 1998, CURR BIOL, V8, P243; Wang XD, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-3; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Xie T, 2013, WIRES DEV BIOL, V2, P261, DOI 10.1002/wdev.60; Zamparini AL, 2011, DEVELOPMENT, V138, P4039, DOI 10.1242/dev.069187; Zhu CH, 2003, DEVELOPMENT, V130, P2579, DOI 10.1242/dev.00499	63	58	60	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90267	10.1371/journal.pone.0090267	http://dx.doi.org/10.1371/journal.pone.0090267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658126	gold, Green Published, Green Submitted			2022-12-27	WOS:000333355300013
J	Pecchinenda, A; Bertamini, M; Makin, ADJ; Ruta, N				Pecchinenda, Anna; Bertamini, Marco; Makin, Alexis David James; Ruta, Nicole			The Pleasantness of Visual Symmetry: Always, Never or Sometimes	PLOS ONE			English	Article							AFFECT MISATTRIBUTION; IMPLICIT ASSOCIATION; SELECTIVE ATTENTION; PERCEPTION; ATTRACTIVENESS; DISSOCIATION; ORIENTATION; ACTIVATION; RESPONSES; PLEASURE	There is evidence of a preference for visual symmetry. This is true from mate selection in the animal world to the aesthetic appreciation of works of art. It has been proposed that this preference is due to processing fluency, which engenders positive affect. But is visual symmetry pleasant? Evidence is mixed as explicit preferences show that this is the case. In contrast, implicit measures show that visual symmetry does not spontaneously engender positive affect but it depends on participants intentionally assessing visual regularities. In four experiments using variants of the affective priming paradigm, we investigated when visual symmetry engenders positive affect. Findings showed that, when no Stroop-like effects or post-lexical mechanisms enter into play, visual symmetry spontaneously elicits positive affect and results in affective congruence effects.	[Pecchinenda, Anna; Ruta, Nicole] Sapienza Univ, Dept Psychol, Rome, Italy; [Bertamini, Marco; Makin, Alexis David James] Univ Liverpool, Dept Expt Psychol, Liverpool L69 3BX, Merseyside, England	Sapienza University Rome; University of Liverpool	Pecchinenda, A (corresponding author), Sapienza Univ, Dept Psychol, Rome, Italy.	anna.pecchinenda@uniroma1.it	Bertamini, Marco/C-2495-2011; Ruta, Nicole/ABG-9148-2020; Makin, Alexis/I-9828-2019; Bertamini, Marco/H-2752-2019	Bertamini, Marco/0000-0001-8617-6864; Ruta, Nicole/0000-0001-5300-2913; Makin, Alexis/0000-0002-4490-7400; Bertamini, Marco/0000-0001-8617-6864; Pecchinenda, Anna/0000-0001-9139-5295	Leverhulme Trust research grant [F/00 025/AR]; ESRC Grant [ES/K000187/1]; Economic and Social Research Council [ES/K000187/1] Funding Source: researchfish; ESRC [ES/K000187/1] Funding Source: UKRI	Leverhulme Trust research grant(Leverhulme Trust); ESRC Grant(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Leverhulme Trust research grant awarded to MB and AP (F/00 025/AR) and an ESRC Grant to MB and AM (ES/K000187/1. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnheim R., 1974, ART VISUAL PERCEPTIO; Bar-Anan Y, 2012, PERS SOC PSYCHOL B, V38, P1194, DOI 10.1177/0146167212446835; BARLOW HB, 1979, VISION RES, V19, P783, DOI 10.1016/0042-6989(79)90154-8; Bertamini M, 1997, ACTA PSYCHOL, V95, P119, DOI 10.1016/S0001-6918(96)00038-8; Bertamini M, 2013, I-PERCEPTION, V4, P317, DOI 10.1068/i0601JW; Bertamini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068403; Blaison C, 2012, EMOTION, V12, P403, DOI 10.1037/a0026907; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; BRUCE VG, 1975, PERCEPTION, V4, P239, DOI 10.1068/p040239; Cannon PR, 2010, COGNITION EMOTION, V24, P681, DOI 10.1080/02699930902927698; Carbon CC, 2010, VIS COGN, V18, P641, DOI 10.1080/13506280903462471; Cardenas RA, 2006, EVOL HUM BEHAV, V27, P1, DOI 10.1016/j.evolhumbehav.2005.05.002; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; De Houwer J, 2004, COGNITION EMOTION, V18, P251, DOI 10.1080/02699930341000022; Duckworth KL, 2002, PSYCHOL SCI, V13, P513, DOI 10.1111/1467-9280.00490; ENQUIST M, 1994, NATURE, V372, P169, DOI 10.1038/372169a0; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Friedenberg J, 2000, ACTA PSYCHOL, V105, P107, DOI 10.1016/S0001-6918(00)00051-2; Gattol V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015849; Gawronski B, 2008, EUR J PSYCHOL ASSESS, V24, P218, DOI 10.1027/1015-5759.24.4.218; GLASER WR, 1989, J EXP PSYCHOL GEN, V118, P13, DOI 10.1037/0096-3445.118.1.13; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hofel L, 2007, INT J PSYCHOPHYSIOL, V65, P20, DOI 10.1016/j.ijpsycho.2007.02.007; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Jacobsen T, 2003, COGN AFFECT BEHAV NE, V3, P289, DOI 10.3758/CABN.3.4.289; Klauer KC, 2003, PSYCHOLOGY OF EVALUATION, P7; Leppanen JM, 2003, J PSYCHOPHYSIOL, V17, P113, DOI 10.1027//0269-8803.17.3.113; Mach E., 1886, ANAL SENSATIONS RELA; Makin A, 2012, I-PERCEPTION, V3, P519, DOI 10.1068/i0538; Makin ADJ, 2013, PSYCHOPHYSIOLOGY, V50, P1045, DOI 10.1111/psyp.12082; Makin ADJ, 2012, NEUROPSYCHOLOGIA, V50, P3250, DOI 10.1016/j.neuropsychologia.2012.10.003; Makin ADJ, 2012, EMOTION, V12, P1021, DOI 10.1037/a0026924; Mammarella N, 2013, NEUROPSYCHOL REHABIL, V23, P416, DOI 10.1080/09602011.2013.775065; MOLLER AP, 1992, NATURE, V357, P238, DOI 10.1038/357238a0; Murphy ST, 1993, J PERS SOC PSYCHOL, V59, P27; Muth C, 2013, ACTA PSYCHOL, V144, P25, DOI 10.1016/j.actpsy.2013.05.001; Nosek B. A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1080/10463280701489053; Olivers CNL, 1998, PERCEPT PSYCHOPHYS, V60, P1101, DOI 10.3758/BF03206161; PALMER SE, 1978, J EXP PSYCHOL HUMAN, V4, P691, DOI 10.1037/0096-1523.4.4.691; Payne BK, 2013, PERS SOC PSYCHOL B, V39, P375, DOI 10.1177/0146167212475225; Payne BK, 2010, PERS SOC PSYCHOL B, V36, P1397, DOI 10.1177/0146167210383440; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; Pecchinenda A, 2007, EUR J COGN PSYCHOL, V19, P898, DOI 10.1080/09541440601095388; Pecchinenda A, 2006, EXP PSYCHOL, V53, P268, DOI 10.1027/1618-3169.53.4.268; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Reber R, 2004, CONSCIOUS COGN, V13, P47, DOI 10.1016/S1053-8100(03)00049-7; Reber R., 2006, POLISH PSYCHOL B, V37, P16; Rhodes G, 1998, PSYCHON B REV, V5, P659, DOI 10.3758/BF03208842; ROYER FL, 1981, J EXP PSYCHOL HUMAN, V7, P1186, DOI 10.1037/0096-1523.7.6.1186; Schneider W., 2002, E PRIME USERS GUIDE; SWADDLE JP, 1994, NATURE, V367, P165, DOI 10.1038/367165a0; Topolinski S, 2009, COGNITION EMOTION, V23, P260, DOI 10.1080/02699930801994112; Topolinski S, 2010, PSYCHOL SCI, V21, P1220, DOI 10.1177/0956797610378308; TYLER CW, 1995, SPATIAL VISION, V9, P1, DOI 10.1163/156856895X00089; Unkelbach C, 2008, J PERS SOC PSYCHOL, V95, P36, DOI 10.1037/0022-3514.95.1.36; Van Dongen S, 2011, ANN HUM BIOL, V38, P317, DOI 10.3109/03014460.2010.544676; WAGEMANS J, 1995, SPATIAL VISION, V9, P9, DOI 10.1163/156856895X00098; Washburn Dorothy, 1988, SYMMETRIES CULTURE; WENDEROTH P, 1994, PERCEPTION, V23, P221, DOI 10.1068/p230221; Wentura D, 2003, PSYCHOLOGY OF EVALUATION, P51; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989; Winkielman P, 2006, PSYCHOL SCI, V17, P799, DOI 10.1111/j.1467-9280.2006.01785.x; Zhao J, 2014, PSYCHOL SCI IN PRESS	65	28	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92685	10.1371/journal.pone.0092685	http://dx.doi.org/10.1371/journal.pone.0092685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6GL	24658112	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300112
J	Russell, ES; Mohammed, T; Smeaton, L; Jorowe, B; MacLeod, IJ; Hoffman, RM; Currier, JS; Moyo, S; Essex, M; Lockman, S				Russell, Elizabeth S.; Mohammed, Terence; Smeaton, Laura; Jorowe, Baitshepi; MacLeod, Iain J.; Hoffman, Risa M.; Currier, Judith S.; Moyo, Sikhulile; Essex, Max; Lockman, Shahin			Immune Activation Markers in Peripartum Women in Botswana: Association with Feeding Strategy and Maternal Morbidity	PLOS ONE			English	Article							C-REACTIVE PROTEIN; DISEASE PROGRESSION; HIV-INFECTION; PREGNANCY; MORTALITY; INFLAMMATION; POSTPARTUM; MODULATION; INCREASES; PROLACTIN	Hormone levels shift the immune state in HIV-uninfected pregnant and breastfeeding women away from Th1 responses and toward regulation to permit fetal tolerance. Limited data exist on inflammation during pregnancy or postpartum in HIV-infected women, though certain inflammatory markers are associated with adverse health outcomes among HIV-infected persons. We measured hsCRP, D-dimer, IFN-gamma, IL-6, IL-10 and TNF-alpha at 34 weeks gestation and six months postpartum in HIV-infected women from the Botswana Mashi PMTCT trial who were randomized to breastfeeding or formula-feeding. Differences in inflammatory markers between gestation and postpartum periods, and by randomized feeding method, were estimated using generalized estimating equations, adjusting for baseline plasma HIV-1 viral load, CD4 count, calendar time, and antiretroviral treatment status. Additionally, we studied the association between marker concentrations at six months postpartum and major adverse clinical events over the following 4.5 years, using case-cohort sampling and adjusted Cox proportional hazards models. In 86 breastfeeding and 75 formula-feeding women, hsCRP and D-dimer decreased significantly between 34 weeks gestation and six months postpartum, while IFN-gamma increased. There was no significant association between inflammatory marker change and randomized feeding method after adjusting for multiple comparisons and removing outliers. In univariate analysis, TNF-alpha, D-dimer, and IFN-gamma concentrations at six months postpartum were significant predictors of subsequent clinical events, and TNF-alpha remained significant in multivariate analysis (HR = 4.16, p = 0.001). In young HIV-infected women in Botswana inflammatory marker concentrations did not differ significantly between women who breast- vs. formula-fed. However, postpartum TNF-alpha level was predictive of subsequent adverse clinical event.	[Russell, Elizabeth S.; MacLeod, Iain J.; Essex, Max; Lockman, Shahin] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Harvard AIDS Initiat, Boston, MA 02115 USA; [Russell, Elizabeth S.; Mohammed, Terence; Jorowe, Baitshepi; MacLeod, Iain J.; Moyo, Sikhulile; Essex, Max; Lockman, Shahin] Botswana Harvard AIDS Inst, Gaborone, Botswana; [Smeaton, Laura] Harvard Univ, Sch Publ Hlth, Dept Biostat, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Hoffman, Risa M.; Currier, Judith S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lockman, Shahin] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Brigham & Women's Hospital	Russell, ES (corresponding author), Kentucky Dept Publ Hlth, Frankfort, KY 40601 USA.	elizabeth.russell@ky.gov	Moyo, Sikhulile/E-1464-2015	Moyo, Sikhulile/0000-0003-3821-4592; Russell, Elizabeth S/0000-0001-7462-9280; MacLeod, Iain/0000-0001-5608-634X	National Institutes of Health National Institute of Child Health and Human Development [R01 HD37793, R01 HD44391]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037793, R01HD044391] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009610] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by National Institutes of Health National Institute of Child Health and Human Development Grants: R01 HD37793 and R01 HD44391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns DN, 1999, J REPROD IMMUNOL, V42, P147, DOI 10.1016/S0165-0378(98)00085-0; Cai JW, 2004, BIOMETRICS, V60, P1015, DOI 10.1111/j.0006-341X.2004.00257.x; Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; Chaudhary M, 2008, VIRAL IMMUNOL, V21, P263, DOI 10.1089/vim.2007.0083; Coutsoudis A, 2001, AIDS, V15, P653, DOI 10.1097/00002030-200103300-00019; CUTOLO M, 1995, CLIN EXP RHEUMATOL, V13, P217; Dabis F, 2005, JAIDS-J ACQ IMM DEF, V39, P430, DOI 10.1097/01.qai.0000148531.04706.c0; Denney JM, 2011, CYTOKINE, V53, P170, DOI 10.1016/j.cyto.2010.11.005; Drain PK, 2007, AIDS, V21, P2067, DOI 10.1097/QAD.0b013e32826fb6c7; Eller MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018779; Feldman JG, 2003, JAIDS-J ACQ IMM DEF, V32, P210, DOI 10.1097/00126334-200302010-00014; Fraternale A, 2011, VACCINE, V29, P6823, DOI 10.1016/j.vaccine.2011.07.101; Grutzmeier S, 1999, SCAND J INFECT DIS, V31, P229, DOI 10.1080/00365549950163491; Kelesidis T, 2012, J INFECT DIS, V206, P1558, DOI 10.1093/infdis/jis545; Kuhn L, 2005, AIDS, V19, P1677, DOI 10.1097/01.aids.0000186817.38112.da; Kulathinal Sangita, 2007, Epidemiol Perspect Innov, V4, P15; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lau B, 2006, ARCH INTERN MED, V166, P64, DOI 10.1001/archinte.166.1.64; Lockman S, 2009, 16 C RETR OPP INF MO; MacLeod IJ, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17393; Mayanja BN, 2012, TROP MED INT HEALTH, V17, P343, DOI 10.1111/j.1365-3156.2011.02921.x; Melchior JC, 1999, NUTRITION, V15, P865, DOI 10.1016/S0899-9007(99)00210-5; Mikyas Y, 1997, J REPROD IMMUNOL, V33, P157, DOI 10.1016/S0165-0378(97)00018-1; National Institute of Allergy and Infectious Diseases, 2009, HAART STAND VERS PRO; Nduati R, 2001, LANCET, V357, P1651, DOI 10.1016/S0140-6736(00)04820-0; Otieno PA, 2007, J INFECT DIS, V195, P220, DOI 10.1086/510245; Piconi S, 2011, BLOOD, V118, P3263, DOI 10.1182/blood-2011-01-329060; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Stylianou E, 1999, CLIN EXP IMMUNOL, V116, P115; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Truong HHM, 2010, CLIN VACCINE IMMUNOL, V17, P2024, DOI 10.1128/CVI.00088-10; Watts DH, 2003, JAIDS-J ACQ IMM DEF, V33, P585, DOI 10.1097/00126334-200308150-00006; Weetman AP, 2010, NAT REV ENDOCRINOL, V6, P311, DOI 10.1038/nrendo.2010.46; Yu-Lee LY, 2002, RECENT PROG HORM RES, V57, P435, DOI 10.1210/rp.57.1.435; Zimmer JP, 1996, J REPROD IMMUNOL, V30, P81, DOI 10.1016/0165-0378(96)00956-4	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e89928	10.1371/journal.pone.0089928	http://dx.doi.org/10.1371/journal.pone.0089928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24657960	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300007
J	Apthorp, D; Palmisano, S				Apthorp, Deborah; Palmisano, Stephen			The Role of Perceived Speed in Vection: Does Perceived Speed Modulate the Jitter and Oscillation Advantages?	PLOS ONE			English	Article							SELF-MOTION PERCEPTION; 2ND-ORDER MOTION; OPTIC FLOW; PERIPHERAL-VISION; VIEWPOINT JITTER; GLOBAL-MOTION; IN-DEPTH; ILLUSIONS; ACCOUNTS; WALKING	Illusory self-motion ('vection') in depth is strongly enhanced when horizontal/vertical simulated viewpoint oscillation is added to optic flow inducing displays; a similar effect is found for simulated viewpoint jitter. The underlying cause of these oscillation and jitter advantages for vection is still unknown. Here we investigate the possibility that perceived speed of motion in depth (MID) plays a role. First, in a 2AFC procedure, we obtained MID speed PSEs for briefly presented (vertically oscillating and smooth) radial flow displays. Then we examined the strength, duration and onset latency of vection induced by oscillating and smooth radial flow displays matched either for simulated or perceived MID speed. The oscillation advantage was eliminated when displays were matched for perceived MID speed. However, when we tested the jitter advantage in the same manner, jittering displays were found to produce greater vection in depth than speed-matched controls. In summary, jitter and oscillation advantages were the same across experiments, but slower MID speed was required to match jittering than oscillating stimuli. Thus, to the extent that vection is driven by perceived speed of MID, this effect is greater for oscillating than for jittering stimuli, which suggests that the two effects may arise from separate mechanisms.	[Apthorp, Deborah] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia; [Apthorp, Deborah; Palmisano, Stephen] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia	Australian National University; University of Wollongong	Apthorp, D (corresponding author), Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia.	deborah.apthorp@anu.edu.au	Palmisano, Stephen/O-1553-2018; Apthorp, Deborah/N-5623-2014	Palmisano, Stephen/0000-0002-9140-5681; Apthorp, Deborah/0000-0001-5785-024X	Australian Research Council [DP0772398]	Australian Research Council(Australian Research Council)	This research was supported by an Australian Research Council Discovery grant to SP (DP0772398). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen-Stockdale C, 2012, VISION RES, V68, P28, DOI 10.1016/j.visres.2012.07.004; ANDERSEN GJ, 1985, J EXP PSYCHOL HUMAN, V11, P122, DOI 10.1037/0096-1523.11.2.122; Ash A, 2013, PERCEPTION, V42, P562, DOI 10.1068/p7449; Badcock DR, 2001, PSYCHOL RES-PSYCH FO, V65, P50, DOI 10.1007/s004260000020; BERTHOZ A, 1975, EXP BRAIN RES, V23, P471; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRANDT T, 1974, EXP BRAIN RES, V21, P337; BRANDT T, 1973, EXP BRAIN RES, V16, P476, DOI 10.1007/BF00234474; BRANDT T, 1975, PERCEPT PSYCHOPHYS, V17, P497, DOI 10.3758/BF03203301; Bruggeman H, 2007, CURR BIOL, V17, P2035, DOI 10.1016/j.cub.2007.10.059; Bubka A, 2010, PERCEPTION, V39, P627, DOI 10.1068/p6315; CASEY SM, 1992, J SAFETY RES, V23, P135, DOI 10.1016/0022-4375(92)90016-3; Cassanello CR, 2011, VISION RES, V51, P352, DOI 10.1016/j.visres.2010.11.012; Curran W, 2009, P R SOC B, V276, P263, DOI 10.1098/rspb.2008.1065; DEGRAAF B, 1990, VISION RES, V30, P637, DOI 10.1016/0042-6989(90)90074-U; DENTON GG, 1980, PERCEPTION, V9, P393, DOI 10.1068/p090393; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Dichgans Johannes, 1978, PERCEPTION, P755, DOI DOI 10.1007/978-3-642-46354-9_25; Durgin FH, 2005, J EXP PSYCHOL HUMAN, V31, P339, DOI 10.1037/0096-1523.31.2.339; Durgin FH, 2007, PERCEPTION, V36, P1465, DOI 10.1068/p5845; EDWARDS M, 1995, VISION RES, V35, P2589, DOI 10.1016/0042-6989(95)00003-I; Edwards M, 2012, VISION RES, V64, P23, DOI 10.1016/j.visres.2012.05.006; Kim J, 2012, PERCEPTION, V41, P402, DOI 10.1068/p6919; Kim J, 2010, J VISION, V10, DOI 10.1167/10.12.7; Kim J, 2010, EXP BRAIN RES, V202, P355, DOI 10.1007/s00221-009-2137-2; Kim J, 2008, BRAIN RES BULL, V77, P335, DOI 10.1016/j.brainresbull.2008.09.011; Lecuyer A, 2006, P IEEE VIRT REAL ANN, P11, DOI 10.1109/VR.2006.31; LEIBOWITZ HW, 1980, PERCEPT PSYCHOPHYS, V28, P173, DOI 10.3758/BF03204344; Li L, 2002, PSYCHOL SCI, V13, P485, DOI 10.1111/1467-9280.00486; LISHMAN JR, 1973, PERCEPTION, V2, P287, DOI 10.1068/p020287; Maloney RT, 2013, J NEUROPHYSIOL, V110, P2545, DOI 10.1152/jn.00445.2013; Nakamura S, 2013, PERCEPTION, V42, P529, DOI 10.1068/p7486; Nakamura S, 2010, PERCEPTION, V39, P320, DOI 10.1068/p6534; Palmisano S, 2004, PERCEPTION, V33, P987, DOI 10.1068/p5242; Palmisano S, 2003, PERCEPTION, V32, P97, DOI 10.1068/p3468; Palmisano S, 2002, PERCEPTION, V31, P463, DOI 10.1068/p3321; Palmisano S, 1998, PERCEPTION, V27, P1067, DOI 10.1068/p271067; Palmisano S, 1996, PERCEPT PSYCHOPHYS, V58, P1168, DOI 10.3758/BF03207550; Palmisano S, 2000, PERCEPTION, V29, P57, DOI 10.1068/p2990; Palmisano S, 2008, PERCEPTION, V37, P22, DOI 10.1068/p5806; Palmisano S, 2012, J VISION, V12, DOI 10.1167/12.12.15; Palmisano S, 2011, SEEING PERCEIVING, V24, P173, DOI 10.1163/187847511X570817; Palmisano S, 2009, ATTEN PERCEPT PSYCHO, V71, P1842, DOI 10.3758/APP.71.8.1842; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Riecke BE, 2006, ACM T APPL PERCEPT, V3, P194, DOI [10.1145/1166087.1166091., DOI 10.1145/1166087.1166091, 10.1145/1166087.1166091]; Riecke BE, 2011, VIRTUAL REALITY, P149; SCHMIDT F, 1969, J APPL PSYCHOL, V53, P536, DOI 10.1037/h0028674; Schulte-Pelkum J, 2003, 6 ANN WORKSH PRES PR, P37; Seno T, 2012, SEEING PERCEIVING, V25, P631, DOI 10.1163/18784763-00002394; Seno T, 2012, SEEING PERCEIVING, V25, P213, DOI 10.1163/187847612X626390; Seno T, 2011, VISION RES, V51, P2499, DOI 10.1016/j.visres.2011.10.007; Seno T, 2010, SEEING PERCEIVING, V23, P273, DOI 10.1163/187847510X532667; SMEETS JBJ, 1994, VISION RES, V34, P191, DOI 10.1016/0042-6989(94)90331-X; Vaina LM, 2012, ATTEN PERCEPT PSYCHO, V74, P1009, DOI 10.3758/s13414-012-0290-3; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Welchman AE, 2008, P NATL ACAD SCI USA, V105, P12087, DOI 10.1073/pnas.0804378105; Wist ER, 1975, ATTEN PERCEPT PSYCHO, V16, P549	59	34	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92260	10.1371/journal.pone.0092260	http://dx.doi.org/10.1371/journal.pone.0092260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651861	Green Submitted, gold, Green Published			2022-12-27	WOS:000333352800088
J	Clynes, D; Jelinska, C; Xella, B; Ayyub, H; Taylor, S; Mitson, M; Bachrati, CZ; Higgs, DR; Gibbons, RJ				Clynes, David; Jelinska, Clare; Xella, Barbara; Ayyub, Helena; Taylor, Stephen; Mitson, Matthew; Bachrati, Csanad Z.; Higgs, Douglas R.; Gibbons, Richard J.			ATRX Dysfunction Induces Replication Defects in Primary Mouse Cells	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; HUMAN TELOMERES; MRE11/RAD50/NBS1 COMPLEX; X SYNDROME; PROTEIN; MUTATIONS; H3.3; RECOMBINATION; RESTART; LOCALIZATION	The chromatin remodeling protein ATRX, which targets tandem repetitive DNA, has been shown to be required for expression of the alpha globin genes, for proliferation of a variety of cellular progenitors, for chromosome congression and for the maintenance of telomeres. Mutations in ATRX have recently been identified in tumours which maintain their telomeres by a telomerase independent pathway involving homologous recombination thought to be triggered by DNA damage. It is as yet unknown whether there is a central underlying mechanism associated with ATRX dysfunction which can explain the numerous cellular phenomena observed. There is, however, growing evidence for its role in the replication of various repetitive DNA templates which are thought to have a propensity to form secondary structures. Using a mouse knockout model we demonstrate that ATRX plays a direct role in facilitating DNA replication. Ablation of ATRX alone, although leading to a DNA damage response at telomeres, is not sufficient to trigger the alternative lengthening of telomere pathway in mouse embryonic stem cells.	[Clynes, David; Jelinska, Clare; Xella, Barbara; Ayyub, Helena; Mitson, Matthew; Higgs, Douglas R.; Gibbons, Richard J.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC,Mol Haematol Unit, Oxford OX3 9DU, England; [Taylor, Stephen] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford OX3 9DU, England; [Bachrati, Csanad Z.] Lincoln Univ, Sch Life Sci, Lincoln, England	University of Oxford; University of Oxford; University of Lincoln	Gibbons, RJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC,Mol Haematol Unit, Oxford OX3 9DU, England.	richard.gibbons@imm.ox.ac.uk	Bachrati, Csanad/ABF-2020-2021; Gibbons, Richard/E-6937-2011	Bachrati, Csanad/0000-0003-1703-5894; Gibbons, Richard/0000-0002-7680-9311; Higgs, Douglas/0000-0003-3579-8705; Clynes, David/0000-0003-4516-0043	Medical Research Council, United Kingdom; Medical Research Council [G0902418, G1000801, MC_U137961147, MC_UU_12009/4, MC_UU_12009/3, G1000801j, G1000801b] Funding Source: researchfish; MRC [MC_UU_12009/3, G1000801, MC_UU_12009/4, G0902418, MC_U137961147] Funding Source: UKRI	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RJG and co-workers are funded by the Medical Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachrati CZ, 2006, METHOD ENZYMOL, V409, P86, DOI 10.1016/S0076-6879(05)09005-1; Bagheri-Fam S, 2011, HUM MOL GENET, V20, P2213, DOI 10.1093/hmg/ddr109; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Clynes D, 2013, TRENDS BIOCHEM SCI, V38, P461, DOI 10.1016/j.tibs.2013.06.011; Conti C, 2007, CELL CYCLE, V6, P2760, DOI 10.4161/cc.6.22.4932; De La Fuente R, 2004, DEV BIOL, V272, P1, DOI 10.1016/j.ydbio.2003.12.012; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Ghosal G, 2005, NUCLEIC ACIDS RES, V33, P4692, DOI 10.1093/nar/gki777; GIBBONS RJ, 1995, HUM MOL GENET, V4, P1705, DOI 10.1093/hmg/4.suppl_1.1705; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Huh MS, 2012, J CLIN INVEST, V122, P4412, DOI 10.1172/JCI63765; Jiang WQ, 2005, MOL CELL BIOL, V25, P2708, DOI 10.1128/MCB.25.7.2708-2721.2005; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Leung JWC, 2013, J BIOL CHEM, V288, P6342, DOI 10.1074/jbc.M112.411603; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; Mitson M, 2011, HUM MOL GENET, V20, P2603, DOI 10.1093/hmg/ddr163; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; Robison JG, 2004, J BIOL CHEM, V279, P34802, DOI 10.1074/jbc.M404750200; Sarkies P, 2012, NUCLEIC ACIDS RES, V40, P1485, DOI 10.1093/nar/gkr868; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Schwab RA, 2010, EMBO J, V29, P806, DOI 10.1038/emboj.2009.385; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Watson LA, 2013, J CLIN INVEST, V123, P2049, DOI 10.1172/JCI65634; Wojewodzka M, 2002, MUTAT RES-GEN TOX EN, V518, P9, DOI 10.1016/S1383-5718(02)00070-0; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	41	64	66	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92915	10.1371/journal.pone.0092915	http://dx.doi.org/10.1371/journal.pone.0092915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651726	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000333352800164
J	Duggan, KA; Friedman, HS; McDevitt, EA; Mednick, SC				Duggan, Katherine A.; Friedman, Howard S.; McDevitt, Elizabeth A.; Mednick, Sara C.			Personality and Healthy Sleep: The Importance of Conscientiousness and Neuroticism	PLOS ONE			English	Article							CIRCADIAN-RHYTHM; MORTALITY; QUALITY; DURATION; METAANALYSIS; COMPLAINTS; BEHAVIORS; SEROTONIN; DISEASE; TRAITS	Although previous research has shown personality and sleep are each substantial predictors of health throughout the lifespan, little is known about links between personality and healthy sleep patterns. This study examined Big Five personality traits and a range of factors related to sleep health in 436 university students (M-age = 19.88, SD = 1.50, 50% Male). Valid self-report measures of personality, chronotype, sleep hygiene, sleep quality, and sleepiness were analyzed. To remove multicollinearity between personality factors, each sleep domain was regressed on relevant demographic and principal component-derived personality factors in multiple linear regressions. Results showed that low conscientiousness and high neuroticism were the best predictors of poor sleep (poor sleep hygiene, low sleep quality, and increased sleepiness), consistent with other research on predictors of poor health and mortality risk. In this first comprehensive study of the topic, the findings suggest that personality has a significant association with sleep health, and researchers could profitably examine both personality and sleep in models of health and well-being.	[Duggan, Katherine A.; Friedman, Howard S.; McDevitt, Elizabeth A.; Mednick, Sara C.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Mednick, SC (corresponding author), Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA.	smednick@ucr.edu		mednick, sara/0000-0002-0906-3097; Duggan, Katherine A./0000-0003-1768-3365	 [K01MH080992]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH080992] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grant K01MH080992 (http://www.nimh.nih.gov/) awarded to Sara C. Mednick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Bailey SL, 2001, CHRONOBIOL INT, V18, P249, DOI 10.1081/CBI-100103189; Blagrove M, 2001, PERS INDIV DIFFER, V30, P819, DOI 10.1016/S0191-8869(00)00075-1; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; BOOTHKEWLEY S, 1994, J PERS, V62, P282; Briones B, 1996, SLEEP, V19, P583, DOI 10.1093/sleep/19.7.583; Bruni O, 1999, CEPHALALGIA, V19, P57, DOI 10.1177/0333102499019S2516; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cajochen C, 2003, J NEUROENDOCRINOL, V15, P432, DOI 10.1046/j.1365-2826.2003.00989.x; Calkins AW, 2013, BEHAV SLEEP MED, V11, P133, DOI 10.1080/15402002.2011.643968; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Carver CS, 2006, PSYCHIAT RES, V144, P1, DOI 10.1016/j.psychres.2006.03.013; Carver CS, 2009, CURR DIR PSYCHOL SCI, V18, P195, DOI 10.1111/j.1467-8721.2009.01635.x; CASPI A, 1989, J PERS, V57, P375, DOI 10.1111/j.1467-6494.1989.tb00487.x; Cohen J., 2003, APPL MULTIPLE REGRES; COSTA PT, 1987, J PERS, V55, P299, DOI 10.1111/j.1467-6494.1987.tb00438.x; DeYoung CG, 2007, PERS INDIV DIFFER, V43, P267, DOI 10.1016/j.paid.2006.11.030; Dorsey CM, 1997, BIOL PSYCHIAT, V41, P209, DOI 10.1016/0006-3223(95)00659-1; Friedman EM, 2007, PSYCHOSOM MED, V69, P682, DOI 10.1097/PSY.0b013e31814ceada; Friedman H.S., 2011, LONGEVITY PROJECT SU; Friedman HS, 2014, DEV PSYCHOL, V50, P1377, DOI 10.1037/a0030373; Friedman HS, 2000, J PERS, V68, P1089, DOI 10.1111/1467-6494.00127; FRIEDMAN HS, 1987, AM PSYCHOL, V42, P539, DOI 10.1037/0003-066X.42.6.539; FRIEDMAN HS, 1995, AM PSYCHOL, V50, P69, DOI 10.1037/0003-066X.50.2.69; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Gray EK, 2002, J PERS, V70, P177; Hampson SE, 2012, ANNU REV PSYCHOL, V63, P315, DOI 10.1146/annurev-psych-120710-100419; Hogben AL, 2007, CHRONOBIOL INT, V24, P1249, DOI 10.1080/07420520701791596; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Howell AJ, 2008, PERS INDIV DIFFER, V45, P773, DOI 10.1016/j.paid.2008.08.005; Hublin C, 2007, SLEEP, V30, P1245, DOI 10.1093/sleep/30.10.1245; Jackson JJ, 2009, J PERS SOC PSYCHOL, V96, P446, DOI 10.1037/a0014156; John O, 1991, BIG 5 INVENTORY VERS; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; John OP, 2004, J PERS, V72, P1301, DOI 10.1111/j.1467-6494.2004.00298.x; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kern ML, 2008, HEALTH PSYCHOL, V27, P505, DOI 10.1037/0278-6133.27.5.505; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Mallon L, 2002, J INTERN MED, V251, P207, DOI 10.1046/j.1365-2796.2002.00941.x; Mastin DF, 2006, J BEHAV MED, V29, P223, DOI 10.1007/s10865-006-9047-6; Mastin DF, 2005, PERS INDIV DIFFER, V39, P1471, DOI 10.1016/j.paid.2005.08.007; NEUBAUER AC, 1992, PERS INDIV DIFFER, V13, P125, DOI 10.1016/0191-8869(92)90035-N; Pilcher JJ, 1997, J PSYCHOSOM RES, V42, P583, DOI 10.1016/S0022-3999(97)00004-4; PROSSER RA, 1993, J BIOL RHYTHM, V8, P1, DOI 10.1177/074873049300800101; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; REYNER A, 1995, SLEEP, V18, P127; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; SCARR S, 1983, CHILD DEV, V54, P424, DOI 10.2307/1129703; Schmitt DP, 2007, J CROSS CULT PSYCHOL, V38, P173, DOI 10.1177/0022022106297299; Shipley BA, 2007, PSYCHOSOM MED, V69, P923, DOI 10.1097/PSY.0b013e31815abf83; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Tonetti L, 2009, CHRONOBIOL INT, V26, P337, DOI 10.1080/07420520902750995; Urban R, 2011, CHRONOBIOL INT, V28, P238, DOI 10.3109/07420528.2010.549599; Vitiello MV, 2004, J PSYCHOSOM RES, V56, P503, DOI 10.1016/S0022-3999(04)00023-6; Voderholzer U, 2003, DEPRESS ANXIETY, V17, P162, DOI 10.1002/da.10101; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Williams PG, 2009, PERS INDIV DIFFER, V46, P598, DOI 10.1016/j.paid.2008.12.017; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979	65	118	124	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90628	10.1371/journal.pone.0090628	http://dx.doi.org/10.1371/journal.pone.0090628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651274	Green Published, gold			2022-12-27	WOS:000333352800018
J	Jahanian, H; Ni, WW; Christen, T; Moseley, ME; Tamura, MK; Zaharchuk, G				Jahanian, Hesamoddin; Ni, Wendy W.; Christen, Thomas; Moseley, Michael E.; Tamura, Manjula Kurella; Zaharchuk, Greg			Spontaneous BOLD Signal Fluctuations in Young Healthy Subjects and Elderly Patients with Chronic Kidney Disease	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; FUNCTIONAL CONNECTIVITY; PHYSIOLOGICAL NOISE; BRAIN ACTIVITY; WHITE-MATTER; MR-IMAGES; 7 TESLA; FMRI; ISCHEMIA; HUMANS	Spontaneous fluctuations in blood oxygenation level-dependent (BOLD) images are the basis of resting-state fMRI and frequently used for functional connectivity studies. However, there may be intrinsic information in the amplitudes of these fluctuations. We investigated the possibility of using the amplitude of spontaneous BOLD signal fluctuations as a biomarker for cerebral vasomotor reactivity. We compared the coefficient of variation (CV) of the time series (defined as the temporal standard deviation of the time series divided by the mean signal intensity) in two populations: 1) Ten young healthy adults and 2) Ten hypertensive elderly subjects with chronic kidney disease (CKD). We found a statistically significant increase (P<0.01) in the CV values for the CKD patients compared with the young healthy adults in both gray matter (GM) and white matter (WM). The difference was independent of the exact segmentation method, became more significant after correcting for physiological signals using RETROICOR, and mainly arose from very low frequency components of the BOLD signal fluctuation (f<0.025 Hz). Furthermore, there was a strong relationship between WM and GM signal fluctuation CV's (R-2 = 0.87) in individuals, with a ratio of about 1:3. These results suggest that amplitude of the spontaneous BOLD signal fluctuations may be used to assess the cerebrovascular reactivity mechanisms and provide valuable information about variations with age and different disease states.	[Jahanian, Hesamoddin; Ni, Wendy W.; Christen, Thomas; Moseley, Michael E.; Zaharchuk, Greg] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Ni, Wendy W.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Tamura, Manjula Kurella] Stanford Univ, Geriatr Res & Educ Clin Ctr, Palo Alto Vet Affairs Hlth Care Syst, Stanford, CA 94305 USA; [Tamura, Manjula Kurella] Stanford Univ, Div Nephrol, Stanford, CA 94305 USA	Stanford University; Stanford University; Geriatric Research Education & Clinical Center; Stanford University; Stanford University	Jahanian, H (corresponding author), Stanford Univ, Dept Radiol, Stanford, CA 94305 USA.	hesamj@stanford.edu	Tamura, Manjula Kurella/C-8284-2014; christen, thomas/O-4482-2018	Tamura, Manjula Kurella/0000-0001-5227-2479; christen, thomas/0000-0002-8791-9145	NIH [1R01NS066506, 2R01NS047607, R01DK092241]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047607, R01NS066506] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by NIH grants 1R01NS066506, 2R01NS047607, R01DK092241. However, NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Chang KV, 2011, J CLIN ULTRASOUND, V39, P383, DOI 10.1002/jcu.20819; Fazekas G, 1996, NUCL MED COMMUN, V17, P603, DOI 10.1097/00006231-199607000-00011; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Jain V, 2011, J CEREBR BLOOD F MET, V31, P1504, DOI 10.1038/jcbfm.2011.34; Kimoto E, 2006, J AM SOC NEPHROL, V17, P2245, DOI 10.1681/ASN.2005101038; Kozera GM, 2010, AM J HYPERTENS, V23, P1198, DOI 10.1038/ajh.2010.152; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Liu YT, 2007, J MAGN RESON IMAGING, V26, P1112, DOI 10.1002/jmri.21131; Lux S, 2010, KIDNEY INT, V78, P794, DOI 10.1038/ki.2010.253; Makedonov I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067652; Markus HS, 2000, J NEUROL NEUROSUR PS, V69, P48, DOI 10.1136/jnnp.69.1.48; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Pan WJ, 2013, NEUROIMAGE, V74, P288, DOI 10.1016/j.neuroimage.2013.02.035; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Wang HH, 2008, J MAGN RESON IMAGING, V27, P866, DOI 10.1002/jmri.21007; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080; Yao QL, 2012, NEUROSCI LETT, V509, P22, DOI 10.1016/j.neulet.2011.12.036; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	24	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92539	10.1371/journal.pone.0092539	http://dx.doi.org/10.1371/journal.pone.0092539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651703	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800124
J	Kedjarune-Leggat, U; Supaprutsakul, C; Chotigeat, W				Kedjarune-Leggat, Ureporn; Supaprutsakul, Chanyapat; Chotigeat, Wilaiwan			Ultrasound Treatment Increases Transfection Efficiency of Low Molecular Weight Chitosan in Fibroblasts but Not in KB Cells	PLOS ONE			English	Article							GENE DELIVERY; IN-VITRO; INTRACELLULAR TRAFFICKING; NANOPARTICLES; DNA; SYSTEM; DRUG; MICROBUBBLES; PATHWAYS	The aim of this study was to optimize transfection efficiency (TE) of the depolymerized low molecular weight (LW) chitosan with molecular weight (Mw) at 16 kDa and 54% degree of deacetylation (DDA) on three primary cells of fibroblast (F), dental pulp (P), and periodontal ligament (PDL). The effect of low frequency ultrasound treatment on the chitosan-DNA complexes prior transfection on TE was also evaluated. This LW chitosan required high N/P ratio (>34) to bind DNA completely. An N/P ratio above 56 tended to improve TE in most primary cells nearly at the level of Lipofectamine. Ultrasonication can reduce the aggregation and sizes of the chitosan-DNA microparticles. It increased TE of F cells at an N/P ratio above 34, which was higher than Lipofectamine. However, this ultrasound treatment caused loss of TE in KB cells. MTT assay of these chitosan-DNA complexes revealed no significant cytotoxicity to both KB and F cells. This LW chitosan has potential for further development into a safer alternative to gene delivery systems in various cells of interest; however the optimal conditions have to be adjusted, depending on each cell source.	[Kedjarune-Leggat, Ureporn; Supaprutsakul, Chanyapat] Prince Songkla Univ, Fac Dent, Dept Oral Biol & Occlus, Hat Yai, Songkhla, Thailand; [Supaprutsakul, Chanyapat; Chotigeat, Wilaiwan] Prince Songkla Univ, Fac Sci, Dept Mol Biotechnol & Bioinformat, Hat Yai, Songkhla, Thailand	Prince of Songkla University; Prince of Songkla University	Kedjarune-Leggat, U (corresponding author), Prince Songkla Univ, Fac Dent, Dept Oral Biol & Occlus, Hat Yai, Songkhla, Thailand.	ureporn.l@psu.ac.th			Prince of Songkla University [DEN50109900106s]; Prince of Songkla University	Prince of Songkla University; Prince of Songkla University	Prince of Songkla University grant No. DEN50109900106s and a Prince of Songkla University post graduate grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alameh M, 2012, INT J NANOMED, V7, P1399, DOI 10.2147/IJN.S26571; Bai WK, 2012, ONCOL REP, V27, P475, DOI 10.3892/or.2011.1510; Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015; Bernkop-Schnurch A, 2012, EUR J PHARM BIOPHARM; Buschmann MD, 2013, ADV DRUG DELIVER REV, V65, P1234, DOI 10.1016/j.addr.2013.07.005; Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001; Douglas KL, 2008, EUR J PHARM BIOPHARM, V68, P676, DOI 10.1016/j.ejpb.2007.09.002; Duceppe N, 2009, BIOMATERIALS; Duceppe N, 2010, EXPERT OPIN DRUG DEL, V7, P1191, DOI 10.1517/17425247.2010.514604; Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671; FRESHNEY RI, 1985, ANTICANCER RES, V5, P111; Hsu SH, 2012, BIOMATERIALS, V33, P3639, DOI 10.1016/j.biomaterials.2012.02.005; Huang M, 2004, PHARM RES-DORDR, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5; Izumisawa T, 2011, INT J PHARMACEUT, V404, P264, DOI 10.1016/j.ijpharm.2010.11.017; Jreyssaty C, 2012, ISRN PHARM, V2012, P369270; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Komamura K, 2011, DRUG DELIV, V2011; Koping-Hoggard M, 2003, J GENE MED, V5, P130, DOI 10.1002/jgm.327; Mao SR, 2010, ADV DRUG DELIVER REV, V62, P12, DOI 10.1016/j.addr.2009.08.004; Mao SR, 2004, INT J PHARMACEUT, V281, P45, DOI 10.1016/j.ijpharm.2004.05.019; Morris VB, 2008, J BIOMED MAT RES B; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nimesh S, 2010, MOL BIOTECHNOL, V46, P182, DOI 10.1007/s12033-010-9286-1; Omata D, 2011, MOL PHARMACEUT, V8, P2416, DOI 10.1021/mp200353m; Phillips LC, 2010, ULTRASOUND MED BIOL, V36, P1470, DOI 10.1016/j.ultrasmedbio.2010.06.010; Pua EC, 2009, IEEE ENG MED BIOL, V28, P64, DOI 10.1109/MEMB.2008.931017; Ramesan RM, 2012, NANOMEDICINE-UK, V7, P5, DOI [10.2217/nnm.11.170, 10.2217/NNM.11.170]; Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0; Romoren K, 2003, INT J PHARM, V261, P115, DOI 10.1016/S0378-5173(03)00301-6; Saito A, 2001, APPL ENVIRON MICROB, V67, P1268, DOI 10.1128/AEM.67.3.1268-1273.2001; Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013; Supaprutsakul S, 2010, J MATER SCI-MATER M, V21, P1553, DOI 10.1007/s10856-010-3993-9; Tang ESK, 2003, INT J PHARMACEUT, V265, P103, DOI 10.1016/S0378-5173(03)00408-3; Thibault M, 2011, BIOMATERIALS, V32, P4639, DOI 10.1016/j.biomaterials.2011.03.010; Thibault M, 2010, MOL THER, V18, P1787, DOI 10.1038/mt.2010.143; Tripathi SK, 2012, BIOMATERIALS, V33, P4204, DOI 10.1016/j.biomaterials.2012.02.035; Turan K, 2006, PHARM DEV TECHNOL, V11, P503, DOI 10.1080/10837450600940873; Wang JJ, 2011, INT J NANOMED, V6, P765, DOI 10.2147/IJN.S17296; Yuan QY, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-56; Zhang L, 2011, J HUAZHONG U SCI-MED, V31, P39, DOI 10.1007/s11596-011-0147-3; Zhao X, 2006, J CONTROL RELEASE, V112, P223, DOI 10.1016/j.jconrel.2006.01.016; Zhou SJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-170; Zhu WL, 2008, ANTICANCER RES, V28, P1575	43	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92076	10.1371/journal.pone.0092076	http://dx.doi.org/10.1371/journal.pone.0092076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651870	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800068
J	Keilwagen, J; Grosse, I; Grau, J				Keilwagen, Jens; Grosse, Ivo; Grau, Jan			Area under Precision-Recall Curves for Weighted and Unweighted Data	PLOS ONE			English	Article							CLASSIFICATION; DISCOVERY	Precision-recall curves are highly informative about the performance of binary classifiers, and the area under these curves is a popular scalar performance measure for comparing different classifiers. However, for many applications class labels are not provided with absolute certainty, but with some degree of confidence, often reflected by weights or soft labels assigned to data points. Computing the area under the precision-recall curve requires interpolating between adjacent supporting points, but previous interpolation schemes are not directly applicable to weighted data. Hence, even in cases where weights were available, they had to be neglected for assessing classifiers using precision-recall curves. Here, we propose an interpolation for precision-recall curves that can also be used for weighted data, and we derive conditions for classification scores yielding the maximum and minimum area under the precision-recall curve. We investigate accordances and differences of the proposed interpolation and previous ones, and we demonstrate that taking into account existing weights of test data is important for the comparison of classifiers.	[Keilwagen, Jens] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Inst Biosafety Plant Biotechnol, Quedlinburg, Germany; [Grosse, Ivo; Grau, Jan] Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Saale, Germany; [Grosse, Ivo] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Julius Kuhn-Institut; Martin Luther University Halle Wittenberg	Keilwagen, J (corresponding author), Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Inst Biosafety Plant Biotechnol, Quedlinburg, Germany.	jens.keilwagen@jki.bund.de	Grau, Jan/H-5465-2019	Grau, Jan/0000-0003-2081-6405; Keilwagen, Jens/0000-0002-6792-7076				Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Aslam J. A., 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P573, DOI 10.1145/1076034.1076134; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bleakley K, 2007, BIOINFORMATICS, V23, pI57, DOI 10.1093/bioinformatics/btm204; Boyd Kendrick, 2013, Machine Learning and Knowledge Discovery in Databases. European Conference, ECML PKDD 2013. Proceedings: LNCS 8190, P451, DOI 10.1007/978-3-642-40994-3_29; Boyd K., 2012, ICML; Brodersen K. H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P4263, DOI 10.1109/ICPR.2010.1036; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fawcett Tom, 2004, TECHNICAL REPORT; Goldberg A.B., 2009, 10 ANN C N AM CHAPTE, P263, DOI DOI 10.3115/1620754.1620793; Grau J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt831; Grau J, 2012, J MACH LEARN RES, V13, P1967; Keilwagen J, 2007, LWA LERN WISS ABST A, P67; Kekalainen J, 2002, J AM SOC INF SCI TEC, V53, P1120, DOI 10.1002/asi.10137; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Martin DR, 2004, IEEE T PATTERN ANAL, V26, P530, DOI 10.1109/TPAMI.2004.1273918; Ohsaki M, 2007, ARTIF INTELL MED, V41, P177, DOI 10.1016/j.artmed.2007.07.005; Poulter GL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-108; Prechelt L, 2002, J UNIVERS COMPUT SCI, V8, P1016; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Sonnenburg S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S10-S7; Stehman SV, 1997, REMOTE SENS ENVIRON, V62, P77, DOI 10.1016/S0034-4257(97)00083-7; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zheng SF, 2010, COMPUT VIS IMAGE UND, V114, P1055, DOI 10.1016/j.cviu.2010.07.004; Zucchini W, 2000, J MATH PSYCHOL, V44, P41, DOI 10.1006/jmps.1999.1276	28	71	73	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92209	10.1371/journal.pone.0092209	http://dx.doi.org/10.1371/journal.pone.0092209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651729	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800085
J	Pearson, AL; Winter, PR; McBreen, B; Stewart, G; Roets, R; Nutsford, D; Bowie, C; Donnellan, N; Wilson, N				Pearson, Amber L.; Winter, Pieta R.; McBreen, Ben; Stewart, Georgia; Roets, Rianda; Nutsford, Daniel; Bowie, Christopher; Donnellan, Niamh; Wilson, Nick			Obtaining Fruit and Vegetables for the Lowest Prices: Pricing Survey of Different Outlets and Geographical Analysis of Competition Effects	PLOS ONE			English	Article							FARMERS MARKETS; LOW-INCOME; FOOD; SUPERMARKETS; ACCESS; STORES; URBAN	Aims: Inadequate fruit and vegetable (F&V) consumption is an important dietary risk factor for disease internationally. High F&V prices can be a barrier to dietary intake and so to improve understanding of this topic we surveyed prices and potential competition between F&V outlet types. Methods: Over a three week early autumn period in 2013, prices were collected bi-weekly for 18 commonly purchased F&Vs from farmers' markets (FM) selling local produce (n = 3), other F&V markets (OFVM) (n = 5), supermarkets that neighbored markets (n = 8), and more distant supermarkets (n = 8), (in urban Wellington and Christchurch areas of New Zealand). Prices from an online supermarket were also collected. Results: A total of 3120 prices were collected. Most F&Vs (13/18) were significantly cheaper at OFVMs than supermarkets. Over half of the F&Vs (10/18) were significantly cheaper at nearby compared to distant supermarkets, providing evidence of a moderate 'halo effect' in price reductions in supermarkets that neighbored markets. Weekend (vs midweek) prices were also significantly cheaper at nearby (vs distant) supermarkets, supporting evidence for a 'halo effect'. Ideal weekly 'food basket' prices for a two adult, two child family were: OFVMs (NZ$76), online supermarket ($113), nearby supermarkets ($124), distant supermarkets ($127), and FMs ($138). This represents a savings of $49 per week (US$26) by using OFVMs relative to (non-online) supermarkets. Similarly, a shift from non-online supermarkets to the online supermarket would generate a $13 saving. Conclusions: In these locations general markets appear to be providing some substantially lower prices for fruit and vegetables than supermarkets. They also appear to be depressing prices in neighboring supermarkets. These results, when supplemented by other needed research, may help inform the case for interventions to improve access to fruit and vegetables, particularly for low-income populations.	[Pearson, Amber L.; Winter, Pieta R.; McBreen, Ben; Stewart, Georgia; Roets, Rianda; Wilson, Nick] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Pearson, Amber L.; Nutsford, Daniel; Bowie, Christopher; Donnellan, Niamh] Univ Canterbury, Dept Geog, Christchurch 1, New Zealand	University of Otago; University of Canterbury	Pearson, AL (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, New Zealand.	amber.pearson@otago.ac.nz	Donnellan, Niamh/AAR-7481-2020; Donnellan, Niamh/AAB-7147-2019	Donnellan, Niamh/0000-0002-9411-7642				Black AP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1099; Blakely T, 2011, J EPIDEMIOL COMMUN H, V65, P902, DOI 10.1136/jech.2010.118588; Caldwell EM, 2009, PUBLIC HEALTH NUTR, V12, P1743, DOI 10.1017/S1368980008004308; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Evans AE, 2012, HEALTH PLACE, V18, P1137, DOI 10.1016/j.healthplace.2012.04.007; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Freedman DA, 2013, PREV MED, V56, P288, DOI 10.1016/j.ypmed.2013.01.018; George DR, 2011, AM J PUBLIC HEALTH, V101, P2226, DOI 10.2105/AJPH.2011.300197; Herman DR, 2008, AM J PUBLIC HEALTH, V98, P98, DOI 10.2105/AJPH.2005.079418; Inland Revenue Department, 2013, G4110 SUP GROC STOR; Larsen K, 2009, HEALTH PLACE, V15, P1158, DOI 10.1016/j.healthplace.2009.06.007; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McGuirt JT, 2011, J HUNGER ENVIRON NUT, V6, P86, DOI 10.1080/19320248.2010.551031; Mhurchu CN, 2007, NEW ZEAL MED J, V120, P13; Ministry of Health, 2012, HLTH NZ AD 2011 12 K; Murphy AJ, 2011, INT J RETAIL DISTRIB, V39, P582, DOI 10.1108/09590551111148668; Pearce J, 2008, J EPIDEMIOL COMMUN H, V62, P198, DOI 10.1136/jech.2006.059196; Ruelas V, 2012, J COMMUN HEALTH, V37, P554, DOI 10.1007/s10900-011-9479-y; Sauer C, 2012, IS LOCAL FOOD MORE E; Smith DM, 2010, INT J EPIDEMIOL, V39, P277, DOI 10.1093/ije/dyp221; Smith-Spangler C, 2012, ANN INTERN MED, V157, P348, DOI 10.7326/0003-4819-157-5-201209040-00007; Suarez-Balcazar Y., 2006, Journal of Extension, V44, p2FEA2; Swenson PJ, 2012, PAIRED PRICE COMP FA; Thornton LE, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-29; Turrell G, 2002, J HUM NUTR DIET, V15, P355, DOI 10.1046/j.1365-277X.2002.00384.x; Wall J, 2006, NUTR REV, V64, P518, DOI [10.1301/nr.2006.dec.518-531, 10.1111/j.1753-4887.2006.tb00185.x]; Wilson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059648; Wilson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058539; WRAP (The Waste and Resources Action Programme), 2009, HOUS FOOD DRINK WAST	29	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e89775	10.1371/journal.pone.0089775	http://dx.doi.org/10.1371/journal.pone.0089775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651475	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800003
J	Sturz, BR; Edwards, JE; Boyer, TW				Sturz, Bradley R.; Edwards, Joshua E.; Boyer, Ty W.			Asymmetrical Interference Effects between Two-Dimensional Geometric Shapes and Their Corresponding Shape Words	PLOS ONE			English	Article							SPATIAL REORIENTATION; YOUNG-CHILDREN; CORE KNOWLEDGE; DUAL-TASK; 2 SYSTEMS; MODULE; REPRESENTATION; ENVIRONMENT; BOUNDARIES; NAVIGATION	Nativists have postulated fundamental geometric knowledge that predates linguistic and symbolic thought. Central to these claims is the proposal for an isolated cognitive system dedicated to processing geometric information. Testing such hypotheses presents challenges due to difficulties in eliminating the combination of geometric and non-geometric information through language. We present evidence using a modified matching interference paradigm that an incongruent shape word interferes with identifying a two-dimensional geometric shape, but an incongruent two-dimensional geometric shape does not interfere with identifying a shape word. This asymmetry in interference effects between two-dimensional geometric shapes and their corresponding shape words suggests that shape words activate spatial representations of shapes but shapes do not activate linguistic representations of shape words. These results appear consistent with hypotheses concerning a cognitive system dedicated to processing geometric information isolated from linguistic processing and provide evidence consistent with hypotheses concerning knowledge of geometric properties of space that predates linguistic and symbolic thought.	[Sturz, Bradley R.; Edwards, Joshua E.; Boyer, Ty W.] Georgia So Univ, Dept Psychol, Statesboro, GA 30460 USA	University System of Georgia; Georgia Southern University	Sturz, BR (corresponding author), Georgia So Univ, Dept Psychol, Statesboro, GA 30460 USA.	bradleysturz@georgiasouthern.edu	Sturz, Bradley R./H-7564-2019; Boyer, Ty W./H-7445-2019	Boyer, Ty W./0000-0001-9844-802X	Office of the Vice President for Research; Jack N. Averitt College of Graduate Studies at Georgia Southern University	Office of the Vice President for Research; Jack N. Averitt College of Graduate Studies at Georgia Southern University	This research was supported by funds from the Office of the Vice President for Research and the Jack N. Averitt College of Graduate Studies at Georgia Southern University to BRS and TWB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown AA, 2007, PSYCHOL SCI, V18, P569, DOI 10.1111/j.1467-9280.2007.01941.x; Cheng K, 2005, PSYCHON B REV, V12, P1, DOI 10.3758/BF03196346; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Cheng K, 2013, PSYCHON B REV, V20, P1033, DOI 10.3758/s13423-013-0416-1; Chiandetti C, 2008, ANIM COGN, V11, P139, DOI 10.1007/s10071-007-0099-y; Chiandetti C, 2010, ANIM COGN, V13, P463, DOI 10.1007/s10071-009-0297-x; COMPTON RP, 1977, PERCEPT PSYCHOPHYS, V22, P303, DOI 10.3758/BF03199694; Dakin SC, 2009, J VISION, V9, DOI [10.1167/9.4.2, 10.1167/9.11.28]; Dehaene S, 2006, SCIENCE, V311, P381, DOI 10.1126/science.1121739; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5909, DOI 10.1073/pnas.0711433105; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Gallistel C. R., 1990, ORG LEARNING; Hatfield Gary, 1990, NATURAL NORMATIVE TH; HERMER L, 1994, NATURE, V370, P57, DOI 10.1038/370057a0; Hermer-Vazquez L, 1999, COGNITIVE PSYCHOL, V39, P3, DOI 10.1006/cogp.1998.0713; Lee SA, 2006, PSYCHOL SCI, V17, P577, DOI 10.1111/j.1467-9280.2006.01747.x; Lee SA, 2010, COGNITIVE PSYCHOL, V61, P152, DOI 10.1016/j.cogpsych.2010.04.002; Lee SA, 2010, EXP BRAIN RES, V206, P179, DOI 10.1007/s00221-010-2349-5; Ratliff KR, 2008, COGNITIVE PSYCHOL, V56, P142, DOI 10.1016/j.cogpsych.2007.06.002; Ratliff KR, 2008, PSYCHOL SCI, V19, P1301, DOI 10.1111/j.1467-9280.2008.02239.x; Smith LB, 2003, PSYCHOL SCI, V14, P244, DOI 10.1111/1467-9280.03439; Smith LB, 2009, CURR DIR PSYCHOL SCI, V18, P290, DOI 10.1111/j.1467-8721.2009.01654.x; Spelke E, 2010, COGNITIVE SCI, V34, P863, DOI 10.1111/j.1551-6709.2010.01110.x; Spelke ES, 2012, PHILOS T R SOC B, V367, P2784, DOI 10.1098/rstb.2012.0210; Sturz BR, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00842; Vallortigara G, 2004, J COGNITIVE NEUROSCI, V16, P390, DOI 10.1162/089892904322926737	26	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92740	10.1371/journal.pone.0092740	http://dx.doi.org/10.1371/journal.pone.0092740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651272	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800151
J	Zhang, HT; Wei, Q; Liu, RL; Qi, SY; Liang, PH; Qi, C; Wang, AD; Sheng, B; Li, L; Xu, Y				Zhang, Hongtuan; Wei, Qiang; Liu, Ranlu; Qi, Shiyong; Liang, Peihe; Qi, Can; Wang, Andi; Sheng, Bin; Li, Liang; Xu, Yong			Overexpression of LAPTM4B-35: A Novel Marker of Poor Prognosis of Prostate Cancer	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; TETRATRANSMEMBRANE PROTEIN; EXPRESSION; PROGRESSION; NUCB2; PLAY	Background: Lysosome-associated protein transmembrane 4b-35 (LAPTM4B-35) is a member of the mammalian 4-tetratransmembrane spanning protein superfamily, which is overexpressed in several solid malignancies. However, the expression of LAPTM4B-35 and its role in the progression of prostate cancer (PCa) is unknown. The aim of the present study was to investigate the LAPTM4B-35 expression in PCa and its potential relevance to clinicopathological variables and prognosis. Methods: Immunohistochemistry was used to determine the expression of LAPTM4B-35 protein in 180 PCa tissues in comparison with 180 normal benign prostatic hyperplasia (BPH) specimens. The correlation between the expression of the LAPTM4B-35 protein and the clinicopathologic characteristics of patients with PCa was analyzed. Results: Statistical analysis showed that LAPTM4B-35 expression was significantly elevated in PCa compared with the BPH controls. High LAPTM4B-35 staining was present in 71.11% of all the cases with PCa. The overexpression of LAPTM4B-35 was significantly associated with the lymph node metastasis, seminal vesicle invasion, PCa stage, higher Gleason score, higher preoperative PSA, and biochemical recurrence (BCR). The Kaplan-Meier survival analysis showed that the high expression of LAPTM4B-35 was related to the poor overall survival and BCR-free survival of patients with PCa. Multivariate Cox analysis showed that LAPTM4B-35 was an independent prognostic factor for both overall survival and BCR-free survival of patients with PCa. Conclusions: Overexpression of LAPTM4B-35 may be associated with tumor progression and poor prognosis in PCa and thus may serve as a new molecular marker to predict the prognosis of PCa patients.	[Zhang, Hongtuan; Wei, Qiang; Liu, Ranlu; Qi, Shiyong; Qi, Can; Wang, Andi; Sheng, Bin; Xu, Yong] Tianjin Med Univ, Hosp 2, Tianjin Key Inst Urol, Dept Urol,Natl Key Clin Specialty Urol, Tianjin, Peoples R China; [Liang, Peihe] Chongqing Med Univ, Affiliated Hosp 2, Dept Urol, Chongqing, Peoples R China; [Li, Liang] Tianjin Med Univ, Hosp 2, Dept Radiol, Tianjin, Peoples R China	Tianjin Medical University; Chongqing Medical University; Tianjin Medical University	Xu, Y (corresponding author), Tianjin Med Univ, Hosp 2, Tianjin Key Inst Urol, Dept Urol,Natl Key Clin Specialty Urol, Tianjin, Peoples R China.	xymnwk@163.com		Wang, Yuzhuo/0000-0002-9749-8591	National Natural Science Foundation of China [81172451]; Tianjin Major Anti-Cancer Project [12ZCDZSY17200]; Science Foundation of Tianjin medical university [2009GSI18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Major Anti-Cancer Project; Science Foundation of Tianjin medical university	This study was supported by the National Natural Science Foundation of China (NO: 81172451), Tianjin Major Anti-Cancer Project (12ZCDZSY17200), and Science Foundation of Tianjin medical university. (NO: 2009GSI18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren O, 2006, J UROLOGY, V175, P1337, DOI 10.1016/S0022-5347(05)00734-2; Cabrita MA, 1999, CANCER RES, V59, P4890; Carroll PR, 2005, J UROLOGY, V173, P1061, DOI 10.1097/01.ju.0000156838.67623.10; Kasper G, 2005, CANCER LETT, V224, P93, DOI 10.1016/j.canlet.2004.10.004; Liu XR, 2004, WORLD J GASTROENTERO, V10, P1555, DOI 10.3748/wjg.v10.i11.1555; Liu XR, 2009, CANCER SCI, V100, P2335, DOI 10.1111/j.1349-7006.2009.01346.x; Molina R, 2012, TUMOR BIOL, V33, P463, DOI 10.1007/s13277-011-0275-1; Overdevest JB, 2009, CLIN CHEM, V55, P684, DOI 10.1373/clinchem.2008.118554; Pandith AA, 2012, TUMOR BIOL, V33, P1629, DOI 10.1007/s13277-012-0418-z; Pinto A, 2012, TUMOR BIOL, V33, P421, DOI 10.1007/s13277-011-0299-6; Ribeiro R, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-32; Sardana G, 2008, CLIN CHEM, V54, P1951, DOI 10.1373/clinchem.2008.110668; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Vaarala MH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-136; Vickers A, 2010, J CLIN ONCOL, V28, P2493, DOI 10.1200/JCO.2009.24.1968; Xiao M, 2013, J CANCER RES CLIN, V139, P661, DOI 10.1007/s00432-012-1368-y; Yang H, 2010, J CANCER RES CLIN, V136, P275, DOI 10.1007/s00432-009-0659-4; Yang Y, 2008, ONCOL REP, V20, P1077, DOI 10.3892/or_00000112; Zhang HT, 2014, TUMOR BIOL, V35, P2025, DOI 10.1007/s13277-013-1268-z; Zhang HT, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-77; Zhang HT, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-56; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025; Zhou L, 2010, AM J SURG, V199, P515, DOI 10.1016/j.amjsurg.2009.03.031	25	28	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91069	10.1371/journal.pone.0091069	http://dx.doi.org/10.1371/journal.pone.0091069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651764	gold, Green Submitted, Green Published			2022-12-27	WOS:000333352800029
J	Ikeda, S; Tainaka, K; Matsumoto, K; Shinohara, Y; Ode, KL; Susaki, EA; Ueda, HR				Ikeda, Shuji; Tainaka, Kazuki; Matsumoto, Katsuhiko; Shinohara, Yuta; Ode, Koji L.; Susaki, Etsuo A.; Ueda, Hiroki R.			Non-Enzymatic DNA Cleavage Reaction Induced by 5-Ethynyluracil in Methylamine Aqueous Solution and Application to DNA Concatenation	PLOS ONE			English	Article							STRAND CLEAVAGE; RESTRICTION	DNA can be concatenated by hybridization of DNA fragments with protruding single-stranded termini. DNA cleavage occurring at a nucleotide containing a DNA base analogue is a useful method to obtain DNA with designed protruding termini. Here, we report a novel non-enzymatic DNA cleavage reaction for DNA concatenation. We found that DNA is cleaved at a nucleotide containing 5-ethynyluracil in a methylamine aqueous solution to generate 59-phosphorylated DNA fragment as a cleavage product. We demonstrated that the reaction can be applied to DNA concatenation of PCR-amplified DNA fragments. This novel non-enzymatic DNA cleavage reaction is a simple practical approach for DNA concatenation.	[Ikeda, Shuji; Matsumoto, Katsuhiko; Ueda, Hiroki R.] RIKEN, Quantitat Biol Ctr, Lab Synthet Biol, Chuo Ku, Kobe, Hyogo, Japan; [Ueda, Hiroki R.] RIKEN, Ctr Dev Biol, Lab Syst Biol, Chuo Ku, Kobe, Hyogo, Japan; [Tainaka, Kazuki; Ode, Koji L.; Susaki, Etsuo A.; Ueda, Hiroki R.] Univ Tokyo, Grad Sch Med, Dept Syst Pharmacol, Bunkyo Ku, Tokyo, Japan; [Ueda, Hiroki R.] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 560, Japan; [Shinohara, Yuta; Ueda, Hiroki R.] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan	RIKEN; RIKEN; University of Tokyo; Osaka University; Osaka University	Ueda, HR (corresponding author), RIKEN, Quantitat Biol Ctr, Lab Synthet Biol, Chuo Ku, Kobe, Hyogo, Japan.	uedah-tky@umin.ac.jp	Ueda, Hiroki R/C-5037-2014	Ueda, Hiroki R/0000-0001-8342-9176; Susaki, Etsuo/0000-0001-5621-7311; Tainaka, Kazuki/0000-0002-5943-8723; Matsumoto, Katsuhiko/0000-0002-9680-8711	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25221004]; MEXT/Japan Society for the Promotion of Science (JSPS) [23115006]; RIKEN; RIKEN Center for Developmental Biology; RIKEN Quantitative Biology Center; Core Research for Evolutional Science and Technology (CREST); Japan Foundation for Applied Enzymology;  [A2559890]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT/Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN; RIKEN Center for Developmental Biology; RIKEN Quantitative Biology Center; Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Foundation for Applied Enzymology; 	This work was supported by the Program for Innovative Cell Biology by Innovative Technology from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to HRU), a Grant-in-Aid for Scientific Research (S) (Grant No. 25221004) (to HRU), a Grant-in-Aid for Scientific Research on Innovative Areas (Grant No. 23115006) from MEXT/Japan Society for the Promotion of Science (JSPS) (to HRU), a grant for the strategic programs for R&D (President's discretionary fund) of RIKEN (to HRU), an intramural Grant-in-Aid from the RIKEN Center for Developmental Biology and RIKEN Quantitative Biology Center (to HRU), a grant from Core Research for Evolutional Science and Technology (CREST) (to HRU), the RIKEN Special Postdoctoral Research Program (to EAS), a Grant-in-Aid from Japan Foundation for Applied Enzymology (to EAS), and a Grant-in-Aid for JSPS Fellows A2559890 (to YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COOMBS MM, 1969, BIOCHIM BIOPHYS ACTA, V174, P161, DOI 10.1016/0005-2787(69)90239-1; Ding P, 2010, CHEM-EUR J, V16, P14385, DOI 10.1002/chem.201001572; Dumas A, 2010, J AM CHEM SOC, V132, P18004, DOI 10.1021/ja1079578; FROEHLER BC, 1983, NUCLEIC ACIDS RES, V11, P8031, DOI 10.1093/nar/11.22.8031; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Graham D, 1998, J CHEM SOC PERK T 1, P1131, DOI 10.1039/a707031d; Hamilton MD, 2007, NUCLEIC ACIDS RES, V35, P143, DOI 10.1093/nar/gkl1015; HORN T, 1986, TETRAHEDRON LETT, V27, P4705, DOI 10.1016/S0040-4039(00)85043-1; Hudson HER, 2006, SYNLETT, V18, P2997; Irwin C. R., 2012, METHOD MOL BIOL, V890, P23, DOI DOI 10.1007/978-1-61779-876-4_; Kuzuya A, 2009, BIOCONJUGATE CHEM, V20, P3; Loakes D, 2003, HELV CHIM ACTA, V86, P1193, DOI 10.1002/hlca.200390103; Meyer C, 2003, CHEMBIOCHEM, V4, P610, DOI 10.1002/cbic.200300587; MIYAURA N, 1979, TETRAHEDRON LETT, V20, P3437, DOI 10.1016/S0040-4039(01)95429-2; Nichols N.M, 2009, CURR PROTOC MOL BIOL, P3; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Rai D, 2005, J MED CHEM, V48, P7012, DOI 10.1021/jm058167w; Rospigliosi A, 2007, LANGMUIR, V23, P8264, DOI 10.1021/la063704g; Saito I, 2011, Japan patent, Patent No. [JP2011-037796A, 2011037796]; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; Stein V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp589; SUGIYAMA H, 1994, CHEM RES TOXICOL, V7, P673, DOI 10.1021/tx00041a013; Tanaka K, 2008, CHEMBIOCHEM, V9, P2120, DOI 10.1002/cbic.200800285; TardyPlanechaud S, 1997, NUCLEIC ACIDS RES, V25, P553, DOI 10.1093/nar/25.3.553; Tataurov AV, 2008, BIOPHYS CHEM, V133, P66, DOI 10.1016/j.bpc.2007.12.004; Western EC, 2003, J ORG CHEM, V68, P6767, DOI 10.1021/jo034289p	27	2	2	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92369	10.1371/journal.pone.0092369	http://dx.doi.org/10.1371/journal.pone.0092369			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647759	Green Submitted, gold, Green Published			2022-12-27	WOS:000333348500123
J	Schmitt, V; Schloegl, C; Fischer, J				Schmitt, Vanessa; Schloegl, Christian; Fischer, Julia			Seeing the Experimenter Influences the Response to Pointing Cues in Long-Tailed Macaques	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; DOGS CANIS-FAMILIARIS; OBJECT-CHOICE TASKS; GAZE DIRECTION; PONGO-PYGMAEUS; SOCIAL CUES; GIVEN CUES; COMPREHENSION; GESTURES; DOMESTICATION	Methodological variations in experimental conditions can strongly influence animals' performances in cognitive tests. Specifically, the procedure of the so-called object-choice task has been controversially discussed; here, a human experimenter indicates the location of hidden food by pointing or gazing at one of two or more containers. Whereas dogs usually succeed, results for nonhuman primates are ambiguous. In the standard version of the task the majority of subjects do not respond appropriately to human pointing. However, modifying the task setup, such as placing the containers further apart, seems to improve subjects' performances, suggesting that cue salience may be an important variable. Here we investigated whether the visibility of the experimenter inhibits long-tailed macaques' (Macaca fascicularis) usage of the pointing cue. In our baseline condition, with the experimenter fully visible, the monkeys chose the correct container in 61% of the trials. The performance increased significantly, however, when the experimenter was hidden behind a curtain and only the arm of the experimenter, a doll's arm, or a stick was visible. Furthermore, the monkeys performed significantly better when the tip of the pointing finger or device was close to the target compared to the more distant condition. Intriguingly, after these experiments the monkeys' performance was also significantly improved in the baseline condition (70%). Apparently, the monkeys were first distracted by the presence of the experimenter, but then learned to use the cue. These findings highlight the importance of the test conditions, and question some of the assumptions about species-specific differences in the object-choice task.	[Schmitt, Vanessa] Univ Cologne, Social Cognit Cologne, D-50931 Cologne, Germany; [Schmitt, Vanessa; Schloegl, Christian; Fischer, Julia] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Schmitt, Vanessa; Schloegl, Christian; Fischer, Julia] Univ Gottingen, Courant Res Ctr Evolut Social Behav, D-37073 Gottingen, Germany	University of Cologne; Deutsches Primatenzentrum (DPZ); University of Gottingen	Schmitt, V (corresponding author), Univ Cologne, Social Cognit Cologne, D-50931 Cologne, Germany.	vschmitt@dpz.eu	Fischer, Julia/B-6674-2008	Fischer, Julia/0000-0002-5807-0074	German Initiative of Excellence; Leibniz Graduate School for Primate Neurobiology (Neuroprimm); Leibniz Graduate School "Foundations of Primate Social Behaviour"	German Initiative of Excellence; Leibniz Graduate School for Primate Neurobiology (Neuroprimm); Leibniz Graduate School "Foundations of Primate Social Behaviour"	This study was funded by the German Initiative of Excellence and the Leibniz Graduate School for Primate Neurobiology (Neuroprimm). CS was supported by the Leibniz Graduate School "Foundations of Primate Social Behaviour" (http://www.dpz.eu/en/career/leibniz-graduate-schools.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 1996, BEHAV PROCESS, V37, P47, DOI 10.1016/0376-6357(95)00074-7; Barrera G, 2012, BEHAV PROCESS, V89, P44, DOI 10.1016/j.beproc.2011.10.013; Barth J, 2005, ANIM COGN, V8, P84, DOI 10.1007/s10071-004-0235-x; Behne T, 2005, DEVELOPMENTAL SCI, V8, P492, DOI 10.1111/j.1467-7687.2005.00440.x; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; CALL J, 1994, J COMP PSYCHOL, V108, P307, DOI 10.1037/0735-7036.108.4.307; Elgier AM, 2012, ANIM COGN, V15, P1111, DOI 10.1007/s10071-012-0534-6; Elgier AM, 2009, BEHAV PROCESS, V81, P402, DOI 10.1016/j.beproc.2009.03.017; Emery NJ, 2009, ANNU REV PSYCHOL, V60, P87, DOI 10.1146/annurev.psych.60.110707.163526; Emery NJ, 2000, EYES HAVE IT NEUROET; Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Hare B, 2004, ANIM BEHAV, V68, P571, DOI 10.1016/j.anbehav.2003.11.011; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hare B, 2006, COGNITION, V101, P495, DOI 10.1016/j.cognition.2005.01.011; Hare B, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2009.06.031; Hauser MD, 2007, P ROY SOC B-BIOL SCI, V274, P1913, DOI 10.1098/rspb.2007.0586; Hauser MD, 2011, P ROY SOC B-BIOL SCI, V278, P158, DOI 10.1098/rspb.2010.1441; Herman LM, 1999, J COMP PSYCHOL, V113, P347, DOI 10.1037/0735-7036.113.4.347; Herrmann E, 2006, DEVELOPMENTAL SCI, V9, P518, DOI 10.1111/j.1467-7687.2006.00519.x; Itakura S, 1998, J COMP PSYCHOL, V112, P119, DOI 10.1037/0735-7036.112.2.119; Itakura S, 1999, DEVELOPMENTAL SCI, V2, P448, DOI 10.1111/1467-7687.00089; Kaminski J, 2005, ANIM BEHAV, V69, P11, DOI 10.1016/j.anbehav.2004.05.008; Lakatos G, 2012, ANIM COGN, V15, P201, DOI 10.1007/s10071-011-0446-x; Lakatos G, 2009, ANIM COGN, V12, P621, DOI 10.1007/s10071-009-0221-4; Lyn H., 2010, J EVOLUTIONARY PSYCH, V8, P333, DOI DOI 10.1556/JEP.8.2010.4.3; MacLean EL, 2012, ANIM COGN, V15, P223, DOI 10.1007/s10071-011-0448-8; Maros K, 2008, ANIM COGN, V11, P457, DOI 10.1007/s10071-008-0136-5; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; MORISSETTE P, 1995, BRIT J DEV PSYCHOL, V13, P163, DOI 10.1111/j.2044-835X.1995.tb00671.x; Mulcahy NJ, 2012, ANIM BEHAV, V83, P313, DOI 10.1016/j.anbehav.2011.11.019; Mulcahy NJ, 2011, J COMP PSYCHOL, V125, P112, DOI 10.1037/a0020905; Mulcahy NJ, 2009, J COMP PSYCHOL, V123, P304, DOI 10.1037/a0016222; POVINELLI DJ, 1992, ANIM BEHAV, V43, P633, DOI 10.1016/0003-3472(92)90085-N; Povinelli DJ, 1999, BRIT J DEV PSYCHOL, V17, P37, DOI 10.1348/026151099165140; POVINELLI DJ, 1990, J COMP PSYCHOL, V104, P203, DOI 10.1037/0735-7036.104.3.203; Povinelli DJ, 1997, COGNITIVE DEV, V12, P327, DOI 10.1016/S0885-2014(97)90017-4; Reid PJ, 2009, BEHAV PROCESS, V80, P325, DOI 10.1016/j.beproc.2008.11.002; Russell JL, 2011, DEVELOPMENTAL SCI, V14, P1459, DOI 10.1111/j.1467-7687.2011.01090.x; Sandel AA, 2011, ANIM BEHAV, V81, P925, DOI 10.1016/j.anbehav.2011.01.020; Scheumann M, 2004, ANIM COGN, V7, P224, DOI 10.1007/s10071-004-0216-0; Schmitt V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032024; Schmitt V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1262; Tomasello M, 2008, JEAN NICOD LECT, P1; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; Udell MAR, 2010, ANIM BEHAV, V79, pE9, DOI 10.1016/j.anbehav.2009.11.033; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y	48	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91348	10.1371/journal.pone.0091348	http://dx.doi.org/10.1371/journal.pone.0091348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646501	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500029
J	Winkler, PA; Gornik, KR; Ramsey, DT; Dubielzig, RR; Venta, PJ; Petersen-Jones, SM; Bartoe, JT				Winkler, Paige A.; Gornik, Kara R.; Ramsey, David T.; Dubielzig, Richard R.; Venta, Patrick J.; Petersen-Jones, Simon M.; Bartoe, Joshua T.			A Partial Gene Deletion of SLC45A2 Causes Oculocutaneous Albinism in Doberman Pinscher Dogs	PLOS ONE			English	Article							CONGENITAL SENSORINEURAL DEAFNESS; MESSENGER-RNA DECAY; CREAM COAT COLOR; STRIA VASCULARIS; MALIGNANT-MELANOMA; INNER-EAR; MATP GENE; MUTATIONS; MELANOCYTES; POLYMORPHISMS	The first white Doberman pinscher (WDP) dog was registered by the American Kennel Club in 1976. The novelty of the white coat color resulted in extensive line breeding of this dog and her offspring. The WDP phenotype closely resembles human oculocutaneous albinism (OCA) and clinicians noticed a seemingly high prevalence of pigmented masses on these dogs. This study had three specific aims: (1) produce a detailed description of the ocular phenotype of WDPs, (2) objectively determine if an increased prevalence of ocular and cutaneous melanocytic tumors was present in WDPs, and (3) determine if a genetic mutation in any of the genes known to cause human OCA is causal for the WDP phenotype. WDPs have a consistent ocular phenotype of photophobia, hypopigmented adnexal structures, blue irides with a tan periphery and hypopigmented retinal pigment epithelium and choroid. WDPs have a higher prevalence of cutaneous melanocytic neoplasms compared with control standard color Doberman pinschers (SDPs); cutaneous tumors were noted in 12/20 WDP (<5 years of age: 4/12; >5 years of age: 8/8) and 1/20 SDPs (p<0.00001). Using exclusion analysis, four OCA causative genes were investigated for their association with WDP phenotype; TYR, OCA2, TYRP1 and SLC45A2. SLC45A2 was found to be linked to the phenotype and gene sequencing revealed a 4,081 base pair deletion resulting in loss of the terminus of exon seven of SLC45A2 (chr4: 77,062,968-77,067,051). This mutation is highly likely to be the cause of the WDP phenotype and is supported by a lack of detectable SLC45A2 transcript levels by reverse transcriptase PCR. The WDP provides a valuable model for studying OCA4 visual disturbances and melanocytic neoplasms in a large animal model.	[Winkler, Paige A.; Venta, Patrick J.; Petersen-Jones, Simon M.; Bartoe, Joshua T.] Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Winkler, Paige A.; Venta, Patrick J.; Petersen-Jones, Simon M.] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Gornik, Kara R.] Tufts Univ, Cummings Sch Vet Med, North Grafton, MA USA; [Ramsey, David T.] Anim Ophthalmol Ctr, Williamston, MI USA; [Dubielzig, Richard R.] Univ Wisconsin, Sch Vet Med, Comparat Ocular Pathol Lab Wisconsin, Madison, WI 53706 USA	Michigan State University; Michigan State University; Tufts University; University of Wisconsin System; University of Wisconsin Madison	Bartoe, JT (corresponding author), Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA.	bartoejo@cvm.msu.edu	Petersen-Jones, Simon/B-3822-2018	Petersen-Jones, Simon/0000-0002-7410-2304; Gornik, Kara/0000-0002-5523-7991	MSU Faculty Development Funds; Myers-Dunlap Endowment for Canine Health; Animal Ophthalmology Center Research Fund	MSU Faculty Development Funds; Myers-Dunlap Endowment for Canine Health; Animal Ophthalmology Center Research Fund	Funding support for this project included: MSU Faculty Development Funds, Myers-Dunlap Endowment for Canine Health, and The Animal Ophthalmology Center Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; CABLE J, 1992, HEARING RES, V64, P6, DOI 10.1016/0378-5955(92)90164-I; Chong GT, 2009, ARCH OPHTHALMOL-CHIC, V127, P37, DOI 10.1001/archophthalmol.2008.550; Christophers AJ, 1998, MUTAT RES-FUND MOL M, V422, P113, DOI 10.1016/S0027-5107(98)00182-1; Clark LA, 2011, GENOMICS, V97, P244, DOI 10.1016/j.ygeno.2011.01.003; Dooley CM, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12053; Du JY, 2002, J BIOL CHEM, V277, P402, DOI 10.1074/jbc.M110229200; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Graf J, 2007, HUM MUTAT, V28, P710, DOI 10.1002/humu.20504; Guedj M, 2008, HUM MUTAT, V29, P1154, DOI 10.1002/humu.20823; Hogg JR, 2010, CELL, V143, P379, DOI 10.1016/j.cell.2010.10.005; Ibarrola-Villava M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019271; Inagaki K, 2004, AM J HUM GENET, V74, P466, DOI 10.1086/382195; Jin Z, 2007, CELL TISSUE RES, V328, P257, DOI 10.1007/s00441-006-0369-z; Juzeniene A, 2013, SUNLIGHT VITAMIN D S, P1; King RA, 1997, EMERY RIMOINS PRINCI, P1171; Kumar A, 2011, INVEST OPHTH VIS SCI, V52, P2306, DOI 10.1167/iovs.10-5685; LOOKINGBILL DP, 1995, J AM ACAD DERMATOL, V32, P653, DOI 10.1016/0190-9622(95)90352-6; Mabula JB, 2012, BMC DERMATOL, V12, DOI 10.1186/1471-5945-12-5; Mariat D, 2003, GENET SEL EVOL, V35, P119, DOI 10.1051/gse:2002039; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Montoliu L, 2013, PIGMENT CELL MELANOM; Neilan BA, 1997, NUCLEIC ACIDS RES, V25, P2938, DOI 10.1093/nar/25.14.2938; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Opara KO, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-73; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Prado-Martinez J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-363; Rak SG, 2005, VET J, V169, P188, DOI 10.1016/j.tvjl.2004.01.015; Rooryck C, 2008, PIGM CELL MELANOMA R, V21, P583, DOI 10.1111/j.1755-148X.2008.00496.x; Rundshagen U, 2004, HUM MUTAT, V23, P106, DOI 10.1002/humu.10311; RUSSELLEGGITT I, 1990, BRIT J OPHTHALMOL, V74, P136, DOI 10.1136/bjo.74.3.136; Schmutz SM, 2007, ANIM GENET, V38, P539, DOI 10.1111/j.1365-2052.2007.01664.x; Schmutz SM, 2007, J HERED, V98, P544, DOI 10.1093/jhered/esm018; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Simeonov DR, 2013, HUM MUTAT, V34, P827, DOI 10.1002/humu.22315; STEEL KP, 1989, DEVELOPMENT, V107, P453; Strain GM, 2009, J VET INTERN MED, V23, P282, DOI 10.1111/j.1939-1676.2008.0257.x; Stritzel S, 2009, J ANIM BREED GENET, V126, P59, DOI 10.1111/j.1439-0388.2008.00761.x; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Tachibana M, 1999, PIGM CELL RES, V12, P344, DOI 10.1111/j.1600-0749.1999.tb00518.x; Vitavska O, 2013, MOL ASPECTS MED, V34, P655, DOI 10.1016/j.mam.2012.05.014; Winkler PA, 2013, J NEGAT RESULTS BIOM, V12, DOI 10.1186/1477-5751-12-6; Winkler PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072229; Wolf AB, 2005, J AAPOS, V9, P363, DOI 10.1016/j.jaapos.2005.03.003; Xu X, 2013, CURR BIOL, V23, P1031, DOI 10.1016/j.cub.2013.04.054	47	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92127	10.1371/journal.pone.0092127	http://dx.doi.org/10.1371/journal.pone.0092127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647637	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500088
J	Oksanen, KM; Waldum, ER; McDaniel, MA; Braver, TS				Oksanen, Kevin M.; Waldum, Emily R.; McDaniel, Mark A.; Braver, Todd S.			Neural Mechanisms of Time-Based Prospective Memory: Evidence for Transient Monitoring	PLOS ONE			English	Article							ROSTRAL PREFRONTAL CORTEX; MULTIPLE PROCESSES; RETRIEVAL; EVENT; AGE; COSTS; PERFORMANCE; ATTENTION; AREA-10; REVEAL	In daily life, we often need to remember to perform an action after, or at, a specific period of time (e. g., take pizza out of oven in 15 minutes). Surprisingly, little is known about the neural mechanisms that support this form of memory, termed time-based prospective memory (PM). Here we pioneer an fMRI paradigm that enables examination of both sustained and transient processes engaged during time-based PM. Participants were scanned while performing a demanding on-going task (n-back working memory), with and without an additional time-based PM demand. During the PM condition participants could access a hidden clock with a specific button-press response, while in the control condition, pseudo-clocks randomly appeared and were removed via the same response. Analyses tested for sustained activation associated with the PM condition, and also transient activation associated with clock-checks and the PM target response. Contrary to prior findings with event-based PM (i.e., remembering to perform a future action when a specific event occurs), no sustained PM-related activity was observed in anterior prefrontal cortex (aPFC) or elsewhere in the brain; instead, transient clock-related activity was observed in this region. Critically, the activation was anticipatory, increasing before clock-check responses. Anticipatory activity prior to the PM target response was weaker in aPFC, but strong in pre-Supplementary Motor Area (pre-SMA; relative to clock-check responses), suggesting a functional double dissociation related to volitional decision-making. Together, the results suggest that aPFC-activity dynamics during time-based PM reflect a distinct transient monitoring process, enabling integration of the PM intention with current temporal information to facilitate scheduling of upcoming PM-related actions.	[Oksanen, Kevin M.; Waldum, Emily R.; McDaniel, Mark A.; Braver, Todd S.] Washington Univ, St Louis, MO 63130 USA	Washington University (WUSTL)	Oksanen, KM (corresponding author), Washington Univ, St Louis, MO 63130 USA.	kevinoksanen@gmail.com		Braver, Todd/0000-0002-2631-3393	National Institutes of Health (NIH) [1RC1AG036258]; Aging Training grant [5T32AG000030-37]; Washington University Institute of Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences (NCATS) of the NIH [UL1 TR000448]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC1AG036258, T32AG000030] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aging Training grant; Washington University Institute of Clinical and Translational Sciences grant from the National Center for Advancing Translational Sciences (NCATS) of the NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by National Institutes of Health (NIH) grants 1RC1AG036258-Neural Mechanisms of Age Related Changes in Prospective Memory, and The Aging Training grant 5T32AG000030-37. Additionally support was provided by the Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences (NCATS) of the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit RG, 2012, CEREB CORTEX, V22, P1876, DOI 10.1093/cercor/bhr264; Brewer GA, 2010, MEM COGNITION, V38, P304, DOI 10.3758/MC.38.3.304; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Cona G, 2012, NEUROPSYCHOLOGIA, V50, P2692, DOI 10.1016/j.neuropsychologia.2012.07.033; Cona G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031659; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Craik FIM, 1996, BRAIN COGNITION, V49, P402; Einstein GO, 2010, J EXP PSYCHOL LEARN, V36, P1082, DOI 10.1037/a0019184; Einstein GO, 2005, CURR DIR PSYCHOL SCI, V14, P286, DOI 10.1111/j.0963-7214.2005.00382.x; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; HARRIS JE, 1982, HUM LEARN, V1, P123; Jager T, 2008, J GEN PSYCHOL, V135, P4, DOI 10.3200/GENP.135.1.4-22; Katai S, 2003, J NEUROL NEUROSUR PS, V74, P704, DOI 10.1136/jnnp.74.6.704; Kvavilashvili L, 2007, J EXP PSYCHOL GEN, V136, P112, DOI 10.1037/0096-3445.136.1.112; Marsh RL, 2006, MEM COGNITION, V34, P1037, DOI 10.3758/BF03193250; McDaniel MA, 2004, J EXP PSYCHOL LEARN, V30, P605, DOI 10.1037/0278-7393.30.3.605; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA., 2007, PROSPECTIVE MEMORY O, DOI [10.4135/9781452225913, DOI 10.4135/9781452225913]; McDaniel MA, 2013, PSYCHOL SCI, V24, P1791, DOI 10.1177/0956797613481233; McDaniel MA, 2011, NEUROPSYCHOLOGIA, V49, P2147, DOI 10.1016/j.neuropsychologia.2010.12.029; Miller GA, 1960, PLANS STRUCTURE BEHA; Momennejad I, 2012, NEUROIMAGE, V61, P139, DOI 10.1016/j.neuroimage.2012.02.079; Moscovitch Morris, 1994, P269; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park DC, 1997, PSYCHOL AGING, V12, P314, DOI 10.1037/0882-7974.12.2.314; Rendell PG, 2007, AGING NEUROPSYCHOL C, V14, P236, DOI 10.1080/13825580600579186; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P736, DOI 10.1037/a0018971; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P190, DOI 10.1037/a0017732; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shum D, 2004, SCHIZOPHRENIA BULL, V30, P693, DOI 10.1093/oxfordjournals.schbul.a007123; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith RE, 2010, J EXP PSYCHOL LEARN, V36, P1089, DOI 10.1037/a0019183; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Waldum ER, 2013, J EXP PSYCHOL GEN, V142, P809, DOI 10.1037/a0030113; Yarkoni T, 2009, PERSPECT PSYCHOL SCI, V4, P294, DOI 10.1111/j.1745-6924.2009.01127.x; Yarkoni T, 2010, SPRINGER SER HUM EXC, P87, DOI 10.1007/978-1-4419-1210-7_6	47	33	34	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92123	10.1371/journal.pone.0092123	http://dx.doi.org/10.1371/journal.pone.0092123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643226	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900090
J	Rao, K; Erb-Downward, JR; Walk, ST; Micic, D; Falkowski, N; Santhosh, K; Mogle, JA; Ring, C; Young, VB; Huffnagle, GB; Aronoff, DM				Rao, Krishna; Erb-Downward, John R.; Walk, Seth T.; Micic, Dejan; Falkowski, Nicole; Santhosh, Kavitha; Mogle, Jill A.; Ring, Cathrin; Young, Vincent B.; Huffnagle, Gary B.; Aronoff, David M.			The Systemic Inflammatory Response to Clostridium difficile Infection	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TOXIN-B; INTERLEUKIN-8; AMERICA; RANTES; MODEL	Background: The systemic inflammatory response to Clostridium difficile infection (CDI) is incompletely defined, particularly for patients with severe disease. Methods: Analysis of 315 blood samples from 78 inpatients with CDI (cases), 100 inpatients with diarrhea without CDI (inpatient controls), and 137 asymptomatic outpatient controls without CDI was performed. Serum or plasma was obtained from subjects at the time of CDI testing or shortly thereafter. Severe cases had intensive care unit admission, colectomy, or death due to CDI within 30 days after diagnosis. Thirty different circulating inflammatory mediators were quantified using an antibody-linked bead array. Principal component analysis (PCA), multivariate analysis of variance (MANOVA), and logistic regression were used for analysis. Results: Based on MANOVA, cases had a significantly different inflammatory profile from outpatient controls but not from inpatient controls. In logistic regression, only chemokine (C-C motif) ligand 5 (CCL5) levels were associated with cases vs. inpatient controls. Several mediators were associated with cases vs. outpatient controls, especially hepatocyte growth factor, CCL5, and epithelial growth factor (inversely associated). Eight cases were severe and associated with elevations in IL8, IL-6, and eotaxin. Conclusions: A broad systemic inflammatory response occurs during CDI and severe cases appear to differ from non-severe infections.	[Rao, Krishna; Walk, Seth T.; Santhosh, Kavitha; Mogle, Jill A.; Ring, Cathrin; Young, Vincent B.] Univ Michigan, Sch Med, Div Infect Dis, Ann Arbor, MI USA; [Erb-Downward, John R.; Falkowski, Nicole; Huffnagle, Gary B.] Univ Michigan, Sch Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Rao, Krishna; Erb-Downward, John R.; Walk, Seth T.; Micic, Dejan; Falkowski, Nicole; Santhosh, Kavitha; Mogle, Jill A.; Ring, Cathrin; Young, Vincent B.; Huffnagle, Gary B.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Young, Vincent B.; Huffnagle, Gary B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Aronoff, David M.] Vanderbilt Univ, Med Ctr, Div Infect Dis, Nashville, TN 37235 USA; [Aronoff, David M.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Walk, Seth T.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Rao, Krishna] Vet Affairs Ann Arbor Healthcare Syst, Div Infect Dis, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University; Vanderbilt University; Montana State University System; Montana State University Bozeman; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Aronoff, DM (corresponding author), Vanderbilt Univ, Med Ctr, Div Infect Dis, Nashville, TN 37235 USA.	daronoff@umich.edu	Huffnagle, Gary B./ABF-1323-2020; Rao, Krishna/R-3726-2019; Young, Vincent B/B-3179-2009; Young, Vincent Bensan/M-9916-2019	Rao, Krishna/0000-0002-9213-7850; Young, Vincent B/0000-0003-3687-2364; Young, Vincent Bensan/0000-0003-3687-2364; Aronoff, David/0000-0003-4587-6121	National Institute of Allergy and Infectious Diseases at the National Institutes of Health [U19-AI090871, K01-AI097281]; Claude D. Pepper Older Americans Independence Center [AG-024824]; Michigan Institute for Clinical and Health Research [2UL1TR000433]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI097281, U19AI090871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Claude D. Pepper Older Americans Independence Center; Michigan Institute for Clinical and Health Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health [grant numbers U19-AI090871 and K01-AI097281], the Claude D. Pepper Older Americans Independence Center [grant number AG-024824], and the Michigan Institute for Clinical and Health Research [grant number 2UL1TR000433]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akha AS, 2012, J IMMUNOL, V188; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Brown NA, 2011, INFECT DIS REP, V3, P15, DOI 10.4081/idr.2011.e5; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; El Feghaly RE, 2013, CLIN INFECT DIS; Figueroa I, 2012, CLIN INFECT DIS, V55, pS104, DOI 10.1093/cid/cis357; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jarchum I, 2012, INFECT IMMUN, V80, P2989, DOI 10.1128/IAI.00448-12; Jarchum I, 2011, INFECT IMMUN, V79, P1498, DOI 10.1128/IAI.01196-10; Jiang ZD, 2007, CLIN GASTROENTEROL H, V5, P964, DOI 10.1016/j.cgh.2007.04.018; Klapproth JMA, 2010, INFLAMM BOWEL DIS, V16, P2173, DOI 10.1002/ibd.21332; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Lawrence JP, 1997, J PEDIATR SURG, V32, P430, DOI 10.1016/S0022-3468(97)90598-4; Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; MEURER R, 1993, J EXP MED, V178, P1913, DOI 10.1084/jem.178.6.1913; Morteau O, 2002, GASTROENTEROLOGY, V122, P725, DOI 10.1053/gast.2002.31873; Neal MD, 2011, ANN SURG, V254, P423, DOI 10.1097/SLA.0b013e31822ade48; Persson S, 2008, CLIN MICROBIOL INFEC, V14, P1057, DOI 10.1111/j.1469-0691.2008.02092.x; PRICE AB, 1977, J CLIN PATHOL, V30, P1, DOI 10.1136/jcp.30.1.1; Rao K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058265; Reeves AE, 2011, GUT MICROBES, V2, P145, DOI 10.4161/gmic.2.3.16333; Riegler M, 1997, AM J PHYSIOL-GASTR L, V273, pG1014, DOI 10.1152/ajpgi.1997.273.5.G1014; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; Steiner TS, 1997, CLIN DIAGN LAB IMMUN, V4, P719, DOI 10.1128/CDLI.4.6.719-722.1997; Walk ST, 2012, CLIN INFECT DIS, V55, P1661, DOI 10.1093/cid/cis786; Wilcox MH, 2012, CLIN MICROBIOL INFEC, V18, P13, DOI 10.1111/1469-0691.12057; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	37	39	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92578	10.1371/journal.pone.0092578	http://dx.doi.org/10.1371/journal.pone.0092578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643077	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900147
J	Ocan, M; Bwanga, F; Bbosa, GS; Bagenda, D; Waako, P; Ogwal-Okeng, J; Obua, C				Ocan, Moses; Bwanga, Freddie; Bbosa, Godfrey S.; Bagenda, Danstan; Waako, Paul; Ogwal-Okeng, Jasper; Obua, Celestino			Patterns and Predictors of Self-Medication in Northern Uganda	PLOS ONE			English	Article							ANTIMICROBIAL DRUGS; RESISTANCE; ANTIBIOTICS; PHARMACIES; COMMUNITY; CHILDREN; INDIA; CARE	Self-medication with antimicrobial agents is a common form of self-care among patients globally with the prevalence and nature differing from country to country. Here we assessed the prevalence and predictors of antimicrobial self-medication in post-conflict northern Uganda. A cross-sectional study was carried out using structured interviews on 892 adult (>= 18 years) participants. Information on drug name, prescriber, source, cost, quantity of drug obtained, and drug use was collected. Households were randomly selected using multistage cluster sampling method. One respondent who reported having an illness within three months in each household was recruited. In each household, information was obtained from only one adult individual. Data was analyzed using STATA at 95% level of significance. The study found that a high proportion (75.7%) of the respondents practiced antimicrobial self-medication. Fever, headache, lack of appetite and body weakness were the disease symptoms most treated through self-medication (30.3%). The commonly self-medicated antimicrobials were coartem (27.3%), amoxicillin (21.7%), metronidazole (12.3%), and cotrimoxazole (11.6%). Drug use among respondents was mainly initiated by self-prescription (46.5%) and drug shop attendants (57.6%). On average, participants obtained 13.9 +/- 8.8 (95% CI: 12.6-13.8) tablets/capsules of antimicrobial drugs from drug shops and drugs were used for an average of 3.7 +/- 2.8 days (95% CI: 3.3-3.5). Over half (68.2%) of the respondents would recommend self-medication to another sick person. A high proportion (76%) of respondents reported that antimicrobial self-medication had associated risks such as wastage of money (42.1%), drug resistance (33.2%), and masking symptoms of underlying disease (15.5%). Predictors of self-medication with antimicrobial agents included gender, drug knowledge, drug leaflets, advice from friends, previous experience, long waiting time, and distance to the health facility. Despite knowledge of associated risks, use of self-medication with antimicrobial drugs in management of disease symptoms is a common practice in post-conflict northern Uganda.	[Ocan, Moses; Bbosa, Godfrey S.; Waako, Paul; Obua, Celestino] Makerere Univ, Coll Hlth Sci, Dept Pharmacol & Therapeut, Kampala, Uganda; [Bwanga, Freddie] Makerere Univ, Coll Hlth Sci, Dept Microbiol, Kampala, Uganda; [Bagenda, Danstan] Makerere Univ, Coll Hlth Sci, Dept Biostat, Kampala, Uganda; [Ogwal-Okeng, Jasper] Gulu Univ, Fac Med, Gulu, Uganda	Makerere University; Makerere University; Makerere University	Ocan, M (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Pharmacol & Therapeut, Kampala, Uganda.	mocan@chs.mak.ac.ug	Kawooya, Ismael/O-4541-2016	Kawooya, Ismael/0000-0002-7159-7153; Obua, Celestino/0000-0001-6949-3059; Ocan, Moses/0000-0002-8852-820X	OGAC; NIH; HRSA;  [5R24TW008886]; FOGARTY INTERNATIONAL CENTER [R24TW008886] Funding Source: NIH RePORTER	OGAC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by grant number 5R24TW008886 supported by OGAC, NIH and HRSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akello Grace, 2010, WARTIME CHILDRENS SU; Asiimwe D, 2000, TRANSFORMATIONS PROG; Awad A, 2005, J PHARM PHARM SCI, V8, P326; Bennet S, 1993, B INT STAT I, V55, P21; Brass EP, 2011, CLIN PHARMACOL THER, V90, P791, DOI 10.1038/clpt.2011.231; Brass EP, 2001, NEW ENGL J MED, V345, P810, DOI 10.1056/NEJMra011080; Calva J, 1996, SOC SCI MED, V42, P1121, DOI 10.1016/0277-9536(95)00385-1; Cars O., 2005, International Journal of Risk & Safety in Medicine, V17, P103; DUA V, 1994, SOC SCI MED, V38, P717, DOI 10.1016/0277-9536(94)90462-6; ETKIN NL, 1990, SOC SCI MED, V30, P919, DOI 10.1016/0277-9536(90)90220-M; Figueiras A, 2000, EUR J EPIDEMIOL, V16, P19, DOI 10.1023/A:1007608702063; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Hussain S, 2010, S MED REV, V3, P32; Kamat VR, 1998, SOC SCI MED, V47, P779, DOI 10.1016/S0277-9536(98)00134-8; KHALLAF N, 1991, LANCET, V338, P248, DOI 10.1016/0140-6736(91)90380-8; Kiwanuka SN, 2008, T ROY SOC TROP MED H, V102, P1067, DOI 10.1016/j.trstmh.2008.04.023; KUNIN CM, 1993, ANN INTERN MED, V118, P557, DOI 10.7326/0003-4819-118-7-199304010-00011; Ministry of Health, 2002, UG NAT DRUG POL; Ministry of Health, 2010, INT COMM CAS MAN IMP; Naila K, 2009, WOMENS EC EMPOWERMEN; NICHTER M, 1994, SOC SCI MED, V39, P1509, DOI 10.1016/0277-9536(94)90003-5; RICHARDS L, 1993, PEDIATR INFECT DIS J, V12, P5, DOI 10.1097/00006454-199301000-00003; Sharma R., 2005, INDIAN J PHARM, V3, P37; Skliros E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-58; STOLLER EP, 1993, MED CARE, V31, P24, DOI 10.1097/00005650-199301000-00002; Uganda Bureau of Statistics, 2002, 2002 UG POP HOUS CEN; UNICEF, 2007, UG UNICEF HUM SIT RE; Vialle-Valentin CE, 2012, TROP MED INT HEALTH, V17, P211, DOI 10.1111/j.1365-3156.2011.02895.x; WERNSDORFER WH, 1991, PHARMACOL THERAPEUT, V50, P95, DOI 10.1016/0163-7258(91)90074-V; WHO, 2001, WHOCDSCSRDRS20012; Whyte SR, 2000, P WORKSH PEOPL MED E, P127; World Health Organization, 1986, GUID ASS DRUGS US SE; World Health Organization, 2000, GUID REG ASS MED PRO	33	79	84	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92323	10.1371/journal.pone.0092323	http://dx.doi.org/10.1371/journal.pone.0092323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6GL	24658124	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300073
J	Fouqueray, TD; Blumstein, DT; Monclus, R; Martin, JGA				Fouqueray, Timothee D.; Blumstein, Daniel T.; Monclus, Raquel; Martin, Julien G. A.			Maternal Effects on Anogenital Distance in a Wild Marmot Population	PLOS ONE			English	Article							YELLOW-BELLIED MARMOTS; INTRAUTERINE POSITION; FEMALE RATS; HOUSE MICE; TRAITS; HERITABILITY; REPRODUCTION; STRATEGIES; TRANSPORT; PLAY	In mammals, prenatal exposure to sex steroid hormones may have profound effects on later behavior and fitness and have been reported under both laboratory and field conditions. Anogenital distance is a non-invasive measure of prenatal exposure to sex steroid hormones. While we know that intra-uterine position and litter sex ratio influence anogenital distance, there are other, heretofore unstudied, factors that could influence anogenital distance, including maternal effects. We capitalized on a long-term study of wild yellow-bellied marmots (Marmota flaviventris) to study the importance of maternal effects on explaining variation in anogenital distance and found significant effects. The strength of these effects varied annually. Taken together, our data highlights the strong variability due to environmental effects, and illustrates the importance of additive genetic and maternal genetic effects on neonatal anogenital distance. We suspect that, as others apply recently popularised quantitative genetic techniques to study free-living populations, such effects will be identified in other systems.	[Fouqueray, Timothee D.; Blumstein, Daniel T.; Martin, Julien G. A.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Fouqueray, Timothee D.] Ecole Normale Super Lyon, Dept Biol, F-69364 Lyon, France; [Blumstein, Daniel T.] Rocky Mt Biol Labs, Crested Butte, CO USA; [Monclus, Raquel] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Martin, Julien G. A.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	University of California System; University of California Los Angeles; Ecole Normale Superieure de Lyon (ENS de LYON); Autonomous University of Madrid; University of Aberdeen	Martin, JGA (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.	marmots@ucla.edu	Monclús, Raquel/B-2540-2017; Martin, Julien GA/H-5843-2019	Martin, Julien GA/0000-0001-7726-6809; Fouqueray, Timothee/0000-0003-4773-4733; Monclus Burgoa, Raquel/0000-0001-7117-3521; Blumstein, Daniel/0000-0001-5793-9244	National Geographic Society; UCLA (Faculty Senate and the Division of Life Sciences); Rocky Mountain Biological Laboratory research fellowship; NSF [IDBR-0754247, DEB-1119660, DBI 0242960, 0731346]; Spanish Ministerio de Innovacion y Ciencia; Fulbright program; FRQNT postdoctoral fellowship; NSF	National Geographic Society(National Geographic Society); UCLA (Faculty Senate and the Division of Life Sciences); Rocky Mountain Biological Laboratory research fellowship; NSF(National Science Foundation (NSF)); Spanish Ministerio de Innovacion y Ciencia(Spanish Government); Fulbright program; FRQNT postdoctoral fellowship; NSF(National Science Foundation (NSF))	DTB was supported by the National Geographic Society, UCLA (Faculty Senate and the Division of Life Sciences), a Rocky Mountain Biological Laboratory research fellowship, and by the NSF (IDBR-0754247 and DEB-1119660 to DTB, as well as DBI 0242960 and 0731346 to the Rocky Mountain Biological Laboratory). RM was supported by postdoctoral fellowships from the Spanish Ministerio de Innovacion y Ciencia and the Fulbright program. JGAM was supported by a FRQNT postdoctoral fellowship and the NSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE KB, 2003, WILD MAMMALS N AM BI, P188; Banszegi O, 2012, PHYSIOL BEHAV, V105, P1226, DOI 10.1016/j.physbeh.2012.01.002; Bayless DW, 2013, HORM BEHAV, V64, P764, DOI 10.1016/j.yhbeh.2013.10.003; Blumstein DT, 2010, J EVOLUTION BIOL, V23, P879, DOI 10.1111/j.1420-9101.2010.01967.x; Chawnshang C, 2002, ANDROGENS ANDROGEN R; DOHLER KD, 1991, EXP CLIN ENDOCRINOL, V98, P99; Drickamer LC, 1996, ANIM BEHAV, V51, P925, DOI 10.1006/anbe.1996.0096; Duckworth RA, 2009, PHILOS T R SOC B, V364, P1075, DOI 10.1098/rstb.2008.0294; Eisenberg ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018973; EVEN MD, 1992, J REPROD FERTIL, V96, P709, DOI 10.1530/jrf.0.0960709; Field EF, 2006, DEV PSYCHOBIOL, V48, P111, DOI 10.1002/dev.20121; Garnier R, 2012, EVOLUTION, V66, P3067, DOI 10.1111/j.1558-5646.2012.01665.x; Gilmour AR, 2009, ASREML USER GUIDE RE; Gobrogge KL, 2008, ARCH SEX BEHAV, V37, P112, DOI 10.1007/s10508-007-9272-2; Kerin TK, 2003, PHYSIOL BEHAV, V78, P697, DOI 10.1016/S0031-9384(03)00054-4; Kruuk LEB, 2007, J EVOLUTION BIOL, V20, P1890, DOI 10.1111/j.1420-9101.2007.01377.x; MEANEY MJ, 1986, BRAIN RES, V398, P324, DOI 10.1016/0006-8993(86)91492-7; Mendiola J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-90; Monclus R, 2012, BIOL LETTERS, V8, P208, DOI 10.1098/rsbl.2011.0754; Monclus R, 2012, J ANIM ECOL, V81, P80, DOI 10.1111/j.1365-2656.2011.01888.x; Monclus R, 2011, HORM BEHAV, V60, P660, DOI 10.1016/j.yhbeh.2011.08.019; Nelson E, 2010, PRIMATES, V51, P1, DOI 10.1007/s10329-009-0173-y; PALANZA P, 1995, PHYSIOL BEHAV, V58, P827, DOI 10.1016/0031-9384(95)00107-T; Paul SN, 2006, TWIN RES HUM GENET, V9, P215, DOI 10.1375/twin.9.2.215; Pinheiro J, 2001, MIXED EFFECTS MODELS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodel HG, 2008, J COMP PSYCHOL, V122, P73, DOI 10.1037/0735-7036.122.1.73; Ryan BC, 2002, NEUROSCI BIOBEHAV R, V26, P665, DOI 10.1016/S0149-7634(02)00038-6; SAAL FSV, 1980, SCIENCE, V208, P597, DOI 10.1126/science.7367881; SAAL FSV, 1989, J ANIM SCI, V67, P1824; Sathishkumar K, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-110; SRIDARAN R, 1981, ENDOCRINOLOGY, V108, P855, DOI 10.1210/endo-108-3-855; VANDENBERGH JG, 1995, LAB ANIM SCI, V45, P567; Vandenbergh John G., 2009, P203; Voracek M, 2009, AM J PHYS ANTHROPOL, V140, P376, DOI 10.1002/ajpa.21105; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Zehr JL, 2001, DEV PSYCHOBIOL, V38, P229, DOI 10.1002/dev.1017	38	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92718	10.1371/journal.pone.0092718	http://dx.doi.org/10.1371/journal.pone.0092718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651864	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800148
J	Grabowicz, PA; Ramasco, JJ; Goncalves, B; Eguiluz, VM				Grabowicz, Przemyslaw A.; Ramasco, Jose J.; Goncalves, Bruno; Eguiluz, Victor M.			Entangling Mobility and Interactions in Social Media	PLOS ONE			English	Article							NETWORKS	Daily interactions naturally define social circles. Individuals tend to be friends with the people they spend time with and they choose to spend time with their friends, inextricably entangling physical location and social relationships. As a result, it is possible to predict not only someone's location from their friends' locations but also friendship from spatial and temporal co-occurrence. While several models have been developed to separately describe mobility and the evolution of social networks, there is a lack of studies coupling social interactions and mobility. In this work, we introduce a model that bridges this gap by explicitly considering the feedback of mobility on the formation of social ties. Data coming from three online social networks (Twitter, Gowalla and Brightkite) is used for validation. Our model reproduces various topological and physical properties of the networks not captured by models uncoupling mobility and social interactions such as: i) the total size of the connected components, ii) the distance distribution between connected users, iii) the dependence of the reciprocity on the distance, iv) the variation of the social overlap and the clustering with the distance. Besides numerical simulations, a mean-field approach is also used to study analytically the main statistical features of the networks generated by a simplified version of our model. The robustness of the results to changes in the model parameters is explored, finding that a balance between friend visits and long-range random connections is essential to reproduce the geographical features of the empirical networks.	[Grabowicz, Przemyslaw A.; Ramasco, Jose J.; Eguiluz, Victor M.] CSIC UIB, Inst Fis Interdisciplinar & Sistemas Complejos, Palma De Mallorca, Spain; [Grabowicz, Przemyslaw A.] MPG, Max Planck Inst Software Syst, Saarbrucken, Germany; [Goncalves, Bruno] Aix Marseille Univ, CNRS, Ctr Phys Theor, Marseille, France; [Goncalves, Bruno] Univ Toulon & Var, CNRS, Ctr Phys Theor, La Garde, France	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Barcelona; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Toulon	Grabowicz, PA (corresponding author), CSIC UIB, Inst Fis Interdisciplinar & Sistemas Complejos, Palma De Mallorca, Spain.	pms@mpi-sws.org	Gonçalves, Bruno/A-8541-2009; Eguíluz, Víctor M./B-9655-2008; Ramasco, Jose J/F-2860-2010	Gonçalves, Bruno/0000-0001-5644-3749; Eguíluz, Víctor M./0000-0003-1133-1289; Ramasco, Jose J/0000-0003-2499-6095	Spanish Ministry of Economy (MINECO); FEDER (EU) under project MODASS [FIS2011-24785]; EU Commission; JAE-Predoc program of Consejo Superior de Investigaciones Cientificas; Ramon y Cajal program of MINECO; French ANR project HarMS-flu [ANR-12-MONU-0018]	Spanish Ministry of Economy (MINECO)(Spanish Government); FEDER (EU) under project MODASS; EU Commission(European CommissionEuropean Commission Joint Research Centre); JAE-Predoc program of Consejo Superior de Investigaciones Cientificas; Ramon y Cajal program of MINECO(Spanish Government); French ANR project HarMS-flu(French National Research Agency (ANR))	We have received partial financial support from the Spanish Ministry of Economy (MINECO) and FEDER (EU) under project MODASS (FIS2011-24785), and from the EU Commission through projects EUNOIA, INSIGHT and LASAGNE. PAG acknowledges funding from the JAE-Predoc program of Consejo Superior de Investigaciones Cientificas and JJR from the Ramon y Cajal program of MINECO. BG was partially supported by the French ANR project HarMS-flu (ANR-12-MONU-0018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstrom L., 2010, PROCEEDINGS OF THE 1, P61, DOI [10.1145/1772690.1772698, DOI 10.1145/1772690.1772698]; Bakshy E., 2012, P 21 INT C WORLD WID, P519, DOI [10.1145/2187836.2187907, DOI 10.1145/2187836.2187907]; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Borge-Holthoefer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023883; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brockmann D, 2010, NAT PHYS, V6, P720, DOI 10.1038/nphys1792; Butts CT, 2012, SOC NETWORKS, V34, P82, DOI 10.1016/j.socnet.2011.08.003; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055957; Crandall DJ, 2010, P NATL ACAD SCI USA, V107, P22436, DOI 10.1073/pnas.1006155107; Ferrara E, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds9; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gonzalez MC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088702; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; Grabowicz P. A., 2013, P 6 ACM INT C WEB SE, DOI DOI 10.1145/2433396.2433475; Grabowicz PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029358; Hasan S, 2013, J STAT PHYS, V151, P304, DOI 10.1007/s10955-012-0645-0; Jia T, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/11/P11024; Krings G, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/L07003; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lehmann J., 2012, P 21 INT C WORLD WID, P251, DOI [10.1145/2187836.2187871, DOI 10.1145/2187836.2187871]; Leskovec J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P497; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Lu X, 2012, P NATL ACAD SCI USA, V109, P11576, DOI 10.1073/pnas.1203882109; Mascolo C., 2011, 5 INT AAAI C WEBL SO, V5, P329; Miritello G, 2013, SOC NETWORKS, V35, P89, DOI 10.1016/j.socnet.2013.01.003; Mislove A, 2008, P 1 WORKSHOP ONLINE, P25, DOI [10.1145/1397735.1397742, DOI 10.1145/1397735.1397742]; NASA Socioeconomic Data and Applications Center (SEDAC), GRIDD POP WORLD VERS; Ratkiewicz J., 2011, PROC 20 INT C COMPAN, P297, DOI [10.1.1.646.5073, 10.1145/1963192.1963301, DOI 10.1145/1963192.1963301]; Renso C, 2013, MOBILITY DATA: MODELING, MANAGEMENT, AND UNDERSTANDING, P1, DOI 10.1017/CBO9781139128926; Rivera MT, 2010, ANNU REV SOCIOL, V36, P91, DOI 10.1146/annurev.soc.34.040507.134743; Sadilek A., 2012, P 5 ACM INT C WEB SE, P723, DOI DOI 10.1145/2124295.2124380; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; State Bogdan, 2013, P 6 ACM INT C WEB SE, P265, DOI DOI 10.1177/1753193412471107; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Takhteyev Y, 2012, SOC NETWORKS, V34, P73, DOI 10.1016/j.socnet.2011.05.006; *TWITT API, SECT DEV TWITT WEB P; Ugander J., 2011, 11114503 ARXIV; Ugander J, 2012, P NATL ACAD SCI USA, V109, P5962, DOI 10.1073/pnas.1116502109; Volkovich Y., 2012, INT AAAI C WEB SOC M; Wang D., 2011, P 17 ACM SIGKDD INT, P1100, DOI DOI 10.1145/2020408.2020581; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053	47	61	61	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92196	10.1371/journal.pone.0092196	http://dx.doi.org/10.1371/journal.pone.0092196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651657	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800083
J	Grosse-Dresselhaus, F; Galinovic, I; Villringer, K; Audebert, HJ; Fiebach, JB				Grosse-Dresselhaus, Florian; Galinovic, Ivana; Villringer, Kersten; Audebert, Heinrich J.; Fiebach, Jochen B.			Difficulty of MRI Based Identification of Lesion Age by Acute Infra-Tentorial Ischemic Stroke	PLOS ONE			English	Article							SYMPTOM ONSET; MISMATCH; TIME	Background: Systemic thrombolysis in acute ischemic stroke is restricted to the 4.5 h time window. Many patients are excluded from this treatment because symptom onset is unknown. Magnetic resonance imaging (MRI) studies have shown that stroke patients presenting with acute supra-tentorial diffusion-weighted imaging (DWI) lesions that do not have matching lesions on fluid attenuated inversion recovery (FLAIR) are likely to be within a 4.5 hour time window. This study examines the DWI-FLAIR mismatch in infra-tentorial stroke. Methods: This was a retrospectively conducted substudy of the "1000+" study; a prospective, single-center observational study (http://clinicaltrials.gov; NCT00715533). Fifty-six patients with infra-tentorial stroke confirmed by MRI and known symptom onset who underwent the scan within 24 h after symptom onset were analysed. Two neurologists blinded to clinical information separately rated the DWI lesion visibility on FLAIR. Lesion volume, relative signal intensities of DWI and relative apparent diffusion coefficient values were determined. Results: Regarding baseline characteristics our study population had a median age of 66 years, a median time from symptom onset to MRI of 616.5 minutes, a median NIHSS of 3 and a median DWI lesion volume of 0.26 ml. A negative FLAIR allocated patients to a time window under 4.5 h correctly with a sensitivity of 55% and a specificity of 61%, a positive predictive value of 44% and a negative predictive value of 71%. FLAIR positivity decreased with age (p = 0.018), and showed no significant correlation to lesion volume (p = 0.145). Conclusions: In our study the DWI-FLAIR-Mismatch does not help to reliably identify patients within 4.5 h of symptom onset in acute ischemic infra-tentorial stroke. Thus therapeutical decisions based on the DWI-FLAIR mismatch estimation of time from onset cannot be recommended in patients with infra-tentorial stroke.	[Grosse-Dresselhaus, Florian; Galinovic, Ivana; Villringer, Kersten; Audebert, Heinrich J.; Fiebach, Jochen B.] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Grosse-Dresselhaus, F (corresponding author), Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany.	grosse-dresselhaus@gmx.de		Fiebach, Jochen B./0000-0002-7936-6958; Galinovic, Ivana/0000-0003-4904-8251; Audebert, Heinrich J./0000-0002-4785-0366	Charite University, Berlin, Germany; German Federal Ministry of Education and Research	Charite University, Berlin, Germany; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The work was supported by Charite University, Berlin, Germany and German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2011, CEREBROVASC DIS, V31, P435, DOI 10.1159/000323850; Aoki J, 2010, J NEUROL SCI, V293, P39, DOI 10.1016/j.jns.2010.03.011; Ebinger M, 2010, STROKE, V41, P250, DOI 10.1161/STROKEAHA.109.568410; Fiebach JB, 2002, NEURORADIOLOGY, V44, P294, DOI 10.1007/s00234-001-0720-8; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Oppenheim C, 2000, AM J NEURORADIOL, V21, P1434; Petkova M, 2010, RADIOLOGY, V257, P782, DOI 10.1148/radiol.10100461; Schaefer PW, 2008, STROKE, V39, P3107, DOI 10.1161/STROKEAHA.108.517680; Thomalla G, 2011, LANCET NEUROL, V10, P978, DOI 10.1016/S1474-4422(11)70192-2; Thomalla G, 2009, ANN NEUROL, V65, P724, DOI 10.1002/ana.21651	10	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92868	10.1371/journal.pone.0092868	http://dx.doi.org/10.1371/journal.pone.0092868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651570	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800160
J	He, Q; Wu, C; Luo, H; Wang, ZY; Ma, XQ; Zhao, YF; Lu, J; Xiang, C; Qin, YY; Wu, SQ; Yu, FF; He, J				He, Qian; Wu, Cheng; Luo, Hong; Wang, Zhi-Yong; Ma, Xiu-Qiang; Zhao, Yan-Fang; Lu, Jian; Xiang, Chun; Qin, Ying-Yi; Wu, Shun-Quan; Yu, Fei-Fei; He, Jia			Trends in In-Hospital Mortality among Patients with Stroke in China	PLOS ONE			English	Article							BIRACIAL POPULATION; 30-DAY MORTALITY; ISCHEMIC-STROKE; CARE; SUBTYPES; AGE	Background: The incidence and burden of stroke in China is increasing rapidly. However, little is known about trends in mortality during stroke hospitalization. The objectives of this study were to assess trends of in-hospital mortality among patients with stroke and explore influence factors of in-hospital death after stroke in China. Methods: 109 grade III class A hospitals were sampled by multistage stratified cluster sampling. All patients admitted to hospitals between 2007 and 2010 with a discharge diagnosis of stroke were included. Trends in in-hospital mortality among patients with stroke were assessed. Influence factors of in-hospital death after stroke were explored using multivariable logistic regression. Results: Overall stroke hospitalizations increased from 79,894 in 2007 to 85,475 in 2010, and in-hospital mortality of stroke decreased from 3.16% to 2.30% (P<0.0001). The percentage of severe patients increased while odds of mortality (2010 versus 2007) decreased regardless of stroke type: subarachnoid hemorrhage (OR 0.792, 95% CI = 0.636 to 0.987), intracerebral hemorrhage (OR 0.647, 95% CI = 0.591 to 0.708), and ischemic stroke (OR 0.588, 95% CI = 0.532 to 0.649). In multivariable analyses, older age, male, basic health insurance, multiple comorbidities and severity of disease were linked to higher odds of in-hospital mortality. Conclusions: The mortality of stroke hospitalizations decreased likely reflecting advancements in stroke care and prevention. Decreasing of mortality with increasing of severe stroke patients indicated that we should pay more attention to rehabilitation and life quality of stroke patients. Specific individual and hospital-level characteristics may be targets for facilitating further declines.	[He, Qian; Wu, Cheng; Ma, Xiu-Qiang; Zhao, Yan-Fang; Lu, Jian; Xiang, Chun; Qin, Ying-Yi; Wu, Shun-Quan; Yu, Fei-Fei; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Luo, Hong] Second Mil Med Univ, Ctr Educ Technol, Shanghai, Peoples R China; [Wang, Zhi-Yong] Second Mil Med Univ, Changhai Hosp, Dept Informat, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	He, J (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yeah.net	zhao, yan/GWC-9174-2022	He, Jia/0000-0002-2338-9501	key discipline construction of Evidence-based Public Health in Shanghai [12GWZX0602]; 2 national "Eleven Five" "Significant new drugs creation" special science and technology major [2008ZX09312-007, 2009ZX09312-025]; foundation of Faculty of Health Service, Second Military Medical University [2013wk02]; foundation of Second Military Medical University [2012JS11]	key discipline construction of Evidence-based Public Health in Shanghai; 2 national "Eleven Five" "Significant new drugs creation" special science and technology major; foundation of Faculty of Health Service, Second Military Medical University; foundation of Second Military Medical University	This study was funded by the key discipline construction of Evidence-based Public Health in Shanghai No 12GWZX0602, 2 national "Eleven Five" "Significant new drugs creation" special science and technology major (2008ZX09312-007, 2009ZX09312-025), the foundation of Faculty of Health Service, Second Military Medical University (2013wk02), the foundation of Second Military Medical University (2012JS11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	China Ministry of Health, 2010, CHIN HLTH STAT YB 20; Cole JW, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-37; Deng YX, 2012, CNS NEUROSCI THER, V18, P819, DOI 10.1111/j.1755-5949.2012.00378.x; Heeley E, 2009, STROKE, V40, P2149, DOI 10.1161/STROKEAHA.108.540054; Jiang B, 2006, STROKE, V37, P63, DOI 10.1161/01.STR.0000194955.34820.78; Kissela B, 2004, STROKE, V35, P426, DOI 10.1161/01.STR.0000110982.74967.39; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Lichtman JH, 2013, STROKE, V44, P531, DOI 10.1161/STROKEAHA.112.670547; Lichtman JH, 2011, STROKE, V42, P3387, DOI 10.1161/STROKEAHA.111.622613; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Liu ZR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-394; Nimptsch U, 2012, DTSCH ARZTEBL INT, V109, P885, DOI 10.3238/arztebl.2012.0885; Ovbiagele B, 2010, STROKE, V41, P1748, DOI 10.1161/STROKEAHA.110.585455; Rao Y, 2007, XIANDAI YUFANG YIXUE, V34, P1615; Rao Y, 2007, XIANDAI YUFANG, V34, P1610; Wang De-zheng, 2012, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V30, P902; Wang PL, 2012, CHINESE MED J-PEKING, V125, P2449, DOI 10.3760/cma.j.issn.0366-6999.2012.14.010; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056459; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C; Zhao D, 2008, STROKE, V39, P1668, DOI 10.1161/STROKEAHA.107.502807; [赵玉华 Zhao Yuhua], 2011, [中华神经医学杂志, Chinese Journal of Neuromedicine], V10, P1255	22	33	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92763	10.1371/journal.pone.0092763	http://dx.doi.org/10.1371/journal.pone.0092763			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651454	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800155
J	Liang, CM; Ji, DM; Yuan, X; Ren, LL; Shen, J; Zhang, HY				Liang, Chun-mei; Ji, Dong-mei; Yuan, Xu; Ren, Ling-ling; Shen, Juan; Zhang, Hai-yan			RET and PHOX2B Genetic Polymorphisms and Hirschsprung's Disease Susceptibility: A Meta-Analysis	PLOS ONE			English	Article							ASSOCIATION; PROTOONCOGENE; VARIANTS; HAPLOTYPES; PROMOTER; CHINESE; POPULATION; MUTATIONS; RISK; SNPS	Background: Many publications have evaluated the correlation between RET, PHOX2B polymorphisms and Hirschsprung's disease with conflicting results. We performed this meta-analysis to clarify the association of RET, PHOX2B polymorphisms with HSCR. Methods: We searched Pubmed, Elsevier Science Direct, China National Knowledge Infrastructure database, Chinese Biomedical database, Google scholar. The combined odds ratio (OR) with 95% CI was calculated to estimate the strength of the association. Heterogeneity and publication bias were also assessed. Results: In total, 16 studies concerning RET and 4 studies concerning PHOX2B were included in the meta-analysis. The effects of five polymorphisms of RET (rs1800858, rs1800860, rs1800861, rs10900297, rs2435357) and one polymorphism (rs28647582) of PHOX2B were evaluated. We found a significant correlation between RET polymorphisms and HSCR. For rs1800858, the overall ORs (95% CI) of the A versus G, AA versus GG, AA/AG versus GG and AA versus GG/AG were 3.81 (2.28-6.35); 8.36 (3.45-0.25); 3.59 (1.83-7.02); and 6.60 (3.66-11.89). For rs1800861, the comparison of subjects in the G versus T, GG versus TT, GG/TG versus TT and GG versus TT/TG were 2.85(1.81-4.47); 5.38(2.68-10.80); 3.07(2.17-4.34) and 4.14(1.84-9.30) respectively. For rs10900297, the comparison results showed statistically significant. (ORC versus A = 5.05,95% CI = 4.16-6.13; ORCC versus AA = 9.73, 95% CI = 5.94-15.94; ORCC/AC versus AA = 5.31, 95% CI = 3.27-6.82; ORCC versus AC/AA = 7.06,95% CI = 5.60-8.91.) But, for rs1800860, the GG/GA versus AA did not reach statistical association (OR = 3.77, 95% CI = 0.94-15.07) and the G versus A, GG versus AA, GG versus GA/AA were 2.23 (1.60-3.11); 4.56 (1.14-18.27); 2.38 (1.66-3.43) respectively. For rs2435357, the T versus C, TT versus CC, TT/TC versus CC and TT versus CC/TC were 4.53 (3.27-6.27); 11.44 (5.67-23.10); 4.04 (2.92-5.57), and 9.01(5.25-15.46). The single polymorphism of PHOX2B gene wasn't related to the risk for HSCR. Conclusions: This meta-analysis shows a significant association between RET polymorphisms and HSCR.	[Liang, Chun-mei; Ren, Ling-ling; Shen, Juan; Zhang, Hai-yan] Anhui Med Univ, Sch Publ Hlth, Dept Hyg Anal & Detect, Hefei, Peoples R China; [Ji, Dong-mei] Anhui Med Univ, Affiliated Hosp 1, Dept Reprod Med Ctr, Hefei, Peoples R China; [Yuan, Xu] Anhui Med Univ, Affiliated Hosp 1, Dept Stomatol, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Liang, CM (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Hyg Anal & Detect, Hefei, Peoples R China.	liang_chun_mei@126.com; zhanghaiyan61@yahoo.com.cn	Ren, Lingling/HHC-2204-2022		Youth Foundation Training Programme of National Natural Science Foundation of the First Affiliated Hospital of Anhui Medical University [2010KJ24]	Youth Foundation Training Programme of National Natural Science Foundation of the First Affiliated Hospital of Anhui Medical University	This was funded by the Youth Foundation Training Programme of National Natural Science Foundation of the First Affiliated Hospital of Anhui Medical University (No. 2010KJ24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2001, J MED GENET, V38, P729, DOI 10.1136/jmg.38.11.729; Arnold S, 2009, HUM MUTAT, V30, P771, DOI 10.1002/humu.20944; Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8; Banerjee I, 2010, EUR J EPIDEMIOL, V25, P449, DOI 10.1007/s10654-010-9470-4; Borrego S, 2000, J MED GENET, V37, P572, DOI 10.1136/jmg.37.8.572; Burzynski GM, 2005, AM J HUM GENET, V76, P850, DOI 10.1086/429589; Burzynski GM, 2004, EUR J HUM GENET, V12, P604, DOI 10.1038/sj.ejhg.5201199; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cornes BK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010918; Du Han-song, 2006, Zhonghua Wei Chang Wai Ke Za Zhi, V9, P152; Du Y, 2005, J CLIN PEDIAT, V19, P221; Fitze G, 2003, HUM MOL GENET, V12, P3207, DOI 10.1093/hmg/ddg354; Fitze G, 2002, LANCET, V359, P1200, DOI 10.1016/S0140-6736(02)08218-1; Garcia-Barcelo M, 2005, HUM MOL GENET, V14, P191, DOI 10.1093/hmg/ddi015; Garcia-Barcelo M, 2003, GUT, V52, P563, DOI 10.1136/gut.52.4.563; Iwashita T, 2001, GASTROENTEROLOGY, V121, P24, DOI 10.1053/gast.2001.25515; Lantieri F, 2006, ANN MED, V38, P11, DOI 10.1080/07853890500442758; Lantieri F, 2006, ANN HUM GENET, V70, P12, DOI 10.1111/j.1529-8817.2005.00196.x; Li XJ, 2011, CHIN J CLIN ELECT ED, V5, P5775; Liu CP, 2010, BIOCHEM GENET, V48, P496, DOI 10.1007/s10528-010-9333-4; Liu CP, 2009, J PEDIATR SURG, V44, P1805, DOI 10.1016/j.jpedsurg.2008.12.009; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Moore SW, 2012, J PEDIATR SURG, V47, P299, DOI 10.1016/j.jpedsurg.2011.11.018; Nunez-Torres R, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-138; Phusantisampan T, 2012, J HUM GENET, V57, P286, DOI 10.1038/jhg.2012.18; Prato AP, 2009, MEDICINE, V88, P83, DOI 10.1097/MD.0b013e31819cf5da; Sadewa AH, 2008, PAEDIATR INDONES, V48, P88, DOI 10.14238/pi48.2.2008.88-92; Smigiel R, 2006, J APPL GENET, V47, P261, DOI 10.1007/BF03194634; Sribudiani Y, 2011, GASTROENTEROLOGY, V140, P572, DOI 10.1053/j.gastro.2010.10.044; Tou JF, 2007, STUDY POLYMORPHISMS; Tou JF, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-32; Xiao D, 2009, J SHANXI MED U, V40, P1083; Zhang XN, 2007, BIOCHEM GENET, V45, P523, DOI 10.1007/s10528-007-9093-y; [张宪生 Zhang Xiongsheng], 2005, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University.Medical Sciences], V26, P470; Zhao WY, 2012, CHINESE J BIRTH HLTH, V11, P17	35	35	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90091	10.1371/journal.pone.0090091	http://dx.doi.org/10.1371/journal.pone.0090091			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651702	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800009
J	Perez, AG; Leon, L; Pascual, M; Romero-Segura, C; Sanchez-Ortiz, A; de la Rosa, R; Sanz, C				Perez, Ana G.; Leon, Lorenzo; Pascual, Mar; Romero-Segura, Carmen; Sanchez-Ortiz, Araceli; de la Rosa, Raul; Sanz, Carlos			Variability of Virgin Olive Oil Phenolic Compounds in a Segregating Progeny from a Single Cross in Olea europaea L. and Sensory and Nutritional Quality Implications	PLOS ONE			English	Article							HYDROXYTYROSYL ACETATE; MEDITERRANEAN DIET; POLYPHENOLS; PROFILE; SECOIRIDOIDS; METABOLISM; TYROSOL; CHEMISTRY; LIGNANS; HEALTH	Virgin olive oil phenolic compounds are responsible for its nutritional and sensory quality. The synthesis of phenolic compounds occurs when enzymes and substrates meet as olive fruit is crushed during the industrial process to obtain the oil. The genetic variability of the major phenolic compounds of virgin olive oil was studied in a progeny of the cross of Picual x Arbequina olive cultivars (Olea europaea L.). They belong to four different groups: compounds that included tyrosol or hydroxytyrosol in their molecules, lignans, flavonoids, and phenolic acids. Data of phenolics in the oils showed that the progeny displayed a large degree of variability, widely transgressing the genitor levels. This high variability can be of interest on breeding programs. Thus, multivariate analysis allowed to identify genotypes within the progeny particularly interesting in terms of phenolic composition and deduced organoleptic and nutritional quality. The present study has demonstrated that it is possible to obtain enough degree of variability with a single cross of olive cultivars for compounds related to the nutritional and organoleptic properties of virgin olive oil.	[Perez, Ana G.; Pascual, Mar; Romero-Segura, Carmen; Sanchez-Ortiz, Araceli; Sanz, Carlos] CSIC, Inst Grasa, Dept Biochem & Mol Biol Plant Prod, E-41080 Seville, Spain; [Leon, Lorenzo; de la Rosa, Raul] Ctr Alameda Obispo, IFAPA, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG)	Sanz, C (corresponding author), CSIC, Inst Grasa, Dept Biochem & Mol Biol Plant Prod, E-41080 Seville, Spain.	carlos.sanz@ig.csic.es	Pérez, Ana/GQA-6861-2022; Pérez, Ana G. G/K-1221-2014; SANCHEZ, ARACELI/M-1413-2014; De la Rosa, Raul/AIB-1463-2022; Pérez, Ana G./AAB-4513-2021; Sanz, Carlos/K-1743-2014; De la Rosa, Raul/B-5755-2008; Leon, Lorenzo/N-7355-2013	Pérez, Ana G. G/0000-0002-8096-9190; SANCHEZ, ARACELI/0000-0003-1648-2924; De la Rosa, Raul/0000-0002-0752-9607; Pérez, Ana G./0000-0002-8096-9190; Sanz, Carlos/0000-0002-7387-3393; De la Rosa, Raul/0000-0002-0752-9607; Leon, Lorenzo/0000-0002-5664-3393	OLEAGEN project by Genoma Espana; Programa Nacional de Recursos y Tecnologias Agroalimentarias [AGL2011-24442]; Spanish Government	OLEAGEN project by Genoma Espana; Programa Nacional de Recursos y Tecnologias Agroalimentarias; Spanish Government(Spanish GovernmentEuropean Commission)	The financial support of the OLEAGEN project by Genoma Espana and AGL2011-24442 from the Programa Nacional de Recursos y Tecnologias Agroalimentarias funded by the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrewes P, 2003, J AGR FOOD CHEM, V51, P1415, DOI 10.1021/jf026042j; Artajo LS, 2006, EUR J LIPID SCI TECH, V108, P19, DOI 10.1002/ejlt.200500227; Bouallagui Z, 2011, APPL BIOCHEM BIOTECH, V163, P592, DOI 10.1007/s12010-010-9065-2; Caruso D, 1999, NUTR METAB CARDIOVAS, V9, P102; Cicerale S, 2009, CRIT REV FOOD SCI, V49, P218, DOI 10.1080/10408390701856223; Cook NC, 1996, J NUTR BIOCHEM, V7, P66, DOI 10.1016/0955-2863(95)00168-9; de la Puerta R, 1999, BIOCHEM PHARMACOL, V57, P445, DOI 10.1016/S0006-2952(98)00320-7; DZIEDZIC SZ, 1983, FOOD CHEM, V12, P205, DOI 10.1016/0308-8146(83)90007-9; El Riachy M, 2012, SPAN J AGRIC RES, V10, P443, DOI 10.5424/sjar/2012102-264-11; El Riachy M, 2012, J SCI FOOD AGR, V92, P2524, DOI 10.1002/jsfa.5662; El Riachy M, 2012, EUR J LIPID SCI TECH, V114, P542, DOI 10.1002/ejlt.201100129; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Garcia-Gonzalez DL, 2010, J AGR FOOD CHEM, V58, P8357, DOI 10.1021/jf101316d; Garcia-Rodriguez R, 2011, FOOD RES INT, V44, P629, DOI 10.1016/j.foodres.2010.12.023; Giovannini C, 1999, J NUTR, V129, P1269, DOI 10.1093/jn/129.7.1269; Grasso S, 2007, BIOORG CHEM, V35, P137, DOI 10.1016/j.bioorg.2006.09.003; Konstantinidou V, 2010, FASEB J, V24, P2546, DOI 10.1096/fj.09-148452; Leon L, 2011, EUR J LIPID SCI TECH, V113, P870, DOI 10.1002/ejlt.201000535; Luaces P, 2007, J SCI FOOD AGR, V87, P2721, DOI 10.1002/jsfa.3049; Lucas L, 2011, CURR PHARM DESIGN, V17, P754, DOI 10.2174/138161211795428911; Inarejos-Garcia AM, 2009, FOOD RES INT, V42, P279, DOI 10.1016/j.foodres.2008.11.009; Martines Suarez J. M., 1975, Grasas y Aceites, V26, P379; Mateos R, 2005, J AGR FOOD CHEM, V53, P9897, DOI 10.1021/jf051721q; Mateos R, 2004, J AM OIL CHEM SOC, V81, P71, DOI 10.1007/s11746-004-0859-x; Mateos R, 2011, FOOD CHEM, V125, P865, DOI 10.1016/j.foodchem.2010.09.054; Mateos R, 2001, J AGR FOOD CHEM, V49, P2185, DOI 10.1021/jf0013205; Menendez JA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-377; Menendez JA, 2009, INT J ONCOL, V34, P43, DOI 10.3892/ijo_00000127; Miro-Casas E, 2003, EUR J CLIN NUTR, V57, P186, DOI 10.1038/sj.ejcn.1601532; Montedoro G, 2002, ACTA HORTIC, P551, DOI 10.17660/ActaHortic.2002.586.115; Neveu V, 2010, PHEN EXPL ONL COMPR; Obied HK, 2008, NAT PROD REP, V25, P1167, DOI 10.1039/b719736e; Pereira-Caro G, 2012, INT J FOOD SCI NUTR, V63, P703, DOI 10.3109/09637486.2011.652943; Pinto J, 2011, BRIT J NUTR, V105, P1607, DOI 10.1017/S000711451000526X; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; Rjiba I, 2011, J FOOD BIOCHEM, V35, P1413, DOI 10.1111/j.1745-4514.2010.00462.x; Romero-Segura C, 2012, FOOD RES INT, V45, P191, DOI 10.1016/j.foodres.2011.10.024; Santos-Antunes F, 2005, HORTSCIENCE, V40, P1213, DOI 10.21273/HORTSCI.40.5.1213; Savarese M, 2007, FOOD CHEM, V105, P761, DOI 10.1016/j.foodchem.2007.01.037; Scotece M, 2013, CURR MED CHEM, V20, P2467, DOI 10.2174/0929867311320190006; Servili M, 2004, J CHROMATOGR A, V1054, P113, DOI 10.1016/S0021-9673(04)01423-2; Visioli F, 2011, CURR PHARM DESIGN, V17, P786, DOI 10.2174/138161211795428885	42	24	25	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92898	10.1371/journal.pone.0092898	http://dx.doi.org/10.1371/journal.pone.0092898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651694	gold, Green Published			2022-12-27	WOS:000333352800163
J	Yilancioglu, K; Cokol, M; Pastirmaci, I; Erman, B; Cetiner, S				Yilancioglu, Kaan; Cokol, Murat; Pastirmaci, Inanc; Erman, Batu; Cetiner, Selim			Oxidative Stress Is a Mediator for Increased Lipid Accumulation in a Newly Isolated Dunaliella salina Strain	PLOS ONE			English	Article							REACTIVE OXYGEN; NILE RED; GROWTH; MICROALGAE; REINHARDTII; EXPRESSION; RESPONSES; PROTEIN; ALGAE; OIL	Green algae offer sustainable, clean and eco-friendly energy resource. However, production efficiency needs to be improved. Increasing cellular lipid levels by nitrogen depletion is one of the most studied strategies. Despite this, the underlying physiological and biochemical mechanisms of this response have not been well defined. Algae species adapted to hypersaline conditions can be cultivated in salty waters which are not useful for agriculture or consumption. Due to their inherent extreme cultivation conditions, use of hypersaline algae species is better suited for avoiding culture contamination issues. In this study, we identified a new halophilic Dunaliella salina strain by using 18S ribosomal RNA gene sequencing. We found that growth and biomass productivities of this strain were directly related to nitrogen levels, as the highest biomass concentration under 0.05 mM or 5 mM nitrogen regimes were 495 mg/l and 1409 mg/l, respectively. We also confirmed that nitrogen limitation increased cellular lipid content up to 35% under 0.05 mM nitrogen concentration. In order to gain insight into the mechanisms of this phenomenon, we applied fluorometric, flow cytometric and spectrophotometric methods to measure oxidative stress and enzymatic defence mechanisms. Under nitrogen depleted cultivation conditions, we observed increased lipid peroxidation by measuring an important oxidative stress marker, malondialdehyde and enhanced activation of catalase, ascorbate peroxidase and superoxide dismutase antioxidant enzymes. These observations indicated that oxidative stress is accompanied by increased lipid content in the green alga. In addition, we also showed that at optimum cultivation conditions, inducing oxidative stress by application of exogenous H2O2 leads to increased cellular lipid content up to 44% when compared with non-treated control groups. Our results support that oxidative stress and lipid overproduction are linked. Importantly, these results also suggest that oxidative stress mediates lipid accumulation. Understanding such relationships may provide guidance for efficient production of algal biodiesels.	[Yilancioglu, Kaan; Cokol, Murat; Pastirmaci, Inanc; Erman, Batu; Cetiner, Selim] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey; [Cokol, Murat] Sabanci Univ, Nanotechnol Res & Applicat Ctr, Istanbul, Turkey	Sabanci University; Sabanci University	Cetiner, S (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey.	cetiner@sabanciuniv.edu	Cetiner, Selim/AAX-1782-2020; erman, batu/AAE-1963-2020	Pastirmaci, Inanc/0000-0002-0316-0718	Sabanci University	Sabanci University(Sabanci University)	This work was financially supported by research fund of Sabanci University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H., 1984, METHODS ENZYMOL, V105, P121, DOI [10.1016/S0076-6879(84)05016-3, DOI 10.1016/S0076-6879(84)05016-3]; Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Barbarino E, 2005, J APPL PHYCOL, V17, P447, DOI 10.1007/s10811-005-1641-4; Bhaduri AM, 2012, REV ENVIRON SCI BIO, V11, P55, DOI 10.1007/s11157-011-9251-x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cakmak T, 2012, BIOENGINEERED, V3, P343, DOI 10.4161/bioe.21427; Cash TP, 2007, FREE RADICAL BIO MED, V43, P1219, DOI 10.1016/j.freeradbiomed.2007.07.001; Chen M, 2011, BIORESOURCE TECHNOL, V102, P1649, DOI 10.1016/j.biortech.2010.09.062; Chen W, 2011, BIORESOURCE TECHNOL, V102, P135, DOI 10.1016/j.biortech.2010.06.076; Chen W, 2009, J MICROBIOL METH, V77, P41, DOI 10.1016/j.mimet.2009.01.001; COLE TA, 1990, EUR J PROTISTOL, V25, P361, DOI 10.1016/S0932-4739(11)80129-X; Converti A, 2009, CHEM ENG PROCESS, V48, P1146, DOI 10.1016/j.cep.2009.03.006; Courchesne NMD, 2009, J BIOTECHNOL, V141, P31, DOI 10.1016/j.jbiotec.2009.02.018; Csavina JL, 2011, J APPL MICROBIOL, V111, P312, DOI 10.1111/j.1365-2672.2011.05064.x; del Rio LA, 2006, PLANT PHYSIOL, V141, P330, DOI 10.1104/pp.106.078204; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Fredslund J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-315; Camacho FG, 2007, BIOTECHNOL ADV, V25, P176, DOI 10.1016/j.biotechadv.2006.11.008; GARCIAFERRIS C, 1993, PHOTOSYNTH RES, V35, P55, DOI 10.1007/BF02185411; Gordillo FJL, 1998, J APPL PHYCOL, V10, P135, DOI 10.1023/A:1008067022973; Govender T, 2012, BIORESOURCE TECHNOL, V114, P507, DOI 10.1016/j.biortech.2012.03.024; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Griffiths MJ, 2012, J APPL PHYCOL, V24, P989, DOI 10.1007/s10811-011-9723-y; Ho SH, 2010, BIORESOURCE TECHNOL, V101, P8725, DOI 10.1016/j.biortech.2010.06.112; Hong Y, 2008, ECOTOX ENVIRON SAFE, V71, P527, DOI 10.1016/j.ecoenv.2007.10.010; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kimura K, 2004, J MICROBIOL METH, V56, P331, DOI 10.1016/j.mimet.2003.10.018; Kobayashi M, 2003, BIOTECHNOL BIOPROC E, V8, P322, DOI 10.1007/BF02949275; Lee SJ, 1998, BIOTECHNOL TECH, V12, P553, DOI 10.1023/A:1008811716448; LEVASSEUR M, 1993, J PHYCOL, V29, P587, DOI 10.1111/j.0022-3646.1993.00587.x; Li X, 2011, BIORESOURCE TECHNOL, V102, P3098, DOI 10.1016/j.biortech.2010.10.055; Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1; Liang ZJ, 2013, AQUAT TOXICOL, V138, P81, DOI 10.1016/j.aquatox.2013.04.010; Lin QA, 2011, BIORESOURCE TECHNOL, V102, P1615, DOI 10.1016/j.biortech.2010.09.008; Liu WH, 2012, J EXP MAR BIOL ECOL, V418, P24, DOI 10.1016/j.jembe.2012.03.005; Mallick N, 2000, J PLANT PHYSIOL, V157, P183, DOI 10.1016/S0176-1617(00)80189-3; Miller SR, 2002, ARCH MICROBIOL, V177, P392, DOI 10.1007/s00203-002-0404-8; Msanne J, 2012, PHYTOCHEMISTRY, V75, P50, DOI 10.1016/j.phytochem.2011.12.007; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; Olmos J, 2000, LETT APPL MICROBIOL, V30, P80, DOI 10.1046/j.1472-765x.2000.00672.x; Pinto E, 2003, J PHYCOL, V39, P1008, DOI 10.1111/j.0022-3646.2003.02-193.x; Sabatini SE, 2009, ECOTOX ENVIRON SAFE, V72, P1200, DOI 10.1016/j.ecoenv.2009.01.003; Schonswetter P, 2002, MOL ECOL, V11, P2637, DOI 10.1046/j.1365-294X.2002.01651.x; Sharma KK, 2012, ENERGIES, V5, P1532, DOI 10.3390/en5051532; Singh SP, 2010, AGEING RES REV, V9, P79, DOI 10.1016/j.arr.2009.05.004; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; Tang HY, 2011, APPL ENERG, V88, P3324, DOI 10.1016/j.apenergy.2010.09.013; Tsukagoshi H, 2012, PLANT SCI, V197, P30, DOI 10.1016/j.plantsci.2012.08.011; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Zhang YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069225; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004	54	187	191	2	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91957	10.1371/journal.pone.0091957	http://dx.doi.org/10.1371/journal.pone.0091957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651514	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800059
J	Aufauvre, J; Misme-Aucouturier, B; Vigues, B; Texier, C; Delbac, F; Blot, N				Aufauvre, Julie; Misme-Aucouturier, Barbara; Vigues, Bernard; Texier, Catherine; Delbac, Frederic; Blot, Nicolas			Transcriptome Analyses of the Honeybee Response to Nosema ceranae and Insecticides	PLOS ONE			English	Article							BEE APIS-MELLIFERA; PESTICIDE-RESIDUES; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; NATURAL INFECTION; TOXICITY; PATHOGEN; DETOXIFICATION; MICROSPORIDIA; METABOLISM	Honeybees (Apis mellifera) are constantly exposed to a wide variety of environmental stressors such as parasites and pesticides. Among them, Nosema ceranae and neurotoxic insecticides might act in combination and lead to a higher honeybee mortality. We investigated the molecular response of honeybees exposed to N. ceranae, to insecticides (fipronil or imidacloprid), and to a combination of both stressors. Midgut transcriptional changes induced by these stressors were measured in two independent experiments combining a global RNA-Seq transcriptomic approach with the screening of the expression of selected genes by quantitative RT-PCR. Although N. ceranae-insecticide combinations induced a significant increase in honeybee mortality, we observed that they did not lead to a synergistic effect. According to gene expression profiles, chronic exposure to insecticides had no significant impact on detoxifying genes but repressed the expression of immunity-related genes. Honeybees treated with N. ceranae, alone or in combination with an insecticide, showed a strong alteration of midgut immunity together with modifications affecting cuticle coatings and trehalose metabolism. An increasing impact of treatments on gene expression profiles with time was identified suggesting an absence of stress recovery which could be linked to the higher mortality rates observed.	[Aufauvre, Julie; Misme-Aucouturier, Barbara; Vigues, Bernard; Texier, Catherine; Delbac, Frederic; Blot, Nicolas] Univ Blaise Pascal, Clermont Univ, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Aufauvre, Julie; Misme-Aucouturier, Barbara; Vigues, Bernard; Texier, Catherine; Delbac, Frederic; Blot, Nicolas] CNRS, LMGE, UMR 6023, Aubiere, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA)	Blot, N (corresponding author), Univ Blaise Pascal, Clermont Univ, Lab Microorganismes Genome & Environm, BP 10448, Clermont Ferrand, France.	Nicolas.Blot@univ-bpclermont.fr	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216; TOTTEY, Julie/0000-0001-6500-1117	French Centre National de la Recherche Scientifique APEGE program (ParaTox-Synergie project); French Agence Nationale de la Recherche (BEELOSS program) [ANR-12-BSV3-0020]	French Centre National de la Recherche Scientifique APEGE program (ParaTox-Synergie project); French Agence Nationale de la Recherche (BEELOSS program)(French National Research Agency (ANR))	This work was supported by the French Centre National de la Recherche Scientifique APEGE program (ParaTox-Synergie project) and the French Agence Nationale de la Recherche (BEELOSS program, grant no. ANR-12-BSV3-0020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Aliferis KA, 2012, J INSECT PHYSIOL, V58, P1349, DOI 10.1016/j.jinsphys.2012.07.010; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; Badiou-Beneteau A, 2012, ECOTOX ENVIRON SAFE, V82, P22, DOI 10.1016/j.ecoenv.2012.05.005; Barraza A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24778; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; Bernadou A, 2009, J INSECT PHYSIOL, V55, P1099, DOI 10.1016/j.jinsphys.2009.08.019; Bernal J, 2010, J ECON ENTOMOL, V103, P1964, DOI 10.1603/EC10235; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Botias C, 2012, RES VET SCI, V93, P150, DOI 10.1016/j.rvsc.2011.08.002; Broderick NA, 2009, RECOGNITION RESPONSE, P272; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chandor-Proust A, 2013, BIOCHEM J, V455, P75, DOI 10.1042/BJ20130577; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010133; Chung EY, 2007, IMMUNITY, V27, P952, DOI 10.1016/j.immuni.2007.11.014; Colin ME, 2004, ARCH ENVIRON CON TOX, V47, P387, DOI 10.1007/s00244-004-3052-y; Cook AL, 2008, PIGM CELL MELANOMA R, V21, P611, DOI 10.1111/j.1755-148X.2008.00510.x; David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Decourtye A, 2009, HAZ PEST BEES 10 INT; Decourtye A, 2011, ECOTOXICOLOGY, V20, P429, DOI 10.1007/s10646-011-0594-4; Derecka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068191; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Ding ZP, 2013, INSECT BIOCHEM MOLEC, V43, P1021, DOI 10.1016/j.ibmb.2013.08.005; Dussaubat C, 2013, VET MICROBIOL, V162, P670, DOI 10.1016/j.vetmic.2012.09.012; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; El Hassani AK, 2005, PHARMACOL BIOCHEM BE, V82, P30, DOI 10.1016/j.pbb.2005.07.008; Garcia-Palencia P, 2010, J APICULT RES, V49, P278, DOI 10.3896/IBRA.1.49.3.08; Gonzalez-Varo JP, 2013, TRENDS ECOL EVOL, V28, P524, DOI 10.1016/j.tree.2013.05.008; Gregorc A, 2012, J INSECT PHYSIOL, V58, P1042, DOI 10.1016/j.jinsphys.2012.03.015; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hao ZG, 2003, INSECT BIOCHEM MOLEC, V33, P1155, DOI 10.1016/j.ibmb.2003.07.001; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Junell A, 2010, MOL CELL BIOL, V30, P3672, DOI 10.1128/MCB.00223-10; Kanost MR, 2005, PROTEASES COMPREHENS, V4, P247; Kievits J., 2007, ABEILLES CIE, V118, P12; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Lambert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067007; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lovallo N, 1999, J INSECT PHYSIOL, V45, P1037, DOI 10.1016/S0022-1910(99)00086-4; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Mayack C, 2010, J INSECT PHYSIOL, V56, P1572, DOI 10.1016/j.jinsphys.2010.05.016; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; McDonnell CM, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-25; Garrido PM, 2013, J INSECT PHYSIOL, V59, P113, DOI 10.1016/j.jinsphys.2012.10.019; Min-Oo G, 2010, EXP PARASITOL, V125, P315, DOI 10.1016/j.exppara.2010.02.009; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Pareja L, 2011, INT J ENV RES PUB HE, V8, P3844, DOI 10.3390/ijerph8103844; Pauchet Y, 2009, J BIOL CHEM, V284, P2214, DOI 10.1074/jbc.M806204200; Pick L, 2012, ANN NY ACAD SCI, V1256, P15, DOI 10.1111/j.1749-6632.2011.06385.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Sun W, 2012, INSECT BIOCHEM MOLEC, V42, P935, DOI 10.1016/j.ibmb.2012.09.006; Terra WR, 2001, ARCH INSECT BIOCHEM, V47, P47, DOI 10.1002/arch.1036; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550	75	147	153	7	186	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91686	10.1371/journal.pone.0091686	http://dx.doi.org/10.1371/journal.pone.0091686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646894	gold, Green Submitted, Green Published			2022-12-27	WOS:000333348500045
J	Bocchetta, S; Maillard, P; Yamamoto, M; Gondeau, C; Douam, F; Lebreton, S; Lagaye, S; Pol, S; Helle, F; Plengpanich, W; Guerin, M; Bourgine, M; Michel, ML; Lavillette, D; Roingeard, P; le Goff, W; Budkowska, A				Bocchetta, Simone; Maillard, Patrick; Yamamoto, Mami; Gondeau, Claire; Douam, Florian; Lebreton, Stephanie; Lagaye, Sylvie; Pol, Stanislas; Helle, Francois; Plengpanich, Wanee; Guerin, Maryse; Bourgine, Maryline; Michel, Marie Louise; Lavillette, Dimitri; Roingeard, Philippe; le Goff, Wilfried; Budkowska, Agata			Up-Regulation of the ATP-Binding Cassette Transporter A1 Inhibits Hepatitis C Virus Infection	PLOS ONE			English	Article							LIVER X RECEPTOR; CHOLESTEROL EXPORTER ABCA1; GPI-ANCHORED PROTEINS; NASCENT HDL FORMATION; LOW-DENSITY; LIPID-METABOLISM; PLASMA-MEMBRANE; REPLICATION; ENTRY; PATHWAY	Hepatitis C virus (HCV) establishes infection using host lipid metabolism pathways that are thus considered potential targets for indirect anti-HCV strategies. HCV enters the cell via clathrin-dependent endocytosis, interacting with several receptors, and virus-cell fusion, which depends on acidic pH and the integrity of cholesterol-rich domains of the hepatocyte membrane. The ATP-binding Cassette Transporter A1 (ABCA1) mediates cholesterol efflux from hepatocytes to extracellular Apolipoprotein A1 and moves cholesterol within cell membranes. Furthermore, it generates high-density lipoprotein (HDL) particles. HDL protects against arteriosclerosis and cardiovascular disease. We show that the up-regulation of ABCA1 gene expression and its cholesterol efflux function in Huh7.5 hepatoma cells, using the liver X receptor (LXR) agonist GW3965, impairs HCV infection and decreases levels of virus produced. ABCA1-stimulation inhibited HCV cell entry, acting on virus-host cell fusion, but had no impact on virus attachment, replication, or assembly/secretion. It did not affect infectivity or properties of virus particles produced. Silencing of the ABCA1 gene and reduction of the specific cholesterol efflux function counteracted the inhibitory effect of the GW3965 on HCV infection, providing evidence for a key role of ABCA1 in this process. Impaired virus-cell entry correlated with the reorganisation of cholesterol-rich membrane microdomains (lipid rafts). The inhibitory effect could be reversed by an exogenous cholesterol supply, indicating that restriction of HCV infection was induced by changes of cholesterol content/distribution in membrane regions essential for virus-cell fusion. Stimulation of ABCA1 expression by GW3965 inhibited HCV infection of both human primary hepatocytes and isolated human liver slices. This study reveals that pharmacological stimulation of the ABCA1-dependent cholesterol efflux pathway disrupts membrane cholesterol homeostasis, leading to the inhibition of virus-cell fusion and thus HCV cell entry. Therefore besides other beneficial roles, ABCA1 might represent a potential target for HCV therapy.	[Bocchetta, Simone; Maillard, Patrick; Yamamoto, Mami; Budkowska, Agata] CNRS, Unite Hepacivirus & Immunite Innee, UMR3569, Paris, France; [Bocchetta, Simone] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Med Translaz, Novara, Italy; [Yamamoto, Mami] Nihon Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Gondeau, Claire] Hop St Eloi, Inst Rech Biotherapie, INSERM, U1040, Montpellier, France; [Douam, Florian; Lavillette, Dimitri] CNRS, Gup Rech Dynam Microbienne & Transmiss Virale, UMR 5557, Villeurbanne, France; [Lebreton, Stephanie] Inst Pasteur, Unite Traf Membranaire & Pathogenese, Paris, France; [Lagaye, Sylvie; Pol, Stanislas] Grp Hosp Cochin Hotel Dieu, AP HP, Unite Hepatol, Paris, France; [Pol, Stanislas] CNRS, INSERM, Equipe Cycle Cellulaire Regenerat & Hepatopathies, Inst Cochin,U1016,UMR8104, Paris, France; [Helle, Francois] CHU Sud Amiens, Lab Virol, Ctr Biol Humaine, Amiens, France; [Plengpanich, Wanee; Guerin, Maryse; le Goff, Wilfried] INSERM, UMRS939, Paris, France; [Plengpanich, Wanee] Chulalongkorn Univ, Dept Med, Endocrinol & Metab Unit, Bangkok, Thailand; [Plengpanich, Wanee] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok, Thailand; [Bourgine, Maryline; Michel, Marie Louise] Inst Pasteur, INSERM, U845, F-75724 Paris, France; [Roingeard, Philippe] Univ Tours, INSERM, U966, Tours, France; [Roingeard, Philippe] CHRU Tours, Tours, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Eastern Piedmont Amedeo Avogadro; Nihon University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm); Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours	Budkowska, A (corresponding author), CNRS, Unite Hepacivirus & Immunite Innee, UMR3569, Paris, France.	agata.budkowska@pasteur.fr	Guerin, Maryse/N-5794-2017; BOURGINE, Maryline/G-3940-2017; Le Goff, Wilfried/N-6326-2017; Le Goff, Wilfried/N-7593-2019; HELLE, Francois/G-7427-2011; Michel, Marie-Louise/N-4384-2017	BOURGINE, Maryline/0000-0002-8850-8073; Le Goff, Wilfried/0000-0002-7611-9644; Le Goff, Wilfried/0000-0002-7611-9644; HELLE, Francois/0000-0001-6884-2456; GUERIN, Maryse/0000-0003-0150-1360; Lebreton, Stephanie/0000-0002-9879-0404; Lavillette, Dimitri/0000-0002-4706-1519	Italian Ministry of Science and Education; French Embassy in Japan	Italian Ministry of Science and Education; French Embassy in Japan	SB was supported by the Doctoral Fellowship from the Italian Ministry of Science and Education and MY by the Postdoctoral Fellowship from the French Embassy in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Amemiya F, 2008, J INFECT DIS, V197, P361, DOI 10.1086/525287; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Asselah T, 2012, LIVER INT, V32, P88, DOI 10.1111/j.1478-3231.2011.02699.x; Bartenschlager R, 2010, J HEPATOL, V53, P583, DOI 10.1016/j.jhep.2010.04.015; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bassendine MF, 2013, SEMIN IMMUNOPATHOL, V35, P87, DOI 10.1007/s00281-012-0356-2; Bassendine MF, 2011, J HEPATOL, V55, P1428, DOI 10.1016/j.jhep.2011.06.004; Blackham S, 2010, J VIROL, V84, P5404, DOI 10.1128/JVI.02529-09; Buhler S, 2012, LIVER INT, V32, P9, DOI 10.1111/j.1478-3231.2011.02701.x; Burlone ME, 2009, J GEN VIROL, V90, P1055, DOI 10.1099/vir.0.008300-0; Carter GC, 2009, VIROLOGY, V386, P192, DOI 10.1016/j.virol.2008.12.031; Chamoun-Emanuelli AM, 2013, ANTIMICROB AGENTS CH, V57, P2571, DOI 10.1128/AAC.02593-12; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; Cui HL, 2012, J LIPID RES, V53, P696, DOI 10.1194/jlr.M023119; Denis M, 2008, J BIOL CHEM, V283, P16178, DOI 10.1074/jbc.M709597200; Di DM, 2012, BIOCHEM BIOPH RES CO, V421, P152, DOI 10.1016/j.bbrc.2012.04.022; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Gondeau C, 2013, GUT, DOI 10.1136; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Hassan HH, 2007, J LIPID RES, V48, P2428, DOI 10.1194/jlr.M700206-JLR200; Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Iatan I, 2011, J LIPID RES, V52, P2043, DOI 10.1194/jlr.M016196; Ji AL, 2012, J LIPID RES, V53, P446, DOI 10.1194/jlr.M017079; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Lagaye S, 2012, HEPATOLOGY, V56, P861, DOI 10.1002/hep.25738; Lambert D, 2007, CELL PHYSIOL BIOCHEM, V20, P495, DOI 10.1159/000107533; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lange CM, 2014, EMBO MOL MED, V6, P4, DOI 10.1002/emmm.201303131; Larrede S, 2009, ARTERIOSCL THROM VAS, V29, P1930, DOI 10.1161/ATVBAHA.109.194548; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Le Goff W, 2006, J LIPID RES, V47, P51, DOI 10.1194/jlr.M500255-JLR200; Lebreton S, 2008, J BIOL CHEM, V283, P29545, DOI 10.1074/jbc.M803819200; Lopez CA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002020; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Maillard P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026637; Meex SJR, 2011, J LIPID RES, V52, P152, DOI 10.1194/jlr.D008888; Milosavljevic D, 2003, BBA-MOL CELL BIOL L, V1631, P51, DOI 10.1016/S1388-1981(02)00355-4; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Morrow MP, 2010, MOL PHARMACOL, V78, P215, DOI 10.1124/mol.110.065029; Nagao K, 2011, FEBS J, V278, P3190, DOI 10.1111/j.1742-4658.2011.08170.x; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Oosterveer MH, 2010, PROG LIPID RES, V49, P343, DOI 10.1016/j.plipres.2010.03.002; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Peng DC, 2011, BRIT J PHARMACOL, V162, P1792, DOI 10.1111/j.1476-5381.2011.01202.x; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Ramcharran D, 2011, J VIRAL HEPATITIS, V18, pe144, DOI 10.1111/j.1365-2893.2010.01394.x; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Sahoo D, 2004, J LIPID RES, V45, P1122, DOI 10.1194/jlr.M300529-JLR200; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; Smith B, 2012, CELL REP, V2, P580, DOI 10.1016/j.celrep.2012.08.011; Sorci-Thomas MG, 2012, J LIPID RES, V53, P1890, DOI 10.1194/jlr.M026674; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Tang CR, 2009, BBA-MOL CELL BIOL L, V1791, P563, DOI 10.1016/j.bbalip.2009.03.011; Targett-Adams P, 2005, J GEN VIROL, V86, P3075, DOI 10.1099/vir.0.81334-0; Teissier E, 2007, EUR BIOPHYS J BIOPHY, V36, P887, DOI 10.1007/s00249-007-0201-z; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Vieira FS, 2010, BIOL CELL, V102, P391, DOI 10.1042/BC20090138; Thi VLD, 2012, J BIOL CHEM, V287, P31242, DOI 10.1074/jbc.M112.365924; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Ye J, 2007, PLOS PATHOG, V3, P1017, DOI 10.1371/journal.ppat.0030108; Yin K, 2010, MOL MED, V16, P438, DOI 10.2119/molmed.2010.00004; Zarubica A, 2009, FASEB J, V23, P1775, DOI 10.1096/fj.08-122192; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271	78	40	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92140	10.1371/journal.pone.0092140	http://dx.doi.org/10.1371/journal.pone.0092140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646941	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500090
J	Dodge, KL; Galuardi, B; Miller, TJ; Lutcavage, ME				Dodge, Kara L.; Galuardi, Benjamin; Miller, Timothy J.; Lutcavage, Molly E.			Leatherback Turtle Movements, Dive Behavior, and Habitat Characteristics in Ecoregions of the Northwest Atlantic Ocean	PLOS ONE			English	Article							TUNA THUNNUS-THYNNUS; DERMOCHELYS-CORIACEA; SEA-TURTLES; FORAGING BEHAVIOR; SATELLITE TELEMETRY; CARETTA-CARETTA; SCALE MOVEMENTS; GPS TRACKING; MIGRATION; WATERS	Leatherback sea turtles, Dermochelys coriacea, are highly migratory predators that feed exclusively on gelatinous zooplankton, thus playing a unique role in coastal and pelagic food webs. From 2007 to 2010, we used satellite telemetry to monitor the movements and dive behavior of nine adult and eleven subadult leatherbacks captured on the Northeast USA shelf and tracked throughout the Northwest Atlantic. Leatherback movements and environmental associations varied by oceanographic region, with slow, sinuous, area-restricted search behavior and shorter, shallower dives occurring in cool (median sea surface temperature: 18.4 degrees C), productive (median chlorophyll a: 0.80 mg m(-3)), shallow (median bathymetry: 57 m) shelf habitat with strong sea surface temperature gradients (median SST gradient: 0.23 degrees C km(-1)) at temperate latitudes. Leatherbacks were highly aggregated in temperate shelf and slope waters during summer, early fall, and late spring and more widely dispersed in subtropical and tropical oceanic and neritic habitat during late fall, winter and early spring. We investigated the relationship of ecoregion, satellite-derived surface chlorophyll, satellite-derived sea surface temperature, SST gradient, chlorophyll gradient and bathymetry with leatherback search behavior using generalized linear mixed-effects models. The most well supported model showed that differences in leatherback search behavior were best explained by ecoregion and regional differences in bathymetry and SST. Within the Northwest Atlantic Shelves region, leatherbacks increased path sinuosity (i.e., looping movements) with increasing SST, but this relationship reversed within the Gulf Stream region. Leatherbacks increased path sinuosity with decreasing water depth in temperate and tropical shelf habitats. This relationship is consistent with increasing epipelagic gelatinous zooplankton biomass with decreasing water depth, and bathymetry may be a key feature in identifying leatherback foraging habitat in neritic regions. High-use habitat for leatherbacks in our study occurred in coastal waters of the North American eastern seaboard and eastern Caribbean, putting turtles at heightened risk from land- and ocean-based human activity.	[Dodge, Kara L.] Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA; [Dodge, Kara L.; Galuardi, Benjamin; Lutcavage, Molly E.] Univ Massachusetts Amherst, Large Pelag Res Ctr, Gloucester, MA USA; [Miller, Timothy J.] Natl Marine Fisheries Serv, Northeast Fisheries Sci Ctr, Woods Hole, MA 02543 USA	University System Of New Hampshire; University of New Hampshire; University of Massachusetts System; University of Massachusetts Amherst; National Oceanic Atmospheric Admin (NOAA) - USA	Dodge, KL (corresponding author), Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA.	kara.dodge@post.harvard.edu		Miller, Timothy/0000-0003-1411-1206	University of New Hampshire; National Oceanic and Atmospheric Administration [NA04NMF4550391]; National Fish and Wildlife Foundation [2008-0076-000]; Cape Cod Commercial Fishermen's Alliance; Massachusetts Division of Marine Fisheries through National Oceanic and Atmospheric Administration [NA07NMF4720052]	University of New Hampshire; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Fish and Wildlife Foundation; Cape Cod Commercial Fishermen's Alliance; Massachusetts Division of Marine Fisheries through National Oceanic and Atmospheric Administration	KD was supported by a University of New Hampshire Marine Program Fellowship administered by the Large Pelagics Research Center. This study was funded by a National Oceanic and Atmospheric Administration Grant #NA04NMF4550391 (www.noaa.gov) and National Fish and Wildlife Foundation Grant #2008-0076-000 (www.nfwf.org) to ML. Additional funding was provided by the Cape Cod Commercial Fishermen's Alliance (www.capecodfishermen.org). Turtle disentanglement was supported by the Massachusetts Division of Marine Fisheries through National Oceanic and Atmospheric Administration Grant #NA07NMF4720052. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alfaro-Shigueto J, 2007, CHELONIAN CONSERV BI, V6, P129, DOI 10.2744/1071-8443(2007)6[129:IBLTAP]2.0.CO;2; Alfaro-Shigueto J, 2010, FISH RES, V106, P8, DOI 10.1016/j.fishres.2010.06.004; ASPER ED, 1975, J FISH RES BOARD CAN, V32, P1191, DOI 10.1139/f75-138; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bailey H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036401; Bailey H, 2012, ECOL APPL, V22, P735, DOI 10.1890/11-0633; Batschelet E, 1981, CIRCULAR STAT BIOL; Belkin IM, 2009, J MARINE SYST, V78, P319, DOI 10.1016/j.jmarsys.2008.11.018; Belkin IM, 2009, PROG OCEANOGR, V81, P223, DOI 10.1016/j.pocean.2009.04.015; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Benson SR, 2007, FISH B-NOAA, V105, P337; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; BLEAKNEY J. SHERMAN, 1965, CAN FIELD NATUR, V79, P120; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Brudenall DK, 2008, VET OPHTHALMOL, V11, P99, DOI 10.1111/j.1463-5224.2008.00607.x; Bryant E., 2007, 2D LOCATION ACCURACY; Burnham K. P., 1998, MODEL SELECTION INFE; Carr AF, 1959, AM MUS NOVIT, P1835; Casey J, 2010, J EXP BIOL, V213, P3961, DOI 10.1242/jeb.048611; Chapman EW, 2011, CAN J FISH AQUAT SCI, V68, P1934, DOI 10.1139/F2011-109; CHI EM, 1989, J AM STAT ASSOC, V84, P452, DOI 10.2307/2289929; Deibel D, 2009, J PLANKTON RES, V31, P1571, DOI 10.1093/plankt/fbp091; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Dodge KL, 2011, MAR BIOL, V158, P2813, DOI 10.1007/s00227-011-1780-x; Doyle Thomas K., 2008, Endangered Species Research, V4, P23, DOI 10.3354/esr00076; ECKERT SA, 1989, CAN J ZOOL, V67, P2834, DOI 10.1139/z89-399; Eckert SA, 2006, CHELONIAN CONSERV BI, V5, P239, DOI 10.2744/1071-8443(2006)5[239:IAPMAF]2.0.CO;2; Eckert SA, 2006, MAR BIOL, V149, P1257, DOI 10.1007/s00227-006-0262-z; Faes C, 2009, AM STAT, V63, P389, DOI 10.1198/tast.2009.08196; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; Fossette Sabrina, 2008, Endangered Species Research, V4, P33, DOI 10.3354/esr00039; Fossette S, 2012, BIOL LETTERS, V8, P351, DOI 10.1098/rsbl.2011.0965; Fossette S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013908; Fossette S, 2010, J MARINE SYST, V81, P225, DOI 10.1016/j.jmarsys.2009.12.002; FRAIR W, 1972, SCIENCE, V177, P791, DOI 10.1126/science.177.4051.791; Fratantoni DM, 2006, J PHYS OCEANOGR, V36, P1241, DOI 10.1175/JPO2907.1; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Gaspar P, 2006, P ROY SOC B-BIOL SCI, V273, P2697, DOI 10.1098/rspb.2006.3623; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Graham WM, 2003, MAR ECOL PROG SER, V254, P129, DOI 10.3354/meps254129; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hays GC, 2004, ANIM BEHAV, V67, P733, DOI 10.1016/j.anbehav.2003.08.011; Hays GC, 2004, NATURE, V429, P522, DOI 10.1038/429522a; Hays GC, 2006, ECOLOGY, V87, P2647, DOI 10.1890/0012-9658(2006)87[2647:FFMOLT]2.0.CO;2; Heaslip SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033259; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; Hughes GR, 1998, J EXP MAR BIOL ECOL, V229, P209, DOI 10.1016/S0022-0981(98)00052-5; Innis C, 2010, CHELONIAN CONSERV BI, V9, P205, DOI 10.2744/CCB-0838.1; James MC, 2006, CAN J ZOOL, V84, P754, DOI 10.1139/Z06-046; James MC, 2005, MAR BIOL, V147, P845, DOI 10.1007/s00227-005-1581-1; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; James MC, 2005, P ROY SOC B-BIOL SCI, V272, P1547, DOI 10.1098/rspb.2005.3110; James MC, 2007, MAR ECOL PROG SER, V337, P245, DOI 10.3354/meps337245; James MC, 2006, BIOL CONSERV, V133, P347, DOI 10.1016/j.biocon.2006.06.012; JOHNS WE, 1990, J GEOPHYS RES-OCEANS, V95, P22103, DOI 10.1029/JC095iC12p22103; Jones TT, 2011, NMFSSWFSC480 NOAA; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jorgensen C, 2006, CAN J FISH AQUAT SCI, V63, P200, DOI 10.1139/F05-210; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kuhn Carey E., 2010, Endangered Species Research, V12, P125, DOI 10.3354/esr00297; Larson RJ, 1976, 397 NOAA NMFS; LAZELL JD, 1980, COPEIA, P290, DOI 10.2307/1444006; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Lilley MKS, 2011, MAR BIOL, V158, P2429, DOI 10.1007/s00227-011-1744-1; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Lopez-Mendilaharsu M, 2009, J EXP MAR BIOL ECOL, V378, P31, DOI 10.1016/j.jembe.2009.07.010; Lum Lori Lee, 2006, Applied Herpetology, V3, P357, DOI 10.1163/157075406778905081; Luschi P, 2003, P ROY SOC B-BIOL SCI, V270, pS129, DOI 10.1098/rsbl.2003.0036; Lutcavage M., 2001, MAR TURT NEWSL, V95, P9; Lutcavage ME, 1996, P 15 ANN WORKSH SEA, P355; Madin LP, 2006, DEEP-SEA RES PT I, V53, P804, DOI 10.1016/j.dsr.2005.12.018; Mann KH, 2006, DYNAMICS MARINE ECOS; McCarthy AL, 2010, PROG OCEANOGR, V86, P224, DOI 10.1016/j.pocean.2010.04.009; McClellan CM, 2007, BIOLOGY LETT, V3, P592, DOI 10.1098/rsbl.2007.0355; McMahon CR, 2006, GLOBAL CHANGE BIOL, V12, P1330, DOI 10.1111/j.1365-2486.2006.01174.x; Morreale SJ, 1996, NATURE, V384, P319, DOI 10.1038/384319a0; Musick John A., 1997, P137; Myers AE, 2006, MAR ECOL PROG SER, V322, P259, DOI 10.3354/meps322259; Neilson JD, 2009, REV-METHODS TECHNOL, V9, P145, DOI 10.1007/978-1-4020-9640-2_9; Olson D., 1994, OCEANOGRAPHY, V7, P52, DOI DOI 10.5670/OCEANOG.1994.03; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plot V, 2013, PHYSIOL BIOCHEM ZOOL, V86, P385, DOI 10.1086/671127; Plotkin P., 2002, BIOL SEA TURTLES, V2, P225; Polovina JJ, 2000, FISH OCEANOGR, V9, P71, DOI 10.1046/j.1365-2419.2000.00123.x; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; Potter IF, 2011, MAR BIOL, V158, P531, DOI 10.1007/s00227-010-1578-2; Purcell J.E., 2001, JELLYFISH BLOOMS ECO; R Core Team, 2021, R LANGUAGE ENV STAT; Rakow KC, 2006, LIMNOL OCEANOGR, V51, P1097, DOI 10.4319/lo.2006.51.2.1097; Reina RD, 2005, J EXP MAR BIOL ECOL, V316, P1, DOI 10.1016/j.jembe.2004.10.002; Robinson PW, 2007, DEEP-SEA RES PT II, V54, P356, DOI 10.1016/j.dsr2.2006.11.020; Royer F, 2008, J EXP MAR BIOL ECOL, V359, P1, DOI 10.1016/j.jembe.2008.01.026; Saba VS, 2008, ECOLOGY, V89, P1414, DOI 10.1890/07-0364.1; Saba VS, 2013, CRC MAR BIOL SER, P163; Schick RS, 2004, FISH OCEANOGR, V13, P225, DOI 10.1111/j.1365-2419.2004.00290.x; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; SHENKER JM, 1984, ESTUAR COAST SHELF S, V19, P619, DOI 10.1016/0272-7714(84)90019-2; Sherman K, 2002, LAR MAR ECOSYST, P195; Shillinger GL, 2011, MAR ECOL PROG SER, V422, P275, DOI 10.3354/meps08884; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; SHOOP CR, 1992, HERPETOL MONOGR, V6, P43; Sibert JR, 2006, CAN J FISH AQUAT SCI, V63, P2154, DOI 10.1139/F06-114; Skomal GB, 2009, CURR BIOL, V19, P1019, DOI 10.1016/j.cub.2009.04.019; TEWG (Turtle Expert Working Group), 2007, NMFSSEFSC555 TEWG NO; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034; Weng KC, 2008, MAR ECOL PROG SER, V372, P253, DOI 10.3354/meps07706; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; Whitehead H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060901; Witt MJ, 2007, MAR ECOL PROG SER, V337, P231, DOI 10.3354/meps337231; Witt MJ, 2011, P ROY SOC B-BIOL SCI, V278, P2338, DOI 10.1098/rspb.2010.2467; Zuur Alain F., 2009, P1	118	46	49	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91726	10.1371/journal.pone.0091726	http://dx.doi.org/10.1371/journal.pone.0091726			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646920	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500048
J	Martinelli, VC; Kyle, WB; Kojic, S; Vitulo, N; Li, ZH; Belgrano, A; Maiuri, P; Banks, L; Vatta, M; Valle, G; Faulkner, G				Martinelli, Valentina C.; Kyle, W. Buck; Kojic, Snezana; Vitulo, Nicola; Li, Zhaohui; Belgrano, Anna; Maiuri, Paolo; Banks, Lawrence; Vatta, Matteo; Valle, Giorgio; Faulkner, Georgine			ZASP Interacts with the Mechanosensing Protein Ankrd2 and p53 in the Signalling Network of Striated Muscle	PLOS ONE			English	Article							SARCOMERIC Z-DISC; SKELETAL-MUSCLE; LIM-DOMAIN; DILATED CARDIOMYOPATHY; TRANSCRIPTIONAL REPRESSION; MYOGENIC DIFFERENTIATION; ALPHA-ACTININ; SEVERE FORM; PDZ; BINDING	ZASP is a cytoskeletal PDZ-LIM protein predominantly expressed in striated muscle. It forms multiprotein complexes and plays a pivotal role in the structural integrity of sarcomeres. Mutations in the ZASP protein are associated with myofibrillar myopathy, left ventricular non-compaction and dilated cardiomyopathy. The ablation of its murine homologue Cypher results in neonatal lethality. ZASP has several alternatively spliced isoforms, in this paper we clarify the nomenclature of its human isoforms as well as their dynamics and expression pattern in striated muscle. Interaction is demonstrated between ZASP and two new binding partners both of which have roles in signalling, regulation of gene expression and muscle differentiation; the mechanosensing protein Ankrd2 and the tumour suppressor protein p53. These proteins and ZASP form a triple complex that appears to facilitate poly-SUMOylation of p53. We also show the importance of two of its functional domains, the ZM-motif and the PDZ domain. The PDZ domain can bind directly to both Ankrd2 and p53 indicating that there is no competition between it and p53 for the same binding site on Ankrd2. However there is competition for this binding site between p53 and a region of the ZASP protein lacking the PDZ domain, but containing the ZM-motif. ZASP is negative regulator of p53 in transactivation experiments with the p53-responsive promoters, MDM2 and BAX. Mutations in the ZASP ZM-motif induce modification in protein turnover. In fact, two mutants, A165V and A171T, were not able to bind Ankrd2 and bound only poorly to alpha-actinin2. This is important since the A165V mutation is responsible for zaspopathy, a well characterized autosomal dominant distal myopathy. Although the mechanism by which this mutant causes disease is still unknown, this is the first indication of how a ZASP disease associated mutant protein differs from that of the wild type ZASP protein.	[Martinelli, Valentina C.; Belgrano, Anna; Maiuri, Paolo; Banks, Lawrence; Faulkner, Georgine] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Kyle, W. Buck; Li, Zhaohui; Vatta, Matteo] Baylor Coll Med, Dept Paediat Cardiol, Houston, TX 77030 USA; [Kojic, Snezana] Univ Belgrade, Inst Mol Genet & Genet Engn, Mol Biol Lab, Belgrade, Serbia; [Vitulo, Nicola; Valle, Giorgio; Faulkner, Georgine] Univ Padua, Ctr Ric Interdipartimentale Biotecnol Innovat, Padua, Italy; [Maiuri, Paolo] Inst Curie, Syst Cell Biol Cell Polar & Cell Div, Paris, France; [Vatta, Matteo] Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46204 USA	International Center for Genetic Engineering & Biotechnology (ICGEB); Baylor College of Medicine; University of Belgrade; University of Padua; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Indiana University System; Indiana University-Purdue University Indianapolis	Faulkner, G (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	georgine.faulkner@cribi.unipd.it	Vitulo, Nicola/GVT-2319-2022; Kojic, Snezana/AAF-4873-2019	VALLE, GIORGIO/0000-0003-4377-5685; Kojic, Snezana/0000-0001-5090-1278; Maiuri, Paolo/0000-0001-5079-445X; Vitulo, Nicola/0000-0002-9571-0747	Fondazione Cariparo, Italy; Italian Ministry of Research [PRIN 20108XYHJS]; Collaborative Research Programme, ICGEB, Italy [CRP/YUG-05-01]; Ministry of Education and Science of Serbia [173008]; NIH [R21-HL07887]; Indiana University Health - Indiana University School of Medicine Strategic Research Initiative	Fondazione Cariparo, Italy(Fondazione Cariparo); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); Collaborative Research Programme, ICGEB, Italy; Ministry of Education and Science of Serbia(Ministry of Education, Science & Technological Development, Serbia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Health - Indiana University School of Medicine Strategic Research Initiative	This study was supported by grants from the Fondazione Cariparo, Italy (Progetto Eccellenza 2010 CHROMUS to GV and GF), the Italian Ministry of Research (PRIN 20108XYHJS to GV) as well as the Collaborative Research Programme, ICGEB, Italy (grant CRP/YUG-05-01 to SK) and the Ministry of Education and Science of Serbia (Project No. 173008). This work was also supported in part by NIH R21-HL07887 (MV) and by the Indiana University Health - Indiana University School of Medicine Strategic Research Initiative (MV.)(http://www.fondazionecariparo.it, http://www.mpn.gov.rs/, http://medicine.iu.edu/research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Vargas D, 2002, CARCINOGENESIS, V23, P541, DOI 10.1093/carcin/23.4.541; Arimura T, 2004, J BIOL CHEM, V279, P6746, DOI 10.1074/jbc.M311849200; Arimura T, 2009, CARDIOVASC RES, V83, P80, DOI 10.1093/cvr/cvp119; Au YH, 2004, STRUCTURE, V12, P611, DOI 10.1016/j.str.2004.02.019; Bean C, 2008, BBA-MOL CELL RES, V1783, P1023, DOI 10.1016/j.bbamcr.2008.01.027; Belgrano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025519; Benna C, 2009, CELL TISSUE RES, V337, P463, DOI 10.1007/s00441-009-0813-y; Birks EJ, 2008, CARDIOVASC RES, V79, P472, DOI 10.1093/cvr/cvn083; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Cai HY, 2012, J NEUROL, V259, P1913, DOI 10.1007/s00415-012-6439-0; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; Carrero G, 2004, B MATH BIOL, V66, P1515, DOI 10.1016/j.bulm.2004.02.005; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Cenni V, 2011, MOL BIOL CELL, V22, P2946, DOI 10.1091/mbc.E10-11-0928; Chen LH, 2003, ONCOGENE, V22, P5348, DOI 10.1038/sj.onc.1206851; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Conte M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081064, 10.1371/journal.pone.0073709]; Dogra C, 2008, MOL CELL BIOCHEM, V312, P17, DOI 10.1007/s11010-008-9716-6; Ehrnhoefer DE, 2014, HUM MOL GENET, V23, P717, DOI 10.1093/hmg/ddt458; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Faulkner G, 2001, IUBMB LIFE, V51, P275, DOI 10.1080/152165401317190761; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Frank D, 2007, FUTUR CARDIOL, V3, P611, DOI 10.2217/14796678.3.6.611; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Griggs R, 2007, BRAIN, V130, P1477, DOI 10.1093/brain/awm006; Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayashi C, 2008, J BIOL CHEM, V283, P14801, DOI 10.1074/jbc.M708262200; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Holmes WB, 2008, CELL MOTIL CYTOSKEL, V65, P130, DOI 10.1002/cm.20249; Huang CQ, 2003, J BIOL CHEM, V278, P7360, DOI 10.1074/jbc.M211875200; Hudson AM, 2008, DEV BIOL, V314, P329, DOI 10.1016/j.ydbio.2007.11.029; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Isogai T, 2007, HOMOSAPIENS CDNA FLJ; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Katzemich A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003342; Katzemich A, 2011, GENE EXPR PATTERNS, V11, P484, DOI 10.1016/j.gep.2011.08.004; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; Klaavuniemi T, 2006, EXP CELL RES, V312, P1299, DOI 10.1016/j.yexcr.2005.12.036; Klaavuniemi T, 2004, J BIOL CHEM, V279, P26402, DOI 10.1074/jbc.M401871200; Knoll R, 2013, CELL BIOCHEM BIOPHYS, V66, P65, DOI 10.1007/s12013-012-9430-6; Knoll R, 2011, CIRC RES, V109, P758, DOI 10.1161/CIRCRESAHA.111.245787; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; Kojic S, 2004, J MOL BIOL, V339, P313, DOI 10.1016/j.jmb.2004.03.071; Leung MC, 2013, J BIOL CHEM, V288, P4891, DOI 10.1074/jbc.M112.410316; Lin CS, 2013, J BIOL CHEM, V288, P29403, DOI 10.1074/jbc.M113.470708; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mohamed JS, 2013, J BIOL CHEM, V288, P24560, DOI 10.1074/jbc.M112.434423; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Pallavicini A, 2001, BIOCHEM BIOPH RES CO, V285, P378, DOI 10.1006/bbrc.2001.5131; Passier R, 2000, MECH DEVELOP, V92, P277, DOI 10.1016/S0925-4773(99)00330-5; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Salem IH, 2012, MOL BIOL REP, V39, P7479, DOI 10.1007/s11033-012-1581-4; Sanger JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.132pe37; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Santiago A, 2013, MOL BIOL CELL, V24, P2739, DOI 10.1091/mbc.E12-10-0771; Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376; Selcen D, 2005, GENEREVIEW, P1993; Sheikh F, 2007, TRENDS CARDIOVAS MED, V17, P258, DOI 10.1016/j.tcm.2007.09.002; Stehmeier P, 2009, DNA REPAIR, V8, P491, DOI 10.1016/j.dnarep.2009.01.002; Stindt Maren H, 2011, Cell Cycle, V10, P3176; Te Velthuis Aartjan J W, 2007, PLoS One, V2, pe189, DOI 10.1371/journal.pone.0000189; Theis JL, 2006, BIOCHEM BIOPH RES CO, V351, P896, DOI 10.1016/j.bbrc.2006.10.119; Toyama R, 1998, MECH DEVELOP, V71, P197, DOI 10.1016/S0925-4773(97)00202-5; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van der Meer DLM, 2006, DEV BIOL, V299, P356, DOI 10.1016/j.ydbio.2006.07.032; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Vatta M, 2013, ZASP8 IS NOVEL ISOFO; Vink M, 2006, CURR BIOL, V16, P755, DOI 10.1016/j.cub.2006.03.057; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; von Nandelstadh P, 2009, MOL CELL BIOL, V29, P822, DOI 10.1128/MCB.01454-08; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang J, 2005, CELL MOTIL CYTOSKEL, V61, P34, DOI 10.1002/cm.20063; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xi YT, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1017, DOI 10.1161/CIRCEP.111.969220; Yanku Y, 2012, REGULATION PROTEIN P; Yoshida N, 1998, J CELL SCI, V111, P769; Zeng G, 2000, Z BAND ALTERNATIVELY; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	93	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92259	10.1371/journal.pone.0092259	http://dx.doi.org/10.1371/journal.pone.0092259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647531	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500103
J	Villegas-Patraca, R; Cabrera-Cruz, SA; Herrera-Alsina, L				Villegas-Patraca, Rafael; Cabrera-Cruz, Sergio A.; Herrera-Alsina, Leonel			Soaring Migratory Birds Avoid Wind Farm in the Isthmus of Tehuantepec, Southern Mexico	PLOS ONE			English	Article							COLLISION RISK; RADAR; MORTALITY; BEHAVIOR; TURBINES; IMPACT; RATES	The number of wind farms operating in the Isthmus of Tehuantepec, southern Mexico, has rapidly increased in recent years; yet, this region serves as a major migration route for various soaring birds, including Turkey Vultures (Cathartes aura) and Swainson's Hawks (Buteo swainsoni). We analyzed the flight trajectories of soaring migrant birds passing the La Venta II wind farm during the two migratory seasons of 2011, to determine whether an avoidance pattern existed or not. We recorded three polar coordinates for the flight path of migrating soaring birds that were detected using marine radar, plotted the flight trajectories and estimated the number of trajectories that intersected the polygon defined by the wind turbines of La Venta II. Finally, we estimated the actual number of intersections per kilometer and compared this value with the null distributions obtained by running 10,000 simulations of our datasets. The observed number of intersections per kilometer fell within or beyond the lower end of the null distributions in the five models proposed for the fall season and in three of the four models proposed for the spring season. Flight trajectories had a non-random distribution around La Venta II, suggesting a strong avoidance pattern during fall and a possible avoidance pattern during spring. We suggest that a nearby ridgeline plays an important role in this pattern, an issue that may be incorporated into strategies to minimize the potential negative impacts of future wind farms on soaring birds. Studies evaluating these issues in the Isthmus of Tehuantepec have not been previously published; hence this work contributes important baseline information about the movement patterns of soaring birds and its relationship to wind farms in the region.	[Villegas-Patraca, Rafael; Cabrera-Cruz, Sergio A.] Inst Ecol AC, Red Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico; [Herrera-Alsina, Leonel] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico	Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico	Cabrera-Cruz, SA (corresponding author), Inst Ecol AC, Red Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico.	sergio.cabrera@inecol.mx	Colorado, Rafael/E-8091-2010; Villegas-Patraca, Rafael/T-2682-2018; Cabrera-Cruz, Sergio A./E-6424-2011	Colorado, Rafael/0000-0003-2078-8467; Villegas-Patraca, Rafael/0000-0003-4403-2613; Cabrera-Cruz, Sergio A./0000-0001-8742-4719; Herrera-Alsina, Leonel/0000-0003-0474-3592	World Bank; CFE	World Bank(The World Bank India); CFE	This research was made possible with funding from the World Bank to the Comision Federal de Electricidad (CFE) for monitoring the environmental impacts of the wind farm. The funders of this study were the CFE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMDEE, 2012, PROYECT EOL OP MEX; Arnold TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024708; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Bildstein KL, 2004, ORNITOL NEOTROP, V15, P83; Binford L.C, 1989, ORNITHOLOGICAL MONOG, V43, P1; COOPER BA, 1991, J FIELD ORNITHOL, V62, P367; De Lucas M, 2004, BIODIVERS CONSERV, V13, P395, DOI 10.1023/B:BIOC.0000006507.22024.93; Desholm M, 2005, BIOL LETTERS, V1, P296, DOI 10.1098/rsbl.2005.0336; Devereux CL, 2008, J APPL ECOL, V45, P1689, DOI 10.1111/j.1365-2664.2008.01560.x; Diehl RH, 2013, TRENDS ECOL EVOL, V28, P377, DOI 10.1016/j.tree.2013.02.015; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Elliott D., 2003, WIND ENERGY RESOURCE; Fuller MR, 1998, J AVIAN BIOL, V29, P433, DOI 10.2307/3677162; Gallo-Gomez CA, 2009, IMPLICACIONES FISIOG; Garvin JC, 2011, J APPL ECOL, V48, P199, DOI 10.1111/j.1365-2664.2010.01912.x; Harmata AR, 1999, WILDLIFE SOC B, V27, P44; Hau E., 2006, WIND TURBINES FUNDAM, Vsecond, DOI [10.1007/3-540-29284-5, DOI 10.1007/3-540-29284-5]; Huppop O, 2006, IBIS, V148, P90, DOI 10.1111/j.1474-919X.2006.00536.x; Hull CL, 2013, WILDLIFE SOC B, V37, P49, DOI 10.1002/wsb.254; Instituto de Ecologia AC, 2003, MAN IMP AMB MOD PART; Jaramillo OA, 2004, RENEW ENERG, V29, P1613, DOI 10.1016/j.renene.2004.02.001; Kerlinger P, 1995, BIRDS MIGRATE; Kovach W.L., 2012, ORIANA CIRCULAR STAT; Larsen JK, 2007, J APPL ECOL, V44, P516, DOI 10.1111/j.1365-2664.2007.01303.x; LEDEC GC, 2011, GREENING WIND ENV SO; Leung DYC, 2012, RENEW SUST ENERG REV, V16, P1031, DOI 10.1016/j.rser.2011.09.024; Loss SR, 2013, BIOL CONSERV, V168, P201, DOI 10.1016/j.biocon.2013.10.007; Martinez-Abrain A, 2012, J APPL ECOL, V49, P109, DOI 10.1111/j.1365-2664.2011.02080.x; National Research Council, 2007, ENV IMP WIND EN PROJ; Plonczkier P, 2012, J APPL ECOL, V49, P1187, DOI 10.1111/j.1365-2664.2012.02181.x; Portador-Garcia TJ, 2009, CLAROSCUROS FUTURO E; R Development Core Team, 2012, R LANG ENV STAT COMP; Secretaria de Energia, 2012, ESTR NAC EN 2012 202; Winker K, 1995, AUK, V112, P690; World Wind Energy Association, 2013, 2013 HALF YEAR REP; Zalles J.I., 2000, BIRDL CONSERV SER	36	24	25	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92462	10.1371/journal.pone.0092462	http://dx.doi.org/10.1371/journal.pone.0092462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647442	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500134
J	Lauer, SA; Iyer, S; Sanchez, T; Forst, CV; Bowden, B; Carlson, K; Sriranganathan, N; Boyle, SM				Lauer, Sabine A.; Iyer, Srinivas; Sanchez, Timothy; Forst, Christian V.; Bowden, Brent; Carlson, Kay; Sriranganathan, Nammalwar; Boyle, Stephen M.			Proteomic Analysis of Detergent Resistant Membrane Domains during Early Interaction of Macrophages with Rough and Smooth Brucella melitensis	PLOS ONE			English	Article							IV SECRETION SYSTEM; ENDOPLASMIC-RETICULUM; LIPID RAFTS; CELL-DEATH; INTRACELLULAR SURVIVAL; GENE-EXPRESSION; ABORTUS; VIRB; IDENTIFICATION; SUIS	The plasma membrane contains discrete nanometer-sized domains that are resistant to non-ionic detergents, and which are called detergent resistant membrane domains (DRMDs) or lipid rafts. Exposure of host cells to pathogenic bacteria has been shown to induce the re-distribution of specific host proteins between DRMDs and detergent soluble membranes, which leads to the initiation of cell signaling that enable pathogens to access host cells. DRMDs have been shown to play a role in the invasion of Brucella into host macrophages and the formation of replicative phagosomes called Brucella-containing vacuoles (BCVs). In this study we sought to characterize changes to the protein expression profiles in DRMDs and to respective cellular pathways and networks of Mono Mac 6 cells in response to the adherence of rough VTRM1 and smooth 16 M B. melitensis strains. DRMDs were extracted from Mono Mac 6 cells exposed for 2 minutes at 4 degrees C to Brucella (no infection occurs) and from unexposed control cells. Protein expression was determined using the non-gel based quantitative iTRAQ (Isobaric Tags for Relative and Absolute Quantitation) mass spectrometry technique. Using the identified iTRAQ proteins we performed enrichment analyses and probed constructed human biochemical networks for interactions and metabolic reactions. We identified 149 proteins, which either became enriched, depleted or whose amounts did not change in DRMDs upon Brucella exposure. Several of these proteins were distinctly enriched or depleted in DRMDs upon exposure to rough and smooth B. melitensis strains which results in the differential engagement of cellular pathways and networks immediately upon Brucella encounter. For some of the proteins such as myosin 9, small G protein signaling modulator 3, lysine-specific demethylase 5D, erlin-2, and voltage-dependent anion-selective channel protein 2, we observed extreme differential depletion or enrichment in DRMDs. The identified proteins and pathways could provide the basis for novel ways of treating or diagnosing Brucellosis.	[Lauer, Sabine A.; Iyer, Srinivas; Sanchez, Timothy] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Forst, Christian V.] Univ Texas Dallas, SW Med Ctr, Dept Clin Sci, Dallas, TX USA; [Bowden, Brent; Carlson, Kay; Sriranganathan, Nammalwar; Boyle, Stephen M.] Virginia Polytech & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA; [Bowden, Brent; Carlson, Kay; Sriranganathan, Nammalwar; Boyle, Stephen M.] Ctr Mol Med & Infect Dis, Blacksburg, VA USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Virginia Polytechnic Institute & State University	Lauer, SA (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA.	zellarhoen@gmail.com		Sanchez, Timothy/0000-0001-8952-4414; Forst, Christian/0000-0003-0229-9459	Chem-Bio Diagnostics program from the Department of Defense Chemical and Biological Defense program through the Defense Threat Reduction Agency (DTRA) [IACRO B0844741]	Chem-Bio Diagnostics program from the Department of Defense Chemical and Biological Defense program through the Defense Threat Reduction Agency (DTRA)	This work was supported by the Chem-Bio Diagnostics program contract IACRO B0844741 from the Department of Defense Chemical and Biological Defense program through the Defense Threat Reduction Agency (DTRA). [http://www.dtra.mil/missions/ChemicalbiologicalDefense/ChemicalBiologicalDefenseHome.aspx] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Arocena GM, 2010, J BACTERIOL, V192, P3434, DOI 10.1128/JB.00232-10; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bini L, 2003, BIOCHEM J, V369, P301, DOI 10.1042/BJ20020503; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Bronner DN, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00083; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Cabusora L, 2005, BIOINFORMATICS, V21, P2898, DOI 10.1093/bioinformatics/bti440; Celli J, 2005, P NATL ACAD SCI USA, V102, P1673, DOI 10.1073/pnas.0406873102; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chen F, 2011, INFECT IMMUN, V79, P2460, DOI 10.1128/IAI.00050-11; Chen F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006830; Cloeckaert A, 2002, VACCINE, V20, P1820, DOI 10.1016/S0264-410X(02)00035-X; Colmenero JD, 1996, MEDICINE, V75, P195, DOI 10.1097/00005792-199607000-00003; Comerci DJ, 1998, INFECT IMMUN, V66, P3862, DOI 10.1128/IAI.66.8.3862-3866.1998; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Corbel MJ, 1997, J MED MICROBIOL, V46, P101, DOI 10.1099/00222615-46-2-101; Crockford D, 2010, ANN NY ACAD SCI, V1194, P179, DOI 10.1111/j.1749-6632.2010.05492.x; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Delrue RM, 2005, CELL MICROBIOL, V7, P1151, DOI 10.1111/j.1462-5822.2005.00543.x; Delrue RM, 2001, CELL MICROBIOL, V3, P487, DOI 10.1046/j.1462-5822.2001.00131.x; Eppstein D, 1998, SIAM J COMPUT, V28, P652, DOI 10.1137/S0097539795290477; Fernandez-Prada CM, 2003, INFECT IMMUN, V71, P2110, DOI 10.1128/IAI.71.4.2110-2119.2003; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; FREEMAN BA, 1961, J INFECT DIS, V108, P333, DOI 10.1093/infdis/108.3.333; Gekara NO, 2005, CELL MICROBIOL, V7, P1345, DOI 10.1111/j.1462-5822.2005.00561.x; Gross A, 2000, INFECT IMMUN, V68, P342, DOI 10.1128/IAI.68.1.342-351.2000; Guzman-Verri C, 2001, J BIOL CHEM, V276, P44435, DOI 10.1074/jbc.M105606200; He YQ, 2006, INFECT IMMUN, V74, P5035, DOI 10.1128/IAI.01998-05; Hershbereger J, 2003, FINDING K SHORTEST S; Hong PC, 2000, INFECT IMMUN, V68, P4102, DOI 10.1128/IAI.68.7.4102-4107.2000; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kim S, 2004, MICROB PATHOGENESIS, V37, P11, DOI 10.1016/j.micpath.2004.04.002; Kim S, 2002, MICROB PATHOGENESIS, V33, P225, DOI 10.1006/mpat.2002.0531; Kim YE, 2011, J VIROL, V85, P11928, DOI 10.1128/JVI.00758-11; Koppers-Lalic D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000080; Kusumawati A, 2000, MICROB PATHOGENESIS, V28, P343, DOI 10.1006/mpat.2000.0354; Lamontagne J, 2007, J PROTEOME RES, V6, P1519, DOI 10.1021/pr060636a; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Leser GP, 2005, VIROLOGY, V342, P215, DOI 10.1016/j.virol.2005.09.049; Li N, 2000, BIOCHEM BIOPH RES CO, V279, P487, DOI 10.1006/bbrc.2000.3935; Li XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043512; Ling PD, 2005, EMBO J, V24, P3565, DOI 10.1038/sj.emboj.7600820; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Manterola L, 2005, J BACTERIOL, V187, P5631, DOI 10.1128/JB.187.16.5631-5639.2005; Martinez-Nunez C, 2010, J BACTERIOL, V192, P5603, DOI 10.1128/JB.00567-10; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Myeni S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003556; Naroeni A, 2002, INFECT IMMUN, V70, P1640, DOI 10.1128/IAI.70.3.1640-1644.2002; Nguyen DH, 2005, EXP CELL RES, V304, P559, DOI 10.1016/j.yexcr.2004.11.022; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pappas G, 2006, CELL MOL LIFE SCI, V63, P2229, DOI 10.1007/s00018-006-6311-4; Pearce MMP, 2009, J BIOL CHEM, V284, P10433, DOI 10.1074/jbc.M809801200; Pei JW, 2008, MICROBES INFECT, V10, P582, DOI 10.1016/j.micinf.2008.01.005; Pei JW, 2006, INFECT IMMUN, V74, P2667, DOI 10.1128/IAI.74.5.2667-2675.2006; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Pizarro-Cerda J, 2000, MICROBES INFECT, V2, P829, DOI 10.1016/S1286-4579(00)90368-X; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Raulin J, 2002, PROG LIPID RES, V41, P27, DOI 10.1016/S0163-7827(01)00019-4; Reynaud EG, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-21; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rossetti CA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-81; Ruppen I, 2010, MOL CELL PROTEOMICS, V9, P2276, DOI 10.1074/mcp.M900255-MCP200; Seleem M, 2007, APPL MICROBIOL BIOT, V75, P1385, DOI 10.1007/s00253-007-0970-4; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Shiomi T, 2010, PATHOL INT, V60, P477, DOI 10.1111/j.1440-1827.2010.02547.x; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000; Sieira R, 2004, MOL MICROBIOL, V54, P808, DOI 10.1111/j.1365-2958.2004.04316.x; Sieira R, 2010, J BACTERIOL, V192, P217, DOI 10.1128/JB.01124-09; Smith JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003785; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x; Solera J, 2010, INT J ANTIMICROB AG, V36, pS18, DOI 10.1016/j.ijantimicag.2010.06.015; Spera JM, 2013, J BIOL CHEM, V288, P20208, DOI 10.1074/jbc.M113.453282; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tolomeo M, 2003, CLIN INFECT DIS, V36, P1533, DOI 10.1086/375223; Uzureau S, 2007, J BACTERIOL, V189, P6035, DOI 10.1128/JB.00265-07; Valderas MW, 2008, J ANTIMICROB CHEMOTH, V61, P128, DOI 10.1093/jac/dkm433; Watarai M, 2002, INFECT IMMUN, V70, P4818, DOI 10.1128/IAI.70.9.4818-4825.2002; Watarai M, 2002, CELL MICROBIOL, V4, P341, DOI 10.1046/j.1462-5822.2002.00195.x; Wu M, 2004, P NATL ACAD SCI USA, V101, P13798, DOI 10.1073/pnas.0403835101; Yang H, 2007, GENOMICS, V90, P249, DOI 10.1016/j.ygeno.2007.03.013; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	92	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91706	10.1371/journal.pone.0091706	http://dx.doi.org/10.1371/journal.pone.0091706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643124	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900030
J	Spira, B; Ferreira, GM; de Almeida, LG				Spira, Beny; Ferreira, Gerson Moura; de Almeida, Luiz Gustavo			relA Enhances the Adherence of Enteropathogenic Escherichia coli	PLOS ONE			English	Article							BUNDLE-FORMING PILUS; TRANSCRIPTIONAL REGULATION; PATHOGENICITY ISLAND; PROTEIN-SYNTHESIS; EPITHELIAL-CELLS; GENE-EXPRESSION; PPGPP SYNTHESIS; IN-VIVO; VIRULENCE; (P)PPGPP	Enteropathogenic Escherichia coli (EPEC) is a known causative agent of diarrhea in children. In the process of colonization of the small intestine, EPEC synthesizes two types of adhesins, the bundle-forming pilus (BFP) and intimin. The BFP pilus is an adhesin associated with the initial stages of adherence of EPEC to epithelial cells, while the outer membrane protein intimin carries out the intimate adherence that takes place at the third stage of infection. BFP is encoded by the bfp operon located in plasmid EAF, present only in typical EPEC isolates, while eae, the gene that encodes intimin is situated in the LEE, a chromosomal pathogenicity island. Transcription of bfp and eae is regulated by the products of the perABC operon, also present in plasmid EAF. Here we show that deletion of relA, that encodes a guanosine penta and tetraphosphate synthetase impairs EPEC adherence to epithelial cells in vitro. In the absence of relA, the transcription of the regulatory operon perABC is reduced, resulting in lower levels of BFP and intimin. Bacterial adherence, BFP and intimin synthesis and perABC expression are restored upon complementation with the wild-type relA allele.	[Spira, Beny; Ferreira, Gerson Moura; de Almeida, Luiz Gustavo] Univ Sao Paulo, Dept Microbiol, Inst Ceincias Biomed, Sao Paulo, Brazil	Universidade de Sao Paulo	Spira, B (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Ceincias Biomed, Sao Paulo, Brazil.	benys@usp.br	Spira, Beny/D-6928-2012; Spira, Beny/GSD-2097-2022; Ferreira, Gerson Moura/B-4698-2017; Spira, Beny/AAR-2287-2020	Spira, Beny/0000-0001-5394-9074; Spira, Beny/0000-0001-5394-9074; Ferreira, Gerson Moura/0000-0002-3467-2580; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); FAPESP scholarship; CNPq; CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP scholarship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). GMF was supported by a FAPESP scholarship. LGA was supported by CNPq and CAPES scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg A, 2006, MOL MICROBIOL, V60, P1520, DOI 10.1111/j.1365-2958.2006.05191.x; Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Bustamante VH, 1998, J BACTERIOL, V180, P3013, DOI 10.1128/JB.180.11.3013-3016.1998; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; CASHEL M, 1969, J BIOL CHEM, V244, P3133; CASHEL M, 1996, ESCHERICHIA COLI SAL, V1, P1458; Chen HD, 2005, FEMS MICROBIOL REV, V29, P83, DOI 10.1016/j.femsre.2004.07.002; Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0; CRAVIOTO A, 1979, CURR MICROBIOL, V3, P95, DOI 10.1007/BF02602439; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Jong P, 2007, APPL ENVIRON MICROB, V73, P508, DOI 10.1128/AEM.01299-06; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1418, DOI 10.1172/JCI116718; DONNENBERG MS, 1992, MOL MICROBIOL, V6, P3427, DOI 10.1111/j.1365-2958.1992.tb02210.x; Dutta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056068; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; ECHOLS H, 1961, J MOL BIOL, V3, P425, DOI 10.1016/S0022-2836(61)80055-7; EDLIN G, 1971, J BIOL CHEM, V246, P4371; Erickson DL, 2004, INFECT IMMUN, V72, P5638, DOI 10.1128/IAI.72.10.5638-5645.2004; Faron M, 2013, INFECT IMMUN, V81, P2800, DOI 10.1128/IAI.00073-13; Ferenci T, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-62; Ferreira GM, 2008, MICROBIOL-SGM, V154, P2025, DOI 10.1099/mic.0.2008/016634-0; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; GENTRY DR, 1993, J BACTERIOL, V175, P7982, DOI 10.1128/JB.175.24.7982-7989.1993; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; GOLDMAN E, 1990, MOL MICROBIOL, V4, P2035, DOI 10.1111/j.1365-2958.1990.tb00563.x; GOMEZDUARTE OG, 1995, INFECT IMMUN, V63, P1767; Gummesson B, 2013, J BIOL CHEM; HERNANDEZ VJ, 1995, J MOL BIOL, V252, P536; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kenny B, 1997, INFECT IMMUN, V65, P2606, DOI 10.1128/IAI.65.7.2606-2612.1997; LANGE R, 1995, J BACTERIOL, V177, P4676, DOI 10.1128/jb.177.16.4676-4680.1995; Martinez-Laguna Y, 1999, MOL MICROBIOL, V33, P153, DOI 10.1046/j.1365-2958.1999.01460.x; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Murphy KC, 2000, GENE, V246, P321, DOI 10.1016/S0378-1119(00)00071-8; Murray KD, 1996, J MOL BIOL, V259, P41; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Pizarro-Cerda J, 2004, MOL MICROBIOL, V52, P1827, DOI 10.1111/j.1365-2958.2004.04122.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Puente JL, 1996, MOL MICROBIOL, V20, P87, DOI 10.1111/j.1365-2958.1996.tb02491.x; Moreno ACR, 2010, DIAGN MICR INFEC DIS, V66, P50, DOI 10.1016/j.diagmicrobio.2008.03.017; RUDD KE, 1985, J BACTERIOL, V163, P534, DOI 10.1128/JB.163.2.534-542.1985; SCALETSKY ICA, 1984, INFECT IMMUN, V45, P534, DOI 10.1128/IAI.45.2.534-536.1984; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHREIBER G, 1991, J BIOL CHEM, V266, P3760; SPIRA B, 1995, J BACTERIOL, V177, P4053, DOI 10.1128/jb.177.14.4053-4058.1995; Spira B, 1998, MOL GEN GENET, V257, P469, DOI 10.1007/s004380050671; Spira B, 2008, MICROBIOL-SGM, V154, P2887, DOI 10.1099/mic.0.2008/018457-0; Sugisaki K, 2013, MICROBIOL-SGM, V159, P1379, DOI 10.1099/mic.0.066597-0; Sun W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006720; SVITIL AL, 1993, J BIOL CHEM, V268, P2307; Tobe T, 2001, CELL MICROBIOL, V3, P579, DOI 10.1046/j.1462-5822.2001.00136.x; XIAO H, 1991, J BIOL CHEM, V266, P5980; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x; Zhang WL, 2002, J CLIN MICROBIOL, V40, P4486, DOI 10.1128/JCM.40.12.4486-4492.2002	56	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91703	10.1371/journal.pone.0091703	http://dx.doi.org/10.1371/journal.pone.0091703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643076	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900029
J	Dose, F; Zanon, P; Coslovich, T; Taccola, G				Dose, Francesco; Zanon, Patrizia; Coslovich, Tamara; Taccola, Giuliano			Nanomolar Oxytocin Synergizes with Weak Electrical Afferent Stimulation to Activate the Locomotor CPG of the Rat Spinal Cord In Vitro	PLOS ONE			English	Article							CENTRAL PATTERN GENERATORS; VENTRAL HORN NEURONS; NEONATAL-RAT; DORSAL-HORN; PARAVENTRICULAR NUCLEUS; SYNAPTIC-TRANSMISSION; EPIDURAL STIMULATION; LUMBAR MOTONEURONS; VASOPRESSIN; RECEPTOR	Synergizing the effect of afferent fibre stimulation with pharmacological interventions is a desirable goal to trigger spinal locomotor activity, especially after injury. Thus, to better understand the mechanisms to optimize this process, we studied the role of the neuropeptide oxytocin (previously shown to stimulate locomotor networks) on network and motoneuron properties using the isolated neonatal rat spinal cord. On motoneurons oxytocin (1 nM-1 mu M) generated sporadic bursts with superimposed firing and dose-dependent depolarization. No desensitization was observed despite repeated applications. Tetrodotoxin completely blocked the effects of oxytocin, demonstrating the network origin of the responses. Recording motoneuron pool activity from lumbar ventral roots showed oxytocin mediated depolarization with synchronous bursts, and depression of reflex responses in a stimulus and peptide-concentration dependent fashion. Disinhibited bursting caused by strychnine and bicuculline was accelerated by oxytocin whose action was blocked by the oxytocin antagonist atosiban. Fictive locomotion appeared when subthreshold concentrations of NMDA plus 5HT were coapplied with oxytocin, an effect prevented after 24 h incubation with the inhibitor of 5HT synthesis, PCPA. When fictive locomotion was fully manifested, oxytocin did not change periodicity, although cycle amplitude became smaller. A novel protocol of electrical stimulation based on noisy waveforms and applied to one dorsal root evoked stereotypic fictive locomotion. Whenever the stimulus intensity was subthreshold, low doses of oxytocin triggered fictive locomotion although oxytocin per se did not affect primary afferent depolarization evoked by dorsal root pulses. Among the several functional targets for the action of oxytocin at lumbar spinal cord level, the present results highlight how small concentrations of this peptide could bring spinal networks to threshold for fictive locomotion in combination with other protocols, and delineate the use of oxytocin to strengthen the efficiency of electrical stimulation to activate locomotor circuits.	[Dose, Francesco; Zanon, Patrizia; Coslovich, Tamara; Taccola, Giuliano] Int Sch Adv Studies SISSA, Dept Neurosci, Trieste, Italy; [Dose, Francesco; Zanon, Patrizia; Coslovich, Tamara; Taccola, Giuliano] IMFR, SPINL, Udine, Italy	International School for Advanced Studies (SISSA)	Taccola, G (corresponding author), Int Sch Adv Studies SISSA, Dept Neurosci, Trieste, Italy.	taccola@sissa.it		Taccola, Giuliano/0000-0003-2675-1438	Vertical Foundation, Rome, Italy	Vertical Foundation, Rome, Italy	This work was supported by Vertical Foundation, Rome, Italy (http://www.fondazione-vertical.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; ARTMAN HG, 1984, DEV PHARMACOL THERAP, V7, P39, DOI 10.1159/000457142; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Barriere G, 2005, PEPTIDES, V26, P277, DOI 10.1016/j.peptides.2004.09.002; Beato M, 1998, P ROY SOC B-BIOL SCI, V265, P2073, DOI 10.1098/rspb.1998.0542; Bertrand SS, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00015; Boulenguez P, 2009, CURR OPIN NEUROBIOL, V19, P587, DOI 10.1016/j.conb.2009.10.005; Bracci E, 1996, J NEUROPHYSIOL, V75, P640, DOI 10.1152/jn.1996.75.2.640; Bracci E, 1998, J NEUROPHYSIOL, V79, P2643, DOI 10.1152/jn.1998.79.5.2643; Branchereau P, 2002, J NEUROSCI, V22, P2598, DOI 10.1523/JNEUROSCI.22-07-02598.2002; Butt SJB, 2002, J NEUROSCI, V22, P9961; Chini B, 2007, BIOCHEM SOC T, V35, P737, DOI 10.1042/BST0350737; Cina C, 2000, J COMP NEUROL, V423, P590, DOI 10.1002/1096-9861(20000807)423:4<590::AID-CNE5>3.0.CO;2-L; Condes-Lara M, 2003, BRAIN RES, V976, P75, DOI 10.1016/S0006-8993(03)02690-8; Domingo A, 2012, J NEUROTRAUM, V29, P865, DOI 10.1089/neu.2011.2052; Dose F, 2012, J NEUROPHYSIOL, V108, P2977, DOI 10.1152/jn.00554.2012; Dunbar MJ, 2010, J PHYSIOL-LONDON, V588, P139, DOI 10.1113/jphysiol.2009.177378; Eaton JL, 2012, DEV PSYCHOBIOL, V54, P92, DOI 10.1002/dev.20566; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; Etlin A, 2013, J NEUROSCI, V33, P734, DOI 10.1523/JNEUROSCI.4390-12.2013; Fong AJ, 2009, PROG BRAIN RES, V175, P393, DOI 10.1016/S0079-6123(09)17526-X; Frigon A, 2012, NEUROSCIENTIST, V18, P56, DOI 10.1177/1073858410396101; FULTON BP, 1986, J PHYSIOL-LONDON, V370, P651, DOI 10.1113/jphysiol.1986.sp015956; Gad P, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-108; Garraway SM, 2001, BRIT J PHARMACOL, V132, P1789, DOI 10.1038/sj.bjp.0703983; Gerasimenko YP, 2007, J NEUROPHYSIOL, V98, P2525, DOI 10.1152/jn.00836.2007; GIBSON SJ, 1981, J COMP NEUROL, V201, P65, DOI 10.1002/cne.902010106; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Hagglund M, 2013, P NATL ACAD SCI USA, V110, P11589, DOI 10.1073/pnas.1304365110; Han P, 2007, J NEUROSCI, V27, P13192, DOI 10.1523/JNEUROSCI.1279-07.2007; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Harris-Warrick RM, 2011, CURR OPIN NEUROBIOL, V21, P685, DOI 10.1016/j.conb.2011.05.011; HAWTHORN J, 1985, BRAIN RES, V346, P51, DOI 10.1016/0006-8993(85)91093-5; Hochman S, 2013, ANN NY ACAD SCI, V1279, P103, DOI 10.1111/nyas.12055; Hochman S, 2012, FRONT BIOSCI-LANDMRK, V17, P2158, DOI 10.2741/4043; Hochman S, 2010, ANN NY ACAD SCI, V1198, P140, DOI 10.1111/j.1749-6632.2010.05436.x; Ichiyama RM, 2008, NEUROSCI LETT, V438, P281, DOI 10.1016/j.neulet.2008.04.080; JACOBS BL, 1993, TRENDS NEUROSCI, V16, P346, DOI 10.1016/0166-2236(93)90090-9; Jo YH, 1998, J NEUROSCI, V18, P2377; Jojart J, 2009, ACTA BIOL HUNG, V60, P333, DOI 10.1556/ABiol.60.2009.4.1; Juif PE, 2013, J NEUROSCI, V33, P16617, DOI 10.1523/JNEUROSCI.3084-12.2013; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kombian SB, 2002, PROG BRAIN RES, V139, P235; LANG RE, 1983, BRAIN RES, V260, P326, DOI 10.1016/0006-8993(83)90690-X; Liu X, 2003, EUR J NEUROSCI, V17, P1833, DOI 10.1046/j.1460-9568.2003.02625.x; Mandadi S, 2013, J COMP NEUROL, V521, P2870, DOI 10.1002/cne.23321; Marazziti D, 2012, EUR NEUROPSYCHOPHARM, V22, P578, DOI 10.1016/j.euroneuro.2011.12.010; Marchetti C, 2001, J PHYSIOL-LONDON, V530, P105, DOI 10.1111/j.1469-7793.2001.0105m.x; Martinez-Lorenzan G, 2008, PAIN, V140, P265, DOI 10.1016/j.pain.2008.08.015; Miles GB, 2011, PHYSIOLOGY, V26, P393, DOI 10.1152/physiol.00013.2011; Moreno-Lopez Y, 2013, NEUROPEPTIDES, V47, P117, DOI 10.1016/j.npep.2012.09.008; Musienko P, 2011, J NEUROSCI, V31, P9264, DOI 10.1523/JNEUROSCI.5796-10.2011; Oz M, 2001, J NEUROPHYSIOL, V86, P1202, DOI 10.1152/jn.2001.86.3.1202; Pearson SA, 2003, J NEUROSCI, V23, P10154; REITER MK, 1994, EUR J NEUROSCI, V6, P98, DOI 10.1111/j.1460-9568.1994.tb00251.x; RYCKEBUSCH S, 1994, J NEUROPHYSIOL, V72, P2771, DOI 10.1152/jn.1994.72.6.2771; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; SCHOENEN J, 1985, NEUROLOGY, V35, P881, DOI 10.1212/WNL.35.6.881; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; Strauss I, 2003, J NEUROPHYSIOL, V89, P773, DOI 10.1152/jn.00716.2002; SUZUE T, 1981, NEUROSCI LETT, V26, P137, DOI 10.1016/0304-3940(81)90339-6; Taccola G, 2006, NEUROSCIENCE, V137, P659, DOI 10.1016/j.neuroscience.2005.09.025; Taccola G, 2005, NEUROSCIENCE, V132, P1187, DOI 10.1016/j.neuroscience.2005.02.012; Taccola G, 2004, EXP BRAIN RES, V156, P495, DOI 10.1007/s00221-003-1798-5; Taccola G, 2012, NEUROSCIENCE, V222, P191, DOI 10.1016/j.neuroscience.2012.07.030; Taccola G, 2011, J NEUROPHYSIOL, V106, P872, DOI 10.1152/jn.00170.2011; Taccola G, 2010, EUR J NEUROSCI, V31, P60, DOI 10.1111/j.1460-9568.2009.07040.x; TRIBOLLET E, 1989, J NEUROSCI, V9, P1764; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Veronneau-Longueville F, 1999, NEUROSCIENCE, V93, P1437, DOI 10.1016/S0306-4522(99)00262-6; Viero C, 2010, CNS NEUROSCI THER, V16, pe138, DOI 10.1111/j.1755-5949.2010.00185.x; Wilson LA, 2009, J SEX MED, V6, P947, DOI 10.1111/j.1743-6109.2008.01150.x; Wrobel L, 2011, NEUROSCI LETT, V495, P49, DOI 10.1016/j.neulet.2011.03.033	76	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92967	10.1371/journal.pone.0092967	http://dx.doi.org/10.1371/journal.pone.0092967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658101	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300149
J	Jardeleza, C; Rao, S; Thierry, B; Gajjar, P; Vreugde, S; Prestidge, CA; Wormald, PJ				Jardeleza, Camille; Rao, Shasha; Thierry, Benjamin; Gajjar, Pratik; Vreugde, Sarah; Prestidge, Clive A.; Wormald, Peter-John			Liposome-Encapsulated ISMN: A Novel Nitric Oxide-Based Therapeutic Agent against Staphylococcus aureus Biofilms	PLOS ONE			English	Article							ENDOSCOPIC SINUS SURGERY; DRUG-DELIVERY SYSTEMS; CHRONIC RHINOSINUSITIS; CATIONIC LIPOSOMES; BACTERIAL BIOFILMS; HELICOBACTER-PYLORI; MAXILLARY SINUSITIS; PARANASAL SINUSES; NANOPARTICLES; INFECTIONS	Background: Staphylococcus aureus in its biofilm form has been associated with recalcitrant chronic rhinosinusitis with resistance to conventional therapies. This study aims to determine if liposomal-encapsulation of a precursor of naturally occurring antimicrobial nitric oxide (NO) enhances its desired anti-biofilm effects against S. aureus, in the hope improving its efficacy can provide an effective topical agent for future clinical use. Methodology: S. aureus ATCC 25923 biofilms were grown in-vitro using the Minimum Biofilm Eradication Concentration (MBEC) device and exposed to 3 and 60 mg/mL of the NO donor isosorbide mononitrate (ISMN) encapsulated into different anionic liposomal formulations based on particle size (unilamellar ULV, multilamellar MLV) and lipid content (5 and 25 mM) at 24 h and 5 min exposure times. Biofilms were viewed using Live-Dead Baclight stain and confocal scanning laser microscopy and quantified using the software COMSTAT2. Results: At 3 and 60 mg/mL, ISMN-ULV liposomes had comparable and significant anti-biofilm effects compared to untreated control at 24 h exposure (p = 0.012 and 0.02 respectively). ULV blanks also had significant anti-biofilm effects at both 24 h and 5 min exposure (p = 0.02 and 0.047 respectively). At 5 min exposure, 60 mg/mL ISMN-MLV liposomes appeared to have greater anti-biofilm effects compared to pure ISMN or ULV particles. Increasing liposomal lipid content improved the anti-biofilm efficacy of both MLV and ULVs at 5 min exposure. Conclusion: Liposome-encapsulated "nitric oxide" is highly effective in eradicating S. aureus biofilms in-vitro, giving great promise for use in the clinical setting to treat this burdensome infection. Further studies however are needed to assess its safety and efficacy in-vivo before clinical translation is attempted.	[Jardeleza, Camille; Vreugde, Sarah; Wormald, Peter-John] Univ Adelaide, Queen Elizabeth Hosp, Dept Surg Otorhinolaryngol Head & Neck Surg, Adelaide, SA, Australia; [Rao, Shasha; Thierry, Benjamin; Gajjar, Pratik; Prestidge, Clive A.] Univ S Australia, Ian Wark Inst, Mawson Lakes, SA, Australia	University of Adelaide; University of South Australia	Wormald, PJ (corresponding author), Univ Adelaide, Queen Elizabeth Hosp, Dept Surg Otorhinolaryngol Head & Neck Surg, Adelaide, SA, Australia.	peterj.wormald@adelaide.edu.au	Thierry, benjamin/B-2785-2009	Thierry, benjamin/0000-0002-6757-2842; Vreugde, Sarah/0000-0003-4719-9785; Prestidge, Clive/0000-0001-5401-7535	Garnett Passe and Rodney Williams Memorial Foundation; National Health and Medical Research Council (NHMRC) [GNT1047576]	Garnett Passe and Rodney Williams Memorial Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants from The Garnett Passe and Rodney Williams Memorial Foundation to CJ and from The National Health and Medical Research Council (NHMRC: GNT1047576). The contents of the published material are solely the responsibility of the Administering Institution, a Participating Institution or individual authors and do not reflect the views of NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, LANCET, V345, P669; Baek YW, 2011, SCI TOTAL ENVIRON, V409, P1603, DOI 10.1016/j.scitotenv.2011.01.014; Barraud N, 2009, MICROB BIOTECHNOL, V2, P370, DOI 10.1111/j.1751-7915.2009.00098.x; Bradley JS, 2007, LANCET INFECT DIS, V7, P68, DOI 10.1016/S1473-3099(06)70689-2; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Campanha MTN, 1999, J LIPID RES, V40, P1495; Chaturvedi R, 2007, INFECT IMMUN, V75, P4305, DOI 10.1128/IAI.00578-07; CHRYSANT SG, 1993, AM J CARDIOL, V72, P1249, DOI 10.1016/0002-9149(93)90292-K; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cunha BA, 1996, INFECT DIS CLIN N AM, V10, P811, DOI 10.1016/S0891-5520(05)70328-7; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Degano B, 2005, CHEST, V128, P1699, DOI 10.1378/chest.128.3.1699; Deja M, 2003, AM J RESP CRIT CARE, V168, P281, DOI 10.1164/rccm.200207-640OC; Foreman A, 2010, LARYNGOSCOPE, V120, P1701, DOI 10.1002/lary.21024; Foreman A, 2009, AM J RHINOL ALLERGY, V23, P556, DOI 10.2500/ajra.2009.23.3413; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Ha KR, 2008, LARYNGOSCOPE, V118, P535, DOI 10.1097/MLG.0b013e31815bf2e3; Habimana O, 2011, APPL ENVIRON MICROB, V77, P367, DOI 10.1128/AEM.02163-10; Hajipour MJ, 2012, TRENDS BIOTECHNOL, V30, P499, DOI 10.1016/j.tibtech.2012.06.004; Hetrick EM, 2009, BIOMATERIALS, V30, P2782, DOI 10.1016/j.biomaterials.2009.01.052; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Huang CM, 2011, BIOMATERIALS, V32, P214, DOI 10.1016/j.biomaterials.2010.08.076; Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Jardeleza C, 2011, INT FORUM ALLERGY RH, V1, P438, DOI 10.1002/alr.20083; Jervis-Bardy J, 2009, AM J RHINOL ALLERGY, V23, P549, DOI 10.2500/ajra.2009.23.3366; Jones MN, 2005, METHOD ENZYMOL, V391, P211, DOI 10.1016/S0076-6879(05)91013-6; Kilty SJ, 2008, CURR ALLERGY ASTHM R, V8, P227, DOI 10.1007/s11882-008-0038-2; Kim HJ, 1999, COLLOID SURFACE A, V149, P561, DOI 10.1016/S0927-7757(98)00765-1; Kluytmans JAJW, 2005, INFECTION, V33, P3, DOI 10.1007/s15010-005-4012-9; Lian T, 2001, J PHARM SCI-US, V90, P667, DOI 10.1002/jps.1023; Lindberg S, 1997, ACTA OTO-LARYNGOL, V117, P113, DOI 10.3109/00016489709118001; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; LUNDBERG JON, 1995, NAT MED, V1, P370, DOI 10.1038/nm0495-370; Lundberg JO, 2008, ANAT REC, V291, P1479, DOI 10.1002/ar.20782; Maherani B, 2011, CURR NANOSCI, V7, P436, DOI 10.2174/157341311795542453; Meng JR, 2009, ANTIMICROB AGENTS CH, V53, P2871, DOI 10.1128/AAC.01542-08; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Obonyo M, 2012, MOL PHARMACEUT, V9, P2677, DOI 10.1021/mp300243w; Peulen TO, 2011, ENVIRON SCI TECHNOL, V45, P3367, DOI 10.1021/es103450g; Runer T, 1998, OTOLARYNG HEAD NECK, V119, P278, DOI 10.1016/S0194-5998(98)70063-4; Samadikhah HR, 2011, INT J NANOMED, V6, P2275, DOI 10.2147/IJN.S23074; Singhal D, 2011, LARYNGOSCOPE, V121, P1578, DOI 10.1002/lary.21805; Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632	46	31	34	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92117	10.1371/journal.pone.0092117	http://dx.doi.org/10.1371/journal.pone.0092117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658315	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000333355300056
J	Morris, T; Sumners, DP; Green, DA				Morris, Theresa; Sumners, David Paul; Green, David Andrew			Inspiratory High Frequency Airway Oscillation Attenuates Resistive Loaded Dyspnea and Modulates Respiratory Function in Young Healthy Individuals	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHEST-WALL VIBRATION; MUSCLE-SPINDLE ENDINGS; HIGH-INTENSITY; LUNG-FUNCTION; INTERCOSTAL MUSCLES; EXERCISE TOLERANCE; SOCIETY STATEMENT; UPTAKE KINETICS; MOTOR CONTROL	Direct chest-wall percussion can reduce breathlessness in Chronic Obstructive Pulmonary Disease and respiratory function may be improved, in health and disease, by respiratory muscle training (RMT). We tested whether high-frequency airway oscillation (HFAO), a novel form of airflow oscillation generation can modulate induced dyspnoea and respiratory strength and/or patterns following 5 weeks of HFAO training (n = 20) compared to a SHAM-RMT (conventional flow-resistive RMT) device (n = 15) in healthy volunteers (13 males; aged 20-36 yrs). HFAO causes oscillations with peak-to-peak amplitude of 1 cm H2O, whereas the SHAM-RMT device was identical but created no pressure oscillation. Respiratory function, dyspnoea and ventilation during 3 minutes of spontaneous resting ventilation, 1 minute of maximal voluntary hyperventilation and 1 minute breathing against a moderate inspiratory resistance, were compared PRE and POST 5-weeks of training (2630 breaths at 70% peak flow, 5 days a week). Training significantly reduced NRS dyspnoea scores during resistive loaded ventilation, both in the HFAO (p = 0.003) and SHAM-RMT (p = 0.005) groups. Maximum inspiratory static pressure (cm H2O) was significantly increased by HFAO training (vs. PRE; p<0.001). Maximum inspiratory dynamic pressure was increased by training in both the HFAO (vs. PRE; p<0.001) and SHAM-RMT (vs. PRE; p = 0.021) groups. Peak inspiratory flow rate (L. s(-1)) achieved during the maximum inspiratory dynamic pressure manoeuvre increased significantly POST (vs. PRE; p = 0.001) in the HFAO group only. HFAO reduced inspiratory resistive loading-induced dyspnoea and augments static and dynamic maximal respiratory manoeuvre performance in excess of flow-resistive IMT (SHAM-RMT) in healthy individuals without the respiratory discomfort associated with RMT.	[Morris, Theresa; Green, David Andrew] Kings Coll London, Ctr Human & Aerosp Physiol Sci, London, England; [Sumners, David Paul] London S Bank Univ, London, England	University of London; King's College London; London South Bank University	Green, DA (corresponding author), Kings Coll London, Ctr Human & Aerosp Physiol Sci, London, England.	David.a.green@kcl.ac.uk			Guys & St Thomas Charity [R090766]	Guys & St Thomas Charity	The work has been facilitated by a Guys & St Thomas Charity (http://www.gsttcharity.org.uk/) grant (R090766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosino N, 2008, RESP MED, V102, pS17, DOI 10.1016/S0954-6111(08)70004-0; Bailey CD, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-63; Bailey SJ, 2010, J APPL PHYSIOL, V109, P457, DOI 10.1152/japplphysiol.00077.2010; Beckerman M, 2005, CHEST, V128, P3177, DOI 10.1378/chest.128.5.3177; BOLSER DC, 1988, J APPL PHYSIOL, V64, P2458, DOI 10.1152/jappl.1988.64.6.2458; BOLSER DC, 1987, J APPL PHYSIOL, V62, P1046, DOI 10.1152/jappl.1987.62.3.1046; Bongianni F, 1996, BRAIN RES BULL, V39, P267, DOI 10.1016/0361-9230(95)02139-6; BONGIOVANNI LG, 1990, J PHYSIOL-LONDON, V423, P1; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Braido F, 2011, CURR MED RES OPIN, V27, P981, DOI 10.1185/03007995.2011.563285; BRESLIN EH, 1990, CHEST, V98, P298, DOI 10.1378/chest.98.2.298; Brown PI, 2008, EUR J APPL PHYSIOL, V104, P111, DOI 10.1007/s00421-008-0794-7; BURKE D, 1976, J PHYSIOL-LONDON, V261, P673, DOI 10.1113/jphysiol.1976.sp011580; Butler JE, 2001, J PHYSIOL-LONDON, V534, P583, DOI 10.1111/j.1469-7793.2001.00583.x; Calverley PMA, 2006, EUR RESPIR REV, V15, P72, DOI 10.1183/09059180.00010004; COON RL, 1993, J APPL PHYSIOL, V74, P811, DOI 10.1152/jappl.1993.74.2.811; Cristiano LM, 1997, AM J RESP CRIT CARE, V155, P1552, DOI 10.1164/ajrccm.155.5.9154856; Decramer M, 2009, J APPL PHYSIOL, V107, P971, DOI 10.1152/japplphysiol.91459.2008; Delecluse C, 2003, MED SCI SPORT EXER, V35, P1033, DOI 10.1249/01.MSS.0000069752.96438.B0; DETROYER A, 1994, AM J RESP CRIT CARE, V150, P41, DOI 10.1164/ajrccm.150.1.8025770; Diba C, 2011, RESP MED, V105, P1345, DOI 10.1016/j.rmed.2011.03.013; Downey AE, 2007, RESP PHYSIOL NEUROBI, V156, P137, DOI 10.1016/j.resp.2006.08.006; Edwards AM, 2004, EUR J APPL PHYSIOL, V93, P139, DOI 10.1007/s00421-004-1188-0; ELDRIDGE FL, 1992, RESP PHYSIOL, V90, P31, DOI 10.1016/0034-5687(92)90132-G; ELMANSHAWI A, 1986, J APPL PHYSIOL, V61, P896, DOI 10.1152/jappl.1986.61.3.896; Enright S, 2004, CHEST, V126, P405, DOI 10.1378/chest.126.2.405; Enright SJ, 2006, PHYS THER, V86, P345, DOI 10.1093/ptj/86.3.345; Evans KC, 2010, BIOL PSYCHOL, V84, P13, DOI 10.1016/j.biopsycho.2010.02.005; FLUME PA, 1994, RESP PHYSIOL, V95, P53, DOI 10.1016/0034-5687(94)90047-7; Fujie T, 2002, RESP PHYSIOL NEUROBI, V130, P305, DOI 10.1016/S0034-5687(02)00014-2; Gandevia SC, 1996, AM J RESP CRIT CARE, V153, P622, DOI 10.1164/ajrccm.153.2.8564108; GANDEVIA SC, 1987, TRENDS NEUROSCI, V10, P81, DOI 10.1016/0166-2236(87)90030-0; GANDEVIA SC, 1989, RESP PHYSIOL, V77, P203, DOI 10.1016/0034-5687(89)90007-8; Geddes EL, 2008, RESP MED, V102, P1715, DOI 10.1016/j.rmed.2008.07.005; Gerodimos V, 2010, J SCI MED SPORT, V13, P438, DOI 10.1016/j.jsams.2009.09.001; Gift A G, 1989, Rehabil Nurs, V14, P323; Gift A G, 1998, Am J Crit Care, V7, P200; Gosselink R, 2000, ARCH PHYS MED REHAB, V81, P747, DOI 10.1016/S0003-9993(00)90105-9; Gosselink R, 2011, EUR RESPIR J, V37, P416, DOI 10.1183/09031936.00031810; Griffin L, 2001, J PHYSIOL-LONDON, V535, P929, DOI 10.1111/j.1469-7793.2001.00929.x; Grimby G, 2012, RELATIVE CONTRIBUTIO, P159; Guenette JA, 2007, J SCI MED SPORT, V10, P341, DOI 10.1016/j.jsams.2007.02.003; GUYATT GH, 1987, J CHRON DIS, V40, P1129, DOI 10.1016/0021-9681(87)90080-4; HOMMA I, 1978, RESP PHYSIOL, V35, P335, DOI 10.1016/0034-5687(78)90007-5; How SC, 2007, RESP PHYSIOL NEUROBI, V157, P270, DOI 10.1016/j.resp.2007.01.008; Huang CH, 2009, APPL PSYCHOPHYS BIOF, V34, P17, DOI 10.1007/s10484-008-9073-y; HUFSCHMIDT HJ, 1958, PFLUG ARCH GES PHYS, V267, P508, DOI 10.1007/BF00361737; Jolley CJ, 2009, EUR RESPIR J, V33, P289, DOI 10.1183/09031936.00093408; Kaminsky DA, 2012, RESP CARE, V57, P85, DOI 10.4187/respcare.01411; Kellerman BA, 2000, MED SCI SPORT EXER, V32, P1859, DOI 10.1097/00005768-200011000-00007; KILLIAN KJ, 1984, J APPL PHYSIOL, V57, P686, DOI 10.1152/jappl.1984.57.3.686; Koppers RJH, 2006, RESP MED, V100, P714, DOI 10.1016/j.rmed.2005.07.013; Lamb TW, 2012, NATURE VIBRATION HYP, P404; Leduc D, 2003, J PHYSL; Lee LY, 2009, RESP PHYSIOL NEUROBI, V167, P26, DOI 10.1016/j.resp.2008.05.006; Mahler Donald A, 2005, COPD, V2, P99; Mahut B, 2011, RESPIROLOGY, V16, P666, DOI 10.1111/j.1440-1843.2011.01953.x; MAN GCW, 1990, J APPL PHYSIOL, V68, P714, DOI 10.1152/jappl.1990.68.2.714; MANNING HL, 1992, RESP PHYSIOL, V90, P19, DOI 10.1016/0034-5687(92)90131-F; Marks GB, 1996, THORAX, V51, P793, DOI 10.1136/thx.51.8.793; MARSDEN CD, 1969, BRAIN, V92, P647, DOI 10.1093/brain/92.3.647; McConnell AK, 2004, INT J SPORTS MED, V25, P284, DOI 10.1055/s-2004-815827; McConnell AK, 2004, SPORTS MED, V34, P117, DOI 10.2165/00007256-200434020-00005; McConnell AK, 2010, MED SCI SPORT EXER, V42, P1696, DOI 10.1249/MSS.0b013e3181d435cf; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mitchell GS, 2003, J APPL PHYSIOL, V94, P358, DOI 10.1152/japplphysiol.00523.2002; Moosavi SH, 2004, J APPL PHYSIOL, V97, P2098, DOI 10.1152/japplphysiol.00056.2004; Moosavi SH, 2000, RESP PHYSIOL, V122, P45, DOI 10.1016/S0034-5687(00)00135-3; NADEL JA, 1961, J APPL PHYSIOL, V16, P717, DOI 10.1152/jappl.1961.16.4.717; Nakayama H, 1998, INTERNAL MED, V37, P831, DOI 10.2169/internalmedicine.37.831; Nici L, 2006, AM J RESP CRIT CARE, V173, P1390, DOI 10.1164/rccm.200508-1211ST; Nield MA, 1999, ARCH PHYS MED REHAB, V80, P100, DOI 10.1016/S0003-9993(99)90315-5; Nishino T, 2000, AM J RESP CRIT CARE, V161, P1963, DOI 10.1164/ajrccm.161.6.9910009; Nishino T, 2009, J PAIN SYMPTOM MANAG, V37, P212, DOI 10.1016/j.jpainsymman.2008.02.017; O'Donnell DE, 2009, RESP PHYSIOL NEUROBI, V167, P116, DOI 10.1016/j.resp.2009.01.010; O'Donnell DE, 2008, J APPL PHYSIOL, V105, P753, DOI 10.1152/japplphysiol.90336.2008b; OKROY JA, 1993, RESPIRATION, V60, P279; Oxberry SG, 2012, AM HEART J, V164, P229, DOI 10.1016/j.ahj.2012.05.003; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Ramirez-Sarmiento A, 2002, AM J RESP CRIT CARE, V166, P1491, DOI 10.1164/rccm.200202-075OC; REDLINE S, 1991, J APPL PHYSIOL, V70, P240, DOI 10.1152/jappl.1991.70.1.240; REID WD, 1995, PHYS THER, V75, P996, DOI 10.1093/ptj/75.11.996; Ries Andrew L, 2005, COPD, V2, P105; Ries AL, 2007, CHEST, V131, p4S, DOI 10.1378/chest.06-2418; Romer LM, 2003, MED SCI SPORT EXER, V35, P237, DOI 10.1249/01.MSS.0000048642.58419.1E; Romer LM, 2002, INT J SPORTS MED, V23, P353, DOI 10.1055/s-2002-33143; SIBUYA M, 1994, AM J RESP CRIT CARE, V149, P1235, DOI 10.1164/ajrccm.149.5.8173764; SIMON PM, 1989, AM REV RESPIR DIS, V140, P1021, DOI 10.1164/ajrccm/140.4.1021; Sloan Jeff A, 2005, COPD, V2, P57; SMITH JC, 1986, J APPL PHYSIOL, V60, P928, DOI 10.1152/jappl.1986.60.3.928; Sonetti DA, 2001, RESP PHYSIOL, V127, P185, DOI 10.1016/S0034-5687(01)00250-X; Sumners DP, 2008, RESP PHYSIOL NEUROBI, V160, P350, DOI 10.1016/j.resp.2007.10.005; Sumners DP, 2009, EUROPEAN J APPL; Turner LA, 2012, J APPL PHYSIOL, V112, P127, DOI 10.1152/japplphysiol.00954.2011; Turner LA, 2011, MED SCI SPORT EXER, V43, P2031, DOI 10.1249/MSS.0b013e31821f4090; Undem BJ, 2009, RESP PHYSIOL NEUROBI, V167, P36, DOI 10.1016/j.resp.2008.11.012; Verges S, 2009, RESP PHYSIOL NEUROBI, V169, P282, DOI 10.1016/j.resp.2009.09.005; Volianitis S, 2001, MED SCI SPORT EXER, V33, P803; Wang QX, 2010, RESP CARE, V55, P1449; Weiner P, 2004, EUR RESPIR J, V23, P61, DOI 10.1183/09031936.03.00059503; Weiner P, 2003, CHEST J, V124; Widdicombe J, 2009, RESP PHYSIOL NEUROBI, V167, P2, DOI 10.1016/j.resp.2008.09.012; Wilcock IM, 2009, J STRENGTH COND RES, V23, P593, DOI 10.1519/JSC.0b013e318196b81f; Witt JD, 2007, J PHYSIOL-LONDON, V584, P1019, DOI 10.1113/jphysiol.2007.140855; Wouters EFM, 2002, THORAX, V57, P1067, DOI 10.1136/thorax.57.12.1067	105	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91291	10.1371/journal.pone.0091291	http://dx.doi.org/10.1371/journal.pone.0091291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651392	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800037
J	VanderLaan, DP; Blanchard, R; Wood, H; Zucker, KJ				VanderLaan, Doug P.; Blanchard, Ray; Wood, Hayley; Zucker, Kenneth J.			Birth Order and Sibling Sex Ratio of Children and Adolescents Referred to a Gender Identity Service	PLOS ONE			English	Article							OLDER BROTHERS; ORIENTATION; HOMOSEXUALITY; MEN; PREGNANCY; DNA; MICROCHIMERISM; PROPORTION; WEIGHT; PLASMA	In adult male samples, homosexuality is associated with a preponderance of older brothers (i.e., the fraternal birth order effect). In several studies comparing gender dysphoric youth, who are likely to be homosexual in adulthood, to clinical or non-clinical control groups, the findings have been consistent with the fraternal birth order effect in males; however, less is known about unique sibship characteristics of gender dysphoric females. The current study investigated birth order and sibling sex ratio in a large sample of children and adolescents referred to the same Gender Identity Service (N = 768). Probands were classified as heterosexual males, homosexual males, or homosexual females based on clinical diagnostic information. Groups differed significantly in age and sibship size, and homosexual females were significantly more likely to be only children. Subsequent analyses controlled for age and for sibship size. Compared to heterosexual males, homosexual males had a significant preponderance of older brothers and homosexual females had a significant preponderance of older sisters. Similarly, the older sibling sex ratio of homosexual males showed a significant excess of brothers whereas that of homosexual females showed a significant excess of sisters. Like previous studies of gender dysphoric youth and adults, these findings were consistent with the fraternal birth order effect. In addition, the greater frequency of only children and elevated numbers of older sisters among the homosexual female group adds to a small literature on sibship characteristics of potential relevance to the development of gender identity and sexual orientation in females.	[VanderLaan, Doug P.; Wood, Hayley; Zucker, Kenneth J.] Ctr Addict & Mental Hlth, Gender Ident Serv, Toronto, ON, Canada; [Blanchard, Ray; Zucker, Kenneth J.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto	Zucker, KJ (corresponding author), Ctr Addict & Mental Hlth, Gender Ident Serv, Toronto, ON, Canada.	ken.zucker@camh.ca			Canadian Institutes of Health Research Postdoctoral Fellowship	Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR))	The first author was supported by a Canadian Institutes of Health Research Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ariga H, 2001, TRANSFUSION, V41, P1524, DOI 10.1046/j.1537-2995.2001.41121524.x; Bearman PS, 2002, AM J SOCIOL, V107, P1179, DOI 10.1086/341906; Bianchi DW, 2001, ANN NY ACAD SCI, V945, P119; Blanchard R, 1996, ARCH SEX BEHAV, V25, P495, DOI 10.1007/BF02437544; BLANCHARD R, 1995, DEV PSYCHOL, V31, P22, DOI 10.1037/0012-1649.31.1.22; BLANCHARD R, 1992, J NERV MENT DIS, V180, P40, DOI 10.1097/00005053-199201000-00009; Blanchard R, 2004, AM J HUM BIOL, V16, P151, DOI 10.1002/ajhb.20006; Blanchard R, 1997, Annu Rev Sex Res, V8, P27; Blanchard R, 1996, AM J PSYCHIAT, V153, P27; Blanchard R, 2004, J THEOR BIOL, V230, P173, DOI 10.1016/j.jtbi.2004.04.021; Blanchard R, 1997, J THEOR BIOL, V185, P373, DOI 10.1006/jtbi.1996.0315; Blanchard R, 2002, HORM BEHAV, V41, P321, DOI 10.1006/hbeh.2002.1765; Blanchard R, 2001, J BIOSOC SCI, V33, P451, DOI 10.1017/S0021932001004515; Blanchard R, 2008, ARCH SEX BEHAV, V37, P970, DOI 10.1007/s10508-006-9107-6; Blanchard R, 2008, LATERALITY, V13, P51, DOI 10.1080/13576500701710432; Blanchard R, 2014, ARCH SEX BEHAV, V43, P845, DOI 10.1007/s10508-013-0245-3; Blanchard R, 2012, ARCH SEX BEHAV, V41, P1507, DOI 10.1007/s10508-011-9896-0; Bogaert AF, 1997, BEHAV NEUROSCI, V111, P1395, DOI 10.1037/0735-7044.111.6.1395; Bogaert AF, 2003, J PERS SOC PSYCHOL, V84, P644, DOI 10.1037/0022-3514.84.3.644; Bogaert AF, 2006, P NATL ACAD SCI USA, V103, P10771, DOI 10.1073/pnas.0511152103; Bogaert AF, 2011, FRONT NEUROENDOCRIN, V32, P247, DOI 10.1016/j.yfrne.2011.02.004; Camperio-Ciani A, 2004, P ROY SOC B-BIOL SCI, V271, P2217, DOI 10.1098/rspb.2004.2872; CHAHNAZARIAN A, 1988, SOC BIOL, V35, P214; Drummond KD, 2008, DEV PSYCHOL, V44, P34, DOI 10.1037/0012-1649.44.1.34; Ellis L, 2001, PERS INDIV DIFFER, V30, P543, DOI 10.1016/S0191-8869(00)00051-9; Francis AM, 2008, J SEX RES, V45, P371, DOI 10.1080/00224490802398357; Gomez-Gil E, 2011, ARCH SEX BEHAV, V40, P505, DOI 10.1007/s10508-010-9614-3; Green R, 2000, PSYCHOL MED, V30, P789, DOI 10.1017/S0033291799001932; Green R, 1987, SISSY BOY SYNDROME D; JAMES WH, 1987, HUM BIOL, V59, P721; King M, 2005, ARCH SEX BEHAV, V34, P117, DOI 10.1007/s10508-005-1006-8; Lambert NC, 2001, ANN NY ACAD SCI, V945, P164; LANG T, 1960, Acta Genet Med Gemellol (Roma), V9, P370; Nelson JL, 2002, TRENDS MOL MED, V8, P109, DOI 10.1016/S1471-4914(01)02269-9; Pertl B, 2001, OBSTET GYNECOL, V98, P483, DOI 10.1016/S0029-7844(01)01195-4; Piper KP, 2007, BIOL REPROD, V76, P96, DOI 10.1095/biolreprod.106.055426; Poasa KH, 2004, J SEX MARITAL THER, V30, P13, DOI 10.1080/00926230490247110; Schagen SEE, 2012, ARCH SEX BEHAV, V41, P541, DOI 10.1007/s10508-011-9777-6; Schwartz G, 2010, ARCH SEX BEHAV, V39, P93, DOI 10.1007/s10508-009-9499-1; Singh D, 2012, FOLLOW UP STUDY BOYS; Steensma T. D., 2013, THESIS VRIJE U AMSTE; TSOI WF, 1977, BRIT J PSYCHIAT, V131, P405, DOI 10.1192/bjp.131.4.405; VanderLaan DP, 2011, ARCH SEX BEHAV, V40, P495, DOI 10.1007/s10508-009-9576-5; Vasey PL, 2007, P ROY SOC B-BIOL SCI, V274, P1437, DOI 10.1098/rspb.2007.0120; Wallien MSC, 2008, J AM ACAD CHILD PSY, V47, P1413, DOI 10.1097/CHI.0b013e31818956b9; Wood H, 2013, J SEX MARITAL THER, V39, P1, DOI 10.1080/0092623X.2012.675022; Zucker KJ, 2007, PSYCHIAT CLIN NEUROS, V61, P529, DOI 10.1111/j.1440-1819.2007.01703.x; Zucker KJ, 2012, J SEX MARITAL THER, V38, P151, DOI 10.1080/0092623X.2011.611219; Zucker KJ, 2003, J SEX MARITAL THER, V29, P251, DOI 10.1080/00926230390195489; Zucker KJ, 1998, EUR CHILD ADOLES PSY, V7, P30, DOI 10.1007/s007870050042; Zucker KJ, 1997, J CHILD PSYCHOL PSYC, V38, P543, DOI 10.1111/j.1469-7610.1997.tb01541.x	52	25	26	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90257	10.1371/journal.pone.0090257	http://dx.doi.org/10.1371/journal.pone.0090257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651045	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800013
J	Beltran-Garcia, MJ; Prado, FM; Oliveira, MS; Ortiz-Mendoza, D; Scalfo, AC; Pessoa, A; Medeiros, MHG; White, JF; Di Mascio, P				Beltran-Garcia, Miguel J.; Prado, Fernanda M.; Oliveira, Marilene S.; Ortiz-Mendoza, David; Scalfo, Alexsandra C.; Pessoa, Adalberto, Jr.; Medeiros, Marisa H. G.; White, James F.; Di Mascio, Paolo			Singlet Molecular Oxygen Generation by Light-Activated DHN-Melanin of the Fungal Pathogen Mycosphaerella fijiensis in Black Sigatoka Disease of Bananas	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; CELLULAR-DNA; MELANIZATION; BIOSYNTHESIS; APPRESSORIA; MECHANISMS; EUMELANIN; OXIDATION; RADICALS; SHUTTLE	In pathogenic fungi, melanin contributes to virulence, allowing tissue invasion and inactivation of the plant defence system, but has never been implicated as a factor for host cell death, or as a light-activated phytotoxin. Our research shows that melanin synthesized by the fungal banana pathogen Mycosphaerella fijiensis acts as a virulence factor through the photogeneration of singlet molecular oxygen O-2 ((1)Delta(g)). Using analytical tools, including elemental analysis, ultraviolet/infrared absorption spectrophometry and MALDI-TOF mass spectrometry analysis, we characterized both pigment content in mycelia and secreted to the culture media as 1,8-dihydroxynaphthalene (DHN)-melanin type compound. This is sole melanin-type in M. fijiensis. Isolated melanins irradiated with a Nd:YAG laser at 532 nm produced monomol light emission at 1270 nm, confirming generation of O-2 ((1)Delta(g)), a highly reactive oxygen specie (ROS) that causes cellular death by reacting with all cellular macromolecules. Intermediary polyketides accumulated in culture media by using tricyclazole and pyroquilon (two inhibitors of DHN-melanin synthesis) were identified by ESI-HPLC-MS/MS. Additionally, irradiation at 532 nm of that mixture of compounds and whole melanized mycelium also generated O-2 ((1)Delta(g)). A pigmented-strain generated more O-2 ((1)Delta(g)) than a strain with low melanin content. Banana leaves of cultivar Cavendish, naturally infected with different stages of black Sigatoka disease, were collected from field. Direct staining of the naturally infected leaf tissues showed the presence of melanin that was positively correlated to the disease stage. We also found hydrogen peroxide (H2O2) but we cannot distinguish the source. Our results suggest that O-2 ((1)Delta(g)) photogenerated by DHN-melanin may be involved in the destructive effects of Mycosphaerella fijiensis on banana leaf tissues. Further studies are needed to fully evaluate contributions of melanin-mediated ROS to microbial pathogenesis.	[Beltran-Garcia, Miguel J.] Univ Autonoma Guadalajara, Dept Quim ICET, Zapopan, Jalisco, Mexico; [Beltran-Garcia, Miguel J.; Prado, Fernanda M.; Oliveira, Marilene S.; Scalfo, Alexsandra C.; Medeiros, Marisa H. G.; Di Mascio, Paolo] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Ortiz-Mendoza, David] Univ Autonoma Baja California, Inst Ingn, Mexicali 21100, Baja California, Mexico; [Pessoa, Adalberto, Jr.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Tecnol Bioquim Farmaceut, Sao Paulo, Brazil; [White, James F.] Rutgers State Univ, Dept Plant Biol & Pathol, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA	Universidad Autonoma de Guadalajara; Universidade de Sao Paulo; Universidad Autonoma de Baja California; Universidade de Sao Paulo; Rutgers State University New Brunswick	Beltran-Garcia, MJ (corresponding author), Univ Autonoma Guadalajara, Dept Quim ICET, Zapopan, Jalisco, Mexico.	jbeltran@uag.mx; pdmascio@iq.usp.br	Beltran, Miguel/GPX-3786-2022; Pessoa, Adalberto/B-7963-2012; Medeiros, Marisa Helena Gennari de/A-5212-2008	White, James/0000-0002-6780-7066; Pessoa, Adalberto/0000-0002-5268-8690; Medeiros, Marisa Helena Gennari de/0000-0002-5438-1174	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [Proc. 2006/56530-4, Pr. 2012/12663-1]; CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); PRONEX/FINEP (Programa de Apoio aos Nucleos de Excelencia); PRPUSP (Pro-Reitoria de Pesquisa da Universidade de Sao Paulo); Instituto do Milenio-Redoxoma [Proc. 420011/2005-6]; INCT Redoxoma (FAPESP/CNPq/CAPES) [Proc. 573530/2008-4]; NAP Redoxoma (PRPUSP) [Proc. 2011.1.9352.1.8]; CEPID Redoxoma (FAPESP) [Proc. 2013/07937-8]; John Simon Guggenheim Memorial Foundation; CONACYT [SEP-CB-79626, 217649]; National Council of Science and Technology (CONACYT) of Mexico [186241]; Program of Estancias Sabaticas y Posdoctorales al Extranjero para la Consolidacion de Grupos de Investigacion [186241]; John E. and Christina C. Craighead Foundation; United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) [W3147]; New Jersey Agricultural Experiment Station	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PRONEX/FINEP (Programa de Apoio aos Nucleos de Excelencia); PRPUSP (Pro-Reitoria de Pesquisa da Universidade de Sao Paulo); Instituto do Milenio-Redoxoma; INCT Redoxoma (FAPESP/CNPq/CAPES); NAP Redoxoma (PRPUSP); CEPID Redoxoma (FAPESP); John Simon Guggenheim Memorial Foundation; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Council of Science and Technology (CONACYT) of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Program of Estancias Sabaticas y Posdoctorales al Extranjero para la Consolidacion de Grupos de Investigacion; John E. and Christina C. Craighead Foundation; United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA)(United States Department of Agriculture (USDA)); New Jersey Agricultural Experiment Station	The authors acknowledge the Brazilian research funding institutions FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Proc. 2006/56530-4 and Pr. 2012/12663-1), CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), PRONEX/FINEP (Programa de Apoio aos Nucleos de Excelencia), PRPUSP (Pro-Reitoria de Pesquisa da Universidade de Sao Paulo), Instituto do Milenio-Redoxoma (Proc. 420011/2005-6), INCT Redoxoma (FAPESP/CNPq/CAPES; Proc. 573530/2008-4), NAP Redoxoma (PRPUSP; Proc. 2011.1.9352.1.8), CEPID Redoxoma (FAPESP; Proc. 2013/07937-8) and John Simon Guggenheim Memorial Foundation (PDM Fellowship). MJB-G thanks CONACYT for Grant SEP-CB-79626 and National Council of Science and Technology (CONACYT) of Mexico and the Program of Estancias Sabaticas y Posdoctorales al Extranjero para la Consolidacion de Grupos de Investigacion awarded with the Fellowship number 186241. DO-M thanks CONACYT fellowship # 217649 for his PhD studies. JFW thanks funding support from the John E. and Christina C. Craighead Foundation, United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) Multistate Project W3147, and the New Jersey Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Loayza P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016386; Arzanlou M, 2007, PHYTOPATHOLOGY, V97, P1112, DOI 10.1094/PHYTO-97-9-1112; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; Beltran-Garcia MJ, 2009, CAN J MICROBIOL, V55, P887, DOI [10.1139/w09-023, 10.1139/W09-023]; Busogoro JP, 2004, BANANA IMPROVEMENT: CELLULAR, MOLECULAR BIOLOGY, AND INDUCED MUTATIONS, P161; Butler MJ, 2005, MYCOLOGIA, V97, P312, DOI 10.3852/mycologia.97.2.312; Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; Cadet J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1219, DOI 10.1562/2006-06-09-IR-914; Chatterjee S, 2012, BIOCHEMISTRY-US, V51, P6080, DOI 10.1021/bi300325m; Chiarelli-Neto O, 2011, FREE RADICAL BIO MED, V51, P1195, DOI 10.1016/j.freeradbiomed.2011.06.013; Churchill ACL, 2011, MOL PLANT PATHOL, V12, P307, DOI 10.1111/j.1364-3703.2010.00672.x; Cunha MML, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-80; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Daub ME, 2000, ANNU REV PHYTOPATHOL, V38, P461, DOI 10.1146/annurev.phyto.38.1.461; de Lucas NC, 2012, PHOTOCH PHOTOBIO SCI, V11, P1201, DOI 10.1039/c2pp05412d; DI MASCIO P, 1990, PHOTOCHEM PHOTOBIOL, V51, P293; Donzelli BGG, 2007, PHYTOPATHOLOGY, V97, P916, DOI 10.1094/PHYTO-97-8-0916; Edens WA, 1999, APPL ENVIRON MICROB, V65, P3071; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; El Hadrami A, 2005, EUR J PLANT PATHOL, V113, P241, DOI 10.1007/s10658-005-8675-y; Foure E., 1987, ACIAR Proceedings Series, Australian Centre for International Agricultural Research, P110; Frederick BA, 1999, MYCOL RES, V103, P99, DOI 10.1017/S0953756298006959; Gachomo EW, 2010, MOL BIOL REP, V37, P3583, DOI 10.1007/s11033-010-0007-4; Gomez-Gutierrez A., 2012, THESIS U AUTONOMA GU; Gomez-Marin AM, 2010, J NON-CRYST SOLIDS, V356, P1576, DOI 10.1016/j.jnoncrysol.2010.05.054; Goncalves RCR, 2012, WORLD J MICROB BIOT, V28, P1467, DOI 10.1007/s11274-011-0948-3; Gutierrez I, 1997, CAN J CHEM, V75, P423, DOI 10.1139/v97-048; Henson JM, 1999, ANNU REV PHYTOPATHOL, V37, P447, DOI 10.1146/annurev.phyto.37.1.447; Hoss R, 2000, J PHYTOPATHOL, V148, P387, DOI 10.1046/j.1439-0434.2000.00530.x; Idnurm A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000470; Kogej T, 2004, FEMS MICROBIOL LETT, V232, P203, DOI 10.1016/S0378-1097(04)00073-4; KORYTOWSKI W, 1987, PHOTOCHEM PHOTOBIOL, V45, P185, DOI 10.1111/j.1751-1097.1987.tb05362.x; Krol ES, 1998, CHEM RES TOXICOL, V11, P1434, DOI 10.1021/tx980114c; KUBO Y, 1991, MOL PLANT MICROBE IN, V4, P440, DOI 10.1094/MPMI-4-440; Kunwar A, 2012, TOXICOL APPL PHARM, V264, P202, DOI 10.1016/j.taap.2012.08.002; Liu JJ, 2010, PIGM CELL MELANOMA R, V23, P741, DOI 10.1111/j.1755-148X.2010.00775.x; Llorente C, 2012, MYCOPATHOLOGIA, V174, P397, DOI 10.1007/s11046-012-9558-3; Mednick AJ, 2005, INFECT IMMUN, V73, P2012, DOI 10.1128/IAI.73.4.2012-2019.2005; Miyamoto S, 2006, P NATL ACAD SCI USA, V103, P293, DOI 10.1073/pnas.0508170103; Netto-Ferreira JC, 2008, PHYS CHEM CHEM PHYS, V10, P6645, DOI 10.1039/b810413a; Nofsinger JB, 2002, FREE RADICAL BIO MED, V32, P720, DOI 10.1016/S0891-5849(02)00763-3; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosfinger JB, 2002, BIOPOLYMERS, V67, P302; PAIM S, 1990, BIOL FERT SOILS, V10, P72; Ravanat JL, 2004, BIOL CHEM, V385, P17, DOI 10.1515/BC.2004.003; Rizner TL, 2003, CAN J MICROBIOL, V49, P110, DOI [10.1139/W03-016, 10.1139/w03-016]; Ronsein GE, 2008, CHEM RES TOXICOL, V21, P1271, DOI 10.1021/tx800026g; Seagle BLL, 2005, J AM CHEM SOC, V127, P11220, DOI 10.1021/ja052773z; SENESI N, 1987, BIOL FERT SOILS, V5, P120, DOI 10.1007/BF00257646; Steiner U, 2007, PHYTOPATHOLOGY, V97, P1222, DOI 10.1094/PHYTO-97-10-1222; STIERLE AA, 1991, EXPERIENTIA, V47, P853, DOI 10.1007/BF01922472; Suzukawa AA, 2012, FREE RADICAL BIO MED, V52, P1945, DOI 10.1016/j.freeradbiomed.2012.02.039; Tada M, 2010, J CLIN BIOCHEM NUTR, V46, P224, DOI 10.3164/jcbn.09-84; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Turick CE, 2002, APPL ENVIRON MICROB, V68, P2436, DOI 10.1128/AEM.68.5.2436-2444.2002; Turick CE, 2009, FEMS MICROBIOL ECOL, V68, P223, DOI 10.1111/j.1574-6941.2009.00670.x; Wang A, 2008, PHOTOCHEM PHOTOBIOL, V84, P679, DOI 10.1111/j.1751-1097.2008.00353.x; Ye M, 2011, ADV MATER RES-SWITZ, V284-286, P1742, DOI 10.4028/www.scientific.net/AMR.284-286.1742	59	49	52	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91616	10.1371/journal.pone.0091616	http://dx.doi.org/10.1371/journal.pone.0091616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646830	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500042
J	Corley, CD; Pullum, LL; Hartley, DM; Benedum, C; Noonan, C; Rabinowitz, PM; Lancaster, MJ				Corley, Courtney D.; Pullum, Laura L.; Hartley, David M.; Benedum, Corey; Noonan, Christine; Rabinowitz, Peter M.; Lancaster, Mary J.			Disease Prediction Models and Operational Readiness	PLOS ONE			English	Article							RIFT-VALLEY FEVER; DECISION-SUPPORT-SYSTEMS; INFECTIOUS-DISEASE; MOUTH-DISEASE; SPATIAL-DISTRIBUTION; AIRBORNE SPREAD; RISK-ASSESSMENT; CLIMATE; VECTOR; SURVEILLANCE	The objective of this manuscript is to present a systematic review of biosurveillance models that operate on select agents and can forecast the occurrence of a disease event. We define a disease event to be a biological event with focus on the One Health paradigm. These events are characterized by evidence of infection and or disease condition. We reviewed models that attempted to predict a disease event, not merely its transmission dynamics and we considered models involving pathogens of concern as determined by the US National Select Agent Registry (as of June 2011). We searched commercial and government databases and harvested Google search results for eligible models, using terms and phrases provided by public health analysts relating to biosurveillance, remote sensing, risk assessments, spatial epidemiology, and ecological niche modeling. After removal of duplications and extraneous material, a core collection of 6,524 items was established, and these publications along with their abstracts are presented in a semantic wiki at http://BioCat.pnnl.gov. As a result, we systematically reviewed 44 papers, and the results are presented in this analysis. We identified 44 models, classified as one or more of the following: event prediction (4), spatial (26), ecological niche (28), diagnostic or clinical (6), spread or response (9), and reviews (3). The model parameters (e. g., etiology, climatic, spatial, cultural) and data sources (e. g., remote sensing, non-governmental organizations, expert opinion, epidemiological) were recorded and reviewed. A component of this review is the identification of verification and validation (V&V) methods applied to each model, if any V&V method was reported. All models were classified as either having undergone Some Verification or Validation method, or No Verification or Validation. We close by outlining an initial set of operational readiness level guidelines for disease prediction models based upon established Technology Readiness Level definitions.	[Corley, Courtney D.; Benedum, Corey; Noonan, Christine; Lancaster, Mary J.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Pullum, Laura L.] Oak Ridge Natl Lab, Oak Ridge, TN USA; [Hartley, David M.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Rabinowitz, Peter M.] Yale Univ, Sch Med, New Haven, CT USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Georgetown University; Yale University	Corley, CD (corresponding author), Pacific NW Natl Lab, Richland, WA 99352 USA.	court@pnnl.gov	Lancaster, Mary/A-5065-2015	Lancaster, Mary/0000-0002-2530-7004; Corley, Courtney/0000-0003-3741-9705; Pullum, Laura/0000-0001-6045-7668; Noonan, Christine/0000-0002-6931-0520; Hartley, David/0000-0003-2589-2538	National Biosurveillance Integration Center, Office of Health Affairs; Science and Technology Directorate, Chemical and Biological Division, Threat Characterization and Attribution Branch, of the U.S. Department of Homeland Securit	National Biosurveillance Integration Center, Office of Health Affairs; Science and Technology Directorate, Chemical and Biological Division, Threat Characterization and Attribution Branch, of the U.S. Department of Homeland Securit	This study was supported through a contract to Pacific Northwest National Laboratory from the National Biosurveillance Integration Center, Office of Health Affairs, and the Science and Technology Directorate, Chemical and Biological Division, Threat Characterization and Attribution Branch, of the U.S. Department of Homeland Security (DHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjemian JCZ, 2006, J MED ENTOMOL, V43, P93, DOI 10.1603/0022-2585(2006)043[0093:AOGAFR]2.0.CO;2; ANDERSON R M, 1991; ANGULO JJ, 1987, SOC SCI MED, V24, P57, DOI 10.1016/0277-9536(87)90140-7; Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106; Baptista-Rosas RC, 2007, ANN NY ACAD SCI, V1111, P35, DOI 10.1196/annals.1406.003; Bernard KW, 2013, BIOSECUR BIOTERROR, V11, P157, DOI 10.1089/bsp.2013.8522; Boehm B., 1981, SOFTWARE ENG EC; Boily MC, 1997, CAN J PUBLIC HEALTH, V88, P255, DOI 10.1007/BF03404793; Bos MEH, 2007, VET RES, V38, P493, DOI 10.1051/vetres:2007008; Bravata DM, 2004, EMERG INFECT DIS, V10, P100, DOI 10.3201/eid1001.030243; Brooker S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000779; Brown ST, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-353; Brownstein JS, 2003, ENVIRON HEALTH PERSP, V111, P1152, DOI 10.1289/ehp.6052; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Cappelle J, ECOHEALTH E IN PRESS, P1; Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206; Chhetri BK, 2010, TROP ANIM HEALTH PRO, V42, P1441, DOI 10.1007/s11250-010-9573-7; Cooke III WH, 2006, INT J HLTH GEOGRAPHI, V5; Corley CD, 2012, BIOSECUR BIOTERROR, V10, P131, DOI 10.1089/bsp.2011.0096; Costa J, 2002, AM J TROP MED HYG, V67, P516, DOI 10.4269/ajtmh.2002.67.516; Daniel M, 1998, EXP APPL ACAROL, V22, P417, DOI 10.1023/A:1006030827216; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2009, ECOHEALTH, V6, P1, DOI 10.1007/s10393-009-0253-x; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Eisen L, 2011, ANNU REV ENTOMOL, V56, P41, DOI 10.1146/annurev-ento-120709-144847; Eisen RJ, 2008, J MED ENTOMOL, V45, P181, DOI 10.1603/0022-2585(2008)45[181:SMOHRO]2.0.CO;2; Eisen RJ, 2007, AM J TROP MED HYG, V77, P121, DOI 10.4269/ajtmh.2007.77.121; Eisen RJ, 2010, AM J TROP MED HYG, V82, P904, DOI 10.4269/ajtmh.2010.09-0737; Erraguntla Madhav, 2010, 2010 43rd Hawaii International Conference on System Sciences (HICSS-43), DOI 10.1109/HICSS.2010.79; Estrada-Pena A, 2007, VECTOR-BORNE ZOONOT, V7, P667, DOI 10.1089/vbz.2007.0134; Favier C, 2006, TROP MED INT HEALTH, V11, P1878, DOI 10.1111/j.1365-3156.2006.01746.x; Feighner Brian H, 2009, Emerg Infect Dis, V15, pe1, DOI 10.3201/eid1509.090702; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; Ford TE, 2009, EMERG INFECT DIS, V15, P1341, DOI 10.3201/eid1509.081334; Green AL, 2005, AM J VET RES, V66, P853, DOI 10.2460/ajvr.2005.66.853; Hadorn DC, 2009, VET RES, V40, DOI 10.1051/vetres/2009040; Halliday J, 2012, PHILOS T R SOC B, V367, P2872, DOI 10.1098/rstb.2011.0362; Halliday JEB, 2007, J R SOC INTERFACE, V4, P973, DOI 10.1098/rsif.2007.0237; Hartley DM, 2012, AM J TROP MED HYG, V86, P884, DOI 10.4269/ajtmh.2012.11-0342; Hartley DM, 2014, MILBANK Q IN PRESS; Hartley DM, 2010, EMERGING HLTH THREAT, V3; Hashimoto S, 2000, INT J EPIDEMIOL, V29, P905, DOI 10.1093/ije/29.5.905; Hutber AM, 2006, RES VET SCI, V81, P31, DOI 10.1016/j.rvsc.2005.09.014; IEEE, 2012, 10122012 IEEE STAND; ISO, 2008, 152882008 ISOIEC; ISO/IEC-IEEE, 2008, 122072008 ISOIECIEEE; Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5; Jewell CP, 2009, PREV VET MED, V91, P19, DOI 10.1016/j.prevetmed.2009.05.019; Johnson DA, 1996, PHYTOPATHOLOGY, V86, P480, DOI 10.1094/Phyto-86-480; Kawaguchi R, 2009, EMERG INFECT DIS, V15, P1685, DOI 10.3201/eid1510.091029; Keller M, 2009, EMERG INFECT DIS, V15, P689, DOI 10.3201/eid1505.081114; Kim DR, 2008, HEALTH PLACE, V14, P755, DOI 10.1016/j.healthplace.2007.12.003; Kirkbride JB, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001998; Kleinman K, 2004, AM J EPIDEMIOL, V159, P217, DOI 10.1093/aje/kwh029; Knorr-Held L, 1998, STAT MED, V17, P2045, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2045::AID-SIM943>3.0.CO;2-P; Kolivras KN, 2003, INT J BIOMETEOROL, V47, P87, DOI 10.1007/s00484-002-0155-x; Kolivras KN, 2010, CLIM RES, V42, P1, DOI 10.3354/cr00861; Kong XH, 2008, LECT N BIOINFORMAT, V5354, P97, DOI 10.1007/978-3-540-89746-0_10; Koopman J, 2004, ANNU REV PUBL HEALTH, V25, P303, DOI 10.1146/annurev.publhealth.25.102802.124353; Liao YC, 2008, BIOINFORMATICS, V24, P505, DOI 10.1093/bioinformatics/btm638; Liccardo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063935; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Lockhart CY, 2008, SURVEILLANCE DIS POU; Lu HM, 2008, ISI 2008: 2008 IEEE INTERNATIONAL CONFERENCE ON INTELLIGENCE AND SECURITY INFORMATICS, P76, DOI 10.1109/ISI.2008.4565033; Mankins J. C., 1995, CISC VIS NETW IND GL, V6, P1995; Marechal F, 2008, GEOSPATIAL HEALTH, V3, P1; Margevicius KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083730; Martin PAJ, 2006, PREVENTIVE VET MED; Martinez-Lopez B, 2011, VET MICROBIOL, V147, P300, DOI 10.1016/j.vetmic.2010.07.009; Matsuda F, 2008, EPIDEMIOL INFECT, V136, P73, DOI 10.1017/S0950268807008175; Mayer D, 2008, ATMOS ENVIRON, V42, P466, DOI 10.1016/j.atmosenv.2007.09.069; Metras R, 2011, VECTOR-BORNE ZOONOT, V11, P761, DOI 10.1089/vbz.2010.0200; Miller JC, 2012, J R SOC INTERFACE, V9, P890, DOI 10.1098/rsif.2011.0403; Mongkolsawat C, 2009, INT J GEOINFORMATICS, V5, P7; Mubangizi M, 2009, COMPUTATIONAL PREDIC; Munar-Vivas O, 2010, CROP PROT, V29, P936, DOI 10.1016/j.cropro.2010.04.021; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; National Aeronautics and Space Administration, 2008, NASASTD7009; Nordin JD, 2005, EMERG INFECT DIS, V11, P1394, DOI 10.3201/eid1109.050223; Ortiz-Pelaez A, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-22; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; PCoI-S Models, MOD PCOL S WORKSH GF; Perez L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-50; Pitman R, 2012, VALUE HEALTH, V15, P828, DOI 10.1016/j.jval.2012.06.011; Prieto DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-251; Pullum L. L., 2012, TECHNIQUES ISSUES AG; Pullum LL, 2012, HYBRID SENSITIVITY A; Purse BV, 2004, REV SCI TECH OIE, V23, P761, DOI 10.20506/rst.23.3.1515; Rabinowitz P, 2006, EMERG INFECT DIS, V12, P647, DOI 10.3201/eid1204.051120; Racloz V, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-42; Radosavljevic V, 2009, BIOSECUR BIOTERROR, V7, P443, DOI 10.1089/bsp.2009.0016; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Rolka H, 2007, STAT MED, V26, P1834, DOI 10.1002/sim.2793; Rubel F, 2005, METHOD INFORM MED, V44, P590; Schaafsma AW, 2007, INT J FOOD MICROBIOL, V119, P116, DOI 10.1016/j.ijfoodmicro.2007.08.006; Scotch M, 2011, ECOHEALTH, V8, P376, DOI 10.1007/s10393-011-0706-x; Scotch M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-15; Siettos CI, 2013, VIRULENCE, V4, P295, DOI 10.4161/viru.24041; Takla A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-576; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Tatem AJ, 2003, VET MICROBIOL, V97, P13, DOI 10.1016/j.vetmic.2003.08.009; U.S Army, 1998, TRADOC REG 5 11 US A; U.S DoD, 2011, VERIFICATION VALIDAT; U.S DoD, 2008, MILSTD3022 US DOD MO; U.S Navy, 2005, BEST PRACT GUID VER; Van den Broeck W, 2011, BMC INFECT DIS, V11, DOI [10.1186/1471-2334-11-37, 10.1186/1471-2458-11-575]; Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802; Verdugo C, 2009, PREV VET MED, V88, P109, DOI 10.1016/j.prevetmed.2008.08.007; Wagner M. M., 2002, Reference Librarian, P343, DOI 10.1300/J120v38n79_24; Woolhouse M, 2007, CRIT REV MICROBIOL, V33, P231, DOI 10.1080/10408410701647560; Woolhouse MEJ, 1999, PHILOS T R SOC B, V354, P751, DOI 10.1098/rstb.1999.0427; Yamamoto T, 2008, PREV VET MED, V86, P57, DOI 10.1016/j.prevetmed.2008.03.004; Yuen JE, 2002, PLANT PATHOL, V51, P407, DOI 10.1046/j.0032-0862.2002.00741.x	115	21	21	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91989	10.1371/journal.pone.0091989	http://dx.doi.org/10.1371/journal.pone.0091989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647562	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500066
J	Frontzek, K; Fluri, F; Siemerkus, J; Muller, B; Gass, A; Christ-Crain, M; Katan, M				Frontzek, Karl; Fluri, Felix; Siemerkus, Jakob; Mueller, Beat; Gass, Achim; Christ-Crain, Mirjam; Katan, Mira			Isolated Insular Strokes and Plasma MR-proANP Levels Are Associated with Newly Diagnosed Atrial Fibrillation: A Pilot Study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; PROATRIAL NATRIURETIC PEPTIDE; INVOLVEMENT; PREVENTION; PREDICTOR; CORTEX; VOLUME; RISK	Introduction: In this study, we assessed the relationship of insular strokes and plasma MR-proANP levels with newly diagnosed atrial fibrillation (NDAF). Methods: This study is based on a prospective acute stroke cohort (http://www.clinicaltrials.gov, NCT00390962). Patient eligibility was dependent on the diagnosis of acute ischemic stroke, absence of previous stroke based on past medical history and MRI, no history of AF and congestive heart failure (cohort A) and, additionally, no stroke lesion size >= 20 mL (sub-cohort A*). AF, the primary endpoint, was detected on 24-hour electrocardiography and/or echocardiography. Involvement of the insula was assessed by two experienced readers on MRI blinded to clinical data. MR-proANP levels were obtained through a novel sandwich immunoassay. Logistic-regression-models were fitted to estimate odds ratios for the association of insular strokes and MR-proANP with NDAF. The discriminatory accuracy of insular strokes and MR-proANP was assessed by a model-wise comparison of the area under the receiver-operating-characteristics-curve (AUC) with known predictors of AF. Results: 104 (cohort A) and 83 (cohort A*) patients fulfilled above-mentioned criteria. Patients with isolated insular strokes had a 10.7-fold higher odds of NDAF than patients with a small ischemic stroke at any other location. The AUC of multivariate logistic regression models for the prediction of NDAF improved significantly when adding stroke location and MR-proANP levels. Moreover, MR-proANP levels remained significantly elevated throughout the acute hospitalization period in patients with NDAF compared to those without. Conclusions: Isolated insular strokes and plasma MR-proANP levels on admission are independent predictors of NDAF and significantly improve the prediction accuracy of identifying patients with NDAF compared to known predictors including age, the NIHSS and lesion size. To accelerate accurate diagnosis and enhance secondary prevention in acute stroke, higher levels of MR-proANP and insular strokes may represent easily accessible indicators of AF if confirmed in an independent validation cohort.	[Frontzek, Karl] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Frontzek, Karl; Fluri, Felix] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Fluri, Felix; Katan, Mira] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Siemerkus, Jakob] Univ Hosp Psychiat, Zurich, Switzerland; [Mueller, Beat] Cantonal Hosp Aarau, Med Univ Clin, Aarau, Switzerland; [Gass, Achim] Univ Hosp Mannheim, Dept Neurol, Mannheim, Germany; [Christ-Crain, Mirjam] Univ Basel Hosp, Dept Endocrinol, CH-4031 Basel, Switzerland	University of Zurich; University Zurich Hospital; University of Basel; University of Zurich; University Zurich Hospital; Kantonsspital Aarau AG (KSA); Ruprecht Karls University Heidelberg; University of Basel	Katan, M (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	mira.katan@usz.ch	Mueller, Beat/G-2662-2012	Katan, Mira/0000-0002-9265-8066; Frontzek, Karl/0000-0002-0945-8857; Christ-Crain, Mirjam/0000-0002-6336-0965	Swiss National Science Foundation [PBZHP3-130982]; Fondation Leducq	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Leducq(Leducq Foundation)	This work was supported by the Swiss National Science Foundation (PBZHP3-130982 [M.Katan]) as well as the Fondation Leducq (M.Katan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud H, 2006, ANN NEUROL, V59, P691, DOI 10.1002/ana.20806; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ala-Kopsala M, 2004, CLIN CHEM, V50, P1576, DOI 10.1373/clinchem.2004.032490; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Butti C, 2010, BRAIN STRUCT FUNCT, V214, P477, DOI 10.1007/s00429-010-0264-y; Christensen H, 2005, J NEUROL NEUROSUR PS, V76, P269, DOI 10.1136/jnnp.2004.037531; Colivicchi F, 2004, STROKE, V35, P2094, DOI 10.1161/01.STR.0000138452.81003.4c; Cotter PE, 2013, NEUROLOGY, V80, P1546, DOI 10.1212/WNL.0b013e31828f1828; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Katan M, 2010, J AM COLL CARDIOL, V56, P1045, DOI 10.1016/j.jacc.2010.02.071; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kennedy DN, 2012, NEUROINFORMATICS, V10, P129, DOI 10.1007/s12021-011-9130-1; Laowattana S, 2006, NEUROLOGY, V66, P477, DOI 10.1212/01.wnl.0000202684.29640.60; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Longstreth WT, 2013, STROKE, V44, P714, DOI 10.1161/STROKEAHA.112.675942; Menezes AR, 2013, MAYO CLIN PROC, V88, P394, DOI 10.1016/j.mayocp.2013.01.022; Meune C, 2011, CLIN BIOCHEM, V44, P1315, DOI 10.1016/j.clinbiochem.2011.08.906; Meyer S, 2004, NEUROREPORT, V15, P357, DOI 10.1097/00001756-200402090-00029; Morgenthaler NG, 2004, CLIN CHEM, V50, P234, DOI 10.1373/clinchem.2003.021204; Nagai M, 2010, J AM SOC HYPERTENS, V4, P174, DOI 10.1016/j.jash.2010.05.001; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Rossi A, 2000, J AM COLL CARDIOL, V35, P1256, DOI 10.1016/S0735-1097(00)00515-5; Shibazaki K, 2012, AM J CARDIOL, V109, P1303, DOI 10.1016/j.amjcard.2011.12.022; Taggart P, 2011, HEART, V97, P698, DOI 10.1136/hrt.2010.209304; Vickers AJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-13	25	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92421	10.1371/journal.pone.0092421	http://dx.doi.org/10.1371/journal.pone.0092421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647802	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500128
J	Wang, Y; Wang, LF; Zhang, JW; Wang, GX; Chen, WB; Chen, L; Zhang, XL				Wang, Ying; Wang, Lifang; Zhang, Jianwei; Wang, Guangxi; Chen, Wenbi; Chen, Lin; Zhang, Xilin			Preparation of Colloidal Gold Immunochromatographic Strip for Detection of Paragonimiasis skrjabini	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; ASSAY; CHINA; NANOPARTICLES; PERFORMANCE; WESTERMANI; PROTEINS; FEATURES; CAMEROON; SIZE	Background: Paragonimiasis is a food-borne trematodiasis, a serious public health issue and a neglected tropical disease. Paragonimus skrjabini is a unique species found in China. Unlike paragonimiasis westermani, it is nearly impossible to make a definitive diagnosis for paragonimiasis skrjabini by finding eggs in sputum or feces. Immunodiagnosis is the best choice to detect paragonimiasis skrjabini. There is an urgent need to develop a novel, rapid and simple immunoassay for large-scale screening patients in endemic areas. Methodology/Principal Findings: To develop a rapid, simple immunodiagnostic assay for paragonimiasis, rabbit antihuman IgG was conjugated to colloidal gold particles and used to detect antibodies in the sera of paragonimiasis patients. The synthesis and identification of colloidal gold particles and antibody-colloidal gold conjugates were performed. The size of colloidal gold particles was examined using a transmission electron microscope (TEM). The average diameter of colloidal gold particles was 17.46 nm with a range of 14.32-21.80 nm according to the TEM images. The formation of antibody-colloidal gold conjugates was monitored by UV/Vis spectroscopy. Excretory-secretory (ES) antigen of Paragonimus skrjabini was coated on nitrocellulose membrane as the capture line. Recombinant Staphylococcus protein A was used to prepare the control line. This rapid gold immunochromatographic strip was assembled in regular sequence through different accessories sticked on PVC board. The relative sensitivity and specificity of the strip was 94.4% (51/54) and 94.1% (32/34) respectively using ELISA as the standard method. Its stability and reproducibility were quite excellent after storage of the strip at 4 degrees C for 6 months. Conclusions/Significance: Immunochromatographic strip prepared in this study can be used in a rapid one-step immunochromatographic assay, which is instantaneous and convenient.	[Wang, Ying; Zhang, Xilin] Third Mil Med Univ, Inst Trop Med, Chongqing, Peoples R China; [Wang, Lifang; Wang, Guangxi; Chen, Wenbi] Luzhou Med Coll, Dept Pathogen Biol, Luzhou, Sichuan, Peoples R China; [Zhang, Jianwei] Chengdu Med Coll, Dept Phys, Chengdu, Sichuan, Peoples R China; [Chen, Lin; Zhang, Xilin] Third Mil Med Univ, Dept Pathogen Biol, Chongqing, Peoples R China	Army Medical University; Southwest Medical University; Chengdu Medical College; Army Medical University	Zhang, XL (corresponding author), Third Mil Med Univ, Inst Trop Med, Chongqing, Peoples R China.	zhxljsc120@163.com		Wang, Ying/0000-0003-1368-6497	Natural Science Foundation of Chongqing (CSTC) [2007BB5055]; Military Pre-research Fund [2009XYY01]; Education Sciences Foundation of Sichuan [2005A067]; National Natural Science Foundation of China [30872366, 30371261]	Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Military Pre-research Fund; Education Sciences Foundation of Sichuan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of Chongqing (CSTC, 2007BB5055), the Military Pre-research Fund (No. 2009XYY01) and the Education Sciences Foundation of Sichuan (No. 2005A067). The author's laboratory was supported in part by grants from the National Natural Science Foundation of China (No. 30872366 and No. 30371261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzazy HME, 2009, CLIN CHIM ACTA, V403, P1, DOI 10.1016/j.cca.2009.01.016; Chai Jong-Yil, 2013, Handb Clin Neurol, V114, P283, DOI 10.1016/B978-0-444-53490-3.00023-6; Devi KR, 2007, T ROY SOC TROP MED H, V101, P786, DOI 10.1016/j.trstmh.2007.02.028; Doanh PN, 2009, PARASITOL RES, V104, P1149, DOI 10.1007/s00436-008-1302-z; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Jurgens L, 1999, CYTOMETRY, V37, P87; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; Kim YJ, 2010, J CLIN MICROBIOL, V48, P2365, DOI 10.1128/JCM.02506-09; Liu Q, 2008, TRENDS PARASITOL, V24, P318, DOI 10.1016/j.pt.2008.03.014; Lou S, 2012, ANALYST, V137, P1174, DOI 10.1039/c2an15844b; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P399, DOI 10.1111/1469-0691.12151; Nkouawa A, 2011, SE ASIAN J TROP MED, V42, P1365; Nkouawa A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000732; Odermatt P, 2007, ACTA TROP, V103, P108, DOI 10.1016/j.actatropica.2007.05.015; Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036; Perfetti M, 2013, SMALL; Philip D, 2008, SPECTROCHIM ACTA A, V71, P80, DOI 10.1016/j.saa.2007.11.012; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; Rouf M A, 2009, Mymensingh Med J, V18, pS1; Sheele JM, 2013, TROP MED INT HEALTH, V18, P477, DOI 10.1111/tmi.12063; Sheng XZ, 2012, J APPL MICROBIOL, V113, P737, DOI 10.1111/j.1365-2672.2012.05389.x; Thobhani S, 2010, J IMMUNOL METHODS, V356, P60, DOI 10.1016/j.jim.2010.02.007; Yan J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-73; Yang SH, 2004, AM J TROP MED HYG, V71, P87, DOI 10.4269/ajtmh.2004.71.87; Zhang GP, 2006, VET PARASITOL, V137, P286, DOI 10.1016/j.vetpar.2006.01.026; Zhang XL, 2012, PARASITOL INT, V61, P645, DOI 10.1016/j.parint.2012.06.007; Zhang ZH, 2005, DIS NATURAL FOCUS, P1085; Zhu YC, 2005, ACTA TROP, V96, P130, DOI 10.1016/j.actatropica.2005.07.007	30	16	23	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92034	10.1371/journal.pone.0092034	http://dx.doi.org/10.1371/journal.pone.0092034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643068	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900067
J	Montasser, ME; Shimmin, LC; Gu, DF; Chen, J; Gu, C; Kelly, TN; Jaquish, CE; Rice, TK; Rao, DC; Cao, J; Chen, JC; De-Peliu; Whelton, PK; Hamm, LL; He, J; Hixson, JE				Montasser, May E.; Shimmin, Lawrence C.; Gu, Dongfeng; Chen, Jing; Gu, Charles; Kelly, Tanika N.; Jaquish, Cashell E.; Rice, Treva K.; Rao, Dabeeru C.; Cao, Jie; Chen, Jichun; De-Peliu; Whelton, Paul K.; Hamm, Lotuce Lee; He, Jiang; Hixson, James E.			Variation in Genes that Regulate Blood Pressure Are Associated with Glomerular Filtration Rate in Chinese	PLOS ONE			English	Article							ALPHA-ADDUCIN GENE; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; RENIN-ANGIOTENSIN SYSTEM; CHRONIC KIDNEY-DISEASE; CHANNEL GAMMA-SUBUNIT; BETA(2)-ADRENERGIC RECEPTOR; ESSENTIAL-HYPERTENSION; METABOLIC SYNDROME; SERUM CREATININE; LINKAGE ANALYSIS	Chronic kidney disease (CKD) can be a consequence of diabetes, hypertension, immunologic disorders, and other exposures, as well as genetic factors that are still largely unknown. Glomerular filtration rate (GFR), which is widely used to measure kidney function, has a heritability ranging from 25% to 75%, but only 1.5% of this heritability is explained by genetic loci that have been identified to date. In this study we tested for associations between GFR and 234 SNPs in 26 genes from pathways of blood pressure regulation in 3,025 rural Chinese participants of the "Genetic Epidemiology Network of Salt Sensitivity" (GenSalt) study. We estimated GFR (eGFR) using baseline serum creatinine measurements obtained prior to dietary intervention. We identified significant associations between eGFR and 12 SNPs in 6 genes (ACE, ADD1, AGT, GRK4, HSD11B1, and SCNN1G). The cumulative effect of the protective alleles was an increase in mean eGFR of 4 mL/min per 1.73 m(2), while the cumulative effect of the risk alleles was a decrease in mean eGFR of 3 mL/min per 1.73 m(2). In addition, we identified a significant interaction between SNPs in CYP11B1 and ADRB2. We have identified common variants in genes from pathways that regulate blood pressure and influence kidney function as measured by eGFR, providing new insights into the genetic determinants of kidney function. Complex genetic effects on kidney function likely involve interactions among genes as we observed for CYP11B1 and ADRB2.	[Montasser, May E.; Shimmin, Lawrence C.; Hixson, James E.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Sch Publ Hlth, Houston, TX 77030 USA; [Gu, Dongfeng; Cao, Jie; Chen, Jichun] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Gu, Dongfeng; Cao, Jie; Chen, Jichun] Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100730, Peoples R China; [Chen, Jing; Hamm, Lotuce Lee] Tulane Univ, Sch Med, New Orleans, LA 70112 USA; [Gu, Charles; Rice, Treva K.; Rao, Dabeeru C.] Washington Univ, Sch Med, St Louis, MO USA; [Kelly, Tanika N.; Whelton, Paul K.; He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Jaquish, Cashell E.] NHLBI, NIH, Bethesda, MD 20892 USA; [De-Peliu] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Tulane University; Washington University (WUSTL); Tulane University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Montasser, ME (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA.	mmontass@medicine.umaryland.edu	He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652; Hixson, James/0000-0002-0849-9315; Rice, Treva/0000-0001-7452-2600	National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland [U01HL072507, R01HL087263, R01HL090682]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072507, R01HL087263, R01HL090682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Genetic Epidemiology Network of Salt Sensitivity (GenSalt) is supported by several grants (U01HL072507, R01HL087263, and R01HL090682) from the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Adler S, 2006, ETHN DIS, V16; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahluwalia TS, 2009, DNA CELL BIOL, V28, P141, DOI 10.1089/dna.2008.0810; Arar NH, 2008, NEPHROL DIAL TRANSPL, V23, P3184, DOI 10.1093/ndt/gfn215; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basson J, 2012, CURR HYPERTENS REP, V14, P46, DOI 10.1007/s11906-011-0241-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit G, 2010, ANN NY ACAD SCI, V1214, P83, DOI 10.1111/j.1749-6632.2010.05817.x; Bianchi G, 2005, HYPERTENSION, V45, P331, DOI 10.1161/01.HYP.0000156497.39375.37; Boger CA, 2011, KIDNEY BLOOD PRESS R, V34, P225, DOI 10.1159/000326901; Bray MS, 2000, AM J HYPERTENS, V13, P699, DOI 10.1016/S0895-7061(00)00242-9; Brodde OE, 2008, PHARMACOL THERAPEUT, V117, P1, DOI 10.1016/j.pharmthera.2007.07.002; Busst CJ, 2011, HYPERTENSION, V58, P1073, DOI 10.1161/HYPERTENSIONAHA.111.176370; Busst CJ, 2007, HYPERTENSION, V50, P672, DOI 10.1161/HYPERTENSIONAHA.107.089128; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Chang Hung-Rong, 2003, J Chin Med Assoc, V66, P51; Chelala C, 2009, BIOINFORMATICS, V25, P655, DOI 10.1093/bioinformatics/btn653; de Borst MH, 2008, NAT CLIN PRACT NEPHR, V4, P265, DOI 10.1038/ncpneph0785; Dluhy RG, 1999, J CLIN ENDOCR METAB, V84, P4341, DOI 10.1210/jc.84.12.4341; Fox CS, 2004, J AM SOC NEPHROL, V15, P2457, DOI 10.1097/01.ASN.0000135972.13396.6F; Freedman BI, 2007, CLIN J AM SOC NEPHRO, V2, P1306, DOI 10.2215/CJN.02560607; Freel EM, 2004, J AM SOC NEPHROL, V15, P1993, DOI 10.1097/01.ASN.0000132473.50966.14; Ge D, 2005, ANN HUM GENET, V69, P36, DOI 10.1046/j.1529-8817.2003.00093.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gjesing AP, 2007, DIABETOLOGIA, V50, P563, DOI 10.1007/s00125-006-0578-8; Gong R, 2008, LIFE SCI, V82, P631, DOI 10.1016/j.lfs.2007.12.019; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Harris DM, 2008, CLIN SCI, V115, P79, DOI 10.1042/CS20070442; He J, 2007, J HUM HYPERTENS, V21, P639, DOI 10.1038/sj.jhh.1002207; He X, 2001, CLIN EXP HYPERTENS, V23, P579, DOI 10.1081/CEH-100106828; Hinds DR, 1999, ASPEX PACKAGE AFFECT; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; [黄晓红 HUANG Xiaohong], 2007, [中华医学杂志, National Medical Journal of China], V87, P1682; Ichihara A, 2004, CONTRIB NEPHROL, V143, P117; Jose PA, 2010, BBA-MOL BASIS DIS, V1802, P1259, DOI 10.1016/j.bbadis.2010.02.004; Ju ZY, 2003, J HYPERTENS, V21, P1861, DOI 10.1097/00004872-200310000-00013; Kelly JJ, 1998, CLIN EXP PHARMACOL P, V25, pS51, DOI 10.1111/j.1440-1681.1998.tb02301.x; Kim S, 2000, PHARMACOL REV, V52, P11; Kiryluk K, 2008, KIDNEY INT, V74, P1109, DOI 10.1038/ki.2008.479; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Lu XF, 2013, NEPHROL DIAL TRANSPL, V28, P2977, DOI 10.1093/ndt/gft333; Maeda Shiro, 2008, Ther Adv Cardiovasc Dis, V2, P363, DOI 10.1177/1753944708094768; Morris BJ, 2009, AM J HYPERTENS, V22, P235, DOI 10.1038/ajh.2008.337; Morton NM, 2008, FRONT HORM RES, V36, P146, DOI 10.1159/000115363; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Park HS, 2008, METABOLISM, V57, P1064, DOI 10.1016/j.metabol.2008.03.009; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Pereira TV, 2008, HYPERTENSION, V51, P778, DOI 10.1161/HYPERTENSIONAHA.107.100370; Phillips JK, 2005, CLIN EXP PHARMACOL P, V32, P415, DOI 10.1111/j.1440-1681.2005.04204.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritz E, 2003, HERZ, V28, P663, DOI 10.1007/s00059-003-2509-5; Rodriguez-Soriano J, 2000, PEDIATR NEPHROL, V14, P1121, DOI 10.1007/s004670000407; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Saran Anita M, 2008, Ther Adv Cardiovasc Dis, V2, P425, DOI 10.1177/1753944708096379; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; Schelling JR, 2008, DIABETES, V57, P235, DOI 10.2337/db07-0313; Shioji K, 2004, HYPERTENS RES, V27, P31, DOI 10.1291/hypres.27.31; Staessen JA, 2005, PHARMACOGENOMICS, V6, P665, DOI 10.2217/14622416.6.7.665; Stimson R H, 2007, Minerva Endocrinol, V32, P141; Strautnieks SS, 1996, NAT GENET, V13, P248, DOI 10.1038/ng0696-248; Tesson F, 2007, HYPERTENSION, V50, P607, DOI 10.1161/HYPERTENSIONAHA.107.096800; Tobler Andreas R, 2005, J Biomol Tech, V16, P398; Ullah AZD, 2012, NUCLEIC ACIDS RES, V40, pW65, DOI 10.1093/nar/gks364; Wang JG, 2002, KIDNEY INT, V62, P2152, DOI 10.1046/j.1523-1755.2002.00691.x; Warnock DG, 2001, AM J MED SCI, V322, P302, DOI 10.1097/00000441-200112000-00002; WHITWORTH JA, 1995, STEROIDS, V60, P76, DOI 10.1016/0039-128X(94)00033-9; Yamagishi K, 2004, AM J HYPERTENS, V17, P385, DOI 10.1016/j.amjhyper.2003.12.018; Yu SF, 2008, BIOMED ENVIRON SCI, V21, P239, DOI 10.1016/S0895-3988(08)60036-7; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zeng CY, 2008, HYPERTENSION, V51, P1449, DOI 10.1161/HYPERTENSIONAHA.107.096487; Zhuo Jia L, 2013, Front Endocrinol (Lausanne), V4, P166, DOI 10.3389/fendo.2013.00166	75	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92468	10.1371/journal.pone.0092468	http://dx.doi.org/10.1371/journal.pone.0092468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658007	Green Submitted, gold, Green Published			2022-12-27	WOS:000333355300086
J	Amato, MC; Pizzolanti, G; Torregrossa, V; Misiano, G; Milano, S; Giordano, C				Amato, Marco C.; Pizzolanti, Giuseppe; Torregrossa, Vittoria; Misiano, Gabriella; Milano, Salvatore; Giordano, Carla			Visceral Adiposity Index (VAI) Is Predictive of an Altered Adipokine Profile in Patients with Type 2 Diabetes	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; INSULIN-RESISTANCE; CARDIOMETABOLIC RISK; LIVER HISTOLOGY; NORMAL-WEIGHT; OBESITY; ADIPONECTIN; SENSITIVITY; DISEASE; PROTEIN	Aims: Although there is still no clear definition of "adipose tissue dysfunction'' or ATD, the identification of a clinical marker of altered fat distribution and function may provide the needed tools for early identification of a condition of cardiometabolic risk. Our aim was to evaluate the correlations among various anthropometric indices [BMI, Waist Circumference (WC), Hip Circumference (HC), Waist/Hip ratio (WHR), Body Adiposity Index (BAI) and Visceral adiposity Index (VAI)] and several adipocytokines [Visfatin, Resistin, Leptin, Soluble leptin receptors (sOB-R), Adiponectin, Ghrelin, Adipsin, PAI-1, vascular endothelial growth factor (VEGF), Hepatocyte growth factor (HGF) TNF-alpha, hs-CRP, IL-6, IL-18] in patients with type 2 diabetes (DM2). Materials and Methods: Ninety-one DM2 patients (age: 65.25 +/- 6.38 years; 42 men and 49 women) in stable treatment for the last six months with metformin in monotherapy (1.5-2 g/day) were cross-sectionally studied. Clinical, anthropometric, and metabolic parameters were evaluated. Serum adipocytokine levels were assayed with Luminex based kits. Results: At the Pearson's correlation, among all the indices investigated, VAI showed a significant correlation with almost all adipocytokines analyzed [Visfatin, Resistin and hsCRP (all p<0.001); Adiponectin, sOb-R, IL-6, IL-18, HGF (all p<0.010); Ghrelin and VEGF (both p<0.05)]. Through a two-step cluster analysis, 55 patients were identified with the most altered adipocytokine profile (patients with ATD). At a ROC analysis, VAI showed the highest C-statistic [0.767 (95% CI 0.66-0.84)] of all the indices. Conclusions: Our study suggests that the VAI, among the most common indexes of adiposity assessment, shows the best correlation with the best known adipocytokines and cardiometabolic risk serum markers. Although to date we are still far from clearly identifying an ATD, the VAI would be an easy tool for clearly mirroring a condition of cardiometabolic risk, in the absence of an overt metabolic syndrome.	[Amato, Marco C.; Pizzolanti, Giuseppe; Torregrossa, Vittoria; Giordano, Carla] Univ Palermo, Dipartimento Biomed Med Interna & Specialist DiBi, Sect Endocrinol Diabetol & Metab, Palermo, Italy; [Misiano, Gabriella; Milano, Salvatore] Univ Palermo, Dipartimento Biopatol & Biotecnol Med & Forensi D, Sect Clin Pathol, Palermo, Italy	University of Palermo; University of Palermo	Giordano, C (corresponding author), Univ Palermo, Dipartimento Biomed Med Interna & Specialist DiBi, Sect Endocrinol Diabetol & Metab, Palermo, Italy.	carla.giordano@unipa.it	Pizzolanti, Giuseppe/I-4547-2019; GIORDANO, Carla/R-4296-2017; Pizzolanti, Giuseppe/K-7097-2016	GIORDANO, Carla/0000-0003-1731-9395; Pizzolanti, Giuseppe/0000-0001-6052-8438				Abbasi F, 2002, J AM COLL CARDIOL, V40, P937, DOI 10.1016/S0735-1097(02)02051-X; Al-Daghri NM, 2013, EUR J CLIN INVEST, V43, P183, DOI 10.1111/eci.12030; Amato MC, 2013, NUTR METAB CARDIOVAS, V23, pE31, DOI 10.1016/j.numecd.2013.04.006; Amato MC, 2013, HUM REPROD, V28, P1919, DOI 10.1093/humrep/det105; Amato MC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-183; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Amato MC, 2011, HUM REPROD, V26, P1486, DOI 10.1093/humrep/der088; Bays H, 2005, FUTUR CARDIOL, V1, P39, DOI 10.1517/14796678.1.1.39; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Boyle JG, 2011, DIABETOLOGIA, V54, P1799, DOI 10.1007/s00125-011-2126-4; Bremer AA, 2013, J OBES, V2013, DOI 10.1155/2013/393192; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Chandalia M, 1999, J CLIN ENDOCR METAB, V84, P2329, DOI 10.1210/jc.84.7.2329; Ciresi A, 2012, J CLIN ENDOCR METAB, V97, P2907, DOI 10.1210/jc.2012-1518; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Devaraj Sridevi, 2010, Expert Rev Endocrinol Metab, V5, P19; Elisha B, 2013, APPL PHYSIOL NUTR ME, V38, P892, DOI 10.1139/apnm-2012-0307; Fernandez-Real JM, 2007, DIABETES CARE, V30, P616, DOI 10.2337/dc06-1581; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Garg Abhimanyu, 2006, Clin Cornerstone, V8 Suppl 4, pS7, DOI 10.1016/S1098-3597(06)80039-6; Kennedy A, 1997, J CLIN ENDOCR METAB, V82, P1293, DOI 10.1210/jc.82.4.1293; Kizer JR, 2012, DIABETES CARE, V35, P415, DOI 10.2337/dc11-1519; Knowles KM, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/931402; Musso G, 2012, HEPATOLOGY, V56, DOI 10.1002/hep.25677; Oh JY, 2013, OBESITY, V21, P1690, DOI 10.1002/oby.20096; Petta S, 2012, ALIMENT PHARM THER, V35, P238, DOI 10.1111/j.1365-2036.2011.04929.x; Petta S, 2010, HEPATOLOGY, V52, P1543, DOI 10.1002/hep.23859; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Soino M, 2006, DIABETES CARE, V29, P329, DOI 10.2337/diacare.29.02.06.dc05-1700; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Vongsuvanh R, 2012, J HEPATOL, V57, P392, DOI 10.1016/j.jhep.2012.03.013; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Zhang XL, 2013, INT J CARDIOL, V168, P2141, DOI 10.1016/j.ijcard.2013.01.275	41	79	85	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91969	10.1371/journal.pone.0091969	http://dx.doi.org/10.1371/journal.pone.0091969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651545	Green Published, gold			2022-12-27	WOS:000333352800060
J	Han, ZP; Ku, LX; Zhang, ZZ; Zhang, J; Guo, SL; Liu, HY; Zhao, RF; Ren, ZZ; Zhang, LK; Su, HH; Dong, L; Chen, YH				Han, Zanping; Ku, Lixia; Zhang, Zhenzhen; Zhang, Jun; Guo, ShuLei; Liu, Haiying; Zhao, Ruifang; Ren, Zhenzhen; Zhang, Liangkun; Su, Huihui; Dong, Lei; Chen, Yanhui			QTLs for Seed Vigor-Related Traits Identified in Maize Seeds Germinated under Artificial Aging Conditions	PLOS ONE			English	Article							CONTROLLED DETERIORATION; LONGEVITY; LOCI; ARABIDOPSIS; PROTEINS; STORABILITY; GERMINABILITY; ANTIOXIDANTS; PERFORMANCE; POPULATION	High seed vigor is important for agricultural production due to the associated potential for increased growth and productivity. However, a better understanding of the underlying molecular mechanisms is required because the genetic basis for seed vigor remains unknown. We used single-nucleotide polymorphism (SNP) markers to map quantitative trait loci (QTLs) for four seed vigor traits in two connected recombinant inbred line (RIL) maize populations under four treatment conditions during seed germination. Sixty-five QTLs distributed between the two populations were identified and a meta-analysis was used to integrate genetic maps. Sixty-one initially identified QTLs were integrated into 18 meta-QTLs (mQTLs). Initial QTLs with contribution to phenotypic variation values of R-2>10% were integrated into mQTLs. Twenty-three candidate genes for association with seed vigor traits coincided with 13 mQTLs. The candidate genes had functions in the glycolytic pathway and in protein metabolism. QTLs with major effects (R-2>10%) were identified under at least one treatment condition for mQTL2, mQTL3-2, and mQTL3-4. Candidate genes included a calcium-dependent protein kinase gene (302810918) involved in signal transduction that mapped in the mQTL3-2 interval associated with germination energy (GE) and germination percentage (GP), and an hsp20/alpha crystallin family protein gene (At5g51440) that mapped in the mQTL3-4 interval associated with GE and GP. Two initial QTLs with a major effect under at least two treatment conditions were identified for mQTL5-2. A cucumisin-like Ser protease gene (At5g67360) mapped in the mQTL5-2 interval associated with GP. The chromosome regions for mQTL2, mQTL3-2, mQTL3-4, and mQTL5-2 may be hot spots for QTLs related to seed vigor traits. The mQTLs and candidate genes identified in this study provide valuable information for the identification of additional quantitative trait genes.	[Han, Zanping; Ku, Lixia; Zhang, Zhenzhen; Zhang, Jun; Guo, ShuLei; Liu, Haiying; Zhao, Ruifang; Ren, Zhenzhen; Zhang, Liangkun; Su, Huihui; Dong, Lei; Chen, Yanhui] Henan Agr Univ, Synerget Innovat Ctr Henan Grain Crops, Coll Agron, Zhengzhou, Peoples R China; [Han, Zanping; Ku, Lixia; Zhang, Zhenzhen; Zhang, Jun; Guo, ShuLei; Liu, Haiying; Zhao, Ruifang; Ren, Zhenzhen; Zhang, Liangkun; Su, Huihui; Dong, Lei; Chen, Yanhui] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China; [Han, Zanping] Henan Univ Sci & Technol, Coll Agron, Luoyang, Peoples R China	Henan Agricultural University; Henan Agricultural University; Henan University of Science & Technology	Chen, YH (corresponding author), Henan Agr Univ, Synerget Innovat Ctr Henan Grain Crops, Coll Agron, Zhengzhou, Peoples R China.	chy9890@163.com			National Basic Research Program of China [2009CB118400]; Key Base Research Project of Henan Province; Corn Industry Technology System in Henan Province [S2010-02]	National Basic Research Program of China(National Basic Research Program of China); Key Base Research Project of Henan Province; Corn Industry Technology System in Henan Province	This work was supported by grants from the National Basic Research Program of China (No. 2009CB118400), and the Key Base Research Project of Henan Province and Corn Industry Technology System in Henan Province (S2010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almoguera C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-75; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Arif MAR, 2012, EUPHYTICA, V186, P1, DOI 10.1007/s10681-011-0471-5; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; BASAVARAJAPPA BS, 1991, SEED SCI TECHNOL, V19, P279; Bentsink L, 2000, PLANT PHYSIOL, V124, P1595, DOI 10.1104/pp.124.4.1595; Bewley J. D., 2013, SEEDS, DOI [10.1017/S0960258513000287, DOI 10.1007/978-1-4614-4693-4_1]; Bingham IJ, 1999, SEED SCI TECHNOL, V27, P151; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; CHING TM, 1968, CROP SCI, V8, P407, DOI 10.2135/cropsci1968.0011183X000800040003x; Clerkx EJM, 2004, PHYSIOL PLANTARUM, V121, P448, DOI 10.1111/j.0031-9317.2004.00339.x; Contreras S, 2008, HORTSCIENCE, V43, P845, DOI 10.21273/HORTSCI.43.3.845; Contreras S, 2009, HORTSCIENCE, V44, P130, DOI 10.21273/HORTSCI.44.1.130; Devaiah SP, 2007, PLANT J, V50, P950, DOI 10.1111/j.1365-313X.2007.03103.x; DeVries M, 2007, CROP SCI, V47, P2089, DOI 10.2135/cropsci2007.01.0005; DICKSON MH, 1980, HORTSCIENCE, V15, P771; Galleschi L, 2002, J AGR FOOD CHEM, V50, P5450, DOI 10.1021/jf0201430; Goffinet B, 2000, GENETICS, V155, P463; Gupta ML, 2005, SEED SCI TECHNOL, V33, P167, DOI 10.15258/sst.2005.33.1.17; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hilhorst HWM, 2010, TOP CURR GENET, V21, P43, DOI 10.1007/978-3-642-12422-8_4; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Kazmi RH, 2012, PLANT CELL ENVIRON, V35, P929, DOI 10.1111/j.1365-3040.2011.02463.x; Kibinza S, 2006, PHYSIOL PLANTARUM, V128, P496, DOI 10.1111/j.1399-3054.2006.00771.x; Kocsy G, 2001, PLANT PHYSIOL, V127, P1147, DOI 10.1104/pp.010107; Kumar GNM, 1999, PLANT PHYSIOL, V119, P89, DOI 10.1104/pp.119.1.89; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; McDonald MB, 1999, SEED SCI TECHNOL, V27, P177; Miura K, 2002, THEOR APPL GENET, V104, P981, DOI 10.1007/s00122-002-0872-x; Nagel M, 2009, EUPHYTICA, V170, P5, DOI 10.1007/s10681-009-9975-7; Nagel M, 2011, PLANT GENET RESOUR-C, V9, P260, DOI 10.1017/S1479262111000372; Oge L, 2008, PLANT CELL, V20, P3022, DOI 10.1105/tpc.108.058479; Prieto-Dapena P, 2006, PLANT PHYSIOL, V142, P1102, DOI 10.1104/pp.106.087817; Rajjou L, 2004, PLANT PHYSIOL, V134, P1598, DOI 10.1104/pp.103.036293; Rajjou L, 2008, CR BIOL, V331, P796, DOI 10.1016/j.crvi.2008.07.021; Rajjou L, 2008, PLANT PHYSIOL, V148, P620, DOI 10.1104/pp.108.123141; Rodo Angélica B., 2003, Hortic. Bras., V21, P220, DOI 10.1590/S0102-05362003000200020; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Schwember AR, 2010, J EXP BOT, V61, P4423, DOI 10.1093/jxb/erq248; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; Shin JH, 2009, PLANT PHYSIOL, V149, P905, DOI 10.1104/pp.108.130716; Soti C, 2007, J BIOSCIENCES, V32, P511, DOI 10.1007/s12038-007-0050-z; STONE JM, 1995, PLANT PHYSIOL, V108, P451, DOI 10.1104/pp.108.2.451; Suzuki Y, 1996, J AGR FOOD CHEM, V44, P3479, DOI 10.1021/jf9600465; TEKRONY DM, 1989, CROP SCI, V29, P1523, DOI 10.2135/cropsci1989.0011183X002900060042x; Trachsel S, 2009, THEOR APPL GENET, V119, P1413, DOI 10.1007/s00122-009-1144-9; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Vazquez-Ramos JM, 2000, SEED BIOLOGY: ADVANCES AND APPLICATIONS, P261, DOI 10.1079/9780851994048.0261; Wang SJ, 2003, AM J PHYSIOL-HEART C, V284, pH1917, DOI 10.1152/ajpheart.00861.2002; Wu XL, 2011, ACTA PHYSIOL PLANT, V33, P181, DOI 10.1007/s11738-010-0536-4; Xin X, 2011, PHYSIOL PLANTARUM, V143, P126, DOI 10.1111/j.1399-3054.2011.01497.x; Xue Y, 2008, EUPHYTICA, V164, P739, DOI 10.1007/s10681-008-9696-3; [曾大力 Zeng Dali], 2002, [作物学报, Acta Agronomica Sinica], V28, P551; Zeng DL, 2006, PLANT BREEDING, V125, P57, DOI 10.1111/j.1439-0523.2006.01169.x; ZENG ZB, 1994, GENETICS, V136, P1457	60	54	60	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92535	10.1371/journal.pone.0092535	http://dx.doi.org/10.1371/journal.pone.0092535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651614	Green Submitted, gold, Green Published			2022-12-27	WOS:000333352800122
J	Lenoir, B; Wagner, DR; Blacher, S; Sala-Newby, GB; Newby, AC; Noel, A; Devaux, Y				Lenoir, Benedicte; Wagner, Daniel R.; Blacher, Silvia; Sala-Newby, Graciela B.; Newby, Andrew C.; Noel, Agnes; Devaux, Yvan			Effects of Adenosine on Lymphangiogenesis	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE-9 SECRETION; ANGIOGENIC SWITCH; MACROPHAGES; INFLAMMATION; CELLS; RECEPTORS; GROWTH; CANCER; VEGF	Background: The lymphatic system controls tissue homeostasis by draining protein-rich lymph to the vascular system. Lymphangiogenesis, the formation of lymphatic vessels, is a normal event in childhood but promotes tumor spread and metastasis during adulthood. Blocking lymphangiogenesis may therefore be of therapeutic interest. Production of adenosine is enhanced in the tumor environment and contributes to tumor progression through stimulation of angiogenesis. In this study, we determined whether adenosine affects lymphangiogenesis. Methods: Lymphatic endothelial cells (HMVEC-dLy) were cultured in presence of adenosine and their proliferation, migration and tube formation was assessed. Gelatin sponges embedded with the stable analogue of adenosine 2-chloro adenosine were implanted in mice ear and lymphangiogenesis was quantified. Mice were intravenously injected with adenoviruses containing expression vector for 5'-endonucleotidase, which plays a major role in the formation of adenosine. Results: In vitro, we observed that adenosine decreased the proliferation of lymphatic endothelial cells, their migration and tube formation. However, in vivo, gelatin sponges containing 2-chloro adenosine and implanted in mice ear displayed an elevated level of lymphangiogenesis (2.5-fold, p<0.001). Adenovirus-mediated over-expression of cytosolic 5'-nucleotidase IA stimulated lymphangiogenesis and the recruitment of macrophages in mouse liver. Proliferation of lymphatic endothelial cells was enhanced (2-fold, p<0.001) when incubated in the presence of conditioned medium from murine macrophages. Conclusion: We have shown that adenosine stimulates lymphangiogenesis in vivo, presumably through a macrophage-mediated mechanism. This observation suggests that blockade of adenosine receptors may help in anti-cancer therapies.	[Lenoir, Benedicte; Wagner, Daniel R.; Devaux, Yvan] CRP Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg; [Wagner, Daniel R.] Ctr Hosp Luxembourg, Div Cardiol, Luxembourg, Luxembourg; [Blacher, Silvia; Noel, Agnes] Univ Liege, Lab Tumor & Dev Biol, Grp Interdisciplinaire Genoprote Appl Canc, Liege, Belgium; [Sala-Newby, Graciela B.; Newby, Andrew C.] Univ Bristol, Bristol Royal Infirm, Bristol Heart Inst, Bristol, Avon, England	Luxembourg Institute of Health; Luxembourg Hospital Center; University of Liege; Bristol Royal Infirmary; University of Bristol	Devaux, Y (corresponding author), CRP Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg.	yvan.devaux@crp-sante.lu	DEVAUX, Yvan/AAK-3463-2020	Noel, Agnes/0000-0002-7670-6179; Devaux, Yvan/0000-0002-5321-8543	Ministry of Higher Education; Health of Luxembourg; Research of Luxembourg [PhD-AFR-09-110]; Fondation contre le Cancer (foundation of public interest, Belgium); Fonds speciaux de la Recherche (University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege); Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium)	Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); Health of Luxembourg; Research of Luxembourg; Fondation contre le Cancer (foundation of public interest, Belgium); Fonds speciaux de la Recherche (University of Liege)(University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege)(University of Liege); Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office)	This study was funded by the Ministry of Higher Education and Health of Luxembourg. BL was supported by a fellowship from the National Fund of Research of Luxembourg (grant PhD-AFR-09-110). This work was also supported by grants from the Fondation contre le Cancer (foundation of public interest, Belgium), the Fonds speciaux de la Recherche (University of Liege), the Centre Anticancereux pres l'Universite de Liege, the Fonds Leon Fredericq (University of Liege), the Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Auchampach JA, 2007, CIRC RES, V101, P1075, DOI 10.1161/CIRCRESAHA.107.165761; Avraham-Davidi I, 2013, J EXP MED, V210, P2611, DOI 10.1084/jem.20120690; Azuaje F, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-7; Blay J, 1997, CANCER RES, V57, P2602; Bruyere F, 2010, FASEB J, V24, P8, DOI 10.1096/fj.09-132852; Cekic C, 2012, J IMMUNOL, V188, P198, DOI 10.4049/jimmunol.1101845; Chiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069114; Chung CH, 2013, CLIN MOL HEPATOL, V19, P99, DOI 10.3350/cmh.2013.19.2.99; Detry B, 2013, INVEST OPHTH VIS SCI, V54, P3082, DOI 10.1167/iovs.12-10856; Eklund L, 2013, MOL ONCOL, V7, P259, DOI 10.1016/j.molonc.2013.02.007; Ernens I, 2006, CIRC RES, V99, P590, DOI 10.1161/01.RES.0000241428.82502.d4; Ernens I, 2010, BIOCHEM BIOPH RES CO, V392, P351, DOI 10.1016/j.bbrc.2010.01.023; Feoktistov Igor, 2009, Handb Exp Pharmacol, P383, DOI 10.1007/978-3-540-89615-9_13; Ferrante CJ, 2013, INFLAMMATION, V36, P921, DOI 10.1007/s10753-013-9621-3; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Goblyos A, 2009, PURINERG SIGNAL, V5, P51, DOI 10.1007/s11302-008-9105-3; Harvey NL, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-15; Hasko G, 2012, ARTERIOSCL THROM VAS, V32, P865, DOI 10.1161/ATVBAHA.111.226852; Hocher B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017891; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Ji RC, 2012, CELL MOL LIFE SCI, V69, P897, DOI 10.1007/s00018-011-0848-6; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Kelley PM, 2013, AM J PATHOL, V182, P2418, DOI 10.1016/j.ajpath.2013.02.025; Kumar V, 2013, PURINERG SIGNAL, V9, P145, DOI 10.1007/s11302-012-9349-9; Leonard F, 2011, J LEUKOCYTE BIOL, V90, P199, DOI 10.1189/jlb.0910505; Martin C, 2000, CRIT CARE MED, V28, P3198, DOI 10.1097/00003246-200009000-00014; Norrmen C, 2011, CIRCULATION, V123, P1335, DOI 10.1161/CIRCULATIONAHA.107.704098; Olah Mark E, 2003, Mol Interv, V3, P370, DOI 10.1124/mi.3.7.370; Paupert J, 2011, MOL ASPECTS MED, V32, P146, DOI 10.1016/j.mam.2011.04.002; Pinhal-Enfield G, 2003, AM J PATHOL, V163, P711, DOI 10.1016/S0002-9440(10)63698-X; Ramanathan M, 2009, J LEUKOCYTE BIOL, V86, P681, DOI 10.1189/jlb.0109021; Ran Sophia, 2012, Cancers (Basel), V4, P618, DOI 10.3390/cancers4030618; Rolland-Turner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054135; Sala-Newby GB, 1999, J BIOL CHEM, V274, P17789, DOI 10.1074/jbc.274.25.17789; Sala-Newby GB, 2003, AM J PHYSIOL-HEART C, V285, pH991, DOI 10.1152/ajpheart.00053.2003; Sperlagh B, 2000, J NEUROIMMUNOL, V111, P45, DOI 10.1016/S0165-5728(00)00365-9; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Utrera-Barillas D, 2010, EXP MOL PATHOL, V89, P190, DOI 10.1016/j.yexmp.2010.06.002; Velot E, 2008, CARDIOVASC RES, V80, P246, DOI 10.1093/cvr/cvn201	44	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92715	10.1371/journal.pone.0092715	http://dx.doi.org/10.1371/journal.pone.0092715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651845	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800146
J	Muziasari, WI; Managaki, S; Parnanen, K; Karkman, A; Lyra, C; Tamminen, M; Suzuki, S; Virta, M				Muziasari, Windi Indra; Managaki, Satoshi; Parnanen, Katariina; Karkman, Antti; Lyra, Christina; Tamminen, Manu; Suzuki, Satoru; Virta, Marko			Sulphonamide and Trimethoprim Resistance Genes Persist in Sediments at Baltic Sea Aquaculture Farms but Are Not Detected in the Surrounding Environment	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; WASTE-WATER; BACTERIA; INTEGRONS; QUANTIFICATION; CASSETTES; ABUNDANCE; SPREAD; SITE	Persistence and dispersal of antibiotic resistance genes (ARGs) are important factors for assessing ARG risk in aquaculture environments. Here, we quantitatively detected ARGs for sulphonamides (sul1 and sul2) and trimethoprim (dfrA1) and an integrase gene for a class 1 integron (intI1) at aquaculture facilities in the northern Baltic Sea, Finland. The ARGs persisted in sediments below fish farms at very low antibiotic concentrations during the 6-year observation period from 2006 to 2012. Although the ARGs persisted in the farm sediments, they were less prevalent in the surrounding sediments. The copy numbers between the sul1 and intI1 genes were significantly correlated suggesting that class 1 integrons may play a role in the prevalence of sul1 in the farm sediments through horizontal gene transfer. In conclusion, the presence of ARGs may limit the effectiveness of antibiotics in treating fish illnesses, thereby causing a potential risk to the aquaculture industry. However, the restricted presence of ARGs at the farms is unlikely to cause serious effects in the northern Baltic Sea sediment environments around the farms.	[Muziasari, Windi Indra; Parnanen, Katariina; Karkman, Antti; Lyra, Christina; Tamminen, Manu; Virta, Marko] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Managaki, Satoshi] Musashino Univ, Dept Environm Sci, Tokyo, Japan; [Suzuki, Satoru] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime, Japan	University of Helsinki; Ehime University	Virta, M (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.	windi.muziasari@helsinki.fi	Muziasari, Windi/C-7746-2017; Karkman, Antti/AAW-9096-2021; Virta, Marko/B-4292-2010; Karkman, Antti/HFZ-8618-2022; Pärnänen, Katariina M M/P-5176-2016	Muziasari, Windi/0000-0002-5542-4375; Karkman, Antti/0000-0003-0983-3319; Virta, Marko/0000-0001-5981-7566; Pärnänen, Katariina M M/0000-0003-2220-1738; /0000-0001-5891-7653	Maj and Tor Nessling Foundation; Academy of Finland; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [22241014] Funding Source: KAKEN	Maj and Tor Nessling Foundation; Academy of Finland(Academy of Finland); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The research was funded by the Maj and Tor Nessling Foundation, Academy of Finland and Japan Society for the Promotion of Science (JSPS) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbowale OL, 2006, J APPL MICROBIOL, V100, P1103, DOI 10.1111/j.1365-2672.2006.02812.x; Blahna MT, 2006, J ANTIMICROB CHEMOTH, V57, P666, DOI 10.1093/jac/dkl020; Buschmann AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042724; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Cabello FC, 2013, ENVIRON MICROBIOL, V15, P1917, DOI 10.1111/1462-2920.12134; Capone DG, 1996, AQUACULTURE, V145, P55, DOI 10.1016/S0044-8486(96)01330-0; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Gao PP, 2012, WATER RES, V46, P2355, DOI 10.1016/j.watres.2012.02.004; Giraud E, 2006, FEMS MICROBIOL ECOL, V55, P439, DOI 10.1111/j.1574-6941.2005.00036.x; Goebel NL, 2010, ENVIRON MICROBIOL, V12, P3272, DOI 10.1111/j.1462-2920.2010.02303.x; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; Hardwick SA, 2008, FEMS MICROBIOL LETT, V278, P207, DOI 10.1111/j.1574-6968.2007.00992.x; Hastings PJ, 2004, TRENDS MICROBIOL, V12, P401, DOI 10.1016/j.tim.2004.07.003; Hoa PTP, 2008, SCI TOTAL ENVIRON, V405, P377, DOI 10.1016/j.scitotenv.2008.06.023; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; L'Abee-Lund TM, 2001, MICROB DRUG RESIST, V7, P263, DOI 10.1089/10766290152652819; Lai HT, 2011, BIORESOURCE TECHNOL, V102, P5017, DOI 10.1016/j.biortech.2011.01.070; Lopez-Gutierrez JC, 2004, J MICROBIOL METH, V57, P399, DOI 10.1016/j.mimet.2004.02.009; Luo Y, 2011, ENVIRON SCI TECHNOL, V45, P1827, DOI 10.1021/es104009s; Nonaka L, 2007, MICROBES ENVIRON, V22, P355, DOI 10.1264/jsme2.22.355; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r; Serrano PH, 2005, 469 FAO FISH; Shah SQA, 2012, ENVIRON SCI TECHNOL, V46, P8672, DOI 10.1021/es3018607; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Stalder T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00119; Stokes HW, 2006, J BACTERIOL, V188, P5722, DOI 10.1128/JB.01950-05; Suzuki S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00067; Szczepanowski R, 2009, MICROBIOL-SGM, V155, P2306, DOI 10.1099/mic.0.028233-0; Tamminen M, 2011, ENVIRON SCI TECHNOL, V45, P386, DOI 10.1021/es102725n	35	79	84	4	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92702	10.1371/journal.pone.0092702	http://dx.doi.org/10.1371/journal.pone.0092702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651770	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800145
J	Abeles, IY; Gomez-Ramirez, M				Abeles, Ilana Y.; Gomez-Ramirez, Manuel			Impairments in Background and Event-Related Alpha-Band Oscillatory Activity in Patients with Schizophrenia	PLOS ONE			English	Article							VISUAL EVOKED-RESPONSE; VISUOSPATIAL ATTENTION; WORKING-MEMORY; NEURONAL OSCILLATIONS; PHASE SYNCHRONIZATION; SELECTIVE ATTENTION; PROCESSING DEFICITS; SPATIAL ATTENTION; QUANTITATIVE EEG; OCCIPITAL CORTEX	Studies show that patients with schizophrenia exhibit impaired responses to sensory stimuli, especially at the early stages of neural processing. In particular, patients' alpha-band (8-14 Hz) event-related desynchronization (ERD) and visual P1 event-related potential (ERP) component tend to be significantly reduced, with P1 ERP deficits greater for visual stimuli biased towards the magnocellular system. In healthy controls, studies show that pre-stimulus alpha (background alpha) plays a pivotal role in sensory processing and behavior, largely by shaping the neural responses to incoming stimuli. Here, we address whether patients' ERD and P1 deficits stem from impairments in pre-stimulus alpha mechanisms. To address this question we recorded electrophysiological activity in patients with schizophrenia and healthy controls while they engaged in a visual discrimination task with low, medium, and high contrast stimuli. The results revealed a significant decrease in patients' ERDs, which was largely driven by reductions in pre-stimulus alpha. These reductions were most prominent in right-hemispheric areas. We also observed a systematic relationship between pre-stimulus alpha and the P1 component across different contrast levels. However, this relationship was only observed in healthy controls. Taken together, these findings highlight a substantial anomaly in patients' amplitude-based alpha background activity over visual areas. The results provide further support that pre-stimulus alpha activity plays an active role in perception by modulating the neural responses to incoming sensory inputs, a mechanism that seems to be compromised in schizophrenia.	[Abeles, Ilana Y.; Gomez-Ramirez, Manuel] CUNY City Coll, Dept Psychol, Program Cognit Neurosci, New York, NY 10031 USA; [Abeles, Ilana Y.] Nathan S Kline Inst Psychiat Res, Program Cognit Neurosci & Schizophrenia, Orangeburg, NY 10962 USA; [Gomez-Ramirez, Manuel] Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD USA	City University of New York (CUNY) System; City College of New York (CUNY); Nathan Kline Institute for Psychiatric Research; Johns Hopkins University	Gomez-Ramirez, M (corresponding author), CUNY City Coll, Dept Psychol, Program Cognit Neurosci, New York, NY 10031 USA.	gomezramirezm@jhu.edu		gomez-ramirez, manuel/0000-0002-1017-5256	National Institute of Mental Health; Johns Hopkins University Libraries;  [RO1 MH84848]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084848] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johns Hopkins University Libraries(Johns Hopkins University); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The funders, National Institute of Mental Health, had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript. Funding source: RO1 MH84848 awarded to Dr. Pamela D. Butler. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries.	Bachman P, 2008, SCHIZOPHR RES, V103, P293, DOI 10.1016/j.schres.2008.04.006; Barry RJ, 2004, CLIN NEUROPHYSIOL, V115, P2593, DOI 10.1016/j.clinph.2004.06.004; BASAR E, 1984, INT J NEUROSCI, V24, P1, DOI 10.3109/00207458409079530; Basar-Eroglu C, 2008, BRAIN RES, V1235, P143, DOI 10.1016/j.brainres.2008.06.114; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; BRANDT ME, 1991, INT J NEUROSCI, V61, P261, DOI 10.3109/00207459108990744; BRANDT ME, 1991, ELECTROEN CLIN NEURO, V80, P16, DOI 10.1016/0168-5597(91)90037-X; Butler PD, 2007, BRAIN, V130, P417, DOI 10.1093/brain/awl233; Butler PD, 2005, CURR OPIN PSYCHIATR, V18, P151, DOI 10.1097/00001504-200503000-00008; Butler PD, 2001, AM J PSYCHIAT, V158, P1126, DOI 10.1176/appi.ajp.158.7.1126; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Ciulla C, 1999, BRAIN TOPOGR, V11, P211, DOI 10.1023/A:1022233828999; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Collins HR, 2012, J COGNITIVE NEUROSCI, V24, P2428, DOI 10.1162/jocn_a_00273; Dias EC, 2011, ARCH GEN PSYCHIAT, V68, P654, DOI 10.1001/archgenpsychiatry.2011.17; Dockree PM, 2007, EUR J NEUROSCI, V25, P900, DOI 10.1111/j.1460-9568.2007.05324.x; Dockree PM, 2005, NEUROIMAGE, V27, P587, DOI 10.1016/j.neuroimage.2005.05.044; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Doniger GM, 2002, ARCH GEN PSYCHIAT, V59, P1011, DOI 10.1001/archpsyc.59.11.1011; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; EKMAN P, 1974, WESTERN J MED, V120, P310; Fellinger R, 2011, BRAIN RES BULL, V85, P417, DOI 10.1016/j.brainresbull.2011.03.025; Ford JM, 2008, BRAIN RES, V1235, P133, DOI 10.1016/j.brainres.2008.06.048; Foxe JJ, 2001, NEUROREPORT, V12, P3815, DOI 10.1097/00001756-200112040-00043; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Gaspar PA, 2011, SCHIZOPHR RES, V131, P268, DOI 10.1016/j.schres.2011.06.010; Gomez-Ramirez M, 2011, J NEUROSCI, V31, P18556, DOI 10.1523/JNEUROSCI.2164-11.2011; Gomez-Ramirez M, 2009, BRAIN TOPOGR, V22, P44, DOI 10.1007/s10548-008-0068-z; Gordon E, 2010, CLIN EEG NEUROSCI, V41, P178, DOI 10.1177/155005941004100404; Gruber WR, 2005, CEREB CORTEX, V15, P371, DOI 10.1093/cercor/bhh139; Haegens S, 2012, J COGNITIVE NEUROSCI, V24, P677, DOI 10.1162/jocn_a_00164; Haegens S, 2011, P NATL ACAD SCI USA, V108, P19377, DOI 10.1073/pnas.1117190108; Haegens S, 2011, J NEUROSCI, V31, P5197, DOI 10.1523/JNEUROSCI.5199-10.2011; Higashima M, 2007, INT J PSYCHOPHYSIOL, V65, P95, DOI 10.1016/j.ijpsycho.2007.03.008; Holz EM, 2008, BRAIN TOPOGR, V21, P93, DOI 10.1007/s10548-008-0066-1; Hsieh LT, 2011, J NEUROSCI, V31, P10803, DOI 10.1523/JNEUROSCI.0828-11.2011; ITIL TM, 1972, BIOL PSYCHIAT, V5, P1; ITIL TM, 1977, SCHIZOPHRENIA BULL, V3, P61, DOI 10.1093/schbul/3.1.61; JANSEN BH, 1991, ELECTROEN CLIN NEURO, V80, P241, DOI 10.1016/0168-5597(91)90107-9; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Kelly SP, 2009, EUR J NEUROSCI, V30, P2224, DOI 10.1111/j.1460-9568.2009.06980.x; Klimesch W, 1998, NEUROSCI LETT, V244, P73, DOI 10.1016/S0304-3940(98)00122-0; Knott V, 2001, SCHIZOPHR RES, V50, P41, DOI 10.1016/S0920-9964(00)00165-1; Koh Y, 2011, SCHIZOPHR RES, V126, P36, DOI 10.1016/j.schres.2010.10.001; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lakatos P, 2013, J NEUROSCI, V33, P11692, DOI 10.1523/JNEUROSCI.0010-13.2013; Martinez A, 2012, CEREB CORTEX, V22, P1282, DOI 10.1093/cercor/bhr195; McCourt ME, 2008, SCHIZOPHR RES, V102, P189, DOI 10.1016/j.schres.2008.03.021; Mishra J, 2012, NEUROIMAGE, V59, P1968, DOI 10.1016/j.neuroimage.2011.09.028; Mizuno M, 1997, J NERV MENT DIS, V185, P427, DOI 10.1097/00005053-199707000-00002; O'Connell RG, 2009, J NEUROSCI, V29, P8604, DOI 10.1523/JNEUROSCI.5967-08.2009; OMORI M, 1995, BIOL PSYCHIAT, V38, P303, DOI 10.1016/0006-3223(95)00300-6; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Parvizi J, 2012, J NEUROSCI, V32, P14915, DOI 10.1523/JNEUROSCI.2609-12.2012; PFURTSCHELLER G, 1994, INT J PSYCHOPHYSIOL, V16, P147, DOI 10.1016/0167-8760(89)90041-X; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Popov T, 2011, NEUROIMAGE, V56, P307, DOI 10.1016/j.neuroimage.2011.02.016; Praamstra P, 2007, J NEUROPHYSIOL, V98, P2848, DOI 10.1152/jn.00224.2007; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Schechter I, 2005, CLIN NEUROPHYSIOL, V116, P2204, DOI 10.1016/j.clinph.2005.06.013; SCHIMKE H, 1990, EEG-EMG-Z ELEK ELEKT, V21, P219; Sehatpour P, 2010, ARCH GEN PSYCHIAT, V67, P772, DOI 10.1001/archgenpsychiatry.2010.85; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; SPONHEIM SR, 1994, PSYCHOPHYSIOLOGY, V31, P37, DOI 10.1111/j.1469-8986.1994.tb01023.x; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; TOOTELL RBH, 1988, J NEUROSCI, V8, P1594; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Vanni S, 1997, J NEUROSCI, V17, P7141; White TP, 2010, CLIN NEUROPHYSIOL, V121, P1427, DOI 10.1016/j.clinph.2010.03.024; Whitford TJ, 2011, NEUROIMAGE, V54, P2318, DOI 10.1016/j.neuroimage.2010.10.048; Witham CL, 2012, J NEUROPHYSIOL, V108, P3342, DOI 10.1152/jn.00462.2012; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Worden MS, 2000, J NEUROSCI, V20	79	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91720	10.1371/journal.pone.0091720	http://dx.doi.org/10.1371/journal.pone.0091720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646909	Green Published, gold			2022-12-27	WOS:000333348500047
J	Goltz, D; Hittetiya, K; Yadegari, H; Driesen, J; Kirfel, J; Neuhaus, T; Steiner, S; Esch, C; Bedorf, J; Hertfelder, HJ; Fischer, HP				Goltz, Diane; Hittetiya, Kanishka; Yadegari, Hamideh; Driesen, Julia; Kirfel, Jutta; Neuhaus, Thomas; Steiner, Susanne; Esch, Christiane; Bedorf, Joerg; Hertfelder, Hans-Joerg; Fischer, Hans-Peter			ATZ11 Recognizes Not Only Z-alpha(1)-Antitrypsin-Polymers and Complexed Forms of Non-Z-alpha(1)-Antitrypsin but Also the von Willebrand Factor	PLOS ONE			English	Article							ALPHA(1)-ANTITRYPSIN DEFICIENCY; ALPHA-1-ANTITRYPSIN; IDENTIFICATION; POLYMERS; INSIGHTS; ALLELE; MUTANT; TISSUE; ELISA	Aims: The ATZ11 antibody has been well established for the identification of alpha(1)-anti-trypsin (AAT) molecule type PiZ (Z-AAT) in blood samples and liver tissue. In this study, we systematically analyzed the antibody for additional binding sites in human tissue. Methods and Results: Ultrastructural ATZ11 binding was investigated immunoelectron microscopically in human umbilical vein endothelial cells (HUVECs) and in platelets of a healthy individual. Human embryonic kidney (HEK293) cells were transiently transfected with Von Willebrand factor (VWF) and analyzed immunocytochemically using confocal microscopy and SDS-PAGE electrophoresis followed by western blotting (WB). Platelets and serum samples of VWF-competent and VWF-deficient patients were investigated using native PAGE and SDS-PAGE electrophoresis followed by WB. The specificity of the ATZ11 reaction was tested immunohistochemically by extensive antibody-mediated blocking of AAT- and VWF-antigens. ATZ11-positive epitopes could be detected in Weibel-Palade bodies (WPBs) of HUVECs and alpha-granules of platelets. ATZ11 stains pseudo-WBP containing recombinant wild-type VWF (rVWF-WT) in HEK293 cells. In SDS-PAGE electrophoresis followed by WB, anti-VWF and ATZ11 both identified rVWF-WT. However, neither rVWF-WT-multimers, human VWF-multimers, nor serum proteins of VWF-deficient patients were detected using ATZ11 by WB, whereas anti-VWF antibody (anti-VWF) detected rVWF-WT-multimers as well as human VWF-multimers. In human tissue specimens, AAT-antigen blockade using anti-AAT antibody abolished ATZ11 staining of Z-AAT in a heterozygous AAT- deficient patient, whereas VWF-antigen blockade using anti-VWF abolished ATZ11 staining of endothelial cells and megakaryocytes. Conclusions: ATZ11 reacts with cellular bound and denatured rVWF-WT and human VWF as shown using immunocytochemistry and subsequent confocal imaging, immunoelectron microscopy, SDS-PAGE and WB, and immunohistology. These immunoreactions are independent of the binding of Z-AAT-molecules and non-Z-AAT complexes.	[Goltz, Diane; Hittetiya, Kanishka; Kirfel, Jutta; Steiner, Susanne; Esch, Christiane; Bedorf, Joerg; Fischer, Hans-Peter] Univ Bonn, Dept Pathol, Bonn, Germany; [Yadegari, Hamideh; Driesen, Julia; Hertfelder, Hans-Joerg] Univ Bonn, Inst Expt Hematol, Bonn, Germany; [Neuhaus, Thomas] St Vincenz Hosp, Med Clin, Limburg, Germany	University of Bonn; University of Bonn	Fischer, HP (corresponding author), Univ Bonn, Dept Pathol, Bonn, Germany.	hans-peter.fischer@ukb.uni-bonn.de	Yadegari, Hamideh/AAA-8749-2019					Aldonyte R, 2004, HISTOPATHOLOGY, V45, P587, DOI 10.1111/j.1365-2559.2004.02021.x; Baslund B, 1996, EUR J CLIN INVEST, V26, P786, DOI 10.1046/j.1365-2362.1996.2070553.x; Blano I, 2008, PAIN REASEARCH PORGR, P113; BUDDE U, 1990, THROMB HAEMOSTASIS, V63, P312; CALLEA F, 1991, J HEPATOL, V12, P372, DOI 10.1016/0168-8278(91)90842-Y; Fischer HP, 2000, J HEPATOL, V33, P883, DOI 10.1016/S0168-8278(00)80119-1; GEE B, 1991, J HISTOCHEM CYTOCHEM, V39, P863, DOI 10.1177/39.6.1709659; Gershagen S, 2004, CLIN CHEM, V50, P2407, DOI 10.1373/clinchem.2004.042424; Janciauskiene S, 2004, HEPATOLOGY, V40, P1203, DOI 10.1002/hep.20451; Janciauskiene S, 1996, SCAND J CLIN LAB INV, V56, P597, DOI 10.3109/00365519609090594; Janciauskiene S, 2002, J BIOL CHEM, V277, P26540, DOI 10.1074/jbc.M203832200; Kiskin NI, 2010, J CELL SCI, V123, P2964, DOI 10.1242/jcs.073593; Mahadeva R, 2005, AM J PATHOL, V166, P377, DOI 10.1016/S0002-9440(10)62261-4; Mahr AD, 2010, ARTHRITIS RHEUM-US, V62, P3760, DOI 10.1002/art.27742; Mazodier P, 1996, QJM-INT J MED, V89, P599; Morris H, 2011, ANN RHEUM DIS, V70, P1851, DOI 10.1136/ard.2011.153569; Pannerden HVT, 2010, BLOOD, V116, P1147, DOI 10.1182/blood-2010-02-268680; ROTH J, 1989, HISTOCHEMISTRY, V92, P47, DOI 10.1007/BF00495015; SAVIGE JA, 1995, CLIN EXP IMMUNOL, V100, P194; Theuerkauf I, 2001, VIRCHOWS ARCH, V438, P498, DOI 10.1007/s004280000364; WALLMARK A, 1984, P NATL ACAD SCI-BIOL, V81, P5690, DOI 10.1073/pnas.81.18.5690; Yadegari H, 2013, HAEMATOLOGICA, V98, P1315, DOI 10.3324/haematol.2013.084111; Zelvyte I, 2003, EUR J CANCER PREV, V12, P117, DOI 10.1097/00008469-200304000-00005	23	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91538	10.1371/journal.pone.0091538	http://dx.doi.org/10.1371/journal.pone.0091538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646657	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500038
J	Lee, WH; Hsu, PC; Chu, CY; Su, HM; Lee, CS; Yen, HW; Lin, TH; Voon, WC; Lai, WT; Sheu, SH				Lee, Wen-Hsien; Hsu, Po-Chao; Chu, Chun-Yuan; Su, Ho-Ming; Lee, Chee-Siong; Yen, Hsueh-Wei; Lin, Tsung-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung			Cardiovascular Events in Patients with Atherothrombotic Disease: A Population-Based Longitudinal Study in Taiwan	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ASIA-PACIFIC REGION; PERIPHERAL ARTERY-DISEASE; ANKLE-BRACHIAL INDEX; ISCHEMIC-STROKE; RISK-FACTORS; REACH REGISTRY; ETHNIC-DIFFERENCES; CAROTID PLAQUE; BLOOD-PRESSURE	Background: Atherothrombotic diseases including cerebrovascular disease (CVD), coronary artery disease (CAD), and peripheral arterial disease (PAD), contribute to the major causes of death in the world. Although several studies showed the association between polyvascular disease and poor cardiovascular (CV) outcomes in Asian population, there was no large-scale study to validate this relationship in this population. Methods and Results: This retrospective cohort study included patients with a diagnosis of CVD, CAD, or PAD from the database contained in the Taiwan National Health Insurance Bureau during 2001-2004. A total of 19954 patients were enrolled in this study. The atherothrombotic disease score was defined according to the number of atherothrombotic disease. The study endpoints included acute coronary syndrome (ACS), all strokes, vascular procedures, in hospital mortality, and so on. The event rate of ischemic stroke (18.2%) was higher than that of acute myocardial infarction (5.7%) in our patients (P = 0.0006). In the multivariate Cox regression analyses, the adjusted hazard ratios (HRs) of each increment of atherothrombotic disease score in predicting ACS, all strokes, vascular procedures, and in hospital mortality were 1.41, 1.66, 1.30, and 1.14, respectively (P <= 0.0169). Conclusions: This large population-based longitudinal study in patients with atherothrombotic disease demonstrated the risk of subsequent ischemic stroke was higher than that of subsequent AMI. In addition, the subsequent adverse CV events including ACS, all stroke, vascular procedures, and in hospital mortality were progressively increased as the increase of atherothrombotic disease score.	[Lee, Wen-Hsien; Hsu, Po-Chao; Chu, Chun-Yuan; Su, Ho-Ming; Lee, Chee-Siong; Yen, Hsueh-Wei; Lin, Tsung-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan; [Lee, Wen-Hsien; Su, Ho-Ming] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Su, Ho-Ming; Lee, Chee-Siong; Yen, Hsueh-Wei; Lin, Tsung-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University	Su, HM (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan.	cobeshm@seed.net.tw	蘇, 河名/AAE-9843-2019	Su, Ho-Ming/0000-0003-0247-3250; Chu, Chun-Yuan/0000-0001-5550-102X; Lin, Tsung-Hsien/0000-0002-7226-8730				ASSAF AR, 1993, NEW ENGL J MED, V329, P931, DOI 10.1056/NEJM199309233291307; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Blanco M, 2010, ATHEROSCLEROSIS, V208, P587, DOI 10.1016/j.atherosclerosis.2009.07.041; Brevetti G, 2010, CIRCULATION, V122, P1862, DOI 10.1161/CIRCULATIONAHA.109.918417; Brilakis ES, 2009, CIRCULATION, V120, P560, DOI 10.1161/CIRCULATIONAHA.109.877092; Chang KC, 2003, STROKE, V34, pE219, DOI 10.1161/01.STR.0000095565.12945.18; Chang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053207; Chen CL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-118; Chen JJ, 2011, ANGIOLOGY, V62, P306, DOI 10.1177/0003319710382771; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chien KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003435; Directorate-general of budget accounting and statistics executive yuan republic of china, 2010, HEALTH, V114; Huang HL, 2013, J FORMOS MED ASSOC, P1, DOI DOI 10.1007/S10878-013-9633-9; Ji RJ, 2013, JAMA NEUROL, V70, P51, DOI 10.1001/jamaneurol.2013.575; Klein LW, 2003, J AM COLL CARDIOL, V41, P529, DOI 10.1016/S0735-1097(02)02861-9; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Lee WH, 2013, THROMB RES, V132, P190, DOI 10.1016/j.thromres.2013.01.036; Lee WH, 2013, CIRC J, V77, P1046, DOI 10.1253/circj.CJ-12-1122; Li CY, 2012, ACTA CARDIOL SIN, V28, P17; Lin MS, 2008, CIRC-CARDIOVASC INTE, V1, P119, DOI 10.1161/CIRCINTERVENTIONS.108.772350; Lombardo A, 2004, CIRCULATION, V109, P3158, DOI 10.1161/01.CIR.0000130786.28008.56; Mukherjee D, 2007, AM J CARDIOL, V100, P1, DOI 10.1016/j.amjcard.2007.02.046; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nakano T, 2004, CEREBROVASC DIS, V17, P212, DOI 10.1159/000075793; Reddy KS, 2004, NEW ENGL J MED, V350, P2438, DOI 10.1056/NEJMp048024; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Suarez C, 2010, VASC MED, V15, P259, DOI 10.1177/1358863X10373299; Uchiyama S, 2009, J NEUROL SCI, V287, P45, DOI 10.1016/j.jns.2009.09.011; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; Wang TD, 2010, METABOLISM, V59, P400, DOI 10.1016/j.metabol.2009.08.009; Wen HC, 2006, ANN THORAC SURG, V81, P835, DOI 10.1016/j.athoracsur.2005.09.031; Woodward M, 2003, DIABETES CARE, V26, P360; Woodward M, 2005, INT J EPIDEMIOL, V34, P1036, DOI 10.1093/ije/dyi104; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106	37	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92577	10.1371/journal.pone.0092577	http://dx.doi.org/10.1371/journal.pone.0092577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647769	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500146
J	Nakashima, R; Shioiri, S				Nakashima, Ryoichi; Shioiri, Satoshi			Why Do We Move Our Head to Look at an Object in Our Peripheral Region? Lateral Viewing Interferes with Attentive Search	PLOS ONE			English	Article							VISUAL-ATTENTION; EYE-MOVEMENTS; GAZE; COORDINATION; ORIENTATION; PERFORMANCE; DIFFICULTY; IMAGE; SIZE	Why do we frequently fixate an object of interest presented peripherally by moving our head as well as our eyes, even when we are capable of fixating the object with an eye movement alone (lateral viewing)? Studies of eye-head coordination for gaze shifts have suggested that the degree of eye-head coupling could be determined by an unconscious weighing of the motor costs and benefits of executing a head movement. The present study investigated visual perceptual effects of head direction as an additional factor impacting on a cost-benefit organization of eye-head control. Three experiments using visual search tasks were conducted, manipulating eye direction relative to head orientation (front or lateral viewing). Results show that lateral viewing increased the time required to detect a target in a search for the letter T among letter L distractors, a serial attentive search task, but not in a search for T among letter O distractors, a parallel preattentive search task (Experiment 1). The interference could not be attributed to either a deleterious effect of lateral gaze on the accuracy of saccadic eye movements, nor to potentially problematic optical effects of binocular lateral viewing, because effect of head directions was obtained under conditions in which the task was accomplished without saccades (Experiment 2), and during monocular viewing (Experiment 3). These results suggest that a difference between the head and eye directions interferes with visual processing, and that the interference can be explained by the modulation of attention by the relative positions of the eyes and head (or head direction).	[Nakashima, Ryoichi; Shioiri, Satoshi] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi, Japan; [Nakashima, Ryoichi; Shioiri, Satoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Tokyo, Japan	Tohoku University; Japan Science & Technology Agency (JST)	Nakashima, R (corresponding author), Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi, Japan.	one.island.one@gmail.com	Shioiri, Satoshi/B-9625-2008	Shioiri, Satoshi/0000-0003-2149-6132	Japan Science and Technology Agency (JST); JSPS KAKENHI [25780441]; Grants-in-Aid for Scientific Research [25780441] Funding Source: KAKEN	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST) to RN and SS, and by JSPS KAKENHI Grant Number 25780441 to RN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belopolsky AV, 2010, VISION RES, V50, P2543, DOI 10.1016/j.visres.2010.08.023; Blohm G, 2008, J VISION, V8, DOI 10.1167/8.16.3; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burns JK, 2011, J VISION, V11, DOI 10.1167/11.9.3; Burns JK, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00221; Carrasco M, 1998, J EXP PSYCHOL HUMAN, V24, P673, DOI 10.1037/0096-1523.24.2.673; CARRASCO M, 1995, PERCEPT PSYCHOPHYS, V57, P1241, DOI 10.3758/BF03208380; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Donner TH, 2002, NEUROIMAGE, V15, P16, DOI 10.1006/nimg.2001.0951; Doshi A, 2012, J VISION, V12, DOI [10.1167/12.6.9, 10.1167/12.2.9]; Dunham DN, 1997, INT J PSYCHOPHYSIOL, V27, P171, DOI 10.1016/S0167-8760(97)00054-8; Ettwig JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053093; FISCHER B, 1984, EXP BRAIN RES, V57, P191; FULLER JH, 1992, EXP BRAIN RES, V92, P152; HENDERSON JM, 1989, PERCEPT PSYCHOPHYS, V45, P196, DOI 10.3758/BF03210697; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Khan AZ, 2009, J NEUROPHYSIOL, V101, P198, DOI 10.1152/jn.90815.2008; Khan AZ, 2001, VISION RES, V41, P1743, DOI 10.1016/S0042-6989(01)00079-7; KLEIN R, 1989, PERCEPT PSYCHOPHYS, V46, P476, DOI 10.3758/BF03210863; Lee C, 1999, VISION RES, V39, P3761, DOI 10.1016/S0042-6989(99)00111-X; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Nakashima R, 2013, ATTEN PERCEPT PSYCHO, V75, P299, DOI 10.3758/s13414-012-0402-0; Nothdurft HC, 1999, VISION RES, V39, P2305, DOI 10.1016/S0042-6989(99)00006-1; Oommen BS, 2005, BRAIN RES, V1065, P68, DOI 10.1016/j.brainres.2005.10.029; Oommen BS, 2005, EXP BRAIN RES, V167, P276, DOI 10.1007/s00221-005-0036-8; Oommen BS, 2004, EXP BRAIN RES, V155, P9, DOI 10.1007/s00221-003-1694-z; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Proudlock FA, 2003, INVEST OPHTH VIS SCI, V44, P2991, DOI 10.1167/iovs.02-1315; SHIOIRI S, 1993, PERCEPT PSYCHOPHYS, V53, P305, DOI 10.3758/BF03205185; SHIOIRI S, 1992, VISION RES, V32, P943, DOI 10.1016/0042-6989(92)90037-J; Smilek D, 2006, VIS COGN, V14, P543, DOI 10.1080/13506280500193487; Stahl JS, 2001, EXP BRAIN RES, V136, P200, DOI 10.1007/s002210000593; Stahl JS, 1999, EXP BRAIN RES, V126, P41, DOI 10.1007/s002210050715; Thumser ZC, 2008, EXP BRAIN RES, V191, P419, DOI 10.1007/s00221-008-1534-2; Thumser ZC, 2013, HUM MOVEMENT SCI, V32, P1, DOI 10.1016/j.humov.2012.03.002; Thumser ZC, 2009, EXP BRAIN RES, V195, P393, DOI 10.1007/s00221-009-1803-8; Townsend J. T., 1983, STOCHASTIC MODELING; TREISMAN A, 1988, Q J EXP PSYCHOL-A, V40, P201, DOI 10.1080/02724988843000104; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Vlaskamp BNS, 2009, J VISION, V9, DOI 10.1167/9.2.17; Watson MR, 2010, PSYCHON B REV, V17, P543, DOI 10.3758/PBR.17.4.543; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wright R.D, 2008, ORIENTING ATTENTION; Xu YD, 2010, J VISION, V10, DOI 10.1167/10.14.24; Zelinsky GJ, 1997, J EXP PSYCHOL HUMAN, V23, P244, DOI 10.1037/0096-1523.23.1.244	47	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92284	10.1371/journal.pone.0092284	http://dx.doi.org/10.1371/journal.pone.0092284			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24647634	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500107
J	Tang, J; Liu, H; Gao, C; Mu, LX; Yang, SL; Rong, MQ; Zhang, ZY; Liu, J; Ding, Q; Lai, R				Tang, Jing; Liu, Han; Gao, Chen; Mu, Lixian; Yang, Shilong; Rong, Mingqiang; Zhang, Zhiye; Liu, Jie; Ding, Qiang; Lai, Ren			A Small Peptide with Potential Ability to Promote Wound Healing	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SKIN; MYOFIBROBLASTS; MIGRATION; SMAD2	Wound-healing represents a major health burden, such as diabetes-induced skin ulcers and burning. Many works are being tried to find ideal clinical wound-healing biomaterials. Especially, small molecules with low cost and function to promote production of endogenous wound healing agents (i.e. transforming growth factor beta, TGF-beta) are excellent candidates. In this study, a small peptide (tiger17, c[WCKPKPKPRCH-NH2]) containing only 11 amino acid residues was designed and proved to be a potent wound healer. It showed strong wound healing-promoting activity in a murine model of full thickness dermal wound. Tiger17 exerted significant effects on three stages of wound healing progresses including (1) the induction of macrophages recruitment to wound site at inflammatory reaction stage; (2) the promotion of the migration and proliferation both keratinocytes and fibroblasts, leading to reepithelialization and granulation tissue formation; and (3) tissue remodeling phase, by promoting the release of transforming TGF-beta 1 and interleukin 6 (IL-6) in murine macrophages and activating mitogen-activated protein kinases (MAPK) signaling pathways. Considering its easy production, store and transfer and function to promote production of endogenous wound healing agents (TGF-beta), tiger17 might be an exciting biomaterial or template for the development of novel wound-healing agents.	[Tang, Jing; Liu, Han; Mu, Lixian; Yang, Shilong; Rong, Mingqiang; Zhang, Zhiye; Liu, Jie; Lai, Ren] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Tang, Jing; Liu, Han; Mu, Lixian; Yang, Shilong; Rong, Mingqiang; Zhang, Zhiye; Liu, Jie; Lai, Ren] Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Ding, Qiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China; [Gao, Chen] Jiangsu Anim Husb & Vet Coll, Coll Vet Med, Taizhou, Jiangsu, Peoples R China; [Tang, Jing; Liu, Han; Mu, Lixian; Yang, Shilong; Zhang, Zhiye; Liu, Jie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Nanjing Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ding, Q (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.	dqnj2000@aliyun.com; rlai@mail.kiz.ac.cn		Liu, Jie/0000-0002-1069-2384	Ministry of Science and Technology [2010CB529800, 2013CB911300]; National Natural Science Foundation [30830021, 31070701, 31000960, 31025025, U1132601, 31200590]; Yunnan Province [2011CI139, 2012BC009]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Yunnan Province	This work was supported by Ministry of Science and Technology (2010CB529800, 2013CB911300), National Natural Science Foundation (30830021, 31025025, 31070701, 31000960, 31025025, U1132601, 31200590), and Yunnan Province (2011CI139, 2012BC009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badid C, 2000, HISTOL HISTOPATHOL, V15, P269, DOI 10.14670/HH-15.269; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Block ER, 2010, MOL BIOL CELL, V21, P2172, DOI 10.1091/mbc.E09-12-1026; Breitkreutz D, 2009, HISTOCHEM CELL BIOL, V132, P1, DOI 10.1007/s00418-009-0586-0; Brem H, 2000, ARCH SURG-CHICAGO, V135, P627, DOI 10.1001/archsurg.135.6.627; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; DARBY I, 1990, LAB INVEST, V63, P21; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; GABBIANI G, 1972, PATHOL BIOL, V20, P6; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haroon ZA, 2000, ANN SURG, V231, P137, DOI 10.1097/00000658-200001000-00020; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hosokawa R, 2005, J INVEST DERMATOL, V125, P1302, DOI 10.1111/j.0022-202X.2005.23963.x; Katherine MM, 1998, J IMMUNOL, V160, P1001; KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Kondo T, 2010, FORENSIC SCI INT, V203, P93, DOI 10.1016/j.forsciint.2010.07.004; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Luckett-Chastain LR, 2009, BRIT J DERMATOL, V161, P237, DOI 10.1111/j.1365-2133.2009.09215.x; Malinda KM, 1997, FASEB J, V11, P474, DOI 10.1096/fasebj.11.6.9194528; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nwomeh BC, 1998, CLIN PLAST SURG, V25, P341; Plikus MV, 2012, SEMIN CELL DEV BIOL, V23, P946, DOI 10.1016/j.semcdb.2012.10.001; Raja, 2007, Front Biosci, V12, P2849; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Song YZ, 2009, PEPTIDES, V30, P1228, DOI 10.1016/j.peptides.2009.03.020; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tredget EB, 2005, WOUND REPAIR REGEN, V13, P61, DOI 10.1111/j.1067-1927.2005.130108.x; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; WOODLEY DT, 1993, DERMATOL CLIN, V11, P641, DOI 10.1016/S0733-8635(18)30217-1; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Zhang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072923	39	55	58	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92082	10.1371/journal.pone.0092082	http://dx.doi.org/10.1371/journal.pone.0092082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647450	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500081
J	Vollmer, AL; Muhlig, M; Steil, JJ; Pitsch, K; Fritsch, J; Rohlfing, KJ; Wrede, B				Vollmer, Anna-Lisa; Muehlig, Manuel; Steil, Jochen J.; Pitsch, Karola; Fritsch, Jannik; Rohlfing, Katharina J.; Wrede, Britta			Robots Show Us How to Teach Them: Feedback from Robots Shapes Tutoring Behavior during Action Learning	PLOS ONE			English	Article							KNOWLEDGE; TASK	Robot learning by imitation requires the detection of a tutor's action demonstration and its relevant parts. Current approaches implicitly assume a unidirectional transfer of knowledge from tutor to learner. The presented work challenges this predominant assumption based on an extensive user study with an autonomously interacting robot. We show that by providing feedback, a robot learner influences the human tutor's movement demonstrations in the process of action learning. We argue that the robot's feedback strongly shapes how tutors signal what is relevant to an action and thus advocate a paradigm shift in robot action learning research toward truly interactive systems learning in and benefiting from interaction.	[Vollmer, Anna-Lisa] Univ Plymouth, Sch Comp & Math, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England; [Muehlig, Manuel; Fritsch, Jannik] Honda Res Inst Europe, Offenbach, Germany; [Steil, Jochen J.; Pitsch, Karola; Rohlfing, Katharina J.; Wrede, Britta] Univ Bielefeld, Fac Technol, Res Inst Cognit & Robot, D-33615 Bielefeld, Germany	University of Plymouth; Honda Motor Company; University of Bielefeld	Vollmer, AL (corresponding author), Univ Plymouth, Sch Comp & Math, Ctr Robot & Neural Syst, Portland Sq, Plymouth PL4 8AA, Devon, England.	anna-lisa.vollmer@plymouth.ac.uk		Vollmer, Anna-Lisa/0000-0002-9378-7249; Pitsch, Karola/0000-0002-6458-7264	Honda Research Institute Europe	Honda Research Institute Europe	The authors gratefully acknowledge the financial support from Honda Research Institute Europe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAJCSY R, 1988, P IEEE, V76, P996, DOI 10.1109/5.5968; Calinon S, 2008, P WORKSH SOC INT INT, P27; Calinon S, 2007, IEEE T SYST MAN CY B, V37, P286, DOI 10.1109/TSMCB.2006.886952; Call J, 2002, FROM ANIM ANIMAT, P211; Chao C, 2010, ACMIEEE INT CONF HUM, P317, DOI 10.1109/HRI.2010.5453178; De Jaegher H, 2010, TRENDS COGN SCI, V14, P441, DOI 10.1016/j.tics.2010.06.009; Fischer K, 2011, INTERACT STUD, V12, P134, DOI 10.1075/is.12.1.06fis; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; Gergely G, 2006, WENNER GREN INT S SE, P229; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; KUNIYOSHI Y, 1994, IEEE T ROBOTIC AUTOM, V10, P799, DOI 10.1109/70.338535; Mirnig N., 2011, 2011 RO-MAN: The 20th IEEE International Symposium on Robot and Human Interactive Communication, P343, DOI 10.1109/ROMAN.2011.6005260; Muhlig M, 2012, AUTON ROBOT, V32, P97, DOI 10.1007/s10514-011-9261-0; Nagai Y, 2009, IEEE T AUTON MENT DE, V1, P44, DOI 10.1109/TAMD.2009.2021090; Pitsch K, 2009, P INT C GEST SPEECH; Pitsch K, 2013, INTERACT STUD, V14, P268, DOI 10.1075/is.14.2.06pit; Rohlfing KJ, 2006, ADV ROBOTICS, V20, P1183, DOI 10.1163/156855306778522532; Rosenthal Stephanie, 2009, RO-MAN 2009 - The 18th IEEE International Symposium on Robot and Human Interactive Communication, P1137, DOI 10.1109/ROMAN.2009.5326291; Schaal S, 1999, TRENDS COGN SCI, V3, P233, DOI 10.1016/S1364-6613(99)01327-3; Strauss S, 2002, COGNITIVE DEV, V17, P1473, DOI 10.1016/S0885-2014(02)00128-4; Tennie C, 2006, ETHOLOGY, V112, P1159, DOI 10.1111/j.1439-0310.2006.01269.x; Thibault PJ, 2011, ECOL PSYCHOL, V23, P210, DOI 10.1080/10407413.2011.591274; Thomaz A. L., 2009, 2009 4th ACM/IEEE International Conference on Human-Robot Interaction (HRI), P15; Thomaz AL, 2006, P IEEE 5 INT C DEV L; Vollmer Anna-Lisa, 2010, 2010 IEEE 9th International Conference on Development and Learning (ICDL 2010), P76, DOI 10.1109/DEVLRN.2010.5578863; Vollmer A-L, 2009, P IEEE 8 INT C DEV L; Vollmer A-L, 2013, P 17 WORKSH SEM PRAG; Weiss A, 2011, ADV INTERACT STUD, V2, P89	28	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91349	10.1371/journal.pone.0091349	http://dx.doi.org/10.1371/journal.pone.0091349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24646510	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500030
J	Wan, SB; Mak, MW; Kung, SY				Wan, Shibiao; Mak, Man-Wai; Kung, Sun-Yuan			HybridGO-Loc: Mining Hybrid Features on Gene Ontology for Predicting Subcellular Localization of Multi-Location Proteins	PLOS ONE			English	Article							SEMANTIC SIMILARITY MEASURES; FUNCTIONAL SIMILARITY; GO; EXPRESSION; TAXONOMY; CLASSIFIER; LOCATION; ATTRIBUTES; MECHANISMS; SEQUENCE	Protein subcellular localization prediction, as an essential step to elucidate the functions in vivo of proteins and identify drugs targets, has been extensively studied in previous decades. Instead of only determining subcellular localization of single-label proteins, recent studies have focused on predicting both single-and multi-location proteins. Computational methods based on Gene Ontology (GO) have been demonstrated to be superior to methods based on other features. However, existing GO-based methods focus on the occurrences of GO terms and disregard their relationships. This paper proposes a multi-label subcellular-localization predictor, namely HybridGO-Loc, that leverages not only the GO term occurrences but also the inter-term relationships. This is achieved by hybridizing the GO frequencies of occurrences and the semantic similarity between GO terms. Given a protein, a set of GO terms are retrieved by searching against the gene ontology database, using the accession numbers of homologous proteins obtained via BLAST search as the keys. The frequency of GO occurrences and semantic similarity (SS) between GO terms are used to formulate frequency vectors and semantic similarity vectors, respectively, which are subsequently hybridized to construct fusion vectors. An adaptive-decision based multi-label support vector machine (SVM) classifier is proposed to classify the fusion vectors. Experimental results based on recent benchmark datasets and a new dataset containing novel proteins show that the proposed hybrid-feature predictor significantly outperforms predictors based on individual GO features as well as other state-of-the-art predictors. For readers' convenience, the HybridGO-Loc server, which is for predicting virus or plant proteins, is available online at http://bioinfo.eie.polyu.edu.hk/HybridGoServer/.	[Wan, Shibiao; Mak, Man-Wai] Hong Kong Polytech Univ, Dept Elect & Informat Engn, Hong Kong, Hong Kong, Peoples R China; [Kung, Sun-Yuan] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA	Hong Kong Polytechnic University; Princeton University	Mak, MW (corresponding author), Hong Kong Polytech Univ, Dept Elect & Informat Engn, Hong Kong, Hong Kong, Peoples R China.	enmwmak@polyu.edu.hk	Mak, Manwai/C-3750-2014; Wan, Shibiao/P-1667-2014	Mak, Manwai/0000-0001-8854-3760; Wan, Shibiao/0000-0003-0661-2684	HKPolyU [G-YJ86, G-YL78]	HKPolyU	This work was in part supported by HKPolyU Grant Nos. G-YJ86 and G-YL78. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCY RES DESIGN, P655; Adelfio A, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-502; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Bodenreider O, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P91; Brady Scott, 2008, Pac Symp Biocomput, P604; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Chabalier J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-235; CHEN YM, 1995, SCIENCE, V270, P789, DOI 10.1126/science.270.5237.789; Cheng Jill, 2004, J Biopharm Stat, V14, P687, DOI 10.1081/BIP-200025659; Chi SM, 2012, BIOINFORMATICS, V28, P1028, DOI 10.1093/bioinformatics/bts062; Chou KC, 2005, BIOINFORMATICS, V21, P944, DOI 10.1093/bioinformatics/bti104; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Couto F.M., 2005, P 14 ACM INT C INF K, P343, DOI DOI 10.1145/1099554.1099658; del Pozo A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-50; Dembczynski K, 2012, MACH LEARN, V88, P5, DOI 10.1007/s10994-012-5285-8; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Faria D., 2007, PROTEINON WEB TOOL P; Fyshe A, 2008, BIOINFORMATICS, V24, P2512, DOI 10.1093/bioinformatics/btn463; Gao W, 2013, ARTIF INTELL, V199, P22, DOI 10.1016/j.artint.2013.03.001; Guo X, 2006, BIOINFORMATICS, V22, P967, DOI 10.1093/bioinformatics/btl042; Guzzi PH, 2012, BRIEF BIOINFORM, V13, P569, DOI 10.1093/bib/bbr066; Hastie T., 2001, ELEMENT STAT LEARNIN; Hayama A, 2003, HISTOCHEM CELL BIOL, V119, P485, DOI 10.1007/s00418-003-0535-2; He J, 2011, PLOS ONE, V7; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang WL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-80; Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110; Jiang J.J., 1997, P INT C RES COMP LIN, P19; Kaytor MD, 1999, J BIOL CHEM, V274, P37507, DOI 10.1074/jbc.274.53.37507; KRUTOVSKIKH V, 1994, INT J CANCER, V56, P87; Kung S.Y., 2011, 2011 IEEE INT WORKSH, P1; Lee X, 2001, PLACENTA, V22, P808, DOI 10.1053/plac.2001.0722; Lei ZD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-491; Li LQ, 2012, PROTEIN PEPTIDE LETT, V19, P375, DOI 10.2174/092986612799789369; Li LQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031057, 10.1371/journal.pone.0045115]; Lin D., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P296; Liu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075826; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Lubec G, 2005, PROG NEUROBIOL, V77, P90, DOI 10.1016/j.pneurobio.2005.10.001; Mak MW, 2008, IEEE ACM T COMPUT BI, V5, P416, DOI 10.1109/TCBB.2007.70256; Mei SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037716; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; Mueller JC, 2004, MITOCHONDRION, V3, P315, DOI 10.1016/j.mito.2004.02.002; Nair R, 2008, METHODS MOL BIOL, V484, P435, DOI 10.1007/978-1-59745-398-1_27; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Odell J., 1998, ADV OBJECT ORIENTED, P139; Pesquita C, 2009, JB2009 CHALLENGES BI, V157; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Riensche Roderick M., 2007, 2007 IEEE Congress on Services, P99, DOI 10.1109/SERVICES.2007.73; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Sevilla JL, 2005, IEEE ACM T COMPUT BI, V2, P330, DOI 10.1109/TCBB.2005.50; Sheehan B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-468; Shen HB, 2010, J BIOMOL STRUCT DYN, V28, P175, DOI 10.1080/07391102.2010.10507351; Tao Y, 2007, BIOINFORMATICS, V23, pI529, DOI 10.1093/bioinformatics/btm195; Wan S, 2013, ENGINEERING, V5, P68; Wan SB, 2013, INT CONF ACOUST SPEE, P3547, DOI 10.1109/ICASSP.2013.6638318; Wan SB, 2013, J THEOR BIOL, V323, P40, DOI 10.1016/j.jtbi.2013.01.012; Wan SB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-290; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036317; WINSTON ME, 1987, COGNITIVE SCI, V11, P417, DOI 10.1207/s15516709cog1104_2; Wu HW, 2005, NUCLEIC ACIDS RES, V33, P2822, DOI 10.1093/nar/gki573; Wu XM, 2006, NUCLEIC ACIDS RES, V34, P2137, DOI 10.1093/nar/gkl219; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xu T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-472; Yang D, 2008, BIOINFORMATICS, V24, P265, DOI 10.1093/bioinformatics/btm558; Yang Y, 2010, INT J NEURAL SYST, V20, P13, DOI 10.1142/S0129065710002206; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Yu H, 2005, GENE, V352, P75, DOI 10.1016/j.gene.2005.03.033; Zhu MZ, 2007, GENE, V391, P113, DOI 10.1016/j.gene.2006.12.008	83	65	67	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89545	10.1371/journal.pone.0089545	http://dx.doi.org/10.1371/journal.pone.0089545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647341	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500006
J	Nabae, K; Satoh, H; Nishiura, H; Tanaka-Taya, K; Okabe, N; Oishi, K; Matsumoto, K; Hasegawa, T				Nabae, Koji; Satoh, Hiroshi; Nishiura, Hiroshi; Tanaka-Taya, Keiko; Okabe, Nobuhiko; Oishi, Kazunori; Matsumoto, Kunichika; Hasegawa, Tomonori			Estimating the Risk of Parvovirus B19 Infection in Blood Donors and Pregnant Women in Japan	PLOS ONE			English	Article							SEROLOGICAL SURVEY DATA; 5TH DISEASE; AGE; RUBELLA; EPIDEMIOLOGY; PREVALENCE; VACCINE; VIREMIA; MEASLES	Background: Seroepidemiological study of parvovirus B19 has not taken place for some 20 years in Japan. To estimate the risk of parvovirus B19 infection in Japan among blood donors and pregnant women in this century, a seroepidemiological survey and statistical modeling of the force of infection were conducted. Methodology/Principal Findings: The time- and age-specific seroprevalence data were suggestive of strong age-dependency in the risk of infection. Employing a piecewise constant model, the highest forces of infection of 0.05 and 0.12 per year were observed among those aged 0-4 and 5-9 years, respectively, while estimates among older individuals were less than 0.01 per year. Analyzing the antigen detection data among blood donors, the age-specific proportion positive was highest among those aged 30-39 years, agreeing with the presence of dip in seroprevalence in this age-group. Among pregnant women, up to 107 fetal deaths and 21 hydrops fetalis were estimated to have occurred annually across Japan. Conclusions: Seroepidemiological profiles of PVB19 infection in Japan was characterized with particular emphasis on the risk of infection in blood donors and the burden of infection among pregnant women. When a vaccine becomes available in the future, a similar seroepidemiological study is expected to play a key role in planning the appropriate immunization policy.	[Nabae, Koji] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Field Epidemiol Training Program, Tokyo, Japan; [Nabae, Koji; Matsumoto, Kunichika; Hasegawa, Tomonori] Toho Univ, Sch Med, Dept Social Med, Tokyo, Japan; [Satoh, Hiroshi; Tanaka-Taya, Keiko; Okabe, Nobuhiko; Oishi, Kazunori] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Nishiura, Hiroshi] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Okabe, Nobuhiko] Kawasaki City Inst Publ Hlth, Kanagawa, Japan	National Institute of Infectious Diseases (NIID); Toho University; National Institute of Infectious Diseases (NIID); University of Tokyo	Nabae, K (corresponding author), Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Field Epidemiol Training Program, Tokyo, Japan.	k-nabae@umin.ac.jp		Nishiura, Hiroshi/0000-0003-0941-8537	Ministry of Health, Labour, and Welfare, Japan [H.21-Shinko-Ippan-002]; Japan Science and Technology Agency PRESTO program	Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency PRESTO program(Japan Science & Technology Agency (JST))	This study is partly supported by a Health Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare, Japan (grant number: H.21-Shinko-Ippan-002). HN received financial support from the Japan Science and Technology Agency PRESTO program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MJ, 1983, LANCET, V1, P1378; ANDERSON RM, 1986, J HYG-CAMBRIDGE, V96, P305, DOI 10.1017/S0022172400066079; Bernstein DI, 2011, VACCINE, V29, P7357, DOI 10.1016/j.vaccine.2011.07.080; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cohen BJ, 1986, PUBLIC HLTH VIROLOGY, P130; Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P617, DOI 10.1017/S0950268800004660; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ejima K, 2012, INT J BIOL SCI, V8, P620, DOI 10.7150/ijbs.4329; FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811; Farrington CP, 2001, J R STAT SOC C-APPL, V50, P251, DOI 10.1111/1467-9876.00233; Gay N J, 1994, Commun Dis Rep CDR Rev, V4, pR104; Japanese Red Cross Society, 2011, ANN REP BLOOD PROD; Kelly HA, 2000, EPIDEMIOL INFECT, V124, P449, DOI 10.1017/S0950268899003817; Kooistra K, 2011, VOX SANG, V100, P261, DOI 10.1111/j.1423-0410.2010.01423.x; Matsunaga Y, 1995, Kansenshogaku Zasshi, V69, P1371; Miller E, 1998, BRIT J OBSTET GYNAEC, V105, P174, DOI 10.1111/j.1471-0528.1998.tb10048.x; Ministry of Health Labour and Welfare (MHLW) Committee of NESVPD in National Institute of Infectious Diseases, 2011, PROC NAT EP SURV VAC; Mossong J, 2008, EPIDEMIOL INFECT, V136, P1059, DOI 10.1017/S0950268807009661; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nishiura H, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-5; OKABE N, 1984, ARCH DIS CHILD, V59, P1016, DOI 10.1136/adc.59.11.1016; Rohrer C, 2008, EPIDEMIOL INFECT, V136, P1564, DOI 10.1017/S0950268807009958; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Satou Kunio, 2007, BMC Vet Res, V3, P9, DOI 10.1186/1746-6148-3-9; Taniguchi K, 2007, J EPIDEMIOL, V17, pS3, DOI 10.2188/jea.17.S3; Vyse AJ, 2007, EPIDEMIOL INFECT, V135, P1354, DOI 10.1017/S0950268807007856; Whitaker HJ, 2004, STAT MED, V23, P2429, DOI 10.1002/sim.1819; Yaegashi N, 1999, J INFECTION, V38, P30, DOI 10.1016/S0163-4453(99)90026-9; Yaegashi N, 1998, J INFECTION, V37, P28, DOI 10.1016/S0163-4453(98)90346-2; YAMASHITA K, 1992, JPN J MED SCI BIOL, V45, P49, DOI 10.7883/yoken1952.45.49; Zaaijer HL, 2004, EPIDEMIOL INFECT, V132, P1161, DOI 10.1017/S0950268804002730	31	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92519	10.1371/journal.pone.0092519	http://dx.doi.org/10.1371/journal.pone.0092519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658180	Green Submitted, gold, Green Published			2022-12-27	WOS:000333355300093
J	Park, W; Kim, J; Kim, HJ; Choi, JY; Park, JW; Cho, HW; Kim, BW; Park, MH; Shin, TS; Cho, SK; Park, JK; Kim, H; Hwang, JY; Lee, CK; Lee, HK; Cho, S; Cho, BW				Park, Woncheoul; Kim, Jaemin; Kim, Hyeon Jeong; Choi, Jae Young; Park, Jeong-Woong; Cho, Hyun-Woo; Kim, Byeong-Woo; Park, Myung Hum; Shin, Teak-Soon; Cho, Seong-Keun; Park, Jun-Kyu; Kim, Heebal; Hwang, Jae Yeon; Lee, Chang-Kyu; Lee, Hak-Kyo; Cho, Seoae; Cho, Byung-Wook			Investigation of De Novo Unique Differentially Expressed Genes Related to Evolution in Exercise Response during Domestication in Thoroughbred Race Horses	PLOS ONE			English	Article							RNA-SEQ DATA; SKELETAL-MUSCLE; GENOME; SELECTION; DISCOVERY; FRAMEWORK; APOPTOSIS; FORMAT; SCANS; P53	Previous studies of horse RNA-seq were performed by mapping sequence reads to the reference genome during transcriptome analysis. However in this study, we focused on two main ideas. First, differentially expressed genes (DEGs) were identified by de novo-based analysis (DBA) in RNA-seq data from six Thoroughbreds before and after exercise, hereafter referred to as "de novo unique differentially expressed genes'' (DUDEG). Second, by integrating both conventional DEGs and genes identified as being selected for during domestication of Thoroughbred and Jeju pony from whole genome re-sequencing (WGS) data, we give a new concept to the definition of DEG. We identified 1,034 and 567 DUDEGs in skeletal muscle and blood, respectively. DUDEGs in skeletal muscle were significantly related to exercise-induced stress biological process gene ontology (BP-GO) terms: 'immune system process'; 'response to stimulus'; and, 'death' and a KEGG pathways: 'JAK-STAT signaling pathway'; 'MAPK signaling pathway'; 'regulation of actin cytoskeleton'; and, 'p53 signaling pathway'. In addition, we found TIMELESS, EIF4A3 and ZNF592 in blood and CHMP4C and FOXO3 in skeletal muscle, to be in common between DUDEGs and selected genes identified by evolutionary statistics such as FST and Cross Population Extended Haplotype Homozygosity (XP-EHH). Moreover, in Thoroughbreds, three out of five genes (CHMP4C, EIF4A3 and FOXO3) related to exercise response showed relatively low nucleotide diversity compared to the Jeju pony. DUDEGs are not only conceptually new DEGs that cannot be attained from reference-based analysis (RBA) but also supports previous RBA results related to exercise in Thoroughbred. In summary, three exercise related genes which were selected for during domestication in the evolutionary history of Thoroughbred were identified as conceptually new DEGs in this study.	[Park, Woncheoul; Hwang, Jae Yeon; Lee, Chang-Kyu] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Park, Woncheoul; Hwang, Jae Yeon; Lee, Chang-Kyu] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Kim, Jaemin] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Kim, Hyeon Jeong; Kim, Heebal; Cho, Seoae] Seoul Natl Univ, C&K Genom, Seoul, South Korea; [Choi, Jae Young; Park, Jeong-Woong; Cho, Hyun-Woo; Kim, Byeong-Woo; Shin, Teak-Soon; Cho, Seong-Keun; Cho, Byung-Wook] Pusan Natl Univ, Coll Life Sci, Dept Anim Sci, Miryang, South Korea; [Park, Myung Hum] TNT Res, Anyang, South Korea; [Park, Jun-Kyu] Pusan Natl Univ, Leaders Ind Univ Cooperat, Miryang, South Korea; [Lee, Hak-Kyo] Hankyong Natl Univ, Genom Informat Ctr, Anseong, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Pusan National University; Pusan National University; Hankyong National University	Cho, S (corresponding author), Seoul Natl Univ, C&K Genom, Seoul, South Korea.	seoae@cnkgenomics.com; bwcho@pusan.ac.kr	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303; Park, WonCheoul/0000-0003-3140-5628; Hwang, Jae Yeon/0000-0002-6493-4182	Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008106]; 'Leaders Industry-University Cooperation' project, Ministry of Education (MOE), Republic of Korea	Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; 'Leaders Industry-University Cooperation' project, Ministry of Education (MOE), Republic of Korea	This work was supported by a grant from the Next Generation BioGreen 21 Program (No. PJ008106), Rural Development Administration, Republic of Korea and 'Leaders Industry-University Cooperation' project, Ministry of Education (MOE), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterovitz G., 2011, KNOWL BAS BIOINF AN; Andersson L, 2012, J INTERN MED, V271, P1, DOI 10.1111/j.1365-2796.2011.02450.x; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Birzele F, 2010, NUCLEIC ACIDS RES, V38, P3999, DOI 10.1093/nar/gkq116; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Cecchetti L, 2011, BLOOD, V118, P1903, DOI 10.1182/blood-2010-12-324517; Chen G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-590; Chen G, 2011, SCI CHINA LIFE SCI, V54, P1129, DOI 10.1007/s11427-011-4256-9; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dousset E, 2007, MED SCI SPORT EXER, V39, P453, DOI 10.1249/mss.0b013e31802dd74e; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Gunn H, 1987, MUSCLE BONE FAT PROP; Henschel R, 2012, TRINITY RNA SEQ ASSE, P45; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jamart C, 2012, EUR J APPL PHYSIOL, V112, P3173, DOI 10.1007/s00421-011-2287-3; KAYAR SR, 1989, PFLUG ARCH EUR J PHY, V413, P343, DOI 10.1007/BF00584481; KESTIN AS, 1993, CIRCULATION, V88, P1502, DOI 10.1161/01.CIR.88.4.1502; Kim H, 2013, DNA RES; Kingston SG, 1996, PHYSIOL BEHAV, V60, P145, DOI 10.1016/0031-9384(95)02241-4; Kinsella M, 2011, BIOINFORMATICS, V27, P1068, DOI 10.1093/bioinformatics/btr085; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long YC, 2004, P NUTR SOC, V63, P227, DOI 10.1079/PNS2004346; Martin JA, 2011, NATURE REV GENETICS; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; McGivney BA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-398; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Niess AC, 1999, EXERC IMMUNOL REV, V5, P22; O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441; Park KD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-473; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Poole D. C., 2004, Equine and Comparative Exercise Physiology, V1, P5, DOI 10.1079/ECP20036; REYNOLDS J, 1983, GENETICS, V105, P767; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Saleem A, 2009, PHYSIOL GENOMICS, V37, P58, DOI 10.1152/physiolgenomics.90346.2008; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Stefansson S, 2004, J BIOL CHEM, V279, P29981, DOI 10.1074/jbc.M401913200; STEVEN L, 2005, BIOINFORMATICS, V21, P320; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tao T, 2006, PROGRAM PARAMETERS B; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Weatherby J., 1791, INTRO GEN STUD BOOK; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Young BL, 2002, EQUINE VET J, V34, P469, DOI 10.2746/042516402776117755; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	69	14	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91418	10.1371/journal.pone.0091418	http://dx.doi.org/10.1371/journal.pone.0091418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658125	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300032
J	Villareal, TA; Wilson, C				Villareal, Tracy A.; Wilson, Cara			A Comparison of the Pac-X Trans-Pacific Wave Glider Data and Satellite Data (MODIS, Aquarius, TRMM and VIIRS)	PLOS ONE			English	Article							MID-ATLANTIC BIGHT; SURFACE-LAYER; CHLOROPHYLL FLUORESCENCE; VARIABILITY; NORTH; DIEL; SYSTEM; CARBON; ZONE	Four wave-propelled autonomous vehicles (Wave Gliders) instrumented with a variety of oceanographic and meteorological sensors were launched from San Francisco, CA in November 2011 for a trans-Pacific (Pac-X) voyage to test platform endurance. Two arrived in Australia, one in Dec 2012 and one in February 2013, while the two destined for Japan both ran into technical difficulties and did not arrive at their destination. The gliders were all equipped with sensors to measure temperature, salinity, turbidity, oxygen, and both chlorophyll and oil fluorescence. Here we conduct an initial assessment of the data set, noting necessary quality control steps and instrument utility. We conduct a validation of the Pac-X dataset by comparing the glider data to equivalent, or near-equivalent, satellite measurements. Sea surface temperature and salinity compared well to satellite measurements. Chl fluorescence from the gliders was more poorly correlated, with substantial between glider variability. Both turbidity and oil CDOM sensors were compromised to some degree by interfering processes. The well-known diel cycle in chlorophyll fluorescence was observed suggesting that mapping physiological data over large scales is possible. The gliders captured the Pacific Ocean's major oceanographic features including the increased chlorophyll biomass of the California Current and equatorial upwelling. A comparison of satellite sea surface salinity (Aquarius) and glider-measured salinity revealed thin low salinity lenses in the southwestern Pacific Ocean. One glider survived a direct passage through a tropical cyclone. Two gliders traversed an open ocean phytoplankton bloom; extensive spiking in the chlorophyll fluorescence data is consistent with aggregation and highlights another potential future use for the gliders. On long missions, redundant instrumentation would aid in interpreting unusual data streams, as well as a means to periodically image the sensor heads. Instrument placement is critical to minimize bubble-related problems in the data.	[Villareal, Tracy A.] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX 78373 USA; [Villareal, Tracy A.] Univ Texas Austin, Dept Marine Sci, Port Aransas, TX USA; [Wilson, Cara] NOAA, Natl Marine Fisheries Serv, Southwest Fisheries Sci Ctr, Div Environm Res, Pacific Grove, CA USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; National Oceanic Atmospheric Admin (NOAA) - USA	Villareal, TA (corresponding author), Univ Texas Austin, Inst Marine Sci, Port Aransas, TX 78373 USA.	tracyv@austin.utexas.edu	Villareal, Tracy A/I-9462-2012; Wilson, Cara/A-8816-2009	Villareal, Tracy A/0000-0002-5717-8163; Wilson, Cara/0000-0001-9318-2322	Liquid Robotics	Liquid Robotics	This work is part of a sponsored competition by Liquid Robotics. They have selected 5 teams to prepare a manuscript that will be evaluated by an independent panel. Details may be found at: ? http://liquidr.com/pacx/challenge.html. This paper was selected as the winner and the authors have received a $50,000 research grant award from British Petroleum (deposited at the University of Texas, Austin and 6 months of glider time). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Auad G, 2011, PROG OCEANOGR, V91, P576, DOI 10.1016/j.pocean.2011.09.004; Behrenfeld MJ, 2006, NATURE, V442, P1025, DOI 10.1038/nature05083; Bingham B, 2012, J FIELD ROBOT, V29, P911, DOI 10.1002/rob.21424; Bishop JKB, 2008, DEEP-SEA RES PT I, V55, P1684, DOI 10.1016/j.dsr.2008.07.012; Bishop JKB, 1999, DEEP-SEA RES PT II, V46, P2699; Board OS, 2009, SCI SEA M FUT OC GOA; Board OS, 2000, 50 YARS OC DISC NAT, P1; BRAND LE, 1982, MAR BIOL, V69, P253, DOI 10.1007/BF00397491; Briggs N, 2011, DEEP-SEA RES PT I, V58, P1031, DOI 10.1016/j.dsr.2011.07.007; Brown W, 2012, 2012 OCEANS; Brunet C, 2008, J PLANKTON RES, V30, P645, DOI 10.1093/plankt/fbn028; Calil PHR, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005360; Calil PHR, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006704; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Cannizzaro JP, 2009, HARMFUL ALGAE, V8, P898, DOI 10.1016/j.hal.2009.05.001; Church MJ, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003418; Creed EL, 2002, USING FLEET SLOCUM B, P320; Crimmins DA, 2006, OCEANS-IEEE, P1690; Daniel T, 2011, OCEAN DYNAM, V61, P1509, DOI 10.1007/s10236-011-0408-5; Delcroix T, 1998, J GEOPHYS RES-OCEANS, V103, P1087, DOI 10.1029/97JC01912; Dickey T, 2006, REV GEOPHYS, V44, DOI 10.1029/2003RG000148; Dore JE, 2008, PROG OCEANOGR, V76, P2, DOI 10.1016/j.pocean.2007.10.002; Eriksen CC, 2001, IEEE J OCEANIC ENG, V26, P424, DOI 10.1109/48.972073; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Gardner WD, 2000, DEEP-SEA RES PT II, V47, P3423, DOI 10.1016/S0967-0645(00)00074-6; Glenn S, 2011, MAR TECHNOL SOC J, V45, P52, DOI 10.4031/MTSJ.45.1.12; Guidi L, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001984; Harper RJ, 2007, PROC SPIE, V6540, DOI 10.1117/12.719742; Hasson AEA, 2013, OCEAN DYNAM, V63, P179, DOI 10.1007/s10236-013-0596-2; Herdman W. A., 1923, FOUNDERS OCEANOGRAPH; Jalbert J, 2003, OCEANS 2003 MTS/IEEE: CELEBRATING THE PAST...TEAMING TOWARD THE FUTURE, P1132, DOI 10.1109/OCEANS.2003.178503; Johnson KS, 2010, NATURE, V465, P1062, DOI 10.1038/nature09170; Kahl LA, 2010, INTEGR COMP BIOL, V50, P1041, DOI 10.1093/icb/icq098; Karl DM, 2012, P NATL ACAD SCI USA, V109, P1842, DOI 10.1073/pnas.1120312109; Lagerloef G., 2012, EOS T AM GEOPHYS UN, V93, P233, DOI [DOI 10.1029/2012E0250001, 10.1029/2012EO250001]; Lagerloef G, 2013, SEA TECHNOLOGY, V54; Lee DK, 2013, OCEANOGRAPHY, V26, P28, DOI 10.5670/oceanog.2013.02; Lubchenco J, 2012, P NATL ACAD SCI; Malone T. C., 2000, OCEANOGRAPHY, V13, P7, DOI DOI 10.5670/0CEAN0G.2000.48; McGillivary P, 2005, OCEANS-IEEE, P1305; Neveux J, 2003, J GEOPHYS RES-OCEANS, V108, P17; PRICE JF, 1979, J PHYS OCEANOGR, V9, P643, DOI 10.1175/1520-0485(1979)009<0643:OOARFM>2.0.CO;2; RODEN GI, 1980, J PHYS OCEANOGR, V10, P342, DOI 10.1175/1520-0485(1980)010<0342:OTSFZN>2.0.CO;2; Schlitzer R., 2013, OCEAN DATA VIEW; Schofield O, 2010, MAR TECHNOL SOC J, V44, P185, DOI 10.4031/MTSJ.44.6.20; Schofield O, 2008, OCEANOGRAPHY, V21, P108, DOI 10.5670/oceanog.2008.08; Simons RA, 2011, ERDDAP ENV RES DIVIS; Smale DA, 2012, ICES J MAR SCI, V69, P1108, DOI 10.1093/icesjms/fss082; Soloviev A, 1997, DEEP-SEA RES PT I, V44, P1055, DOI 10.1016/S0967-0637(96)00124-0; STRAMSKA M, 1992, J GEOPHYS RES-OCEANS, V97, P17873, DOI 10.1029/92JC01570; Vaulot D, 1999, J GEOPHYS RES-OCEANS, V104, P3297, DOI 10.1029/98JC01333; Villareal TA, 2009, AGU FALL M 14 18 DEC; Villareal TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033109; Villareal TA, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006268; Wijesekera HW, 1996, J GEOPHYS RES-OCEANS, V101, P977, DOI 10.1029/95JC02553; Wijesekera HW, 1999, J PHYS OCEANOGR, V29, P612, DOI 10.1175/1520-0485(1999)029<0612:TEOROT>2.0.CO;2; Wilson C, 2004, AGU WINT M 13 17 DEC; Wilson C, 2013, J GEOPHYS RES-OCEANS, V118, P1; Winsor P, 2012, OCEANS-IEEE; Wood S, 2009, INTELLIGENT UNDERWAT; YOU YZ, 1995, J PHYS OCEANOGR, V25, P2778, DOI 10.1175/1520-0485(1995)025<2778:SVAIRI>2.0.CO;2	61	26	28	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92280	10.1371/journal.pone.0092280	http://dx.doi.org/10.1371/journal.pone.0092280			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658053	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300068
J	Chen, SP; Li, S; Xie, WW; Li, XC; Zhang, CL; Jiang, HJ; Zheng, J; Pan, XY; Zheng, HC; Liu, JS; Deng, YQ; Chen, F; Jiang, H				Chen, Shengpei; Li, Sheng; Xie, Weiwei; Li, Xuchao; Zhang, Chunlei; Jiang, Haojun; Zheng, Jing; Pan, Xiaoyu; Zheng, Hancheng; Liu, Jia Sophie; Deng, Yongqiang; Chen, Fang; Jiang, Hui			Performance Comparison between Rapid Sequencing Platforms for Ultra-Low Coverage Sequencing Strategy	PLOS ONE			English	Article							ANEUPLOIDIES	Ultra-low coverage sequencing (ULCS) is one of the most promising strategies for sequencing based clinical application. These clinical applications, especially prenatal diagnosis, have a strict requirement of turn-around-time; therefore, the application of ULCS is restricted by current high throughput sequencing platforms. Recently, the emergence of rapid sequencing platforms, such as MiSeq and Ion Proton, brings ULCS strategy into a new era. The comparison of their performance could shed lights on their potential application in large-scale clinic trials. In this study, we performed ULCS (, 0.1X coverage) on both MiSeq and Ion Proton platforms for 18 spontaneous abortion fetuses carrying aneuploidy and compared their performance on different levels. Overall basic data and GC bias showed no significant difference between these two platforms. We also found the sex and aneuploidy detection indicated 100% sensitivity and 100% specificity on both platforms. Our study generated essential data from these two rapid sequencing platforms, which provides useful reference for later research and potentially accelerates the clinical applications of ULCS.	[Chen, Shengpei; Li, Sheng; Jiang, Haojun] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China; [Chen, Shengpei; Li, Sheng; Xie, Weiwei; Li, Xuchao; Zhang, Chunlei; Jiang, Haojun; Zheng, Jing; Pan, Xiaoyu; Zheng, Hancheng; Chen, Fang; Jiang, Hui] BGI Shenzhen, Shenzhen, Peoples R China; [Chen, Shengpei] BGI Shenzhen, Shenzhen Municipal Key Lab Birth Defects Screenin, Shenzhen, Peoples R China; [Chen, Shengpei] BGI Shenzhen, Guangdong Prov Key Lab Dis Genome, Shenzhen, Guangdong, Peoples R China; [Chen, Shengpei] BGI Nanjing, Nanjing, Jiangsu, Peoples R China; [Chen, Shengpei] Key Technol R&D Program Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Liu, Jia Sophie] Res Grp, Mountain View, CA USA; [Deng, Yongqiang] Second Peoples Hosp Shenzhen, Dept Stomatol, Shenzhen, Peoples R China	Southeast University - China; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Second People's Hospital of Shenzhen	Jiang, H (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	jianghui@genomics.cn	Pan, Xiaoyu/AAT-9002-2021	Pan, Xiaoyu/0000-0002-0282-6047	ShenZhen Engineering Laboratory for Clinical molecular diagnostic; Shenzhen Engineering Laboratory for Birth Defects Screening; China National GeneBank-Shenzhen	ShenZhen Engineering Laboratory for Clinical molecular diagnostic; Shenzhen Engineering Laboratory for Birth Defects Screening; China National GeneBank-Shenzhen	The study was funded by ShenZhen Engineering Laboratory for Clinical molecular diagnostic, Shenzhen Engineering Laboratory for Birth Defects Screening, and China National GeneBank-Shenzhen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Cartwright DA, 2007, GENETICS, V176, P2521, DOI 10.1534/genetics.106.063982; Chen SP, 2013, PRENATAL DIAG, V33, P584, DOI 10.1002/pd.4110; Dan S, 2012, PRENATAL DIAG, V32, P1225, DOI 10.1002/pd.4002; Dan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027835; Jiang FM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-57; Lebedev IN, 2004, EUR J HUM GENET, V12, P513, DOI 10.1038/sj.ejhg.5201178; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Xie WW, 2013, PRENATAL DIAG, V33, P232, DOI 10.1002/pd.4049; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977	12	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92192	10.1371/journal.pone.0092192	http://dx.doi.org/10.1371/journal.pone.0092192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651575	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800081
J	Mao, L; Kawao, N; Tamura, Y; Okumoto, K; Okada, K; Yano, M; Matsuo, O; Kaji, H				Mao, Li; Kawao, Naoyuki; Tamura, Yukinori; Okumoto, Katsumi; Okada, Kiyotaka; Yano, Masato; Matsuo, Osamu; Kaji, Hiroshi			Plasminogen Activator Inhibitor-1 Is Involved in Impaired Bone Repair Associated with Diabetes in Female Mice	PLOS ONE			English	Article							FRACTURE; TYPE-1; MELLITUS; RISK; DEFICIENCY; MECHANISMS; RESORPTION; CARTILAGE; OBESITY; LACKING	Previous studies suggest that fracture healing is impaired in diabetes; however, the underlying mechanism remains unclear. Here, we investigated the roles of plasminogen activator inhibitor-1 (PAI-1) in the impaired bone repair process by using streptozotocin (STZ)-induced diabetic female wild-type (PAI-1(+/+)) and PAI-1-deficient (PAI-1(-/-)) mice. Bone repair and the number of alkaline phosphatase (ALP)-positive cells at the site of a femoral bone damage were comparable in PAI-1(+/+) and PAI-1(-/-) mice without STZ treatment. Although the bone repair process was delayed by STZ treatment in PAI-1(+/+) mice, this delayed bone repair was blunted in PAI-1(-/-) mice. The reduction in the number of ALP-positive cells at the site of bone damage induced by STZ treatment was attenuated in PAI-1(-/-) mice compared to PAI-1(+/+) mice. On the other hand, PAI-1 deficiency increased the levels of ALP and type I collagen mRNA in female mice with or without STZ treatment, and the levels of Osterix and osteocalcin mRNA, suppressed by diabetic state in PAI-1(+/+) mice, were partially protected in PAI-1(-/-) mice. PAI-1 deficiency did not affect formation of the cartilage matrix and the levels of types II and X collagen and aggrecan mRNA suppressed by STZ treatment, although PAI-1 deficiency increased the expression of chondrogenic markers in mice without STZ treatment. The present study indicates that PAI-1 is involved in the impaired bone repair process induced by the diabetic state in part through a decrease in the number of ALP-positive cells.	[Mao, Li; Kawao, Naoyuki; Tamura, Yukinori; Okada, Kiyotaka; Yano, Masato; Matsuo, Osamu; Kaji, Hiroshi] Kinki Univ, Fac Med, Dept Physiol & Regenerat Med, Osaka, Japan; [Okumoto, Katsumi] Kinki Univ, Life Sci Res Inst, Osaka, Japan	Kindai University (Kinki University); Kindai University (Kinki University)	Kaji, H (corresponding author), Kinki Univ, Fac Med, Dept Physiol & Regenerat Med, Osaka, Japan.	hkaji@med.kindai.ac.jp	MATSUO, OSAMU/AAM-9703-2020; Kaji, Hiroshi/AAI-5628-2020	Kawao, Naoyuki/0000-0002-4148-5476; Matsuo, Osamu/0000-0002-9806-2204	Ministry of Science, Education [24590289]; Japan China Sasakawa Medical Fellowship; Grants-in-Aid for Scientific Research [24590289] Funding Source: KAKEN	Ministry of Science, Education; Japan China Sasakawa Medical Fellowship; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a grant-in-aid (24590289) from the Ministry of Science, Education to H. Kaji and Japan China Sasakawa Medical Fellowship to L. Mao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN EH, 1995, CLIN ORTHOP RELAT R, P54; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Daci E, 1999, J BONE MINER RES, V14, P946, DOI 10.1359/jbmr.1999.14.6.946; Daci E, 2000, J BONE MINER RES, V15, P1510, DOI 10.1359/jbmr.2000.15.8.1510; Declerck PJ, 2013, SEMIN THROMB HEMOST, V39, P356, DOI 10.1055/s-0033-1334487; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Fadini GP, 2013, DIABETES CARE, V36, P943, DOI 10.2337/dc12-1084; Gandhi A, 2005, BONE, V37, P482, DOI 10.1016/j.bone.2005.04.039; Hofbauer LC, 2007, J BONE MINER RES, V22, P1317, DOI 10.1359/JBMR.070510; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kawao N, 2013, J BONE MINER RES, V28, P1561, DOI 10.1002/jbmr.1921; Kayal RA, 2007, J BONE MINER RES, V22, P560, DOI 10.1359/JBMR.070115; Kayal RA, 2010, J BONE MINER RES, V25, P1604, DOI 10.1002/jbmr.59; Kayal R, 2009, BONE, V44, P357, DOI 10.1016/j.bone.2008.10.042; Krause MP, 2011, DIABETES, V60, P1964, DOI 10.2337/db11-0007; Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7; Liao YF, 2010, VASC MED, V15, P279, DOI 10.1177/1358863X10367537; Lu HF, 2003, ENDOCRINOLOGY, V144, P346, DOI 10.1210/en.2002-220072; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Mathieu P, 2010, CLIN PHARMACOL THER, V87, P407, DOI 10.1038/clpt.2009.311; McCabe LR, 2007, J CELL BIOCHEM, V102, P1343, DOI 10.1002/jcb.21573; Merlotti D, 2010, NUTR METAB CARDIOVAS, V20, P683, DOI 10.1016/j.numecd.2010.07.008; Oh CK, 2002, BIOCHEM BIOPH RES CO, V294, P1155, DOI 10.1016/S0006-291X(02)00577-6; PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x; Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P673, DOI 10.1111/j.1600-0501.2010.01923.x; Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20; Rundle CH, 2008, CALCIFIED TISSUE INT, V83, P276, DOI 10.1007/s00223-008-9169-7; Shin L, 2012, STEM CELL TRANSL MED, V1, P125, DOI [10.5966/sctm.2011-0031, 10.5966/sctm.2012-0031]; Shoji T, 2006, DIABETES, V55, P2245, DOI 10.2337/db05-1375; Simpson CM, 2012, EXPERT OPIN DRUG SAF, V11, P215, DOI 10.1517/14740338.2012.639359; SPRENGERS ED, 1987, BLOOD, V69, P381; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Tamura Y, 2013, DIABETES, V62, P3170, DOI 10.2337/db12-1552; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Wang H, 2007, FEBS LETT, V581, P3098, DOI 10.1016/j.febslet.2007.05.049; Wongdee K, 2011, WORLD J DIABETES, V2, P41, DOI 10.4239/wjd.v2.i3.41	36	44	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92686	10.1371/journal.pone.0092686	http://dx.doi.org/10.1371/journal.pone.0092686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651693	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800143
J	Morimoto, T; Kanda, H; Miyoshi, T; Hirohara, Y; Mihashi, T; Kitaguchi, Y; Nishida, K; Fujikado, T				Morimoto, Takeshi; Kanda, Hiroyuki; Miyoshi, Tomomitsu; Hirohara, Yoko; Mihashi, Toshifumi; Kitaguchi, Yoshiyuki; Nishida, Kohji; Fujikado, Takashi			Characteristics of Retinal Reflectance Changes Induced by Transcorneal Electrical Stimulation in Cat Eyes	PLOS ONE			English	Article							INTRINSIC OPTICAL SIGNALS; EVOKED RESPONSE; BLOOD-FLOW; FUNCTIONAL ARCHITECTURE; MACAQUE RETINA; VISUAL-SYSTEM; NERVE; VOLUME	Transcorneal electrical stimulation (TES) activates retinal neurons leading to visual sensations. How the retinal cells are activated by TES has not been definitively determined. Investigating the reflectance changes of the retina is an established technique and has been used to determine the mechanism of retinal activation. The purpose of this study was to evaluate the reflectance changes elicited by TES in cat eyes. Eight eyes of Eight cats were studied under general anesthesia. Biphasic electrical pulses were delivered transcornealy. The fundus images observed with near-infrared light (800-880 nm) were recorded every 25 ms for 26 s. To improve the signal-to-noise ratio, the images of 10 consecutive recordings were averaged. Two-dimensional topographic maps of the reflective changes were constructed by subtracting images before from those after the TES. The effects of different stimulus parameters, e. g., current intensity, pulse duration, frequency, and stimulus duration, on the reflective changes were studied. Our results showed that after TES, the reflective changes appeared on the retinal vessels and optic disc. The intensity of reflectance changes increased as the current intensity, pulse duration, and stimulation duration increased (P<0.05 for all). The maximum intensity of the reflective change was obtained when the stimulus frequency was 20 Hz. The time course of the reflectance changes was also altered by the stimulation parameters. The response started earlier and returned to the baseline later with higher current intensities, longer pulse durations, but the time of the peak of the response was not changed. These results showed that the reflective changes were due to the activation of retinal neurons by TES and might involve the vascular changes induced by an activation of the retinal neurons.	[Morimoto, Takeshi; Kanda, Hiroyuki; Kitaguchi, Yoshiyuki; Fujikado, Takashi] Osaka Univ, Grad Sch Med, Dept Appl Visual Sci, Suita, Osaka, Japan; [Miyoshi, Tomomitsu] Osaka Univ, Grad Sch Med, Dept Integrat Physiol, Suita, Osaka, Japan; [Hirohara, Yoko] Topcon Corp, Res Inst, Itabashi Ku, Tokyo, Japan; [Mihashi, Toshifumi] Tokyo Inst Technol, Innovat Res Initiat, Yokohama, Kanagawa 227, Japan; [Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan	Osaka University; Osaka University; Topcon Corporation; Tokyo Institute of Technology; Osaka University	Morimoto, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Appl Visual Sci, Suita, Osaka, Japan.	takeshi.morimoto@ophthal.med.osaka-u.ac.jp		Nishida, Kohji/0000-0001-9069-3610	Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder; Grants-in-Aid for Scientific Research [25670730, 22249058] Funding Source: KAKEN	Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2006, INVEST OPHTH VIS SCI, V47, P715, DOI 10.1167/iovs.05-0008; COHEN LB, 1973, PHYSIOL REV, V53, P373; Delbeke J, 2001, INVEST OPHTH VIS SCI, V42, P291; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Fujikado T, 2007, GRAEF ARCH CLIN EXP, V245, P1411, DOI 10.1007/s00417-007-0563-z; Fujikado T, 2006, JPN J OPHTHALMOL, V50, P266, DOI 10.1007/s10384-005-0304-y; Fukuda M, 2005, CEREB CORTEX, V15, P823, DOI 10.1093/cercor/bhh183; Gall C, 2010, NEUROREHABILITATION, V27, P335, DOI 10.3233/NRE-2010-0617; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hanazono G, 2008, INVEST OPHTH VIS SCI, V49, P4655, DOI 10.1167/iovs.08-1936; Hanazono G, 2007, INVEST OPHTH VIS SCI, V48, P2903, DOI 10.1167/iovs.06-1294; Inomata K, 2008, INVEST OPHTH VIS SCI, V49, P2193, DOI 10.1167/iovs.07-0727; Inomata K, 2007, GRAEF ARCH CLIN EXP, V245, P1773, DOI 10.1007/s00417-007-0610-9; KNIGHTON RW, 1975, J NEUROPHYSIOL, V38, P185, DOI 10.1152/jn.1975.38.1.185; Kurimoto T, 2010, CLIN OPHTHALMOL, V4, P1441, DOI 10.2147/OPTH.S14573; Mihashi T, 2011, JPN J OPHTHALMOL, V55, P49, DOI 10.1007/s10384-010-0906-x; Miyake Y, 1980, Nippon Ganka Gakkai Zasshi, V84, P354; Morimoto T, 2006, GRAEF ARCH CLIN EXP, V244, P1283, DOI 10.1007/s00417-006-0260-3; Naycheva L, 2012, INVEST OPHTH VIS SCI, V53, P7440, DOI 10.1167/iovs.12-9612; Okawa Y, 2007, INVEST OPHTH VIS SCI, V48, P4777, DOI 10.1167/iovs.07-0209; POTTS AM, 1968, INVEST OPHTH VISUAL, V7, P269; POTTS AM, 1969, INVEST OPHTH VISUAL, V8, P605; RIVA CE, 1991, NEUROSCI LETT, V128, P291, DOI 10.1016/0304-3940(91)90282-X; Riva CE, 1996, MICROVASC RES, V52, P258, DOI 10.1006/mvre.1996.0063; Riva CE, 2005, PROG RETIN EYE RES, V24, P183, DOI 10.1016/j.preteyeres.2004.07.002; Roy C S, 1890, J Physiol, V11, P85; Schallek J, 2011, INVEST OPHTH VIS SCI, V52, P1325, DOI 10.1167/iovs.10-5215; Schallek J, 2009, INVEST OPHTH VIS SCI, V50, P4873, DOI 10.1167/iovs.08-3291; Schallek J, 2009, INVEST OPHTH VIS SCI, V50, P4865, DOI 10.1167/iovs.08-3290; Schatz A, 2011, INVEST OPHTH VIS SCI, V52, P4485, DOI 10.1167/iovs.10-6932; Shah HA, 2006, EXP EYE RES, V83, P247, DOI 10.1016/j.exer.2005.11.023; Shimazu K, 1999, VISION RES, V39, P2251, DOI 10.1016/S0042-6989(98)00331-9; Ts'o D, 2009, JPN J OPHTHALMOL, V53, P334, DOI 10.1007/s10384-009-0687-2; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Tsunoda K, 2004, INVEST OPHTH VIS SCI, V45, P3820, DOI 10.1167/iovs.04-0394; Tsunoda K, 2009, JPN J OPHTHALMOL, V53, P297, DOI 10.1007/s10384-009-0686-3	36	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92186	10.1371/journal.pone.0092186	http://dx.doi.org/10.1371/journal.pone.0092186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651530	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800080
J	Thompson, RL; Williams, RW; Kotb, M; Sawtell, NM				Thompson, Richard L.; Williams, Robert W.; Kotb, Malak; Sawtell, Nancy M.			A Forward Phenotypically Driven Unbiased Genetic Analysis of Host Genes That Moderate Herpes Simplex Virus Virulence and Stromal Keratitis in Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GAMMA-INTERFERON; THYMIDINE KINASE; TYPE-1 INFECTION; MURINE MODEL; MOUSE LINES; WILD-TYPE; SUSCEPTIBILITY; REACTIVATION; ENCEPHALITIS	Both viral and host genetics affect the outcome of herpes simplex virus type 1 (HSV-1) infection in humans and experimental models. Little is known about specific host gene variants and molecular networks that influence herpetic disease progression, severity, and episodic reactivation. To identify such host gene variants we have initiated a forward genetic analysis using the expanded family of BXD strains, all derived from crosses between C57BL/6J and DBA/2J strains of mice. One parent is highly resistant and one highly susceptible to HSV-1. Both strains have also been fully sequenced, greatly facilitating the search for genetic modifiers that contribute to differences in HSV-1 infection. We monitored diverse disease phenotypes following infection with HSV-1 strain 17syn+ including percent mortality (herpes simplex encephalitis, HSE), body weight loss, severity of herpetic stromal keratitis (HSK), spleen weight, serum neutralizing antibody titers, and viral titers in tear films in BXD strains. A significant quantitative trait locus (QTL) on chromosome (Chr) 16 was found to associate with both percent mortality and HSK severity. Importantly, this QTL maps close to a human QTL and the gene proposed to be associated with the frequency of recurrent herpetic labialis (cold sores). This suggests that a single host locus may influence these seemingly diverse HSV-1 pathogenic phenotypes by as yet unknown mechanisms. Additional suggestive QTLs for percent mortality were identified-one on Chr X that is epistatically associated with that on Chr 16. As would be anticipated the Chr 16 QTL also modulated weight loss, reaching significance in females. A second significant QTL for maximum weight loss in male and female mice was mapped to Chr 12. To our knowledge this is the first report of a host genetic locus that modulates the severity of both herpetic disease in the nervous system and herpetic stromal keratitis.	[Thompson, Richard L.; Kotb, Malak] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Ctr Genom & Bioinformat, Memphis, TN 38163 USA; [Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Sawtell, Nancy M.] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Thompson, RL (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	richard.thompson@uc.edu; nancy.sawtell@cchmc.org	Williams, Robert W./H-8789-2016	Williams, Robert W./0000-0001-8924-4447; Thompson, Richard/0000-0002-0246-2810	NIH [RC1 AI087336]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093614, RC1AI087336] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by NIH RC1 AI087336, www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RC, 1996, NEUROPSYCHOPHARMACOL, V15, P484, DOI 10.1016/S0893-133X(96)00058-9; Aziz RK, 2007, GENES IMMUN, V8, P404, DOI 10.1038/sj.gene.6364402; Bourane S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-97; BRANDT CR, 1992, J VIROL METHODS, V36, P209, DOI 10.1016/0166-0934(92)90052-F; Brandt CR, 2005, EXP EYE RES, V80, P607, DOI 10.1016/j.exer.2004.09.007; Brandt CR, 2004, CURR EYE RES, V29, P103, DOI 10.1080/02713680490504533; Brandt CR, 2007, INVEST OPHTH VIS SCI, V48, P5118, DOI 10.1167/iovs.07-0302; Broman KW, 2001, LAB ANIMAL, V30, P44; Cantin E, 1999, J VIROL, V73, P5196, DOI 10.1128/JVI.73.6.5196-5200.1999; Cantin E, 1999, J VIROL, V73, P3418, DOI 10.1128/JVI.73.4.3418-3423.1999; Carneiro AMD, 2009, P NATL ACAD SCI USA, V106, P2047, DOI 10.1073/pnas.0809449106; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Conejero-Goldberg C, 2003, SCHIZOPHR RES, V60, P65, DOI 10.1016/S0920-9964(02)00160-3; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Corey L, 2007, NEW ENGL J MED, V356, P854, DOI 10.1056/NEJMe068302; Du T, 2010, P NATL ACAD SCI USA, V107, P15904, DOI 10.1073/pnas.1010741107; Everett RD, 2010, J VIROL, V84, P3476, DOI 10.1128/JVI.02544-09; FOSTER CS, 1986, CLIN IMMUNOL IMMUNOP, V40, P313, DOI 10.1016/0090-1229(86)90036-X; Geisert EE, 2009, MOL VIS, V15, P1730; Gimenez F, 2013, PROG RETIN EYE RES, V33, P1, DOI 10.1016/j.preteyeres.2012.07.002; Glynn JR, 2009, AIDS, V23, P1595, DOI 10.1097/QAD.0b013e32832e15e8; Griffiths A, 2003, J VIROL, V77, P4703, DOI 10.1128/JVI.77.8.4703-4709.2003; Griffiths A, 2003, J VIROL, V77, P2282, DOI 10.1128/JVI.77.3.2282-2286.2003; Gu Wei, 1995, Journal of Biomedical Science, V2, P203, DOI 10.1007/BF02253381; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Halford WP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-44; Han X, 2001, J VIROL, V75, P3048, DOI 10.1128/JVI.75.6.3048-3052.2001; Hazlett LD, 2010, OCUL IMMUNOL INFLAMM, V18, P237, DOI 10.3109/09273948.2010.501946; HILL TJ, 1986, J GEN VIROL, V67, P309, DOI 10.1099/0022-1317-67-2-309; Hobbs MR, 2008, J INFECT DIS, V197, P340, DOI 10.1086/525540; Horsburgh BC, 1998, J INFECT DIS, V178, P618, DOI 10.1086/515375; Huster KM, 2002, EUR J IMMUNOL, V32, P1414, DOI 10.1002/1521-4141(200205)32:5<1414::AID-IMMU1414>3.0.CO;2-Q; Inoue Yoshitsugu, 2008, Semin Ophthalmol, V23, P221, DOI 10.1080/08820530802111390; Kanno H, 2009, J NEUROTRAUM, V26, P31, DOI 10.1089/neu.2008.0667; Kriesel JD, 1997, J INFECT DIS, V175, P821, DOI 10.1086/513977; Kriesel JD, 2011, J INFECT DIS, V204, P1654, DOI 10.1093/infdis/jir633; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Levitz RE, 1998, HEART LUNG, V27, P209, DOI 10.1016/S0147-9563(98)90009-7; Lieu PT, 2000, VIROLOGY, V272, P191, DOI 10.1006/viro.2000.0365; LOPEZ C, 1975, NATURE, V258, P152, DOI 10.1038/258152a0; Lu H, 2011, MOL VIS, V17, P2455; Lundberg P, 2003, J VIROL, V77, P11661, DOI 10.1128/JVI.77.21.11661-11673.2003; METCALF JF, 1984, INVEST OPHTH VIS SCI, V25, P1222; Nedelko T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-411; Norose K, 2002, J VIROL, V76, P3502, DOI 10.1128/JVI.76.7.3502-3510.2002; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Piers TM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00199; PLUMMER G, 1974, VIROLOGY, V60, P206, DOI 10.1016/0042-6822(74)90378-X; Pruett ND, 2004, J BIOL CHEM, V279, P51524, DOI 10.1074/jbc.M404331200; Rantakallio P, 1997, INT J EPIDEMIOL, V26, P837, DOI 10.1093/ije/26.4.837; Roizman B, 2005, CELL CYCLE, V4, P1019, DOI 10.4161/cc.4.8.1902; Rulten SL, 2006, GENES BRAIN BEHAV, V5, P257, DOI 10.1111/j.1601-183X.2005.00157.x; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Sawtell NA, 2004, J VIROL, V78, P7784, DOI 10.1128/JVI.78.14.7784-7794.2004; SHIMELD C, 1985, ARCH VIROL, V85, P175, DOI 10.1007/BF01314229; Smith G, 2012, ANNU REV MICROBIOL, V66, P153, DOI 10.1146/annurev-micro-092611-150051; Steiner I, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0414-8; Suryawanshi A, 2011, J IMMUNOL, V187, P1919, DOI 10.4049/jimmunol.1100736; TAYLOR BA, 1973, P SOC EXP BIOL MED, V143, P629, DOI 10.3181/00379727-143-37380; Thompson RL, 2011, J NEUROVIROL, V17, P552, DOI 10.1007/s13365-011-0071-0; Thompson RL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000352; THOMPSON RL, 1989, VIROLOGY, V172, P435, DOI 10.1016/0042-6822(89)90186-4; THOMPSON RL, 1986, J VIROL, V58, P203, DOI 10.1128/JVI.58.1.203-211.1986; THOMPSON RL, 1983, VIROLOGY, V131, P171, DOI 10.1016/0042-6822(83)90543-3; Veiga-Parga T, 2013, MICROBES INFECT, V15, P677, DOI 10.1016/j.micinf.2013.07.001; Veiga-Parga T, 2012, J IMMUNOL, V189, P5924, DOI 10.4049/jimmunol.1202322; Whitley Richard J, 2002, Semin Pediatr Infect Dis, V13, P6, DOI 10.1053/spid.2002.29752; WHITLEY RJ, 1990, NEW ENGL J MED, V323, P242, DOI 10.1056/NEJM199007263230406; Whitley RJ, FIELDS VIROLOGY FIEL, V2, P297; Yadav JS, 2011, INFECT IMMUN, V79, P3204, DOI 10.1128/IAI.01389-10; Zhang SY, 2013, HAND CLINIC, V112, P1091, DOI 10.1016/B978-0-444-52910-7.00027-1; Zhao ZS, 1998, SCIENCE, V279, P1344, DOI 10.1126/science.279.5355.1344; Zumbrun EE, 2012, VIRUSES-BASEL, V4, P3468, DOI 10.3390/v4123468	74	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92342	10.1371/journal.pone.0092342	http://dx.doi.org/10.1371/journal.pone.0092342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651695	Green Submitted, gold, Green Published			2022-12-27	WOS:000333352800103
J	Wu, YL; Hwang, DY; Hsiao, HP; Ting, WH; Huang, CY; Tsai, WY; Chen, HC; Chao, MC; Lo, FS; Tsai, JD; Yang, S; Shih, SL; Lin, SP; Lin, CL; Lee, YJ				Wu, Yi-Lei; Hwang, Daw-Yang; Hsiao, Hui-Pin; Ting, Wei-Hsin; Huang, Chi-Yu; Tsai, Wen-Yu; Chen, Hung-Chun; Chao, Mei-Chyn; Lo, Fu-Sung; Tsai, Jeng-Daw; Yang, Stone; Shih, Shin-Lin; Lin, Shuan-Pei; Lin, Chiung-Ling; Lee, Yann-Jinn			Mutations in Pseudohypoparathyroidism 1a and Pseudopseudohypoparathyroidism in Ethnic Chinese	PLOS ONE			English	Article							ALBRIGHT HEREDITARY OSTEODYSTROPHY; GS-ALPHA GENE; IDENTIFIES PDE4D MUTATIONS; NONSENSE-MEDIATED DECAY; STIMULATORY G-PROTEIN; HORMONE RESISTANCE; PARATHYROID-HORMONE; MULTIPLE HORMONES; GNAS; DELETION	An inactivating mutation in the GNAS gene causes either pseudohypoparathyroidism 1a (PHP1A) when it is maternally inherited or pseudopseudohypoparathyroidism (PPHP) when it is paternally inherited. We investigated clinical manifestations and mutations of the GNAS gene in ethnic Chinese patients with PHP1A or PPHP. Seven patients from 5 families including 4 girls and 2 boys with PHP1A and 1 girl with PPHP were studied. All PHP1A patients had mental retardation. They were treated with calcitriol and CaCO3 with regular monitoring of serum Ca levels, urinary Ca/Cr ratios, and renal sonography. Among them, 5 patients also had primary hypothyroidism suggesting TSH resistance. One female patient had a renal stone which was treated with extracorporeal shockwave lithotripsy. She had an increased urinary Ca/Cr ratio of 0.481 mg/mg when the stone was detected. We detected mutations using PCR and sequencing as well as analysed a splice acceptor site mutation using RT-PCR, sequencing, and minigene construct. We detected 5 mutations: c.85C>T (Q29*), c.103C>T (Q35*), c.840-2A>G (R280Sfs*21), c.1027_1028delGA (D343*), and c.1174G>A (E392K). Mutations c.840-2A>G and c.1027_1028delGA were novel. The c.840-2A>G mutation at the splice acceptor site of intron 10 caused retention of intron 10 in the minigene construct but skipping of exon 11 in the peripheral blood cells. The latter was the most probable mechanism which caused a frameshift, changing Arg to Ser at residue 280 and invoking a premature termination of translation at codon 300 (R280Sfs*21). Five GNAS mutations in ethnic Chinese with PHP1A and PPHP were reported. Two of them were novel. Mutation c.840-2A>G destroyed a spice acceptor site and caused exon skipping. Regular monitoring and adjustment in therapy are mandatory to achieve optimal therapeutic effects and avoid nephrolithiasis in patients with PHP1A.	[Wu, Yi-Lei; Ting, Wei-Hsin; Huang, Chi-Yu; Tsai, Jeng-Daw; Lin, Shuan-Pei; Lee, Yann-Jinn] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Wu, Yi-Lei] Changhua Christian Hosp, Dept Pediat, Changhua, Taiwan; [Hwang, Daw-Yang; Chen, Hung-Chun] Kaohsiung Med Univ Hosp, Dept Med, Div Nephrol, Kaohsiung, Taiwan; [Hsiao, Hui-Pin] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Pediat, Kaohsiung, Taiwan; [Tsai, Wen-Yu] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Dept Med, Fac Renal Care, Kaohsiung, Taiwan; [Chao, Mei-Chyn] Kaohsiung Med Univ Hosp, Dept Pediat, Div Genet Endocrinol & Metab, Kaohsiung, Taiwan; [Chao, Mei-Chyn] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Lo, Fu-Sung] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan; [Lo, Fu-Sung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Ting, Wei-Hsin; Huang, Chi-Yu; Lin, Shuan-Pei] Mackay Jr Coll Med Nursing & Management, New Taipei City, Taiwan; [Yang, Stone] Mackay Mem Hosp, Dept Urol, Taipei, Taiwan; [Shih, Shin-Lin] Mackay Mem Hosp, Dept Radiol, Taipei, Taiwan; [Lin, Shuan-Pei; Lin, Chiung-Ling; Lee, Yann-Jinn] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Lin, Shuan-Pei] Natl Taipei Univ Nursing & Hlth, Dept Infant & Child Care, Taipei, Taiwan; [Tsai, Jeng-Daw; Shih, Shin-Lin; Lee, Yann-Jinn] Taipei Med Univ, Coll Med, Taipei, Taiwan; [Lin, Shuan-Pei; Lee, Yann-Jinn] Mackay Med Coll, Inst Biomed Sci, New Taipei City, Taiwan; [Lin, Shuan-Pei; Lee, Yann-Jinn] Mackay Med Coll, Dept Med, New Taipei City, Taiwan	Mackay Memorial Hospital; Changhua Christian Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; National Taipei University of Nursing & Health Science (NTUNHS); Taipei Medical University; Mackay Medical College; Mackay Medical College	Lee, YJ (corresponding author), Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan.	yannlee@mmh.org.tw		TSAI, WEN-YU/0000-0003-1332-2650	Mackay Memorial Hospital [MMH-E-10007, MMH10170]; Kaohsiung Medical University Hospital [KMUH 99-9M35]; KMUH Nephrology Research Fund from Kaohsiung Medical University Hospital	Mackay Memorial Hospital; Kaohsiung Medical University Hospital; KMUH Nephrology Research Fund from Kaohsiung Medical University Hospital	This work was supported by grants MMH-E-10007 and MMH10170 from Mackay Memorial Hospital and KMUH 99-9M35 and KMUH Nephrology Research Fund from Kaohsiung Medical University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbite NS, 2008, AM J MED GENET A, V146A, P1788, DOI 10.1002/ajmg.a.32346; Albright F, 1942, ENDOCRINOLOGY, V30, P922; Allgrove J, 2009, CLIN PEDIAT ENDOCRIN, P374; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bastepe M, 2003, J CLIN ENDOCR METAB, V88, P4055, DOI 10.1210/jc.2003-031271; Bastepe M, 2002, MOL ENDOCRINOL, V16, P1912, DOI 10.1210/me.2002-0054; Bastepe M, 2001, AM J HUM GENET, V68, P1283, DOI 10.1086/320117; Bastepe M, 2013, ENDOCR DEV, V24, P11, DOI 10.1159/000342494; Bertaux K, 2006, BONE, V38, P943, DOI 10.1016/j.bone.2005.11.025; Bringhurst FR., 2011, WILLIAMS TXB ENDOCRI, P1237, DOI [10.1016/B978-1-4377-0324-5.00028-6, DOI 10.1016/B978-1-4377-0324-5.00028-6]; Chen W, 2010, PEDIATR NEONATOL, V51, P69, DOI 10.1016/S1875-9572(10)60014-9; Chillambhi S, 2010, J CLIN ENDOCR METAB, V95, P3993, DOI 10.1210/jc.2009-2205; Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015; Craigen WJ, 1997, AM J MED GENET, V72, P63; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; D'Souza-Li L, 2001, HUM MUTAT, V18, P411, DOI 10.1002/humu.1212; de Sanctis L, 2004, J CLIN ENDOCR METAB, V89, P1650, DOI 10.1210/jc.2003-030850; de Sanctis L, 2003, PEDIATR RES, V53, P749, DOI 10.1203/01.PDR.0000059752.07086.A2; Elli FM, 2013, HUM MUTAT, V34, P411, DOI 10.1002/humu.22265; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; Fernandez-Rebollo E, 2013, J CLIN ENDOCR METAB, V98, pE996, DOI 10.1210/jc.2012-4164; Fernandez-Rebollo E, 2011, J BONE MINER RES, V26, P1854, DOI 10.1002/jbmr.408; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Gelfand IM, 2006, J PEDIATR-US, V149, P877, DOI 10.1016/j.jpeds.2006.08.050; Germain-Lee EL, 2003, J CLIN ENDOCR METAB, V88, P4059, DOI 10.1210/jc.2003-030028; Germain-Lee EL, 2002, BIOCHEM BIOPH RES CO, V296, P67, DOI 10.1016/S0006-291X(02)00833-1; Greer FR, 2006, PEDIATRICS, V117, P578, DOI 10.1542/peds.2005-2822; Harries LW, 2004, DIABETES, V53, P500, DOI 10.2337/diabetes.53.2.500; Hwang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025492; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Ishikawa Y, 2001, J HUM GENET, V46, P426, DOI 10.1007/s100380170062; Jin HY, 2011, CLIN ENDOCRINOL, V75, P207, DOI 10.1111/j.1365-2265.2011.04026.x; KOZASA T, 1988, P NATL ACAD SCI USA, V85, P2081, DOI 10.1073/pnas.85.7.2081; Lam ACF, 2006, HK J PAEDIAT, V11, P284; Lee H, 2012, AM J HUM GENET, V90, P746, DOI 10.1016/j.ajhg.2012.03.004; LEVINE MA, 1983, AM J MED, V74, P545, DOI 10.1016/0002-9343(83)91008-2; LEVINE MA, 1988, P NATL ACAD SCI USA, V85, P617, DOI 10.1073/pnas.85.2.617; Lim SHM, 2002, J PEDIATR ENDOCR MET, V15, P259; Linglart A, 2005, AM J HUM GENET, V76, P804, DOI 10.1086/429932; Linglart A, 2002, J CLIN ENDOCR METAB, V87, P189, DOI 10.1210/jc.87.1.189; Linglart A, 2013, HORM RES PAEDIAT, V79, P119, DOI 10.1159/000348516; Linglart A, 2011, NEW ENGL J MED, V364, P2218, DOI 10.1056/NEJMoa1012717; Mantovani G, 2002, J CLIN ENDOCR METAB, V87, P4736, DOI 10.1210/jc.2002-020183; Mantovani G, 2000, J CLIN ENDOCR METAB, V85, P4243, DOI 10.1210/jc.85.11.4243; Mantovani G, 2011, J CLIN ENDOCR METAB, V96, P3020, DOI 10.1210/jc.2011-1048; Miao ZM, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/509549; Michot C, 2012, AM J HUM GENET, V90, P740, DOI 10.1016/j.ajhg.2012.03.003; Nakamura Y, 2000, J Epidemiol, V10, P29; Park CH, 2010, ANN CLIN LAB SCI, V40, P261; PHELAN MC, 1995, AM J MED GENET, V58, P1, DOI 10.1002/ajmg.1320580102; Richard N, 2012, J CLIN ENDOCR METAB, V97, pE863, DOI 10.1210/jc.2011-2804; Romano M, 2001, NUCLEIC ACIDS RES, V29, P886, DOI 10.1093/nar/29.4.886; STONE MD, 1993, BONE, V14, P727, DOI 10.1016/8756-3282(93)90204-N; Strachan T, 2011, HUMAN MOLECULAR GENETICS 4TH EDITION, P405; Sun LH, 2009, ENDOCRINE, V36, P25, DOI 10.1007/s12020-009-9193-z; Thiele S, 2011, HUM MUTAT, V32, P653, DOI 10.1002/humu.21489; Wu SJ, 2007, ASIA PAC J CLIN NUTR, V16, P518	57	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90640	10.1371/journal.pone.0090640	http://dx.doi.org/10.1371/journal.pone.0090640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651309	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800019
J	Yoshida, K; Nakashima, E; Kubo, Y; Yamaoka, M; Kajimura, J; Kyoizumi, S; Hayashi, T; Ohishi, W; Kusunoki, Y				Yoshida, Kengo; Nakashima, Eiji; Kubo, Yoshiko; Yamaoka, Mika; Kajimura, Junko; Kyoizumi, Seishi; Hayashi, Tomonori; Ohishi, Waka; Kusunoki, Yoichiro			Inverse Associations between Obesity Indicators and Thymic T-Cell Production Levels in Aging Atomic-Bomb Survivors	PLOS ONE			English	Article							AGE-RELATED-CHANGES; CALORIC RESTRICTION; LYMPHOCYTE POPULATIONS; GROWTH-HORMONE; HOMEOSTASIS; LEPTIN; DEFICIENCY; INCREASES; IMMUNITY; SUBSETS	Reduction of the naive T-cell population represents a deteriorating state in the immune system that occurs with advancing age. In animal model studies, obesity compromises the T-cell immune system as a result of enhanced adipogenesis in primary lymphoid organs and systemic inflammation. In this study, to test the hypothesis that obesity may contribute to the aging of human T-cell immunity, a thousand atomic-bomb survivors were examined for obesity status and ability to produce naive T cells, i.e., T-cell receptor excision circle (TREC) numbers in CD4 and CD8 T cells. The number of TRECs showed a strong positive correlation with naive T cell numbers, and lower TREC numbers were associated with higher age. We found that the TREC number was inversely associated with levels of obesity indicators (BMI, hemoglobin A1c) and serum CRP levels. Development of type-2 diabetes and fatty liver was also associated with lower TREC numbers. This population study suggests that obesity with enhanced inflammation is involved in aging of the human T-cell immune system. Given the fact that obesity increases the risk of numerous age-related diseases, attenuated immune competence is a possible mechanistic link between obesity and disease development among the elderly.	[Yoshida, Kengo; Kubo, Yoshiko; Yamaoka, Mika; Kajimura, Junko; Kyoizumi, Seishi; Hayashi, Tomonori; Kusunoki, Yoichiro] Radiat Effects Res Fdn, Dept Radiobiol Mol Epidemiol, Hiroshima, Japan; [Nakashima, Eiji] Radiat Effects Res Fdn, Dept Stat, Hiroshima, Japan; [Ohishi, Waka] Radiat Effects Res Fdn, Dept Clin Studies, Hiroshima, Japan	Radiation Effects Research Foundation - Japan; Radiation Effects Research Foundation - Japan; Radiation Effects Research Foundation - Japan	Yoshida, K (corresponding author), Radiat Effects Res Fdn, Dept Radiobiol Mol Epidemiol, Hiroshima, Japan.	kyoshi@rerf.or.jp			Japanese Ministry of Health, Labour and Welfare (MHLW); U.S. Department of Energy (DOE) [DE-HS0000031]; MHLW; U.S. National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200900059C]	Japanese Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); MHLW(Ministry of Health, Labour and Welfare, Japan); U.S. National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Radiation Effects Research Foundation (RERF, http://www.rerf.or.jp), Hiroshima and Nagasaki, Japan is a private, non-profit foundation funded by the Japanese Ministry of Health, Labour and Welfare (MHLW) and the U.S. Department of Energy (DOE), the latter in part through DOE Award DE-HS0000031 to the National Academy of Sciences. This study is based on RERF Research Protocols #4-02 and 3-09, and is supported by the MHLW (http://www.mhlw.go.jp) Grant-in-Aid and the U.S. National Institute of Allergy and Infectious Diseases (NIAID Contract HHSN272200900059C, http://www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views of the authors do not necessarily reflect those of the two governments.	Beebe GW, 1960, 1060 AT BOMB CAS COM; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Chen J, 2010, MECH AGEING DEV, V131, P29, DOI 10.1016/j.mad.2009.11.003; Chinn IK, 2012, SEMIN IMMUNOL, V24, P309, DOI 10.1016/j.smim.2012.04.005; Cullings HM, 2006, RADIAT RES, V166, P219, DOI 10.1667/RR3546.1; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Ferrando-Martinez S, 2013, AGE, V35, P251, DOI 10.1007/s11357-011-9341-2; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Haynes L, 2012, SEMIN IMMUNOL, V24, P350, DOI 10.1016/j.smim.2012.04.001; Herasimtschuk AA, 2013, CLIN EXP IMMUNOL, V173, P444, DOI 10.1111/cei.12141; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Hsu HC, 2010, CURR OPIN IMMUNOL, V22, P541, DOI 10.1016/j.coi.2010.05.002; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; Koetz K, 2000, P NATL ACAD SCI USA, V97, P9203, DOI 10.1073/pnas.97.16.9203; Kusunoki Y, 2008, INT J RADIAT BIOL, V84, P1, DOI 10.1080/09553000701616106; Kyoizumi S, 2010, INT J RADIAT BIOL, V86, P56, DOI 10.3109/09553000903272641; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Messaoudi I, 2006, P NATL ACAD SCI USA, V103, P19448, DOI 10.1073/pnas.0606661103; Morrhaye G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005668; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Nikolich-Zugich J, 2012, SEMIN IMMUNOL, V24, P356, DOI 10.1016/j.smim.2012.04.009; Oysyannikova IG, 2014, VACCINE, V32, P881, DOI 10.1016/j.vaccine.2013.12.009; Palmer G, 2006, J IMMUNOL, V177, P2899, DOI 10.4049/jimmunol.177.5.2899; Prasad S, 2012, PREV MED, V54, pS29, DOI 10.1016/j.ypmed.2011.11.011; Priceman SJ, 2013, P NATL ACAD SCI USA, V110, P13079, DOI 10.1073/pnas.1311557110; Qiu Q, 2010, J IMMUNOL, V184, P1681, DOI 10.4049/jimmunol.0900062; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; Serana F, 2011, J CLIN IMMUNOL, V31, P540, DOI 10.1007/s10875-011-9526-6; Thewissen M, 2007, CLIN IMMUNOL, V123, P209, DOI 10.1016/j.clim.2007.01.005; Verschuren MCM, 1997, J IMMUNOL, V158, P1208; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yamaoka M, 2004, RADIAT RES, V161, P290, DOI 10.1667/RR3143; Yang H, 2009, BLOOD, V114, P3803, DOI 10.1182/blood-2009-03-213595; Yang HW, 2009, J IMMUNOL, V183, P3040, DOI 10.4049/jimmunol.0900562; Yasunaga J, 2001, BLOOD, V97, P3177, DOI 10.1182/blood.V97.10.3177; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	40	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91985	10.1371/journal.pone.0091985	http://dx.doi.org/10.1371/journal.pone.0091985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651652	Green Submitted, gold, Green Published			2022-12-27	WOS:000333352800062
J	Himsworth, CG; Jardine, CM; Parsons, KL; Feng, AYT; Patrick, DM				Himsworth, Chelsea G.; Jardine, Claire M.; Parsons, Kirbee L.; Feng, Alice Y. T.; Patrick, David M.			The Characteristics of Wild Rat (Rattus spp.) Populations from an Inner-City Neighborhood with a Focus on Factors Critical to the Understanding of Rat-Associated Zoonoses	PLOS ONE			English	Article							LEPTOSPIRA-INTERROGANS; NORWAY RATS; HANTAVIRUS INFECTION; NORVEGICUS BERK.; BUENOS-AIRES; ECOLOGY; RODENTS; PREVALENCE; BALTIMORE; PATHOGENS	Norway and black rats (Rattus norvegicus and Rattus rattus) are among the most ubiquitous urban wildlife species and are the source of a number of zoonotic diseases responsible for significant human morbidity and mortality in cities around the world. Rodent ecology is a primary determinant of the dynamics of zoonotic pathogens in rodent populations and the risk of pathogen transmission to people, yet many studies of rat-associated zoonoses do not account for the ecological characteristics of urban rat populations. This hinders the development of an in-depth understanding of the ecology of rat-associated zoonoses, limits comparability among studies, and can lead to erroneous conclusions. We conducted a year-long trapping-removal study to describe the ecological characteristics of urban rat populations in an inner-city neighborhood of Vancouver, Canada. The study focused on factors that might influence the ecology of zoonotic pathogens in these populations and/or our understanding of that ecology. We found that rat population density varied remarkably over short geographical distances, which could explain observed spatial distributions of rat-associated zoonoses and have implications for sampling and data analysis during research and surveillance. Season appeared to influence rat population composition even within the urban environment, which could cause temporal variation in pathogen prevalence. Body mass and bite wounds, which are often used in epidemiologic analyses as simple proxies for age and aggression, were shown to be more complex than previously thought. Finally, we found that factors associated with trapping can determine the size and composition of sampled rat population, and thus influence inferences made about the source population. These findings may help guide future studies of rats and rat-associated zoonoses.	[Himsworth, Chelsea G.; Parsons, Kirbee L.; Feng, Alice Y. T.; Patrick, David M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Himsworth, Chelsea G.] British Columbia Minist Agr, Ctr Anim Hlth, Abbotsford, BC, Canada; [Jardine, Claire M.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	University of British Columbia; University of Guelph	Himsworth, CG (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	Chelsea.Himsworth@gov.bc.ca			Canadian Institutes of Health Research [MOP -119530, CGV -104833]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) MOP -119530 and CGV -104833. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowicz KF, 2011, VECTOR-BORNE ZOONOT, V11, P979, DOI 10.1089/vbz.2010.0117; Agudelo-Florez P, 2009, AM J TROP MED HYG, V81, P906, DOI 10.4269/ajtmh.2009.09-0195; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Antoniou M, 2010, VECTOR-BORNE ZOONOT, V10, P867, DOI 10.1089/vbz.2009.0123; Aplin K., 2003, RATS MICE PEOPLE ROD, P487; Aplin KP, 2003, FIELD METHODS RODENT; Aviat F, 2009, COMP IMMUNOL MICROB, V32, P463, DOI 10.1016/j.cimid.2008.05.004; BABINSKA J, 1969, Acta Theriologica, V14, P267; Barnett S. A., 1963, RAT STUDY BEHAV; BARNETT SA, 1951, BEHAVIOUR, V3, P229; Bastos AD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-26; Billeter SA, 2011, APPL ENVIRON MICROB, V77, P7850, DOI 10.1128/AEM.06012-11; Cavia R, 2009, LANDSCAPE URBAN PLAN, V90, P11, DOI 10.1016/j.landurbplan.2008.10.017; Clapperton B. K., 2006, REV CURRENT KNOWLEDG; CLINTON JM, 1969, PUBLIC HEALTH REP, V84, P1, DOI 10.2307/4593484; Cueto GR, 2008, TROP MED INT HEALTH, V13, P46, DOI 10.1111/j.1365-3156.2007.01968.x; DAVIS DE, 1951, ECOLOGY, V32, P469, DOI 10.2307/1931724; DAVIS DE, 1949, J MAMMAL, V30, P125, DOI 10.2307/1375259; DAVIS DE, 1953, Q REV BIOL, V28, P373, DOI 10.1086/399860; DAVIS DE, 1948, J MAMMAL, V29, P207, DOI 10.2307/1375387; Davis S, 2005, VECTOR-BORNE ZOONOT, V5, P305, DOI 10.1089/vbz.2005.5.305; de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005; Dohoo I, 2007, VET EPIDEMIOLOGIC RE; Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746; Easterbrook JD, 2005, VECTOR-BORNE ZOONOT, V5, P296, DOI 10.1089/vbz.2005.5.296; EMLEN JT, 1949, ECOLOGY, V30, P430, DOI 10.2307/1932446; Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4; Gardner-Santana LC, 2009, MOL ECOL, V18, P2766, DOI 10.1111/j.1365-294X.2009.04232.x; GLASS GE, 1988, EPIDEMIOL INFECT, V101, P459, DOI 10.1017/S0950268800054418; GLASS GE, 1988, J MAMMAL, V69, P587, DOI 10.2307/1381350; Villafane IEG, 2013, MAMMALIA, V77, P187, DOI 10.1515/mammalia-2012-0075; Guan P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-109; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; GURNELL J, 1980, ACTA THERIOL, V25, P255, DOI 10.4098/AT.arch.80-20; Harrell FE, 2001, REGRESSION MODELING; Hickman DL, 2010, J AM ASSOC LAB ANIM, V49, P155; Himsworth CG, 2014, APPL ENVIRON MICROB, V80, P1299, DOI 10.1128/AEM.03609-13; Himsworth CG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002270; Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195; Himsworth CG, 2013, URBAN ECOSYST, V16, P341, DOI 10.1007/s11252-012-0261-4; Hinson ER, 2004, AM J TROP MED HYG, V70, P310, DOI 10.4269/ajtmh.2004.70.310; Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660; Koizumi N, 2009, J MED MICROBIOL, V58, P1227, DOI 10.1099/jmm.0.011528-0; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Krebs Charles J., 1999, ACIAR Monograph Series, V59, P33; Krojgaard LH, 2009, EPIDEMIOL INFECT, V137, P1586, DOI 10.1017/S0950268809002647; Leslie PH, 1939, J ANIM ECOL, V8, P94, DOI 10.2307/1255; MARGULIS HL, 1977, GEOGR REV, V67, P221, DOI 10.2307/214022; Meyer A., 2003, RATS MICE PEOPLE ROD, P446; Migliani R, 2006, TROP MED INT HEALTH, V11, P1228, DOI 10.1111/j.1365-3156.2006.01677.x; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; Nagorsen D.W, 2002, IDENTIFICATION MANUA; NELSON L, 1973, J MAMMAL, V54, P295, DOI 10.2307/1378903; Olsson GE, 2002, EMERG INFECT DIS, V8, P924, DOI 10.3201/eid0809.020037; Palma RE, 2012, J WILDLIFE DIS, V48, P267, DOI 10.7589/0090-3558-48.2.267; Psaroulaki A, 2010, T ROY SOC TROP MED H, V104, P733, DOI 10.1016/j.trstmh.2010.08.005; Reeves WK, 2008, J VECTOR ECOL, V33, P205, DOI 10.3376/1081-1710(2008)33[205:SEOTGR]2.0.CO;2; Scialfa E, 2010, REV ARGENT MICROBIOL, V42, P126, DOI 10.1590/S0325-75412010000200012; Smith H. A., 2000, WORLDS COLLIDE SOCIA; Tagliapietra V, 2009, EMERG INFECT DIS, V15, P1019, DOI 10.3201/eid1507.081524; TAYLOR KD, 1974, J APPL ECOL, V11, P453, DOI 10.2307/2402199; Taylor PJ, 2008, INTEGR ZOOL, V3, P38, DOI 10.1111/j.1749-4877.2008.00072.x; Traweger D, 2005, J PEST SCI, V78, P17, DOI 10.1007/s10340-004-0062-5; Traweger D, 2006, J PEST SCI, V79, P113, DOI 10.1007/s10340-006-0123-z; United Nations, 2012, WORLD URB PROSP 2011; Vanasco NB, 2003, PREV VET MED, V60, P227, DOI 10.1016/S0167-5877(03)00144-2; Vadell MV, 2010, INT J PEST MANAGE, V56, P327, DOI 10.1080/09670874.2010.499479; Villanueva SYAM, 2010, AM J TROP MED HYG, V82, P889, DOI 10.4269/ajtmh.2010.09-0711; WORTH CB, 1950, J MAMMAL, V31, P293, DOI 10.2307/1375298	69	63	66	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91654	10.1371/journal.pone.0091654	http://dx.doi.org/10.1371/journal.pone.0091654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646877	gold, Green Submitted, Green Published			2022-12-27	WOS:000333348500043
J	Kimble, SJA; Rhodes, OE; Williams, RN				Kimble, Steven J. A.; Rhodes, O. E., Jr.; Williams, Rod N.			Unexpectedly Low Rangewide Population Genetic Structure of the Imperiled Eastern Box Turtle Terrapene c. carolina	PLOS ONE			English	Article							FLOW; MIGRATION; DIVERSITY; CONSERVATION; INFERENCE; SOFTWARE; DIFFERENTIATION; INDIVIDUALS; BOTTLENECK; DISTANCE	Rangewide studies of genetic parameters can elucidate patterns and processes that operate only over large geographic scales. Herein, we present a rangewide population genetic assessment of the eastern box turtle Terrapene c. carolina, a species that is in steep decline across its range. To inform conservation planning for this species, we address the hypothesis that disruptions to demographic and movement parameters associated with the decline of the eastern box turtle has resulted in distinctive genetic signatures in the form of low genetic diversity, high population structuring, and decreased gene flow. We used microsatellite genotype data from (n = 799) individuals from across the species range to perform two Bayesian population assignment approaches, two methods for comparing historical and contemporary migration among populations, an evaluation of isolation by distance, and a method for detecting barriers to gene flow. Both Bayesian methods of population assignment indicated that there are two populations rangewide, both of which have maintained high levels of genetic diversity (H-O = 0.756). Evidence of isolation by distance was detected in this species at a spatial scale of 300 - 500 km, and the Appalachian Mountains were identified as the primary barrier to gene flow across the species range. We also found evidence for historical but not contemporary migration between populations. Our prediction of many, highly structured populations across the range was not supported. This may point to cryptic contemporary gene flow, which might in turn be explained by the presence of rare transients in populations. However these data may be influenced by historical signatures of genetic connectivity because individuals of this species can be long-lived.	[Kimble, Steven J. A.; Williams, Rod N.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Rhodes, O. E., Jr.] Savannah River Ecol Lab, Aiken, SC USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Energy (DOE); Savannah River Ecology Laboratory	Kimble, SJA (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	sjkimble@gmail.com			Indiana Department of Natural Resources, Division of Fish and Wildlife, Wildlife Diversity Section, State Wildlife Improvement [E2-08-WDS15]; Indiana Division of Forestry [E-9-6-A558]; Department of Forestry and Natural Resources, Purdue University	Indiana Department of Natural Resources, Division of Fish and Wildlife, Wildlife Diversity Section, State Wildlife Improvement; Indiana Division of Forestry; Department of Forestry and Natural Resources, Purdue University	Support for this project was provided by the Indiana Department of Natural Resources, Division of Fish and Wildlife, Wildlife Diversity Section, State Wildlife Improvement Grant E2-08-WDS15; Indiana Division of Forestry Grant E-9-6-A558; and the Department of Forestry and Natural Resources, Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aresco MJ, 2005, J WILDLIFE MANAGE, V69, P549, DOI 10.2193/0022-541X(2005)069[0549:MMTRHM]2.0.CO;2; AVISE JC, 1988, MOL BIOL EVOL, V5, P331; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bishop JM, 2009, BIOL CONSERV, V142, P2335, DOI 10.1016/j.biocon.2009.05.016; Burke RL, 2011, CHELONIAN CONSERV BI, V10, P256, DOI 10.2744/CCB-0855.1; Butler JM, 2011, BIOL J LINN SOC, V102, P889, DOI 10.1111/j.1095-8312.2011.01625.x; Cook RP, 2010, NPSNCBNNRTR2010380 U; Currylow AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040473; Dharmarajan G, 2013, J WILDLIFE MANAGE, V77, P226, DOI 10.1002/jwmg.458; Dharmarajan G, 2009, CAN J ZOOL, V87, P814, DOI 10.1139/Z09-072; DODD CK, 2001, N AM BOX TURTLES NAT; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ERNST C H, 1974, Transactions of the Kentucky Academy of Science, V35, P27; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Falush D, 2003, GENETICS, V164, P1567; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hagood S, 2009, THESIS U MARYLAND; Hall RJ, 1999, BIOL CONSERV, V88, P165; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KIESTER AR, 1982, EVOLUTION, V36, P617, DOI 10.1111/j.1558-5646.1982.tb05086.x; Kimble SJA, 2011, CONSERV GENET RESOUR, V3, P65, DOI 10.1007/s12686-010-9291-5; Kimble SJA, 2012, J WILDLIFE DIS, V48, P799, DOI 10.7589/0090-3558-48.3.799; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Latch EK, 2008, J HERED, V99, P265, DOI 10.1093/jhered/esn009; Latch EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027794; Lemer S, 2011, J HERED, V102, P243, DOI 10.1093/jhered/esq123; Lerner HRL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007336; Lesica P, 1999, RESTOR ECOL, V7, P42, DOI 10.1046/j.1526-100X.1999.07105.x; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; MADDEN R. C., 1975, THESIS CITY U NEW YO; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; Marsack K, 2009, COPEIA, P647, DOI 10.1643/CE-08-233; McKay JK, 2005, RESTOR ECOL, V13, P432, DOI 10.1111/j.1526-100X.2005.00058.x; METCALF E, 1970, Transactions of the Kansas Academy of Science, V73, P96, DOI 10.2307/3627283; MILLER BK, 1993, HOOSIER FARMLAND WIL, V1, P2; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; Murray J., 1910, REPORTS SCI EXPEDITI, P17; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Palme AE, 2003, MOL ECOL, V12, P201, DOI 10.1046/j.1365-294X.2003.01724.x; Pearse DE, 2006, MOL ECOL, V15, P985, DOI 10.1111/j.1365-294X.2006.02869.x; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2020, R LANG ENV STAT COMP; Rambaut A, 2007, TRACER V 5; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richtsmeier RJ, 2008, CHELONIAN CONSERV BI, V7, P3, DOI 10.2744/CCB-0653.1; Rousset F, 1997, GENETICS, V145, P1219; Sambrook J., 2001, MOL CLONING LAB MANU; Schwartz CW, 1974, 3 TOED BOX TURTLE 1; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; SOKAL RR, 1983, GENETICS, V105, P219; Steen DA, 2004, CONSERV BIOL, V18, P1143, DOI 10.1111/j.1523-1739.2004.00240.x; Steyaert LT, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2006JD008277; STICKEL LF, 1978, COPEIA, P221; Tsai YHE, 2010, P NATL ACAD SCI USA, V107, P17035, DOI 10.1073/pnas.1006225107; Turtle Conservation Genetics Working Group, 2007, Chelonian Research Monographs, V4, P107; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Victory ER, 2006, AM J BOT, V93, P118, DOI 10.3732/ajb.93.1.118; Waples RS, 1995, AM FISH S S, V17, P8; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; WILLIAMS EC, 1987, HERPETOLOGICA, V43, P328; Wilson GA, 2003, GENETICS, V163, P1177; Wright S, 1943, GENETICS, V28, P114	71	13	13	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92274	10.1371/journal.pone.0092274	http://dx.doi.org/10.1371/journal.pone.0092274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647580	gold, Green Submitted, Green Published			2022-12-27	WOS:000333348500105
J	Liu, XL; Ward, BD; Binder, JR; Li, SJ; Hudetz, AG				Liu, Xiaolin; Ward, B. Douglas; Binder, Jeffrey R.; Li, Shi-Jiang; Hudetz, Anthony G.			Scale-Free Functional Connectivity of the Brain Is Maintained in Anesthetized Healthy Participants but Not in Patients with Unresponsive Wakefulness Syndrome	PLOS ONE			English	Article							PROPOFOL-INDUCED LOSS; PERSISTENT VEGETATIVE STATE; SMALL-WORLD; THALAMOCORTICAL CONNECTIVITY; ADAPTIVE-RECONFIGURATION; INDUCED UNCONSCIOUSNESS; NEURONAL AVALANCHES; CEREBRAL METABOLISM; GENERAL-ANESTHESIA; FREE ORGANIZATION	Loss of consciousness in anesthetized healthy participants and in patients with unresponsive wakefulness syndrome (UWS) is associated with substantial alterations of functional connectivity across large-scale brain networks. Yet, a prominent distinction between the two cases is that after anesthesia, brain connectivity and consciousness are spontaneously restored, whereas in patients with UWS this restoration fails to occur, but why? A possible explanation is that the self-organizing capability of the brain is compromised in patients with UWS but not in healthy participants undergoing anesthesia. According to the theory of self-organized criticality, many natural complex systems, including the brain, evolve spontaneously to a critical state wherein system behaviors display spatial and/or temporal scale-invariant characteristics. Here we tested the hypothesis that the scale-free property of brain network organization is in fact fundamentally different between anesthetized healthy participants and UWS patients. We introduced a novel, computationally efficient approach to determine anatomical-functional parcellation of the whole-brain network at increasingly finer spatial scales. We found that in healthy participants, scale-free distributions of node size and node degree were present across wakefulness, propofol sedation, and recovery, despite significant propofol-induced functional connectivity changes. In patients with UWS, the scale-free distribution of node degree was absent, reflecting a fundamental difference between the two groups in adaptive reconfiguration of functional interaction between network components. The maintenance of scale-invariance across propofol sedation in healthy participants suggests the presence of persistent, on-going self-organizing processes to a critical state - a capacity that is compromised in patients with UWS.	[Liu, Xiaolin; Ward, B. Douglas; Li, Shi-Jiang] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Binder, Jeffrey R.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Hudetz, Anthony G.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Hudetz, AG (corresponding author), Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA.	ahudetz@mcw.edu	Li, Shi-Jiang/M-2534-2017; Binder, Jeff/CAJ-3303-2022	Binder, Jeffrey/0000-0002-2233-5640	National Institute of General Medical Sciences of the National Institutes of Health [R01-GM103894]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103894] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01-GM103894. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Agnati LF, 2004, LECT NOTES COMPUT SC, V3146, P24; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alkire MT, 2005, PROG BRAIN RES, V150, P229, DOI 10.1016/S0079-6123(05)50017-7; Alkire MT, 1997, ANESTHESIOLOGY, V86, P549, DOI 10.1097/00000542-199703000-00006; Baars BJ, 2005, PROG BRAIN RES, V150, P45, DOI 10.1016/S0079-6123(05)50004-9; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; BAK P, 1995, P NATL ACAD SCI USA, V92, P6689, DOI 10.1073/pnas.92.15.6689; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beggs JM, 2008, PHILOS T R SOC A, V366, P329, DOI 10.1098/rsta.2007.2092; Boonstra TW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00079; Boubela RN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00168; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chialvo DR, 2004, PHYSICA A, V340, P756, DOI 10.1016/j.physa.2004.05.064; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; de Reus MA, 2013, NEUROIMAGE, V80, P397, DOI 10.1016/j.neuroimage.2013.03.053; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fiset P, 1999, J NEUROSCI, V19, P5506; Fraiman D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00307; Gisiger T, 2001, BIOL REV, V76, P161, DOI 10.1017/S1464793101005607; Hudetz AG, 2012, BRAIN CONNECT, V2, P291, DOI 10.1089/brain.2012.0107; Isono M, 2002, BRAIN INJURY, V16, P705, DOI 10.1080/02699050210127303; Kaiser M, 2007, PHILOS T R SOC A, V365, P3033, DOI 10.1098/rsta.2007.0007; Kello CT, 2010, TRENDS COGN SCI, V14, P223, DOI 10.1016/j.tics.2010.02.005; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Klaus A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019779; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2009, NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY, P1; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 1999, J NEUROL NEUROSUR PS, V67, P121, DOI 10.1136/jnnp.67.1.121; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Lee H, 2013, ANESTHESIOLOGY, V119, P1347, DOI 10.1097/ALN.0b013e3182a8ec8c; Lee U, 2010, ANESTHESIOLOGY, V113, P1081, DOI 10.1097/ALN.0b013e3181f229b5; Liang ZF, 2012, J NEUROSCI, V32, P10183, DOI 10.1523/JNEUROSCI.1020-12.2012; Liu XL, 2013, ANESTHESIOLOGY, V118, P59, DOI 10.1097/ALN.0b013e318277a801; Liu XL, 2012, HUM BRAIN MAPP, V33, P2487, DOI 10.1002/hbm.21385; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Perlin K, 2002, ACM T GRAPHIC, V21, P681, DOI 10.1145/566570.566636; Plourde G, 2006, ANESTHESIOLOGY, V104, P448, DOI 10.1097/00000542-200603000-00011; Ribeiro TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014129; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Schroter MS, 2012, J NEUROSCI, V32, P12832, DOI 10.1523/JNEUROSCI.6046-11.2012; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2012, CLIN NEUROPHYSIOL, V123, P1067, DOI 10.1016/j.clinph.2012.01.011; Stam CJ, 2004, HUM BRAIN MAPP, V22, P97, DOI 10.1002/hbm.20016; Steyn-Ross ML, 2004, PROG BIOPHYS MOL BIO, V85, P369, DOI 10.1016/j.pbiomolbio.2004.02.001; SteynRoss DA, 2010, SPR SER COMPUT NEURO, V4, P1; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Touboul J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008982; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Werner G, 2007, J PHYSIOL-PARIS, V101, P273, DOI 10.1016/j.jphysparis.2007.12.001; Werner G, 2007, BIOSYSTEMS, V90, P496, DOI 10.1016/j.biosystems.2006.12.001; Werner G, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00015; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0; Zhou JS, 2011, CONSCIOUS COGN, V20, P257, DOI 10.1016/j.concog.2010.08.003	68	28	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92182	10.1371/journal.pone.0092182	http://dx.doi.org/10.1371/journal.pone.0092182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647227	gold, Green Published			2022-12-27	WOS:000333348500095
J	Nugraha, C; Bora, M; Venkatraman, SS				Nugraha, Chandra; Bora, Meghali; Venkatraman, Subbu S.			Release Retardation of Model Protein on Polyelectrolyte-Coated PLGA Nano- and Microparticles	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; POLYMERIC MICROSPHERES; MULTILAYERED LIPOSOMES; ORAL DELIVERY; NANOPARTICLES; NANOCAPSULES; CELLS; FILMS; FUNCTIONALIZATION; PARTICLES	PEM capsules have been proposed for vehicles of drug microencapsulation, with the release triggered by pH, salt, magnetic field, or light. When built on another carrier encapsulating drugs, such as nanoparticles, it could provide additional release barrier to the releasing drug, providing further control to drug release. Although liposomes have received considerable attention with PEM coating for sustained drug release, similar results employing PEM built on poly(lactic-co-lycolic acid) (PLGA) particles is scant. In this work, we demonstrate that the build-up pH and polyelectrolyte pairs of PEM affect the release retardation of BSA from PLGA particles. PAH/PSS pair, the most commonly used polyelectrolyte pair, was used in comparison with PLL/DES. In addition, we also demonstrate that the release retardation effect of PEM-coated PLGA particles diminishes as the particle size increases. We attribute this to the diminishing relative thickness of the PEM coating with respect to the size of the particle as the particle size increases, reducing the diffusional resistance of the PEM.	[Nugraha, Chandra; Bora, Meghali; Venkatraman, Subbu S.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Venkatraman, SS (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.	assubbu@ntu.edu.sg	Venkatraman, Subramanian/A-2228-2011	Venkatraman, Subramanian/0000-0002-8693-1070; Bora, Meghali/0000-0002-8676-6810	National Research Foundation	National Research Foundation	This study was supported by the grant from National Research Foundation (http://www.nrf.gov.sg/) under the Competitive Research Programme Funding Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AO, 2008, J PHARM SCI-US, V97, P2448, DOI 10.1002/jps.21215; Acharya S, 2011, ADV DRUG DELIVER REV, V63, P170, DOI 10.1016/j.addr.2010.10.008; Anandhakumar S, 2010, COLLOID SURFACE B, V78, P266, DOI 10.1016/j.colsurfb.2010.03.016; Antipov AA, 2001, J PHYS CHEM B, V105, P2281, DOI 10.1021/jp002184+; Antipov AA, 2004, ADV COLLOID INTERFAC, V111, P49, DOI 10.1016/j.cis.2004.07.006; Ball V, 2002, J PHYS CHEM B, V106, P2357, DOI 10.1021/jp012522m; Bordi F, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/20/203102; Crouzier T, 2009, BIOMACROMOLECULES, V10, P433, DOI 10.1021/bm8012378; Cuomo F, 2012, SOFT MATTER, V8, P4415, DOI 10.1039/c2sm07388a; De Geest BG, 2007, CHEM SOC REV, V36, P636, DOI 10.1039/b600460c; Dejeu J, 2006, COLLOID SURFACE A, V288, P26, DOI 10.1016/j.colsurfa.2006.03.050; Fischer S, 2006, J CONTROL RELEASE, V111, P135, DOI 10.1016/j.jconrel.2005.11.015; Fischer S, 2007, BIOMATERIALS, V28, P994, DOI 10.1016/j.biomaterials.2006.10.034; Fujimoto K, 2007, MACROMOLECULES, V40, P5122, DOI 10.1021/ma070477w; Gebhart B., 1993, HEAT CONDUCTION MASS; Gillies G, 2007, J PHYS CHEM B, V111, P8626, DOI 10.1021/jp069009z; Girod S, 2004, CARBOHYD POLYM, V55, P37, DOI 10.1016/j.carbpol.2003.07.006; Gupta GK, 2011, AAPS PHARMSCITECH, V12, P344, DOI 10.1208/s12249-011-9593-2; Haidar ZS, 2008, BIOMATERIALS, V29, P1207, DOI 10.1016/j.biomaterials.2007.11.012; Huang XB, 2013, CARBOHYD POLYM, V92, P1064, DOI 10.1016/j.carbpol.2012.10.063; Jain P, 2009, MOL PHARMACEUT, V6, P593, DOI 10.1021/mp8002539; Jain S, 2012, MOL PHARMACEUT, V9, P2626, DOI 10.1021/mp300202c; Jain S, 2012, BIOMATERIALS, V33, P6758, DOI 10.1016/j.biomaterials.2012.05.026; Kakade S, 2009, INT J PHARMACEUT, V365, P44, DOI 10.1016/j.ijpharm.2008.08.019; Kato N, 2002, MACROMOLECULES, V35, P9780, DOI 10.1021/ma0209388; Keren K, 2002, PHYS REV LETT, V89, P4; Kittitheeranun P, 2010, LANGMUIR, V26, P6869, DOI 10.1021/la1003676; Luo RC, 2012, SMALL, V8, P2585, DOI 10.1002/smll.201200398; Monge C, 2012, TISSUE ENG PT A, V18, P1664, DOI [10.1089/ten.tea.2012.0079, 10.1089/ten.TEA.2012.0079]; Na K, 2007, J AM CHEM SOC, V129, P5788, DOI 10.1021/ja067707r; Palama IE, 2013, BIOTECHNOL BIOENG, V110, P586, DOI 10.1002/bit.24626; Pechenkin MA, 2012, SOFT MATTER, V8, P8659, DOI 10.1039/c2sm25971k; SACCO D, 1986, FEBS LETT, V199, P254, DOI 10.1016/0014-5793(86)80490-2; Salis A, 2011, LANGMUIR, V27, P11597, DOI 10.1021/la2024605; Sato K, 2012, POLYM BULL, V68, P891, DOI 10.1007/s00289-011-0670-1; Sennato S, 2009, COLLOID SURFACE A, V343, P34, DOI 10.1016/j.colsurfa.2009.01.026; Shu SJ, 2010, BIOMATERIALS, V31, P6039, DOI 10.1016/j.biomaterials.2010.04.016; Shu SJ, 2010, ACTA BIOMATER, V6, P210, DOI 10.1016/j.actbio.2009.06.020; Sukhorukov GB, 1998, COLLOID SURFACE A, V137, P253, DOI 10.1016/S0927-7757(98)00213-1; Tripathy J, 2013, COLLOID SURFACE B, V101, P487, DOI 10.1016/j.colsurfb.2012.07.025; van der Walle CF, 2009, EXPERT OPIN DRUG DEL, V6, P177, DOI [10.1517/17425240802680169, 10.1517/17425240802680169 ]; Volodkin D, 2007, J CONTROL RELEASE, V117, P111, DOI 10.1016/j.jconrel.2006.10.021; Wang ZJ, 2009, COLLOID SURFACE A, V348, P137, DOI 10.1016/j.colsurfa.2009.07.008; Yang YW, 2008, BIOMATERIALS, V29, P2516, DOI 10.1016/j.biomaterials.2008.02.015; Yang YY, 2001, BIOMATERIALS, V22, P231, DOI 10.1016/S0142-9612(00)00178-2; Zhang JX, 2004, J MICROENCAPSUL, V21, P775, DOI 10.1080/02652040400008465; Zhao QH, 2008, NANOMED-NANOTECHNOL, V4, P302, DOI 10.1016/j.nano.2008.06.004; Zhou J, 2010, J COLLOID INTERF SCI, V345, P241, DOI 10.1016/j.jcis.2010.02.004; Zhou J, 2009, MACROMOL BIOSCI, V9, P326, DOI 10.1002/mabi.200800188	49	6	6	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92393	10.1371/journal.pone.0092393	http://dx.doi.org/10.1371/journal.pone.0092393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647768	Green Published, gold			2022-12-27	WOS:000333348500125
J	Moloney, TM; Witney, AG				Moloney, Tonya M.; Witney, Alice G.			Pressure Pain Thresholds Increase after Preconditioning 1 Hz Repetitive Transcranial Magnetic Stimulation with Transcranial Direct Current Stimulation	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; NEUROPATHIC PAIN; HOMEOSTATIC METAPLASTICITY; INTRACORTICAL INHIBITION; ELECTRICAL-STIMULATION; WRITERS CRAMP; FIBROMYALGIA; TDCS; EXCITABILITY; MODULATION	Background: The primary motor cortex (M1) is an effective target of non-invasive cortical stimulation (NICS) for pain threshold modulation. It has been suggested that the initial level of cortical excitability of M1 plays a key role in the plastic effects of NICS. Objective: Here we investigate whether transcranial direct current stimulation (tDCS) primed 1 Hz repetitive transcranial magnetic stimulation (rTMS) modulates experimental pressure pain thresholds and if this is related to observed alterations in cortical excitability. Method: 15 healthy, male participants received 10 min 1 mA anodal, cathodal and sham tDCS to the left M1 before 15 min 1 Hz rTMS in separate sessions over a period of 3 weeks. Motor cortical excitability was recorded at baseline, post-tDCS priming and post-rTMS through recording motor evoked potentials (MEPs) from right FDI muscle. Pressure pain thresholds were determined by quantitative sensory testing (QST) through a computerized algometer, on the palmar thenar of the right hand pre- and post-stimulation. Results: Cathodal tDCS-primed 1 Hz-rTMS was found to reverse the expected suppressive effect of 1 Hz rTMS on cortical excitability; leading to an overall increase in activity (p < 0.001) with a parallel increase in pressure pain thresholds (p < 0.01). In contrast, anodal tDCS-primed 1 Hz-rTMS resulted in a corresponding decrease in cortical excitability (p < 0.05), with no significant effect on pressure pain. Conclusion: This study demonstrates that priming the M1 before stimulation of 1 Hz-rTMS modulates experimental pressure pain thresholds in a safe and controlled manner, producing a form of analgesia.	[Moloney, Tonya M.] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dept Physiol, Dublin, Ireland; Trinity Coll Dublin, Trinity Ctr BioEngn, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Moloney, TM (corresponding author), Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dept Physiol, Dublin, Ireland.	molonet@tcd.ie	Witney, Alice G./AAH-3107-2021	Witney, Alice G./0000-0002-3726-8479	Department of Physiology, Trinity College, Dublin	Department of Physiology, Trinity College, Dublin	This study was supported by the Department of Physiology, Trinity College, Dublin [http://www.tcd.ie/Graduate_Studies/prospectivestudents/awards/studentships/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2008, CEREB CORTEX, V18, P2701, DOI 10.1093/cercor/bhn032; Antal A, 2010, J PAIN SYMPTOM MANAG, V39, P890, DOI 10.1016/j.jpainsymman.2009.09.023; Bachmann CG, 2010, CLIN NEUROPHYSIOL, V121, P2083, DOI 10.1016/j.clinph.2010.05.005; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Borckardt JJ, 2011, CLIN J PAIN, V27, P486, DOI 10.1097/AJP.0b013e31820d2733; Borckardt JJ, 2006, J ECT, V22, P259, DOI 10.1097/01.yct.0000244248.40662.9a; Carli G, 2002, PAIN, V100, P259, DOI 10.1016/S0304-3959(02)00297-X; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Cosentino G, 2012, EUR J NEUROSCI, V35, P119, DOI 10.1111/j.1460-9568.2011.07939.x; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P525, DOI 10.1007/s002210050649; FISCHER AA, 1987, PAIN, V30, P115, DOI 10.1016/0304-3959(87)90089-3; Fregni F, 2007, LANCET NEUROL, V6, P188, DOI 10.1016/S1474-4422(07)70032-7; Garcia-Larrea L, 1999, PAIN, V83, P259, DOI 10.1016/S0304-3959(99)00114-1; Garcia-Larrea L, 2007, NEUROIMAGE, V37, pS71, DOI 10.1016/j.neuroimage.2007.05.062; Harstall C, 2003, PAIN CLIN UPDATES, V11, P1, DOI DOI 10.1016/S1070-7212(03)00004-6; Harte SE, 2013, MED BIOL ENG COMPUT, P1, DOI DOI 10.1002/MMA.2899; Lang N, 2004, BIOL PSYCHIAT, V56, P634, DOI 10.1016/j.biopsych.2004.07.017; Lefaucheur JP, 2006, NEUROLOGY, V67, P1568, DOI 10.1212/01.wnl.0000242731.10074.3c; Lucas JM, 2011, PAIN, V152, P1398, DOI 10.1016/j.pain.2011.02.025; Marlow NM, 2013, PAIN PRACT, V13, P131, DOI 10.1111/j.1533-2500.2012.00562.x; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Moloney TM, 2013, NEUROSCI LETT, V534, P289, DOI 10.1016/j.neulet.2012.11.049; Mylius V, 2012, PAIN, V153, P1350, DOI 10.1016/j.pain.2012.04.009; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; O'Connell NE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008208.pub2; Peyron R, 2007, NEUROIMAGE, V34, P310, DOI 10.1016/j.neuroimage.2006.08.037; Pleger B, 2004, NEUROSCI LETT, V356, P87, DOI 10.1016/j.neulet.2003.11.037; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Ruohonen J, 2012, CLIN NEUROPHYSIOL, V123, P2006, DOI 10.1016/j.clinph.2012.02.082; Schepers RJ, 2010, NEUROSCI BIOBEHAV R, V34, P177, DOI 10.1016/j.neubiorev.2009.10.003; Siebner HR, 1999, NEUROSCI LETT, V262, P133, DOI 10.1016/S0304-3940(99)00056-7; Siebner HR, 1999, NEUROLOGY, V52, P529, DOI 10.1212/WNL.52.3.529; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Summers J, 2004, NEUROSCI LETT, V368, P197, DOI 10.1016/j.neulet.2004.07.008; Tamura Y, 2004, PAIN, V107, P107, DOI 10.1016/j.pain.2003.10.011; Treede RD, 2002, PAIN, V98, P235, DOI 10.1016/S0304-3959(02)00203-8; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Valle Angela, 2009, J Pain Manag, V2, P353; Villamar MF, 2013, J PAIN, V14, P371, DOI 10.1016/j.jpain.2012.12.007; Wiethoff S, 2014, BRAIN STIMUL, V7, P468, DOI 10.1016/j.brs.2014.02.003; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zaghi Soroush, 2009, J Pain Manag, V2, P339; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003	45	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92540	10.1371/journal.pone.0092540	http://dx.doi.org/10.1371/journal.pone.0092540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658333	gold, Green Submitted, Green Published			2022-12-27	WOS:000333355300096
J	Sergeant, MJ; Constantinidou, C; Cogan, TA; Bedford, MR; Penn, CW; Pallen, MJ				Sergeant, Martin J.; Constantinidou, Chrystala; Cogan, Tristan A.; Bedford, Michael R.; Penn, Charles W.; Pallen, Mark J.			Extensive Microbial and Functional Diversity within the Chicken Cecal Microbiome	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE GENES; GASTROINTESTINAL-TRACT; GUT MICROFLORA; DIETARY FIBER; AVIAN CECUM; BACTERIAL; METABOLISM; ACID; SUPPLEMENTATION; PURIFICATION	Chickens are major source of food and protein worldwide. Feed conversion and the health of chickens relies on the largely unexplored complex microbial community that inhabits the chicken gut, including the ceca. We have carried out deep microbial community profiling of the microbiota in twenty cecal samples via 16S rRNA gene sequences and an in-depth metagenomics analysis of a single cecal microbiota. We recovered 699 phylotypes, over half of which appear to represent previously unknown species. We obtained 648,251 environmental gene tags (EGTs), the majority of which represent new species. These were binned into over two-dozen draft genomes, which included Campylobacter jejuni and Helicobacter pullorum. We found numerous polysaccharide- and oligosaccharide-degrading enzymes encoding within the metagenome, some of which appeared to be part of polysaccharide utilization systems with genetic evidence for the co-ordination of polysaccharide degradation with sugar transport and utilization. The cecal metagenome encodes several fermentation pathways leading to the production of short-chain fatty acids, including some with novel features. We found a dozen uptake hydrogenases encoded in the metagenome and speculate that these provide major hydrogen sinks within this microbial community and might explain the high abundance of several genera within this microbiome, including Campylobacter, Helicobacter and Megamonas.	[Sergeant, Martin J.; Constantinidou, Chrystala; Pallen, Mark J.] Univ Warwick, Warwick Med Sch, Div Microbiol & Infect, Coventry CV4 7AL, W Midlands, England; [Cogan, Tristan A.] Sch Clin Vet Sci, Bristol, Avon, England; [Bedford, Michael R.] AB Vista Feed Ingredients, Marlborough, MA USA; [Penn, Charles W.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England	University of Warwick; University of Bristol; University of Birmingham	Pallen, MJ (corresponding author), Univ Warwick, Warwick Med Sch, Div Microbiol & Infect, Coventry CV4 7AL, W Midlands, England.	m.pallen@warwick.ac.uk	Bedford, Michael/AAV-8204-2020	Bedford, Michael/0000-0002-5308-4290; Sergeant, Martin/0000-0001-7264-2668; Pallen, Mark/0000-0003-1807-3657	BBSRC; Biotechnology and Biological Sciences Research Council [BB/H019340/2, BB/H019340/1] Funding Source: researchfish; BBSRC [BB/H019340/2, BB/H019340/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Amit-Romach E, 2004, POULTRY SCI, V83, P1093, DOI 10.1093/ps/83.7.1093; Apajalahti J, 2005, J APPL POULTRY RES, V14, P444, DOI 10.1093/japr/14.2.444; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bott M, 1997, EUR J BIOCHEM, V250, P590, DOI 10.1111/j.1432-1033.1997.0590a.x; Burt DW, 2007, POULTRY SCI, V86, P1460, DOI 10.1093/ps/86.7.1460; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CLENCH MH, 1995, WILSON BULL, V107, P93; Clokie Martha Rj, 2011, Bacteriophage, V1, P31, DOI 10.4161/bact.1.1.14942; COLBY GD, 1992, APPL ENVIRON MICROB, V58, P3297, DOI 10.1128/AEM.58.10.3297-3302.1992; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Darwin Ch., 1868, P411; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Eastwood M, 1995, DIETARY FIBRE MECH A; Eddy SR, 1998, FASEB J, V12, pA1327; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Eeckhaut V, 2011, MICROB BIOTECHNOL, V4, P503, DOI 10.1111/j.1751-7915.2010.00244.x; Fumihito A, 1996, P NATL ACAD SCI USA, V93, P6792, DOI 10.1073/pnas.93.13.6792; Gagen EJ, 2010, APPL ENVIRON MICROB, V76, P7785, DOI 10.1128/AEM.01679-10; Gross R, 2003, FEMS MICROBIOL LETT, V227, P197, DOI 10.1016/S0378-1097(03)00681-5; Harre R, 1981, ARISTOTLE EMBRYOLOGY, P31; HEGDE SN, 1982, BRIT J NUTR, V48, P73, DOI 10.1079/BJN19820089; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Howlett RM, 2012, MICROBIOL-SGM, V158, P1645, DOI 10.1099/mic.0.054130-0; Hubener K, 2002, ARCH ANIM NUTR, V56, P167, DOI 10.1080/00039420214191; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Jorgensen H, 1996, BRIT J NUTR, V75, P379, DOI 10.1079/BJN19960141; Jozefiak D, 2004, ANIM FEED SCI TECH, V113, P1, DOI 10.1016/j.anifeedsci.2003.09.007; Karasawa Y, 1999, J EXP ZOOL, V283, P418, DOI 10.1002/(SICI)1097-010X(19990301/01)283:4/5&lt;418::AID-JEZ11&gt;3.0.CO;2-G; Kien CL, 2007, J NUTR, V137, P916, DOI 10.1093/jn/137.4.916; Kim T, 2011, METHODS MOL BIOL, V733, P185, DOI 10.1007/978-1-61779-089-8_13; Lan PTN, 2002, MICROBIOL IMMUNOL, V46, P371, DOI 10.1111/j.1348-0421.2002.tb02709.x; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Louis P, 2007, FEMS MICROBIOL LETT, V269, P240, DOI 10.1111/j.1574-6968.2006.00629.x; Louis P, 2007, APPL ENVIRON MICROB, V73, P2009, DOI 10.1128/AEM.02561-06; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; MCNAB JM, 1973, WORLD POULTRY SCI J, V29, P251, DOI 10.1079/WPS19730014; McWhorter TJ, 2009, BIOL REV, V84, P533, DOI 10.1111/j.1469-185X.2009.00086.x; MEAD GC, 1989, J EXP ZOOL, P48, DOI 10.1002/jez.1402520508; Medie FM, 2012, NAT REV MICROBIOL, V10, P227, DOI 10.1038/nrmicro2729; Meimandipour A, 2011, ARCH GEFLUGELKD, V75, P164; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; OBST BS, 1989, J EXP ZOOL, P117, DOI 10.1002/jez.1402520519; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Saengkerdsub S, 2007, APPL ENVIRON MICROB, V73, P353, DOI 10.1128/AEM.01931-06; SALANITR.JP, 1974, APPL MICROBIOL, V28, P439, DOI 10.1128/AEM.28.3.439-447.1974; SALANITRO JP, 1978, APPL ENVIRON MICROB, V35, P782, DOI 10.1128/AEM.35.4.782-790.1978; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sergeant MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038094; STAMS AJM, 1994, ANTON LEEUW INT J G, V66, P271, DOI 10.1007/BF00871644; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Torok VA, 2011, APPL ENVIRON MICROB, V77, P3380, DOI 10.1128/AEM.02300-10; Van Immerseel F, 2005, POULTRY SCI, V84, P1851, DOI 10.1093/ps/84.12.1851; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Zhou W, 2012, APPL ENVIRON MICROB, V78, P3028, DOI 10.1128/AEM.06920-11; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002	70	262	279	1	182	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91941	10.1371/journal.pone.0091941	http://dx.doi.org/10.1371/journal.pone.0091941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24657972	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300046
J	Wijgerde, T; van Melis, A; Silva, CIF; Leal, MC; Vogels, L; Mutter, C; Osinga, R				Wijgerde, Tim; van Melis, Anne; Silva, Catarina I. F.; Leal, Miguel C.; Vogels, Luc; Mutter, Claudia; Osinga, Ronald			Red Light Represses the Photophysiology of the Scleractinian Coral Stylophora pistillata	PLOS ONE			English	Review							GREEN FLUORESCENT PROTEIN; REEF-BUILDING CORALS; CHLOROPHYLL BIOSYNTHESIS; ZINC TOXICITY; CELL-CYCLE; ZOOXANTHELLAE; PHOTOSYNTHESIS; AQUACULTURE; PERFORMANCE; PIGMENTS	Light spectrum plays a key role in the biology of symbiotic corals, with blue light resulting in higher coral growth, zooxanthellae density, chlorophyll a content and photosynthesis rates as compared to red light. However, it is still unclear whether these physiological processes are blue-enhanced or red-repressed. This study investigated the individual and combined effects of blue and red light on the health, zooxanthellae density, photophysiology and colouration of the scleractinian coral Stylophora pistillata over 6 weeks. Coral fragments were exposed to blue, red, and combined 50/50% blue red light, at two irradiance levels (128 and 256 mu mol m(-2) s(-1)). Light spectrum affected the health/survival, zooxanthellae density, and NDVI (a proxy for chlorophyll a content) of S. pistillata. Blue light resulted in highest survival rates, whereas red light resulted in low survival at 256 mu mol m(-2) s(-1). Blue light also resulted in higher zooxanthellae densities compared to red light at 256 mu mol m(-2) s(-1), and a higher NDVI compared to red and combined blue red light. Overall, our results suggest that red light negatively affects the health, survival, symbiont density and NDVI of S. pistillata, with a dominance of red over blue light for NDVI.	[Wijgerde, Tim; van Melis, Anne; Osinga, Ronald] Wageningen Univ, Dept Anim Sci, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands; [Wijgerde, Tim; van Melis, Anne; Osinga, Ronald] Res Ctr, Wageningen, Netherlands; [Silva, Catarina I. F.] Royal Netherlands Inst Sea Res, Texel, Netherlands; [Leal, Miguel C.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Leal, Miguel C.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Leal, Miguel C.] Univ Georgia, Skidaway Inst Oceanog, Savannah, GA USA; [Vogels, Luc; Mutter, Claudia] Philips Lighting BG Light Sources & Elect LED Pla, Eindhoven, Netherlands	Wageningen University & Research; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Universidade de Aveiro; Universidade de Aveiro; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography; Philips	Wijgerde, T (corresponding author), Wageningen Univ, Dept Anim Sci, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands.	wijgerde@coralpublications.com	Leal, Miguel Costa/C-8611-2009	Leal, Miguel Costa/0000-0003-0672-6251	EU [244161]	EU(European Commission)	This study was funded by the EU Seventh Framework Programme (FP7 / 2007-2013) under grant agreement no. 244161 (FORCE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIA, 1995, PHYTOCHEMISTRY, V39, P45, DOI 10.1016/0031-9422(94)00919-K; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Brunelle SA, 2007, J PHYCOL, V43, P509, DOI 10.1111/j.1529-8817.2007.00339.x; D'Angelo C, 2008, MAR ECOL PROG SER, V364, P97, DOI 10.3354/meps07588; Daniels WMU, 2004, METAB BRAIN DIS, V19, P79, DOI 10.1023/B:MEBR.0000027419.79032.bd; DAVIES PS, 1984, CORAL REEFS, V2, P181; DemmigAdams B, 1996, PLANTA, V198, P460, DOI 10.1007/BF00620064; Dove SG, 2001, CORAL REEFS, V19, P197, DOI 10.1007/PL00006956; Ferrier-Pages C, 2005, CORAL REEFS, V24, P636, DOI 10.1007/s00338-005-0045-x; Gilmore AM, 2003, PHOTOCHEM PHOTOBIOL, V77, P515, DOI 10.1562/0031-8655(2003)077<0515:STROTE>2.0.CO;2; HALLDAL P, 1968, BIOL BULL, V134, P411, DOI 10.2307/1539860; Hoadley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019755; HUANG XD, 1995, ECOTOX ENVIRON SAFE, V32, P194, DOI 10.1006/eesa.1995.1102; Huq E, 2004, SCIENCE, V305, P1937, DOI 10.1126/science.1099728; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Iglesias-Prieto R, 1997, MAR BIOL, V130, P23, DOI 10.1007/s002270050221; JEFFREY SW, 1968, BIOL BULL, V135, P149, DOI 10.2307/1539622; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; KINZIE RA, 1987, MAR BIOL, V94, P95, DOI 10.1007/BF00392902; KINZIE RA, 1984, MAR BIOL, V78, P239, DOI 10.1007/BF00393009; Leal MC, 2013, TRENDS BIOTECHNOL, V31, P555, DOI 10.1016/j.tibtech.2013.06.004; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Liu XC, 2013, PLANT CELL, V25, P1258, DOI 10.1105/tpc.113.109710; Mass T, 2010, J EXP BIOL, V213, P4084, DOI 10.1242/jeb.039891; Matz MV, 2006, PHOTOCHEM PHOTOBIOL, V82, P345, DOI 10.1562/2005-08-18-RA-653; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Osinga R, 2011, MAR BIOTECHNOL, V13, P658, DOI 10.1007/s10126-011-9382-7; Palmer CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007298; Prasad KVSK, 1999, ENVIRON EXP BOT, V42, P1, DOI 10.1016/S0098-8472(99)00013-1; Reef R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007995; Reichelt-Brushett AJ, 2005, CORAL REEFS, V24, P524, DOI 10.1007/s00338-005-0013-5; Rocha RJM, 2013, AQUACULTURE, V414, P235, DOI 10.1016/j.aquaculture.2013.08.018; Rocha RJM, 2013, AQUACULTURE, V402, P38, DOI 10.1016/j.aquaculture.2013.03.028; Rocha RJM, 2013, AQUACULTURE, V388, P24, DOI 10.1016/j.aquaculture.2013.01.013; Rouse W., 1973, P 3 ETRS S, VI, P309; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Sheridan C, 2013, AQUACULTURE, V396, P124, DOI 10.1016/j.aquaculture.2013.02.037; Shoguchi E, 2013, GENE, V515, P426, DOI 10.1016/j.gene.2012.12.038; Sorek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043264; Titlyanov EA, 2002, RUSS J MAR BIOL, V28, pS19; Wang LH, 2008, CORAL REEFS, V27, P823, DOI 10.1007/s00338-008-0434-z; Wilmann PG, 2005, J MOL BIOL, V349, P223, DOI 10.1016/j.jmb.2005.03.020	43	33	34	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92781	10.1371/journal.pone.0092781	http://dx.doi.org/10.1371/journal.pone.0092781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658108	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300128
J	Barhoumi, R; Mouneimne, Y; Chapkin, RS; Burghardt, RC				Barhoumi, Rola; Mouneimne, Youssef; Chapkin, Robert S.; Burghardt, Robert C.			Effects of Fatty Acids on Benzo[a]pyrene Uptake and Metabolism in Human Lung Adenocarcinoma A549 Cells	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; MULTIPHOTON SPECTRAL-ANALYSIS; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; ANTAGONIST ACTIVITY; BREAST-CANCER; RAT; LIVER; LINES; SUPPLEMENTATION	Dietary supplementation with natural chemoprotective agents is receiving considerable attention because of health benefits and lack of toxicity. In recent in vivo and in vitro experimental studies, diets rich in n-3 polyunsaturated fatty acids have been shown to provide significant anti-tumor action. In this investigation, the effects of control fatty acids (oleic acid (OA), linoleic acid (LA)) and n-3 PUFA, e. g., docosahexaenoic acid (DHA) on the uptake and metabolism of the carcinogenic polycyclic aromatic hydrocarbon, benzo[a] pyrene (BaP) was investigated in A549 cells, a human adenocarcinoma alveolar basal epithelial cell line. A549 cells activate BaP through the cytochrome P450 enzyme system to form reactive metabolites, a few of which covalently bind to DNA and proteins. Therefore, multiphoton microscopy spectral analysis combined with linear unmixing was used to identify the parent compound and BaP metabolites formed in cells, in the presence and absence of fatty acids. The relative abundance of select metabolites was associated with altered P450 activity as determined using ethoxyresorufin-O-deethylase activity in cells cultured in the presence of BSA-conjugated fatty acids. In addition, the parent compound within cellular membranes increases significantly in the presence of each of the fatty acids, with the greatest accumulation observed following DHA treatment. DHA treated cells exhibit significantly lower pyrene-like metabolites indicative of lower adducts including DNA adducts compared to control BSA, OA or LA treated cells. Further, DHA reduced the abundance of the proximate carcinogen BaP 7,8-dihydrodiol and the 3-hydroxybenzo[a]pyene metabolites compared to other treatments. The significant changes in BaP metabolites in DHA treated cells may be mediated by the effects on the physicochemical properties of the membrane known to affect enzyme activity related to phase I and phase II metabolism. In summary, DHA is a highly bioactive chemo-protective agent capable of modulating BaP-induced DNA adducts.	[Barhoumi, Rola; Chapkin, Robert S.; Burghardt, Robert C.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Mouneimne, Youssef] Amer Univ Beirut, KAS CRSL, Beirut, Lebanon; [Chapkin, Robert S.] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; American University of Beirut; Texas A&M University System; Texas A&M University College Station	Barhoumi, R (corresponding author), Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA.	rmouneimne@cvm.tamu.edu	PANTAZI, DESPINA/F-4170-2016; Burghardt, Robert C./AAF-4847-2021	PANTAZI, DESPINA/0000-0002-3534-8889; Burghardt, Robert C./0000-0003-1021-8444; Chapkin, Robert/0000-0002-6515-3898	National Institutes of Health-National Center for Research Resources (NIH-NCRR) [1S10RR22532-01]; NIH [P30-ES09106, P42-ES04917, R01 CA129444]; NATIONAL CANCER INSTITUTE [R01CA129444] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023512, P30ES009106, P42ES004917] Funding Source: NIH RePORTER	National Institutes of Health-National Center for Research Resources (NIH-NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by National Institutes of Health-National Center for Research Resources (NIH-NCRR) (1S10RR22532-01), and NIH grants P30-ES09106, P42-ES04917 and R01 CA129444. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin Z, 2012, CHEM RES TOXICOL, V25, P113, DOI 10.1021/tx200272v; Banni M, 2009, FISH PHYSIOL BIOCHEM, V35, P293, DOI 10.1007/s10695-008-9210-9; BARHOUMI R, 1995, CYTOMETRY, V19, P226, DOI 10.1002/cyto.990190306; Barhoumi R, 2011, TOXICOL APPL PHARM, V253, P45, DOI 10.1016/j.taap.2011.03.009; Barhoumi R, 2009, J TOXICOL SCI, V34, P13, DOI 10.2131/jts.34.13; BEGIN ME, 1985, PROSTA LEUKOTR MED, V19, P177, DOI 10.1016/0262-1746(85)90084-8; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; BROWN ER, 1994, LIPIDS, V29, P825, DOI 10.1007/BF02536249; Calviello G, 1998, INT J CANCER, V75, P699, DOI 10.1002/(SICI)1097-0215(19980302)75:5&lt;699::AID-IJC7&gt;3.0.CO;2-U; CARROLL KK, 1991, NUTR CANCER, V16, P79, DOI 10.1080/01635589109514146; Casper RF, 1999, MOL PHARMACOL, V56, P784; Castell JV, 2005, EXP TOXICOL PATHOL, V57, P189, DOI 10.1016/j.etp.2005.05.008; CAVE WT, 1982, J NATL CANCER I, V68, P319; Chang KW, 1999, LIFE SCI, V65, P1339, DOI 10.1016/S0024-3205(99)00373-2; Chapkin RS, 2008, BBA-BIOMEMBRANES, V1778, P466, DOI 10.1016/j.bbamem.2007.11.003; Dai JF, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-71; DANNENBERG AJ, 1992, J NUTR, V122, P1607, DOI 10.1093/jn/122.8.1607; DONATO MT, 1993, ANAL BIOCHEM, V213, P29, DOI 10.1006/abio.1993.1381; Gammon MD, 2004, ARCH ENVIRON HEALTH, V59, P640, DOI 10.1080/00039890409602948; Gasiewicz TA, 1996, BIOCHEM PHARMACOL, V52, P1787, DOI 10.1016/S0006-2952(96)00600-4; Genies C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078356; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; HATALA MA, 1994, LIPIDS, V29, P831, DOI 10.1007/BF02536250; Kim JH, 1998, CARCINOGENESIS, V19, P1847, DOI 10.1093/carcin/19.10.1847; KINOSHITA N, 1978, SCIENCE, V199, P307, DOI 10.1126/science.619459; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Little JM, 2002, DRUG METAB DISPOS, V30, P531, DOI 10.1124/dmd.30.5.531; Lutz M, 1998, ANN NUTR METAB, V42, P350, DOI 10.1159/000012755; MAHONEY EM, 1977, P NATL ACAD SCI USA, V74, P4895, DOI 10.1073/pnas.74.11.4895; Ramesh A, 2004, INT J TOXICOL, V23, P301, DOI 10.1080/10915810490517063; Registration OotF, 1982, FED REG, V47; SANTOSTEFANO M, 1993, MOL PHARMACOL, V43, P200; Sawada N, 2012, GASTROENTEROLOGY, V142, P1468, DOI 10.1053/j.gastro.2012.02.018; Seo J, 2006, FASEB J, V20, P770, DOI 10.1096/fj.05-4683fje; Shimada T, 2002, CARCINOGENESIS, V23, P1199, DOI 10.1093/carcin/23.7.1199; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; THAKKER DR, 1984, J BIOL CHEM, V259, P1249; Turk HF, 2012, FASEB J, V26; Turk HF, 2012, PLOS ONE, V7; Uno S, 2004, MOL PHARMACOL, V65, P1225, DOI 10.1124/mol.65.5.1225; Uno S, 2006, MOL PHARMACOL, V69, P1103, DOI 10.1124/mol.105.021501; Urani C, 1998, CHEMOSPHERE, V37, P2785, DOI 10.1016/S0045-6535(98)00321-X; Wang LQ, 2004, DRUG METAB DISPOS, V32, P1162, DOI 10.1124/dmd.104.000273; WEEKS SJ, 1991, APPL SPECTROSC, V45, P1093, DOI 10.1366/0003702914336066; WILLIAMS CM, 1994, BRIT J NUTR, V71, P543, DOI 10.1079/BJN19940161; Zhou GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026589; Zhu SQ, 2008, J CHROMATOGR B, V863, P141, DOI 10.1016/j.jchromb.2008.01.018	47	15	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90908	10.1371/journal.pone.0090908	http://dx.doi.org/10.1371/journal.pone.0090908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651647	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800026
J	Bjerke, GA; Pietrzak, K; Melhuish, TA; Frierson, HF; Paschal, BM; Wotton, D				Bjerke, Glen A.; Pietrzak, Karolina; Melhuish, Tiffany A.; Frierson, Henry F., Jr.; Paschal, Bryce M.; Wotton, David			Prostate Cancer Induced by Loss of Apc Is Restrained by TGF beta Signaling	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; TRANSCRIPTION FACTORS; MOLECULAR-GENETICS; ANIMAL-MODELS; CELL-SURVIVAL; MOUSE MODELS; II RECEPTORS; PTEN; GROWTH; PTEN/MMAC1	Recent work with mouse models of prostate cancer (CaP) has shown that inactivation of TGF beta signaling in prostate epithelium can cooperate with deletion of the Pten tumor suppressor to drive locally aggressive cancer and metastatic disease. Here, we show that inactivating the TGF beta pathway by deleting the gene encoding the TGF beta type II receptor (Tgfbr2) in combination with a deletion of the Apc tumor suppressor gene specifically in mouse prostate epithelium, results in the rapid onset of invasive CaP. Micro-metastases were observed in the lymph nodes and lungs of a proportion of the double mutant mice, whereas no metastases were observed in Apc single mutant mice. Prostate-specific Apc; Tgfbr2 mutants had a lower frequency of metastasis and survived significantly longer than Pten; Tgfbr2 double mutants. However, all Apc; Tgfbr2 mutants developed invasive cancer by 30 weeks of age, whereas invasive cancer was rarely observed in Apc single mutant animals, even by one year of age. Further comparison of the Pten and Apc models of CaP revealed additional differences, including adenosquamous carcinoma in the Apc; Tgfbr2 mutants that was not seen in the Pten model, and a lack of robust induction of the TGF beta pathway in Apc null prostate. In addition to causing high-grade prostate intra-epithelial neoplasia (HGPIN), deletion of either Pten or Apc induced senescence in affected prostate ducts, and this restraint was overcome by loss of Tgfbr2. In summary, this work demonstrates that TGF beta signaling restrains the progression of CaP induced by different tumor suppressor mutations, suggesting that TGF beta signaling exerts a general tumor suppressive effect in prostate.	[Bjerke, Glen A.; Pietrzak, Karolina; Melhuish, Tiffany A.; Paschal, Bryce M.; Wotton, David] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; [Bjerke, Glen A.; Pietrzak, Karolina; Melhuish, Tiffany A.; Paschal, Bryce M.; Wotton, David] Univ Virginia, Ctr Cell Signaling, Charlottesville, VA USA; [Pietrzak, Karolina] Univ Lodz, Dept Cytobiochem, PL-90131 Lodz, Poland; [Frierson, Henry F., Jr.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia; University of Lodz; University of Virginia	Wotton, D (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA.	dw2p@virginia.edu		Wotton, David/0000-0002-4652-5350	National Cancer Institute [2P01CA104106]; UVA Cancer Center; CCSG [P30 CA44579]; James and Rebecca CraigFoundation; UVA Women's Oncology fund; NATIONAL CANCER INSTITUTE [P01CA104106, P30CA044579] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UVA Cancer Center; CCSG; James and Rebecca CraigFoundation; UVA Women's Oncology fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Program Project Grant from the National Cancer Institute (2P01CA104106 to B. Paschal and D. Wotton), and by a pilot grant from the UVA Cancer Center (funded from the CCSG P30 CA44579, the James and Rebecca CraigFoundation, and UVA Women's Oncology fund) to D. Wotton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison AA, 2008, PROSTATE, V68, P661, DOI 10.1002/pros.20730; Bartholin L, 2008, DEV BIOL, V319, P285, DOI 10.1016/j.ydbio.2008.04.027; Bjerke GA, 2013, ONCOGENE; Bruxvoort KJ, 2007, CANCER RES, V67, P2490, DOI 10.1158/0008-5472.CAN-06-3028; Cairns P, 1997, CANCER RES, V57, P4997; Chen Y, 2013, EUR J HUM GENET, V21, P929, DOI 10.1038/ejhg.2012.281; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dahia PLM, 2000, ENDOCR-RELAT CANCER, V7, P115, DOI 10.1677/erc.0.0070115; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fine SW, 2012, ADV ANAT PATHOL, V19, P204, DOI 10.1097/PAP.0b013e31825c6b92; Francis JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003180; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Galgano MT, 2009, HUM PATHOL, V40, P1434, DOI 10.1016/j.humpath.2009.02.008; Guo YP, 1997, INT J CANCER, V71, P573, DOI 10.1002/(SICI)1097-0215(19970516)71:4<573::AID-IJC11>3.3.CO;2-1; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Jakel H, 2012, CELL CYCLE, V11, P1910, DOI 10.4161/cc.19957; Jeronimo C, 2011, EUR UROL, V60, P753, DOI 10.1016/j.eururo.2011.06.035; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Kim J, 2012, ONCOGENE, V31, P322, DOI 10.1038/onc.2011.236; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Kypta RM, 2012, NAT REV UROL; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Pearson HB, 2009, CANCER RES, V69, P94, DOI 10.1158/0008-5472.CAN-08-2895; Pienta KJ, 2008, PROSTATE, V68, P629, DOI 10.1002/pros.20726; Powers SE, 2010, DEVELOPMENT, V137, P249, DOI 10.1242/dev.040782; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Roy-Burman P, 2004, ENDOCR-RELAT CANCER, V11, P225, DOI 10.1677/erc.0.0110225; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki H, 1998, CANCER RES, V58, P204; Taniguchi K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002524; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tu WH, 2003, NEOPLASIA, V5, P267, DOI 10.1016/S1476-5586(03)80058-1; Voeller HJ, 1998, CANCER RES, V58, P2520; Wang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041330; Wang SI, 1998, CLIN CANCER RES, V4, P811; Williams RH, 1996, CLIN CANCER RES, V2, P635; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Yamada KM, 2001, J CELL SCI, V114, P2375; Yu XP, 2009, PROSTATE, V69, P249, DOI 10.1002/pros.20877; Zhang Y, 1999, TRENDS CELL BIOL, V9, P274, DOI 10.1016/S0962-8924(99)01579-2; Zhao H, 2005, CANCER-AM CANCER SOC, V104, P44, DOI 10.1002/cncr.21135	60	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92800	10.1371/journal.pone.0092800	http://dx.doi.org/10.1371/journal.pone.0092800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651496	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800158
J	Zucchi, FCR; Yao, YL; Ilnytskyy, Y; Robbins, JC; Soltanpour, N; Kovalchuk, I; Kovalchuk, O; Metz, GAS				Zucchi, Fabiola C. R.; Yao, Youli; Ilnytskyy, Yaroslav; Robbins, Jerrah C.; Soltanpour, Nasrin; Kovalchuk, Igor; Kovalchuk, Olga; Metz, Gerlinde A. S.			Lifetime Stress Cumulatively Programs Brain Transcriptome and Impedes Stroke Recovery: Benefit of Sensory Stimulation	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; ANXIETY-LIKE BEHAVIOR; TACTILE STIMULATION; SKILLED MOVEMENT; MASSAGE THERAPY; CORTICAL INJURY; PRENATAL STRESS; MOTOR FUNCTION; BLOOD-FLOW; EXPRESSION	Prenatal stress (PS) represents a critical variable affecting lifetime health trajectories, metabolic and vascular functions. Beneficial experiences may attenuate the effects of PS and its programming of health outcomes in later life. Here we investigated in a rat model (1) if PS modulates recovery following cortical ischemia in adulthood; (2) if a second hit by adult stress (AS) exaggerates stress responses and ischemic damage; and (3) if tactile stimulation (TS) attenuates the cumulative effects of PS and AS. Prenatally stressed and non-stressed adult male rats underwent focal ischemic motor cortex lesion and were tested in skilled reaching and skilled walking tasks. Two groups of rats experienced recurrent restraint stress in adulthood and one of these groups also underwent daily TS therapy. Animals that experienced both PS and AS displayed the most severe motor disabilities after lesion. By contrast, TS promoted recovery from ischemic lesion and reduced hypothalamic-pituitary-adrenal axis activity. The data also showed that cumulative effects of adverse and beneficial lifespan experiences interact with disease outcomes and brain plasticity through the modulation of gene expression. Microarray analysis of the lesion motor cortex revealed that cumulative PS and AS interact with genes related to growth factors and transcription factors, which were not affected by PS or lesion alone. TS in PS+AS animals reverted these changes, suggesting a critical role for these factors in activity-dependent motor cortical reorganization after ischemic lesion. These findings suggest that beneficial experience later in life can moderate adverse consequences of early programming to improve cerebrovascular health.	[Zucchi, Fabiola C. R.; Yao, Youli; Robbins, Jerrah C.; Soltanpour, Nasrin; Metz, Gerlinde A. S.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Zucchi, Fabiola C. R.] Univ Mato Grosso State, Dept Med, Caceres, MT, Brazil; [Zucchi, Fabiola C. R.] Univ Mato Grosso State, Dept Biol Sci, Caceres, MT, Brazil; [Yao, Youli; Ilnytskyy, Yaroslav; Kovalchuk, Igor; Kovalchuk, Olga] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge; Universidade Estadual de Mato Grosso do Sul; Universidade Estadual de Mato Grosso do Sul; University of Lethbridge	Metz, GAS (corresponding author), Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada.	gerlinde.metz@uleth.ca	Zucchi, Fabiola/K-1296-2017	Zucchi, Fabiola/0000-0002-2252-613X; Metz, Gerlinde/0000-0002-5801-7716	Alberta Innovates - Health Solutions (AI-HS); Preterm Birth and Healthy Outcomes; AI-HS Interdisciplinary Team Grant [200700595]; Hotchkiss Brain Institute; Norlien Foundation; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Alberta Innovates - Health Solutions (AI-HS); Preterm Birth and Healthy Outcomes; AI-HS Interdisciplinary Team Grant; Hotchkiss Brain Institute; Norlien Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by Alberta Innovates - Health Solutions (AI-HS; FZ and GM), Preterm Birth and Healthy Outcomes funded by the AI-HS Interdisciplinary Team Grant #200700595 (GM), Hotchkiss Brain Institute (FZ), Norlien Foundation (FZ), the Canadian Institutes of Health Research (GM), and the Natural Sciences and Engineering Research Council of Canada (GM). GM is a Senior Scholar of Alberta Innovates-Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuhatzira L, 2011, J BIOL CHEM, V286, P42051, DOI 10.1074/jbc.M111.300541; Adlard PA, 2004, NEUROSCIENCE, V124, P985, DOI 10.1016/j.neuroscience.2003.12.039; Arai Y, 2005, J NEUROSCI, V25, P9752, DOI 10.1523/JNEUROSCI.2512-05.2005; Armitage GA, 2010, J CEREBR BLOOD F MET, V30, P1432, DOI 10.1038/jcbfm.2010.73; Babenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029441; Babenko O, 2012, BRAIN RES, V1444, P96, DOI 10.1016/j.brainres.2012.01.038; Bernal GM, 2011, AGING CELL, V10, P466, DOI 10.1111/j.1474-9726.2011.00694.x; Bernal-Pacheco O, 2007, J NEUROL SCI, V262, P60, DOI 10.1016/j.jns.2007.06.026; Birger Y, 2003, EMBO J, V22, P1665, DOI 10.1093/emboj/cdg142; Bruno E, 2010, NEUROSCI LETT, V482, P112, DOI 10.1016/j.neulet.2010.07.012; Canu MH, 2007, BEHAV NEUROSCI, V121, P177, DOI 10.1037/0735-7044.121.1.177; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cohen DRS, 2003, MOL CELL NEUROSCI, V22, P417, DOI 10.1016/S1044-7431(03)00026-5; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Crane JD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002882; Devaux J, 2008, J CELL BIOL, V183, P909, DOI 10.1083/jcb.200808034; DeVries AC, 2001, P NATL ACAD SCI USA, V98, P11824, DOI 10.1073/pnas.201215298; Donoyama N, 2011, J ALTERN COMPLEM MED, V17, P553, DOI 10.1089/acm.2010.0209; Faraji J, 2013, BEHAV BRAIN RES, V253, P78, DOI 10.1016/j.bbr.2013.07.022; Field T, 2002, MED CLIN N AM, V86, P163, DOI 10.1016/S0025-7125(03)00078-6; Field T, 1996, INT J NEUROSCI, V86, P197, DOI 10.3109/00207459608986710; FIELD TM, 1986, PEDIATRICS, V77, P654; Furusawa T, 2006, MOL CELL BIOL, V26, P592, DOI 10.1128/MCB.26.2.592-604.2006; Garcia-Caceres C, 2011, ENDOCRINOLOGY, V152, P1809, DOI 10.1210/en.2010-1252; Gibb RL, 2010, BEHAV BRAIN RES, V214, P102, DOI 10.1016/j.bbr.2010.04.008; Gray JD, 2012, NEUROSCIENCE; Guzzetta A, 2009, J NEUROSCI, V29, P6042, DOI 10.1523/JNEUROSCI.5548-08.2009; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hauser J, 2008, ENDOCRINOLOGY, V149, P6343, DOI 10.1210/en.2008-0615; Hellstrom IC, 2012, PHILOS T R SOC B, V367, P2495, DOI 10.1098/rstb.2012.0223; Holmes MC, 2006, J NEUROSCI, V26, P3840, DOI 10.1523/JNEUROSCI.4464-05.2006; Hsu FC, 2003, P NATL ACAD SCI USA, V100, P12213, DOI 10.1073/pnas.2131679100; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jadavji NM, 2006, NEUROSCIENCE, V140, P1127, DOI 10.1016/j.neuroscience.2006.03.027; Jadavji NM, 2008, BEHAV BRAIN RES, V195, P251, DOI 10.1016/j.bbr.2008.09.011; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Kirkland SW, 2008, BRAIN RES, V1201, P151, DOI 10.1016/j.brainres.2008.01.032; Kirkland SW, 2012, J INTEGR NEUROSCI, V11, P33, DOI 10.1142/S0219635212500033; Knieling M, 2009, NEUROSCIENCE, V163, P759, DOI 10.1016/j.neuroscience.2009.07.004; Kolb B, 2010, BEHAV BRAIN RES, V214, P115, DOI 10.1016/j.bbr.2010.04.024; Koning-Tijssen M. A. J., 1993, GENEREVIEWS; Kovalchuk I, 2007, MUTAT RES-FUND MOL M, V624, P101, DOI 10.1016/j.mrfmmm.2007.04.009; KUHN CM, 1991, J PEDIATR-US, V119, P434, DOI 10.1016/S0022-3476(05)82059-1; Laloux C, 2012, PSYCHONEUROENDOCRINO, V37, P1646, DOI 10.1016/j.psyneuen.2012.02.010; Li Y, 2007, J CEREBR BLOOD F MET, V27, P1043, DOI 10.1038/sj.jcbfm.9600417; Lim JH, 2004, MOL CELL, V15, P573, DOI 10.1016/j.molcel.2004.08.006; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Marrocco J, 2012, J NEUROSCI, V32, P17143, DOI 10.1523/JNEUROSCI.1040-12.2012; McArthur S, 2007, NEUROPSYCHOPHARMACOL, V32, P1462, DOI 10.1038/sj.npp.1301277; Merrett DL, 2010, BEHAV BRAIN RES, V214, P55, DOI 10.1016/j.bbr.2010.04.035; Metz G.A., 2009, J VIS EXP, V28; Metz GA, 2005, EUR J NEUROSCI, V22, P1190, DOI 10.1111/j.1460-9568.2005.04285.x; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Metz GAS, 2000, BEHAV BRAIN RES, V116, P111, DOI 10.1016/S0166-4328(00)00245-X; Metz GAS, 2001, PHYSIOL BEHAV, V72, P29, DOI 10.1016/S0031-9384(00)00371-1; Metz GA, 2007, REV NEUROSCIENCE, V18, P209; Mok Esther, 2004, Complement Ther Nurs Midwifery, V10, P209, DOI 10.1016/j.ctnm.2004.05.006; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Muhammad A, 2012, NEUROSCIENCE, V216, P103, DOI 10.1016/j.neuroscience.2012.04.041; Muller-Oerlinghausen B, 2004, DEUT MED WOCHENSCHR, V129, P1363, DOI 10.1055/s-2004-826874; PASH J, 1990, P NATL ACAD SCI USA, V87, P3836, DOI 10.1073/pnas.87.10.3836; PAUK J, 1986, LIFE SCI, V39, P2081, DOI 10.1016/0024-3205(86)90359-0; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010; Rasmussen MH, 2007, OBESITY, V15, P879, DOI 10.1038/oby.2007.607; Rodrigues AL, 2004, BRAIN RES, V1002, P94, DOI 10.1016/j.brainres.2003.12.020; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; SCHEFF SW, 1980, EXP NEUROL, V68, P195, DOI 10.1016/0014-4886(80)90077-1; Schwab Matthias, 2009, Gynaekologisch-Geburtshilfliche Rundschau, V49, P13, DOI 10.1159/000184442; Seckl JR, 2006, ANN NY ACAD SCI, V1071, P351, DOI 10.1196/annals.1364.027; Shan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028105; Sharp H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045446; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Sokolova OO, 2009, B EXP BIOL MED+, V148, P227, DOI 10.1007/s10517-009-0660-6; Suenaga T, 2012, NEUROREPORT, V23, P430, DOI 10.1097/WNR.0b013e3283529805; Takenaga K, 2006, GLIA, V53, P313, DOI 10.1002/glia.20284; Vansthertem D, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/193259; Vyas A, 2002, J NEUROSCI, V22, P6810; Ward AMV, 2004, J HYPERTENS, V22, P2295, DOI 10.1097/00004872-200412000-00011; Ward ID, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S9; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Whishaw IQ, 2000, NEUROPHARMACOLOGY, V39, P788, DOI 10.1016/S0028-3908(99)00259-2; WHISHAW IQ, 1993, BEHAV BRAIN RES, V56, P59, DOI 10.1016/0166-4328(93)90022-I; Xie GL, 2011, MOL VIS, V17, P32; Yao YL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00061; Zucchi FCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056967; Zucchi Fabiola C. R., 2012, Frontiers in Genetics, V3, P96, DOI 10.3389/fgene.2012.00096; Zucchi FCR, 2009, BEHAV BRAIN RES, V205, P67, DOI 10.1016/j.bbr.2009.06.030	90	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92130	10.1371/journal.pone.0092130	http://dx.doi.org/10.1371/journal.pone.0092130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651125	Green Published, gold			2022-12-27	WOS:000333352800071
J	Chiang, CH; Huang, PH; Chiu, CC; Hsu, CY; Leu, HB; Huang, CC; Chen, JW; Lin, SJ				Chiang, Chia-Hung; Huang, Po-Hsun; Chiu, Chun-Chih; Hsu, Chien-Yi; Leu, Hsin-Bang; Huang, Chin-Chou; Chen, Jaw-Wen; Lin, Shing-Jong			Reduction of Circulating Endothelial Progenitor Cell Level Is Associated with Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary and Peripheral Interventions	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ACUTE-RENAL-FAILURE; NITRIC-OXIDE; ISCHEMIA; PROLIFERATION; MOBILIZATION; DYSFUNCTION	Objectives: Reduced number and impaired function of circulating endothelial progenitor cells (EPCs) in patients with chronic kidney disease have been reported. However, there is little data about the association between circulating EPC levels and risk of contrast-induced nephropathy (CIN). The aim of this study was to investigate the relationship between circulating EPCs and CIN in patients after angiography. Methods and Results: A total of 77 consecutive patients undergoing elective percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) were enrolled. Flow cytometry with quantification of EPC markers (defined as CD34(+), CD34(+)KDR(+), and CD34(+)KDR(+)CD133(+)) in peripheral blood samples was used to assess EPC number before the procedure. CIN was defined as an absolute increase >= 0.5 mg/dl or a relative increase >= 25% in the serum creatinine level at 48 hours after the procedure. Eighteen (24%) of the study subjects developed CIN. Circulating EPC levels were significantly lower in patients who developed CIN than in those without CIN (CD34(+)KDR(+), 4.11 +/- 2.59 vs. 9.25 +/- 6.30 cells/10(5) events, P<0.001). The incidence of CIN was significantly greater in patients in the lowest EPC tertile (CD34(+)KDR(+); from lowest to highest, 52%, 15%, and 4%, P<0.001). Using univariate logistic regression, circulating EPC number (CD34(+)KDR(+)) was a significant negative predictor for development of CIN (odds ratio 0.69, 95% CI 0.54-0.87, P = 0.002). Over a two-year follow-up, patients with CIN had a higher incidence of major adverse cardiovascular events including myocardial infarction, stroke, revascularization of treated vessels, and death (66.7% vs. 25.4%, P = 0.004) than did patients without CIN. Conclusions: Decreased EPC level is associated with a greater risk of CIN, which may explain part of the pathophysiology of CIN and the poor prognosis in CIN patients.	[Chiang, Chia-Hung] Taipei Vet Gen Hosp, Hsinchu Branch, Dept Med, Div Cardiol, Hsinchu, Taiwan; [Chiang, Chia-Hung; Huang, Po-Hsun; Chiu, Chun-Chih; Hsu, Chien-Yi; Leu, Hsin-Bang; Huang, Chin-Chou; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan; [Huang, Chin-Chou; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Leu, Hsin-Bang] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Chiang, Chia-Hung; Huang, Po-Hsun; Leu, Hsin-Bang; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chiang, Chia-Hung; Huang, Po-Hsun; Chiu, Chun-Chih; Hsu, Chien-Yi; Leu, Hsin-Bang; Huang, Chin-Chou; Chen, Jaw-Wen; Lin, Shing-Jong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Huang, Chin-Chou; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst & Dept Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, PH (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan.	huangbs@vghtpe.gov.tw		Hsu, Chien-Yi/0000-0002-9493-7325	UST-UCSD International Center of Excellence in Advanced Bio-engineering from National Science Council [NSC-99-2911-I-009-101]; Taipei Veterans General Hospital [VGH-V98B1-003, VGH-V100E2-002]; Ministry of Education "Aim for the Top University" Plan;  [NSC 97-2314-B-075-039];  [NSC 98-2314-B-075-035]	UST-UCSD International Center of Excellence in Advanced Bio-engineering from National Science Council; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education "Aim for the Top University" Plan(Ministry of Education, Taiwan); ; 	This study was supported in part by research grants from the NSC 97-2314-B-075-039, NSC 98-2314-B-075-035, and UST-UCSD International Center of Excellence in Advanced Bio-engineering NSC-99-2911-I-009-101 from the National Science Council; VGH-V98B1-003 and VGH-V100E2-002 from Taipei Veterans General Hospital, and also a grant from the Ministry of Education "Aim for the Top University" Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGMON Y, 1994, J CLIN INVEST, V94, P1069, DOI 10.1172/JCI117421; Bahlmann FH, 2003, KIDNEY INT, V64, P1648, DOI 10.1046/j.1523-1755.2003.00279.x; Chiang CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031799; Chu K, 2008, STROKE, V39, P1441, DOI 10.1161/STROKEAHA.107.499236; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Heyman SN, 2010, INVEST RADIOL, V45, P188, DOI 10.1097/RLI.0b013e3181d2eed8; Iwami Y, 2004, J CELL MOL MED, V8, P488, DOI 10.1111/j.1582-4934.2004.tb00473.x; Jialal I, 2010, ATHEROSCLEROSIS, V211, P297, DOI 10.1016/j.atherosclerosis.2010.01.036; Jie KE, 2010, NEPHROL DIAL TRANSPL, V25, P1875, DOI 10.1093/ndt/gfp749; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; McCullough Peter A, 2003, Rev Cardiovasc Med, V4 Suppl 5, pS3; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; Ozuyaman B, 2005, THROMB HAEMOSTASIS, V94, P770, DOI 10.1160/TH05-01-0038; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; Patschan D, 2006, AM J PHYSIOL-RENAL, V291, pF176, DOI 10.1152/ajprenal.00454.2005; Perticone F, 2010, CIRCULATION, V122, P379, DOI 10.1161/CIRCULATIONAHA.110.940932; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Ribeiro L, 2004, KIDNEY INT, V65, P589, DOI 10.1111/j.1523-1755.2004.00408.x; Ricardo SD, 2005, NEPHROLOGY, V10, P276, DOI 10.1111/j.1440-1797.2005.00373.x; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; SCHWARTZ D, 1994, AM J PHYSIOL, V267, pF374, DOI 10.1152/ajprenal.1994.267.3.F374; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Tepel M, 2006, CIRCULATION, V113, P1799, DOI 10.1161/CIRCULATIONAHA.105.595090; Vallance P, 2001, HEART, V85, P342, DOI 10.1136/heart.85.3.342; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wong PCY, 2012, INT J CARDIOL, V158, P186, DOI 10.1016/j.ijcard.2011.06.115; Yip HK, 2008, STROKE, V39, P69, DOI 10.1161/STROKEAHA.107.489401; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460	28	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89942	10.1371/journal.pone.0089942	http://dx.doi.org/10.1371/journal.pone.0089942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646509	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500010
J	Fonjungo, PN; Kalish, ML; Schaefer, A; Rayfield, M; Mika, J; Rose, LE; Heslop, O; Soudre, R; Pieniazek, D				Fonjungo, Peter N.; Kalish, Marcia L.; Schaefer, Amanda; Rayfield, Mark; Mika, Jennifer; Rose, Laura E.; Heslop, Orville; Soudre, Robert; Pieniazek, Danuta			Recombinant Viruses Initiated the Early HIV-1 Epidemic in Burkina Faso	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; WEST CENTRAL-AFRICA; GROUP-N; HIGHLY DIVERGENT; GROUP-O; GENETIC DIVERSITY; TYPE-1 SUBTYPE; GUINEA-BISSAU; GENOME SEQUENCES; ANTIBODY-BINDING	We analyzed genetic diversity and phylogenetic relationships among 124 HIV-1 and 19 HIV-2 strains in sera collected in 1986 from patients of the state hospital in Ouagadougou, Burkina Faso. Phylogenetic analysis of the HIV-1 env gp41 region of 65 sequences characterized 37 (56.9%) as CRF06_cpx strains, 25 (38.5%) as CRF02_AG, 2 (3.1%) as CRF09_cpx, and 1 (1.5%) as subtype A. Similarly, phylogenetic analysis of the protease (PR) gene region of 73 sequences identified 52 (71.2%) as CRF06_cpx, 15 (20.5%) as CRF02_AG, 5 (6.8%) as subtype A, and 1 (1.4%) was a unique strain that clustered along the B/D lineage but basal to the node connecting the two lineages. HIV-2 PR or integrase (INT) groups A (n = 17 [89.5%]) and B (n = 2 [10.5%]) were found in both monotypic (n = 11) and heterotypic HIV-1/HIV-2 (n = 8) infections, with few HIV-2 group B infections. Based on limited available sampling, evidence suggests two recombinant viruses, CRF06_cpx and CRF02_AG, appear to have driven the beginning of the mid-1980s HIV-1 epidemic in Burkina Faso.	[Fonjungo, Peter N.; Kalish, Marcia L.; Schaefer, Amanda; Rayfield, Mark; Mika, Jennifer; Rose, Laura E.; Heslop, Orville; Pieniazek, Danuta] Ctr Dis Control, Natl Ctr Infect Dis, HIV & Retrovirol Branch, Div AIDS STD & TB Lab Res, Atlanta, GA 30333 USA; [Fonjungo, Peter N.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA; [Soudre, Robert] Univ Ouagadougou, Unite Format & Rech Sci Sante UFR SDS, Ouagadougou, Burkina Faso	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Fonjungo, PN (corresponding author), Ctr Dis Control, Natl Ctr Infect Dis, HIV & Retrovirol Branch, Div AIDS STD & TB Lab Res, Atlanta, GA 30333 USA.	Pfonjungo@cdc.gov			Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The work was funded by the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LOS ALAMOS DATABASE; Ayouba A, 2000, AIDS, V14, P2623, DOI 10.1097/00002030-200011100-00033; Ayouba A, 2001, EMERG INFECT DIS, V7, P466, DOI 10.3201/eid0703.017321; Barin F, 1996, AIDS RES HUM RETROV, V12, P1279, DOI 10.1089/aid.1996.12.1279; Barin F, 2007, AIDS, V21, P2351, DOI 10.1097/QAD.0b013e3282f15637; BARNETT SW, 1993, J VIROL, V67, P1006, DOI 10.1128/JVI.67.2.1006-1014.1993; Brennan CA, 1997, AIDS RES HUM RETROV, V13, P401, DOI 10.1089/aid.1997.13.401; Campbell-Yesufu OT, 2011, CLIN INFECT DIS, V52, P780, DOI 10.1093/cid/ciq248; Carr JK, 1998, VIROLOGY, V247, P22, DOI 10.1006/viro.1998.9211; CHARNEAU P, 1994, VIROLOGY, V205, P247, DOI 10.1006/viro.1994.1640; CHEINGSONGPOPOV R, 1994, AIDS RES HUM RETROV, V10, P1379, DOI 10.1089/aid.1994.10.1379; Damond F, 2004, AIDS RES HUM RETROV, V20, P666, DOI 10.1089/0889222041217392; DELEYS R, 1990, J VIROL, V64, P1207, DOI 10.1128/JVI.64.3.1207-1216.1990; DIETRICH U, 1989, NATURE, V342, P948, DOI 10.1038/342948a0; EsuWilliams E, 1997, J ACQ IMMUN DEF SYND, V16, P204, DOI 10.1097/00042560-199711010-00010; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fonjungo PN, 2000, AIDS RES HUM RETROV, V16, P1319, DOI 10.1089/08892220050117087; Fonjungo PN, 2002, J CLIN MICROBIOL, V40, P837, DOI 10.1128/JCM.40.3.837-845.2002; GAO F, 1994, J VIROL, V68, P7433, DOI 10.1128/JVI.68.11.7433-7447.1994; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; Hamel DJ, 2007, AIDS RES HUM RETROV, V23, P1189, DOI 10.1089/aid.2007.0037; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Howard TM, 1996, AIDS RES HUM RETROV, V12, P1413, DOI 10.1089/aid.1996.12.1413; Hu DJ, 2001, AIDS, V15, P683, DOI 10.1097/00002030-200104130-00003; Imamichi H, 2009, AIDS RES HUM RETROV, V25, P45, DOI 10.1089/aid.2008.0111; Ishikawa K, 2001, AIDS RES HUM RETROV, V17, P1661, DOI 10.1089/088922201753342077; Janini LM, 1996, VIRUS GENES, V13, P69, DOI 10.1007/BF00576981; Kalish ML, 2004, EMERG INFECT DIS, V10, P1227; KANKI PJ, 1987, SCIENCE, V236, P827, DOI 10.1126/science.3033826; KIRCHHOFF F, 1990, AIDS, V4, P847, DOI 10.1097/00002030-199009000-00003; KONG LI, 1988, SCIENCE, V240, P1525, DOI 10.1126/science.3375832; Lankoande S, 1998, INT J STD AIDS, V9, P146, DOI 10.1258/0956462981921909; Machuca A, 1999, INTERVIROLOGY, V42, P37, DOI 10.1159/000024958; Manigart O, 2004, AIDS, V18, P1645, DOI 10.1097/01.aids.0000131333.30548.db; Masciotra S, 2000, AIDS RES HUM RETROV, V16, P1007, DOI 10.1089/08892220050058425; Masciotra S, 2002, J CLIN MICROBIOL, V40, P3167, DOI 10.1128/JCM.40.9.3167-3171.2002; McCutchan FE, 1999, VIROLOGY, V254, P226, DOI 10.1006/viro.1998.9505; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; MIURA T, 1990, AIDS, V4, P1257, DOI 10.1097/00002030-199012000-00012; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; Montano MA, 2000, J INFECT DIS, V181, P76, DOI 10.1086/315185; Montavon C, 2000, J ACQ IMMUN DEF SYND, V23, P363; Montavon C, 1999, AIDS RES HUM RETROV, V15, P1707, DOI 10.1089/088922299309757; Montavon C, 2002, J ACQ IMMUN DEF SYND, V29, P522, DOI 10.1097/00126334-200204150-00014; NAUCLER A, 1991, AIDS, V5, P301, DOI 10.1097/00002030-199103000-00009; Ndung'u T, 2006, VIROLOGY, V347, P247, DOI 10.1016/j.virol.2005.11.047; Njai HF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-40; Nkengasong JN, 2000, J ACQ IMMUN DEF SYND, V23, P430; Oelrichs RB, 1998, AIDS RES HUM RETROV, V14, P1495, DOI 10.1089/aid.1998.14.1495; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; Ouedraogo-Traore R, 2003, AIDS, V17, P441, DOI 10.1097/00002030-200302140-00019; Peeters M, 2000, AIDS RES HUM RETROV, V16, P315, DOI 10.1089/088922200309197; Peeters M, 1999, J VIROL, V73, P7368, DOI 10.1128/JVI.73.9.7368-7375.1999; Piedade J, 2000, ACTA TROP, V76, P119, DOI 10.1016/S0001-706X(00)00096-6; Pieniazek D, 1999, AIDS RES HUM RETROV, V15, P603, DOI 10.1089/088922299311132; PIENIAZEK D, 1991, AIDS, V5, P1293, DOI 10.1097/00002030-199111000-00002; Plantier JC, 1999, J ACQ IMMUN DEF SYND, V20, P432, DOI 10.1097/00042560-199904150-00004; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; POULSEN AG, 1993, J ACQ IMMUN DEF SYND, V6, P941; Ramos A, 1999, EMERG INFECT DIS, V5, P65, DOI 10.3201/eid0501.990108; Roques P, 2004, AIDS, V18, P1371, DOI 10.1097/01.aids.0000125990.86904.28; Ruelle J, 2007, AIDS RES HUM RETROV, V23, P955, DOI 10.1089/aid.2007.0034; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; SMITH TF, 1981, J MOL EVOL, V18, P38, DOI 10.1007/BF01733210; Soriano V, 2000, J MED VIROL, V61, P111, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;111::AID-JMV18&gt;3.0.CO;2-W; Tapia N, 2003, J GEN VIROL, V84, P607, DOI 10.1099/vir.0.18754-0; Tebit DM, 2008, JAIDS-J ACQ IMM DEF, V49, P17, DOI 10.1097/QAI.0b013e318182d2bc; Tebit DM, 2006, JAIDS-J ACQ IMM DEF, V43, P144, DOI 10.1097/01.qai.0000228148.40539.d3; Tebit DM, 2009, J MED VIROL, V81, P1691, DOI 10.1002/jmv.21600; Vallari A, 2011, J VIROL, V85, P1403, DOI 10.1128/JVI.02005-10; Vallari A, 2010, AIDS RES HUM RETROV, V26, P109, DOI 10.1089/aid.2009.0178; van der Loeff MFS, 1999, AIDS, V13, pS69; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94; Wiktor SZ, 1999, AIDS, V13, P695, DOI 10.1097/00002030-199904160-00010; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Yamaguchi J, 2000, AIDS RES HUM RETROV, V16, P925; Yamaguchi J, 2006, AIDS RES HUM RETROV, V22, P83, DOI 10.1089/aid.2006.22.83; Yamaguchi J, 2006, AIDS RES HUM RETROV, V22, P453, DOI 10.1089/aid.2006.22.453; Yang CF, 2000, J INFECT DIS, V181, P1791, DOI 10.1086/315439; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	82	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92423	10.1371/journal.pone.0092423	http://dx.doi.org/10.1371/journal.pone.0092423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647246	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500129
J	Harter, PN; Zinke, J; Scholz, A; Tichy, J; Zachskorn, C; Kvasnicka, HM; Goeppert, B; Delloye-Bourgeois, C; Hattingen, E; Senft, C; Steinbach, JP; Plate, KH; Mehlen, P; Schulte, D; Mittelbronn, M				Harter, Patrick N.; Zinke, Jenny; Scholz, Alexander; Tichy, Julia; Zachskorn, Cornelia; Kvasnicka, Hans M.; Goeppert, Benjamin; Delloye-Bourgeois, Celine; Hattingen, Elke; Senft, Christian; Steinbach, Joachim P.; Plate, Karl H.; Mehlen, Patrick; Schulte, Dorothea; Mittelbronn, Michel			Netrin-1 Expression Is an Independent Prognostic Factor for Poor Patient Survival in Brain Metastases	PLOS ONE			English	Article							CELL LUNG-CANCER; COLORECTAL-CANCER; RECEPTOR; CARCINOMA; NUCLEAR; DCC; ANGIOGENESIS; APOPTOSIS; UNC5C; OVEREXPRESSION	The multifunctional molecule netrin-1 is upregulated in various malignancies and has recently been presented as a major general player in tumorigenesis leading to tumor progression and maintenance in various animal models. However, there is still a lack of clinico-epidemiological data related to netrin-1 expression. Therefore, the aim of our study was to elucidate the association of netrin-1 expression and patient survival in brain metastases since those constitute one of the most limiting factors for patient prognosis. We investigated 104 brain metastases cases for netrin-1 expression using in-situ hybridization and immunohistochemistry with regard to clinical parameters such as patient survival and MRI data. Our data show that netrin-1 is strongly upregulated in most cancer subtypes. Univariate analyses revealed netrin-1 expression as a significant factor associated with poor patient survival in the total cohort of brain metastasis patients and in sub-entities such as non-small cell lung carcinomas. Interestingly, many cancer samples showed a strong nuclear netrin-1 signal which was recently linked to a truncated netrin-1 variant that enhances tumor growth. Nuclear netrin-1 expression was associated with poor patient survival in univariate as well as in multivariate analyses. Our data indicate both total and nuclear netrin-1 expression as prognostic factors in brain metastases patients in contrast to other prognostic markers in oncology such as patient age, number of brain metastases or Ki67 proliferation index. Therefore, nuclear netrin-1 expression constitutes one of the first reported molecular biomarkers for patient survival in brain metastases. Furthermore, netrin-1 may constitute a promising target for future anti-cancer treatment approaches in brain metastases.	[Harter, Patrick N.; Zinke, Jenny; Scholz, Alexander; Zachskorn, Cornelia; Plate, Karl H.; Schulte, Dorothea; Mittelbronn, Michel] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, D-60054 Frankfurt, Germany; [Harter, Patrick N.; Zachskorn, Cornelia; Kvasnicka, Hans M.; Goeppert, Benjamin; Steinbach, Joachim P.; Plate, Karl H.; Mittelbronn, Michel] German Canc Consortium DKTK, Heidelberg, Germany; [Harter, Patrick N.; Zachskorn, Cornelia; Kvasnicka, Hans M.; Goeppert, Benjamin; Steinbach, Joachim P.; Plate, Karl H.; Mittelbronn, Michel] German Canc Res Ctr, Heidelberg, Germany; [Tichy, Julia; Steinbach, Joachim P.] Goethe Univ Frankfurt, Senckenberg Inst Neurooncol, D-60054 Frankfurt, Germany; [Kvasnicka, Hans M.] Goethe Univ Frankfurt, Senckenberg Inst Pathol, D-60054 Frankfurt, Germany; [Goeppert, Benjamin] Heidelberg Univ, Inst Pathol, Heidelberg, Germany; [Delloye-Bourgeois, Celine; Mehlen, Patrick] Univ Lyon, Apoptosis Canc & Dev Lab,,Ctr Leon Berard, Equipe Labellisee La Ligue,CNRS,UMR5286, LabEx DEVweCAN,Ctr Cancerol Lyon,INSERM,U1052, Lyon, France; [Hattingen, Elke] Goethe Univ Frankfurt, Inst Neuroradiol, D-60054 Frankfurt, Germany; [Senft, Christian] Goethe Univ Frankfurt, Dept Neurosurg, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Goethe University Frankfurt; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Goethe University Frankfurt; Goethe University Frankfurt	Mittelbronn, M (corresponding author), Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, D-60054 Frankfurt, Germany.	michel.mittelbronn@kgu.de	Delloye-Bourgeois, Céline/G-8988-2017; Hattingen, Elke/D-7880-2015; Kvasnicka, Hans Michael/E-7993-2011; Senft, Christian/F-4252-2010; Goeppert, Benjamin/AAC-2303-2022	Delloye-Bourgeois, Céline/0000-0002-7162-0034; Kvasnicka, Hans Michael/0000-0002-3081-1395; Senft, Christian/0000-0003-1288-6913; Harter, Patrick N./0000-0001-5530-6910; Mittelbronn, Michel/0000-0002-2998-052X; Goeppert, Benjamin/0000-0002-4135-9250; Schulte, Dorothea/0000-0002-7243-6319; Hattingen, Elke/0000-0002-8392-9004	Goethe University Frankfurt am Main, Germany	Goethe University Frankfurt am Main, Germany	The present study was financially supported by the Goethe University Frankfurt am Main, Germany (UCT-Trx program 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDIN V, 1990, EMBO J, V9, P1511, DOI 10.1002/j.1460-2075.1990.tb08269.x; Barnholtz-Sloan JS, 2012, NEURO-ONCOLOGY, V14, P910, DOI 10.1093/neuonc/nos087; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; Bouvree K, 2008, DEV BIOL, V318, P172, DOI 10.1016/j.ydbio.2008.03.023; CAO H, 1995, ENDOCRINOLOGY, V136, P3163, DOI 10.1210/en.136.7.3163; Castets M, 2012, NATURE, V482, P534, DOI 10.1038/nature10708; Castets M, 2009, DEV CELL, V16, P614, DOI 10.1016/j.devcel.2009.02.006; Coissieux MM, 2011, GASTROENTEROLOGY, V141, P2039, DOI 10.1053/j.gastro.2011.08.041; Delloye-Bourgeois C, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002456; Delloye-Bourgeois C, 2009, JNCI-J NATL CANCER I, V101, P237, DOI 10.1093/jnci/djn491; Dumartin L, 2010, GASTROENTEROLOGY, V138, P1595, DOI 10.1053/j.gastro.2009.12.061; Eichler AF, 2010, NEURO-ONCOLOGY, V12, P1193, DOI 10.1093/neuonc/noq076; Fan YF, 2008, J CEREBR BLOOD F MET, V28, P1543, DOI 10.1038/jcbfm.2008.39; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; Flannery TW, 2008, INT J RADIAT ONCOL, V72, P19, DOI 10.1016/j.ijrobp.2007.12.031; GALICICH JH, 1980, J NEUROSURG, V53, P63, DOI 10.3171/jns.1980.53.1.0063; Hammoud MA, 1996, ANN SURG ONCOL, V3, P453, DOI 10.1007/BF02305763; Harter PN, 2010, NEUROPATH APPL NEURO, V36, P623, DOI 10.1111/j.1365-2990.2010.01100.x; Hibi K, 2010, ANTICANCER RES, V30, P107; Hibi K, 2009, WORLD J SURG, V33, P1053, DOI 10.1007/s00268-008-9909-x; Kefeli U, 2012, BIOMARKERS, V17, P663, DOI 10.3109/1354750X.2012.709882; Krimpenfort P, 2012, NATURE, V482, P538, DOI 10.1038/nature10790; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Link BC, 2007, ANN SURG ONCOL, V14, P2591, DOI 10.1245/s10434-007-9469-6; Lo H-W, 2005, CANCER RES, V65, P338; Lv D, 2011, EUR J CANCER, V47, P2068, DOI 10.1016/j.ejca.2011.04.021; Mazelin L, 2004, NATURE, V431, P80, DOI 10.1038/nature02788; Mille F, 2009, CELL DEATH DIFFER, V16, P1344, DOI 10.1038/cdd.2009.75; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Papanastasiou AD, 2011, ONCOTARGET, V2, P363; Paradisi A, 2008, GASTROENTEROLOGY, V135, P1248, DOI 10.1053/j.gastro.2008.06.080; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; Ramesh G, 2011, BIOMARKERS, V16, P172, DOI 10.3109/1354750X.2010.541564; Schouten LJ, 2002, CANCER, V94, P2698, DOI 10.1002/cncr.10541; Shuch B, 2008, CANCER-AM CANCER SOC, V113, P1641, DOI 10.1002/cncr.23769; Sperduto PW, 2012, J CLIN ONCOL, V30, P419, DOI 10.1200/JCO.2011.38.0527; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012	39	27	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92311	10.1371/journal.pone.0092311	http://dx.doi.org/10.1371/journal.pone.0092311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647424	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500113
J	Herzog, E; Falke, KC; Presterl, T; Scheuermann, D; Ouzunova, M; Frisch, M				Herzog, Eva; Falke, Karen Christin; Presterl, Thomas; Scheuermann, Daniela; Ouzunova, Milena; Frisch, Matthias			Selection Strategies for the Development of Maize Introgression Populations	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ARABIDOPSIS-THALIANA; CHROMOSOME SEGMENTS; LINES; QTL; RESISTANCE; CONSTRUCTION; LIBRARIES; BLIGHT; WHEAT	Introgression libraries are valuable resources for QTL detection and breeding, but their development is costly and time-consuming. Selection strategies for the development of introgression populations with a limited number of individuals and high-throughput (HT) marker assays are required. The objectives of our simulation study were to design and compare selection strategies for the development of maize introgression populations of 100 lines with population sizes of 360-720 individuals per generation for different DH and S-2 crossing schemes. Pre-selection for complete donor chromosomes or donor chromosome halves reduced the number of simultaneous backcross programs. The investigated crossing and selection schemes differed considerably with respect to their suitability to create introgression populations with clearly separated, evenly distributed target donor chromosome segments. DH crossing schemes were superior to S-2 crossing schemes, mainly due to complete homozygosity, which greatly reduced the total number of disjunct genome segments in the introgression populations. The S-2 crossing schemes were more flexible with respect to selection and provided economic alternatives to DH crossing schemes. For the DH crossing schemes, increasing population sizes gradually over backcross generations was advantageous as it reduced the total number of required HT assays compared to constant population sizes. For the S-2 crossing schemes, large population sizes in the final backcross generation facilitated selection for the target segments in the final backcross generation and reduced fixation of large donor chromosome segments. The suggested crossing and selection schemes can help to make the genetic diversity of exotic germplasm available for enhancing the genetic variation of narrow-based breeding populations of crops.	[Herzog, Eva; Frisch, Matthias] Univ Giessen, Inst Agron & Plant Breeding 2, D-35390 Giessen, Germany; [Falke, Karen Christin] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany; [Presterl, Thomas; Scheuermann, Daniela; Ouzunova, Milena] KWS Saat AG, Einbeck, Germany	Justus Liebig University Giessen; University of Munster; KWS Saat AG	Frisch, M (corresponding author), Univ Giessen, Inst Agron & Plant Breeding 2, D-35390 Giessen, Germany.	matthias.frisch@uni-giessen.de	Frisch, Matthias/R-1564-2019	Frisch, Matthias/0000-0003-4234-8972	German Federal Ministry of Education and Research (BMBF) [0315951]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Funding from the German Federal Ministry of Education and Research (BMBF Grant 0315951) is gratefully acknowledged. [http://www.bmbf.de/en/index.php] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belcher AR, 2012, THEOR APPL GENET, V124, P433, DOI 10.1007/s00122-011-1718-1; Cheema KK, 2008, EUPHYTICA, V160, P401, DOI 10.1007/s10681-007-9560-x; ESHED Y, 1994, EUPHYTICA, V79, P175, DOI 10.1007/BF00022516; Falke KC, 2008, THEOR APPL GENET, V117, P641, DOI 10.1007/s00122-008-0808-1; Falke KC, 2011, HEREDITY, V106, P576, DOI 10.1038/hdy.2010.87; Falke KC, 2009, THEOR APPL GENET, V119, P595, DOI 10.1007/s00122-009-1069-3; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Lin SY, 1998, THEOR APPL GENET, V96, P997, DOI 10.1007/s001220050831; Liu SB, 2006, THEOR APPL GENET, V112, P1360, DOI 10.1007/s00122-006-0238-x; Lubberstedt T, 2012, PLANT BREEDING, V131, P449, DOI 10.1111/j.1439-0523.2011.01948.x; Mahone GS, 2012, CROP SCI, V52, P2198, DOI 10.2135/cropsci2011.06.0341; Mano Y, 2013, ANN BOT-LONDON, V112, P1125, DOI 10.1093/aob/mct160; Matus I, 2003, GENOME, V46, P1010, DOI 10.1139/G03-080; McCouch S, 2004, PLOS BIOL, V2, P1507, DOI 10.1371/journal.pbio.0020347; Pumphrey MO, 2007, CROP SCI, V47, P200, DOI 10.2135/cropsci2006.03.0206; R Core Team, 2021, R LANGUAGE ENV STAT; Ribaut JM, 2007, J EXP BOT, V58, P351, DOI 10.1093/jxb/erl214; Schmalenbach I, 2008, THEOR APPL GENET, V117, P1093, DOI 10.1007/s00122-008-0847-7; STAM P, 1979, GENETICS, V92, P573; Syed NH, 2004, MOL BREEDING, V13, P59, DOI 10.1023/B:MOLB.0000012845.37366.b5; Szalma SJ, 2007, THEOR APPL GENET, V114, P1211, DOI 10.1007/s00122-007-0512-6; Torjek O, 2008, J HERED, V99, P396, DOI 10.1093/jhered/esn014; Welcker C, 2011, PLANT PHYSIOL, V157, P718, DOI 10.1104/pp.111.176479; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590	24	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92429	10.1371/journal.pone.0092429	http://dx.doi.org/10.1371/journal.pone.0092429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647313	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500130
J	Leblond, F; Poirier, S; Yu, C; Duquette, N; Mayer, G; Thorin, E				Leblond, Francois; Poirier, Steve; Yu, Carol; Duquette, Natacha; Mayer, Gaetan; Thorin, Eric			The Anti-Hypercholesterolemic Effect of Low p53 Expression Protects Vascular Endothelial Function in Mice	PLOS ONE			English	Article							SMALL HETERODIMER PARTNER; BILE-ACID HOMEOSTASIS; TUMOR-SUPPRESSOR; OXIDATIVE STRESS; DEPENDENT CONTRACTIONS; ATHEROSCLEROTIC PATIENTS; CARDIOVASCULAR-DISEASE; CELLULAR SENESCENCE; POSSIBLE MECHANISM; NUCLEAR RECEPTOR	Aims: To demonstrate that p53 modulates endothelial function and the stress response to a high-fat western diet (WD). Methods and Results: Three-month old p53(+/+) wild type (WT) and p53(+/-) male mice were fed a regular or WD for 3 months. Plasma levels of total cholesterol (TC) and LDL-cholesterol were significantly elevated (p < 0.05) in WD-fed WT (from 2.1 +/- 0.2 mmol/L to 3.1 +/- 0.2, and from 0.64 +/- 0.09 mmol/L to 1.25 +/- 0.11, respectively) but not in p53(+/-) mice. The lack of cholesterol accumulation in WD-fed p53(+/-) mice was ass-ociated with high bile acid plasma concentrations (p53(+/-) = 4.7 +/- 0.9 vs. WT = 3.3 +/- 0.2 mu mol/L, p < 0.05) concomitant with an increased hepatic 7-alpha-hydroxylase mRNA expression. While the WD did not affect aortic endothelial relaxant function in p53(+/-) mice (WD = 8365 and RD = 82 +/- 4% relaxation), it increased the maximal response to acetylcholine in WT mice (WD = 8762 vs. RD = 62 +/- 5% relaxation, p < 0.05) to levels of p53(+/-). In WT mice, the rise in TC associated with higher (p < 0.05) plasma levels of pro-inflammatory keratinocyte-derived chemokine, and an over-activation (p < 0.05) of the relaxant non-nitric oxide/non-prostacyclin endothelial pathway. It is likely that in WT mice, activations of these pathways are adaptive and contributed to maintain endothelial function, while the WD neither promoted inflammation nor affected endothelial function in p53(+/-) mice. Conclusions: Our data demonstrate that low endogenous p53 expression prevents the rise in circulating levels of cholesterol when fed a WD. Consequently, the endothelial stress of hypercholesterolemia is absent in young p53(+/-) mice as evidenced by the absence of endothelial adaptive pathway over-activation to minimize stress-related damage.	[Leblond, Francois; Poirier, Steve; Yu, Carol; Mayer, Gaetan; Thorin, Eric] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Thorin, Eric] Univ Montreal, Dept Surg, Montreal, PQ H3C 3J7, Canada; [Leblond, Francois; Poirier, Steve; Yu, Carol; Mayer, Gaetan; Thorin, Eric] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Leblond, Francois; Poirier, Steve; Yu, Carol; Duquette, Natacha; Mayer, Gaetan; Thorin, Eric] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Thorin, E (corresponding author), Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.	eric.thorin@umontreal.ca	Thorin, Eric/K-3978-2013	Thorin, Eric/0000-0001-5827-8935	Canadian Institutes of Health Research [MOP 14496]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (MOP 14496 to E. T.). F. Leblond is supported by a Banting and Best PhD scholarship from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; Bailey-Downs LC, 2013, J GERONTOL A-BIOL, V68, P780, DOI 10.1093/gerona/gls238; Benkhoff S, 2012, ARTERIOSCL THROM VAS, V32, P1605, DOI 10.1161/ATVBAHA.112.251140; Bensaad K, 2005, NAT MED, V11, P1278, DOI 10.1038/nm1205-1278; Cheng HM, 2007, EUR J CLIN INVEST, V37, P197, DOI 10.1111/j.1365-2362.2007.01772.x; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Chumakov PM, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1399, DOI 10.1134/S0006297907130019; Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Drouin A, 2011, PFLUG ARCH EUR J PHY, V462, P371, DOI 10.1007/s00424-011-0973-y; Drouin A, 2011, AM J PHYSIOL-HEART C, V300, pH1032, DOI 10.1152/ajpheart.00410.2010; Durrant JR, 2009, J PHYSIOL-LONDON, V587, P3271, DOI 10.1113/jphysiol.2009.169771; Farhat N, 2008, CAN J PHYSIOL PHARM, V86, P761, DOI 10.1139/Y08-082; Feletou M, 2011, BRIT J PHARMACOL, V164, P894, DOI 10.1111/j.1476-5381.2011.01276.x; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Gendron ME, 2007, AM J PHYSIOL-HEART C, V293, pH2508, DOI 10.1152/ajpheart.00352.2007; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Grigore L, 2013, EUR J CLIN PHARMACOL, V69, P341, DOI 10.1007/s00228-012-1345-z; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; Higashi Y, 2009, CIRC J, V73, P411, DOI 10.1253/circj.CJ-08-1102; Huo YQ, 2001, J CLIN INVEST, V108, P1307, DOI 10.1172/JCI12877; Insull W, 2006, SOUTH MED J, V99, P257, DOI 10.1097/01.smj.0000208120.73327.db; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kim CS, 2008, CIRC RES, V103, P1441, DOI 10.1161/CIRCRESAHA.108.181644; Kim DH, 2011, MOL ENDOCRINOL, V25, P2076, DOI 10.1210/me.2011-1198; Kim DH, 2011, P NATL ACAD SCI USA, V108, P12266, DOI 10.1073/pnas.1019678108; Krummen S, 2005, BRIT J PHARMACOL, V145, P264, DOI 10.1038/sj.bjp.0706194; Kumar A, 2011, ARTERIOSCL THROM VAS, V31, P133, DOI 10.1161/ATVBAHA.110.215061; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Maeda Y, 2006, BIOCHEM J, V400, P303, DOI 10.1042/BJ20060614; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mercer J, 2005, CIRC RES, V96, P667, DOI 10.1161/01.RES.0000161069.15577.ca; Mercer J, 2006, CELL CYCLE, V5, P1907, DOI 10.4161/cc.5.17.3166; Merched AJ, 2003, ARTERIOSCL THROM VAS, V23, P1608, DOI 10.1161/01.ATV.0000084825.88022.53; MINOR RL, 1990, J CLIN INVEST, V86, P2109, DOI 10.1172/JCI114949; NISHINA PM, 1993, J LIPID RES, V34, P1413; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rippe C, 2010, AGING CELL, V9, P304, DOI 10.1111/j.1474-9726.2010.00557.x; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sansbury BE, 2012, CIRC RES, V111, P1176, DOI [10.1161/circresaha.112.266395, 10.1161/CIRCRESAHA.112.266395]; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Shi Y, 2008, ACTA PHARMACOL SIN, V29, P185, DOI 10.1111/j.1745-7254.2008.00749.x; Thorin E, 2000, CIRCULATION, V101, P1430, DOI 10.1161/01.CIR.101.12.1430; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330; Voghel G, 2008, MECH AGEING DEV, V129, P261, DOI 10.1016/j.mad.2008.01.004; Voghel G, 2007, MECH AGEING DEV, V128, P662, DOI 10.1016/j.mad.2007.09.006; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Webster NJG, 1996, CANCER RES, V56, P2781; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wong SL, 2009, CIRC RES, V104, P228, DOI 10.1161/CIRCRESAHA.108.179770; Yang D, 2002, BRIT J PHARMACOL, V136, P104, DOI 10.1038/sj.bjp.0704669	59	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92394	10.1371/journal.pone.0092394	http://dx.doi.org/10.1371/journal.pone.0092394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647794	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500126
J	Mayas, J; Parmentier, FBR; Andres, P; Ballesteros, S				Mayas, Julia; Parmentier, Fabrice B. R.; Andres, Pilar; Ballesteros, Soledad			Plasticity of Attentional Functions in Older Adults after Non-Action Video Game Training: A Randomized Controlled Trial	PLOS ONE			English	Article							AGE-RELATED-CHANGES; INVOLUNTARY ATTENTION; WORKING-MEMORY; LIFE-SPAN; MISMATCH NEGATIVITY; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; ACOUSTIC NOVELTY; BRAIN; DISTRACTION	A major goal of recent research in aging has been to examine cognitive plasticity in older adults and its capacity to counteract cognitive decline. The aim of the present study was to investigate whether older adults could benefit from brain training with video games in a cross-modal oddball task designed to assess distraction and alertness. Twenty-seven healthy older adults participated in the study (15 in the experimental group, 12 in the control group. The experimental group received 20 1-hr video game training sessions using a commercially available brain-training package (Lumosity) involving problem solving, mental calculation, working memory and attention tasks. The control group did not practice this package and, instead, attended meetings with the other members of the study several times along the course of the study. Both groups were evaluated before and after the intervention using a cross-modal oddball task measuring alertness and distraction. The results showed a significant reduction of distraction and an increase of alertness in the experimental group and no variation in the control group. These results suggest neurocognitive plasticity in the old human brain as training enhanced cognitive performance on attentional functions.	[Mayas, Julia; Ballesteros, Soledad] Univ Nacl Educ Distancia, Dept Basic Psychol 2, Studies Aging & Neurodegenerat Dis Res Grp, E-28040 Madrid, Spain; [Parmentier, Fabrice B. R.; Andres, Pilar] Univ Balearic Isl, Dept Psychol, Neuropsychol & Cognit Grp, Mallorca, Spain; [Parmentier, Fabrice B. R.; Andres, Pilar] Univ Balearic Isl, Inst Hlth Sci iUNICS, Mallorca, Spain; [Parmentier, Fabrice B. R.; Andres, Pilar] Inst Invest Sanitaria Palma IdISPa, Mallorca, Spain; [Parmentier, Fabrice B. R.] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia	Universidad Nacional de Educacion a Distancia (UNED); Universitat de les Illes Balears; Universitat de les Illes Balears; Institut Investigacio Sanitaria Illes Balears (IdISBa); University of Western Australia	Ballesteros, S (corresponding author), Univ Nacl Educ Distancia, Dept Basic Psychol 2, Studies Aging & Neurodegenerat Dis Res Grp, E-28040 Madrid, Spain.	mballesteros@psi.uned.es	Benito, Pilar Andres/G-3411-2011; Ballesteros, Soledad/ABG-8762-2020; Ballesteros, Soledad/F-5561-2015; Mayas, Julia/L-3679-2014; Parmentier, Fabrice B. R./B-4485-2011	Ballesteros, Soledad/0000-0002-8391-9615; Ballesteros, Soledad/0000-0002-8391-9615; Mayas, Julia/0000-0001-5003-4995; Parmentier, Fabrice B. R./0000-0001-7439-0097; Andres, Pilar/0000-0003-2220-8198	Spanish Government [PSI2010-21609-C02-01, PSI2010-21609-C02-02]; Madrid Community Biomedical Research [S2010/BMD-2349]; Spanish Ministry of Science and Innovation [PSI-2009-08427]; RamA3n y Cajal Fellowship [RYC-2007-00701]; Plan E	Spanish Government(Spanish GovernmentEuropean Commission); Madrid Community Biomedical Research; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); RamA3n y Cajal Fellowship; Plan E	This work was supported by grants from the Spanish Government to SB (PSI2010-21609-C02-01) and PA (PSI2010-21609-C02-02), Madrid Community Biomedical Research grant to SB (S2010/BMD-2349), as well as a research grant from the Spanish Ministry of Science and Innovation (PSI-2009-08427) and Plan E and a RamA3n y Cajal Fellowship (RYC-2007-00701) awarded to FP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PL, 2010, PSYCHOL AGING, V25, P753, DOI 10.1037/a0019277; Ahveninen J, 2000, ALCOHOL CLIN EXP RES, V24, P1850, DOI 10.1097/00000374-200012000-00014; Andres P, 2000, J GERONTOL B-PSYCHOL, V55, pP373, DOI 10.1093/geronb/55.6.P373; Andres P, 2003, CORTEX, V39, P871, DOI 10.1016/S0010-9452(08)70868-2; Andres P, 2006, NEUROPSYCHOLOGIA, V44, P2564, DOI 10.1016/j.neuropsychologia.2006.05.005; Ballesteros S, 2004, NEUROPSYCHOLOGIA, V42, P1063, DOI 10.1016/j.neuropsychologia.2003.12.008; Ballesteros S, 2012, 5 ACM INT C PERV TEC; Ballesteros S, 2013, CURRENT AGING SCI, V6; Ballesteros S, 2014, FRONTIERS AGING NEUR; Ballesteros S, 2007, PSICOTHEMA, V19, P239; Ballesteros S, 2013, PSICOTHEMA, V25, P18, DOI 10.7334/psicothema2012.181; Ballesteros S, 2013, NEUROBIOL AGING, V34, P1254, DOI 10.1016/j.neurobiolaging.2012.09.019; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Basak C, 2008, PSYCHOL AGING, V23, P765, DOI 10.1037/a0013494; Bendixen A, 2009, J NEUROSCI, V29, P8447, DOI 10.1523/JNEUROSCI.1493-09.2009; Berti S, 2004, EXP PSYCHOL, V51, P249, DOI 10.1027/1618-3169.51.4.249; Berti S, 2001, COGNITIVE BRAIN RES, V10, P265, DOI 10.1016/S0926-6410(00)00044-6; Berti S, 2008, PSYCHOPHYSIOLOGY, V45, P608, DOI 10.1111/j.1469-8986.2008.00660.x; Berti S, 2013, BRAIN RES, V1491, P156, DOI 10.1016/j.brainres.2012.11.009; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; Brehmer Y, 2007, DEV PSYCHOL, V43, P465, DOI 10.1037/0012-1649.43.2.465; Buitenweg JIV, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00183; Cabeza R., 2013, PRINCIPLES FRONTAL L; CHAO LL, 1995, NEUROREPORT, V6, P1605, DOI 10.1097/00001756-199508000-00005; Charlton RA, 2006, NEUROLOGY, V66, P217, DOI 10.1212/01.wnl.0000194256.15247.83; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; FABIANI M, 1995, PSYCHOPHYSIOLOGY, V32, P579, DOI 10.1111/j.1469-8986.1995.tb01234.x; Festa-Martino E, 2004, NEUROPSYCHOLOGY, V18, P258, DOI 10.1037/0894-4105.18.2.258; Fleischman DA, 2007, CORTEX, V43, P889, DOI 10.1016/S0010-9452(08)70688-9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaeta H, 2001, PSYCHOL AGING, V16, P55, DOI 10.1037//0882-7974.16.1.55; Goh JO, 2012, PSYCHOL AGING, V27, P707, DOI 10.1037/a0026715; Green CS, 2008, PSYCHOL AGING, V23, P692, DOI 10.1037/a0014345; Green CS, 2006, J EXP PSYCHOL HUMAN, V32, P1465, DOI 10.1037/0096-1523.32.6.1465; Green CS, 2010, TOP COGN SCI, V2, P202, DOI 10.1111/j.1756-8765.2009.01054.x; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Greenwood PM, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00150; Greenwood PM, 2000, J INT NEUROPSYCH SOC, V6, P705, DOI 10.1017/S1355617700666092; Hampstead BM, 2012, HIPPOCAMPUS, V22, P1652, DOI 10.1002/hipo.22006; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Jennings JM, 2007, AGING NEUROPSYCHOL C, V14, P353, DOI 10.1080/13825580600788837; Karbach J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00048; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Kueider AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040588; Lee H, 2012, ACTA PSYCHOL, V139, P146, DOI 10.1016/j.actpsy.2011.11.003; Li BQ, 2013, EXP PSYCHOL, V60, P260, DOI 10.1027/1618-3169/a000196; Ljungberg JK, 2012, J EXP PSYCHOL LEARN, V38, P1461, DOI 10.1037/a0028149; Martinez J, 2002, MEDIFAM, V12, P620, DOI DOI 10.4321/S1131-57682002001000003; Mitchell DB, 2003, PSYCHOL AGING, V18, P807, DOI 10.1037/0882-7974.18.4.807; Mueller V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-18; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Nilsson LG, 2003, ACTA NEUROL SCAND, V107, P7, DOI 10.1034/j.1600-0404.107.s179.5.x; Nithianantharajah J, 2009, PROG NEUROBIOL, V89, P369, DOI 10.1016/j.pneurobio.2009.10.001; Nouchi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029676; Oei AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058546; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Parmentier FBR, 2008, COGNITION, V106, P408, DOI 10.1016/j.cognition.2007.03.008; Parmentier FBR, 2014, PSYCHOL RES-PSYCH FO, V78, P321, DOI 10.1007/s00426-013-0534-4; Parmentier FBR, 2014, J EXP PSYCHOL GEN, V143, P38, DOI 10.1037/a0031550; Parmentier FBR, 2011, COGNITION, V119, P374, DOI 10.1016/j.cognition.2011.02.001; Parmentier FBR, 2011, EXP PSYCHOL, V58, P92, DOI 10.1027/1618-3169/a000072; Parmentier FBR, 2010, COGNITION, V115, P504, DOI 10.1016/j.cognition.2010.03.002; Parmentier FBR, 2010, EXP PSYCHOL, V57, P68, DOI 10.1027/1618-3169/a000009; Parmentier FBR, 2008, COGNITION, V109, P345, DOI 10.1016/j.cognition.2008.09.005; Peter C, 2013, J MULTIMODAL USER IN, V7, P229, DOI 10.1007/s12193-013-0118-z; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Raz N., 2000, HDB AGING COGNITION, V2nd, P1; Rosen AC, 2011, J ALZHEIMERS DIS, V26, P349, DOI 10.3233/JAD-2011-0009; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schneiders JA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00173; Schroger E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001131; Schroger E, 1996, J COGNITIVE NEUROSCI, V8, P527, DOI 10.1162/jocn.1996.8.6.527; Schroger E, 1998, COGNITIVE BRAIN RES, V7, P71, DOI 10.1016/S0926-6410(98)00013-5; Schroger E, 1997, PSYCHOPHYSIOLOGY, V34, P245, DOI 10.1111/j.1469-8986.1997.tb02395.x; Schroger E, 2005, ACTA ACUST UNITED AC, V91, P490; Schroger E, 2000, CLIN NEUROPHYSIOL, V111, P1450, DOI 10.1016/S1388-2457(00)00337-0; Shipstead Z, 2010, PSYCHOL BELG, V50, P245, DOI 10.5334/pb-50-3-4-245; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Sternberg DA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00292; Thompson G, 2005, EDUC GERONTOL, V31, P603, DOI 10.1080/03601270591003364; Toril P, IS VIDEOGAME T UNPUB; Vance DE, 2010, J PSYCHOSOC NURS MEN, V48, P23, DOI 10.3928/02793695-20100302-01; Wechsler D, 1999, WECHSLER ADULT INTEL; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wiggs CL, 2006, AGING NEUROPSYCHOL C, V13, P308, DOI 10.1080/138255890968718; WOODS DL, 1992, ELECTROEN CLIN NEURO, V84, P456, DOI 10.1016/0168-5597(92)90033-8; Yago E, 2003, COGNITIVE BRAIN RES, V16, P383, DOI 10.1016/S0926-6410(03)00052-1; Yago E, 2001, NEUROREPORT, V12, P4093, DOI 10.1097/00001756-200112210-00046	99	67	72	1	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92269	10.1371/journal.pone.0092269	http://dx.doi.org/10.1371/journal.pone.0092269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24647551	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500104
J	Nakajima, M; Toyoizumi, H; Abe, K; Nakai, H; Taguchi, H; Kitaoka, M				Nakajima, Masahiro; Toyoizumi, Hiroyuki; Abe, Koichi; Nakai, Hiroyuki; Taguchi, Hayao; Kitaoka, Motomitsu			1,2-beta-Oligoglucan Phosphorylase from Listeria innocua	PLOS ONE			English	Article							CYCLIC-BETA-GLUCANS; N-BIOSE-I; CELLOBIOSE PHOSPHORYLASE; CELLODEXTRIN PHOSPHORYLASE; CLOSTRIDIUM-THERMOCELLUM; PRACTICAL PREPARATION; VIRULENCE FACTOR; RHIZOBIUM; IDENTIFICATION; AGROBACTERIUM	We characterized recombinant Lin1839 protein (Lin1839r) belonging to glycoside hydrolase family 94 from Listeria innocua. Lin1839r catalyzed the synthesis of a series of 1,2-beta-oligoglucans (Sop(n): n denotes degree of polymerization) using sophorose (Sop(2)) as the acceptor and alpha-D-glucose 1-phosphate (Glc1P) as the donor. Lin1839r recognized glucose as a very weak acceptor substrate to form polymeric 1,2-beta-glucan. The degree of polymerization of the 1,2-beta-glucan gradually decreased with long-term incubation to generate a series of Sop(n)s. Kinetic analysis of the phosphorolytic reaction towards sophorotriose revealed that Lin1839r followed a sequential Bi Bi mechanism. The kinetic parameters of the phosphorolysis of sophorotetraose and sophoropentaose were similar to those of sophorotriose, although the enzyme did not exhibit significant phosphorolytic activity on Sop(2). These results indicate that the Lin1839 protein is a novel inverting phosphorylase that catalyzes reversible phosphorolysis of 1,2-beta-glucan with a degree of polymerization of >= 3. We propose 1,2-beta-oligoglucan: phosphate a-glucosyltransferase as the systematic name and 1,2-beta-oligoglucan phosphorylase as the short name for this Lin1839 protein.	[Nakajima, Masahiro; Toyoizumi, Hiroyuki; Abe, Koichi; Taguchi, Hayao] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan; [Nakajima, Masahiro; Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan; [Nakai, Hiroyuki] Niigata Univ, Grad Sch Sci & Technol, Niigata 9518510, Japan	Tokyo University of Science; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Niigata University	Kitaoka, M (corresponding author), Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan.	mkitaoka@affrc.go.jp	Nakajima, Masahiro/J-3566-2019; Kitaoka, Motomitsu/R-1536-2019	Nakajima, Masahiro/0000-0002-3182-0859; Kitaoka, Motomitsu/0000-0002-0083-1838; Taguchi, Hayao/0000-0001-5270-581X	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; NARO; Tokyo University of Science	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; NARO; Tokyo University of Science	This work was supported by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, Internal Research Fund of NARO, and Research Fund of Tokyo University of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Bianchetti CM, 2011, ACTA CRYSTALLOGR F, V67, P1345, DOI 10.1107/S1744309111032660; Bohin JP, 2000, FEMS MICROBIOL LETT, V186, P11, DOI 10.1016/S0378-1097(00)00110-5; BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994; Buchrieser C, 2003, FEMS IMMUNOL MED MIC, V35, P207, DOI 10.1016/S0928-8244(02)00448-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castro OA, 1996, J BACTERIOL, V178, P6043, DOI 10.1128/jb.178.20.6043-6048.1996; Ciocchini AE, 2007, P NATL ACAD SCI USA, V104, P16492, DOI 10.1073/pnas.0708025104; COHEN JL, 1991, J BACTERIOL, V173, P4271, DOI 10.1128/JB.173.14.4271-4276.1991; De Iannino NI, 1998, J BACTERIOL, V180, P4392; DOUGLAS CJ, 1982, J BACTERIOL, V152, P1265; Gay-Fraret J, 2012, FEMS MICROBIOL LETT, V333, P28, DOI 10.1111/j.1574-6968.2012.02595.x; GEREMIA RA, 1987, J BACTERIOL, V169, P880, DOI 10.1128/jb.169.2.880-884.1987; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; HIGASHIURA T, 1985, AGR BIOL CHEM TOKYO, V49, P1865, DOI 10.1080/00021369.1985.10866991; Hiraishi M, 2009, CARBOHYD RES, V344, P2468, DOI 10.1016/j.carres.2009.10.002; Kim YK, 2002, J BIOCHEM, V132, P197, DOI 10.1093/oxfordjournals.jbchem.a003210; Kitaoka M, 2002, TRENDS GLYCOSCI GLYC, V14, P35, DOI 10.4052/tigg.14.35; Kitaoka M, 2012, BIOSCI BIOTECH BIOCH, V76, P343, DOI 10.1271/bbb.110772; KOIZUMI K, 1983, J CHROMATOGR, V265, P89, DOI 10.1016/S0021-9673(01)96701-9; Krishnareddy M., 2002, J APPL GLYCOSCI, V49, P1, DOI [DOI 10.5458/jag.49.1, DOI 10.5458/JAG.49.1]; LOWRY OH, 1946, J BIOL CHEM, V162, P421; Luley-Goedl C, 2010, BIOTECHNOL J, V5, P1324, DOI 10.1002/biot.201000217; MANDELS M, 1962, J BACTERIOL, V83, P400, DOI 10.1128/JB.83.2.400-408.1962; Michal G., 1984, METHODS ENZYMATIC AN, P185; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Nakajima M, 2008, APPL ENVIRON MICROB, V74, P6333, DOI 10.1128/AEM.02846-07; Nakajima M, 2008, APPL MICROBIOL BIOT, V78, P465, DOI 10.1007/s00253-007-1319-8; Nakajima M, 2010, BIOSCI BIOTECH BIOCH, V74, P1652, DOI 10.1271/bbb.100263; Nakajima M, 2009, J BIOL CHEM, V284, P19220, DOI 10.1074/jbc.M109.007666; Nihira T, 2013, FEBS LETT, V587, P3556, DOI 10.1016/j.febslet.2013.09.014; Nihira T, 2012, CARBOHYD RES, V361, P49, DOI 10.1016/j.carres.2012.08.006; Nihira T, 2012, APPL MICROBIOL BIOT, V93, P1513, DOI 10.1007/s00253-011-3515-9; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2009, CARBOHYD RES, V344, P2573, DOI 10.1016/j.carres.2009.09.031; Ohdan K, 2007, J BIOTECHNOL, V127, P496, DOI 10.1016/j.jbiotec.2006.07.023; Ohdan K, 2006, BIOCATAL BIOTRANSFOR, V24, P77, DOI 10.1080/10242420600598152; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rajashekhara E, 2002, BIOSCI BIOTECH BIOCH, V66, P2578, DOI 10.1271/bbb.66.2578; Reichenbecher M, 1997, EUR J BIOCHEM, V247, P262, DOI 10.1111/j.1432-1033.1997.00262.x; Rigano LA, 2007, PLANT CELL, V19, P2077, DOI 10.1105/tpc.106.047944; Roset MS, 2006, J BACTERIOL, V188, P5003, DOI 10.1128/JB.00086-06; Sawano T, 2013, FEBS J, V280, P4463, DOI 10.1111/febs.12408; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TSUMURAYA Y, 1990, ARCH BIOCHEM BIOPHYS, V281, P58, DOI 10.1016/0003-9861(90)90412-R; Van Hoorebeke A, 2010, ACTA CRYSTALLOGR F, V66, P346, DOI 10.1107/S1744309110002642	48	27	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92353	10.1371/journal.pone.0092353	http://dx.doi.org/10.1371/journal.pone.0092353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647662	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500121
J	Richards, MH; Seaton, MS; Wallace, J; Al-Harthi, L				Richards, Maureen H.; Seaton, Melanie S.; Wallace, Jennilee; Al-Harthi, Lena			Porcupine Is Not Required for the Production of the Majority of Wnts from Primary Human Astrocytes and CD8+T Cells	PLOS ONE			English	Article							SEGMENT POLARITY GENES; BETA-CATENIN; N-GLYCOSYLATION; DROSOPHILA; SECRETION; WINGLESS; PROTEIN; REPLICATION; LIPIDATION; HOMOLOG	Wnts are small secreted glycoproteins that are highly conserved among species. To date, 19 Wnts have been described, which initiate a signal transduction cascade that is either beta-catenin dependent or independent, culminating in the regulation of hundreds of target genes. Extracellular release of Wnts is dependent on lipidation of Wnts by porcupine, a membrane-bound-O-acyltransferase protein in the endoplasmic reticulum. Studies demonstrating the requirement of porcupine for Wnts production are based on cell line and non-human primary cells. We evaluated the requirement for porcupine for Wnts production in human primary astrocytes and CD8+ T cells. Using IWP-2, an inhibitor of porcupine, or siRNA targeting porcupine, we demonstrate that porcupine is not required for the release of Wnt 1, 3, 5b, 6,7a, 10b, and 16a. While IWP had no effect on Wnt 2b release, knockdown of porcupine by siRNA reduced Wnt 2b release by 60%. These data indicate that porcupine-mediated production of Wnts is context dependent and is not required for all Wnts production, suggesting that alternative mechanisms exist for Wnts production.	[Richards, Maureen H.; Seaton, Melanie S.; Wallace, Jennilee; Al-Harthi, Lena] Rush Univ, Dept Immunol Microbiol, Med Ctr, Chicago, IL 60612 USA	Rush University	Al-Harthi, L (corresponding author), Rush Univ, Dept Immunol Microbiol, Med Ctr, Chicago, IL 60612 USA.	Lena_Al-Harthi@rush.edu			National Institute of Mental Health [R01 NIMH100628]; National Institute of Neurologic Diseases and Stroke [R01 NS060632, 1F32NS080657-01A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS080657, R01NS060632] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurologic Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding came from the National Institute of Mental Health R01 NIMH100628 to LA, the National Institute of Neurologic Diseases and Stroke R01 NS060632 to LA and 1F32NS080657-01A to MHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harthi L, 2012, J NEUROIMMUNE PHARM, V7, P725, DOI 10.1007/s11481-012-9412-x; Al-Harthi L, 2012, J NEUROIMMUNE PHARM, V7, P731, DOI 10.1007/s11481-012-9411-y; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Caricasole A, 2002, GENE, V288, P147, DOI 10.1016/S0378-1119(02)00467-5; Cerpa W, 2009, DRUG NEWS PERSPECT, V22, P579, DOI [10.1358/dnp.2009.10.1436817, 10.1358/dnp.2009.22.10.1443391]; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Ching W, 2008, J BIOL CHEM, V283, P17092, DOI 10.1074/jbc.M802059200; Coombs GS, 2008, CURR DRUG TARGETS, V9, P513, DOI 10.2174/138945008784911796; Covey TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034532; Dawson K, 2013, J PHYSIOL-LONDON, V591, P1409, DOI 10.1113/jphysiol.2012.235382; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Galli LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026636; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Hadian K, 2009, J BIOL CHEM, V284, P33384, DOI 10.1074/jbc.M109.021659; Herr P, 2012, TRENDS MOL MED, V18, P483, DOI 10.1016/j.molmed.2012.06.008; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kumar A, 2008, J VIROL, V82, P2813, DOI 10.1128/JVI.02498-07; Lamba S, 2009, GLIA, V57, P971, DOI 10.1002/glia.20821; Lancaster MA, 2010, TRENDS MOL MED, V16, P349, DOI 10.1016/j.molmed.2010.05.004; Li W, 2011, J IMMUNOL, V186, P6771, DOI 10.4049/jimmunol.1100099; Narasipura SD, 2012, J VIROL, V86, P1911, DOI 10.1128/JVI.06266-11; NOORDERMEER J, 1995, MECH DEVELOP, V51, P145, DOI 10.1016/0925-4773(95)00348-7; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; PERRIMON N, 1987, DEV BIOL, V119, P587, DOI 10.1016/0012-1606(87)90061-3; PERRIMON N, 1989, GENETICS, V121, P333; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Tang XF, 2012, DEV BIOL, V364, P32, DOI 10.1016/j.ydbio.2012.01.009; Tsukiyama T, 2012, NEUROSCI LETT, V512, P48, DOI 10.1016/j.neulet.2012.01.062; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Wang XL, 2013, J MED CHEM, V56, P2700, DOI 10.1021/jm400159c; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	41	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92159	10.1371/journal.pone.0092159	http://dx.doi.org/10.1371/journal.pone.0092159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647048	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500092
J	Son, M; Bang, WY; Park, C; Lee, Y; Kwon, SG; Kim, SW; Kim, CW; Lee, KW				Son, Minky; Bang, Woo Young; Park, Chanin; Lee, Yuno; Kwon, Seul Gi; Kim, Sam Woong; Kim, Chul Wook; Lee, Keun Woo			Functional Mechanism of C-Terminal Tail in the Enzymatic Role of Porcine Testicular Carbonyl Reductase: A Combined Experiment and Molecular Dynamics Simulation Study of the C-Terminal Tail in the Enzymatic Role of PTCR	PLOS ONE			English	Article							GENERAL FORCE-FIELD; NEONATAL PIG TESTIS; SHORT-CHAIN DEHYDROGENASES/REDUCTASES; BETA-HYDROXYSTEROID DEHYDROGENASE; PARTICLE MESH EWALD; 20-BETA-HYDROXYSTEROID DEHYDROGENASE; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; TERNARY COMPLEX	Porcine testicular carbonyl reductase, PTCR which is one of the short chain dehydrogenases/reductases (SDR) superfamily catalyzes the NADPH-dependent reduction of carbonyl compounds including steroids and prostaglandins. Previously we reported C-terminal tail of PTCR was deleted due to a nonsynonymous single nucleotide variation (nsSNV). Here we identified from kinetic studies that the enzymatic properties for 5 alpha-dihydrotestosterone (5 alpha-DHT) were different between wild-type and C-terminal-deleted PTCRs. Compared to wild-type PTCR, C-terminal-deleted PTCR has much higher reduction rate. To investigate structural difference between wild-type and C-terminal-deleted PTCRs upon 5a-DHT binding, we performed molecular dynamics simulations for two complexes. Using trajectories, molecular interactions including hydrogen bonding patterns, distance between 5a-DHT and catalytic Tyr193, and interaction energies are analyzed and compared. During the MD simulation time, the dynamic behavior of C-terminal tail in wild-type PTCR is also examined using essential dynamics analysis. The results of our simulations reveal that the binding conformation of 5 alpha-DHT in C-terminal-deleted PTCR is more favorable for reduction reaction in PTCR, which shows strong agreement with kinetic data. These structural findings provide valuable information to understand substrate specificity of PTCR and further kinetic properties of enzymes belonging to the SDR superfamily.	[Son, Minky; Park, Chanin; Lee, Yuno; Lee, Keun Woo] GNU, Div Appl Life Sci, Plus Program BK21, SSAC,PMBBRC,RINS, Jinju, South Korea; [Bang, Woo Young] Gyeongnam Natl Univ Sci & Technol, Ind Acad Cooperat Fdn, Jinju, South Korea; [Kwon, Seul Gi; Kim, Sam Woong; Kim, Chul Wook] Gyeongnam Natl Univ Sci & Technol, Swine Sci & Technol Ctr, Jinju, South Korea	Gyeongnam National University of Science and Technology; Gyeongnam National University of Science and Technology	Lee, KW (corresponding author), GNU, Div Appl Life Sci, Plus Program BK21, SSAC,PMBBRC,RINS, 501 Jinju Daero, Jinju, South Korea.	kwlee@gnu.ac.kr			Management of Climate Change Program [2010-0029084]; Basic Science Research Program [2011-0024925]; Priority Research Centers Program through the National Research Foundation of Korea (NRF) [2011-0022965]; Ministry of Education of Republic of Korea; Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea [PJ009486]	Management of Climate Change Program; Basic Science Research Program; Priority Research Centers Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education of Republic of Korea(Ministry of Education (MOE), Republic of Korea); Next-Generation BioGreen 21 Program from Rural Development Administration (RDA) of Republic of Korea	This research was supported by Management of Climate Change Program (2010-0029084), Basic Science Research Program (2011-0024925), and Priority Research Centers Program (2011-0022965) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education of Republic of Korea. And this work was also supported by the Next-Generation BioGreen 21 Program (PJ009486) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Benach J, 1998, J MOL BIOL, V282, P383, DOI 10.1006/jmbi.1998.2015; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Brigo A, 2005, BIOPHYS J, V88, P3072, DOI 10.1529/biophysj.104.050286; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; GHOSH D, 1994, STRUCTURE, V2, P629, DOI 10.1016/S0969-2126(00)00064-2; Ghosh D, 2001, CHEM-BIOL INTERACT, V130, P637, DOI 10.1016/S0009-2797(00)00255-6; Ghosh D, 2001, J BIOL CHEM, V276, P18457, DOI 10.1074/jbc.M100538200; GHOSH D, 1995, STRUCTURE, V3, P503, DOI 10.1016/S0969-2126(01)00183-6; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Joernvall H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI DOI 10.1021/BI00018A001; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jung WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042198; Kobayashi K, 1996, J STEROID BIOCHEM, V59, P485, DOI 10.1016/S0960-0760(96)00137-9; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nakajin S, 1997, BIOL PHARM BULL, V20, P1215; Nakajin S, 2001, BBA-PROTEIN STRUCT M, V1550, P175, DOI 10.1016/S0167-4838(01)00285-0; NAKAJIN S, 1987, CHEM PHARM BULL, V35, P2490; NAKAJIN S, 1988, J BIOCHEM-TOKYO, V104, P565, DOI 10.1093/oxfordjournals.jbchem.a122511; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; OHNO S, 1991, J STEROID BIOCHEM, V38, P787, DOI 10.1016/0960-0760(91)90093-K; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sawicki MW, 1999, P NATL ACAD SCI USA, V96, P840, DOI 10.1073/pnas.96.3.840; TANAKA M, 1992, J BIOL CHEM, V267, P13451; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Tanaka N, 1996, STRUCTURE, V4, P33, DOI 10.1016/S0969-2126(96)00007-X; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; VARUGHESE KI, 1992, P NATL ACAD SCI USA, V89, P6080, DOI 10.1073/pnas.89.13.6080; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Yesselman JD, 2012, J COMPUT CHEM, V33, P189, DOI 10.1002/jcc.21963; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	39	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e90712	10.1371/journal.pone.0090712	http://dx.doi.org/10.1371/journal.pone.0090712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646606	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500016
J	He, T; Sa, J; Zhong, PS; Cui, YH				He, Tao; Sa, Jian; Zhong, Ping-Shou; Cui, Yuehua			Statistical Dissection of Cyto-Nuclear Epistasis Subject to Genomic Imprinting in Line Crosses	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; COMPREHENSIVE GENETIC-MAP; MITOCHONDRIAL EPISTASIS; ENDOSPERM TRAITS; LINKAGE MAP; CYTOPLASM; FITNESS; MODEL; DROSOPHILA; FRAMEWORK	Cytoplasm contains important metabolism reaction organelles such as mitochondria and chloroplast (in plant). In particular, mitochondria contains special DNA information which can be passed to offsprings through maternal gametes, and has been confirmed to play a pivotal role in nuclear activities. Experimental evidences have documented the importance of cyto-nuclear interactions in affecting important biological traits. While studies have also pointed out the role of interaction between imprinting nuclear DNA and cytoplasm, no statistical method has been developed to efficiently model such effect and further quantify its effect size. In this work, we developed an efficient statistical model for genome-wide estimating and testing the cytoplasmic effect, nuclear DNA imprinting effect as well as the interaction between them under reciprocal backcross and F-2 designs derived from inbred lines. Parameters are estimated under maximum likelihood framework implemented with the EM algorithm. Extensive simulations show good performance in a variety of scenarios. The utility of the method is demonstrated by analyzing a published data set in an F-2 family derived from C3H/HeJBir and C57BL/6 J mouse strains. Important cyto-nuclear interactions were identified. Our approach provides a quantitative framework for identifying and estimating cyto-nuclear interactions subject to genomic imprinting involved in the genetic control of complex traits.	[He, Tao; Sa, Jian; Zhong, Ping-Shou; Cui, Yuehua] Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA; [Sa, Jian; Cui, Yuehua] Shanxi Med Univ, Sch Publ Hlth, Div Med Stat, Taiyuan, Shanxi, Peoples R China	Michigan State University; Shanxi Medical University	Cui, YH (corresponding author), Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA.	cui@stt.msu.edu	Cui, Yuehua/A-3529-2008; Cui, Yuehua/E-8004-2010	Cui, Yuehua/0000-0001-8099-1753; Cui, Yuehua/0000-0001-8099-1753	NSF [DMS-1209112, IOS-1237969, MCB-1121650]; National Natural Science Foundation of China [31371336]; Division Of Mathematical Sciences [1209112] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was partially supported by NSF grants DMS-1209112, IOS-1237969, and MCB-1121650, and by National Natural Science Foundation of China grant 31371336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgess KS, 2004, AM J BOT, V91, P1802, DOI 10.3732/ajb.91.11.1802; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; Chinnery PF, 2003, TRENDS GENET, V19, P60, DOI 10.1016/S0168-9525(02)00030-6; CHURCHILL GA, 1994, GENETICS, V138, P963; CLERGETDARPOUX F, 1991, AM J HUM GENET, V49, P42; Cui YH, 2006, GENOMICS, V87, P543, DOI 10.1016/j.ygeno.2005.11.021; Cui YH, 2007, GENETICA, V130, P227, DOI 10.1007/s10709-006-9101-x; Cui YH, 2007, J THEOR BIOL, V244, P115, DOI 10.1016/j.jtbi.2006.07.009; de Koning DJ, 2002, GENETICS, V161, P931; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Elfgang C, 1999, P NATL ACAD SCI USA, V96, P6229, DOI 10.1073/pnas.96.11.6229; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; Farmer MA, 2001, P NATL ACAD SCI USA, V98, P13820, DOI 10.1073/pnas.241258698; HAGA N, 1995, J CELL SCI, V108, P3671; HALDANE JBS, 1922, AM NAT, V67, P5; Hanson RL, 2001, AM J HUM GENET, V68, P951, DOI 10.1086/319508; Huxley JS, 1928, J GENET, V20, P145, DOI 10.1007/BF02983136; Isles AR, 2005, EARLY HUM DEV, V81, P73, DOI 10.1016/j.earlhumdev.2004.10.006; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; LANDER ES, 1989, GENETICS, V121, P185; Levin DA, 2003, SYST BOT, V28, P5; Li GX, 2010, ANN APPL STAT, V4, P1214, DOI 10.1214/09-AOAS323; Li SY, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1474; Li ZT, 2012, THEOR APPL GENET, V125, P419, DOI 10.1007/s00122-012-1892-9; Lynch M., 1998, GENETICS ANAL QUANTI; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Manichaikul A, 2006, GENETICS, V174; Marklund L, 1996, ANIM GENET, V27, P255, DOI 10.1111/j.1365-2052.1996.tb00487.x; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; NANNEY DL, 1953, BIOL BULL, V105, P133, DOI 10.2307/1538562; Neff MW, 1999, GENETICS, V151, P803; Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003; Rand DM, 2006, GENETICS, V172, P329, DOI 10.1534/genetics.105.046698; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rhode JM, 2005, AM NAT, V166, pE124, DOI 10.1086/491798; Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230; Tang ZX, 2007, GENETICS, V177, P669, DOI 10.1534/genetics.107.074302; Tao DY, 2004, EUPHYTICA, V135, P129, DOI 10.1023/B:EUPH.0000009548.81467.73; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Wu RL, 2002, GENETICS, V162, P875; Zeng Z, 1994, GENETICS, V136, P228; Zeyl C, 2005, EVOLUTION, V59, P910	44	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91702	10.1371/journal.pone.0091702	http://dx.doi.org/10.1371/journal.pone.0091702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643065	gold, Green Submitted, Green Published			2022-12-27	WOS:000333259900028
J	Heller, KG; Hemp, C				Heller, Klaus-Gerhard; Hemp, Claudia			Fiddler on the Tree - A Bush-Cricket Species with Unusual Stridulatory Organs and Song	PLOS ONE			English	Article							SOUND PRODUCTION; KATYDIDS ORTHOPTERA; MOLE CRICKETS; TETTIGONIIDAE; CONSTRAINTS; MECHANICS	Insects of the order Orthoptera are well-known for their acoustic communication. The structures used for this purpose show a high diversity which obviously relates to differences in song parameters and to the physics of sound production. Here we describe song and morphology of the sound producing organs of a tropical bush-cricket, Ectomoptera nepicauda, from East Africa. It has a very unusual calling song consisting of frequency-modulated, pure-tone sounds in the high ultrasonic range of 80 to 120 kHz and produced by extremely fast wing movements. Concerning morphology, it represents the most extreme state in the degree of left-right fore-wing differentiation found among Orthoptera: the acoustic parts of the left fore-wing consist exclusively of the stridulatory file, comparable in function to the bow of a violin, while the right wing carries only the plectrum (= string) and mirror (= soundbox).	[Heller, Klaus-Gerhard] Humboldt Univ, Dept Biol, Berlin, Germany; [Hemp, Claudia] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany	Humboldt University of Berlin; University of Wurzburg	Heller, KG (corresponding author), Humboldt Univ, Dept Biol, Berlin, Germany.	heller.volleth@t-online.de	Hemp, Claudia/AAL-3227-2020	Hemp, Claudia/0000-0001-9170-7113	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We gratefully acknowledge grants by the Deutsche Forschungsgemeinschaft (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY WJ, 1970, J EXP BIOL, V52, P495; Belwood J.J., 1990, P8; Bennet-Clark H.C., 1989, P227; Bennet-Clark HC, 2003, J EXP BIOL, V206, P1479, DOI 10.1242/jeb.00281; Bennet-Clark HC, 1999, J EXP BIOL, V202, P3347; Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; BENNETCLARK HC, 1970, J EXP BIOL, V52, P619; Bethoux O, 2012, ARTHROPOD SYST PHYLO, V70, P43; Chivers B, 2014, BIOACOUSTICS, V23, P67, DOI 10.1080/09524622.2013.816639; Eades DC, ORTHOPTERA SPECIES F; ELLIOTT CJH, 1983, ANIM BEHAV, V31, P887, DOI 10.1016/S0003-3472(83)80244-9; FORREST TG, 1987, FLA ENTOMOL, V70, P284, DOI 10.2307/3495161; Harz K, 1969, ORTHOPTEREN EUROPAS, V5; Heller K.-G., 1988, BIOAKUSTIK EUROPAISC; Heller KG, 1997, ZOOL-ANAL COMPLEX SY, V100, P110; Hemp C, 2013, ORG DIVERS EVOL, V13, P373, DOI 10.1007/s13127-012-0123-1; Henry G. M., 1940, Proceedings of the Royal Entomological Society of London, V9, P97; Karsch F., 1891, BERL ENTOMOL ZEIT, V36, P210, DOI [10.1002/mmnd.18910360119, DOI 10.1002/MMND.18910360119]; LEROY Y, 1969, ANN SOC ENTOMOL FR, V5, P775; Montealegre-Z F, 2005, J EXP BIOL, V208, P1219, DOI 10.1242/jeb.01526; Montealegre-Z F, 2004, SYST ENTOMOL, V29, P21, DOI 10.1111/j.1365-3113.2004.00223.x; Montealegre-Z F, 2009, J EVOLUTION BIOL, V22, P355, DOI 10.1111/j.1420-9101.2008.01652.x; Montealegre-Z F, 2006, J EXP BIOL, V209, P4923, DOI 10.1242/jeb.02608; Montealegre-Z F, 2012, J INSECT PHYSIOL, V58, P116, DOI 10.1016/j.jinsphys.2011.10.006; Montealegre ZF, 2009, J EXP BIOL, V212, P257, DOI 10.1242/jeb.022731; MORRIS G K, 1978, Psyche (Cambridge), V85, P147, DOI 10.1155/1978/84389; MORRIS GK, 1994, J ZOOL, V233, P129, DOI 10.1111/j.1469-7998.1994.tb05266.x; Ragge D.R., 1980, Bulletin of the British Museum (Natural History) Entomology, V40, P67; Ragge D. R., 1969, Bulletin of the British Museum (Natural History) Entomology, V23, P167; Regen J, 1903, ARBEITEN WIENER ZOOL, V14, P38; SPOONER JD, 1973, ANN ENTOMOL SOC AM, V66, P4, DOI 10.1093/aesa/66.1.4; Spooner John D., 1995, Journal of Orthoptera Research, V4, P127; WALKER TJ, 1972, SCIENCE, V178, P174, DOI 10.1126/science.178.4057.174	33	13	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92366	10.1371/journal.pone.0092366	http://dx.doi.org/10.1371/journal.pone.0092366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643071	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900127
J	Liu, Y; Yang, L; Chen, KL; Zhou, B; Yan, H; Zhou, ZG; Li, Y				Liu, Yong; Yang, Lie; Chen, Ke-Ling; Zhou, Bin; Yan, Hui; Zhou, Zong-Guang; Li, Yuan			Knockdown of GRP78 Promotes Apoptosis in Pancreatic Acinar Cells and Attenuates the Severity of Cerulein and LPS Induced Pancreatic Inflammation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NECROSIS-FACTOR-ALPHA; ER CHAPERONE GRP78; REGULATOR GRP78/BIP; CASPASE ACTIVATION; DEATH PROGRAM; CANCER CELLS; AR42J CELLS; CROSS-TALK; PROTEIN	Acute pancreatitis (AP) is a potentially lethal disease characterized by inflammation and parenchymal cell death; also, the severity of AP correlates directly with necrosis and inversely with apoptosis. However, mechanisms of regulating cell death in AP remain unclear. The endoplasmic reticulum (ER) chaperone protein GRP78 has anti-apoptotic properties, in addition to modulating ER stress responses. This study used RNA interference (RNAi) approach to investigate the potential role of GRP78 in regulating apoptosis during AP. In vitro models of AP were successfully developed by treating AR42J cells with cerulein or cerulein plus lipoplysaccharide (LPS). There was more pancreatic inflammation and less apoptosis with the cerulein plus LPS treatment. Furthermore, knockdown of GRP78 expression markedly promoted apoptosis and reduced necrosis in pancreatic acinar cells. This was accomplished by enhancing the activation of caspases and inhibiting the activity of X-linked inhibitor of apoptosis protein (XIAP), as well as a receptor interacting protein kinase-1(RIPK1), which is a key mediator of necrosis. This attenuated the severity of pancreatic inflammation, especially after cerulein plus LPS treatment. In conclusion, these findings indicate that GRP78 plays an anti-apoptotic role in regulating the cell death response during AP. Therefore, GRP78 is a potential therapeutic target for AP.	[Liu, Yong; Yang, Lie; Yan, Hui; Zhou, Zong-Guang] Sichuan Univ, West China Hosp, Dept Surg Gastroenterol, Chengdu 610064, Sichuan, Peoples R China; [Chen, Ke-Ling; Zhou, Bin; Zhou, Zong-Guang; Li, Yuan] Sichuan Univ, Inst Digest Surg, Chengdu 610064, Sichuan, Peoples R China; [Chen, Ke-Ling; Zhou, Bin; Zhou, Zong-Guang; Li, Yuan] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Li, Y (corresponding author), Sichuan Univ, Inst Digest Surg, Chengdu 610064, Sichuan, Peoples R China.	liyuanletters@163.com		, Zongguang/0000-0002-7616-1199	National Natural Science Fund of China (NSFC) [30830100, 30972924, 81170439]; SRF for ROCS, SEM [20101174-4-2]; Research Fund for the Doctoral Program of Higher Education, SEM [200806100058]	National Natural Science Fund of China (NSFC)(National Natural Science Foundation of China (NSFC)); SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Research Fund for the Doctoral Program of Higher Education, SEM	This work was supported by grants from the National Natural Science Fund of China (NSFC key project No. 30830100; project No. 30972924; project No. 81170439) and The Project-sponsored by SRF for ROCS, SEM (No. 20101174-4-2); The Research Fund for the Doctoral Program of Higher Education, SEM (No. 200806100058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia M, 2004, AM J PHYSIOL-GASTR L, V286, pG189, DOI 10.1152/ajpgi.00304.2003; Bhatia M, 1998, BIOCHEM BIOPH RES CO, V246, P476, DOI 10.1006/bbrc.1998.8519; BUJA LM, 1993, ARCH PATHOL LAB MED, V117, P1208; Chao KC, 2006, BRIT J SURG, V93, P332, DOI 10.1002/bjs.5251; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Gukovskaya AS, 2002, J BIOL CHEM, V277, P22595, DOI 10.1074/jbc.M202929200; Gukovskaya AS, 2004, PANCREATOLOGY, V4, P567, DOI 10.1159/000082182; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Kubisch CH, 2007, AM J PHYSIOL-GASTR L, V292, pG1804, DOI 10.1152/ajpgi.00078.2007; Kubisch CH, 2006, AM J PHYSIOL-GASTR L, V291, pG238, DOI 10.1152/ajpgi.00471.2005; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee HC, 2000, J BIOMED SCI, V7, P2, DOI 10.1007/BF02255913; LESER HG, 1991, GASTROENTEROLOGY, V101, P782, DOI 10.1016/0016-5085(91)90539-W; Liu Y, 2012, HEPATO-GASTROENTEROL, V59, P1670, DOI 10.5754/hge12281; Lomberk G, 2009, PANCREATOLOGY, V9, P6, DOI 10.1159/000178860; Malka D, 2000, GASTROENTEROLOGY, V119, P816, DOI 10.1053/gast.2000.16491; Malleo G, 2007, SHOCK, V28, P130, DOI 10.1097/shk.0b013e3180487ba1; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; Mayer J, 2000, GUT, V47, P546, DOI 10.1136/gut.47.4.546; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Naidoo N, 2009, SLEEP MED REV, V13, P195, DOI 10.1016/j.smrv.2009.01.001; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Norman J, 1998, AM J SURG, V175, P76, DOI 10.1016/S0002-9610(97)00240-7; Norman JG, 1997, DIGEST DIS SCI, V42, P1783, DOI 10.1023/A:1018886120711; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Qian YC, 2007, AM J PHYSIOL-CELL PH, V293, pC897, DOI 10.1152/ajpcell.00059.2007; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Yew KH, 2005, J BIOL CHEM, V280, P32209, DOI 10.1074/jbc.M505465200; Yu JH, 2005, FREE RADICAL BIO MED, V39, P590, DOI 10.1016/j.freeradbiomed.2005.04.019; Yu JH, 2008, INT J BIOCHEM CELL B, V40, P503, DOI 10.1016/j.biocel.2007.09.001; Zhang XP, 2007, DIGEST DIS SCI, V52, P1199, DOI 10.1007/s10620-006-9388-6; Zhao M, 2007, WORLD J GASTROENTERO, V13, P5612, DOI 10.3748/wjg.v13.i42.5612	50	16	17	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92389	10.1371/journal.pone.0092389	http://dx.doi.org/10.1371/journal.pone.0092389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643222	gold, Green Published, Green Submitted			2022-12-27	WOS:000333259900130
J	Hood, RR; Kendall, EL; Junqueira, M; Vreeland, WN; Quezado, Z; Finkel, JC; Devoe, DL				Hood, Renee R.; Kendall, Eric L.; Junqueira, Mariana; Vreeland, Wyatt N.; Quezado, Zenaide; Finkel, Julia C.; Devoe, Don L.			Microfluidic-Enabled Liposomes Elucidate Size-Dependent Transdermal Transport	PLOS ONE			English	Article							PORCINE EAR SKIN; PARTICLE-SIZE; IN-VITRO; LIPID VESICLES; DRUG CARRIERS; DELIVERY; PENETRATION; NANOPARTICLES; PERMEABILITY	Microfluidic synthesis of small and nearly-monodisperse liposomes is used to investigate the size-dependent passive transdermal transport of nanoscale lipid vesicles. While large liposomes with diameters above 105 nm are found to be excluded from deeper skin layers past the stratum corneum, the primary barrier to nanoparticle transport, liposomes with mean diameters between 31-41 nm exhibit significantly enhanced penetration. Furthermore, multicolor fluorescence imaging reveals that the smaller liposomes pass rapidly through the stratum corneum without vesicle rupture. These findings reveal that nanoscale liposomes with well-controlled size and minimal size variance are excellent vehicles for transdermal delivery of functional nanoparticle drugs.	[Hood, Renee R.; Devoe, Don L.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA; [Kendall, Eric L.; Devoe, Don L.] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA; [Junqueira, Mariana; Quezado, Zenaide; Finkel, Julia C.] Childrens Natl Med Ctr, Dept Anesthesiol Sedat & Perioperat Med, Washington, DC 20010 USA; [Vreeland, Wyatt N.] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Children's National Health System; National Institute of Standards & Technology (NIST) - USA	Devoe, DL (corresponding author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.	ddev@umd.edu	DeVoe, Don L/A-2891-2011; Quezado, Zenaide/O-4860-2016	DeVoe, Don L/0000-0002-7740-9993; Quezado, Zenaide/0000-0001-9793-4368	Sheikh Zayed Institute - Clark School of Engineering; National Science Foundation [CBET0966407]; Div Of Chem, Bioeng, Env, & Transp Sys [0966407] Funding Source: National Science Foundation	Sheikh Zayed Institute - Clark School of Engineering; National Science Foundation(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was funded by a Sheikh Zayed Institute - Clark School of Engineering seed grant and the National Science Foundation through grant CBET0966407. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akomeah FK, 2007, J PHARM SCI-US, V96, P824, DOI 10.1002/jps.20773; BARENHOLZT Y, 1979, FEBS LETT, V99, P210, DOI 10.1016/0014-5793(79)80281-1; BATZRI S, 1973, BIOCHIM BIOPHYS ACTA, V298, P1015, DOI 10.1016/0005-2736(73)90408-2; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bouwstra JA, 2003, PROG LIPID RES, V42, P1, DOI 10.1016/S0163-7827(02)00028-0; Brewer J, 2013, J INVEST DERMATOL, V133, P1260, DOI 10.1038/jid.2012.461; Cevc G, 1998, BBA-BIOMEMBRANES, V1368, P201, DOI 10.1016/S0005-2736(97)00177-6; Cevc G, 2004, ADV DRUG DELIVER REV, V56, P675, DOI 10.1016/j.addr.2003.10.028; Chu MQ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/45/455103; DUPLESSIS J, 1994, INT J PHARMACEUT, V103, P277, DOI 10.1016/0378-5173(94)90178-3; Elsayed MMA, 2007, INT J PHARMACEUT, V332, P1, DOI 10.1016/j.ijpharm.2006.12.005; [Gao Shumei 高淑梅], 2004, Chinese Optics Letters, V2, P160; HAMILTON RL, 1980, J LIPID RES, V21, P981; Hood RR, 2013, PHARM RES-DORDR, V30, P1597, DOI 10.1007/s11095-013-0998-3; Immordino ML, 2006, INT J NANOMED, V1, P297; Jacobi U, 2007, SKIN RES TECHNOL, V13, P19, DOI 10.1111/j.1600-0846.2006.00179.x; Jahn A, 2004, J AM CHEM SOC, V126, P2674, DOI 10.1021/ja0318030; Jahn A, 2007, LANGMUIR, V23, P6289, DOI 10.1021/la070051a; Jahn A, 2010, ACS NANO, V4, P2077, DOI 10.1021/nn901676x; Karande P, 2005, P NATL ACAD SCI USA, V102, P4688, DOI 10.1073/pnas.0501176102; Kong R, 2011, ANALYST, V136, P2359, DOI 10.1039/c1an15111h; Kuchler S, 2009, EUR J PHARM BIOPHARM, V71, P243, DOI 10.1016/j.ejpb.2008.08.019; Maulucci G, 2005, BIOPHYS J, V88, P3545, DOI 10.1529/biophysj.104.048876; Mitragotri S, 2003, J CONTROL RELEASE, V86, P69, DOI 10.1016/S0168-3659(02)00321-8; Mordon S, 2003, LASER SURG MED, V33, P119, DOI 10.1002/lsm.10204; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Prow TW, 2011, ADV DRUG DELIVER REV, V63, P470, DOI 10.1016/j.addr.2011.01.012; ROLLAND A, 1993, PHARMACEUT RES, V10, P1738, DOI 10.1023/A:1018922114398; Ryman-Rasmussen JP, 2006, TOXICOL SCI, V91, P159, DOI 10.1093/toxsci/kfj122; Schleich N, 2012, RSC DRUG DISCOV, V22, P316, DOI 10.1039/9781849735292-00316; SCHREIER H, 1994, J CONTROL RELEASE, V30, P1, DOI 10.1016/0168-3659(94)90039-6; Sekkat N, 2002, J PHARM SCI-US, V91, P2376, DOI 10.1002/jps.10220; Sentjurc M, 1999, J CONTROL RELEASE, V59, P87, DOI 10.1016/S0168-3659(98)00181-3; Sudhakar C.K., 2012, NANOMEDICINE DRUG DE, P1, DOI [10.1201/b13119-5, DOI 10.1201/B13119-5]; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Touitou E, 2000, J CONTROL RELEASE, V65, P403, DOI 10.1016/S0168-3659(99)00222-9; Verma DD, 2003, INT J PHARM, V258, P141, DOI 10.1016/S0378-5173(03)00183-2; Vogt A, 2006, J INVEST DERMATOL, V126, P1316, DOI 10.1038/sj.jid.5700226; Zook JM, 2010, SOFT MATTER, V6, P1352, DOI 10.1039/b923299k	39	29	31	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92978	10.1371/journal.pone.0092978	http://dx.doi.org/10.1371/journal.pone.0092978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658111	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300150
J	Madai, VI; Galinovic, I; Grittner, U; Zaro-Weber, O; Schneider, A; Martin, SZ; Samson-Himmelstjerna, FCV; Stengl, KL; Mutke, MA; Moeller-Hartmann, W; Ebinger, M; Fiebach, JB; Sobesky, J				Madai, Vince I.; Galinovic, Ivana; Grittner, Ulrike; Zaro-Weber, Olivier; Schneider, Alice; Martin, Steve Z.; Samson-Himmelstjerna, Federico C. v.; Stengl, Katharina L.; Mutke, Matthias A.; Moeller-Hartmann, Walter; Ebinger, Martin; Fiebach, Jochen B.; Sobesky, Jan			DWI Intensity Values Predict FLAIR Lesions in Acute Ischemic Stroke	PLOS ONE			English	Article							APPARENT DIFFUSION-COEFFICIENT; ATTENUATED INVERSION-RECOVERY; UNKNOWN ONSET TIME; SIGNAL INTENSITY; SYMPTOM ONSET; EVOLUTION; MISMATCH; BRAIN; GUIDELINES; MANAGEMENT	Background and Purpose: In acute stroke, the DWI-FLAIR mismatch allows for the allocation of patients to the thrombolysis window (<4.5 hours). FLAIR-lesions, however, may be challenging to assess. In comparison, DWI may be a useful bio-marker owing to high lesion contrast. We investigated the performance of a relative DWI signal intensity (rSI) threshold to predict the presence of FLAIR-lesions in acute stroke and analyzed its association with time-from-stroke-onset. Methods: In a retrospective, dual-center MR-imaging study we included patients with acute stroke and time-from-stroke-onset <= 12 hours (group A: n = 49, 1.5T; group B: n = 48, 3T). DW- and FLAIR-images were coregistered. The largest lesion extent in DWI defined the slice for further analysis. FLAIR-lesions were identified by 3 raters, delineated as regions-of-interest (ROIs) and copied on the DW-images. Circular ROIs were placed within the DWI-lesion and labeled according to the FLAIR-pattern (FLAIR+ or FLAIR-). ROI-values were normalized to the unaffected hemisphere. Adjusted and nonadjusted receiver-operating-characteristics (ROC) curve analysis on patient level was performed to analyze the ability of a DWI- and ADC-rSI threshold to predict the presence of FLAIR-lesions. Spearman correlation and adjusted linear regression analysis was performed to assess the relationship between DWI-intensity and time-from-stroke-onset. Results: DWI-rSI performed well in predicting lesions in FLAIR-imaging (mean area under the curve (AUC): group A: 0.84; group B: 0.85). An optimal mean DWI-rSI threshold was identified (A: 162%; B: 161%). ADC-maps performed worse (mean AUC: A: 0.58; B: 0.77). Adjusted regression models confirmed the superior performance of DWI-rSI. Correlation coefficents and linear regression showed a good association with time-from-stroke-onset for DWI-rSI, but not for ADC-rSI. Conclusion: An easily assessable DWI-rSI threshold identifies the presence of lesions in FLAIR-imaging with good accuracy and is associated with time-from-stroke-onset in acute stroke. This finding underlines the potential of a DWI-rSI threshold as a marker of lesion age.	[Madai, Vince I.; Galinovic, Ivana; Grittner, Ulrike; Zaro-Weber, Olivier; Schneider, Alice; Martin, Steve Z.; Samson-Himmelstjerna, Federico C. v.; Stengl, Katharina L.; Mutke, Matthias A.; Ebinger, Martin; Fiebach, Jochen B.; Sobesky, Jan] Charite, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany; [Zaro-Weber, Olivier] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Samson-Himmelstjerna, Federico C. v.] Fraunhofer MEVIS, Bremen, Germany; [Moeller-Hartmann, Walter] Krankenhaus Ludmillenstift, Dept Radiol, Meppen, Germany; [Madai, Vince I.; Stengl, Katharina L.; Mutke, Matthias A.; Ebinger, Martin; Sobesky, Jan] Charite, Dept Neurol, D-13353 Berlin, Germany; [Grittner, Ulrike; Schneider, Alice] Charite, Dept Clin Epidemiol & Biostat, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sobesky, J (corresponding author), Charite, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany.	jan.sobesky@charite.de	Madai, Vince/AAF-5525-2020; Madai, Vince/GYD-7365-2022; Grittner, Ulrike/I-2026-2019	Madai, Vince/0000-0002-8552-6954; Madai, Vince/0000-0002-8552-6954; Grittner, Ulrike/0000-0003-2595-0224; Martin, Steve/0000-0003-0653-6458; Fiebach, Jochen B./0000-0002-7936-6958; Galinovic, Ivana/0000-0003-4904-8251; Sobesky, Jan/0000-0001-5459-3655	German Federal Ministry of Education and Research via the grant "Center for Stroke Research Berlin'' [01 EO 0801]	German Federal Ministry of Education and Research via the grant "Center for Stroke Research Berlin''	The research leading to these results has received funding from the German Federal Ministry of Education and Research via the grant "Center for Stroke Research Berlin'' (01 EO 0801; http://www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; [Anonymous], 2008, CEREBROVASC DIS, V25, P457, DOI DOI 10.1159/000131083; Aoki J, 2010, J NEUROL SCI, V293, P39, DOI 10.1016/j.jns.2010.03.011; BRENNAN RL, 1981, EDUC PSYCHOL MEAS, V41, P687, DOI 10.1177/001316448104100307; Cheng B, 2012, J CEREB BLOOD FLOW M; Cizek J, 2004, NEUROIMAGE, V22, P434, DOI 10.1016/j.neuroimage.2004.01.016; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eastwood JD, 2003, AM J NEURORADIOL, V24, P680; Ebinger M, 2010, STROKE, V41, P250, DOI 10.1161/STROKEAHA.109.568410; Elliott WJ, 1998, STROKE, V29, P992, DOI 10.1161/01.STR.29.5.992; Emeriau S, 2013, STROKE, V44, P1647, DOI 10.1161/STROKEAHA.113.001001; Fiebach JB, 2002, NEURORADIOLOGY, V44, P294, DOI 10.1007/s00234-001-0720-8; Galinovic I, 2014, STROKE          0220; Heiss WD, 2004, STROKE, V35, P1892, DOI 10.1161/01.STR.0000134746.93535.9b; Khademi A, 2012, IEEE T BIO-MED ENG, V59, P860, DOI 10.1109/TBME.2011.2181167; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lansberg MG, 2011, STROKE, V42, P1608, DOI 10.1161/STROKEAHA.110.609008; Lansberg MG, 2001, AM J NEURORADIOL, V22, P637; Petkova M, 2010, RADIOLOGY, V257, P782, DOI 10.1148/radiol.10100461; Randolph J. J., 2005, P JOENS LEARN INSTR; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113; Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268; Sobesky J, 2012, J CEREBR BLOOD F MET, V32, P1416, DOI 10.1038/jcbfm.2012.54; Song SS, 2012, STROKE, V43, P2331, DOI 10.1161/STROKEAHA.111.630947; Srivastava AK, 2008, J MED PHYS, V33, P162, DOI 10.4103/0971-6203.44479; Thomalla G, 2011, LANCET NEUROL, V10, P978, DOI 10.1016/S1474-4422(11)70192-2; WARACH S, 1995, ANN NEUROL, V37, P231, DOI 10.1002/ana.410370214; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Ziegler A, 2011, J NEUROL	30	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92295	10.1371/journal.pone.0092295	http://dx.doi.org/10.1371/journal.pone.0092295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658092	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300070
J	Mathad, JS; Bhosale, R; Sangar, V; Mave, V; Gupte, N; Kanade, S; Nangude, A; Chopade, K; Suryavanshi, N; Deshpande, P; Kulkarni, V; Glesby, MJ; Fitzgerald, D; Bharadwaj, R; Sambarey, P; Gupta, A				Mathad, Jyoti S.; Bhosale, Ramesh; Sangar, Vikrant; Mave, Vidya; Gupte, Nikhil; Kanade, Savita; Nangude, Ashwini; Chopade, Kavita; Suryavanshi, Nishi; Deshpande, Prasad; Kulkarni, Vandana; Glesby, Marshall J.; Fitzgerald, Daniel; Bharadwaj, Renu; Sambarey, Pradeep; Gupta, Amita			Pregnancy Differentially Impacts Performance of Latent Tuberculosis Diagnostics in a High-Burden Setting	PLOS ONE			English	Article							GAMMA RELEASE ASSAY; SKIN-TEST; INFECTION; CONVERSION; WOMEN; RISK; GOLD; CARE	Background: Targeted screening for latent TB infection (LTBI) in vulnerable populations is a recommended TB control strategy. Pregnant women are at high risk for developing TB and likely to access healthcare, making pregnancy an important screening opportunity in developing countries. The sensitivity of the widely-used tuberculin skin test (TST), however, may be reduced during pregnancy. Methods: We performed a cross-sectional study comparing the TST with the QuantiFERON Gold In-tube (QGIT) in 401 HIV-negative women presenting antepartum (n = 154), at delivery (n = 148), or postpartum (n = 99) to a government hospital in Pune, India. A subset of 60 women enrolled during pregnancy was followed longitudinally and received both tests at all three stages of pregnancy. Results: The QGIT returned significantly more positive results than the TST. Of the 401 women in the cross-sectional study, 150 (37%) had a positive QGIT, compared to 59 (14%) for the TST (p<0.005). Forty-nine (12%) did not have their TST read. Of 356 who had both results available, 46 (13%) were concordant positive, 91 (25%) were discordant (12 (3%) TST+/QGIT-; 79 (22%) TST2/QGIT+), and 206 (57%) concordant negative. Comparison by stage of pregnancy revealed that QGIT percent positivity remained stable between antepartum and delivery, unlike TST results (QGIT 31-32% vs TST 11-17%). Median IFN-gamma concentration was lower at delivery than in antepartum or postpartum (1.66 vs 2.65 vs 8.99 IU/mL, p = 0.001). During postpartum, both tests had significantly increased positives (QGIT 31% vs 32% vs 52%, p = 0.01; TST 17% vs 11% vs 25%, p<0.005). The same trends were observed in the longitudinal subset. Conclusions: Timing and choice of LTBI test during pregnancy impact results. QGIT was more stable and more closely approximated the LTBI prevalence in India. But pregnancy stage clearly affects both tests, raising important questions about how the complex immune changes brought on by pregnancy may impact LTBI screening.	[Mathad, Jyoti S.; Glesby, Marshall J.; Fitzgerald, Daniel] Weill Cornell Med Coll, Div Infect Dis, New York, NY 10021 USA; [Bhosale, Ramesh; Sambarey, Pradeep] Sassoon Gen Hosp, Byramjee Jeejeebhoy Govt Med Coll, Dept Obstet & Gynaecol, Pune, Maharashtra, India; [Sangar, Vikrant; Mave, Vidya; Gupte, Nikhil; Kanade, Savita; Nangude, Ashwini; Chopade, Kavita; Suryavanshi, Nishi; Deshpande, Prasad; Kulkarni, Vandana; Gupta, Amita] Byramjee Jeejeebhoy Govt Med Coll, Johns Hopkins Clin Trials Unit, Pune, Maharashtra, India; [Bharadwaj, Renu] Sassoon Gen Hosp, Byramjee Jeejeebhoy Govt Med Coll, Dept Microbiol, Pune, Maharashtra, India; [Mave, Vidya; Gupte, Nikhil; Gupta, Amita] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA	Cornell University; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Johns Hopkins University	Mathad, JS (corresponding author), Weill Cornell Med Coll, Div Infect Dis, New York, NY 10021 USA.	jsm9009@med.cornell.edu; agupta25@jhmi.edu	Bharadwaj, Renu/I-1979-2019	Bharadwaj, Renu/0000-0002-4286-7337; Gupta, Amita/0000-0001-7036-2718	National Institute of Allergy and Infectious Diseases; National Institutes of Health (NIH) [U01 AI069497, K24 AI078884]; Gilead Foundation; Ujala Foundation; World Health Organization; NIH [T32 AI007613]; Weill Cornell Clinical and Translational Science Center [KL2 TR00458]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI078884, U01AI069497, T32AI007613] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead Foundation(Gilead Sciences); Ujala Foundation; World Health Organization(World Health Organization); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell Clinical and Translational Science Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases, the National Institutes of Health (NIH) (grant number U01 AI069497 for the Byramjee Jeejeebhoy Government Medical College HIV Clinical Trials Unit to AG, grant number K24 AI078884 to MG), the Gilead Foundation, the Ujala Foundation, and the World Health Organization. JSM was supported by a training grant from the NIH (grant number T32 AI007613) and the Weill Cornell Clinical and Translational Science Center (grant number KL2 TR00458). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; American Academy of Pediatrics Committee on Drugs, 2001, Pediatrics, V108, P776; [Anonymous], 2009, QUANTIFERON TB GOLD; [Anonymous], 2000, MMWR RECOMM REP, V49, P1; Boggess KA, 2000, OBSTET GYNECOL, V96, P757, DOI 10.1016/S0029-7844(00)01039-5; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; COVELLI HD, 1978, AM J OBSTET GYNECOL, V132, P256, DOI 10.1016/0002-9378(78)90889-X; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; El Fakih RO, 2010, KANSAS J MED, V3, P24; GOOD JT, 1981, AM J OBSTET GYNECOL, V140, P492, DOI 10.1016/0002-9378(81)90222-2; Grange J, 2010, INT J GYNECOL OBSTET, V108, P181, DOI 10.1016/j.ijgo.2009.12.005; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; International Institute for Population Sciences (IIPS) and ICF, 2007, NAT FAM HLTH SURV NF; Jackson TD, 2001, AM J OBSTET GYNECOL, V184, P1090, DOI 10.1067/mob.2001.114921; Jonnalagadda S, 2010, J INFECT DIS, V202, P1826, DOI 10.1086/657411; Jonnalagadda Sasi R, 2012, Infect Dis Obstet Gynecol, V2012, P950650, DOI 10.1155/2012/950650; Kim EY, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-207; Kim JH, 2013, SEMIN ARTHRITIS RHEU, V42, P424, DOI 10.1016/j.semarthrit.2012.07.001; Kruse A, 2002, BIOL REPROD, V66, P333, DOI 10.1095/biolreprod66.2.333; Lighter-Fisher J, 2012, OBSTET GYNECOL, V119, P1088, DOI 10.1097/AOG.0b013e3182546aff; Machado A, 2009, INT J TUBERC LUNG D, V13, P446; Mathad JS, 2012, CLIN INFECT DIS, V55, P1532, DOI 10.1093/cid/cis732; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; OJANUGA DN, 1992, SOC SCI MED, V35, P613; Organization WH, 2011, GUID INT TUB CAS FIN; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Revised National Tuberculosis Control Programme, 2006, IND TB RNTCP STAT RE; Ritz N, 2011, INT J TUBERC LUNG D, V15, P767, DOI 10.5588/ijtld.10.0339; Sarrazin H, 2009, J INFECT DIS, V199, P702, DOI 10.1086/596735; Sauzullo I, 2011, TUBERCULOSIS, V91, P322, DOI 10.1016/j.tube.2011.05.004; Schulte Joann M, 2002, J Perinatol, V22, P159, DOI 10.1038/sj.jp.7210617; Singh N, 2007, CLIN INFECT DIS, V45, P1192, DOI 10.1086/522182; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Weinfurter P, 2011, INT J TUBERC LUNG D, V15, P1056, DOI 10.5588/ijtld.10.0650; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wilkinson KA, 2005, CLIN INFECT DIS, V40, P184, DOI 10.1086/426139; Worjoloh A, 2011, OBSTET GYNECOL, V118, P1363, DOI 10.1097/AOG.0b013e31823834a9; World Health Organization. UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, 2011, US INT INT GAM REL A; Zenner D, 2012, AM J RESP CRIT CARE, V185, P779, DOI 10.1164/rccm.201106-1083OC	41	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92308	10.1371/journal.pone.0092308	http://dx.doi.org/10.1371/journal.pone.0092308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658103	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300071
J	Bergada, L; Yeramian, A; Sorolla, A; Matias-Guiu, X; Dolcet, X				Bergada, Laura; Yeramian, Andree; Sorolla, Annabel; Matias-Guiu, Xavier; Dolcet, Xavier			Antioxidants Impair Anti-Tumoral Effects of Vorinostat, but Not Anti-Neoplastic Effects of Vorinostat and Caspase-8 Downregulation	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; SUBEROYLANILIDE HYDROXAMIC ACID; CANCER-CELLS; HDAC INHIBITORS; PROTEASOME INHIBITOR; DEPENDENT APOPTOSIS; ANTICANCER AGENTS; OXIDATIVE STRESS; CARCINOMA-CELLS; LEUKEMIA-CELLS	We have recently demonstrated that histone deacetylase inhibitor, Vorinostat, applied as a single therapy or in combination with caspase-8 downregulation exhibits high anti-tumoral activity on endometrial carcinoma cell lines. In the present study, we have assessed the signalling processes underlying anti-tumoral effects of Vorinostat. Increasing evidence suggests that reactive oxygen species are responsible for histone deacetylase inhibitor-induced cell killing. We have found that Vorinostat induces formation of reactive oxygen species and DNA damage. To investigate the role of oxidative stress as anti-neoplastic mechanism, we have evaluated the effects of different antioxidants (Bha, Nac and Tiron) on endometrial carcinoma cell line Ishikawa treated with Vorinostat. We show that Bha, Nac and Tiron markedly inhibited the cytotoxic effects of Vorinostat, increasing cell viability in vitro. We found that all three antioxidants did not inhibited accumulation of acetyl Histone H4, so that antioxidants did not inhibit Vorinostat activity. Finally, we have evaluated the effects of antioxidants on anti-tumoral activity of Vorinostat as monotherapy or in combination with caspase-8 downregulation in vivo. Interestingly, antioxidants blocked the reduction of tumour growth caused by Vorinostat, but they were unable to inhibit anti-tumoral activity of Vorinostat plus caspase-8 inhibition.	[Bergada, Laura; Yeramian, Andree; Sorolla, Annabel; Matias-Guiu, Xavier; Dolcet, Xavier] Univ Lleida, Hosp Univ Arnau de Vilanova, Inst Recerca Biomed Lleida, Oncol Pathol Grp,Dept Ciencies Med Basiques,IRBLl, Lleida, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; University Hospital Arnau de Vilanova	Dolcet, X (corresponding author), Univ Lleida, Hosp Univ Arnau de Vilanova, Inst Recerca Biomed Lleida, Oncol Pathol Grp,Dept Ciencies Med Basiques,IRBLl, Lleida, Spain.	dolcet@cmb.udl.cat	yeramian, andree/B-5936-2009; Dolcet, Xavi/B-5665-2009; Sorolla, Anabel/E-2546-2012; matias-guiu, xavier/C-3039-2009; Yeramian, Andree/P-6724-2019	yeramian, andree/0000-0002-9569-6316; Dolcet, Xavi/0000-0003-1921-0449; Sorolla, Anabel/0000-0001-8238-8763; matias-guiu, xavier/0000-0002-7201-6605; 	Grupos estables AECC; Catalunya contra el cancer; programa de intensificacion de la investigacion, Instituto Carlos III; Alicia Cuello de Merigo Fellowship;  [FIS PI10/00604];  [PI10/00922];  [RD06/0020/1034];  [2009SGR794];  [2004XT00090]	Grupos estables AECC; Catalunya contra el cancer; programa de intensificacion de la investigacion, Instituto Carlos III; Alicia Cuello de Merigo Fellowship; ; ; ; ; 	Supported by grants FIS PI10/00604, PI10/00922, RD06/0020/1034, 2009SGR794, and 2004XT00090, Grupos estables AECC, Catalunya contra el cancer and programa de intensificacion de la investigacion, Instituto Carlos III. LB holds an Alicia Cuello de Merigo Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barneda-Zahonero B, 2012, MOL ONCOL, V6, P579, DOI 10.1016/j.molonc.2012.07.003; Basu HS, 2011, CANCER CHEMOTH PHARM, V67, P705, DOI 10.1007/s00280-010-1364-3; Bergada L, 2013, MOL ONCOL, V7, P763, DOI 10.1016/j.molonc.2013.03.003; Bi GF, 2006, CELL MOL IMMUNOL, V3, P285; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Catalano MG, 2012, J CLIN ENDOCR METAB, V97, pE1150, DOI 10.1210/jc.2011-2970; Catalano MG, 2012, INT J CANCER, V130, P694, DOI 10.1002/ijc.26057; Fuchs-Tarlovsky V, 2013, NUTRITION, V29, P15, DOI 10.1016/j.nut.2012.02.014; Gilbert J, 2004, CLIN CANCER RES, V10, P4589, DOI 10.1158/1078-0432.CCR-03-0297; Guasconi V, 2004, CANCER BIOL THER, V3, P825, DOI 10.4161/cbt.3.9.1102; He Hongpeng, 2003, Briefings in Functional Genomics & Proteomics, V2, P234, DOI 10.1093/bfgp/2.3.234; Hu YM, 2010, BLOOD, V116, P2732, DOI 10.1182/blood-2009-11-256354; Jin JS, 2012, PATHOL ONCOL RES, V18, P713, DOI 10.1007/s12253-012-9499-7; Kim DH, 2003, J BIOCHEM MOL BIOL, V36, P110; Kubo M, 2013, BREAST CANCER RES TR, V137, P93, DOI 10.1007/s10549-012-2332-x; La Thangue NB, 2004, J CHEMOTHERAPY, V16, P64, DOI 10.1179/joc.2004.16.Supplement-1.64; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Llobet D, 2008, ANTI-CANCER DRUG, V19, P115, DOI 10.1097/CAD.0b013e3282f24031; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Martinez-Iglesias O, 2008, CLIN TRANSL ONCOL, V10, P395, DOI 10.1007/s12094-008-0221-x; Mataga MA, 2012, ANTICANCER RES, V32, P2523; Mei SP, 2004, INT J ONCOL, V25, P1509; Miller CP, 2007, BLOOD, V110, P267, DOI 10.1182/blood-2006-03-013128; New M, 2012, MOL ONCOL, V6, P637, DOI 10.1016/j.molonc.2012.09.003; Nihal M, 2010, PHARM RES-DORDR, V27, P1103, DOI 10.1007/s11095-010-0054-5; Papi A, 2012, ANTICANCER RES, V32, P2855; Petruccelli LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020987; Portanova P, 2008, INT J ONCOL, V33, P325, DOI 10.3892/ijo_00000012; Robert C, 2012, ADV CANCER RES, V116, P87, DOI 10.1016/B978-0-12-394387-3.00003-3; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Singh BN, 2011, FUTURE ONCOL, V7, P1415, DOI [10.2217/fon.11.124, 10.2217/FON.11.124]; Singh BN, 2010, EXPERT REV ANTICANC, V10, P935, DOI [10.1586/era.10.62, 10.1586/ERA.10.62]; Villar-Garea A, 2004, INT J CANCER, V112, P171, DOI 10.1002/ijc.20372; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044265; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang DF, 2012, J IMMUNOL, V188, P4441, DOI 10.4049/jimmunol.1103035; Yaseen A, 2012, MOL PHARMACOL, V82, P1030, DOI 10.1124/mol.112.079624; You BR, 2013, INT J ONCOL, V42, P359, DOI 10.3892/ijo.2012.1705; You BR, 2010, MOL CELL BIOCHEM, V344, P203, DOI 10.1007/s11010-010-0543-1; Yu CR, 2007, CLIN CANCER RES, V13, P1140, DOI 10.1158/1078-0432.CCR-06-1751	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92764	10.1371/journal.pone.0092764	http://dx.doi.org/10.1371/journal.pone.0092764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651472	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800156
J	Hocevar, BA; Kamendulis, LM; Pu, XZ; Perkins, SM; Wang, ZY; Johnston, EL; DeWitt, JM; Li, L; Loehrer, PJ; Klaunig, JE; Chiorean, EG				Hocevar, Barbara A.; Kamendulis, Lisa M.; Pu, Xinzhu; Perkins, Susan M.; Wang, Zheng-Yu; Johnston, Erica L.; DeWitt, John M.; Li, Lang; Loehrer, Patrick J.; Klaunig, James E.; Chiorean, E. Gabriela			Contribution of Environment and Genetics to Pancreatic Cancer Susceptibility	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; ANTIOXIDANT STATUS; REPAIR GENES; POLYMORPHISMS; RISK; STRESS; SMOKING; DISEASE; EPIDEMIOLOGY; INFLAMMATION	Several risk factors have been identified as potential contributors to pancreatic cancer development, including environmental and lifestyle factors, such as smoking, drinking and diet, and medical conditions such as diabetes and pancreatitis, all of which generate oxidative stress and DNA damage. Oxidative stress status can be modified by environmental factors and also by an individual's unique genetic makeup. Here we examined the contribution of environment and genetics to an individual's level of oxidative stress, DNA damage and susceptibility to pancreatic cancer in a pilot study using three groups of subjects: a newly diagnosed pancreatic cancer group, a healthy genetically-unrelated control group living with the case subject, and a healthy genetically-related control group which does not reside with the subject. Oxidative stress and DNA damage was evaluated by measuring total antioxidant capacity, direct and oxidative DNA damage by Comet assay, and malondialdehyde levels. Direct DNA damage was significantly elevated in pancreatic cancer patients (age and sex adjusted mean 6 standard error: 1.00 +/- 0.05) versus both healthy unrelated and related controls (0.70 +/- 0.06, p<0.001 and 0.82 +/- 0.07, p = 0.046, respectively). Analysis of 22 selected SNPs in oxidative stress and DNA damage genes revealed that CYP2A6 L160H was associated with pancreatic cancer. In addition, DNA damage was found to be associated with TNFA -308G>A and ERCC4 R415Q polymorphisms. These results suggest that measurement of DNA damage, as well as select SNPs, may provide an important screening tool to identify individuals at risk for development of pancreatic cancer.	[Hocevar, Barbara A.; Kamendulis, Lisa M.; Pu, Xinzhu; Klaunig, James E.] Indiana Univ, Dept Environm Hlth, Bloomington, IN 47405 USA; [Perkins, Susan M.; Wang, Zheng-Yu; DeWitt, John M.; Li, Lang; Loehrer, Patrick J.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Hocevar, Barbara A.; Kamendulis, Lisa M.; Perkins, Susan M.; Johnston, Erica L.; Li, Lang; Loehrer, Patrick J.; Klaunig, James E.; Chiorean, E. Gabriela] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Chiorean, E. Gabriela] Univ Washington, Seattle, WA 98195 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; University of Washington; University of Washington Seattle	Klaunig, JE (corresponding author), Indiana Univ, Dept Environm Hlth, Bloomington, IN 47405 USA.	jklauni@indiana.edu; gchiorea@uw.edu	DeWitt, John/AAP-3977-2020	Klaunig, James/0000-0002-4736-2223	Indiana University Simon Cancer Center Translational Research Acceleration Collaboration; Robert B. Forney professorship [R01 CA100908, P30 CA82709]; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408] Funding Source: NIH RePORTER	Indiana University Simon Cancer Center Translational Research Acceleration Collaboration; Robert B. Forney professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded in part by the Indiana University Simon Cancer Center Translational Research Acceleration Collaboration (EGC), the Robert B. Forney professorship (JEK), R01 CA100908 (JEK), and P30 CA82709 (SMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Blasiak J, 2004, MUTAT RES-FUND MOL M, V554, P297, DOI 10.1016/j.mrfmmm.2004.05.011; Collins AR, 1998, FREE RADICAL BIO MED, V25, P373, DOI 10.1016/S0891-5849(98)00053-7; Duell EJ, 2006, CANCER EPIDEM BIOMAR, V15, P726, DOI 10.1158/1055-9965.EPI-05-0797; Duell EJ, 2002, CANCER RES, V62, P4630; Duell EJ, 2002, JNCI-J NATL CANCER I, V94, P297, DOI 10.1093/jnci/94.4.297; Elahi MM, 2009, BBA-MOL BASIS DIS, V1792, P163, DOI 10.1016/j.bbadis.2009.01.007; Fuss JO, 2006, PLOS BIOL, V4, P899, DOI 10.1371/journal.pbio.0040203; Hadidi H, 1997, FOOD CHEM TOXICOL, V35, P903, DOI 10.1016/S0278-6915(97)00066-5; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Jiao L, 2007, CANCER-AM CANCER SOC, V109, P840, DOI 10.1002/cncr.22468; Jiao L, 2006, CANCER DETECT PREV, V30, P284, DOI 10.1016/j.cdp.2006.05.002; Jorgensen TJ, 2009, CANCER EPIDEM BIOMAR, V18, P346, DOI 10.1158/1055-9965.EPI-08-0659; Kadlubar S, 2009, J PANCREAS, V10, P263; Klaunig JE, 2011, TOXICOL APPL PHARM, V254, P86, DOI 10.1016/j.taap.2009.11.028; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Koorstra JBM, 2009, MODERN PATHOL, V22, P1439, DOI 10.1038/modpathol.2009.114; Kubaszek A, 2003, DIABETES, V52, P1872, DOI 10.2337/diabetes.52.7.1872; Kushwaha S, 2011, MUTAT RES-GEN TOX EN, V726, P242, DOI 10.1016/j.mrgentox.2011.10.004; Li DH, 2009, CLIN CANCER RES, V15, P740, DOI 10.1158/1078-0432.CCR-08-1607; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Maisonneuve P, 2010, DIGEST DIS, V28, P645, DOI 10.1159/000320068; McWilliams RR, 2008, CANCER RES, V68, P4928, DOI 10.1158/0008-5472.CAN-07-5539; McWilliams RR, 2009, CANCER EPIDEM BIOMAR, V18, P1295, DOI 10.1158/1055-9965.EPI-08-1109; Mena S, 2009, MUTAT RES-GEN TOX EN, V674, P36, DOI 10.1016/j.mrgentox.2008.09.017; Miri R, 2012, FOOD CHEM TOXICOL, V50, P920, DOI 10.1016/j.fct.2011.12.031; Pannuru P, 2011, HUM EXP TOXICOL, V30, P1475, DOI 10.1177/0960327110396527; Paz-Elizur T, 2008, CANCER LETT, V266, P60, DOI 10.1016/j.canlet.2008.02.032; Pu XZ, 2009, TOXICOL SCI, V111, P64, DOI 10.1093/toxsci/kfp133; Qidwai T, 2011, SCAND J IMMUNOL, V74, P522, DOI 10.1111/j.1365-3083.2011.02602.x; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rojas E, 1999, J CHROMATOGR B, V722, P225, DOI 10.1016/S0378-4347(98)00313-2; Rotunno M, 2009, PLOS ONE, V4, P1; Sachse C, 2002, CARCINOGENESIS, V23, P1839, DOI 10.1093/carcin/23.11.1839; Sengerova B, 2011, CELL CYCLE, V10, P3999, DOI 10.4161/cc.10.23.18385; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Smith TR, 2003, CANCER EPIDEM BIOMAR, V12, P1200; Song FF, 2007, CLIN SCI, V112, P599, DOI 10.1042/CS20060323; Verlaan M, 2006, WORLD J GASTROENTERO, V12, P5705, DOI 10.3748/wjg.v12.i35.5705; Vuppalanchi R, 2011, AM J MED SCI, V342, P314, DOI 10.1097/MAJ.0b013e31821d9905; Weng HC, 2009, MUTAT RES-GEN TOX EN, V679, P59, DOI 10.1016/j.mrgentox.2009.07.005; Xu C, 2002, ADV DRUG DELIVER REV, V54, P1245, DOI 10.1016/S0169-409X(02)00065-0	45	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90052	10.1371/journal.pone.0090052	http://dx.doi.org/10.1371/journal.pone.0090052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651674	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800008
J	Kondo, R; Atsuta, I; Ayukawa, Y; Yamaza, T; Matsuura, Y; Furuhashi, A; Tsukiyama, Y; Koyano, K				Kondo, Ryosuke; Atsuta, Ikiru; Ayukawa, Yasunori; Yamaza, Takayoshi; Matsuura, Yuri; Furuhashi, Akihiro; Tsukiyama, Yoshihiro; Koyano, Kiyoshi			Therapeutic Interaction of Systemically-Administered Mesenchymal Stem Cells with Peri-Implant Mucosa	PLOS ONE			English	Article							JUNCTIONAL EPITHELIUM; IN-VIVO; TITANIUM; ATTACHMENT; LAMININ-5; TISSUE; TRANSPLANTATION; FIBROBLASTS; MECHANISMS; INTERFACE	Objectives: The objective of this study was to investigate the effect of systemically transplanted mesenchymal stem cells (MSCs) on the peri-implant epithelial sealing around dental implants. Materials and Methods: MSCs were isolated from bone marrow of donor rats and expanded in culture. After recipient rats received experimental titanium dental implants in the bone sockets after extraction of maxillary right first molars, donor rat MSCs were intravenously transplanted into the recipient rats. Results: The injected MSCs were found in the oral mucosa surrounding the dental implants at 24 hours post-transplantation. MSC transplantation accelerated the formation of the peri-implant epithelium (PIE)-mediated mucosa sealing around the implants at an early stage after implantation. Subsequently, enhanced deposition of laminin-332 was found along the PIE-implant interface at 4 weeks after the replacement. We also observed enhanced attachment and proliferation of oral mucous epithelial cells. Conclusion: Systemically transplanted MSCs might play a critical role in reinforcing the epithelial sealing around dental implants.	[Kondo, Ryosuke; Atsuta, Ikiru; Ayukawa, Yasunori; Matsuura, Yuri; Furuhashi, Akihiro; Tsukiyama, Yoshihiro; Koyano, Kiyoshi] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Implant & Rehabilitat Dent, Fukuoka 812, Japan; [Yamaza, Takayoshi] Kyushu Univ, Grad Sch Dent Sci, Dept Mol Cell Biol & Oral Anat, Fukuoka 812, Japan	Kyushu University; Kyushu University	Atsuta, I (corresponding author), Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Implant & Rehabilitat Dent, Fukuoka 812, Japan.	atyuta@dent.kyushu-u.ac.jp	Ayukawa, Yasunori/AAS-8602-2020; Ayukawa, Yasunori/I-2342-2014	Ayukawa, Yasunori/0000-0003-0039-716X; Yamaza, Takayoshi/0000-0001-7055-3370	Ministry of Education, Culture, Sports, Science and Technology of Japan [23592888]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for Scientific Research (C) No. 23592888 (to I. Atsuta) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Kentaro, 2012, Methods Mol Biol, V887, P111, DOI 10.1007/978-1-61779-860-3_11; Atsuta I, 2005, BIOMATERIALS, V26, P6280, DOI 10.1016/j.biomaterials.2005.03.046; Atsuta I, 2005, BIOMATERIALS, V26, P1751, DOI 10.1016/j.biomaterials.2004.05.033; Atsuta I, 2013, J BIOMED A IN PRESS; Atsuta I, 2013, CLIN ORAL I IN PRESS; Atsuta I, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt322; Atsuta I, 2012, CLIN ORAL IMPLAN RES, V23, P459, DOI 10.1111/j.1600-0501.2011.02163.x; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; BRANEMARK PI, 1983, BIOMATERIALS, V4, P25, DOI 10.1016/0142-9612(83)90065-0; BUSER D, 1992, J PERIODONTOL, V63, P225, DOI 10.1902/jop.1992.63.3.225; Chen WL, 2008, INVEST OPHTH VIS SCI, V49, P2416, DOI 10.1167/iovs.07-1085; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Egusa H, 2012, J PROSTHODONT RES, V56, P151, DOI 10.1016/j.jpor.2012.06.001; Esposito M, 1997, CLIN ORAL IMPLAN RES, V8, P352, DOI 10.1034/j.1600-0501.1997.080502.x; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; Furuhashi A, 2012, ODONTOLOGY, V100, P199, DOI 10.1007/s10266-011-0029-y; Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-005-0052-6; GOULD TRL, 1984, J PROSTHET DENT, V52, P418, DOI 10.1016/0022-3913(84)90459-1; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Ikeda H, 2002, CLIN ORAL IMPLAN RES, V13, P243, DOI 10.1034/j.1600-0501.2002.130303.x; Ikeda H, 2000, J PERIODONTOL, V71, P961, DOI 10.1902/jop.2000.71.6.961; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lindhe J, 1998, PERIODONTOL 2000, V17, P47, DOI 10.1111/j.1600-0757.1998.tb00122.x; Metrailler-Ruchonnet I, 2007, FREE RADICAL BIO MED, V42, P1062, DOI 10.1016/j.freeradbiomed.2007.01.008; Okawachi H, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0027-9; SCHROEDER A, 1981, J MAXILLOFAC SURG, V9, P15, DOI 10.1016/S0301-0503(81)80007-0; SCHROEDER HE, 1986, DEUT ZAHNAERZTL Z, V41, P536; Shimono M, 2003, J ELECTRON MICROSC, V52, P627, DOI 10.1093/jmicro/52.6.627; Shiraiwa M, 2002, J PERIODONTOL, V73, P852, DOI 10.1902/jop.2002.73.8.852; Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021; Takano T, 2014, LAB INVEST IN PRESS; Tamura RN, 1997, J PERIODONTAL RES, V32, P287, DOI 10.1111/j.1600-0765.1997.tb00536.x; Tarnawski AS, 2005, DIGEST DIS SCI, V50, pS24, DOI 10.1007/s10620-005-2803-6; Wang L, 2013, STEM CELLS IN PRESS; Yamaza T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002615; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	39	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90681	10.1371/journal.pone.0090681	http://dx.doi.org/10.1371/journal.pone.0090681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651408	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800020
J	Langhans, C; Weber-Carstens, S; Schmidt, F; Hamati, J; Kny, M; Zhu, XX; Wollersheim, T; Koch, S; Krebs, M; Schulz, H; Lodka, D; Saar, K; Labeit, S; Spies, C; Hubner, N; Spranger, J; Spuler, S; Boschmann, M; Dittmar, G; Butler-Browne, G; Mouly, V; Fielitz, J				Langhans, Claudia; Weber-Carstens, Steffen; Schmidt, Franziska; Hamati, Jida; Kny, Melanie; Zhu, Xiaoxi; Wollersheim, Tobias; Koch, Susanne; Krebs, Martin; Schulz, Herbert; Lodka, Doerte; Saar, Kathrin; Labeit, Siegfried; Spies, Claudia; Hubner, Norbert; Spranger, Joachim; Spuler, Simone; Boschmann, Michael; Dittmar, Gunnar; Butler-Browne, Gillian; Mouly, Vincent; Fielitz, Jens			Inflammation-Induced Acute Phase Response in Skeletal Muscle and Critical Illness Myopathy	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INTENSIVE-CARE UNIT; A GENE FAMILY; ACQUIRED WEAKNESS; TRANSGENIC MICE; ILL PATIENTS; SERUM; SEPSIS; PARESIS; DISABILITY	Objectives: Systemic inflammation is a major risk factor for critical-illness myopathy (CIM) but its pathogenic role in muscle is uncertain. We observed that interleukin 6 (IL-6) and serum amyloid A1 (SAA1) expression was upregulated in muscle of critically ill patients. To test the relevance of these responses we assessed inflammation and acute-phase response at early and late time points in muscle of patients at risk for CIM. Design: Prospective observational clinical study and prospective animal trial. Setting: Two intensive care units (ICU) and research laboratory. Patients/Subjects: 33 patients with Sequential Organ Failure Assessment scores >= 8 on 3 consecutive days within 5 days in ICU were investigated. A subgroup analysis of 12 patients with, and 18 patients without CIM (non-CIM) was performed. Two consecutive biopsies from vastus lateralis were obtained at median days 5 and 15, early and late time points. Controls were 5 healthy subjects undergoing elective orthopedic surgery. A septic mouse model and cultured myoblasts were used for mechanistic analyses. Measurements and Main Results: Early SAA1 expression was significantly higher in skeletal muscle of CIM compared to non-CIM patients. Immunohistochemistry showed SAA1 accumulations in muscle of CIM patients at the early time point, which resolved later. SAA1 expression was induced by IL-6 and tumor necrosis factor-alpha in human and mouse myocytes in vitro. Inflammation-induced muscular SAA1 accumulation was reproduced in a sepsis mouse model. Conclusions: Skeletal muscle contributes to general inflammation and acute-phase response in CIM patients. Muscular SAA1 could be important for CIM pathogenesis.	[Langhans, Claudia; Schmidt, Franziska; Hamati, Jida; Kny, Melanie; Zhu, Xiaoxi; Lodka, Doerte; Spranger, Joachim; Spuler, Simone; Boschmann, Michael; Fielitz, Jens] Expt & Clin Res Ctr, Berlin, Germany; [Weber-Carstens, Steffen; Fielitz, Jens] Charite, D-13353 Berlin, Germany; [Schulz, Herbert; Saar, Kathrin; Hubner, Norbert; Dittmar, Gunnar] Max Delbruck Ctr Mol Med, Berlin, Germany; [Labeit, Siegfried] Univ Med Mannheim, Mannheim, Germany; [Spranger, Joachim] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Spranger, Joachim] Charite, Dept Endocrinol Diabet & Nutr, D-13353 Berlin, Germany; [Butler-Browne, Gillian; Mouly, Vincent] INSERM, Inst Myol, Paris, France; [Butler-Browne, Gillian; Mouly, Vincent] Univ Paris 06, Paris, France	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Fielitz, J (corresponding author), Expt & Clin Res Ctr, Campus Buch, Berlin, Germany.	jens.fielitz@charite.de	Weber-Carstens, Steffen/A-6401-2009; Fielitz, Jens/AAF-4178-2020; Dittmar, Gunnar/B-6383-2016; Dittmar, Gunnar/C-6333-2019; Spies, Claudia/AAJ-5412-2020; Mouly, Gillian/G-6595-2017	Dittmar, Gunnar/0000-0003-3647-8623; Dittmar, Gunnar/0000-0003-3647-8623; Spies, Claudia/0000-0002-1062-0495; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Kny, Melanie/0000-0001-7132-8079; Zhu, Xiaoxi/0000-0001-7858-1114; Mouly, Vincent/0000-0003-3809-4033; Weber-Carstens, Steffen/0000-0001-7405-0172; butler-browne, gillian/0000-0002-3431-242X; Fielitz, Jens/0000-0001-8522-1045; Wollersheim, Tobias/0000-0002-3170-0996; Koch, Susanne/0000-0001-5663-7447; Saar, Kathrin/0000-0002-4483-1557; Spuler, Simone/0000-0002-0155-1117	Deutsche forschungsgemeinschaft [FI 965/2-1, FI 965/4-1, La668/14-1]; MyoGrad (Deutsche Forschungsgemeinschaft) [GK1631]; Universite Franco-Allemand [CDFA-06-11]; Muscular Dystrophy Association; Marie Curie International Reintegration grant; Deutsche Gesellschaft fur Muskelkranke e. V.;  [KFO 192]	Deutsche forschungsgemeinschaft(German Research Foundation (DFG)); MyoGrad (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Universite Franco-Allemand; Muscular Dystrophy Association(Muscular Dystrophy Association); Marie Curie International Reintegration grant(European Commission); Deutsche Gesellschaft fur Muskelkranke e. V.; 	Funding from the Deutsche forschungsgemeinschaft (FI 965/2-1, FI 965/4-1 and La668/14-1), KFO 192, MyoGrad (Deutsche Forschungsgemeinschaft, GK1631, Universite Franco-Allemand [CDFA-06-11] and AFM), Muscular Dystrophy Association, Marie Curie International Reintegration grant, and the Deutsche Gesellschaft fur Muskelkranke e. V. all supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2008, J MOL BIOL, V384, P48, DOI 10.1016/j.jmb.2008.08.087; Ali NA, 2008, AM J RESP CRIT CARE, V178, P261, DOI 10.1164/rccm.200712-1829OC; Anker SD, 1997, J AM COLL CARDIOL, V30, P997, DOI 10.1016/S0735-1097(97)00262-3; Bierbrauer J, 2012, CRIT CARE MED, V40, P647, DOI 10.1097/CCM.0b013e31823295e6; BOLTON CF, 1993, ANN NEUROL, V33, P94, DOI 10.1002/ana.410330115; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Bruun CF, 1998, CLIN EXP IMMUNOL, V111, P231, DOI 10.1046/j.1365-2249.1998.00503.x; Callahan Leigh Ann, 2009, Crit Care Med, V37, pS354, DOI 10.1097/CCM.0b013e3181b6e439; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; deBeer MC, 1996, GENOMICS, V34, P139, DOI 10.1006/geno.1996.0253; Dellinger RP, 2012, CRIT CARE MED, V41, P580; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Filippin-Monteiro FB, 2012, INT J OBESITY, V36, P1032, DOI 10.1038/ijo.2011.193; Friedrich O, 2006, CURR OPIN CLIN NUTR, V9, P403, DOI 10.1097/01.mco.0000232900.59168.a0; Furuya DT, 2013, MOL CELL ENDOCRINOL, V370, P87, DOI 10.1016/j.mce.2013.01.019; GOODMAN MN, 1991, AM J PHYSIOL, V260, pE727, DOI 10.1152/ajpendo.1991.260.5.E727; Helliwell TR, 1998, NEUROPATH APPL NEURO, V24, P507; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Koch S, 2011, J NEUROL NEUROSUR PS, V82, P287, DOI 10.1136/jnnp.2009.192997; Kress JP, 2012, SEMIN RESP CRIT CARE, V33, P339, DOI 10.1055/s-0032-1321983; Lefaucheur JP, 2006, J NEUROL NEUROSUR PS, V77, P500, DOI 10.1136/jnnp.2005.070813; LOWELL CA, 1986, J BIOL CHEM, V261, P8442; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; Rich MM, 1996, NEUROLOGY, V46, P731, DOI 10.1212/WNL.46.3.731; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; STEEL DM, 1993, GENOMICS, V16, P447, DOI 10.1006/geno.1993.1209; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; WAAGE A, 1987, LANCET, V1, P355; Weber-Carstens S, 2012, AM J RESP CRIT CARE; Weber-Carstens S, 2010, CRIT CARE, V14, DOI 10.1186/cc9074; Weber-Carstens S, 2009, CRIT CARE MED, V37, P2632, DOI 10.1097/CCM.0b013e3181a92f28; Winkelman C, 2010, CRIT CARE, V14, DOI 10.1186/cc9187; ZAMIR O, 1992, ARCH SURG-CHICAGO, V127, P170; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628; Zhang N, 2005, J IMMUNOL, V174, P8125, DOI 10.4049/jimmunol.174.12.8125; Zimmers TA, 2003, HEPATOLOGY, V38, P326, DOI 10.1053/jhep.2003.50318	39	54	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92048	10.1371/journal.pone.0092048	http://dx.doi.org/10.1371/journal.pone.0092048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651840	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800066
J	Yu, BB; Wang, Y; Zhou, QX				Yu, Binbin; Wang, Yu; Zhou, Qixing			Human Health Risk Assessment Based on Toxicity Characteristic Leaching Procedure and Simple Bioaccessibility Extraction Test of Toxic Metals in Urban Street Dust of Tianjin, China	PLOS ONE			English	Article							HEAVY-METALS; CONTAMINATED SOILS; BIOAVAILABILITY; GEOCHEMISTRY; AREA	The potential ecological and human health risk related with urban street dust from urban areas of Tianjin, China was quantitatively analyzed using the method of toxicity characteristic leaching procedure (TCLP) and simple bioaccessibility extraction test (SBET). In the study, Hakason index, Nemerow index (P), the hazard index (HI) and the cancer risk index (RI) were calculated to assess the potential risk. The sequence of potential ecological risk based on Hakason index was arsenic (As) > cadmium (Cd) > lead (Pb) > copper (Cu) > chromium (Cr), in particular, As and Cd were regarded as high polluted metals. While the results of extraction of TCLP were assessed using P, the sequence was As > Pb > Cd > Cr > Cu, which mean that As and Pb should be low polluted, and Cd, Cr and Cu would barely not polluted. For human health, total carcinogenic risk for children and adults was 2.01x10(-3) and 1.05x10(-3), respectively. This could be considered to be intolerable in urban street dust exposure. The sequence in the hazard quotient (HQ) of each element was As > Cr > Pb > Cu > Cd. The HI value of these toxic metals in urban street dust for children and adults was 5.88x10(-1) and 2.80x10(-1), respectively. According to the characters of chemistry, mobility, and bioavailability of metals in urban street dust, we estimated the hazards on the environment and human health, which will help us to get more reasonable information for risk management of metals in urban environment.	[Yu, Binbin; Zhou, Qixing] Nankai Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Tianjin 300071, Peoples R China; [Wang, Yu] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL USA	Nankai University; State University System of Florida; University of Florida	Zhou, QX (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Tianjin 300071, Peoples R China.	zhouqx@nankai.edu.cn	Wang, Yu/M-4220-2013	Wang, Yu/0000-0002-9614-5057	National Natural Science Foundation of China [21037002]; Ministry of Science and Technology, People's Republic of China [2012AA101403-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China)	This work was financially supported by the National Natural Science Foundation of China as a key project (grant No. 21037002) and the Ministry of Science and Technology, People's Republic of China as a 863 project (grant No. 2012AA101403-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khashman OA, 2004, ATMOS ENVIRON, V38, P6803, DOI 10.1016/j.atmosenv.2004.09.011; [Anonymous], 1561811995 GB; Arslan H, 2001, J TRACE MICROPROBE T, V19, P439, DOI 10.1081/TMA-100105058; BMEPRI, 2007, GUID SIT ENV ASS; Calabrese E., 1987, Comments on Toxicology. Comments on Modern Biology, Part B, V1, P229; Chang EE, 2001, CHEMOSPHERE, V45, P91, DOI 10.1016/S0045-6535(01)00002-9; Chen BL, 2001, J ENVIRON MONITOR, V3, P7, DOI 10.1039/b006633h; China National Environmental Monitoring Centre, EL BACKGR VAL SOIL C; Ferreira-Baptista L, 2005, ATMOS ENVIRON, V39, P4501, DOI 10.1016/j.atmosenv.2005.03.026; Ge Y, 2000, ENVIRON POLLUT, V107, P137, DOI 10.1016/S0269-7491(99)00119-0; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Han YM, 2006, SCI TOTAL ENVIRON, V355, P176, DOI 10.1016/j.scitotenv.2005.02.026; HARRISON RM, 1981, ENVIRON SCI TECHNOL, V15, P1378, DOI 10.1021/es00093a013; Hu X, 2011, ENVIRON POLLUT, V159, P1215, DOI 10.1016/j.envpol.2011.01.037; Kim JY, 2005, ENVIRON GEOCHEM HLTH, V27, P193, DOI 10.1007/s10653-005-0127-2; Li XD, 2001, APPL GEOCHEM, V16, P1361, DOI 10.1016/S0883-2927(01)00045-2; Liu Rui, 2007, Frontiers of Environmental Science and Engineering in China, V1, P114, DOI 10.1007/s11783-007-0021-5; Lu SG, 2010, ENVIRON EARTH SCI, V60, P1481, DOI 10.1007/s12665-009-0283-2; Lu Y, 2003, GEODERMA, V115, P101, DOI 10.1016/S0016-7061(03)00079-X; Luo XS, 2011, ENVIRON POLLUT, V159, P1317, DOI 10.1016/j.envpol.2011.01.013; Mahanta MJ, 2011, ENVIRON MONIT ASSESS, V173, P221, DOI 10.1007/s10661-010-1383-x; NEMEROW N.L., 1970, 16110 DAJ US EPA SYR; NRIAGU JO, 1988, ENVIRON POLLUT, V50, P139, DOI 10.1016/0269-7491(88)90189-3; Oomen AG, 2002, ENVIRON SCI TECHNOL, V36, P3326, DOI 10.1021/es010204v; OSTAPCZUK P, 1987, SCI TOTAL ENVIRON, V60, P1, DOI 10.1016/0048-9697(87)90403-7; Peng C, 2011, ENVIRON POLLUT, V159, P802, DOI 10.1016/j.envpol.2010.11.003; Poggio L, 2009, ENVIRON POLLUT, V157, P680, DOI 10.1016/j.envpol.2008.08.009; Shi G, 2010, ENVIRON POLLUT, V158, P694, DOI 10.1016/j.envpol.2009.10.020; Shi GT, 2011, ATMOS ENVIRON, V45, P764, DOI 10.1016/j.atmosenv.2010.08.039; Sun Y, 2006, ENVIRON GEOCHEM HLTH, V28, P73, DOI 10.1007/s10653-005-9014-0; Sun YB, 2010, J HAZARD MATER, V174, P455, DOI 10.1016/j.jhazmat.2009.09.074; Tang L, 2005, ENVIRON INT, V31, P822, DOI 10.1016/j.envint.2005.05.031; Tanner PA, 2008, ENVIRON SCI TECHNOL, V42, P7111, DOI 10.1021/es8007613; Thornton I, 2008, ENVIRON GEOCHEM HLTH, V30, P565, DOI 10.1007/s10653-008-9182-9; Tong STY, 2000, SCI TOTAL ENVIRON, V256, P115, DOI 10.1016/S0048-9697(00)00471-X; U.S. E.P.A., 1992, 1311 USEPA; U.S. Environmental Protection Agency, 2007, GUID EV OR BIOAV MET; United States Environmental Protection Agency (USEPA), 2008, STANDARD OPERATING P; US EPA, 2001, RISK ASS GUID SUP A; US EPA, 1997, EPA600P95002F OFF RE; US EPA (United States Environment Protection Agency), 2010, REG 9 REG SCREEN LEV; Wang G, 2012, ATMOS ENVIRON, V46, P289, DOI 10.1016/j.atmosenv.2011.09.059; Wang XS, 2007, ENVIRON MONIT ASSESS, V129, P221, DOI 10.1007/s10661-006-9355-x; Wong CSC, 2006, ENVIRON POLLUT, V142, P1, DOI 10.1016/j.envpol.2005.09.004; Yaman M, 2006, CURR MED CHEM, V13, P2513, DOI 10.2174/092986706778201620; Yeung ZLL, 2003, APPL RADIAT ISOTOPES, V58, P339, DOI 10.1016/S0969-8043(02)00351-2; Zhang L, 2012, FRONT ENV SCI ENG, V6, P360, DOI 10.1007/s11783-011-0353-z; Zheng N, 2010, SCI TOTAL ENVIRON, V408, P726, DOI 10.1016/j.scitotenv.2009.10.075; Zhou Q., 2011, POLLUTION ECOCHEMIST; Zhou QX, 2010, J SOIL SEDIMENT, V10, P1324, DOI 10.1007/s11368-010-0247-x	50	68	70	5	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92459	10.1371/journal.pone.0092459	http://dx.doi.org/10.1371/journal.pone.0092459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651129	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800110
J	Dissanayake, D; Murakami, K; Tran, MD; Elford, AR; Millar, DG; Ohashi, PS				Dissanayake, Dilan; Murakami, Kiichi; Tran, Michael D.; Elford, Alisha R.; Millar, Douglas G.; Ohashi, Pamela S.			Peptide-Pulsed Dendritic Cells Have Superior Ability to Induce Immune-Mediated Tissue Destruction Compared to Peptide with Adjuvant	PLOS ONE			English	Article							REGULATORY T-CELLS; TOLL-LIKE RECEPTOR-2; PHASE-II TRIAL; CANCER-IMMUNOTHERAPY; TRANSGENIC MICE; VACCINATION; ANTIGEN; VIRUS; TOLERANCE; LYMPHOCYTES	Vaccines for cancer immunotherapy are of interest but in general have not yet achieved the desired therapeutic efficacy in clinical trials. We present here a novel model to evaluate vaccine strategies by following tissue destruction in a transgenic model, where a defined antigen is expressed on pancreatic islets. We found that the transfer of syngeneic antigen-pulsed dendritic cells (DCs) resulted in autoimmune cytotoxic T-lymphocyte activation that was not observed following vaccinations that were based on peptides and adjuvants. Importantly, the induction of diabetes by DC transfer is dependent upon the maturation of DCs prior to transfer. Furthermore, diabetes induction only occurred if DCs were pulsed with the immunodominant epitope in addition to at least one other peptide, suggesting greater cytolytic activity upon engagement of multiple T-cell specificities. While the tumor environment undoubtedly will be more complex than healthy tissue, the insights gained through this model provide useful information on variables that can affect CD8-mediated tissue cytolysis in vivo.	[Dissanayake, Dilan; Murakami, Kiichi; Tran, Michael D.; Elford, Alisha R.; Millar, Douglas G.; Ohashi, Pamela S.] Univ Hlth Network, Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Dissanayake, Dilan; Ohashi, Pamela S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Ohashi, PS (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada.	pohashi@uhnres.utoronto.ca		Millar, Douglas/0000-0002-8640-7148; Ohashi, Pamela S./0000-0003-2915-9317; Dissanayake, Dilan/0000-0003-4270-7015	Canadian Institutes for Health Research (CIHR); CIHR; Ontario Ministry of Health and Long Term Care (OMHLTC)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care (OMHLTC)(Ministry of Health and Long-Term Care, Ontario)	This work was supported by a Canadian Institutes for Health Research (CIHR) grant to P.S.O. and a CIHR studentship to D.D. P.S.O. holds a Canada Research Chair in Autoimmunity and Tumor Immunity. This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMHLTC). The views expressed do not necessarily reflect those of the OMHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Aspord C, 2007, J EXP MED, V204, P1037, DOI 10.1084/jem.20061120; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blank C, 2005, CANCER IMMUNOL IMMUN, V54, P307, DOI 10.1007/s00262-004-0593-x; Butterfield LH, 2003, CLIN CANCER RES, V9, P5902; Calzascia T, 2007, J CLIN INVEST, V117, P3833, DOI 10.1172/JCI32567; Clive KS, 2012, J SURG ONCOL, V105, P452, DOI 10.1002/jso.21723; Dissanayake D, 2011, NAT MED, V17, P1663, DOI 10.1038/nm.2556; Draube A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018801; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; GAIRIN JE, 1995, J VIROL, V69, P2297, DOI 10.1128/JVI.69.4.2297-2305.1995; Garza KM, 2000, J EXP MED, V191, P2021, DOI 10.1084/jem.191.11.2021; Gross DA, 2004, J CLIN INVEST, V113, P425, DOI 10.1172/JCI200419418; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Jager E, 2000, J EXP MED, V191, P625, DOI 10.1084/jem.191.4.625; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Knutson KL, 2001, J CLIN INVEST, V107, P477, DOI 10.1172/JCI11752; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee KH, 1999, J IMMUNOL, V163, P6292; Lin ACC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023940; Lovgren T, 2012, CANCER IMMUNOL IMMUN, V61, P817, DOI 10.1007/s00262-011-1140-1; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Madan RA, 2011, EXPERT REV VACCINES, V10, P141, DOI 10.1586/ERV.10.173; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; Nguyen LT, 2002, J EXP MED, V195, P423, DOI 10.1084/jem.20010032; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OHASHI PS, 1993, J IMMUNOL, V150, P5185; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; Palucka AK, 2006, J IMMUNOTHER, V29, P545, DOI 10.1097/01.cji.0000211309.90621.8b; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Pellegrini M, 2009, NAT MED, V15, P528, DOI 10.1038/nm.1953; Phuphanich S, 2013, CANCER IMMUNOL IMMUN, V62, P125, DOI 10.1007/s00262-012-1319-0; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Qi H, 2003, INFECT IMMUN, V71, P3337, DOI 10.1128/IAI.71.6.3337-3342.2003; Rahma OE, 2012, CANCER IMMUNOL IMMUN, V61, P373, DOI 10.1007/s00262-011-1100-9; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Rong YF, 2012, CLIN EXP MED, V12, P173, DOI 10.1007/s10238-011-0159-0; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Schlom J, 2012, JNCI-J NATL CANCER I, V104, P599, DOI 10.1093/jnci/djs033; Schmid DA, 2010, J IMMUNOL, V184, P4936, DOI 10.4049/jimmunol.1000173; Schuler-Thurner B, 2002, J EXP MED, V195, P1279, DOI 10.1084/jem.20012100; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Slingluff CL, 2007, CLIN CANCER RES, V13, P6386, DOI 10.1158/1078-0432.CCR-07-0486; Slingluff CL, 2011, J CLIN ONCOL, V29, P2924, DOI 10.1200/JCO.2010.33.8053; Sommerfeldt N, 2006, CANCER RES, V66, P8258, DOI 10.1158/0008-5472.CAN-05-4201; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373; Speiser DE, 1997, J EXP MED, V186, P645, DOI 10.1084/jem.186.5.645; Vonderheide RH, 2001, CANCER RES, V61, P8366	61	10	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92380	10.1371/journal.pone.0092380	http://dx.doi.org/10.1371/journal.pone.0092380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647761	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500124
J	Fischer, J; Muller, T; Spatz, AK; Greggers, U; Grunewald, B; Menzel, R				Fischer, Johannes; Mueller, Teresa; Spatz, Anne-Kathrin; Greggers, Uwe; Gruenewald, Bernd; Menzel, Randolf			Neonicotinoids Interfere with Specific Components of Navigation in Honeybees	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; ACETYLTRANSFERASE-LIKE IMMUNOREACTIVITY; DECREASES FORAGING SUCCESS; ANTENNAL LOBE NEURONS; APIS-MELLIFERA; BRAIN; BEES; LOCALIZATION; EXPOSURE; SURVIVAL	Three neonicotinoids, imidacloprid, clothianidin and thiacloprid, agonists of the nicotinic acetylcholine receptor in the central brain of insects, were applied at non-lethal doses in order to test their effects on honeybee navigation. A catch-and-release experimental design was applied in which feeder trained bees were caught when arriving at the feeder, treated with one of the neonicotinoids, and released 1.5 hours later at a remote site. The flight paths of individual bees were tracked with harmonic radar. The initial flight phase controlled by the recently acquired navigation memory (vector memory) was less compromised than the second phase that leads the animal back to the hive (homing flight). The rate of successful return was significantly lower in treated bees, the probability of a correct turn at a salient landscape structure was reduced, and less directed flights during homing flights were performed. Since the homing phase in catch-and-release experiments documents the ability of a foraging honeybee to activate a remote memory acquired during its exploratory orientation flights, we conclude that non-lethal doses of the three neonicotinoids tested either block the retrieval of exploratory navigation memory or alter this form of navigation memory. These findings are discussed in the context of the application of neonicotinoids in plant protection.	[Fischer, Johannes; Mueller, Teresa; Gruenewald, Bernd] Goethe Univ Frankfurt, Fachbereich Biowissensch, Inst Bienenkunde Oberursel, Polytech Gesell Frankfurt Main, D-60054 Frankfurt, Germany; [Spatz, Anne-Kathrin] Netzwerk Bluhende Landschaften Fischermuhle, Rosenfeld, Germany; [Greggers, Uwe; Menzel, Randolf] Free Univ Berlin, Inst Biol, Berlin, Germany	Goethe University Frankfurt; Free University of Berlin	Menzel, R (corresponding author), Free Univ Berlin, Inst Biol, Berlin, Germany.	menzel@neurobiologie.fu-berlin.de	Grünewald, Bernd/G-2060-2012; Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216	Deutsche Forschungsgemeinschaft (DFG) [ME 365/34-2]; Hertie Gemeinnutzige Stiftung; Dr. Klaus Tschira Stiftung; EU; Land Hessen, Hessisches Ministerium fur Umwelt, Ernahrung, Landwirtschaft und Verbraucherschutz	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Hertie Gemeinnutzige Stiftung; Dr. Klaus Tschira Stiftung; EU(European Commission); Land Hessen, Hessisches Ministerium fur Umwelt, Ernahrung, Landwirtschaft und Verbraucherschutz	The studies were financially supported by the following institutions: Deutsche Forschungsgemeinschaft (DFG grant ME 365/34-2 to RM), Hertie Gemeinnutzige Stiftung (RM), Dr. Klaus Tschira Stiftung (RM, UG), and by the EU and the Land Hessen, Hessisches Ministerium fur Umwelt, Ernahrung, Landwirtschaft und Verbraucherschutz (BG). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; BAI DL, 1991, PESTIC SCI, V33, P197, DOI 10.1002/ps.2780330208; Barbara GS, 2005, J COMP PHYSIOL A, V191, P823, DOI 10.1007/s00359-005-0007-3; Barbara Guillaume Stephane, 2008, Invertebrate Neuroscience, V8, P19, DOI 10.1007/s10158-007-0062-2; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bortolotti L, 2003, B INSECTOL, V56, P67; Brown LA, 2006, J NEUROCHEM, V99, P608, DOI 10.1111/j.1471-4159.2006.04084.x; BUCHNER E, 1986, CELL TISSUE RES, V246, P57; Cheeseman JF, 2012, P NATL ACAD SCI USA, V109, P7061, DOI 10.1073/pnas.1201734109; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2011, ECOTOXICOLOGY, V20, P429, DOI 10.1007/s10646-011-0594-4; Deglise P, 2002, NEUROSCI LETT, V321, P13, DOI 10.1016/S0304-3940(01)02400-4; Dupuis J, 2012, NEUROSCI BIOBEHAV R, V36, P1553, DOI 10.1016/j.neubiorev.2012.04.003; Eisenhardt D, 2012, HONEYBEE NEUROBIOLOG, P423; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; Fusca D, 2013, J COMP NEUROL, V521, P3556, DOI 10.1002/cne.23371; Gauthier M., 2012, HONEYBEE NEUROBIOLOG, P155, DOI DOI 10.1007/978-94-007-2099-213; Gauthier M, 2006, NEUROBIOL LEARN MEM, V86, P164, DOI 10.1016/j.nlm.2006.02.003; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Gruter C, 2009, TRENDS ECOL EVOL, V24, P242, DOI 10.1016/j.tree.2008.12.007; Guez D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00037; Henry M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00062; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; HOMBERG U, 1995, CELL TISSUE RES, V279, P249, DOI 10.1007/s004410050280; Jepson James E. C., 2006, Invertebrate Neuroscience, V6, P33, DOI 10.1007/s10158-005-0013-8; Jeschke P, 2013, ANGEW CHEM INT EDIT, V52, P9464, DOI 10.1002/anie.201302550; Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206; KREISSL S, 1989, J COMP NEUROL, V286, P71, DOI 10.1002/cne.902860105; Leitinger G, 2000, J COMP NEUROL, V416, P345; Medrzycki P, 2013, B INSECTOL, V56, P59; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R., 2012, HONEYBEE NEUROBIOLOG; Menzel R, 2006, J COMP PHYSIOL A, V192, P889, DOI 10.1007/s00359-006-0136-3; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Menzel R, 2011, CURR BIOL, V21, P645, DOI 10.1016/j.cub.2011.02.039; Nauen R, 2001, PEST MANAG SCI, V57, P577, DOI 10.1002/ps.331; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Riley JR, 1996, NATURE, V379, P29, DOI 10.1038/379029b0; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; SCHUSTER R, 1993, J COMP NEUROL, V335, P149, DOI 10.1002/cne.903350202; Seeley T. D, 2011, HONEYBEE DEMOCRACY; Thany SH, 2005, GENE, V344, P125, DOI 10.1016/j.gene.2004.09.010; Thany SH, 2003, INSECT MOL BIOL, V12, P255, DOI 10.1046/j.1365-2583.2003.00409.x; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Yasuyama K, 2003, J COMP NEUROL, V466, P299, DOI 10.1002/cne.10867; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155	51	193	205	7	256	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91364	10.1371/journal.pone.0091364	http://dx.doi.org/10.1371/journal.pone.0091364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646521	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500033
J	Kim, HS; Kim, TJ; Yoo, YM				Kim, Han Sung; Kim, Tack-Joong; Yoo, Yeong-Min			Melatonin Combined with Endoplasmic Reticulum Stress Induces Cell Death via the PI3K/Akt/mTOR Pathway in B16F10 Melanoma Cells	PLOS ONE			English	Article							INHIBITOR BAY-43-9006; SIGNALING PATHWAY; INDUCED APOPTOSIS; INDUCED AUTOPHAGY; DOWN-REGULATION; CANCER-THERAPY; UP-REGULATION; LNCAP CELLS; ER STRESS; IN-VITRO	This study investigated B16F10 melanoma cell death induced by melatonin combined with endoplasmic reticulum (ER) stress through the PI3K/Akt/mTOR pathway. Cell viability was significantly decreased after treatment with melatonin combined with ER stress from thapsigargin or tunicamycin compared to no treatment or treatment with melatonin only. Combined melatonin and ER stress also significantly reduced expression of p85 beta, p-Akt (Ser473, Thr308), and p-mTOR (Ser2448, Ser2481) compared to treatment with melatonin only. The ER stress protein p-PERK and p-eIF2 alpha were significantly increased under combined melatonin and ER stress treatment compared to no treatment or treatment with melatonin only. Combined melatonin and ER stress significantly reduced Bcl-2 protein and augmented Bax protein compared to melatonin-only treatment. Also, the combined treatment significantly lowered expression of catalase, Cu/Zn-SOD, and Mn-SOD proteins compared to melatonin only. Expression of p85 beta was significantly more decreased under treatment with melatonin and thapsigargin or tunicamycin plus the PI3K inhibitors LY294002 or wortmannin than under treatment with only melatonin or a PI3K inhibitor. The PI3K downstream target p-Akt (Ser473, Thr308) showed significantly decreased expression under treatment with melatonin and thapsigargin or tunicamycin plus PI3K inhibitors than under treatment with melatonin or PI3K inhibitors only. These results indicate that survival of B16F10 melanoma cells after combined treatment with melatonin and ER stress inducers is suppressed through regulation of the PI3K/Akt/mTOR pathway. Melatonin combined with thapsigargin or tunicamycin appears to be a promising strategy for effective melanoma treatment.	[Kim, Han Sung; Yoo, Yeong-Min] Yonsei Univ, Coll Hlth Sci, Dept Biomed Engn, Wonju, Gangwon Do, South Korea; [Kim, Tack-Joong] Yonsei Univ, Coll Sci & Technol, Div Biol Sci & Technol, Wonju, Gangwon Do, South Korea	Yonsei University; Yonsei University	Yoo, YM (corresponding author), Yonsei Univ, Coll Hlth Sci, Dept Biomed Engn, Wonju, Gangwon Do, South Korea.	yyeongm@hanmail.net			Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-00757]	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-00757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnaghi L, 2004, ONCOGENE, V23, P5781, DOI 10.1038/sj.onc.1207698; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Blask DE, 2011, J PINEAL RES, V51, P259, DOI 10.1111/j.1600-079X.2011.00888.x; Bonnefont-Rousselot D, 2011, J PINEAL RES, V50, P328, DOI 10.1111/j.1600-079X.2010.00847.x; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Bush JA, 2003, CLIN EXP METASTAS, V20, P531, DOI 10.1023/A:1025874502181; Cabrera J, 2010, J PINEAL RES, V49, P45, DOI 10.1111/j.1600-079X.2010.00765.x; Cos S, 2001, MELANOMA RES, V11, P197, DOI 10.1097/00008390-200104000-00016; Cui PL, 2012, J PINEAL RES, V52, P236, DOI 10.1111/j.1600-079X.2011.00933.x; de Souza AV, 2003, J PINEAL RES, V34, P242, DOI 10.1034/j.1600-079X.2003.02928.x; Fischer TW, 2006, INT J ONCOL, V29, P665; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Hardeland R, 2009, J PINEAL RES, V47, P109, DOI 10.1111/j.1600-079X.2009.00701.x; HELTON RA, 1993, MELANOMA RES, V3, P403, DOI 10.1097/00008390-199311000-00003; Hong Z, 2006, INT J ONCOL, V28, P661; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Joo SS, 2009, J PINEAL RES, V47, P8, DOI 10.1111/j.1600-079X.2009.00682.x; Jung-Hynes B, 2010, J PINEAL RES, V48, P9, DOI 10.1111/j.1600-079X.2009.00729.x; Kadekaro AL, 2004, J PINEAL RES, V36, P204, DOI 10.1111/j.1600-079X.2004.00119.x; Karbowniczek M, 2008, J INVEST DERMATOL, V128, P980, DOI 10.1038/sj.jid.5701074; Kilic U, 2012, J PINEAL RES, V52, P228, DOI 10.1111/j.1600-079X.2011.00932.x; Kim CH, 2012, J PINEAL RES, V53, P289, DOI 10.1111/j.1600-079X.2012.00998.x; Kim CH, 2010, KOREAN J PHYSIOL PHA, V14, P365, DOI 10.4196/kjpp.2010.14.6.365; Kivela T, EYE LOND, V27, P243; Lasithiotakis KG, 2008, J INVEST DERMATOL, V128, P2013, DOI 10.1038/jid.2008.44; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Liang KV, 2006, MAYO CLIN PROC, V81, P511, DOI 10.4065/81.4.511; Marone R, 2009, MOL CANCER RES, V7, P601, DOI 10.1158/1541-7786.MCR-08-0366; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Mhaidat N, 2008, APOPTOSIS, V13, P1505, DOI 10.1007/s10495-008-0276-8; Min KJ, 2012, J PINEAL RES, V53, P99, DOI 10.1111/j.1600-079X.2012.00975.x; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Mori M, 2003, J CELL PHYSIOL, V195, P290, DOI 10.1002/jcp.10245; NARITA T, 1985, CANCER RES, V45, P4175; Panka DJ, 2006, CANCER RES, V66, P1611, DOI 10.1158/0008-5472.CAN-05-0808; Paradies G, 2010, J PINEAL RES, V48, P297, DOI 10.1111/j.1600-079X.2010.00759.x; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sanchez-Hernandez I, 2012, CANCER LETT, V314, P244, DOI 10.1016/j.canlet.2011.09.037; Sinnberg T, 2009, J INVEST DERMATOL, V129, P1500, DOI 10.1038/jid.2008.379; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slomovitz BM, 2012, CLIN CANCER RES, V18, P5856, DOI 10.1158/1078-0432.CCR-12-0662; Su TR, 2012, MAR DRUGS, V10, P1883, DOI 10.3390/md10081883; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Tan DX, 1993, ENDOCR J, V1, P57; Tirado OM, 2005, ONCOGENE, V24, P3348, DOI 10.1038/sj.onc.1208471; Uguz AC, 2012, J PINEAL RES, V53, P91, DOI 10.1111/j.1600-079X.2012.00974.x; Vega F, 2006, CANCER RES, V66, P6589, DOI 10.1158/0008-5472.CAN-05-3018; Wang JS, 2012, J PINEAL RES, V53, P77, DOI 10.1111/j.1600-079X.2012.00973.x; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Weinstock MA, 2000, JAMA-J AM MED ASSOC, V284, P886, DOI 10.1001/jama.284.7.886; Werzowa J, 2011, J INVEST DERMATOL, V131, P495, DOI 10.1038/jid.2010.327; Xie XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055096; Yerneni LK, 2003, MELANOMA RES, V13, P113, DOI 10.1097/00008390-200304000-00002; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Zha LX, 2012, J PINEAL RES, V52, P322, DOI 10.1111/j.1600-079X.2011.00946.x	58	36	39	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92627	10.1371/journal.pone.0092627	http://dx.doi.org/10.1371/journal.pone.0092627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647338	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500150
J	Lamanna, MC; Sues, HD; Schachner, ER; Lyson, TR				Lamanna, Matthew C.; Sues, Hans-Dieter; Schachner, Emma R.; Lyson, Tyler R.			A New Large-Bodied Oviraptorosaurian Theropod Dinosaur from the Latest Cretaceous of Western North America	PLOS ONE			English	Article							HELL CREEK FORMATION; BAYAN-MANDAHU; DEPOSITIONAL-ENVIRONMENTS; INNER-MONGOLIA; CHINA; CHIROSTENOTES; MANIRAPTORA; SAURISCHIA; EVOLUTION; OSTEOLOGY	The oviraptorosaurian theropod dinosaur clade Caenagnathidae has long been enigmatic due to the incomplete nature of nearly all described fossils. Here we describe Anzu wyliei gen. et sp. nov., a new taxon of large-bodied caenagnathid based primarily on three well-preserved partial skeletons. The specimens were recovered from the uppermost Cretaceous (upper Maastrichtian) Hell Creek Formation of North and South Dakota, and are therefore among the stratigraphically youngest known oviraptorosaurian remains. Collectively, the fossils include elements from most regions of the skeleton, providing a wealth of information on the osteology and evolutionary relationships of Caenagnathidae. Phylogenetic analysis reaffirms caenagnathid monophyly, and indicates that Anzu is most closely related to Caenagnathus collinsi, a taxon that is definitively known only from a mandible from the Campanian Dinosaur Park Formation of Alberta. The problematic oviraptorosaurs Microvenator and Gigantoraptor are recovered as basal caenagnathids, as has previously been suggested. Anzu and other caenagnathids may have favored well-watered floodplain settings over channel margins, and were probably ecological generalists that fed upon vegetation, small animals, and perhaps eggs.	[Lamanna, Matthew C.] Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; [Sues, Hans-Dieter] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Schachner, Emma R.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Lyson, Tyler R.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Utah System of Higher Education; University of Utah; Smithsonian Institution; Smithsonian National Museum of Natural History	Lamanna, MC (corresponding author), Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA.	lamannam@carnegiemnh.org		Schachner, Emma/0000-0002-8636-925X; Sues, Hans-Dieter/0000-0002-9911-7254	Carnegie Museum of Natural History; American Philosophical Society Franklin Research Grant; National Museum of Natural History Peter Buck Postdoctoral Fellowship; American Association of Anatomists Postdoctoral Fellowship	Carnegie Museum of Natural History; American Philosophical Society Franklin Research Grant; National Museum of Natural History Peter Buck Postdoctoral Fellowship; American Association of Anatomists Postdoctoral Fellowship	Funding was provided by the Carnegie Museum of Natural History (http://www.carnegiemnh.org), an American Association of Anatomists Postdoctoral Fellowship (http://www.anatomy.org/content/postdoctoral-fellowship-criteria), and an American Philosophical Society Franklin Research Grant (http://www.amphilsoc.org/grants/franklin) to E. R. S., and a National Museum of Natural History Peter Buck Postdoctoral Fellowship (http://vertebrates.si.edu/vz_buck_fell_info.html) to T. R. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolin F.L., 2013, AVIAN ANCESTORS REV; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Averianov A., 2012, Journal of Stratigraphy, V36, P462; Balanoff AM, 2013, NATURE, V501, P93, DOI 10.1038/nature12424; Balanoff AM, 2012, B AM MUS NAT HIST, P1; Balanoff AM, 2009, AM MUS NOVIT, P1, DOI 10.1206/644.1; Barsbold R, 2000, NATURE, V403, P155, DOI 10.1038/35003103; Barsbold R, 2000, ACTA PALAEONTOL POL, V45, P97; Barsbold R., 1990, P249; Barsbold R., 1983, Sovmestnaya Sovetsko-Mongol'skaya Paleontologicheskaya Ekspeditsiya Trudy, P1; Barsbold R., 1976, Doklady (Proc) Acad Sci USSR (Earth Sci), V226, P221; Barsbold R., 1986, P210; Barsbold R., 1977, JOINT SOV MONG PAL E, V4, P34; Bever GS, 2009, AM MUS NOVIT, P1, DOI 10.1206/650.1; Brown CM, 2013, PALAEOGEOGR PALAEOCL, V372, P108, DOI 10.1016/j.palaeo.2012.06.027; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Clark James M., 1999, American Museum Novitates, V3265, P1; CRACRAFT J, 1971, Journal of Paleontology, V45, P805; Currie P.J., 1990, P245; Currie PJ, 2005, LIFE O PAST, P367; CURRIE PJ, 1989, CAN J EARTH SCI, V26, P1319, DOI 10.1139/e89-111; CURRIE PJ, 1988, CAN J EARTH SCI, V25, P972, DOI 10.1139/e88-097; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2255, DOI 10.1139/e93-196; Dingus L, 2008, AM MUS NOVIT, P1, DOI 10.1206/442.1; Dong ZM, 1996, CAN J EARTH SCI, V33, P631, DOI 10.1139/e96-046; EBERTH DA, 1993, CAN J EARTH SCI, V30, P2196, DOI 10.1139/e93-191; Elzanowski A, 1999, SM C PALEOB, P311; Fanti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031330; Funston GF, CANADIAN J IN PRESS; Gierlinski Gerard, 2013, P526; Gilmore C.W., 1924, GEOLOGICAL SURVEY CA, V38, p1e12; Goloboff P, 2008, CLADISTICS, V24, P91; Harris JD, 1996, CRETACEOUS RES, V17, P381, DOI 10.1006/cres.1996.0024; Hartman JH, 2002, 361 GEOL SOC AM; Hasegawa H, 2009, J ASIAN EARTH SCI, V35, P13, DOI 10.1016/j.jseaes.2008.11.010; He Tao, 2008, Vertebrata Palasiatica, V46, P178; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; [Ji Qiang 季强], 2012, [地质通报, Geological Bulletin of China], V31, P2102; Johnson KR, 2002, GEOL S AM S, P503; KING GM, 1989, ZOOL J LINN SOC-LOND, V96, P185, DOI 10.1111/j.1096-3642.1989.tb01826.x; Koppelhus, 2005, DINOSAUR PROVINCIAL; Kundrat M, 2007, NATURWISSENSCHAFTEN, V94, P499, DOI 10.1007/s00114-007-0219-1; Kurzanov S.M., 1982, Paleontologicheskii Zhurnal, V1982, P108; Kurzanov S.M., 1987, T JOINT SOVIET MONGO, V31, P5; Kurzanov SM, 1985, PALEONTOL J, V1985, P92; Lamanna M, 2011, J VERTEBR PALEONTOL, V31, P140; Lockley Martin G., 2004, Ichnos, V11, P229, DOI 10.1080/10420940490428625; Longrich NR, 2013, B PEABODY MUS NAT HI, V54, P23, DOI 10.3374/014.054.0102; Longrich NR, 2010, PALAEONTOLOGY, V53, P945, DOI 10.1111/j.1475-4983.2010.00968.x; Lu J, 2002, P 5 S SOC AV PAL EV, P175; Lu JC, 2002, J VERTEBR PALEONTOL, V22, P871, DOI 10.1671/0272-4634(2002)022[0871:ANOTOF]2.0.CO;2; Lu Junchang, 2004, Bulletin of the National Science Museum Series C (Geology & Paleontology), V30, P95; Lu JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080557; Lu JC, 2013, NATURWISSENSCHAFTEN, V100, P165, DOI 10.1007/s00114-012-1007-0; Lyson TR, 2010, P ROYAL SOC B, V278, P1158; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Makovicky PJ, 2010, P ROY SOC B-BIOL SCI, V277, P191, DOI 10.1098/rspb.2009.0236; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Maryanska T, 2002, ACTA PALAEONTOL POL, V47, P97; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; NORELL MA, 1994, SCIENCE, V266, P779, DOI 10.1126/science.266.5186.779; OSBORN H.F., 1924, AM MUS NOVIT, V144, P1; Osmolska H, 2004, ACTA PALAEONTOL POL, V49, P321; OSMOLSKA H, 1981, Palaeontologia Polonica, P79; Osmolska H, 2004, DINOSAURIA, 2ND EDITION, P165; Parks W.A., 1933, U TORONTO STUDIES GE, V34, p1e24; Persons IV WS, ACTA PALAEO IN PRESS; Rothschild Bruce, 2001, P331; Sato T, 2005, SCIENCE, V308, P375, DOI 10.1126/science.1110578; Schachner E, 2006, J VERTEBR PALEONTOL, V26, p120A; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Senter Phil, 2005, Paleobios, V25, P9; Smith D., 1992, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V186, P365; Sternberg C. M., 1932, Canadian Field Naturalist, V48, P99; STERNBERG R. M., 1940, JOUR PALEONTOL, V14, P81; Sues HD, 1997, J VERTEBR PALEONTOL, V17, P698, DOI 10.1080/02724634.1997.10011018; Sullivan Robert M., 2011, Bulletin of the New Mexico Museum of Natural History and Science, V53, P418; Triebold M, 2000, PUBLICATIONS PALEONT, V2; Varricchio David J., 2001, P42; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Walker J.D., 2012, GEOLOGIC TIME SCALE; Wang S, 2013, ZOOTAXA, V3640, P242, DOI 10.11646/zootaxa.3640.2.7; Wei XF, 2013, ACTA GEOL SIN-ENGL, V87, P899, DOI 10.1111/1755-6724.12098; Xu X, 2002, NATURE, V419, P291, DOI 10.1038/nature00966; Xu X, 2007, NATURE, V447, P844, DOI 10.1038/nature05849; Xu Xing, 2013, Vertebrata Palasiatica, V51, P85; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2010, CHINESE SCI BULL, V55, P3971, DOI 10.1007/s11434-010-4150-z; Xu Xing, 2010, Vertebrata Palasiatica, V48, P11; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Yan Y, 2007, SEDIMENT GEOL, V197, P127, DOI 10.1016/j.sedgeo.2006.09.004; Zanno LE, 2005, J VERTEBR PALEONTOL, V25, P897, DOI 10.1671/0272-4634(2005)025[0897:ANOTMF]2.0.CO;2; Zanno LE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2526; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; ZHOU ZH, 2000, VERTEBRAT PALASIATIC, V38, P242; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P111	98	75	78	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92022	10.1371/journal.pone.0092022	http://dx.doi.org/10.1371/journal.pone.0092022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647078	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000333348500073
J	Levy, AF; Zayats, M; Guerrero-Cazares, H; Quinones-Hinojosa, A; Searson, PC				Levy, Amanda F.; Zayats, Maya; Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo; Searson, Peter C.			Influence of Basement Membrane Proteins and Endothelial Cell-Derived Factors on the Morphology of Human Fetal-Derived Astrocytes in 2D	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; IN-VITRO; DIFFERENTIATION; PERICYTES; INVITRO; IMPACT	Astrocytes are the most prevalent type of glial cell in the brain, participating in a variety of diverse functions from regulating cerebral blood flow to controlling synapse formation. Astrocytes and astrocyte-conditioned media are widely used in models of the blood-brain barrier (BBB), however, very little is known about astrocyte culture in 2D. To test the hypothesis that surface coating and soluble factors influence astrocyte morphology in 2D, we quantitatively analyzed the morphology of human fetal derived astrocytes on glass, matrigel, fibronectin, collagen IV, and collagen I, and after the addition soluble factors including platelet-derived growth factor (PDGF), laminin, basic fibroblast growth factor (bFGF), and leukemia inhibitory factor (LIF). Matrigel surface coatings, as well as addition of leukemia inhibitory factor (LIF) to the media, were found to have the strongest effects on 2D astrocyte morphology, and may be important in improving existing BBB models. In addition, the novel set of quantitative parameters proposed in this paper provide a test for determining the influence of compounds on astrocyte morphology, both to screen for new endothelial cell-secreted factors that influence astrocytes, and to determine in a high-throughput way which factors are important for translation to more complex, 3D BBB models.	[Levy, Amanda F.; Zayats, Maya; Searson, Peter C.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Levy, Amanda F.; Zayats, Maya; Searson, Peter C.] Johns Hopkins Univ, Inst Nanobiotechnol, Baltimore, MD 21218 USA; [Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo] Johns Hopkins Univ, Sch Med, Dept Neurosurg & Oncol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Searson, PC (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	searson@jhu.edu		Guerrero-Cazares, Hugo/0000-0003-1307-719X; Searson, Peter/0000-0002-5417-0828	National Institutes of Health (NIH) [1R01CA170629, 5R01NS070024]; NATIONAL CANCER INSTITUTE [R01CA170629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070024] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by in part by a National Institutes of Health (NIH) grant 1R01CA170629. AQH and HGC were supported by NIH grant 5R01NS070024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; BLACK JA, 1993, GLIA, V7, P272, DOI 10.1002/glia.440070403; EDGAR D, 1984, EMBO J, V3, P1463, DOI 10.1002/j.1460-2075.1984.tb01997.x; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; ESTRADA C, 1990, J NEUROPATH EXP NEUR, V49, P539, DOI 10.1097/00005072-199011000-00001; Figley CR, 2011, EUR J NEUROSCI, V33, P577, DOI 10.1111/j.1460-9568.2010.07584.x; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Fukushima M, 2009, INT J DEV NEUROSCI, V27, P685, DOI 10.1016/j.ijdevneu.2009.07.006; Hartmann C, 2007, EXP CELL RES, V313, P1318, DOI 10.1016/j.yexcr.2007.01.024; Haseloff RF, 2005, CELL MOL NEUROBIOL, V25, P25, DOI 10.1007/s10571-004-1375-x; Hatherell K, 2011, J NEUROSCI METH, V199, P223, DOI 10.1016/j.jneumeth.2011.05.012; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Igarashi Y, 1999, BIOCHEM BIOPH RES CO, V261, P108, DOI 10.1006/bbrc.1999.0992; Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Siddharthan V, 2007, BRAIN RES, V1147, P39, DOI 10.1016/j.brainres.2007.02.029; Thanabalasundaram G, 2011, INT J BIOCHEM CELL B, V43, P1284, DOI 10.1016/j.biocel.2011.05.002; Tilling T, 2002, CELL TISSUE RES, V310, P19, DOI 10.1007/s00441-002-0604-1; Tilling T, 1998, J NEUROCHEM, V71, P1151; Tzeng SY, 2011, BIOMATERIALS, V32, P5402, DOI 10.1016/j.biomaterials.2011.04.016; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wong AD, 2013, FRONTIERS NEUROENGIN, V6	30	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92165	10.1371/journal.pone.0092165	http://dx.doi.org/10.1371/journal.pone.0092165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647106	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500093
J	Matthews, LP; McCordic, JA; Parks, SE				Matthews, Leanna P.; McCordic, Jessica A.; Parks, Susan E.			Remote Acoustic Monitoring of North Atlantic Right Whales (Eubalaena glacialis) Reveals Seasonal and Diel Variations in Acoustic Behavior	PLOS ONE			English	Article							CALLING PATTERNS; SOUND PRODUCTION; POPULATION; RECORDINGS; MANAGEMENT; MIGRATION; PREY; BAY	Remote acoustic monitoring is a non-invasive tool that can be used to study the distribution, behavior, and habitat use of sound-producing species. The North Atlantic right whale (Eubalaena glacialis) is an endangered baleen whale species that produces a variety of stereotyped acoustic signals. One of these signals, the "gunshot" sound, has only been recorded from adult male North Atlantic right whales and is thought to function for reproduction, either as reproductive advertisement for females or as an agonistic signal toward other males. This study uses remote acoustic monitoring to analyze the presence of gunshots over a two-year period at two sites on the Scotian Shelf to determine if there is evidence that North Atlantic right whales may use these locations for breeding activities. Seasonal analyses at both locations indicate that gunshot sound production is highly seasonal, with an increase in the autumn. One site, Roseway West, had significantly more gunshot sounds overall and exhibited a clear diel trend in production of these signals at night. The other site, Emerald South, also showed a seasonal increase in gunshot production during the autumn, but did not show any significant diel trend. This difference in gunshot signal production at the two sites indicates variation either in the number or the behavior of whales at each location. The timing of the observed seasonal increase in gunshot sound production is consistent with the current understanding of the right whale breeding season, and our results demonstrate that detection of gunshots with remote acoustic monitoring can be a reliable way to track shifts in distribution and changes in acoustic behavior including possible mating activities.	[Matthews, Leanna P.; McCordic, Jessica A.; Parks, Susan E.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Matthews, LP (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	lematthe@syr.edu	Parks, Susan E/D-2675-2014	Parks, Susan E/0000-0001-6663-627X	Right Whale Grants Program of the (U.S.) National Oceanographic and Atmospheric Administration; Office of Naval Research [N00014-03-1-0099]	Right Whale Grants Program of the (U.S.) National Oceanographic and Atmospheric Administration; Office of Naval Research(Office of Naval Research)	Right Whale Grants Program of the (U.S.) National Oceanographic and Atmospheric Administration and by Office of Naval Research grant #N00014-03-1-0099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackleh AS, 2012, J ACOUST SOC AM, V131, P2306, DOI 10.1121/1.3682042; Au W.W.L., 2008, PRINCIPLES MARINE BI; Baumgartner MF, 2008, LIMNOL OCEANOGR, V53, P2197, DOI 10.4319/lo.2008.53.5_part_2.2197; Baumgartner MF, 2003, MAR ECOL PROG SER, V264, P155, DOI 10.3354/meps264155; Baumgartner MF, 2003, MAR ECOL PROG SER, V264, P123, DOI 10.3354/meps264123; BEST PB, 1994, J ZOOL, V232, P175, DOI 10.1111/j.1469-7998.1994.tb01567.x; Bioacoustics Research Program, 2012, RAV PROINT SOUND AN; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Bradbury Jack W., 1998, pi; Bridges AS, 2000, COPEIA, P587, DOI 10.1643/0045-8511(2000)000[0587:TVIACB]2.0.CO;2; Brown MW, 2001, J CETACEAN RES MANAG, V2, P251; Brown MW, 1995, MARINE PROTECTED ARE, P90; Cetacean and Turtle Assessment Program (CETAP), 1982, CHAR MAR MAMM TURLT; Clark C., 1983, COMMUNICATION BEHAV, P163; Clark CW, 2010, MAR MAMMAL SCI, V26, P837, DOI 10.1111/j.1748-7692.2010.00376.x; CLARK CW, 1982, ANIM BEHAV, V30, P1060, DOI 10.1016/S0003-3472(82)80196-6; Fischer FP, 1997, ECOL APPL, V7, P909, DOI 10.1890/1051-0761(1997)007[0909:QAOGQA]2.0.CO;2; Fox CG, 2001, J GEOPHYS RES-SOL EA, V106, P4183, DOI 10.1029/2000JB900404; Hamilton PK, 1998, MAR ECOL PROG SER, V171, P285, DOI 10.3354/meps171285; Hunt KE, 2006, GEN COMP ENDOCR, V148, P260, DOI 10.1016/j.ygcen.2006.03.012; IWC, 2001, J CETACEAN RES MANAG, V2, P1; Kirschel ANG, 2011, IBIS, V153, P255, DOI 10.1111/j.1474-919X.2011.01102.x; Kraus Scott D., 2001, Journal of Cetacean Research and Management Special Issue, V2, P237; Marques Tiago A., 2011, Endangered Species Research, V13, P163, DOI 10.3354/esr00325; Mate BR, 1997, J WILDLIFE MANAGE, V61, P1393, DOI 10.2307/3802143; Matthews J. N., 2001, Journal of Cetacean Research and Management, V3, P271; McDonald MA, 1999, J ACOUST SOC AM, V105, P2643, DOI 10.1121/1.426880; McDonald MA, 2002, J CETACEAN RES MANAG, V43, P261; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Mellinger DK, 2007, MAR MAMMAL SCI, V23, P856, DOI 10.1111/j.1748-7692.2007.00144.x; Mitchell E, 1986, REP INT WHAL COMMN, V10, P83; Morano JL, 2012, J ACOUST SOC AM, V132, P1207, DOI 10.1121/1.4730890; Morano JL, 2012, CONSERV BIOL, V26, P698, DOI 10.1111/j.1523-1739.2012.01866.x; Munger LM, 2008, MAR MAMMAL SCI, V24, P795, DOI 10.1111/j.1748-7692.2008.00219.x; Mussoline Sarah E., 2012, Endangered Species Research, V17, P17, DOI 10.3354/esr00411; Nieukirk SL, 2004, J ACOUST SOC AM, V115, P1832, DOI 10.1121/1.1675816; Parks S. E., 2011, Endangered Species Research, V15, P63, DOI 10.3354/esr00368; Parks SE, 2005, MAR MAMMAL SCI, V21, P458, DOI 10.1111/j.1748-7692.2005.tb01244.x; Parks SE, 2005, J ACOUST SOC AM, V117, P3297, DOI 10.1121/1.1882946; Parks SE, 2003, MAR MAMMAL SCI, V19, P563, DOI 10.1111/j.1748-7692.2003.tb01321.x; Parks SE, 2012, J ACOUST SOC AM, V131, P3173, DOI 10.1121/1.3688507; Payne KB, 2003, AFR J ECOL, V41, P99, DOI 10.1046/j.1365-2028.2003.00421.x; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rountree RA, 2006, FISHERIES, V31, P433, DOI 10.1577/1548-8446(2006)31[433:LTF]2.0.CO;2; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Stafford KM, 2005, ANIM BEHAV, V69, P951, DOI 10.1016/j.anbehav.2004.06.025; Tellechea Javier S., 2012, Journal of Cetacean Research and Management, V12, P361; Tremain SB, 2008, WILSON J ORNITHOL, V120, P499, DOI 10.1676/07-137.1; Van Parijs SM, 2009, MAR ECOL PROG SER, V395, P21, DOI 10.3354/meps08123; Wiggins Sean M., 2005, Aquatic Mammals, V31, P161, DOI 10.1578/AM.31.2.2005.161; Winn H.E., 1986, Reports of the International Whaling Commission Special Issue, P129	52	19	20	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91367	10.1371/journal.pone.0091367	http://dx.doi.org/10.1371/journal.pone.0091367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646524	gold, Green Submitted, Green Published			2022-12-27	WOS:000333348500034
J	Rosskothen-Kuhl, N; Illing, RB				Rosskothen-Kuhl, Nicole; Illing, Robert-Benjamin			Gap43 Transcription Modulation in the Adult Brain Depends on Sensory Activity and Synaptic Cooperation	PLOS ONE			English	Article							LATERAL SUPERIOR OLIVE; GAP-43 MESSENGER-RNA; ELECTRICAL INTRACOCHLEAR STIMULATION; GROWTH-ASSOCIATED PROTEIN; VENTRAL COCHLEAR NUCLEUS; IN-SITU HYBRIDIZATION; C-FOS; INFERIOR COLLICULUS; AUDITORY-SYSTEM; RAT BRAIN	Brain development and learning is accompanied by morphological and molecular changes in neurons. The growth associated protein 43 (Gap43), indicator of neurite elongation and synapse formation, is highly expressed during early stages of development. Upon maturation of the brain, Gap43 is down-regulated by most neurons with the exception of subdivisions such as the CA3 region of hippocampus, the lateral superior olive (LSO) and the central inferior colliculus (CIC). Little is known about the regulation of this mRNA in adult brains. We found that the expression of Gap43 mRNA in specific neurons can be modulated by changing sensory activity of the adult brain. Using the central auditory system of rats as a model, Gap43 protein and mRNA levels were determined in LSO and CIC of hearing-experienced rats unilaterally or bilaterally deafened or unilaterally stimulated by a cochlear implant (CI). Our data indicate that Gap43 is a marker useful beyond monitoring neuronal growth and synaptogenesis, reflecting also specific patterns of synaptic activities on specific neurons. Thus, unilateral loss of input to an adult auditory system directly causes asymmetrical expression of Gap43 mRNA between LSOs or CICs on both sides of the brainstem. This consequence can be prevented by simple-patterned stimulation of a dysfunctional ear by way of a CI. We suggest that as a function of input balance and activity pattern, Gap43 mRNA expression changes as cells associate converging afferent signals.	[Rosskothen-Kuhl, Nicole; Illing, Robert-Benjamin] Univ Freiburg, Dept Otorhinolaryngol, Neurobiol Res Lab, D-79106 Freiburg, Germany	University of Freiburg	Rosskothen-Kuhl, N (corresponding author), Univ Freiburg, Dept Otorhinolaryngol, Neurobiol Res Lab, Hugstetter Str 55, D-79106 Freiburg, Germany.	nicole.rosskothen@uniklinik-freiburg.de		Rosskothen-Kuhl, Nicole/0000-0003-4724-5550				AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Arndt S, 2011, OTOL NEUROTOL, V32, P39, DOI 10.1097/MAO.0b013e3181fcf271; BENDOTTI C, 1991, J NEUROSCI, V11, P600; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BENOWITZ LI, 1991, PROG BRAIN RES, V89, P69; Bischoff P, 2013, OTOLARYGOLOGY S, VS3, DOI [10.4172/2161-119X. S3-005., DOI 10.4172/2161-119X.S3-005]; Casoli T, 2003, MICRON, V34, P415, DOI 10.1016/S0968-4328(03)00038-6; Caspary DM, 1991, NEUROBIOLOGY HEARING, VII, P141; deGroen PC, 1995, J MOL NEUROSCI, V6, P109, DOI 10.1007/BF02736770; Diolaiti D, 2007, EXP CELL RES, V313, P2980, DOI 10.1016/j.yexcr.2007.06.002; EHRET G, 1991, BRAIN RES, V567, P350, DOI 10.1016/0006-8993(91)90819-H; Firszt JB, 2012, OTOL NEUROTOL, V33, P1339, DOI 10.1097/MAO.0b013e318268d52d; Fredrich M, 2013, EUR J NEUROSCI, V38, P2041, DOI 10.1111/ejn.12200; Gerin CG, 2011, SYNAPSE, V65, P1255, DOI 10.1002/syn.20903; Grasselli G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00025; Grasselli G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020791; Hildebrandt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023686; Horvath M, 2000, J COMP NEUROL, V422, P95; Illing R.B., 2010, AUDIOLOGICAL MED, V8, P63, DOI DOI 10.3109/16513860903454583; Illing RB, 1999, J COMP NEUROL, V412, P353, DOI 10.1002/(SICI)1096-9861(19990920)412:2<353::AID-CNE12>3.0.CO;2-W; Illing RB, 2002, EXP NEUROL, V175, P226, DOI 10.1006/exnr.2002.7895; Illing RB, 1997, J COMP NEUROL, V382, P116, DOI 10.1002/(SICI)1096-9861(19970526)382:1<116::AID-CNE8>3.0.CO;2-4; Illing RB, 2001, NEUROREPORT, V12, P875, DOI 10.1097/00001756-200103260-00050; Illing RB, 2012, COCHLEAR IMPLANT RES, DOI [10.5772/34440.137-166., DOI 10.5772/34440.137-166]; Jakob T, 2008, AUDIOL MED, V6, P215, DOI DOI 10.1080/16513860701875521; Jero J, 2001, ACTA OTO-LARYNGOL, V121, P585, DOI 10.1080/000164801316878863; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; KELLY JB, 1991, HEARING RES, V56, P273, DOI 10.1016/0378-5955(91)90177-B; Kelly JB, 1997, HEARING RES, V104, P112, DOI 10.1016/S0378-5955(96)00182-7; Kraus KS, 2004, J COMP NEUROL, V475, P374, DOI 10.1002/cne.20180; KRUGER L, 1993, J COMP NEUROL, V333, P417, DOI 10.1002/cne.903330308; Kullmann PHM, 2002, EUR J NEUROSCI, V15, P1093, DOI 10.1046/j.1460-9568.2002.01946.x; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; Mei HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041311; Meidinger MA, 2006, EUR J NEUROSCI, V23, P3187, DOI 10.1111/j.1460-9568.2006.04853.x; MEIRI KF, 1986, P NATL ACAD SCI USA, V83, P3537, DOI 10.1073/pnas.83.10.3537; Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326; MOORE MJ, 1983, J NEUROSCI, V3, P237; Rekart JL, 2005, HIPPOCAMPUS, V15, P1, DOI 10.1002/hipo.20045; Rosskothen N, 2008, NEUROREPORT, V19, P1091, DOI 10.1097/WNR.0b013e328303bbeb; Rosskothen-Kuhl N, 2012, BRAIN RES, V1435, P40, DOI 10.1016/j.brainres.2011.11.046; Rosskothen-Kuhl N, 2010, BRAIN RES, V1347, P33, DOI 10.1016/j.brainres.2010.05.089; SAINTMARIE RL, 1990, BRAIN RES, V524, P244, DOI 10.1016/0006-8993(90)90698-B; SAINTMARIE RL, 1989, J COMP NEUROL, V279, P382; SANES DH, 1988, J NEUROSCI, V8, P682; Schwartz I.R., 1992, Springer Handbook of Auditory Research, V1, P117; Sharma N, 2010, EXP NEUROL, V223, P183, DOI 10.1016/j.expneurol.2009.04.031; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SKENE JHP, 1981, J NEUROSCI, V1, P419; Smith PH, 1998, J NEUROPHYSIOL, V79, P3127, DOI 10.1152/jn.1998.79.6.3127; SOMMER I, 1993, EXP BRAIN RES, V95, P223; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Thompson AM, 2000, MICROSC RES TECHNIQ, V51, P330, DOI 10.1002/1097-0029(20001115)51:4<330::AID-JEMT4>3.0.CO;2-X; Tollin DJ, 2003, NEUROSCIENTIST, V9, P127, DOI 10.1177/1073858403252228; Winer JA, 1998, J COMP NEUROL, V400, P147; YAO GL, 1993, MOL BRAIN RES, V18, P1, DOI 10.1016/0169-328X(93)90168-O	56	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92624	10.1371/journal.pone.0092624	http://dx.doi.org/10.1371/journal.pone.0092624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647228	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500149
J	Sasahira, T; Ueda, N; Yamamoto, K; Kurihara, M; Matsushima, S; Bhawal, UK; Kirita, T; Kuniyasu, H				Sasahira, Tomonori; Ueda, Nobuhiro; Yamamoto, Kazuhiko; Kurihara, Miyako; Matsushima, Sayako; Bhawal, Ujjal K.; Kirita, Tadaaki; Kuniyasu, Hiroki			Prox1 and FOXC2 Act as Regulators of Lymphangiogenesis and Angiogenesis in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; GROWTH-FACTOR-D; TRANSCRIPTION FACTOR; TUMOR LYMPHANGIOGENESIS; CANCER PROGRESSION; ENDOTHELIAL-CELLS; EXPRESSION; INVASION; GENE; TRANSITION	Prospero homeobox 1 (Prox1) and forkhead box (FOX) C2 regulate angiogenesis and/or lymphangiogenesis. However, the detailed role and function of Prox1 and FOXC2 in cancer remains controversial. In the present study, we examined the expression of Prox1 and FOXC2 proteins in specimens from 163 cases with oral squamous cell carcinoma (OSCC). Furthermore, the role of Prox1 and FOXC2 in cancer cell growth and invasion was evaluated in cultured OSCC cells. Prox1 expression was significantly associated with local progression of the tumor (P = 0.0023), clinical stage (P<0.0001), lymphovessel density (LVD) (P<0.0001), nodal metastasis (P<0.0001), and worse prognosis (P<0.0001). Immunoreactivity of FOXC2 was strongly correlated with microvessel density (MVD) (P<0.0001) and poor prognosis (P = 0.0076). In vitro analysis demonstrated that Prox1 regulates cell growth, proliferation, invasion, and lymphangiogenesis by activating vascular endothelial growth factor (VEGF)-C expression. Furthermore, FOXC2 enhanced the expression level of Prox1 and promoted angiogenesis by enhancement of VEGF-A expression. Our results suggested that Prox1 and FOXC2 play key roles in OSCC progression and that further studies focusing on these proteins may yield useful insights for diagnosis and therapy of OSCC.	[Sasahira, Tomonori; Kurihara, Miyako; Matsushima, Sayako; Bhawal, Ujjal K.; Kuniyasu, Hiroki] Nara Med Univ, Dept Mol Pathol, Kashihara, Nara 634, Japan; [Ueda, Nobuhiro; Yamamoto, Kazuhiko; Kurihara, Miyako; Kirita, Tadaaki] Nara Med Univ, Dept Oral & Maxillofacial Surg, Kashihara, Nara 634, Japan; [Bhawal, Ujjal K.] Nihon Univ, Sch Dent Matsudo, Dept Biochem & Mol Biol, Matsudo, Chiba, Japan	Nara Medical University; Nara Medical University; Nihon University	Kuniyasu, H (corresponding author), Nara Med Univ, Dept Mol Pathol, Kashihara, Nara 634, Japan.	cooninh@zb4.so-net.ne.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	A Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science; http://www.jsps.go.jp/english/e-grants/index.html#. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Allred DC, 1998, MODERN PATHOL, V11, P155; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Birner P, 2001, CLIN CANCER RES, V7, P93; Currie MJ, 2004, J CLIN PATHOL, V57, P829, DOI 10.1136/jcp.2003.015644; Dadras SS, 2008, J INVEST DERMATOL, V128, P2798, DOI 10.1038/jid.2008.176; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; dos Reis PP, 2008, CANCER-AM CANCER SOC, V113, P3169, DOI 10.1002/cncr.23934; Elsir T, 2011, BRIT J CANCER, V104, P1747, DOI 10.1038/bjc.2011.162; Elsir T, 2012, CANCER METAST REV, V31, P793, DOI 10.1007/s10555-012-9390-8; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Franchi A, 2004, CANCER, V101, P973, DOI 10.1002/cncr.20454; Hader C, 2010, ONCOGENE, V29, P1031, DOI 10.1038/onc.2009.397; Harada K, 2009, J CELL SCI, V122, P3923, DOI 10.1242/jcs.052324; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kopfstein L, 2007, AM J PATHOL, V170, P1348, DOI 10.2353/ajpath.2007.060835; Kume T, 2012, J ONCOL, V2012, DOI 10.1155/2012/204593; Kume T, 2010, HISTOL HISTOPATHOL, V25, P637, DOI 10.14670/HH-25.637; Laerm A, 2007, J HEPATOL, V46, P89, DOI 10.1016/j.jhep.2006.07.033; Lahat G, 2009, CLIN CANCER RES, V15, P2637, DOI 10.1158/1078-0432.CCR-08-2442; Li C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075388; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Marsh D, 2011, J PATHOL, V223, P470, DOI 10.1002/path.2830; Matsuo Y, 2009, J SURG ONCOL, V99, P361, DOI 10.1002/jso.21245; Miettinen M, 2012, AM J SURG PATHOL, V36, P351, DOI 10.1097/PAS.0b013e318236c312; Miyahara M, 2007, CANCER-AM CANCER SOC, V110, P1287, DOI 10.1002/cncr.22900; Mydlarz Wojciech K, 2010, Expert Opin Med Diagn, V4, P53; Nagai H, 2003, GENE CHROMOSOME CANC, V38, P13, DOI 10.1002/gcc.10248; Nishida N, 2011, ANN SURG ONCOL, V18, P535, DOI 10.1245/s10434-010-1274-y; Nomiya T, 2006, ONCOL REP, V15, P1497; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Sabine A, 2012, DEV CELL, V22, P430, DOI 10.1016/j.devcel.2011.12.020; Sano H, 2010, BIOCHEM BIOPH RES CO, V392, P201, DOI 10.1016/j.bbrc.2010.01.015; Sasahira T, 2007, HISTOPATHOLOGY, V51, P166, DOI 10.1111/j.1365-2559.2007.02739.x; Sasahira T, 2008, CANCER SCI, V99, P1806, DOI 10.1111/j.1349-7006.2008.00894.x; Sasahira T, 2010, EUR J CANCER, V46, P2285, DOI 10.1016/j.ejca.2010.04.027; Schneider M, 2006, INT J ONCOL, V28, P883; Shimoda M, 2006, CLIN CANCER RES, V12, P6005, DOI 10.1158/1078-0432.CCR-06-0712; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Skog M, 2011, BRIT J CANCER, V105, P1346, DOI 10.1038/bjc.2011.297; Srinivasan RS, 2010, GENE DEV, V24, P696, DOI 10.1101/gad.1859310; Takahashi M, 2006, NEOPLASIA, V8, P1003, DOI 10.1593/neo.06595; Versmold B, 2007, INT J CANCER, V121, P547, DOI 10.1002/ijc.22705; Wu X, 2011, LYMPHOLOGY, V44, P35; Yoshimoto T, 2007, BIOCHEM BIOPH RES CO, V359, P258, DOI 10.1016/j.bbrc.2007.05.071	48	51	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92534	10.1371/journal.pone.0092534	http://dx.doi.org/10.1371/journal.pone.0092534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647631	Green Published, gold			2022-12-27	WOS:000333348500141
J	Stanic, D; Dubois, S; Chua, HK; Tonge, B; Rinehart, N; Horne, MK; Boon, WC				Stanic, Davor; Dubois, Sydney; Chua, Hui Kheng; Tonge, Bruce; Rinehart, Nicole; Horne, Malcolm K.; Boon, Wah Chin			Characterization of Aromatase Expression in the Adult Male and Female Mouse Brain. I. Coexistence with Oestrogen Receptors alpha and beta, and Androgen Receptors	PLOS ONE			English	Article							MESSENGER-RIBONUCLEIC-ACID; CENTRAL-NERVOUS-SYSTEM; IN-SITU HYBRIDIZATION; RAT-BRAIN; GENE-EXPRESSION; STRIA TERMINALIS; BED NUCLEUS; PROTEIN EXPRESSION; PRINCIPAL NUCLEUS; SEX-DIFFERENCES	Aromatase catalyses the last step of oestrogen synthesis. There is growing evidence that local oestrogens influence many brain regions to modulate brain development and behaviour. We examined, by immunohistochemistry, the expression of aromatase in the adult male and female mouse brain, using mice in which enhanced green fluorescent protein (EGFP) is transcribed following the physiological activation of the Cyp19A1 gene. EGFP-immunoreactive processes were distributed in many brain regions, including the bed nucleus of the stria terminalis, olfactory tubercle, medial amygdaloid nucleus and medial preoptic area, with the densest distributions of EGFP-positive cell bodies in the bed nucleus and medial amygdala. Differences between male and female mice were apparent, with the density of EGFP-positive cell bodies and fibres being lower in some brain regions of female mice, including the bed nucleus and medial amygdala. EGFP-positive cell bodies in the bed nucleus, lateral septum, medial amygdala and hypothalamus co-expressed oestrogen receptor (ER) alpha and beta, or the androgen receptor (AR), although single-labelled EGFP-positive cells were also identified. Additionally, single-labelled ER alpha-, ER beta- or AR-positive cell bodies often appeared to be surrounded by EGFP-immunoreactive nerve fibres/terminals. The widespread distribution of EGFP-positive cell bodies and fibres suggests that aromatase signalling is common in the mouse brain, and that locally synthesised brain oestrogens could mediate biological effects by activating pre- and post-synaptic oestrogen alpha and beta receptors, and androgen receptors. The higher number of EGFP-positive cells in male mice may indicate that the autocrine and paracrine effects of oestrogens are more prominent in males than females.	[Stanic, Davor; Dubois, Sydney; Chua, Hui Kheng; Horne, Malcolm K.; Boon, Wah Chin] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Stanic, Davor; Horne, Malcolm K.; Boon, Wah Chin] Univ Melbourne, Dept Florey Neurosci, Parkville, Vic 3052, Australia; [Dubois, Sydney] Ecole Normale Super Lyon, Dept Biol, F-69364 Lyon, France; [Tonge, Bruce; Rinehart, Nicole] Monash Univ, Ctr Dev Psychiat & Psychol, Clayton, Vic, Australia; [Horne, Malcolm K.] St Vincents Hosp, Dept Neurol, Fitzroy, Vic 3065, Australia; [Boon, Wah Chin] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Ecole Normale Superieure de Lyon (ENS de LYON); Monash University; St Vincent's Hospital Melbourne; Monash University	Stanic, D (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.	davor.stanic@florey.edu.au	Tonge, Bruce J/T-8036-2018; Horne, Malcolm/AAL-5214-2020	Tonge, Bruce J/0000-0002-4236-9688; Horne, Malcolm/0000-0001-9427-2100; Stanic, Davor/0000-0002-4310-7030; Rinehart, Nicole/0000-0001-6109-3958	National Health and Medical Research Council of Australia [628553]; National Health and Medical Research Council of Australia, Australia Practitioner Fellowship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia, Australia Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the National Health and Medical Research Council of Australia, Project grant (ID: 628553). Victorian Government through the Operational Infrastructure Scheme. M.K.H. supported by a National Health and Medical Research Council of Australia, Australia Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgadir SE, 1997, BIOL REPROD, V57, P772, DOI 10.1095/biolreprod57.4.772; Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457, DOI 10.1177/40.10.1527370; Adlanmerini M, 2014, P NATL ACAD SCI USA, V111, pE283, DOI 10.1073/pnas.1322057111; Agarwal VR, 2000, MOL CELL ENDOCRINOL, V162, P9, DOI 10.1016/S0303-7207(00)00227-6; Apostolinas S, 1999, BRAIN RES, V817, P19, DOI 10.1016/S0006-8993(98)01180-9; Bakker J, 2006, NAT NEUROSCI, V9, P220, DOI 10.1038/nn1624; Bakker J, 2004, HORM BEHAV, V46, P1, DOI 10.1016/j.yhbeh.2004.02.003; BALTHAZART J, 1991, J NEUROBIOL, V22, P143, DOI 10.1002/neu.480220205; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Balthazart J, 2009, ANN NY ACAD SCI, V1163, P31, DOI 10.1111/j.1749-6632.2008.03637.x; Biegon A, 2010, SYNAPSE, V64, P801, DOI 10.1002/syn.20791; Boon WC, 2010, PROG BRAIN RES, V181, P209, DOI 10.1016/S0079-6123(08)81012-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burke MC, 2006, J COMP NEUROL, V498, P712, DOI 10.1002/cne.21086; Bye CR, 2012, EXP NEUROL IN PRESS; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Corbin CJ, 2009, BIOL REPROD, V81, P388, DOI 10.1095/biolreprod.109.076331; Danielii J.F., 1958, GENERAL CYTOCHEMICAL, P399; Finkelstein DI, 2000, NEUROSCIENCE, V97, P99, DOI 10.1016/S0306-4522(00)00009-9; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gotsiridze T, 2007, DEV NEUROBIOL, V67, P355, DOI 10.1002/dneu.20353; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hisasue S, 2010, J SEX MED, V7, P1401, DOI 10.1111/j.1743-6109.2009.01669.x; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Horvath TL, 1997, J STEROID BIOCHEM, V61, P349; Jacobs EC, 1999, DEV NEUROSCI-BASEL, V21, P453, DOI 10.1159/000017413; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kato J, 1997, J STEROID BIOCHEM, V61, P381; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lephart ED, 2001, BRAIN RES REV, V37, P25, DOI 10.1016/S0165-0173(01)00111-4; Lu SF, 1998, ENDOCRINOLOGY, V139, P1594, DOI 10.1210/en.139.4.1594; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Meitzen J, 2013, ENDOCRINOLOGY, V154, P4293, DOI 10.1210/en.2013-1172; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; Milner TA, 2010, BRAIN RES, V1351, P74, DOI 10.1016/j.brainres.2010.06.038; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; Mouriec K, 2009, BIOL REPROD, V80, P889, DOI 10.1095/biolreprod.108.073643; Naftolin F, 2001, EXP BIOL MED, V226, P717, DOI 10.1177/153537020222600802; Naftolin F, 1975, Recent Prog Horm Res, V31, P295; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P14737, DOI 10.1073/pnas.250473597; Pardo-Bellver C, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00033; Parish CL, 2005, NEUROBIOL DIS, V19, P301, DOI 10.1016/j.nbd.2005.01.009; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pease PC, 1962, ANAT REC, V142, P342; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pellegrini E, 2005, GEN COMP ENDOCR, V142, P60, DOI 10.1016/j.ygcen.2004.12.003; Perez SE, 2003, DEV BRAIN RES, V145, P117, DOI 10.1016/S0165-3806(03)00223-2; RESKO JA, 1993, J CLIN ENDOCR METAB, V76, P1588, DOI 10.1210/jc.76.6.1588; Resko JA, 2000, BIOL REPROD, V62, P1818, DOI 10.1095/biolreprod62.6.1818; Rissman EF, 1997, HORM BEHAV, V31, P232, DOI 10.1006/hbeh.1997.1390; Robertson KM, 2001, J ANDROL, V22, P825; Roselli CE, 2012, J NEUROENDOCRINOL, V24, P443, DOI 10.1111/j.1365-2826.2011.02260.x; ROSELLI CE, 1989, BIOL REPROD, V40, P929, DOI 10.1095/biolreprod40.5.929; Roselli CE, 2001, J STEROID BIOCHEM, V79, P247, DOI 10.1016/S0960-0760(01)00141-8; Roselli CE, 1998, BIOL REPROD, V58, P79, DOI 10.1095/biolreprod58.1.79; ROSELLI CE, 1985, ENDOCRINOLOGY, V117, P2471, DOI 10.1210/endo-117-6-2471; Roselli CE, 1997, BRAIN RES BULL, V44, P351, DOI 10.1016/S0361-9230(97)00214-1; Sakamoto H, 2003, ENDOCRINOLOGY, V144, P4466, DOI 10.1210/en.2003-0307; Saldanha CJ, 2005, GEN COMP ENDOCR, V141, P66, DOI 10.1016/j.ygcen.2004.11.013; Saldanha CJ, 2011, ENDOCR REV, V32, P532, DOI 10.1210/er.2011-0004; SANGHERA MK, 1991, ENDOCRINOLOGY, V129, P2834, DOI 10.1210/endo-129-6-2834; Schlinger BA, 2012, J NEUROENDOCRINOL, V24, P16, DOI 10.1111/j.1365-2826.2011.02150.x; SHIMOZAWA O, 1993, J BIOL CHEM, V268, P21399; Shughrue PJ, 2002, ENDOCRINOLOGY, V143, P1643, DOI 10.1210/en.143.5.1643; Stanic D, 2003, EUR J NEUROSCI, V18, P1175, DOI 10.1046/j.1460-9568.2003.02800.x; Stanic D, 2006, J COMP NEUROL, V499, P357, DOI 10.1002/cne.21046; Stanic D, 2011, J COMP NEUROL, V519, P1219, DOI 10.1002/cne.22608; Tsukahara S, 2011, NEUROENDOCRINOLOGY, V94, P137, DOI 10.1159/000327541; Wagner CK, 1996, J COMP NEUROL, V370, P71; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; YamadaMouri N, 1997, J STEROID BIOCHEM, V60, P325, DOI 10.1016/S0960-0760(96)00222-1; Zamboni I, 1967, J CELL BIOL, V35, p148A; Zhao CJ, 2007, J COMP NEUROL, V500, P557, DOI 10.1002/cne.21193	78	67	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e90451	10.1371/journal.pone.0090451	http://dx.doi.org/10.1371/journal.pone.0090451			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646567	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500015
J	Xu, LH; Zeng, XC; Nie, Y; Luo, XS; Zhou, EM; Zhou, LL; Pan, YF; Li, WJ				Xu, Linghua; Zeng, Xian-Chun; Nie, Yao; Luo, Xuesong; Zhou, Enmin; Zhou, Lingli; Pan, Yunfan; Li, Wenjun			Pontibacter diazotrophicus sp nov., a Novel Nitrogen-Fixing Bacterium of the Family Cytophagaceae	PLOS ONE			English	Article							BIOLOGICAL SOIL CRUSTS; EFFLUVIIBACTER-ROSEUS; COMMUNITY STRUCTURE; SOLAR SALTERN; DESERT SOIL; DIVERSITY; SEQUENCE; ACID	Few diazotrophs have been found to belong to the family Cytophagaceae so far. In the present study, a Gram-negative, rodshaped bacterium that forms red colonies, was isolated from sands of the Takalamakan desert. It was designated H4X(T). Phylogenetic and biochemical analysis indicated that the isolate is a new species of the genus Pontibacter. The 16S rRNA gene of H4X(T) displays 94.2-96.8% sequence similarities to those of other strains in Pontibacter. The major respiratory quinone is menaquinone-7 (MK-7). The DNA G+C content is 46.6 mol%. The major cellular fatty acids are iso-C-15:0, C-16:1 omega 5c, summed feature 3 (containing C-16:1 omega 6c and/or C-16:1 omega 7c) and summed feature 4 (comprising anteiso-C17:1B and/or iso-C17:1I). The major polar lipids are phosphatidylethanolamine (PE), one aminophospholipid (APL) and some unknown phospholipids (PLs). It is interesting to see that this bacterium can grow very well in a nitrogen-free medium. PCR amplification suggested that the bacterium possesses at least one type of nitrogenase gene. Acetylene reduction assay showed that H4X(T) actually possesses nitrogen-fixing activity. Therefore, it can be concluded that H4X(T) is a new diazotroph. We thus referred it to as Pontibacter diazotrophicus sp. nov. The type strain is H4X(T) (= CCTCC AB 2013049(T) = NRRL B-59974(T)).	[Xu, Linghua; Zeng, Xian-Chun; Nie, Yao; Zhou, Lingli; Pan, Yunfan] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China; [Xu, Linghua; Zeng, Xian-Chun; Nie, Yao; Zhou, Lingli; Pan, Yunfan] China Univ Geosci, Dept Biol Sci & Technol, Sch Environm Studies, Wuhan 430074, Peoples R China; [Xu, Linghua] Hubei Polytech Univ, Sch Chem & Mat Engn, Huangshi, Peoples R China; [Luo, Xuesong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Zhou, Enmin; Li, Wenjun] Yunnan Univ, Minist Educ, Key Lab Microbial Divers Southwest China, Kunming, Peoples R China; [Zhou, Enmin; Li, Wenjun] Yunnan Univ, Yunnan Inst Microbiol, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China	China University of Geosciences; China University of Geosciences; Hubei Polytechnic University; Huazhong Agricultural University; Yunnan University; Yunnan University	Zeng, XC (corresponding author), China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China.	xianchun.zeng@gmail.com; xuesongluo@mail.hzau.edu.cn		Zeng, Xian-Chun/0000-0003-2675-2596	National Natural Science Foundation of China [41272257, 41072181]; China Postdoctoral Science Foundation [20110491233]; Research Program for BGEG lab staff [GBL11208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Program for BGEG lab staff	This work was supported by the National Natural Science Foundation of China (Grant no. 41272257 and no. 41072181), the China Postdoctoral Science Foundation (Grant no. 20110491233) and Research Program for BGEG lab staff (Grant no. GBL11208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benata H, 2008, SYST APPL MICROBIOL, V31, P378, DOI 10.1016/j.syapm.2008.08.002; Chowdhury SP, 2007, MICROB ECOL, V54, P82, DOI 10.1007/s00248-006-9174-1; Dai J, 2012, GENET MOL RES, V11, P2683, DOI 10.4238/2012.June.25.5; Dastager SG, 2010, INT J SYST EVOL MICR, V60, P2867, DOI 10.1099/ijs.0.019935-0; DILWORTH MJ, 1966, BIOCHIM BIOPHYS ACTA, V127, P285, DOI 10.1016/0304-4165(66)90383-7; Dwivedi V, 2013, INT J SYST EVOL MICR, V63, P309, DOI 10.1099/ijs.0.040147-0; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020539; Gaby JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042149; Han SO, 1998, MICROB ECOL, V36, P193, DOI 10.1007/s002489900106; Joshi MN, 2012, J BACTERIOL, V194, P6329, DOI 10.1128/JB.01550-12; Joung Y, 2013, J MICROBIOL, V51, P531, DOI 10.1007/s12275-013-2324-5; Joung Y, 2011, J MICROBIOL, V49, P290, DOI 10.1007/s12275-011-0093-6; Kang JY, 2013, INT J SYST EVOL MICR, V63, P565, DOI 10.1099/ijs.0.039867-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; Lacap DC, 2011, EXTREMOPHILES, V15, P31, DOI 10.1007/s00792-010-0334-3; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Langlois RJ, 2005, APPL ENVIRON MICROB, V71, P7910, DOI 10.1128/AEM.71.12.7910-7919.2005; Ludwig W, 2007, INT J FOOD MICROBIOL, V120, P225, DOI 10.1016/j.ijfoodmicro.2007.06.023; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159, DOI 10.1099/00207713-39-2-159; MINNIKIN DE, 1984, J MICROBIOL METH, V2, P233, DOI 10.1016/0167-7012(84)90018-6; Nedashkovskaya OI, 2005, INT J SYST EVOL MICR, V55, P2583, DOI 10.1099/ijs.0.63819-0; Raichand R, 2011, ANTON LEEUW INT J G, V100, P129, DOI 10.1007/s10482-011-9573-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russow R, 2005, RAPID COMMUN MASS SP, V19, P3451, DOI 10.1002/rcm.2214; Singh AK, 2013, INT J SYST EVOL MICR, V63, P2829, DOI 10.1099/ijs.0.045948-0; Smibert Robert M., 1994, P607; Subhash Y, 2013, INT J SYST EVOL MICR, V63, P4524, DOI 10.1099/ijs.0.052183-0; Suresh K, 2006, INT J SYST EVOL MICR, V56, P1703, DOI 10.1099/ijs.0.64144-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang Y, 2010, INT J SYST EVOL MICR, V60, P99, DOI 10.1099/ijs.0.011395-0; Westermann J, 2008, J INTEGR PLANT BIOL, V50, P536, DOI 10.1111/j.1744-7909.2007.00626.x; Xu MB, 2012, INT J SYST EVOL MICR, V62, P665, DOI 10.1099/ijs.0.030122-0; Yeager CM, 2004, APPL ENVIRON MICROB, V70, P973, DOI 10.1128/AEM.70.2.973-983.2004; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; Zhang L, 2008, INT J SYST EVOL MICR, V58, P1210, DOI 10.1099/ijs.0.65667-0; Zhang L, 2013, INT J SYST EVOL MICR, V63, P4462, DOI 10.1099/ijs.0.053165-0; Zhou Y, 2007, INT J SYST EVOL MICR, V57, P321, DOI 10.1099/ijs.0.64716-0	39	50	53	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92294	10.1371/journal.pone.0092294	http://dx.doi.org/10.1371/journal.pone.0092294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647674	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500108
J	Kohl, S; Wolters, C; Gruendler, TOJ; Vogeley, K; Klosterkotter, J; Kuhn, J				Kohl, Sina; Wolters, Carolin; Gruendler, Theo O. J.; Vogeley, Kai; Klosterkoetter, Joachim; Kuhn, Jens			Prepulse Inhibition of the Acoustic Startle Reflex in High Functioning Autism	PLOS ONE			English	Article							NORMAL SEX-DIFFERENCES; SPECTRUM DISORDERS; ASPERGERS-SYNDROME; CHILDREN; ABNORMALITIES; ADULTS; QUOTIENT; HYPERSENSITIVITY; CHILDHOOD; ATTENTION	Background: High functioning autism is an autism spectrum disorder that is characterized by deficits in social interaction and communication as well as repetitive and restrictive behavior while intelligence and general cognitive functioning are preserved. According to the weak central coherence account, individuals with autism tend to process information detail-focused at the expense of global form. This processing bias might be reflected by deficits in sensorimotor gating, a mechanism that prevents overstimulation during the transformation of sensory input into motor action. Prepulse inhibition is an operational measure of sensorimotor gating, which indicates an extensive attenuation of the startle reflex that occurs when a startling pulse is preceded by a weaker stimulus, the prepulse. Methods: In the present study, prepulse inhibition of acoustic startle was compared between 17 adults with high functioning autism and 17 sex-, age-, and intelligence-matched controls by means of electromyography. Results: Results indicate that participants with high functioning autism exhibited significantly higher startle amplitudes than the control group. However, groups did not differ with regard to PPI or habituation of startle. Discussion: These findings challenge the results of two previous studies that reported prepulse inhibition deficits in high-functioning autism and suggest that sensorimotor gating is only impaired in certain subgroups with autism spectrum disorder.	[Kohl, Sina; Wolters, Carolin; Gruendler, Theo O. J.; Vogeley, Kai; Klosterkoetter, Joachim; Kuhn, Jens] Univ Hosp Cologne, Dept Psychiat & Psychotherapy, Cologne, North Rhine Wes, Germany; [Gruendler, Theo O. J.] Univ Magdeburg, Dept Econ, D-39106 Magdeburg, Saxony Anhalt, Germany; [Gruendler, Theo O. J.] Ctr Behav Brain Sci, Magdeburg, Saxony Anhalt, Germany; [Vogeley, Kai] Res Ctr Juelich, Inst Neurosci & Med Cognit Neurosci INM3, Julich, North Rhine Wes, Germany	University of Cologne; Otto von Guericke University; Helmholtz Association; Research Center Julich	Kuhn, J (corresponding author), Univ Hosp Cologne, Dept Psychiat & Psychotherapy, Cologne, North Rhine Wes, Germany.	jens.kuhn@uk-koeln.de	Gruendler, Theo OJ/H-4486-2012; Vogeley, Kai/E-4860-2012	Gruendler, Theo OJ/0000-0002-5631-7352; Kohl, Sina/0000-0002-2316-7706; Vogeley, Kai/0000-0002-5891-5831	Walter and Marga Boll Foundation; German Research Foundation [KFO-219]; Center for Behavioral Brain Sciences	Walter and Marga Boll Foundation; German Research Foundation(German Research Foundation (DFG)); Center for Behavioral Brain Sciences	The authors thank the Walter and Marga Boll Foundation, the German Research Foundation (KFO-219 grant), as well as the Center for Behavioral Brain Sciences for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara JI, 2004, J CHILD PSYCHOL PSYC, V45, P1107, DOI 10.1111/j.1469-7610.2004.t01-1-00303.x; APA, 2000, DIAGN STAT MAN MENT; Baranek GT, 2006, J CHILD PSYCHOL PSYC, V47, P591, DOI 10.1111/j.1469-7610.2005.01546.x; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2006, J AUTISM DEV DISORD, V36, P343, DOI 10.1007/s10803-006-0073-6; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Bruneau N, 1999, CLIN NEUROPHYSIOL, V110, P1927, DOI 10.1016/S1388-2457(99)00149-2; DePape AMR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044084; Filion DL, 1998, BIOL PSYCHOL, V47, P1, DOI 10.1016/S0301-0511(97)00020-3; Fournier KA, 2010, J AUTISM DEV DISORD, V40, P1227, DOI 10.1007/s10803-010-0981-3; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Gage NM, 2003, DEV BRAIN RES, V144, P201, DOI 10.1016/S0165-3806(03)00172-X; Gebhardt J, 2012, PSYCHOPHYSIOLOGY, V49, P484, DOI 10.1111/j.1469-8986.2011.01323.x; Gomes Erissandra, 2008, Pró-Fono R. Atual. Cient., V20, P279, DOI 10.1590/S0104-56872008000400013; Gowen E, 2013, J AUTISM DEV DISORD, V43, P323, DOI 10.1007/s10803-012-1574-0; GRAHAM FK, 1975, PSYCHOPHYSIOLOGY, V12, P238, DOI 10.1111/j.1469-8986.1975.tb01284.x; Groen WB, 2009, J AUTISM DEV DISORD, V39, P742, DOI 10.1007/s10803-008-0682-3; Guiraud JA, 2011, NEUROREPORT, V22, P845, DOI 10.1097/WNR.0b013e32834c0bec; Hautzinger M., 1995, BECK DEPRESSIONS INV; Hitoglou M, 2010, PEDIATR NEUROL, V42, P309, DOI 10.1016/j.pediatrneurol.2009.10.009; Kanner L, 1943, NERV CHILD, V2, P217; Kemner C, 2002, J CLIN PSYCHIAT, V63, P214; Kern JK, 2006, AUTISM, V10, P480, DOI 10.1177/1362361306066564; Kohl S, 2013, J PSYCHIATR RES, V47, P445, DOI 10.1016/j.jpsychires.2012.11.018; Leekam SR, 2007, J AUTISM DEV DISORD, V37, P894, DOI 10.1007/s10803-006-0218-7; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; Lepisto T, 2009, BIOL PSYCHOL, V82, P301, DOI 10.1016/j.biopsycho.2009.09.004; Marco EJ, 2011, PEDIATR RES, V69, p48R, DOI [10.1203/PDR.0b013e3182130c54, 10.1109/SPL.2011.5782616]; Matsuzaki J, 2012, NEUROREPORT, V23, P113, DOI 10.1097/WNR.0b013e32834ebf44; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; Miyahara M, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00016; O'Connor K, 2012, NEUROSCI BIOBEHAV R, V36, P836, DOI 10.1016/j.neubiorev.2011.11.008; Oranje B, 2013, PSYCHIAT RES, V206, P287, DOI 10.1016/j.psychres.2012.10.014; ORNITZ EM, 1993, J AUTISM DEV DISORD, V23, P619, DOI 10.1007/BF01046105; Ouimet T, 2012, ANN NY ACAD SCI, V1252, P325, DOI 10.1111/j.1749-6632.2012.06453.x; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Roberts TPL, 2010, AUTISM RES, V3, P8, DOI 10.1002/aur.111; Schmidt K- H, 1992, WORTSCHATZTEST VOCAB; Swerdlow NR, 2000, BEHAV PHARMACOL, V11, P185, DOI 10.1097/00008877-200006000-00002; Takarae Y, 2008, J INT NEUROPSYCH SOC, V14, P980, DOI 10.1017/S1355617708081277; Teder-Salejarvi WA, 2005, COGNITIVE BRAIN RES, V23, P221, DOI 10.1016/j.cogbrainres.2004.10.021; Tomchek SD, 2007, AM J OCCUP THER, V61, P190, DOI 10.5014/ajot.61.2.190; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yuhas J, 2011, J AUTISM DEV DISORD, V41, P248, DOI 10.1007/s10803-010-1040-9	49	42	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92372	10.1371/journal.pone.0092372	http://dx.doi.org/10.1371/journal.pone.0092372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD4ZE	24643088	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900128
J	Smith, AD; Paton, PWC; McWilliams, SR				Smith, Adam D.; Paton, Peter W. C.; McWilliams, Scott R.			Using Nocturnal Flight Calls to Assess the Fall Migration of Warblers and Sparrows along a Coastal Ecological Barrier	PLOS ONE			English	Article							BIRD MIGRATION; PASSERINE MIGRANTS; LANDBIRD MIGRANTS; MORNING FLIGHT; AUTUMN; WEATHER; RADAR; PATTERNS; BEHAVIOR; WIND	Atmospheric conditions fundamentally influence the timing, intensity, energetics, and geography of avian migration. While radar is typically used to infer the influence of weather on the magnitude and spatiotemporal patterns of nocturnal bird migration, monitoring the flight calls produced by many bird species during nocturnal migration represents an alternative methodology and provides information regarding the species composition of nocturnal migration. We used nocturnal flight call (NFC) recordings of at least 22 migratory songbirds (14 warbler and 8 sparrow species) during fall migration from eight sites along the mainland and island coasts of Rhode Island to evaluate five hypotheses regarding NFC detections. Patterns of warbler and sparrow NFC detections largely supported our expectations in that (1) NFC detections associated positively and strongly with wind conditions that influence the intensity of coastal bird migration and negatively with regional precipitation; (2) NFCs increased during conditions with reduced visibility (e. g., high cloud cover); (3) NFCs decreased with higher wind speeds, presumably due mostly to increased ambient noise; and (4) coastal mainland sites recorded five to nine times more NFCs, on average, than coastal nearshore or offshore island sites. However, we found little evidence that (5) nightly or intra-night patterns of NFCs reflected the well-documented latitudinal patterns of migrant abundance on an offshore island. Despite some potential complications in inferring migration intensity and species composition from NFC data, the acoustic monitoring of NFCs provides a viable and complementary methodology for exploring the spatiotemporal patterns of songbird migration as well as evaluating the atmospheric conditions that shape these patterns.	[Smith, Adam D.; Paton, Peter W. C.; McWilliams, Scott R.] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA	University of Rhode Island	Smith, AD (corresponding author), Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA.	adamsmith@my.uri.edu	McWilliams, Scott R/B-8728-2013	McWilliams, Scott R/0000-0002-9727-1151	Rhode Island National Wildlife Refuge Complex [50181-9-J111]; State of Rhode Island for the Ocean Special Area Management Plan; Rhode Island Agricultural Experiment Station [5358]; Nature Conservancy grant	Rhode Island National Wildlife Refuge Complex; State of Rhode Island for the Ocean Special Area Management Plan; Rhode Island Agricultural Experiment Station; Nature Conservancy grant	This work was funded largely via Cooperative Agreement (50181-9-J111) with the Rhode Island National Wildlife Refuge Complex. Additional funding was provided by the State of Rhode Island for the Ocean Special Area Management Plan to SRM and PWCP, Rhode Island Agricultural Experiment Station to SRM (Contribution No. 5358), and a Nature Conservancy grant to ADS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLE KP, 1973, ECOLOGY, V54, P1031, DOI 10.2307/1935569; ABLE KP, 1977, AUK, V94, P320; ABLE KP, 1970, BIRD BANDING, V41, P282, DOI 10.2307/4511688; Akesson S, 1996, BEHAV ECOL SOCIOBIOL, V38, P293, DOI 10.1007/s002650050245; Akesson S, 1999, ARDEA, V87, P129; AKESSON S, 1993, ORNIS SCAND, V24, P87, DOI 10.2307/3676357; ALERSTAM T, 1978, OIKOS, V30, P405, DOI 10.2307/3543491; Alerstam T, 1990, BIRD MIGRATION; Baird J., 1959, Bird-Banding, V30, P143; BAIRD JAMES, 1960, AUK, V77, P119; BINGMAN VP, 1980, AUK, V97, P465; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Bolser JA, 2013, WILSON J ORNITHOL, V125, P97, DOI 10.1676/12-057.1; Bruderer B, 1998, J AVIAN BIOL, V29, P499, DOI 10.2307/3677169; Diehl RH, 2003, AUK, V120, P278, DOI 10.1642/0004-8038(2003)120[0278:ROOBMO]2.0.CO;2; Dokter AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052300; Drury W. H., 1962, Ibis, V104, P449, DOI 10.1111/j.1474-919X.1962.tb08681.x; Drury W. H. Jr., 1964, Bird-Banding, V35, P69; DUNN EH, 1980, J FIELD ORNITHOL, V51, P254; Erni B, 2002, ARDEA, V90, P155; Evans W. R, 2002, FLIGHT CALLS MIGRATO; Evans William R., 2000, U S Forest Service Rocky Mountain Research Station Proceedings RMRS-P, V16, P151; EVANS WR, 1994, WILSON BULL, V106, P55; Evans WR, 1999, STUD AVIAN BIOL-SER, P219; Farnsworth A, 2005, AUK, V122, P733, DOI 10.1642/0004-8038(2005)122[0733:FCATVF]2.0.CO;2; Farnsworth A, 2004, J AVIAN BIOL, V35, P365, DOI 10.1111/j.0908-8857.2004.03180.x; Farnsworth A, 2007, J FIELD ORNITHOL, V78, P279, DOI 10.1111/j.1557-9263.2007.00115.x; Fitzgerald TM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1499, DOI 10.1007/s00265-008-0579-3; Fortin D, 1999, IBIS, V141, P480, DOI 10.1111/j.1474-919X.1999.tb04417.x; Gagnon F, 2011, AUK, V128, P99, DOI 10.1525/auk.2011.09161; Gagnon F, 2011, CAN J ZOOL, V89, P31, DOI 10.1139/Z10-092; Gagnon F, 2010, AUK, V127, P119, DOI 10.1525/auk.2009.09080; Gauthreaux SA, 2005, BIRDS 2 WORLDS ECOLO, P488; Gauthreaux Sidney A. Jr., 2006, P67; Geo-Marine Inc, 2010, OC WIND POW EC UNPUB, VII; GRABER RR, 1968, WILSON BULL, V80, P36; HALL G A, 1981, American Birds, V35, P135; Harrell FE, 2001, REGRESSION MODELING; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Huppop O, 2006, IBIS, V148, P90, DOI 10.1111/j.1474-919X.2006.00536.x; Huppop O, 2012, J AVIAN BIOL, V43, P85, DOI 10.1111/j.1600-048X.2011.05443.x; Karlsson H, 2011, IBIS, V153, P485, DOI 10.1111/j.1474-919X.2011.01130.x; Kelly JF, 2002, AUK, V119, P210, DOI 10.1642/0004-8038(2002)119[0210:DDMGBW]2.0.CO;2; Kemp MU, 2012, J THEOR BIOL, V308, P56, DOI 10.1016/j.jtbi.2012.05.026; Kerlinger P., 1989, Current Ornithology, V6, P109; La VT, 2012, CONDOR, V114, P245, DOI 10.1525/cond.2012.100193; Larkin RP, 2002, J FIELD ORNITHOL, V73, P2, DOI 10.1648/0273-8570-73.1.2; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; Mizrahi D, 2010, OCEAN SPECIAL AREA M, V2; MOORE FR, 1991, BEHAV ECOL SOCIOBIOL, V28, P85; Morris SR, 1996, CONDOR, V98, P395, DOI 10.2307/1369157; Parrish JD, 1997, CONDOR, V99, P681, DOI 10.2307/1370480; Peckford ML, 2008, J FIELD ORNITHOL, V79, P207, DOI 10.1111/j.1557-9263.2008.00165.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RALPH CJ, 1981, WILSON BULL, V93, P164; RALPH CJ, 1978, BIRD BANDING, V49, P237, DOI 10.2307/4512365; Reinert S.E., 2002, ECOLOGY BLOCK ISLAND, P151; Richardson W.J., 1990, P78; RICHARDSON W J, 1972, American Birds, V26, P10; RICHARDSON WJ, 1978, OIKOS, V30, P224, DOI 10.2307/3543482; RICHARDSON WJ, 1978, AUK, V95, P717; Rimmer Christopher C., 2004, Studies in Avian Biology, P123; Ruxton GD, 2010, METHODS ECOL EVOL, V1, P114, DOI 10.1111/j.2041-210X.2010.00014.x; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schweppenburg G. v. H. F., 1963, Journal fuer Ornithologie, V104, P191; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Smith AD, 2014, OECOLOGIA, V174, P931, DOI 10.1007/s00442-013-2834-1; Smith SB, 2007, WILSON J ORNITHOL, V119, P419, DOI 10.1676/06-073.1; Smith SB, 2010, AUK, V127, P108, DOI 10.1525/auk.2009.09139; WIEDNER DS, 1992, AUK, V109, P500; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	72	11	15	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92218	10.1371/journal.pone.0092218	http://dx.doi.org/10.1371/journal.pone.0092218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643060	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900106
J	Awan, TH; Chauhan, BS; Cruz, PCS				Awan, Tahir Hussain; Chauhan, Bhagirath Singh; Cruz, Pompe C. Sta.			Influence of Environmental Factors on the Germination of Urena lobata L. and Its Response to Herbicides	PLOS ONE			English	Article							SEED-GERMINATION; SUBTERRANEAN CLOVER; SIERRA-LEONE; HARD SEEDS; EMERGENCE; ECOLOGY; DORMANCY; SOIL; WEEDS; RICE	Urena lobata is becoming a noxious and invasive weed in rangelands, pastures, and undisturbed areas in the Philippines. This study determined the effects of seed scarification, light, salt and water stress, amount of rice residue, and seed burial depth on seed germination and emergence of U. lobata; and evaluated the weed's response to post-emergence herbicides. Germination was stimulated by both mechanical and chemical seed scarifications. The combination of the two scarification methods provided maximum (99%) seed germination. Germination was slightly stimulated when seeds were placed in light (65%) compared with when seeds were kept in the dark (46%). Sodium chloride concentrations ranging from 0 to 200 mM and osmotic potential ranging from 0 to -1.6 MPa affected the germination of U. lobata seeds significantly. The osmotic potential required for 50% inhibition of the maximum germination was -0.1 MPa; however, some seeds germinated at -0.8 MPa, but none germinated at -1.6 MPa. Seedling emergence and biomass increased with increase in rice residue amount up to 4 t ha(-1), but declined beyond this amount. Soil surface placement of weed seeds resulted in the highest seedling emergence (84%), which declined with increase in burial depth. The burial depth required for 50% inhibition of maximum emergence was 2 cm; emergence was greatly reduced (93%) at burial depth of 4 cm or more. Weed seedling biomass also decreased with increase in burial depth. Bispyribac-sodium, a commonly used herbicide in rice, sprayed at the 4-leaf stage of the weed, provided 100% control, which did not differ much with 2,4-D (98%), glyphosate (97%), and thiobencarb + 2,4-D (98%). These herbicides reduced shoot and root biomass by 99-100%.	[Awan, Tahir Hussain; Chauhan, Bhagirath Singh] Int Rice Res Inst, Weed Sci Crop & Environm Sci Div, Los Banos, Laguna, Philippines; [Cruz, Pompe C. Sta.] Univ Philippines Los Banos, Coll Agr, Crop Sci Cluster, Los Banos, Laguna, Philippines	CGIAR; International Rice Research Institute (IRRI); University of the Philippines System; University of the Philippines Los Banos	Awan, TH (corresponding author), Int Rice Res Inst, Weed Sci Crop & Environm Sci Div, Los Banos, Laguna, Philippines.	t.awan@irri.org	Chauhan, Bhagirath/G-8892-2014	Chauhan, Bhagirath/0000-0003-1540-4668				AULD TD, 1991, AUST J ECOL, V16, P53, DOI 10.1111/j.1442-9993.1991.tb01481.x; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Benvenuti S, 2003, AGRON J, V95, P191, DOI 10.2134/agronj2003.0191; Benvenuti S, 1998, WEED RES, V38, P199, DOI 10.1046/j.1365-3180.1998.00086.x; BENVENUTI S, 1995, WEED RES, V35, P343, DOI 10.1111/j.1365-3180.1995.tb01629.x; Bolfrey-Arku GEK, 2011, WEED SCI, V59, P182, DOI 10.1614/WS-D-10-00095.1; BRADFORD KJ, 1990, PLANT PHYSIOL, V94, P840, DOI 10.1104/pp.94.2.840; Carter Ed, 1989, P 5 AUSTR AGR C 24 2, P437; Chauhan BS, 2008, WEED SCI, V56, P722, DOI 10.1614/WS-08-049.1; Chauhan BS, 2008, WEED SCI, V56, P567, DOI 10.1614/WS-07.200.1; Chauhan BS, 2008, WEED SCI, V56, P383, DOI 10.1614/WS-07-154.1; Chauhan BS, 2010, ADV AGRON, V105, P221, DOI 10.1016/S0065-2113(10)05006-6; Chauhan BS, 2009, WEED SCI, V57, P379, DOI 10.1614/WS-08-179.1; Chauhan BS, 2012, WEED SCI, V60, P199, DOI 10.1614/WS-D-11-00137.1; Crocker W, 1907, BOT GAZ, V44, P0375, DOI 10.1086/329379; Culpepper AS, 2001, WEED TECHNOL, V15, P56, DOI 10.1614/0890-037X(2001)015[0056:MISALC]2.0.CO;2; Dasgupta DK, 1973, SOLS AFR, V18, P33; Dempsey JM, 1975, FIBER CROPS, P382; EVANS CE, 1990, NEW PHYTOL, V115, P539, DOI 10.1111/j.1469-8137.1990.tb00482.x; FAIRBROTHER TE, 1991, SEED SCI TECHNOL, V19, P93; FLERPC, 2008, WILDLAND WEEDS, V10, P13; Foley ME, 2001, WEED SCI, V49, P305, DOI 10.1614/0043-1745(2001)049[0305:SDAUOT]2.0.CO;2; Forest Research Institute of Malaysia, 2003, PLANT INF UR LOB GRI; Francis JK, 2003, URENA LOBATA; Ghorbani R, 1999, WEED SCI, V47, P505, DOI 10.1017/S0043174500092183; HAGON M W, 1971, Australian Journal of Experimental Agriculture and Animal Husbandry, V11, P440, DOI 10.1071/EA9710440; HARRIS PJC, 1986, TROP AGR, V63, P30; HARRIS PJC, 1985, TROP AGR, V62, P229; HARRIS PJC, 1981, TROP AGR, V58, P205; Horn Claud L., 1942, JOUR AMER SOC AGRON, V34, P1137; Kirby RH, 1963, VEGETABLE FIBRES, P135; Lafitte H.R., 2006, ORYZA, V43, P171; Liu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069364; MACDONALD GE, 1992, WEED SCI, V40, P424, DOI 10.1017/S0043174500051857; MANN RK, 1981, WEED SCI, V29, P83, DOI 10.1017/S0043174500025881; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Moody K, 1989, WEEDS REPORTE RICE S; Pearson TRH, 2002, ECOLOGY, V83, P2798, DOI 10.1890/0012-9658(2002)083[2798:GEONPI]2.0.CO;2; PEART MH, 1984, J ECOL, V72, P437, DOI 10.2307/2260057; Sanchez PA, 1976, PROPERTIES MANAGEMEN, P413; SCOTT KA, 2006, P 15 AUSTR WEEDS C A, P268; SMITH CA, 1992, WEED RES, V32, P103, DOI 10.1111/j.1365-3180.1992.tb01867.x; Squella F, 1993, P 17 INT GRASSL C PA, V1, p[419, 437]; Tanji K. K., 2002, 61 FAO; TAYLOR GB, 1985, AUST J EXP AGR, V25, P568, DOI 10.1071/EA9850568; TAYLOR GB, 1988, AUST J EXP AGR, V28, P77, DOI 10.1071/EA9880077; Taylor GB, 1982, ANN REPORT; Thomas WE, 2006, WEED SCI, V54, P316; THOMPSON K, 1994, FUNCT ECOL, V8, P29, DOI 10.2307/2390108; Tieu A, 2001, ANN BOT-LONDON, V88, P259, DOI 10.1006/anbo.2001.1451; Wing JJ, 2009, WEED SCI, V57, P31, DOI 10.1614/WS-08-092.1; WOOLLEY JT, 1978, PLANT PHYSIOL, V61, P597, DOI 10.1104/pp.61.4.597	52	20	21	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90305	10.1371/journal.pone.0090305	http://dx.doi.org/10.1371/journal.pone.0090305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658143	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300014
J	Gonzalez-Orozco, CE; Ebach, MC; Laffan, S; Thornhill, AH; Knerr, NJ; Schmidt-Lebuhn, AN; Cargill, CC; Clements, M; Nagalingum, NS; Mishler, BD; Miller, JT				Gonzalez-Orozco, Carlos E.; Ebach, Malte C.; Laffan, Shawn; Thornhill, Andrew H.; Knerr, Nunzio J.; Schmidt-Lebuhn, Alexander N.; Cargill, Christine C.; Clements, Mark; Nagalingum, Nathalie S.; Mishler, Brent D.; Miller, Joseph T.			Quantifying Phytogeographical Regions of Australia Using Geospatial Turnover in Species Composition	PLOS ONE			English	Article							BIOGEOGRAPHICAL REGIONS; SPATIAL TURNOVER; BETA DIVERSITY; RICHNESS; CLIMATE; DISTRIBUTIONS; COMMUNITIES; EVOLUTION; FRAMEWORK; ENDEMISM	The largest digitized dataset of land plant distributions in Australia assembled to date (750,741 georeferenced herbarium records; 6,043 species) was used to partition the Australian continent into phytogeographical regions. We used a set of six widely distributed vascular plant groups and three non-vascular plant groups which together occur in a variety of landscapes/habitats across Australia. Phytogeographical regions were identified using quantitative analyses of species turnover, the rate of change in species composition between sites, calculated as Simpson's beta. We propose six major phytogeographical regions for Australia: Northern, Northern Desert, Eremaean, Eastern Queensland, Euronotian and South-Western. Our new phytogeographical regions show a spatial agreement of 65% with respect to previously defined phytogeographical regions of Australia. We also confirm that these new regions are in general agreement with the biomes of Australia and other contemporary biogeographical classifications. To assess the meaningfulness of the proposed phytogeographical regions, we evaluated how they relate to broad scale environmental gradients. Physiographic factors such as geology do not have a strong correspondence with our proposed regions. Instead, we identified climate as the main environmental driver. The use of an unprecedentedly large dataset of multiple plant groups, coupled with an explicit quantitative analysis, makes this study novel and allows an improved historical bioregionalization scheme for Australian plants. Our analyses show that: (1) there is considerable overlap between our results and older biogeographic classifications; (2) phytogeographical regions based on species turnover can be a powerful tool to further partition the landscape into meaningful units; (3) further studies using phylogenetic turnover metrics are needed to test the taxonomic areas.	[Gonzalez-Orozco, Carlos E.; Thornhill, Andrew H.; Knerr, Nunzio J.; Schmidt-Lebuhn, Alexander N.; Cargill, Christine C.; Clements, Mark; Miller, Joseph T.] Commonwealth Sci & Ind Res Org, Ctr Australian Natl Biodivers Res, Canberra, ACT, Australia; [Ebach, Malte C.; Laffan, Shawn] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Nagalingum, Nathalie S.] Natl Herbarium New South Wales, Bot Gardens Trust, Sydney, NSW, Australia; [Mishler, Brent D.] Univ Calif Berkeley, Dept Integrat Biol, Univ & Jepson Herbaria, Berkeley, CA 94720 USA; [Thornhill, Andrew H.] James Cook Univ, Australian Trop Herbarium, Cairns, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of New South Wales Sydney; University of California System; University of California Berkeley; James Cook University	Gonzalez-Orozco, CE (corresponding author), Commonwealth Sci & Ind Res Org, Ctr Australian Natl Biodivers Res, Canberra, ACT, Australia.	carlos.gonzalez-orozco@canberra.edu.au	Miller, Joseph T./M-2693-2016; Cargill, Christine/Z-2856-2019; Knerr, Nunzio/AAW-1449-2021; Schmidt-Lebuhn, Alexander N/C-2482-2009; Thornhill, Andrew/I-3363-2012; Laffan, Shawn W/A-3761-2008; Yeates, David K/A-9917-2008; Ebach, Malte/D-8274-2016	Miller, Joseph T./0000-0002-5788-9010; Cargill, Christine/0000-0001-8390-3245; Knerr, Nunzio/0000-0002-0562-9479; Schmidt-Lebuhn, Alexander N/0000-0002-7402-8941; Thornhill, Andrew/0000-0002-0325-5725; Laffan, Shawn W/0000-0002-5996-0570; Yeates, David K/0000-0001-7729-6143; Ebach, Malte/0000-0002-9594-9010	Australian Research Council [FT0992002]; University of New South Wales, Australia [RG114989, RG124461]; CSIRO (Australia); Cancer Research UK; EPSRC Cancer Imaging Centre; MRC; Department of Health (England) [C1060/A10334]; NHS; Chang Gung Medical Foundation (Taiwan) [CMRPG370443, CMRPG3B1922]	Australian Research Council(Australian Research Council); University of New South Wales, Australia; CSIRO (Australia)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Cancer Research UK(Cancer Research UK); EPSRC Cancer Imaging Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); NHS; Chang Gung Medical Foundation (Taiwan)	MCE's contribution was supported under Australian Research Council's 'Future Fellow' funding scheme (project number FT0992002). MCE and SWL also wish to thank the University of New South Wales, Australia for two Goldstar Grants (RG114989 & RG124461). The authors would like to thank Bernd Gruber for supporting the spatial overlap analyses. BDM thanks CSIRO (Australia) for a Distinguished Visiting Scientist Award. The authors acknowledge the support received from the Cancer Research UK and EPSRC Cancer Imaging Centre in association with the MRC and Department of Health (England) grant C1060/A10334, also NHS funding to the NIHR Biomedical Research Centre, MRC-funded studentship, also Chang Gung Medical Foundation (Taiwan) grants CMRPG370443 and CMRPG3B1922. MOL is an NIHR Senior Investigator. The authors thank Alice Warley at the Kings College London Centre for Ultrastructural Imaging (CUI) for assistance with electron microscopy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	BARLOW B A, 1984, Brunonia, V7, P195, DOI 10.1071/BRU9840195; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; BEADLE NCW, 1962, ECOLOGY, V43, P281, DOI 10.2307/1931983; Beard J.S., 1981, ECOLOGICAL BIOGEOGRA, P335; Brooker MIH, 2006, EUCLID EUC SO AUSTR; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; BURBRIDGE NANCY T., 1960, AUSTRALIAN JOUR BOT, V8, P75, DOI 10.1071/BT9600075; CHAH, 2010, AUSTR PLANT CENS; CHAH [Council of Heads of Australasian Herbaria], 2020, AUSTR PLANT CENSUS; Clarke GL, 1980, GEOLOGY, V4, P1; Conran JG, 1995, J BIOGEOGR, V22, P1023, DOI 10.2307/2845832; CRACRAFT J, 1991, Australian Systematic Botany, V4, P211, DOI 10.1071/SB9910211; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Crisp MD, 1995, SYST BIOL, V44, P457, DOI 10.2307/2413654; Dapporto L, 2013, ECOGRAPHY, V36, P1070, DOI 10.1111/j.1600-0587.2013.00444.x; DOING H., 1970, Miscellaneous Papers. Landbouwhogeschool Wageningen, No. 6, P81; DWER, 2007, AUSTR NAT VEG SUMM A; Ebach MC, 2012, ZOOTAXA, P1; Ebach MC, 2013, ZOOTAXA, V3619, P315, DOI 10.11646/zootaxa.3619.3.4; *ESRI, 2005, ARCGIS 9 2; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Garcillan PP, 2003, J VEG SCI, V14, P475, DOI 10.1111/j.1654-1103.2003.tb02174.x; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Gonzalez-Orozco CE, 2014, DIVERS DISTRIB, V20, P46, DOI 10.1111/ddi.12129; Gonzalez-Orozco CE, 2013, J BIOGEOGR, V40, P2156, DOI 10.1111/jbi.12153; Gonzalez-Orozco CE, 2011, AUST J BOT, V59, P600, DOI 10.1071/BT11112; Hedley C., 1894, REPORTS AUSTR ASS AD, V5, P444, DOI DOI 10.1080/00222939408677821; HNATIUK RJ, 1988, AUST J BOT, V36, P361, DOI 10.1071/BT9880361c; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Houlder D. J., 2000, ANUCLIM USERS GUIDE; Hutchinson MF, 2000, BIOCLIM USERS GUIDE; Integrated Marine and Coastal Regionalisation of Australia, 2006, IMCRA VERS 4 0; Interim Biogeographic Regionalisation for Australia, 1995, IBRA VERS 6 1; Johnston RM, 2003, AUST J SOIL RES, V41, P1021, DOI 10.1071/SR02033; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Kulheim C, 2011, NEW PHYTOL, V191, P1041, DOI 10.1111/j.1469-8137.2011.03769.x; Ladiges PY, 2005, J BIOGEOGR, V32, P1909, DOI 10.1111/j.1365-2699.2005.01347.x; Ladiges PY, 1991, AUSTRAL BIOGEOGRAPHY; Laffan SW, 2010, ECOGRAPHY, V33, P643, DOI 10.1111/j.1600-0587.2010.06237.x; Laffan SW, 2002, INT J GEOGR INF SCI, V16, P245, DOI 10.1080/13658810110099107; Linder HP, 2012, J BIOGEOGR, V39, P1189, DOI 10.1111/j.1365-2699.2012.02728.x; Mackey BG, 2008, J BIOGEOGR, V35, P213, DOI 10.1111/j.1365-2699.2007.01822.x; MOORE CWE, 1959, ECOLOGY, V40, P734, DOI 10.2307/1929834; Nicholls G. E., 1933, Report Australian and New Zealand Association for the Advancement of Science, V21, P93; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Parenti L. R., 2009, COMP BIOGEOGRAPHY DI; Pepper M, 2013, J BIOGEOGR, V40, P1225, DOI 10.1111/jbi.12080; R Development Core Team, 2005, R LANG ENV STAT COMP; Rosauer DF, 2014, ECOGRAPHY, V37, P21, DOI 10.1111/j.1600-0587.2013.00466.x; Stern H, 1985, OBJECTIVE CLASSIFICA; Stevenson LA, 2012, J BRYOL, V34, P101, DOI 10.1179/1743282012Y.0000000004; Tate R, 1889, 1 M AUSTR ASS ADV SC, P312; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Udvardy M.D.F, 1975, 18 IUCN; von Mueller F, 1858, ESQ PRECEDING ROYAL, V2, P137; Wulff EV, 1950, INTRO HIST PLANT GEO, P223; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	57	71	78	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92558	10.1371/journal.pone.0092558	http://dx.doi.org/10.1371/journal.pone.0092558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658356	Green Accepted, Green Published, gold			2022-12-27	WOS:000333355300097
J	Ren, T; Liu, Y; Zhao, XW; Ni, SB; Zhang, C; Guo, CG; Ren, MH				Ren, Tong; Liu, Yan; Zhao, Xiaowen; Ni, Shaobin; Zhang, Cheng; Guo, Changgang; Ren, Minghua			Transperitoneal Approach versus Retroperitoneal Approach: A Meta-Analysis of Laparoscopic Partial Nephrectomy for Renal Cell Carcinoma	PLOS ONE			English	Article							RADICAL NEPHRECTOMY	Objective: To compare the efficiency and safety of the transperitoneal approaches with retroperitoneal approaches in laparoscopic partial nephrectomy for renal cell carcinoma and provide evidence-based medicine support for clinical treatment. Methods: A systematic computer search of PUBMED, EMBASE, and the Cochrane Library was executed to identify retrospective observational and prospective randomized controlled trials studies that compared the outcomes of the two approaches in laparoscopic partial nephrectomy. Two reviewers independently screened, extracted, and evaluated the included studies and executed statistical analysis by using software STATA 12.0. Outcomes of interest included perioperative and postoperative variables, surgical complications and oncological variables. Results: There were 8 studies assessed transperitoneal laparoscopic partial nephrectomy (TLPN) versus retroperitoneal laparoscopic partial nephrectomy (RLPN) were included. RLPN had a shorter operating time (SMD = 1.001,95% confidence interval[CI] 0.609-1.393, P<0.001), a lower estimated blood loss (SMD = 0.403,95% CI 0.015-0.791, P = 0.042) and a shorter length of hospital stay (WMD = 0.936 DAYS, 95% CI 0.609-1.263, P<0.001) than TLPN. There were no significant differences between the transperitoneal and retroperitoneal approaches in other outcomes of interest. Conclusions: This meta-analysis indicates that, in appropriately selected patients, especially patients with intraperitoneal procedures history or posteriorly located renal tumors, the RLPN can shorten the operation time, reduce the estimated blood loss and shorten the length of hospital stay. RLPN may be equally safe and be faster compared with the TLPN.	[Ren, Tong; Ni, Shaobin; Zhang, Cheng; Guo, Changgang; Ren, Minghua] Harbin Med Univ, Affiliated Hosp 1, Dept Urinary Surg, Harbin, Heilongjiang Pr, Peoples R China; [Liu, Yan] Harbin Med Univ, Sch Publ Hlth, Dept Biostat, Harbin, Peoples R China; [Zhao, Xiaowen] Harbin Med Univ, Sch Publ Hlth, Dept Hlth Econ, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Ren, MH (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Urinary Surg, Harbin, Heilongjiang Pr, Peoples R China.	renminghua1972@163.com						Allan JDD, 2001, EUR UROL, V40, P17, DOI 10.1159/000049744; Burgess NA, 2007, J ENDOUROL, V21, P610, DOI 10.1089/end.2006.0277; Clarke M, 2001, LANCET, V357, P1728, DOI 10.1016/S0140-6736(00)04934-5; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunn MD, 2000, J UROLOGY, V164, P1153, DOI 10.1016/S0022-5347(05)67131-5; Emara AM, 2011, J ENDOUROL, V25, pA283; GILL IS, 1994, J UROLOGY, V152, P1539, DOI 10.1016/S0022-5347(17)32465-5; Hughes-Hallett A, 2013, J ENDOUROL, V27, P869, DOI 10.1089/end.2013.0023; Kane CJ, 2008, CANCER, V113, P78, DOI 10.1002/cncr.23518; Kieran K, 2007, J ENDOUROL, V21, P754, DOI 10.1089/end.2007.0337; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Luo JH, 2010, WORLD J UROL, V28, P289, DOI 10.1007/s00345-009-0487-9; Marszalek M, 2011, UROLOGY, V77, P109, DOI 10.1016/j.urology.2010.02.057; Mathew A, 2002, EUR J CANCER PREV, V11, P171, DOI 10.1097/00008469-200204000-00010; McAllister M, 2004, J UROLOGY, V172, P183, DOI 10.1097/01.ju.0000132143.33340.51; Ng CS, 2005, J UROLOGY, V174, P846, DOI 10.1097/01.ju.0000169259.49754.02; Ouzaid I, 2012, ADV UROL, V2012, DOI 10.1155/2012/473457; Pattaras JG, 2002, UROLOGY, V59, P37, DOI 10.1016/S0090-4295(01)01474-1; Permpongkosol S, 2005, J UROLOGY, V174, P1222, DOI 10.1097/01.ju.0000173917.37265.41; Portis AJ, 2002, J UROLOGY, V167, P1257, DOI 10.1016/S0022-5347(05)65277-9; Portis AJ, 2001, J ENDOUROL, V15, P345, DOI 10.1089/089277901300189330; Saika T, 2003, UROLOGY, V62, P1018, DOI 10.1016/j.urology.2003.07.009; Shekarriz B, 2004, J UROLOGY, V172, P54, DOI 10.1097/01.ju.0000132125.78189.93; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tugcu Volkan, 2011, Arch Ital Urol Androl, V83, P175; Uzzo RG, 2001, J UROLOGY, V166, P6, DOI 10.1016/S0022-5347(05)66066-1; WINFIELD HN, 1993, J ENDOUROL, V7, P521, DOI 10.1089/end.1993.7.521; Wright JL, 2005, J UROLOGY, V174, P841, DOI 10.1097/01.ju.0000169423.94253.46	29	33	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91978	10.1371/journal.pone.0091978	http://dx.doi.org/10.1371/journal.pone.0091978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658032	gold, Green Published, Green Submitted			2022-12-27	WOS:000333355300048
J	Wang, Y; Kou, Y; Wang, XD; Cederbaum, A; Wang, R				Wang, Yuan; Kou, Yan; Wang, Xiaodong; Cederbaum, Arthur; Wang, Rong			Multifactorial Comparative Proteomic Study of Cytochrome P450 2E1 Function in Chronic Alcohol Administration	PLOS ONE			English	Article							INDUCED LIVER-INJURY; GLUTATHIONE-S-TRANSFERASES; OXIDATIVE STRESS; FATTY LIVER; MITOCHONDRIAL PROTEOME; T-LYMPHOCYTES; RAT-LIVER; ETHANOL; EXPRESSION; DISEASE	With the use of iTRAQ technique, a multifactorial comparative proteomic study can be performed. In this study, to obtain an overview of ethanol, CYP2E1 and gender effects on liver injury and gain more insight into the underlying molecular mechanism, mouse liver proteomes were quantitatively analyzed using iTRAQ under eight conditions including mice of different genders, wild type versus CYP2E1 knockout, and normal versus alcohol diet. A series of statistical and bioinformatic analyses were explored to simplify and clarify multifactorial comparative proteomic data. First, with the Principle Component analysis, six proteins, CYP2E1, FAM25, CA3, BHMT, HIBADH and ECHS1, involved in oxidation reduction, energy and lipid metabolism and amino acid metabolism, were identified as the most differentially expressed gene products across all of the experimental conditions of our chronic alcoholism model. Second, hierarchical clustering analysis showed CYP2E1 knockout played a primary role in the overall differential protein expression compared with ethanol and gender factors. Furthermore, pair-wise multiple comparisons have revealed that the only significant expression difference lied in wild-type and CYP2E1 knockout mice both treated with ethanol. Third, K-mean clustering analysis indicated that the CYP2E1 knockout had the reverse effect on ethanol induced oxidative stress and lipid oxidation. More importantly, IPA analysis of proteomic data inferred that the gene expressions of two upstream regulators, NRF2 and PPAR alpha, regulated by chronic alcohol feeding and CYP2E1 knockout, are involved in ethanol induced oxidative stress and lipid oxidation. The present study provides an effectively comprehensive data analysis strategy to compare multiple biological factors, contributing to biochemical effects of alcohol on the liver. The mass spectrometry proteomics data have been deposited to the ProteomeXchange with data set identifier of PXD000635.	[Wang, Yuan; Wang, Rong] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kou, Yan; Wang, Xiaodong; Cederbaum, Arthur] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Wang, R (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	rong.wang@mssm.edu	Wang, Rong/A-8721-2009		USPHS NIH [R01 AA018790, R21 AA021362, P30 NS061777, S10 RR022415]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA021362, R01AA018790] Funding Source: NIH RePORTER	USPHS NIH(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported, in part, by USPHS NIH grants R01 AA018790 and R21 AA021362 to AC, and P30 NS061777 and S10 RR022415 to RW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2009, J MED FOOD, V12, P1190, DOI 10.1089/jmf.2009.0017; Apte UM, 2004, TOXICOL PATHOL, V32, P567, DOI 10.1080/01926230490508812; Aroor AR, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-29; Arteel GE, 2003, GASTROENTEROLOGY, V124, P778, DOI 10.1053/gast.2003.50087; Banerjee A, 2006, J PATHOL, V208, P473, DOI 10.1002/path.1917; Banerjee A, 2008, PROTEOMICS, V8, P4327, DOI 10.1002/pmic.200700368; BONDY SC, 1992, TOXICOL LETT, V63, P231, DOI 10.1016/0378-4274(92)90086-Y; Braeuning A, 2009, DRUG METAB DISPOS, V37, P1138, DOI 10.1124/dmd.108.026179; BRUDZYNSKI K, 1992, DIABETOLOGIA, V35, P316, DOI 10.1007/BF00401198; Cederbaum AI, 2001, FREE RADICAL BIO MED, V31, P1524, DOI 10.1016/S0891-5849(01)00741-9; Cohen JI, 2011, ANTIOXID REDOX SIGN, V15, P523, DOI 10.1089/ars.2010.3746; Colantoni A, 2000, ALCOHOL CLIN EXP RES, V24, P1467, DOI 10.1097/00000374-200009000-00020; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Diehl AM, 2002, ALCOHOL, V27, P7, DOI 10.1016/S0741-8329(02)00204-5; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fogle RL, 2011, PHYSIOL GENOMICS, V43, P346, DOI 10.1152/physiolgenomics.00203.2010; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gallucci RM, 2004, ALCOHOL CLIN EXP RES, V28, P365, DOI 10.1097/01.ALC.0000118316.20560.0D; Habich C, 2002, J IMMUNOL, V168, P569, DOI 10.4049/jimmunol.168.2.569; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; HOLOSHITZ J, 1986, LANCET, V2, P305; Jia XF, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-39; Jia ZQ, 2008, MOL CELL BIOCHEM, V307, P185, DOI 10.1007/s11010-007-9598-z; Khana AJ, 2009, DRUG ALCOHOL DEPEN, V101, P183, DOI 10.1016/j.drugalcdep.2008.12.001; Kharbanda KK, 2009, BIOCHEM BIOPH RES CO, V381, P523, DOI 10.1016/j.bbrc.2009.02.082; Klouckova I, 2006, PROTEOMICS, V6, P3060, DOI 10.1002/pmic.200500725; Kohls D, 1999, ACTA CRYSTALLOGR D, V55, P1206, DOI 10.1107/S0907444999003601; Kono H, 2000, AM J PHYSIOL-GASTR L, V278, pG652, DOI 10.1152/ajpgi.2000.278.4.G652; Ladero JM, 2005, SCAND J GASTROENTERO, V40, P348, DOI 10.1080/00365520510012109; Lai XY, 2009, ELECTROPHORESIS, V30, P2207, DOI 10.1002/elps.200800775; Lamle J, 2008, GASTROENTEROLOGY, V134, P1159, DOI 10.1053/j.gastro.2008.01.011; Lapierre P, 1999, GASTROENTEROLOGY, V116, P643, DOI 10.1016/S0016-5085(99)70186-1; Leung TM, 2012, HEPATOLOGY, V55, P1596, DOI 10.1002/hep.25543; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Lieber CS, 1997, CLIN CHIM ACTA, V257, P59, DOI 10.1016/S0009-8981(96)06434-0; LIEBER CS, 1984, MED CLIN N AM, V68, P3, DOI 10.1016/S0025-7125(16)31238-X; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Lu YK, 2011, DRUG METAB DISPOS, V39, P330, DOI 10.1124/dmd.110.035691; Lu YK, 2010, FREE RADICAL BIO MED, V49, P1406, DOI 10.1016/j.freeradbiomed.2010.07.026; Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011; Mandrekar P, 2009, J HEPATOL, V50, P1258, DOI 10.1016/j.jhep.2009.03.007; Medici V, 2012, MOL NUTR FOOD RES; Medici V, 2010, J HEPATOL, V53, P551, DOI 10.1016/j.jhep.2010.03.029; Min H, 2005, ALCOHOL CLIN EXP RES, V29, P2188, DOI 10.1097/01.alc.0000191756.02856.a8; Moon KH, 2006, HEPATOLOGY, V44, P1218, DOI 10.1002/hep.21372; Muller C, 2006, WIEN MED WOCHENSCHR, V156, P523, DOI [10.1007/s10354-006-0348-8, 10.1007/s10354-006-0314-5]; Nanji AA, 2001, AM J PHYSIOL-GASTR L, V281, pG1348, DOI 10.1152/ajpgi.2001.281.6.G1348; Nanji AA, 2004, J PHARMACOL EXP THER, V310, P417, DOI 10.1124/jpet.103.064717; Nanji AA, 2002, ALCOHOL CLIN EXP RES, V26, P731, DOI 10.1097/00000374-200205000-00020; Newton BW, 2009, J PROTEOME RES, V8, P1663, DOI 10.1021/pr800905w; NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K; Park B, 2004, PROTEOMICS, V4, P3413, DOI 10.1002/pmic.200400975; Purohit V, 2009, ALCOHOL CLIN EXP RES, V33, P191, DOI 10.1111/j.1530-0277.2008.00827.x; Ramaiah SK, 2004, INT J TOXICOL, V23, P217, DOI 10.1080/10915810490502069; Rao Prahlad K, 2009, J Proteomics Bioinform, V2, P19; REINKE LA, 1985, DRUG METAB DISPOS, V13, P548; Sekine S, 2006, HEPATOLOGY, V43, P817, DOI 10.1002/hep.21131; Shi L, 2008, J PROTEOME RES, V7, P3137, DOI 10.1021/pr700853j; Sun W, 2007, MOL CELL PROTEOMICS, V6, P1798, DOI 10.1074/mcp.M600449-MCP200; Szabo G, 2010, WORLD J GASTROENTERO, V16, P1321, DOI 10.3748/wjg.v16.i11.1321; Venkatraman A, 2004, J BIOL CHEM, V279, P22092, DOI 10.1074/jbc.M402245200; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; WISEMAN MS, 1991, ARCH BIOCHEM BIOPHYS, V290, P191, DOI 10.1016/0003-9861(91)90607-K; XU QB, 1993, J CLIN INVEST, V91, P2693, DOI 10.1172/JCI116508; Zhang LJ, 2011, ACTA BIOCH BIOPH SIN, V43, P19, DOI 10.1093/abbs/gmq108; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P71, DOI 10.1007/s12012-008-9016-0; Zhu H, 2012, J DIGEST DIS, V13, P133, DOI 10.1111/j.1751-2980.2011.00569.x	67	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92504	10.1371/journal.pone.0092504	http://dx.doi.org/10.1371/journal.pone.0092504			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658151	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300092
J	Sheppard, NC; Jones, RB; Burwitz, BJ; Nimityongskul, FA; Newman, LP; Buechler, MB; Reed, JS; Piaskowski, SM; Weisgrau, KL; Castrovinci, PA; Wilson, NA; Ostrowski, MA; Park, B; Nixon, DF; Rakasz, EG; Sacha, JB				Sheppard, Neil C.; Jones, R. Brad; Burwitz, Benjamin J.; Nimityongskul, Francesca A.; Newman, Laura P.; Buechler, Matthew B.; Reed, Jason S.; Piaskowski, Shari M.; Weisgrau, Kim L.; Castrovinci, Philip A.; Wilson, Nancy A.; Ostrowski, Mario A.; Park, Byung; Nixon, Douglas F.; Rakasz, Eva G.; Sacha, Jonah B.			Vaccination against Endogenous Retrotransposable Element Consensus Sequences Does Not Protect Rhesus Macaques from SIVsmE660 Infection and Replication	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL RESPONSES; RETROVIRUS-K; L1 RETROTRANSPOSITION; POOR-PROGNOSIS; EXPRESSION; HIV-1; SIV; GAG; ACQUISITION	The enormous sequence diversity of HIV remains a major roadblock to the development of a prophylactic vaccine and new approaches to induce protective immunity are needed. Endogenous retrotransposable elements (ERE) such as endogenous retrovirus K (ERV)-K and long interspersed nuclear element-1 (LINE-1) are activated during HIV-1-infection and could represent stable, surrogate targets to eliminate HIV-1-infected cells. Here, we explored the hypothesis that vaccination against ERE would protect macaques from acquisition and replication of simian immunodeficiency virus (SIV). Following vaccination with antigens derived from LINE-1 and ERV-K consensus sequences, animals mounted immune responses that failed to delay acquisition of SIVsmE660. We observed no differences in acute or set point viral loads between ERE-vaccinated and control animals suggesting that ERE-specific responses were not protective. Indeed, ERE-specific T cells failed to expand anamnestically in vivo following infection with SIVsmE660 and did not recognize SIV-infected targets in vitro, in agreement with no significant induction of targeted ERE mRNA by SIV in macaque CD4+ T cells. Instead, lower infection rates and viral loads correlated significantly to protective TRIM5 alpha alleles. Cumulatively, these data demonstrate that vaccination against the selected ERE consensus sequences in macaques did not lead to immune-mediated recognition and killing of SIV-infected cells, as has been shown for HIV-infected human cells using patient-derived HERV-K-specific T cells. Thus, further research is required to identify the specific nonhuman primate EREs and retroviruses that recapitulate the activity of HIV-1 in human cells. These results also highlight the complexity in translating observations of the interplay between HIV-1 and human EREs to animal models.	[Sheppard, Neil C.] Pfizer Inc, Vaccine Res, Worldwide R&D, San Diego, CA USA; [Jones, R. Brad; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Burwitz, Benjamin J.; Reed, Jason S.; Sacha, Jonah B.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97239 USA; [Burwitz, Benjamin J.; Reed, Jason S.; Sacha, Jonah B.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Nimityongskul, Francesca A.; Newman, Laura P.; Buechler, Matthew B.; Piaskowski, Shari M.; Weisgrau, Kim L.; Castrovinci, Philip A.; Wilson, Nancy A.; Rakasz, Eva G.] Univ Wisconsin, Wisconsin Natl Primate Ctr, Madison, WI USA; [Nixon, Douglas F.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Expt Med, San Francisco, CA USA; [Sacha, Jonah B.] Oregon Hlth & Sci Univ, Dept Med Microbiol & Immunol, Portland, OR 97201 USA; [Park, Byung] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Div Biostat, Portland, OR 97201 USA	Pfizer; University of Toronto; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; University of Wisconsin System; University of Wisconsin Madison; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Oregon Health & Science University; Oregon Health & Science University	Sacha, JB (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97239 USA.	sacha@ohsu.edu	Rakasz, Eva G/H-9197-2019; Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786; Sheppard, Neil/0000-0002-9551-9491; Buechler, Matthew/0000-0003-1902-622X	Pfizer Inc. [140-N-2076312]; National Institutes of Health [R21 AI087474]; National Center for Research Resources [P51 OD011092]; Bill and Melinda Gates Foundation [01526000084]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, C06RR015459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087474] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092, P51OD011106] Funding Source: NIH RePORTER	Pfizer Inc.(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Pfizer Inc.-sponsored research agreement 140-N-2076312 with JBS, National Institutes of Health (R21 AI087474 to JBS), the National Center for Research Resources (P51 OD011092), and the Bill and Melinda Gates Foundation (grant 01526000084 to JBS). Additionally, this research was conducted at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. RBJ is a Canadian Institute for Health Research Banting fellow and an Ontario HIV Treatment Network Junior Investigator Development awardee. Neil C. Sheppard, an employee of Pfizer, had a role in the design of the study, the data collection and analysis, and preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Asch HL, 1996, ONCOL RES, V8, P239; Baroncelli S, 2008, EXPERT REV VACCINES, V7, P1419, DOI 10.1586/14760584.7.9.1419; Buscher K, 2006, MELANOMA RES, V16, P223; Buscher K, 2005, CANCER RES, V65, P4172, DOI 10.1158/0008-5472.CAN-04-2983; Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P116, DOI 10.1089/aid.2006.0117; Contreras-Galindo R, 2006, AIDS RES HUM RETROV, V22, P979, DOI 10.1089/aid.2006.22.979; Contreras-Galindo R, 2013, GENOME RES, V23, P1505, DOI 10.1101/gr.144303.112; Contreras-Galindo R, 2012, J VIROL, V86, P262, DOI 10.1128/JVI.00602-11; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Esqueda D, 2013, ANN CLIN LAB SCI, V43, P122; Evans LH, 2009, J VIROL, V83, P2429, DOI 10.1128/JVI.01926-08; Feng WJN, 2007, INT J CANCER, V120, P81, DOI 10.1002/ijc.22256; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Gasior SL, 2008, DNA REPAIR, V7, P983, DOI 10.1016/j.dnarep.2008.02.006; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Goering W, 2011, CARCINOGENESIS, V32, P1484, DOI 10.1093/carcin/bgr181; Gonzalez-Hernandez MJ, 2012, J VIROL, V86, P7790, DOI 10.1128/JVI.07215-11; Hakim ST, 2008, BIOCHEM BIOPH RES CO, V369, P357, DOI 10.1016/j.bbrc.2008.02.025; Han K, 2007, SCIENCE, V316, P238, DOI 10.1126/science.1139462; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Herbst H, 1996, AM J PATHOL, V149, P1727; Iramaneerat K, 2011, INT J GYNECOL CANCER, V21, P51, DOI 10.1097/IGC.0b013e3182021c1a; Jones RB, 2013, J VIROL, V87, P13307, DOI 10.1128/JVI.02257-13; Jones RB, 2012, J CLIN INVEST, V122, P4473, DOI 10.1172/JCI64560; Kaizu M, 2007, IMMUNOGENETICS, V59, P693, DOI 10.1007/s00251-007-0233-7; Kamada K, 2006, MICROBES INFECT, V8, P1075, DOI 10.1016/j.micinf.2005.11.006; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462; Laderoute MP, 2007, AIDS, V21, P2417, DOI 10.1097/QAD.0b013e3282f14d64; Lee YN, 2008, J VIROL, V82, P8762, DOI 10.1128/JVI.00751-08; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Marsh AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040158; Medstrand P, 1998, J VIROL, V72, P9782, DOI 10.1128/JVI.72.12.9782-9787.1998; Monde K, 2012, J VIROL, V86, P11194, DOI 10.1128/JVI.00301-12; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Nomaguchi M, 2013, J VIROL, V87, P11447, DOI 10.1128/JVI.01549-13; Ormsby CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041021; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Reynolds MR, 2011, J VIROL, V85, P9637, DOI 10.1128/JVI.05074-11; Reynolds MR, 2010, J VIROL, V84, P9190, DOI 10.1128/JVI.00041-10; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Sacha JB, 2012, J IMMUNOL, V189, P1467, DOI 10.4049/jimmunol.1200079; Sacha JB, 2010, NAT PROTOC, V5, P239, DOI 10.1038/nprot.2009.227; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Saito A, 2011, MICROBES INFECT, V13, P58, DOI 10.1016/j.micinf.2010.10.001; Saito K, 2010, CLIN CANCER RES, V16, P2418, DOI 10.1158/1078-0432.CCR-09-2819; SAUTER M, 1995, J VIROL, V69, P414, DOI 10.1128/JVI.69.1.414-421.1995; Schiavetti F, 2002, CANCER RES, V62, P5510; SenGupta D, 2011, J VIROL, V85, P6977, DOI 10.1128/JVI.00179-11; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stoddart CA, 2011, VIROLOGY, V417, P154, DOI 10.1016/j.virol.2011.05.013; Takahashi Y, 2008, J CLIN INVEST, V118, P1099, DOI 10.1172/JCI34409; Tandon R, 2011, J VIROL, V85, P11526, DOI 10.1128/JVI.05418-11; Tenbusch M, 2012, J VIROL, V86, P10533, DOI 10.1128/JVI.00796-12; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Vincent BJ, 2003, MOL BIOL EVOL, V20, P1338, DOI 10.1093/molbev/msg146; Wang-Johanning F, 2008, CANCER RES, V68, P5869, DOI 10.1158/0008-5472.CAN-07-6838; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Yeh WW, 2011, J VIROL, V85, P10389, DOI 10.1128/JVI.00854-11; Zhao Jing, 2011, Genes Cancer, V2, P914, DOI 10.1177/1947601911431841; Zwolinska K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077820	67	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92012	10.1371/journal.pone.0092012	http://dx.doi.org/10.1371/journal.pone.0092012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651676	gold, Green Submitted, Green Published			2022-12-27	WOS:000333352800063
J	Silva, MA; Jonsen, I; Russell, DJF; Prieto, R; Thompson, D; Baumgartner, MF				Silva, Monica A.; Jonsen, Ian; Russell, Deborah J. F.; Prieto, Rui; Thompson, Dave; Baumgartner, Mark F.			Assessing Performance of Bayesian State-Space Models Fit to Argos Satellite Telemetry Locations Processed with Kalman Filtering	PLOS ONE			English	Article							MEASUREMENT ERROR; MOVEMENT; ACCURACY; TRACKING; GPS	Argos recently implemented a new algorithm to calculate locations of satellite-tracked animals that uses a Kalman filter (KF). The KF algorithm is reported to increase the number and accuracy of estimated positions over the traditional Least Squares (LS) algorithm, with potential advantages to the application of state-space methods to model animal movement data. We tested the performance of two Bayesian state-space models (SSMs) fitted to satellite tracking data processed with KF algorithm. Tracks from 7 harbour seals (Phoca vitulina) tagged with ARGOS satellite transmitters equipped with Fastloc GPS loggers were used to calculate the error of locations estimated from SSMs fitted to KF and LS data, by comparing those to "true" GPS locations. Data on 6 fin whales (Balaenoptera physalus) were used to investigate consistency in movement parameters, location and behavioural states estimated by switching state-space models (SSSM) fitted to data derived from KF and LS methods. The model fit to KF locations improved the accuracy of seal trips by 27% over the LS model. 82% of locations predicted from the KF model and 73% of locations from the LS model were <5 km from the corresponding interpolated GPS position. Uncertainty in KF model estimates (5.6 +/- 5.6 km) was nearly half that of LS estimates (11.6 +/- 8.4 km). Accuracy of KF and LS modelled locations was sensitive to precision but not to observation frequency or temporal resolution of raw Argos data. On average, 88% of whale locations estimated by KF models fell within the 95% probability ellipse of paired locations from LS models. Precision of KF locations for whales was generally higher. Whales' behavioural mode inferred by KF models matched the classification from LS models in 94% of the cases. State-space models fit to KF data can improve spatial accuracy of location estimates over LS models and produce equally reliable behavioural estimates.	[Silva, Monica A.; Prieto, Rui] Univ Azores, Ctr Inst Marine Res IMAR, Horta, Portugal; [Silva, Monica A.; Prieto, Rui] Univ Azores, Dept Oceanog & Fisheries, Horta, Portugal; [Silva, Monica A.; Prieto, Rui] Lab Robot & Syst Engn & Sci LARSyS, Lisbon, Portugal; [Silva, Monica A.; Baumgartner, Mark F.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Jonsen, Ian] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Russell, Deborah J. F.; Thompson, Dave] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Russell, Deborah J. F.] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland	Universidade dos Acores; Universidade dos Acores; Woods Hole Oceanographic Institution; Dalhousie University; University of St Andrews; University of St Andrews	Silva, MA (corresponding author), Univ Azores, Ctr Inst Marine Res IMAR, Horta, Portugal.	monica@uac.pt	Silva, Mónica/D-1893-2012; Prieto, Rui/G-8286-2011; Russell, Debbie J.F./AAA-6487-2021	Silva, Mónica/0000-0002-2683-309X; Prieto, Rui/0000-0002-0354-2572; Russell, Debbie J.F./0000-0002-1969-102X; Thompson, David/0000-0003-1546-2876; Jonsen, Ian/0000-0001-5423-6076	Fundacao para a Ciencia e a Tecnologia (FCT); Fundo Regional da Ciencia, Tecnologia (FRCT) [TRACE-PTDC/MAR/74071/2006, MAPCET-M2.1.2/F/012/2011]; Competitiveness Factors Operational (COMPETE); QREN European Social Fund; Proconvergencia Acores/EU Program; FCT; IMAR-University of the Azores/the Thematic Area D & E of the Strategic Project [PEst-OE/EEI/LA0009/2011-1012]; FRCT - Government of the Azores; FCT [SFRH/BPD/29841/2006, SFRH/BD/41192/2007]; POPH; Portuguese Ministry for Science and Education through an FCT Investigator grant; Azores Regional Fund for Science and Technology [M3.1.5/F/115/2012]; Natural Sciences and Engineering Research Council (NSERC); Canada Foundation for Innovation (CFI) through Ocean Tracking Network; United Kingdom Department of Energy and Climate Change as part of their Offshore Energy Strategic Environmental Assessment program; Natural Environment Research Council; Marine Scotland; LARSyS Associated Laboratory through FCT/MCE project [PEst-OE/EEI/LA0009/2013-2014]; Natural Environment Research Council [smru10001] Funding Source: researchfish	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Regional da Ciencia, Tecnologia (FRCT); Competitiveness Factors Operational (COMPETE); QREN European Social Fund; Proconvergencia Acores/EU Program; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); IMAR-University of the Azores/the Thematic Area D & E of the Strategic Project; FRCT - Government of the Azores; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); POPH; Portuguese Ministry for Science and Education through an FCT Investigator grant; Azores Regional Fund for Science and Technology; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI) through Ocean Tracking Network; United Kingdom Department of Energy and Climate Change as part of their Offshore Energy Strategic Environmental Assessment program; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Marine Scotland; LARSyS Associated Laboratory through FCT/MCE project; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was primarily funded by Fundacao para a Ciencia e a Tecnologia (FCT), Fundo Regional da Ciencia, Tecnologia (FRCT), through research projects TRACE-PTDC/MAR/74071/2006 and MAPCET-M2.1.2/F/012/2011 [FEDER], the Competitiveness Factors Operational (COMPETE), QREN European Social Fund, and Proconvergencia Acores/EU Program]. We acknowledge funds provided by FCT to LARSyS Associated Laboratory and IMAR-University of the Azores/the Thematic Area D & E of the Strategic Project PEst-OE/EEI/LA0009/2011-1012 and 2013-2014 (OE & Compete) and by the FRCT - Government of the Azores pluriannual funding. MAS was supported by an FCT postdoctoral grant (SFRH/BPD/29841/2006) and is currently supported by POPH, QREN European Social Fund and the Portuguese Ministry for Science and Education through an FCT Investigator grant. RP was supported by an FCT doctoral grant (SFRH/BD/41192/2007) and by the research grant from the Azores Regional Fund for Science and Technology (M3.1.5/F/115/2012). IJ was supported by the Natural Sciences and Engineering Research Council (NSERC) and the Canada Foundation for Innovation (CFI) through their support of the Ocean Tracking Network. DJFR is funded by the United Kingdom Department of Energy and Climate Change as part of their Offshore Energy Strategic Environmental Assessment program. DT is funded by Natural Environment Research Council and Marine Scotland. Publication fees for this open access publication were supported by LARSyS Associated Laboratory through FCT/MCE project Project PEst-OE/EEI/LA0009/2013-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bailey H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036401; Bestley S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2262; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Boyd JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063051; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Breed GA, 2012, ECOL MODEL, V235, P49, DOI 10.1016/j.ecolmodel.2012.03.021; Breed GA, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00021.1; Bryant E, 2007, FASTLOCTR01 WILDTR T; CLS (Collecte Localisation Satellites), 2011, COLLECTE LOCALISATIO; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Dragon AC, 2012, MAR ECOL PROG SER, V452, P253, DOI 10.3354/meps09618; Fancy S. G., 1988, US FISH WILDLIFE SER, V172; Flemming JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014245; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Hoenner X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040713; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2006, J ANIM ECOL, V75, P1046, DOI 10.1111/j.1365-2656.2006.01129.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Kuhn CE, 2009, MAR ECOL PROG SER, V393, P97, DOI 10.3354/meps08229; Lopez R., 2011, CLSDTMEMO1165; McClintock BT, 2013, ECOLOGY, V94, P838, DOI 10.1890/12-0954.1; Morehouse AT, 2013, WILDLIFE SOC B, V37, P596, DOI 10.1002/wsb.292; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Sharples RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037216; Silva MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076507; TINBERGEN N, 1967, BEHAVIOUR, V28, P307, DOI 10.1163/156853967X00064; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Winship AJ, 2012, METHODS ECOL EVOL, V3, P291, DOI 10.1111/j.2041-210X.2011.00161.x; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022	36	26	28	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92277	10.1371/journal.pone.0092277	http://dx.doi.org/10.1371/journal.pone.0092277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651252	Green Published, gold			2022-12-27	WOS:000333352800092
J	Spolding, B; Connor, T; Wittmer, C; Abreu, LLF; Kaspi, A; Ziemann, M; Kaur, G; Cooper, A; Morrison, S; Lee, S; Sinclair, A; Gibert, Y; Trevaskis, JL; Roth, JD; El-Osta, A; Standish, R; Walder, K				Spolding, Briana; Connor, Timothy; Wittmer, Carrie; Abreu, Lelia L. F.; Kaspi, Antony; Ziemann, Mark; Kaur, Gunveen; Cooper, Adrian; Morrison, Shona; Lee, Scott; Sinclair, Andrew; Gibert, Yann; Trevaskis, James L.; Roth, Jonathon D.; El-Osta, Assam; Standish, Richard; Walder, Ken			Rapid Development of Non-Alcoholic Steatohepatitis in Psammomys obesus (Israeli Sand Rat)	PLOS ONE			English	Article							FATTY LIVER; HEPATIC STEATOSIS; GENE-EXPRESSION; CHOLESTEROL; METABOLISM; THERAPY; MICE	Background and Aims: A major impediment to establishing new treatments for non-alcoholic steatohepatitis is the lack of suitable animal models that accurately mimic the biochemical and metabolic characteristics of the disease. The aim of this study was to explore a unique polygenic animal model of metabolic disease as a model of non-alcoholic steatohepatitis by determining the effects of 2% dietary cholesterol supplementation on metabolic and liver endpoints in Psammomys obesus (Israeli sand rat). Methods: P. obesus were provided ad libitum access to either a standard rodent diet (20% kcal/fat) or a standard rodent diet supplemented with 2% cholesterol (w/w) for 4 weeks. Histological sections of liver from animals on both diets were examined for key features of non-alcoholic steatohepatitis. The expression levels of key genes involved in hepatic lipid metabolism were measured by real-time PCR. Results: P. obesus fed a cholesterol-supplemented diet exhibited profound hepatomegaly and steatosis, and higher plasma transaminase levels. Histological analysis identified extensive steatosis, inflammation, hepatocyte injury and fibrosis. Hepatic gene expression profiling revealed decreased expression of genes involved in delivery and uptake of lipids, and fatty acid and triglyceride synthesis, and increased expression of genes involved in very low density lipoprotein cholesterol synthesis, triglyceride and cholesterol export. Conclusions: P. obesus rapidly develop non-alcoholic steatohepatitis when fed a cholesterol-supplemented diet that appears to be histologically and mechanistically similar to patients.	[Spolding, Briana; Connor, Timothy; Abreu, Lelia L. F.; Cooper, Adrian; Morrison, Shona; Lee, Scott; Sinclair, Andrew; Gibert, Yann; Standish, Richard; Walder, Ken] Deakin Univ, Sch Med, Metab Res Unit, Geelong, Vic 3217, Australia; [Wittmer, Carrie; Trevaskis, James L.; Roth, Jonathon D.] Amylin Pharmaceut LLC, San Diego, CA USA; [Kaspi, Antony; Ziemann, Mark; El-Osta, Assam] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Kaur, Gunveen] Victoria Univ, Inst Sport Exercise & Act Living, Melbourne, Vic 8001, Australia	Deakin University; Baker Heart and Diabetes Institute; Victoria University	Spolding, B (corresponding author), Deakin Univ, Sch Med, Metab Res Unit, Geelong, Vic 3217, Australia.	briana.spolding@deakin.edu.au	Ziemann, Mark Daniel/AAE-8466-2019	Randall, Briana/0000-0001-7453-4580; El-Osta, Assam/0000-0003-2969-9137; Ziemann, Mark/0000-0002-7688-6974; Trevaskis, James/0000-0002-5356-6118; El-Osta, Assam/0000-0001-7968-7375; Kaspi, Antony/0000-0001-6576-5862	Amylin Pharmaceuticals, Inc., San Diego, USA; Deakin University Molecular and Medical Research Strategic Research Centre	Amylin Pharmaceuticals, Inc., San Diego, USA; Deakin University Molecular and Medical Research Strategic Research Centre	This research was supported in part by Amylin Pharmaceuticals, Inc., San Diego, USA, and in part by the Deakin University Molecular and Medical Research Strategic Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNETT M, 1994, DIABETOLOGIA, V37, P671, DOI 10.1007/s001250050162; Boone LR, 2011, J LIPIDS, V2011, DOI 10.1155/2011/101242; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Caballero F, 2009, J HEPATOL, V50, P789, DOI 10.1016/j.jhep.2008.12.016; Chang XX, 2010, J LIPID RES, V51, P2504, DOI 10.1194/jlr.M001958; Charlton M, 2009, HEPATOLOGY, V49, P1375, DOI 10.1002/hep.22927; Collier GR, 2000, DIABETES, V49, P1766, DOI 10.2337/diabetes.49.11.1766; Du R, 2011, EUR J PHARMACOL, V666, P183, DOI 10.1016/j.ejphar.2011.05.014; FOLCH J, 1957, J BIOL CHEM, V226, P497; Harano Y, 2006, LIVER INT, V26, P613, DOI 10.1111/j.1478-3231.2006.01265.x; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kohjima M, 2007, INT J MOL MED, V20, P351; Maislos M, 2006, DIABETES RES CLIN PR, V72, P1, DOI 10.1016/j.diabres.2005.09.007; Masterton GS, 2010, ALIMENT PHARM THER, V31, P679, DOI 10.1111/j.1365-2036.2010.04230.x; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Mitsuyoshi H, 2009, HEPATOL RES, V39, P366, DOI 10.1111/j.1872-034X.2008.00464.x; Moseley RH, 2008, J CLIN GASTROENTEROL, V42, P332, DOI 10.1097/MCG.0b013e31815e4079; Nakamuta M, 2005, INT J MOL MED, V16, P631; Obika M, 2012, EXP DIABETES RES, DOI 10.1155/2012/145754; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; RUDEL L, 1994, J CLIN INVEST, V93, P2463, DOI 10.1172/JCI117255; Savard C, 2013, HEPATOLOGY, V57, P81, DOI 10.1002/hep.25789; SINCLAIR AJ, 1987, LIPIDS, V22, P523, DOI 10.1007/BF02540369; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Trevaskis JL, 2012, AM J PHYSIOL-GASTR L, V302, pG762, DOI 10.1152/ajpgi.00476.2011; Walder K, 2002, DIABETES, V51, P1859, DOI 10.2337/diabetes.51.6.1859; Walder K R, 2000, Int J Exp Diabetes Res, V1, P177, DOI 10.1155/EDR.2000.177; Walder Ken, 2002, Endocr Regul, V36, P1; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Zhang B, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-48	32	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92656	10.1371/journal.pone.0092656	http://dx.doi.org/10.1371/journal.pone.0092656			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651520	Green Published, Green Accepted, gold			2022-12-27	WOS:000333352800138
J	Tang, GQ; Nandakumar, D; Bandwar, RP; Lee, KS; Roy, R; Ha, T; Patel, SS				Tang, Guo-Qing; Nandakumar, Divya; Bandwar, Rajiv P.; Lee, Kyung Suk; Roy, Rahul; Ha, Taekjip; Patel, Smita S.			Relaxed Rotational and Scrunching Changes in P266L Mutant of T7 RNA Polymerase Reduce Short Abortive RNAs while Delaying Transition into Elongation	PLOS ONE			English	Article							OPEN COMPLEX-FORMATION; TRANSCRIPTION INITIATION; PROMOTER CLEARANCE; SINGLE-MOLECULE; MECHANISM; DNA; BINDING; DYNAMICS; PROCEEDS; RELEASE	Abortive cycling is a universal feature of transcription initiation catalyzed by DNA-dependent RNA polymerases (RNAP). In bacteriophage T7 RNAP, mutation of proline 266 to leucine (P266L) in the C-linker region connecting the N-terminal promoter binding domain with the C-terminal catalytic domain drastically reduces short abortive products (4-7 nt) while marginally increasing long abortives (9-11 nt). Here we have investigated the transcription initiation pathway of P266L with the goal of understanding the mechanistic basis for short and long abortive synthesis. We show that the P266L mutation does not alter the affinity for the promoter, mildly affects promoter opening, and increases the +1/+2 GTP K-d by 2-fold. However, unlike wild-type T7 RNAP that undergoes stepwise rotation of the promoter binding domain and DNA scrunching during initial transcription, the P266L mutant does not undergo coupled rotational/scrunching movements until 7 nt RNA synthesis. The lack of rotation/scrunching correlates with greater stabilities of the initiation complexes of the P266L and decreased short abortive products. The results indicate that the increased flexibility in the C-linker due to P266L mutation enables T7 RNAP to absorb the stress from the growing RNA: DNA hybrid thereby decreasing short abortive products. Increased C-linker flexibility, however, has an adverse effect of delaying the transition into elongation by 1-2 nt, which gives rise to long abortive products. However, a mutation in the upstream promoter region greatly decreases long abortive products in P266L reactions, rendering the combination of P266L and A-15C promoter a desirable pair for efficient in vitro transcription for RNA production. We conclude that the conformational rigidity in the C-linker region conferred by the proline at position 266 is responsible for the undesirable short abortive products, but the rigidity is critical for efficient promoter clearance and transition into elongation.	[Tang, Guo-Qing; Nandakumar, Divya; Bandwar, Rajiv P.; Patel, Smita S.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Lee, Kyung Suk; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL USA; [Lee, Kyung Suk; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL USA; [Roy, Rahul; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Patel, SS (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	patelss@rwjms.rutgers.edu	Roy, Rahul/D-5329-2009; Nandakumar, Divya/K-6250-2014; Ha, Taekjip/B-9506-2009; Roy, Rahul/Y-5878-2019	Roy, Rahul/0000-0003-3329-8803; Nandakumar, Divya/0000-0001-7672-0213; Ha, Taekjip/0000-0003-2195-6258; Roy, Rahul/0000-0003-3329-8803; Bandwar, Rajiv/0000-0002-8081-8958	National Institutes for Health (NIH) [R37 GM051966, GM065367]; National Science Foundation [0822613]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051966, R01GM065367] Funding Source: NIH RePORTER	National Institutes for Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the National Institutes for Health (NIH) grant R37 GM051966 to SSP and NIH grant GM065367 and National Science Foundation grant 0822613 to TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandwar RP, 2007, J BIOL CHEM, V282, P22879, DOI 10.1074/jbc.M702589200; Bandwar RP, 2006, J MOL BIOL, V360, P466, DOI 10.1016/j.jmb.2006.05.029; Bandwar RP, 2001, J BIOL CHEM, V276, P14075, DOI 10.1074/jbc.M011289200; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; DIAZ GA, 1993, J MOL BIOL, V229, P805, DOI 10.1006/jmbi.1993.1086; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Goldman SR, 2009, SCIENCE, V324, P927, DOI 10.1126/science.1169237; Gong P, 2004, J BIOL CHEM, V279, P44277, DOI 10.1074/jbc.M409118200; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; Guillerez J, 2005, P NATL ACAD SCI USA, V102, P5958, DOI 10.1073/pnas.0407141102; Guo Q, 2005, J BIOL CHEM, V280, P14956, DOI 10.1074/jbc.M500518200; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Jia YP, 1997, J BIOL CHEM, V272, P30147, DOI 10.1074/jbc.272.48.30147; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; KING GC, 1986, BIOCHEMISTRY-US, V25, P36, DOI 10.1021/bi00349a006; MULLER DK, 1988, BIOCHEMISTRY-US, V27, P5763, DOI 10.1021/bi00415a055; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Patel Smita S., 2003, P87; Ramirez-Tapia LE, 2012, J BIOL CHEM, V287, P37352, DOI 10.1074/jbc.M112.370643; Rasnik I, 2004, J MOL BIOL, V336, P395, DOI 10.1016/j.jmb.2003.12.031; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; SOUSA R, 1992, J MOL BIOL, V224, P319, DOI 10.1016/0022-2836(92)90997-X; Stano NM, 2002, J BIOL CHEM, V277, P37292, DOI 10.1074/jbc.M201600200; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; Tang GQ, 2005, J BIOL CHEM, V280, P40707, DOI 10.1074/jbc.M508013200; Tang GQ, 2008, MOL CELL, V30, P567, DOI 10.1016/j.molcel.2008.04.003; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; Temiakov D, 2002, J BIOL CHEM, V277, P47035, DOI 10.1074/jbc.M208923200; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	32	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91859	10.1371/journal.pone.0091859	http://dx.doi.org/10.1371/journal.pone.0091859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651161	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800052
J	Xu, B; Liu, P				Xu, Bei; Liu, Peng			No Survival Improvement for Patients with Angioimmunoblastic T-Cell Lymphoma over the Past Two Decades: A Population-Based Study of 1207 Cases	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMAS; PROGNOSTIC-FACTORS; MARROW TRANSPLANTATION; CLINICAL-FEATURES; EUROPEAN GROUP; WORKING PARTY; LYMPHADENOPATHY; CHEMOTHERAPY; REMISSIONS; SUBTYPE	Angioimmunoblastic T-cell lymphoma (AITL) is a rare lymphoid malignancy with dismal prognosis. We conducted a large population-based study using the Surveillance, Epidemiology, and End Results (SEER) database (1973-2010) to determine the temporal survival trends and prognostic factors of AITL patients. A total of 1207 patients with AITL were included in this study, with a median age at diagnosis of 69 years. At presentation, most patients (79.5%) had an advanced-stage disease. Overall survival (OS) probabilities at 2, 5 and 10 years were 46.8%, 32.9%, and 21.9% respectively. Two-year, 5-year, and 10-year disease-specific survival (DSS) rates were 56.1%, 44.0%, and 35.9% respectively. On multivariate analysis, age older than 70 years, advanced-stage disease and male sex were identified adverse predictors for OS and DSS. We failed to find any survival differences among subgroups diagnosed in the 5 periods studied (1992 to 1998, 1999 to 2001, 2002 to 2004, 2005 to 2007, and 2008 to 2010). The current study represents the largest specific series of patients with AITL and the first investigation on temporal changes in survival of AITL patients. There has been no survival improvement for AITL patients over the past two decades. Further investigations are warranted to develop more effective treatment for AITL.	[Xu, Bei] Nanjing Med Univ, Affiliated Hosp 1, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Liu, Peng] Nanjing Med Univ, Affiliated Hosp 1, Dept Hematol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Liu, P (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Hematol, Nanjing, Jiangsu, Peoples R China.	liupeng9098@163.com			National Natural Science Foundation of China [81170486, 81101498]; Natural Science Fund for Distinguished Young Scholars of Jiangsu Province [BK20130049]; Scientific Research Foundation from the Ministry of Education of China [43-NJYKDX-3]; Jiangsu Province's Medical Elite Program [RC2011168]; Jiangsu Province Health Agency [K201107]; "Liu Da Ren Cai Gao Feng" Project [2012-WS-017]; Priority Academic Program Development of Jiangsu Higher Education Institut [JX10231801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund for Distinguished Young Scholars of Jiangsu Province; Scientific Research Foundation from the Ministry of Education of China; Jiangsu Province's Medical Elite Program; Jiangsu Province Health Agency; "Liu Da Ren Cai Gao Feng" Project; Priority Academic Program Development of Jiangsu Higher Education Institut	This work was supported by National Natural Science Foundation of China (81170486, 81101498), Natural Science Fund for Distinguished Young Scholars of Jiangsu Province (BK20130049), Scientific Research Foundation from the Ministry of Education of China (43-NJYKDX-3), Jiangsu Province's Medical Elite Program (RC2011168), Key Project of Jiangsu Province Health Agency (K201107), "Liu Da Ren Cai Gao Feng" Project (2012-WS-017), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institute (JX10231801). Web site: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOZASA K, 1989, CANCER, V63, P1625, DOI 10.1002/1097-0142(19890415)63:8<1625::AID-CNCR2820630832>3.0.CO;2-J; ARCHIMBAUD E, 1987, CANCER-AM CANCER SOC, V59, P208, DOI 10.1002/1097-0142(19870115)59:2<208::AID-CNCR2820590205>3.0.CO;2-7; Chang HJ, 1997, ONCOLOGY, V54, P193; Clarke CA, 2004, CANCER EPIDEM BIOMAR, V13, P138, DOI 10.1158/1055-9965.EPI-03-0250; Corradini P, 2004, J CLIN ONCOL, V22, P2172, DOI 10.1200/JCO.2004.12.050; de Leval L, 2010, BRIT J HAEMATOL, V148, P673, DOI 10.1111/j.1365-2141.2009.08003.x; Delfau-Larue MH, 2012, HAEMATOL-HEMATOL J, V97, P1594, DOI 10.3324/haematol.2011.061507; Delmer A, 2009, ASCO M ABSTR S, V27, P8554; Federico M, 2013, J CLIN ONCOL, V31, P240, DOI 10.1200/JCO.2011.37.3647; Gallamini A, 2007, BLOOD, V110, P2316, DOI 10.1182/blood-2007-02-074641; Hershman DL, 2012, J CLIN ONCOL, V30, P4215, DOI 10.1200/JCO.2012.41.6701; Iannitto E, 2008, CRIT REV ONCOL HEMAT, V68, P264, DOI 10.1016/j.critrevonc.2008.06.012; Kyriakou C, 2008, J CLIN ONCOL, V26, P218, DOI 10.1200/JCO.2007.12.6219; Kyriakou C, 2009, J CLIN ONCOL, V27, P3951, DOI 10.1200/JCO.2008.20.4628; Le Gouill S, 2008, J CLIN ONCOL, V26, P2264, DOI 10.1200/JCO.2007.14.1366; Lee SS, 2003, INT J CANCER, V103, P12, DOI 10.1002/ijc.10758; Lin HN, 2010, LEUKEMIA LYMPHOMA, V51, P2208, DOI 10.3109/10428194.2010.525270; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Mourad N, 2008, BLOOD, V111, P4463, DOI 10.1182/blood-2007-08-105759; O'Connor OA, 2007, BRIT J HAEMATOL, V139, P425, DOI 10.1111/j.1365-2141.2007.06658.x; Odejide O, 2013, BLOOD; PANGALIS GA, 1983, CANCER-AM CANCER SOC, V52, P318, DOI 10.1002/1097-0142(19830715)52:2<318::AID-CNCR2820520221>3.0.CO;2-G; Park BB, 2007, LEUKEMIA LYMPHOMA, V48, P716, DOI 10.1080/10428190601123989; Percy C., 1990, INT CLASSIFICATION D; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Rudiger T, 2002, ANN ONCOL, V13, P140, DOI 10.1093/annonc/mdf033; Schetelig J, 2003, HAEMATOLOGICA, V88, P1272; SIEGERT W, 1995, ANN ONCOL, V6, P659, DOI 10.1093/oxfordjournals.annonc.a059281; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; Tokunaga T, 2012, BLOOD, V119, P2837, DOI 10.1182/blood-2011-08-374371; Yu JB, 2009, ONCOLOGY-NY, V23, P288	32	38	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92585	10.1371/journal.pone.0092585	http://dx.doi.org/10.1371/journal.pone.0092585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651162	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800130
J	Silva, FBE; Koomen, E; Diogo, V; Lavalle, C				Batista e Silva, Filipe; Koomen, Eric; Diogo, Vasco; Lavalle, Carlo			Estimating Demand for Industrial and Commercial Land Use Given Economic Forecasts	PLOS ONE			English	Article							CHANGE MODELS; EUROPE; SCALE; SCENARIOS; ACCURACY; DYNAMICS; IMPACTS; GROWTH; CHINA	Current developments in the field of land use modelling point towards greater level of spatial and thematic resolution and the possibility to model large geographical extents. Improvements are taking place as computational capabilities increase and socioeconomic and environmental data are produced with sufficient detail. Integrated approaches to land use modelling rely on the development of interfaces with specialized models from fields like economy, hydrology, and agriculture. Impact assessment of scenarios/policies at various geographical scales can particularly benefit from these advances. A comprehensive land use modelling framework includes necessarily both the estimation of the quantity and the spatial allocation of land uses within a given timeframe. In this paper, we seek to establish straightforward methods to estimate demand for industrial and commercial land uses that can be used in the context of land use modelling, in particular for applications at continental scale, where the unavailability of data is often a major constraint. We propose a set of approaches based on 'land use intensity' measures indicating the amount of economic output per existing areal unit of land use. A base model was designed to estimate land demand based on regional-specific land use intensities; in addition, variants accounting for sectoral differences in land use intensity were introduced. A validation was carried out for a set of European countries by estimating land use for 2006 and comparing it to observations. The models' results were compared with estimations generated using the 'null model' (no land use change) and simple trend extrapolations. Results indicate that the proposed approaches clearly outperformed the 'null model', but did not consistently outperform the linear extrapolation. An uncertainty analysis further revealed that the models' performances are particularly sensitive to the quality of the input land use data. In addition, unknown future trends of regional land use intensity widen considerably the uncertainty bands of the predictions.	[Batista e Silva, Filipe; Lavalle, Carlo] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy; [Batista e Silva, Filipe] Ctr Estudos Geog & Ordenamento Terr, Oporto, Portugal; [Koomen, Eric; Diogo, Vasco] Vrije Univ Amsterdam, Dept Spatial Econ SPINlab, Amsterdam, Netherlands	European Commission Joint Research Centre; EC JRC ISPRA Site; Vrije Universiteit Amsterdam	Silva, FBE (corresponding author), Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy.	filipe.batista@jrc.ec.europa.eu		Koomen, Eric/0000-0002-0676-1252; Batista e Silva, Filipe/0000-0002-8752-6464; Diogo, Vasco/0000-0001-5732-9390				Silva FBE, 2013, J LAND USE SCI, V8, P255, DOI 10.1080/1747423X.2012.667450; Batty M, 1997, J AM PLANN ASSOC, V63, P266, DOI 10.1080/01944369708975918; Batty M., 1999, Computers, Environment and Urban Systems, V23, P205, DOI 10.1016/S0198-9715(99)00015-0; Beckers P, 2013, REG STUD IN PRESS; Brulhart M, 2005, REG SCI URBAN ECON, V35, P597, DOI 10.1016/j.regsciurbeco.2004.09.002; Brulhart M, 2001, WELTWIRTSCH ARCH, V137, P215, DOI 10.1007/BF02707264; Buttner G, 2006, CORINE LAND CO UNPUB; Caetano M, 2009, TECHNICAL REPORT; CARD DH, 1982, PHOTOGRAMM ENG REM S, V48, P431; Carrao H, 2010, INT J REMOTE SENS, V31, P2063, DOI 10.1080/01431160902942910; Chen S.Y., 2007, J CHINA UNIVE MIN TE, V17, P215, DOI [10.1016/S1006-1266(07)60075-3, DOI 10.1016/S1006-1266(07)60075-3]; Cochran WG., 1963, SAMPLING TECHNIQUES; Cohen JP, 2005, REG SCI URBAN ECON, V35, P215, DOI 10.1016/j.regsciurbeco.2004.04.005; De Vor F, 2011, TINBERGEN I RES SERI; Esteban J, 2000, REG SCI URBAN ECON, V30, P353, DOI 10.1016/S0166-0462(00)00035-1; European Environment Agency, 2007, 172007 EUR ENV AG; European Environment Agency, 2006, 72006 EUR ENV AG; Ezcurra R, 2007, EASTERN EUR ECON, V45, P5, DOI 10.2753/EEE0012-8775450301; Forrester J.W, 1961, COMMUNICATIONS; Forrester JW., 1969, URBAN DYNAMICS; Fragkias M, 2010, J LAND USE SCI, V5, P45, DOI 10.1080/17474230903437162; Heistermann M, 2006, AGR ECOSYST ENVIRON, V114, P141, DOI 10.1016/j.agee.2005.11.015; Hoymann J, 2012, J LAND USE SCI, V7, P67, DOI 10.1080/1747423X.2010.522600; Huang DQ, 2011, CHINESE GEOGR SCI, V21, P222, DOI 10.1007/s11769-011-0459-z; JANSSON T, 2008, SUSTAINABILITY IMPAC, P159; Koomen E, 2007, GEOJOURNAL LIB, V90, P1; Koomen E, 2011, GEOJOURNAL LIB, V101; Koomen E, 2008, ANN REGIONAL SCI, V42, P1, DOI 10.1007/s00168-007-0155-1; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Lauf S, 2012, ENVIRON PLANN B, V39, P229, DOI 10.1068/b36046t; Lavalle C, 2011, LECT NOTES COMPUT SC, V6782, P60; Le Mouel P, 2009, SENSOR REPORT SERIES, V2009; Louw E, 2012, REG STUD, V46, P137, DOI 10.1080/00343404.2010.530250; Luo GP, 2010, ECOL COMPLEX, V7, P198, DOI 10.1016/j.ecocom.2010.02.001; Meng Y, 2008, LANDSCAPE URBAN PLAN, V85, P40, DOI 10.1016/j.landurbplan.2007.09.004; Mubareka S, 2013, INT J GEOGR INF SCI, V27, P1740, DOI 10.1080/13658816.2013.782408; Mulatu A, 2010, ENVIRON RESOUR ECON, V45, P459, DOI 10.1007/s10640-009-9323-3; National Research Council, 2013, ADV LAND CHANG MOD O; Pontius GR, 2005, INT J GEOGR INF SCI, V19, P243, DOI 10.1080/13658810410001713434; Pontius RG, 2004, ECOL MODEL, V179, P445, DOI 10.1016/j.ecolmodel.2004.05.010; Raspe O, 2011, ANN REGIONAL SCI, V46, P495, DOI 10.1007/s00168-009-0357-9; Reginster I, 2006, ENVIRON PLANN B, V33, P619, DOI 10.1068/b31079; Rounsevell MDA, 2012, LAND USE POLICY, V29, P899, DOI 10.1016/j.landusepol.2012.01.007; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Tregenna F, 2009, CAMB J ECON, V33, P433, DOI 10.1093/cje/ben032; Veldkamp A, 2001, AGR ECOSYST ENVIRON, V85, P1, DOI 10.1016/S0167-8809(01)00199-2; Verburg PH, 2008, ANN REGIONAL SCI, V42, P57, DOI 10.1007/s00168-007-0136-4; Verburg PH, 2009, LANDSCAPE ECOL, V24, P1167, DOI 10.1007/s10980-009-9355-7; Verburg PH, 2006, GLO CH IGBP, P117; Wu YZ, 2011, CITIES, V28, P147, DOI 10.1016/j.cities.2010.11.002; Zheng XQ, 2012, LANDSCAPE URBAN PLAN, V106, P51, DOI 10.1016/j.landurbplan.2012.02.006	51	23	23	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91991	10.1371/journal.pone.0091991	http://dx.doi.org/10.1371/journal.pone.0091991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24647587	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500067
J	Cai, Y; Yang, QT; Tang, YQ; Zhang, MX; Liu, HY; Zhang, GL; Deng, QY; Huang, J; Gao, ZL; Zhou, BP; Feng, CG; Chen, XC				Cai, Yi; Yang, Qianting; Tang, Yueqiang; Zhang, Mingxia; Liu, Haiying; Zhang, Guoliang; Deng, Qunyi; Huang, Jian; Gao, Zhiliang; Zhou, Boping; Feng, Carl G.; Chen, Xinchun			Increased Complement C1q Level Marks Active Disease in Human Tuberculosis	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; GENE-EXPRESSION; T-CELLS; PULMONARY TUBERCULOSIS; DENDRITIC CELLS; ACTIVATION; INFECTION; METAANALYSIS; DIAGNOSIS; MODULATION	Background: Complement functions as an important host defense system and complement C5 and C7 have been implicated in immunopathology of tuberculosis. However, little is known about the role of other complement components in tuberculosis. Methods: Complement gene expression in peripheral blood mononuclear cells of tuberculosis patients and controls were determined using whole genome transcriptional microarray assays. The mRNA and protein levels of three C1q components, C1qA, C1qB, and C1qC, were further validated by qRT-PCR and enzyme-linked immunosorbent assay, respectively. The percentages of C1q expression in CD14 positive cells were determined by flow cytometry. Finally, C1qC protein level was quantified in the pleural fluid of tuberculosis and non-tuberculosis pleurisy. Results: C1q expression increases significantly in the peripheral blood of patients with active tuberculosis compared to healthy controls and individuals with latent TB infection. The percentage of C1q-expressing CD14 positive cells is significantly increased in active TB patients. C1q expression in the peripheral blood correlates with sputum smear positivity in tuberculosis patients and is reduced after anti-tuberculosis chemotherapy. Notably, receiver operating characteristic analysis showed that C1qC mRNA levels in peripheral blood efficiently discriminate active from latent tuberculosis infection and healthy controls. Additionally, C1qC protein level in pleural effusion shows improved power in discriminating tuberculosis from non-tuberculosis pleurisy when compared to other inflammatory markers, such as IL-6 and TNF-alpha. Conclusions: C1q expression correlates with active disease in human tuberculosis. C1q could be a potential diagnostic marker to discriminate active tuberculosis from latent tuberculosis infection as well as tuberculosis pleurisy from non-tuberculosis pleurisy.	[Cai, Yi; Gao, Zhiliang] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Qianting; Tang, Yueqiang; Zhang, Mingxia; Zhang, Guoliang; Zhou, Boping; Chen, Xinchun] Shenzhen Third Peoples Hosp, Guangdong Key Lab Emerging Infect Dis, Shenzhen, Peoples R China; [Cai, Yi; Yang, Qianting; Tang, Yueqiang; Deng, Qunyi; Huang, Jian; Chen, Xinchun] Shenzhen Third Peoples Hosp, Guangdong Med Coll, Shenzhen Key Lab Infect & Immun, Shenzhen, Peoples R China; [Liu, Haiying] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Huang, Jian] Natl Engn Ctr Biochip Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China; [Feng, Carl G.] Univ Sydney Univ, Sydney Med Sch, Dept Infect Dis & Immunol, Sydney, NSW, Australia	Sun Yat Sen University; Guangdong Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; University of Sydney	Chen, XC (corresponding author), Shenzhen Third Peoples Hosp, Guangdong Key Lab Emerging Infect Dis, Shenzhen, Peoples R China.	chenxinchun@gmail.com	Cai, Yi/AAJ-2789-2020; Zhang, Guoliang/C-7678-2017	Cai, Yi/0000-0002-1363-2328; Zhang, Guoliang/0000-0002-3617-5449; feng, carl/0000-0003-4301-4640	Twelfth-Fifth Mega-Scientific Project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases'' [2012ZX10003002]; Natural Science Foundation of China [81171535, 81273140]; Shenzhen science and technology innovation project [JCYJ20130329171031738]	Twelfth-Fifth Mega-Scientific Project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases''; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen science and technology innovation project	This work was supported by Twelfth-Fifth Mega-Scientific Project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases'' (2012ZX10003002), Natural Science Foundation of China Grant (81171535, 81273140), Shenzhen science and technology innovation project (JCYJ20130329171031738). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/678570; [Anonymous], 2013, GLOB TUB CONTR; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Benoit ME, 2012, J IMMUNOL, V188, P5682, DOI 10.4049/jimmunol.1103760; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bohlson SS, 2007, MOL IMMUNOL, V44, P33, DOI 10.1016/j.molimm.2006.06.021; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Castano D, 2011, TUBERCULOSIS, V91, P348, DOI 10.1016/j.tube.2011.04.002; Castellano G, 2007, EUR J IMMUNOL, V37, P2803, DOI 10.1002/eji.200636845; CHEN A, 1994, J IMMUNOL, V153, P1430; Chen GB, 2011, J BIOL CHEM, V286, P34941, DOI 10.1074/jbc.M111.286427; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Chen XC, 2009, CLIN VACCINE IMMUNOL, V16, P879, DOI 10.1128/CVI.00044-09; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Cortes-Hernandez J, 2004, EUR J IMMUNOL, V34, P3713, DOI 10.1002/eji.200425616; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Dorman SE, 2010, CLIN INFECT DIS, V50, pS173, DOI 10.1086/651488; El-Sony A, 2002, INT J TUBERC LUNG D, V6, P91; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Farber K, 2009, J NEUROSCI RES, V87, P644, DOI 10.1002/jnr.21875; Fraser DA, 2006, J LEUKOCYTE BIOL, V80, P107, DOI 10.1189/jlb.1105683; Heeger PS, 2012, IMMUNOBIOLOGY, V217, P216, DOI 10.1016/j.imbio.2011.06.004; KOROTZER AR, 1995, EXP NEUROL, V134, P214, DOI 10.1006/exnr.1995.1051; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Liang QL, 2008, RESP MED, V102, P744, DOI 10.1016/j.rmed.2007.12.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Losi M, 2007, EUR RESPIR J, V30, P1173, DOI 10.1183/09031936.00067307; Lu J, 2008, CELL MOL IMMUNOL, V5, P9, DOI 10.1038/cmi.2008.2; MAEDA M, 1988, CELL TISSUE RES, V254, P543; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Merchant S, 2013, IMMUNOBIOLOGY, V218, P869, DOI 10.1016/j.imbio.2012.10.010; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Mutoloki S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-336; Nayak A, 2012, INNATE IMMUN-LONDON, V18, P350, DOI 10.1177/1753425910396252; Ors F, 2007, J THORAC IMAG, V22, P154, DOI 10.1097/01.rti.0000213590.29472.ce; Petry F, 2001, J IMMUNOL, V167, P4033, DOI 10.4049/jimmunol.167.7.4033; Qiu ZG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00216; REID KBM, 1986, ESSAYS BIOCHEM, V22, P27; Schorey JS, 1997, SCIENCE, V277, P1091, DOI 10.1126/science.277.5329.1091; Son M, 2012, P NATL ACAD SCI USA, V109, pE3160, DOI 10.1073/pnas.1212753109; Tuberculosis, 2011, NICE CLIN GUID; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044944	47	70	74	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92340	10.1371/journal.pone.0092340	http://dx.doi.org/10.1371/journal.pone.0092340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647646	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500120
J	Scheyer, TM; Romano, C; Jenks, J; Bucher, H				Scheyer, Torsten M.; Romano, Carlo; Jenks, Jim; Bucher, Hugo			Early Triassic Marine Biotic Recovery: The Predators' Perspective	PLOS ONE			English	Article							SULFUR MOUNTAIN FORMATION; PERMIAN MASS EXTINCTION; MONTE-SAN-GIORGIO; U-PB AGES; BRITISH-COLUMBIA; GUIZHOU PROVINCE; ANHUI PROVINCE; SOUTH CHINA; WAPITI LAKE; TIME-SCALE	Examining the geological past of our planet allows us to study periods of severe climatic and biological crises and recoveries, biotic and abiotic ecosystem fluctuations, and faunal and floral turnovers through time. Furthermore, the recovery dynamics of large predators provide a key for evaluation of the pattern and tempo of ecosystem recovery because predators are interpreted to react most sensitively to environmental turbulences. The end-Permian mass extinction was the most severe crisis experienced by life on Earth, and the common paradigm persists that the biotic recovery from the extinction event was unusually slow and occurred in a step-wise manner, lasting up to eight to nine million years well into the early Middle Triassic (Anisian) in the oceans, and even longer in the terrestrial realm. Here we survey the global distribution and size spectra of Early Triassic and Anisian marine predatory vertebrates (fishes, amphibians and reptiles) to elucidate the height of trophic pyramids in the aftermath of the end-Permian event. The survey of body size was done by compiling maximum standard lengths for the bony fishes and some cartilaginous fishes, and total size (estimates) for the tetrapods. The distribution and size spectra of the latter are difficult to assess because of preservation artifacts and are thus mostly discussed qualitatively. The data nevertheless demonstrate that no significant size increase of predators is observable from the Early Triassic to the Anisian, as would be expected from the prolonged and stepwise trophic recovery model. The data further indicate that marine ecosystems characterized by multiple trophic levels existed from the earliest Early Triassic onwards. However, a major change in the taxonomic composition of predatory guilds occurred less than two million years after the end-Permian extinction event, in which a transition from fish/amphibian to fish/reptile-dominated higher trophic levels within ecosystems became apparent.	[Scheyer, Torsten M.; Romano, Carlo; Bucher, Hugo] Univ Zurich, Palaontol Inst & Museum, Zurich, Switzerland; [Jenks, Jim] New Mexico Museum Nat Hist & Sci, Albuquerque, NM USA	University of Zurich	Scheyer, TM (corresponding author), Univ Zurich, Palaontol Inst & Museum, Zurich, Switzerland.	tscheyer@pim.uzh.ch; carlo.romano@pim.uzh.ch	Romano, Carlo/H-8903-2012; Romano, Carlo/AAG-2859-2021; Bucher, Hugo F.R./O-2212-2013	Romano, Carlo/0000-0003-4438-2736; Romano, Carlo/0000-0003-4438-2736; Bucher, Hugo F.R./0000-0001-9164-5258; Scheyer, Torsten M./0000-0002-6301-8983	The Swiss National Science Foundation [31003A_127053, 146440, 135446, 120311/135075]	The Swiss National Science Foundation(Swiss National Science Foundation (SNSF))	The Swiss National Science Foundation (http://www.snsf.ch) is acknowledged for past and present project funding (Grant Nos. 31003A_127053 and 146440 to TMS; 135446 to HB and 120311/135075 to W. Brinkmann, Zurich). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aellen M., 1972, RAPPORT GRONLANDS GE, V48, P39, DOI https://doi.org/10.34194/rapggu.v48.7308; [Anonymous], 2005, ANN U FERRARA MUSEOL; [Anonymous], 2010, ZBL GEOL PALAONTOL 2; [Anonymous], 2002, FIELDIANA GEOLOGY, DOI DOI 10.5962/BHL.TITLE.3275; [Anonymous], 2001, FIELDIANA GEOL NS, DOI DOI 10.5962/BHL.TITLE.3449; Balini M, 2012, RIV ITAL PALEONTOL S, V118, P155, DOI 10.13130/2039-4942/5996; Balini M, 2010, GEOL SOC SPEC PUBL, V334, P221, DOI 10.1144/SP334.10; Bardet Nathalie, 1995, Palaeovertebrata (Montpellier), V24, P177; Bardet Nathalie, 1994, Historical Biology, V7, P313; Beltan L., 1979, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1979, P257; Benson RBJ, 2011, GEOL SOC SPEC PUBL, V358, P191, DOI 10.1144/SP358.13; Benson RBJ, 2010, P ROY SOC B-BIOL SCI, V277, P829, DOI 10.1098/rspb.2009.1845; Benton M. J., 2005, VERTEBRATE PALEONTOL; Benton MJ, 2013, EARTH-SCI REV, V125, P199, DOI 10.1016/j.earscirev.2013.05.014; Benton MJ, 2004, NATURE, V432, P97, DOI 10.1038/nature02950; Bernard A, 2010, SCIENCE, V328, P1379, DOI 10.1126/science.1187443; BIRKENMAJER K, 1979, Studia Geologica Polonica, V60, P7; Bjerager M, 2006, GEOL MAG, V143, P635, DOI 10.1017/S0016756806002020; Bjerring HC, 1999, NEW AMPHIBIOUS TETRA; Blazejowski Blazej, 2004, Polish Polar Research, V25, P153; Bohme W, 2010, SPEZIELLE ZOOLOGIE 2, P360; Brack P, 2005, EPISODES, V28, P233, DOI 10.18814/epiiugs/2005/v28i4/001; BRINKMAN DB, 1992, PALAEONTOLOGY, V35, P465; Brinkmann Winand, 2004, Schweizerische Palaeontologische Abhandlungen, V124, P1; BRUHWILER T., 2012, SPEC PAP PALAEONTOL, V88, p[22, 1]; Buchan SH, 1965, NOR POLARINST SKR, P5; BUCHER H, 1989, ECLOGAE GEOL HELV, V82, P945; Bucher H, 2013, 125 ANN ANN M GEOL S; Callaway J.M., 1989, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V178, P37; CALLAWAY JM, 1989, J PALEONTOL, V63, P930, DOI 10.1017/S0022336000036635; Camargo JA, 1995, OIKOS, V74, P538, DOI 10.2307/3546000; CARROLL RL, 1981, PHILOS T ROY SOC B, V293, P315, DOI 10.1098/rstb.1981.0079; CARROLL RL, 1991, PHILOS T ROY SOC B, V331, P131, DOI 10.1098/rstb.1991.0004; Case E. C., 1936, Contributions from the Museum of Paleontology University of Michigan, V5, P1; Casini M, 2012, P NATL ACAD SCI USA, V109, P8185, DOI 10.1073/pnas.1113286109; Chen XH, 2013, ACTA GEOL SIN-ENGL, V87, P672, DOI 10.1111/1755-6724.12078; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/ngeo1475, 10.1038/NGEO1475]; Chin K., 2002, PREDATION FOSSIL REC, V8, P43; Clement G, 1999, J VERTEBR PALEONTOL, V19, P234, DOI 10.1080/02724634.1999.10011137; COX CB, 1973, GEOL MAG, V110, P405, DOI 10.1017/S0016756800036190; CURRIE P J, 1981, Palaeontologia Africana, V24, P99; Cuthbertson RS, 2013, J VERTEBR PALEONTOL, V33, P831, DOI 10.1080/02724634.2013.755989; Cuthbertson RS, 2013, J VERTEBR PALEONTOL, V33, P817, DOI 10.1080/02724634.2013.756495; D-y Jiang, 2013, 125 ANN ANN M GEOL S; Domning DP, 2001, NATURE, V413, P625, DOI 10.1038/35098072; Dong Z-M, 1972, I VERTEBRATE PALEONT, V9, P7; Embry AF, 1997, B CAN PETROL GEOL, V45, P415; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; Fortuny J, 2011, J EVOLUTION BIOL, V24, P2040, DOI 10.1111/j.1420-9101.2011.02338.x; Friedman M, 2012, PALAEONTOLOGY, V55, P707, DOI 10.1111/j.1475-4983.2012.01165.x; Frobisch J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003733; Frobisch J, 2013, PALAEOGEOGR PALAEOCL, V372, P50, DOI 10.1016/j.palaeo.2012.10.036; Frobisch NB, 2013, P NATL ACAD SCI USA, V110, P1393, DOI 10.1073/pnas.1216750110; Furin S, 2006, GEOLOGY, V34, P1009, DOI 10.1130/G22967A.1; Fv Huene, 1920, ACTA ZOOL-STOCKHOLM, V1, P433; Galfetti T, 2008, SEDIMENT GEOL, V204, P36, DOI 10.1016/j.sedgeo.2007.12.008; Galfetti T, 2007, PALAEOGEOGR PALAEOCL, V243, P394, DOI 10.1016/j.palaeo.2006.08.014; Galfetti T, 2007, EARTH PLANET SC LETT, V258, P593, DOI 10.1016/j.epsl.2007.04.023; Galfetti T, 2007, GEOLOGY, V35, P291, DOI 10.1130/G23117A.1; Gheerbrant Emmanuel, 2005, P84; GINGERICH P D, 1981, Contributions from the Museum of Paleontology University of Michigan, V25, P235; Gingerich P. D., 2005, PLACENTAL MAMMALS OR, P234; GINGERICH PD, 1994, NATURE, V368, P844, DOI 10.1038/368844a0; Ginter Michal, 2010, P1; Goudemand N, 2012, PALAEONTOLOGY, V55, P1021, DOI 10.1111/j.1475-4983.2012.01174.x; Goudemand N, 2012, GEOBIOS-LYON, V45, P199, DOI 10.1016/j.geobios.2011.06.001; Goudemand N, 2011, P NATL ACAD SCI USA, V108, P8720, DOI 10.1073/pnas.1101754108; Gradstein FM, 2004, LETHAIA, V37, P175, DOI 10.1080/00241160410006483; GRIFFITH JOHN, 1959, PROC ZOOL SOC LONDON, V132, P587; Guex J., 2010, MEM GEOL LAUSANNE, V49, P1; Guffroy S, 1956, B SOC GEOLOGIQUE FRA, V6, P847; Guinot G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3669; Guinot G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044632; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hammer WR, 1987, PALEONTOLOGY AM GEOP, V41; HARLAND W.B., 1997, GEOLOGICAL SOC MEMOI, V17; Hewison RH, 2007, J TEMNOSPONDYL PALAE, V1; HOGLER J A, 1992, Palaios, V7, P108, DOI 10.2307/3514800; Hu SX, 2011, P ROY SOC B-BIOL SCI, V278, P2274, DOI 10.1098/rspb.2010.2235; Hulbert RC, 1998, J PALEONTOL, V72, P907, DOI 10.1017/S0022336000027232; Huttenlocker AK, 2012, AM MUS NOVIT, P1; Ivanov Alexander, 2007, Bulletin of the New Mexico Museum of Natural History and Science, V41, P108; Jackson JBC, 2006, TRENDS ECOL EVOL, V21, P322, DOI 10.1016/j.tree.2006.03.017; Janvier P, 2008, MAJOR TRANSITION VER, P57; Jiang DY, 2012, J VERTEBR PALEONTOL, V32, P117; Jiang DY, 2008, PROG NAT SCI-MATER, V18, P1315, DOI 10.1016/j.pnsc.2008.01.039; Jiang DY, 2009, ACTA GEOL SIN-ENGL, V83, P451, DOI 10.1111/j.1755-6724.2009.00047.x; Jiang DY, 2005, ACTA GEOL SIN-ENGL, V79, P729; Jin Fan, 2006, Vertebrata Palasiatica, V44, P28; Kasumzadeh AA, 2000, SOSTOJANIE IZUCHENNO; Kauffman EG, 1996, GEOL SOC SP, P15, DOI 10.1144/GSL.SP.1996.001.01.02; Kelley NP, 2012, J VERTEBR PALEONTOL, V32, P120; Kelley NP, 2012, PALAEOGEOGR PALAEOCL, DOI [10.1016/j.palaeo.2012.1007.1026, DOI 10.1016/J.PALAEO.2012.1007.1026]; Ketchum HF, 2004, CAN J EARTH SCI, V41, P1, DOI 10.1139/E03-084; Klein N, 2014, ACTA PALAEONTOL POL, V59, P887, DOI 10.4202/app.2012.0147; Kogan I, 2011, B GEOL SOC DENMARK, V59, P93; Koot MB, 2013, THESIS PLYMOUTH U PL; Kosch B.F., 1990, Journal of Vertebrate Paleontology, V10, P512; Kuraku S, 2006, ZOOL SCI, V23, P1053, DOI 10.2108/zsj.23.1053; Lehman J. -P., 1956, ANN PALEONTOL, V42, P67; Lehman J.P., 1961, ANN PALEONTOL, V47, P42; LEHMAN JEAN-PIERRE, 1952, K SVENSKA VETENSKAPS AKAD HANDL, V2, P1; Lehrmann DJ, 2007, AAPG BULL, V91, P287, DOI 10.1306/10160606065; Leidy J., 1868, P ACAD NAT SCI PHILA, V20, P177; Li C., 2010, CHINESE SCI BULL, V24, P80; Li Jin-Ling, 2006, Vertebrata Palasiatica, V44, P99; Li Jin-Ling, 2002, Vertebrata Palasiatica, V40, P241; Li QG, 2009, PALAEONTOLOGY, V52, P369, DOI 10.1111/j.1475-4983.2009.00848.x; Lindemann F.-J., 1991, 5 S MES TERR EC BIOT, V364, P39; Lindemann F.-J., 2006, BOR TRIASS 2006 LONG, P94; Liu Guan-Bang, 2002, Acta Palaeontologica Sinica, V41, P27; Liu H-T, 1964, VERTEBRAT PALASIATIC, V8, P213; Long C, 2006, J PALEONTOL, V80, P583, DOI 10.1666/0022-3360(2006)80[583:GITTIP]2.0.CO;2; Lucas Spencer G., 2000, Albertiana, V24, P27; Lucas Spencer G., 1997, P423, DOI 10.1016/B978-012155210-7/50022-3; Maganuco Simone, 2009, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V36, P1; Maisch Michael W., 2010, Palaeodiversity, P151; Maisch Michael W., 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V298, P1; Maisch MW, 2003, NEUES JAHRB GEOL P-A, V229, P317, DOI 10.1127/njgpa/229/2003/317; Maisch MW, 2003, NEUES JAHRB GEOL P-A, V227, P93, DOI 10.1127/njgpa/227/2003/93; Maisch MW, 2002, NEUES JAHRB GEOL P-A, V226, P59; Maisch MW, 2002, LETHAIA, V35, P250, DOI 10.1080/00241160260288839; Maisey, 1989, AM MUS NOVIT, V2931, P1; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; MASSARE JA, 1990, GEOL SOC AM BULL, V102, P409, DOI 10.1130/0016-7606(1990)102<0409:TAAEOT>2.3.CO;2; MASSARE JA, 1994, J VERTEBR PALEONTOL, V14, P139, DOI 10.1080/02724634.1994.10011545; Maxwell EE, 2013, GFF, V135, P85, DOI 10.1080/11035897.2012.759145; Mazin J-M, 1984, 3 S MES TERR EC, P135; Mazin J-M, 1984, 3 S MES TERR EC TURB, P141; Mazin Jean Michel, 1993, Paleontologia Lombarda, V2, P93; MAZIN JM, 1989, GEOBIOS-LYON, V22, P725, DOI 10.1016/S0016-6995(89)80069-5; MAZIN JM, 1991, CR ACAD SCI II, V313, P1207; MAZIN JM, 1981, CR ACAD SCI II, V293, P203; MAZIN JM, 1987, CR ACAD SCI II, V305, P823; McAllister J, 2003, T GEOBIOL, V20, P303; McGowan C, 1996, CAN J EARTH SCI, V33, P1011, DOI 10.1139/e96-077; MCGOWAN C., 2003, HDB PALEOHERPETOLOGY, V8, P1; Merriam J. C., 1904, Bulletin Geol University California, Viii, P419; Merriam John C., 1908, Memoirs of the University of California Berkeley, VNo.1; Merriam John Campbell, 1906, Berkeley University of California Publ Bull Dept Geol, V5, P75; Mork A, 1999, POLAR RES, V18, P51, DOI 10.1111/j.1751-8369.1999.tb00277.x; Motani R, 2005, ANNU REV EARTH PL SC, V33, P395, DOI 10.1146/annurev.earth.33.092203.122707; Motani R, 1999, J VERTEBR PALEONTOL, V19, P473, DOI 10.1080/02724634.1999.10011160; Motani R, 1996, NATURE, V382, P347, DOI 10.1038/382347a0; Motani R, 1997, J VERTEBR PALEONTOL, V17, P39, DOI 10.1080/02724634.1997.10010951; Motani R, 1999, J VERTEBR PALEONTOL, V19, P28, DOI 10.1080/02724634.1999.10011120; Motani R, 1998, NATURE, V393, P255, DOI 10.1038/30473; Motani R, 1996, J VERTEBR PALEONTOL, V16, P396, DOI 10.1080/02724634.1996.10011329; Motani R, 2000, J VERTEBR PALEONTOL, V20, P295, DOI 10.1671/0272-4634(2000)020[0295:IOIAPP]2.0.CO;2; Motani R, 1998, J VERTEBR PALEONTOL, V18, P533, DOI 10.1080/02724634.1998.10011080; Motani R, 2000, PALAEONTOLOGY, V43, P1, DOI 10.1111/1475-4983.00115; Motani R, 1997, THESIS U TORONTO TOR; Motani R, 2008, J VERTEBR PALEONTOL, V28, P900, DOI 10.1671/0272-4634(2008)28[900:HAAOMT]2.0.CO;2; Motani Ryosuke, 1999, Paludicola, V2, P174; Motani R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066075; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Motani R, 2010, SCIENCE, V328, P1361, DOI 10.1126/science.1191409; Muller J, 2007, J VERTEBR PALEONTOL, V27, P236, DOI 10.1671/0272-4634(2007)27[236:FROATF]2.0.CO;2; Muller J, 2005, CAN J EARTH SCI, V42, P1347, DOI 10.1139/E05-030; Muller J, 2005, BIOESSAYS, V27, P1069, DOI 10.1002/bies.20286; Mundil R, 2010, GEOL SOC SPEC PUBL, V334, P41, DOI 10.1144/SP334.3; Mutter RJ, 2008, ZOOL J LINN SOC-LOND, V154, P419, DOI 10.1111/j.1096-3642.2008.00488.x; Mutter RJ, 2007, ZOOL J LINN SOC-LOND, V149, P309; Mutter Raoul J., 2008, P103; Mutter RJ, 2008, GEOL SOC SPEC PUBL, V295, P9, DOI 10.1144/SP295.3; Mutter RJ, 2009, PALAEOGEOGR PALAEOCL, V284, P22, DOI 10.1016/j.palaeo.2009.08.024; Mutter RJ, 2006, ACTA PALAEONTOL POL, V51, P271; Mutter RJ, 2005, ECLOGAE GEOL HELV, V98, P271, DOI 10.1007/s00015-005-1164-7; Neenan JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2633; Neenan JM, 2012, J VERTEBR PALEONTOL, V32, P1350, DOI 10.1080/02724634.2012.695241; Nicholls EL, 2004, J VERTEBR PALEONTOL, V24, P838, DOI 10.1671/0272-4634(2004)024[0838:GIOTTN]2.0.CO;2; NICHOLLS EL, 1993, J PALEONTOL, V67, P263, DOI 10.1017/S0022336000032194; Nicholls EL, 2001, CAN J EARTH SCI, V38, P983, DOI 10.1139/e00-115; NICHOLLS EL, 1993, CAN J EARTH SCI, V30, P486, DOI 10.1139/e93-037; Nicholls Elizabeth L., 1999, Paleobios, V19, P1; Nicholls Elizabeth L., 1995, P521; Nield CM, 2006, ALCHERINGA, V30, P263, DOI 10.1080/03115510608619317; Nielsen E, 1949, PALAEOZOOLOGICA GROE, V3, P1; Nielsen E., 1935, MEDDELELSER GRONLAND, V98, P1, DOI DOI 10.1017/S1477201907002040; Nielsen E., 1942, PALAEOZOOLOGICA GROE, V1, P1; Nielsen E., 1961, P 1 INT S ARCT GEOL, P255; NIELSEN EIGIL, 1952, MEDDEL GRONLAND, V144, P1; Noetling F, 1901, NEUES JB MINERALOGIE, VXIV, P369; Obruchev DB, 1965, T PALEONTOLOGISCHESK, V108, P266; Orchard MJ, 2007, PALAEOGEOGR PALAEOCL, V252, P93, DOI 10.1016/j.palaeo.2006.11.037; Organ CL, 2009, NATURE, V461, P389, DOI 10.1038/nature08350; Ovtcharova M, 2006, EARTH PLANET SC LETT, V243, P463, DOI 10.1016/j.epsl.2006.01.042; Ovtcharova M, 2013, 125 ANN ANN M GEOL S; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Payne JL, 2012, ANNU REV EARTH PL SC, V40, P89, DOI 10.1146/annurev-earth-042711-105329; Peyer B., 1939, ABHANDLUNGEN SCHWEIZ, V62:, P1; PITRAT CW, 1973, PALAEOGEOGR PALAEOCL, V14, P249, DOI 10.1016/0031-0182(73)90011-4; Piveteau J., 1926, Annales de Paleontologie, V15, P53; Piveteau J., 1935, CR SEANCES SOC GEOL, V1935, P113; PIVETEAU JEAN, 1944, ANN PALEONTOL, V31, P79; Rieppel O, 2005, CAN J EARTH SCI, V42, P2081, DOI 10.1139/E05-076; RIEPPEL O, 1992, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V221, P63; Rieppel O., 1980, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1980, P43; Rieppel O, 1999, J VERTEBR PALEONTOL, V19, P321, DOI 10.1080/02724634.1999.10011144; Rieppel O, 1998, ZOOL J LINN SOC-LOND, V124, P1; Rieppel O, 2000, HDB PALAOHERPETOLO A, V12A, P1; Rieppel Olivier, 2001, Palaeontologische Zeitschrift, V75, P207; Rieppel O, 2010, J VERTEBR PALEONTOL, V30, P1082, DOI 10.1080/02724634.2010.483548; Rieppel Olivier, 1997, P121, DOI 10.1016/B978-012155210-7/50009-0; Romano C, 2013, 125 ANN ANN M GEOL S; Romano C, 2013, NAT GEOSCI, V6, P57, DOI [10.1038/ngeo1667, 10.1038/NGEO1667]; Romano C, 2012, B GEOSCI, V87, P543, DOI 10.3140/bull.geosci.1337; Romano C, 2010, J VERTEBR PALEONTOL, V30, P1673, DOI 10.1080/02724634.2010.521962; Romano C, 2009, NEUES JAHRB GEOL P-A, V252, P17, DOI 10.1127/0077-7749/2009/0252-0017; Romanuk TN, 2011, GLOBAL ECOL BIOGEOGR, V20, P231, DOI 10.1111/j.1466-8238.2010.00579.x; Roopnarine PD, 2007, P ROY SOC B-BIOL SCI, V274, P2077, DOI 10.1098/rspb.2007.0515; Rothschild BM, 2012, NATURWISSENSCHAFTEN, V99, P443, DOI 10.1007/s00114-012-0918-0; RUSSELL LORIS S., 1951, NATL MUS CANADA BULL, V123, P218; Ruta M, 2011, PALAEONTOLOGY, V54, P1117, DOI 10.1111/j.1475-4983.2011.01051.x; Sander P. Martin, 1998, Palaeontologische Zeitschrift, V72, P149; Sander PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019480; Sander P. Martin, 2000, Palaeontologische Zeitschrift, V74, P1; Sander PM, 2003, J VERTEBR PALEONTOL, V23, P799, DOI 10.1671/6; Sander PM, 1989, J VERTEBR PALEONTOL, V9, P163; SAVAGE RJG, 1994, J VERTEBR PALEONTOL, V14, P427, DOI 10.1080/02724634.1994.10011569; Save-Soderbergh G., 1935, Meddelelser om Gronland, V98, P1; Save-Soderburgh G., 1937, Bulletin of the Geological Institution University of Uppsala, V27, P189; Schaeffer B., 1976, Bulletin Am Mus nat Hist, V156, P515; Scheyer TM, 2012, HIST BIOL, V24, P257, DOI 10.1080/08912963.2011.621083; Scheyer TM, 2010, PALAEONTOL ELECTRON, V13; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schoch R.R., 2000, ENCY PALEOHERPETOL B, P1, DOI DOI 10.1127/0077-7749/2007/0246-0001; Schoch Rainer R., 2002, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V321, P1; Schoch RR, 2011, FOSS REC, V14, P119, DOI 10.1002/mmng.201100002; Schultze Hans-Peter, 2004, P463; Sennikov AG, 2011, PALEONTOL J+, V45, P90, DOI 10.1134/S0031030111010151; Shang Qing-Hua, 2009, Vertebrata Palasiatica, V47, P178; Shen SZ, 2011, SCIENCE, V334, P1367, DOI 10.1126/science.1213454; Shikama T., 1978, SCI REP TOHO UNIV-G, V48, P77; Spa th L.F., 1934, CATALOGUE FOSSIL C 4; Steneck RS, 2012, P NATL ACAD SCI USA, V109, P7953, DOI 10.1073/pnas.1205591109; Stensio E., 1925, KUNGLIGA SVENSKA VET, V3, P1; Stensio E, 1921, TRIASSIC FISHES SPIT; STENSIo ERIE A., 1932, MEDDELEL OM GRONLAND, V83, P1; Steyer JS, 2010, CR PALEVOL, V9, P463, DOI 10.1016/j.crpv.2010.07.007; Steyer JS, 2002, PALAEONTOLOGY, V45, P771, DOI 10.1111/1475-4983.00260; Storrs G.W., 1991, B PEABODY MUS NAT HI, V44, P1; SU DZ, 1981, VERTEBRAT PALASIATIC, V19, P107; SU T. T., 1959, VERTEBRATA PALASIATICA [CHINA], V3, P205; Sun ZY, 2009, ACTA GEOL SIN-ENGL, V83, P460, DOI 10.1111/j.1755-6724.2009.00067.x; Sun ZY, 2008, RIV ITAL PALEONTOL S, V114, P363, DOI 10.13130/2039-4942/5908; Tapanila L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0057; Theodori C, 1854, BESCHREIBUNG KOLOSSA; Thomson KS., 1977, DEV PALAEONTOLOGY ST, Vvol. 5, P377, DOI DOI 10.1016/S0920-5446(08)70332-7; Thorne PM, 2011, P NATL ACAD SCI USA, V108, P8339, DOI 10.1073/pnas.1018959108; Tichy Gottfried, 1995, Geologisch-Palaeontologische Mitteilungen, V20, P349; Tintori A., 2004, MESOZOIC FISHES, P565; Tintori A, 2014, INTEGR ZOOL, V9, P394, DOI 10.1111/1749-4877.12077; Tintori A, 2010, RIV ITAL PALEONTOL S, V116, P161, DOI 10.13130/2039-4942/5947; Tong JN, 2011, ACTA GEOL SIN-ENGL, V85, P399, DOI 10.1111/j.1755-6724.2011.00408.x; Tong JN, 2006, J PALEONTOL, V80, P146, DOI 10.1666/0022-3360(2006)080[0146:FFFTLT]2.0.CO;2; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; Tuomisto H, 2010, OECOLOGIA, V164, P853, DOI 10.1007/s00442-010-1812-0; Turner S, 2010, GEODIVERSITAS, V32, P545, DOI 10.5252/g2010n4a1; Walker Sally E., 2002, Paleontological Society Papers, V8, P119; Wang K, 1959, ACTA PAL SIN, V7, P373; Wang Nian-Zhong, 2001, Vertebrata Palasiatica, V39, P237; Wang X.F., 2003, GEOLOGY CHINA, V30, P20; Wang XF, 2008, PALAEONTOLOGY, V51, P27, DOI 10.1111/j.1475-4983.2007.00735.x; Warren Anne, 2000, Amphibian Biology, V4, P1121; Weitschat W., 1989, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V68, P179; Welles Samuel P., 1993, Paleobios, V14, P1; Wendruff AJ, 2013, CAN J EARTH SCI, V50, P904, DOI 10.1139/cjes-2013-0010; Wendruff AJ, 2012, J VERTEBR PALEONTOL, V32, P499, DOI 10.1080/02724634.2012.657317; Wild R., 1980, SCHWEIZERISCHE PALAO, V102, P1; Wiman C., 1913, B GEOL I U UPPSALA, V12, P1; Wiman C., 1916, B GEOL I U UPPSALA, V13, P209; Wiman C., 1929, B GEOLOGICAL I U UPP, V22, P183; Wiman C, 1910, B GEOLOGICAL I U UPS, V10, P124; Wiman C., 1914, B GEOLOGICAL I U UPP, V13, P1; Wiman C., 1910, B GEOLOGICAL I U UPP, V9, P34; Witzmann F, 2008, NATURWISSENSCHAFTEN, V95, P67, DOI 10.1007/s00114-007-0291-6; Witzmann F, 2010, ACTA ZOOL-STOCKHOLM, V91, P96, DOI 10.1111/j.1463-6395.2008.00385.x; Wu FX, 2011, ACTA PALAEONTOL POL, V56, P581, DOI 10.4202/app.2010.0007; Wu FX, 2009, ACTA GEOL SIN-ENGL, V83, P440, DOI 10.1111/j.1755-6724.2009.00056.x; Wu XC, 2003, NATURE, V426, P516, DOI 10.1038/426516a; Yin Gongzheng, 2000, Geology Geochemistry, V28, P1; Young CC, 1972, IVPP CHINESE ACAD SC, V9, P1; YOUNG CHUNG-CHIEN, 1958, VERTEBR PALASIAT [CHINA], V2, P69; ZHANG M, 1976, SCI GEOL SINICA, P332; Zhang Qi-yue, 2010, Dizhi Tongbao, V29, P26; Zhang QY, 2008, GEOLOGICAL REV, V54, P145; Zhang Y, 2014, J ASIAN EARTH SCI, V80, P75, DOI 10.1016/j.jseaes.2013.10.032; Zhao Li-jun, 2007, Acta Palaeontologica Sinica, V46, P238	289	84	87	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e88987	10.1371/journal.pone.0088987	http://dx.doi.org/10.1371/journal.pone.0088987			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647136	Green Published, Green Accepted, gold			2022-12-27	WOS:000333348500003
J	Chen, X; Yousef, KP; Duwe, S; Karsch, K; Grover, S; Wahlisch, S; Obermeier, P; Tief, F; Muhlhans, S; Seeber, L; von Kleist, M; Schweiger, B; Rath, B				Chen, Xi; Yousef, Kaveh Pouran; Duwe, Susanne; Karsch, Katharina; Grover, Sandeep; Waehlisch, Stephanie; Obermeier, Patrick; Tief, Franziska; Muehlhans, Susann; Seeber, Lea; von Kleist, Max; Schweiger, Brunhilde; Rath, Barbara			Quantitative Influenza Follow-Up Testing (QIFT)-A Novel Biomarker for the Monitoring of Disease Activity at the Point-of-Care	PLOS ONE			English	Article							RAPID INFLUENZA; FLUORESCENT IMMUNOASSAY; OSELTAMIVIR TREATMENT; B VIRUSES; CHILDREN; MANAGEMENT; RESISTANCE; ACCURACY; INFANTS; IMPACT	Background: Influenza infections induce considerable disease burden in young children. Biomarkers for the monitoring of disease activity at the point-of-care (POC) are currently lacking. Recent methodologies for fluorescence-based rapid testing have been developed to provide improved sensitivities with the initial diagnosis. The present study aims to explore the utility of second-generation rapid testing during longitudinal follow-up of influenza patients (Rapid Influenza Follow-up Testing = RIFT). Signal/control fluorescent readouts (Quantitative Influenza Follow-up Testing = QIFT) are evaluated as a potential biomarker for the monitoring of disease activity at the POC. Methods and Findings: RIFT (SOFIA) and QIFT were performed at the POC and compared to blinded RT-PCR at the National Reference Centre for Influenza. From 10/2011-4/2013, a total of 2048 paediatric cases were studied prospectively; 273 cases were PCR-confirmed for influenza. During follow-up, RIFT results turned negative either prior to PCR (68%), or simultaneously (30%). The first negative RIFT occurred after a median of 8 days with a median virus load (VL) of 5.6x10 boolean AND 3 copies/ml and cycle threshold of 37, with no evidence of viral rebound. Binning analysis revealed that QIFT differentiated accurately between patients with low, medium and high viral titres. QIFT increase/decrease showed 88% agreement (sensitivity = 52%, specificity = 95%) with VL increase/decrease, respectively. QIFT-based viral clearance estimates showed similar values compared to PCR-based estimates. Variations in viral clearance rates were lower in treated compared to untreated patients. The study was limited by use of non-invasive, semi-quantitative nasopharyngeal samples. VL measurements below the limit of detection could not be quantified reliably. Conclusions: During follow-up, RIFT provides a first surrogate measure for influenza disease activity. A "switch" from positive to negative values may indicate a drop in viral load below a critical threshold, where rebound is no longer expected. QIFT may provide a useful tool for the monitoring of disease burden and viral clearance at the POC.	[Chen, Xi; Karsch, Katharina; Grover, Sandeep; Obermeier, Patrick; Tief, Franziska; Muehlhans, Susann; Seeber, Lea; Rath, Barbara] Charite Univ Med Ctr, Dept Paediat, Div Pneumonol Immunol, Berlin, Germany; [Yousef, Kaveh Pouran] Free Univ Berlin, AG Syst Pharmacol & Dis Control, Dept Math & Comp Sci, Berlin, Germany; [Waehlisch, Stephanie; Schweiger, Brunhilde] Robert Koch Inst, Natl Reference Ctr Influenza, Div Influenza & Other Resp Viruses 17, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Robert Koch Institute	Rath, B (corresponding author), Charite Univ Med Ctr, Dept Paediat, Div Pneumonol Immunol, Berlin, Germany.	Barbara.Rath@gmail.com	von Kleist, Max/K-3023-2016	von Kleist, Max/0000-0001-6587-6394; Obermeier, Patrick E./0000-0002-5631-9112; Duwe, Susanne/0000-0003-3171-819X	Hoffmann La Roche Inc.; DFG research centre "MATHEON" [A21]	Hoffmann La Roche Inc.(Hoffmann-La Roche); DFG research centre "MATHEON"(German Research Foundation (DFG))	Charite received an unrestricted grant by Hoffmann La Roche Inc. for the analysis of virologic outcomes in hospitalized children with influenza infection. KPY and MvK received funding through the DFG research centre "MATHEON" (project A21: "Modelling, Simulation and Therapy Optimization for Infectious Diseases"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benito-Fernandez J, 2006, PEDIATR INFECT DIS J, V25, P1153, DOI 10.1097/01.inf.0000246826.93142.b0; Biswas B, 2006, FDA IND STAT WORKSH; Bonner AB, 2003, PEDIATRICS, V112, P363, DOI 10.1542/peds.112.2.363; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Brady MT, 2013, PEDIATRICS, V132, pE1089, DOI 10.1542/peds.2013-2377; Chin BS, 2012, JPN J INFECT DIS, V65, P105; Cho CH, 2013, J VIROL METHODS, V187, P51, DOI 10.1016/j.jviromet.2012.09.003; Dunn G, 1995, STAT MED, V15, P2121; Esposito S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-349; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fleiss J. L., 1981, STAT METHODS RATES P, V2; FRANK AL, 1981, J INFECT DIS, V144, P433, DOI 10.1093/infdis/144.5.433; Gavin P.J., 2004, CLIN APPL IMMUNOL RE, V4, P151, DOI DOI 10.1016/S1529-1049(03)00064-3; Grijalva CG, 2007, PEDIATRICS, V119, pE6, DOI 10.1542/peds.2006-1694; Jennings LC, 2009, INFLUENZA OTHER RESP, V3, P91, DOI 10.1111/j.1750-2659.2009.00079.x; Lee CK, 2012, J CLIN VIROL, V55, P239, DOI 10.1016/j.jcv.2012.07.008; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Leonardi GP, 2013, J VIROL METHODS, V189, P379, DOI 10.1016/j.jviromet.2013.02.008; Lewandrowski K, 2013, AM J CLIN PATHOL, V139, P684, DOI 10.1309/AJCP7ZTLJCP3LLMA; Moore C, 2013, J HOSP INFECT, V85, P1, DOI 10.1016/j.jhin.2013.06.005; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Pepe M. S., 2003, STAT EVALUATION MED; Poehling KA, 2006, ARCH PEDIAT ADOL MED, V160, P713, DOI 10.1001/archpedi.160.7.713; Pongthanapisith V, 2011, INFECTION, V39, P105, DOI 10.1007/s15010-011-0092-x; Rath B, 2013, 15 INT S RESP VIR IN; Rath B, 2012, J CLIN VIROL, V55, P329, DOI 10.1016/j.jcv.2012.08.002; Rath B, 2012, PEDIATR INFECT DIS J, V31, P899, DOI 10.1097/INF.0b013e31825c7304; Schulze M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009966; Siqueira M, 2013, INFLUENZA OTHER RESP, V7, P1, DOI 10.1111/irv.12041; Stephenson I, 2009, CLIN INFECT DIS, V48, P389, DOI 10.1086/596311; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; van der Vries E, 2013, ADV PHARMACOL, V67, P217, DOI 10.1016/B978-0-12-405880-4.00006-8; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; Weitzel T, 2007, CLIN MICROBIOL INFEC, V13, P665, DOI 10.1111/j.1469-0691.2007.01739.x; WHO-EURO, 2011, SEAS INFL KEY ISS CA	36	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92500	10.1371/journal.pone.0092500	http://dx.doi.org/10.1371/journal.pone.0092500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658130	Green Submitted, gold, Green Published			2022-12-27	WOS:000333355300091
J	Ge, C; Cui, YN; Jing, PY; Hong, XY				Ge, Cheng; Cui, Yu-Nan; Jing, Peng-Yu; Hong, Xiao-Yue			An Alternative Suite of Universal Primers for Genotyping in Multiplex PCR	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE MARKERS; COMPUTER-PROGRAM; SOFTWARE; LINKAGE; REPEAT	The universal primer three-primer approach can dramatically reduce the cost when genotyping the microsatellites. One former research reported four universal primers that can be used in singleplex and multiplex genotyping. In this study, we proposed an alternative suite of universal primers with four dyes for genotyping 8-12 loci in one single run. This multiplex method was tested on Tetranychus truncatus. Published microsatellite loci of T. kanzawai, Frankliniella occidentalis and Nilaparvata lugens were modified as needed and also tested. The robustness of the method was confirmed by comparing with singleplex using multiple fluorophores and genotyping two populations of T. truncatus. This method showed lower signal strength than the singleplex three-primer system, but it was still sufficient to determine the fragment length. The cost of such a project can be reduced dramatically when many loci of different species are involved. In this way, laboratories performing population genetic analyses or studying several different species may benefit from the use of this cost-effective protocol.	[Ge, Cheng; Cui, Yu-Nan; Jing, Peng-Yu; Hong, Xiao-Yue] Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Hong, XY (corresponding author), Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China.	xyhong@njau.edu.cn	Hong, Xiao-Yue/AAF-4759-2020	Ge, Cheng/0000-0002-0740-5428	National Public Welfare Professional Fund from the Ministry of Agriculture of China [201103020]; National Natural Science Foundation of China [31172131]	National Public Welfare Professional Fund from the Ministry of Agriculture of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by a Grant-in-Aid from the Science and Technology Program of the National Public Welfare Professional Fund (No. 201103020) from the Ministry of Agriculture of China (www.moa.gov.cn) and a Grant-in-Aid for Scientific Research (No. 31172131) from the National Natural Science Foundation of China (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blacket MJ, 2012, MOL ECOL RESOUR, V12, P456, DOI 10.1111/j.1755-0998.2011.03104.x; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; de Arruda MP, 2010, MOL BIOL REP, V37, P2031, DOI 10.1007/s11033-009-9655-7; Ge C, 2013, EXP APPL ACAROL, V61, P195, DOI 10.1007/s10493-013-9684-8; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; LITT M, 1989, AM J HUM GENET, V44, P397; Miller AD, 2013, MOL BIOL REP, V40, P4415, DOI 10.1007/s11033-013-2531-5; Miller AD, 2013, MOL BIOL REP, V40, P35, DOI 10.1007/s11033-012-1950-z; Miller AD, 2012, CONSERV GENET RESOUR, V4, P257, DOI 10.1007/s12686-011-9519-z; Missiaggia A, 2006, GENET MOL RES, V5, P72; Neilan BA, 1997, NUCLEIC ACIDS RES, V25, P2938, DOI 10.1093/nar/25.14.2938; Nishimura S, 2003, EXP APPL ACAROL, V31, P93, DOI 10.1023/B:APPA.0000005128.70282.a4; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Smith TM, 2013, CONSERV GENET RESOUR, V5, P607, DOI 10.1007/s12686-013-9862-3; Spathis R, 2008, J FORENSIC SCI, V53, P1353, DOI 10.1111/j.1556-4029.2008.00881.x; STEFFENS DL, 1993, BIOTECHNIQUES, V15, P580; Sun JT, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.13401; Tsagkarakou A, 2007, PHYTOPARASITICA, V35, P519, DOI 10.1007/BF03020610; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Yang XM, 2012, INT J MOL SCI, V13, P2863, DOI 10.3390/ijms13032863	26	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92826	10.1371/journal.pone.0092826	http://dx.doi.org/10.1371/journal.pone.0092826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658225	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300132
J	Das, T; Sehar, S; Koop, L; Wong, YK; Ahmed, S; Siddiqui, KS; Manefield, M				Das, Theerthankar; Sehar, Shama; Koop, Leena; Wong, Yie Kuan; Ahmed, Safia; Siddiqui, Khawar Sohail; Manefield, Mike			Influence of Calcium in Extracellular DNA Mediated Bacterial Aggregation and Biofilm Formation	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-EPIDERMIDIS; STREPTOCOCCUS-MUTANS; VIRULENCE FACTORS; ADHESION; ATTACHMENT; PROTEINS; EXPOSURE; RELEASE; CATIONS	Calcium (Ca2+) has an important structural role in guaranteeing the integrity of the outer lipopolysaccharide layer and cell walls of bacterial cells. Extracellular DNA (eDNA) being part of the slimy matrix produced by bacteria promotes biofilm formation through enhanced structural integrity of the matrix. Here, the concurrent role of Ca2+ and eDNA in mediating bacterial aggregation and biofilm formation was studied for the first time using a variety of bacterial strains and the thermodynamics of DNA to Ca2+ binding. It was found that the eDNA concentrations under both planktonic and biofilm growth conditions were different among bacterial strains. Whilst Ca2+ had no influence on eDNA release, presence of eDNA by itself favours bacterial aggregation via attractive acid-base interactions in addition, its binding with Ca2+ at biologically relevant concentrations was shown further increase in bacterial aggregation via cationic bridging. Negative Gibbs free energy (Delta G) values in iTC data confirmed that the interaction between DNA and Ca2+ is thermodynamically favourable and that the binding process is spontaneous and exothermic owing to its highly negative enthalpy. Removal of eDNA through DNase I treatment revealed that Ca2+ alone did not enhance cell aggregation and biofilm formation. This discovery signifies the importance of eDNA and concludes that existence of eDNA on bacterial cell surfaces is a key facilitator in binding of Ca2+ to eDNA thereby mediating bacterial aggregation and biofilm formation.	[Das, Theerthankar; Sehar, Shama; Koop, Leena; Wong, Yie Kuan; Manefield, Mike] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Marine BioInnovat, Sydney, NSW, Australia; [Sehar, Shama; Ahmed, Safia] Quaid I Azam Univ, Dept Microbiol, Islamabad, Pakistan; [Siddiqui, Khawar Sohail] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of New South Wales Sydney; Quaid I Azam University; University of New South Wales Sydney	Das, T (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Marine BioInnovat, Sydney, NSW, Australia.	theerthankar_das11@rediffmail.com	Ahmed, Safia/GNH-4127-2022	Ahmed, Safia/0000-0001-9773-6433; Das, Theerthankar/0000-0003-0581-6060; Siddiqui, Khawar/0000-0001-8574-3177	Australian Research Council (ARC) [FT100100078]	Australian Research Council (ARC)(Australian Research Council)	This work was funded by Australian Research Council (ARC) Future Fellowship Project ID FT100100078, http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammendolia MG, 1999, J CLIN MICROBIOL, V37, P3235, DOI 10.1128/JCM.37.10.3235-3238.1999; Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; Barnes AMT, 2012, MBIO, V3, DOI 10.1128/mBio.00193-12; Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001; Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0; Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2; Chen CZS, 2002, BIOMATERIALS, V23, P3359, DOI 10.1016/S0142-9612(02)00036-4; Chiang WC, 2013, ANTIMICROB AGENTS CH, V57, P2352, DOI 10.1128/AAC.00001-13; Chong G, 2010, THESIS U NEW S WALES; Crismaru M, 2011, ANTIMICROB AGENTS CH, V55, P5010, DOI 10.1128/AAC.05062-11; Cruz LF, 2012, APPL ENVIRON MICROB, V78, P1321, DOI 10.1128/AEM.06501-11; Das Theerthankar, 2013, Commun Integr Biol, V6, pe23570, DOI 10.4161/cib.23570; Das T, 2013, ENV MICROBIOL REP, V5, P778, DOI 10.1111/1758-2229.12085; Das T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058299; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; Das T, 2011, LANGMUIR, V27, P10113, DOI 10.1021/la202013m; Das T, 2011, SOFT MATTER, V7, P2927, DOI 10.1039/c0sm01142h; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Davey CA, 2002, P NATL ACAD SCI USA, V99, P11169, DOI 10.1073/pnas.172271399; De Kerchove AJ, 2008, LANGMUIR, V24, P3392, DOI 10.1021/la7036229; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FLETCHER M, 1988, J BACTERIOL, V170, P2027, DOI 10.1128/jb.170.5.2027-2030.1988; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Goodman SD, 2011, MUCOSAL IMMUNOL, V4, P625, DOI 10.1038/mi.2011.27; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HAYNES CA, 1995, J COLLOID INTERF SCI, V169, P313, DOI 10.1006/jcis.1995.1039; HEPTINSTALL S, 1970, NATURE, V225, P519, DOI 10.1038/225519a0; Huseby MJ, 2010, P NATL ACAD SCI USA, V107, P14407, DOI 10.1073/pnas.0911032107; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Kaplan JB, 2011, RES MICROBIOL, V162, P535, DOI 10.1016/j.resmic.2011.03.008; Kirkpatrick CL, 2010, MOL MICROBIOL, V77, P801, DOI 10.1111/j.1365-2958.2010.07268.x; Lattner D, 2003, INT J BIOL MACROMOL, V33, P81, DOI 10.1016/S0141-8130(03)00070-9; Lee M, 2012, ENVIRON MICROBIOL, V14, P883, DOI 10.1111/j.1462-2920.2011.02656.x; Liu HH, 2008, CURR MICROBIOL, V57, P139, DOI 10.1007/s00284-008-9166-0; McKenney D, 1998, INFECT IMMUN, V66, P4711, DOI 10.1128/IAI.66.10.4711-4720.1998; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c; Patrauchan MA, 2005, MICROBIOL-SGM, V151, P2885, DOI 10.1099/mic.0.28041-0; Peterson BW, 2013, MBIO, V4, DOI 10.1128/mBio.00497-13; Postollec F, 2003, J MICROBIOL METH, V55, P241, DOI 10.1016/S0167-7012(03)00145-3; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Sarkisova S, 2005, J BACTERIOL, V187, P4327, DOI 10.1128/JB.187.13.4327-4337.2005; Sharma PK, 2003, COLLOID SURFACE B, V29, P21, DOI 10.1016/S0927-7765(02)00180-7; Shoji T, 2008, WATER SCI TECHNOL, V58, P1023, DOI 10.2166/wst.2008.457; SMITHIES WR, 1955, CAN J MICROBIOL, V1, P614, DOI 10.1139/m55-074; Spiliopoulou AI, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-76; Steichen CT, 2011, INFECT IMMUN, V79, P1504, DOI 10.1128/IAI.01162-10; Subirana JA, 2003, ANNU REV BIOPH BIOM, V32, P27, DOI 10.1146/annurev.biophys.32.110601.141726; Tsuneda S, 2003, FEMS MICROBIOL LETT, V223, P287, DOI 10.1016/S0378-1097(03)00399-9; van Veen HW, 1997, ANTON LEEUW INT J G, V72, P299, DOI 10.1023/A:1000530927928; VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7; Venkataraman A, 2010, ELECTROCHEM COMMUN, V12, P459, DOI 10.1016/j.elecom.2010.01.019; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Xu CP, 2007, COLLOID SURFACE B, V54, P193, DOI 10.1016/j.colsurfb.2006.10.016; Xu CP, 2008, APPL ENVIRON MICROB, V74, P7522, DOI 10.1128/AEM.00948-08	57	103	110	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91935	10.1371/journal.pone.0091935	http://dx.doi.org/10.1371/journal.pone.0091935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651318	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800055
J	Gupta, SK; Anderson, AM; Ebrahimi, R; Fralich, T; Graham, H; Scharen-Guivel, V; Flaherty, JF; Fortin, C; Kalayjian, RC; Rachlis, A; Wyatt, CM				Gupta, Samir K.; Anderson, Albert M.; Ebrahimi, Ramin; Fralich, Todd; Graham, Hiba; Scharen-Guivel, Valeska; Flaherty, John F.; Fortin, Claude; Kalayjian, Robert C.; Rachlis, Anita; Wyatt, Christina M.			Fanconi Syndrome Accompanied by Renal Function Decline with Tenofovir Disoproxil Fumarate: A Prospective, Case-Control Study of Predictors and Resolution in HIV-Infected Patients	PLOS ONE			English	Article							ANTIRETROVIRAL-EXPERIENCED PATIENTS; THERAPY; DYSFUNCTION; REVERSIBILITY; IMPAIRMENT; CLEARANCE; REGIMENS; COHORT	Objective: The predictors of Fanconi syndrome (FS) accompanied by renal function decline with use of the antiretroviral tenofovir disoproxil fumarate (TDF) have not been assessed. In addition, the natural history of renal recovery from FS after TDF discontinuation is not well-described. Design: We prospectively enrolled HIV-infected patients receiving TDF with newly identified FS (defined as at least two markers of proximal tubulopathy and either a >25% decline in creatinine clearance (CrCl) from pre-TDF values or a CrCl <60 mL/min in those without a known pre-TDF CrCl) in a multicenter observational study. These case participants were matched 1: 2 to controls; characteristics between the two groups were compared. Case participants with known pre-TDF CrCl values were then followed over 48 weeks to assess renal recovery. Results: Nineteen cases and 37 controls were enrolled. In multivariable analysis, previous or concurrent use of lopinavir/ritonavir [OR 16.37, 95% CI (2.28, 117.68); P = 0.006] and reduced creatinine clearance prior to initiation of TDF [OR 1.44 for every 5 mL/min reduction, 95% CI (1.09, 1.92); P = 0.012; OR 19.77 for pre-TDF CrCl lower than 83 mL/min, 95% CI (2.24, 174.67); P = 0.007] were significantly associated with FS. Of the 14 cases followed for resolution, 7 (50%) achieved at least partial resolution (defined as recovering CrCl >70% of pre-TDF values) although most participants had full normalization of proximal tubulopathy markers within two months of TDF discontinuation. Conclusions: FS, defined by specific CrCl decreases and markers of tubulopathy, is more likely in those who have received or are currently receiving concomitant lopinavir/ritonavir or who had lower CrCl prior to TDF initiation. Half of those with protocol-defined FS had CrCl recover to near pre-TDF values during the first year after TDF discontinuation.	[Gupta, Samir K.] Indiana Univ Sch Med, Div Infect Dis, Indianapolis, IN 46202 USA; [Anderson, Albert M.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA; [Ebrahimi, Ramin; Fralich, Todd; Graham, Hiba; Scharen-Guivel, Valeska; Flaherty, John F.] Gilead Sci Inc, Foster City, CA 94404 USA; [Fortin, Claude] Univ Montreal, Med Ctr, Hop Notre Dame, Montreal, PQ, Canada; [Kalayjian, Robert C.] Metrohlth Med Ctr, Div Infect Dis, Cleveland, OH USA; [Rachlis, Anita] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Wyatt, Christina M.] Icahn Sch Med Mt Sinai, Div Nephrol, New York, NY USA	Indiana University System; Indiana University Bloomington; Emory University; Gilead Sciences; Universite de Montreal; MetroHealth System; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Icahn School of Medicine at Mount Sinai	Gupta, SK (corresponding author), Indiana Univ Sch Med, Div Infect Dis, Indianapolis, IN 46202 USA.	sgupta1@iu.edu			Gilead Sciences, Inc.; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH095679] Funding Source: NIH RePORTER	Gilead Sciences, Inc.(Gilead Sciences); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded entirely by Gilead Sciences, Inc. (http://www.gilead.com/). The funder provided support in the form of salaries for authors RE, TF, HG, VS-G, and JF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Besides the listed authors who are employees of Gilead Sciences, Inc., no other employees of Gilead Sciences, Inc. contributed to this work or were involved with the decision to publish this manuscript.	Atta MG, 2008, EXPERT REV ANTI-INFE, V6, P365, DOI 10.1586/14787210.6.3.365; Bonjoch A, 2012, ANTIVIR RES, V96, P65, DOI 10.1016/j.antiviral.2012.07.009; Brennan A, 2011, AIDS, V25, P1603, DOI 10.1097/QAD.0b013e32834957da; Calcagno A, 2013, ANTIMICROB AGENTS CH, V57, P1840, DOI 10.1128/AAC.02434-12; Choi AI, 2007, KIDNEY INT, V72, P1380, DOI 10.1038/sj.ki.5002541; Choi AI, 2007, J AM SOC NEPHROL, V18, P2968, DOI 10.1681/ASN.2007040402; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Dauchy FA, 2011, KIDNEY INT, V80, P302, DOI 10.1038/ki.2011.124; Franceschini N, 2006, J ACQUIR IMMUNE DEFI; Gallant JE, 2005, CLIN INFECT DIS, V40, P1194, DOI 10.1086/428840; Gerard L, 2007, ANTIVIR THER, V12, P31; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; Gupta SK, 2008, AIDS PATIENT CARE ST, V22, P99, DOI 10.1089/apc.2007.0052; Gupta SK, 2009, ANTIVIR THER, V14, P543; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Izzedine H, 2006, J INFECT DIS, V194, P1481, DOI 10.1086/508546; Jones R, 2004, JAIDS-J ACQ IMM DEF, V37, P1489, DOI 10.1097/01.qai.0000138983.45235.02; Kiser JJ, 2008, CLIN PHARMACOL THER, V83, P265, DOI 10.1038/sj.clpt.6100269; Labarga P, 2009, AIDS, V23, P689, DOI 10.1097/QAD.0b013e3283262a64; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; O'Donnell EP, 2011, J ANTIMICROB CHEMOTH, V66, P1120, DOI 10.1093/jac/dkr039; Padilla S, 2005, AIDS PATIENT CARE ST, V19, P421, DOI 10.1089/apc.2005.19.421; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUID US ANT AG HIV 1; Poizot-Martin I, 2012, J ACQUIR IMMUNE DEFI; Pushpakom SP, 2011, J INFECT DIS, V204, P145, DOI 10.1093/infdis/jir215; Ryom L, 2013, J INFECT DIS; Schooley RT, 2002, AIDS, V16, P1257, DOI 10.1097/00002030-200206140-00008; Wever K, 2010, JAIDS-J ACQ IMM DEF, V55, P78, DOI 10.1097/QAI.0b013e3181d05579; Yoshino M, 2011, J INFECT CHEMOTHER	30	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92717	10.1371/journal.pone.0092717	http://dx.doi.org/10.1371/journal.pone.0092717			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651857	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800147
J	Kasama, Y; Mizukami, T; Kusunoki, H; Peveling-Oberhag, J; Nishito, Y; Ozawa, M; Kohara, M; Mizuochi, T; Tsukiyama-Kohara, K				Kasama, Yuri; Mizukami, Takuo; Kusunoki, Hideki; Peveling-Oberhag, Jan; Nishito, Yasumasa; Ozawa, Makoto; Kohara, Michinori; Mizuochi, Toshiaki; Tsukiyama-Kohara, Kyoko			B-Cell-Intrinsic Hepatitis C Virus Expression Leads to B-Cell-Lymphomagenesis and Induction of NF-kappa B Signalling	PLOS ONE			English	Article							LYMPHOTOXIN-BETA RECEPTOR; NON-HODGKINS-LYMPHOMA; MICRORNA EXPRESSION; CORE PROTEIN; FULL GENOME; STEM-CELLS; A20; INFECTION; PATHWAY; EPIDEMIOLOGY	Hepatitis C virus (HCV) infection leads to the development of hepatic diseases, as well as extrahepatic disorders such as B-cell non-Hodgkin's lymphoma (B-NHL). To reveal the molecular signalling pathways responsible for HCV-associated B-NHL development, we utilised transgenic (Tg) mice that express the full-length HCV genome specifically in B cells and develop non-Hodgkin type B-cell lymphomas (BCLs). The gene expression profiles in B cells from BCL-developing HCV-Tg mice, from BCL-non-developing HCV-Tg mice, and from BCL-non-developing HCV-negative mice were analysed by genome-wide microarray. In BCLs from HCV-Tg mice, the expression of various genes was modified, and for some genes, expression was influenced by the gender of the animals. Markedly modified genes such as Fos, C3, LT beta R, A20, NF-kappa B and miR-26b in BCLs were further characterised using specific assays. We propose that activation of both canonical and alternative NF-kappa B signalling pathways and down-regulation of miR-26b contribute to the development of HCV-associated B-NHL.	[Kasama, Yuri] Kumamoto Univ, Fac Life Sci, Dept Expt Phylaxiol, Kumamoto, Japan; [Mizukami, Takuo; Kusunoki, Hideki; Mizuochi, Toshiaki] Natl Inst Infect Dis, Dept Res Blood & Biol Prod, Musashimurayama, Tokyo, Japan; [Peveling-Oberhag, Jan] Goethe Univ Hosp, Dept Internal Med, Frankfurt, Germany; [Nishito, Yasumasa] Tokyo Metropolitan Inst Med Sci, Ctr Microarray Anal, Tokyo 113, Japan; [Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo 113, Japan; [Ozawa, Makoto; Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima 890, Japan; [Ozawa, Makoto; Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Joint Fac Vet Med, Lab Anim Hyg, Kagoshima 890, Japan	Kumamoto University; National Institute of Infectious Diseases (NIID); Goethe University Frankfurt; Goethe University Frankfurt Hospital; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Kagoshima University; Kagoshima University	Tsukiyama-Kohara, K (corresponding author), Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima 890, Japan.	kkohara@vet.kagoshima-u.ac.jp	Mizukami, Takuo/F-9248-2016; Ozawa, Makoto/AFM-4137-2022	Mizukami, Takuo/0000-0001-6105-6049; Ozawa, Makoto/0000-0002-7731-5321	Ministry of Education, Culture, Sports, Science and Technology of Japan [23590547]; Ministry of Health, Labour and Welfare of Japan [H21-011]; Grants-in-Aid for Scientific Research [23791093] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (23590547) and the Ministry of Health, Labour and Welfare of Japan (H21-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh A, 1999, CLIN EXP IMMUNOL, V118, P23; Arsura M, 2005, CANCER LETT, V229, P157, DOI 10.1016/j.canlet.2005.07.008; Ascoli V, 1998, AM J CLIN PATHOL, V109, P600, DOI 10.1093/ajcp/109.5.600; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Bassig BA, 2012, ENVIRON MOL MUTAGEN, V53, P145, DOI 10.1002/em.21675; Cai X, 2013, GENE, V517, P205, DOI 10.1016/j.gene.2012.12.026; Chen CM, 1997, J VIROL, V71, P9417, DOI 10.1128/JVI.71.12.9417-9426.1997; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Dammacco F, 2000, SEMIN LIVER DIS, V20, P143, DOI 10.1055/s-2000-9613; De Re V, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/623465; De Sanjose S, 2008, CLIN GASTROENTEROL H, V6, P451, DOI 10.1016/j.cgh.2008.02.011; Dondelinger Y, 2013, CELL DEATH DIFFER, V20, P1381, DOI 10.1038/cdd.2013.94; Fischer WH, 1999, J IMMUNOL, V162, P453; Fognani E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062965; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gisbert JP, 2003, GASTROENTEROLOGY, V125, P1723, DOI 10.1053/j.gastro.2003.09.025; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; HE L, 2004, NAT REV GENET, V5, P522; Hermine O, 2002, NEW ENGL J MED, V347, P89, DOI 10.1056/NEJMoa013376; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Honma K, 2008, GENE CHROMOSOME CANC, V47, P1, DOI 10.1002/gcc.20499; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Hother C, 2013, INVEST OPHTH VIS SCI, V54, P5169, DOI 10.1167/iovs.13-12272; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Ito M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00177; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Ji YH, 2010, FEBS LETT, V584, P961, DOI 10.1016/j.febslet.2010.01.036; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kasama Y, 2010, BLOOD, V116, P4926, DOI 10.1182/blood-2010-05-283358; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Koh CM, 2011, ONCOTARGET, V2, P669, DOI 10.18632/oncotarget.327; Lawrie CH, 2007, EXPERT OPIN BIOL TH, V7, P1363, DOI 10.1517/14712598.7.9.1363; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Libra M, 2005, FRONT BIOSCI, V10, P2460, DOI 10.2741/1710; Ma YL, 2011, J CELL MOL MED, V15, P1941, DOI 10.1111/j.1582-4934.2010.01170.x; Malynn BA, 2009, J EXP MED, V206, P977, DOI 10.1084/jem.20090765; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; Matsumoto M, 1997, J VIROL, V71, P1301, DOI 10.1128/JVI.71.2.1301-1309.1997; Matsuo K, 2004, CANCER SCI, V95, P745, DOI 10.1111/j.1349-7006.2004.tb03256.x; Mele A, 2003, BLOOD, V102, P996, DOI 10.1182/blood-2002-10-3230; Nishimura T, 2009, J BIOL CHEM, V284, P36442, DOI 10.1074/jbc.M109.043232; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Palumbo T, 2013, ONCOGENE, V32, P1651, DOI 10.1038/onc.2012.190; Parvatiyar K, 2011, MICROBES INFECT, V13, P209, DOI 10.1016/j.micinf.2010.11.003; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Pekarsky Y, 2008, P NATL ACAD SCI USA, V105, P19643, DOI 10.1073/pnas.0810965105; Peveling-Oberhag J, 2012, LEUKEMIA, V26, P1654, DOI 10.1038/leu.2012.29; Peveling-Oberhag J, 2013, J HEPATOL, V59, P169, DOI 10.1016/j.jhep.2013.03.018; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Silvestri F, 1996, BLOOD, V87, P4296, DOI 10.1182/blood.V87.10.4296.bloodjournal87104296; Simonin Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003234; Song GX, 2014, GENE, V533, P481, DOI 10.1016/j.gene.2013.10.011; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Sun B, 2008, ONCOGENE, V27, P6228, DOI 10.1038/onc.2008.300; Szremska AP, 2003, BLOOD, V102, P4159, DOI 10.1182/blood-2003-03-0915; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Tsukiyama-Kohara K, 2004, J BIOL CHEM, V279, P14531, DOI 10.1074/jbc.M312822200; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; Vladareanu Ana-Maria, 2010, J Med Life, V3, P320; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yamazaki J, 2009, BLOOD, V114, P2709, DOI 10.1182/blood-2008-08-174425; You LR, 1999, J VIROL, V73, P1672, DOI 10.1128/JVI.73.2.1672-1681.1999; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	73	17	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91373	10.1371/journal.pone.0091373	http://dx.doi.org/10.1371/journal.pone.0091373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651473	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800039
J	Krings, M; Nyakatura, JA; Fischer, MS; Wagner, H				Krings, Markus; Nyakatura, John A.; Fischer, Martin S.; Wagner, Hermann			The Cervical Spine of the American Barn Owl (Tyto furcata pratincola): I. Anatomy of the Vertebrae and Regionalization in Their S-Shaped Arrangement	PLOS ONE			English	Article							NECK; MORPHOLOGY; RECONSTRUCTION; MOVEMENTS; DINOSAURS; COLUMN	Background: Owls possess an extraordinary neck and head mobility. To understand this mobility it is necessary to have an anatomical description of cervical vertebrae with an emphasis on those criteria that are relevant for head positioning. No functional description specific to owls is available. Methodology/Principal findings: X-ray films and micro-CT scans were recorded from American barn owls (Tyto furcata pratincola) and used to obtain three-dimensional head movements and three-dimensional models of the 14 cervical vertebrae (C1-C14). The diameter of the vertebral canal, the zygapophyseal protrusion, the distance between joint centers, and the pitching angle were quantified. Whereas the first two variables are purely osteological characteristics of single vertebrae, the latter two take into account interactions between vertebrae. These variables change in characteristic ways from cranial to caudal. The vertebral canal is wide in the cranial and caudal neck regions, but narrow in the middle, where both the zygapophyseal protrusion and the distance between joint centers are large. Pitching angles are more negative in the cranial and caudal neck regions than in the middle region. Cluster analysis suggested a complex regionalization. Whereas the borders (C1 and C13/C14) formed stable clusters, the other cervical vertebrae were sorted into 4 or 5 additional clusters. The borders of the clusters were influenced by the variables analyzed. Conclusions/Significance: A statistical analysis was used to evaluate the regionalization of the cervical spine in the barn owl. While earlier measurements have shown that there appear to be three regions of flexibility of the neck, our indicators suggest 3-7 regions. These many regions allow a high degree of flexibility, potentially facilitating the large head turns that barn owls are able to make. The cervical vertebral series of other species should also be investigated using statistical criteria to further characterize morphology and the potential movements associated with it.	[Krings, Markus; Wagner, Hermann] Rhein Westfal TH Aachen, Inst Zool, Aachen, Germany; [Nyakatura, John A.; Fischer, Martin S.] Univ Jena, Inst Spezielle Zool & Evolut Biol, Phylet Museum, Jena, Germany	RWTH Aachen University; Friedrich Schiller University of Jena	Wagner, H (corresponding author), Rhein Westfal TH Aachen, Inst Zool, Aachen, Germany.	wagner@bio2.rwth-aachen.de	Nyakatura, John A./AAC-9807-2019; Wagner, Hermann/G-5454-2012	Nyakatura, John A./0000-0001-8088-8684; 				Bachmann T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-23; Baumel JJ, 1993, HDB AVIAN ANATOMY NO, V23, P45; Boas J.E.V., 1929, K DANSK VIDENSK SELS, V9, P101; Bout RG, 1997, J MORPHOL, V231, P287, DOI 10.1002/(SICI)1097-4687(199703)231:3<287::AID-JMOR7>3.0.CO;2-8; Brainerd EL, 2010, J EXP ZOOL PART A, V313A, P262, DOI 10.1002/jez.589; Buchholtz EA, 2009, EVOL DEV, V11, P69, DOI 10.1111/j.1525-142X.2008.00303.x; Christian Andreas, 2007, Fossil Record, V10, P38; Cobley MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072187; de Kok-Mercado F, 2013, SCIENCE, V339, P514; DESSELBERGER HERMANN, 1930, JOUR ORNITH [BERLIN], V78, P86, DOI 10.1007/BF01950903; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Fischer MS, 2010, ZOOLOGY, V113, P67, DOI 10.1016/j.zool.2009.07.001; Gatesy SM, 2010, J EXP ZOOL PART A, V313A, P244, DOI 10.1002/jez.588; Gray H., 2000, ANATOMY HUMAN BODY; Guinard G, 2010, POLAR BIOL, V33, P807, DOI 10.1007/s00300-009-0759-2; Hivernaud EA, 2010, THESIS U TOULOUSE; Kaiser G., 2007, INNER BIRD ANATOMY E; King AS, 1978, ANATOMIE VOGEL; Krings M, 2013, THESIS RWTH U; Martin John, 1998, Oryctos, V1, P113; MASINO T, 1990, NATURE, V345, P434, DOI 10.1038/345434a0; Nyakatura JA, 2010, ZOOLOGY, V113, P221, DOI 10.1016/j.zool.2009.11.003; Ohayon S, 2006, J COMP PHYSIOL A, V192, P927, DOI 10.1007/s00359-006-0130-9; Owen R., 1866, ANATOMY VERTEBRATES; Proctor NS, 1993, MANUAL ORNITHOLOGY; Spaeth H., 1985, CLUSTER DISSECTION A; STEINBACH MJ, 1973, VISION RES, V13, P889, DOI 10.1016/0042-6989(73)90055-2; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Tambussi CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037701; Van der Leeuw AHJ, 2001, NETH J ZOOL, V51, P243, DOI 10.1163/156854201750385172; VANDERLEEUW AHJ, 1992, NETH J ZOOL, V42, P23, DOI 10.1163/156854292X00026; VIDAL PP, 1986, EXP BRAIN RES, V61, P549; Wolff RG, 1991, FUNCTIONAL CHRODATE	33	25	26	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91653	10.1371/journal.pone.0091653	http://dx.doi.org/10.1371/journal.pone.0091653			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651767	Green Submitted, gold, Green Published			2022-12-27	WOS:000333352800046
J	Corvaglia, L; Fantini, MP; Aceti, A; Gibertoni, D; Rucci, P; Baronciani, D; Faldella, G				Corvaglia, Luigi; Fantini, Maria Pia; Aceti, Arianna; Gibertoni, Dino; Rucci, Paola; Baronciani, Dante; Faldella, Giacomo		Emilia Romagna Perinatal Network	Predictors of Full Enteral Feeding Achievement in Very Low Birth Weight Infants	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; PATENT DUCTUS-ARTERIOSUS; CLINICAL RISK INDEX; PRETERM INFANTS; ANTENATAL CORTICOSTEROIDS; PREMATURE-INFANTS; MORTALITY; AGE; TERM; MORBIDITY	Background: To elucidate the role of prenatal, neonatal and early postnatal variables in influencing the achievement of full enteral feeding (FEF) in very low birth weight (VLBW) infants and to determine whether neonatal intensive care units (NICUs) differ in this outcome. Methods: Population-based retrospective cohort study using data on 1,864 VLBW infants drawn from the "Emilia-Romagna Perinatal Network'' Registry from 2004 to 2009. The outcome of interest was time to FEF achievement. Eleven prenatal, neonatal and early postnatal variables and the study NICUs were selected as potential predictors of time to FEF. Parametric survival analysis was used to model time to FEF as a function of the predictors. Marginal effects were used to obtain adjusted estimates of median time to FEF for specific subgroups of infants. Results: Lower gestational age, exclusive formula feeding, higher CRIB II score, maternal hypertension, cesarean delivery, SGA and PDA predicted delayed FEF. NICUs proved to be heterogeneous in terms of FEF achievement. Newborns with PDA had a 4.2 days longer predicted median time to FEF compared to those without PDA; newborns exclusively formula-fed had a 1.4 days longer time to FEF compared to those fed human milk. Conclusions: The results of our study suggest that time to FEF is influenced by clinical variables and NICU-specific practices. Knowledge of the variables associated with delayed/earlier FEF achievement could help in improving specific aspects of routine clinical management of VLBW infants and to reduce practice variability.	[Corvaglia, Luigi; Aceti, Arianna; Faldella, Giacomo] Univ Bologna, S Orsola Malpighi Hosp, Neonatol & Neonatal Intens Care Unit, Bologna, Italy; [Fantini, Maria Pia; Gibertoni, Dino; Rucci, Paola] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Baronciani, Dante] Direz Gen Sanita & Polit Sociali, Serv Presidi Osped, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna	Aceti, A (corresponding author), Univ Bologna, S Orsola Malpighi Hosp, Neonatol & Neonatal Intens Care Unit, Bologna, Italy.	arianna.aceti2@unibo.it	Gibertoni, Dino/H-4443-2017; Aceti, Arianna/AAB-4007-2019	Gibertoni, Dino/0000-0002-1722-3724; Aceti, Arianna/0000-0001-9274-985X; Garani, Giampaolo/0000-0002-3514-2717; Rucci, Paola/0000-0002-7704-0831				Abitbol CL, 2012, NAT REV NEPHROL, V8, P265, DOI 10.1038/nrneph.2012.38; Bakker R, 2011, AM J EPIDEMIOL, V174, P797, DOI 10.1093/aje/kwr151; Bartels DB, 2005, ARCH DIS CHILD-FETAL, V90, pF53, DOI 10.1136/adc.2004.053892; Baud O, 2000, BRIT J OBSTET GYNAEC, V107, P877, DOI 10.1111/j.1471-0528.2000.tb11086.x; Been JV, 2013, J PEDIATR-US, V162, P236, DOI 10.1016/j.jpeds.2012.07.012; Been JV, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.025; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Berrington JE, 2013, ARCH DIS CHILD-FETAL, V98, pF286, DOI 10.1136/archdischild-2012-302134; BERSETH CL, 1990, J PEDIATR-US, V117, P777, DOI 10.1016/S0022-3476(05)83343-8; Bertino E, 2012, J MATERN-FETAL NEO M, V25, P67, DOI 10.3109/14767058.2012.664889; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Bozzetti V, 2013, J MATERN-FETAL NEO M, V26, P1610, DOI 10.3109/14767058.2012.746303; Burrin DG, 2002, CLIN PERINATOL, V29, P65, DOI 10.1016/S0095-5108(03)00065-4; Carlisle EM, 2013, CURR OPIN PEDIATR, V25, P382, DOI 10.1097/MOP.0b013e3283600e91; Cleves M., 2010, INTRO SURVIVAL ANAL; COOMBS RC, 1990, ARCH DIS CHILD-FETAL, V65, P1067, DOI 10.1136/adc.65.10_Spec_No.1067; Corpeleijn WE, 2012, NEONATOLOGY, V102, P276, DOI 10.1159/000341335; Costalos C, 2003, EARLY HUM DEV, V74, P83, DOI 10.1016/S0378-3782(03)00087-2; Database VON, 2012, DAT VON MAN OP 2; Dorling J, 2005, ARCH DIS CHILD-FETAL, V90, pF359, DOI 10.1136/adc.2004.060350; Ehrenkranz RA, 2011, PEDIATR RES, V69, P522, DOI 10.1203/PDR.0b013e318217f4f1; Ersch J, 2008, J PAEDIATR CHILD H, V44, P651, DOI 10.1111/j.1440-1754.2008.01375.x; Faldella G, 2011, EARLY HUM DEV, V87, pS5, DOI 10.1016/j.earlhumdev.2011.01.001; Fang S, 2001, ARCH DIS CHILD-FETAL, V85, pF42, DOI 10.1136/fn.85.1.F42; Greenwood S, 2012, J PAEDIATR CHILD H, V48, P588, DOI 10.1111/j.1440-1754.2012.02430.x; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Horbar J D, 1999, Pediatrics, V103, P350; Horbar JD, 1997, PEDIATRICS, V99, P149, DOI 10.1542/peds.99.2.149; Horbar JD, 2010, CLIN PERINATOL, V37, P29, DOI 10.1016/j.clp.2010.01.003; Hovi P, 2007, NEW ENGL J MED, V357, P617; Hyde MJ, 2012, BIOL REV, V87, P229, DOI 10.1111/j.1469-185X.2011.00195.x; ISTAT, 2011, VOL POP LEG 15 CENS; Kandasamy Y, 2009, ARCH DIS CHILD-FETAL, V94, pF78, DOI 10.1136/adc.2008.145284; Kent AL, 2012, PEDIATRICS, V129, P124, DOI 10.1542/peds.2011-1578; Lanigan J, 2009, P NUTR SOC, V68, P422, DOI 10.1017/S002966510999019X; Leaf A, 2012, PEDIATRICS, V129, pE1260, DOI 10.1542/peds.2011-2379; Lodha A, 2009, DEV MED CHILD NEUROL, V51, P895, DOI 10.1111/j.1469-8749.2009.03284.x; Mihatsch WA, 2002, J PEDIATR GASTR NUTR, V35, P144, DOI 10.1097/00005176-200208000-00008; Morgan J, 2011, COCHRANE DB SYST REV, V3; Mosalli R, 2010, COCHRANE DB SYST REV, V1; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Parry G, 2003, LANCET, V361, P1789, DOI 10.1016/S0140-6736(03)13397-1; Patole SK, 2007, ARCH DIS CHILD-FETAL, V92, pF53, DOI 10.1136/adc.2006.093708; Regev RH, 2004, CLIN PERINATOL, V31, P453, DOI 10.1016/j.clp.2004.04.017; Regev RH, 2003, J PEDIATR-US, V143, P186, DOI 10.1067/S0022-3476(03)00181-1; Ronnestad A, 2005, PEDIATRICS, V115, pE269, DOI 10.1542/peds.2004-1833; SAIGAL S, 1991, J PEDIATR-US, V118, P751, DOI 10.1016/S0022-3476(05)80043-5; Shulman RJ, 1998, PEDIATR RES, V44, P519, DOI 10.1203/00006450-199810000-00009; Smith PB, 2012, PEDIATRICS, V129, pE1508, DOI 10.1542/peds.2011-2216; Surbek D, 2012, ARCH GYNECOL OBSTET, V286, P277, DOI 10.1007/s00404-012-2339-x; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; Wold SHW, 2009, ARCH DIS CHILD-FETAL, V94, pF363, DOI 10.1136/adc.2009.157800; Wolfs TGAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005837	54	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92235	10.1371/journal.pone.0092235	http://dx.doi.org/10.1371/journal.pone.0092235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647523	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500102
J	Gritsun, DJ; Jones, IM; Gould, EA; Gritsun, TS				Gritsun, Dmitri J.; Jones, Ian M.; Gould, Ernest A.; Gritsun, Tamara S.			Molecular Archaeology of Flaviviridae Untranslated Regions: Duplicated RNA Structures in the Replication Enhancer of Flaviviruses and Pestiviruses Emerged via Convergent Evolution	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; STEM-LOOP STRUCTURE; 3'-UNTRANSLATED REGION; SECONDARY STRUCTURE; DENGUE VIRUS; DIRECT REPEATS; NONCODING REGION; WEB SERVER; CDNA-CLONE; VIRAL-RNA	RNA secondary structures in the 3'untranslated regions (3'UTR) of the viruses of the family Flaviviridae, previously identified as essential (promoters) or beneficial (enhancers) for replication, have been analysed. Duplicated enhancer elements are revealed as a global feature in the evolution of the 3'UTR of distantly related viruses within the genera Flavivirus and Pestivirus. For the flaviviruses, duplicated structures occur in the 3'UTR of all four distantly related ecological virus subgroups (tick-borne, mosquito-borne, no known vector and insect-specific flaviviruses (ISFV). RNA structural differences distinguish tick-borne flaviviruses with discrete pathogenetic characteristics. For Aedes-and Culex-associated ISFV, secondary RNA structures with different conformations display numerous short ssRNA direct repeats, exposed as loops and bulges. Long quadruplicate regions comprise almost the entire 3'UTR of Culex-associated ISFV. Extended duplicated sequence and associated RNA structures were also discovered in the 3'UTR of pestiviruses. In both the Flavivirus and Pestivirus genera, duplicated RNA structures were localized to the enhancer regions of the 3'UTR suggesting an adaptive role predominantly in wild-type viruses. We propose sequence reiteration might act as a scaffold for dimerization of proteins involved in assembly of viral replicase complexes. Numerous nucleotide repeats exposed as loops/bulges might also interfere with host immune responses acting as a molecular sponge to sequester key host proteins or microRNAs.	[Gritsun, Dmitri J.; Jones, Ian M.; Gritsun, Tamara S.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Gould, Ernest A.] Univ Aix Marseille, Fac Med Timone, Unite Virus Emergents, Marseille, France	University of Reading; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Gritsun, TS (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	t.s.gritsun@reading.ac.uk	Jones, Ian/AAF-4986-2019	Jones, Ian/0000-0002-7738-2516	Medical Research Council grant [G0801208]; EU FP7 project SILVER [260644]; EU FP7 project PREDEMICS [278433]; MRC [G0801208] Funding Source: UKRI; Medical Research Council [G0801208] Funding Source: researchfish	Medical Research Council grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU FP7 project SILVER; EU FP7 project PREDEMICS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council grant (G0801208) and EU FP7 projects SILVER and PREDEMICS (grant agreement numbers 260644 and 278433 respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher P, 1998, J VIROL, V72, P5165, DOI 10.1128/JVI.72.6.5165-5173.1998; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; BLACKWELL JL, 1995, J VIROL, V69, P5650, DOI 10.1128/JVI.69.9.5650-5658.1995; Blaney JE, 2008, VACCINE, V26, P817, DOI 10.1016/j.vaccine.2007.11.082; Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0; CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Charlier N, 2002, J GEN VIROL, V83, P1875, DOI 10.1099/0022-1317-83-8-1875; Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997; Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0; Crabtree MB, 2009, ARCH VIROL, V154, P857, DOI 10.1007/s00705-009-0373-1; Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7; Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213; DENG RT, 1993, NUCLEIC ACIDS RES, V21, P1949, DOI 10.1093/nar/21.8.1949; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Gritsun TS, 2007, VIROLOGY, V366, P8, DOI 10.1016/j.virol.2007.04.011; Gritsun TS, 2007, VIROLOGY, V358, P258, DOI 10.1016/j.virol.2006.09.033; Gritsun TS, 2007, ADV VIRUS RES, V69, P203, DOI 10.1016/S0065-3527(06)69005-2; Gritsun TS, 2006, J GEN VIROL, V87, P3297, DOI 10.1099/vir.0.82235-0; Gritsun TS, 2006, J GEN VIROL, V87, P2615, DOI 10.1099/vir.0.81950-0; Gritsun TS, 2006, VIROLOGY, V350, P269, DOI 10.1016/j.virol.2006.03.002; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Gritsun TS, 2001, J GEN VIROL, V82, P1667, DOI 10.1099/0022-1317-82-7-1667; Gritsun TS, 1997, VIRUS RES, V49, P27, DOI 10.1016/S0168-1702(97)01451-2; Gritsun TS, 2013, MOL ARCHAEOLOGY FLAV; Gritsun TS, 2006, FLAVIVIRIDAE PATHOGE, P47; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hayasaka D, 2001, J GEN VIROL, V82, P1319, DOI 10.1099/0022-1317-82-6-1319; HEINZ FX, 2000, VIRUS TAXONOMY, P859; Hofacker IL, 2004, BIOINFORMATICS, V20, P1495, DOI 10.1093/bioinformatics/bth108; Hoshino K, 2006, VIROLOGY; Isken O, 2004, RNA, V10, P1637, DOI 10.1261/rna.7290904; Isken O, 2003, EMBO J, V22, P5655, DOI 10.1093/emboj/cdg562; Kenny NJ, 2013, GEN COMP ENDOCR, V188, P16, DOI 10.1016/j.ygcen.2013.02.013; LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002; Lindenbach B.D., 2001, FIELDS VIROLOGY, V1, P991, DOI DOI 10.1016/J.JMB.2013.11.024; Liu LH, 2009, VIROLOGY, V385, P351, DOI 10.1016/j.virol.2008.12.004; Maglennon GA, 2011, VIROLOGY, V414, P153, DOI 10.1016/j.virol.2011.03.019; Mandl CW, 1998, J VIROL, V72, P2132, DOI 10.1128/JVI.72.3.2132-2140.1998; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996; Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112; Olsthoorn RCL, 2001, RNA, V7, P1370; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; Pankraz A, 2005, J VIROL, V79, P9119, DOI 10.1128/JVI.79.14.9119-9127.2005; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; PILIPENKO EV, 1995, NUCLEIC ACIDS RES, V23, P1870, DOI 10.1093/nar/23.11.1870; Pletnev AG, 2001, VIROLOGY, V282, P288, DOI 10.1006/viro.2001.0846; Proutski V, 1999, VIRUS RES, V64, P107, DOI 10.1016/S0168-1702(99)00079-9; Proutski V, 1997, J GEN VIROL, V78, P1543, DOI 10.1099/0022-1317-78-7-1543; Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194; Romero TA, 2006, J GEN VIROL, V87, P3291, DOI 10.1099/vir.0.82182-0; Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12; Schubert AM, 2010, INFECT GENET EVOL, V10, P129, DOI 10.1016/j.meegid.2009.11.004; Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12; Silva PAGC, 2007, J GEN VIROL, V88, P1738, DOI 10.1099/vir.0.82811-0; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0; Tilgner M, 2004, J VIROL, V78, P8159, DOI 10.1128/JVI.78.15.8159-8171.2004; Tuplin A, 2011, NUCLEIC ACIDS RES, V39, P7034, DOI 10.1093/nar/gkr237; Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410; WALLNER G, 1995, VIROLOGY, V213, P169, DOI 10.1006/viro.1995.1557; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; Yu HY, 1999, J VIROL, V73, P3638, DOI 10.1128/JVI.73.5.3638-3648.1999; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	67	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92056	10.1371/journal.pone.0092056	http://dx.doi.org/10.1371/journal.pone.0092056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647143	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000333348500075
J	Nance, T; Smith, KS; Anaya, V; Richardson, R; Ho, L; Pala, M; Mostafavi, S; Battle, A; Feghali-Bostwick, C; Rosen, G; Montgomery, SB				Nance, Tracy; Smith, Kevin S.; Anaya, Vanessa; Richardson, Rhea; Ho, Lawrence; Pala, Mauro; Mostafavi, Sara; Battle, Alexis; Feghali-Bostwick, Carol; Rosen, Glenn; Montgomery, Stephen B.			Transcriptome Analysis Reveals Differential Splicing Events in IPF Lung Tissue	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GLYCATION END-PRODUCTS; GROWTH-FACTOR; PULMONARY-FIBROSIS; GENE-EXPRESSION; CELL-ADHESION; HB-EGF; PERIOSTIN; BINDING; PROTEIN	Idiopathic pulmonary fibrosis (IPF) is a complex disease in which a multitude of proteins and networks are disrupted. Interrogation of the transcriptome through RNA sequencing (RNA-Seq) enables the determination of genes whose differential expression is most significant in IPF, as well as the detection of alternative splicing events which are not easily observed with traditional microarray experiments. We sequenced messenger RNA from 8 IPF lung samples and 7 healthy controls on an Illumina HiSeq 2000, and found evidence for substantial differential gene expression and differential splicing. 873 genes were differentially expressed in IPF (FDR<5%), and 440 unique genes had significant differential splicing events in at least one exonic region (FDR<5%). We used qPCR to validate the differential exon usage in the second and third most significant exonic regions, in the genes COL6A3 (RNA-Seq adjusted pval = 7.18e-10) and POSTN (RNA-Seq adjusted pval = 2.06e-09), which encode the extracellular matrix proteins collagen alpha-3(VI) and periostin. The increased gene-level expression of periostin has been associated with IPF and its clinical progression, but its differential splicing has not been studied in the context of this disease. Our results suggest that alternative splicing of these and other genes may be involved in the pathogenesis of IPF. We have developed an interactive web application which allows users to explore the results of our RNA-Seq experiment, as well as those of two previously published microarray experiments, and we hope that this will serve as a resource for future investigations of gene regulation in IPF.	[Nance, Tracy; Smith, Kevin S.; Anaya, Vanessa; Richardson, Rhea; Pala, Mauro; Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Ho, Lawrence] Univ Washington, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Mostafavi, Sara; Battle, Alexis] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Feghali-Bostwick, Carol] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Rosen, Glenn] Stanford Univ, Dept Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA	Stanford University; University of Washington; University of Washington Seattle; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University	Nance, T (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	tracy.nance@gmail.com; grosen@stanford.edu; smontgom@stanford.edu	Pala, Mauro/AAY-4774-2020	Pala, Mauro/0000-0002-3165-5291; Montgomery, Stephen/0000-0002-5200-3903	NIH T32 training grant in Pulmonary Care and Critical Medicine; Edward Mallinckrodt Jr. Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	NIH T32 training grant in Pulmonary Care and Critical Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt Jr. Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Tracy Nance was funded by an NIH T32 training grant in Pulmonary Care and Critical Medicine, and Stephen Montgomery is funded by the Edward Mallinckrodt Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2009, AM J RESP CELL MOL, V40, P422, DOI 10.1165/rcmb.2008-0174OC; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anders S, 2011, ANAL RNA SEQ DATA DI; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arafat H, 2011, SURGERY, V150, P306, DOI 10.1016/j.surg.2011.05.011; AUMAILLEY M, 1989, EXP CELL RES, V181, P463, DOI 10.1016/0014-4827(89)90103-1; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonner JC, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-15; Bozyk PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031336; Bromberg KD, 2007, CANCER RES, V67, P8172, DOI 10.1158/0008-5472.CAN-07-0045; Chang W, 2010, J BIOL CHEM, V285, P8196, DOI 10.1074/jbc.M109.025684; Deng N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068352; Didier C, 2003, MOL CELL BIOL, V23, P5331, DOI 10.1128/MCB.23.15.5331-5345.2003; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Faull RJ, 2001, KIDNEY INT, V59, P614, DOI 10.1046/j.1523-1755.2001.059002614.x; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Hoersch S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-30; Huang GC, 2012, LAB INVEST, V92, P703, DOI 10.1038/labinvest.2012.3; Kass DJ, 2011, CTS-CLIN TRANSL SCI, V4, P372, DOI 10.1111/j.1752-8062.2011.00287.x; Lee MH, 2011, FASEB J, V25, P613, DOI 10.1096/fj.10-161380; Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044946; Means AL, 2003, GASTROENTEROLOGY, V124, P1020, DOI 10.1053/gast.2003.50150; Meltzer EB, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-70; Michaylira CZ, 2010, CANCER RES, V70, P5281, DOI 10.1158/0008-5472.CAN-10-0704; Moeller MJ, 2004, EMBO J, V23, P3769, DOI 10.1038/sj.emboj.7600380; Morra L, 2012, LUNG CANCER, V76, P183, DOI 10.1016/j.lungcan.2011.10.013; Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5; Mushiroda T, 2008, J MED GENET, V45, P654, DOI 10.1136/jmg.2008.057356; Naik PK, 2012, AM J PHYSIOL-LUNG C, V303, pL1046, DOI 10.1152/ajplung.00139.2012; Okamoto M, 2011, EUR RESPIR J, V37, P1119, DOI 10.1183/09031936.00059810; Poumay Y, 2012, J INVEST DERMATOL, V132, P2129, DOI 10.1038/jid.2012.225; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Queisser MA, 2008, AM J RESP CELL MOL, V39, P337, DOI 10.1165/rcmb.2007-0244OC; RStudio Inc, 2013, SHIN WEB APPL FRAM R; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Shi-Wen Xu, 2006, Mol Cell Biol, V26, P5518, DOI 10.1128/MCB.00625-06; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Uchida M, 2012, AM J RESP CELL MOL, V46, P677, DOI 10.1165/rcmb.2011-0115OC; Valletta D, 2012, BIOCHEM BIOPH RES CO, V426, P404, DOI 10.1016/j.bbrc.2012.08.104; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Yagi H, 2008, MOL CANCER THER, V7, P3441, DOI 10.1158/1535-7163.MCT-08-0417; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Yang IV, 2013, THORAX, V68, P1114, DOI 10.1136/thoraxjnl-2012-202943; Yang Y, 2006, EXP CELL RES, V312, P2379, DOI 10.1016/j.yexcr.2006.04.001; Yoshida K, 2002, J PATHOL, V198, P388, DOI 10.1002/path.1208; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	58	45	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92111	10.1371/journal.pone.0092111	http://dx.doi.org/10.1371/journal.pone.0092111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647608	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000333348500087
J	Wang, MM; Bethoux, O; Bradler, S; Jacques, FMB; Cui, YY; Ren, D				Wang, Maomin; Bethoux, Olivier; Bradler, Sven; Jacques, Frederic M. B.; Cui, Yingying; Ren, Dong			Under Cover at Pre-Angiosperm Times: A Cloaked Phasmatodean Insect from the Early Cretaceous Jehol Biota	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; BODY-SIZE; WING VENATION; STICK INSECT; FOSSIL; EVOLUTION; MALES	Background: Fossil species that can be conclusively identified as stem-relatives of stick- and leaf-insects (Phasmatodea) are extremely rare, especially for the Mesozoic era. This dearth in the paleontological record makes assessments on the origin and age of the group problematic and impedes investigations of evolutionary key aspects, such as wing development, sexual size dimorphism and plant mimicry. Methodology/Principal Findings: A new fossil insect species, Cretophasmomima melanogramma Wang, Bethoux and Ren sp. nov., is described on the basis of one female and two male specimens recovered from the Yixian Formation (Early Cretaceous, ca. 126 +/- 4 mya; Inner Mongolia, NE China; known as 'Jehol biota'). The occurrence of a female abdominal operculum and of a characteristic 'shoulder pad' in the forewing allows for the interpretation of a true stem-Phasmatodea. In contrast to the situation in extant forms, sexual size dimorphism is only weakly female-biased in this species. The peculiar wing coloration, viz. dark longitudinal veins, suggests that the leaf-shaped plant organ from the contemporaneous 'gymnosperm' Membranifolia admirabilis was used as model for crypsis. Conclusions/Significance: As early as in the Early Cretaceous, some stem-Phasmatodea achieved effective leaf mimicry, although additional refinements characteristic of recent forms, such as curved fore femora, were still lacking. The diversification of small-sized arboreal insectivore birds and mammals might have triggered the acquisition of such primary defenses.	[Wang, Maomin; Cui, Yingying; Ren, Dong] Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing, Peoples R China; [Bethoux, Olivier] UPMC Paris6, MNHN, CNRS, Sorbonne Univ,CR2P, Paris, France; [Bradler, Sven] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Jacques, Frederic M. B.] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Lab Palaeoecol, Xishuangbanna, Yunnan, Peoples R China; [Cui, Yingying] Tech Univ Bergakad Freiberg, Dept Palaeontol, Inst Geol, D-09596 Freiberg, Germany	Capital Normal University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Gottingen; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Technical University Freiberg	Ren, D (corresponding author), Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing, Peoples R China.	rendong@mail.cnu.edu.cn	Béthoux, Olivier/C-7308-2009; Jacques, Frederic MB/G-5009-2011; Bradler, Sven/D-8655-2015	Jacques, Frederic MB/0000-0002-7539-9218; Bradler, Sven/0000-0001-9307-1032	National Basic Research Program of China (973 Program) [2012CB821906]; National Science Foundation of China [31230065, 31272352, 41272006]; Beijing Municipal Commission of Education [KZ201310028033]; China Geological Survey [1212011120115]; Project of Great Wall Scholar	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); China Geological Survey(China Geological Survey); Project of Great Wall Scholar	This research is partly supported by the National Basic Research Program of China (973 Program) (grant 2012CB821906), National Science Foundation of China (grants 31230065, 31272352, 41272006), Project of Great Wall Scholar and KEY project of Beijing Municipal Commission of Education (grants KZ201310028033), China Geological Survey (grant 1212011120115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOCK J, 1994, ANNU REV ENTOMOL, V39, P1, DOI 10.1146/annurev.en.39.010194.000245; [Anonymous], 1971, PHYLOGENY ORTHOPTERO; BEDFORD GO, 1978, ANNU REV ENTOMOL, V23, P125, DOI 10.1146/annurev.en.23.010178.001013; Beier M., 1968, Handbuch der Zoologie Berlin, V4, P1; Bethoux O, 2007, PALEONTOL J+, V41, P338, DOI 10.1134/S0031030107030136; Bethoux O., 2001, Journal of Orthoptera Research, V10, P195, DOI 10.1665/1082-6467(2001)010[0195:VPOO]2.0.CO;2; Bethoux O, 2009, SYST ENTOMOL, V34, P599, DOI 10.1111/j.1365-3113.2009.00484.x; Bethoux Olivier, 2002, Zootaxa, V96, P1; Bethoux O, 2010, ORG DIVERS EVOL, V10, P173, DOI 10.1007/s13127-010-0005-3; Bethoux Olivier, 2008, Alavesia, V2, P219; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Bradler S, 1999, COUR FOR SEKENBG, V215, P43; Bradler S., 2009, SPECIES PHYLOGENY EV, V2, P3, DOI DOI 10.17875/GUP2009-710; Bradler S, 2011, SYST ENTOMOL, V36, P218, DOI 10.1111/j.1365-3113.2010.00564.x; Buckley TR, 2009, P ROY SOC B-BIOL SCI, V276, P1055, DOI 10.1098/rspb.2008.1552; Carpenter F. M., 1992, TREATISE INVERTEBRAT; Chang SC, 2009, PALAEOGEOGR PALAEOCL, V280, P94, DOI 10.1016/j.palaeo.2009.06.021; Crampton G. C., 1916, Psyche, V23, DOI 10.1155/1916/92637; Crespi BJ, 2000, J EVOLUTION BIOL, V13, P249, DOI 10.1046/j.1420-9101.2000.00164.x; Delclos X, 2008, NEUES JAHRB GEOL P-A, V247, P353, DOI 10.1127/0077-7749/2008/0247-0353; Doyle JA, 2006, J TORREY BOT SOC, V133, P169, DOI 10.3159/1095-5674(2006)133[169:SFATOO]2.0.CO;2; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Friedemann K, 2012, ACTA ZOOL-STOCKHOLM, V93, P184, DOI 10.1111/j.1463-6395.2010.00497.x; Gorochov A.V., 1993, Trudy Paleontologicheskogo Instituta, V252, P112; Gorochov A.V., 1994, PALEONTOL J+, V28, P83; Gorochov A.V, 2000, PALEONTOL J+, V34, P295; Gorochov AV, 1988, P ZOOL I RUSS ACAD S, V178, P32; Gorochov AV., 2002, HIST INSECTS, P293, DOI DOI 10.1007/0-306-47577-4; Gorokhov AV, 2005, PALEONTOL J+, V39, P178; Gottardo M, 2012, CR BIOL, V335, P594, DOI 10.1016/j.crvi.2012.07.004; Gottardo M, 2011, CR BIOL, V334, P555, DOI 10.1016/j.crvi.2011.04.003; Grimaldi David, 2005, pi; Hcchkirch Axel, 2008, Journal of Orthoptera Research, V17, P189, DOI 10.1665/1082-6467-17.2.189; Hennig W., 1981, INSECT PHYLOGENY; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Jin M, 2006, GEOL J, V41, P439, DOI 10.1002/gj.1054; Kukalova-Peck J., 1991, P141; Kuzmina S. A, 1985, PALEONTOL J+, V19, P56; Labandeira CC, 2013, CURR OPIN PLANT BIOL, V16, P414, DOI 10.1016/j.pbi.2013.06.003; Mohanta TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032822; Nel A, 2010, SYST ENTOMOL, V40, P31; Nel A, 2011, ACTA PALAEONTOL POL, V56, P429, DOI 10.4202/app.2009.1108; RAGGE D. R., 1955, TRANS ROY ENT SOC LONDON, V106, P375; Rasnitsyn AP, 2007, PALEONTOL J+, V41, P341, DOI 10.1134/S0031030107030148; Redtenbacher J, 1906, PHASMIDAE AREOLATAE, P1; Ren Dong, 1997, Acta Zootaxonomica Sinica, V22, P268; Scott AC, 2004, J GEOL SOC LONDON, V161, P401, DOI 10.1144/0016-764903-118; Shang LJ, 2011, EUR J ENTOMOL, V108, P677, DOI 10.14411/eje.2011.086; SHAROV AG, 1968, T PALEONTOL I ACAD S, V118, P1; Sivinski J., 1978, Psyche (Cambridge), V85, P395, DOI 10.1155/1978/35784; Sun G, 2001, EARLY ANGIOSPERMS TH; Teder T, 2005, OIKOS, V108, P321, DOI 10.1111/j.0030-1299.2005.13609.x; Thornhill R., 1983, pi; Tilgner E, 2000, INSECT SYST EVOL, V31, P473, DOI 10.1163/187631200X00507; Tilgner EH, 1999, DEUT ENTOMOL Z, V46, P149, DOI 10.1002/mmnd.19990460203; Wang YJ, 2012, P NATL ACAD SCI USA, V109, P20514, DOI 10.1073/pnas.1205517109; Wang YJ, 2010, P NATL ACAD SCI USA, V107, P16212, DOI 10.1073/pnas.1006460107; Wedmann S, 2007, P NATL ACAD SCI USA, V104, P565, DOI 10.1073/pnas.0606937104; Wedmann S, 2010, PALAEONTOGR ABT B, V283, P175, DOI 10.1127/palb/283/2010/175; Whiting MF, 2003, NATURE, V421, P264, DOI 10.1038/nature01313; Zeuner F. E, 1939, FOSSIL ORTHOPTERA EN; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhou ZH, 2007, FRONTIERS BIOL CHINA, V2, P1, DOI [DOI 10.1007/S11515-007-0001-Y, 10.1007/s11515-007-0001-y]; Zhou ZY., 2009, PALAEOWORLD, V18, P1, DOI [10.1016/j.palwor.2009.01.001, DOI 10.1016/j.palwor.2009.01.001]	64	33	34	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91290	10.1371/journal.pone.0091290	http://dx.doi.org/10.1371/journal.pone.0091290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646906	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500027
J	Anderson, DJ; Moehring, RW; Sloane, R; Schmader, KE; Weber, DJ; Fowler, VG; Smathers, E; Sexton, DJ				Anderson, Deverick J.; Moehring, Rebekah W.; Sloane, Richard; Schmader, Kenneth E.; Weber, David J.; Fowler, Vance G., Jr.; Smathers, Emily; Sexton, Daniel J.			Bloodstream Infections in Community Hospitals in the 21st Century: A Multicenter Cohort Study	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS BACTEREMIA; METHICILLIN-RESISTANT; ANTIMICROBIAL TREATMENT; MORTALITY; EPIDEMIOLOGY; ENDOCARDITIS; METAANALYSIS; VALIDATION; PREVENTION; SEVERITY	Background: While the majority of healthcare in the US is provided in community hospitals, the epidemiology and treatment of bloodstream infections in this setting is unknown. Methods and Findings: We undertook this multicenter, retrospective cohort study to 1) describe the epidemiology of bloodstream infections (BSI) in a network of community hospitals and 2) determine risk factors for inappropriate therapy for bloodstream infections in community hospitals. 1,470 patients were identified as having a BSI in 9 community hospitals in the southeastern US from 2003 through 2006. The majority of BSIs were community-onset, healthcare associated (n = 823, 56%); 432 (29%) patients had community-acquired BSI, and 215 (15%) had hospital-onset, healthcare-associated BSI. BSIs due to multidrug-resistant pathogens occurred in 340 patients (23%). Overall, the three most common pathogens were S. aureus (n = 428, 28%), E. coli (n = 359, 24%), coagulase-negative Staphylococci (n = 148, 10%), though type of infecting organism varied by location of acquisition (e. g., community-acquired). Inappropriate empiric antimicrobial therapy was given to 542 (38%) patients. Proportions of inappropriate therapy varied by hospital (median = 33%, range 21-71%). Multivariate logistic regression identified the following factors independently associated with failure to receive appropriate empiric antimicrobial therapy: hospital where the patient received care (p<0.001), assistance with >= 3 ADLs (p = 0.005), Charlson score (p = 0.05), community-onset, healthcare-associated infection (p = 0.01), and hospital-onset, healthcare-associated infection (p = 0.02). Important interaction was observed between Charlson score and location of acquisition. Conclusions: Our large, multicenter study provides the most complete picture of BSIs in community hospitals in the US to date. The epidemiology of BSIs in community hospitals has changed: community-onset, healthcare-associated BSI is most common, S. aureus is the most common cause, and 1 of 3 patients with a BSI receives inappropriate empiric antimicrobial therapy. Our data suggest that appropriateness of empiric antimicrobial therapy is an important and needed performance metric for physicians and hospital stewardship programs in community hospitals.	[Anderson, Deverick J.; Moehring, Rebekah W.; Fowler, Vance G., Jr.; Sexton, Daniel J.] Duke Univ, Med Ctr, Duke Univ Div Infect Dis, Durham, NC 27708 USA; [Anderson, Deverick J.; Moehring, Rebekah W.; Smathers, Emily; Sexton, Daniel J.] Duke Infect Control Outreach Network, Durham, NC USA; [Sloane, Richard] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Schmader, Kenneth E.] Duke Univ, Med Ctr, Dept Geriatr Med, Durham, NC USA; [Schmader, Kenneth E.] Durham VA Med Ctr, GRECC, Durham, NC USA; [Weber, David J.] Univ North Carolina Hlth Syst, Dept Hosp Epidemiol, Chapel Hill, NC USA	Duke University; Duke University; Duke University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; University North Carolina Hospital	Anderson, DJ (corresponding author), Duke Univ, Med Ctr, Duke Univ Div Infect Dis, Durham, NC 27708 USA.	deverick.anderson@duke.edu	Fowler, Vance/AAW-2017-2021	Sexton, Daniel J/0000-0001-9604-5948; Anderson, Deverick/0000-0001-6882-5496	Robert Wood Johnson Foundation [66327]; National Institute of Health/National Institute of Allergy and Infectious Diseases [K23 AIO95357, K24 AI093969]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI093969, K23AI095357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028716] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institute of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Robert Wood Johnson Foundation [#66327 to DJA] and the National Institute of Health/National Institute of Allergy and Infectious Diseases [K23 AIO95357 to DJA; K24 AI093969 to VGF]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2013, HEALTHC COST UT PROJ; Ammerlaan HSM, 2013, CLIN INFECT DIS, V56, P798, DOI 10.1093/cid/cis1006; Anderson DJ, 2007, INFECT CONT HOSP EP, V28, P767, DOI 10.1086/518518; Anderson DJ, 2011, INFECT CONT HOSP EP, V32, P315, DOI 10.1086/658940; BION JF, 1985, BRIT MED J, V291, P432, DOI 10.1136/bmj.291.6493.432; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; ELHANAN G, 1995, J ANTIMICROB CHEMOTH, V36, P681, DOI 10.1093/jac/36.4.681; Fishman N, 2012, INFECT CONT HOSP EP, V33, P322, DOI 10.1086/665010; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Haddy RI, 1996, J FAM PRACTICE, V42, P273; HADDY RI, 1987, J FAM PRACTICE, V24, P253; HADDY RI, 1991, J FAM PRACTICE, V32, P601; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Jarvis WR, 1998, AM J INFECT CONTROL, V26, P522; Javaloyas M, 2002, SCAND J INFECT DIS, V34, P436, DOI 10.1080/00365540110080629; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kaye KS, 2008, CLIN INFECT DIS, V46, P1568, DOI 10.1086/587673; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kollef MH, 2011, J INFECTION, V62, P130, DOI 10.1016/j.jinf.2010.12.009; Landerman LR, 1997, SOCIOL METHOD RES, V26, P3, DOI 10.1177/0049124197026001001; Magiorakos AP, 2011, CLIN MICROBIOLOGY IN; Micek ST, 2006, CRIT CARE MED, V34, P2707, DOI 10.1097/01.CCM.0000241151.25426.D7; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Mylotte JM, 2001, AM J INFECT CONTROL, V29, P13, DOI 10.1067/mic.2001.110567; National Center for Health Statistics, 2012, HLTH US 2011 SPEC FE; Paul M, 2010, ANTIMICROB AGENTS CH, V54, P4851, DOI 10.1128/AAC.00627-10; Pittet D, 1997, CLIN INFECT DIS, V24, P1068, DOI 10.1086/513640; Scheckler WE, 2003, INFECT CONT HOSP EP, V24, P936, DOI 10.1086/502162; Schramm GE, 2006, CRIT CARE MED, V34, P2069, DOI 10.1097/01.CCM.0000227655.41566.3E; SETIA U, 1977, ARCH INTERN MED, V137, P1698, DOI 10.1001/archinte.137.12.1698; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Warren DK, 2001, CLIN INFECT DIS, V33, P1329, DOI 10.1086/322483	35	59	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91713	10.1371/journal.pone.0091713	http://dx.doi.org/10.1371/journal.pone.0091713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643200	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900031
J	Blanc, S; Ruggiero, F; Birot, AM; Acloque, H; Decimo, D; Lerat, E; Ohlmann, T; Samarut, J; Mey, A				Blanc, Sophie; Ruggiero, Florence; Birot, Anne-Marie; Acloque, Herve; Decimo, Didier; Lerat, Emmanuelle; Ohlmann, Theophile; Samarut, Jacques; Mey, Anne			Subcellular Localization of ENS-1/ERNI in Chick Embryonic Stem Cells	PLOS ONE			English	Article							HUMAN ENDOGENOUS RETROVIRUS; TRANSCRIPTION FACTORS; EXPRESSION; PLURIPOTENCY; BINDING; SOX2; IDENTIFICATION; GASTRULATION; PROTEINS; GENOME	The protein of retroviral origin ENS-1/ERNI plays a major role during neural plate development in chick embryos by controlling the activity of the epigenetic regulator HP1 gamma, but its function in the earlier developmental stages is still unknown. ENS-1/ERNI promoter activity is down-regulated upon differentiation but the resulting protein expression has never been examined. In this study, we present the results obtained with custom-made antibodies to gain further insights into ENS-1 protein expression in Chicken embryonic stem cells (CES) and during their differentiation. First, we show that ENS-1 controls the activity of HP1 gamma in CES and we examined the context of its interaction with HP1 gamma. By combining immunofluorescence and western blot analysis we show that ENS-1 is localized in the cytoplasm and in the nucleus, in agreement with its role on gene's promoter activity. During differentiation, ENS-1 decreases in the cytoplasm but not in the nucleus. More precisely, three distinct forms of the ENS-1 protein co-exist in the nucleus and are differently regulated during differentiation, revealing a new level of control of the protein ENS-1. In silico analysis of the Ens-1 gene copies and the sequence of their corresponding proteins indicate that this pattern is compatible with at least three potential regulation mechanisms, each accounting only partially. The results obtained with the anti-ENS-1 antibodies presented here reveal that the regulation of ENS-1 expression in CES is more complex than expected, providing new tracks to explore the integration of ENS-1 in CES cells regulatory networks.	[Blanc, Sophie; Ruggiero, Florence; Birot, Anne-Marie; Acloque, Herve; Samarut, Jacques; Mey, Anne] Univ Lyon 1, CNRS UMR 5242, INRA USC 1370, Inst Genom Fonct Lyon,Ecole Normale Super Lyon, F-69365 Lyon, France; [Acloque, Herve] ENVT, Lab Genet Cellulaire INRA, Castanet Tolosan, France; [Decimo, Didier; Ohlmann, Theophile] Univ Lyon, Int Ctr Infectiol Res, Ecole Normale Super Lyon, CIRI,INSERM,U1111, Lyon, France; [Lerat, Emmanuelle] Univ Lyon, Lyon, France; [Lerat, Emmanuelle] Univ Lyon 1, F-69622 Villeurbanne, France; [Lerat, Emmanuelle] CNRS, UMR5558, Lab Biometrie & Biol Evolut, Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup	Samarut, J (corresponding author), Univ Lyon 1, CNRS UMR 5242, INRA USC 1370, Inst Genom Fonct Lyon,Ecole Normale Super Lyon, F-69365 Lyon, France.	jacques.samarut@ens-lyon.fr; anne.mey@lyon.inra.fr	Ohlmann, Theophile/H-6522-2016; Samarut, Jacques/AAD-2587-2019; ohlmann, Theophile/M-4463-2014	ohlmann, Theophile/0000-0002-2001-8916; Acloque, Herve/0000-0003-4761-1055; RUGGIERO, Florence/0000-0003-2915-5359; MEY, Anne/0000-0002-2643-5702; Decimo, Didier/0000-0002-0390-1205; LERAT, Emmanuelle/0000-0001-6757-8796	ANR (Agence Nationale pour la Recherche) Genanimal [ANR-06-GANI-007-01]; ANR Blanc [ANR-09-BLAN-0141]	ANR (Agence Nationale pour la Recherche) Genanimal(French National Research Agency (ANR)); ANR Blanc(French National Research Agency (ANR))	This work was supported by grants from the ANR (Agence Nationale pour la Recherche) Genanimal (ANR-06-GANI-007-01), from the ANR Blanc (ANR-09-BLAN-0141) http://www.agence-nationale-recherche.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2004, NUCLEIC ACIDS RES, V32, P2259, DOI 10.1093/nar/gkh545; Acloque H, 2001, MECH DEVELOP, V103, P79, DOI 10.1016/S0925-4773(01)00336-7; Acloque H, 2011, DEV CELL, V21, P546, DOI 10.1016/j.devcel.2011.07.005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Caillier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015507; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Dialynas GK, 2007, J CELL SCI, V120, P3415, DOI 10.1242/jcs.012914; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Lerat E, 2007, J MOL EVOL, V65, P215, DOI 10.1007/s00239-007-9001-4; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Mey A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-21; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Pain B, 1996, DEVELOPMENT, V122, P2339; Papanayotou C, 2008, PLOS BIOL, V6, P109, DOI 10.1371/journal.pbio.0060002; Pi WH, 2004, P NATL ACAD SCI USA, V101, P805, DOI 10.1073/pnas.0307698100; Prevot D, 2003, EMBO J, V22, P1909, DOI 10.1093/emboj/cdg175; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Smallwood A, 2008, NAT STRUCT MOL BIOL, V15, P318, DOI 10.1038/nsmb.1385; Soto Rifo R, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm682; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Waltzer L, 1996, J VIROL, V70, P5909, DOI 10.1128/JVI.70.9.5909-5915.1996; Wicker T, 2005, GENOME RES, V15, P126, DOI 10.1101/gr.2438005; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606	33	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92039	10.1371/journal.pone.0092039	http://dx.doi.org/10.1371/journal.pone.0092039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643087	Green Published, gold, Green Submitted			2022-12-27	WOS:000333259900068
J	Homolya, L; Fu, D; Sengupta, P; Jarnik, M; Gillet, JP; Vitale-Cross, L; Gutkind, JS; Lippincott-Schwartz, J; Arias, IM				Homolya, Laszlo; Fu, Dong; Sengupta, Prabuddha; Jarnik, Michal; Gillet, Jean-Pierre; Vitale-Cross, Lynn; Gutkind, J. Silvio; Lippincott-Schwartz, Jennifer; Arias, Irwin M.			LKB1/AMPK and PKA Control ABCB11 Trafficking and Polarization in Hepatocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SALT EXPORT PUMP; BINDING CASSETTE TRANSPORTERS; BILE-ACID TRANSPORT; CANALICULAR MEMBRANE; EXTRACELLULAR-MATRIX; LKB1; LIVER; AMPK; EXPRESSION	Polarization of hepatocytes is manifested by bile canalicular network formation and activation of LKB1 and AMPK, which control cellular energy metabolism. The bile acid, taurocholate, also regulates development of the canalicular network through activation of AMPK. In the present study, we used collagen sandwich hepatocyte cultures from control and liver-specific LKB1 knockout mice to examine the role of LKB1 in trafficking of ABCB11, the canalicular bile acid transporter. In polarized hepatocytes, ABCB11 traffics from Golgi to the apical plasma membrane and endogenously cycles through the rab 11a-myosin Vb recycling endosomal system. LKB1 knockout mice were jaundiced, lost weight and manifested impaired bile canalicular formation and intracellular trafficking of ABCB11, and died within three weeks. Using live cell imaging, fluorescence recovery after photobleaching (FRAP), particle tracking, and biochemistry, we found that LKB1 activity is required for microtubule-dependent trafficking of ABCB11 to the canalicular membrane. In control hepatocytes, ABCB11 trafficking was accelerated by taurocholate and cAMP; however, in LKB1 knockout hepatocytes, ABCB11 trafficking to the apical membrane was greatly reduced and restored only by cAMP, but not taurocholate. cAMP acted through a PKA-mediated pathway which did not activate AMPK. Our studies establish a regulatory role for LKB1 in ABCB11 trafficking to the canalicular membrane, hepatocyte polarization, and canalicular network formation.	[Homolya, Laszlo; Fu, Dong; Sengupta, Prabuddha; Jarnik, Michal; Lippincott-Schwartz, Jennifer; Arias, Irwin M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Homolya, Laszlo] Hungarian Acad Sci, Mol Cell Biol Lab, Inst Mol Pharmacol, Res Ctr Nat Sci, Budapest, Hungary; [Fu, Dong] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Gillet, Jean-Pierre] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Gillet, Jean-Pierre] Belgium Univ Namur, Univ Namur, Fac Med, Lab Mol Canc Biol,Mol Physiol Res Unit URPhyM,Nam, Namur, Belgium; [Vitale-Cross, Lynn; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Sydney; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Namur; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Homolya, L (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	homolya.laszlo@ttk.mta.hu	Gutkind, J. Silvio/J-1201-2016; gillet, jean-pierre/A-1419-2017; Homolya, Laszlo/N-1154-2016	Gutkind, J. Silvio/0000-0002-5150-4482; gillet, jean-pierre/0000-0003-2453-590X; Homolya, Laszlo/0000-0003-1639-8140; Fu, Dong/0000-0002-6865-5033; Sengupta, Prabuddha/0000-0001-7094-6967; VItale-Cross, Lynn/0000-0001-7850-547X	Hungarian-American Enterprise Scholarship Fund (HAESF); Momentum Program of the Hungarian Academy of Sciences [LP2012-025]; Ministry of National Development/National Development Agency/Hungarian Scientific Research Fund [KTIA_OTKA_CK80283, KTIA_AIK_12-1-2012-0025]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	Hungarian-American Enterprise Scholarship Fund (HAESF); Momentum Program of the Hungarian Academy of Sciences; Ministry of National Development/National Development Agency/Hungarian Scientific Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work has been supported by a scholarship from the Hungarian-American Enterprise Scholarship Fund (HAESF), grants from the Momentum Program of the Hungarian Academy of Sciences (LP2012-025), and Ministry of National Development/National Development Agency/Hungarian Scientific Research Fund (KTIA_OTKA_CK80283 and KTIA_AIK_12-1-2012-0025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Alexander A, 2011, FEBS LETT, V585, P952, DOI 10.1016/j.febslet.2011.03.010; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Fu D, 2010, J CELL SCI, V123, P3294, DOI 10.1242/jcs.068098; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Hoffmaster KA, 2004, PHARM RES-DORDR, V21, P1294, DOI 10.1023/B:PHAM.0000033018.97745.0d; Kipp H, 2001, J BIOL CHEM, V276, P7218, DOI 10.1074/jbc.M007794200; Lam P, 2010, SEMIN LIVER DIS, V30, P125, DOI 10.1055/s-0030-1253222; Lecluyse E, 1999, DRUG METAB DISPOS, V27, P909; Lee HS, 2010, MOL BIOL CELL, V21, P2661, DOI 10.1091/mbc.E09-12-1036; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lo B, 2012, J CELL BIOL, V199, P1117, DOI 10.1083/jcb.201208080; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Orina JN, 2009, MOL CANCER THER, V8, P2057, DOI 10.1158/1535-7163.MCT-09-0256; Partanen JI, 2012, P NATL ACAD SCI USA, V109, pE388, DOI 10.1073/pnas.1120421109; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Swift B, 2010, MOL PHARMACEUT, V7, P491, DOI 10.1021/mp900227a; Treyer A, 2013, COMPR PHYSIOL, V3, P243, DOI 10.1002/cphy.c120009; Wakabayashi Y, 2005, P NATL ACAD SCI USA, V102, P15087, DOI 10.1073/pnas.0503702102; Wakabayashi Y, 2004, MOL BIOL CELL, V15, P3485, DOI 10.1091/mbc.E03-10-0737; Woods A, 2011, BIOCHEM J, V434, P49, DOI 10.1042/BJ20101721; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104	29	36	39	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91921	10.1371/journal.pone.0091921	http://dx.doi.org/10.1371/journal.pone.0091921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643070	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000333259900048
J	Anyamba, A; Small, JL; Britch, SC; Tucker, CJ; Pak, EW; Reynolds, CA; Crutchfield, J; Linthicum, KJ				Anyamba, Assaf; Small, Jennifer L.; Britch, Seth C.; Tucker, Compton J.; Pak, Edwin W.; Reynolds, Curt A.; Crutchfield, James; Linthicum, Kenneth J.			Recent Weather Extremes and Impacts on Agricultural Production and Vector-Borne Disease Outbreak Patterns	PLOS ONE			English	Article							RIFT-VALLEY FEVER; WEST NILE VIRUS; EL-NINO; CROP YIELDS; NOAA-AVHRR; CLIMATE; ENCEPHALITIS; DYNAMICS; TEMPERATURE; RESPONSES	We document significant worldwide weather anomalies that affected agriculture and vector-borne disease outbreaks during the 2010-2012 period. We utilized 2000-2012 vegetation index and land surface temperature data from NASA's satellite-based Moderate Resolution Imaging Spectroradiometer (MODIS) to map the magnitude and extent of these anomalies for diverse regions including the continental United States, Russia, East Africa, Southern Africa, and Australia. We demonstrate that shifts in temperature and/or precipitation have significant impacts on vegetation patterns with attendant consequences for agriculture and public health. Weather extremes resulted in excessive rainfall and flooding as well as severe drought, which caused similar to 10 to 80% variation in major agricultural commodity production (including wheat, corn, cotton, sorghum) and created exceptional conditions for extensive mosquito-borne disease outbreaks of dengue, Rift Valley fever, Murray Valley encephalitis, and West Nile virus disease. Analysis of MODIS data provided a standardized method for quantifying the extreme weather anomalies observed during this period. Assessments of land surface conditions from satellite-based systems such as MODIS can be a valuable tool in national, regional, and global weather impact determinations.	[Anyamba, Assaf; Small, Jennifer L.; Tucker, Compton J.; Pak, Edwin W.; Reynolds, Curt A.] NASA, Goddard Space Flight Ctr, Biospher Sci Lab, Greenbelt, MD 20771 USA; [Britch, Seth C.; Linthicum, Kenneth J.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Crutchfield, James] USDA, Int Prod & Assessment Div, Foreign Agr Serv, Washington, DC 20250 USA; [Anyamba, Assaf] Univ Space Res Assoc, Columbia, MD USA; [Small, Jennifer L.; Pak, Edwin W.] Sci Syst & Applicat Inc, Lanham, MD USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Universities Space Research Association (USRA); Science Systems and Applications Inc	Anyamba, A (corresponding author), NASA, Goddard Space Flight Ctr, Biospher Sci Lab, Greenbelt, MD 20771 USA.	assaf.anyamba@nasa.gov		Anyamba, Assaf/0000-0003-0932-9585	USDA Foreign Agricultural Service; DoD Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response System (AFHSC/GEIS) under the Human Febrile and Vector -Borne Illnesses (FVBI) Program; USDA Agricultural Research Service	USDA Foreign Agricultural Service; DoD Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response System (AFHSC/GEIS) under the Human Febrile and Vector -Borne Illnesses (FVBI) Program; USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was made possible by funding from USDA Foreign Agricultural Service towards the Global Agricultural Monitoring project, DoD Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response System (AFHSC/GEIS) under the Human Febrile and Vector -Borne Illnesses (FVBI) Program and USDA Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Anderson DP, 2012, CHOICES MAGAZINE FOO, V27, P1; Anyamba A, 2005, J ARID ENVIRON, V63, P596, DOI 10.1016/j.jaridenv.2005.03.007; Anyamba A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001465; Australian Government Bureau of Meteorology Queensland Climate Services Centre, 2010, MONTHL WEATH REV QUE; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Becker-Reshef I, 2010, REMOTE SENS-BASEL, V2, P1589, DOI 10.3390/rs2061589; Blunden J, 2013, B AM METEOROL SOC, V94, pS1, DOI 10.1175/2013BAMSStateoftheClimate.1; Bouma MJ, 1997, JAMA-J AM MED ASSOC, V278, P1772, DOI 10.1001/jama.278.21.1772; Caviedes C.N., 1992, P355, DOI 10.1017/CBO9780511565625.015; Chanson H, 2011, CH8211 U QUEENSL SCH; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; Congressional Research Service, 2012, R42046 C RES SERV; Epstein P.R., 2001, GLOBAL CHANGE HUMAN, V2, P105, DOI DOI 10.1023/A:1015089901425; Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079; Glantz M. H, 1991, TELECONNECTIONS LINK, P1; Grobbelaar AA, 2011, EMERG INFECT DIS, V17, P2270, DOI 10.3201/eid1712.111035; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hoerling M, 2013, J CLIMATE, V26, P2811, DOI 10.1175/JCLI-D-12-00270.1; Hoerling MP, 2000, EL NINO SO OSCILLATI, P57, DOI DOI 10.1017/CBO9780511573125.003; IRIN, 2011, KEN MED OV DENG FEV; Johnson BJ, 2013, J MED ENTOMOL, V50, P195, DOI 10.1603/ME12035; Justice CO, 2002, REMOTE SENS ENVIRON, V83, P3, DOI 10.1016/S0034-4257(02)00084-6; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Knox J, 2012, MED J AUSTRALIA, V196, P322, DOI 10.5694/mja11.11026; Legler DM, 1999, CLIMATIC CHANGE, V42, P351, DOI 10.1023/A:1005401101129; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Lyon B, 2005, J CLIMATE, V18, P5095, DOI 10.1175/JCLI3598.1; Matsueda M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046557; Metras R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001808; Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365; MUELLERDOMBOIS D, 1990, ECOL STU AN, V84, P1; Munich RE, 2010, GEORISKS RES HEAT WA; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; NICHOLLS N, 1986, AUST J EXP BIOL MED, V64, P587, DOI 10.1038/icb.1986.62; Nicholls N, 1996, GEOPHYS RES LETT, V23, P3357, DOI 10.1029/96GL03166; Nielsen-Gammon JW., 2012, TEX WATER J, V3, P59, DOI DOI 10.21423/TWJ.V3I1.6463; NOAA National Climatic Data Center, 2011, STAT CLIM WILDF ANN; NOAA/NWS, 2011, NOAA NWS CLIM DIAGN; Padmanabha H, 2010, ECOHEALTH, V7, P78, DOI 10.1007/s10393-010-0301-6; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; PRINCE SD, 1986, INT J REMOTE SENS, V7, P1555, DOI 10.1080/01431168608948953; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; SEMENOV MA, 1995, AGR FOREST METEOROL, V73, P265, DOI 10.1016/0168-1923(94)05078-K; SUBRA R, 1983, ANN TROP MED PARASIT, V77, P195, DOI 10.1080/00034983.1983.11811697; Trenberth KE, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018020; Tubiello FN, 2007, P NATL ACAD SCI USA, V104, P19686, DOI 10.1073/pnas.0701728104; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; TURELL MJ, 1993, AM J TROP MED HYG, V49, P672, DOI 10.4269/ajtmh.1993.49.672; TURNER NC, 1986, FIELD CROP RES, V14, P153, DOI 10.1016/0378-4290(86)90054-7; USDA Foreign Agricultural Service, 2011, AS1101 USDA FOR AGR; USDA Foreign Agricultural Service, 2010, CA0043 USDA FOR AGR; Van Den Hurk AF, 2010, ANN TROP MED PARASIT, V104, P623, DOI 10.1179/136485910X12851868779984; Wan ZM, 2008, REMOTE SENS ENVIRON, V112, P59, DOI 10.1016/j.rse.2006.06.026; Winters KE, 2013, 20135113 US DEP INT; Yang X B, 2001, GLOB CHANGE HUM HLTH, V2, P90, DOI [10.1023/A:1015086831467, DOI 10.1023/A:1015086831467]	58	88	90	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92538	10.1371/journal.pone.0092538	http://dx.doi.org/10.1371/journal.pone.0092538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658301	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300095
J	Chang, HH; Wang, YL; Chiang, YC; Chen, YL; Chuang, YH; Tsai, SJ; Heish, KH; Lin, FH; Lin, CP				Chang, Hao-Hueng; Wang, Yin-Lin; Chiang, Yu-Chih; Chen, Yen-Liang; Chuang, Yu-Horng; Tsai, Shang-Jye; Heish, Kuo-Huang; Lin, Feng-Huei; Lin, Chun-Pin			A Novel Chitosan-gamma PGA Polyelectrolyte Complex Hydrogel Promotes Early New Bone Formation in the Alveolar Socket Following Tooth Extraction	PLOS ONE			English	Article							RIDGE PRESERVATION; FORMATION ADJACENT; TISSUE; SCAFFOLD; BIOCHEMISTRY; BIOMATERIAL; IMPLANTS; COLLAGEN; MODEL	A novel chitosan-gamma PGA polyelectrolyte complex hydrogel (C-PGA) has been developed and proven to be an effective dressing for wound healing. The purpose of this study was to evaluate if C-PGA could promote new bone formation in the alveolar socket following tooth extraction. An animal model was proposed using radiography and histomorphology simultaneously to analyze the symmetrical sections of Wistar rats. The upper incisors of Wistar rats were extracted and the extraction sockets were randomly treated with gelatin sponge, neat chitosan, C-PGA, or received no treatment. The extraction sockets of selected rats from each group were evaluated at 1, 2, 4, or 6 wk post-extraction. The results of radiography and histopathology indicated that the extraction sockets treated with C-PGA exhibited lamellar bone formation (6.5%) as early as 2 wk after the extraction was performed. Moreover, the degree of new bone formation was significantly higher (P < 0.05) in the extraction sockets treated with C-PGA at 6 wk post-extraction than that in the other study groups. In this study, we demonstrated that the proposed animal model involving symmetrical sections and simultaneous radiography and histomorphology evaluation is feasible. We also conclude that the novel C-PGA has great potential for new bone formation in the alveolar socket following tooth extraction.	[Chang, Hao-Hueng; Wang, Yin-Lin; Chiang, Yu-Chih; Chen, Yen-Liang; Chuang, Yu-Horng; Tsai, Shang-Jye; Lin, Chun-Pin] Natl Taiwan Univ, Sch Dent, Taipei 10764, Taiwan; [Chang, Hao-Hueng; Wang, Yin-Lin; Chiang, Yu-Chih; Chen, Yen-Liang; Lin, Chun-Pin] Natl Taiwan Univ, Dept Dent, Taipei 10764, Taiwan; [Tsai, Shang-Jye] Cardinal Tien Hosp, Dept Dent, Yonghe Branch, New Taipei, Taiwan; [Heish, Kuo-Huang] Natl Taiwan Univ, Dept Chem Engn, Taipei 10764, Taiwan; [Lin, Feng-Huei] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Lin, CP (corresponding author), Natl Taiwan Univ, Sch Dent, Taipei 10764, Taiwan.	pinlin@ntu.edu.tw		CHIANG, YU-CHIH/0000-0001-8110-3033; WANG, YIN-LIN/0000-0001-6790-1311; Lin, Chun-Pin/0000-0002-3498-1113	National Science Council, Taiwan [98-2314-B-002-070-MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The authors also declare this study was supported in part by a grant from the National Science Council, Taiwan (98-2314-B-002-070-MY2) and no additional or current funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x; Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x; Arruda T, 2013, J BIOMED MATER RES A, V101, P1971, DOI 10.1002/jbm.a.34501; Badawy Mohamed E. I., 2011, International Journal of Carbohydrate Chemistry, DOI 10.1155/2011/460381; Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x; Boyan BD, 2006, J PERIODONTOL, V77, P1555, DOI 10.1902/jop.2006.060019; Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P423, DOI 10.1163/156856203766652048; Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P1401, DOI 10.1163/156856203322599734; DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x; Ezoddini-Ardakani Fatemeh, 2012, Dent Res J (Isfahan), V9, P694; Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375; Hsieh CY, 2006, DENT MATER, V22, P622, DOI 10.1016/j.dental.2005.05.012; Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012; Khanna R, 2011, ACTA BIOMATER, V7, P1173, DOI 10.1016/j.actbio.2010.10.028; Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009; Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170; Li M, 2010, CLIN ORTHOP RELAT R, V468, P1978, DOI 10.1007/s11999-010-1321-9; Liu HH, 2013, BIOMATERIALS, V34, P4404, DOI 10.1016/j.biomaterials.2013.02.048; Miranda SCCC, 2011, ARCH ORAL BIOL, V56, P1, DOI 10.1016/j.archoralbio.2010.08.018; MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0; Muzzarelli RAA, 1999, EXS, V87, P235; Muzzarelli RAA, 1999, EXS, V87, P293; Muzzarelli RAA, 1999, EXS, V87, P251; Oka S, 2013, TISSUE ENG PT A, V19, P1233, DOI [10.1089/ten.tea.2012.0325, 10.1089/ten.TEA.2012.0325]; Roriz VM, 2010, CLIN ORAL IMPLAN RES, V21, P148, DOI 10.1111/j.1600-0501.2009.01812.x; Santos FA, 2010, CLIN IMPLANT DENT R, V12, P18, DOI 10.1111/j.1708-8208.2008.00126.x; SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x; Shokrgozar Mohammad Ali, 2012, Iranian Biomedical Journal, V16, P68, DOI 10.6091/ibj.1053.2012; Tsao CT, 2011, CARBOHYD POLYM, V84, P812, DOI 10.1016/j.carbpol.2010.04.034; Tsao CT, 2011, CARBOHYD RES, V346, P94, DOI 10.1016/j.carres.2010.10.010; Tsao CT, 2010, CARBOHYD RES, V345, P1774, DOI 10.1016/j.carres.2010.06.002; TSUCHIDA E, 1994, J MACROMOL SCI PURE, VA31, P1; Vignoletti F, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2011.02331.x	33	17	17	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92362	10.1371/journal.pone.0092362	http://dx.doi.org/10.1371/journal.pone.0092362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658174	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300075
J	Feenstra, F; van Gennip, RGP; van de Water, SGP; van Rijn, PA				Feenstra, Femke; van Gennip, Rene G. P.; van de Water, Sandra G. P.; van Rijn, Piet A.			RNA Elements in Open Reading Frames of the Bluetongue Virus Genome Are Essential for Virus Replication	PLOS ONE			English	Article							INTRAGENIC RECOMBINATION; INSECT CELLS; VP6 PROTEIN; SEGMENT; BINDING; NS2; IDENTIFICATION; LOCALIZATION; TRAFFICKING; BACULOVIRUS	Members of the Reoviridae family are non-enveloped multi-layered viruses with a double stranded RNA genome consisting of 9 to 12 genome segments. Bluetongue virus is the prototype orbivirus (family Reoviridae, genus Orbivirus), causing disease in ruminants, and is spread by Culicoides biting midges. Obviously, several steps in the Reoviridae family replication cycle require virus specific as well as segment specific recognition by viral proteins, but detailed processes in these interactions are still barely understood. Recently, we have shown that expression of NS3 and NS3a proteins encoded by genome segment 10 of bluetongue virus is not essential for virus replication. This gave us the unique opportunity to investigate the role of RNA sequences in the segment 10 open reading frame in virus replication, independent of its protein products. Reverse genetics was used to generate virus mutants with deletions in the open reading frame of segment 10. Although virus with a deletion between both start codons was not viable, deletions throughout the rest of the open reading frame led to the rescue of replicating virus. However, all bluetongue virus deletion mutants without functional protein expression of segment 10 contained inserts of RNA sequences originating from several viral genome segments. Subsequent studies showed that these RNA inserts act as RNA elements, needed for rescue and replication of virus. Functionality of the inserts is orientation-dependent but is independent from the position in segment 10. This study clearly shows that RNA in the open reading frame of Reoviridae members does not only encode proteins, but is also essential for virus replication.	[Feenstra, Femke; van Gennip, Rene G. P.; van de Water, Sandra G. P.; van Rijn, Piet A.] Cent Vet Inst Wageningen UR CVI, Dept Virol, Lelystad, Netherlands; [Feenstra, Femke] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [van Rijn, Piet A.] North West Univ, Ctr Human Metabon, Dept Biochem, Potchefstroom, South Africa	Wageningen University & Research; Utrecht University; North West University - South Africa	Feenstra, F (corresponding author), Cent Vet Inst Wageningen UR CVI, Dept Virol, Lelystad, Netherlands.	femke2.feenstra@wur.nl	van Rijn, Piet A/C-1163-2017; van Rijn, Piet A./AAG-7398-2019	van Rijn, Piet A/0000-0002-2594-1232; van Rijn, Piet A./0000-0002-2594-1232; van Gennip, Rene/0000-0002-5450-3493	Dutch Ministry of Economic Affairs [1600020-01]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This study was funded by the Dutch Ministry of Economic Affairs (CVI-project 1600020-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKITA GY, 1992, J VET DIAGN INVEST, V4, P400, DOI 10.1177/104063879200400405; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Boyce M, 2004, J VIROL, V78, P3994, DOI 10.1128/JVI.78.8.3994-4002.2004; Boyce M, 2012, 11 INT S DOUBL STRAN, P45; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Boyce M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-178; Brierley I, 2007, NAT REV MICROBIOL, V5, P598, DOI 10.1038/nrmicro1704; Celma CCP, 2011, J VIROL, V85, P4783, DOI 10.1128/JVI.02352-10; Celma CCP, 2009, J VIROL, V83, P6806, DOI 10.1128/JVI.00263-09; Chauveau E, 2013, J VIROL, V87, P8241, DOI 10.1128/JVI.00678-13; Fillmore GC, 2002, J VIROL, V76, P499, DOI 10.1128/JVI.76.2.499-506.2002; Fujii Y, 2003, P NATL ACAD SCI USA, V100, P2002, DOI 10.1073/pnas.0437772100; GOTTLIEB P, 1994, VIROLOGY, V200, P42, DOI 10.1006/viro.1994.1160; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; He CQ, 2010, J VIROL, V84, P11487, DOI 10.1128/JVI.00889-10; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; Kalthoff D, 2013, J VIROL, V87, P13556, DOI 10.1128/JVI.02244-13; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; King A.M.Q., 2012, VIRUS TAXONOMY, P541; KIRKEGAARD K, 1986, CELL, V47, P433, DOI 10.1016/0092-8674(86)90600-8; Kortekaas J, 2011, J VIROL, V85, P12622, DOI 10.1128/JVI.00841-11; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; LOUDON PT, 1992, VIROLOGY, V191, P231, DOI 10.1016/0042-6822(92)90184-Q; Lymperopoulos K, 2003, J BIOL CHEM, V278, P31722, DOI 10.1074/jbc.M301072200; Lymperopoulos K, 2006, VIROLOGY, V353, P17, DOI 10.1016/j.virol.2006.04.022; Maan NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032601; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Markotter W, 2004, VIRUS RES, V105, P1, DOI 10.1016/j.virusres.2004.04.005; Matsuo E, 2013, J VIROL, V87, P882, DOI 10.1128/JVI.02363-12; Matsuo E, 2009, J VIROL, V83, P8842, DOI 10.1128/JVI.00465-09; Nagy PD, 1997, VIROLOGY, V235, P1, DOI 10.1006/viro.1997.8681; Noad R, 2009, BIOL ANIM INFECT, P53, DOI 10.1016/B978-012369368-6.50008-3; ONODERA S, 1993, J VIROL, V67, P4914, DOI 10.1128/JVI.67.8.4914-4922.1993; Orru G, 2006, J VIROL METHODS, V137, P34, DOI 10.1016/j.jviromet.2006.05.028; Paillart JC, 1996, BIOCHIMIE, V78, P639, DOI 10.1016/S0300-9084(96)80010-1; Phan TG, 2007, J VIROL, V81, P10188, DOI 10.1128/JVI.00337-07; Ramadevi N, 1998, J GEN VIROL, V79, P2475, DOI 10.1099/0022-1317-79-10-2475; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; Roner MR, 2007, VIROLOGY, V358, P89, DOI 10.1016/j.virol.2006.08.017; Roy P, 2005, ADV VIRUS RES, V64, P69, DOI 10.1016/S0065-3527(05)64004-3; ROY P, 1990, J VIROL, V64, P1; SATO M, 1977, ARCH VIROL, V54, P333, DOI 10.1007/BF01314778; Schneemann A, 2006, ANNU REV MICROBIOL, V60, P51, DOI 10.1146/annurev.micro.60.080805.142304; Stauber N, 1997, J VIROL, V71, P7220; Sutton G, 2007, NAT STRUCT MOL BIOL, V14, P449, DOI 10.1038/nsmb1225; THOMAS CP, 1990, J GEN VIROL, V71, P2073, DOI 10.1099/0022-1317-71-9-2073; URAKAWA T, 1989, NUCLEIC ACIDS RES, V17, P7395, DOI 10.1093/nar/17.18.7395; van Gennip HGP, 2013, VACCINE; van Gennip RGP, 2012, PLOS ONE, V7; van Rijn PA, 2014, PLOS ONE IN PRESS; van Rijn PA, 2012, J VET DIAGN INVEST, V24, P469, DOI 10.1177/1040638712440986; WENSVOORT G, 1986, VET MICROBIOL, V12, P101, DOI 10.1016/0378-1135(86)90072-6; WU XY, 1992, J VIROL, V66, P7104, DOI 10.1128/JVI.66.12.7104-7112.1992; ZHAO Y, 1994, J VIROL, V68, P2179, DOI 10.1128/JVI.68.4.2179-2185.1994	57	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92377	10.1371/journal.pone.0092377	http://dx.doi.org/10.1371/journal.pone.0092377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658296	gold, Green Published, Green Submitted			2022-12-27	WOS:000333355300077
J	Kefi, S; Guttal, V; Brock, WA; Carpenter, SR; Ellison, AM; Livina, VN; Seekell, DA; Scheffer, M; van Nes, EH; Dakos, V				Kefi, Sonia; Guttal, Vishwesha; Brock, William A.; Carpenter, Stephen R.; Ellison, Aaron M.; Livina, Valerie N.; Seekell, David A.; Scheffer, Marten; van Nes, Egbert H.; Dakos, Vasilis			Early Warning Signals of Ecological Transitions: Methods for Spatial Patterns	PLOS ONE			English	Article							PATCH-SIZE DISTRIBUTION; REGIME SHIFTS; VEGETATION PATTERNS; CATASTROPHIC SHIFTS; SUITABLE INDICATOR; LEADING INDICATOR; SLOWING-DOWN; CLIMATE; DESERTIFICATION; LAW	A number of ecosystems can exhibit abrupt shifts between alternative stable states. Because of their important ecological and economic consequences, recent research has focused on devising early warning signals for anticipating such abrupt ecological transitions. In particular, theoretical studies show that changes in spatial characteristics of the system could provide early warnings of approaching transitions. However, the empirical validation of these indicators lag behind their theoretical developments. Here, we summarize a range of currently available spatial early warning signals, suggest potential null models to interpret their trends, and apply them to three simulated spatial data sets of systems undergoing an abrupt transition. In addition to providing a step-by-step methodology for applying these signals to spatial data sets, we propose a statistical toolbox that may be used to help detect approaching transitions in a wide range of spatial data. We hope that our methodology together with the computer codes will stimulate the application and testing of spatial early warning signals on real spatial data.	[Kefi, Sonia] Univ Montpellier 2, CNRS, Inst Sci Evolut, Montpellier, France; [Guttal, Vishwesha] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Brock, William A.] Univ Wisconsin, Dept Econ, Madison, WI 53706 USA; [Brock, William A.; Carpenter, Stephen R.] Univ Missouri, Dept Econ, Columbia, MO USA; [Carpenter, Stephen R.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Ellison, Aaron M.] Harvard Univ, Petersham, MA USA; [Livina, Valerie N.] Natl Phys Lab, Teddington TW11 0LW, Middx, England; [Seekell, David A.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Scheffer, Marten; van Nes, Egbert H.] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AP Wageningen, Netherlands; [Dakos, Vasilis] Integrat Ecol Grp, Estn Biol Donana, Seville, Spain	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Indian Institute of Science (IISC) - Bangalore; University of Wisconsin System; University of Wisconsin Madison; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison; Harvard University; National Physical Laboratory - UK; University of Virginia; Wageningen University & Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Kefi, S (corresponding author), Univ Montpellier 2, CNRS, Inst Sci Evolut, Montpellier, France.	sonia.kefi@univ-montp2.fr	Livina, Valerie N/C-7636-2011; Guttal, Vishwesha/A-3007-2008; Carpenter, Stephen/AAQ-6404-2020; van Nes, Egbert H/F-2681-2011	Livina, Valerie N/0000-0003-3759-9013; Guttal, Vishwesha/0000-0002-2677-857X; van Nes, Egbert/0000-0002-6345-104X; Kefi, Sonia/0000-0002-9678-7770; Dakos, Vasilis/0000-0001-8862-718X; Ellison, Aaron/0000-0003-4151-6081	Santa Fe Institute; Arizona State University; European Union [283068]; Ramalingaswami Fellowship; Department of Biotechnology, Government of India; Ministry of Environment and Forests, Government of India; NSF; NSF [11-44056]; NERC of the AXA Research Fund [NE/F005474/1]; National Measurement Office; RUBICON; EU Marie Curie fellowship; NERC [NE/F005474/1] Funding Source: UKRI; Direct For Biological Sciences [1144683] Funding Source: National Science Foundation; Natural Environment Research Council [NE/F005474/1] Funding Source: researchfish	Santa Fe Institute; Arizona State University; European Union(European Commission); Ramalingaswami Fellowship; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Ministry of Environment and Forests, Government of India(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of India); NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NERC of the AXA Research Fund(AXA Research Fund); National Measurement Office; RUBICON(European Commission); EU Marie Curie fellowship(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors are grateful to the Santa Fe Institute and the Arizona State University for the financial support. SK acknowledges support from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 283068 (CASCADE). VG acknowledges support from a Ramalingaswami Fellowship, Department of Biotechnology, Government of India, and the Ministry of Environment and Forests, Government of India. SRC's work is supported by NSF. AME is supported by NSF award 11-44056. VNL is supported by NERC (NE/F005474/1) postdoctoral fellowship of the AXA Research Fund and grant of the National Measurement Office (2013-2016). VD acknowledges a RUBICON (NWO funded) grant and an EU Marie Curie fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbier N, 2006, J ECOL, V94, P537, DOI 10.1111/j.1365-2745.2006.01126.x; Blois JL, 2013, P NATL ACAD SCI USA, V110, P9374, DOI 10.1073/pnas.1220228110; Boettiger C, 2013, NATURE, V493, P157, DOI 10.1038/493157a; Boettiger C, 2012, J R SOC INTERFACE, V9, P2527, DOI 10.1098/rsif.2012.0125; Carpenter SR, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00016.1; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Corrado R, 2013, 2013 22ND INTERNATIONAL CONFERENCE ON NOISE AND FLUCTUATIONS (ICNF), DOI 10.1109/ICNF.2013.6578895; Couteron P, 2002, INT J REMOTE SENS, V23, P3407, DOI 10.1080/01431160110107699; Dai L, 2013, NATURE, V496, P355, DOI 10.1038/nature12071; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2013, THEOR ECOL-NETH, V6, P309, DOI 10.1007/s12080-013-0186-4; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; Deblauwe V, 2011, ECOGRAPHY, V34, P990, DOI 10.1111/j.1600-0587.2010.06694.x; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Foti R, 2013, P NATL ACAD SCI USA, V110, P6296, DOI 10.1073/pnas.1302558110; Gilmore R., 1981, CATASTROPHE THEORY S; Guttal V, 2008, THESIS OHIO STATE U, V3, P39; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Guttal V, 2007, ECOL MODEL, V201, P420, DOI 10.1016/j.ecolmodel.2006.10.005; Guttal V, 2009, THEOR ECOL-NETH, V2, P3, DOI 10.1007/s12080-008-0033-1; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Held H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020972; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Kefi S, 2010, ECOLOGY, V91, P3739, DOI 10.1890/09-1915.1; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kefi S, 2013, OIKOS, V122, P641, DOI 10.1111/j.1600-0706.2012.20838.x; Kefi S, 2011, ECOL LETT, V14, P29, DOI 10.1111/j.1461-0248.2010.01553.x; Kefi S, 2010, THEOR ECOL-NETH, V3, P257, DOI 10.1007/s12080-009-0067-z; Keitt TH, 2001, AM NAT, V157, P203, DOI 10.1086/318633; Lade SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002360; Legendre P., 2012, NUMERICAL ECOLOGY; Lin Y, 2010, LANDSCAPE ECOL, V25, P1519, DOI 10.1007/s10980-010-9520-z; Litzow MA, 2008, ECOL APPL, V18, P1331, DOI 10.1890/07-0998.1; Livina VN, 2011, CLIM DYNAM, V37, P2437, DOI 10.1007/s00382-010-0980-2; Livina VN, 2010, CLIM PAST, V6, P77, DOI 10.5194/cp-6-77-2010; Maestre FT, 2010, ECOLOGY, V91, P3742, DOI 10.1890/10-0391.1; Manor A, 2008, J THEOR BIOL, V253, P838, DOI 10.1016/j.jtbi.2008.04.012; Marcos-Nikolaus P, 2002, INT J BIFURCAT CHAOS, V12, P369, DOI 10.1142/S0218127402004371; Mocenni C, 2010, P NATL ACAD SCI USA, V107, P8097, DOI 10.1073/pnas.0910414107; Mugglestone MA, 1998, COMPUT GEOSCI, V24, P771, DOI 10.1016/S0098-3004(98)00065-X; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Oborny B, 2005, OIKOS, V109, P291; Pueyo S, 2011, LANDSCAPE ECOL, V26, P305, DOI 10.1007/s10980-010-9569-8; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Scanlon TM, 2007, NATURE, V449, P209, DOI 10.1038/nature06060; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Seekell DA, 2012, ECOSYSTEMS, V15, P741, DOI 10.1007/s10021-012-9542-2; Sethna JP, 2007, STAT MECH ENTROPY OR; Shnerb NM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.038101; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; van Nes EH, 2005, ECOLOGY, V86, P1797, DOI 10.1890/04-0550; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; von Hardenberg J, 2010, P ROY SOC B-BIOL SCI, V277, P1771, DOI 10.1098/rspb.2009.2208; Walters C, 1999, ECOSYSTEMS, V2, P539, DOI 10.1007/s100219900101; Wang R, 2012, NATURE, V492, P419, DOI 10.1038/nature11655; Weerman EJ, 2012, ECOLOGY, V93, P608, DOI 10.1890/11-0625.1; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	69	200	205	5	201	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92097	10.1371/journal.pone.0092097	http://dx.doi.org/10.1371/journal.pone.0092097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658137	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000333355300053
J	Wei, L; Zhou, QY; Hou, SP; Bai, L; Liu, YJ; Qi, J; Xiang, Q; Zhou, Y; Kijlstra, A; Yang, PZ				Wei, Lin; Zhou, Qingyun; Hou, Shengping; Bai, Lin; Liu, Yunjia; Qi, Jian; Xiang, Qin; Zhou, Yan; Kijlstra, Aize; Yang, Peizeng			MicroRNA-146a and Ets-1 Gene Polymorphisms Are Associated with Pediatric Uveitis	PLOS ONE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; EXPRESSION; MIR-146A; LUPUS; SUSCEPTIBILITY; EPIDEMIOLOGY; PRE-MIR-146A; CONTRIBUTES; ACTIVATION; MEMBRANE	Background: MicroRNA-146a (miR-146a) was a key negative regulator of autoimmunity. V-Ets oncogene homolog 1 (Ets-1) was demonstrated to bind to the miR-146a promoter region and markedly affects miR-146a promoter activity. This study aimed to investigate the association of miR-146a and Ets-1 gene polymorphisms with pediatric uveitis in a Han Chinese population. Methodology/Principal Findings: A total of 520 patients and 1204 healthy controls were included in the present study. Five single-nucleotide polymorphisms (SNPs), miR-146a/rs2910164, miR-146a/rs57095329, miR-146a/rs6864584, ets-1/rs1128334 and ets-1/rs10893872 were genotyped using a polymerase chain reaction-restriction fragment length polymorphism assay. The expression of Ets-1 in peripheral blood mononuclear cells from genotyped healthy controls was tested by real-time PCR. Two SNPs (rs2910164 and rs10893872) were associated with pediatric uveitis in this study. The frequencies of the rs2910164 GG genotype and G allele were significantly increased (P-c = -3.11x10(-4); P-c = -2.75x10(-6)) while the CC genotype and C allele were significantly decreased (P-c = 0.001; P-c = 2.75x10(-6)) in patients compared with normal controls. The frequencies of the rs10893872 CC genotype and C allele were significantly increased (P-c = 3.89x10(-4); P-c = 0.01) while the CT genotype and T allele were significantly decreased (P-c = 0.004; P-c = 0.01) in patients compared with normal controls. The SNP rs2910164 GG genotype and G/C allele were also associated with the presence of microvascular leakage as detected by fundus fluorescein angiography in pediatric uveitis (P-c = 0.01; P-c = 0.005, respectively). Ets-1 expression in rs10893872 CC carriers was significantly higher than in CT and TT individuals (P-c = 0.013). There was no association of the other three SNPs with pediatric uveitis. Conclusions: This study shows that miR-146a and Ets-1 are both associated with pediatric uveitis in Han Chinese. SNP rs10893872 may affect the genetic predisposition to pediatric uveitis by modulating expression of Ets-1.	[Wei, Lin; Zhou, Qingyun; Hou, Shengping; Bai, Lin; Liu, Yunjia; Qi, Jian; Xiang, Qin; Zhou, Yan; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Wei, Lin; Zhou, Qingyun; Hou, Shengping; Bai, Lin; Liu, Yunjia; Qi, Jian; Xiang, Qin; Zhou, Yan; Yang, Peizeng] Chongqing Eye Inst, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Eye Clin Maastricht, Maastricht, Netherlands	Chongqing Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com			National Basic Research Program of China (973 Program) [2011CB510200]; Key Project of Natural Science Foundation [81130019]; Research Fund for the Doctoral Program of Higher Education of China [20115503110002]; Ministry of Health, Basic Research program of Chongqing, Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Key Project of Health Bureau of Chongqing [2012-1-003]; Fund for PAR-EU Scholars Program	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Project of Natural Science Foundation; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Ministry of Health, Basic Research program of Chongqing, Chongqing Key Laboratory of Ophthalmology (CSTC); Key Project of Health Bureau of Chongqing; Fund for PAR-EU Scholars Program	This work was supported by National Basic Research Program of China (973 Program)(2011CB510200), Key Project of Natural Science Foundation(81130019), Research Fund for the Doctoral Program of Higher Education of China (20115503110002), Clinic Key Project of Ministry of Health, Basic Research program of Chongqing, Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), Key Project of Health Bureau of Chongqing(2012-1-003) and Fund for PAR-EU Scholars Program. The authors have declared that no competing interests exist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu K, 2013, INDIAN J OPHTHALMOL, V61, P277, DOI 10.4103/0301-4738.114099; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Clarke LAL, 2013, CLIN EXP RHEUMATOL, V31, P633; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cunningham ET, 2000, OCUL IMMUNOL INFLAMM, V8, P251; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Garrett-Sinha LA, 2013, CELL MOL LIFE SCI, V70, P3375, DOI 10.1007/s00018-012-1243-7; Guo H, 2010, FAM CANCER, V9, P599, DOI 10.1007/s10689-010-9370-5; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jimenez-Morales S, 2012, TISSUE ANTIGENS, P9999; Leng RX, 2011, AUTOIMMUN REV, V10, P439, DOI 10.1016/j.autrev.2011.01.007; Lerman MA, 2013, J RHEUMATOL, V40, P1394, DOI 10.3899/jrheum.121180; Li Y, 2010, CHINESE MED J-PEKING, V123, P2287, DOI 10.3760/cma.j.issn.0366-6999.2010.16.025; Luo XB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002128; MELINALDANA H, 1992, J PEDIATR-US, V121, P56, DOI 10.1016/S0022-3476(05)82541-7; Nunn MF, 1983, TRIPARTITE STRUCTURE; Paivonsalo-Hietanen T, 2000, ACTA OPHTHALMOL SCAN, V78, P84, DOI 10.1034/j.1600-0420.2000.078001084.x; Petty RE, 2004, J RHEUMATOL, V31, P390; Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1; Qi J, 2013, HUM GENET, P1; Redlich K, 2001, ARTHRITIS RHEUM, V44, P266, DOI 10.1002/1529-0131(200102)44:2<266::AID-ANR43>3.3.CO;2-7; Russell L, 2010, CYTOKINE, V51, P217, DOI 10.1016/j.cyto.2010.03.006; Smith JA, 2009, OPHTHALMOLOGY, V116, P1544, DOI 10.1016/j.ophtha.2009.05.002; Szumilas M, 2010, J CAN ACAD CHILD ADO, V19, P227; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Tugal-Tutkun Ilknur, 2011, J Ophthalmic Vis Res, V6, P259; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zeggini E, 2006, RHEUMATOLOGY, V45, P972, DOI 10.1093/rheumatology/kel049; Zhang J, 2013, ANN HUMAN GENETICS; Zhou FY, 2012, DNA CELL BIOL, V31, P1290, DOI 10.1089/dna.2011.1596; Zhou Q, 2012, ANN RHEUMATIC DIS; Zhou QY, 2012, MOL VIS, V18, P426; Zulian F, 2002, J RHEUMATOL, V29, P2446	38	21	24	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91199	10.1371/journal.pone.0091199	http://dx.doi.org/10.1371/journal.pone.0091199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658012	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300027
J	Aguilar, A; Gimenez, J; Gomez-Campos, E; Cardona, L; Borrell, A				Aguilar, Alex; Gimenez, Joan; Gomez-Campos, Encarna; Cardona, Luis; Borrell, Asuncion			delta N-15 Value Does Not Reflect Fasting in Mysticetes	PLOS ONE			English	Article							ELEPHANT SEAL PUPS; STABLE-ISOTOPES; NUTRITIONAL CONDITION; NITROGEN-METABOLISM; PROTEIN CATABOLISM; BALAENA-MYSTICETUS; FEEDING ECOLOGY; FIN WHALES; BALEEN; CARBON	The finding that tissue delta N-15 values increase with protein catabolism has led researchers to apply this value to gauge nutritive condition in vertebrates. However, its application to marine mammals has in most occasions failed. We investigated the relationship between delta N-15 values and the fattening/fasting cycle in a model species, the fin whale, a migratory capital breeder that experiences severe seasonal variation in body condition. We analyzed two tissues providing complementary insights: one with isotopic turnover (muscle) and one that keeps a permanent record of variations in isotopic values (baleen plates). In both tissues delta N-15 values increased with intensive feeding but decreased with fasting, thus contradicting the pattern previously anticipated. The apparent inconsistency during fasting is explained by the fact that a) individuals migrate between different isotopic isoscapes, b) starvation may not trigger significant negative nitrogen balance, and c) excretion drops and elimination of N-15-depleted urine is minimized. Conversely, when intensive feeding is resumed in the northern grounds, protein anabolism and excretion start again, triggering N-15 enrichment. It can be concluded that in whales and other mammals that accrue massive depots of lipids as energetic reserves and which have limited access to drinking water, the delta N-15 value is not affected by fasting and therefore cannot be used as an indicatior of nutritive condition.	[Aguilar, Alex] Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain; Univ Barcelona, Fac Biol, Biodivers Res Inst IrBio, Barcelona, Spain	University of Barcelona; University of Barcelona	Aguilar, A (corresponding author), Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain.	aaguilar@ub.edu	Borrell, Asunción/B-8257-2009; Aguilar, Alex/L-1283-2014; Cardona, Luis/AAL-1354-2021; Cardona, Luis/L-1680-2014; Gimenez, Joan/C-6107-2015	Borrell, Asunción/0000-0002-6714-0724; Aguilar, Alex/0000-0002-5751-2512; Cardona, Luis/0000-0002-7892-1323; Cardona, Luis/0000-0002-7892-1323; Gimenez, Joan/0000-0001-9207-4792	Fundacio Barcelona Zoo	Fundacio Barcelona Zoo	This work was conducted as part of a project on fin whale population structure supported by the Fundacio Barcelona Zoo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SH, 1993, J COMP PHYSIOL B, V163, P367; Aguilar A., 1999, Journal of Cetacean Research and Management Special Issue, V1, P83; AGUILAR A, 1990, J MAMMAL, V71, P544, DOI 10.2307/1381793; Aguilar A, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P433; AMBROSE SH, 1991, J ARCHAEOL SCI, V18, P293, DOI 10.1016/0305-4403(91)90067-Y; AMBROSE SH, 1987, NATURE, V325, P201, DOI 10.1038/325201a0; AMBROSE SH, 1986, J HUM EVOL, V15, P707, DOI 10.1016/S0047-2484(86)80006-9; Anonymous, 1977, Report int Whal Commn, V27, P369; Bahar B, 2009, J ANIM SCI, V87, P905, DOI 10.2527/jas.2008-1360; Barboza PS, 1997, CAN J ZOOL, V75, P2129, DOI 10.1139/z97-848; Ben-David M, 1999, CAN J ZOOL, V77, P1373, DOI 10.1139/cjz-77-9-1373; Bentaleb I, 2011, MAR ECOL PROG SER, V438, P285, DOI 10.3354/meps09269; BENTLEY PJ, 1963, COMP BIOCHEM PHYSIOL, V10, P257, DOI 10.1016/0010-406X(63)90040-9; Best PB, 1996, MAR BIOL, V124, P483, DOI 10.1007/BF00351030; Borrell A, 2012, RAPID COMMUN MASS SP, V26, P1596, DOI 10.1002/rcm.6267; Caraveo-Patino J, 2007, HYDROBIOLOGIA, V586, P17, DOI 10.1007/s10750-006-0477-5; Castellote M, 2012, MAR MAMMAL SCI, V28, P325, DOI 10.1111/j.1748-7692.2011.00491.x; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Ciancio JE, 2008, J FISH BIOL, V72, P1708, DOI 10.1111/j.1095-8649.2008.01846.x; Cormie AB, 1996, GEOCHIM COSMOCHIM AC, V60, P4161, DOI 10.1016/S0016-7037(96)00251-7; Costa DP, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P801; Das K, 2004, MAR ECOL PROG SER, V281, P283, DOI 10.3354/meps281283; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; del Rio CM, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P141; DELGIUDICE GD, 1994, J WILDLIFE MANAGE, V58, P430, DOI 10.2307/3809313; Doucett RR, 1999, CAN J FISH AQUAT SCI, V56, P2172, DOI 10.1139/cjfas-56-11-2172; FISHER LR, 1959, J MAR BIOL ASSOC UK, V38, P291, DOI 10.1017/S0025315400006093; Florin ST, 2011, FUNCT ECOL, V25, P519, DOI 10.1111/j.1365-2435.2010.01799.x; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Gaye-Siessegger J, 2007, J FISH BIOL, V71, P90, DOI 10.1111/j.1095-8649.2007.01469.x; Gimenez J, 2013, RAPID COMMUN MASS SP, V27, P1801, DOI 10.1002/rcm.6633; Gomez-Campos E, 2011, J EXP MAR BIOL ECOL, V405, P18, DOI 10.1016/j.jembe.2011.05.013; Gomez-Campos E, 2011, RAPID COMMUN MASS SP, V25, P1343, DOI 10.1002/rcm.4999; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Habran S, 2010, MAR MAMMAL SCI, V26, P880, DOI 10.1111/j.1748-7692.2010.00372.x; Hartman G, 2011, FUNCT ECOL, V25, P122, DOI 10.1111/j.1365-2435.2010.01782.x; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Hobson KA, 1999, OECOLOGIA, V120, P312, DOI 10.1007/s004420050864; Hobson KA, 1998, CAN J FISH AQUAT SCI, V55, P2601, DOI 10.1139/cjfas-55-12-2601; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Houser DS, 2001, J COMP PHYSIOL B, V171, P635, DOI 10.1007/s003600100214; HUI CA, 1981, PHYSIOL ZOOL, V54, P430, DOI 10.1086/physzool.54.4.30155836; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Knoche M, 2007, SC59BRG13 INT WHAL C; Kurle CM, 2001, OECOLOGIA, V126, P254, DOI 10.1007/s004420000518; Lee SH, 2005, MAR ECOL PROG SER, V285, P271, DOI 10.3354/meps285271; Lee TN, 2012, J EXP BIOL, V215, P3354, DOI 10.1242/jeb.068528; Lockyer C., 1987, S ZOOLOGICAL SOC LON, V57, P343; Lockyer C., 1981, FAO FISHERIES SERIES, V5, P379; Lohuis TD, 2007, COMP BIOCHEM PHYS B, V147, P20, DOI 10.1016/j.cbpb.2006.12.020; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; Mitani Y, 2006, FISHERIES SCI, V72, P69, DOI 10.1111/j.1444-2906.2006.01118.x; Nelson R.A., 1989, P299; Nelson RA, 1983, BEARS THEIR BIOL MAN, V5, P284, DOI [DOI 10.2307/3872551, 10.2307/3872551]; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; NORDOY ES, 1990, ACTA PHYSIOL SCAND, V139, P361, DOI 10.1111/j.1748-1716.1990.tb08935.x; Oelbermann K, 2002, OECOLOGIA, V130, P337, DOI 10.1007/s004420100813; Ortiz RM, 2001, J EXP BIOL, V204, P1831; Polischuk SC, 2001, CAN J ZOOL, V79, P499, DOI 10.1139/cjz-79-3-499; ROBBINS CT, 1974, J ANIM SCI, V38, P186, DOI 10.2527/jas1974.381186x; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Saltz D, 1995, WILDLIFE SOC B, V23, P694; Schell D.M., 1989, Ecological Studies, V68, P260; Schell DM, 2000, LIMNOL OCEANOGR, V45, P459, DOI 10.4319/lo.2000.45.2.0459; SCHELL DM, 1989, MAR BIOL, V103, P433, DOI 10.1007/BF00399575; Schmidt K, 2010, ADV MAR BIOL, V57, P127, DOI 10.1016/S0065-2881(10)57005-6; SEALY JC, 1987, GEOCHIM COSMOCHIM AC, V51, P2707, DOI 10.1016/0016-7037(87)90151-7; Sick H, 1997, Z ERNAHRUNGSWISS, V36, P340, DOI 10.1007/BF01617819; Sonanez-Organis JG, 2012, J EXP BIOL, V215, P1448, DOI 10.1242/jeb.067173; Summers Erin L., 2006, Journal of Cetacean Research and Management, V8, P241; TELFER N, 1970, J AM VET MED ASSOC, V157, P555; YOUNG VR, 1971, SCI AM, V225, P14, DOI 10.1038/scientificamerican1071-14	73	45	47	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92288	10.1371/journal.pone.0092288	http://dx.doi.org/10.1371/journal.pone.0092288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651388	Green Published, gold			2022-12-27	WOS:000333352800095
J	Araujo, RM; Serrao, EA; Sousa-Pinto, I; Aberg, P				Araujo, Rita M.; Serrao, Ester A.; Sousa-Pinto, Isabel; Aberg, Per			Spatial and Temporal Dynamics of Fucoid Populations (Ascophyllum nodosum and Fucus serratus): A Comparison between Central and Range Edge Populations	PLOS ONE			English	Article							LIFE-HISTORY; MARGINAL POPULATIONS; SENSITIVITY-ANALYSIS; REPRODUCTIVE EFFORT; SOUTHERN LIMIT; CLIMATE-CHANGE; SEAWEED; PHAEOPHYCEAE; FUCALES; GROWTH	Persistence of populations at range edges relies on local population dynamics and fitness, in the case of geographically isolated populations of species with low dispersal potential. Focusing on spatial variations in demography helps to predict the long-term capability for persistence of populations across the geographical range of species' distribution. The demography of two ecological and phylogenetically close macroalgal species with different life history characteristics was investigated by using stochastic, stage-based matrix models. Populations of Ascophyllum nodosum and Fucus serratus were sampled for up to 4 years at central locations in France and at their southern range limits in Portugal. The stochastic population growth rate (lambda(s)) of A. nodosum was lower and more variable in central than in southern sites whilst for F. serratus this trend was reversed with lambda(s) much lower and more variable in southern than in central populations. Individuals were larger in central than in southern populations for both species, which was reflected in the lower transition probabilities of individuals to larger size classes and higher probability of shrinkage in the southern populations. In both central and southern populations elasticity analysis (proportional sensitivity) of population growth rate showed that fertility elements had a small contribution to lambda(s) that was more sensitive to changes in matrix transitions corresponding to survival. The highest elasticities were found for loop transitions in A. nodosum and for growth to larger size classes in F. serratus. Sensitivity analysis showed high selective pressure on individual growth for both species at both locations. The results of this study highlight the deterministic role of species-specific life-history traits in population demography across the geographical range of species. Additionally, this study demonstrates that individuals' life-transitions differ in vulnerability to environmental variability and shows the importance of vegetative compared to reproductive stages for the long-term persistence of populations.	[Araujo, Rita M.; Sousa-Pinto, Isabel] Univ Porto, Interdisciplinary Ctr Marine & Environm Res CIIMA, P-4100 Oporto, Portugal; [Serrao, Ester A.] Univ Algarve CIMAR Algarve, Ctr Marine Sci, Faro, Portugal; [Sousa-Pinto, Isabel] Univ Porto, Fac Sci, Dept Biol, P-4100 Oporto, Portugal; [Aberg, Per] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	Universidade do Porto; Universidade do Algarve; Universidade do Porto; University of Gothenburg	Araujo, RM (corresponding author), Univ Porto, Interdisciplinary Ctr Marine & Environm Res CIIMA, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ritaraujo@ciimar.up.pt	Araujo, Rita/S-2065-2019; Serrao, Ester A/C-6686-2012; Pinto, Isabel Sousa/W-1591-2019; Araujo, Rita M/I-2964-2015	Serrao, Ester A/0000-0003-1316-658X; Pinto, Isabel Sousa/0000-0002-9231-0553; Araujo, Rita M/0000-0001-8062-972X	Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/75843/2011]; European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; FCT [Pest-CIMAR LA 0015/2013, EXCL/AAG-GLO/0661/2012]; Fundação para a Ciência e a Tecnologia [EXCL/AAG-GLO/0661/2012] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was funded by a fellowship from Portuguese Foundation for Science and Technology (FCT) (SFRH/BPD/75843/2011). This research was partially supported by the European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme and national funds through FCT, (under the project Pest-CIMAR LA 0015/2013 and the project EXCL/AAG-GLO/0661/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERG P, 1992, ECOLOGY, V73, P1473, DOI 10.2307/1940691; ABERG P, 1992, ECOLOGY, V73, P1488, DOI 10.2307/1940692; Aberg P, 1997, MAR ECOL PROG SER, V158, P111, DOI 10.3354/meps158111; ABERG P, 1990, MAR ECOL PROG SER, V63, P281, DOI 10.3354/meps063281; Aberg P, 1996, MAR ECOL PROG SER, V138, P199, DOI 10.3354/meps138199; Aberg P, 2009, ECOL MODEL, V220, P605, DOI 10.1016/j.ecolmodel.2008.11.014; Alexandre A, 2005, MAR ECOL PROG SER, V298, P115, DOI 10.3354/meps298115; Allen MR, 2000, NATURE, V407, P617, DOI 10.1038/35036559; Ang PO, 1996, HYDROBIOLOGIA, V327, P179, DOI 10.1007/BF00047804; ANG PO, 1992, MAR ECOL PROG SER, V89, P25, DOI 10.3354/meps089025; ANG PO, 1993, MAR ECOL PROG SER, V93, P253, DOI 10.3354/meps093253; ANG PO, 1990, MAR ECOL PROG SER, V59, P171, DOI 10.3354/meps059171; ANG PO, 1993, HYDROBIOLOGIA, V261, P321; Angert AL, 2006, ECOLOGY, V87, P2014, DOI 10.1890/0012-9658(2006)87[2014:DOCAMP]2.0.CO;2; Araujo R, 2011, J PHYCOL, V47, P451, DOI 10.1111/j.1529-8817.2011.00986.x; Araujo R, 2009, MAR ECOL PROG SER, V378, P81, DOI 10.3354/meps07814; Araujo R, 2009, BOT MAR, V52, P24, DOI 10.1515/BOT.2009.026; Arrontes J, 2005, MAR ECOL PROG SER, V295, P57, DOI 10.3354/meps295057; ARRONTES J, 1993, MAR ECOL PROG SER, V93, P183, DOI 10.3354/meps093183; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2005, AUST NZ J STAT, V47, P75, DOI 10.1111/j.1467-842X.2005.00373.x; CASWELL H, 1994, ECOLOGY, V75, P1299, DOI 10.2307/1937455; Coleman RA, 2006, OECOLOGIA, V147, P556, DOI 10.1007/s00442-005-0296-9; Coyer JA, 2003, MOL ECOL, V12, P1817, DOI 10.1046/j.1365-294X.2003.01850.x; Davies AJ, 2007, MAR ECOL PROG SER, V339, P131, DOI 10.3354/meps339131; Diekmann OE, 2012, MOL ECOL, V21, P1647, DOI 10.1111/j.1365-294X.2012.05500.x; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Engel C, 2001, J ECOL, V89, P436, DOI 10.1046/j.1365-2745.2001.00567.x; Engelen AH, 2005, CORAL REEFS, V24, P670, DOI 10.1007/s00338-005-0052-y; Engkvist R, 2004, AQUAT ECOL, V38, P403, DOI 10.1023/B:AECO.0000035162.07481.1f; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Hoarau G, 2007, MOL ECOL, V16, P3606, DOI 10.1111/j.1365-294X.2007.03408.x; Holt RD, 2005, OIKOS, V108, P3, DOI 10.1111/j.0030-1299.2005.13145.x; Keitt TH, 2001, AM NAT, V157, P203, DOI 10.1086/318633; Keser M, 2005, J SEA RES, V54, P211, DOI 10.1016/j.seares.2005.05.001; Kraufvelin P, 2010, MAR BIOL, V157, P29, DOI 10.1007/s00227-009-1293-z; Ladah LB, 1999, J PHYCOL, V35, P1106, DOI 10.1046/j.1529-8817.1999.3561106.x; Lester SE, 2007, ECOL LETT, V10, P745, DOI 10.1111/j.1461-0248.2007.01070.x; MARBA N, 1995, J ECOL, V83, P381, DOI 10.2307/2261592; Nicastro KR, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-6; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Olsen JL, 2010, J BIOGEOGR, V37, P842, DOI 10.1111/j.1365-2699.2009.02262.x; Pavia H, 1999, J ECOL, V87, P761, DOI 10.1046/j.1365-2745.1999.00397.x; Pearson GA, 2009, J ECOL, V97, P450, DOI 10.1111/j.1365-2745.2009.01481.x; Purves DW, 2009, P R SOC B, V276, P1477, DOI 10.1098/rspb.2008.1241; REED DC, 1988, ECOL MONOGR, V58, P321, DOI 10.2307/1942543; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Svensson CJ, 2009, MAR BIOL, V156, P1139, DOI 10.1007/s00227-009-1156-7; Svensson CJ, 2005, OECOLOGIA, V142, P117, DOI 10.1007/s00442-004-1703-3; Toth GB, 2000, P NATL ACAD SCI USA, V97, P14418, DOI 10.1073/pnas.250226997; Toth GB, 2006, MAR BIOL, V148, P1193, DOI 10.1007/s00227-005-0167-2; Toth GB, 2007, OECOLOGIA, V152, P245, DOI 10.1007/s00442-006-0643-5; Viejo RM, 2003, MAR BIOL, V142, P1229, DOI 10.1007/s00227-002-0994-3; Viejo RM, 2011, ECOGRAPHY, V34, P75, DOI 10.1111/j.1600-0587.2010.06365.x; Welham CVJ, 1998, CAN J BOT, V76, P166, DOI 10.1139/cjb-76-1-166	59	29	29	3	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92177	10.1371/journal.pone.0092177	http://dx.doi.org/10.1371/journal.pone.0092177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651480	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800078
J	Cui, J; Wang, HD; Liu, SK; Zhu, LF; Qiu, XM; Jiang, ZQ; Wang, XL; Liu, ZJ				Cui, Jun; Wang, Hongdi; Liu, Shikai; Zhu, Lifu; Qiu, Xuemei; Jiang, Zhiqiang; Wang, Xiuli; Liu, Zhanjiang			SNP Discovery from Transcriptome of the Swimbladder of Takifugu rubripes	PLOS ONE			English	Article							EMBRYONIC LUNG GROWTH; RNA-SEQ ANALYSIS; SONIC HEDGEHOG; GENE POLYMORPHISMS; READ ALIGNMENT; BETA-CATENIN; LINKAGE MAP; EXPRESSION; CATFISH; GENOME	Single nucleotide polymorphisms (SNPs) have become the marker of choice for genome-wide association studies in many species. High-throughput sequencing of RNA was developed primarily to analyze global gene expression, while it is an efficient way to discover SNPs from the expressed genes. In this study, we conducted transcriptome sequencing of the swimbladder of Takifugu rubripes using Illumina HiSeq2000 platform to identify gene-associated SNPs in the swimbladder. A total of 30,312,181 unique-mapped-reads were obtained from 44,736,850 raw reads. A total of 62,270 putative SNPs were discovered, which were located in 11,306 expressed genes and 2,246 scaffolds. The average minor allele frequency (MAF) of the SNPs was 0.26. GO and KEGG pathway analysis were conducted to analyze the genes containing SNPs. Validation of selected SNPs revealed that 54% of SNPs (26/48) were true SNPs. The results suggest that RNA-Seq is an efficient and cost-effective approach to discover gene-associated SNPs. In this study, a large number of SNPs were identified and these data will be useful resources for population genetic study, evolution analysis, resource assessment, genetic linkage analysis and genome-wide association studies.	[Cui, Jun; Wang, Hongdi; Qiu, Xuemei; Jiang, Zhiqiang; Wang, Xiuli] Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Fish Mol Genet & Biotechnol Lab, Aquat Genom Unit, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Program Cell & Mol Biosci, Auburn, AL 36849 USA; [Zhu, Lifu] Dalian Jiaotong Univ, Sch Environm & Chem Engn, Dalian, Peoples R China	Dalian Ocean University; Ministry of Agriculture & Rural Affairs; Auburn University System; Auburn University; Auburn University System; Auburn University; Dalian Jiaotong University	Jiang, ZQ (corresponding author), Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China.	zhqjiang@dlou.edu.cn; xiuliwang417@sina.com; LIUZHAN@auburn.edu	Liu, Zhanjiang/R-9633-2019; Liu, Shikai/AAO-2247-2021; Cui, Jun/P-9378-2015	Liu, Shikai/0000-0001-5777-489X; 	Program for Liaoning Excellent Talents in University [LR201010]; Dalian Ocean University [2012HYDX07]	Program for Liaoning Excellent Talents in University; Dalian Ocean University	This project was supported by the Program for Liaoning Excellent Talents in University (LR201010) and the grant of Dalian Ocean University (2012HYDX07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Avaron F, 2006, DEV DYNAM, V235, P478, DOI 10.1002/dvdy.20619; Bekker V, 2010, J VIRAL HEPATITIS, V17, P192, DOI 10.1111/j.1365-2893.2009.01166.x; Bellusci S, 1997, DEVELOPMENT, V124, P53; BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Cui P, 2010, GENOMICS, V96, P259, DOI 10.1016/j.ygeno.2010.07.010; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Gu Jing-jing, 2010, Fisheries Science (Liaoning), V29, P527; Hao Jun, 2007, Dalian Shuichan Xueyuan Xuebao, V22, P97; Hao Jun, 2006, Shanghai Shuichan Daxue Xuebao, V15, P21; Hirata H, 2009, CANCER-AM CANCER SOC, V115, P4488, DOI 10.1002/cncr.24491; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kai W, 2011, GENOME BIOL EVOL, V3, P424, DOI 10.1093/gbe/evr041; Kim IC, 2011, J NUTR BIOCHEM, V22, P252, DOI 10.1016/j.jnutbio.2010.02.002; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lako M, 1998, GENE, V219, P101, DOI 10.1016/S0378-1119(98)00393-X; Lewis KE, 1999, DEV BIOL, V208, P14, DOI 10.1006/dbio.1998.9169; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Liu SK, 2013, PHYSIOL GENOMICS, V45, P462, DOI 10.1152/physiolgenomics.00026.2013; Liu SK, 2013, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-595; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Loh YH, 2004, GENOME RES, V14, P1248, DOI 10.1101/gr.2400004; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Moen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-223; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Perry SF, 2004, RESP PHYSIOL NEUROBI, V144, P125, DOI 10.1016/j.resp.2004.06.018; Perry SF, 2011, COMP BIOCH PHYSL A, V129, P37; Quilang J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-157; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Ross-Hansen K, 2013, BRIT J DERMATOL, V168, P762, DOI 10.1111/bjd.12126; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Shin H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-30; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Shu WG, 2002, DEVELOPMENT, V129, P4831; Sun FY, 2012, DEV COMP IMMUNOL, V38, P169, DOI 10.1016/j.dci.2012.05.006; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Wang BB, 2012, J ANDROL, V33, P951, DOI 10.2164/jandrol.110.012849; Wang FS, 2003, AM J RESP CELL MOL, V29, P62, DOI 10.1165/rcmb.2002-0180OC; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Winata CL, 2009, DEV BIOL, V331, P222, DOI 10.1016/j.ydbio.2009.04.035; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059703; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Yang AF, 2012, J GENET, V91, pE49; Yin A, 2012, BBA-MOL CELL RES, V1823, P236, DOI 10.1016/j.bbamcr.2011.09.018; Yin A, 2010, GENE EXPR PATTERNS, V10, P338, DOI 10.1016/j.gep.2010.07.005; Zabek T, 2013, HEREDITAS, V150, P38, DOI 10.1111/j.1601-5223.2013.02282.x; [张丽 Zhang Li], 2012, [生物技术通报, Biotechnology Bulletin], P97; Zhao XX, 2012, MAR BIOTECHNOL, V14, P730, DOI 10.1007/s10126-012-9438-3; Zheng WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024019; Zheng Xian-Hu, 2011, Yichuan, V33, P1366, DOI 10.3724/SP.J.1005.2011.01366	66	20	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92502	10.1371/journal.pone.0092502	http://dx.doi.org/10.1371/journal.pone.0092502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651578	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800121
J	Habibi, R; Lexchin, J				Habibi, Roojin; Lexchin, Joel			Quality and Quantity of Information in Summary Basis of Decision Documents Issued by Health Canada	PLOS ONE			English	Article							DRUGS; DOCTORS; SAFETY	Background: Health Canada's Summary Basis of Decision (SBD) documents outline the clinical trial information that was considered in approving a new drug. We examined the ability of SBDs to inform clinician decision-making. We asked if SBDs answered three questions that clinicians might have prior to prescribing a new drug: 1) Do the characteristics of patients enrolled in trials match those of patients in their practice? 2) What are the details concerning the drug's risks and benefits? 3) What are the basic characteristics of trials? Methods: 14 items of clinical trial information were identified from all SBDs published on or before April 2012. Each item received a score of 2 (present), 1 (unclear) or 0 (absent). The unit of analysis was the individual SBD, and an overall SBD score was derived based on the sum of points for each item. Scores were expressed as a percentage of the maximum possible points, and then classified into five descriptive categories based on that score. Additionally, three overall 'component' scores were tallied for each SBD: "patient characteristics'', "benefit/risk information'' and "basic trial characteristics''. Results: 161 documents, spanning 456 trials, were analyzed. The majority (126/161) were rated as having information sometimes present (score of >33 to 66%). No SBDs had either no information on any item, or 100% of the information. Items in the patient characteristics component scored poorest (mean component score of 40.4%), while items corresponding to basic trial information were most frequently provided (mean component score of 71%). Conclusion: The significant omissions in the level of clinical trial information in SBDs provide little to aid clinicians in their decision-making. Clinicians' preferred source of information is scientific knowledge, but in Canada, access to such information is limited. Consequently, we believe that clinicians are being denied crucial tools for decision-making.	[Habibi, Roojin] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada; [Lexchin, Joel] York Univ, Sch Hlth Policy & Management, Toronto, ON M3J 2R7, Canada; [Lexchin, Joel] Univ Hlth Network, Toronto, ON, Canada; [Lexchin, Joel] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada	McMaster University; York University - Canada; University of Toronto; University Health Network Toronto; University of Toronto	Lexchin, J (corresponding author), York Univ, Sch Hlth Policy & Management, Toronto, ON M3J 2R7, Canada.	jlexchin@yorku.ca	Habibi, Roojin/AAR-3799-2021	Habibi, Roojin/0000-0001-7948-0438	Pharmaceutical Policy Research Collaboration through an Emerging Team Grant from the Canadian Institutes of Health Research	Pharmaceutical Policy Research Collaboration through an Emerging Team Grant from the Canadian Institutes of Health Research	Funding for Roojin Habibi was provided by the Pharmaceutical Policy Research Collaboration through an Emerging Team Grant from the Canadian Institutes of Health Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbui C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2291; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; Doshi Peter, 2013, BMJ Open, V3, DOI 10.1136/bmjopen-2012-002496; Doshi P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7898; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; European Medicines Agency, 2013, POL 70 PUBL IN PRESS; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Gotzsche PC, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2686; Health Canada, 2012, LAUNCH PHAS 2 SUMM B; Health Canada, 2004, ISS AN SUMM SUMM BAS; Health Canada, 2012, FREQ ASK QUEST SUMM; Health Canada, 2010, EV PHAS 1 SUMM BAS D; Herder M, 2012, CAN MED ASSOC J, V184, P194, DOI 10.1503/cmaj.110721; Hoertel N, 2012, DEPRESS ANXIETY, V29, P614, DOI 10.1002/da.21937; House of Commons Standing Committee on Health, 2004, 1 HOUS COMM STAND CO; International Society of Drug Bulletins, 1998, ISDB ASS 9 EUR PUBL; Jefferson T, 2012, COCHRANE DATABASE SY; Jones MI, 2001, BMJ-BRIT MED J, V323, P378, DOI 10.1136/bmj.323.7309.378; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Lexchin J, 2004, CAN MED ASSOC J, V171, P1363, DOI 10.1503/cmaj.1041446; Lexchin J, 2002, CAN FAM PHYSICIAN, V48, P1487; Lexchin Joel, 2014, Open Med, V8, pe14; Lexchin J, 2012, ARCH INTERN MED, V172, P1680, DOI 10.1001/archinternmed.2012.4444; Lurie P, 2006, LAW CONTEMP PROBL, V68, P85; McGettigan P, 2001, BRIT J CLIN PHARMACO, V51, P184; Nisen P, 2013, NEW ENGL J MED, V369, P475, DOI 10.1056/NEJMsr1302541; Office of the Auditor General of Canada, 2011, REP AUD GEN CAN HOUS; Prosser H, 2006, SOC SCI MED, V62, P1565, DOI 10.1016/j.socscimed.2005.08.035; Schumock GT, 2004, ANN PHARMACOTHER, V38, P557, DOI 10.1345/aph.1D390; Science Advisory Board Committee on the Drug Review Process, 2000, REP HLTH CAN; Vedula SS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001378; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wieseler B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001526	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92038	10.1371/journal.pone.0092038	http://dx.doi.org/10.1371/journal.pone.0092038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651766	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800065
J	Lacotte, S; Oldani, G; Slits, F; Orci, LA; Rubbia-Brandt, L; Morel, P; Mentha, G; Toso, C				Lacotte, Stephanie; Oldani, Graziano; Slits, Florence; Orci, Lorenzo A.; Rubbia-Brandt, Laura; Morel, Philippe; Mentha, Gilles; Toso, Christian			Alloimmune Activation Promotes Anti-Cancer Cytotoxicity after Rat Liver Transplantation	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HEPATOCELLULAR-CARCINOMA; NK-CELLS; DENDRITIC CELLS; RISK-FACTORS; RECURRENCE; EXPRESSION; ALLOGRAFTS; MONOCYTES; INNATE	Liver transplantation for hepatocellular carcinoma (HCC) results in a specific condition where the immune response is potentially directed against both allogeneic and cancer antigens. We have investigated the level of anti-cancer immunity during allogeneic immune response. Dark Agouti-to-Lewis and Lewis-to-Lewis rat liver transplantations were performed and the recipients anti-cancer immunity was analysed at the time of alloimmune activation. The occurrence of rejection in the allogeneic recipients was confirmed by a shorter survival (p<0.01), increased liver function tests (p<0.01), the presence of signs of rejection on histology, and a donor-specific ex vivo mixed lymphocyte reaction. At the time of alloimmune activation, blood mononuclear cells of the allogeneic group demonstrated increased anti-cancer cytotoxicity (p<0.005), which was related to an increased natural killer (NK) cell frequency (p<0.05) and a higher monocyte/macrophage activation level (p<0.01). Similarly, liver NK cell anti-cancer cytotoxicity (p<0.005), and liver monocyte/macrophage activation levels (p<0.01) were also increased. The alloimmune-associated cytotoxicity was mediated through the NKG2D receptor, whose expression was increased in the rejected graft (p<0.05) and on NK cells and monocyte/macrophages. NKG2D ligands were expressed on rat HCC cells, and its inhibition prevented the alloimmune-associated cytotoxicity. Although waiting for in vivo validation, alloimmune-associated cytotoxicity after rat liver transplantation appears to be linked to increased frequencies and levels of activation of NK cells and monocyte/macrophages, and is at least in part mediated through the NKG2D receptor.	[Lacotte, Stephanie; Oldani, Graziano; Slits, Florence; Orci, Lorenzo A.; Morel, Philippe; Mentha, Gilles; Toso, Christian] Univ Geneva, Univ Hosp Geneva, Dept Surg, Geneva, Switzerland; [Rubbia-Brandt, Laura] Univ Geneva, Univ Hosp Geneva, Hepatopancreatobiliary Ctr, Geneva, Switzerland; [Rubbia-Brandt, Laura; Mentha, Gilles; Toso, Christian] Univ Geneva, Univ Hosp Geneva, Dept Pathol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Lacotte, S (corresponding author), Univ Geneva, Univ Hosp Geneva, Dept Surg, Geneva, Switzerland.	stephanie.lacotte@unige.ch; christian.toso@hcuge.ch	Stéphanie, LACOTTE/I-1693-2019	Stéphanie, LACOTTE/0000-0002-5921-6389	Swiss National Science Foundation [PP00P3_139021]; Arteres Foundation; Astellas European Foundation; Boninchi Foundation; Elsie and Carlos de Reuter; Marie-France and Francis Minkoff Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Arteres Foundation; Astellas European Foundation(Astellas Pharmaceuticals); Boninchi Foundation; Elsie and Carlos de Reuter; Marie-France and Francis Minkoff Foundation	This study was supported by grants from the Swiss National Science Foundation (PP00P3_139021), the Arteres Foundation, the Astellas European Foundation, and the Boninchi Foundation, the Elsie and Carlos de Reuter, and the Marie-France and Francis Minkoff Foundation. Christian Toso was supported by a Professorship from the Swiss National Science Foundation (PP00P3_139021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chanvillard C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00063; Chen GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033626; Cheng JW, 2011, J CANCER RES CLIN, V137, P1445, DOI 10.1007/s00432-011-1014-0; Decaens T, 2006, WORLD J GASTROENTERO, V12, P7319, DOI 10.3748/wjg.v12.i45.7319; Demetris AJ, 1997, HEPATOLOGY, V25, P658; Ding T, 2009, HUM PATHOL, V40, P381, DOI 10.1016/j.humpath.2008.08.011; Eissens DN, 2010, AM J TRANSPLANT, V10, P1981, DOI 10.1111/j.1600-6143.2010.03242.x; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Hama N, 2009, LIVER TRANSPLANT, V15, P509, DOI 10.1002/lt.21708; Ishiyama K, 2006, HEPATOLOGY, V43, P362, DOI 10.1002/hep.21035; Ishiyama K, 2011, TRANSPLANTATION, V91, P952, DOI 10.1097/TP.0b013e3182139dc1; Jose MD, 2003, TRANSPLANTATION, V76, P1015, DOI 10.1097/01.TP.0000083507.67995.13; Kamimura H, 2012, J HEPATOL, V56, P381, DOI 10.1016/j.jhep.2011.06.017; Kohga K, 2008, CANCER SCI, V99, P1643, DOI 10.1111/j.1349-7006.2008.00859.x; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Kveberg L, 2010, J LEUKOCYTE BIOL, V88, P87, DOI 10.1189/jlb.0110039; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; McGilvray RW, 2009, CLIN CANCER RES, V15, P6993, DOI 10.1158/1078-0432.CCR-09-0991; Motomura T, 2013, J HEPATOL, V58, P58, DOI 10.1016/j.jhep.2012.08.017; NOVICKI DL, 1983, IN VITRO CELL DEV B, V19, P191; Obara H, 2005, AM J TRANSPLANT, V5, P2094, DOI 10.1111/j.1600-6143.2005.00995.x; Oertel M, 2001, TRANSPLANTATION, V72, P116, DOI 10.1097/00007890-200107150-00023; Oldani G, 2012, JOVE-J VIS EXP, DOI 10.3791/4143; Poggi A, 1997, EUR J IMMUNOL, V27, P2965, DOI 10.1002/eji.1830271132; Pozo D, 2006, J IMMUNOL, V176, P2397, DOI 10.4049/jimmunol.176.4.2397; Rolstad B, 1997, IMMUNOL REV, V155, P91, DOI 10.1111/j.1600-065X.1997.tb00942.x; Sageshima J, 2011, TRANSPL IMMUNOL, V25, P104, DOI 10.1016/j.trim.2011.07.002; Sharma R, 2014, IMMUNOL RES, V58, P125, DOI 10.1007/s12026-013-8477-9; Sorrentino C, 2006, J PATHOL, V209, P400, DOI 10.1002/path.1980; Sposito C, 2013, J HEPATOL, V59, P59, DOI 10.1016/j.jhep.2013.02.026; Srivastava RM, 2008, J IMMUNOL, V180, P1117, DOI 10.4049/jimmunol.180.2.1117; Toso C, 2011, AM J TRANSPLANT, V11, P2031, DOI 10.1111/j.1600-6143.2011.03689.x; Toso C, 2009, TRANSPL INT, V22, P182, DOI 10.1111/j.1432-2277.2008.00746.x; Vivarelli M, 2005, LIVER TRANSPLANT, V11, P497, DOI 10.1002/lt.20391; Vivarelli M, 2008, ANN SURG, V248, P857, DOI 10.1097/SLA.0b013e3181896278; Werner JM, 2011, TRANSPL IMMUNOL, V25, P27, DOI 10.1016/j.trim.2011.05.006; Zerbini A, 2010, GASTROENTEROLOGY, V138, P1931, DOI 10.1053/j.gastro.2009.12.051; Zhou ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036928; Zhuo M, 2010, EUR J IMMUNOL, V40, P1748, DOI 10.1002/eji.200939779; ZIMMERMANN FA, 1984, TRANSPLANTATION, V37, P406, DOI 10.1097/00007890-198404000-00019	41	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91515	10.1371/journal.pone.0091515	http://dx.doi.org/10.1371/journal.pone.0091515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651497	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800041
J	Lee, MF; Yang, KJ; Wang, NM; Chiu, YT; Chen, PC; Chen, YH				Lee, Mey-Fann; Yang, Kai-Jei; Wang, Nancy M.; Chiu, Yung-Tsung; Chen, Pei-Chih; Chen, Yi-Hsing			The Development of a Murine Model for Forcipomyia taiwana (Biting Midge) Allergy	PLOS ONE			English	Article							ITCH-ASSOCIATED RESPONSE; MOUSE MODEL; MOSQUITO ALLERGY; IMMUNE-RESPONSES; ANIMAL-MODELS; SAND FLIES; MICE; ALLERGENICITY; BITES; IGE	Background: Forcipomyia taiwana (biting midge) allergy is the most prevalent biting insect allergy in Taiwan. An animal model corresponding to the human immuno-pathologic features of midge allergy is needed for investigating the mechanisms and therapies. This study successfully developed a murine model of Forcipomyia taiwana allergy. Methods: BALB/c mice were sensitized intra-peritoneally with midge extract on days 0, 7, 14, 21 then intra-dermally on days 28, 31 and 35. Serum midge-specific IgE, IgG1, and IgG2a were measured every 14 days by indirect ELISA. The mice were challenged intradermally with midge extract at day 40 and then sacrificed. Proliferation and cytokine production of splenocytes after stimulation with midge extract were determined by MTT assay and ELISA, respectively. The cytokine mRNA expression in response to midge stimulation was analyzed by RT-PCR. Results: Serum IgE, total IgG, and IgG1 antibody levels against midge extract were significantly higher in the midge-sensitized mice than in the control mice. After the two-step sensitization, all mice in the midge-sensitized group displayed immediate itch and plasma extravasation reactions in response to challenge with midge extract. Skin histology from midge-sensitized mice showed marked eosinophil and lymphocyte infiltrations similar to that observed in humans. Stimulation of murine splenocytes with midge extract elicited significant proliferation, IL-4, IL-10, IL-13 and IFN-gamma protein production, and up-regulation of mRNA in a dose-dependent manner in the midge-sensitized group, but not in the control group. Conclusions: A murine model of midge bite allergy has been successfully developed using a two-step sensitization protocol. The sensitized mice have very similar clinical and immunologic reactions to challenge with midge proteins as the reactions of human to midge bites. This murine model may be a useful platform for future research and the development of treatment strategies for insect bite allergy.	[Lee, Mey-Fann; Chiu, Yung-Tsung] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Lee, Mey-Fann; Chen, Yi-Hsing] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Yang, Kai-Jei; Wang, Nancy M.] Natl Changhua Univ Educ, Inst Biotechnol, Changhua, Taiwan; [Chen, Pei-Chih; Chen, Yi-Hsing] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Yi-Hsing] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan	Taichung Veterans General Hospital; Tunghai University; National Changhua University of Education; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, YH (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.	ysanne@vghtc.gov.tw			Taiwan National Science Council [NSC-98-2314-B-075A-008-MY3]; Taichung Veterans General Hospital [TCVGH-1023804C]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital	This study was supported by grants NSC-98-2314-B-075A-008-MY3 from the Taiwan National Science Council (www.nsc.gov.tw) and TCVGH-1023804C from Taichung Veterans General Hospital (www.vghtc.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldemir H, 2009, REGUL TOXICOL PHARM, V54, pS52, DOI 10.1016/j.yrtph.2008.11.004; Andoh T, 2010, J PHARMACOL SCI, V114, P292, DOI 10.1254/jphs.10180FP; Aslan H, 2013, J INFECT DIS, V207, P1328, DOI 10.1093/infdis/jis932; CHEN C-S, 1981, Chinese Journal of Microbiology and Immunology (Taipei), V14, P54; Chen YH, 2005, ALLERGY, V60, P1518, DOI 10.1111/j.1398-9995.2005.00918.x; Chen YH, 2009, INT ARCH ALLERGY IMM, V150, P66, DOI 10.1159/000210382; Chen YL, 1998, INT ARCH ALLERGY IMM, V116, P269, DOI 10.1159/000023955; Chuang YY, 2000, J MED ENTOMOL, V37, P205, DOI 10.1603/0022-2585-37.2.205; Dearman RJ, 2009, CLIN EXP ALLERGY, V39, P458, DOI 10.1111/j.1365-2222.2008.03194.x; Dearman RJ, 2007, METHODS, V41, P91, DOI 10.1016/j.ymeth.2006.07.008; Depinay N, 2006, J IMMUNOL, V176, P4141, DOI 10.4049/jimmunol.176.7.4141; Diesner SC, 2008, IMMUNOL LETT, V121, P45, DOI 10.1016/j.imlet.2008.08.006; Elberink JNGO, 2003, CURR OPIN ALLERGY CL, V3, P287, DOI [10.1097/00130832-200308000-00009, 10.1097/01.all.0000083957.99396.b7]; Fischer R, 2005, AM J PATHOL, V167, P1621, DOI 10.1016/S0002-9440(10)61246-1; Gotoh Y, 2011, J PHARMACOL SCI, V115, P417, DOI 10.1254/jphs.10305SC; Hardy CL, 2003, AM J RESP CRIT CARE, V167, P1393, DOI 10.1164/rccm.200209-1002OC; Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Kuraishi Y, 2007, J PHARMACOL SCI, V105, P41, DOI 10.1254/jphs.FP0070404; Lehrer SB, 2009, REGUL TOXICOL PHARM, V54, pS46, DOI 10.1016/j.yrtph.2009.01.001; Nakano T, 2008, ACTA DERM-VENEREOL, V88, P449, DOI 10.2340/00015555-0479; Nakano T, 2008, NEUROREPORT, V19, P723, DOI 10.1097/WNR.0b013e3282fdf6c5; Ohtsuka E, 2003, J PHARMACOL SCI, V91, P263, DOI 10.1254/jphs.91.263; Parvataneni S, 2009, INT ARCH ALLERGY IMM, V149, P299, DOI 10.1159/000205575; Pauluhn M, 2005, EXP TOXICOL PATHOL, V56, P203, DOI 10.1016/j.etp.2004.10.002; Rupa P, 2008, INT ARCH ALLERGY IMM, V146, P11, DOI 10.1159/000112498; Van Gramberg JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051386; Wang HS, 1999, INT ARCH ALLERGY IMM, V120, P135, DOI 10.1159/000024231; Winkler B, 2003, IMMUNOLOGY, V110, P376, DOI 10.1046/j.1365-2567.2003.01751.x; Yeh CC, 1996, J MED ENTOMOL, V33, P445, DOI 10.1093/jmedent/33.3.445	30	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91871	10.1371/journal.pone.0091871	http://dx.doi.org/10.1371/journal.pone.0091871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651257	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800053
J	Ramachandra, S; Linde, J; Brock, M; Guthke, R; Hube, B; Brunke, S				Ramachandra, Shruthi; Linde, Joerg; Brock, Matthias; Guthke, Reinhard; Hube, Bernhard; Brunke, Sascha			Regulatory Networks Controlling Nitrogen Sensing and Uptake in Candida albicans	PLOS ONE			English	Article							NUCLEAR-MEMBRANE PROTEIN; GERM TUBE FORMATION; TRANSCRIPTION FACTORS; GENE FAMILY; ASPARTYL PROTEINASES; NUTRIENT ACQUISITION; IRON ACQUISITION; PATHOGEN; EXPRESSION; VIRULENCE	Nitrogen is one of the key nutrients for microbial growth. During infection, pathogenic fungi like C. albicans need to acquire nitrogen from a broad range of different and changing sources inside the host. Detecting the available nitrogen sources and adjusting the expression of genes for their uptake and degradation is therefore crucial for survival and growth as well as for establishing an infection. Here, we analyzed the transcriptional response of C. albicans to nitrogen starvation and feeding with the infection-relevant nitrogen sources arginine and bovine serum albumin (BSA), representing amino acids and proteins, respectively. The response to nitrogen starvation was marked by an immediate repression of protein synthesis and an up-regulation of general amino acid permeases, as well as an up-regulation of autophagal processes in its later stages. Feeding with arginine led to a fast reduction in expression of general permeases for amino acids and to resumption of protein synthesis. The response to BSA feeding was generally slower, and was additionally characterized by an upregulation of oligopeptide transporter genes. From time-series data, we inferred network interaction models for genes relevant in nitrogen detection and uptake. Each individual network was found to be largely specific for the experimental condition (starvation or feeding with arginine or BSA). In addition, we detected several novel connections between regulator and effector genes, with putative roles in nitrogen uptake. We conclude that C. albicans adopts a particular nitrogen response network, defined by sets of specific gene-gene connections for each environmental condition. All together, they form a grid of possible gene regulatory networks, increasing the transcriptional flexibility of C. albicans.	[Ramachandra, Shruthi; Brock, Matthias] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Biochem & Physiol, Jena, Germany; [Linde, Joerg; Guthke, Reinhard] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Syst Biol & Bioinformat, Jena, Germany; [Ramachandra, Shruthi; Hube, Bernhard; Brunke, Sascha] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Hube, Bernhard; Brunke, Sascha] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Brock, Matthias; Hube, Bernhard] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Brunke, S (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany.	sascha.brunke@hki-jena.de	Brunke, Sascha/G-1486-2012; Brock, Matthias/AAX-1430-2021	Brunke, Sascha/0000-0001-7740-4570; Brock, Matthias/0000-0003-2774-1856	German Federal Ministry of Education and Health (BMBF) Germany - Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC) [FKZ: 01EO1002]; excellent graduate school Jena School for Microbial Communication (JSMC); Deutsche Forschungsgemeinschaft (DFG) [CRC/Transregio 124]	German Federal Ministry of Education and Health (BMBF) Germany - Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC); excellent graduate school Jena School for Microbial Communication (JSMC); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the German Federal Ministry of Education and Health (BMBF) Germany, FKZ: 01EO1002 - Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC, www.cscc.uniklinikum-jena.de). SR was supported by the excellent graduate school Jena School for Microbial Communication (JSMC; www.jsmc.uni-jena.de). JL was supported by the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de) CRC/Transregio 124 'Pathogenic fungi and their human host: Networks of interaction', subproject INF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RS, 2009, FEMS YEAST RES, V9, P1000, DOI 10.1111/j.1567-1364.2009.00570.x; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Boban M, 2007, GENETICS, V176, P2087, DOI 10.1534/genetics.107.075077; Boban M, 2006, J CELL BIOL, V173, P695, DOI 10.1083/jcb.200601011; Brock M, 2009, CURR OPIN MICROBIOL, V12, P371, DOI 10.1016/j.mib.2009.05.004; Citiulo F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002777; Dabas N, 2007, EUKARYOT CELL, V6, P875, DOI 10.1128/EC.00307-06; Dumitru R, 2004, ANTIMICROB AGENTS CH, V48, P2350, DOI 10.1128/AAC.48.7.2350-2354.2004; Ernst JF, 2009, CELL MICROBIOL, V11, P183, DOI 10.1111/j.1462-5822.2008.01259.x; FERRARIS RP, 1990, AM J PHYSIOL, V259, pG822, DOI 10.1152/ajpgi.1990.259.5.G822; Fleck CB, 2011, INT J MED MICROBIOL, V301, P400, DOI 10.1016/j.ijmm.2011.04.007; Ghosh S, 2009, INFECT IMMUN, V77, P1596, DOI 10.1128/IAI.01452-08; Grundmann O, 2001, J BIOL CHEM, V276, P25661, DOI 10.1074/jbc.M101068200; Guthke R, 2005, BIOINFORMATICS, V21, P1626, DOI 10.1093/bioinformatics/bti226; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Horn Fabian, 2012, Front Microbiol, V3, P108, DOI 10.3389/fmicb.2012.00108; HUBE B, 1994, MOL MICROBIOL, V14, P87, DOI 10.1111/j.1365-2958.1994.tb01269.x; Hube B, 2006, FUTURE MICROBIOL, V1, P209, DOI 10.2217/17460913.1.2.209; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Kraidlova L, 2011, EUKARYOT CELL, V10, P1219, DOI 10.1128/EC.05026-11; Limjindaporn T, 2003, MOL MICROBIOL, V50, P993, DOI 10.1046/j.1365-2958.2003.03747.x; Linde J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-6; Linde J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-148; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Martinez P, 2005, MOL CELL BIOL, V25, P9435, DOI 10.1128/MCB.25.21.9435-9446.2005; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Mayer FL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002592; Mejia-Guerra MK, 2012, BBA-GENE REGUL MECH, V1819, P454, DOI 10.1016/j.bbagrm.2012.02.016; Miramon P, 2013, MED MICROBIOL IMMUN, V202, P183, DOI 10.1007/s00430-013-0288-z; Murad AMA, 2001, MOL MICROBIOL, V42, P981, DOI 10.1046/j.1365-2958.2001.02713.x; Murillo LA, 2005, EUKARYOT CELL, V4, P1562, DOI 10.1128/EC.4.9.1562-1573.2005; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Otzen C, 2013, FEMS YEAST RES, V13, P553, DOI 10.1111/1567-1364.12057; Palmer GE, 2007, MICROBIOL-SGM, V153, P51, DOI 10.1099/mic.0.2006/001610-0; Park JY, 2003, YONSEI MED J, V44, P110, DOI 10.3349/ymj.2003.44.1.110; R Core Team, 2018, R LANG ENV STAT COMP; Reuss O, 2006, MOL MICROBIOL, V60, P795, DOI 10.1111/j.1365-2958.2006.05136.x; Roetzer A, 2010, CELL MICROBIOL, V12, P199, DOI 10.1111/j.1462-5822.2009.01391.x; Russnak R, 2001, J BIOL CHEM, V276, P23849, DOI 10.1074/jbc.M008028200; Sandai D, 2012, MBIO, V3, DOI 10.1128/mBio.00495-12; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SYCHROVA H, 1994, YEAST, V10, P1647, DOI 10.1002/yea.320101214; Tiemey L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00085; Tripathi G, 2002, EMBO J, V21, P5448, DOI 10.1093/emboj/cdf507; Vieira N, 2010, MOL MICROBIOL, V75, P1337, DOI 10.1111/j.1365-2958.2009.07003.x; Weber M, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-1; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298	52	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92734	10.1371/journal.pone.0092734	http://dx.doi.org/10.1371/journal.pone.0092734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651113	Green Submitted, gold, Green Published			2022-12-27	WOS:000333352800149
J	Gan, VC; Tan, LK; Lye, DC; Pok, KY; Mok, SQ; Chua, RCR; Leo, YS; Ng, LC				Gan, Victor C.; Tan, Li-Kiang; Lye, David C.; Pok, Kwoon-Yong; Mok, Shi-Qi; Chua, Rachel Choon-Rong; Leo, Yee-Sin; Ng, Lee-Ching			Diagnosing Dengue at the Point-of-Care: Utility of a Rapid Combined Diagnostic Kit in Singapore	PLOS ONE			English	Article							TESTS; NS1; ANTIGEN; ASSAYS; SENSITIVITY; INFECTION; ACCURACY; VIRUS; SURVEILLANCE; PROPORTIONS	WHO recommendations for dengue diagnosis require laboratory facilities. Antibody-based rapid diagnostic tests (RDTs) have performed poorly, and clinical diagnosis remains the mainstay in dengue-endemic countries. We evaluated a combination antigen-antibody RDT for point-of-care testing in a high-prevalence setting. In this prospective cohort study, adults were enrolled from a tertiary infectious disease centre for evaluation of undifferentiated febrile illness from October 2011 to May 2012. SD Bioline Dengue Duo was evaluated at point-of-care against a WHO-based reference standard of viral isolation, RT-PCR, NS1-, IgM-, and IgG-ELISA. 246 adults were enrolled (median age 34 years, range 18-69), of which 197 could be confirmed definitively as either dengue or non-dengue. DENV-2 was the predominant serotype (79.5%) and the ratio of primary to secondary cases was 1:1.1. There were no test failures and minimal interobserver variation with a Fleiss' kappa of 0.983 (95% CI 0.827-1.00). Overall sensitivity and specificity were 93.9% (95% CI 88.8-96.8%) and 92.0% (95% CI 81.2-96.9%) respectively. Using WHO clinical criteria alone for diagnosis had similar sensitivities (95.9%, 95% CI 91.4-98.1%) and lower specificities (20.0%, 95% CI 11.2-33.0%). No significant difference in performance was found when testing early versus late presenters, primary versus secondary cases, or DENV-1 versus DENV-2 infections. The use of a combination RDT fulfills WHO ASSURED criteria for point-of-care testing and can enhance dengue diagnosis in an endemic setting. This has the potential to markedly improve clinical management of dengue in the field.	[Gan, Victor C.; Lye, David C.; Mok, Shi-Qi; Leo, Yee-Sin] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore; [Tan, Li-Kiang; Pok, Kwoon-Yong; Chua, Rachel Choon-Rong; Ng, Lee-Ching] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore; [Lye, David C.; Leo, Yee-Sin] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Ng, Lee-Ching] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Tan Tock Seng Hospital; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Gan, VC (corresponding author), Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore.	Victor.Gan@mohh.com.sg	Lye, David/ABF-4402-2021	Lye, David/0000-0003-0324-0205; Gan, Victor/0000-0002-6966-2729	Singapore National Research Foundation [NMRC/TCR/005]	Singapore National Research Foundation(National Research Foundation, Singapore)	This research is supported by the Singapore National Research Foundation under its TCR Flagship Programmes (NMRC/TCR/005) and administered by the Singapore Ministry of Health's National Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993; Anker M, 2011, W PACIFIC SURVEILLAN, V2, pe1; Banoo S, 2006, NAT REV MICROBIOL, pS20, DOI 10.1038/nrmicro1570; Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967; Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11; Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Chadwick D, 2006, J CLIN VIROL, V35, P147, DOI 10.1016/j.jcv.2005.06.002; Chaterji S, 2011, AM J TROP MED HYG, V84, P224, DOI 10.4269/ajtmh.2011.10-0316; Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811; Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360; Kettler H., 2004, MAPPING LANDSCAPE DI; Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06; Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012; Low JGH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001191; Ministry of Health Singapore, 2012, COMM DIS SURV SING 2; Newcombe RG, 2001, STAT MED, V20, P907, DOI 10.1002/sim.906; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nga TTT, 2007, CLIN VACCINE IMMUNOL, V14, P799, DOI 10.1128/CVI.00483-06; Ooi EE, 2001, DENGUE B, V25, P41; Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361; Pan-ngum W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050765; Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459; Peeling RW, 2009, EVALUATION COMMERCIA; Pok KY, 2010, VECTOR-BORNE ZOONOT, V10, P1009, DOI 10.1089/vbz.2008.0176; Sabchareon A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001732; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Tango T, 1998, STAT MED, V17, P891, DOI 10.1002/(SICI)1097-0258(19980430)17:8<891::AID-SIM780>3.0.CO;2-B; Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142; Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117; WHO, 1997, DENG HAEM FEV DIAGN; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization Regional Office for South-East Asia, 2011, REG OFF S E COMPR GU; Wright WF, 2012, DIAGN MICR INFEC DIS, V73, P215, DOI 10.1016/j.diagmicrobio.2012.03.021	37	53	54	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e90037	10.1371/journal.pone.0090037	http://dx.doi.org/10.1371/journal.pone.0090037			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646519	Green Published, gold			2022-12-27	WOS:000333348500013
J	Hack, N; Fayad, SM; Monari, EH; Akbar, U; Hardwick, A; Rodriguez, RL; Malaty, IA; Romrell, J; Shukla, AAW; McFarland, N; Ward, HE; Okun, MS				Hack, Nawaz; Fayad, Sarah M.; Monari, Erin H.; Akbar, Umer; Hardwick, Angela; Rodriguez, Ramon L.; Malaty, Irene A.; Romrell, Janet; Shukla, Aparna A. Wagle; McFarland, Nikolaus; Ward, Herbert E.; Okun, Michael S.			An Eight-Year Clinic Experience with Clozapine Use in a Parkinson's Disease Clinic Setting	PLOS ONE			English	Article							DRUG-INDUCED PSYCHOSIS; COGNITIVE IMPAIRMENT; NONMOTOR SYMPTOMS; RISK-FACTORS; MOTOR; HALLUCINATIONS; MANAGEMENT; QUETIAPINE; PATIENT	Background: To examine our eight year clinic-based experience in a Parkinson's disease expert clinical care center using clozapine as a treatment for refractory psychosis in Parkinson's disease (PD). Methods: The study was a retrospective chart review which covered eight years of clozapine registry use. Statistical T-tests, chi-square, correlations and regression analysis were used to analyze treatment response for potential associations of age, disease duration, and Hoehn & Yahr (H&Y) score, and degree of response to clozapine therapy. Results: There were 36 participants included in the analysis (32 PD, 4 parkinsonism-plus). The characteristics included 30.6% female, age 45-87 years (mean 68.3 +/- 10.15), disease duration of 17-240 months (mean 108.14 +/- 51.13) and H&Y score of 2 to 4 (mean 2.51 +/- 0.51). The overall retention rate on clozapine was 41% and the most common reasons for discontinuation were frequent blood testing (28%), nursing home (NH) placement (11%) and leucopenia (8%). Responses to clozapine across the cohort were: complete (33%), partial (33%), absent (16%), and unknown (16%). Age (r = -0.36, p < 0.01) and H&Y score (r = -0.41, p < 0.01) were shown to be related to response to clozapine therapy, but disease duration was not an associated factor (r = 0.21, p > 0.05). Conclusions: This single-center experience highlights the challenges associated with clozapine therapy in PD psychosis. Frequent blood testing remains a significant barrier for clozapine, even in patients with therapeutic benefit. Surprisingly, all patients admitted to a NH discontinued clozapine due to logistical issues of administration and monitoring within that setting. Consideration of the barriers to clozapine therapy will be important to its use and to its continued success in an outpatient setting.	[Hack, Nawaz; Fayad, Sarah M.; Monari, Erin H.; Akbar, Umer; Hardwick, Angela; Rodriguez, Ramon L.; Malaty, Irene A.; Romrell, Janet; Shukla, Aparna A. Wagle; McFarland, Nikolaus; Ward, Herbert E.; Okun, Michael S.] Univ Florida, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA; [Fayad, Sarah M.; Ward, Herbert E.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Hack, N (corresponding author), Univ Florida, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA.	nawaz@ufl.edu	Shukla, Aparna Wagle/AAN-1344-2020; Hack, Nawaz/AAH-4509-2020; Malaty, Irene/AAE-2553-2020; McFarland, Nikolaus R/I-4209-2017	McFarland, Nikolaus R/0000-0002-8699-8857; WAGLE SHUKLA, APARNA/0000-0002-9757-9973; Hastings Monari, Erin/0000-0002-4075-3360; Hack, Nawaz/0000-0001-9867-4334; Okun, Michael/0000-0002-6247-9358				Gondim FDA, 2010, MOVEMENT DISORD, V25, P1505, DOI 10.1002/mds.22553; Chadda RK, 2013, J PHARMACOL PHARMACO, V4, P176, DOI 10.4103/0976-500X.114596; Crump K, 2011, RES SOC ADMIN PHARM, V7, P122, DOI 10.1016/j.sapharm.2010.03.006; Cubo E, 2013, NEUROLOGY, V80; Driver JA, 2009, NEUROLOGY, V72, P432, DOI 10.1212/01.wnl.0000341769.50075.bb; Durif F, 2004, NEUROLOGY, V62, P381, DOI 10.1212/01.WNL.0000110317.52453.6C; Ellis T, 2000, J NEUROPSYCH CLIN N, V12, P364, DOI 10.1176/appi.neuropsych.12.3.364; Factor SA, 2003, NEUROLOGY, V60, P1756, DOI 10.1212/01.WNL.0000068010.82167.CF; Factor SA, 2001, MOVEMENT DISORD, V16, P135, DOI 10.1002/1531-8257(200101)16:1<135::AID-MDS1006>3.0.CO;2-Q; Fernandez Hubert H, 2012, Cleve Clin J Med, V79 Suppl 2, pS14, DOI 10.3949/ccjm.79.s2a.03; Filia SL, 2012, AUST NZ J PSYCHIAT, V46, P225, DOI 10.1177/0004867411433210; Friedberg G, 1998, CLIN NEUROPHARMACOL, V21, P280; Friedman J, 1999, NEW ENGL J MED, V340, P757; Friedman JH, 2013, BEHAV NEUROL, V27, P469, DOI [10.1155/2013/645429, 10.3233/BEN-129016]; Friedman Joseph H, 2011, J Pharm Pract, V24, P534, DOI 10.1177/0897190011426556; Goetz CG, 1998, NEUROLOGY, V51, P811, DOI 10.1212/WNL.51.3.811; Goetz CG, 2000, NEUROLOGY, V55, P789, DOI 10.1212/WNL.55.6.789; Goldman JG, 2011, EXPERT OPIN PHARMACO, V12, P2009, DOI 10.1517/14656566.2011.587122; Hack N, 2012, ANN NEUROL, V72, P912, DOI 10.1002/ana.23697; Hassan A, 2013, PARKINSONISM RELAT D, V19, P949, DOI 10.1016/j.parkreldis.2013.06.006; Hassan Anhar, 2012, Parkinsonism Relat Disord, V18 Suppl 3, pS10, DOI 10.1016/j.parkreldis.2012.06.014; Hattori N, 2013, CLIN NUCL MED, V38, P315, DOI 10.1097/RLU.0b013e3182873511; Hindle JV, 2013, J NEURAL TRANSM, V120, P649, DOI 10.1007/s00702-013-0994-0; Honigfeld G, 1998, J CLIN PSYCHIAT, V59, P3; Liperoti R, 2005, J CLIN PSYCHIAT, V66, P1090, DOI 10.4088/JCP.v66n0901; Maher KN, 2013, J CHILD ADOL PSYCHOP, V23, P110, DOI 10.1089/cap.2011.0136; Menza M M, 1999, Ann Clin Psychiatry, V11, P141, DOI 10.1023/A:1022360027358; Merims D, 2006, CLIN NEUROPHARMACOL, V29, P331, DOI 10.1097/01.WNF.0000236769.31279.19; Michalski LS, 2009, KIDNEY INT, V75, P243, DOI 10.1038/ki.2008.464; Morgante L, 2004, CLIN NEUROPHARMACOL, V27, P153, DOI 10.1097/01.wnf.0000136891.17006.ec; Munhoz RP, 2013, PARKINSONISM RELAT D, V19, P77, DOI 10.1016/j.parkreldis.2012.07.008; Neagoe AD, 2013, GEN HOSP PSYCHIAT, V35, DOI 10.1016/j.genhosppsych.2013.03.023; Nishikawa N, 2009, PARKINSONISM RELAT D, V15, P351, DOI 10.1016/j.parkreldis.2008.08.005; Pintor L, 2012, CLIN NEUROPHARMACOL, V35, P61, DOI 10.1097/WNF.0b013e31824d5115; Poewe Werner, 2008, Pract Neurol, V8, P238, DOI 10.1136/jnnp.2008.152579; Pollak P, 2004, J NEUROL NEUROSUR PS, V75, P689, DOI 10.1136/jnnp.2003.029868; POSTMA JU, 1975, J AM GERIATR SOC, V23, P212, DOI 10.1111/j.1532-5415.1975.tb00187.x; Rabey JM, 2009, PARKINSONISM RELAT D, V15, pS105, DOI 10.1016/S1353-8020(09)70846-6; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; Smith EJ, 2008, AM J PSYCHIAT, V165, P1613, DOI 10.1176/appi.ajp.2008.08081228; Stefanis N, 2010, PARKINSONISM RELAT D, V16, P550, DOI 10.1016/j.parkreldis.2010.06.010; Trosch RM, 1998, MOVEMENT DISORD, V13, P377, DOI 10.1002/mds.870130302; Weerkamp NJ, 2012, J AM GERIATR SOC, V60, P2277, DOI 10.1111/jgs.12027; Weintraub D, 2011, ARCH NEUROL-CHICAGO, V68, P899, DOI 10.1001/archneurol.2011.139; WOLTERS EC, 1990, NEUROLOGY, V40, P832, DOI 10.1212/WNL.40.5.832; Yoritaka A, 2013, PARKINSONISM RELAT D, V19, P725, DOI 10.1016/j.parkreldis.2013.04.001	46	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91545	10.1371/journal.pone.0091545	http://dx.doi.org/10.1371/journal.pone.0091545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646688	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500039
J	Liu, XNL; Liang, PP; Li, KC; Reder, LM				Liu, Xiaonan L.; Liang, Peipeng; Li, Kuncheng; Reder, Lynne M.			Uncovering the Neural Mechanisms Underlying Learning from Tests	PLOS ONE			English	Article							PREFRONTAL CORTEX; EPISODIC MEMORY; FUNCTIONAL ROLES; RETRIEVAL; FMRI; ACTIVATION; BRAIN; PARAHIPPOCAMPAL; RETENTION	People learn better when re-study opportunities are replaced with tests. While researchers have begun to speculate on why testing is superior to study, few studies have directly examined the neural underpinnings of this effect. In this fMRI study, participants engaged in a study phase to learn arbitrary word pairs, followed by a cued recall test (recall second half of pair when cued with first word of pair), re-study of each pair, and finally another cycle of cued recall tests. Brain activation patterns during the first test (recall) of the studied pairs predicts performance on the second test. Importantly, while subsequent memory analyses of encoding trials also predict later accuracy, the brain regions involved in predicting later memory success are more extensive for activity during retrieval (testing) than during encoding (study). Those additional regions that predict subsequent memory based on their activation at test but not at encoding may be key to understanding the basis of the testing effect.	[Liu, Xiaonan L.; Reder, Lynne M.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Liu, Xiaonan L.; Reder, Lynne M.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Liang, Peipeng; Li, Kuncheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Liang, Peipeng; Li, Kuncheng] Beijing Key Lab Magnet Resonance Imaging & Brain, Beijing, Peoples R China	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Capital Medical University	Li, KC (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China.	lkc1955@gmail.com; reder@cmu.edu	Liang, Peipeng/A-9502-2015	Liang, Peipeng/0000-0003-3795-4134; Liu, Xiaonan/0000-0001-6021-9889; Reder, Lynne/0000-0002-6858-4466	National Natural Science Foundation of China [61105118]; Beijing Nova Program [Z12111000250000]; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning [CNKOPZD1001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning	This work was supported by the grant from the National Natural Science Foundation of China (61105118), Beijing Nova Program (No. Z12111000250000) and the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning (CNKOPZD1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson John R, 1979, LEVELS PROCESSING HU, P385; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; Buckner RL, 2001, J COGNITIVE NEUROSCI, V13, P406, DOI 10.1162/08989290151137430; Carpenter SK, 2007, PSYCHON B REV, V14, P474, DOI 10.3758/BF03194092; CARRIER M, 1992, MEM COGNITION, V20, P633, DOI 10.3758/BF03202713; Eriksson J, 2011, NEUROSCI LETT, V505, P36, DOI 10.1016/j.neulet.2011.08.061; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; Fletcher PC, 1998, BRAIN, V121, P1249, DOI 10.1093/brain/121.7.1249; Friston K., 2007, STAT PARAMETRIC MAPP, DOI [10.1016/B978-0-12-372560-8.X5000-1, DOI 10.1016/B978-0-12-372560-8.X5000-1]; Gates AI, 1917, SCHOOL SOC, V6, P743; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Halamish V, 2011, J EXP PSYCHOL LEARN, V37, P801, DOI 10.1037/a0023219; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Hashimoto T, 2011, NEUROBIOL LEARN MEM, V96, P143, DOI 10.1016/j.nlm.2011.03.008; Jamal NI, 2012, HUM BRAIN MAPP, V33, P235, DOI 10.1002/hbm.21208; Karpicke JD, 2008, SCIENCE, V319, P966, DOI 10.1126/science.1152408; Keresztes A, 2013, CEREB CORTE IN PRESS; Kim H, 2011, NEUROIMAGE, V54, P2446, DOI 10.1016/j.neuroimage.2010.09.045; Kornell N, 2009, J EXP PSYCHOL LEARN, V35, P989, DOI 10.1037/a0015729; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Manelis A, 2013, HIPPOCAMPUS, V23, P53, DOI 10.1002/hipo.22053; Manenti R, 2010, NEUROSCIENCE, V166, P501, DOI 10.1016/j.neuroscience.2009.12.037; Manoach DS, 1997, NEUROREPORT, V8, P545, DOI 10.1097/00001756-199701200-00033; McDaniel MA, 2007, PSYCHON B REV, V14, P200, DOI 10.3758/BF03194052; Nolde SF, 1998, TRENDS COGN SCI, V2, P399, DOI 10.1016/S1364-6613(98)01233-9; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Pashler H, 2007, PSYCHON B REV, V14, P187, DOI 10.3758/BF03194050; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; Pugh K., 2005, LEARN DISABIL RES PR, V20, P24, DOI [10.1111/j.1540-5826.2005.00117.x, DOI 10.1111/J.1540-5826.2005.00117.X]; Roediger HL, 2006, PERSPECT PSYCHOL SCI, V1, P181, DOI 10.1111/j.1745-6916.2006.00012.x; Roediger HL, 2006, PSYCHOL SCI, V17, P249, DOI 10.1111/j.1467-9280.2006.01693.x; Sommer T, 2005, NEUROPSYCHOLOGIA, V43, P732, DOI 10.1016/j.neuropsychologia.2004.08.002; Spitzer HF, 1939, J EDUC PSYCHOL, V30, P641, DOI 10.1037/h0063404; Stark CEL, 2003, J NEUROSCI, V23, P6748; Toppino TC, 2009, EXP PSYCHOL, V56, P252, DOI 10.1027/1618-3169.56.4.252; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011; van den Broek GSE, 2013, NEUROIMAGE, V78, P94, DOI 10.1016/j.neuroimage.2013.03.071; Verkoeijen PPJL, 2012, PSYCHOL SCI, V23, P567, DOI 10.1177/0956797611435132; Wagner AD, 1998, NEUROREPORT, V9, P3711, DOI 10.1097/00001756-199811160-00026; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wheeler M, 2003, MEMORY, V11, P571, DOI 10.1080/09658210244000414; Wing EA, 2013, NEUROPSYCHOLOGIA; Xue G, 2010, SCIENCE, V330, P97, DOI 10.1126/science.1193125; Yonelinas AP, 2001, NEUROREPORT, V12, P359, DOI 10.1097/00001756-200102120-00035	48	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92025	10.1371/journal.pone.0092025	http://dx.doi.org/10.1371/journal.pone.0092025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647122	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500074
J	van Mierlo, T; Fournier, R; Jean-Charles, A; Hovington, J; Ethier, I; Selby, P				van Mierlo, Trevor; Fournier, Rachel; Jean-Charles, Anathalie; Hovington, Jacinthe; Ethier, Isabelle; Selby, Peter			I'll Txt U if I Have a Problem: How the Societe Canadienne du Cancer in Quebec Applied Behavior-Change Theory, Data Mining and Agile Software Development to Help Young Adults Quit Smoking	PLOS ONE			English	Article							HEALTH; MODEL; TOBACCO; SMOKERS; AIM	Introduction: For many organizations, limited budgets and phased funding restrict the development of digital health tools. This problem is often exacerbated by the ever-increasing sophistication of technology and costs related to programming and maintenance. Traditional development methods tend to be costly and inflexible and not client centered. The purpose of this study is to analyze the use of Agile software development and outcomes of a three-phase mHealth program designed to help young adult Quebecers quit smoking. Methods: In Phase I, literature reviews, focus groups, interviews, and behavior change theory were used in the adaption and re-launch of an existing evidence-based mHealth platform. Based on analysis of user comments and utilization data from Phase I, the second phase expanded the service to allow participants to live text-chat with counselors. Phase II evaluation led to the third and current phase, in which algorithms were introduced to target pregnant smokers, substance users, students, full-time workers, those affected by mood disorders and chronic disease. Results: Data collected throughout the three phases indicate that the incremental evolution of the intervention has led to increasing numbers of smokers being enrolled while making functional enhancements. In Phase I (240 days) 182 smokers registered with the service. 51% (n = 94) were male and 61.5% (n = 112) were between the ages of 18-24. In Phase II (300 days), 994 smokers registered with the service. 51% (n = 508) were male and 41% (n = 403) were between the ages of 18-24. At 174 days to date 873 smokers have registered in the third phase. 44% (n = 388) were male and 24% (n = 212) were between the ages of 18-24. Conclusions: Emerging technologies in behavioral science show potential, but do not have defined best practices for application development. In phased-based projects with limited funding, Agile appears to be a viable approach to building and expanding digital tools.	[van Mierlo, Trevor; Fournier, Rachel] Evolut Hlth Syst Inc, Toronto, ON, Canada; [Jean-Charles, Anathalie; Hovington, Jacinthe; Ethier, Isabelle] Soc Canadienne Canc, Montreal, PQ, Canada; [Selby, Peter] Ctr Addict & Mental Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	van Mierlo, T (corresponding author), Evolut Hlth Syst Inc, Toronto, ON, Canada.	tvanmierlo@evolutionhs.com		van Mierlo, Trevor/0000-0002-5675-0084	Health Canada; Province of Quebec	Health Canada; Province of Quebec	Health Canada and the Province of Quebec have funded SMAT and its ongoing development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRANGI B, 1987, J SYST MANAGE, V38, P21; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Boehm BW, 1984, IEEE T SOFTWARE ENG, V10; Briand L. C., 2002, ENCY SOFTWARE ENG, P1160; Canada S, 2012, CANADIAN TOBACCO USE; Cockburn A, 2001, COMPUTER, V34, P131, DOI 10.1109/2.963450; Collins F, 2012, SCI AM, V307, P16, DOI 10.1038/scientificamerican0712-16; Cunningham JA, 2008, PATIENT EDUC COUNS, V70, P193, DOI 10.1016/j.pec.2007.10.003; Curry SJ, 2007, AM J PUBLIC HEALTH, V97, P1464, DOI 10.2105/AJPH.2006.103788; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Dyba T, 2008, INFORM SOFTWARE TECH, V50, P833, DOI 10.1016/j.infsof.2008.01.006; Erdogmus H., 2002, Engineering Economist, V47, P308, DOI 10.1080/00137910208965037; Erdogmus H, 2010, AGILE SOFTWARE DEV C; Glasgow RE, 2001, PATIENT EDUC COUNS, V44, P119, DOI 10.1016/S0738-3991(00)00186-5; Hazrati V, 2010, DISCUSSING AGLIE CFO; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jorgensen M, 2007, IEEE T SOFTWARE ENG, V33, P33, DOI 10.1109/TSE.2007.256943; Kea Beck, 2001, MANIFESTO AGILE SOFT; Larman C, 2003, COMPUTER, V36, P47, DOI 10.1109/MC.2003.1204375; Le Moullec B, 2009, IFMBE PROC, V25, P223, DOI 10.1007/978-3-642-03893-8_63; Little T, 2004, IEEE SOFTWARE, V21, P48, DOI 10.1109/MS.2004.1293072; Mackay J, 2012, PUBLIC HEALTH, V126, P199, DOI 10.1016/j.puhe.2012.01.027; Moe NB, 2010, INFORM SOFTWARE TECH, V52, P480, DOI 10.1016/j.infsof.2009.11.004; Office for Civil Rights, 2003, SUMM HIPAA PRIV RUL; Office of the Privacy Commissioner of Canada, 2000, PERS INF PROT EL DOC; Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; PROCHASKA JO, 1982, PSYCHOTHER-THEOR RES, V19, P276, DOI 10.1037/h0088437; Reid JL, 2013, TOBACCO USE CANADA P; Rollnick S, 1997, PATIENT EDUC COUNS, V31, P191, DOI 10.1016/S0738-3991(97)01004-5; Royce W. W., 1987, P 9 INT C SOFTW ENG, P328; Selby P, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1340; van Mierlo T, 2010, MHEALTH SUMM 2010 WA; Wells J, 2012, UTMJ, V89; Whitaker WA, 1993, ADA PROJECT DOD HIGH; Whittaker R, 2012, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858; World Medical Association, 2008, WORLD MED ASS DECL H	37	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91832	10.1371/journal.pone.0091832	http://dx.doi.org/10.1371/journal.pone.0091832			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24647098	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500054
J	Yokoyama, S; Hori, K; Tamine, KI; Fujiwara, S; Inoue, M; Maeda, Y; Funami, T; Ishihara, S; Ono, T				Yokoyama, Sumiko; Hori, Kazuhiro; Tamine, Ken-ichi; Fujiwara, Shigehiro; Inoue, Makoto; Maeda, Yoshinobu; Funami, Takahiro; Ishihara, Sayaka; Ono, Takahiro			Tongue Pressure Modulation for Initial Gel Consistency in a Different Oral Strategy	PLOS ONE			English	Article							QUALITY-OF-LIFE; FOOD CONSISTENCY; HARD PALATE; DYSPHAGIA; FORCE; VISCOSITY; VOLUME; AGE	Background: In the recent hyper-aged societies of developed countries, the market for soft diets for patients with dysphagia has been growing and numerous jelly-type foods have become available. However, interrelationships between the biomechanics of oral strategies and jelly texture remain unclear. The present study investigated the influence of the initial consistency of jelly on tongue motor kinetics in different oral strategies by measuring tongue pressure against the hard palate. Methods: Jellies created as a mixture of deacylated gellan gum and psyllium seed gum with different initial consistencies (hard, medium or soft) were prepared as test foods. Tongue pressure production while ingesting 5 ml of jelly using different oral strategies (Squeezing or Mastication) was recorded in eight healthy volunteers using an ultra-thin sensor sheet system. Maximal magnitude, duration and total integrated values (tongue work) of tongue pressure for size reduction and swallowing in each strategy were compared among initial consistencies of jelly, and between Squeezing and Mastication. Results: In Squeezing, the tongue performed more work for size reduction with increasing initial consistency of jelly by modulating both the magnitude and duration of tongue pressure over a wide area of hard palate, but tongue work for swallowing increased at the posterior-median and circumferential parts by modulating only the magnitude of tongue pressure. Conversely, in Mastication, the tongue performed more work for size reduction with increasing initial consistency of jelly by modulating both magnitude and duration of tongue pressure mainly at the posterior part of the hard palate, but tongue work as well as other tongue pressure parameters for swallowing showed no differences by type of jelly. Conclusions: These results reveal fine modulations in tongue-palate contact according to the initial consistency of jelly and oral strategies.	[Yokoyama, Sumiko; Tamine, Ken-ichi; Fujiwara, Shigehiro; Maeda, Yoshinobu; Ono, Takahiro] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka, Japan; [Hori, Kazuhiro; Inoue, Makoto] Niigata Univ, Grad Sch Med & Dent Sci, Div Dysphagia Rehabil, Niigata, Japan; [Funami, Takahiro; Ishihara, Sayaka] San Ei Gen FFI Inc, Texture Design Div, Toyonaka, Osaka, Japan	Osaka University; Niigata University; San-Ei Gen F.F.I., Inc.	Ono, T (corresponding author), Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka, Japan.	ono@dent.osaka-u.ac.jp		Inoue, Makoto/0000-0002-6503-2973	1 Japan Food Chemical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [24659859]	1 Japan Food Chemical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partially supported by the research grant from the 1 Japan Food Chemical Research Foundation and the Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 24659859). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, DYSPHAGIA, V26, P150, DOI 10.1007/s00455-010-9285-1; Arai E., 1993, JAPANESE J ORAL BIOL, V35, P312; Arai E, 1999, J JPN DYSPHAG REHABI, V3, P21; Bourne M.C., 2002, FOOD TEXTURE VISCOSI, V2nd ed., P107, DOI [10.1016/B978-012119062-0/50004-8, DOI 10.1016/B978-012119062-0/50004-8]; Brandao DM, 2010, REV ASSOC MED BRAS, V55, P38; Chen PH, 2009, DYSPHAGIA, V24, P1, DOI 10.1007/s00455-008-9156-1; Deto A, 2008, JAPANESE J DYSPHAGIA, V12, P197; Fujisaki T, 2012, SHOKUHIN TO YOUKI, V53, P30; Furuya M, 1996, J JPN PROSTHODONT SO, V40, P718; Gonzalez-Fernandez M, 2009, STROKE RECOVERY REHA, P183; HIRAI T, 1991, J PROSTHET DENT, V65, P840, DOI 10.1016/S0022-3913(05)80024-1; Hirota N, 2010, STROKE, V41, P2982, DOI 10.1161/STROKEAHA.110.594960; Hori K, 2006, J DENT RES, V85, P187, DOI 10.1177/154405910608500214; Hori Kazuhiro, 2005, Gerodontology, V22, P227; Hori K, 2011, DYSPHAGIA, V26, P238, DOI 10.1007/s00455-010-9292-2; Hori K, 2009, J PROSTHODONT RES, V53, P28, DOI 10.1016/j.jpor.2008.08.008; Ishihara S, 2011, FOOD HYDROCOLLOID, V25, P1016, DOI 10.1016/j.foodhyd.2010.09.022; Ishihara S, 2011, J TEXTURE STUD, V42, P254, DOI 10.1111/j.1745-4603.2010.00272.x; Ishihara S, 2011, FOOD HYDROCOLLOID, V25, P1210, DOI 10.1016/j.foodhyd.2010.11.008; Japanese Ministry of Consumers, 2009, TREATM APPR IND FOOD; Kodama S, 1984, KYUSHU DENT SOC, V38, P1128; Konaka K, 2010, EUR NEUROL, V64, P101, DOI 10.1159/000315140; Langmore Susan E, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P485, DOI 10.1097/00020840-200312000-00014; Leopold NA, 1996, DYSPHAGIA, V11, P14, DOI 10.1007/BF00385794; Logemann Jeri A., 1993, Dysphagia, V8, P230, DOI 10.1007/BF01354543; Maclean J, 2009, DYSPHAGIA, V24, P314, DOI 10.1007/s00455-009-9209-0; Miller JL, 1996, DYSPHAGIA, V11, P117, DOI 10.1007/BF00417901; MORITA A, 2002, J HOME EC JPN, V53, P7; Nagaosa S, 2005, J JPN DYSPHAG REHABI, V9, P127; Nicosia MA, 2000, J GERONTOL A-BIOL, V55, pM634, DOI 10.1093/gerona/55.11.M634; Ono T, 2004, DYSPHAGIA, V19, P259, DOI 10.1007/s00455-004-0010-9; Ono T, 2007, GERODONTOLOGY, V24, P143, DOI 10.1111/j.1741-2358.2007.00172.x; Palmer JB, 1997, ARCH ORAL BIOL, V42, P429, DOI 10.1016/S0003-9969(97)00020-4; Palmer JB, 2000, AM FAM PHYSICIAN, V61, P2453; Palmer JB., 1992, DYSPHAGIA, V7, P187, DOI DOI 10.1007/BF02493469; Plowman-Prine EK, 2009, MOVEMENT DISORD, V24, P1352, DOI 10.1002/mds.22617; POUDEROUX P, 1995, GASTROENTEROLOGY, V108, P1418, DOI 10.1016/0016-5085(95)90690-8; Prinz JF, 1997, P ROY SOC B-BIOL SCI, V264, P1715, DOI 10.1098/rspb.1997.0238; Reimers-Neils L., 1994, DYSPHAGIA, V9, P101, DOI DOI 10.1007/BF00714596; Shaker R, 1988, Dysphagia, V3, P79, DOI 10.1007/BF02412424; Steele CM, 2010, J SPEECH LANG HEAR R, V53, P273, DOI 10.1044/1092-4388(2009/09-0076); Stone M, 1986, Dysphagia, V1, P78; Sugita K, 2006, J ORAL BIOSCI, V48, P278, DOI 10.2330/joralbiosci.48.278; TAKAHASHI J, 1991, J TEXTURE STUD, V22, P1, DOI 10.1111/j.1745-4603.1991.tb00001.x; Tamine K, 2010, J DENT RES, V89, P1097, DOI 10.1177/0022034510370801; Taniguchi H, 2008, J APPL PHYSIOL, V105, P791, DOI 10.1152/japplphysiol.90485.2008; Tsutsumino T, 2007, JAPANESE J DYSPHAGIA, V11, P13; Ueda Koichiro, 2004, Gerodontology, V21, P108, DOI 10.1111/j.1741-2358.2004.00016.x; Yoshikawa M, 2006, J AM GERIATR SOC, V54, P444, DOI 10.1111/j.1532-5415.2005.00619.x; Youmans SR, 2009, DYSPHAGIA, V24, P57, DOI 10.1007/s00455-008-9171-2	50	25	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91920	10.1371/journal.pone.0091920	http://dx.doi.org/10.1371/journal.pone.0091920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643054	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900047
J	Sanders, SS; Mui, KKN; Sutton, LM; Hayden, MR				Sanders, Shaun S.; Mui, Katherine K. N.; Sutton, Liza M.; Hayden, Michael R.			Identification of Binding Sites in Huntingtin for the Huntingtin Interacting Proteins HIP14 and HIP14L	PLOS ONE			English	Article							PALMITOYLATION; TRAFFICKING; DOMAIN; LOCALIZATION; FEATURES; DISEASE	Huntington disease is an adult onset neurodegenerative disease characterized by motor, cognitive, and psychiatric dysfunction, caused by a CAG expansion in the HTT gene. Huntingtin Interacting Protein 14 (HIP14) and Huntingtin Interacting Protein 14-like (HIP14L) are palmitoyl acyltransferases (PATs), enzymes that mediate the post-translational addition of long chain fatty acids to proteins in a process called palmitoylation. HIP14 and HIP14L interact with and palmitoylate HTT and are unique among PATs as they are the only two that have an ankyrin repeat domain, which mediates the interaction between HIP14 and HTT. These enzymes show reduced interaction with and palmitoylation of mutant HTT, leading to increased mutant HTT inclusion formation and toxicity. The interaction between HIP14 and HTT goes beyond that of only an enzyme-substrate interaction as HTT is essential for the full enzymatic activity of HIP14. It is important to further understand and characterize the interactions of HTT with HIP14 and HIP14L to guide future efforts to target and enhance this interaction and increase enzyme activity to remediate palmitoylation of HTT and their substrates, as well as to understand the relationship between the three proteins. HIP14 and HIP14L have been previously shown to interact with HTT amino acids 1-548. Here the interaction of HIP14 and HIP14L with N- and C-terminal HTT 1-548 deletion mutations was assessed. We show that HTT amino acids 1-548 were sufficient for full interaction of HTT with HIP14 and HIP14L, but partial interaction was also possible with HTT 1-427 and HTT 224-548. To further characterize the binding domain we assessed the interaction of HIP14-GFP and HIP14L-GFP with 15Q HTT 1-548D257-315. Both enzymes showed reduced but not abolished interaction with 15Q HTT 1-548D257-315. This suggests that two potential binding domains exist, one around residues 224 and the other around 427, for the PAT enzymes HIP14 and HIP14L.	[Hayden, Michael R.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Child & Family Research Institute; University of British Columbia	Hayden, MR (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	mrh@cmmt.ubc.ca	Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419	CHDI Foundation, Inc.; Canadian Institutes for Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR); Ripples of Hope Pfizer Trainee Award in Rare Diseases	CHDI Foundation, Inc.; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Ripples of Hope Pfizer Trainee Award in Rare Diseases	This work was supported by the CHDI Foundation, Inc. (chdifoundation.org operating grant to MRH). SSS is funded by the Canadian Institutes for Health Research (CIHR; www.cihr-irsc.gc.ca; Doctoral Research Award) and the Michael Smith Foundation for Health Research (MSFHR; www.msfhr.org; Junior Graduate Scholarship). LMS was funded by the Ripples of Hope Pfizer 2011 Trainee Award in Rare Diseases (http://www.cmmt.ubc.ca/getinvolved/trainees/funding/Ripples-of-Hope). MRH is a University Killam Professor and the Canada Research Chair in Human Genetics and Molecular Medicine. The funders had no role in study design and analysis, decision to publish or preparation of the manuscript.	Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Gao TY, 2009, PROTEINS, V76, P772, DOI 10.1002/prot.22452; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; HALLAK H, 1994, J BIOL CHEM, V269, P4713; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Li W, 2006, J BIOL CHEM, V281, P15916, DOI 10.1074/jbc.M511007200; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Palidwor GA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000304; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Singaraja RR, 2011, HUM MOL GENET, V20, P3899, DOI 10.1093/hmg/ddr308; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Sturrock A, 2010, J GERIATR PSYCH NEUR, V23, P243, DOI 10.1177/0891988710383573; Sutton LM, 2013, HUM MOL GENET, V22, P452, DOI 10.1093/hmg/dds441; Takano H, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-15; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002	22	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90669	10.1371/journal.pone.0090669	http://dx.doi.org/10.1371/journal.pone.0090669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24651384	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200242
J	Smith, ZA; Vastardis, GA; Carandang, G; Havey, RM; Hannon, S; Dahdaleh, N; Voronov, LI; Fessler, RG; Patwardhan, AG				Smith, Zachary A.; Vastardis, Georgios A.; Carandang, Gerard; Havey, Robert M.; Hannon, Sean; Dahdaleh, Nader; Voronov, Leonard I.; Fessler, Richard G.; Patwardhan, Avinash G.			Biomechanical Effects of a Unilateral Approach to Minimally Invasive Lumbar Decompression	PLOS ONE			English	Article							SPINAL STENOSIS; INTERBODY FUSION; LAMINECTOMY; OUTCOMES; LAMINOTOMY	Minimally invasive (MI) lumbar decompression became a common approach to treat lumbar stenosis. This approach may potentially mitigate postoperative increases in segmental motion. The goal of this study was to evaluate modifications to segmental motion in the lumbar spine following a MI unilateral approach as compared to traditional facet-sparing and non-facet sparing decompressions. Six human lumbar cadaveric specimens were used. Each specimen was tested in flexion-extension 0 N and 400 N of follower preload), axial rotation, and lateral bending. Each testing condition was evaluated following three separate interventions at L4-L5: 1) Minimally invasive decompression, 2) Facet-sparing, bilateral decompression, and 3) Bilateral decompression with a wide facetectomy. Range of motion following each testing condition was compared to intact specimens. Both MI and traditional decompression procedures create significant increases in ROM in all modes of loading. However, when compared to the MI approach, traditional decompression produces significantly larger increase in ROM in flexion-extension (p<0.005) and axial rotation (p<0.05). It additionally creates increased ROM with lateral bending on the approach side (p<0.05). Lateral bending on the non-approach side is not significantly changed. Lastly, wide medial facet removal (40% to 50%) causes significant hypermobility, especially in axial rotation. While both MI and traditional lumbar decompressions may increase post-operative ROM in all conditions, a MI approach causes significantly smaller increase in ROM. With an MI approach, increased movement with lateral bending is only toward the approach side. Further, non-facet sparing decompression is further destabilizing in all loading modes.	[Smith, Zachary A.; Dahdaleh, Nader; Fessler, Richard G.] Northwestern Univ, Northwest Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA; [Vastardis, Georgios A.; Carandang, Gerard; Havey, Robert M.; Hannon, Sean; Voronov, Leonard I.; Patwardhan, Avinash G.] Loyola Univ, Stritch Sch Med, Dept Orthopaed Surg, Maywood, IL 60153 USA; [Vastardis, Georgios A.; Carandang, Gerard; Havey, Robert M.; Hannon, Sean; Voronov, Leonard I.; Patwardhan, Avinash G.] Edward Hines Jr VA Hosp, Hines, IL USA	Northwestern University; Feinberg School of Medicine; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Patwardhan, AG (corresponding author), Loyola Univ, Stritch Sch Med, Dept Orthopaed Surg, Maywood, IL 60153 USA.	apatwar@lumc.edu	Voronov, Leonard/AFU-5796-2022	Vastardis, Georgios/0000-0002-2663-9561	AANS/CNS Apfelbaum Award; CNS Spine Fellowship Award; US Department of Veterans Affairs, Washington, DC	AANS/CNS Apfelbaum Award; CNS Spine Fellowship Award; US Department of Veterans Affairs, Washington, DC(US Department of Veterans Affairs)	The first author (Dr. Smith) was supported by the AANS/CNS Apfelbaum Award and the CNS Spine Fellowship Award. The last author (Dr. Patwardhan) received funding from the US Department of Veterans Affairs, Washington, DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMI K, 1990, SPINE, V15, P1142, DOI 10.1097/00007632-199011010-00011; Billinghurst J, 2009, CURR ORTHOP PRACT, V20, P238, DOI 10.1097/BCO.0b013e3181a32ead; Bisschop A, 2012, EUR SPINE J; Bisschop A, 2012, EUR SPINE J, V21, P530, DOI 10.1007/s00586-011-1968-2; Bresnahan L, 2009, SPINE, V34, P17, DOI 10.1097/BRS.0b013e318191438b; Fessler RG., 2002, NEUROSURGERY S, V51, pIII; Fox MW, 1996, J NEUROSURG, V85, P793, DOI 10.3171/jns.1996.85.5.0793; Fu YS, 2008, SPINE, V33, P514, DOI 10.1097/BRS.0b013e3181657dde; Hamasaki T, 2009, J SPINAL DISORD TECH, V22, P486, DOI 10.1097/BSD.0b013e31818d7dc9; Iguchi T, 2000, SPINE, V25, P1754, DOI 10.1097/00007632-200007150-00003; Ikuta K, 2005, J NEUROSURG-SPINE, V2, P624, DOI 10.3171/spi.2005.2.5.0624; Isaacs RE, 2005, J NEUROSURG-SPINE, V3, P98, DOI 10.3171/spi.2005.3.2.0098; Jonsson B, 1997, SPINE, V11, P107; KATZ JN, 1991, J BONE JOINT SURG AM, V73A, P809, DOI 10.2106/00004623-199173060-00003; Khoo LT, 2011, J NEUROSURG-SPINE, V14, P250, DOI 10.3171/2010.10.SPINE09456; Khoo LT, 2002, NEUROSURGERY, V51, pS146, DOI 10.1227/01.NEU.0000031220.75770.29; Lawton CD, 2011, J NEUROSURG SCI, V55, P259; Lee MJ, 2010, SPINE, V35, P1789, DOI 10.1097/BRS.0b013e3181c9b8d6; McCulloch J, 1998, ESSENTIALS MICROSURG, P453; Ogden AT, 2009, CLIN BIOMECH, V24, P143, DOI 10.1016/j.clinbiomech.2008.11.005; Palmer S, 2002, J NEUROSURG, V97, P213, DOI 10.3171/spi.2002.97.2.0213; Palmer S, 2012, SURG NEUROL INT, V3; Patwardhan AG, 1999, SPINE, V24, P1003, DOI 10.1097/00007632-199905150-00014; Perez-Cruet MJ, 2002, NEUROSURGERY, V51, pS129, DOI 10.1227/01.NEU.0000031004.69814.2D; Rosen DS, 2008, NEUROSURGERY, V63, P956, DOI 10.1227/01.NEU.0000313626.23194.3F; Rosen DS, 2007, NEUROSURGERY, V60, P503, DOI 10.1227/01.NEU.0000255332.87909.58; Scholz M, 1998, SPINAL CORD, V36, P200, DOI 10.1038/sj.sc.3100567; Weiner BK, 1999, SPINE, V24, P2268, DOI 10.1097/00007632-199911010-00016	28	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92611	10.1371/journal.pone.0092611	http://dx.doi.org/10.1371/journal.pone.0092611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658010	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300106
J	Antal, M; Braunitzer, G; Mattheos, N; Gyulai, R; Nagy, K				Antal, Mark; Braunitzer, Gabor; Mattheos, Nikos; Gyulai, Rolland; Nagy, Katalin			Smoking as a Permissive Factor of Periodontal Disease in Psoriasis	PLOS ONE			English	Article							GINGIVAL BLOOD-FLOW; CIGARETTE-SMOKE; RISK-FACTORS; ALPHA; CELLS; IL-12	Background: Population-based studies have identified smoking as a pathogenetic factor in chronic periodontitis. At the same time, chronic periodontal disease has also been found to occur more often in persons suffering from psoriasis than in controls with no psoriasis. It is known that smoking aggravates both periodontal disease and psoriasis, but so far it has not been investigated how smoking influences the occurrence and severity of periodontal disease in psoriasis. Methods: A hospital-based study was conducted to investigate this question. The study population consisted of 82 psoriasis patients and 89 controls. All patients received a full-mouth periodontal examination, and a published classification based on bleeding on probing, clinical attachment level and probing depth was utilized for staging. Both patients and controls were divided into smoker and non-smoker groups, and the resulting groups were compared in terms of periodontal status. Beyond the descriptive statistics, odds ratios were computed. Results: Psoriasis in itself increased the likelihood of severe periodontal disease to 4.373 (OR, as compared to non-smoker controls, p<0.05), while smoking increased it to 24.278 (OR, as compared to non-smoker controls, p<0.001) in the studied population. In other words, the risk of severe periodontal disease in psoriasis turned out to be six times higher in smokers than in non-smokers. Conclusions: The results of this study corroborate those of other studies regarding the link between psoriasis and periodontal disease, but they also seem to reveal a powerful detrimental effect of smoking on the periodontal health of psoriasis patients, whereby the authors propose that smoking may have a permissive effect on the development of severe periodontal disease in psoriasis.	[Antal, Mark] Univ Szeged, Fac Dent, Dept Operat & Esthet Dent, Szeged, Hungary; [Braunitzer, Gabor; Nagy, Katalin] Univ Szeged, Fac Dent, Dept Oral Surg, Szeged, Hungary; [Mattheos, Nikos] Univ Hong Kong, Fac Dent, Dept Oral Rehabil, Hong Kong, Hong Kong, Peoples R China; [Gyulai, Rolland] Univ Szeged, Fac Dent, Dept Dermatol & Allergol, Szeged, Hungary; [Gyulai, Rolland] Univ Pecs, Sch Med, Dept Dermatol Venerol & Oncodermatol, Pecs, Hungary	Szeged University; Szeged University; University of Hong Kong; Szeged University; University of Pecs	Antal, M (corresponding author), Univ Szeged, Fac Dent, Dept Operat & Esthet Dent, Szeged, Hungary.	antalmarkdr@gmail.com	Lauschner, Flavia H/P-2457-2018; Mattheos, Nikos/C-8614-2011; Antal, Mark Adam/AAB-3996-2022; Nagy, Katalin/ABG-5846-2021; Antal, Mark/AAJ-5947-2021; Gyulai, Rolland/AAE-2765-2020	Mattheos, Nikos/0000-0001-7358-7496; Antal, Mark/0000-0002-4109-9356; Gyulai, Rolland/0000-0002-3286-8846; Nagy, Katalin/0000-0001-9383-5952				Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Barmes D, 1994, Int Dent J, V44, P523; BECK JD, 1990, J PERIODONTOL, V61, P521, DOI 10.1902/jop.1990.61.8.521; Cortina-Borja M SD, 2009, BMC RES NOTES, V2; Curry JL, 2003, ARCH PATHOL LAB MED, V127, P178; Del Prete G, 1998, Int Rev Immunol, V16, P427, DOI 10.3109/08830189809043004; Durali D, 2003, BLOOD, V102, P4084, DOI 10.1182/blood-2003-02-0518; Edwards R, 2004, BRIT MED J, V328, P217, DOI 10.1136/bmj.328.7433.217; Emre S, 2012, J EUR ACAD DERMATOL; FALKOFF RJM, 1983, J IMMUNOL, V131, P801; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernandes JK, 2009, J PERIODONTOL, V80, P1062, DOI 10.1902/jop.2009.080486; Genco RJ, 1996, J PERIODONTOL, V67, P1041, DOI 10.1902/jop.1996.67.10s.1041; Genco RJ, 2013, PERIODONTOL 2000, V62, P59, DOI 10.1111/j.1600-0757.2012.00457.x; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Keller JJ, 2012, BRIT J DERMATOL, V167, P1338, DOI 10.1111/j.1365-2133.2012.11126.x; Korn S, 2005, AM J RESP CELL MOL, V32, P142, DOI 10.1165/rcmb.2004-0239OC; Kubota M, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-1; Lazaridou E, 2013, J EUR ACAD DERMATOL, V27, P967, DOI 10.1111/j.1468-3083.2012.04615.x; Masdottir B, 2000, RHEUMATOLOGY, V39, P1202, DOI 10.1093/rheumatology/39.11.1202; MATHEWS JD, 1973, LANCET, V2, P754; Mavropoulos A, 2007, J PERIODONTOL, V78, P1774, DOI 10.1902/jop.2007.060472; Morozumi T, 2004, J CLIN PERIODONTOL, V31, P267, DOI 10.1111/j.1600-051X.2004.00476.x; Netea MG, 2005, ANTIMICROB AGENTS CH, V49, P3991, DOI 10.1128/AAC.49.10.3991-3996.2005; Ohlrich EJ, 2009, AUST DENT J, V54, pS2, DOI 10.1111/j.1834-7819.2009.01139.x; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Preus HR, 2010, ACTA ODONTOL SCAND, V68, P165, DOI 10.3109/00016350903583678; RIECKMANN P, 1991, J IMMUNOL, V146, P3462; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Sullivan AK, 2005, AM J RESP CRIT CARE, V172, P590, DOI 10.1164/rccm.200410-1332OC; Tomar SL, 2000, J PERIODONTOL, V71, P743, DOI 10.1902/jop.2000.71.5.743; Tonetti M S, 1998, Ann Periodontol, V3, P88; YAMADA J, 1992, J PERIODONTOL, V63, P854, DOI 10.1902/jop.1992.63.10.854	34	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92333	10.1371/journal.pone.0092333	http://dx.doi.org/10.1371/journal.pone.0092333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651659	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000333352800102
J	Avraham, A; Cho, SS; Uhlmann, R; Polak, ML; Sandbank, J; Karni, T; Pappo, I; Halperin, R; Vaknin, Z; Sella, A; Sukumar, S; Evron, E				Avraham, Ayelet; Cho, Sean Soonweng; Uhlmann, Ronit; Polak, Mia Leonov; Sandbank, Judith; Karni, Tami; Pappo, Itzhak; Halperin, Ruvit; Vaknin, Zvi; Sella, Avishay; Sukumar, Saraswati; Evron, Ella			Tissue Specific DNA Methylation in Normal Human Breast Epithelium and in Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; TUMOR-SUPPRESSOR; CELLS; TRIM29; ACTIVATION; PATTERNS	Cancer is a heterogeneous and tissue-specific disease. Thus, the tissue of origin reflects on the natural history of the disease and dictates the therapeutic approach. It is suggested that tissue differentiation, mediated mostly by epigenetic modifications, could guide tissue-specific susceptibility and protective mechanisms against cancer. Here we studied breast specific methylation in purified normal epithelium and its reflection in breast cancers. We established genome wide methylation profiles of various normal epithelial tissues and identified 110 genes that were differentially methylated in normal breast epithelium. A number of these genes also showed methylation alterations in breast cancers. We elaborated on one of them, TRIM29 (ATDC), and showed that its promoter was hypo-methylated in normal breast epithelium and heavily methylated in other normal epithelial tissues. Moreover, in breast carcinomas methylation increased and expression decreased whereas the reverse was noted for multiple other carcinomas. Interestingly, TRIM29 regulation in breast tumors clustered according to the PAM50 classification. Thus, it was repressed in the estrogen receptor positive tumors, particularly in the more proliferative luminal B subtype. This goes in line with previous reports indicating tumor suppressive activity of TRIM29 in estrogen receptor positive luminal breast cells in contrast to oncogenic function in pancreatic and lung cancers. Overall, these findings emphasize the linkage between breast specific epigenetic regulation and tissue specificity of cancer.	[Avraham, Ayelet; Uhlmann, Ronit; Sella, Avishay; Evron, Ella] Tel Aviv Univ, Assaf Harofeh Med Ctr, Dept Oncol, Zerifin, Israel; [Cho, Sean Soonweng; Sukumar, Saraswati] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Polak, Mia Leonov; Sandbank, Judith] Tel Aviv Univ, Assaf Harofeh Med Ctr, Dept Pathol, Zerifin, Israel; [Karni, Tami; Pappo, Itzhak] Tel Aviv Univ, Assaf Harofeh Med Ctr, Dept Surg, Zerifin, Israel; [Halperin, Ruvit; Vaknin, Zvi] Tel Aviv Univ, Assaf Harofeh Med Ctr, Dept Genecol, Zerifin, Israel	Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Johns Hopkins University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University	Avraham, A (corresponding author), Tel Aviv Univ, Assaf Harofeh Med Ctr, Dept Oncol, Zerifin, Israel.	ayeleta@asaf.health.gov.il		Evron, Ella/0000-0002-1003-5042; Cho, Soonweng/0000-0002-1637-2875	Israeli Cancer Association [20130158]	Israeli Cancer Association	This study was supported by the Israeli Cancer Association grant no. 20130158. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, R LANG ENV STAT COMP; Avraham A, 2010, EPIGENETICS-US, V5, P41, DOI 10.4161/epi.5.1.10724; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Chang H, 2009, J CLIN PATHOL, V62, P908, DOI 10.1136/jcp.2009.067298; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ernst T, 2002, AM J PATHOL, V160, P2169, DOI 10.1016/S0002-9440(10)61165-0; Goldman M, 2013, NUCLEIC ACIDS RES, V41, P29; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huggins GS, 2006, CANCER RES, V66, P1384, DOI 10.1158/0008-5472.CAN-05-2715; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ivanov SV, 2013, BRIT J CANCER, V109, P444, DOI 10.1038/bjc.2013.326; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Klajic J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-456; Kosaka Y, 2007, ANN SURG ONCOL, V14, P2543, DOI 10.1245/s10434-007-9461-1; Liu J, 2012, AM J PATHOL, V180, P839, DOI 10.1016/j.ajpath.2011.10.020; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nacht M, 1999, CANCER RES, V59, P5464; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Perou CM, 2011, COLD SPRING HARB PER, V3; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tollervey JR, 2012, EPIGENETICS-US, V7, P823, DOI 10.4161/epi.21141; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Yuan ZG, 2010, MOL CELL BIOL, V30, P3004, DOI 10.1128/MCB.01023-09; Zhang YH, 2012, J BIOL CHEM, V287, P17746, DOI 10.1074/jbc.M112.358143; Zhou ZY, 2012, J CHIN MED ASSOC, V75, P269, DOI 10.1016/j.jcma.2012.04.015	35	22	26	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91805	10.1371/journal.pone.0091805	http://dx.doi.org/10.1371/journal.pone.0091805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651077	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800050
J	Morgan, HM; Davis, NJ; Bracewell, RM				Morgan, Helen M.; Davis, Nick J.; Bracewell, R. Martyn			Does Transcranial Direct Current Stimulation to Prefrontal Cortex Affect Mood and Emotional Memory Retrieval in Healthy Individuals?	PLOS ONE			English	Article							MAGNETIC STIMULATION; DOUBLE-BLIND; MAJOR DEPRESSION; COGNITIVE CONTROL; BRAIN-STIMULATION; NEGATIVE AFFECT; CLINICAL-TRIAL; RISK-TAKING; TDCS; EFFICACY	Studies using transcranial direct current stimulation (tDCS) of prefrontal cortex to improve symptoms of depression have had mixed results. We examined whether using tDCS to change the balance of activity between left and right dorsolateral prefrontal cortex (DLPFC) can alter mood and memory retrieval of emotional material in healthy volunteers. Participants memorised emotional images, then tDCS was applied bilaterally to DLPFC while they performed a stimulus-response compatibility task. Participants were then presented with a set of images for memory retrieval. Questionnaires to examine mood and motivational state were administered at the beginning and end of each session. Exploratory data analyses showed that the polarity of tDCS to DLPFC influenced performance on a stimulus-response compatibility task and this effect was dependent on participants' prior motivational state. However, tDCS polarity had no effect on the speed or accuracy of memory retrieval of emotional images and did not influence positive or negative affect. These findings suggest that the balance of activity between left and right DLPFC does not play a critical role in the mood state of healthy individuals. We suggest that the efficacy of prefrontal tDCS depends on the initial activation state of neurons and future work should take this into account.	[Morgan, Helen M.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England; [Davis, Nick J.] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Bracewell, R. Martyn] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Bracewell, R. Martyn] Bangor Univ, Sch Med Sci, Bangor, Gwynedd, Wales	Liverpool John Moores University; Swansea University; Bangor University; Bangor University	Morgan, HM (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England.	H.M.Morgan@ljmu.ac.uk		Davis, Nick/0000-0001-7630-2097	Future and Emerging Technologies (FET) program within the Seventh Framework Programme for Research of the European Commission (FET-Open grant) [222079]	Future and Emerging Technologies (FET) program within the Seventh Framework Programme for Research of the European Commission (FET-Open grant)	This work was supported by the Future and Emerging Technologies (FET) program within the Seventh Framework Programme for Research of the European Commission (FET-Open grant no. 222079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P516, DOI 10.1037//0894-4105.15.4.516; AHERN GL, 1985, NEUROPSYCHOLOGIA, V23, P745, DOI 10.1016/0028-3932(85)90081-8; American Electroencephalographic Society, J CLIN NEUROPHYSIOL, V8, P200; Baeken C, 2006, J AFFECT DISORDERS, V90, P63, DOI 10.1016/j.jad.2005.09.013; Berlim MT, 2013, NEUROPSYCHOPHARMACOL, V38, P543, DOI 10.1038/npp.2012.237; Berlim MT, 2013, J PSYCHIATR RES, V47, P1, DOI 10.1016/j.jpsychires.2012.09.025; Berman RM, 2000, BIOL PSYCHIAT, V47, P332, DOI 10.1016/S0006-3223(99)00243-7; BLANEY PH, 1986, PSYCHOL BULL, V99, P229, DOI 10.1037/0033-2909.99.2.229; Blumberger Daniel M, 2012, Front Psychiatry, V3, P74, DOI 10.3389/fpsyt.2012.00074; Boggio PS, 2008, INT J NEUROPSYCHOPH, V11, P249, DOI 10.1017/S1461145707007833; Boggio PS, 2010, DRUG ALCOHOL DEPEN, V112, P220, DOI 10.1016/j.drugalcdep.2010.06.019; Boggio PS, 2009, NEUROPSYCHOLOGIA, V47, P212, DOI 10.1016/j.neuropsychologia.2008.07.022; British Psychological Society (BPS), 2009, COD ETH COND; Brunoni AR, 2013, PSYCHONEUROENDOCRINO, V38, P58, DOI 10.1016/j.psyneuen.2012.04.020; Campbell S., 2001, P HUMAN FACTORS ERGO, V45, P906, DOI [10.1177/154193120104501302, DOI 10.1177/154193120104501302]; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; DONALDSON W, 1993, B PSYCHONOMIC SOC, V31, P271; Egner T, 2009, NAT NEUROSCI, V12, P821, DOI 10.1038/nn0709-821; Fecteau S, 2007, J NEUROSCI, V27, P12500, DOI 10.1523/JNEUROSCI.3283-07.2007; Figiel GS, 1998, J NEUROPSYCH CLIN N, V10, P20, DOI 10.1176/jnp.10.1.20; FITTS PM, 1954, J EXP PSYCHOL, V48, P483, DOI 10.1037/h0054967; Fregni F, 2006, BIPOLAR DISORD, V8, P203, DOI 10.1111/j.1399-5618.2006.00291.x; Fregni F, 2006, DEPRESS ANXIETY, V23, P482, DOI 10.1002/da.20201; Gainotti G, 1972, Cortex, V8, P41; George MS, 1997, AM J PSYCHIAT, V154, P1752, DOI 10.1176/ajp.154.12.1752; GRIER JB, 1971, PSYCHOL BULL, V75, P424, DOI 10.1037/h0031246; Grisaru N, 2001, J ECT, V17, P184, DOI 10.1097/00124509-200109000-00007; Hagler DJ, 2006, NEUROIMAGE, V29, P567, DOI 10.1016/j.neuroimage.2005.08.058; Heller W, 1997, COGNITION EMOTION, V11, P637, DOI 10.1080/026999397379845a; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jenkins J, 2002, BMC PSYCHIATRY, V2, DOI 10.1186/1471-244X-2-1; Kalu UG, 2012, PSYCHOL MED, V42, P1791, DOI 10.1017/S0033291711003059; Kessler SK, 2012, BRAIN STIMUL, V5, P155, DOI 10.1016/j.brs.2011.02.007; Kirov R, 2009, P NATL ACAD SCI USA, V106, P15460, DOI 10.1073/pnas.0904438106; Klein E, 1999, ARCH GEN PSYCHIAT, V56, P315, DOI 10.1001/archpsyc.56.4.315; Koenigs M, 2009, CLIN NEUROPHYSIOL, V120, P80, DOI 10.1016/j.clinph.2008.10.010; Koessler L, 2009, NEUROIMAGE, V46, P64, DOI 10.1016/j.neuroimage.2009.02.006; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Lenth RV., 2006, JAVA APPLETS POWER S; Loo CK, 2012, BRIT J PSYCHIAT, V200, P52, DOI 10.1192/bjp.bp.111.097634; Loo CK, 2010, INT J NEUROPSYCHOPH, V13, P61, DOI 10.1017/S1461145709990411; Maeoka H, 2012, NEUROSCI LETT, V512, P12, DOI 10.1016/j.neulet.2012.01.037; Marshall L, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-23; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Metuki N, 2012, BRAIN STIMUL, V5, P110, DOI 10.1016/j.brs.2012.03.002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miranda PC, 2009, CLIN NEUROPHYSIOL, V120, P1183, DOI 10.1016/j.clinph.2009.03.023; Morey RD, 2011, PSYCHOL METHODS, V16, P406, DOI 10.1037/a0024377; Mosimann UP, 2000, PSYCHIAT RES, V94, P251, DOI 10.1016/S0165-1781(00)00146-3; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche M A, 2012, Front Psychiatry, V3, P58, DOI 10.3389/fpsyt.2012.00058; Nitsche MA, 2009, EXP NEUROL, V219, P14, DOI 10.1016/j.expneurol.2009.03.038; O'Connell NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047514; Palm U, 2012, BRAIN STIMUL, V5, P242, DOI 10.1016/j.brs.2011.08.005; PascualLeone A, 1996, LANCET, V348, P233, DOI 10.1016/S0140-6736(96)01219-6; Pena-Gomez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022812; Penolazzi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010623; Plazier M, 2012, BRAIN STIMUL, V5, P454, DOI 10.1016/j.brs.2011.07.005; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; ROBINSON RG, 1984, BRAIN, V107, P81, DOI 10.1093/brain/107.1.81; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Russo R, 2013, BRAIN STIMUL, V6, P946, DOI 10.1016/j.brs.2013.05.009; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Schaller G, 2011, J PSYCHIATR RES, V45, P1178, DOI 10.1016/j.jpsychires.2011.02.006; Sela T, 2012, NEUROPSYCHOLOGIA, V50, P2271, DOI 10.1016/j.neuropsychologia.2012.05.031; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Slotema CW, 2010, J CLIN PSYCHIAT, V71, P873, DOI 10.4088/JCP.08m04872gre; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wise EA, 2012, J PSYCHIATR RES, V46, P412, DOI 10.1016/j.jpsychires.2011.11.005	77	21	22	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92162	10.1371/journal.pone.0092162	http://dx.doi.org/10.1371/journal.pone.0092162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651375	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800075
J	Ogura, T				Ogura, Toshihiko			Direct Observation of Unstained Biological Specimens in Water by the Frequency Transmission Electric-Field Method Using SEM	PLOS ONE			English	Article							IMPEDANCE TOMOGRAPHY; RADIATION-DAMAGE; MICROSCOPY; CELLS; CONTRAST; EIT	Scanning electron microscopy (SEM) is a powerful tool for the direct visualization of biological specimens at nanometre-scale resolution. However, images of unstained specimens in water using an atmospheric holder exhibit very poor contrast and heavy radiation damage. Here, we present a new form of microscopy, the frequency transmission electric-field (FTE) method using SEM, that offers low radiation damage and high-contrast observation of unstained biological samples in water. The wet biological specimens are enclosed in two silicon nitride (SiN) films. The metal-coated SiN film is irradiated using a focused modulation electron beam (EB) at a low-accelerating voltage. A measurement terminal under the sample holder detects the electric-field frequency signal, which contains structural information relating to the biological specimens. Our results in very little radiation damage to the sample, and the observation image is similar to the transmission image, depending on the sample volume. Our developed method can easily be utilized for the observation of various biological specimens in water.	Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Ogura, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan.	t-ogura@aist.go.jp	Ogura, Toshihiko/M-4089-2018		Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [25650057] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by KAKENHI Grant-in-Aid for Scientific Research (B) and for Challenging Exploratory Research of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan-Wojtas P, 2008, LWT-FOOD SCI TECHNOL, V41, P101, DOI 10.1016/j.lwt.2007.02.003; BOONE K, 1994, PHYSIOL MEAS, V15, pA189, DOI 10.1088/0967-3334/15/2A/024; Boverman G, 2009, IEEE T BIO-MED ENG, V56, P2762, DOI 10.1109/TBME.2009.2027129; BRANDIS E, 1980, APPL PHYS LETT, V37, P98, DOI 10.1063/1.91718; CARGILL GS, 1980, NATURE, V286, P691, DOI 10.1038/286691a0; de Jonge N, 2009, P NATL ACAD SCI USA, V106, P2159, DOI 10.1073/pnas.0809567106; Drouin D, 2007, SCANNING, V29, P92, DOI 10.1002/sca.20000; DUCKETT JG, 1995, ANN BOT-LONDON, V76, P405, DOI 10.1006/anbo.1995.1114; Egerton RF, 2004, MICRON, V35, P399, DOI 10.1016/j.micron.2004.02.003; GLAESER RM, 1971, J ULTRA MOL STRUCT R, V36, P466, DOI 10.1016/S0022-5320(71)80118-1; HENDERSON R, 1985, ULTRAMICROSCOPY, V16, P139, DOI 10.1016/0304-3991(85)90069-5; Inayoshi Y, 2012, MICRON, V43, P1091, DOI 10.1016/j.micron.2012.02.001; Kulkarni R, 2009, PHYSIOL MEAS, V30, pS19, DOI 10.1088/0967-3334/30/6/S02; LAMED R, 1987, J MICROBIOL METH, V7, P233, DOI 10.1016/0167-7012(87)90045-5; McEwan A, 2007, PHYSIOL MEAS, V28, pS197, DOI 10.1088/0967-3334/28/7/S15; MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368; MOTTA PM, 1994, ARCH HISTOL CYTOL, V57, P369, DOI 10.1679/aohc.57.369; NAGATA F, 1972, JPN J APPL PHYS, V11, P1239, DOI 10.1143/JJAP.11.1239; Nguyen DT, 2012, PHYSIOL MEAS, V33, P695, DOI 10.1088/0967-3334/33/5/695; Ogura T, 2008, BIOCHEM BIOPH RES CO, V377, P79, DOI 10.1016/j.bbrc.2008.09.097; Ogura T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046904; Ogura T, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/8/085402; Ogura T, 2010, BIOCHEM BIOPH RES CO, V391, P198, DOI 10.1016/j.bbrc.2009.11.031; PARSONS DF, 1974, SCIENCE, V186, P407, DOI 10.1126/science.186.4162.407; RICHARDS SR, 1984, WATER RES, V18, P767, DOI 10.1016/0043-1354(84)90173-8; Thiberge S, 2004, P NATL ACAD SCI USA, V101, P3346, DOI 10.1073/pnas.0400088101	26	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92780	10.1371/journal.pone.0092780	http://dx.doi.org/10.1371/journal.pone.0092780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651483	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800157
J	Baumgartner, FA; Toth, GB				Baumgartner, Finn A.; Toth, Gunilla B.			Abundance and Size Distribution of the Sacoglossan Elysia viridis on Co-Occurring Algal Hosts on the Swedish West Coast	PLOS ONE			English	Article							SEA SLUGS; INTRODUCED MACROALGAE; SPECIALIST HERBIVORES; PLACIDA-DENDRITICA; FEEDING ECOLOGY; ROCKY SHORES; OPISTHOBRANCHIA; MOLLUSCA; CHLOROPLASTS; ASSOCIATIONS	Sacoglossans are specialized marine herbivores that tend to have a close evolutionary relationship with their macroalgal hosts, but the widely distributed species Elysia viridis can associate with several algal species. However, most previous investigations on the field abundance and size distribution of E. viridis have focussed on Codium spp. in the British Isles, and algae from this genus are considered superior hosts for E. viridis. In the present study, we investigated the abundance and size distribution of E. viridis on 6 potential host algae with differing morphologies (the septate species Cladophora sericea, Cladophora rupestris, Chaetomorpha melagonium, and Ceramium virgatum, as well as the siphonaceous species Codium fragile and Bryopsis sp.) at 2 sites on the Swedish west coast over the course of a year. In spring, slugs were almost absent from all algal hosts. In summer and autumn, E. viridis consistently occurred on several of the algal species at both sites. The highest number of small E. viridis were found on C. sericea, intermediate numbers of significantly larger E. viridis were found on C. rupestris, while fewer, intermediate sized animals were found on C. fragile. Throughout the study period, only a few E. viridis individuals were found on C. melagonium, Bryopsis sp., and C. virgatum. Our results indicate that E. viridis is an annual species in Sweden, capable of exploiting co-occurring congeneric and intergeneric algal hosts with differing morphologies. These results corroborate previous findings that E. viridis can exploit several different algal species, but does not indicate that C. fragile is a superior host.	[Baumgartner, Finn A.; Toth, Gunilla B.] Tjarno Univ Gothenburg, Dept Biol & Environm Sci, Stromstad, Sweden		Toth, GB (corresponding author), Tjarno Univ Gothenburg, Dept Biol & Environm Sci, Stromstad, Sweden.	gunilla.toth@bioenv.gu.se	Toth, Gunilla B/E-8737-2013	Toth, Gunilla/0000-0002-1225-7773	Swedish Research Council [621-2007-5874]; Faculty of Sciences University of Gothenburg through the strategic research platform in Marine Chemical Ecology (MARICE); Colliander foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Faculty of Sciences University of Gothenburg through the strategic research platform in Marine Chemical Ecology (MARICE); Colliander foundation	This work was financially supported by the Swedish Research Council through contract no. 621-2007-5874, the Faculty of Sciences University of Gothenburg through the strategic research platform in Marine Chemical Ecology (MARICE), and via grants from the Colliander foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner FA, 2009, MAR ECOL PROG SER, V396, P1, DOI 10.3354/meps08359; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; BRANDLEY BK, 1984, B MAR SCI, V34, P207; Christa G, 2013, PLANTA, V237, P559, DOI 10.1007/s00425-012-1788-6; CLARK KB, 1987, AM MALACOL BULL, V5, P259; Curtis NE, 2007, MAR BIOL, V150, P797, DOI 10.1007/s00227-006-0398-x; Curtis NE, 2006, INVERTEBR BIOL, V125, P336, DOI 10.1111/j.1744-7410.2006.00065.x; Evertsen J, 2009, MAR BIOL, V156, P847, DOI 10.1007/s00227-009-1128-y; Handeler K, 2010, MOL ECOL RESOUR, V10, P968, DOI 10.1111/j.1755-0998.2010.02853.x; Haendeler Katharina, 2007, Bonner Zoologische Beitraege, V55, P231; HINDE R, 1975, BIOL J LINN SOC, V7, P161, DOI 10.1111/j.1095-8312.1975.tb00738.x; JENSEN KR, 1989, J MOLLUS STUD, V55, P79, DOI 10.1093/mollus/55.1.79; Jensen KR, 1997, EVOL ECOL, V11, P301, DOI 10.1023/A:1018468420368; JOHANNESSON K, 1989, OIKOS, V54, P77, DOI 10.2307/3565899; Klochkova TA, 2013, MAR BIOL, V160, P155, DOI 10.1007/s00227-012-2074-7; Krug PJ, 2011, AM MALACOL BULL, V29, P169, DOI 10.4003/006.029.0210; Maeda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042024; MARIN A, 1992, MAR BIOL, V112, P677, DOI 10.1007/BF00346186; Marin A, 2004, SCI MAR, V68, P227, DOI 10.3989/scimar.2004.68s1227; Middlebrooks ML, 2012, THESIS U S FLORIDA T; Nohren E, 2009, ESTUAR COAST SHELF S, V84, P1, DOI 10.1016/j.ecss.2009.05.012; Pierce SK, 2012, INT REV CEL MOL BIO, V293, P123, DOI 10.1016/B978-0-12-394304-0.00009-9; Quinn GP, 2003, EXPT DESIGN DATA ANA; Sotka EE, 2005, ECOL LETT, V8, P448, DOI 10.1111/j.1461-0248.2004.00719.x; Sotka EE, 2007, MAR BIOL, V151, P1831, DOI 10.1007/s00227-007-0612-5; Thomasson MA, 2005, MAR BIOL RES, V1, P107, DOI 10.1080/17451000510019051; TROWBRIDGE CD, 1991, ECOLOGY, V72, P1880, DOI 10.2307/1940985; TROWBRIDGE CD, 1992, MAR ECOL PROG SER, V83, P207, DOI 10.3354/meps083207; TROWBRIDGE CD, 1993, J EXP MAR BIOL ECOL, V169, P233, DOI 10.1016/0022-0981(93)90195-T; Trowbridge CD, 2001, ECOL MONOGR, V71, P219, DOI 10.1890/0012-9615(2001)071[0219:HPCIMS]2.0.CO;2; Trowbridge CD, 2004, J ANIM ECOL, V73, P294, DOI 10.1111/j.0021-8790.2004.00808.x; Trowbridge CD, 2002, J MAR BIOL ASSOC UK, V82, P1029, DOI 10.1017/S0025315402006586; Trowbridge CD, 2000, J MAR BIOL ASSOC UK, V80, P1087, DOI 10.1017/S0025315400003155; TROWBRIDGE CD, 1992, MAR BIOL, V114, P443, DOI 10.1007/BF00350036; Trowbridge CD, 2008, J MAR BIOL ASSOC UK, V88, P771, DOI 10.1017/S0025315408001690; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; Vieira S, 2009, MAR BIOL, V156, P1007, DOI 10.1007/s00227-009-1144-y; Williams SI, 1999, OCEANOGR MAR BIOL, V37, P87	38	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92472	10.1371/journal.pone.0092472	http://dx.doi.org/10.1371/journal.pone.0092472			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647524	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500136
J	Lee, EJ; Malik, A; Pokharel, S; Ahmad, S; Mir, BA; Cho, KH; Kim, J; Kong, JC; Lee, DM; Chung, KY; Kim, SH; Choi, I				Lee, Eun Ju; Malik, Adeel; Pokharel, Smritee; Ahmad, Sarafraz; Mir, Bilal Ahmad; Cho, Kyung Hyun; Kim, Jihoe; Kong, Joon Chan; Lee, Dong-Mok; Chung, Ki Yong; Kim, Sang Hoon; Choi, Inho			Identification of Genes Differentially Expressed in Myogenin Knock-Down Bovine Muscle Satellite Cells during Differentiation through RNA Sequencing Analysis	PLOS ONE			English	Article							SKELETAL MYOBLAST DIFFERENTIATION; ENHANCER FACTOR-2 MEF2; STEM-CELLS; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; CYCLE WITHDRAWAL; DNA-REPLICATION; UP-REGULATION; MCM PROTEINS; MYOD	Background: The expression of myogenic regulatory factors (MRFs) consisting of MyoD, Myf5, myogenin (MyoG) and MRF4 characterizes various phases of skeletal muscle development including myoblast proliferation, cell-cycle exit, cell fusion and the maturation of myotubes to form myofibers. Although it is well known that the function of MyoG cannot be compensated for other MRFs, the molecular mechanism by which MyoG controls muscle cell differentiation is still unclear. Therefore, in this study, RNA-Seq technology was applied to profile changes in gene expression in response to MyoG knockdown (MyoG(kd)) in primary bovine muscle satellite cells (MSCs). Results: About 61-64% of the reads of over 42 million total reads were mapped to more than 13,000 genes in the reference bovine genome. RNA-Seq analysis identified 8,469 unique genes that were differentially expressed in MyoG(kd). Among these genes, 230 were up-regulated and 224 were down-regulated by at least four-fold. DAVID Functional Annotation Cluster (FAC) and pathway analysis of all up- and down-regulated genes identified overrepresentation for cell cycle and division, DNA replication, mitosis, organelle lumen, nucleoplasm and cytosol, phosphate metabolic process, phosphoprotein phosphatase activity, cytoskeleton and cell morphogenesis, signifying the functional implication of these processes and pathways during skeletal muscle development. The RNA-Seq data was validated by real time RT-PCR analysis for eight out of ten genes as well as five marker genes investigated. Conclusions: This study is the first RNA-Seq based gene expression analysis of MyoG(kd) undertaken in primary bovine MSCs. Computational analysis of the differentially expressed genes has identified the significance of genes such as SAP30-like (SAP30L), Protein lyl-1 (LYL1), various matrix metalloproteinases, and several glycogenes in myogenesis. The results of the present study widen our knowledge of the molecular basis of skeletal muscle development and reveal the vital regulatory role of MyoG in retaining muscle cell differentiation.	[Lee, Eun Ju; Malik, Adeel; Pokharel, Smritee; Ahmad, Sarafraz; Mir, Bilal Ahmad; Cho, Kyung Hyun; Kim, Jihoe; Choi, Inho] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; [Lee, Eun Ju; Choi, Inho] Yeungnam Univ, Bovine Genome Resources Bank, Gyongsan, South Korea; [Kong, Joon Chan; Lee, Dong-Mok] Korea Inst Ind Technol, Biomed Mfg Technol Ctr, Yeongcheon Si, South Korea; [Chung, Ki Yong] RDA, Hanwoo Expt Stn, Natl Inst Anim Sci, Pyeongchang, South Korea; [Kim, Sang Hoon] Kyung Hee Univ, Dept Biol, Seoul, South Korea	Yeungnam University; Yeungnam University; Korea Institute of Industrial Technology (KITECH); National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Kyung Hee University	Choi, I (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea.	inhochoi@ynu.ac.kr	Malik, Adeel/ABD-4831-2020; Mir, Bilal Ahmad/ABB-2374-2021; Kim, Sang Hoon/AAJ-7334-2020	Malik, Adeel/0000-0002-3453-6001; Mir, Bilal Ahmad/0000-0002-8194-5991; Kim, Sanghoon/0000-0002-4078-6269	BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ907099]	BioGreen 21 Program, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the BioGreen 21 Program (Project no. PJ907099), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Al-Khalili L, 2004, ACTA PHYSIOL SCAND, V180, P395, DOI 10.1111/j.1365-201X.2004.01259.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Barela AJ, 2006, J NEUROSCI, V26, P2714, DOI 10.1523/JNEUROSCI.2977-05.2006; Bentzinger CF, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt27; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Brand NJ, 1997, INT J BIOCHEM CELL B, V29, P1467, DOI 10.1016/S1357-2725(97)00084-8; Brand-Saberi B, 1999, CELL TISSUE RES, V296, P199, DOI 10.1007/s004410051281; Brandan E, 2013, MATRIX BIOL, V32, P289, DOI 10.1016/j.matbio.2013.03.007; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Cherian MG, 2000, CELL MOL BIOL, V46, P347; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Costa ML, 2004, BRAZ J MED BIOL RES, V37, P1819, DOI 10.1590/S0100-879X2004001200007; Dahiya S, 2011, HUM MOL GENET, V20, P4345, DOI 10.1093/hmg/ddr362; de Oliveira MV, 2009, FEBS LETT, V583, P2975, DOI 10.1016/j.febslet.2009.08.022; Delgado I, 2003, GENOMICS, V82, P109, DOI 10.1016/S0888-7543(03)00104-6; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fornaro M, 2006, J CELL BIOL, V175, P87, DOI 10.1083/jcb.200602029; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fukumoto S, 2006, J PHARMACOL SCI, V100, P195, DOI 10.1254/jphs.FMJ05004X3; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; Henning MS, 2011, VIROLOGY, V415, P114, DOI 10.1016/j.virol.2011.04.006; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Hinard V, 2008, DEVELOPMENT, V135, P859, DOI 10.1242/dev.011387; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424, DOI 10.1113/jphysiol.1952.sp004716; Huang T, 2006, ACTA BIOCH BIOPH SIN, V38, P450, DOI 10.1111/j.1745-7270.2006.00187.x; Janot M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-483; Jin RX, 2002, CARCINOGENESIS, V23, P81, DOI 10.1093/carcin/23.1.81; Jung DW, 2011, ACS CHEM BIOL, V6, P553, DOI 10.1021/cb2000154; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Kim JM, 2009, J ANIM BREED GENET, V126, P134, DOI 10.1111/j.1439-0388.2008.00724.x; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Knight J, 2011, PRIORITY OF DEMOCRACY: POLITICAL CONSEQUENCES OF PRAGMATISM, P1; Labib K, 2001, MOL BIOL CELL, V12, P3658, DOI 10.1091/mbc.12.11.3658; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Lee DM, 2011, IN VITRO CELL DEV-AN, V47, P438, DOI 10.1007/s11626-011-9427-2; Lee EJ, 2013, PLOS ONE, DOI [10.1371/journal.pone.0079780, DOI 10.1371/J0URNAL.P0NE.0079780]; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063627; Lee EJ, 2012, GENOMICS, V100, P195, DOI 10.1016/j.ygeno.2012.06.005; Lee EJ, 2012, GENES GENOM, V34, P133, DOI 10.1007/s13258-011-0096-z; Leppanen VM, 2011, BLOOD, V117, P1507, DOI 10.1182/blood-2010-08-301549; Lin X, 2012, MOL CELL BIOL, V32, P297, DOI 10.1128/MCB.05484-11; Lindfors K, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-53; Liu QC, 2012, J MOL CELL BIOL, V4, P386, DOI 10.1093/jmcb/mjs045; Lu HG, 2002, J BIOL CHEM, V277, P46687, DOI 10.1074/jbc.M209643200; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MARTIN JF, 1994, MOL CELL BIOL, V14, P1647, DOI 10.1128/MCB.14.3.1647; Martinez-Marmol R, 2007, CARDIOVASC RES, V76, P430, DOI 10.1016/j.cardiores.2007.08.009; Mastroyiannopoulos NP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029896; McCullagh KJA, 2008, MAMM GENOME, V19, P339, DOI 10.1007/s00335-008-9120-2; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; McGann CJ, 2001, P NATL ACAD SCI USA, V98, P13699, DOI 10.1073/pnas.221297398; Meadows E, 2008, DEV BIOL, V322, P406, DOI 10.1016/j.ydbio.2008.07.024; Merkulova T, 2000, EUR J BIOCHEM, V267, P3735, DOI 10.1046/j.1432-1327.2000.01408.x; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; Miyamoto A, 1996, MOL CELL BIOL, V16, P2394; Mohun Tim, 1992, Current Opinion in Cell Biology, V4, P923, DOI 10.1016/0955-0674(92)90119-W; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Moran JL, 2002, PHYSIOL GENOMICS, V10, P103, DOI 10.1152/physiolgenomics.00011.2002; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Myer A, 2001, DEV BIOL, V229, P340, DOI 10.1006/dbio.2000.9985; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nagel S, 2009, LEUKEMIA LYMPHOMA, V50, P101, DOI 10.1080/10428190802626632; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Newey SE, 2001, J BIOL CHEM, V276, P6645, DOI 10.1074/jbc.M008305200; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V433, P558, DOI 10.1016/j.bbrc.2013.03.033; OLSON EN, 1991, MOL CELL BIOCHEM, V104, P7; Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Qiong Wang, 2008, Frontiers of Agriculture in China, V2, P512, DOI 10.1007/s11703-008-0065-8; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Rajan S, 2012, PHYSIOL GENOMICS, V44, P183, DOI 10.1152/physiolgenomics.00093.2011; RAWLS A, 1995, DEV BIOL, V172, P37, DOI 10.1006/dbio.1995.0004; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Sahin F, 2010, INT J BIOL SCI, V6, P116; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; Shen Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013086; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Singh K, 2013, FEBS J, V280, P3991, DOI 10.1111/febs.12188; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Sterrenburg E, 2004, NEUROMUSCULAR DISORD, V14, P507, DOI 10.1016/j.nmd.2004.03.008; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Ugarte G, 2006, J BIOL CHEM, V281, P18473, DOI 10.1074/jbc.M600918200; Vega AV, 2011, J PHYSIOL-LONDON, V589, P4649, DOI 10.1113/jphysiol.2011.210765; Wang CJ, 2011, J BIOL CHEM, V286, P24253, DOI 10.1074/jbc.M111.245803; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Wicik Z, 2011, POL J VET SCI, V14, P643, DOI 10.2478/v10181-011-0095-7; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; ZHANG W, 1995, GENE DEV, V9, P1388, DOI 10.1101/gad.9.11.1388	118	30	33	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92447	10.1371/journal.pone.0092447	http://dx.doi.org/10.1371/journal.pone.0092447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647404	Green Published, gold			2022-12-27	WOS:000333348500133
J	Pang, H; Han, B; Yu, T; Peng, Z				Pang, Hui; Han, Bing; Yu, Tao; Peng, Zhen			The Complex Regulation of Tanshinone IIA in Rats with Hypertension-Induced Left Ventricular Hypertrophy	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; HEART-FAILURE; ISCHEMIA/REPERFUSION INJURY; CARDIOMYOCYTE APOPTOSIS; APELIN PROTECTS; MECHANISMS; PATHWAY; GROWTH; METALLOPROTEINASES; DEATH	Tanshinone IIA has definite protective effects on various cardiovascular diseases. However, in hypertension-induced left ventricular hypertrophy (H-LVH), the signaling pathways of tanshinone IIA in inhibition of remodeling and cardiac dysfunction remain unclear. Two-kidney, one-clip induced hypertensive rats (n = 32) were randomized to receive tanshinone IIA (5, 10, 15 mg/kg per day) or 5% glucose injection (GS). Sham-operated rats (n = 8) received 5% GS as control. Cardiac function and dimensions were assessed by using an echocardiography system. Histological determination of the fibrosis and apoptosis was performed using hematoxylin eosin, Masson's trichrome and TUNEL staining. Matrix metalloproteinase 2 (MMP2) and tissue inhibitor of matrix metalloproteinases type 2 (TIMP2) protein expressions in rat myocardial tissues were detected by immunohistochemistry. Rat cardiomyocytes were isolated by a Langendorff perfusion method. After 48 h culture, the supernatant and cardiomyocytes were collected to determine the potential related proteins impact on cardiac fibrosis and apoptosis. Compared with the sham rats, the heart tissues of H-LVH (5% GS) group suffered severely from the oxidative damage, apoptosis of cardiomyocytes and extracellular matrix (ECM) deposition. In the H-LVH group, tanshinone IIA treated decreased malondialdehyde (MDA) content and increased superoxide dismutase (SOD) activity. Tanshinone IIA inhibited cardiomyocytes apoptosis as confirmed by the reduction of TUNEL positive cardiomyocytes and the down-regulation of Caspase-3 activity and Bax/Bcl-2 ratio. Meanwhile, plasma apelin level increased with down-regulation of APJ receptor. Tanshinone IIA suppressed cardiac fibrosis through regulating the paracrine factors released by cardiomyocytes and the TGF-beta/Smads signaling pathway activity. In conclusion, our in vivo study showed that tanshinone IIA could improve heart function by enhancing myocardial contractility, inhibiting ECM deposition, and limiting apoptosis of cardiomyocytes and oxidative damage.	[Pang, Hui; Han, Bing; Yu, Tao] Southeast Univ, Affiliated Hosp, Xuzhou Med Coll, Dept Cardiovasc Med,Cent Hosp Xuzhou,Xuzhou Clin, Xuzhou, Jiangsu, Peoples R China; [Peng, Zhen] Southeast Univ, Affiliated Hosp, Xuzhou Med Coll, Dept Ultrasonog,Cent Hosp Xuzhou,Xuzhou Clin Sch, Xuzhou, Jiangsu, Peoples R China	Southeast University - China; Xuzhou Medical University; Southeast University - China; Xuzhou Medical University	Pang, H (corresponding author), Southeast Univ, Affiliated Hosp, Xuzhou Med Coll, Dept Cardiovasc Med,Cent Hosp Xuzhou,Xuzhou Clin, Xuzhou, Jiangsu, Peoples R China.	phui81@126.com			Xuzhou Municipal Bureau of Science and Technology [XZZD1020]; Xuzhou Municipal Health Bureau [XWJ2011030]	Xuzhou Municipal Bureau of Science and Technology; Xuzhou Municipal Health Bureau	This research was supported by the Xuzhou Municipal Bureau of Science and Technology (No. XZZD1020) and Xuzhou Municipal Health Bureau (No. XWJ2011030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2006, CIRCULATION, V113, P2089, DOI 10.1161/CIRCULATIONAHA.105.573865; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chan P, 2011, AM J CHINESE MED, V39, P381, DOI 10.1142/S0192415X11008890; Chen Chu-Huang, 2004, Current Vascular Pharmacology, V2, P33, DOI 10.2174/1570161043476500; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Davia K, 1999, PHYSIOL GENOMICS, V1, P41, DOI 10.1152/physiolgenomics.1999.1.2.41; Diez J, 2010, HYPERTENSION, V55, P1, DOI 10.1161/HYPERTENSIONAHA.109.141887; Dixon JA, 2011, ANNU REV PHYSIOL, V73, P47, DOI 10.1146/annurev-physiol-012110-142230; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Ekhterae D, 2011, J SURG RES, V166, P59, DOI 10.1016/j.jss.2009.05.002; FANG J, 2010, DISCOVER, V31, P18, DOI DOI 10.1016/J.PHYMED.2010.06.002.PUBMED:20638255; Fedak PWM, 2008, SEMIN THORAC CARDIOV, V20, P87, DOI 10.1053/j.semtcvs.2008.04.001; Feng Jun, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P930; Gao S, 2012, ATHEROSCLEROSIS, V220, P3, DOI 10.1016/j.atherosclerosis.2011.06.041; Gradman Alan H, 2009, Curr Cardiol Rep, V11, P422; Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hong HJ, 2010, ACTA PHARMACOL SIN, V31, P1569, DOI 10.1038/aps.2010.176; Iturrioz X, 2007, ARCH MAL COEUR VAISS, V100, P704; Iturrioz X, 2010, FASEB J, V24, P1506, DOI 10.1096/fj.09-140715; Kandalam V, 2010, CIRC RES, V106, P796, DOI 10.1161/CIRCRESAHA.109.209189; Khouri MG, 2010, CIRC-CARDIOVASC IMAG, V3, P164, DOI 10.1161/CIRCIMAGING.109.883652; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051; Langelaan DN, 2013, BBA-BIOMEMBRANES, V1828, P1471, DOI 10.1016/j.bbamem.2013.02.005; Lewis CJ, 2004, BRIT J PHARMACOL, V141, P813, DOI 10.1038/sj.bjp.0705668; Li Yong-Sheng, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P499; Li YS, 2009, J HUAZHONG U SCI-MED, V29, P476, DOI 10.1007/s11596-009-0417-5; Liao YH, 2012, J AM COLL CARDIOL, V59, P420, DOI 10.1016/j.jacc.2011.10.863; Martos R, 2009, EUR J HEART FAIL, V11, P191, DOI 10.1093/eurjhf/hfn036; Narine K, 2006, TISSUE ENG, V12, P2707, DOI 10.1089/ten.2006.12.2707; Qiao ZY, 2011, MOLECULES, V16, P10002, DOI 10.3390/molecules161210002; Sadoshima J, 2006, ANTIOXID REDOX SIGN, V8, P1621, DOI 10.1089/ars.2006.8.1621; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Shah A, 2012, AM J PHYSIOL-HEART C, V302, pH2372, DOI 10.1152/ajpheart.00846.2011; Song Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050436; Spinale FG, 2008, CIRCULATION, V118, pS16, DOI 10.1161/CIRCULATIONAHA.108.786640; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Suzuki T, 2008, J HYPERTENS, V26, P2436, DOI 10.1097/HJH.0b013e328312c889; Tan XY, 2011, INT J BIOL SCI, V7, P383, DOI 10.7150/ijbs.7.383; Tsai WC, 2011, VASC HEALTH RISK MAN, V7, P137, DOI 10.2147/VHRM.S11235; Wang P, 2011, PHARMAZIE, V66, P517, DOI 10.1691/ph.2011.0806; [王照华 Wang Zhaohua], 2009, [华中科技大学学报. 医学版, Acta Medicinae Universitatis Scientiae et Technologiae Huazhong], V38, P500; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Xu SW, 2013, EXPERT OPIN THER PAT, V23, P149, DOI 10.1517/13543776.2013.743995; Yang P, 2010, J TRADIT CHIN MED, V30, P259, DOI 10.1016/S0254-6272(10)60053-2; Zeng XJ, 2009, PEPTIDES, V30, P1144, DOI 10.1016/j.peptides.2009.02.010; Zhang Y, 2010, CELL PHYSIOL BIOCHEM, V26, P991, DOI 10.1159/000324012; Zhang Z, 2009, CHINESE MED J-PEKING, V122, P2360, DOI 10.3760/cma.j.issn.0366-6999.2009.19.031; Zhou Dai-Xing, 2008, Zhongguo Zhong Yao Za Zhi, V33, P936; Zile MR, 2008, CIRCULATION, V118, P1433, DOI 10.1161/CIRCULATIONAHA.108.783910	56	34	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92216	10.1371/journal.pone.0092216	http://dx.doi.org/10.1371/journal.pone.0092216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647357	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500098
J	Rathakrishnan, A; Klekamp, B; Wang, SM; Komarasamy, TV; Natkunam, SK; Sathar, J; Azizan, A; Sanchez-Anguiano, A; Manikam, R; Sekaran, SD				Rathakrishnan, Anusyah; Klekamp, Benjamin; Wang, Seok Mui; Komarasamy, Thamil Vaani; Natkunam, Santha Kumari; Sathar, Jameela; Azizan, Azliyati; Sanchez-Anguiano, Aurora; Manikam, Rishya; Sekaran, Shamala Devi			Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia	PLOS ONE			English	Article							T-CELL RESPONSES; HEMORRHAGIC-FEVER PATIENTS; DISEASE SEVERITY; VIRUS-INFECTIONS; SERUM-LEVELS; PROTEIN NS1; PATHOGENESIS; HLA; ASSOCIATIONS; EXPRESSION	Background: With its elusive pathogenesis, dengue imposes serious healthcare, economic and social burden on endemic countries. This study describes the clinical and immunological parameters of a dengue cohort in a Malaysian city, the first according to the WHO 2009 dengue classification. Methodology and Findings: This longitudinal descriptive study was conducted in two Malaysian hospitals where patients aged 14 and above with clinical symptoms suggestive of dengue were recruited with informed consent. Among the 504 participants, 9.3% were classified as non-dengue, 12.7% without warning signs, 77.0% with warning signs and 1.0% with severe dengue based on clinical diagnosis. Of these, 37% were misdiagnosed as non-dengue, highlighting the importance of both clinical diagnosis and laboratory findings. Thrombocytopenia, prolonged clotting time, liver enzymes, ALT and AST served as good markers for dengue progression but could not distinguish between patients with and without warning signs. HLA-A*24 and -B*57 were positively associated with Chinese and Indians patients with warning signs, respectively, whereas A*03 may be protective in the Malays. HLA-A*33 was also positively associated in patients with warning signs when compared to those without. Dengue NS1, NS2A, NS4A and NS4B were found to be important T cell epitopes; however with no apparent difference between with and without warning signs patients. Distinction between the 2 groups of patients was also not observed in any of the cytokines analyzed; nevertheless, 12 were significantly differentially expressed at the different phases of illness. Conclusion: The new dengue classification system has allowed more specific detection of dengue patients, however, none of the clinical parameters allowed distinction of patients with and without warning signs. While the HLA-A*33 may be predictive marker for development of warning signs; larger studies will be needed to support this findings.	[Rathakrishnan, Anusyah; Komarasamy, Thamil Vaani; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Klekamp, Benjamin; Azizan, Azliyati; Sanchez-Anguiano, Aurora] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL USA; [Wang, Seok Mui] Univ Teknol MARA, Fac Med, Inst Med Mol Biotechnol, Selangor, Malaysia; [Natkunam, Santha Kumari] Persiaran Tengku Ampuan Rahimah, Hosp Tengku Ampuan Rahimah, Klang, Selangor, Malaysia; [Sathar, Jameela] Hosp Ampang, Dept Hematol, Clin Hematol Lab, Ampang, Selangor, Malaysia; [Manikam, Rishya] Univ Malaya, Med Ctr, Dept Trauma & Emergency Med, Kuala Lumpur, Malaysia	Universiti Malaya; State University System of Florida; University of South Florida; Universiti Teknologi MARA; Universiti Malaya	Sekaran, SD (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamalamy@yahoo.com	Wang, Seok Mui/X-5856-2019; Sekaran, Shamala Devi/B-8482-2008; Manikam, Rishya/F-5908-2014; Rathakrishnan, Anusyah/K-4115-2014; Devi, Shamala Devi/B-9735-2010	Wang, Seok Mui/0000-0002-3631-6504; Sekaran, Shamala Devi/0000-0002-0478-0425; Rathakrishnan, Anusyah/0000-0002-5177-7624; Devi, Shamala Devi/0000-0002-0478-0425	University of Malaya [Vote PV050/2011A]; UM High Impact Research Grant UM-MOHE from the Ministry of Higher Education Malaysia [UM.C/625/1/HIR/MOHE/E-20001-00-E000053]	University of Malaya(Universiti Malaya); UM High Impact Research Grant UM-MOHE from the Ministry of Higher Education Malaysia	This research was supported by Vote PV050/2011A from the University of Malaya as well as UM High Impact Research Grant UM-MOHE UM.C/625/1/HIR/MOHE/E-20001-00-E000053 from the Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang K T, 2010, Med J Malaysia, V65, P58; Anker M, 2011, WEST PAC SURVEILL RE, V2, P17, DOI [10.5365/WPSAR.2011.2.1.002, 10.5365/wpsar.2011.2.1.002]; Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07; Appanna R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013029; Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Brown MG, 2011, W INDIAN MED J, V60, P126; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Cardier JE, 2006, ENDOTHELIUM-J ENDOTH, V13, P335, DOI 10.1080/10623320600972135; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x; Chaturvedi UC, 2006, FEMS IMMUNOL MED MIC, V47, P155, DOI 10.1111/j.1574-695X.2006.00058.x; Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142; Chuang YC, 2011, CYTOKINE, V54, P222, DOI 10.1016/j.cyto.2011.01.013; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Dussart P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001482; FALGOUT B, 1989, J VIROL, V63, P1852, DOI 10.1128/JVI.63.5.1852-1860.1989; Fernandez-Mestre M., 2009, Inmunologia, V28, P96; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Green SL, 1997, VET CLIN N AM-EQUINE, V13, P1; Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108; HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1; Halstead SB, 2012, PAEDIATR INT CHILD H, V32, P5, DOI 10.1179/2046904712Z.00000000045; Hottz E, 2011, DRUG DISCOVERY TODAY, V8, P33, DOI [10.1016/j. ddmec.2011.09.001, DOI 10.1016/J.DDMEC.2011.09.001]; Kalayanarooj Siripen, 2003, J Med Assoc Thai, V86 Suppl 3, pS673; Khongphatthanayothin A, 2006, JPN J INFECT DIS, V59, P186; Koraka P, 2004, J MED VIROL, V72, P445, DOI 10.1002/jmv.20007; Kumar Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001887; KUO CH, 1992, AM J TROP MED HYG, V47, P265, DOI 10.4269/ajtmh.1992.47.265; Kurane I, 1992, SEMIN IMMUNOL, V4, P121; LAM S K, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P532; Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304; Lee LK, 2011, ANN ACAD MED SINGAP, V40, P533; Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320; Malavige GN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020581; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; Matsuura C, 2012, T ROY SOC TROP MED H, V106, P174, DOI 10.1016/j.trstmh.2011.10.009; McNicholl J, 1998, EMERG INFECT DIS, V4, P423, DOI 10.3201/eid0403.980322; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Muhammad Azami Nor Azila, 2011, BMC Res Notes, V4, P216, DOI 10.1186/1756-0500-4-216; Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080; Priyadarshini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008709; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215; Reche PA, 2002, HUM IMMUNOL, V63, P701, DOI 10.1016/S0198-8859(02)00432-9; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Srikiatkhachorn A, 2010, CURR TOP MICROBIOL, V338, P67, DOI 10.1007/978-3-642-02215-9_6; Stephens HAF, 2010, CURR TOP MICROBIOL, V338, P99, DOI 10.1007/978-3-642-02215-9_8; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846; Vinomarlini G, 2011, SE ASIAN J TROP MED, V42, P94; Wanigasuriya K, 2012, USEFULNESS WHO DENGU; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2010, W PAC COUNTR HLTH IN; Yong Y. K., 2007, SMJ Singapore Medical Journal, V48, P662	59	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92021	10.1371/journal.pone.0092021	http://dx.doi.org/10.1371/journal.pone.0092021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647042	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500072
J	Wang, W; Cai, JY; Lin, Y; Liu, ZK; Ren, QH; Hu, L; Huang, Z; Guo, MX; Li, WX				Wang, Wei; Cai, Jinyang; Lin, Yi; Liu, Zikou; Ren, Qihao; Hu, Li; Huang, Zan; Guo, Mingxiong; Li, Wenxin			Zinc Fingers Function Cooperatively with KRAB Domain for Nuclear Localization of KRAB-Containing Zinc Finger Proteins	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; DNA-BINDING; GENE ZNF268; NUCLEOLAR LOCALIZATION; RNA-BINDING; KRUPPEL; SIGNALS; COREPRESSOR; REPRESSION; EXPRESSION	Multiple nuclear localization domains have been identified in nuclear proteins, and they finely control nuclear import and functions of those proteins. ZNF268 is a typical KRAB-containing zinc finger protein (KRAB-ZFP), and previous studies have shown that the KRAB domain reinforces nuclear localization of KRAB-ZFPs by interacting with KAP1. In this study, we find that some of 24 zinc fingers of ZNF268 also possess nuclear localization activity. Results of mutagenesis studies suggest that KRAB and zinc fingers are both necessary, and they function both independently and cooperatively for the nuclear localization of ZNF268. However, the subnuclear targeting activities of KRAB and zinc fingers are different. KRAB targets proteins in nucleoplasm, but not in the nucleolus, which is mediated by interaction with KAP1, while zinc fingers target proteins in the whole nucleus uniformly. The cooperative activities of KAP1-KRAB-zinc fingers result in the precise nucleoplasmic, but not nucleolar localization of KRAB-ZFPs. Our studies reveal a novel mechanism for the subcellular localization of KRAB-ZFPs and may help us to further explore their biological functions.	[Wang, Wei; Cai, Jinyang; Lin, Yi; Liu, Zikou; Ren, Qihao; Hu, Li; Guo, Mingxiong; Li, Wenxin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Huang, Zan] Wuhan Univ, Dept Biochem & Mol Biol, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Guo, MX (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	guomx@whu.edu.cn; liwxlab@whu.edu.cn	Cai, Jinyang/HCH-0290-2022; Ren, Qihao/HDN-5402-2022; LIN, YI/AAC-3335-2020	Ren, Qihao/0000-0001-5178-1829; LIN, YI/0000-0001-8209-1185; Liu, Zikou/0000-0002-0787-5083; Wang, Wei/0000-0002-6179-4188; Wang, Wei/0000-0001-7429-1013; Huang, Zan/0000-0001-5623-6950; Cai, Jinyang/0000-0002-7385-8281	National High Technology Research and Development Program of China (863 Program) [2006AA02A306]; National Natural Science Foundation of China [30871245, 31271511]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National High Technology Research and Development Program of China (863 Program) Grant 2006AA02A306, National Natural Science Foundation of China Grants 30871245 and 31271511. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; Birtle Z, 2006, BIOINFORMATICS, V22, P2841, DOI 10.1093/bioinformatics/btl498; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; Chun JN, 2008, MOL CELLS, V26, P175; Dai C, 2007, CELL MOL BIOL LETT, V12, P362, DOI 10.2478/s11658-007-0008-z; Do HJ, 2006, FEBS LETT, V580, P1865, DOI 10.1016/j.febslet.2006.02.049; Fernandez-Martinez J, 2003, J MOL BIOL, V334, P667, DOI 10.1016/j.jmb.2003.09.072; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gou DM, 2001, BBA-GENE STRUCT EXPR, V1518, P306, DOI 10.1016/S0167-4781(01)00194-4; Guo MX, 2006, J BIOL CHEM, V281, P24623, DOI 10.1074/jbc.M602753200; Hanover JA, 2007, J BIOL CHEM, V282, P33743, DOI 10.1074/jbc.M705875200; Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Ito T, 2009, BIOCHEM BIOPH RES CO, V380, P28, DOI 10.1016/j.bbrc.2008.12.165; Krackhardt AM, 2002, BLOOD, V100, P2123, DOI 10.1182/blood-2002-02-0513; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; Lam YW, 2005, J CELL SCI, V118, P1335, DOI 10.1242/jcs.01736; Liu MT, 1998, VIROLOGY, V247, P62, DOI 10.1006/viro.1998.9228; Luo M, 2004, TRAFFIC, V5, P847, DOI 10.1111/j.1600-0854.2004.00227.x; Lupo A, 2011, INT J BIOCHEM CELL B, V43, P470, DOI 10.1016/j.biocel.2010.12.020; MAEDA Y, 1992, EMBO J, V11, P3695, DOI 10.1002/j.1460-2075.1992.tb05454.x; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; MATHENY C, 1994, J BIOL CHEM, V269, P8176; Medugno L, 2007, GENE, V403, P125, DOI 10.1016/j.gene.2007.07.036; Michael WM, 1996, J BIOL CHEM, V271, P11571, DOI 10.1074/jbc.271.19.11571; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Russo G, 1997, J BIOL CHEM, V272, P5229, DOI 10.1074/jbc.272.8.5229; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; SCHUH R, 1986, CELL, V47, P1025, DOI 10.1016/0092-8674(86)90817-2; Shao HJ, 2006, INT J MOL MED, V18, P457; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Sun Y, 2004, INT J MOL MED, V14, P971; Sun Y, 2003, IUBMB LIFE, V55, P127, DOI 10.1080/1521654031000110208; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wang D, 2008, J BIOL CHEM, V283, P16299, DOI 10.1074/jbc.M706426200; Wang W, 2013, CELL MOL LIFE SCI, V70, P3947, DOI 10.1007/s00018-013-1359-4; Wang W, 2012, J BIOL CHEM, V287, P42856, DOI 10.1074/jbc.M112.399923; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029518; Zhao ZZ, 2008, ONCOL REP, V20, P1243, DOI 10.3892/or_00000136	42	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92155	10.1371/journal.pone.0092155	http://dx.doi.org/10.1371/journal.pone.0092155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647005	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500091
J	Yang, F; Zheng, TP; Gao, Y; Baskota, A; Chen, T; Ran, XW; Tian, HM				Yang, Fan; Zheng, Tianpeng; Gao, Yun; Baskota, Attit; Chen, Tao; Ran, Xingwu; Tian, Haoming			Increased Plasma DPP4 Activity Is an Independent Predictor of the Onset of Metabolic Syndrome in Chinese over 4 Years: Result from the China National Diabetes and Metabolic Disorders Study	PLOS ONE			English	Article							AMIDE	Aims: To determine whether fasting plasma Dipeptidyl Peptidase 4 (DPP4) activity and active Glucagon-Like Peptide-1 (GLP-1) were predictive of the onset of metabolic syndrome. Methods: A prospective cohort study was conducted of 2042 adults (863 men and 1,179 women) aged 18-70 years without metabolic syndrome examined in 2007(baseline) and 2011(follow-up). Baseline plasma DPP4 activity was determined as the rate of cleavage of 7-amino-4-methylcoumarin (AMC) from the synthetic substrate H-glycyl-prolyl-AMC and active GLP-1 was determined by enzymoimmunoassay. Results: During an average of 4 years of follow-up, 131 men (15.2%) and 174 women (14.8%) developed metabolic syndrome. In multiple linear regression analysis, baseline DPP4 activity was an independent predictor of an increase in insulin resistance over a 4-year period (P<0.01). In multivariable-adjusted models, the odds ratio (OR) for incident metabolic syndrome comparing the highest with the lowest quartiles of DPP4 activity and active GLP-1 were 2.82, 0.45 for men and 2.48, 0.36 for women respectively. Furthermore, plasma DPP4 activity significantly improved the area under the ROC curve for predicting new-onset metabolic syndrome based on information from metabolic syndrome components (Both P<0.01). Conclusions: DPP4 activity is an important predictor of the onset of insulin resistance and metabolic syndrome in apparently healthy Chinese men and women. This finding may have important implications for understanding the aetiology of metabolic syndrome.	[Yang, Fan; Zheng, Tianpeng; Gao, Yun; Baskota, Attit; Chen, Tao; Ran, Xingwu; Tian, Haoming] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu, Sichuan, Peoples R China; [Yang, Fan; Zheng, Tianpeng] Guilin Med Univ, Affiliated Hosp, Dept Endocrinol & Metab, Guangxi, Peoples R China	Sichuan University; Guilin Medical University	Tian, HM (corresponding author), Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu, Sichuan, Peoples R China.	w19831120@126.com			Chinese Medical Association Foundation; Chinese Diabetes Society [07020470055]	Chinese Medical Association Foundation; Chinese Diabetes Society	This study was supported by grants from the Chinese Medical Association Foundation and Chinese Diabetes Society (No. 07020470055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Kirino Y, 2012, ENDOCR J, V59, P949, DOI 10.1507/endocrj.EJ12-0158; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Li L, 2005, DIABETOLOGIA, V48, P1339, DOI 10.1007/s00125-005-1787-2; Luepker R. V., 2004, CARDIOVASCULAR SURVE; Matteucci E, 2009, CURR MED CHEM, V16, P2943, DOI 10.2174/092986709788803114; ORSKOV C, 1993, DIABETES, V42, P658, DOI 10.2337/diabetes.42.5.658; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Sell H, 2006, TRENDS ENDOCRIN MET, V17, P416, DOI 10.1016/j.tem.2006.10.010; von Bibra H, 2010, DIABETOLOGIA, V53, P1033, DOI 10.1007/s00125-010-1682-3; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang J, 2007, DIABETOLOGIA, V50, P1900, DOI 10.1007/s00125-007-0737-6	13	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92222	10.1371/journal.pone.0092222	http://dx.doi.org/10.1371/journal.pone.0092222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647445	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500100
J	Yi, XF; Zhang, MM; Bartlow, AW; Dong, Z				Yi, Xianfeng; Zhang, Mingming; Bartlow, Andrew W.; Dong, Zhong			Incorporating Cache Management Behavior into Seed Dispersal: The Effect of Pericarp Removal on Acorn Germination	PLOS ONE			English	Article							PEROMYSCUS-LEUCOPUS; PIGNUT HICKORY; WEEVIL LARVAE; OAK; PREDATION; SQUIRRELS; SURVIVAL; INFESTATION; MAMMALS; RODENTS	Selecting seeds for long-term storage is a key factor for food hoarding animals. Siberian chipmunks (Tamias sibiricus) remove the pericarp and scatter hoard sound acorns of Quercus mongolica over those that are insect-infested to maximize returns from caches. We have no knowledge of whether these chipmunks remove the pericarp from acorns of other species of oaks and if this behavior benefits seedling establishment. In this study, we tested whether Siberian chipmunks engage in this behavior with acorns of three other Chinese oak species, Q. variabilis, Q. aliena and Q. serrata var. brevipetiolata, and how the dispersal and germination of these acorns are affected. Our results show that when chipmunks were provided with sound and infested acorns of Quercus variabilis, Q. aliena and Q. serrata var. brevipetiolata, the two types were equally harvested and dispersed. This preference suggests that Siberian chipmunks are incapable of distinguishing between sound and insect-infested acorns. However, Siberian chipmunks removed the pericarp from acorns of these three oak species prior to dispersing and caching them. Consequently, significantly more sound acorns were scatter hoarded and more infested acorns were immediately consumed. Additionally, indoor germination experiments showed that pericarp removal by chipmunks promoted acorn germination while artificial removal showed no significant effect. Our results show that pericarp removal allows Siberian chipmunks to effectively discriminate against insect-infested acorns and may represent an adaptive behavior for cache management. Because of the germination patterns of pericarp-removed acorns, we argue that the foraging behavior of Siberian chipmunks could have potential impacts on the dispersal and germination of acorns from various oak species.	[Yi, Xianfeng] Jiangxi Normal Univ, Coll Life Sci, Nanchang, Jiangxi, Peoples R China; [Yi, Xianfeng; Zhang, Mingming; Dong, Zhong] Henan Univ Sci & Technol, Coll Agr, Luoyang, Henan, Peoples R China; [Bartlow, Andrew W.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Jiangxi Normal University; Henan University of Science & Technology; Utah System of Higher Education; University of Utah	Yi, XF (corresponding author), Jiangxi Normal Univ, Coll Life Sci, Nanchang, Jiangxi, Peoples R China.	yxfeng1975@126.com	Bartlow, Andrew/J-5435-2019	Bartlow, Andrew/0000-0002-1254-4481	Natural Science Foundation of China [31172101]; Program for New Century Excellent Talents in University [NCET-12-0693]; State Key Laboratory of Integrated Management of Pest Insects and Rodents [ChineseIPM1404]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory of Integrated Management of Pest Insects and Rodents	This work was funded by the Natural Science Foundation of China (No. 31172101), the Program for New Century Excellent Talents in University (NCET-12-0693) and the State Key Laboratory of Integrated Management of Pest Insects and Rodents (ChineseIPM1404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN DC, 1993, J MAMMAL, V74, P656, DOI 10.2307/1382287; ANDERSSON C, 1992, FOREST ECOL MANAG, V50, P247, DOI 10.1016/0378-1127(92)90339-B; AUGSPURGER CK, 1984, ECOLOGY, V65, P1705, DOI 10.2307/1937766; Barcelos AR, 2013, INTEGR ZOOL, V8, P63, DOI 10.1111/1749-4877.12003; BARNETT RJ, 1977, AM MIDL NAT, V98, P319, DOI 10.2307/2424983; Brancalion PHS, 2011, BIOTROPICA, V43, P12, DOI 10.1111/j.1744-7429.2010.00726.x; Branco M, 2002, FOREST ECOL MANAG, V166, P159, DOI 10.1016/S0378-1127(01)00669-7; Capece PI, 2013, INTEGR ZOOL, V8, P57, DOI 10.1111/j.1749-4877.2012.00313.x; Cheng JR, 2011, CURR ZOOL, V57, P50, DOI 10.1093/czoolo/57.1.50; Crawley M. J., 2000, Seeds: the ecology of regeneration in plant communities, P167, DOI 10.1079/9780851994321.0167; Dixon MD, 1997, OECOLOGIA, V111, P201, DOI 10.1007/s004420050226; DORSEY CK, 1962, J ECON ENTOMOL, V55, P885, DOI 10.1093/jee/55.6.885; Emery NJ, 2004, ANIM COGN, V7, P37, DOI 10.1007/s10071-003-0178-7; FOX JF, 1982, EVOLUTION, V36, P800, DOI 10.2307/2407893; Fukumoto H., 2000, J FOREST RES, V5, P31, DOI [10.1007/BF02762760, DOI 10.1007/BF02762760]; Galvez D, 2007, J TROP ECOL, V23, P381, DOI 10.1017/S0266467407003975; Hou XG, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010036; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Hulme Philip E., 2002, P132; JOHNSON WC, 1985, AM MIDL NAT, V113, P319, DOI 10.2307/2425577; Kitajima K., 2000, Seeds: the ecology of regeneration in plant communities, P331, DOI 10.1079/9780851994321.0331; Lai X, 2014, INTEGR ZOOL, V9, P246, DOI 10.1111/1749-4877.12046; Leiva MJ, 2005, FOREST ECOL MANAG, V212, P221, DOI 10.1016/j.foreco.2005.03.036; Li HJ, 2007, FOREST ECOL MANAG, V242, P511, DOI 10.1016/j.foreco.2007.01.063; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047682; Livoreil B, 1996, ETHOL ECOL EVOL, V8, P199, DOI 10.1080/08927014.1996.9522929; Meng LZ, 2012, INTEGR ZOOL, V7, P30, DOI [10.1111/j.1749-4877.2012.00273.x, 10.1111/j.1749-4877.2011.00275.x]; Munoz A, 2008, BEHAV ECOL SOCIOBIOL, V62, P913, DOI 10.1007/s00265-007-0515-y; NIXON CM, 1968, J WILDLIFE MANAGE, V32, P294, DOI 10.2307/3798974; O'Farrill G, 2013, INTEGR ZOOL, V8, P4, DOI 10.1111/j.1749-4877.2012.00316.x; Perea R, 2011, J ECOL, V99, P194, DOI 10.1111/j.1365-2745.2010.01749.x; PETERSON JK, 1983, ANN BOT-LONDON, V52, P81, DOI 10.1093/oxfordjournals.aob.a086555; R Development Core Team, 2012, R LANG ENV STAT COMP; REICHMAN OJ, 1988, ANIM BEHAV, V36, P1525, DOI 10.1016/S0003-3472(88)80223-9; Schroder T., 2002, Dendrobiology, V47, P13; SEMEL B, 1988, AM MIDL NAT, V119, P385, DOI 10.2307/2425821; Silvius KM, 2002, J TROP ECOL, V18, P707, DOI 10.1017/S0266467402002468; SMITH CC, 1984, ANNU REV ECOL SYST, V15, P329, DOI 10.1146/annurev.es.15.110184.001553; SORK VL, 1977, OECOLOGIA, V28, P289, DOI 10.1007/BF00751606; SORK VL, 1983, ECOLOGY, V64, P1049, DOI 10.2307/1937813; SORK VL, 1987, ECOLOGY, V68, P1341, DOI 10.2307/1939218; Steele MA, 2001, J MAMMAL, V82, P35, DOI 10.1644/1545-1542(2001)082&lt;0035:CMBSME&gt;2.0.CO;2; Steele MA, 1996, J MAMMAL, V77, P305, DOI 10.2307/1382802; Takahashi A, 2010, FOREST PATHOL, V40, P96, DOI 10.1111/j.1439-0329.2009.00612.x; Terborgh J., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P1, DOI 10.1079/9780851995250.0001; WECKERLY FW, 1989, AM MIDL NAT, V122, P412, DOI 10.2307/2425929; WINSTON PW, 1956, ECOLOGY, V37, P120, DOI 10.2307/1929675; Xiao Zhishu, 2003, Acta Theriologica Sinica, V23, P312; Xiao ZS, 2006, FOREST ECOL MANAG, V222, P46, DOI 10.1016/j.foreco.2005.10.020; Yang YQ, 2012, PLANT ECOL, V213, P197, DOI 10.1007/s11258-011-0016-y; Yi XF, 2008, PHOTOSYNTHETICA, V46, P139, DOI 10.1007/s11099-008-0022-z; Yi XF, 2010, PLANT ECOL, V209, P291, DOI 10.1007/s11258-010-9730-0; Yi XF, 2012, ETHOLOGY, V118, P87, DOI 10.1111/j.1439-0310.2011.01989.x; Zhang HM, 2007, THESIS BEIJING GRADU	54	11	12	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92544	10.1371/journal.pone.0092544	http://dx.doi.org/10.1371/journal.pone.0092544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647670	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500142
J	Zhang, GS; Sun, HJ				Zhang, Gaosen; Sun, Henry J.			Racemization in Reverse: Evidence that D-Amino Acid Toxicity on Earth Is Controlled by Bacteria with Racemases	PLOS ONE			English	Article							D-ASPARTATE OXIDASE; PHYSIOLOGICAL-ROLE; ALANINE RACEMASE; RHODOTORULA-GRACILIS; CANDIDA-BOIDINII; ORGANIC NITROGEN; SOILS; YEAST; DETOXIFICATION; PEPTIDOGLYCAN	D-amino acids are toxic for life on Earth. Yet, they form constantly due to geochemical racemization and bacterial growth (the cell walls of which contain D-amino acids), raising the fundamental question of how they ultimately are recycled. This study provides evidence that bacteria use D-amino acids as a source of nitrogen by running enzymatic racemization in reverse. Consequently, when soils are inundated with racemic amino acids, resident bacteria consume D-as well as L-enantiomers, either simultaneously or sequentially depending on the level of their racemase activity. Bacteria thus protect life on Earth by keeping environments D-amino acid free.	[Zhang, Gaosen; Sun, Henry J.] Desert Res Inst, Div Earth & Ecosyst Sci, Las Vegas, NV 89512 USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Sun, HJ (corresponding author), Desert Res Inst, Div Earth & Ecosyst Sci, Las Vegas, NV 89512 USA.	henry.sun@dri.edu		zhang, gao sen/0000-0002-1144-6919	NASA Exobiology program; NASA Astrobiology Institute	NASA Exobiology program(National Aeronautics & Space Administration (NASA)); NASA Astrobiology Institute	The funding for this work was provided by the NASA Exobiology program and the NASA Astrobiology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDAG RW, 1970, AGRON J, V62, P184, DOI 10.2134/agronj1970.00021962006200020002x; Amelung W, 2006, GEODERMA, V130, P207, DOI 10.1016/j.geoderma.2005.01.017; Amelung W, 2003, J PLANT NUTR SOIL SC, V166, P677, DOI 10.1002/jpln.200321274; BADA JL, 1982, INTERDISCIPL SCI REV, V7, P30, DOI 10.1179/030801882789801304; BADA JL, 1979, NATURE, V282, P822, DOI 10.1038/282822a0; Brinton KLF, 2002, ASTROBIOLOGY, V2, P77, DOI 10.1089/153110702753621358; DANIELLO A, 1993, J BIOL CHEM, V268, P26941; Dittmar T, 2001, GEOCHIM COSMOCHIM AC, V65, P4103, DOI 10.1016/S0016-7037(01)00688-3; Drechsel H, 1998, J PEPT SCI, V4, P147, DOI 10.1002/(SICI)1099-1387(199805)4:3<147::AID-PSC136>3.0.CO;2-C; Forsum O, 2008, NEW PHYTOL, V179, P1058, DOI 10.1111/j.1469-8137.2008.02546.x; Friedman M, 2012, METHODS MOL BIOL, V794, P337, DOI 10.1007/978-1-61779-331-8_23; Gabler M, 1999, APPL ENVIRON MICROB, V65, P3750; GRIFFIN CV, 1988, AUST J SOIL RES, V26, P531, DOI 10.1071/SR9880531; KIMBER RWL, 1994, AUST J EARTH SCI, V41, P19, DOI 10.1080/08120099408728109; LARUE TA, 1967, CAN J MICROBIOL, V13, P777, DOI 10.1139/m67-103; LEE C, 1977, LIMNOL OCEANOGR, V22, P502, DOI 10.4319/lo.1977.22.3.0502; Lester ED, 2007, SOIL BIOL BIOCHEM, V39, P704, DOI 10.1016/j.soilbio.2006.09.020; Lomstein BA, 2006, GEOCHIM COSMOCHIM AC, V70, P2970, DOI 10.1016/j.gca.2006.03.015; Martinez-Rodriguez S, 2010, CHEM BIODIVERS, V7, P1531, DOI 10.1002/cbdv.200900245; McCarthy MD, 1998, SCIENCE, V281, P231, DOI 10.1126/science.281.5374.231; Moore BC, 2005, J BACTERIOL, V187, P972, DOI 10.1128/JB.187.3.972-979.2005; Nagata T, 2003, LIMNOL OCEANOGR, V48, P745, DOI 10.4319/lo.2003.48.2.0745; Pedersen AGU, 2001, LIMNOL OCEANOGR, V46, P1358, DOI 10.4319/lo.2001.46.6.1358; PEROTTI ME, 1991, EUR J CELL BIOL, V55, P104; Peypoux F, 1999, APPL MICROBIOL BIOT, V51, P553, DOI 10.1007/s002530051432; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; PUCCI MJ, 1995, J BACTERIOL, V177, P336, DOI 10.1128/jb.177.2.336-342.1995; ROGERS HJ, 1974, ANN NY ACAD SCI, V235, P29, DOI 10.1111/j.1749-6632.1974.tb43255.x; SIKORA L, 1982, MOL GEN GENET, V186, P33, DOI 10.1007/BF00422908; SIMONETTA MP, 1989, J GEN MICROBIOL, V135, P593; Smith HD, 2012, ASTROBIOLOGY, V12, P247, DOI 10.1089/ast.2010.0549; Takahashi S, 2005, YEAST, V22, P1203, DOI 10.1002/yea.1303; Uo T, 2001, J BACTERIOL, V183, P2226, DOI 10.1128/JB.183.7.2226-2233.2001; Veuger B, 2006, LIMNOL OCEANOGR, V51, P1572, DOI 10.4319/lo.2006.51.4.1572; VOLLMER A T, 1977, Great Basin Naturalist, V37, P81; WASSERMAN SA, 1983, J BACTERIOL, V153, P1439, DOI 10.1128/JB.153.3.1439-1450.1983; Yoshimura T, 2003, J BIOSCI BIOENG, V96, P103, DOI 10.1016/S1389-1723(03)90111-3; Yow GY, 2006, ARCH MICROBIOL, V185, P39, DOI 10.1007/s00203-005-0060-x; Yurimoto H, 2000, YEAST, V16, P1217; Yurimoto H, 2001, BIOSCI BIOTECH BIOCH, V65, P627, DOI 10.1271/bbb.65.627; ZHAO MX, 1995, J CHROMATOGR A, V690, P55, DOI 10.1016/0021-9673(94)00927-2	41	42	42	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92101	10.1371/journal.pone.0092101	http://dx.doi.org/10.1371/journal.pone.0092101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647559	Green Submitted, gold, Green Published			2022-12-27	WOS:000333348500085
J	Bilano, VL; Ota, E; Ganchimeg, T; Mori, R; Souza, JP				Bilano, Ver Luanni; Ota, Erika; Ganchimeg, Togoobaatar; Mori, Rintaro; Souza, Joao Paulo			Risk Factors of Pre-Eclampsia/Eclampsia and Its Adverse Outcomes in Low- and Middle-Income Countries: A WHO Secondary Analysis	PLOS ONE			English	Article							PREECLAMPSIA; MORTALITY; HEALTH; WOMEN; CARE	Background: Pre-eclampsia has an immense adverse impact on maternal and perinatal health especially in low-and middle-income settings. We aimed to estimate the associations between pre-eclampsia/eclampsia and its risk factors, and adverse maternal and perinatal outcomes. Methods: We performed a secondary analysis of the WHO Global Survey on Maternal and Perinatal Health. The survey was a multi-country, facility-based cross-sectional study. A global sample consisting of 24 countries from three regions and 373 health facilities was obtained via a stratified multi-stage cluster sampling design. Maternal and offspring data were extracted from records using standardized questionnaires. Multi-level logistic regression modelling was conducted with random effects at the individual, facility and country levels. Results: Data for 276,388 mothers and their infants was analysed. The prevalence of pre-eclampsia/eclampsia in the study population was 10,754 (4%). At the individual level, sociodemographic characteristics of maternal age >= 30 years and low educational attainment were significantly associated with higher risk of pre-eclampsia/eclampsia. As for clinical and obstetric variables, high body mass index (BMI), nulliparity (AOR: 2.04; 95% CI 1.92-2.16), absence of antenatal care (AOR: 1.41; 95% CI 1.26-1.57), chronic hypertension (AOR: 7.75; 95% CI 6.77-8.87), gestational diabetes (AOR: 2.00; 95% CI 1.63-2.45), cardiac or renal disease (AOR: 2.38; 95% CI 1.86-3.05), pyelonephritis or urinary tract infection (AOR: 1.13; 95% CI 1.03-1.24) and severe anemia (AOR: 2.98; 95% CI 2.47-3.61) were found to be significant risk factors, while having >8 visits of antenatal care was protective (AOR: 0.90; 95% CI 0.83-0.98). Pre-eclampsia/eclampsia was found to be a significant risk factor for maternal death, perinatal death, preterm birth and low birthweight. Conclusion: Chronic hypertension, obesity and severe anemia were the highest risk factors of preeclampsia/eclampsia. Implementation of effective interventions prioritizing risk factors, provision of quality health services during pre-pregnancy and during pregnancy for joint efforts in the areas of maternal health are recommended.	[Bilano, Ver Luanni] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Ota, Erika; Ganchimeg, Togoobaatar; Mori, Rintaro] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Souza, Joao Paulo] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	University of Tokyo; National Center for Child Health & Development - Japan; World Health Organization	Ota, E (corresponding author), Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan.	e-i@umin.ac.jp	Souza, João Paulo/G-1982-2010	Souza, João Paulo/0000-0002-2288-4244; Bilano, Ver/0000-0002-1220-6220; Ota, Erika/0000-0002-3945-7441; Mori, Rintaro/0000-0001-7656-6156	UNDP/UNFPA/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP); Department of Reproductive Health and Research (RHR); Ministry of Health, Labor and Welfare of Japan; United States Agency for International Development (USAID); Ministry of Public Health, Beijing, China; Indian Council of Medical Research, Delhi, India; Grants-in-Aid for Scientific Research [24790612] Funding Source: KAKEN	UNDP/UNFPA/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP); Department of Reproductive Health and Research (RHR); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Ministry of Public Health, Beijing, China; Indian Council of Medical Research, Delhi, India(Indian Council of Medical Research (ICMR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by the UNDP/UNFPA/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP); Department of Reproductive Health and Research (RHR); Ministry of Health, Labor and Welfare of Japan; the United States Agency for International Development (USAID); Ministry of Public Health, Beijing, China; and Indian Council of Medical Research, Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman E, 2007, NEONATAL PERINATAL M; Ali Abdelaziem A, 2011, BMC Res Notes, V4, P311, DOI 10.1186/1756-0500-4-311; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bygbjerg IC, 2012, SCIENCE, V337, P1499, DOI 10.1126/science.1223466; Conde-Agudelo A, 2000, BRIT J OBSTET GYNAEC, V107, P75, DOI 10.1111/j.1471-0528.2000.tb11582.x; Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040; Countdown Coverage Writing G, 2008, LANCET, V371, P1247; Dowswell T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000934.pub2; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Haelterman E, 2003, EUR J OBSTET GYN R B, V111, P25, DOI 10.1016/S0301-2115(03)00161-1; Jammeh A., 2011, OPEN J OBSTETR GYNEC, V01, P94, DOI [10.4236/ojog.2011.13017, DOI 10.4236/OJOG.2011.13017]; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lee CJ, 2000, INT J GYNECOL OBSTET, V70, P327, DOI 10.1016/S0020-7292(00)00240-X; Lopez-Jaramillo P, 2005, J HYPERTENS, V23, P1121, DOI 10.1097/01.hjh.0000170371.49010.4a; Lopez-Jaramillo P, 2009, COLOMB MEDICA, V40, P226; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Reyes LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041622; Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Villar J, 2009, BJOG-INT J OBSTET GY, V116, P780, DOI 10.1111/j.1471-0528.2009.02158.x; WHO, 2004, LOW BIRTHW COUNTR RE; *WORLD BANK GROUP, 2012, WE CLASS COUNTR	23	175	185	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91198	10.1371/journal.pone.0091198	http://dx.doi.org/10.1371/journal.pone.0091198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24657964	Green Published, gold			2022-12-27	WOS:000333355300026
J	Bertness, MD; Brisson, CP; Bevil, MC; Crotty, SM				Bertness, Mark D.; Brisson, Caitlin P.; Bevil, Matthew C.; Crotty, Sinead M.			Herbivory Drives the Spread of Salt Marsh Die-Off	PLOS ONE			English	Article							CONSUMER CONTROL; CRAB HERBIVORY; DIEBACK; EUTROPHICATION; DEGRADATION; COLLAPSE	Salt marsh die-off is a Western Atlantic conservation problem that has recently spread into Narragansett Bay, Rhode Island, USA. It has been hypothesized to be driven by: 1) eutrophication decreasing plant investment into belowground biomass causing plant collapse, 2) boat wakes eroding creek banks, 3) pollution or disease affecting plant health, 4) substrate hardness controlling herbivorous crab distributions and 5) trophic dysfunction releasing herbivorous crabs from predator control. To distinguish between these hypotheses we quantified these variables at 14 Narragansett Bay salt marshes where die-off intensity ranged from <5% to nearly 98%. Nitrogen availability, wave intensity and plant growth did not explain any variation in die-off. Herbivory explained 73% of inter-site variation in die-off and predator control of herbivores and substrate hardness also varied significantly with die-off. This suggests that salt marsh die-off is being largely driven by intense herbivory via the release of herbivorous crabs from predator control. Our results and those from other marsh systems suggest that consumer control may not simply be a factor to consider in marsh conservation, but with widespread predator depletion impacting near shore habitats globally, trophic dysfunction and runaway consumption may be the largest and most urgent management challenge for salt marsh conservation.	[Bertness, Mark D.; Brisson, Caitlin P.; Bevil, Matthew C.; Crotty, Sinead M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Brown University	Bertness, MD (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	Mark_Bertness@brown.edu		Brisson, Caitlin/0000-0001-8567-1863	National Science Foundation Biological Oceanography Program [BIO OCE-0927090]; Brown University Undergraduate Teaching and Research Award Program; Voss Environmental Fellowship Program	National Science Foundation Biological Oceanography Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Brown University Undergraduate Teaching and Research Award Program; Voss Environmental Fellowship Program	This research was made possible by a grant from the National Science Foundation Biological Oceanography Program BIO OCE-0927090, the Brown University Undergraduate Teaching and Research Award Program, and the Voss Environmental Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber M, 2008, ESTUAR COAST SHELF S, V80, P1, DOI 10.1016/j.ecss.2008.08.009; Alberti J, 2008, ECOLOGY, V89, P155, DOI 10.1890/07-0045.1; Altieri AH, 2012, ECOLOGY, V93, P1402, DOI 10.1890/11-1314.1; Anisfeld SC, 2012, ESTUAR COAST, V35, P201, DOI 10.1007/s12237-011-9440-4; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bertness MD, 2008, CONSERV BIOL, V22, P618, DOI 10.1111/j.1523-1739.2008.00962.x; Bertness MD, 2008, CONSERV BIOL, V22, P131, DOI 10.1111/j.1523-1739.2007.00801.x; Bertness MD, 2009, ECOLOGY, V90, P2108, DOI 10.1890/08-1396.1; Bertness MD, 2002, P NATL ACAD SCI USA, V99, P1395, DOI 10.1073/pnas.022447299; BERTNESS MD, 1988, ECOLOGY, V69, P703, DOI 10.2307/1941018; Coverdale TC, 2013, FRONT ECOL ENVIRON, V11, P69, DOI 10.1890/120130; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; Elmer WH, 2013, PLANT DIS, V97, P436, DOI 10.1094/PDIS-09-12-0871-FE; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; HINES AH, 1982, MAR BIOL, V69, P309, DOI 10.1007/BF00397496; Holdredge C, 2009, CONSERV BIOL, V23, P672, DOI 10.1111/j.1523-1739.2008.01137.x; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jefferies RL, 2006, J ECOL, V94, P234, DOI 10.1111/j.1365-2745.2005.01086.x; Kiehn WM, 2009, WETLANDS, V29, P818, DOI 10.1672/08-178.1; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Mendelssohn IA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P59; ODUM E P, 1971, P574; Ogburn MB, 2006, ESTUAR COAST, V29, P54, DOI 10.1007/BF02784698; OLMI EJ, 1983, J CRUSTACEAN BIOL, V3, P575; Randelli G., 2011, LNAI, V6556, P278; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; SMITH JP, 2007, SURVEY POTENTIAL MAR; VALIELA I, 1995, MARINE ECOLOGICAL PR, V2; Wigley S. E., 2003, NMFSNE171 NOAA; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; YUND PO, 1991, LIMNOL OCEANOGR, V36, P1167, DOI 10.4319/lo.1991.36.6.1167	32	42	43	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92916	10.1371/journal.pone.0092916	http://dx.doi.org/10.1371/journal.pone.0092916			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651837	Green Submitted, gold, Green Published			2022-12-27	WOS:000333352800165
J	Chan, KP; Wong, CM; Chiu, SSS; Chan, KH; Wang, XL; Chan, ELY; Peiris, JSM; Yang, L				Chan, King Pan; Wong, Chit Ming; Chiu, Susan S. S.; Chan, Kwok Hung; Wang, Xi Ling; Chan, Eunice L. Y.; Peiris, J. S. Malik; Yang, Lin			A Robust Parameter Estimation Method for Estimating Disease Burden of Respiratory Viruses	PLOS ONE			English	Article							INFLUENZA-ASSOCIATED MORTALITY; SYNCYTIAL VIRUS; HONG-KONG; INFECTIOUS-DISEASES; SEASONAL INFLUENZA; ELDERLY PERSONS; UNITED-STATES; TIME-SERIES; HOSPITALIZATION; CHILDREN	Background: Poisson model has been widely applied to estimate the disease burden of influenza, but there has been little success in providing reliable estimates for other respiratory viruses. Methods: We compared the estimates of excess hospitalization rates derived from the Poisson models with different combinations of inference methods and virus proxies respectively, with the aim to determine the optimal modeling approach. These models were validated by comparing the estimates of excess hospitalization attributable to respiratory viruses with the observed rates of laboratory confirmed paediatric hospitalization for acute respiratory infections obtained from a population based study. Results: The Bayesian inference method generally outperformed the classical likelihood estimation, particularly for RSV and parainfluenza, in terms of providing estimates closer to the observed hospitalization rates. Compared to the other proxy variables, age-specific positive counts provided better estimates for influenza, RSV and parainfluenza, regardless of inference methods. The Bayesian inference combined with age-specific positive counts also provided valid and reliable estimates for excess hospitalization associated with multiple respiratory viruses in both the 2009 H1N1 pandemic and interpandemic period. Conclusions: Poisson models using the Bayesian inference method and virus proxies of age-specific positive counts should be considered in disease burden studies on multiple respiratory viruses.	[Chan, King Pan; Wong, Chit Ming; Wang, Xi Ling; Peiris, J. S. Malik; Yang, Lin] Univ Hong Kong, Sch Publish Hlth, Hong Kong, Hong Kong, Peoples R China; [Chiu, Susan S. S.; Chan, Eunice L. Y.] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Kwok Hung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Peiris, J. S. Malik] HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Yang, Lin] Hong Kong Polytech Univ, Sch Nursing, Squina Int Ctr Infect Control, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Hong Kong Polytechnic University	Wong, CM (corresponding author), Univ Hong Kong, Sch Publish Hlth, Hong Kong, Hong Kong, Peoples R China.	hrmrwcm@hku.hk; ssschiu@hkucc.hku.hk	Chan, Kwok Hung/ABD-5399-2021; YANG, Lin/F-9601-2014; Peiris, Joseph Sriyal Malik/C-4380-2009	YANG, Lin/0000-0002-5964-3233; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995	Research Fund for the Control of Infectious Diseases [RFCID 11100582]; Area of Excellence Scheme of the University Grants Committee of the Hong Kong Special Administrative Region Government [AoE/M-12/06]	Research Fund for the Control of Infectious Diseases; Area of Excellence Scheme of the University Grants Committee of the Hong Kong Special Administrative Region Government	This work was supported by the Research Fund for the Control of Infectious Diseases [RFCID 11100582] and the Area of Excellence Scheme of the University Grants Committee [AoE/M-12/06] of the Hong Kong Special Administrative Region Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl J, 2011, P NATL ACAD SCI USA, V108, P19359, DOI 10.1073/pnas.1109314108; Belongia EA, 2010, JAMA-J AM MED ASSOC, V304, P1091, DOI 10.1001/jama.2010.1277; Birrell PJ, 2011, P NATL ACAD SCI USA, V108, P18238, DOI 10.1073/pnas.1103002108; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Charu V, 2013, INFLUENZA OTHER RESP; Chiu SS, 2009, CLIN INFECT DIS, V49, P1016, DOI 10.1086/605570; Christensen R, 2011, BAYESIAN IDEAS DATA; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Engelhard D, 2011, EMERG INFECT DIS, V17, P1740, DOI 10.3201/eid1709.102022; Fleming DM, 2007, EPIDEMIOL INFECT, V135, P1099, DOI 10.1017/S0950268807007881; Foppa IM, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-26; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hernandez JE, 2012, INFLUENZA OTHER RESP, V6, P305, DOI 10.1111/j.1750-2659.2011.00303.x; Hui SL, 2006, VACCINE, V24, P5371, DOI 10.1016/j.vaccine.2006.04.032; Karageorgopoulos D. E., 2011, PLoS ONE, pe21690, DOI 10.1371/journal.pone.0021690; Lemaitre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045051; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Munoz Flor M, 2003, Paediatr Respir Rev, V4, P99, DOI 10.1016/S1526-0542(03)00027-7; Newall AT, 2010, EPIDEMIOL INFECT, V138, P836, DOI 10.1017/S095026880999118X; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Redlberger-Fritz M, 2012, EUR J EPIDEMIOL, V27, P567, DOI 10.1007/s10654-012-9701-y; Song XY, 2012, INFLUENZA OTHER RESP, V6, P25, DOI 10.1111/j.1750-2659.2011.00258.x; Thompson WW, 2012, EPIDEMIOLOGY, V23, P839, DOI 10.1097/EDE.0b013e31826cc1df; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; van Asten L, 2012, J INFECT DIS, V206, P628, DOI 10.1093/infdis/jis415; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; Wong JY, 2013, AM J EPIDEMIOL, V177, P834, DOI 10.1093/aje/kws314; Wu JT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001103; Wu P, 2012, J INFECT DIS, V206, P1862, DOI 10.1093/infdis/jis628; Yang L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-342; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017882; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211; [No title captured]	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90126	10.1371/journal.pone.0090126	http://dx.doi.org/10.1371/journal.pone.0090126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651832	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800011
J	de Menil, VP; Knapp, M; McDaid, D; Njenga, FG				de Menil, Victoria Pattison; Knapp, Martin; McDaid, David; Njenga, Frank Gitau			Service Use, Charge, and Access to Mental Healthcare in a Private Kenyan Inpatient Setting: The Effects of Insurance	PLOS ONE			English	Article							DEPRESSION; COUNTRIES; COHORT	The gap in Kenya between need and treatment for mental disorders is wide, and private providers are increasingly offering services, funded in part by private health insurance (PHI). Chiromo, a 30-bed psychiatric hospital in Nairobi, forms part of one of the largest private psychiatric providers in East Africa. The study evaluated the effects of insurance on service use and charge, questioning implications on access to care. Data derive from invoices for 455 sequential patients, including 12-month follow-up. Multi-linear and binary logistic regressions explored the effect of PHI on readmission, cumulative length of stay, and treatment charge. Patients were 66.4% male with a mean age of 36.8 years. Half were employed in the formal sector. 70% were admitted involuntarily. Diagnoses were: substance use disorder 31.6%; serious mental disorder 49.5%; common mental disorder 7%; comorbid 7%; other 4.9%. In addition to daily psychiatric consultations, two-thirds received individual counselling or group therapy; half received lab tests or scans; and 16.2% received ECT. Most took a psychiatric medicine. Half of those on antipsychotics were given only brands. Insurance paid in full for 28.8% of patients. Mean length of stay was 11.8 days and, in 12 months, 16.7 days (median 10.6). 22.2% were readmitted within 12 months. Patients with PHI stayed 36% longer than those paying out-of-pocket and had 2.5 times higher odds of readmission. Mean annual charge per patient was Int$4,262 (median Int$2,821). Insurers were charged 71% more than those paying out-of-pocket - driven by higher fees and longer stays. Chiromo delivers acute psychiatric care each year to approximately 450 people, to quality and human rights standards higher than its public counterpart, but at considerably higher cost. With more efficient delivery and wider insurance coverage, Chiromo might expand from its occupancy of 56.6% to reach a larger population in need.	[de Menil, Victoria Pattison] Univ London London Sch Econ & Polit Sci, Dept Social Policy, London WC2A 2AE, England; [Knapp, Martin; McDaid, David] Univ London London Sch Econ & Polit Sci, Personal Social Serv Res Unit, London WC2A 2AE, England; [Njenga, Frank Gitau] Chiromo Lane Med Ctr, Nairobi, Kenya	University of London; London School Economics & Political Science; University of London; London School Economics & Political Science	de Menil, VP (corresponding author), Univ London London Sch Econ & Polit Sci, Dept Social Policy, Houghton St, London WC2A 2AE, England.	v.p.de-menil@lse.ac.uk	McDaid, David/E-5959-2014	McDaid, David/0000-0003-0744-2664; Knapp, Martin/0000-0003-1427-0215	London School of Economics	London School of Economics	The study is self-funded as part of research towards the completion of a PhD at the London School of Economics. Victoria Pattison de Menil designed the study, collected the data, analysed it and wrote it up.	Ambetsa Oparanya W, 2010, KENYA CENSUS 2009 PO; [Anonymous], 2003, GUID US EL THER; Araya R, 2006, AM J PUBLIC HEALTH, V96, P109, DOI 10.2105/AJPH.2004.055715; Barnes J., 2010, PRIVATE HLTH SECTOR; Bodner E, 2010, ISR J PSYCHIATR REL, V47, P284; Cohen A., 2001, EFFECTIVENESS MENTAL; Drechsler D, 2007, J HEALTH POLIT POLIC, V32, P497, DOI 10.1215/03616878-2007-012; Hanson K, 2008, PLOS MED, V5, P1528, DOI 10.1371/journal.pmed.0050233; Hsiao WC, 2007, WBI DEV STUD, P1, DOI 10.1596/978-0-8213-6949-4; Kenya National Bureau of Statistics, 2007, KEN INT HOUS BUDG SU; Kenya National Commission on Human Rights, 2011, SIL MINDS SYST NEGL; Leiknes KA, 2012, BRAIN BEHAV; Machnicki G, 2011, VALUE HEALTH, V14, pS13, DOI 10.1016/j.jval.2011.05.014; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; McKenzie D, 2011, KENYAS MENTALLY ILL; NACADA, 2012, REH KEN; Nakimuli-Mpungu E, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001427; Ndetei D., 2007, S AFRICAN PSYCHIATRI, V10, P33, DOI [10.4314/ajpsy.v10i1.30231, DOI 10.4314/AJPSY.V10I1.30231]; Ndetei DM, 2008, SOC PSYCH PSYCH EPID, V43, P736, DOI 10.1007/s00127-008-0360-y; Niehaus DJH, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-44; Oladeji B D, 2012, Afr J Med Med Sci, V41, P147; Open Capital Advisors, 2012, NEXT 33000000 PRIV S; Patel V, 2000, HLTH SYSTEMS RES PRA, P363; Pollin R, 2009, FESTSCHR C AMH; Preker AS, 2007, PRIVATE VOLUNTARY HEALTH INSURANCE IN DEVELOPMENT: FRIEND OR FOE, P1, DOI 10.1596/978-0-8213-6619-6; Spaan E, 2012, B WORLD HEALTH ORGAN, V90, P685, DOI 10.2471/BLT.12.102301; Tian D, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-151; van Rensburg J, 2010, AFRICAN J PSYCHIAT, V13; van Rensburg J, 2011, AFRICAN J PSYCHIAT, V13; WHO, 2010, WOR HEALT REP, P1; WHO, 2020, MENT HLTH ATL 2011; World Bank, 2013, KEN EC UPD REINV GRO; World Health Organization, 2012, KEN COUNTR DAT; World Health Organization, 2011, EC EST UN COSTS 2007; Zwi AB, 2001, BRIT MED J, V323, P463, DOI 10.1136/bmj.323.7311.463	35	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90297	10.1371/journal.pone.0090297	http://dx.doi.org/10.1371/journal.pone.0090297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651115	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800015
J	Gorski, L; Walker, S; Liang, AS; Nguyen, KM; Govoni, J; Carychao, D; Cooley, MB; Mandrell, RE				Gorski, Lisa; Walker, Samarpita; Liang, Anita S.; Nguyen, Kimberly M.; Govoni, Jessica; Carychao, Diana; Cooley, Michael B.; Mandrell, Robert E.			Comparison of Subtypes of Listeria monocytogenes Isolates from Naturally Contaminated Watershed Samples with and without a Selective Secondary Enrichment	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; LOCUS VARIABLE-NUMBER; IMMUNOMAGNETIC SEPARATION; CHROMOGENIC AGAR; FOOD; STRAINS; DIFFERENTIATION; IDENTIFICATION; DIVERSITY; RECOVERY	Two enrichment methods for Listeria monocytogenes using Immuno Magnetic Separation (IMS) were tested to determine if they selected the same subtypes of isolates. Both methods used a non-selective primary enrichment and one included subculture in Fraser Broth, while the other involved direct plating of IMS beads. Sixty-two naturally contaminated watershed samples from the Central California Coast were used as a source of L. monocytogenes, and subtype diversity was measured by serotype and Multiple Number Variable Tandem Repeat Analysis (MLVA). Three different serotypes were detected from both methods with serotype 4b strains making up 87% of the isolates, serotype 1/2a making up 8%, and serotype 1/2b making up 5%. The data suggest that serotype 1/2a strains were more likely to be isolated from the Fraser Broth culture method. Sixty-two different MLVA types were detected and the more common MLVA types were detected by both culture methods. Forty-three MLVA types were detected only from one culture method or the other, while 19 types were detected from both culture methods. The most common MLVA type-12 was detected in 33 of the 62 water samples, and represented 31% of the isolates from both culture methods. This limited study provides evidence that using both enrichment culture methods allowed for detection of a greater diversity of isolates among the samples than the use of one method alone, and that a wide diversity of L. monocytogenes strains exist in this watershed.	[Gorski, Lisa; Walker, Samarpita; Liang, Anita S.; Nguyen, Kimberly M.; Govoni, Jessica; Carychao, Diana; Cooley, Michael B.; Mandrell, Robert E.] USDA ARS, Prod Safety & Microbiol Res Unit, Albany, CA 94710 USA	United States Department of Agriculture (USDA)	Gorski, L (corresponding author), USDA ARS, Prod Safety & Microbiol Res Unit, Albany, CA 94710 USA.	lisa.gorski@ars.usda.gov	Mandrell, Robert E/O-9814-2018	Gorski, Lisa/0000-0003-2387-1012	Agricultural Research Service CRIS project [5325-42000-046-00D]; FDA grant [224-11-2044]; USDA-NIFA [5325-42000-047-05R]	Agricultural Research Service CRIS project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); FDA grant; USDA-NIFA(United States Department of Agriculture (USDA))	This work was funded through funds from Agricultural Research Service CRIS project 5325-42000-046-00D, FDA grant #224-11-2044, and USDA-NIFA grant project agreement 5325-42000-047-05R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT TJ, 1980, J CLIN MICROBIOL, V11, P385, DOI 10.1128/JCM.11.4.385-388.1980; Bauwens L, 2003, VET MICROBIOL, V91, P115, DOI 10.1016/S0378-1135(02)00265-1; Benoit PW, 2003, J FOOD PROTECT, V66, P1935, DOI 10.4315/0362-028X-66.10.1935; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P961, DOI 10.1128/AEM.71.2.961-967.2005; CURIALE MS, 1994, J FOOD PROTECT, V57, P1048, DOI 10.4315/0362-028X-57.12.1048; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Duarte G, 1999, INT J FOOD MICROBIOL, V52, P163, DOI 10.1016/S0168-1605(99)00121-X; FDA, 2012, FIN UPD MULT OUTBR L; FRANCES N, 1991, EPIDEMIOL INFECT, V107, P235, DOI 10.1017/S0950268800048858; Gelbicova T, 2012, CZECH J FOOD SCI, V30, P83, DOI 10.17221/7/2011-CJFS; Gorski L, 2006, APPL ENVIRON MICROB, V72, P776, DOI 10.1128/AEM.72.1.776-783.2006; Graves LM, 2001, INT J FOOD MICROBIOL, V65, P55, DOI 10.1016/S0168-1605(00)00501-8; Hitchins AD, 2003, BACTERIAL ANAL MANUA; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Loncarevic S, 1996, LETT APPL MICROBIOL, V22, P381, DOI 10.1111/j.1472-765X.1996.tb01184.x; Lyautey E, 2007, APPL ENVIRON MICROB, V73, P5401, DOI 10.1128/AEM.00354-07; Lyautey E, 2012, CAN J MICROBIOL, V58, P1405, DOI 10.1139/cjm-2012-0418; Murphy M, 2007, INT J FOOD MICROBIOL, V115, P187, DOI 10.1016/j.ijfoodmicro.2006.10.022; Ngutter C, 2003, J FOOD PROTECT, V66, P2252, DOI 10.4315/0362-028X-66.12.2252; Norton DM, 2001, APPL ENVIRON MICROB, V67, P198, DOI 10.1128/AEM.67.1.198-205.2001; Osborne CM, 2002, J FOOD PROTECT, V65, P1122, DOI 10.4315/0362-028X-65.7.1122; Palumbo JD, 2003, J CLIN MICROBIOL, V41, P564, DOI 10.1128/JCM.41.2.564-571.2003; PERRY CM, 1990, J FOOD PROTECT, V53, P642, DOI 10.4315/0362-028X-53.8.642; PETRAN RL, 1993, J FOOD PROTECT, V56, P616, DOI 10.4315/0362-028X-56.7.616; Pritchard TJ, 1999, J FOOD PROTECT, V62, P532, DOI 10.4315/0362-028X-62.5.532; Ryser ET, 1996, APPL ENVIRON MICROB, V62, P1781, DOI 10.1128/AEM.62.5.1781-1787.1996; Saleh-Lakha S, 2013, APPL ENVIRON MICROB, DOI [10.1128/AEM.00759-00713, DOI 10.1128/AEM.00759-00713]; Sauders BD, 2012, APPL ENVIRON MICROB, V78, P4420, DOI 10.1128/AEM.00282-12; Silk BJ, 2013, MMWR-MORBID MORTAL W, V62, P448, DOI 10.1016/j.annemergmed.2013.08.006; Silk TM, 2002, J FOOD PROTECT, V65, P1333, DOI 10.4315/0362-028X-65.8.1333; Sperry KEV, 2008, J CLIN MICROBIOL, V46, P1435, DOI 10.1128/JCM.02207-07; Sperry KEV, 2009, J CLIN MICROBIOL, V47, P1984, DOI 10.1128/JCM.00730-09; Szymczak B, 2013, FOLIA MICROBIOL, V58, DOI [10.1007/s12223-12013-10260-12228, DOI 10.1007/S12223-12013-10260-12228]; Uyttendaele M, 2000, INT J FOOD MICROBIOL, V54, P205, DOI 10.1016/S0168-1605(99)00196-8; Wadud S, 2010, J MICROBIOL METH, V81, P153, DOI 10.1016/j.mimet.2010.02.014; Willis C, 2006, J APPL MICROBIOL, V101, P711, DOI 10.1111/j.1365-2672.2006.02917.x	37	13	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92467	10.1371/journal.pone.0092467	http://dx.doi.org/10.1371/journal.pone.0092467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651315	Green Published, gold			2022-12-27	WOS:000333352800114
J	Kato, K; Takamura, T; Takeshita, Y; Ryu, Y; Misu, H; Ota, T; Tokuyama, K; Nagasaka, S; Matsuhisa, M; Matsui, O; Kaneko, S				Kato, Ken-ichiro; Takamura, Toshinari; Takeshita, Yumie; Ryu, Yasuji; Misu, Hirofumi; Ota, Tsuguhito; Tokuyama, Kumpei; Nagasaka, Shoichiro; Matsuhisa, Munehide; Matsui, Osamu; Kaneko, Shuichi			Ectopic Fat Accumulation and Distant Organ-Specific Insulin Resistance in Japanese People with Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							ENDOGENOUS GLUCOSE-PRODUCTION; OXIDATIVE-PHOSPHORYLATION; STEATOSIS; MUSCLE; ACIDS; STEATOHEPATITIS; SPECTROSCOPY; VALIDATION; SECRETION; PROTEIN	Objective: The aim of this study was to examine the association between ectopic fat and organ-specific insulin resistance (IR) in insulin-target organs in patients with nonalcoholic fatty liver disease (NAFLD). Methods: Organ-specific IR in the liver (hepatic glucose production (HGP)xfasting plasma insulin (FPI) and suppression of HGP by insulin [%HGP]), skeletal muscle (insulin-stimulated glucose disposal [Rd]), and adipose tissue (suppression of FFA by insulin [%FFA]) was measured in 69 patients with NAFLD using a euglycemic hyperinsulinemic clamp with tracer infusion ([6,6-H-2(2)]glucose). Liver fat, intramyocellular lipid (IMCL), and body composition were measured by liver biopsy, proton magnetic resonance spectroscopy, and bioelectrical impedance analysis, respectively. Results: HGPxFPI was significantly correlated with Rd (r = -0.57, P<0.001), %HGP with %FFA (r = 0.38, P<0.01), and Rd with %FFA (r = 0.27, P<0.05). Liver steatosis score was negatively associated with Rd (r = -0.47, P<0.001) as well as with HGPxFPI (r = 0.43, P<0.001). Similarly, intrahepatic lipid was negatively associated with Rd (r = -0.32, P<0.05). IMCL was not associated with Rd (r = -0.16, P = 0.26). Fat mass and its percentage were associated with HGPxFPI (r = 0.50, P<0.001; r = 0.48, P<0.001, respectively) and Rd (r = -0.59, P<0.001; r = -0.52, P<0.001, respectively), but not with % FFA (r = -0.21, P = 0.10; r = -0.001, P = 0.99, respectively). Conclusion: Unexpectedly, fat accumulation in the skeletal muscle and adipose tissue was not associated with organ-specific IR. Instead, liver fat was associated not only with hepatic IR but also with skeletal muscle IR, suggesting a central role of fatty liver in systemic IR and that a network exists between liver and skeletal muscle.	[Kato, Ken-ichiro; Takamura, Toshinari; Takeshita, Yumie; Misu, Hirofumi; Ota, Tsuguhito; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan; [Ryu, Yasuji; Matsui, Osamu] Kanazawa Univ, Grad Sch Med Sci, Dept Radiol, Kanazawa, Ishikawa, Japan; [Tokuyama, Kumpei] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Nagasaka, Shoichiro] Jichi Med Univ, Dept Med, Div Endocrinol & Metab, Shimono, Tochigi, Japan; [Matsuhisa, Munehide] Univ Tokushima, Clin Res Ctr Diabet, Tokushima 770, Japan	Kanazawa University; Kanazawa University; University of Tsukuba; Jichi Medical University; Tokushima University	Takamura, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan.	ttakamura@m-kanazawa.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [C-20591054]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for Scientific Research (C-20591054 to TT) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; COBELLI C, 1987, AM J PHYSIOL, V252, pE679, DOI 10.1152/ajpendo.1987.252.5.E679; COBELLI C, 1987, AM J PHYSIOL, V253, pE551, DOI 10.1152/ajpendo.1987.253.5.E551; D'Adamo E, 2010, DIABETES CARE, V33, P1817, DOI 10.2337/dc10-0284; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; FINEGOOD DT, 1987, DIABETES, V36, P914, DOI 10.2337/diabetes.36.8.914; Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206; Gastaldelli A, 2007, GASTROENTEROLOGY, V133, P496, DOI 10.1053/j.gastro.2007.04.068; Iozzo P, 2009, DIABETES CARE, V32, pS168, DOI 10.2337/dc09-S304; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kotronen A, 2008, DIABETOLOGIA, V51, P130, DOI 10.1007/s00125-007-0867-x; Kurioka S, 2002, ENDOCR J, V49, P459, DOI 10.1507/endocrj.49.459; Lomonaco R, 2011, HEPATOLOGY, V54, P837, DOI 10.1002/hep.24483; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; McPherson S, 2009, J HEPATOL, V51, P389, DOI 10.1016/j.jhep.2009.04.012; Misu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034952; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nagasaka S, 1999, DIABETES, V48, P1054, DOI 10.2337/diabetes.48.5.1054; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Ryysy L, 2000, DIABETES, V49, P749, DOI 10.2337/diabetes.49.5.749; Sakurai M, 2007, J GASTROENTEROL, V42, P312, DOI 10.1007/s00535-006-1948; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Takamura T, 2008, OBESITY, V16, P2601, DOI 10.1038/oby.2008.419; Takamura T, 2012, ENDOCR J, V59, P745, DOI 10.1507/endocrj.EJ12-0228; Thamer C, 2003, J CLIN ENDOCR METAB, V88, P1785, DOI 10.1210/jc.2002-021674; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Wolfe RR, 1992, RADIOACTIVE STABLE I; YKIJARVINEN H, 1987, J CLIN INVEST, V79, P1713, DOI 10.1172/JCI113011	40	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92170	10.1371/journal.pone.0092170	http://dx.doi.org/10.1371/journal.pone.0092170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651470	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800077
J	Narimatsu, Y; Kuno, A; Ito, H; Kaji, H; Kaneko, S; Usui, J; Yamagata, K; Narimatsu, H				Narimatsu, Yoshiki; Kuno, Atsushi; Ito, Hiromi; Kaji, Hiroyuki; Kaneko, Syuzo; Usui, Joichi; Yamagata, Kunihiro; Narimatsu, Hisashi			IgA Nephropathy Caused by Unusual Polymerization of IgA1 with Aberrant N-Glycosylation in a Patient with Monoclonal Immunoglobulin Deposition Disease	PLOS ONE			English	Article							LINKED GLYCOSYLATION; LIGHT-CHAINS; SERUM IGA; CARBOHYDRATE; CONFORMATION; ANTIBODIES; BINDING; GLYCAN; LECTIN; REGION	Immunoglobulin A nephropathy (IgAN) is a form of chronic glomerulonephritis characterized by the deposition of IgA immune complexes in the glomerular region. The cause of IgAN is unknown, but multiple mechanisms have been suggested. We previously reported a rare case of mesangioproliferative glomerulonephritis in a patient with monoclonal immunoglobulin deposition disease associated with monoclonal IgA1. In this study, we performed the detailed analyses of serum IgA1 from this patient in comparison with those from patients with mIgA plasma cell disorder without renal involvement and healthy volunteers. We found unusual polymerization of IgA1 with additional N-glycosylation distinctive in this patient, which was different from known etiologies. Glycan profiling of IgA1 by the lectin microarray revealed an intense signal for Wisteria floribunda agglutinin (WFA). This signal was reduced by disrupting the native conformation of IgA1, suggesting that the distinct glycan profile was reflecting the conformational alteration of IgA1, including the glycan conformation detected as additional N-glycans on both the heavy and light chains. This unusually polymerized state of IgA1 would cause an increase of the binding avidity for lectins. WFA specifically recognized highly polymerized and glycosylated IgA1. Our results of analysis in the rare case of a patient with monoclonal immunoglobulin deposition disease suggest that the formation of unusually polymerized IgA1 is caused by divergent mechanisms including multiple structural alterations of glycans, which contributes to IgA1 deposition and mesangium proliferation.	[Narimatsu, Yoshiki; Kuno, Atsushi; Ito, Hiromi; Kaji, Hiroyuki; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki, Japan; [Ito, Hiromi] Fukushima Med Univ, Sch Med, Dept Biochem Life Sci & Social Med, Fukushima, Japan; [Kaneko, Syuzo; Usui, Joichi; Yamagata, Kunihiro] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Nephrol, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Fukushima Medical University; University of Tsukuba	Narimatsu, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki, Japan.	h.narimatsu@aist.go.jp	Narimatsu, Hisashi/M-4757-2018; Kaji, Hiroyuki/L-7122-2018; Kuno, Atsushi/M-2151-2018; Narimatsu, Yoshiki/G-8388-2019	Narimatsu, Hisashi/0000-0002-8402-133X; Kaji, Hiroyuki/0000-0002-0910-9999; Kuno, Atsushi/0000-0002-6147-6171; Narimatsu, Yoshiki/0000-0003-1428-5695	New Energy and Industrial Technology Development Organization of Japan	New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by a grant from New Energy and Industrial Technology Development Organization of Japan. No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; Allen AC, 1999, J AM SOC NEPHROL, V10, P1763; Amore A, 2001, J AM SOC NEPHROL, V12, P1862, DOI 10.1681/ASN.V1291862; ANDRE PM, 1990, J CLIN LAB ANAL, V4, P115, DOI 10.1002/jcla.1860040208; ANDREOTTI AH, 1993, J AM CHEM SOC, V115, P3352, DOI 10.1021/ja00061a053; Boumediene A, 2011, NEPHROL DIAL TRANSPL, V26, P3930, DOI 10.1093/ndt/gfr131; Chen MM, 2010, P NATL ACAD SCI USA, V107, P22528, DOI 10.1073/pnas.1015356107; Chuang PD, 1997, J IMMUNOL, V158, P724; DAVIS JT, 1994, J BIOL CHEM, V269, P3331; Elliott S, 2004, J BIOL CHEM, V279, P16854, DOI 10.1074/jbc.M311095200; GERKEN TA, 1989, BIOCHEMISTRY-US, V28, P5536, DOI 10.1021/bi00439a030; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Hashimoto R, 2007, INT J HEMATOL, V85, P203, DOI 10.1532/IJH97.06074; Ikehara Y, 2006, GLYCOBIOLOGY, V16, P777, DOI 10.1093/glycob/cwl005; Imperiali B, 1995, BIOORGAN MED CHEM, V3, P1565, DOI 10.1016/0968-0896(95)00142-5; Kaneko S, 2010, CLIN EXP NEPHROL, V14, P389, DOI 10.1007/s10157-010-0285-0; KERR MA, 1990, BIOCHEM J, V271, P285, DOI 10.1042/bj2710285; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Kuno A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01065; Kuno A, 2009, MOL CELL PROTEOMICS, V8, P99, DOI 10.1074/mcp.M800308-MCP200; Lee RT, 2000, GLYCOCONJUGATE J, V17, P543, DOI 10.1023/A:1011070425430; Leibiger H, 1999, BIOCHEM J, V338, P529, DOI 10.1042/0264-6021:3380529; Matsuda A, 2010, HEPATOLOGY, V52, P174, DOI 10.1002/hep.23654; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; MESTECKY J, 1993, CONTRIB NEPHROL, V104, P172; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; MONTEIRO RC, 1985, KIDNEY INT, V28, P666, DOI 10.1038/ki.1985.181; Narimatsu Y, 2010, J AM CHEM SOC, V132, P5548, DOI 10.1021/ja9106429; Nishie T, 2007, CONTRIB NEPHROL, V157, P125; Omtvedt LA, 1997, SCAND J IMMUNOL, V45, P551, DOI 10.1046/j.1365-3083.1997.d01-431.x; Omtvedt LA, 2000, AMYLOID, V7, P227, DOI 10.3109/13506120009146437; Oyelaran O, 2009, J PROTEOME RES, V8, P3529, DOI 10.1021/pr9002245; Price JL, 2010, J AM CHEM SOC, V132, P15359, DOI 10.1021/ja106896t; Royle L, 2003, J BIOL CHEM, V278, P20140, DOI 10.1074/jbc.M301436200; SOX HC, 1970, P NATL ACAD SCI USA, V66, P975, DOI 10.1073/pnas.66.3.975; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; TOMINO Y, 1982, CLIN EXP IMMUNOL, V49, P419; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; WORMALD MR, 1991, EUR J BIOCHEM, V198, P131, DOI 10.1111/j.1432-1033.1991.tb15995.x; Wu AM, 2004, FEBS LETT, V562, P51, DOI 10.1016/S0014-5793(04)00180-2; Wu AM, 2003, BIOCHEM J, V371, P311, DOI 10.1042/BJ20021361; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; Yoo EM, 2005, CLIN IMMUNOL, V116, P3, DOI 10.1016/j.clim.2005.03.010	44	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91079	10.1371/journal.pone.0091079	http://dx.doi.org/10.1371/journal.pone.0091079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651839	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800030
J	Peron, J; Grandjean, D; Drapier, S; Verin, M				Peron, Julie; Grandjean, Didier; Drapier, Sophie; Verin, Marc			Effect of Dopamine Therapy on Nonverbal Affect Burst Recognition in Parkinson's Disease	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS; EMOTION RECOGNITION; STIMULATION; LEVODOPA; PROSODY; PERFORMANCE; PERCEPTION; COGNITION; VOICES; MIND	Background: Parkinson's disease (PD) provides a model for investigating the involvement of the basal ganglia and mesolimbic dopaminergic system in the recognition of emotions from voices (i.e., emotional prosody). Although previous studies of emotional prosody recognition in PD have reported evidence of impairment, none of them compared PD patients at different stages of the disease, or ON and OFF dopamine replacement therapy, making it difficult to determine whether their impairment was due to general cognitive deterioration or to a more specific dopaminergic deficit. Methods: We explored the involvement of the dopaminergic pathways in the recognition of nonverbal affect bursts (onomatopoeias) in 15 newly diagnosed PD patients in the early stages of the disease, 15 PD patients in the advanced stages of the disease and 15 healthy controls. The early PD group was studied in two conditions: ON and OFF dopaminergic therapy. Results: Results showed that the early PD patients performed more poorly in the ON condition than in the OFF one, for overall emotion recognition, as well as for the recognition of anger, disgust and fear. Additionally, for anger, the early PD ON patients performed more poorly than controls. For overall emotion recognition, both advanced PD patients and early PD ON patients performed more poorly than controls. Analysis of continuous ratings on target and nontarget visual analog scales confirmed these patterns of results, showing a systematic emotional bias in both the advanced PD and early PD ON (but not OFF) patients compared with controls. Conclusions: These results i) confirm the involvement of the dopaminergic pathways and basal ganglia in emotional prosody recognition, and ii) suggest a possibly deleterious effect of dopatherapy on affective abilities in the early stages of PD.	[Peron, Julie; Grandjean, Didier] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Peron, Julie; Grandjean, Didier] Univ Geneva, Dept Psychol, Neurosci Emot & Affect Dynam Lab, Geneva, Switzerland; [Drapier, Sophie; Verin, Marc] Univ Rennes 1, Host Team 4712, Behav & Basal Ganglia Res Unit, Rennes, France; [Drapier, Sophie; Verin, Marc] Rennes Univ Hosp, Pontchaillou Hosp, Rennes, France; [Drapier, Sophie; Verin, Marc] Rennes Univ Hosp, Pontchaillou Hosp, Neurol Unit, Rennes, France	University of Geneva; University of Geneva; Universite de Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes	Peron, J (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.	julie.peron@unige.ch	Péron, Julie/C-5658-2013; Verin, Marc/ABC-6924-2020	Péron, Julie/0000-0002-6579-4011; Grandjean, Didier/0000-0001-6125-4520	University Hospital of Rennes (France); National Center of Competence in Research (NCCR); Swiss National Science Foundation [51NF40-104897]	University Hospital of Rennes (France); National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was carried out at the Neurology Unit of Pontchaillou Hospital (Rennes University Hospital, rue Henri Le Guilloux, 35033 Rennes, France). The first author (JP) was funded by the University Hospital of Rennes (France) during the data acquisition and by National Center of Competence in Research (NCCR), financed by the Swiss National Science Foundation (no. 51NF40-104897) and hosted by the University of Geneva during the data analysis and writing of the manuscript. The funders had no role in data collection, discussion of content, preparation of the manuscript, or decision to publish.	Baik JH, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00152; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; Breitenstein C, 2001, BRAIN COGNITION, V45, P277, DOI 10.1006/brcg.2000.1246; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cools R, 2007, NEUROPSYCHOPHARMACOL, V32, P180, DOI 10.1038/sj.npp.1301153; Delaveau P, 2005, CLIN NEUROPHARMACOL, V28, P255, DOI 10.1097/01.wnf.0000186651.96351.2e; Derouesne C, 2001, REV NEUROL-FRANCE, V157, P567; Ferreri F, 2006, CAN MED ASSOC J, V175, P1545, DOI 10.1503/cmaj.060542; Fruhholz S, 2012, CEREB CORTEX, V22, P1107, DOI 10.1093/cercor/bhr184; GANCHER ST, 1987, NEUROLOGY, V37, P940, DOI 10.1212/WNL.37.6.940; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Grandjean D, 2006, PROG BRAIN RES, V156, P235, DOI 10.1016/S0079-6123(06)56012-1; Gray HA, 2010, NEUROPSYCHOLOGY, V24, P176, DOI 10.1037/a0018104; Hariri AR, 2002, NEUROPSYCHOPHARMACOL, V27, P1036, DOI 10.1016/S0893-133X(02)00373-1; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Kvernmo T, 2006, CLIN THER, V28, P1065, DOI 10.1016/j.clinthera.2006.08.004; Lawrence AD, 2002, NEUROREPORT, V13, P881, DOI 10.1097/00001756-200205070-00029; Le Jeune F, 2008, BRAIN, V131, P1599, DOI 10.1093/brain/awn084; MacDonald AA, 2013, MOVEMENT DISORD, V28, P153, DOI 10.1002/mds.25152; MacDonald P.A., 2011, PARKINSONS DIS-US, V2011, DOI DOI 10.4061/2011/572743; MacDonald PA, 2011, BRAIN, V134, P1447, DOI 10.1093/brain/awr075; Mattis S, 1988, PSYCHOL ASSESSMENT; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Paulmann S, 2009, BRAIN RES, V1295, P159, DOI 10.1016/j.brainres.2009.07.102; Peron J, 2013, NEUROSCI BIOBEHAV R, V37, P358, DOI 10.1016/j.neubiorev.2013.01.001; Peron J, 2012, MOVEMENT DISORD, V27, P186, DOI 10.1002/mds.24025; Peron J, 2011, PROG NEURO-PSYCHOPH, V35, P987, DOI 10.1016/j.pnpbp.2011.01.019; Peron J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009919; Peron J, 2010, NEUROPSYCHOLOGIA, V48, P1053, DOI 10.1016/j.neuropsychologia.2009.12.003; Peron J, 2010, NEUROPSYCHOLOGY, V24, P1, DOI 10.1037/a0017433; Peron J, 2009, NEUROPSYCHOLOGIA, V47, P406, DOI 10.1016/j.neuropsychologia.2008.09.008; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Salgado-Pineda P, 2005, CLIN NEUROPHARMACOL, V28, P228, DOI 10.1097/01.wnf.0000185824.57690.f0; Sander D, 2005, NEUROIMAGE, V28, P848, DOI 10.1016/j.neuroimage.2005.06.023; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Schwab R.S., 1969, 3 S PARK DIS, P152; Spielberger C. D., 1993, MANUEL INVENTAIRE AN; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Swainson R, 2000, NEUROPSYCHOLOGIA, V38, P596, DOI 10.1016/S0028-3932(99)00103-7; Takahashi H, 2005, NEUROIMAGE, V27, P991, DOI 10.1016/j.neuroimage.2005.05.039; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; UHL GR, 1985, NEUROLOGY, V35, P1215, DOI 10.1212/WNL.35.8.1215; Welter ML, 2002, BRAIN, V125, P575, DOI 10.1093/brain/awf050; Woods SP, 2005, J INT NEUROPSYCH SOC, V11, P408, DOI 10.1017/S1355617705050460	48	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90092	10.1371/journal.pone.0090092	http://dx.doi.org/10.1371/journal.pone.0090092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651759	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800010
J	Angrist, M				Angrist, Misha			Open Window: When Easily Identifiable Genomes and Traits Are in the Public Domain	PLOS ONE			English	Article								"One can't be of an enquiring and experimental nature, and still be very sensible." - Charles Fort [1] As the costs of personal genetic testing "self-quantification" fall, publicly accessible databases housing people's genotypic and phenotypic information are gradually increasing in number and scope. The latest entrant is openSNP, which allows participants to upload their personal genetic/genomic and self-reported phenotypic data. I believe the emergence of such open repositories of human biological data is a natural reflection of inquisitive and digitally literate people's desires to make genomic and phenotypic information more easily available to a community beyond the research establishment. Such unfettered databases hold the promise of contributing mightily to science, science education and medicine. That said, in an age of increasingly widespread governmental and corporate surveillance, we would do well to be mindful that genomic DNA is uniquely identifying. Participants in open biological databases are engaged in a real-time experiment whose outcome is unknown.	[Angrist, Misha] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Angrist, Misha] Duke Univ, Program Sci & Soc, Durham, NC USA; [Angrist, Misha] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA	Duke University; Duke University; Duke University	Angrist, M (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	misha.angrist@duke.edu			NIH [5P50-HG003391-07]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by NIH grant 5P50-HG003391-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrist Misha, 2010, HERE IS HUMAN BEING; Ball MP, 2012, P NATL ACAD SCI USA, V109, P11920, DOI 10.1073/pnas.1201904109; Brady D, 2013, BLOOMBERG BUSINESSWE; Brenner SE, 2013, NATURE, V498, P139, DOI 10.1038/498139a; BUTCHER L, 2011, HOSP HLTH NETW, V85, P13; CHURCH GM, 2005, MOL SYST BIOL, V1; Cole D, 2014, 3 LEAKERS WHAT DO TH; Fort C, 1932, WILD TALENTS; Friedman Emily, 2011, Mod Healthc, V41, P26; Greshake B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089204; Gutierrez A, 2013, COMMUNICATION; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Joly Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-25; Lauerman J, 2012, BLOOMBERG BUSINESSWE; Lunshof JE, 2014, SCIENCE, V343, P373, DOI 10.1126/science.1249382; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; Pennisi E, 2012, SCIENCE, V337, P1167, DOI 10.1126/science.337.6099.1167; Pennisi E, 2012, SCIENCE, V337, P1159, DOI 10.1126/science.337.6099.1159; Pulley J, 2010, CTS-CLIN TRANSL SCI, V3, P42, DOI 10.1111/j.1752-8062.2010.00175.x; Wojcicki A, 2013, 23ANDME PROVIDES UPD	20	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92060	10.1371/journal.pone.0092060	http://dx.doi.org/10.1371/journal.pone.0092060			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647311	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500077
J	Sugumar, M; Kumar, KM; Manoharan, A; Anbarasu, A; Ramaiah, S				Sugumar, Madhan; Kumar, K. M.; Manoharan, Anand; Anbarasu, Anand; Ramaiah, Sudha			Detection of OXA-1 beta-Lactamase Gene of Klebsiella pneumoniae from Blood Stream Infections (BSI) by Conventional PCR and In-Silico Analysis to Understand the Mechanism of OXA Mediated Resistance	PLOS ONE			English	Article								Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases (ESBL) exhibit resistance to antibiotic classes. The production of ESBLs (TEM-1, TEM-2, SHV-1, OXA-1) results in resistance to ampicillin, ticarcillin, piperacillin and cephalosporins. High levels of beta-lactamases leads to development of resistance to beta-lactamase inhibitors. The present study deals with characterizing antimicrobial resistance pattern among septicemia causing K. pneumoniae and the prevalence of inhibitor resistant OXA-1 beta-lactamase genes among them. Of 151 study isolates, 59 were resistant to piperacillin/tazobactam and these isolates were further selected for blaOXA-1 screening. Amplification of beta-lactamases genes by conventional PCR showed the presence of blaOXA-1 genes among 12 K. pneumoniae (20.3%) isolates. OXA-1 beta-lactamase producing strains were found to be resistant to piperacillin/tazobactam(100%), levofloxacin (91.6%), amikacin (75%), cefoxitin (50%), ertapenem (25%), imipenem (16.6%) and meropenem (16.6%); all were susceptible to tigecycline. 3D models of OXA-1 beta-lactamase were generated and docking was performed with various beta-lactam antibiotics. Molecular docking (MD) revealed the molecular basis of drug sensitivity. MD simulation results clearly confirmed the notable loss in stability for tigecycline-blaOXA-1 complex. Findings of the present study will provide useful insights for understanding the mechanism of resistance and help with strategies for the development of new antibiotics. The conventional PCR assay designed in this study can be routinely used in clinical microbiology laboratories to determine the blaOXA-1genes.	[Sugumar, Madhan; Manoharan, Anand] Christian Med Coll & Hosp, Med Unit & Infect Dis 1, Prof Benjamin M Pulimood Labs Infect Immun & Infl, Vellore, Tamil Nadu, India; [Sugumar, Madhan; Kumar, K. M.; Anbarasu, Anand; Ramaiah, Sudha] VIT Univ, Sch Biosci & Technol, Med & Biol Comp Lab, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; Vellore Institute of Technology	Manoharan, A (corresponding author), Christian Med Coll & Hosp, Med Unit & Infect Dis 1, Prof Benjamin M Pulimood Labs Infect Immun & Infl, Vellore, Tamil Nadu, India.	anandvellore@yahoo.com	Ramaiah, Sudha/T-3682-2019; Anbarasu, Anand/U-6323-2019; Anbarasu, Anand/K-4076-2017	Ramaiah, Sudha/0000-0002-4800-329X; Anbarasu, Anand/0000-0003-2216-7488	Institutional Intramural Research Grant	Institutional Intramural Research Grant	The study did not receive any extramural funding. The work formed part of the PhD dissertation of Madhan Sugumar and supported by Institutional Intramural Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; BERGSTROM S, 1979, ANTIMICROB AGENTS CH, V16, P427, DOI 10.1128/AAC.16.4.427; Bert F, 2002, J ANTIMICROB CHEMOTH, V50, P11, DOI 10.1093/jac/dkf069; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gunsteren W. F. V., 1996, BIOMOLECULAR SIMULAT, P1; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Karmele C, 2003, FEMS MICROBIOL LET, V223, P147; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Liao JJL, 2007, CURR TOP MED CHEM, V7, P1394; Manoharan A, 2011, INDIAN J MED MICROBI, V29, P161, DOI 10.4103/0255-0857.81799; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Navia MM, 1999, J CLIN MICROBIOL, V37, P3113, DOI 10.1128/JCM.37.10.3113-3117.1999; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P934, DOI 10.1128/AAC.01247-10; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHANNON K, 1990, FEMS MICROBIOL LETT, V67, P319, DOI 10.1016/0378-1097(90)90016-J; Siu LK, 2000, ANTIMICROB AGENTS CH, V44, P2034, DOI 10.1128/AAC.44.8.2034-2038.2000; Wayne PA, 2011, M100S21 CLSI, P31; ZHOU XY, 1994, ANTIMICROB AGENTS CH, V38, P1085, DOI 10.1128/AAC.38.5.1085	22	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91800	10.1371/journal.pone.0091800	http://dx.doi.org/10.1371/journal.pone.0091800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647004	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500052
J	Fan, XL; Huang, QZ; Ye, XL; Lin, Y; Chen, YT; Lin, XH; Qu, J				Fan, Xiaolan; Huang, Qinzhu; Ye, Xiaolei; Lin, Yi; Chen, Yuting; Lin, Xinhua; Qu, Jia			Drosophila USP5 Controls the Activation of Apoptosis and the Jun N-Terminal Kinase Pathway during Eye Development	PLOS ONE			English	Article							FREE POLYUBIQUITIN CHAINS; CELL-DEATH; PRONEURAL GENE; ENZYME UBA1; UBIQUITIN; JNK; MECHANISMS; DIAP1; HID; ISOPEPTIDASE	The Jun N-terminal kinase pathway plays an important role in inducing programmed cell death (apoptosis) and is activated in a variety of contexts. The deubiquitinating enzymes (DUBs) are proteases regulating the protein stability by ubiquitin-proteasome system. Here, for the first time, we report the phenotypes observed during eye development that are induced by deleting Drosophila USP5 gene, which encodes one of the USP subfamily of DUBs. usp5 mutants displayed defects in photoreceptor differentiation. Using genetic epistasis analysis and molecular markers, we show that most of these phenotypes are caused by the activation of apoptosis and JNK pathway. These data may provide a mechanistic model for understanding the mammalian usp5 gene.	[Qu, Jia] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China; Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Qu, J (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China.	jqu@wz.zj.cn			National Basic Research Program of China [2011CB943900]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Basic Research Program of China (No. 2011CB943900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerik AY, 1997, EMBO J, V16, P4826; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Chai JJ, 2003, NAT STRUCT BIOL, V10, P892, DOI 10.1038/nsb989; Cordero-Herrera I, 2013, NUTR CANCER, V65, P718, DOI 10.1080/01635581.2013.795981; Danon A, 2004, J BIOL CHEM, V279, P779, DOI 10.1074/jbc.M304468200; Dayal S, 2009, J BIOL CHEM, V284, P5030, DOI 10.1074/jbc.M805871200; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Doelling JH, 2001, PLANT J, V27, P393, DOI 10.1046/j.1365-313X.2001.01106.x; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Gulino A, 2012, VITAM HORM, V88, P211, DOI 10.1016/B978-0-12-394622-5.00009-2; HADARI T, 1992, J BIOL CHEM, V267, P719; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kanda H, 2004, J BIOCHEM, V136, P1, DOI 10.1093/jb/mvh098; Kester RS, 2011, INT J DEV BIOL, V55, P109, DOI 10.1387/ijdb.103109rk; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lee TV, 2008, DEVELOPMENT, V135, P43, DOI 10.1242/dev.011288; Lee TV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002261; Lindsey DF, 1998, J BIOL CHEM, V273, P29178, DOI 10.1074/jbc.273.44.29178; Lisi S, 2000, GENETICS, V154, P669; Liu J, 2009, SCIENCE, V323, P1218, DOI 10.1126/science.1157669; Luo X, 2007, EMBO J, V26, P380, DOI 10.1038/sj.emboj.7601484; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; O'Riordan MXD, 2008, DEV CELL, V15, P497, DOI 10.1016/j.devcel.2008.09.012; Oh SW, 2003, GENETICS, V163, P195; Pfleger CM, 2007, FLY, V1, P95, DOI 10.4161/fly.4285; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Shiozaki EN, 2004, TRENDS BIOCHEM SCI, V29, P486, DOI 10.1016/j.tibs.2004.07.003; Shlevkov E, 2012, CELL DEATH DIFFER, V19, P451, DOI 10.1038/cdd.2011.113; STEIN RL, 1995, BIOCHEMISTRY-US, V34, P12616, DOI 10.1021/bi00039a017; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; Tsachaki M, 2012, DEV DYNAM, V241, P40, DOI 10.1002/dvdy.22738; Vanek J, 1995, Acta Chir Orthop Traumatol Cech, V62, P162; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; WILKINSON KD, 1995, ANNU REV NUTR, V15, P161, DOI 10.1146/annurev.nu.15.070195.001113; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; WOLFF T, 1991, DEVELOPMENT, V113, P825; XU T, 1993, DEVELOPMENT, V117, P1223; Yan N, 2004, NAT STRUCT MOL BIOL, V11, P420, DOI 10.1038/nsmb764; Yeh TC, 2013, P NATL ACAD SCI USA, V110, P14284, DOI 10.1073/pnas.1306179110; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Zachariou A, 2003, EMBO J, V22, P6642, DOI 10.1093/emboj/cdg617; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004	62	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92250	10.1371/journal.pone.0092250	http://dx.doi.org/10.1371/journal.pone.0092250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643212	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900110
J	Johnston, JM; Filizola, M				Johnston, Jennifer M.; Filizola, Marta			Differential Stability of the Crystallographic Interfaces of Mu- and Kappa-Opioid Receptors	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; FORCE-FIELD; PROTEIN; PALMITOYLATION; COMPLEX; DIMER	The recent mu-opioid receptor (MOPr) and kappa-opioid receptor (KOPr) crystal structures have inspired hypotheses of physiologically relevant dimerization contacts, specifically: a closely packed interface involving transmembrane (TM) helices TM5 and TM6, and a less compact interface, involving TM1, TM2, and helix 8 (H8). While the former was only found in MOPr crystals, similar arrangements of the latter were identified for both KOPr and MOPr. The relevance of these interfaces outside of a crystal lattice is called into question by the possibility that they might be influenced by the specific crystallization conditions. In this study, we have employed umbrella sampling molecular dynamics simulations of coarse-grained representations of the interacting MOPr or KOPr crystallographic structures, in the absence of the T4 lysozyme, and in an explicit lipid-water environment, to determine the strength of receptor dimerization at the different crystallographic interfaces. We note that the shape of the interface plays a dominant role in the strength of the interaction, and the pattern of contacting residues defines the shape of the potential of mean force. This information can be used to guide experiments aimed at exploring the role of dimerization in opioid receptor function.	[Johnston, Jennifer M.; Filizola, Marta] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Filizola, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA.	marta.filizola@mssm.edu		Filizola, Marta/0000-0002-4382-8276	National Institutes of Health [DA026434, DA034049]; NIDA [T32 DA007135]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034049, T32DA007135, K02DA026434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this work was provided, in whole or in part, by National Institutes of Health grants DA026434 and DA034049. JMJ was supported in part by NIDA grant T32 DA007135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TW, 2004, P NATL ACAD SCI USA, V101, P117, DOI 10.1073/pnas.2635314100; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bertheleme N, 2013, BBA-BIOMEMBRANES, V1828, P2583, DOI 10.1016/j.bbamem.2013.07.013; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Chen CG, 1998, FEBS LETT, V441, P148, DOI 10.1016/S0014-5793(98)01547-6; Cherezov V, 2010, METHODS MOL BIOL, V654, P141, DOI 10.1007/978-1-60761-762-4_8; Duarte JM, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-21; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Hu JX, 2013, J BIOL CHEM, V288, P34777, DOI 10.1074/jbc.M113.503714; Hu JX, 2012, FASEB J, V26, P604, DOI 10.1096/fj.11-191510; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Johnston JM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002649; Johnston JM, 2011, BIOCHEMISTRY-US, V50, P1682, DOI 10.1021/bi101474v; Knepp AM, 2012, BIOCHEMISTRY-US, V51, P1819, DOI 10.1021/bi3001598; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; O'Dowd BF, 2012, BIOCHEM BIOPH RES CO, V422, P556, DOI 10.1016/j.bbrc.2012.05.023; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Provasi D, 2010, BIOCHEMISTRY-US, V49, P6771, DOI 10.1021/bi100686t; Roux B, 1999, BIOPHYS J, V77, P139, DOI 10.1016/S0006-3495(99)76878-5; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Salom D, 2013, METHOD CELL BIOL, V117, P451, DOI 10.1016/B978-0-12-408143-7.00024-4; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Zheng H, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-6; Zhu FQ, 2012, J COMPUT CHEM, V33, P453, DOI 10.1002/jcc.21989	33	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e90694	10.1371/journal.pone.0090694	http://dx.doi.org/10.1371/journal.pone.0090694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24651466	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200245
J	Staege, MS; Muller, K; Kewitz, S; Volkmer, I; Mauz-Korholz, C; Bernig, T; Korholz, D				Staege, Martin S.; Mueller, Katja; Kewitz, Stefanie; Volkmer, Ines; Mauz-Koerholz, Christine; Bernig, Toralf; Koerholz, Dieter			Expression of Dual-Specificity Phosphatase 5 Pseudogene 1 (DUSP5P1) in Tumor Cells	PLOS ONE			English	Article							REED-STERNBERG CELLS; HODGKINS-DISEASE; GENE-EXPRESSION; ENDOGENOUS RETROVIRUSES; DNA-MICROARRAYS; BIM EXPRESSION; LYMPHOMA; VIRUS; EBV; SUPERANTIGEN	Sequencing of individual clones from a newly established cDNA library from the chemoresistant Hodgkin's lymphoma cell line L-1236 led to the isolation of a cDNA clone corresponding to a short sequence from chromosome 1. Reverse transcriptase-polymerase chain reaction indicated high expression of this sequence in Hodgkin's lymphoma derived cell lines but not in normal blood cells. Further characterization of this sequence and the surrounding genomic DNA revealed that this sequence is part of a human endogenous retrovirus locus. The sequence of this endogenous retrovirus is interrupted by a pseudogene of the dual specificity phosphatase 5 (DUSP5). Reverse transcriptase-polymerase chain reaction revealed high expression of this pseudogene (DUSP5P1) in HL cell lines but not in normal blood cells or Epstein-Barr virus-immortalized B cells. Cells from other tumor types (Burkitt's lymphoma, leukemia, neuroblastoma, Ewing sarcoma) also showed a higher DUSP5P1/DUSP5 ratio than normal cells. Furthermore, we observed that higher expression of DUSP5 in relation to DUSP5P1 correlated with the expression of the pro-apoptotic factor B cell leukemia/lymphoma 2-like 11 (BCL2L11) in peripheral blood cells and HL cells. Knock-down of DUSP5 in HL cells resulted in down-regulation of BCL2L11. Thus, the DUSP5/DUSP5P1 system could be responsible for regulation of BCL2L11 leading to inhibition of apoptosis in these tumor cells.	[Staege, Martin S.; Mueller, Katja; Kewitz, Stefanie; Volkmer, Ines; Mauz-Koerholz, Christine; Bernig, Toralf; Koerholz, Dieter] Univ Halle Wittenberg, Dept Pediat, D-06108 Halle, Germany	Martin Luther University Halle Wittenberg	Staege, MS (corresponding author), Univ Halle Wittenberg, Dept Pediat, D-06108 Halle, Germany.	martin.staege@medizin.uni-halle.de	Staege, Martin/AAX-8994-2021; Mauz-Koerholz, Christine/AAX-4349-2020; Körholz, Dieter/AAX-4347-2020	Staege, Martin/0000-0003-3765-7068; 	Peter-Escher-Foundation; Konrad-Adenauer-Stiftung	Peter-Escher-Foundation; Konrad-Adenauer-Stiftung	This work was supported by grants from the Peter-Escher-Foundation for children with cancer and a fellowship from the Konrad-Adenauer-Stiftung (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrarova ND, 2010, MOL BIOL+, V44, P552, DOI 10.1134/S0026893310040084; Aleman BMP, 2007, BLOOD, V109, P1878, DOI 10.1182/blood-2006-07-034405; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambinder Richard F, 2007, Hematology Am Soc Hematol Educ Program, P204, DOI 10.1182/asheducation-2007.1.204; Anderton E, 2008, ONCOGENE, V27, P421, DOI 10.1038/sj.onc.1210668; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Balada E, 2010, INT REV IMMUNOL, V29, P351, DOI 10.3109/08830185.2010.485333; Benharroch D, 2004, BRIT J CANCER, V91, P572, DOI 10.1038/sj.bjc.6601900; Buzdin A, 2007, THESCIENTIFICWORLDJO, V7, P1848, DOI 10.1100/tsw.2007.270; Carbone A, 2008, ONCOLOGIST, V13, P577, DOI 10.1634/theoncologist.2008-0036; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; CHEZZI C, 1976, P NATL ACAD SCI USA, V73, P4649, DOI 10.1073/pnas.73.12.4649; Christensen T, 2010, J NEUROIMMUNE PHARM, V5, P326, DOI 10.1007/s11481-010-9214-y; Clybouw C, 2005, J IMMUNOL, V175, P2968, DOI 10.4049/jimmunol.175.5.2968; DIEHL V, 1981, J CANCER RES CLIN, V101, P111, DOI 10.1007/BF00405072; DREXLER HG, 1986, LEUKEMIA RES, V10, P487, DOI 10.1016/0145-2126(86)90084-6; Emmer A, 2008, SCAND J IMMUNOL, V67, P464, DOI 10.1111/j.1365-3083.2008.02094.x; Farooq A, 2001, MOL CELL, V7, P387, DOI 10.1016/S1097-2765(01)00186-1; Figueiredo CP, 2007, LEUKEMIA LYMPHOMA, V48, P731, DOI 10.1080/10428190701203954; Foell JL, 2008, J IMMUNOL METHODS, V339, P99, DOI 10.1016/j.jim.2008.08.006; Gergely P, 2005, CLIN IMMUNOL, V116, P124, DOI 10.1016/j.clim.2005.04.002; Haase R, 2012, KLIN PADIATR, V224, P377, DOI 10.1055/s-0032-1323824; Habek M, 2008, MULT SCLER, V14, P284, DOI 10.1177/1352458507082600; Hoennscheidt C, 2009, SCAND J IMMUNOL, V70, P216, DOI 10.1111/j.1365-3083.2009.02286.x; Hsiao FC, 2009, VIROLOGY, V385, P261, DOI 10.1016/j.virol.2008.11.025; Huang GS, 2002, INT J ONCOL, V21, P31; Hughes R, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-69; Hwang J, 2013, BMB REP, V46, P9, DOI 10.5483/BMBRep.2013.46.1.002; Jeong DG, 2007, PROTEINS, V66, P253, DOI 10.1002/prot.21224; KAMESAKI H, 1986, BLOOD, V68, P285; Kovanen PE, 2008, J BIOL CHEM, V283, P17362, DOI 10.1074/jbc.M709887200; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Kuppers Ralf, 2009, Hematology Am Soc Hematol Educ Program, P491, DOI 10.1182/asheducation-2009.1.491; Lacroix A, 2010, CLIN CANCER RES, V16, P4711, DOI 10.1158/1078-0432.CCR-10-0470; LAMANTIA G, 1991, NUCLEIC ACIDS RES, V19, P1513; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lin HMJ, 2005, J PEDIAT HEMATOL ONC, V27, P28, DOI 10.1097/01.mph.0000150740.80690.d4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mauz-Korholz C, 2010, J CLIN ONCOL, V28, P3680, DOI 10.1200/JCO.2009.26.9381; McCullough L, 2010, CANCER-AM CANCER SOC, V116, P4866, DOI 10.1002/cncr.25442; Neumann I, 2010, PEDIATR BLOOD CANCER, V55, P464, DOI 10.1002/pbc.22603; NEWELL GR, 1984, CANCER, V54, P1117, DOI 10.1002/1097-0142(19840915)54:6<1117::AID-CNCR2820540633>3.0.CO;2-Y; Ortega-Paino E, 2008, BLOOD, V111, P1617, DOI 10.1182/blood-2007-02-068791; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Paschos K, 2012, NUCLEIC ACIDS RES, V40, P7233, DOI 10.1093/nar/gks391; Paschos K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000492; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Ruprecht K, 2008, CELL MOL LIFE SCI, V65, P3366, DOI 10.1007/s00018-008-8496-1; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Sieniawski M, 2008, ANN ONCOL, V19, P1795, DOI 10.1093/annonc/mdn376; Sospedra Mireia, 2005, PLoS Pathog, V1, pe41; Staege MS, 2008, EXP HEMATOL, V36, P886, DOI 10.1016/j.exphem.2008.02.014; Staege MS, 2003, KLIN PADIATR, V215, P135; Tai AK, 2009, J CLIN VIROL, V46, P47, DOI 10.1016/j.jcv.2009.05.019; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vermeer MH, 2008, CANCER RES, V68, P2689, DOI 10.1158/0008-5472.CAN-07-6398; Villesen Palle, 2004, Retrovirology, V1, P32, DOI 10.1186/1742-4690-1-32; Watanabe M, 2005, CANCER RES, V65, P7628, DOI 10.1158/0008-5472.CAN-05-0925; Watanabe M, 2011, ONCOL RES, V19, P463, DOI 10.3727/096504012X13285365944292; Wolf J, 1996, BLOOD, V87, P3418, DOI 10.1182/blood.V87.8.3418.bloodjournal8783418; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Yip KW, 2004, MOL THER, V10, P533, DOI 10.1016/j.ymthe.2004.05.026; Zheng B, 2003, BLOOD, V102, P1019, DOI 10.1182/blood-2002-11-3507	63	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89577	10.1371/journal.pone.0089577	http://dx.doi.org/10.1371/journal.pone.0089577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24651368	gold, Green Submitted, Green Published			2022-12-27	WOS:000331880700061
J	Brischoux, F; Kornilev, YV				Brischoux, Francois; Kornilev, Yurii V.			Hypernatremia in Dice Snakes (Natrix tessellata) from a Coastal Population: Implications for Osmoregulation in Marine Snake Prototypes	PLOS ONE			English	Article							PELAGIC SEA-SNAKE; SALT-GLANDS; FRESH-WATER; LATICAUDA SPP.; CONVERGENT EVOLUTION; NOTECHIS-SCUTATUS; TIGER SNAKE; ESTUARINE; SALINITY; SODIUM	The widespread relationship between salt excreting structures (e.g., salt glands) and marine life strongly suggests that the ability to regulate salt balance has been crucial during the transition to marine life in tetrapods. Elevated natremia (plasma sodium) recorded in several marine snakes species suggests that the development of a tolerance toward hypernatremia, in addition to salt gland development, has been a critical feature in the evolution of marine snakes. However, data from intermediate stage (species lacking salt glands but occasionally using salty environments) are lacking to draw a comprehensive picture of the evolution of an euryhaline physiology in these organisms. In this study, we assessed natremia of free-ranging Dice snakes (Natrix tessellata, a predominantly fresh water natricine lacking salt glands) from a coastal population in Bulgaria. Our results show that coastal N. tessellata can display hypernatremia (up to 195.5 mmol.l(-1)) without any apparent effect on several physiological and behavioural traits (e.g., hematocrit, body condition, foraging). More generally, a review of natremia in species situated along a continuum of habitat use between fresh- and seawater shows that snake species display a concomitant tolerance toward hypernatremia, even in species lacking salt glands. Collectively, these data suggest that a physiological tolerance toward hypernatremia has been critical during the evolution of an euryhaline physiology, and may well have preceded the evolution of salt glands.	[Brischoux, Francois] CEBC, UMR 7372 CNRS ULR, Villiers En Bois, France; [Kornilev, Yurii V.] NCC Poda, Bulgarian Soc Protect Birds, Burgas, Bulgaria	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Brischoux, F (corresponding author), CEBC, UMR 7372 CNRS ULR, Villiers En Bois, France.	francois.brischoux@gmail.com	Kornilev, Yurii V/N-7035-2013	Kornilev, Yurii V/0000-0002-8596-8728	CNRS (France)	CNRS (France)(Centre National de la Recherche Scientifique (CNRS))	Funding was provided by the CNRS (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babonis LS, 2012, INTEGR COMP BIOL, V52, P245, DOI 10.1093/icb/ics073; Babonis LS, 2011, J EXP BIOL, V214, P2140, DOI 10.1242/jeb.052852; Baha El Din S., 2006, GUIDE REPTILES AMPHI; Bonnet X., 1995, P237; Bonnet X, 2008, AUSTRAL ECOL, V33, P911, DOI 10.1111/j.1442-9993.2008.01917.x; Brischoux F, 2013, COMP BIOCHEM PHYS A, V166, P333, DOI 10.1016/j.cbpa.2013.07.007; Brischoux F, 2012, ECOGRAPHY, V35, P994, DOI 10.1111/j.1600-0587.2012.07717.x; Brischoux F, 2012, INTEGR COMP BIOL, V52, P235, DOI 10.1093/icb/ics081; Campbell T.W, 2004, 55 ANN M AM COLL VET; Carlsson Martin, 2011, Mertensiella, V18, P237; DUGGAN RT, 1978, GEN COMP ENDOCR, V36, P510, DOI 10.1016/0016-6480(78)90090-4; Dunson W.A., 1975, J COMP PHYSL, V101, P89; DUNSON WA, 1983, PHYSIOL ZOOL, V56, P106, DOI 10.1086/physzool.56.1.30159971; DUNSON WA, 1976, J COMP PHYSIOL, V108, P303, DOI 10.1007/BF00691678; DUNSON WA, 1968, AM J PHYSIOL, V215, P1512, DOI 10.1152/ajplegacy.1968.215.6.1512; DUNSON WA, 1973, J COMP PHYSIOL, V86, P193, DOI 10.1007/BF00696339; DUNSON WA, 1974, AM J PHYSIOL, V227, P430, DOI 10.1152/ajplegacy.1974.227.2.430; DUNSON WA, 1971, SCIENCE, V173, P437, DOI 10.1126/science.173.3995.437; DUNSON WA, 1980, COPEIA, P268; DUNSON WA, 1986, COPEIA, P741, DOI 10.2307/1444958; DUNSON WA, 1989, B MAR SCI, V44, P229; Gruschwitz M., 1999, HDB REPTILIEN AMPHIB, V3, P581; Houser DS, 2005, ECOLOGY WATER RELATI, DOI [10.1038/npg.els.0003216, DOI 10.1038/NPG.ELS.0003216)]; Ioannidis Yannis, 2011, Mertensiella, V18, P302; Jelic Dusan, 2011, Mertensiella, V18, P217; Kidera N, 2013, J COMP PHYSIOL A, V199, P191, DOI 10.1007/s00359-012-0782-6; Ladyman M, 2003, J COMP PHYSIOL B, V173, P239, DOI 10.1007/s00360-003-0328-x; Ladyman M, 2006, J COMP PHYSIOL B, V176, P547, DOI 10.1007/s00360-006-0077-8; Lillywhite HB, 2009, J EXP BIOL, V212, P1921, DOI 10.1242/jeb.028704; Lillywhite HB, 2008, PHYSIOL BIOCHEM ZOOL, V81, P785, DOI 10.1086/588306; Lillywhite HB, 2008, BIOSCIENCE, V58, P947, DOI 10.1641/B581008; Lillywhite HB, 2012, INTEGR COMP BIOL, V52, P227, DOI 10.1093/icb/ics039; Mazin J.M., 2001, SECONDARY ADAPTATION; Mebert K., 2011, MERTENSIELLA, V18; Mebert Konrad, 2011, Mertensiella, V18, P234; Mrsic N, 1997, REPTILES REPTILIA SL; Murphy JC, 2012, INTEGR COMP BIOL, V52, P217, DOI 10.1093/icb/ics060; Naumov Borislav, 2011, Mertensiella, V18, P288; Nollert A., 1986, Herpetofauna (Weinstadt), V8, P30; Ortiz RM, 2001, J EXP BIOL, V204, P1831; Peaker M., 1975, SALT GLANDS BIRDS RE; Peterson CC, 2002, CAN J ZOOL, V80, P461, DOI 10.1139/Z02-021; Poda Protected Area Management Plan, 2002, POD PROT AR MAN PLAN; Randall DJ, 2002, ECKERT ANIMAL PHYSL, V5; Roe LJ, 1998, ADV VERT PALEOBIOL, P399; Schmidt-Nielsen K., 1983, ANIMAL PHYSL ADAPTAT; Stoyanov A, 2011, DIE AMPHIBIEN REPTIL; Thieme U., 1986, Sauria, V8, P3; Tome S, 2002, SNAKES WHY DO WE FEA; Tuniyev Boris, 2011, Mertensiella, V18, P343; Zagar Anamarija, 2011, Mertensiella, V18, P207	51	9	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92617	10.1371/journal.pone.0092617	http://dx.doi.org/10.1371/journal.pone.0092617			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658047	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300107
J	Shan, L; Schipper, P; Nonkes, LJP; Homberg, JR				Shan, Ling; Schipper, Pieter; Nonkes, Lourens J. P.; Homberg, Judith R.			Impaired Fear Extinction as Displayed by Serotonin Transporter Knockout Rats Housed in Open Cages Is Disrupted by IVC Cage Housing	PLOS ONE			English	Article							STRESS; ENVIRONMENT; BEHAVIOR; GENE; MICE; GENOTYPE; TESTS	Anxiety disorders are influenced by both environmental and genetic factors. A well-known example for gene x environment interactions in psychiatry is the low activity (s) allelic variant of the serotonin transporter (5-HTT) promoter polymorphism (5-HTTLPR) that in the context of stress increases risk for depression and post-traumatic stress disorder (PTSD). Previously, we observed robust anxiety-related phenotypes, such as an impairment in fear extinction, in 5-HTT knockout (5-HTT-/-) versus wild-type (5-HTT+/+) rats housed in open cages. Recently, housing conditions were changed from open cages to individually ventilated cages (IVC), which are associated with a high ventilation fold and noise. This switch in housing conditions prompted an unplanned 5-HTT gene x environment interaction study in our rats. The current study shows that lifetime stress by means of IVC cage housing abolished genotype differences in fear extinction between 5-HTT-/- and 5-HTT+/+ rats. Although this effect was not attributed specifically to either the 5-HTT+/+ or the 5-HTT-/- genotype, the findings are in agreement with the modulatory role of serotonin in the processing of environmental stimuli. Our findings also underline the possibility that housing conditions confound the interpretation of anxiety-related behaviours in rodents.	[Shan, Ling; Schipper, Pieter; Nonkes, Lourens J. P.; Homberg, Judith R.] Radboud Univ Nijmegen, Med Ctr, Ctr Neurosci, Donders Inst Brain Cognit & Behaviour,Dept Cognit, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Homberg, JR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Ctr Neurosci, Donders Inst Brain Cognit & Behaviour,Dept Cognit, NL-6525 ED Nijmegen, Netherlands.	Judith.Homberg@radboudumc.nl	Shan, Ling/N-7075-2019; Homberg, Judith R/D-2473-2010; Shan, Ling/E-4281-2012; Homberg, J.R./N-4172-2019	Shan, Ling/0000-0002-4765-2474; Shan, Ling/0000-0002-4765-2474; 	Netherlands Organization for Scientific Research (NWO) [864.10.003]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO), grant #864.10.003 awarded to J. R. Homberg. NWO had no further role in the design of the study, in the collection, analysis and interpretation of data.	Bilkei-Gorzo A, 2008, BEHAV BRAIN RES, V186, P289, DOI 10.1016/j.bbr.2007.08.027; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Carroll JC, 2007, BEHAV GENET, V37, P214, DOI 10.1007/s10519-006-9129-9; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Clement Y, 2002, BRAIN RES BULL, V57, P57, DOI 10.1016/S0361-9230(01)00637-2; Heiming RS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.026.2009; Homberg JR, 2007, NEUROSCIENCE, V146, P1662, DOI 10.1016/j.neuroscience.2007.03.030; Homberg JR, 2012, PROG NEUROBIOL, V99, P117, DOI 10.1016/j.pneurobio.2012.08.003; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Jansen F, 2010, BEHAV BRAIN RES, V207, P21, DOI 10.1016/j.bbr.2009.09.033; Joeyen-Waldorf J, 2009, BRAIN RES, V1286, P84, DOI 10.1016/j.brainres.2009.06.079; Kalueff AV, 2010, NEUROSCI BIOBEHAV R, V34, P373, DOI 10.1016/j.neubiorev.2009.08.003; Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064; Lewejohann L, 2006, GENES BRAIN BEHAV, V5, P64, DOI 10.1111/j.1601-183X.2005.00140.x; Muller JM, 2011, GENES BRAIN BEHAV, V10, P166, DOI 10.1111/j.1601-183X.2010.00652.x; Narayanan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022600; Nonkes LJP, 2012, J PSYCHIATR NEUROSCI, V37, P224, DOI 10.1503/jpn.110116; Schipper P, 2011, BEHAV BRAIN RES, V223, P169, DOI 10.1016/j.bbr.2011.04.037; Swaab DF, 2000, PROG BRAIN RES, V126, P369; van der Doelen RHA, 2013, MOL PSYCHIATR, V18, P1244, DOI 10.1038/mp.2012.186; Wahlsten D, 2006, P NATL ACAD SCI USA, V103, P16364, DOI 10.1073/pnas.0605342103	21	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91472	10.1371/journal.pone.0091472	http://dx.doi.org/10.1371/journal.pone.0091472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658187	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300034
J	Cody, JJ; Markert, JM; Hurst, DR				Cody, James J.; Markert, James M.; Hurst, Douglas R.			Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; TRICHOSTATIN; EFFICACY; MUTANT; GLIOMA; RISK; G207	New therapies are needed for metastatic breast cancer patients. Oncolytic herpes simplex virus (oHSV) is an exciting therapy being developed for use against aggressive tumors and established metastases. Although oHSV have been demonstrated safe in clinical trials, a lack of sufficient potency has slowed the clinical application of this approach. We utilized histone deacetylase (HDAC) inhibitors, which have been noted to impair the innate antiviral response and improve gene transcription from viral vectors, to enhance the replication of oHSV in breast cancer cells. A panel of chemically diverse HDAC inhibitors were tested at three different doses (<, =, and >LD50) for their ability to modulate the replication of oHSV in breast cancer cells. Several of the tested HDAC inhibitors enhanced oHSV replication at low multiplicity of infection (MOI) following pre-treatment of the metastatic breast cancer cell line MDA-MB-231 and the oHSV-resistant cell line 4T1, but not in the normal breast epithelial cell line MCF10A. Inhibitors of class I HDACs, including pan-selective compounds, were more effective for increasing oHSV replication compared to inhibitors that selectively target class II HDACs. These studies demonstrate that select HDAC inhibitors increase oHSV replication in breast cancer cells and provides support for preclinical evaluation of this combination strategy.	[Cody, James J.; Hurst, Douglas R.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Markert, James M.] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Hurst, DR (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	dhurst@uab.edu		Hurst, Douglas/0000-0002-1296-2210	American Cancer Society [RSG-11-259-01-CSM]; METAvivor Research and Support, Inc.; National Institutes of Health [P50 CA097247, P01 CA71933]; NATIONAL CANCER INSTITUTE [P50CA097247, P01CA071933] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); METAvivor Research and Support, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by funding from the American Cancer Society RSG-11-259-01-CSM (DRH), METAvivor Research and Support, Inc. (DRH), and the National Institutes of Health P50 CA097247 and P01 CA71933 (JMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Breckenridge CA, 2012, J VIROL, V86, P4566, DOI 10.1128/JVI.05545-11; Andreansky S, 1998, GENE THER, V5, P121, DOI 10.1038/sj.gt.3300550; Bowles EJA, 2012, JNCI-J NATL CANCER I, V104, P1293, DOI 10.1093/jnci/djs317; Campadelli-Fiume G, 2011, REV MED VIROL, V21, P213, DOI 10.1002/rmv.691; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; Cody JJ, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/628697; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Hellums EK, 2005, NEURO-ONCOLOGY, V7, P213, DOI 10.1215/S1152851705000074; Hurst DR, 2008, J BIOL CHEM, V283, P7438, DOI 10.1074/jbc.M709446200; Hurst DR, 2009, CLIN EXP METASTAS, V26, P89, DOI 10.1007/s10585-008-9216-9; Kanai R, 2010, FUTURE ONCOL, V6, P619, DOI [10.2217/fon.10.18, 10.2217/FON.10.18]; Katsura T, 2009, CANCER GENE THER, V16, P237, DOI 10.1038/cgt.2008.81; Liu TC, 2008, MOL THER, V16, P1041, DOI 10.1038/mt.2008.58; MacTavish H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014462; Markert JM, 2012, J VIROL, V86, P5304, DOI 10.1128/JVI.06998-11; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; Markert JM, 2000, GENE THER, V7, P867, DOI 10.1038/sj.gt.3301205; Nguyen TLA, 2010, CYTOKINE GROWTH F R, V21, P153, DOI 10.1016/j.cytogfr.2010.03.002; Nguyen TLA, 2008, P NATL ACAD SCI USA, V105, P14981, DOI 10.1073/pnas.0803988105; Otsuki A, 2008, MOL THER, V16, P1546, DOI 10.1038/mt.2008.155; Ottolino-Perry K, 2010, MOL THER, V18, P251, DOI 10.1038/mt.2009.283; Parker JN, 2000, P NATL ACAD SCI USA, V97, P2208, DOI 10.1073/pnas.040557897; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smith KT, 2009, INT J BIOCHEM CELL B, V41, P21, DOI 10.1016/j.biocel.2008.09.008; THOMAS D, 2003, MANAGE TODAY     JAN, P8	27	38	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92919	10.1371/journal.pone.0092919	http://dx.doi.org/10.1371/journal.pone.0092919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651853	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800166
J	Mendoza, JD; Caso, WS; Valdez, CT; Pons, MJ; del Valle, LJ; Ore, VC; Michelena, DC; Mayra, JB; Gavidea, VZ; Vargas, M; Ruiz, J				del Valle Mendoza, Juana; Silva Caso, Wilmer; Tinco Valdez, Carmen; Pons, Maria J.; del Valle, Luis J.; Casabona Ore, Veronica; Champin Michelena, Denisse; Bazan Mayra, Jorge; Zavaleta Gavidea, Victor; Vargas, Martha; Ruiz, Joaquim			Diagnosis of Carrion's Disease by Direct Blood PCR in Thin Blood Smear Negative Samples	PLOS ONE			English	Article							BARTONELLA-BACILLIFORMIS; INFECTION; IDENTIFICATION; OUTBREAK; ENTRY; FEVER	Bartonella bacilliformis is the etiologic agent of Carrion's disease. This disease has two well established phases, the most relevant being the so called Oroya Fever, in which B. bacilliformis infect the erythrocytes resulting in severe anemia and transient immunosuppression, with a high lethality in the absence of adequate antibiotic treatment. The presence of B. bacilliformis was studied in 113 blood samples suspected of Carrion's disease based on clinical criteria, despite the absence of a positive thin blood smear, by two different PCR techniques (using Bartonella-specific and universal 16S rRNA gene primers), and by bacterial culture. The specific 16S rRNA gene primers revealed the presence of 21 B. bacilliformis and 1 Bartonella elizabethae, while universal primers showed both the presence of 3 coinfections in which a concomitant pathogen was detected plus Bartonella, in addition to the presence of infections by other microorganisms such as Agrobacterium or Bacillus firmus. These data support the need to implement molecular tools to diagnose Carrion's disease.	[del Valle Mendoza, Juana; Silva Caso, Wilmer; Casabona Ore, Veronica; Champin Michelena, Denisse] Univ Peruana Ciencias Aplicadas UPC, Fac Ciencias Salud, Lima, Peru; [del Valle Mendoza, Juana; Tinco Valdez, Carmen; Casabona Ore, Veronica] Inst Invest Nutr, Lima, Peru; [Pons, Maria J.; Ruiz, Joaquim] Univ Barcelona, Hosp Clin Barcelona, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [del Valle, Luis J.] Univ Politecn Cataluna, Barcelona, Spain; [Bazan Mayra, Jorge; Zavaleta Gavidea, Victor] DIRESA Cajamarca, Direcc Reg Salud Cajamarca, Cajamarca, Peru; [Vargas, Martha] Hosp Clin Barcelona, IDIBAPS, Fdn Clin, Barcelona, Spain	Universidad Peruana de Ciencias Aplicadas (UPC); ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Universitat Politecnica de Catalunya; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Mendoza, JD (corresponding author), Univ Peruana Ciencias Aplicadas UPC, Fac Ciencias Salud, Lima, Peru.	jdelvall@upc.edu.pe	Silva, Wilmer Gianfranco/D-2699-2018; Ruiz, Joaquim/D-2704-2013; CASABONA ORE, VERONICA DANIXA/F-1248-2018; Pons, Maria J/Q-6516-2016; del Valle Mendoza, Juana/C-9805-2018; Del Valle, Luis J./I-1342-2015	Silva, Wilmer Gianfranco/0000-0003-1086-8084; Ruiz, Joaquim/0000-0002-4431-2036; CASABONA ORE, VERONICA DANIXA/0000-0002-9922-3786; del Valle Mendoza, Juana/0000-0002-6011-5040; Del Valle, Luis J./0000-0001-9916-1741; CHAMPIN MICHELENA, DENISSE/0000-0002-7563-8661; Vargas, Martha/0000-0002-6260-4403; Pons, Maria Jesus/0000-0001-8384-2315; Zavaleta Gavidia, Victor/0000-0003-1760-4241; Bazan Mayra, jorge enrique/0000-0002-9984-8196	Optimus Foundation; JdVM; program I3, of the ISCIII [CES11/012]; ISCIII [PI11/00983]	Optimus Foundation; JdVM; program I3, of the ISCIII; ISCIII(Instituto de Salud Carlos III)	This work has been partially supported by Optimus Foundation and by personal funds of JdVM. JR is supported by the program I3, of the ISCIII (grant number: CES11/012) and by ISCIII grant PI11/00983. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENSON LA, 1986, INFECT IMMUN, V54, P347, DOI 10.1128/IAI.54.2.347-353.1986; BREÑA CHÁVEZ Judith Patricia, 2006, Rev Med Hered, V17, P122; Chamberlin J, 2002, J INFECT DIS, V186, P983, DOI 10.1086/344054; Chinga-Alayo E, 2004, T ROY SOC TROP MED H, V98, P116, DOI 10.1016/S0035-9203(03)00017-8; Clemente NS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001819; de Vegas EZS, 2006, INFECT CONT HOSP EP, V27, P397, DOI 10.1086/503177; del Valle LJ, 2014, J MICROBIOL RES, V2, P15; del Valle LJ, 2010, INT J INFECT DIS, V14, pE506, DOI 10.1016/j.ijid.2009.07.025; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Eicher SC, 2012, CELL MICROBIOL, V14, P1166, DOI 10.1111/j.1462-5822.2012.01806.x; Ellis BA, 1999, AM J TROP MED HYG, V61, P344; Eremeeva ME, 2007, NEW ENGL J MED, V356, P2381, DOI 10.1056/NEJMoa065987; Garcia-Esteban C, 2008, J CLIN MICROBIOL, V46, P776, DOI 10.1128/JCM.01720-07; Gray KJ, 2000, J INFECTION, V41, P227, DOI 10.1053/jinf.2000.0730; Henríquez César, 2002, Rev Med Hered, V13, P58; Ihler GM, 1996, FEMS MICROBIOL LETT, V144, P1, DOI [10.1016/0378-1097(96)00307-2, 10.1111/j.1574-6968.1996.tb08501.x]; Liberto MC, 2013, J MED MICROBIOL, V62, P1081, DOI 10.1099/jmm.0.050617-0; Liberto MC, 2011, MOL CELL PROBE, V25, P238, DOI 10.1016/j.mcp.2011.07.001; Lu JJ, 2000, J CLIN MICROBIOL, V38, P2076; Maguina C, 2000, INFECT DIS CLIN N AM, V14, P1, DOI 10.1016/S0891-5520(05)70215-4; Pachas P, 2000, SERIE MODULOS TECNIC; Paphitou NI, 2003, INFECTION, V31, P421, DOI 10.1007/s15010-003-3175-5; Rolain JM, 2003, J CLIN MICROBIOL, V41, P4001, DOI 10.1128/JCM.41.8.4001-4002.2003; Ruiz J, 2012, BLOOD TRANSFUS-ITALY, V10, P563, DOI 10.2450/2012.0152-11; Smit PW, 2013, AM J TROP MED HYG, V89, P988, DOI 10.4269/ajtmh.13-0246; Song SH, 2009, J MED MICROBIOL, V58, P270, DOI 10.1099/jmm.0.004697-0; Ticona E, 2010, MED HYPOTHESES, V74, P45, DOI 10.1016/j.mehy.2009.06.054; Tokuyasu H, 2012, INTERNAL MED, V51, P1133, DOI 10.2169/internalmedicine.51.6930	28	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92283	10.1371/journal.pone.0092283	http://dx.doi.org/10.1371/journal.pone.0092283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651298	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800093
J	Kinney, NA; Sharakhov, IV; Onufriev, AV				Kinney, Nicholas Allen; Sharakhov, Igor V.; Onufriev, Alexey V.			Investigation of the Chromosome Regions with Significant Affinity for the Nuclear Envelope in Fruit Fly - A Model Based Approach	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; SPATIAL-ORGANIZATION; 3-DIMENSIONAL ORGANIZATION; POLYTENE CHROMOSOMES; CHROMATIN; DNA; DYNAMICS; GENE; ARCHITECTURE; DOMAINS	Three dimensional nuclear architecture is important for genome function, but is still poorly understood. In particular, little is known about the role of the "boundary conditions'' - points of attachment between chromosomes and the nuclear envelope. We describe a method for modeling the 3D organization of the interphase nucleus, and its application to analysis of chromosome-nuclear envelope (Chr-NE) attachments of polytene (giant) chromosomes in Drosophila melanogaster salivary glands. The model represents chromosomes as self-avoiding polymer chains confined within the nucleus; parameters of the model are taken directly from experiment, no fitting parameters are introduced. Methods are developed to objectively quantify chromosome territories and intertwining, which are discussed in the context of corresponding experimental observations. In particular, a mathematically rigorous definition of a territory based on convex hull is proposed. The self-avoiding polymer model is used to re-analyze previous experimental data; the analysis suggests 33 additional Chr-NE attachments in addition to the 15 already explored Chr-NE attachments. Most of these new Chr-NE attachments correspond to intercalary heterochromatin - gene poor, dark staining, late replicating regions of the genome; however, three correspond to euchromatin - gene rich, light staining, early replicating regions of the genome. The analysis also suggests 5 regions of anti-contact, characterized by aversion for the NE, only two of these correspond to euchromatin. This composition of chromatin suggests that heterochromatin may not be necessary or sufficient for the formation of a Chr-NE attachment. To the extent that the proposed model represents reality, the confinement of the polytene chromosomes in a spherical nucleus alone does not favor the positioning of specific chromosome regions at the NE as seen in experiment; consequently, the 15 experimentally known Chr-NE attachment positions do not appear to arise due to non-specific (entropic) forces. Robustness of the key conclusions to model assumptions is thoroughly checked.	[Kinney, Nicholas Allen] Virginia Tech, Blacksburg, VA USA; [Sharakhov, Igor V.] Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA; [Onufriev, Alexey V.] Virginia Tech, Dept Phys, Blacksburg, VA USA; [Onufriev, Alexey V.] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Sharakhov, IV (corresponding author), Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA.	igor@vt.edu; alexey@cs.vt.edu	Sharakhov, Igor/B-1972-2008; Kinney, Nicholas/I-7168-2016	Sharakhov, Igor/0000-0003-0752-3747; Kinney, Nicholas/0000-0002-4563-1813; Onufriev, Alexey/0000-0002-4930-6612	graduate program in Genomics Bioinformatics and Computational Biology (GBCB) of Virginia Tech; National Institutes of Health [1R21AI094289, R01 GM099450]; NSF [CNS-0960081]; HokieSpeed supercomputer at Virginia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099450] Funding Source: NIH RePORTER	graduate program in Genomics Bioinformatics and Computational Biology (GBCB) of Virginia Tech; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); HokieSpeed supercomputer at Virginia Tech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by the graduate program in Genomics Bioinformatics and Computational Biology (GBCB) of Virginia Tech to Nicholas Kinney and by the grants from the National Institutes of Health 1R21AI094289 to Igor V. Sharakhov and R01 GM099450 to Alexey V. Onufriev. This work was also supported in part by the NSF grant CNS-0960081 and the HokieSpeed supercomputer at Virginia Tech. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2013, NAT CELL BIOL, V15, P694, DOI 10.1038/ncb2745; Albert B, 2013, J CELL BIOL, V202, P201, DOI 10.1083/jcb.201208186; Baricheva EA, 1996, GENE, V171, P171, DOI 10.1016/0378-1119(96)00002-9; Bau D, 2011, CHROMOSOME RES, V19, P25, DOI 10.1007/s10577-010-9167-2; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Bohn M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014428; Cacciuto A, 2006, NANO LETT, V6, P901, DOI 10.1021/nl052351n; Caracciolo S, 1998, PHYS REV E, V57, pR1215, DOI 10.1103/PhysRevE.57.R1215; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Colby R.H., 2003, POLYM PHYS; Cook PR, 2009, J CELL BIOL, V186, P825, DOI 10.1083/jcb.200903083; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Daban JR, 2003, BIOCHEM CELL BIOL, V81, P91, DOI 10.1139/o03-037; DAYANTIS J, 1994, PHYS REV B, V49, P3217, DOI 10.1103/PhysRevB.49.3217; De Gennes PG., 1979, SCALING CONCEPTS POL; de Nooijer S, 2009, NUCLEIC ACIDS RES, V37, P3558, DOI 10.1093/nar/gkp219; Demakov SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-566; Dietzel S, 1998, CHROMOSOME RES, V6, P25, DOI 10.1023/A:1009262223693; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Finan K, 2011, CHROMOSOME RES, V19, P53, DOI 10.1007/s10577-010-9150-y; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Gilbert LI, 2008, MOL CELL ENDOCRINOL, V293, P25, DOI 10.1016/j.mce.2008.02.009; Gonzalez-Melendi P, 2000, J MICROSC-OXFORD, V198, P199, DOI 10.1046/j.1365-2818.2000.00701.x; Grosberg A. I. U., 2011, GIANT MOL HERE THERE; Grosberg A.Y., 1994, STAT PHYS MACROMOLEC; GRUENBAUM Y, 1984, J CELL SCI, P223; GUTTMANN AJ, 1989, J PHYS A-MATH GEN, V22, P2807, DOI 10.1088/0305-4470/22/14/027; HAHNFELDT P, 1993, P NATL ACAD SCI USA, V90, P7854, DOI 10.1073/pnas.90.16.7854; Heermann DW, 2012, METHODS, V58, P307, DOI 10.1016/j.ymeth.2012.04.010; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; HOCHSTRASSER M, 1987, J CELL BIOL, V104, P1455, DOI 10.1083/jcb.104.6.1455; HOCHSTRASSER M, 1987, CHROMOSOMA, V95, P197, DOI 10.1007/BF00330351; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Jerabek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037525; Jinfeng Zhang RC, 2003, J CHEM PHYS, V118, P7; Jun S, 2008, ARXIV08082646; Jun S, 2006, P NATL ACAD SCI USA, V103, P12388, DOI 10.1073/pnas.0605305103; KREMER K, 1990, J CHEM PHYS, V92, P5057, DOI 10.1063/1.458541; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; Lowenstein MG, 2004, MOL BIOL CELL, V15, P5678, DOI 10.1091/mbc.E04-04-0289; MADRAS N, 1988, J STAT PHYS, V50, P109, DOI 10.1007/BF01022990; Marshall WF, 1996, MOL BIOL CELL, V7, P825, DOI 10.1091/mbc.7.5.825; Marshall WF, 2001, CURR BIOL, V11, P569, DOI 10.1016/S0960-9822(01)00180-4; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Marti-Renom MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002125; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; MATHOG D, 1984, NATURE, V308, P414, DOI 10.1038/308414a0; MATHOG D, 1989, GENETICS, V121, P293; MATLAB, 2010, MATLAB 2010 VERS 7 1; Michael Plischke BB, 2006, EQUILIBRIUM STAT PHY; Mirny LA, 2011, CHROMOSOME RES, V19, P37, DOI 10.1007/s10577-010-9177-0; Munkel C, 1998, PHYS REV E, V57, P5888, DOI 10.1103/PhysRevE.57.5888; Munkel C, 1999, J MOL BIOL, V285, P1053, DOI 10.1006/jmbi.1998.2361; Neal Madras GS, 1993, SELF AVOIDING WALK; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Riddle NC, 2009, BIOCHEM CELL BIOL, V87, P229, DOI 10.1139/O08-119; Rosa A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000153; ROSENBLUTH MN, 1955, J CHEM PHYS, V23, P356, DOI 10.1063/1.1741967; Rzepecki R, 1998, J CELL SCI, V111, P121; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Tokuda N, 2012, BIOPHYS J, V102, P296, DOI 10.1016/j.bpj.2011.12.005; van Bemmel JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015013; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Wako T, 2010, CYTOGENET GENOME RES, V129, P55, DOI 10.1159/000314639; Wong H, 2013, NUCLEUS, V4; Wong H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000877; Wong H, 2012, CURR BIOL, V22, P1881, DOI 10.1016/j.cub.2012.07.069; Wong H, 2009, BIOESSAYS, V31, P1357, DOI 10.1002/bies.200900062; Zhao K, 1996, FEBS LETT, V380, P161, DOI 10.1016/0014-5793(96)00034-8; Zhimolev IF, 1996, ADV GENET, V34, P1; Zhimulev IF, 2003, CHROMOSOMA, V111, P377, DOI 10.1007/s00412-002-0218-0; Zhimulev IF, 2012, BIOESSAYS, V34, P498, DOI 10.1002/bies.201100142; Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686	80	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91943	10.1371/journal.pone.0091943	http://dx.doi.org/10.1371/journal.pone.0091943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651400	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800056
J	Galvan-Diaz, AL; Magnet, A; Fenoy, S; Henriques-Gil, N; Haro, M; Gordo, FP; Miro, G; del Aguila, C; Izquierdo, F; Millan, J				Luz Galvan-Diaz, Ana; Magnet, Angela; Fenoy, Soledad; Henriques-Gil, Nuno; Haro, Maria; Ponce Gordo, Francisco; Miro, Guadalupe; del Aguila, Carmen; Izquierdo, Fernando; Millan, Javier			Microsporidia Detection and Genotyping Study of Human Pathogenic E. bieneusi in Animals from Spain	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ENTEROCYTOZOON-BIENEUSI; MOLECULAR CHARACTERIZATION; ENCEPHALITOZOON-CUNICULI; AIDS PATIENT; IDENTIFICATION; SAMPLES; EPIDEMIOLOGY; INFECTIONS; CULTURE	Microsporidia are ubiquitous parasites infecting all animal phyla and we present evidence that supports their zoonotic potential. Fecal samples taken from domestic (cats and dogs), farm (pigs, rabbits and ostriches) and wild animals (foxes) from different provinces of Spain were evaluated for microsporidia infection by light microscopy and PCR. After Microsporidia species identification, E. bieneusi genotypes were additionally studied by sequence analysis of the ITS region. Eighty-five samples out of 159 exhibited structures that were compatible with microsporidia spores by Webers stain with 37 of them being confirmed by PCR. Microsporidia species identified included E. bieneusi, E. intestinalis and A. algerae. We report the first diagnosis of E. intestinalis and E. bieneusi in ostriches and A. algerae in pigs. We also provide new information on the molecular characterization of E. bieneusi isolates both in rabbits and ostriches. All of the E. bieneusi genotypes identified belonged to the zoonotic group of genotypes (Group I) including genotypes A (dogs), I (pigs), D (rabbits and foxes) and type IV (ostriches). Our results demonstrate that microsporidia are present in domestic, farm and wild animals in Spain, corroborating their potential role as a source of human infection and environmental contamination.	[Luz Galvan-Diaz, Ana; Magnet, Angela; Fenoy, Soledad; Haro, Maria; del Aguila, Carmen; Izquierdo, Fernando] Univ San Pablo CEU, Fac Farm, Madrid, Spain; [Luz Galvan-Diaz, Ana] Univ Antioquia, Escuela Microbiol, Grp Parasitol, Medellin, Colombia; [Henriques-Gil, Nuno] Univ San Pablo CEU, Fac Med, Madrid, Spain; [Ponce Gordo, Francisco] Univ Complutense Madrid, Fac Farm, Madrid, Spain; [Miro, Guadalupe] Univ Complutense Madrid, Fac Vet, Madrid, Spain; [Millan, Javier] Univ Andres Bello, Fac Ecol & Nat Resources, Santiago, Chile	San Pablo CEU University; Universidad de Antioquia; San Pablo CEU University; Complutense University of Madrid; Complutense University of Madrid; Universidad Andres Bello	Izquierdo, F (corresponding author), Univ San Pablo CEU, Fac Farm, Madrid, Spain.	ferizqui@ceu.es	MIRO, GUADALUPE/A-9666-2019; Ponce-Gordo, Francisco/Q-2469-2017; Magnet, Angela/G-5325-2013; Arias, Fernando Izquierdo/AAE-3073-2019; Fenoy, Soledad/A-9633-2016; del Aguila, Carmen/A-6063-2016; Millan, Javier/B-5399-2008; Ponce-Gordo, Francisco/AAL-7138-2020	MIRO, GUADALUPE/0000-0003-0981-2470; Magnet, Angela/0000-0002-8642-4343; Arias, Fernando Izquierdo/0000-0003-0367-007X; Fenoy, Soledad/0000-0002-5218-6308; del Aguila, Carmen/0000-0003-0063-7899; Millan, Javier/0000-0001-5608-781X; Ponce-Gordo, Francisco/0000-0001-9034-8606	Instituto de Salud Carlos III; FEDER [FIS-PI061593]; USP-CEU [PC04/07]; Colciencias (Antioquia University, Colombia) in Spain; Ministerio de Educacion y Ciencia de Espana (FPU grant) [AP2009-0415]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER(European Commission); USP-CEU; Colciencias (Antioquia University, Colombia) in Spain; Ministerio de Educacion y Ciencia de Espana (FPU grant)(German Research Foundation (DFG))	This work was funded by grants from Instituto de Salud Carlos III and FEDER (FIS-PI061593); and USP-CEU (PC04/07). Ana Luz Galvan-Diaz was supported in Spain by an overseas fellowship from Colciencias (Antioquia University, Colombia). Angela Magnet was supported by Ministerio de Educacion y Ciencia de Espana (FPU grant AP2009-0415). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Acosta N, 2005, T ROY SOC TROP MED H, V99, P848, DOI 10.1016/j.trstmh.2005.05.010; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; Andreu-Ballester JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062107; Cali A, 2005, FOLIA PARASIT, V52, P51, DOI 10.14411/fp.2005.007; Cali A, 2004, J EUKARYOT MICROBIOL, V51, P678, DOI 10.1111/j.1550-7408.2004.tb00608.x; Cali A, 2010, J EUKARYOT MICROBIOL, V57, P562, DOI 10.1111/j.1550-7408.2010.00510.x; da Silva AJ, 1999, MOL DIAGN, V4, P57, DOI 10.1016/S1084-8592(99)80050-2; Dado D, 2012, ZOONOSES PUBLIC HLTH, V59, P23, DOI 10.1111/j.1863-2378.2011.01411.x; DaSilva AJ, 1996, J CLIN MICROBIOL, V34, P986, DOI 10.1128/JCM.34.4.986-987.1996; DaSilva AJ, 1997, MOL DIAGN, V2, P47, DOI 10.1016/S1084-8592(97)80010-0; DEGROOTE MA, 1995, J INFECT DIS, V171, P1375, DOI 10.1093/infdis/171.5.1375; Del Aguila C, 1999, J EUKARYOT MICROBIOL, V46, p8S; del Aguila C, 2001, J CLIN MICROBIOL, V39, P1105, DOI 10.1128/JCM.39.3.1105-1108.2001; Del Aguila C, 1997, J EUKARYOT MICROBIOL, V44, p84S, DOI 10.1111/j.1550-7408.1997.tb05798.x; delAguila C, 1997, J CLIN MICROBIOL, V35, P1862, DOI 10.1128/JCM.35.7.1862-1866.1997; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier ES, 2004, VET PARASITOL, V126, P145, DOI 10.1016/j.vetpar.2004.09.006; Dowd Scot E., 2003, Journal of Water and Health, V1, P117; Galvan AL, 2011, J CLIN MICROBIOL, V49, P1301, DOI 10.1128/JCM.01833-10; Ghosh Kaya, 2009, Interdiscip Perspect Infect Dis, V2009, P926521, DOI 10.1155/2009/926521; Gray ML, 1998, AVIAN DIS, V42, P832, DOI 10.2307/1592726; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Haro M, 2005, APPL ENVIRON MICROB, V71, P3153, DOI 10.1128/AEM.71.6.3153-3157.2005; Haro M, 2006, J EUKARYOT MICROBIOL, V53, pS58, DOI 10.1111/j.1550-7408.2006.00173.x; Henriques-Gil N, 2010, APPL ENVIRON MICROB, V76, P3333, DOI 10.1128/AEM.03026-09; Izquierdo F, 2011, WATER RES, V45, P4837, DOI 10.1016/j.watres.2011.06.033; Kasickova D, 2009, VET PARASITOL, V165, P125, DOI 10.1016/j.vetpar.2009.06.033; Li W, 2012, INT J PARASITOL, V42, P287, DOI 10.1016/j.ijpara.2012.01.003; Lopez-Velez R, 1999, J TRAVEL MED, V6, P223, DOI 10.1111/j.1708-8305.1999.tb00522.x; Lores B, 2002, MEM I OSWALDO CRUZ, V97, P941, DOI 10.1590/S0074-02762002000700003; Lores B, 2002, CLIN INFECT DIS, V34, P918, DOI 10.1086/339205; Galvan AL, 2013, APPL ENVIRON MICROB, V79, P449, DOI 10.1128/AEM.02737-12; Magnet A, 2012, PARASITOL RES, V111, P383, DOI 10.1007/s00436-012-2849-2; Mathis A, 2005, CLIN MICROBIOL REV, V18, P423, DOI 10.1128/CMR.18.3.423-445.2005; Matos Olga, 2012, J Parasitol Res, V2012, P981424, DOI 10.1155/2012/981424; Santin M, 2008, AM J TROP MED HYG, V79, P215, DOI 10.4269/ajtmh.2008.79.215; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Santin M, 2009, J EUKARYOT MICROBIOL, V56, P34, DOI 10.1111/j.1550-7408.2008.00380.x; Snowden K, 1999, AVIAN DIS, V43, P779, DOI 10.2307/1592748; Sulaiman IM, 2004, PARASITOL RES, V92, P328, DOI 10.1007/s00436-003-1049-5; Sulaiman IM, 2003, APPL ENVIRON MICROB, V69, P4495, DOI 10.1128/AEM.69.8.4495-4501.2003; Thellier M, 2008, PARASITE, V15, P349, DOI 10.1051/parasite/2008153349; Visvesvara GS, 1999, J EUKARYOT MICROBIOL, V46, p10S; VISVESVARA GS, 1994, J CLIN MICROBIOL, V32, P2760, DOI 10.1128/JCM.32.11.2760-2768.1994; WEBER R, 1992, NEW ENGL J MED, V326, P161, DOI 10.1056/NEJM199201163260304; Zhang X, 2011, J CLIN MICROBIOL, V49, P2006, DOI 10.1128/JCM.00372-11	46	55	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92289	10.1371/journal.pone.0092289	http://dx.doi.org/10.1371/journal.pone.0092289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651457	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800096
J	Nyambega, B; Helbig, C; Masiga, DK; Clayton, C; Levin, MJ				Nyambega, Benson; Helbig, Claudia; Masiga, Daniel K.; Clayton, Christine; Levin, Mariano J.			Proteins Associated with SF3a60 in T. brucei	PLOS ONE			English	Article							SPLICING FACTOR SF3A; BOX RNA HELICASE; TRYPANOSOMA-BRUCEI; MESSENGER-RNA; BLOOD-STREAM; YEAST GENES; HEAT-SHOCK; U2 SNRNP; COMPLEX; PRP9	Trypanosoma brucei relies on Spliced leader trans splicing to generate functional messenger RNAs. Trans splicing joins the specialized SL exon from the SL RNA to pre-mRNAs and is mediated by the trans-spliceosome, which is made up of small nuclear ribonucleoprotein particles and non-snRNP factors. Although the trans spliceosome is essential for trypanosomatid gene expression, not all spliceosomal protein factors are known and of these, only a few are completely characterized. In this study, we have characterized the trypanosome Splicing Factor, SF3a60, the only currently annotated SF3a component. As expected, epitope-tagged SF3a60 localizes in the trypanosome nucleus. SF3a60 is essential for cell viability but its depletion seem to have no detectable effect on trans-splicing. In addition, we used SF3a60 as bait in a Yeast-2-hybrid system screen and identified its interacting protein factors. The interactions with SF3a120, SF3a66 and SAP130 were confirmed by tandem affinity purification and mass spectrometry.	[Nyambega, Benson; Levin, Mariano J.] Inst Invest Ingn Genet & Biol Mol INGEBI, Lab Biol Mol Enfermedad Chagas, Buenos Aires, DF, Argentina; [Nyambega, Benson; Masiga, Daniel K.] Int Ctr Insect Physiol & Ecol, Dept Mol Biol & Biotechnol, Nairobi, Kenya; [Nyambega, Benson; Helbig, Claudia; Clayton, Christine] Heidelberg Univ, Zentrum Mol Biol, Heidelberg, Germany	International Centre of Insect Physiology & Ecology (ICIPE); Ruprecht Karls University Heidelberg	Nyambega, B (corresponding author), Maseno Univ, Dept Med Biochem, Kisumu, Kenya.	nyambegadnaubaar@gmail.com	Nyambega, Benson/GOH-3417-2022	Nyambega, Benson/0000-0002-0947-0354; Masiga, Daniel/0000-0001-7513-0887	World Health Organization/Special Program for Research and Training in Tropical Diseases (TDR) [A50737]; European Molecular Biology Organization;  [Sonderforschungsbereich 544]	World Health Organization/Special Program for Research and Training in Tropical Diseases (TDR); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); 	This research has been supported by grants from the World Health Organization/Special Program for Research and Training in Tropical Diseases (TDR ID. A50737) to BN. Fellowships from Sonderforschungsbereich 544 and the European Molecular Biology Organization is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; Ambrosio DL, 2009, EUKARYOT CELL, V8, P990, DOI 10.1128/EC.00075-09; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; BENNETT M, 1993, SCIENCE, V262, P105, DOI 10.1126/science.8211113; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Chang KJ, 2009, RNA, V15, P1729, DOI 10.1261/rna.1625309; CHANG TH, 1988, MOL CELL BIOL, V8, P2379, DOI 10.1128/MCB.8.6.2379; CHAPON C, 1992, EMBO J, V11, P3279, DOI 10.1002/j.1460-2075.1992.tb05406.x; Chen JJ, 2001, J MOL BIOL, V314, P683, DOI 10.1006/jmbi.2001.5162; Colasante C, 2006, EUKARYOT CELL, V5, P1194, DOI 10.1128/EC.00096-06; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Das A, 2006, MOL BIOCHEM PARASIT, V150, P201, DOI 10.1016/j.molbiopara.2006.08.002; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; EVERS R, 1989, CELL, V56, P585, DOI 10.1016/0092-8674(89)90581-3; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Greiner EF, 2000, P NATL ACAD SCI USA, V97, P7160, DOI 10.1073/pnas.97.13.7160; Gunzl A, 2010, EUKARYOT CELL, V9, P1159, DOI 10.1128/EC.00113-10; Haile S, 2007, MOL BIOCHEM PARASIT, V151, P52, DOI 10.1016/j.molbiopara.2006.10.005; Hartmann C, 2007, EUKARYOT CELL, V6, P1964, DOI 10.1128/EC.00279-07; Hendriks EF, 2003, J BIOL CHEM, V278, P26870, DOI 10.1074/jbc.M302405200; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hong WJ, 1997, NUCLEIC ACIDS RES, V25, P354, DOI 10.1093/nar/25.2.354; Jae N, 2011, RNA BIOL, V8, P90, DOI 10.4161/rna.8.1.13985; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Kao HY, 1996, MOL CELL BIOL, V16, P960; Kondo-Okamoto N, 2008, EMBO REP, V9, P63, DOI 10.1038/sj.embor.7401113; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; KRAMER A, 1994, NUCLEIC ACIDS RES, V22, P5223, DOI 10.1093/nar/22.24.5223; KRAMER A, 1995, RNA, V1, P260; KRAMER A, 1992, MOL CELL BIOL, V12, P4545; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuwasako K, 2006, STRUCTURE, V14, P1677, DOI 10.1016/j.str.2006.09.009; LEGRAIN P, 1991, MOL GEN GENET, V225, P199, DOI 10.1007/BF00269848; LEGRAIN P, 1990, EMBO J, V9, P2775, DOI 10.1002/j.1460-2075.1990.tb07465.x; LEGRAIN P, 1993, SCIENCE, V262, P108, DOI 10.1126/science.8211114; LEGRAIN P, 1993, GENE DEV, V7, P1390, DOI 10.1101/gad.7.7b.1390; Liang XH, 2006, MOL BIOCHEM PARASIT, V145, P29, DOI 10.1016/j.molbiopara.2005.09.004; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Mair G, 2000, RNA, V6, P163, DOI 10.1017/S135583820099229X; Manful T, 2009, MOL BIOCHEM PARASIT, V166, P186, DOI 10.1016/j.molbiopara.2009.03.003; MCNALLY KP, 1992, MOL CELL BIOL, V12, P4844, DOI 10.1128/MCB.12.11.4844; McPheeters DS, 2000, NUCLEIC ACIDS RES, V28, P1313, DOI 10.1093/nar/28.6.1313; Morris DP, 2000, J BIOL CHEM, V275, P39935, DOI 10.1074/jbc.M004118200; MUHICH ML, 1989, GENE, V82, P169, DOI 10.1016/0378-1119(89)90042-5; MUHICH ML, 1988, MOL CELL BIOL, V8, P3837, DOI 10.1128/MCB.8.9.3837; Nesic D, 2001, MOL CELL BIOL, V21, P6406, DOI 10.1128/MCB.21.19.6406-6417.2001; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Ouna BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034256; OVERATH P, 1986, EUR J BIOCHEM, V160, P175, DOI 10.1111/j.1432-1033.1986.tb09955.x; Palfi Z, 2005, NUCLEIC ACIDS RES, V33, P2493, DOI 10.1093/nar/gki548; Palfi Z, 2009, GENE DEV, V23, P1650, DOI 10.1101/gad.526109; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Schwer B, 1998, EMBO J, V17, P2086, DOI 10.1093/emboj/17.7.2086; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Stewart M, 2010, MOL BIOCHEM PARASIT, V172, P99, DOI 10.1016/j.molbiopara.2010.03.016; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Tkacz ID, 2007, RNA, V13, P30, DOI 10.1261/rna.174307; Vazquez M, 2003, MOL BIOCHEM PARASIT, V128, P77, DOI 10.1016/S0166-6851(03)00007-0; Vazquez MP, 2009, MOL BIOCHEM PARASIT, V164, P137, DOI 10.1016/j.molbiopara.2008.12.009; Wiest DK, 1996, J BIOL CHEM, V271, P33268, DOI 10.1074/jbc.271.52.33268; Wolkow TD, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-6	73	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91956	10.1371/journal.pone.0091956	http://dx.doi.org/10.1371/journal.pone.0091956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651488	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800058
J	Gavi, MBRO; Vassalo, DV; Amaral, FT; Macedo, DCF; Gava, PL; Dantas, EM; Valim, V				Renoldi Oliveira Gavi, Maria Bernadete; Vassalo, Dalton Valentin; Amaral, Fabian Tadeu; Felicio Macedo, Danielle Constancia; Gava, Pablo Lucio; Dantas, Eduardo Miranda; Valim, Valeria			Strengthening Exercises Improve Symptoms and Quality of Life but Do Not Change Autonomic Modulation in Fibromyalgia: A Randomized Clinical Trial	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ACUTE RESISTANCE EXERCISE; AEROBIC EXERCISE; PREMENOPAUSAL WOMEN; SPECTRAL-ANALYSIS; QUESTIONNAIRE; ADAPTATIONS; DYSFUNCTION; SEVERITY; THERAPY	Objective: Autonomic dysfunction is an important mechanism that could explain many symptoms observed in fibromyalgia (FM). Exercise is an effective treatment, with benefits potentially mediated through changes in autonomic modulation. Strengthening is one of the less studied exercises in FM, and the acute and chronic effects of strengthening on the autonomic system remain unknown. The objective of this study was to assess the chronic effects of strengthening exercises (STRE) on autonomic modulation, pain perception and the quality of life (QOL) of FM patients. Methods: Eighty sedentary women with FM (ACR 1990) were randomly selected to participate in STRE or flexibility (FLEX) exercises in a blinded controlled trial. The intensity of STRE was set at 45% of the estimated load of 1 Repetition Maximum (RM) in 12 different exercises. Outcomes were Visual Analog Scale (VAS) for pain, Heart Rate Variability (HRV) analysis, treadmill test, the sit and reach test (Wells and Dillon's Bench), maximal repetitions test and handgrip dynamometry; and quality of life by the Fibromyalgia Impact Questionnaire (FIQ), the Beck and Idate Trait-State Inventory (IDATE), a short-form health survey (SF-36). Results: The STRE group was more effective to strength gain for all muscles and pain control after 4 and 16 weeks (p<0.05). The FLEX group showed higher improvements in anxiety (p<0.05). Both groups showed improvements in the QOL, and there was no significant difference observed between the groups. There was no change in the HRV of the STRE and FLEX groups. Conclusions: Strengthening exercises show greater and more rapid improvements in pain and strength than flexibility exercises. Despite the benefits in fitness, pain, depression, anxiety and quality of life, no effect was observed on the autonomic modulation in both groups. This observation suggests that changes in autonomic modulation are not a target tobe clinically achieved in fibromyalgia.	[Renoldi Oliveira Gavi, Maria Bernadete] Univ Fed Espirito Santo, Univ Hosp, Div Rheumatol, Vitoria, ES, Brazil; [Vassalo, Dalton Valentin] Univ Fed Espirito Santo, Post Grad Program Physiol Sci, Vitoria, ES, Brazil; [Amaral, Fabian Tadeu] Univ Fed Espirito Santo, Vitoria, ES, Brazil; [Felicio Macedo, Danielle Constancia; Gava, Pablo Lucio] Univ Fed Espirito Santo, Ctr Hlth Sci, Vitoria, ES, Brazil; [Dantas, Eduardo Miranda] Fed Univ Vale do Sao Francisco, Coll Biol Sci, Petrolina, MG, Brazil; [Valim, Valeria] Univ Fed Espirito Santo, Dept Med, Univ Hosp, Div Rheumatol, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo	Valim, V (corresponding author), Univ Fed Espirito Santo, Dept Med, Univ Hosp, Div Rheumatol, Vitoria, ES, Brazil.	val.valim@gmail.com	Dantas, Estélio Henrique Martin/F-6962-2012; Dantas, Eduardo M/F-9290-2013	Dantas, Estélio Henrique Martin/0000-0003-0981-8020; Dantas, Eduardo M/0000-0002-6589-5592				Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; Bircan C, 2008, RHEUMATOL INT, V28, P527, DOI 10.1007/s00296-007-0484-5; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Brosseau L, 2008, PHYS THER, V88, P873, DOI 10.2522/ptj.20070115; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Busch AJ, 2011, CURR PAIN HEADACHE R, V15, P358, DOI 10.1007/s11916-011-0214-2; Clauw Daniel J, 2009, Am J Med, V122, pS3, DOI 10.1016/j.amjmed.2009.09.006; Cooke WH, 2005, EUR J APPL PHYSIOL, V93, P719, DOI 10.1007/s00421-004-1243-x; Cuatrecasas G, 2014, PITUITARY, V17, P277, DOI 10.1007/s11102-013-0486-0; Dantas EM, 2012, COMPUT BIOL MED, V42, P164, DOI 10.1016/j.compbiomed.2011.11.004; Faria TD, 2010, EUR J APPL PHYSIOL, V110, P359, DOI 10.1007/s00421-010-1508-5; Figueroa A, 2008, CLIN PHYSIOL FUNCT I, V28, P49, DOI 10.1111/j.1475-097X.2007.00776.x; Gamelin FX, 2007, INT J SPORTS MED, V28, P564, DOI 10.1055/s-2007-964861; Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453; Grant CC, 2012, ANN NONINVAS ELECTRO, V17, P219, DOI 10.1111/j.1542-474X.2012.00511.x; Hakkinen A, 2001, ANN RHEUM DIS, V60, P21, DOI 10.1136/ard.60.1.21; Hakkinen K, 2002, J RHEUMATOL, V29, P1287; Heffernan KS, 2007, AM J PHYSIOL-HEART C, V293, pH3180, DOI 10.1152/ajpheart.00648.2007; Hooten WM, 2012, PAIN, V153, P915, DOI 10.1016/j.pain.2012.01.020; Innes E, 1999, AUST OCCUP THER J, V46, P120, DOI DOI 10.1046/J.1440-1630.1999.00182.X; Jones KD, 2002, J RHEUMATOL, V29, P1041; Kingsley JD, 2010, ARCH PHYS MED REHAB, V91, P1551, DOI 10.1016/j.apmr.2010.07.003; Kingsley JD, 2009, ARCH PHYS MED REHAB, V90, P1628, DOI 10.1016/j.apmr.2009.02.023; Koziris LP, 1999, J APPL PHYSIOL, V86, P1436, DOI 10.1152/jappl.1999.86.4.1436; Kulshreshtha P, 2013, CLIN PHYSIOL FUNCT I, V33, P83, DOI 10.1111/cpf.12000; Martinez-Lavin M, 2000, SEMIN ARTHRITIS RHEU, V29, P197, DOI 10.1016/S0049-0172(00)80008-6; Martinez-Lavin M, 1998, ARTHRITIS RHEUM-US, V41, P1966, DOI 10.1002/1529-0131(199811)41:11<1966::AID-ART11>3.0.CO;2-O; Martinez-Lavin M, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/981565; Penrod JR, 2004, J RHEUMATOL, V31, P1391; Pereira AM, 2009, CLIN EXP RHEUMATOL, V27, P42; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Routledge FS, 2010, CAN J CARDIOL, V26, P303, DOI 10.1016/S0828-282X(10)70395-0; Sanudo B, 2010, ARCH PHYS MED REHAB, V91, P1838, DOI 10.1016/j.apmr.2010.09.006; Shin K, 1995, JPN J PHYSIOL, V45, P1053, DOI 10.2170/jjphysiol.45.1053; Solano C, 2009, JCR-J CLIN RHEUMATOL, V15, P172, DOI 10.1097/RHU.0b013e3181a1083d; Srikuea R, 2013, ARTHRITIS RHEUM-US, V65, P519, DOI 10.1002/art.37763; Takahashi ACM, 2009, EUR J APPL PHYSIOL, V105, P315, DOI 10.1007/s00421-008-0905-5; Valim V, 2003, J RHEUMATOL, V30, P1060; Valim V, 2013, REV BRAS REUMATOL, V53, P538, DOI [10.1016/j.rbr.2013.02.001, 10.1016/j.rbre.2013.02.001]; Valkeinen H, 2006, ARTHRITIS RHEUM, V54, P1334, DOI 10.1002/art.21751; Valkeinen H, 2004, RHEUMATOLOGY, V43, P225, DOI 10.1093/rheumatology/keh027; Valkeinen H, 2008, ARCH PHYS MED REHAB, V89, P1660, DOI 10.1016/j.apmr.2008.01.022; Wells KF, 1952, RES QUART, V23, P115, DOI 10.1080/10671188.1952.10761965; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203	44	55	55	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90767	10.1371/journal.pone.0090767	http://dx.doi.org/10.1371/journal.pone.0090767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651512	Green Published, gold			2022-12-27	WOS:000333352800023
J	Hung, KC; Huang, HJ; Lin, MW; Lei, YP; Lin, AMY				Hung, Kai-Chih; Huang, Hui-Ju; Lin, Ming-Wei; Lei, Yen-Ping; Lin, Anya Maan-yuh			Roles of Autophagy in MPP+-Induced Neurotoxicity In Vivo: The Involvement of Mitochondria and alpha-Synuclein Aggregation	PLOS ONE			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; INDUCED OXIDATIVE INJURY; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; UP-REGULATION; CELL-DEATH; STRESS; APOPTOSIS; BRAIN; NEURODEGENERATION	Macroautophagy (also known as autophagy) is an intracellular self-eating mechanism and has been proposed as both neuroprotective and neurodestructive in the central nervous system (CNS) neurodegenerative diseases. In the present study, the role of autophagy involving mitochondria and alpha-synuclein was investigated in MPP+ (1-methyl-4-phenylpyridinium)- induced oxidative injury in chloral hydrate-anesthetized rats in vivo. The oxidative mechanism underlying MPP+-induced neurotoxicity was identified by elevated lipid peroxidation and heme oxygenase-1 levels, a redox-regulated protein in MPP+-infused substantia nigra (SN). At the same time, MPP+ significantly increased LC3-II levels, a hallmark protein of autophagy. To block MPP+-induced autophagy in rat brain, Atg7siRNA was intranigrally infused 4 d prior to MPP+ infusion. Western blot assay showed that in vivo Atg7siRNA transfection not only reduced Atg7 levels in the MPP+-infused SN but attenuated MPP+-induced elevation in LC3-II levels, activation of caspase 9 and reduction in tyrosine hydroxylase levels, indicating that autophagy is pro-death. The immunostaining study demonstrated co-localization of LC3 and succinate dehydrogenase (a mitochondrial complex II) as well as LC3 and alpha-synuclein, suggesting that autophagy may engulf mitochondria and alpha-synuclein. Indeed, in vivo Atg7siRNA transfection mitigated MPP+-induced reduction in cytochrome c oxidase. In addition, MPP+-induced autophagy differentially altered the alpha-synuclein aggregates in the infused SN. In conclusion, autophagy plays a prodeath role in the MPP+-induced oxidative injury by sequestering mitochondria in the rat brain. Moreover, our data suggest that the benefits of autophagy depend on the levels of alpha-synuclein aggregates in the nigrostriatal dopaminergic system of the rat brain.	[Hung, Kai-Chih] Natl Yang Ming Univ, Dept Physiol, Taipei 112, Taiwan; [Huang, Hui-Ju; Lin, Anya Maan-yuh] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Lin, Ming-Wei] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lei, Yen-Ping] Natl Yang Ming Univ, Dept Nursing, Taipei 112, Taiwan; [Lin, Anya Maan-yuh] Natl Yang Ming Univ, Dept Pharmacol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, AMY (corresponding author), Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan.	myalin@vghtpe.gov.tw			 [NSC101-2320-B-010-044];  [V103-C-060]	; 	The authors report the following sources of funding: NSC101-2320-B-010-044 and V103-C-060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Bellucci A, 2011, J NEUROCHEM, V116, P588, DOI 10.1111/j.1471-4159.2010.07143.x; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Cai ZL, 2009, NEUROREPORT, V20, P569, DOI 10.1097/WNR.0b013e32832986c4; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chang CF, 2012, J PINEAL RES, V52, P312, DOI 10.1111/j.1600-079X.2011.00945.x; Cherra SJ, 2009, AUTOPHAGY, V5, P1213, DOI 10.4161/auto.5.8.10050; CHIUEH CC, 1983, J PHARMACOL EXP THER, V225, P529; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DEXTER DT, 1994, MOVEMENT DISORD, V9, P92, DOI 10.1002/mds.870090115; Fengsrud M, 2000, EUR J CELL BIOL, V79, P871, DOI 10.1078/0171-9335-00125; Hochfeld WE, 2013, ACTA PHARMACOL SIN, V34, P600, DOI 10.1038/aps.2012.189; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Janda E, 2012, MOL NEUROBIOL, V46, P639, DOI 10.1007/s12035-012-8318-1; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kalivendi SV, 2004, J BIOL CHEM, V279, P15240, DOI 10.1074/jbc.M312497200; KIKUGAWA K, 1989, ADV EXP MED BIOL, V266, P345; Kowall NW, 2000, NEUROREPORT, V11, P211, DOI 10.1097/00001756-200001170-00041; Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Li LY, 2011, NEUROSCI LETT, V489, P62, DOI 10.1016/j.neulet.2010.11.068; Lin AMY, 2004, NEUROCHEM INT, V44, P99, DOI 10.1016/S0197-0186(03)00113-X; Lin AMY, 2007, TOXICOL APPL PHARM, V224, P138, DOI 10.1016/j.taap.2007.06.016; Liu KY, 2013, NEUROCHEM RES, V38, P201, DOI 10.1007/s11064-012-0909-8; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Paxinos G, 1986, RAT BRAIN STEREOTAXI, V27, P121; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schipper HM, 2004, ANN NY ACAD SCI, V1012, P84, DOI 10.1196/annals.1306.007; Shivalingappa PC, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/424285; SINGER TP, 1990, FEBS LETT, V274, P1, DOI 10.1016/0014-5793(90)81315-F; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Tzeng YW, 2010, FREE RADICAL BIO MED, V49, P839, DOI 10.1016/j.freeradbiomed.2010.06.004; Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Xilouri M, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001803; Yu HC, 2010, NEUROPATH APPL NEURO, V36, P612, DOI 10.1111/j.1365-2990.2010.01107.x; Zhu JH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.46; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524; Zhu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036377	52	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91074	10.1371/journal.pone.0091074	http://dx.doi.org/10.1371/journal.pone.0091074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646838	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500022
J	Kuo, MS; Auriau, J; Pierre-Eugene, C; Issad, T				Kuo, Mei-Shiue; Auriau, Johanna; Pierre-Eugene, Cecile; Issad, Tarik			Development of a Human Breast-Cancer Derived Cell Line Stably Expressing a Bioluminescence Resonance Energy Transfer (BRET)-Based Phosphatidyl Inositol-3 Phosphate (PIP3) Biosensor	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PLECKSTRIN HOMOLOGY DOMAIN; BINDING PROTEINS IGFBPS; FACTOR-I-RECEPTOR; INSULIN-RECEPTOR; ACTIVATION STATE; TYROSINE PHOSPHORYLATION; SUBCUTANEOUS INJECTION; TARGETING PI3K; GLARGINE	Stimulation of tyrosine kinase receptors initiates a signaling cascade that activates PI3K. Activated PI3K uses PIP2 to generate PIP3, which recruit Akt to the plasma membrane through its pleckstrin homology (PH) domain, permitting its activation by PDKs. Activated Akt controls important biological functions, including cell metabolism, proliferation and survival. The PI3K pathway is therefore an attractive target for drug discovery. However, current assays for measurement of PIP3 production are technically demanding and not amenable to high-throughput screening. We have established a MCF-7-derived breast cancer cell line, that stably co-expresses the PH domain of Akt fused to Renilla luciferase and YFP fused to a membrane localization signal. This BRET biosensor pair permits to monitor, in real time, in living cells, PIP3 production at the plasma membrane upon stimulation by different ligands, including insulin, the insulin analogue glargine, IGF1, IGF2 and EGF. Moreover, several known inhibitors that target different steps of the PI3K/Akt pathway caused inhibition of ligand-induced BRET. Cetuximab, a humanized anti-EGF receptor monoclonal antibody used for the treatment of cancer, completely inhibited EGF-induced BRET, and the tyrosine kinase inhibitor tyrphostine AG1024 inhibited insulin effect on PIP3 production. Moreover, the effects of insulin and IGF1 were inhibited by molecules that inhibit PI3K catalytic activity or the interaction between PIP3 and the PH domain of Akt. Finally, we showed that human serum induced a dose-dependent increase in BRET signal, suggesting that this stable clone may be used as a prognostic tool to evaluate the PI3K stimulatory activity present in serum of human patients. We have thus established a cell line, suitable for the screening and/or the study of molecules with stimulatory or inhibitory activities on the PI3K/Akt pathway that will constitute a new tool for translational research in diabetes and cancer.	[Kuo, Mei-Shiue; Auriau, Johanna; Pierre-Eugene, Cecile; Issad, Tarik] Univ Paris 05, Inst Cochin, CNRS, UMR8104, Paris, France; [Kuo, Mei-Shiue; Auriau, Johanna; Pierre-Eugene, Cecile; Issad, Tarik] INSERM, U1016, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Issad, T (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR8104, Paris, France.	tarik.issad@inserm.fr		Issad, Tarik/0000-0002-2638-6330	French CNRS (Centre National de la Recherche Scientifique); INSERM (Institut National de Sante et de Recherche Medicale)	French CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); INSERM (Institut National de Sante et de Recherche Medicale)	This work was supported by the French CNRS (Centre National de la Recherche Scientifique) and the INSERM (Institut National de Sante et de Recherche Medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agin A, 2007, DIABETES METAB, V33, P205, DOI 10.1016/j.diabet.2006.12.002; ARTEAGA CL, 1994, CANCER RES, V54, P4703; Berndt N, 2010, CELL DEATH DIFFER, V17, P1795, DOI 10.1038/cdd.2010.63; Blanquart C, 2005, MOL PHARMACOL, V68, P885, DOI 10.1124/mol.105.013151; Blanquart C, 2008, BIOCHEM PHARMACOL, V76, P873, DOI 10.1016/j.bcp.2008.07.027; Blanquart C, 2006, MOL PHARMACOL, V70, P1802, DOI 10.1124/mol.106.026989; Blanquart C, 2009, BIOCHEM BIOPH RES CO, V387, P748, DOI 10.1016/j.bbrc.2009.07.105; Bolli GB, 2012, DIABETES CARE, V35, P2626, DOI 10.2337/dc12-0270; Boubekeur S, 2011, J BIOL CHEM, V286, P19373, DOI 10.1074/jbc.M111.222984; Boute N, 2001, MOL PHARMACOL, V60, P640; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Combettes-Souverain M, 1998, DIABETES METAB, V24, P477; DECUPIS A, 1995, BRIT J PHARMACOL, V116, P2391; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fabre S, 2005, J IMMUNOL, V174, P4161, DOI 10.4049/jimmunol.174.7.4161; Fardini Y, 2014, FASEB J, V28, P1010, DOI 10.1096/fj.13-238378; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fortunati N, 2010, MOL CELL ENDOCRINOL, V316, P86, DOI 10.1016/j.mce.2009.09.012; Frost VJ, 1996, J CLIN ENDOCR METAB, V81, P2216, DOI 10.1210/jc.81.6.2216; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; IMAI Y, 1982, CANCER RES, V42, P4394; ISSAD T, 1995, EUR J BIOCHEM, V234, P108, DOI 10.1111/j.1432-1033.1995.108_c.x; Jo H, 2011, P NATL ACAD SCI USA, V108, P6486, DOI 10.1073/pnas.1019062108; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kanwal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069150; KAREY KP, 1988, CANCER RES, V48, P4083; Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Kuerzel GU, 2003, CURR MED RES OPIN, V19, P34, DOI 10.1185/030079902125001416; Lacasa D, 2005, MOL PHARMACOL, V67, P1206, DOI 10.1124/mol.104.009514; Lahlou N, 2002, DIABETES, V51, P1980, DOI 10.2337/diabetes.51.6.1980; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Liu JF, 1998, EUR J BIOCHEM, V258, P271, DOI 10.1046/j.1432-1327.1998.2580271.x; Mahajan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009646; Martini M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00108; Mayer Doris, 2010, Archives of Physiology and Biochemistry, V116, P73, DOI 10.3109/13813451003631439; Merlin JL, 2002, ANN ONCOL, V13, P1743, DOI 10.1093/annonc/mdf263; Miao BC, 2010, P NATL ACAD SCI USA, V107, P20126, DOI 10.1073/pnas.1004522107; MILAZZO G, 1992, CANCER RES, V52, P3924; Moses SA, 2009, CANCER RES, V69, P5073, DOI 10.1158/0008-5472.CAN-08-3839; Nouaille S, 2006, EMBO REP, V7, P512, DOI 10.1038/sj.embor.7400668; Panasiti V, 2011, J AM ACAD DERMATOL, V64, P865, DOI 10.1016/j.jaad.2010.03.035; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Patil N, 2012, BIOL-TARGETS THER, V6, P221, DOI 10.2147/BTT.S24217; Pierre-Eugene C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041992; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak MN, 1998, BREAST CANCER RES TR, V47, P209, DOI 10.1023/A:1005950916707; ROOS W, 1986, P NATL ACAD SCI USA, V83, P991, DOI 10.1073/pnas.83.4.991; Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200; Sommerfeld MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009540; SOOS MA, 1993, BIOCHEM J, V290, P419, DOI 10.1042/bj2900419; Stephen RL, 2001, J BIOL CHEM, V276, P40080, DOI 10.1074/jbc.M105892200; SYMONS JA, 1991, J EXP MED, V174, P1251, DOI 10.1084/jem.174.5.1251; Tebbutt N, 2013, NAT REV CANCER, V13, P663, DOI 10.1038/nrc3559; Toyoshima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1745; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Yang GQ, 2004, MOL ENDOCRINOL, V18, P1354, DOI 10.1210/me.2004-0027; Zhang Y, 1996, EXP EYE RES, V63, P265, DOI 10.1006/exer.1996.0115	61	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92737	10.1371/journal.pone.0092737	http://dx.doi.org/10.1371/journal.pone.0092737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647478	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500154
J	Liu, DH; Wei, LL; Guo, T; Tan, WF				Liu, Donghua; Wei, Lili; Guo, Ting; Tan, Weifen			Detection of DOPA-Melanin in the Dimorphic Fungal Pathogen Penicillium marneffei and Its Effect on Macrophage Phagocytosis In Vitro	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; FONSECAEA-PEDROSOI; PARACOCCIDIOIDES-BRASILIENSIS; INFECTION; MELANIZATION; GENE; SUSCEPTIBILITY; BIOSYNTHESIS; TYROSINASE; RESISTANCE	The fungal pathogen Penicillium marneffei produces melanin-like pigment in vitro. The synthetic pathway of melanin and its possible influence in the protective yeast cells surviving within macrophage cells are not known. In this work, P. marneffei produced brown black pigment in the presence of L-DOPA and black particles were extracted from yeast cells treated with proteolytic enzymes, denaturant and concentrated hot acid. Kojic acid inhibited the brown-black pigment production of P. marneffei yeast grown on brain heart infusion agar. Transmitting electron microscopy showed spherical granular electron-dense particles with an average diameter of 100 nm in a beaded arrangement in the innermost cell wall. Electron-paramagnetic resonance revealed that the black particles contain a stable free radical compound. The UV-visible and Fourier transform infrared spectra of particles extracted from P. marneffei and synthetic DOPA-melanin showed a high degree of similarity. Melanized yeast cells decreased phagocytosis by macrophage cells and increased resistance to intracellular digestion in vitro. These results indicate that P. marneffei can synthesize DOPA-melanin or melanin-like compounds in vitro and suggest that the DOPA-melanin pathway is associated with cell wall structure and enhances the resistance to phagocytosis by macrophages.	[Liu, Donghua; Wei, Lili; Guo, Ting; Tan, Weifen] Guangxi Med Univ, Dept Dermatol & Venereol, Affiliated Hosp 1, Nanning, Peoples R China	Guangxi Medical University	Liu, DH (corresponding author), Guangxi Med Univ, Dept Dermatol & Venereol, Affiliated Hosp 1, Nanning, Peoples R China.	ldhgxmu@163.com	黎, 伟/GXM-4040-2022; wei, li/GSD-3630-2022		National Natural Science Foundation of China [81160191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81160191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Paes R, 2009, MICROBES INFECT, V11, P554, DOI 10.1016/j.micinf.2009.03.002; Cao CW, 2011, EMERG INFECT DIS, V17, P209, DOI 10.3201/eid1702.100718; Chai LYA, 2010, IMMUNOBIOLOGY, V215, P915, DOI 10.1016/j.imbio.2009.10.002; Cunha MML, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-80; da Silva MB, 2006, MICROBES INFECT, V8, P197, DOI 10.1016/j.micinf.2005.06.018; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; Eisenman HC, 2009, MICROBIOL-SGM, V155, P3860, DOI 10.1099/mic.0.032854-0; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; Franzen AJ, 2008, J STRUCT BIOL, V162, P75, DOI 10.1016/j.jsb.2007.11.004; Franzen AJ, 2006, MICROSC RES TECHNIQ, V69, P729, DOI 10.1002/jemt.20344; Gomez BL, 2001, INFECT IMMUN, V69, P5760, DOI 10.1128/IAI.69.9.5760-5767.2001; Goncalves RCR, 2012, WORLD J MICROB BIOT, V28, P1467, DOI 10.1007/s11274-011-0948-3; Kahn V, 1995, PIGM CELL RES, V8, P234, DOI 10.1111/j.1600-0749.1995.tb00669.x; Kim YJ, 2005, CELL MOL LIFE SCI, V62, P1707, DOI 10.1007/s00018-005-5054-y; Liu DH, 2011, MYCOSES, V54, P113, DOI 10.1111/j.1439-0507.2009.01786.x; Nosanchuk JD, 2000, LANCET, V355, P2049, DOI 10.1016/S0140-6736(00)02356-4; Nosanchuk JD, 2004, FEMS MICROBIOL LETT, V239, P187, DOI 10.1016/j.femsle.2004.08.040; Nosanchuk JD, 2002, INFECT IMMUN, V70, P5124, DOI 10.1128/IAI.70.9.5124-5131.2002; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Pal AK, 2013, MED MYCOL IN PRESS; Pongpom P, 2005, MED MYCOL, V43, P403, DOI 10.1080/13693780400007144; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rosas AL, 2000, INFECT IMMUN, V68, P2845, DOI 10.1128/IAI.68.5.2845-2853.2000; Rosas AL, 2001, MYCOPATHOLOGIA, V151, P53, DOI 10.1023/A:1010977107089; Sajjan S, 2010, J MICROBIOL BIOTECHN, V20, P1513, DOI 10.4014/jmb.1002.02006; Samson RA, 2011, STUD MYCOL, P159, DOI 10.3114/sim.2011.70.04; Thirach S, 2007, MED MYCOL, V45, P409, DOI 10.1080/13693780701381271; Ustianowski AP, 2008, CURR OPIN INFECT DIS, V21, P31, DOI 10.1097/QCO.0b013e3282f406ae; Volling K, 2011, CELL MICROBIOL, V13, P1130, DOI 10.1111/j.1462-5822.2011.01605.x; Woo PCY, 2010, FEBS J, V277, P3750, DOI 10.1111/j.1742-4658.2010.07776.x; Youngchim S, 2005, MICROBIOL-SGM, V151, P291, DOI 10.1099/mic.0.27433-0; Youngchim S, 1999, MED MYCOL, V37, P445, DOI 10.1046/j.1365-280X.1999.00235.x; Youngchim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063764; Zhong JY, 2008, BIOCHEMISTRY-US, V47, P4701, DOI 10.1021/bi702093r	35	28	38	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92610	10.1371/journal.pone.0092610	http://dx.doi.org/10.1371/journal.pone.0092610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647795	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500148
J	Zhao, TT; Zhang, HJ; Lu, XG; Huang, XR; Zhang, WK; Wang, H; Lan, HY; Li, P				Zhao, Ting Ting; Zhang, Hao Jun; Lu, Xiao Guang; Huang, Xiao Ru; Zhang, Wei Ku; Wang, Hua; Lan, Hui Yao; Li, Ping			Chaihuang-Yishen Granule Inhibits Diabetic Kidney Disease in Rats through Blocking TGF-beta/Smad3 Signaling	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; RENAL FIBROSIS; DIVERSE ROLES; NEPHROPATHY; RECEPTOR; MICRORNA; SMAD3; INFLAMMATION; ACTIVATION	Objective: Increasing evidence shows that TGF-beta 1 is a key mediator in diabetic nephropathy (DN) and induces renal fibrosis positively by Smad3 but negatively by Smad7. However, treatment of DN by blocking the TGF-beta/Smad pathway remains limited. The present study investigated the anti-fibrotic effect of a traditional Chinese medicine, Chaihuang-Yishen granule (CHYS), on DN. Research Design and Methods: Protective role of CHYS in DN was examined in an accelerated type 1 DN induced by streptozotocin in uninephrectomized Wistar rats. CHYS, at a dose of 0.56 g/kg body weight, was administered by a daily gastric gavage for 20 weeks and the therapeutic effect and potential mechanisms of CHYS on diabetic kidney injury were examined. Results: Treatment with CHYS attenuated diabetic kidney injury by significantly inhibiting 24-h proteinuria and progressive renal fibrosis including glomerulosclerotic index, tubulointerstitial fibrosis index, and upregulation of extracellular matrix (collagen I, IV, and fibronectin), despite the same levels of blood glucose. Further studies revealed that inhibition of renal fibrosis in CHYS-treated diabetic rats was associated with inhibition of TGF-beta 1/Smad3 signaling as demonstrated by upregulation of Smad7 but downregulation of TGF-beta 1, TGF-beta receptors, activation of Smad3, and expression of miRNA-21. Conclusions: CHYS may be a therapeutic agent for DN. CHYS attenuates DN by blocking TGF-beta/Smad3-mediated renal fibrosis.	[Zhao, Ting Ting; Zhang, Hao Jun; Lu, Xiao Guang; Zhang, Wei Ku; Wang, Hua; Li, Ping] China Japan Friendship Hosp, Inst Clin Med Sci, Dept Pharmacol, Beijing, Peoples R China; [Huang, Xiao Ru; Lan, Hui Yao] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Huang, Xiao Ru; Lan, Hui Yao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Huang, Xiao Ru; Lan, Hui Yao] CUHK Shenzhen Res Inst, Shenzhen, Peoples R China	China-Japan Friendship Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong	Lan, HY (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	hylan@cuhk.edu.hk; lp8675@163.com	Lan, Hui Yao/C-9734-2015	Lan, Hui Yao/0000-0003-4283-9755	National Natural Scientific Foundation of China [30973911, 81173422]; International S&T Cooperation Program of China [2011DFA31860]; Municipal Science and Technology R & D funding of basic research, Shenzhen [JC201104220290A]; Research Grant Council of Hong Kong [CUHK5/CRF/09, CUHK3/CRF/12R]; Focused Investment Scheme A and B from the Chinese University of Hong Kong	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); International S&T Cooperation Program of China; Municipal Science and Technology R & D funding of basic research, Shenzhen; Research Grant Council of Hong Kong(Hong Kong Research Grants Council); Focused Investment Scheme A and B from the Chinese University of Hong Kong	This work was supported by the National Natural Scientific Foundation of China [grant number: 30973911, 81173422 to PL]; International S&T Cooperation Program of China [grant number: 2011DFA31860 to PL]; Municipal Science and Technology R & D funding of basic research, Shenzhen (Major Program JC201104220290A to HYL); the Research Grant Council of Hong Kong (CUHK5/CRF/09 and CUHK3/CRF/12R to HYL); and the Focused Investment Scheme A and B from the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Chen HY, 2011, DIABETES, V60, P590, DOI 10.2337/db10-0403; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Chung ACK, 2013, INT J NEPHROL RENOV, V6, P169, DOI 10.2147/IJNRD.S37885; Critchley JAJH, 2002, CHINESE MED J-PEKING, V115, P129; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fujimoto M, 2003, BIOCHEM BIOPH RES CO, V305, P1002, DOI 10.1016/S0006-291X(03)00885-4; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hong SW, 2001, AM J PATHOL, V158, P1653; Hou CC, 2005, AM J PATHOL, V166, P761, DOI 10.1016/S0002-9440(10)62297-3; Huang CM, 2002, DIABETES, V51, P3577, DOI 10.2337/diabetes.51.12.3577; Huang XR, 2008, J AM SOC NEPHROL, V19, P233, DOI 10.1681/ASN.2007040484; International Diabetes Federation, 2013, COMPL DIAB; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; LAN HY, 1995, J HISTOCHEM CYTOCHEM, V43, P97, DOI 10.1177/43.1.7822770; Li JH, 2004, FASEB J, V18, P176, DOI 10.1096/fj.02-1117fje; Li P, 2007, NEPHROLOGY, V12, P466, DOI 10.1111/j.1440-1797.2007.00828.x; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Meng XM, 2012, J PATHOL, V227, P175, DOI 10.1002/path.3976; Patel V, 2012, CURR OPIN NEPHROL HY, V21, P410, DOI 10.1097/MNH.0b013e328354e559; Reeves WB, 2000, P NATL ACAD SCI USA, V97, P7667, DOI 10.1073/pnas.97.14.7667; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Verrecchia F, 2001, ONCOGENE, V20, P3332, DOI 10.1038/sj.onc.1204448; Vindevoghel L, 1998, P NATL ACAD SCI USA, V95, P14769, DOI 10.1073/pnas.95.25.14769; Wang A, 2007, AM J PHYSIOL-RENAL, V293, pF1657, DOI 10.1152/ajprenal.00274.2007; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Wen XY, 2012, J ETHNOPHARMACOL, V142, P144, DOI 10.1016/j.jep.2012.04.028; Yang FY, 2010, J PATHOL, V221, P390, DOI 10.1002/path.2721; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zhang HT, 2011, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2011-69; Zhao T, 2012, J PHARMACEUT BIOMED, V60, P32, DOI 10.1016/j.jpba.2011.11.010; Zhong X, 2013, DIABETOLOGIA, V56, P663, DOI 10.1007/s00125-012-2804-x; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168	38	51	60	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e90807	10.1371/journal.pone.0090807	http://dx.doi.org/10.1371/journal.pone.0090807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646636	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500017
J	Glenthoj, A; Dahl, S; Larsen, MT; Cowland, JB; Borregaard, N				Glenthoj, Andreas; Dahl, Sara; Larsen, Maria T.; Cowland, Jack B.; Borregaard, Niels			Human alpha-Defensin Expression Is Not Dependent on CCAAT/Enhancer Binding Protein-epsilon in a Murine Model	PLOS ONE			English	Article							COPY NUMBER POLYMORPHISMS; C/EBP-EPSILON; GRANULE DEFICIENCY; TRANSCRIPTION FACTORS; MESSENGER-RNA; NEUTROPHIL; CELLS; MUTATION; GENES; BETA	Specific granule deficiency (SGD) is a rare congenital disorder characterized by recurrent infections. The disease is caused by inactivating mutations of the CCAAT/enhancer binding protein-epsilon (C/EBP-epsilon) gene. As a consequence, specific and gelatinase granules lack most matrix proteins. Furthermore, azurophil granules contain diminished amounts of their most abundant proteins, alpha-defensins, also known as human neutrophil peptides (HNPs). In accordance with this, in vitro models have demonstrated induction of HNPs by C/EBP-epsilon. Since mice do not express myeloid defensins, they cannot per se be used to characterize the role of C/EBP-epsilon in controlling HNP expression in vivo. We therefore crossed a transgenic HNP-1-expressing mouse with the Cebpe(-/-) mouse to study the in vivo significance of C/EBP-epsilon for HNP-1 transcription and expression. Surprisingly, neither expression nor processing of HNP-1 was affected by lack of C/EBP-epsilon in these mice. Transduction of C/EBP-epsilon into primary bone marrow cells from HNP-1 mice induced some HNP-1 expression, but not to levels comparable to expression human cells. Taken together, our data infer that the HNP-1 of the transgenic mouse does not show an expression pattern equivalent to endogenous secondary granule proteins. This limits the use of these transgenic mice as a model for human conditions.	[Glenthoj, Andreas; Dahl, Sara; Larsen, Maria T.; Cowland, Jack B.; Borregaard, Niels] Univ Copenhagen, Natl Univ Hosp, Dept Hematol, Granulocyte Res Lab, Copenhagen, Denmark	University of Copenhagen	Glenthoj, A (corresponding author), Univ Copenhagen, Natl Univ Hosp, Dept Hematol, Granulocyte Res Lab, Copenhagen, Denmark.	angl@rh.dk	Glenthøj, Andreas/ABD-5948-2021	Glenthøj, Andreas/0000-0003-2082-0738; Cowland, Jack Bernard/0000-0002-7429-5388	Danish Medical Research Council; National University Hospital; Danish Cancer Society	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National University Hospital; Danish Cancer Society(Danish Cancer Society)	This work was supported by grants from The Danish Medical Research Council (NB), The National University Hospital (AG), and The Danish Cancer Society (MBP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred PMR, 2005, HUM MOL GENET, V14, P2045, DOI 10.1093/hmg/ddi209; Arnljots K, 1998, LEUKEMIA, V12, P1789, DOI 10.1038/sj.leu.2401202; Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC; Bedi R, 2009, BLOOD, V113, P317, DOI 10.1182/blood-2008-02-139741; Bjerregaard MD, 2003, BLOOD, V101, P4322, DOI 10.1182/blood-2002-03-0835; BORREGAARD N, 1985, AM J HEMATOL, V18, P255, DOI 10.1002/ajh.2830180306; Chen QX, 2010, ANESTHESIOLOGY, V112, P1428, DOI 10.1097/ALN.0b013e3181d968eb; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Du ZP, 2011, BIOCHEM CELL BIOL, V89, P314, DOI 10.1139/O11-002; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3446, DOI 10.1128/IAI.60.8.3446-3447.1992; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; Faurschou M, 2005, J LEUKOCYTE BIOL, V78, P785, DOI 10.1189/jlb.1104688; Faurschou M, 2002, BBA-MOL CELL RES, V1591, P29, DOI 10.1016/S0167-4889(02)00243-4; GANZ T, 1990, EUR J HAEMATOL, V44, P1; GANZ T, 1988, J CLIN INVEST, V82, P552, DOI 10.1172/JCI113631; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Glenthoj A, 2013, EUR J CLIN INVEST, V43, P836, DOI 10.1111/eci.12114; Glenthoj A, 2011, BLOOD, V118, P4440, DOI 10.1182/blood-2011-06-362947; Gombart AF, 2001, BLOOD, V97, P2561, DOI 10.1182/blood.V97.9.2561; Gombart AF, 2003, BLOOD, V101, P3265, DOI 10.1182/blood-2002-04-1039; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; JOHNSTON JJ, 1992, BLOOD, V80, P2088; Khanna-Gupta A, 2003, BLOOD, V101, P3460, DOI 10.1182/blood-2002-09-2767; Larsen MT, 2014, BLOOD, V123, P1079, DOI 10.1182/blood-2013-08-523233; Lekstrom-Himes J, 1999, BLOOD, V93, P3096; Lekstrom-Himes JA, 1999, J EXP MED, V189, P1847, DOI 10.1084/jem.189.11.1847; Lennartsson A, 2006, J LEUKOCYTE BIOL, V80, P196, DOI 10.1189/jlb.1205759; Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003; Linzmeier RM, 2006, GENOMICS, V88, P122, DOI 10.1016/j.ygeno.2006.03.005; McBurney MW, 2002, EXP CELL RES, V274, P1, DOI 10.1006/excr.2001.5443; Rorvig S, 2009, J LEUKOCYTE BIOL, V86, P1439, DOI 10.1189/jlb.1008606; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; TAMURA A, 1994, INT J HEMATOL, V59, P137; Tanaka M, 2007, INT J HEMATOL, V85, P304, DOI 10.1532/IJH97.05162; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Truong BTH, 2003, BLOOD, V101, P1141, DOI 10.1182/blood-2002-05-1374; Tsutsumi-Ishii Y, 2000, J IMMUNOL, V164, P3264, DOI 10.4049/jimmunol.164.6.3264; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; Verbeek W, 1999, BLOOD, V93, P3327, DOI 10.1182/blood.V93.10.3327; Verbeek W, 2001, LEUKEMIA, V15, P103, DOI 10.1038/sj.leu.2401995; Verbeek W, 2013, GENE EXPRESSION NEUT, P3141; Williams SC, 1998, J BIOL CHEM, V273, P13493, DOI 10.1074/jbc.273.22.13493; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187	44	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92471	10.1371/journal.pone.0092471	http://dx.doi.org/10.1371/journal.pone.0092471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658030	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300087
J	Norgaard, LN; Gjerris, ACR; Kirkegaard, I; Berlac, JF; Tabor, A				Norgaard, Lone Nikoline; Gjerris, Anne Cathrine Roslev; Kirkegaard, Ida; Berlac, Janne Foss; Tabor, Ann		Danish Fetal Med Res Grp	Fetal Growth in Pregnancies Conceived after Gastric Bypass Surgery in Relation to Surgery-to-Conception Interval: A Danish National Cohort Study	PLOS ONE			English	Article							BARIATRIC SURGERY; OUTCOMES; OBESITY; WOMEN	Objective: To describe early and late fetal growth in pregnancies conceived after gastric bypass surgery in relation to time from surgery to conception of pregnancy. Methods: National cohort study on 387 Danish women, who had laparoscopic or open gastric bypass surgery prior to a singleton pregnancy in which first trimester screening was performed between January 2008 and June 2011. Data were derived from national registers (Danish National Registry of Patients and Danish National Birth Registry, Pregnancy Complications and Abortion - clinical quality database (PreCAb) and the Danish Fetal Medicine Database). Main outcome measures were early and late fetal growth in relation to time from bariatric surgery to conception of the pregnancy. Early fetal growth was expressed as "Fetal Growth Index": the ratio between the estimated number of days from first trimester ultrasound to second trimester ultrasound biometries and the actual calender time elapsed in days. Late fetal growth was expressed as the observed versus expected birthweight according to gestational age (GA). Results: The surgery-to-conception interval ranged from 3 to 1851 days with a mean value of 502 (SD, 351) days. The mean "fetal growth index" was 0.99 (SD, 0.02) days/day and thus significantly lower than in the background population (mean, 1.04 (SD, 0.09) days/day, p<0.0001). The proportion of infants being small for gestational age was 18.8% and the proportion of large for gestational age infants was 6.7%. The correlation coefficients between surgery-to-conception time and "fetal growth index" and birthweight according to GA were 0.01 (p = 0.8) and 0.04 (p = 0.4), respectively. Conclusion: Fetal growth index was lower than reported in the background population. No correlation was found between the surgery-to-conception interval and early or late fetal growth in pregnancies conceived after gastric bypass surgery.	[Norgaard, Lone Nikoline; Gjerris, Anne Cathrine Roslev] Copenhagen Univ Hosp, Hillerod Hosp, Dept Obstet & Gynecol, Hillerod, Denmark; [Kirkegaard, Ida] Aarhus Univ Hosp, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark; [Berlac, Janne Foss] Copenhagen Univ Hosp, Rigshosp, Dept Obstet, Copenhagen, Denmark; [Tabor, Ann] Copenhagen Univ Hosp, Rigshosp, Dept Obstet, Ctr Fetal Med, Copenhagen, Denmark; [Tabor, Ann] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; Aarhus University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Norgaard, LN (corresponding author), Copenhagen Univ Hosp, Hillerod Hosp, Dept Obstet & Gynecol, Hillerod, Denmark.	lonenoergaard@dadlnet.dk		Norgaard, Lone Nikoline/0000-0002-6511-9796; Jorgensen, Finn Stener/0000-0002-1592-5407; Farlie, Richard/0000-0001-5286-3244; Tabor, Ann/0000-0001-7450-1543				Altman DG, 1997, ULTRASOUND OBST GYN, V10, P174, DOI 10.1046/j.1469-0705.1997.10030174.x; [Anonymous], 2009, Obstet Gynecol, V113, P1405, DOI 10.1097/AOG.0b013e3181ac0544; Dao T, 2006, AM J SURG, V192, P762, DOI 10.1016/j.amjsurg.2006.08.041; Ducarme G, 2007, INT J GYNECOL OBSTET, V98, P244, DOI 10.1016/j.ijgo.2007.02.020; Ducarme G, 2013, J MATERN-FETAL NEO M, V26, P275, DOI 10.3109/14767058.2012.735723; Guelinckx I, 2009, HUM REPROD UPDATE, V15, P189, DOI 10.1093/humupd/dmn057; Hezelgrave NL, 2011, J OBES, V2011, DOI 10.1155/2011/501939; Josefsson A, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.025; Karmon A, 2008, AM J PERINAT, V25, P331, DOI 10.1055/s-2008-1078760; Kirkegaard I, 2011, ULTRASOUND OBST GYN, V37, P341, DOI 10.1002/uog.8808; Lesko J, 2012, OBSTET GYNECOL, V119, P547, DOI 10.1097/AOG.0b013e318239060e; Magdaleno R, 2012, ARCH GYNECOL OBSTET, V285, P559, DOI 10.1007/s00404-011-2187-0; Marceau P, 2004, OBES SURG, V14, P318, DOI 10.1381/096089204322917819; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Patel JA, 2008, SURG OBES RELAT DIS, V4, P39, DOI 10.1016/j.soard.2007.10.008; Renault Kristina, 2012, Ugeskr Laeger, V174, P1076; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Sergienko R, 2011, AM J OBSTET GYNECOL, V204, pS58; Wax JR, 2008, OBES SURG, V18, P540, DOI 10.1007/s11695-008-9459-1	20	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90317	10.1371/journal.pone.0090317	http://dx.doi.org/10.1371/journal.pone.0090317			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658186	gold, Green Published, Green Submitted			2022-12-27	WOS:000333355300015
J	Ouyang, M; Li, SY; Tian, X				Ouyang, Mei; Li, Shuangyan; Tian, Xin			Functional Connectivity among Spikes in Low Dimensional Space during Working Memory Task in Rat	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX	Working memory (WM) is critically important in cognitive tasks. The functional connectivity has been a powerful tool for understanding the mechanism underlying the information processing during WM tasks. The aim of this study is to investigate how to effectively characterize the dynamic variations of the functional connectivity in low dimensional space among the principal components (PCs) which were extracted from the instantaneous firing rate series. Spikes were obtained from medial prefrontal cortex (mPFC) of rats with implanted microelectrode array and then transformed into continuous series via instantaneous firing rate method. Granger causality method is proposed to study the functional connectivity. Then three scalar metrics were applied to identify the changes of the reduced dimensionality functional network during working memory tasks: functional connectivity (GC), global efficiency (E) and casual density (CD). As a comparison, GC, E and CD were also calculated to describe the functional connectivity in the original space. The results showed that these network characteristics dynamically changed during the correct WM tasks. The measure values increased to maximum, and then decreased both in the original and in the reduced dimensionality. Besides, the feature values of the reduced dimensionality were significantly higher during the WM tasks than they were in the original space. These findings suggested that functional connectivity among the spikes varied dynamically during the WM tasks and could be described effectively in the low dimensional space.	[Ouyang, Mei; Li, Shuangyan; Tian, Xin] Tianjin Med Univ, Sch Biomed Engn, Lab Neurobiol Med, Tianjin, Peoples R China	Tianjin Medical University	Tian, X (corresponding author), Tianjin Med Univ, Sch Biomed Engn, Lab Neurobiol Med, Tianjin, Peoples R China.	tianx@tmu.edu.cn			National Natural Science Foundation of China [61375113, 91132722]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants 61375113 and 91132722 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bai WW, 2012, NEUROSCI BULL, V28, P693, DOI 10.1007/s12264-012-1291-x; D'Ardenne K, 2012, P NATL ACAD SCI USA, V109, P19900, DOI 10.1073/pnas.1116727109; Eldawlatly S, 2009, NEURAL COMPUT, V21, P450, DOI 10.1162/neco.2008.09-07-606; Feldt S, 2011, TRENDS NEUROSCI, V34, P225, DOI 10.1016/j.tins.2011.02.007; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Gao L, 2013, BRAIN TOPOGR, V26, P201, DOI 10.1007/s10548-012-0250-1; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Gordon EM, 2012, HUM BRAIN MAPP; Gow DW, 2008, NEUROIMAGE, V43, P614, DOI 10.1016/j.neuroimage.2008.07.027; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Heitger MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062133; Hu J, 2005, IEEE T NEUR SYS REH, V13, P256, DOI 10.1109/TNSRE.2005.847389; Kispersky Tilman, 2011, Neural Syst Circuits, V1, P9, DOI 10.1186/2042-1001-1-9; Leonardi N, 2013, NEUROIMAGE, V83, P937, DOI 10.1016/j.neuroimage.2013.07.019; Li SY, 2012, BRAIN RES BULL, V89, P115, DOI 10.1016/j.brainresbull.2012.07.012; Mikula S, 2006, INT J NEUROSCI, V116, P419, DOI 10.1080/00207450500505761; Nicolaou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033869; Prasad A, 2009, IEEE ENG MED BIO, P582, DOI 10.1109/IEMBS.2009.5332818; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Ries ML, 2012, NEUROPSYCHOLOGIA, V50, P603, DOI 10.1016/j.neuropsychologia.2011.12.014; Roux F, 2012, J NEUROSCI, V32, P12411, DOI 10.1523/JNEUROSCI.0421-12.2012; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Seth AK, 2007, NEURAL COMPUT, V19, P910, DOI 10.1162/neco.2007.19.4.910; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Uddin Lucina Q, 2013, Front Hum Neurosci, V7, P458, DOI 10.3389/fnhum.2013.00458; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Zhou ZY, 2009, BRAIN RES, V1289, P22, DOI 10.1016/j.brainres.2009.06.096; Zhou ZY, 2009, HUM BRAIN MAPP, V30, P2197, DOI 10.1002/hbm.20661; Zhu LQ, 2005, MATH BIOSCI ENG, V2, P1	34	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91481	10.1371/journal.pone.0091481	http://dx.doi.org/10.1371/journal.pone.0091481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658291	Green Submitted, gold, Green Published			2022-12-27	WOS:000333355300035
J	Yukawa, M; Akiyama, T; Franke, V; Mise, N; Isagawa, T; Suzuki, Y; Suzuki, MG; Vlahovicek, K; Abe, K; Aburatani, H; Aoki, F				Yukawa, Masashi; Akiyama, Tomohiko; Franke, Vedran; Mise, Nathan; Isagawa, Takayuki; Suzuki, Yutaka; Suzuki, Masataka G.; Vlahovicek, Kristian; Abe, Kuniya; Aburatani, Hiroyuki; Aoki, Fugaku			Genome-Wide Analysis of the Chromatin Composition of Histone H2A and H3 Variants in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							DNA METHYLATION; CPG ISLANDS; NUCLEOSOME DEPLETION; POLYCOMB COMPLEX; CORE PROMOTER; SELF-RENEWAL; TRANSCRIPTION; CTCF; HETEROCHROMATIN; PLURIPOTENT	Genome-wide distribution of the majority of H2A and H3 variants (H2A, H2AX, H2AZ, macroH2A, H3.1, H3.2 and H3.3) was simultaneously investigated in mouse embryonic stem cells by chromatin immunoprecipitation sequencing. Around the transcription start site, histone variant distribution differed between genes possessing promoters of high and low CpG density, regardless of their expression levels. In the intergenic regions, regulatory elements were enriched in H2A.Z and H3.3, whereas repeat elements were abundant in H2A and macroH2A, and H3.1, respectively. Analysis of H2A and H3 variant combinations composing nucleosomes revealed that the H2A.Z and H3.3 combinations were present at a higher frequency throughout the genome than the other combinations, suggesting that H2A. Z and H3.3 associate preferentially with each other to comprise the nucleosomes independently of genome region. Finally, we found that chromatin was unstable only in regions where it was enriched in both H2A.Z and H3.3, but strongly quantified stable in regions in which only H3.3 was abundant. Therefore, histone variant composition is an important determinant of chromatin structure, which is associated with specific genomic functions.	[Yukawa, Masashi; Akiyama, Tomohiko; Suzuki, Masataka G.; Aoki, Fugaku] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Franke, Vedran; Vlahovicek, Kristian] Univ Zagreb, Fac Sci, Div Biol, Bioinformat Grp, Zagreb 41000, Croatia; [Mise, Nathan; Abe, Kuniya] RIKEN, Bioresource Ctr, Tsukuba Inst, Mammalian Cellular Dynam Team, Tsukuba, Ibaraki, Japan; [Isagawa, Takayuki; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba, Japan	University of Tokyo; University of Zagreb; RIKEN; University of Tokyo; University of Tokyo	Aoki, F (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	aokif@k.u-tokyo.ac.jp	Vlahoviček, Kristian/D-9661-2011; 名丹, 三瀬/AAD-1036-2021; AOKI, FUGAKU/AAO-7617-2021	Vlahoviček, Kristian/0000-0002-5705-2464; Yukawa, Masashi/0000-0003-1798-2410; Franke, Vedran/0000-0003-3606-6792	Ministry of Education, Culture, Sports, Science and Technology of Japan [20062002]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#20062002; URL: http://www.jsps.go.jp/english/index.html). No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almouzni G, 2011, NUCLEUS-PHILA, V2, P332, DOI 10.4161/nucl.2.5.17707; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Chakravarthy S, 2005, MOL CELL BIOL, V25, P7616, DOI 10.1128/MCB.25.17.7616-7624.2005; Changolkar LN, 2010, MOL CELL BIOL, V30, P5473, DOI 10.1128/MCB.00518-10; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; Collas P, 2009, BBA-GEN SUBJECTS, V1790, P900, DOI 10.1016/j.bbagen.2008.10.006; Conerly ML, 2010, GENOME RES, V20, P1383, DOI 10.1101/gr.106542.110; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dimitri P, 1997, GENETICA, V100, P85, DOI 10.1023/A:1018304922862; Dimitri P, 2009, CHROMOSOMA, V118, P419, DOI 10.1007/s00412-009-0211-y; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; Huang C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003558; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jamai A, 2007, MOL CELL, V25, P345, DOI 10.1016/j.molcel.2007.01.019; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Lee BK, 2012, J BIOL CHEM, V287, P30906, DOI 10.1074/jbc.R111.324962; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Nashun B, 2010, DEVELOPMENT, V137, P3785, DOI 10.1242/dev.051805; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Phillips-Cremins JE, 2013, MOL CELL, V50, P461, DOI 10.1016/j.molcel.2013.04.018; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P4537, DOI 10.1073/pnas.0400678101; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Seo J, 2012, NUCLEIC ACIDS RES, V40, P5965, DOI 10.1093/nar/gks287; Shechter D, 2009, P NATL ACAD SCI USA, V106, P749, DOI 10.1073/pnas.0812207106; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tolstorukov MY, 2012, MOL CELL, V47, P596, DOI 10.1016/j.molcel.2012.06.011; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Wang YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042414; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; WEST MHP, 1980, BIOCHEMISTRY-US, V19, P3238, DOI 10.1021/bi00555a022; Wollmann H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002658; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	73	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92689	10.1371/journal.pone.0092689	http://dx.doi.org/10.1371/journal.pone.0092689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658136	Green Submitted, gold, Green Published			2022-12-27	WOS:000333355300114
J	Becker, A; Durante, M; Taucher-Scholz, G; Jakob, B				Becker, Annabelle; Durante, Marco; Taucher-Scholz, Gisela; Jakob, Burkhard			ATM Alters the Otherwise Robust Chromatin Mobility at Sites of DNA Double-Strand Breaks (DSBs) in Human Cells	PLOS ONE			English	Article							END-JOINING PATHWAY; MAMMALIAN-CELLS; HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; LIVING CELLS; H2AX PHOSPHORYLATION; POSITIONAL STABILITY; IONIZING-RADIATION; GENOME INTEGRITY; REPAIR	Ionizing radiation induces DNA double strand breaks (DSBs) which can lead to the formation of chromosome rearrangements through error prone repair. In mammalian cells the positional stability of chromatin contributes to the maintenance of genome integrity. DSBs exhibit only a small, submicron scale diffusive mobility, but a slight increase in the mobility of chromatin domains by the induction of DSBs might influence repair fidelity and the formation of translocations. The radiation-induced local DNA decondensation in the vicinity of DSBs is one factor potentially enhancing the mobility of DSB-containing chromatin domains. Therefore in this study we focus on the influence of different chromatin modifying proteins, known to be activated by the DNA damage response, on the mobility of DSBs. IRIF (ionizing radiation induced foci) in U2OS cells stably expressing 53BP1-GFP were used as a surrogate marker of DSBs. Low angle charged particle irradiation, known to trigger a pronounced DNA decondensation, was used for the defined induction of linear tracks of IRIF. Our results show that movement of IRIF is independent of the investigated chromatin modifying proteins like ACF1 or PARP1 and PARG. Also depletion of proteins that tether DNA strands like MRE11 and cohesin did not alter IRIF dynamics significantly. Inhibition of ATM, a key component of DNA damage response signaling, resulted in a pronounced confinement of DSB mobility, which might be attributed to a diminished radiation induced decondensation. This confinement following ATM inhibition was confirmed using X-rays, proving that this effect is not restricted to densely ionizing radiation. In conclusion, repair sites of DSBs exhibit a limited mobility on a small spatial scale that is mainly unaffected by depletion of single remodeling or DNA tethering proteins. However, it relies on functional ATM kinase which is considered to influence the chromatin structure after irradiation.	[Becker, Annabelle; Durante, Marco; Taucher-Scholz, Gisela; Jakob, Burkhard] GSI Darmstadt, Helmholtzzentrum Schwerionenforsch GmbH, Darmstadt, Germany; [Durante, Marco; Taucher-Scholz, Gisela] Tech Univ Darmstadt, Darmstadt, Germany	Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Technical University of Darmstadt	Jakob, B (corresponding author), GSI Darmstadt, Helmholtzzentrum Schwerionenforsch GmbH, Darmstadt, Germany.	b.jakob@gsi.de	Durante, Marco/L-4795-2017; Jakob, Burkhard/D-2047-2013; Durante, Marco/K-1315-2014	Durante, Marco/0000-0002-4615-553X; Jakob, Burkhard/0000-0003-2404-377X; Durante, Marco/0000-0002-4615-553X	DFG [GRK 1657]; Helmholtz graduate school for hadron and ion research	DFG(German Research Foundation (DFG)); Helmholtz graduate school for hadron and ion research	This work was supported by DFG funded GRK 1657 and the Helmholtz graduate school for hadron and ion research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bauerschmidt C, 2010, NUCLEIC ACIDS RES, V38, P477, DOI 10.1093/nar/gkp976; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bermudez VP, 2012, P NATL ACAD SCI USA, V109, P9366, DOI 10.1073/pnas.1206840109; BURKLE A, 1993, CARCINOGENESIS, V14, P559, DOI 10.1093/carcin/14.4.559; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dion V, 2013, EMBO REP, V14, P984, DOI 10.1038/embor.2013.142; Dion V, 2013, CELL, V152, P1355, DOI 10.1016/j.cell.2013.02.010; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Dorsett D, 2012, CURR BIOL, V22, pR240, DOI 10.1016/j.cub.2012.02.046; Falk M, 2007, BBA-MOL CELL RES, V1773, P1534, DOI 10.1016/j.bbamcr.2007.07.002; Falk M, 2010, MUTAT RES-REV MUTAT, V704, P88, DOI 10.1016/j.mrrev.2010.01.013; Fournier C, 2004, RADIAT RES, V161, P675, DOI 10.1667/RR3182; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Girst S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02511; Gontijo AMDC, 2003, BIOCHIMIE, V85, P1133, DOI 10.1016/j.biochi.2003.10.018; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2012, INT J MOL SCI, V13, P11844, DOI 10.3390/ijms130911844; Guigas G, 2007, FEBS LETT, V581, P5094, DOI 10.1016/j.febslet.2007.09.054; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Jakob B, 2006, NUCL INSTRUM METH B, V245, P292, DOI 10.1016/j.nimb.2005.11.117; Jakob B, 2003, RADIAT RES, V159, P676, DOI 10.1667/0033-7587(2003)159[0676:BIOHCT]2.0.CO;2; Jakob B, 2009, RADIAT RES, V171, P405, DOI 10.1667/RR1520.1; Jakob B, 2009, P NATL ACAD SCI USA, V106, P3172, DOI 10.1073/pnas.0810987106; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Jegou T, 2009, MOL BIOL CELL, V20, P2070, DOI 10.1091/mbc.E08-02-0108; Jezkova L, 2014, APPL RADIAT ISOTOPES, V83, P128; Kase Y, 2008, PHYS MED BIOL, V53, P37, DOI 10.1088/0031-9155/53/1/003; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Krawczyk PM, 2012, J CELL SCI, V125, P2127, DOI 10.1242/jcs.089847; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lan L, 2010, MOL CELL, V40, P976, DOI 10.1016/j.molcel.2010.12.003; Lee JH, 2013, J BIOL CHEM, V288, P12840, DOI 10.1074/jbc.M113.460378; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mansour WY, 2010, NUCLEIC ACIDS RES, V38, P6065, DOI 10.1093/nar/gkq387; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Meyer B, 2013, NUCLEIC ACIDS RES, V41, P6109, DOI 10.1093/nar/gkt304; Mine-Hattab J, 2013, TRENDS CELL BIOL, V23, P529, DOI 10.1016/j.tcb.2013.05.006; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Muller I, 2013, MUTAT RES-GEN TOX EN, V756, P30, DOI 10.1016/j.mrgentox.2013.04.006; Muller I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011560; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Parada LA, 2002, TRENDS CELL BIOL, V12, P425, DOI 10.1016/S0962-8924(02)02351-6; Platani M, 2002, NAT CELL BIOL, V4, P502, DOI 10.1038/ncb809; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Roukos V, 2013, SCIENCE, V341, P660, DOI 10.1126/science.1237150; Sanchez-Molina S, 2011, NUCLEIC ACIDS RES, V39, P8445, DOI 10.1093/nar/gkr435; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shi L, 2012, BBA-GENE REGUL MECH, V1819, P811, DOI 10.1016/j.bbagrm.2012.01.002; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sjogren C, 2010, EXP CELL RES, V316, P1445, DOI 10.1016/j.yexcr.2009.12.018; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Sulli G, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3344; Thomas C, 2013, MOL ASPECTS MED, V34, P1124, DOI 10.1016/j.mam.2013.04.001; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Tommasino F, 2013, RADIAT RES, V180, P524, DOI 10.1667/RR13389.1; van Gent DC, 2007, ONCOGENE, V26, P7731, DOI 10.1038/sj.onc.1210871; Wu N, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-5; Zha S, 2009, NAT STRUCT MOL BIOL, V16, P798, DOI 10.1038/nsmb0809-798	82	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92640	10.1371/journal.pone.0092640	http://dx.doi.org/10.1371/journal.pone.0092640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651490	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800137
J	Fujiwara, T; Kanazawa, S; Ichibori, R; Tanigawa, T; Magome, T; Shingaki, K; Miyata, S; Tohyama, M; Hosokawa, K				Fujiwara, Takashi; Kanazawa, Shigeyuki; Ichibori, Ryoko; Tanigawa, Tomoko; Magome, Takuya; Shingaki, Kenta; Miyata, Shingo; Tohyama, Masaya; Hosokawa, Ko			L-Arginine Stimulates Fibroblast Proliferation through the GPRC6A-ERK1/2 and PI3K/Akt Pathway	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAY; CELL-CYCLE PROGRESSION; NITRIC-OXIDE; GROWTH-FACTORS; AMINO-ACID; MIGRATION; IMMUNE; REGENERATION; SECRETION; APOPTOSIS	L-Arginine is considered a conditionally essential amino acid and has been shown to enhance wound healing. However, the molecular mechanisms through which arginine stimulates cutaneous wound repair remain unknown. Here, we evaluated the effects of arginine supplementation on fibroblast proliferation, which is a key process required for new tissue formation. We also sought to elucidate the signaling pathways involved in mediating the effects of arginine on fibroblasts by evaluation of extracellular signal-related kinase (ERK) 1/2 activation, which is important for cell growth, survival, and differentiation. Our data demonstrated that addition of 6 mM arginine significantly enhanced fibroblast proliferation, while arginine deprivation increased apoptosis, as observed by enhanced DNA fragmentation. In vitro kinase assays demonstrated that arginine supplementation activated ERK1/2, Akt, PKA and its downstream target, cAMP response element binding protein (CREB). Moreover, knockdown of GPRC6A using siRNA blocked fibroblast proliferation and decreased phosphorylation of ERK1/2, Akt and CREB. The present experiments demonstrated a critical role for the GPRC6A-ERK1/2 and PI3K/Akt signaling pathway in arginine-mediated fibroblast survival. Our findings provide novel mechanistic insights into the positive effects of arginine on wound healing.	[Fujiwara, Takashi; Kanazawa, Shigeyuki; Ichibori, Ryoko; Tanigawa, Tomoko; Hosokawa, Ko] Osaka Univ, Grad Sch Med, Dept Plast Surg, Suita, Osaka, Japan; [Magome, Takuya] Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Suita, Osaka, Japan; [Shingaki, Kenta] Noevir Co Ltd, Dept Res & Dev, Higashiomi, Shiga, Japan; [Miyata, Shingo; Tohyama, Masaya] Kinki Univ, Res Inst Tradit Asian Med, Div Mol Brain Sci, Osakasayama, Osaka, Japan	Osaka University; Osaka University; Kindai University (Kinki University)	Kanazawa, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Plast Surg, Suita, Osaka, Japan.	kanazawa@psurg.med.osaka-u.ac.jp						Angele MK, 1999, SURGERY, V126, P279, DOI 10.1067/msy.1999.98743; BARBUL A, 1990, SURGERY, V108, P331; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Chang FM, 2003, INT J ONCOL, V22, P469; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; COLLINS MKL, 1994, BIOESSAYS, V16, P133, DOI 10.1002/bies.950160210; DALY JM, 1988, ANN SURG, V208, P512, DOI 10.1097/00000658-198810000-00013; Du M, 1997, BIOCHEM MOL BIOL INT, V41, P625; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Jones SM, 2001, FEBS LETT, V490, P110, DOI 10.1016/S0014-5793(01)02113-5; Kanazawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012228; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kim JY, 2011, BIOL REPROD, V84, P62, DOI 10.1095/biolreprod.110.085738; KIRK SJ, 1993, SURGERY, V114, P155; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; LANDER HM, 1993, J IMMUNOL, V151, P7182; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; Lovicu FJ, 2001, DEVELOPMENT, V128, P5075; Luiking YC, 2007, CRIT CARE MED, V35, pS557, DOI 10.1097/01.CCM.0000279191.44730.A2; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Oya M, 2013, J BIOL CHEM, V288, P4513, DOI 10.1074/jbc.M112.402677; Pi M, 2012, ENDOCRINOLOGY, V153, P4608, DOI 10.1210/en.2012-1301; Rhoads JM, 2006, AM J PHYSIOL-GASTR L, V291, pG510, DOI 10.1152/ajpgi.00189.2005; ROSE WC, 1949, FED PROC, V8, P546; Schaffer MR, 1996, J SURG RES, V63, P237, DOI 10.1006/jsre.1996.0254; Schaffer MR, 1997, J IMMUNOL, V158, P2375; SEIFTER E, 1978, SURGERY, V84, P224; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tan B, 2010, AMINO ACIDS, V38, P1227, DOI 10.1007/s00726-009-0334-8; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Yatabe J, 2011, J NUTR HEALTH AGING, V15, P282, DOI 10.1007/s12603-010-0306-4; Zheng J, 2006, BIOL REPROD, V74, P375, DOI 10.1095/biolreprod.105.043190; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	37	51	52	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92168	10.1371/journal.pone.0092168	http://dx.doi.org/10.1371/journal.pone.0092168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651445	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800076
J	Moreno-Santos, I; Pavon, FJ; Romero-Cuevas, M; Serrano, A; Cano, C; Suardiaz, M; Decara, J; Suarez, J; de Fonseca, FR; Macias-Gonzalez, M				Moreno-Santos, Inmaculada; Javier Pavon, Francisco; Romero-Cuevas, Miguel; Serrano, Antonia; Cano, Carolina; Suardiaz, Margarita; Decara, Juan; Suarez, Juan; Rodriguez de Fonseca, Fernando; Macias-Gonzalez, Manuel			Computational and Biological Evaluation of N-octadecyl-N '-propylsulfamide, a Selective PPAR alpha Agonist Structurally Related to N-acylethanolamines	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; BODY-WEIGHT; INVERSE-AGONIST; OLEOYLETHANOLAMIDE; SULFAMIDE; ANALOGS	To further understand the pharmacological properties of N-oleoylethanolamine (OEA), a naturally occurring lipid that activates peroxisome proliferator-activated receptor alpha (PPAR alpha), we designed sulfamoyl analogs based on its structure. Among the compounds tested, N-octadecyl-N'-propylsulfamide (CC7) was selected for functional comparison with OEA. The performed studies include the following computational and biological approaches: 1) molecular docking analyses; 2) molecular biology studies with PPAR alpha; 3) pharmacological studies on feeding behavior and visceral analgesia. For the docking studies, we compared OEA and CC7 data with crystallization data obtained with the reference PPAR alpha agonist GW409544. OEA and CC7 interacted with the ligand-binding domain of PPAR alpha in a similar manner to GW409544. Both compounds produced similar transcriptional activation by in vitro assays, including the GST pull-down assay and reporter gene analysis. In addition, CC7 and OEA induced the mRNA expression of CPT1a in HpeG2 cells through PPARa and the induction was avoided with PPAR alpha-specific siRNA. In vivo studies in rats showed that OEA and CC7 had anorectic and antiobesity activity and induced both lipopenia and decreases in hepatic fat content. However, different effects were observed when measuring visceral pain; OEA produced visceral analgesia whereas CC7 showed no effects. These results suggest that OEA activity on the PPARa receptor (e. g., lipid metabolism and feeding behavior) may be dissociated from other actions at alternative targets (e. g., pain) because other non cannabimimetic ligands that interact with PPARa, such as CC7, do not reproduce the full spectrum of the pharmacological activity of OEA. These results provide new opportunities for the development of specific PPAR alpha-activating drugs focused on sulfamide derivatives with a long alkyl chain for the treatment of metabolic dysfunction.	[Moreno-Santos, Inmaculada; Macias-Gonzalez, Manuel] Hosp Univ Virgen Victoria, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Endocrinol & Nutr, Malaga, Spain; [Moreno-Santos, Inmaculada; Javier Pavon, Francisco; Serrano, Antonia; Suarez, Juan; Rodriguez de Fonseca, Fernando; Macias-Gonzalez, Manuel] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, CIBERobn, CB06 03, Santiago De Compostela, Spain; [Javier Pavon, Francisco; Romero-Cuevas, Miguel; Serrano, Antonia; Suardiaz, Margarita; Decara, Juan; Suarez, Juan; Rodriguez de Fonseca, Fernando] Hosp Reg Univ Malaga, Inst IBIMA, Unidad Gest Clin Salud Mental, Malaga, Spain; [Cano, Carolina] CSIC, Ctr Quim Organ Manuel Lora Tamayo, Inst Quim Med, Grp Moduladores Receptores Cannabinoides & PPARs, Madrid, Spain	Hospital Virgen de la Victoria; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Medica (IQM); Organic Chemistry Centre Lora-Tamayo (CENQUIOR)	de Fonseca, FR (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, CIBERobn, CB06 03, Santiago De Compostela, Spain.	fernando.rodriguez@fundacionimabis.org; mmacias.manuel@gmail.com	Romero-Cuevas, Miguel/M-3461-2016; Pavón Morón, Francisco Javier/AAG-9721-2020; Suarez, Juan/I-5188-2015; Decara Del Olmo, Juan Manuel/I-1931-2015; MACIAS-GONZALEZ, MANUEL/E-7584-2016	Romero-Cuevas, Miguel/0000-0002-8323-0893; Pavón Morón, Francisco Javier/0000-0002-5256-8904; Suarez, Juan/0000-0001-5254-9802; Serrano, Antonia/0000-0002-8017-9754; Decara Del Olmo, Juan Manuel/0000-0002-9868-015X; MACIAS-GONZALEZ, MANUEL/0000-0002-6475-4704	Research Stabilization Program of the Instituto de Salud Carlos III [CES 10/004]; European Union [Health-F2-2008-223713]; Spanish Ministry of Science and Innovation [SAF2010-20521]; Ministry of Economy and Competitivity [CP12/03109]; Instituto de Salud 'Carlos III' [PI07/0953, PI11/01661]; Red de Trastornos Adictivos EU-ERDF [RD06/0001/0000, RD12/0028/0001]; CIBERobn EU-ERDF [CB06/03/1008]; Andalusian Ministry of Economy, Innovation, Science; Employment EU-ERDF [CTS-8221, CTS-433]; Fundacio La Marato de TV3	Research Stabilization Program of the Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Union(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Economy and Competitivity; Instituto de Salud 'Carlos III'(Instituto de Salud Carlos IIIEuropean Commission); Red de Trastornos Adictivos EU-ERDF; CIBERobn EU-ERDF; Andalusian Ministry of Economy, Innovation, Science; Employment EU-ERDF; Fundacio La Marato de TV3	MM-G was supported by the Research Stabilization Program of the Instituto de Salud Carlos III (CES 10/004). The present work has been supported by the European Union's 7th Framework Programme (Health-F2-2008-223713, Reprobesity), the Spanish Ministry of Science and Innovation (SAF2010-20521), Ministry of Economy and Competitivity (CP12/03109), Instituto de Salud 'Carlos III' (PI07/0953 and PI11/01661), Red de Trastornos Adictivos EU-ERDF (RD06/0001/0000, RD12/0028/0001), CIBERobn EU-ERDF (CB06/03/1008), the Andalusian Ministry of Economy, Innovation, Science and Employment EU-ERDF (CTS-8221 and CTS-433), and Fundacio La Marato de TV3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GP, 2003, J BIOL CHEM, V278, P30429, DOI 10.1074/jbc.M305051200; Ali HI, 2008, EUR J MED CHEM, V43, P1376, DOI 10.1016/j.ejmech.2007.10.011; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cano C, 2007, J MED CHEM, V50, P389, DOI 10.1021/jm0601102; Leite LFCD, 2007, EUR J MED CHEM, V42, P1263, DOI 10.1016/j.ejmech.2007.02.015; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Gomez R, 2002, J NEUROSCI, V22, P9612; Gonzalez MM, 2003, MOL ENDOCRINOL, V17, P2028, DOI 10.1210/me.2003-0072; Gonzalez MM, 2002, J BIOL CHEM, V277, P18501, DOI 10.1074/jbc.M200205200; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; Kostadinova R, 2005, CURR MED CHEM, V12, P2995, DOI 10.2174/092986705774462905; Lempiainen H, 2005, MOL ENDOCRINOL, V19, P2258, DOI 10.1210/me.2004-0534; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Decara JM, 2012, DIS MODEL MECH, V5, P660, DOI 10.1242/dmm.009233; MARCUS SL, 1993, P NATL ACAD SCI USA, V90, P5723, DOI 10.1073/pnas.90.12.5723; Molnar F, 2005, J BIOL CHEM, V280, P26543, DOI 10.1074/jbc.M502463200; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Nagasawa M, 2007, BIOCHEM PHARMACOL, V74, P1738, DOI 10.1016/j.bcp.2007.08.020; ONATE SA, 1995, SCIENCE, V270, P1354; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Pavon FJ, 2010, DRUG DISCOV TODAY DI, V7, pe175; Reyes-Cabello C, 2012, PHARMACOL BIOCHEM BE, V101, P1, DOI 10.1016/j.pbb.2011.11.011; Serrano A, 2008, OBES METAB-MILAN, V4, P76; Serrano A, 2008, NEUROPHARMACOLOGY, V54, P226, DOI 10.1016/j.neuropharm.2007.03.007; Singh JP, 2005, MOL PHARMACOL, V68, P763, DOI 10.1124/mol.105.010991; Staels B, 2008, NAT CLIN PRACT CARD, V5, P542, DOI 10.1038/ncpcardio1278; Suardiaz M, 2007, PAIN, V133, P99, DOI 10.1016/j.pain.2007.03.008; Thabuis C, 2008, LIPIDS, V43, P887, DOI 10.1007/s11745-008-3217-y; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Yu ST, 2007, BBA-MOL CELL BIOL L, V1771, P936, DOI 10.1016/j.bbalip.2007.01.008; Yu ST, 2003, CURR MOL MED, V3, P561, DOI 10.2174/1566524033479537	34	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92195	10.1371/journal.pone.0092195	http://dx.doi.org/10.1371/journal.pone.0092195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651609	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800082
J	Ugonna, K; Bingle, CD; Plant, K; Wilson, K; Everard, ML				Ugonna, Kelechi; Bingle, Colin D.; Plant, Karen; Wilson, Kirsty; Everard, Mark L.			Macrophages Are Required for Dendritic Cell Uptake of Respiratory Syncytial Virus from an Infected Epithelium	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; DIFFERENTIATION; INFANTS; DISEASE	We have previously shown that the respiratory syncytial virus [RSV] can productively infect monocyte derived dendritic cells [MoDC] and remain dormant within the same cells for prolonged periods. It is therefore possible that infected dendritic cells act as a reservoir within the airways of individuals between annual epidemics. In the present study we explored the possibility that sub-epithelial DCs can be infected with RSV from differentiated bronchial epithelium and that in turn RSV from DCs can infect the epithelium. A dual co-culture model was established in which a differentiated primary airway epithelium on an Air Liquid Interface (ALI) was cultured on a transwell insert and MoDCs were subsequently added to the basolateral membrane of the insert. Further experiments were undertaken using a triple co-culture model in which in which macrophages were added to the apical surface of the differentiated epithelium. A modified RSV [rr-RSV] expressing a red fluorescent protein marker of replication was used to infect either the MoDCs or the differentiated epithelium and infection of the reciprocal cell type was assessed using confocal microscopy. Our data shows that primary epithelium became infected when rr-RSV infected MoDCs were introduced onto the basal surface of the transwell insert. MoDCs located beneath the epithelium did not become infected with virus from infected epithelial cells in the dual co-culture model. However when macrophages were present on the apical surface of the primary epithelium infection of the basal MoDCs occurred. Our data suggests that RSV infected dendritic cells readily transmit infection to epithelial cells even when they are located beneath the basal layer. However macrophages appear to be necessary for the transmission of infection from epithelial cells to basal dendritic cells.	[Ugonna, Kelechi] Sheffield Childrens Hosp, Dept Resp Med, Sheffield, S Yorkshire, England; [Bingle, Colin D.; Plant, Karen; Wilson, Kirsty] Univ Sheffield, Dept Infect & Immun, Acad Unit Resp Med, Sheffield, S Yorkshire, England; [Everard, Mark L.] Univ Western Australia, Princess Margaret Hosp, Sch Paediat & Child Hlth, Subiaco, WA, Australia	Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Sheffield; University of Western Australia	Everard, ML (corresponding author), Univ Western Australia, Princess Margaret Hosp, Sch Paediat & Child Hlth, Subiaco, WA, Australia.	mark.everard@uwa.edu.au		Bingle, Colin/0000-0002-5405-6988; Everard, Mark/0000-0003-1571-261X	Sheffield Children's Hospital Research Committee	Sheffield Children's Hospital Research Committee	The study was funded by the Sheffield Children's Hospital Research Committee. The funders had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	Bataki EL, 2005, CLIN EXP IMMUNOL, V140, P470, DOI 10.1111/j.1365-2249.2005.02780.x; Bingle CD, 2010, HISTOCHEM CELL BIOL, V133, P505, DOI 10.1007/s00418-010-0683-0; Blank F, 2007, AM J RESP CELL MOL, V36, P669, DOI 10.1165/rcmb.2006-0234OC; Blank F, 2011, IMMUNOBIOLOGY, V216, P86, DOI 10.1016/j.imbio.2010.02.006; Condon TV, 2011, J LEUKOCYTE BIOL, V90, P883, DOI 10.1189/jlb.0311134; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; ENGLUND JA, 1994, PEDIATR INFECT DIS J, V13, P449, DOI 10.1097/00006454-199405000-00037; Everard ML, 2006, CURR ALLERGY ASTHM R, V6, P97, DOI 10.1007/s11882-006-0046-z; EVERARD ML, 1992, EUR J PEDIATR, V151, P638, DOI 10.1007/BF01957564; Everard ML, 2009, TXB PAEDIAT RESP MED, P491; GILCHRIST S, 1994, J INFECT DIS, V170, P986, DOI 10.1093/infdis/170.4.986; Gill MA, 2005, J INFECT DIS, V191, P1105, DOI 10.1086/428589; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Guilliams M, 2013, MUCOSAL IMMUNOL, V6, P464, DOI 10.1038/mi.2013.14; HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803; Hobson L, 2008, CLIN EXP IMMUNOL, V151, P359, DOI 10.1111/j.1365-2249.2007.03560.x; Jahnsen FL, 2006, J IMMUNOL, V177, P5861, DOI 10.4049/jimmunol.177.9.5861; Johansen J, 1997, APMIS, V105, P303, DOI 10.1111/j.1699-0463.1997.tb00573.x; Jones A, 2006, CLIN EXP IMMUNOL, V143, P513, DOI 10.1111/j.1365-2249.2005.03004.x; Jones A, 2001, EFFECT RSV HUMAN BON; MIDULLA F, 1993, J INFECT DIS, V168, P1515, DOI 10.1093/infdis/168.6.1515; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Neyt K, 2013, IMMUNOL REV, V255, P57, DOI 10.1111/imr.12100; Obregon C, 2006, AM J PATHOL, V169, P2127, DOI 10.2353/ajpath.2006.060453; PANUSKA JR, 1990, J CLIN INVEST, V86, P113, DOI 10.1172/JCI114672; PARROTT RH, 1973, AM J EPIDEMIOL, V98, P289, DOI 10.1093/oxfordjournals.aje.a121558; Rivera-Toledo E, 2012, VIRUSES-BASEL, V4, P3270, DOI 10.3390/v4123270; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Rothen-Rutishauser B, 2008, EXPERT OPIN DRUG MET, V4, P1075, DOI [10.1517/17425255.4.8.1075, 10.1517/17425255.4.8.1075 ]; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	30	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e91855	10.1371/journal.pone.0091855	http://dx.doi.org/10.1371/journal.pone.0091855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651119	Green Published, Green Accepted, gold			2022-12-27	WOS:000333352800051
J	Wizert, A; Iskander, DR; Cwiklik, L				Wizert, Alicja; Iskander, D. Robert; Cwiklik, Lukasz			Organization of Lipids in the Tear Film: A Molecular-Level View	PLOS ONE			English	Article							COARSE-GRAINED MODEL; DRY EYE DISEASE; MEIBOMIAN GLAND; LAYER; DYNAMICS; SURFACE; DYSFUNCTION; EVAPORATION; PREVALENCE; CURVATURE	Biophysical properties of the tear film lipid layer are studied at the molecular level employing coarse grain molecular dynamics (MD) simulations with a realistic model of the human tear film. In this model, polar lipids are chosen to reflect the current knowledge on the lipidome of the tear film whereas typical Meibomian-origin lipids are included in the thick non-polar lipids subphase. Simulation conditions mimic those experienced by the real human tear film during blinks. Namely, thermodynamic equilibrium simulations at different lateral compressions are performed to model varying surface pressure, and the dynamics of the system during a blink is studied by non-equilibrium MD simulations. Polar lipids separate their non-polar counterparts from water by forming a monomolecular layer whereas the non-polar molecules establish a thick outermost lipid layer. Under lateral compression, the polar layer undulates and a sorting of polar lipids occurs. Moreover, formation of three-dimensional aggregates of polar lipids in both non-polar and water subphases is observed. We suggest that these three-dimensional structures are abundant under dynamic conditions caused by the action of eye lids and that they act as reservoirs of polar lipids, thus increasing stability of the tear film.	[Wizert, Alicja; Iskander, D. Robert] Wroclaw Univ Technol, Inst Biomed Engn & Instrumentat, PL-50370 Wroclaw, Poland; [Cwiklik, Lukasz] Acad Sci Czech Republ, J Heyrovsky Inst Phys Chem, Vvi, Prague, Czech Republic; [Cwiklik, Lukasz] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, Prague, Czech Republic; [Cwiklik, Lukasz] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland	Wroclaw University of Science & Technology; Czech Academy of Sciences; J. Heyrovsky Institute of Physical Chemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Tampere University	Cwiklik, L (corresponding author), Acad Sci Czech Republ, J Heyrovsky Inst Phys Chem, Vvi, Prague, Czech Republic.	lukasz.cwiklik@jh-inst.cas.cz	Cwiklik, Lukasz/A-7206-2008; Iskander, D Robert/E-3576-2017	Cwiklik, Lukasz/0000-0002-2083-8738; Iskander, D Robert/0000-0002-5962-6206				Baoukina S, 2008, P NATL ACAD SCI USA, V105, P10803, DOI 10.1073/pnas.0711563105; Begley CG, 2000, OPTOMETRY VISION SCI, V77, P40, DOI 10.1097/00006324-200001000-00012; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Borchman D, 2007, BIOPOLYMERS, V87, P124, DOI 10.1002/bip.20798; Borchman D, 2007, CHEM PHYS LIPIDS, V147, P87, DOI 10.1016/j.chemphyslip.2007.04.001; Borchman D, 2013, LIPIDS, V48, P1269, DOI 10.1007/s11745-013-3844-9; Bron AJ, 2004, EXP EYE RES, V78, P347, DOI 10.1016/j.exer.2003.09.019; Bron AJ, 2007, OCUL SURF, V5, P108; Butovich IA, 2008, INVEST OPHTH VIS SCI, V49, P3779, DOI 10.1167/iovs.08-1889; Craig JP, 1997, OPTOMETRY VISION SCI, V74, P8, DOI 10.1097/00006324-199701000-00014; Dartt DA, 2011, OCUL SURF, V9, P126, DOI 10.1016/S1542-0124(11)70022-2; Doane M. G., 1980, BER DTSCH OPHTHALMOL, V77, P13; Doughty MJ, 2002, OPTOMETRY VISION SCI, V79, P439, DOI 10.1097/00006324-200207000-00013; Du Toit R, 2001, OPTOMETRY VISION SCI, V78, P455, DOI 10.1097/00006324-200106000-00020; Fonn D, 1999, OPTOMETRY VISION SCI, V76, P700, DOI 10.1097/00006324-199910000-00021; Glasgow BJ, 2010, INVEST OPHTH VIS SCI, V51, P1981, DOI 10.1167/iovs.09-4622; Glasgow BJ, 1999, INVEST OPHTH VIS SCI, V40, P3100; Goto E, 2003, ARCH OPHTHALMOL-CHIC, V121, P173; Guo W, 1996, BIOPHYS J, V71, P2857, DOI 10.1016/S0006-3495(96)79482-1; HAMILTON JA, 1977, J BIOL CHEM, V252, P8071; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOLLY FJ, 1985, T OPHTHAL SOC UK, V104, P374; HOLLY FJ, 1973, EXP EYE RES, V15, P515, DOI 10.1016/0014-4835(73)90064-X; Hu MY, 2012, BIOPHYS J, V102, P1403, DOI 10.1016/j.bpj.2012.02.013; JESTER JV, 1981, INVEST OPHTH VIS SCI, V20, P537; Kamal MM, 2009, P NATL ACAD SCI USA, V106, P22245, DOI 10.1073/pnas.0907354106; KARABORNI S, 1994, MOL PHYS, V83, P345, DOI 10.1080/00268979400101301; Khanal S, 2010, NANOMED-NANOTECHNOL, V6, P707, DOI 10.1016/j.nano.2010.06.002; King-Smith PE, 2008, OPTOMETRY VISION SCI, V85, P623, DOI 10.1097/OPX.0b013e318181ae60; King-Smith PE, 2013, OCUL SURF, V11, P236, DOI 10.1016/j.jtos.2013.05.003; King-Smith PE, 2009, INVEST OPHTH VIS SCI, V50, P2747, DOI 10.1167/iovs.08-2459; Korb DR, 1996, OPTOMETRY VISION SCI, V73, P189, DOI 10.1097/00006324-199603000-00011; Kulovesi P, 2012, SOFT MATTER, V8, P5826, DOI 10.1039/c2sm25210d; Kulovesi P, 2010, BIOPHYS J, V99, P2559, DOI 10.1016/j.bpj.2010.08.001; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2013, CHEM SOC REV, V42, P6801, DOI 10.1039/c3cs60093a; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; McCulley James P, 2003, Ocul Surf, V1, P97; Millar TJ, 2013, CURR EYE RES, V38, P220, DOI 10.3109/02713683.2012.721045; Nagyova B, 1999, CURR EYE RES, V19, P4, DOI 10.1076/ceyr.19.1.4.5341; NICOLAIDES N, 1989, INVEST OPHTH VIS SCI, V30, P946; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Perera MN, 2012, BIOCHEM J, V445, P81, DOI 10.1042/BJ20112103; Rantamaki A, 2011, PROG RETIN EYE RES, V30, P204, DOI 10.1016/j.preteyeres.2011.02.002; Rantamaki AH, 2012, INVEST OPHTH VIS SCI, V53, P6442, DOI 10.1167/iovs.12-10487; Rantamaki AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019553; Rolando M, 2001, SURV OPHTHALMOL, V45, pS203, DOI 10.1016/S0039-6257(00)00203-4; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Shaw AJ, 2009, CORNEA, V28, P181, DOI 10.1097/ICO.0b013e31818a7d61; Shine WE, 1998, ARCH OPHTHALMOL-CHIC, V116, P849, DOI 10.1001/archopht.116.7.849; SMABY JM, 1978, J LIPID RES, V19, P325; Svitova TF, 2010, OPTOMETRY VISION SCI, V87, P10, DOI 10.1097/OPX.0b013e3181c07908; Szczesna DH, 2010, OPTOMETRY VISION SCI, V87, P513, DOI 10.1097/OPX.0b013e3181e17279; Szczesna-Iskander DH, 2012, OPTOMETRY VISION SCI, V89, P749, DOI 10.1097/OPX.0b013e318250192d; Telenius J, 2012, LANGMUIR, V28, P17092, DOI 10.1021/la304366d; Tomlinson A, 2005, OCUL SURF, V3, P81, DOI 10.1016/S1542-0124(12)70157-X; Tragoulias ST, 2005, CORNEA, V24, P189, DOI 10.1097/01.ico.0000138837.52694.37; Tutt R, 2000, INVEST OPHTH VIS SCI, V41, P4117; Vuorela T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000964; WOLLENSAK G, 1990, GRAEF ARCH CLIN EXP, V228, P78, DOI 10.1007/BF02764296	61	32	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92461	10.1371/journal.pone.0092461	http://dx.doi.org/10.1371/journal.pone.0092461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651175	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800111
J	Zhao, X; Yu, Q; Huang, L; Liu, QX				Zhao, Xiao; Yu, Qi; Huang, Ling; Liu, Qing-Xin			Patterns of Positive Selection of the Myogenic Regulatory Factor Gene Family in Vertebrates	PLOS ONE			English	Article							MYOD-FAMILY; PHYLOGENETIC ANALYSIS; MUSCLE DEVELOPMENT; BHLH GENE; EVOLUTION; EXPRESSION; DUPLICATIONS; DIVERGENCE; PROTEINS; ORIGIN	The functional divergence of transcriptional factors is critical in the evolution of transcriptional regulation. However, the mechanism of functional divergence among these factors remains unclear. Here, we performed an evolutionary analysis for positive selection in members of the myogenic regulatory factor (MRF) gene family of vertebrates. We selected 153 complete vertebrate MRF nucleotide sequences from our analyses, which revealed substantial evidence of positive selection. Here, we show that sites under positive selection were more frequently detected and identified from the genes encoding the myogenic differentiation factors (MyoG and Myf6) than the genes encoding myogenic determination factors (Myf5 and MyoD). Additionally, the functional divergence within the myogenic determination factors or differentiation factors was also under positive selection pressure. The positive selection sites were more frequently detected from MyoG and MyoD than Myf6 and Myf5, respectively. Amino acid residues under positive selection were identified mainly in their transcription activation domains and on the surface of protein three-dimensional structures. These data suggest that the functional gain and divergence of myogenic regulatory factors were driven by distinct positive selection of their transcription activation domains, whereas the function of the DNA binding domains was conserved in evolution. Our study evaluated the mechanism of functional divergence of the transcriptional regulation factors within a family, whereby the functions of their transcription activation domains diverged under positive selection during evolution.	[Zhao, Xiao; Yu, Qi; Huang, Ling; Liu, Qing-Xin] Shandong Agr Univ, Lab Dev Genet, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Liu, QX (corresponding author), Shandong Agr Univ, Lab Dev Genet, Tai An, Shandong, Peoples R China.	liuqingxin@sdau.edu.cn	yu, qi/Q-5819-2018	yu, qi/0000-0003-2605-5328	National Basic Research Program of China [2012CB114600]; National Natural Science Foundation of China [31240037, 31301951]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2012CB114600) and National Natural Science Foundation of China (31240037, 31301951). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki I, 1996, GENE, V171, P231, DOI 10.1016/0378-1119(96)00174-6; ATCHLEY WR, 1994, P NATL ACAD SCI USA, V91, P11522, DOI 10.1073/pnas.91.24.11522; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Clark NL, 2005, PLOS GENET, V1, P335, DOI 10.1371/journal.pgen.0010035; Della Gaspera B, 2012, DEV DYNAM, V241, P995, DOI 10.1002/dvdy.23780; Fujisawa-Sehara A, 2000, Tanpakushitsu Kakusan Koso, V45, P2228; Goodsell David S, 2005, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0504s11; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; HOLLAND PWH, 1994, DEVELOPMENT, P125; Innocenzi A, 2011, EMBO REP, V12, P164, DOI 10.1038/embor.2010.195; Jin W, 2012, MOL BIOL EVOL, V29, P3161, DOI 10.1093/molbev/mss123; Kablar B, 1998, BIOCHEM CELL BIOL, V76, P1079, DOI 10.1139/bcb-76-6-1079; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KOUMANS JTM, 1995, COMP BIOCHEM PHYS A, V110, P3, DOI 10.1016/0300-9629(94)00150-R; KRAUSE M, 1990, CELL, V63, P907, DOI 10.1016/0092-8674(90)90494-Y; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Meedel TH, 2002, DEV BIOL, V241, P238, DOI 10.1006/dbio.2001.0511; Meedel TH, 1997, DEVELOPMENT, V124, P1711; Meedel TH, 2007, DEV BIOL, V302, P333, DOI 10.1016/j.ydbio.2006.09.043; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; MICHELSON AM, 1990, GENE DEV, V4, P2086, DOI 10.1101/gad.4.12a.2086; Mok GF, 2011, REPRODUCTION, V141, P301, DOI 10.1530/REP-10-0394; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Rescan PY, 2001, COMP BIOCHEM PHYS B, V130, P1, DOI 10.1016/S1096-4959(01)00412-2; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schubert M, 2003, GENE EXPR PATTERNS, V3, P199, DOI 10.1016/S1567-133X(02)00099-6; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urano A, 2003, EVOL DEV, V5, P447, DOI 10.1046/j.1525-142X.2003.03051.x; VENUTI JM, 1991, P NATL ACAD SCI USA, V88, P6219, DOI 10.1073/pnas.88.14.6219; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yokoyama S, 2011, CELL MOL LIFE SCI, V68, P1843, DOI 10.1007/s00018-011-0629-2; Yuan JD, 2003, BIOCHEM BIOPH RES CO, V301, P960, DOI 10.1016/S0006-291X(03)00081-0; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]	48	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92873	10.1371/journal.pone.0092873	http://dx.doi.org/10.1371/journal.pone.0092873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651579	gold, Green Submitted, Green Published			2022-12-27	WOS:000333352800161
J	Bellon, JA; Moreno-Peral, P; Moreno-Kustner, B; Motrico, E; Aiarzaguena, JM; Fernandez, A; Fernandez-Alonso, C; Monton-Franco, C; Rodriguez-Bayon, A; Ballesta-Rodriguez, MI; Runtel-Geidel, A; Payo-Gordon, J; Serrano-Blanco, A; Olivan-Blazquez, B; Araujo, L; Munoz-Garcia, MD; King, M; Nazareth, I; Amezcua, M				Bellon, Juan A.; Moreno-Peral, Patricia; Moreno-Kuestner, Berta; Motrico, Emma; Aiarzagueena, Jose M.; Fernandez, Anna; Fernandez-Alonso, Carmen; Monton-Franco, Carmen; Rodriguez-Bayon, Antonina; Isabel Ballesta-Rodriguez, Maria; Ruentel-Geidel, Ariadne; Payo-Gordon, Janire; Serrano-Blanco, Antoni; Olivan-Blazquez, Barbara; Araujo, Luz; del Mar Munoz-Garcia, Maria; King, Michael; Nazareth, Irwin; Amezcua, Manuel			Patients' Opinions about Knowing Their Risk for Depression and What to Do about It. The PredictD-Qualitative Study	PLOS ONE			English	Article							GENERAL-PRACTICE ATTENDEES; HEALTH BELIEF MODEL; MAJOR DEPRESSION; MENTAL-DISORDERS; FOCUS GROUPS; PREVENTION; CARE; ONSET; BEHAVIOR; PRACTITIONERS	Background: The predictD study developed and validated a risk algorithm for predicting the onset of major depression in primary care. We aimed to explore the opinion of patients about knowing their risk for depression and the values and criteria upon which these opinions are based. Methods: A maximum variation sample of patients was taken, stratified by city, age, gender, immigrant status, socioeconomic status and lifetime depression. The study participants were 52 patients belonging to 13 urban health centres in seven different cities around Spain. Seven Focus Groups (FGs) were given held with primary care patients, one for each of the seven participating cities. Results: The results showed that patients generally welcomed knowing their risk for depression. Furthermore, in light of available evidence several patients proposed potential changes in their lifestyles to prevent depression. Patients generally preferred to ask their General Practitioners (GPs) for advice, though mental health specialists were also mentioned. They suggested that GPs undertake interventions tailored to each patient, from a "patient-centred'' approach, with certain communication skills, and giving advice to help patients cope with the knowledge that they are at risk of becoming depressed. Conclusions: Patients are pleased to be informed about their risk for depression. We detected certain beliefs, attitudes, values, expectations and behaviour among the patients that were potentially useful for future primary prevention programmes on depression.	[Bellon, Juan A.] Univ Malaga, Dept Med Prevent, Ctr Salud El Palo, E-29071 Malaga, Spain; [Bellon, Juan A.; Moreno-Peral, Patricia; Araujo, Luz] Inst Invest Biomed Malaga, Unidad Invest Distrito Sanitario Malaga, Malaga, Spain; [Moreno-Kuestner, Berta] Univ Malaga, Dept Personalidad Evaluac & Tratamiento Psicol, E-29071 Malaga, Spain; [Motrico, Emma] Univ Seville, Dept Psicol Evolut & Educ, Seville, Spain; [Aiarzagueena, Jose M.] Ctr Salud San Ignacio, Unidad Invest Atenci Primaria, Bilbao, Spain; [Fernandez, Anna] Univ Sydney, Fac Hlth Sci, Ctr Disabil Res & Policy, Sydney, NSW 2006, Australia; [Fernandez-Alonso, Carmen] Gerencia Reg Salud, Serv Programas Asistenciales, Valladolid, Spain; [Monton-Franco, Carmen] Univ Zaragoza, Ctr Salud Casablanca, Inst Aragones Ciencias Salud, Dept Med & Psiquiatria, Zaragoza, Spain; [Rodriguez-Bayon, Antonina] Ctr Salud San Jose, Jaen, Spain; [Isabel Ballesta-Rodriguez, Maria] Ctr Salud Federico Castillo, Jaen, Spain; [Ruentel-Geidel, Ariadne; del Mar Munoz-Garcia, Maria] Univ Granada, Dept Psiquiatria & Med Legal, Granada, Spain; [Payo-Gordon, Janire] Unidad Invest Atenc Primaria, Bilbao, Spain; [Serrano-Blanco, Antoni] Fdn St Joan de Deu, Barcelona, Spain; [Olivan-Blazquez, Barbara] Inst Aragones Ciencias Salud, Unidad Invest Atenc Primaria, Zaragoza, Spain; [King, Michael] UCL, Dept Mental Hlth Sci, London, England; [Nazareth, Irwin] Med Res Council Gen Practice Res Framework, London, England; [Amezcua, Manuel] Univ Granada, Dept Enfermeria, Fac Ciencias Salud, Granada, Spain	Universidad de Malaga; Universidad de Malaga; University of Sevilla; University of Sydney; University of Zaragoza; University of Granada; University of London; University College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Granada	Bellon, JA (corresponding author), Univ Malaga, Dept Med Prevent, Ctr Salud El Palo, E-29071 Malaga, Spain.	jabellon@uma.es	Fernandez, Ana/H-4545-2012; Moreno-Peral, Patricia/I-3594-2012; PRISMA, Grupo/AAI-6753-2021; Oliván-Blázquez, Bárbara/AAS-2130-2020; MOTRICO, EMMA/D-2016-2019; Serrano-Blanco, Antoni/H-4587-2012; Amezcua, Manuel/AAB-8746-2019; ayarzaguena, jose maria/E-3666-2012	Fernandez, Ana/0000-0002-0333-1345; Moreno-Peral, Patricia/0000-0003-4130-9090; Oliván-Blázquez, Bárbara/0000-0001-6565-9699; MOTRICO, EMMA/0000-0002-0720-567X; Serrano-Blanco, Antoni/0000-0001-6123-0633; Moreno Kustner, Berta/0000-0002-9541-215X; Bellon Saameno, Juan Angel/0000-0002-4268-4979; Amezcua, Manuel/0000-0001-6864-6164; Nazareth, Irwin/0000-0003-2146-9628	Andalusian Council of Health [2008/0195]; Department of Health of the Basque Government [2008/111021]; Spanish Network of Primary Care Research "redIAPP'' [RD06/0018]; "Aragon group'' [RD06/0018/0020]; "Sant Joan de Deu group'' [RD07/0018/0017]; "Bizkaya group'' [RD07/0018/0018]; "Castilla-Leon group'' [RD07/0018/0027]; "SAMSERAP group'' [RD06/0018/0039, CTS-587]	Andalusian Council of Health; Department of Health of the Basque Government; Spanish Network of Primary Care Research "redIAPP''; "Aragon group''(Gobierno de Aragon); "Sant Joan de Deu group''; "Bizkaya group''; "Castilla-Leon group''; "SAMSERAP group''	This work was supported by grants from the Andalusian Council of Health [grant reference: 2008/0195][www.juntadeandalucia.es/fundacionprogresoysalud]; the Department of Health of the Basque Government [grant reference: 2008/111021][www.osakidetza.euskadi.net]; the Spanish Network of Primary Care Research "redIAPP'' (RD06/0018), the "Aragon group'' (RD06/0018/0020), the "Sant Joan de Deu group'' (RD07/0018/0017), "Bizkaya group'' (RD07/0018/0018), "Castilla-Leon group'' (RD07/0018/0027) and the "SAMSERAP group'' (RD06/0018/0039 and CTS-587) [www.rediapp.org]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P55; Bellon JA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-256; Angermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x; Barbour RS, 2005, MED EDUC, V39, P742, DOI 10.1111/j.1365-2929.2005.02200.x; Beaulieu MD, 1999, CAN MED ASSOC J, V161, P519; Bellon JA, 2011, PSYCHOL MED, V41, P2075, DOI 10.1017/S0033291711000468; Carpenter CJ, 2010, HEALTH COMMUN, V25, P661, DOI 10.1080/10410236.2010.521906; Clark JP, 2003, PEER REV HLTH SCI, P219; Corrrigan M, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-90; Cuijpers P, 2008, AM J PSYCHIAT, V165, P1272, DOI 10.1176/appi.ajp.2008.07091422; Dam EAV, 2007, J AFFECT DISORDERS, V97, P219, DOI 10.1016/j.jad.2006.06.020; Duggleby W, 2005, QUAL HEALTH RES, V15, P832, DOI 10.1177/1049732304273916; Epstein RM, 2011, ANN FAM MED, V9, P100, DOI 10.1370/afm.1239; Fernandez A, 2010, GEN HOSP PSYCHIAT, V32, P201, DOI 10.1016/j.genhosppsych.2009.11.015; Gask L, 2005, BRIT J GEN PRACT, V55, P854; Glanz K., 2002, HLTH BEHAV HLTH ED T; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Jorm AF, 2006, AUST NZ J PSYCHIAT, V40, P36, DOI 10.1080/j.1440-1614.2006.01738.x; Jorm AF, 2010, J AFFECT DISORDERS, V126, P278, DOI 10.1016/j.jad.2010.03.011; King M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-6; King M, 2008, ARCH GEN PSYCHIAT, V65, P1368, DOI 10.1001/archpsyc.65.12.1368; Kitzinger J., 1995, BMJ-BRIT MED J, V311, P299; Meadows LM, 2001, NATURE QUALITATIVE E, P188; Morgan Amy J, 2008, Ann Gen Psychiatry, V7, P13, DOI 10.1186/1744-859X-7-13; MUNOZ RF, 1995, AM J COMMUN PSYCHOL, V23, P199, DOI 10.1007/BF02506936; Munoz RF, 2010, ANNU REV CLIN PSYCHO, V6, P181, DOI 10.1146/annurev-clinpsy-033109-132040; Murphy E., 1998, HLTH TECHNOLOGY ASSE, V2, P1, DOI DOI 10.3310/HTA2160; Ozmen E, 2005, SOC PSYCH PSYCH EPID, V40, P869, DOI 10.1007/s00127-005-0985-x; Painter JE, 2008, ANN BEHAV MED, V35, P358, DOI 10.1007/s12160-008-9042-y; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Perula de Torres L A, 2007, Aten Primaria, V39 Suppl 3, P5; Pope C., 2020, QUALITATIVE RES HLTH; Priest RG, 1996, BRIT MED J, V313, P858; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Moral RR, 2012, ATEN PRIM, V44, P5, DOI 10.1016/j.aprim.2010.12.011; Salmon P, 2007, J GEN INTERN MED, V22, P565, DOI 10.1007/s11606-006-0094-z; Schomerus G, 2008, J AFFECT DISORDERS, V106, P257, DOI 10.1016/j.jad.2007.06.013; Starfield B, 2008, J EPIDEMIOL COMMUN H, V62, P580, DOI 10.1136/jech.2007.071027; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Van Voorhees BW, 2008, J ADOLESCENT HEALTH, V42, P605, DOI 10.1016/j.jadohealth.2007.11.135; Walter U, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-68; Willcox SJ, 2011, CANCER CAUSE CONTROL, V22, P1503, DOI 10.1007/s10552-011-9824-6; Willense GRWM, 2006, BRIT J PSYCHIAT, V47, P1254; Yap MBH, 2012, J AFFECT DISORDERS, V136, P940, DOI 10.1016/j.jad.2011.09.003	46	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92008	10.1371/journal.pone.0092008	http://dx.doi.org/10.1371/journal.pone.0092008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24646951	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500071
J	Hara, S; Umeyama, K; Yokoo, T; Nagashima, H; Nagata, M				Hara, Satoshi; Umeyama, Kazuhiro; Yokoo, Takashi; Nagashima, Hiroshi; Nagata, Michio			Diffuse Glomerular Nodular Lesions in Diabetic Pigs Carrying a Dominant-Negative Mutant Hepatocyte Nuclear Factor 1-Alpha, an Inheritant Diabetic Gene in Humans	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; TRANSGENIC PIGS; NEPHROPATHY; MICE; GLOMERULOSCLEROSIS; DEFICIENCY; STRESS; MODEL; BETA; LOCALIZATION	Glomerular nodular lesions, known as Kimmelstiel-Wilson nodules, are a pathological hallmark of progressive human diabetic nephropathy. We have induced severe diabetes in pigs carrying a dominant-negative mutant hepatocyte nuclear factor 1-alpha (HNF1 alpha) P291fsinsC, a maturity-onset diabetes of the young type-3 (MODY3) gene in humans. In this model, glomerular pathology revealed that formation of diffuse glomerular nodules commenced as young as 1 month of age and increased in size and incidence until the age of 10 months, the end of the study period. Immunohistochemistry showed that the nodules consisted of various collagen types (I, III, IV, V and VI) with advanced glycation end-product (AGE) and N-epsilon-carboxymethyl-lysine (CML) deposition, similar to those in human diabetic nodules, except for collagen type I. Transforming growth factor-beta (TGF-beta) was also expressed exclusively in the nodules. The ultrastructure of the nodules comprised predominant interstitial-type collagen deposition arising from the mesangial matrices. Curiously, these nodules were found predominantly in the deep cortex. However, diabetic pigs failed to show any of the features characteristic of human diabetic nephropathy; e. g., proteinuria, glomerular basement membrane thickening, exudative lesions, mesangiolysis, tubular atrophy, interstitial fibrosis, and vascular hyalinosis. The pigs showed only Armanni-Ebstein lesions, a characteristic tubular manifestation in human diabetes. RT-PCR analysis showed that glomeruli in wild-type pigs did not express endogenous HNF1 alpha and HNF1 beta, indicating that mutant HNF1 alpha did not directly contribute to glomerular nodular formation in diabetic pigs. In conclusion, pigs harboring the dominant-negative mutant human MODY3 gene showed reproducible and distinct glomerular nodules, possibly due to AGE- and CML-based collagen accumulation. Although the pathology differed in several respects from that of human glomerular nodular lesions, the somewhat acute and constitutive formation of nodules in this mammalian model might provide information facilitating identification of the principal mechanism underlying diabetic nodular sclerosis.	[Hara, Satoshi; Nagata, Michio] Univ Tsukuba, Dept Kidney & Vasc Pathol, Tsukuba, Ibaraki, Japan; [Umeyama, Kazuhiro; Nagashima, Hiroshi] Meiji Univ, Int Inst Bioresource Res, Kawasaki, Kanagawa, Japan; [Yokoo, Takashi] Jikei Univ, Div Nephrol & Hypertens, Dept Internal Med, Sch Med, Tokyo, Japan; [Hara, Satoshi] Kanazawa Univ, Sch Med, Dept Internal Med, Div Rheumatol, Kanazawa, Ishikawa 920, Japan	University of Tsukuba; Meiji University; Jikei University; Kanazawa University	Nagata, M (corresponding author), Univ Tsukuba, Dept Kidney & Vasc Pathol, Tsukuba, Ibaraki, Japan.	nagatam@md.tsukuba.ac.jp	hara, satoshi/AAA-3930-2020	Nagashima, Hiroshi/0000-0001-9940-8783	Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science [23500505]	Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science	This work was partially supported by Grants-in-Aid for Scientific Research (C) (#23500505) from the Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science (HN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellinger DA, 2006, ILAR J, V47, P243, DOI 10.1093/ilar.47.3.243; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Cheng HF, 2012, KIDNEY INT, V82, P1176, DOI 10.1038/ki.2012.248; Fukami K, 2004, KIDNEY INT, V66, P2137, DOI 10.1111/j.1523-1755.2004.66004.x; Furuichi K, 2011, NEPHROL DIAL TRANSPL, V26, P3124, DOI 10.1093/ndt/gfr125; GLICK AD, 1992, HUM PATHOL, V23, P1373, DOI 10.1016/0046-8177(92)90057-A; Heaf JG, 2001, SCAND J UROL NEPHROL, V35, P233; Hong D, 2007, DIABETES RES CLIN PR, V78, P189, DOI 10.1016/j.diabres.2007.03.024; Horie K, 1997, J CLIN INVEST, V100, P2995, DOI 10.1172/JCI119853; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Inagi R, 2006, DIABETES, V55, P356, DOI 10.2337/diabetes.55.02.06.db05-0702; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kimmelstiel P, 1936, AM J PATHOL, V12, P83; Kosugi T, 2009, AM J PATHOL, V174, P1221, DOI 10.2353/ajpath.2009.080605; Larsen MO, 2002, AM J PHYSIOL-ENDOC M, V282, pE1342, DOI 10.1152/ajpendo.00564.2001; MAKINO H, 1994, DIABETIC MED, V11, P304, DOI 10.1111/j.1464-5491.1994.tb00276.x; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; NERLICH A, 1991, AM J PATHOL, V139, P889; Pontoglio M, 2000, J AM SOC NEPHROL, V11, pS140; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Renner S, 2001, NATURE, V414, P813; Renner S, 2013, DIABETES, V62, P1505, DOI 10.2337/db12-1065; RITCHIE S, 1957, AM J PATHOL, V33, P1035; Tanji N, 2000, J AM SOC NEPHROL, V11, P1656, DOI 10.1681/ASN.V1191656; Umeyama K, 2013, J REPROD DEVELOP, V59, P599, DOI 10.1262/jrd.2013-069; Umeyama K, 2009, TRANSGENIC RES, V18, P697, DOI 10.1007/s11248-009-9262-3; White SL, 2008, B WORLD HEALTH ORGAN, V86, P229, DOI 10.2471/BLT.07.041715; Yamagata K, 2003, ENDOCR J, V50, P491, DOI 10.1507/endocrj.50.491; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; YAMAMOTO T, 1993, P NATL ACAD SCI USA, V90, P1814, DOI 10.1073/pnas.90.5.1814; YAN SD, 1994, J BIOL CHEM, V269, P9889; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798	35	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92219	10.1371/journal.pone.0092219	http://dx.doi.org/10.1371/journal.pone.0092219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647409	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500099
J	Lee, J; Kang, Y; Shin, SC; Park, H; Lee, H				Lee, Jungeun; Kang, Yoonjee; Shin, Seung Chul; Park, Hyun; Lee, Hyoungseok			Combined Analysis of the Chloroplast Genome and Transcriptome of the Antarctic Vascular Plant Deschampsia antarctica Desv	PLOS ONE			English	Article							POACEAE; SEQUENCE; PHYLOGENY; ALIGNMENT; GENE; MITOCHONDRIA; EVOLUTION	Background: Antarctic hairgrass (Deschampsia antarctica Desv.) is the only natural grass species in the maritime Antarctic. It has been researched as an important ecological marker and as an extremophile plant for studies on stress tolerance. Despite its importance, little genomic information is available for D. antarctica. Here, we report the complete chloroplast genome, transcriptome profiles of the coding/noncoding genes, and the posttranscriptional processing by RNA editing in the chloroplast system. Results: The complete chloroplast genome of D. antarctica is 135,362 bp in length with a typical quadripartite structure, including the large (LSC: 79,881 bp) and small (SSC: 12,519 bp) single-copy regions, separated by a pair of identical inverted repeats (IR: 21,481 bp). It contains 114 unique genes, including 81 unique protein-coding genes, 29 tRNA genes, and 4 rRNA genes. Sequence divergence analysis with other plastomes from the BEP clade of the grass family suggests a sister relationship between D. antarctica, Festuca arundinacea and Lolium perenne of the Poeae tribe, based on the whole plastome. In addition, we conducted high-resolution mapping of the chloroplast-derived transcripts. Thus, we created an expression profile for 81 protein-coding genes and identified ndhC, psbJ, rps19, psaJ, and psbA as the most highly expressed chloroplast genes. Small RNA-seq analysis identified 27 small noncoding RNAs of chloroplast origin that were preferentially located near the 5'- or 3'-ends of genes. We also found >30 RNA-editing sites in the D. antarctica chloroplast genome, with a dominance of C-to-U conversions. Conclusions: We assembled and characterized the complete chloroplast genome sequence of D. antarctica and investigated the features of the plastid transcriptome. These data may contribute to a better understanding of the evolution of D. antarctica within the Poaceae family for use in molecular phylogenetic studies and may also help researchers understand the characteristics of the chloroplast transcriptome.	[Lee, Jungeun; Kang, Yoonjee; Shin, Seung Chul; Park, Hyun; Lee, Hyoungseok] Korea Polar Res Inst, Div Life Sci, Inchon, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Park, H (corresponding author), Korea Polar Res Inst, Div Life Sci, Inchon, South Korea.	soulaid@kopri.re.kr; hpark@kopri.re.kr		Lee, Hyoungseok/0000-0002-5831-6345	Functional Genomics on Polar Organisms grant [PE13020]; Basic Research Program [PE13120]; Korea Polar Research Institute (KOPRI)	Functional Genomics on Polar Organisms grant; Basic Research Program; Korea Polar Research Institute (KOPRI)	This work was supported by Functional Genomics on Polar Organisms grant (PE13020) and the Basic Research Program (PE13120) funded by Korea Polar Research Institute (KOPRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberdi M, 2002, PHYSIOL PLANTARUM, V115, P479, DOI 10.1034/j.1399-3054.2002.1150401.x; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bock Ralph, 2007, V19, P29, DOI 10.1007/4735_2007_0223; Brudno M, 2003, BIOINFORMATICS, V19, pi54, DOI 10.1093/bioinformatics/btg1005; Catalan P, 1997, MOL PHYLOGENET EVOL, V8, P150, DOI 10.1006/mpev.1997.0416; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Davis JI, 2007, ALISO J SYSTEMATIC E, V23; Souto DPF, 2006, PLANT SYST EVOL, V261, P1, DOI 10.1007/s00606-006-0425-x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Germain A, 2013, WIRES RNA, V4, P295, DOI 10.1002/wrna.1161; Grosskopf D, 1996, CURR GENET, V29, P556, DOI 10.1007/BF02426960; Hand ML, 2013, G3-GENES GENOM GENET, V3, P607, DOI 10.1534/g3.112.005264; Howad W, 1997, P NATL ACAD SCI USA, V94, P11090, DOI 10.1073/pnas.94.20.11090; HSIAO C, 1995, THEOR APPL GENET, V90, P389, DOI 10.1007/BF00221981; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2013, PLANTA, V237, P823, DOI 10.1007/s00425-012-1797-5; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lung B, 2006, NUCLEIC ACIDS RES, V34, P3842, DOI 10.1093/nar/gkl448; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Mower JP, 2009, NUCLEIC ACIDS RES, V37, pW253, DOI 10.1093/nar/gkp337; NADOT S, 1994, PLANT SYST EVOL, V191, P27, DOI 10.1007/BF00985340; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Perez-Torres E, 2004, FUNCT PLANT BIOL, V31, P731, DOI 10.1071/FP03082; Picardi E, 2010, NUCLEIC ACIDS RES, V38, P4755, DOI 10.1093/nar/gkq202; Ruwe H, 2012, NUCLEIC ACIDS RES, V40, P3106, DOI 10.1093/nar/gkr1138; Soreng R. J., 2000, Grasses: systematics and evolution., P61; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tillich M, 2006, MOL BIOL EVOL, V23, P1912, DOI 10.1093/molbev/msl054; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024670; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xiong FSS, 2000, AM J BOT, V87, P700, DOI 10.2307/2656856; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zhang TW, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-38; Zhang YR, 2012, AUST J BOT, V60, P461, DOI 10.1071/BT12073; Zhelyazkova P, 2012, NUCLEIC ACIDS RES, V40, P3092, DOI 10.1093/nar/gkr1137	41	37	38	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92501	10.1371/journal.pone.0092501	http://dx.doi.org/10.1371/journal.pone.0092501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647560	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500138
J	Nagata, JM; Cohen, CR; Young, SL; Wamuyu, C; Armes, MN; Otieno, BO; Leslie, HH; Dandu, M; Stewart, CC; Bukusi, EA; Weiser, SD				Nagata, Jason M.; Cohen, Craig R.; Young, Sera L.; Wamuyu, Catherine; Armes, Mary N.; Otieno, Benard O.; Leslie, Hannah H.; Dandu, Madhavi; Stewart, Christopher C.; Bukusi, Elizabeth A.; Weiser, Sheri D.			Descriptive Characteristics and Health Outcomes of the Food by Prescription Nutrition Supplementation Program for Adults Living with HIV in Nyanza Province, Kenya	PLOS ONE			English	Article							BODY-MASS INDEX; ANTIRETROVIRAL THERAPY; INFECTED ADULTS; WEIGHT-LOSS; INSECURITY; HIV/AIDS; UNDERNUTRITION; CONSUMPTION; COMMUNITY; SURVIVAL	Background: The clinical effects and potential benefits of nutrition supplementation interventions for persons living with HIV remain largely unreported, despite awareness of the multifaceted relationship between HIV infection and nutrition. We therefore examined descriptive characteristics and nutritional outcomes of the Food by Prescription (FBP) nutrition supplementation program in Nyanza Province, Kenya. Methods: Demographic, health, and anthropometric data were gathered from a retrospective cohort of 1,017 non-pregnant adult patients who enrolled into the FBP program at a Family AIDS Care and Education Services (FACES) site in Nyanza Province between July 2009 and July 2011. Our primary outcome was FBP treatment success defined as attainment of BMI>20, and we used Cox proportional hazards to assess socio-demographic and clinical correlates of FBP treatment success. Results: Mean body mass index was 16.4 upon enrollment into the FBP program. On average, FBP clients gained 2.01 kg in weight and 0.73 kg/m(2) in BMI over follow-up (mean 100 days), with the greatest gains among the most severely undernourished (BMI <16) clients (p < 0.001). Only 13.1% of clients attained a BMI>20, though 44.5% achieved a BMI increase >= 0.5. Greater BMI at baseline, younger age, male gender, and not requiring highly active antiretroviral therapy (HAART) were associated with a higher rate of attainment of BMI>20. Conclusion: This study reports significant gains in weight and BMI among patients enrolled in the FBP program, though only a minority of patients achieved stated programmatic goals of BMI>20. Future research should include well-designed prospective studies that examine retention, exit reasons, mortality outcomes, and long-term sustainability of nutrition supplementation programs for persons living with HIV.	[Nagata, Jason M.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Young, Sera L.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Wamuyu, Catherine; Armes, Mary N.; Otieno, Benard O.; Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Family AIDS Care & Educ Serv, Nairobi, Kenya; [Leslie, Hannah H.] Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94720 USA; [Dandu, Madhavi] Univ Calif San Francisco, Div Hosp Med, San Francisco, CA 94143 USA; [Stewart, Christopher C.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Weiser, Sheri D.] Univ Calif San Francisco, Div HIV AIDS, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cornell University; Kenya Medical Research Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nagata, JM (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.	jasonmnagata@gmail.com		Nagata, Jason/0000-0002-6541-0604; Leslie, Hannah Hogan/0000-0002-7464-3645; Young, Sera/0000-0002-1763-1218	University of California, San Francisco Pathways Explore Grant; Northern California Association; National Institutes of Health [R01 MH095683]; National Institute of Mental Health [K01 MH098902]; University of California, San Francisco Library Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH098902, R01MH095683] Funding Source: NIH RePORTER	University of California, San Francisco Pathways Explore Grant(University of California System); Northern California Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of California, San Francisco Library Open Access Publishing Fund(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the University of California, San Francisco Pathways Explore Grant, the University of California, San Francisco Library Open Access Publishing Fund, and the Phi Beta Kappa, Northern California Association, Scholarship (JN), the National Institutes of Health R01 MH095683 (SW), and the National Institute of Mental Health K01 MH098902 (SY).	Agnarson AM, 2007, AIDS, V21, P1225, DOI 10.1097/QAD.0b013e32810f2dad; Anema A, 2012, PUBLIC HEALTH NUTR, V15, P938, DOI 10.1017/S136898001100125X; Argemi X, 2012, AIDS, V26, P1161, DOI 10.1097/QAD.0b013e328353f363; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; de Waal A, 2003, LANCET, V362, P1234, DOI 10.1016/S0140-6736(03)14548-5; FAO, 2000, STATE FOOD INSECURIT; Food and Nutrition Technical Assistance II Project (FANTA-2), 2009, REV KEN FOOD PRESCR; Ivers LC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-33; Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573; Keithley JK, 2002, JPEN-PARENTER ENTER, V26, P6, DOI 10.1177/014860710202600106; Knueppel D, 2010, PUBLIC HEALTH NUTR, V13, P360, DOI 10.1017/S1368980009991121; Koethe JR, 2009, CLIN INFECT DIS, V49, P787, DOI 10.1086/605285; Kuria EN, 2010, PUBLIC HEALTH NUTR, V13, P475, DOI 10.1017/S1368980009990826; Laraia BA, 2006, J NUTR, V136, P177, DOI 10.1093/jn/136.1.177; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Leathers Howard D., 2009, WORLD FOOD PROBLEM E; Leyna GH, 2010, PUBLIC HEALTH NUTR, V13, P1438, DOI 10.1017/S1368980010000327; Mahlungulu S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004536.pub2; Marchione TJ, 2005, J NUTR, V135, P886, DOI 10.1093/jn/135.4.886; Nagata JM, 2013, AIDS CARE, V25, P1491, DOI 10.1080/09540121.2013.775399; Nagata JM, 2012, AIDS CARE, V24, P728, DOI 10.1080/09540121.2011.630358; Nagata JM, 2011, J ETHNOPHARMACOL, V135, P501, DOI 10.1016/j.jep.2011.03.051; Nagata JM, 2009, ECON HUM BIOL, V7, P96, DOI 10.1016/j.ehb.2009.02.002; National AIDS and STI Control Programme, 2013, KEN AIDS IND SURV 20; Ndekha MJ, 2009, BMJ-BRIT MED J, P338; Powell-Tuck J, 2003, CLIN NUTR, V22, P307, DOI 10.1016/S0261-5614(03)00009-8; Rabeneck L, 1998, J AM DIET ASSOC, V98, P434, DOI 10.1016/S0002-8223(98)00099-6; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Sadler K, 2012, MEASURING IMPACT COS, P29; Schwenk A, 1999, CLIN NUTR, V18, P371, DOI 10.1016/S0261-5614(99)80018-1; Shevitz AH, 1999, AIDS, V13, P1351, DOI 10.1097/00002030-199907300-00012; Tang AM, 2002, JAIDS-J ACQ IMM DEF, V31, P230, DOI 10.1097/00126334-200210010-00014; UNAIDS, 2010, UNAIDS REP GLOB AIDS; van der Sande MAB, 2004, JAIDS-J ACQ IMM DEF, V37, P1288, DOI 10.1097/01.qai.0000122708.59121.03; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; World Health Organisation, 2003, NUTR REQ PEOPL LIV H; World Health Organisation, 2007, WHO CAS DEF HIV SURV	37	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91403	10.1371/journal.pone.0091403	http://dx.doi.org/10.1371/journal.pone.0091403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646586	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500036
J	Ruchlewska, A; Wierdsma, AI; Kamperman, AM; van der Gaag, M; Smulders, R; Roosenschoon, BJ; Mulder, CL				Ruchlewska, Asia; Wierdsma, Andre I.; Kamperman, Astrid M.; van der Gaag, Mark; Smulders, Renee; Roosenschoon, Bert-Jan; Mulder, Cornelis L.			Effect of Crisis Plans on Admissions and Emergency Visits: A Randomized Controlled Trial	PLOS ONE			English	Article							ADVANCE DIRECTIVES; COMPULSORY TREATMENT; SELF-REPORT; HEALTH; PEOPLE; PSYCHIATRY; PSYCHOSIS	Objective: To establish whether patients with a crisis plan had fewer voluntary or involuntary admissions, or fewer outpatient emergency visits, than patients without such a plan. Design: Multicenter randomized controlled trial with two intervention conditions and one control condition. Participants: Adult outpatients diagnosed with psychotic or bipolar disorder who had experienced at least one psychiatric crisis in the previous two years. Intervention: Two types of advance statement were used: (1) a crisis plan formulated by the patient with the help of a patient advocate (Patient Advocate Crisis Plan: PACP); and (2) a crisis plan developed together with the clinician (Clinician-facilitated Crisis Plan: CCP). Outcome: The percentages of patients admitted voluntarily or involuntarily (on an emergency basis or by court order), and the percentage who made outpatient emergency visits over an 18-month follow-up period. Results: A total of 212 patients were included: 69 in the PACP condition, 70 in the CCP condition, and 73 in the control condition. No effects of the two interventions were found on the numbers of voluntary admissions, involuntary admissions and emergency visits. Regarding involuntary admissions, there was no significant effect on emergency admissions, which were 17% (12/69) in the PACP condition, 10% (7/70) in the CCP condition, and 19% (14/73) in the control condition. There was a significant effect on planned court-ordered admissions, with 16% (11/69) in the PACP condition, 10% (7/70) in the CCP condition, and 26% (19/73) in the control condition. Finally, the interventions had no effect on outpatient emergency visits, with 32% (22/69) in the PACP group, 31% (22/70) in the CCP group, and 34% (25/73) in the control group. Conclusions: Crisis plans may be an effective intervention for reducing court-ordered admissions in patients with psychotic and bipolar disorders.	[Ruchlewska, Asia; Wierdsma, Andre I.; Kamperman, Astrid M.; Roosenschoon, Bert-Jan; Mulder, Cornelis L.] Erasmus MC, Epidemiol & Social Psychiat Res Inst, Rotterdam, Netherlands; [Roosenschoon, Bert-Jan; Mulder, Cornelis L.] BavoEuropoort, Ctr Mental Hlth Care, Rotterdam, Netherlands; [van der Gaag, Mark] Parnassia Psychiat Inst, The Hague, Netherlands; [van der Gaag, Mark] Vrije Univ Amsterdam, Amsterdam, Netherlands; [van der Gaag, Mark] EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Smulders, Renee] Landelijk Crisiskaart O GGZ Informatie Ondersteun, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Parnassia Psychiatric Institute; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Ruchlewska, A (corresponding author), Erasmus MC, Epidemiol & Social Psychiat Res Inst, Rotterdam, Netherlands.	j.ruchlewska@erasmusmc.nl	van der Gaag, Mark/A-6840-2008; Kamperman, Astrid/J-8046-2015; Mulder, Cornelis Lambert/HGU-3446-2022	van der Gaag, Mark/0000-0002-3525-6415; Kamperman, Astrid/0000-0003-4455-6492; Wierdsma, Andre/0000-0002-0734-4776	Dutch organization for health research and development (ZonMw); BavoEuropoort	Dutch organization for health research and development (ZonMw)(Netherlands Organization for Health Research and Development); BavoEuropoort	The trial was funded by the Dutch organization for health research and development (ZonMw) and BavoEuropoort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRCHWOOD M, 1994, ACTA PSYCHIAT SCAND, V89, P62, DOI 10.1111/j.1600-0447.1994.tb01487.x; Campbell LA, 2009, COCHRANE DB SYST REV, V21; Cohen J.E., 1988, STAT POWER ANAL BEHA; Gaag M. van der, 2002, DTH, V22, P15; Henderson C, 2004, BRIT MED J, V329, P136, DOI 10.1136/bmj.38155.585046.63; Henderson C, 2008, PSYCHIAT SERV, V59, P63, DOI 10.1176/ps.2008.59.1.63; HORVATH AO, 1989, J COUNS PSYCHOL, V36, P223, DOI 10.1037/0022-0167.36.2.223; Mulder CL, 2008, INT J LAW PSYCHIAT, V31, P331, DOI 10.1016/j.ijlp.2008.06.007; Mulder C L, 2008, Tijdschr Psychiatr, V50, P229; Mulder C.L., 2004, TIJDSCHR PSYCHIAT, V46, P273; Mulder CL, 2002, TIJD PSYCHIAT, V44, P523; Papageorgiou A, 2002, BRIT J PSYCHIAT, V181, P513, DOI 10.1192/bjp.181.6.513; Ruchlewska A, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-41; Salize HJ, 2004, BRIT J PSYCHIAT, V184, P163, DOI 10.1192/bjp.184.2.163; Srebnik DS, 1999, PSYCHIAT SERV, V50, P919, DOI 10.1176/ps.50.7.919; Sutherby K, 1999, ACTA PSYCHIAT SCAND, V100, P56, DOI 10.1111/j.1600-0447.1999.tb10914.x; Swanson JW, 2006, AM J PSYCHIAT, V163, P1943, DOI 10.1176/appi.ajp.163.11.1943; Swartz MS, 2003, BEHAV SCI LAW, V21, P459, DOI 10.1002/bsl.539; Tait Lynda, 2002, J Ment Health, V11, P191, DOI 10.1080/09638230020023570-2; Thornicroft G, 2013, LANCET, V381, P1634, DOI 10.1016/S0140-6736(13)60105-1; Vervaeke GAC, 1996, GEDRAGSTEHRAPIE, V2, P139; Wierdsma AI, 2008, CURR OPIN PSYCHIATR, V21, P379, DOI 10.1097/YCO.0b013e328304d99b; Wing JK, 1998, BRIT J PSYCHIAT, V172, P11, DOI 10.1192/bjp.172.1.11; WIZNITZER M, 1992, ACTA PSYCHIAT SCAND, V86, P32, DOI 10.1111/j.1600-0447.1992.tb03221.x	24	28	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91882	10.1371/journal.pone.0091882	http://dx.doi.org/10.1371/journal.pone.0091882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24647274	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500057
J	Li, RZ; Wu, FG; Ruonala, R; Sapkota, D; Hu, ZH; Mu, XQ				Li, Renzhong; Wu, Fuguo; Ruonala, Raili; Sapkota, Darshan; Hu, Zihua; Mu, Xiuqian			Isl1 and Pou4f2 Form a Complex to Regulate Target Genes in Developing Retinal Ganglion Cells	PLOS ONE			English	Article							ELEGANS HOMEOPROTEINS UNC-86; FACTOR-BINDING SITES; TRANSCRIPTION FACTOR; CAENORHABDITIS-ELEGANS; DOMAIN FACTORS; LIM DOMAIN; RNA-SEQ; DIFFERENTIATION; HOMEODOMAIN; EXPRESSION	Precise regulation of gene expression during biological processes, including development, is often achieved by combinatorial action of multiple transcription factors. The mechanisms by which these factors collaborate are largely not known. We have shown previously that Isl1, a Lim-Homeodomain transcription factor, and Pou4f2, a class IV POU domain transcription factor, co-regulate a set of genes required for retinal ganglion cell (RGC) differentiation. Here we further explore how these two factors interact to precisely regulate gene expression during RGC development. By GST pulldown assays, co-immunoprecipitation, and electrophoretic mobility shift assays, we show that Isl1 and Pou4f2 form a complex in vitro and in vivo, and identify the domains within these two proteins that are responsible for this interaction. By luciferase assay, in situ hybridization, and RNA-seq, we further demonstrate that the two factors contribute quantitatively to gene expression in the developing RGCs. Although each factor alone can activate gene expression, both factors are required to achieve optimal expression levels. Finally, we discover that Isl1 and Pou4f2 can interact with other POU and Lim-Homeodomain factors respectively, indicating the interactions between these two classes of transcription factors are prevalent in development and other biological processes.	[Li, Renzhong; Wu, Fuguo; Ruonala, Raili; Sapkota, Darshan; Hu, Zihua; Mu, Xiuqian] SUNY Buffalo, Ross Eye Inst, Dept Ophthalmol, Buffalo, NY 14260 USA; [Sapkota, Darshan; Mu, Xiuqian] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Hu, Zihua] SUNY Buffalo, Dept Biostat, Buffalo, NY 14260 USA; [Hu, Zihua] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA; [Hu, Zihua] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Ctr Computat Res, Buffalo, NY 14260 USA; [Li, Renzhong; Wu, Fuguo; Ruonala, Raili; Sapkota, Darshan; Mu, Xiuqian] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Dev Genom Grp, Buffalo, NY 14260 USA; [Li, Renzhong; Wu, Fuguo; Ruonala, Raili; Sapkota, Darshan; Hu, Zihua; Mu, Xiuqian] SUNY Buffalo, SUNY Eye Inst, Buffalo, NY 14260 USA; [Mu, Xiuqian] Roswell Pk Canc Inst, CCSG Canc Genet Program, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Mu, XQ (corresponding author), SUNY Buffalo, Ross Eye Inst, Dept Ophthalmol, Buffalo, NY 14260 USA.	xmu@buffalo.edu	Mu, Xiuqian/I-9146-2014	Mu, Xiuqian/0000-0002-8003-7529; Sapkota, Darshan/0000-0003-3773-2910	National Eye Institute [EY020545]; Whitehall Foundation; Research to Prevent Blindness; Department of Ophthalmology of University at Buffalo; NATIONAL CANCER INSTITUTE [P30CA016056, P30CA016672] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY020545] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Whitehall Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Department of Ophthalmology of University at Buffalo; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, http://www.nei.nih.gov, EY020545, to XM; the Whitehall Foundation, http://www.whitehall.org, to XM; and Research to Prevent Blindness, https://www.rpbusa.org/rpb/, an Unrestricted Grant from to the Department of Ophthalmology of University at Buffalo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Brown NL, 2001, DEVELOPMENT, V128, P2497; Cepko CL, 1996, CURR OPIN NEUROBIOL, V6, P542, DOI 10.1016/S0959-4388(96)80062-6; Certel SJ, 2004, DEVELOPMENT, V131, P5429, DOI 10.1242/dev.01418; Duggan A, 1998, DEVELOPMENT, V125, P4107; Dykes IM, 2011, J NEUROSCI, V31, P9789, DOI 10.1523/JNEUROSCI.0901-11.2011; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gruber CA, 1997, MOL CELL BIOL, V17, P2391, DOI 10.1128/MCB.17.5.2391; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hwang SB, 2003, J MOL BIOL, V333, P237, DOI 10.1016/j.jmb.2003.08.055; Jacobson EM, 1997, GENE DEV, V11, P198, DOI 10.1101/gad.11.2.198; Johnson K G, 2000, Results Probl Cell Differ, V31, P157; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2008, DEV CELL, V14, P877, DOI 10.1016/j.devcel.2008.03.021; LICHTSTEINER S, 1995, EMBO J, V14, P3937, DOI 10.1002/j.1460-2075.1995.tb00065.x; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Martin SE, 2005, DIFFERENTIATION, V73, P18, DOI 10.1111/j.1432-0436.2005.07301004.x; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu XQ, 2008, P NATL ACAD SCI USA, V105, P6942, DOI 10.1073/pnas.0802627105; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; Mu XQ, 2004, DEVELOPMENT, V131, P1197, DOI 10.1242/dev.01010; Mu XQ, 2004, SEMIN CELL DEV BIOL, V15, P115, DOI 10.1016/j.semcdb.2003.09.009; Mu XQ, 2001, DEVELOPMENT, V128, P2569; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Rockelein I, 2000, MOL CELL BIOL, V20, P4806, DOI 10.1128/MCB.20.13.4806-4813.2000; Rohrig S, 2000, EMBO J, V19, P3694, DOI 10.1093/emboj/19.14.3694; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sapkota D, 2011, EXP EYE RES, V93, P796, DOI 10.1016/j.exer.2011.10.003; Schonemann MD, 1998, ADV EXP MED BIOL, V449, P39; Shi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076347; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Sloop KW, 1999, MOL ENDOCRINOL, V13, P2212, DOI 10.1210/me.13.12.2212; Smit DJ, 2000, EUR J BIOCHEM, V267, P6413, DOI 10.1046/j.1432-1327.2000.01737.x; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trieu M, 1999, J NEUROSCI, V19, P6549; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; XUE D, 1992, EMBO J, V11, P4969, DOI 10.1002/j.1460-2075.1992.tb05604.x; XUE D, 1993, SCIENCE, V261, P1324, DOI 10.1126/science.8103239; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zaffran S, 2005, BIOCHEM BIOPH RES CO, V334, P361, DOI 10.1016/j.bbrc.2005.06.090; Zhang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023069	52	26	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92105	10.1371/journal.pone.0092105	http://dx.doi.org/10.1371/journal.pone.0092105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643061	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900086
J	Li, ZH; Xia, CY; Yu, AX; Qi, BW				Li, Zonghuan; Xia, Chengyan; Yu, Aixi; Qi, Baiwen			Ultrasound- versus Palpation-Guided Injection of Corticosteroid for Plantar Fasciitis: A Meta-Analysis	PLOS ONE			English	Article							STEROID INJECTION; DIAGNOSIS	Background: It is controversial whether ultrasound-guided injection of corticosteroid is superior to palpation-guided injection for plantar fasciitis. This meta-analysis was performed to compare the effectiveness of ultrasound-guided and palpation-guided injection of corticosteroid for the treatment of plantar fasciitis. Methods: Databases (MEDLINE, Cochrane library and EMBASE) and reference lists were searched from their establishment to August 30, 2013 for randomized controlled trials (RCTs) comparing ultrasound-guided with palpation-guided injection for plantar fasciitis. The Cochrane risk of bias (ROB) tool was used to assess the methodological quality. Outcome measurements were visual analogue scale (VAS), tenderness threshold (TT), heel tenderness index (HTI), response rate, plantar fascia thickness (PFT), hypoechogenicity and heel pad thickness (HPT). The statistical analysis was performed with software RevMan 5.2 and Stata 12.0. When I-2<50%, the fixed-effects model was adopted. Otherwise the randomized-effects model was adopted. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was used to assess the quality of evidence. Results: Five RCTs with 149 patients were identified and analyzed. Compared with palpation-guided injection, ultrasound-guided injection was superior with regard to VAS, TT, response rate, PFT and hypoechogenicity. However, there was no statistical significance between the two groups for HPT and HTI. Conclusion: Ultrasound-guided injection of corticosteroid tends to be more effective than palpation-guided injection. However, it needs to be confirmed by further research.	[Li, Zonghuan; Xia, Chengyan; Yu, Aixi; Qi, Baiwen] Wuhan Univ, Zhongnan Hosp, Dept Orthoped, Wuhan 430072, Peoples R China	Wuhan University	Yu, AX (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Orthoped, Wuhan 430072, Peoples R China.	yuaixi666@hotmail.com		Yu, Aixi/0000-0002-3751-0894				Acevedo JI, 1998, FOOT ANKLE INT, V19, P91, DOI 10.1177/107110079801900207; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Ball EMA, 2013, ANN RHEUM DIS, V72, P996, DOI 10.1136/annrheumdis-2012-201508; Buchbinder R, 2004, NEW ENGL J MED, V350, P2159, DOI 10.1056/NEJMcp032745; Chen CM, 2013, AM J PHYS MED REHAB, V92, P597, DOI 10.1097/PHM.0b013e318278a831; Genc H, 2005, JOINT BONE SPINE, V72, P61, DOI 10.1016/j.jbspin.2004.03.006; Goff JD, 2011, AM FAM PHYSICIAN, V84, P676; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Kane D, 1998, ANN RHEUM DIS, V57, P383, DOI 10.1136/ard.57.6.383; Kane D, 2001, RHEUMATOLOGY, V40, P1002, DOI 10.1093/rheumatology/40.9.1002; Kier R, 1994, Magn Reson Imaging Clin N Am, V2, P97; Kim Chul, 2010, Foot Ankle Spec, V3, P335, DOI 10.1177/1938640010378530; McBryde A M Jr, 1984, Instr Course Lect, V33, P278; Neufeld SK, 2008, J AM ACAD ORTHOP SUR, V16, P338, DOI 10.5435/00124635-200806000-00006; Schulhofer S David, 2013, Clin J Sport Med, V23, P83, DOI 10.1097/JSM.0b013e31827e9ec9; Sconfienza LM, 2013, RADIOLOGY, V267, P195, DOI 10.1148/radiol.12120969; Tsai WC, 2000, ARCH PHYS MED REHAB, V81, P1416, DOI 10.1053/apmr.2000.9175; Tsai WC, 2006, J CLIN ULTRASOUND, V34, P12, DOI 10.1002/jcu.20177; Young C, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201030-01001; Yucel I, 2009, ARCH ORTHOP TRAUM SU, V129, P695, DOI 10.1007/s00402-008-0760-1	20	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92671	10.1371/journal.pone.0092671	http://dx.doi.org/10.1371/journal.pone.0092671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658102	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300111
J	Poolsup, N; Suksomboon, N; Amin, M				Poolsup, Nalinee; Suksomboon, Naeti; Amin, Muhammad			Effect of Treatment of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							GLUCOSE-TOLERANCE; PREGNANCY; CHALLENGE; WOMEN; MANAGEMENT; OUTCOMES; TRIAL	Objective: To assess the efficacy and safety of treating pregnant women with gestational diabetes mellitus in comparison to usual antenatal care. Methods: A systematic review and meta-analysis was conducted by including randomized controlled trials comparing any form of therapeutic intervention in comparison to usual antenatal care. A literature search was conducted using electronic databases together with a hand search of relevant journals and conference proceedings. Results: Ten studies involving 3,881 patients contributed to meta-analysis. Our results indicated that gestational diabetes mellitus treatment significantly reduced the risk for macrosomia (RR, 0.47; 95% CI, 0.38-0.57), large for gestational age births (RR, 0.55; 95% CI, 0.45-0.67), shoulder dystocia (RR, 0.42; 95% CI, 0.23-0.77) and gestational hypertension (RR, 0.68; 95% CI, 0.53-0.87) without causing any significant increase in the risk for small for gestational age babies. However, no significant difference was observed between the two groups regarding perinatal/neonatal mortality, neonatal hypoglycemia, birth trauma, preterm births, pre-eclampsia, caesarean section and labor induction. Conclusion: Treating GDM reduces risk for many important adverse pregnancy outcomes and its association with any harm seems unlikely.	[Poolsup, Nalinee] Silpakorn Univ, Fac Pharm, Dept Pharm, Nakhon Pathom, Thailand; [Suksomboon, Naeti; Amin, Muhammad] Mahidol Univ, Fac Pharm, Dept Pharm, Bangkok 10700, Thailand	Silpakorn University; Mahidol University	Suksomboon, N (corresponding author), Mahidol Univ, Fac Pharm, Dept Pharm, Bangkok 10700, Thailand.	naeti.suk@mahidol.ac.th						Agarwal MM, 2005, DIABETIC MED, V22, P1731, DOI 10.1111/j.1464-5491.2005.01706.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; [Anonymous], [No title captured], DOI DOI 10.1097/01.AOG.0000433006.09219.F1; Barton JR, 2001, AM J OBSTET GYNECOL, V184, P979, DOI 10.1067/mob.2001.112905; Bevier WC, 1999, AM J PERINAT, V16, P269, DOI 10.1055/s-2007-993871; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Bonomo M, 2005, DIABETIC MED, V22, P1536, DOI 10.1111/j.1464-5491.2005.01690.x; Deveer R, 2013, EUR REV MED PHARMACO, V17, P1258; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Falavigna M, 2012, DIABETES RES CLIN PR, V98, P396, DOI 10.1016/j.diabres.2012.09.002; Forman MR, 2005, CANCER INVEST, V23, P609, DOI 10.1080/07357900500283093; Garner P, 1997, AM J OBSTET GYNECOL, V177, P190, DOI 10.1016/S0002-9378(97)70461-7; Gofton EN, 2001, AM J OBSTET GYNECOL, V185, P798, DOI 10.1067/mob.2001.117314; Gui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064585; Henriksen T, 2008, ACTA OBSTET GYN SCAN, V87, P134, DOI 10.1080/00016340801899289; Hernandez TL, 2011, DIABETES CARE, V34, P1660, DOI 10.2337/dc11-0241; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Ju Hong, 2008, BMC Pregnancy Childbirth, V8, P31, DOI 10.1186/1471-2393-8-31; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Langer O, 2005, AM J OBSTET GYNECOL, V192, P989, DOI 10.1016/j.ajog.2004.11.039; LANGER O, 1989, AM J OBSTET GYNECOL, V161, P593, DOI 10.1016/0002-9378(89)90361-X; LANGER O, 1989, AM J OBSTET GYNECOL, V161, P646, DOI 10.1016/0002-9378(89)90371-2; LI DFH, 1987, BRIT J OBSTET GYNAEC, V94, P851, DOI 10.1111/j.1471-0528.1987.tb03753.x; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; National Institute for Health and Clinical Excellence, 2008, DIAB PREGN MAN DIAB; Ornoy Asher, 2005, Pediatr Endocrinol Rev, V3, P104; OSULLIVAN JB, 1966, OBSTET GYNECOL, V27, P683; OSULLIVAN JB, 1974, OBSTET GYNECOL, V43, P817; Reece EA, 2009, LANCET, V373, P1789, DOI 10.1016/S0140-6736(09)60515-8; Sadeh-Mestechkin D, 2008, ARCH GYNECOL OBSTET, V278, P225, DOI 10.1007/s00404-008-0566-y; Simmons R, 2011, P NUTR SOC, V70, P73, DOI 10.1017/S0029665110003988; Slining M, 2010, J PEDIATR-US, V157, P20, DOI 10.1016/j.jpeds.2009.12.054	36	26	26	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92485	10.1371/journal.pone.0092485	http://dx.doi.org/10.1371/journal.pone.0092485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658089	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300089
J	Badole, SL; Jangam, GB; Chaudhari, SM; Ghule, AE; Zanwar, AA				Badole, Sachin L.; Jangam, Ganesh B.; Chaudhari, Swapnil M.; Ghule, Arvindkumar E.; Zanwar, Anand A.			L-Glutamine Supplementation Prevents the Development of Experimental Diabetic Cardiomyopathy in Streptozotocin-Nicotinamide Induced Diabetic Rats	PLOS ONE			English	Article							GLP-1; EXPRESSION; TISSUES; DAMAGE	The objective of the present investigation was to evaluate the effect of L-glutamine on cardiac myopathy in streptozotocin-nicotinamide induced diabetic rats. Diabetes was induced in overnight fasted Sprague Dawely rats by using intraperitonial injection of streptozotocin (55 mg/kg). Nicotinamide (100 mg/kg, i.p.) was administered 20 min before administration of streptozotocin. Experimental rats were divided into Group I: non-diabetic control (distilled water; 10 ml/kg, p.o.), II: diabetic control (distilled water, 10 ml/kg, p.o.), III: L-glutamine (500 mg/kg, p.o.) and IV: L-glutamine (1000 mg/kg, p.o.). All groups were diabetic except group I. The plasma glucose level, body weight, electrocardiographic abnormalities, hemodynamic changes and left ventricular contractile function, biological markers of cardiotoxicity, antioxidant markers were determined after 4 months after STZ with nicotinamide injection. Histopathological changes of heart tissue were carried out by using H and E stain. L-glutamine treatment improved the electrocardiographic, hemodynamic changes; LV contractile function; biological markers; oxidative stress parameters and histological changes in STZ induced diabetic rats. Results from the present investigation demonstrated that L-glutamine has seemed a cardioprotective activity.	[Badole, Sachin L.; Jangam, Ganesh B.; Chaudhari, Swapnil M.] PESs Modern Coll Pharm, Dept Pharmacol, Pune, Maharashtra, India; [Ghule, Arvindkumar E.] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmacol, Pune, Maharashtra, India; [Zanwar, Anand A.] Bharati Vidyapeeth Deemed Univ, Interact Res Sch Hlth Affairs, Ctr Innovat Nutr Hlth Dis, Pune, Maharashtra, India	Bharati Vidyapeeth Deemed University; Poona College of Pharmacy; Bharati Vidyapeeth Deemed University	Badole, SL (corresponding author), PESs Modern Coll Pharm, Dept Pharmacol, Pune, Maharashtra, India.	sachinbadole@rediffmail.com	Zanwar, Anand/AAK-6051-2020; Bodhankar, Sunhash/AAQ-4624-2020	Zanwar, Anand/0000-0002-0858-7075; Chaudhari, Swapnil/0000-0002-6547-8596				Akula A, 2003, PHARMACOL RES, V48, P429, DOI 10.1016/S1043-6618(03)00191-9; Alnahdi HS., 2012, J HLTH SCI, V2, P33, DOI DOI 10.5923/J.HEALTH.20120204.03; Badole SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072817; Badole SL, 2013, CHEM-BIOL INTERACT, V203, P530, DOI 10.1016/j.cbi.2013.02.006; Badole SL, 2010, EUR J PHARMACOL, V632, P103, DOI 10.1016/j.ejphar.2010.01.019; BALAZS T, 1978, ENVIRON HEALTH PERSP, V26, P181, DOI 10.2307/3428841; Borges GR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-26; El-Sheikh NM, 2011, FOOD CHEM TOXICOL, V49, P758, DOI 10.1016/j.fct.2010.11.039; Farmer EE, 2007, CURR OPIN PLANT BIOL, V10, P380, DOI 10.1016/j.pbi.2007.04.019; Galera SC, 2010, NUTRITION, V26, P375, DOI 10.1016/j.nut.2009.05.013; Hausenloy DJ, 2008, CIRC-HEART FAIL, V1, P147, DOI 10.1161/CIRCHEARTFAILURE.108.810887; Jia J, 2009, FOOD CHEM, V115, P32, DOI 10.1016/j.foodchem.2008.11.043; Kumar SHS, 2007, J CLIN BIOCHEM NUTR, V40, P49, DOI 10.3164/jcbn.40.49; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao Y, 2011, INT J CARDIOL, V146, P432, DOI 10.1016/j.ijcard.2010.10.102; Maya L, 2010, J MOL CELL CARDIOL, V48, P524, DOI 10.1016/j.yjmcc.2009.06.021; Menge BA, 2010, REGUL PEPTIDES, V160, P75, DOI 10.1016/j.regpep.2009.08.001; MISRA HP, 1972, J BIOL CHEM, V247, P3170; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; Murarka S, 2010, J CARD FAIL, V16, P971, DOI 10.1016/j.cardfail.2010.07.249; Ravassa S, 2012, CARDIOVASC RES, V94, P316, DOI 10.1093/cvr/cvs123; Roth E, 2008, J NUTR, V138, p2025S, DOI 10.1093/jn/138.10.2025S; SLATER TF, 1971, BIOCHEM J, V123, P805, DOI 10.1042/bj1230805; Todorova VK, 2010, J NUTR, V140, P44, DOI 10.3945/jn.109.113415; Tsai PH, 2011, CLIN NUTR, V30, P124, DOI 10.1016/j.clnu.2010.07.005; Ugurlucan M, 2010, EXPERT OPIN THER TAR, V14, P1143, DOI 10.1517/14728222.2010.521500; Xi SG, 2009, EXP MOL MED, V41, P538, DOI 10.3858/emm.2009.41.8.059; Yan H, 2012, INT J CLIN EXP PATHO, V5, P651; Yao P, 2006, FOOD CHEM, V99, P305, DOI 10.1016/j.foodchem.2005.07.047	29	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92697	10.1371/journal.pone.0092697	http://dx.doi.org/10.1371/journal.pone.0092697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651718	Green Submitted, gold, Green Published			2022-12-27	WOS:000333352800144
J	Bai, XS; Gong, XJ; Hau, W; Lin, RQ; Zheng, JX; Liu, CB; Zeng, CZ; Zou, X; Zheng, HR; Song, L				Bai, Xiaosong; Gong, Xiaojing; Hau, William; Lin, Riqiang; Zheng, Jiaxiang; Liu, Chengbo; Zeng, Chengzhi; Zou, Xin; Zheng, Hairong; Song, Liang			Intravascular Optical-Resolution Photoacoustic Tomography with a 1.1 mm Diameter Catheter	PLOS ONE			English	Article							ULTRASOUND; ATHEROSCLEROSIS; MICROSCOPY; PLAQUES	Photoacoustic imaging is an emerging technology that can provide anatomic, functional, and molecular information about biological tissue. Intravascular spectroscopic and molecular photoacoustic imaging can potentially improve the identification of atherosclerotic plaque composition, the detection of inflammation, and ultimately the risk stratification of atherosclerosis. In this study, a first-of-its-kind intravascular optical-resolution photoacoustic tomography (OR-PAT) system with a 1.1 mm diameter catheter is developed, offering optical-diffraction limited transverse resolution as fine as 19.6 mu m, similar to 10-fold finer than that of conventional intravascular photoacoustic and ultrasonic imaging. To offer complementary imaging information and depth, the system also acquires co-registered intravascular ultrasound images in parallel. Imaging of an iliac stent and a lipid phantom shows that the high resolution and contrast of OR-PAT can enable improved stent implantation guidance and lipid identification. In the future, these capabilities may ultimately improve the diagnosis and interventional treatment of vulnerable atherosclerotic plaques, which are prone to cause thrombotic complications such as myocardial infarction and stroke.	[Bai, Xiaosong; Gong, Xiaojing; Lin, Riqiang; Zheng, Jiaxiang; Liu, Chengbo; Zou, Xin; Song, Liang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Shenzhen Key Lab Mol Imaging,Res Lab Biomed Opt &, Shenzhen, Peoples R China; [Hau, William] Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Zeng, Chengzhi; Zheng, Hairong] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China; [Liu, Chengbo; Song, Liang] Beijing Ctr Math & Informat Interdisciplinary Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Song, L (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Shenzhen Key Lab Mol Imaging,Res Lab Biomed Opt &, Shenzhen, Peoples R China.	liang.song@siat.ac.cn	Song, Liang/E-6938-2012		Shenzhen Science and Technology Innovation Committee [CXZZ-2012-0617113635-699, ZDSY-2013-0401165820-357, KQCX-2012-0816155844-962, JCYJ-2012-0615125857-842]; National Natural Science Foundation of China [61205203]; National Key Basic Research (973) Program of China) [2014CB744503]; International Science and Technology Cooperation Program of China [2014DFG32800]; Guangdong Innovation Research Team Fund for Low-cost Healthcare Technologies (GIRTF-LCHT); Low-cost Health Engineering Research Program of the Chinese Academy of Sciences	Shenzhen Science and Technology Innovation Committee; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research (973) Program of China)(National Basic Research Program of China); International Science and Technology Cooperation Program of China; Guangdong Innovation Research Team Fund for Low-cost Healthcare Technologies (GIRTF-LCHT); Low-cost Health Engineering Research Program of the Chinese Academy of Sciences	This work was supported by the following funds: 1. Shenzhen Science and Technology Innovation Committee grants: CXZZ-2012-0617113635-699, ZDSY-2013-0401165820-357, KQCX-2012-0816155844-962, and JCYJ-2012-0615125857-842 (www.szsti.gov.cn) 2. National Natural Science Foundation of China grant: 61205203 (www.nsfc.gov.cn) 3. National Key Basic Research (973) Program of China: 2014CB744503 (http://www.973.gov.cn/Default_3.aspx) 4. International Science and Technology Cooperation Program of China: 2014DFG32800 (http://www.istcp.org.cn/) 5. Guangdong Innovation Research Team Fund for Low-cost Healthcare Technologies (GIRTF-LCHT) (http://cxtd.gdstc.gov.cn/) 6. Low-cost Health Engineering Research Program of the Chinese Academy of Sciences [2011] (http://www.cas.cn/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.061209; Cheng-Lun Tsai, 2001, Journal of Medical and Biological Engineering, V21, P7; DEFEYTER PJ, 1991, CIRCULATION, V84, P412, DOI 10.1161/01.CIR.84.1.412; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hsieh BY, 2010, OPT LETT, V35, P2892, DOI 10.1364/OL.35.002892; Jansen K, 2013, OPT EXPRESS, V21, P21472, DOI 10.1364/OE.21.021472; Jansen K, 2011, OPT LETT, V36, P597, DOI 10.1364/OL.36.000597; Karpiouk AB, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.096008; Karpiouk AB, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3274197; Kim C, 2010, CHEM REV, V110, P2756, DOI 10.1021/cr900266s; Nissen SE, 2001, CIRCULATION, V103, P604, DOI 10.1161/01.CIR.103.4.604; Ntziachristos V, 2010, CHEM REV, V110, P2783, DOI 10.1021/cr9002566; O'Donnell M, 2010, J NUCL MED, V51, p38S, DOI 10.2967/jnumed.109.068155; Pasterkamp G, 2000, J AM COLL CARDIOL, V36, P13, DOI 10.1016/S0735-1097(00)00677-X; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sethuraman S, 2008, OPT EXPRESS, V16, P3362, DOI 10.1364/OE.16.003362; Sethuraman S, 2007, OPT EXPRESS, V15, P16657, DOI 10.1364/OE.15.016657; Song LA, 2011, OPT LETT, V36, P1236, DOI 10.1364/OL.36.001236; Wang B, 2012, ULTRASOUND MED BIOL, V38, P2098, DOI 10.1016/j.ultrasmedbio.2012.08.006; Wang B, 2012, OPT LETT, V37, P1244, DOI 10.1364/OL.37.001244; Wang B, 2010, OPT EXPRESS, V18, P4889, DOI 10.1364/OE.18.004889; Wang HW, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238106; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wang XD, 2003, NAT BIOTECHNOL, V21, P803, DOI 10.1038/nbt839; Wei W, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3631798; Yao JJ, 2013, LASER PHOTONICS REV, V7, P758, DOI 10.1002/lpor.201200060; Yoo H, 2011, NAT MED, V17, P1680, DOI 10.1038/nm.2555; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	29	85	94	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92463	10.1371/journal.pone.0092463	http://dx.doi.org/10.1371/journal.pone.0092463			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651256	gold, Green Submitted, Green Published			2022-12-27	WOS:000333352800112
J	Boberg, JB; Finlay, RD; Stenlid, J; Ekblad, A; Lindahl, BD				Boberg, Johanna B.; Finlay, Roger D.; Stenlid, Jan; Ekblad, Alf; Lindahl, Bjorn D.			Nitrogen and Carbon Reallocation in Fungal Mycelia during Decomposition of Boreal Forest Litter	PLOS ONE			English	Article							LONG-TERM DECOMPOSITION; ORGANIC-MATTER; HUMIC SUBSTANCES; PINE FORESTS; SOIL; WOOD; DYNAMICS; NUTRIENT; ROOTS; MINERALIZATION	Boreal forests are characterized by spatially heterogeneous soils with low N availability. The decomposition of coniferous litter in these systems is primarily performed by basidiomycete fungi, which often form large mycelia with a well-developed capacity to reallocate resources spatially-an advantageous trait in heterogeneous environments. In axenic microcosm systems we tested whether fungi increase their biomass production by reallocating N between Pinus sylvestris (Scots pine) needles at different stages of decomposition. We estimated fungal biomass production by analysing the accumulation of the fungal cell wall compound chitin. Monospecific systems were compared with systems with interspecific interactions. We found that the fungi reallocated assimilated N and mycelial growth away from well-degraded litter towards fresh litter components. This redistribution was accompanied by reduced decomposition of older litter. Interconnection of substrates increased over-all fungal C use efficiency (i.e. the allocation of assimilated C to biomass rather than respiration), presumably by enabling fungal translocation of growth-limiting N to litter with higher C quality. Fungal connection between different substrates also restricted N-mineralization and production of dissolved organic N, suggesting that litter saprotrophs in boreal forest ecosystems primarily act to redistribute rather than release N. This spatial integration of different resource qualities was hindered by interspecific interactions, in which litters of contrasting quality were colonised by two different basidiomycete species. The experiments provide a detailed picture of how resource reallocation in two decomposer fungi leads to a more efficient utilisation of spatially separated resources under N-limitation. From an ecosystem point of view, such economic fungal behaviour could potentially contribute to organic matter accumulation in the litter layers of boreal forests.	[Boberg, Johanna B.; Finlay, Roger D.; Stenlid, Jan; Lindahl, Bjorn D.] Swedish Univ Agr Sci, Uppsala BioCtr, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden; [Ekblad, Alf] Univ Orebro, Sch Sci & Technol, Orebro Isotope Lab, SE-70182 Orebro, Sweden	Swedish University of Agricultural Sciences; Orebro University	Boberg, JB (corresponding author), Swedish Univ Agr Sci, Uppsala BioCtr, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden.	Johanna.Boberg@slu.se	Ekblad, Alf/AAG-2632-2019; Finlay, Roger D/B-4731-2009; Stenlid, Jan/K-5909-2019; Lindahl, Björn D./AAH-4538-2019; Finlay, Roger/Q-7796-2019	Finlay, Roger D/0000-0002-3652-2930; Finlay, Roger/0000-0002-3652-2930; Stenlid, Jan/0000-0002-5344-2094; Boberg, Johanna/0000-0002-1300-8883	Swedish University of Agricultural Sciences [2007-1365, 2011-1747]; Swedish Research Council FORMAS	Swedish University of Agricultural Sciences; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	Strategic grant to JS and RDF from Swedish University of Agricultural Sciences (http://www.slu.se/en/) Grants (2007-1365 and 2011-1747) to BL from The Swedish Research Council FORMAS (http://www.formas.se/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2006, AM NAT, V167, P619, DOI 10.1086/503443; Allison SD, 2009, SOIL BIOL BIOCHEM, V41, P293, DOI 10.1016/j.soilbio.2008.10.032; Appuhn A, 2006, SOIL BIOL BIOCHEM, V38, P1040, DOI 10.1016/j.soilbio.2005.09.002; Axelsson B., 1980, Ecological Bulletins, V32, P25; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Berg B, 2000, FOREST ECOL MANAG, V133, P13, DOI 10.1016/S0378-1127(99)00294-7; Berg B., 1981, Ecological Bulletins, V33, P163; BERG B, 1982, CAN J BOT, V60, P1310, DOI 10.1139/b82-167; Boberg J, 2009, LITTER DECOMPOSING F; Boberg J, 2008, SOIL BIOL BIOCHEM, V40, P995, DOI 10.1016/j.soilbio.2007.11.005; Boberg JB, 2011, FUNGAL ECOL, V4, P408, DOI 10.1016/j.funeco.2011.03.004; Boberg JB, 2011, FUNGAL ECOL, V4, P110, DOI 10.1016/j.funeco.2010.09.002; Boberg JB, 2010, FUNCT ECOL, V24, P454, DOI 10.1111/j.1365-2435.2009.01616.x; Boddy L, 1999, MYCOLOGIA, V91, P13, DOI 10.2307/3761190; BODDY L, 1995, CAN J BOT, V73, pS1377, DOI 10.1139/b95-400; Boddy L, 2000, FEMS MICROBIOL ECOL, V31, P185, DOI 10.1111/j.1574-6941.2000.tb00683.x; Chadwick DR, 1998, SOIL BIOL BIOCHEM, V30, P47, DOI 10.1016/S0038-0717(97)00090-4; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; DOWSON CG, 1989, NEW PHYTOL, V111, P501, DOI 10.1111/j.1469-8137.1989.tb00713.x; Ekblad A, 1996, PLANT SOIL, V178, P29, DOI 10.1007/BF00011160; Ekschmitt K, 2005, GEODERMA, V128, P167, DOI 10.1016/j.geoderma.2004.12.024; FAHEY TJ, 1985, BIOGEOCHEMISTRY, V1, P257, DOI 10.1007/BF02187202; Frankland JC, 1998, MYCOL RES, V102, P1, DOI 10.1017/S0953756297005364; FRANKLAND JC, 1978, SOIL BIOL BIOCHEM, V10, P323, DOI 10.1016/0038-0717(78)90030-5; Frey SD, 2000, SOIL BIOL BIOCHEM, V32, P689, DOI 10.1016/S0038-0717(99)00205-9; Fry B., 2006, STABLE ISOTOPE ECOLO; Gebauer G, 2000, ECOL STU AN, V142, P144; Hart S.C., 1990, BIOGEOCHEMISTRY, V12, P73; JOHANSSON MB, 1995, CAN J BOT, V73, P1509, DOI 10.1139/b95-163; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Lenoir L, 2007, BIOL FERT SOILS, V43, P281, DOI 10.1007/s00374-006-0103-8; LEVI MP, 1969, PHYTOPATHOLOGY, V59, P460; Lindahl BD, 2006, NEW PHYTOL, V169, P389, DOI 10.1111/j.1469-8137.2005.01581.x; LINDAHL BD, 2004, MYCOLOGIST, V18, P79, DOI DOI 10.1017/S0269915X04002046; Lindahl B, 2008, BR MYCOL SY, V28, P183; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Lindahl BO, 2002, PLANT SOIL, V242, P123, DOI 10.1023/A:1019650226585; MELILLO JM, 1989, PLANT SOIL, V115, P189, DOI 10.1007/BF02202587; Moore TR, 2006, ECOSYSTEMS, V9, P46, DOI 10.1007/s10021-004-0026-x; NEWELL K, 1984, SOIL BIOL BIOCHEM, V16, P235, DOI 10.1016/0038-0717(84)90007-5; NORTHUP RR, 1995, NATURE, V377, P227, DOI 10.1038/377227a0; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Paul E.A., 2007, SOIL MICROBIOLOGY EC; Piccolo A, 1996, CHEMOSPHERE, V33, P595, DOI 10.1016/0045-6535(96)00210-X; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; ROBINSON CH, 1993, PLANT SOIL, V151, P139, DOI 10.1007/BF00010794; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Simpson AJ, 2002, NATURWISSENSCHAFTEN, V89, P84, DOI 10.1007/s00114-001-0293-8; Tamm C., 1991, NITROGEN TERRESTRIAL, DOI DOI 10.2307/2260680; van der Wal A, 2013, FEMS MICROBIOL REV, V37, P477, DOI 10.1111/1574-6976.12001; VENABLES CE, 1989, MYCOL RES, V92, P273, DOI 10.1016/S0953-7562(89)80065-6; Wallander H, 2003, SOIL BIOL BIOCHEM, V35, P997, DOI 10.1016/S0038-0717(03)00121-4; Woodward S, 2008, BR MYCOL SY, V28, P125; Zeller B, 1998, ANN SCI FOREST, V55, P375, DOI 10.1051/forest:19980308	55	47	47	0	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92897	10.1371/journal.pone.0092897	http://dx.doi.org/10.1371/journal.pone.0092897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651625	Green Submitted, gold, Green Published			2022-12-27	WOS:000333352800162
J	Cadby, JA; Buehler, E; Godbout, C; van Weeren, PR; Snedeker, JG				Cadby, Jennifer A.; Buehler, Evelyne; Godbout, Charles; van Weeren, P. Rene; Snedeker, Jess G.			Differences between the Cell Populations from the Peritenon and the Tendon Core with Regard to Their Potential Implication in Tendon Repair	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SMOOTH MUSCLE ACTIN; IN-VITRO; ACHILLES-TENDON; GENE-EXPRESSION; SYNOVIAL SHEATH; FLEXOR TENDONS; DIFFERENTIATION; MATRIX; BONE	The role of intrinsic and extrinsic healing in injured tendons is still debated. In this study, we characterized cell plasticity, proliferative capacity, and migration characteristics as proxy measures of healing potential in cells derived from the peritenon (extrinsic healing) and compared these to cells from the tendon core (intrinsic healing). Both cell populations were extracted from horse superficial digital flexor tendon and characterized for tenogenic and matrix remodeling markers as well as for rates of migration and replication. Furthermore, colony-forming unit assays, multipotency assays, and real-time quantitative polymerase chain reaction analyses of markers of osteogenic and adipogenic differentiation after culture in induction media were performed. Finally, cellular capacity for differentiation towards a myofibroblastic phenotype was assessed. Our results demonstrate that both tendon-and peritenon-derived cell populations are capable of adipogenic and osteogenic differentiation, with higher expression of progenitor cell markers in peritenon cells. Cells from the peritenon also migrated faster, replicate more quickly, and show higher differentiation potential toward a myofibroblastic phenotype when compared to cells from the tendon core. Based on these data, we suggest that cells from the peritenon have substantial potential to influence tendon-healing outcome, warranting further scrutiny of their role.	[Cadby, Jennifer A.; Buehler, Evelyne; Snedeker, Jess G.] Univ Zurich, Dept Orthopaed, Balgrist Hosp, Zurich, Switzerland; [Cadby, Jennifer A.; Buehler, Evelyne; Snedeker, Jess G.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [Cadby, Jennifer A.; van Weeren, P. Rene] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Utrecht, Netherlands; [Godbout, Charles] Univ Montreal Hosp, Res Ctr CRCHUM, Osteoarthritis Res Unit, Montreal, PQ, Canada	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Utrecht University; Universite de Montreal	Snedeker, JG (corresponding author), Univ Zurich, Dept Orthopaed, Balgrist Hosp, Zurich, Switzerland.	snedeker@ethz.ch	Snedeker, Jess/C-2105-2009; Snedeker, Jess G./X-2098-2019	Snedeker, Jess/0000-0002-8115-0275; Snedeker, Jess G./0000-0002-8115-0275; Godbout, Charles/0000-0003-4805-3454	Bonizzi-Theler Stiftung; Utrecht University, NL	Bonizzi-Theler Stiftung; Utrecht University, NL	The funding was provided in part by the Bonizzi-Theler Stiftung and in part by internal funds of Utrecht University, NL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIEL D, 1991, MATRIX, V11, P184, DOI 10.1016/S0934-8832(11)80157-5; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Cui QB, 2011, EUR J APPL PHYSIOL, V111, P1457, DOI 10.1007/s00421-010-1764-4; de Mos M, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-16; EIKEN O, 1975, SCAND J PLAST RECONS, V9, P182, DOI 10.3109/02844317509022864; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; FURLOW LT, 1976, PLAST RECONSTR SURG, V57, P39, DOI 10.1097/00006534-197601000-00009; GELBERMAN RH, 1992, J HAND SURG-AM, V17A, P551, DOI 10.1016/0363-5023(92)90370-5; Gohr CM, 2007, CONNECT TISSUE RES, V48, P286, DOI 10.1080/03008200701692362; Guest DJ, 2008, STEM CELLS CLONING, V1, P1, DOI 10.2147/SCCAA.S3824; Harris MT, 2004, J ORTHOP RES, V22, P998, DOI 10.1016/j.orthres.2004.02.012; Harrison RK, 2003, J HAND SURG-AM, V28A, P987, DOI 10.1016/S0363-5023(03)00380-0; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Hoynowski SM, 2007, BIOCHEM BIOPH RES CO, V362, P347, DOI 10.1016/j.bbrc.2007.07.182; Jarvinen M, 1997, SCAND J MED SCI SPOR, V7, P86; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Jones ME, 2003, J HAND SURG-AM, V28A, P221, DOI 10.1053/jhsu.2003.50044; Jung H.J, 2009, SPORTS MED ARTHROSC, V1, P1; Kajikawa Y, 2007, J CELL PHYSIOL, V210, P684, DOI 10.1002/jcp.20876; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; KVIST M, 1985, PATHOL RES PRACT, V180, P416; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovati A B, 2011, J Biol Regul Homeost Agents, V25, pS75; Lundborg G, 1978, J Hand Surg Am, V3, P21; MATTHEWS P, 1974, J BONE JOINT SURG BR, VB 56, P618; Mienaltowski MJ, 2013, TISSUE ENG PT A, V19, P199, DOI [10.1089/ten.tea.2012.0182, 10.1089/ten.TEA.2012.0182]; Mos Md, 2008, TENDON CELL BEHAV MA; Ohberg L, 2002, BRIT J SPORT MED, V36, P173, DOI 10.1136/bjsm.36.3.173; Ohberg L, 2003, KNEE SURG SPORT TR A, V11, P339, DOI 10.1007/s00167-003-0402-7; Patterson-Kane JC, 2012, J COMP PATHOL, V147, P227, DOI 10.1016/j.jcpa.2012.05.010; Penny J, 2012, FRONT BIOSCI-LANDMRK, V17, P892, DOI 10.2741/3963; Pierre-Jerome C, 2010, ACTA RADIOL, V51, P438, DOI 10.3109/02841851003627809; POTENZA AD, 1964, JAMA-J AM MED ASSOC, V187, P187; Reed SA, 2008, J CELL PHYSIOL, V215, P329, DOI 10.1002/jcp.21312; Rees JD, 2009, AM J SPORT MED, V37, P1855, DOI 10.1177/0363546508324283; Salingcarnboriboon R, 2003, EXP CELL RES, V287, P289, DOI 10.1016/S0014-4827(03)00107-1; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Sharma RI, 2010, BIOMATERIALS, V31, P7695, DOI 10.1016/j.biomaterials.2010.06.046; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; SKOOG T, 1954, PLAST RECONSTR SURG, V13, P384, DOI 10.1097/00006534-195405000-00005; Taylor SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016337; Violini S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-29; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhang YWW, 2009, VET IMMUNOL IMMUNOP, V130, P114, DOI 10.1016/j.vetimm.2009.01.012	47	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92474	10.1371/journal.pone.0092474	http://dx.doi.org/10.1371/journal.pone.0092474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651449	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000333352800116
J	Deo, S; Patel, TR; Dzananovic, E; Booy, EP; Zeid, K; McEleney, K; Harding, SE; McKenna, SA				Deo, Soumya; Patel, Trushar R.; Dzananovic, Edis; Booy, Evan P.; Zeid, Khalid; McEleney, Kevin; Harding, Stephen E.; McKenna, Sean A.			Activation of 2 ' 5 '-Oligoadenylate Synthetase by Stem Loops at the 5 '-End of the West Nile Virus Genome	PLOS ONE			English	Article							RNASE-L; INTERFERON; REPLICATION; EXPRESSION; SEDIMENTATION; RESISTANCE; CYCLIZATION; SYSTEM; SPREAD; SHAPE	West Nile virus (WNV) has a positive sense RNA genome with conserved structural elements in the 5' and 3'-untranslated regions required for polyprotein production. Antiviral immunity to WNV is partially mediated through the production of a cluster of proteins known as the interferon stimulated genes (ISGs). The 2' 5'-oligoadenylate synthetases (OAS) are key ISGs that help to amplify the innate immune response. Upon interaction with viral double stranded RNA, OAS enzymes become activated and enable the host cell to restrict viral propagation. Studies have linked mutations in the OAS1 gene to increased susceptibility to WNV infection, highlighting the importance of OAS1 enzyme. Here we report that the region at the 5'-end of the WNV genome comprising both the 5'-UTR and initial coding region is capable of OAS1 activation in vitro. This region contains three RNA stem loops (SLI, SLII, and SLIII), whose relative contribution to OAS1 binding affinity and activation were investigated using electrophoretic mobility shift assays and enzyme kinetics experiments. Stem loop I, comprising nucleotides 1-73, is dispensable for maximum OAS1 activation, as a construct containing only SLII and SLIII was capable of enzymatic activation. Mutations to the RNA binding site of OAS1 confirmed the specificity of the interaction. The purity, monodispersity and homogeneity of the 5'-end (SLI/II/III) and OAS1 were evaluated using dynamic light scattering and analytical ultra-centrifugation. Solution conformations of both the 5'-end RNA of WNV and OAS1 were then elucidated using small-angle x-ray scattering. In the context of purified components in vitro, these data demonstrate the recognition of conserved secondary structural elements of the WNV genome by a member of the interferon-mediated innate immune response.	[Deo, Soumya; Patel, Trushar R.; Dzananovic, Edis; Booy, Evan P.; Zeid, Khalid; McEleney, Kevin; McKenna, Sean A.] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Harding, Stephen E.] Univ Nottingham, Natl Ctr Macromol Hydrodynam, Sutton, Bonington, England; [McKenna, Sean A.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [McEleney, Kevin] Univ Manitoba, Manitoba Inst Mat, Winnipeg, MB, Canada	University of Manitoba; University of Nottingham; University of Manitoba; University of Manitoba	McKenna, SA (corresponding author), Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada.	Sean.mckenna@umanitoba.ca	Patel, Trushar R./AAB-6250-2020; Patel, Trushar R/F-2776-2011	Patel, Trushar R./0000-0003-0627-2923; Patel, Trushar R/0000-0003-0627-2923; McKenna, Sean/0000-0002-9407-7257; Harding, Stephen E./0000-0002-7798-9692	Natural Sciences and Engineering Research Council of Canada (NSERC); Manitoba Health Research Council (MHRC); University of Manitoba GETS program; Manitoba Health Research Council Postdoctoral Fellowship; University of Manitoba; NSERC USRA program; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Health Research Council (MHRC); University of Manitoba GETS program; Manitoba Health Research Council Postdoctoral Fellowship; University of Manitoba; NSERC USRA program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Manitoba Health Research Council (MHRC). ED was partially supported by the University of Manitoba GETS program. EPB was support by a Manitoba Health Research Council Postdoctoral Fellowship. SD was supported by a University of Manitoba Graduate Fellowship and Faculty of Science Scholarships. KZ was supported by the NSERC USRA program. TRP was supported by a Canadian Institutes of Health Research Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737; Bigham AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024745; Booy Evan P, 2012, Methods Mol Biol, V941, P69, DOI 10.1007/978-1-62703-113-4_6; Borisevich V, 2006, VIROLOGY, V349, P371, DOI 10.1016/j.virol.2006.02.013; Brinton MA, 2001, ANN NY ACAD SCI, V951, P207; Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654; Calisher CH, 2000, VIRAL IMMUNOL, V13, P411, DOI 10.1089/vim.2000.13.411; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; CHEBATH J, 1987, NATURE, V330, P587, DOI 10.1038/330587a0; Dam J, 2004, METHOD ENZYMOL, V384, P185; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; Dzananovic E, 2013, RNA, V19, P333, DOI 10.1261/rna.035931.112; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10; Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Han YC, 2012, CELL REP, V2, P902, DOI 10.1016/j.celrep.2012.09.004; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Hartmann R, 1998, J BIOL CHEM, V273, P3236, DOI 10.1074/jbc.273.6.3236; Hovanessian AG, 2007, BIOCHIMIE, V89, P779, DOI 10.1016/j.biochi.2007.02.003; Ivanyi-Nagy R, 2012, VIRUS RES, V167, P226, DOI 10.1016/j.virusres.2012.05.003; Kajaste-Rudnitski A, 2006, J BIOL CHEM, V281, P4624, DOI 10.1074/jbc.M508649200; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lim JK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000321; Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728; Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08; Markoff L, 2003, ADV VIRUS RES, V59, P177, DOI 10.1016/S0065-3527(03)59006-6; McKenna SA, 2007, NAT PROTOC, V2, P3270, DOI 10.1038/nprot.2007.480; Meng H, 2012, J MOL BIOL, V422, P635, DOI 10.1016/j.jmb.2012.06.017; Patel TR, 2012, MATRIX BIOL, V31, P135, DOI 10.1016/j.matbio.2011.11.004; Patel TR, 2010, MATRIX BIOL, V29, P565, DOI 10.1016/j.matbio.2010.07.004; Patel TR, 2008, MACROMOL BIOSCI, V8, P1108, DOI 10.1002/mabi.200800064; Peisley A, 2012, CELL MOL LIFE SCI; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; Polacek C, 2009, J VIROL, V83, P1161, DOI 10.1128/JVI.01362-08; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; SANGSTER MY, 1994, J VIROL, V68, P448, DOI 10.1128/JVI.68.1.448-452.1994; Savage HM, 1999, AM J TROP MED HYG, V61, P600, DOI 10.4269/ajtmh.1999.61.600; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WATHELET M, 1986, FEBS LETT, V196, P113, DOI 10.1016/0014-5793(86)80224-1; Yakub I, 2005, J INFECT DIS, V192, P1741, DOI 10.1086/497340; Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D	55	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92545	10.1371/journal.pone.0092545	http://dx.doi.org/10.1371/journal.pone.0092545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651762	gold, Green Published			2022-12-27	WOS:000333352800125
J	Hibbert, B; Maze, R; Pourdjabbar, A; Simard, T; Ramirez, FD; Moudgil, R; Blondeau, M; Labinaz, M; Dick, A; Glover, C; Froeschl, M; Marquis, JF; So, DYF; Le May, MR				Hibbert, Benjamin; Maze, Ronnen; Pourdjabbar, Ali; Simard, Trevor; Ramirez, F. Daniel; Moudgil, Rohit; Blondeau, Melissa; Labinaz, Marino; Dick, Alexander; Glover, Christopher; Froeschl, Michael; Marquis, Jean-Francois; So, Derek Y. F.; Le May, Michel R.			A Comparative Pharmacodynamic Study of Ticagrelor versus Clopidogrel and Ticagrelor in Patients Undergoing Primary Percutaneous Coronary Intervention: The CAPITAL RELOAD Study	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; TREATMENT PLATELET REACTIVITY; ANTIPLATELET THERAPY; RECEPTOR ANTAGONIST; PRIMARY PCI; PRASUGREL; TRIAL; OUTCOMES; AZD6140; SAFETY	Background: In patients undergoing primary percutaneous coronary intervention (PPCI) ticagrelor is superior to clopidogrel in reducing cardiovascular events. This study sought to evaluate the effect of clopidogrel pretreatment on the pharmacodynamics of ticagrelor in patients undergoing PPCI. Methods: We measured platelet reactivity using the VerifyNow P2Y12 assay at baseline, 1, 2, 4, 6, 12, 24, and 48 hours following ticagrelor bolus in patients previously loaded with clopidogrel (C+T) and in thienopyridine-naive patients (T) referred to our centre for PPCI. Results: In total, 52 consecutive eligible patients with ST-elevation myocardial infarction (STEMI) were enrolled (27 C+T and 25 T). Baseline characteristics and mean baseline platelet reactivity units (PRUs) were similar between the groups. The primary endpoint, the proportion of patients achieving a PRU<208 at 2 hours, was more frequently achieved in the C+T group compared to T treatment (76.0% vs 44.4%, p = 0.026). Notably, C+T therapy resulted in fewer patients with high platelet reactivity at 1 hour (56.0% vs. 14.8%), 4 hours (100.0% vs. 61.5%) and 6 hours (100.0% vs. 64%, p<0.01 for all comparisons). Furthermore, C+T therapy was associated with lower PRU values from 2 to 48 hours. Conclusions: In patients referred for PPCI, ticagrelor bolus following clopidogrel resulted in more rapid and profound platelet inhibition, demonstrating a positive pharmacodynamic interaction. Further study is needed to determine if this pharmacodynamic effect translates into reduced clinical events.	[Hibbert, Benjamin; Maze, Ronnen; Pourdjabbar, Ali; Simard, Trevor; Ramirez, F. Daniel; Moudgil, Rohit; Blondeau, Melissa; Labinaz, Marino; Dick, Alexander; Glover, Christopher; Froeschl, Michael; Marquis, Jean-Francois; So, Derek Y. F.; Le May, Michel R.] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute	Le May, MR (corresponding author), Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada.	mlemay@ottawaheart.ca			University of Ottawa Heart Institute STEMI program	University of Ottawa Heart Institute STEMI program	Funding was provided by the University of Ottawa Heart Institute STEMI program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos D, 2012, CIRC-CARDIOVASC INTE, V5, P797, DOI 10.1161/CIRCINTERVENTIONS.112.972323; Alexopoulos D, 2012, J AM COLL CARDIOL, V60, P193, DOI 10.1016/j.jacc.2012.03.050; Alexopoulos D, 2011, JACC-CARDIOVASC INTE, V4, P403, DOI 10.1016/j.jcin.2010.12.011; Bell AD, 2011, CAN J CARDIOL, V27, P208, DOI 10.1016/j.cjca.2010.12.033; Bliden KP, 2011, AM HEART J, V162, P160, DOI 10.1016/j.ahj.2010.11.025; Brar SS, 2011, J AM COLL CARDIOL, V58, P1945, DOI 10.1016/j.jacc.2011.06.059; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Cannon CP, 2007, J AM COLL CARDIOL, V50, P1844, DOI 10.1016/j.jacc.2007.07.053; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Gurbel PA, 2010, CIRCULATION, V121, P1188, DOI 10.1161/CIRCULATIONAHA.109.919456; Gurbel PA, 2009, CIRCULATION, V120, P2577, DOI 10.1161/CIRCULATIONAHA.109.912550; Haase Jurgen, 2004, J Interv Cardiol, V17, P367, DOI 10.1111/j.1540-8183.2004.04078.x; Heestermans AACM, 2008, THROMB RES, V122, P776, DOI 10.1016/j.thromres.2008.01.021; Hibbert B, 2012, CIRC-CARDIOVASC INTE, V5, P805, DOI 10.1161/CIRCINTERVENTIONS.112.968966; Husted S, 2006, EUR HEART J, V27, P1038, DOI 10.1093/eurheartj/ehi754; Husted S, 2009, CARDIOVASC THER, V27, P259, DOI 10.1111/j.1755-5922.2009.00096.x; Le May MR, 2008, NEW ENGL J MED, V358, P231, DOI 10.1056/NEJMoa073102; Le May MR, 2012, J AM COLL CARDIOL, V60, P1223, DOI 10.1016/j.jacc.2012.07.008; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Parodi G, 2013, J AM COLL CARDIOL, V61, P1601, DOI 10.1016/j.jacc.2013.01.024; Patti G, 2008, J AM COLL CARDIOL, V52, P1128, DOI 10.1016/j.jacc.2008.06.038; Price MJ, 2011, CIRCULATION, V124, P1132, DOI 10.1161/CIRCULATIONAHA.111.029165; Ravnefjord A, 2012, THROMB RES, V130, P622, DOI 10.1016/j.thromres.2012.07.021; Roberts JD, 2012, LANCET, V379, P1705, DOI 10.1016/S0140-6736(12)60161-5; Siller-Matula JM, 2013, JACC-CARDIOVASC INTE, V6, P1111, DOI 10.1016/j.jcin.2013.06.011; Steg PG, 2010, CIRCULATION, V122, P2131, DOI 10.1161/CIRCULATIONAHA.109.927582; Storey RF, 2007, J AM COLL CARDIOL, V50, P1852, DOI 10.1016/j.jacc.2007.07.058; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327	29	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92078	10.1371/journal.pone.0092078	http://dx.doi.org/10.1371/journal.pone.0092078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651043	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800069
J	Shaw, AD; Tiwari, Y; Kaplan, W; Heath, A; Mitchell, PB; Schofield, PR; Fullerton, JM				Shaw, Alex D.; Tiwari, Yash; Kaplan, Warren; Heath, Anna; Mitchell, Philip B.; Schofield, Peter R.; Fullerton, Janice M.			Characterisation of Genetic Variation in ST8SIA2 and Its Interaction Region in NCAM1 in Patients with Bipolar Disorder	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; DNA-SEQUENCING DATA; GENOME-WIDE SCAN; POLYSIALIC-ACID; PSA-NCAM; HUMAN POLYSIALYLTRANSFERASE; SUSCEPTIBILITY LOCUS; PREFRONTAL CORTEX; SCHIZOPHRENIA; EXPRESSION	Alpha-2,8-sialyltransferase 2 (ST8SIA2) is an enzyme responsible for the transfer of polysialic acid (PSA) to glycoproteins, principally the neuronal cell adhesion molecule (NCAM1), and is involved in neuronal plasticity. Variants within ST8SIA2 have previously shown association with bipolar disorder, schizophrenia and autism. In addition, altered PSA-NCAM expression in brains of patients with schizophrenia or bipolar disorder indicates a functional dysregulation of glycosylation in mental illness. To explore the role of sequence variation affecting PSA-NCAM formation, we conducted a targeted re-sequencing study of a similar to 100 kb region - including the entire ST8SIA2 gene and its region of interaction with NCAM1 - in 48 Caucasian cases with bipolar disorder using the Roche 454 platform. We identified over 400 DNA variants, including 47 putative novel variants not described in dbSNP. Validation of a subset of variants via Sequenom showed high reliability of Roche 454 genotype calls (97% genotype concordance, with 80% of novel variants independently verified). We did not observe major loss-of-function mutations that would affect PSA-NCAM formation, either by ablating ST8SIA2 function or by affecting the ability of NCAM1 to be glycosylated. However, we identified 13 SNPs in the UTRs of ST8SIA2, a synonymous coding SNP in exon 5 (rs2305561, P207P) and many additional non-coding variants that may influence splicing or regulation of ST8SIA2 expression. We calculated nucleotide diversity within ST8SIA2 on specific haplotypes, finding that the diversity on the specific "risk" and "protective" haplotypes was lower than other non-disease-associated haplotypes, suggesting that putative functional variation may have arisen on a spectrum of haplotypes. We have identified common and novel variants (rs11074064, rs722645, 15:92961050) that exist on a spectrum of haplotypes, yet are plausible candidates for conferring the effect of risk and protective haplotypes via multiple enhancer elements. A Galaxy workflow/pipeline for sequence analysis used herein is available at: https://main.g2.bx.psu.edu/u/a-shaw-neura/p/next-generation-resources.	[Shaw, Alex D.; Tiwari, Yash; Heath, Anna; Schofield, Peter R.; Fullerton, Janice M.] Neurosci Res Australia, Sydney, NSW, Australia; [Shaw, Alex D.; Tiwari, Yash; Schofield, Peter R.; Fullerton, Janice M.] Schizophrenia Res Inst, Sydney, NSW, Australia; [Tiwari, Yash; Schofield, Peter R.; Fullerton, Janice M.] Univ New S Wales, Fac Med, Sch Med Sci, Sydney, NSW, Australia; [Kaplan, Warren] Garvan Inst, Peter Wills Bioinformat Ctr, Sydney, NSW, Australia; [Mitchell, Philip B.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Mitchell, Philip B.] Black Dog Inst, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney; Black Dog Institute	Fullerton, JM (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	j.fullerton@neura.edu.au	Fullerton, Janice/F-8485-2013; Schofield, Peter/C-9669-2011	Fullerton, Janice/0000-0003-4014-4490; Mitchell, Philip/0000-0002-7954-5235; Shaw, Alex/0000-0001-7548-1329; Schofield, Peter/0000-0003-2967-9662	Australian National Medical and Health Research Council [630574, 510135, 1037196]; Schizophrenia Research Institute; NSW Health; Australian National Health and Medical Research Council [401184]; Cancer Institute NSW [11/REG/1-10]; Australian Postgraduate Award	Australian National Medical and Health Research Council(National Health and Medical Research Council (NHMRC) of Australia); Schizophrenia Research Institute; NSW Health; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW; Australian Postgraduate Award(Australian Government)	This work was supported by the Australian National Medical and Health Research Council (project grant 630574, and program grants 510135 and 1037196) and by the Schizophrenia Research Institute, utilizing infrastructure funding from NSW Health. Genetic Repositories Australia is supported by an Australian National Health and Medical Research Council (Grant # 401184). The authors used Garvan Galaxy, funded by a Cancer Institute NSW grant (11/REG/1-10). Mr Yash Tiwari was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; America N, 2011, NATURE, V467, P1026; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Arai M, 2004, BIOL PSYCHIAT, V55, P804, DOI 10.1016/j.biopsych.2004.01.009; Atz ME, 2007, PSYCHIAT GENET, V17, P55, DOI 10.1097/YPG.0b013e328012d850; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Castillo-Gomez E, 2008, EXP NEUROL, V214, P97, DOI 10.1016/j.expneurol.2008.07.018; Chazal G, 2000, J NEUROSCI, V20, P1446; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Darnell JC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012344; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; FINNE J, 1982, J BIOL CHEM, V257, P1966; Foley DA, 2010, J BIOL CHEM, V285, P27360, DOI 10.1074/jbc.M110.140038; Foley DA, 2009, J BIOL CHEM, V284, P15505, DOI 10.1074/jbc.M809696200; Frasca A, 2008, INT J NEUROPSYCHOPH, V11, P591, DOI 10.1017/S1461145708009061; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Harismendy O, 2009, BIOTECHNIQUES, V46, P229, DOI 10.2144/000113082; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Kamien B, 2014, AM J MED GENET A, V164, P782, DOI 10.1002/ajmg.a.36345; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Krocher T, 2015, BRAIN STRUCT FUNCT, V220, P71, DOI 10.1007/s00429-013-0638-z; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mackowiak M, 2009, EUR NEUROPSYCHOPHARM, V19, P125, DOI 10.1016/j.euroneuro.2008.10.001; Maheu ME, 2013, J PSYCHIATR RES, V47, P384, DOI 10.1016/j.jpsychires.2012.11.013; Maziade M, 2005, MOL PSYCHIATR, V10, P486, DOI 10.1038/sj.mp.4001594; McAuley EZ, 2009, MOL PSYCHIATR, V14, P492, DOI 10.1038/sj.mp.4002146; McAuley EZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038172; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mikkonen M, 1998, ANN NEUROL, V44, P923, DOI 10.1002/ana.410440611; Muhlenhoff M, 2013, NEUROCHEM RES, V38, P1134, DOI 10.1007/s11064-013-0979-2; Muhleisen T, 2014, NAT COMMUN IN PRESS; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Nakayama J, 1996, J BIOL CHEM, V271, P1829, DOI 10.1074/jbc.271.4.1829; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Park N, 2004, MOL PSYCHIATR, V9, P1091, DOI 10.1038/sj.mp.4001541; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; R Core Team, 2012, R LANG ENV STAT COMP; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Roy-Engel AM, 2002, GENOME RES, V12, P1333, DOI 10.1101/gr.384802; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00061; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P902, DOI 10.1016/j.biopsych.2006.07.036; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; van Baren MJ, 2004, BIOINFORMATICS, V20, P591, DOI 10.1093/bioinformatics/btg473; Varea E, 2012, J PSYCHIATR RES, V46, P189, DOI 10.1016/j.jpsychires.2011.10.011; Vazza G, 2007, MOL PSYCHIATR, V12, P87, DOI 10.1038/sj.mp.4001895	63	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92556	10.1371/journal.pone.0092556	http://dx.doi.org/10.1371/journal.pone.0092556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651862	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800128
J	Venturini, G; Di Gioia, SA; Harper, S; Weigel-DiFranco, C; Rivolta, C; Berson, EL				Venturini, Giulia; Di Gioia, Silvio Alessandro; Harper, Shyana; Weigel-DiFranco, Carol; Rivolta, Carlo; Berson, Eliot L.			Molecular Genetics of FAM161A in North American Patients with Early-Onset Retinitis Pigmentosa	PLOS ONE			English	Article							MUTATIONS; PRPF31	Retinitis pigmentosa (RP) is a hereditary disease that leads to the progressive degeneration of retinal photoreceptor cells and to blindness. It is caused by mutations in several distinct genes, including the ciliary gene FAM161A, which is associated with a recessive form of this disorder. Recent investigations have revealed that defects in FAM161A represent a rather prevalent cause of hereditary blindness in Israel and the Palestinian territories, whereas they seem to be rarely present within patients from Germany. Genetic or clinical data are currently not available for other countries. In this work, we screened a cohort of patients with recessive RP from North America to determine the frequency of FAM161A mutations in this ethnically-mixed population and to assess the phenotype of positive cases. Out of 273 unrelated patients, only 3 subjects had defects in FAM161A. A fourth positive patient, the sister of one of these index cases, was also identified following pedigree analysis. They were all homozygous for the p.T452Sfx3 mutation, which was previously reported as a founder DNA variant in the Israeli and Palestinian populations. Analysis of cultured lymphoblasts from patients revealed that mutant FAM161A transcripts were actively degraded by nonsense-mediated mRNA decay. Electroretinographic testing showed 30 Hz cone flicker responses in the range of 0.10 to 0.60 microvolts in all cases at their first visit (age 12 to 23) (lower norm = 50 mu V) and of 0.06 to 0.32 microvolts at their most recent examination (age 27 to 43), revealing an early-onset of this progressive disease. Our data indicate that mutations in FAM161A are responsible for 1% of recessive RP cases in North America, similar to the prevalence detected in Germany and unlike the data from Israel and the Palestinian territories. We also show that, at the molecular level, the disease is likely caused by FAM161A protein deficiency.	[Venturini, Giulia; Di Gioia, Silvio Alessandro; Rivolta, Carlo] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Harper, Shyana; Weigel-DiFranco, Carol; Berson, Eliot L.] Harvard Univ, Sch Med, Berman Gund Lab Study Retinal Degenerat, Massachusetts Eye & Ear, Boston, MA USA	University of Lausanne; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Rivolta, C (corresponding author), Univ Lausanne, Dept Med Genet, Lausanne, Switzerland.	carlo.rivolta@unil.ch		Rivolta, Carlo/0000-0002-0733-9950; Di Gioia, Silvio Alessandro/0000-0002-7235-5682	Swiss National Science Foundation [310030_138346]; Gebert Ruf Foundation, Switzerland; Foundation Fighting Blindness, Columbia, Maryland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gebert Ruf Foundation, Switzerland; Foundation Fighting Blindness, Columbia, Maryland	This work was supported by the Swiss National Science Foundation (Grant 310030_138346), the Gebert Ruf Foundation, Switzerland (Rare Diseases - New Technologies grant), and a Center Grant to the Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, to Dr. Berson from The Foundation Fighting Blindness, Columbia, Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P382, DOI 10.1016/j.ajhg.2010.07.022; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Di Gioia SA, 2012, HUM MOL GENET, V21, P5174, DOI 10.1093/hmg/dds368; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Frio TR, 2008, J CLIN INVEST, V118, P1519, DOI 10.1172/JCI34211; Gu SM, 1999, J MED GENET, V36, P705; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Langmann T, 2010, AM J HUM GENET, V87, P376, DOI 10.1016/j.ajhg.2010.07.018; Mort M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r19; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Rivolta C, 2006, HUM MUTAT, V27, P644, DOI 10.1002/humu.20325; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Zach F, 2012, HUM MOL GENET, V21, P4573, DOI 10.1093/hmg/dds268	17	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92479	10.1371/journal.pone.0092479	http://dx.doi.org/10.1371/journal.pone.0092479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651477	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000333352800117
J	Veselits, M; Tanaka, A; Lipkowitz, S; O'Neill, S; Sciammas, R; Finnegan, A; Zhang, J; Clark, MR				Veselits, Margaret; Tanaka, Azusa; Lipkowitz, Stanley; O'Neill, Shannon; Sciammas, Roger; Finnegan, Alison; Zhang, Jian; Clark, Marcus R.			Recruitment of Cbl-b to B Cell Antigen Receptor Couples Antigen Recognition to Toll-Like Receptor 9 Activation in Late Endosomes	PLOS ONE			English	Article							MHC CLASS-II; LIGHT-CHAIN RECOMBINATION; UBIQUITIN LIGASE CBL; C-CBL; NEGATIVE REGULATION; IG-BETA; PROTEINS; CIN85; COMPARTMENTS; DEGRADATION	Casitas B-lineage lymphoma-b (Cbl-b) is a ubiquitin ligase (E3) that modulates signaling by tagging molecules for degradation. It is a complex protein with multiple domains and binding partners that are not involved in ubiquitinating substrates. Herein, we demonstrate that Cbl-b, but not c-Cbl, is recruited to the clustered B cell antigen receptor (BCR) and that Cbl-b is required for entry of endocytosed BCRs into late endosomes. The E3 activity of Cbl-b is not necessary for BCR endocytic trafficking. Rather, the ubiquitin associated (UBA) domain is required. Furthermore, the Cbl-b UBA domain is sufficient to confer the receptor trafficking functions of Cbl-b on c-Cbl. Cbl-b is also required for entry of the Toll-like receptor 9 (TLR9) into late endosomes and for the in vitro activation of TLR9 by BCR-captured ligands. These data indicate that Cbl-b acts as a scaffolding molecule to coordinate the delivery of the BCR and TLR9 into subcellular compartments required for productively delivering BCR-captured ligands to TLR9.	[Veselits, Margaret; Tanaka, Azusa; Sciammas, Roger; Clark, Marcus R.] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Veselits, Margaret; Tanaka, Azusa; Sciammas, Roger; Clark, Marcus R.] Univ Chicago, Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Lipkowitz, Stanley] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [O'Neill, Shannon] Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO USA; [O'Neill, Shannon] Univ Colorado, Denver, CO 80202 USA; [O'Neill, Shannon] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Finnegan, Alison] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA; [Finnegan, Alison] Rush Univ, Med Ctr, Dept Internal Med, Rheumatol Sect, Chicago, IL 60612 USA; [Zhang, Jian] Univ Chicago, Dept Med, Nephrol Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Jewish Health; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Rush University; Rush University; University of Chicago	Clark, MR (corresponding author), Univ Chicago, Dept Med, Rheumatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mclark@medicine.bsd.uchicago.edu	Zhang, Jian/A-2564-2008	Zhang, Jian/0000-0002-9523-5296	National Institutes of Health [GM088847, GM101090, AI090901]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101090, R01GM088847, R01GM067772, R21GM076601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health (MRC, GM088847 and GM101090 and JZ, AI090901). This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bustelo XR, 1997, ONCOGENE, V15, P2511, DOI 10.1038/sj.onc.1201430; Cascalho M, 2007, CRIT REV IMMUNOL, V27, P141, DOI 10.1615/CritRevImmunol.v27.i2.20; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Clark MR, 2004, CURR OPIN IMMUNOL, V16, P382, DOI 10.1016/j.coi.2004.03.007; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Ferrari G, 1997, J CELL BIOL, V139, P1433, DOI 10.1083/jcb.139.6.1433; Haglund K, 2002, P NATL ACAD SCI USA, V99, P12191, DOI 10.1073/pnas.192462299; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hou P, 2006, PLOS BIOL, V4, P1147, DOI 10.1371/journal.pbio.0040200; Hunt SD, 2011, BIOCHEM SOC T, V39, P1179, DOI 10.1042/BST0391179; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Kitaura Y, 2007, IMMUNITY, V26, P567, DOI 10.1016/j.immuni.2007.03.015; Kowanetz K, 2004, MOL BIOL CELL, V15, P3155, DOI 10.1091/mbc.E03-09-0683; Lankar D, 2002, J EXP MED, V195, P461, DOI 10.1084/jem.20011543; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Li C, 2002, INT IMMUNOL, V14, P1179, DOI 10.1093/intimm/dxf083; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Luisiri P, 1996, J BIOL CHEM, V271, P5158; Mandal M, 2009, NAT IMMUNOL, V10, P1110, DOI 10.1038/ni.1785; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; O'Neill SK, 2009, P NATL ACAD SCI USA, V106, P6262, DOI 10.1073/pnas.0812922106; Oksvold MP, 2008, MOL IMMUNOL, V45, P925, DOI 10.1016/j.molimm.2007.08.002; Paolino M, 2010, SEMIN IMMUNOPATHOL, V32, P137, DOI 10.1007/s00281-010-0197-9; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Qiao GL, 2007, J IMMUNOL, V179, P4473, DOI 10.4049/jimmunol.179.7.4473; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; RIBERDY JM, 1994, J CELL BIOL, V125, P1225, DOI 10.1083/jcb.125.6.1225; Schnyder T, 2011, IMMUNITY, V34, P905, DOI 10.1016/j.immuni.2011.06.001; Siemasko K, 1998, J IMMUNOL, V160, P5203; Siemasko K, 2001, CURR OPIN IMMUNOL, V13, P32, DOI 10.1016/S0952-7915(00)00178-3; Smit GDV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000217; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; Yasuda T, 2000, J EXP MED, V191, P641, DOI 10.1084/jem.191.4.641; Zhang J, 2009, CELL RES, V19, P733, DOI 10.1038/cr.2009.51; Zhang M, 2007, J IMMUNOL, V179, P4435, DOI 10.4049/jimmunol.179.7.4435	50	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e89792	10.1371/journal.pone.0089792	http://dx.doi.org/10.1371/journal.pone.0089792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651487	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800004
J	Wilken, PM; Steenkamp, ET; Wingfield, MJ; de Beer, ZW; Wingfield, BD				Wilken, P. Markus; Steenkamp, Emma T.; Wingfield, Michael J.; de Beer, Z. Wilhelm; Wingfield, Brenda D.			DNA Loss at the Ceratocystis fimbriata Mating Locus Results in Self- Sterility	PLOS ONE			English	Article							ASCOSPORE DIMORPHISM; NEUROSPORA-CRASSA; GENES; SEQUENCE; SEX; EVOLUTION; STRAINS; PATHOGEN; BEHAVIOR; SYSTEMS	Fungi have evolved a remarkable diversity of reproductive strategies. Some of these, most notably those of the model fungi, have been well studied but others are poorly understood. The latter is also true for uni-directional mating type switching, which has been reported in only five fungal genera, including Ceratocystis. Mating type switching allows a self-fertile fungal isolate to produce both self-fertile and self-sterile offspring. This study considered the molecular nature of uni-directional mating type switching in the type species of Ceratocystis, C. fimbriata. To do this, the genome of C. fimbriata was first examined for the presence of mating type genes. Three mating genes (MAT1-1-1, MAT1-2-1 and MAT1-1-2) were found in an atypical organisation of the mating type locus. To study the effect that uni-directional switching has on this locus, several self-sterile offspring were analysed. Using a combination of next generation and conventional Sanger sequencing, it was shown that a 3581 base pair (bp) region had been completely deleted from the MAT locus. This deletion, which includes the entire MAT1-2-1 gene, results in the permanent loss of self-fertility, rendering these isolates exclusively self-sterile. Our data also suggest that the deletion mechanism is tightly controlled and that it always occurs at the same genomic position. Two 260 bp direct repeats flanking the deleted region are strongly implicated in the process, although the exact mechanism behind the switching remains unclear.	[Wilken, P. Markus; Wingfield, Michael J.; Wingfield, Brenda D.] Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Genet, ZA-0002 Pretoria, South Africa; [Steenkamp, Emma T.; de Beer, Z. Wilhelm] Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Microbiol & Plant Pathol, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria	Wingfield, BD (corresponding author), Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Genet, ZA-0002 Pretoria, South Africa.	brenda.wingfield@up.ac.za	de Beer, Z. Wilhelm/B-6353-2008; Wilken, Markus/B-2049-2010; Steenkamp, Emma T/B-7958-2009; Wingfield, Michael J/A-9473-2008; de Beer, Wilhelm/AAK-9266-2020; de Beer, Z. Wilhelm/O-3194-2019; Wingfield, Brenda D./B-1376-2008	de Beer, Z. Wilhelm/0000-0001-9758-8987; Wilken, Markus/0000-0003-0827-6098; Steenkamp, Emma T/0000-0003-0217-8219; de Beer, Z. Wilhelm/0000-0001-9758-8987; Wingfield, Brenda D./0000-0002-6189-1519	National Research Foundation (NRF); Centres of Excellence and the Technology and Human Resources Programmes of the South African Departments of Science and Technology (DST); Trade Industry (DTI); University of Pretoria; National Research Foundation of South Africa [83924]	National Research Foundation (NRF); Centres of Excellence and the Technology and Human Resources Programmes of the South African Departments of Science and Technology (DST); Trade Industry (DTI); University of Pretoria; National Research Foundation of South Africa(National Research Foundation - South Africa)	The authors thank the following institutions and programmes for financial support: the National Research Foundation (NRF) and the Centres of Excellence and the Technology and Human Resources Programmes of the South African Departments of Science and Technology (DST) and Trade Industry (DTI), respectively, as well as the University of Pretoria and members of the Tree Pathology Co-operative Programme (TPCP). This work is based on research supported in part by a number of grants from the National Research Foundation of South Africa (includes Grant specific unique reference number (UID) 83924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Arie T, 1997, FUNGAL GENET BIOL, V21, P118, DOI 10.1006/fgbi.1997.0961; Aronstein KA, 2007, MYCOLOGIA, V99, P553, DOI 10.3852/mycologia.99.4.553; ASTELL CR, 1981, CELL, V27, P15, DOI 10.1016/0092-8674(81)90356-1; Barnes I, 2001, PLANT DIS, V85, P317, DOI [10.1094/PDIS.2001.85.3.317, 10.1094/PDIS.2001.85.9.1029B]; BARNETT HL, 1947, MYCOLOGIA, V39, P699, DOI 10.2307/3755220; Betley JN, 2002, CURR BIOL, V12, P1756, DOI 10.1016/S0960-9822(02)01220-4; Bidard F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021476; Billiard S, 2012, J EVOLUTION BIOL, V25, P1020, DOI 10.1111/j.1420-9101.2012.02495.x; Bobrowicz P, 2002, MOL MICROBIOL, V45, P795, DOI 10.1046/j.1365-2958.2002.03052.x; BUTLER ET, 1982, J BIOL CHEM, V257, P5772; Butler G, 2010, CLIN MICROBIOL REV, V23, P140, DOI 10.1128/CMR.00053-09; Chitrampalam P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056895; Conde-Ferraez L, 2007, MOL PLANT PATHOL, V8, P111, DOI [10.1111/j.1364-3703.2006.00376.x, 10.1111/J.1364-3703.2006.00376.X]; Coppin E, 1997, MICROBIOL MOL BIOL R, V61, P411, DOI 10.1128/.61.4.411-428.1997; COPPINRAYNAL E, 1989, MOL GEN GENET, V219, P270, DOI 10.1007/BF00261187; Cozijnsen AJ, 2003, CURR GENET, V43, P351, DOI 10.1007/s00294-003-0391-6; Debuchy R, 2006, MYCOTA, P293, DOI DOI 10.1007/3-540-28135-5_15; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; FARETRA F, 1988, J GEN MICROBIOL, V134, P2543; Fraser JA, 2005, CURR OPIN GENET DEV, V15, P645, DOI 10.1016/j.gde.2005.09.002; Gioti A, 2012, MOL BIOL EVOL, V29, P3215, DOI 10.1093/molbev/mss132; GLASS NL, 1990, P NATL ACAD SCI USA, V87, P4912, DOI 10.1073/pnas.87.13.4912; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Harrington TC, 1997, CURR GENET, V32, P52, DOI 10.1007/s002940050247; Harrington TC, 1995, INOCULUM, V46, P18; Heitman J., 2007, SEX FUNGI MOL DETERM; Heitman J, 2013, MYCOLOGIA, V105, P1, DOI 10.3852/12-253; Kanematsu S, 2007, CURR GENET, V52, P11, DOI 10.1007/s00294-007-0132-3; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; LABARERE J, 1992, GENETICS, V131, P307; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Li WJ, 2010, EUKARYOT CELL, V9, P46, DOI 10.1128/EC.00259-09; Lin Xiaorong, 2007, P35; Martin SH, 2011, FUNGAL GENET BIOL, V48, P731, DOI 10.1016/j.fgb.2011.03.005; MATHIESON MJ, 1952, ANN BOT-LONDON, V16, P449, DOI 10.1093/oxfordjournals.aob.a083327; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; Nelson MA, 1996, TRENDS GENET, V12, P69, DOI 10.1016/0168-9525(96)81403-X; Ni M, 2011, ANNU REV GENET, V45, P405, DOI 10.1146/annurev-genet-110410-132536; NICKOLOFF JA, 1986, P NATL ACAD SCI USA, V83, P7831, DOI 10.1073/pnas.83.20.7831; Nygren K, 2012, MOL BIOL EVOL, V29, P3827, DOI 10.1093/molbev/mss193; OLSON EO, 1949, PHYTOPATHOLOGY, V39, P548; PERKINS DD, 1987, GENETICS, V115, P215; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 2001, MOL CLONING LAB MANU; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Stanke M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s11; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Turgeon B. Gillian, 2007, P93; Turgeon BG, 1998, ANNU REV PHYTOPATHOL, V36, P115, DOI 10.1146/annurev.phyto.36.1.115; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; UHM JY, 1983, PHYTOPATHOLOGY, V73, P565, DOI 10.1094/Phyto-73-565; van Wyk M, 2004, STUD MYCOL, P273; Waalwijk C, 2002, FUNGAL GENET BIOL, V35, P277, DOI 10.1006/fgbi.2001.1322; Wada R, 2012, APPL ENVIRON MICROB, V78, P2819, DOI 10.1128/AEM.07034-11; WEBSTER RK, 1967, MYCOLOGIA, V59, P212, DOI 10.2307/3756794; Wik L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-109; Wilken PM, 2013, IMA FUNGUS, V4, P357, DOI 10.5598/imafungus.2013.04.02.14; Witthuhn RC, 2000, CURR GENET, V38, P48, DOI 10.1007/s002940000131; Yokoyama E, 2003, APPL ENVIRON MICROB, V69, P5019, DOI 10.1128/AEM.69.8.5019-5022.2003; Yokoyama E, 2005, FEMS MICROBIOL LETT, V250, P145, DOI 10.1016/j.femsle.2005.07.004; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	66	38	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92180	10.1371/journal.pone.0092180	http://dx.doi.org/10.1371/journal.pone.0092180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651494	Green Submitted, Green Published, gold			2022-12-27	WOS:000333352800079
J	Ren, YC; Chen, L; Niu, QH; Hui, FL				Ren, Yongcheng; Chen, Liang; Niu, Qiuhong; Hui, Fengli			Description of Scheffersomyces henanensis sp nov., a New D-Xylose-Fermenting Yeast Species Isolated from Rotten Wood	PLOS ONE			English	Article							RPB1 SEQUENCES; RIBOSOMAL DNA; FERMENTATION; ETHANOL; PHYLOGENY; STRAIN; FOREST; FRASS; GUT	Two strains of a D-xylose-fermenting yeast species were isolated from rotten wood samples collected from the Baotianman Nature Reserve in Henan Province, central China. These strains formed hat-shaped ascospores in conjugated and deliquescent asci. Multilocus phylogenetic analysis that included the nearly complete small subunit (SSU), the internal transcribed spacer (ITS) region and the D1/D2 domain of the large subunit (LSU) rRNA genes, as well as RNA polymerase II largest subunit (RPB1) gene demonstrated that the two strains represent a novel yeast species closely related to Scheffersomyces segobiensis. A sequence comparison of xylose reductase (XYL1) gene, which was recently recommended for rapid identification of cryptic species in the Scheffersomyces clade, revealed a significant sequence divergence of 25 nucleotides between the novel strains and their closest relative S. segobiensis, supporting their classification as a distinct species. Furthermore, these new strains can be clearly distinguished from S. segobiensis by a number of morphological and physiological characteristics. Therefore, a novel yeast species, Scheffersomyces henanensis sp. nov., is proposed to accommodate these strains. The type strain is BY-41(T) (= CICC 1974(T) = CBS 12475(T)).	[Ren, Yongcheng; Chen, Liang; Niu, Qiuhong; Hui, Fengli] Nanyang Normal Univ, Sch Life Sci & Technol, Nanyang, Peoples R China	Nanyang Normal College	Hui, FL (corresponding author), Nanyang Normal Univ, Sch Life Sci & Technol, Nanyang, Peoples R China.	huifl@126.com		liang, CHEN/0000-0001-7429-4505	National Natural Science Foundation of China [31370073]; Research Planning Project of Basic and Advanced Technology of Henan Province, China [122300410032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Planning Project of Basic and Advanced Technology of Henan Province, China	This work was supported by the National Natural Science Foundation of China (31370073) and the Research Planning Project of Basic and Advanced Technology of Henan Province, China (122300410032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbogbo FK, 2008, BIOTECHNOL LETT, V30, P1515, DOI 10.1007/s10529-008-9728-z; Agbogbo FK, 2007, J IND MICROBIOL BIOT, V34, P723, DOI 10.1007/s10295-007-0247-z; Agbogbo FK, 2006, BIOTECHNOL LETT, V28, P2065, DOI 10.1007/s10529-006-9192-6; BARNETT JA, 2000, YEASTS CHARACTERISTI; Cadete RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043135; Chandel AK, 2011, BIOTECHNOL MOL BIOL, V6; DUPREEZ JC, 1983, BIOTECHNOL LETT, V5, P357, DOI 10.1007/BF01141138; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hahn-Hagerdal B, 2004, APPL BIOCHEM BIOTECH, V113, P1207; Hibbett DS, 1996, MOL BIOL EVOL, V13, P903, DOI 10.1093/oxfordjournals.molbev.a025658; JEFFRIES TW, 1985, TRENDS BIOTECHNOL, V3, P208, DOI 10.1016/0167-7799(85)90048-4; JEFFRIES TW, 1994, ENZYME MICROB TECH, V16, P922, DOI 10.1016/0141-0229(94)90001-9; Jindamorakot S, 2007, FEMS YEAST RES, V7, P1409, DOI 10.1111/j.1567-1364.2007.00305.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kurtzman CP, 2010, MYCOSCIENCE, V51, P2, DOI 10.1007/s10267-009-0011-5; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Limtong S, 2007, INT J SYST EVOL MICR, V57, P419, DOI 10.1099/ijs.0.64539-0; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; RAMIREZ C, 1984, MYCOPATHOLOGIA, V88, P83, DOI 10.1007/BF00436436; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos R, 2011, ANTON LEEUW INT J G, V99, P635, DOI 10.1007/s10482-010-9536-z; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Suh SO, 2003, MOL ECOL, V12, P3137, DOI 10.1046/j.1365-294X.2003.01973.x; Suh SO, 2013, INT J SYST EVOL MICR, V63, P4330, DOI 10.1099/ijs.0.053009-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe Y, 2004, MOL PHYLOGENET EVOL, V30, P438, DOI 10.1016/S1055-7903(03)00185-4; Thanh VN, 2003, FEMS YEAST RES, V4, P113, DOI 10.1016/S1567-1356(03)00079-5; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Urbina H, 2013, MYCOLOGIA, V105, P650, DOI 10.3852/12-094; Urbina H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039128; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; YAMADA Y, 1973, J GEN APPL MICROBIOL, V19, P59, DOI 10.2323/jgam.19.59; Yarrow D., 1998, P77, DOI 10.1016/B978-044481312-1/50014-9	35	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92315	10.1371/journal.pone.0092315	http://dx.doi.org/10.1371/journal.pone.0092315			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647466	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500114
J	Tempelmann, S; Kaminski, J; Tomasello, M				Tempelmann, Sebastian; Kaminski, Juliane; Tomasello, Michael			Do Domestic Dogs Learn Words Based on Humans' Referential Behaviour?	PLOS ONE			English	Article							INFANTS; COMPREHENSION; WOLVES; CHIMPANZEES; CHILDREN	Some domestic dogs learn to comprehend human words, although the nature and basis of this learning is unknown. In the studies presented here we investigated whether dogs learn words through an understanding of referential actions by humans rather than simple association. In three studies, each modelled on a study conducted with human infants, we confronted four word-experienced dogs with situations involving no spatial-temporal contiguity between the word and the referent; the only available cues were referential actions displaced in time from exposure to their referents. We found that no dogs were able to reliably link an object with a label based on social-pragmatic cues alone in all the tests. However, one dog did show skills in some tests, possibly indicating an ability to learn based on social-pragmatic cues.	[Tempelmann, Sebastian; Kaminski, Juliane; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Tempelmann, Sebastian; Kaminski, Juliane] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England; [Tempelmann, Sebastian] Univ Appl Sci & Arts Northwestern Switzerland, Liestal, Switzerland	Max Planck Society; University of Portsmouth	Kaminski, J (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany.	juliane.kaminski@port.ac.uk		Kaminski, Juliane/0000-0002-3437-3484	Max Planck Society; Volkswagenstiftung for JK	Max Planck Society(Max Planck SocietyFoundation CELLEX); Volkswagenstiftung for JK	Funding for this study was provided by the Max Planck Society as well as the Volkswagenstiftung for JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN DA, 1993, J CHILD LANG, V20, P395, DOI 10.1017/S0305000900008345; BALDWIN DA, 1991, CHILD DEV, V62, P875, DOI 10.2307/1131140; Baldwin DA, 1996, CHILD DEV, V67, P3135, DOI 10.1111/j.1467-8624.1996.tb01906.x; Bates E., 1979, EMERGENCE SYMBOLS CO, DOI [10.1016/b978-0-12-081540-1.50011-9, DOI 10.1016/B978-0-12-081540-1.50011-9]; Bloom P, 2004, SCIENCE, V304, P1605, DOI 10.1126/science.1099899; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Carey S., 1978, P STANFORD CHILD LAN, V15, P17; Coppinger R., 2001, DOGS STARTLING NEW U; Grassmann S, 2012, ANIM COGN, V15, P657, DOI 10.1007/s10071-012-0494-x; Griebel U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030182; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hare B, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2009.06.031; HEIBECK TH, 1987, CHILD DEV, V58, P1021, DOI 10.1111/j.1467-8624.1987.tb01438.x; HERMAN LM, 1984, COGNITION, V16, P129, DOI 10.1016/0010-0277(84)90003-9; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Kaminski J, 2008, ANIM COGN, V11, P367, DOI 10.1007/s10071-007-0124-1; Kaminski J, 2012, DEVELOPMENTAL SCI, V15, P222, DOI 10.1111/j.1467-7687.2011.01120.x; Kaminski J, 2009, DEVELOPMENTAL SCI, V12, P831, DOI 10.1111/j.1467-7687.2009.00815.x; Kirchhofer KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030913; Liszkowski U, 2007, J CHILD LANG, V34, P1, DOI 10.1017/S0305000906007689; Liszkowski U, 2009, PSYCHOL SCI, V20, P654, DOI 10.1111/j.1467-9280.2009.02346.x; Manly BFJ, 1997, RANDOMIZATION BOOTST; Markman EM, 2004, TRENDS COGN SCI, V8, P479, DOI 10.1016/j.tics.2004.09.007; Markson L, 1997, NATURE, V385, P813, DOI 10.1038/385813a0; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; PEPPERBERG IM, 1981, Z TIERPSYCHOL, V55, P139; Pilley JW, 2011, BEHAV PROCESS, V86, P184, DOI 10.1016/j.beproc.2010.11.007; Riedel J, 2008, ANIM BEHAV, V75, P1003, DOI 10.1016/j.anbehav.2007.08.010; Savage-Rumbaugh E.S., 1986, APE LANGUAGE CONDITI, DOI DOI 10.7312/SAVA90374; SAVAGERUMBAUGH S, 1986, J EXP PSYCHOL GEN, V115, P211, DOI 10.1037/0096-3445.115.3.211; SCHUSTERMAN RJ, 1986, J COMP PSYCHOL, V100, P348, DOI 10.1037/0735-7036.100.4.348; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; TOMASELLO M, 1994, DEV PSYCHOL, V30, P639, DOI 10.1037/0012-1649.30.5.639; Tomasello M, 1996, J CHILD LANG, V23, P157, DOI 10.1017/S0305000900010138; Tomasello M., 2001, LANGUAGE DEV ESSENTI, P132, DOI [DOI 10.1017/CBO9780511620669.007, 10.1017/CBO9780511620669.007]; Tomasello M, 2008, JEAN NICOD LECT, P1; Udell MAR, 2008, ANIM BEHAV, V76, P1767, DOI 10.1016/j.anbehav.2008.07.028; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y; Wobber V, 2011, WHAT DO DOGS UNDERST, P93	40	5	5	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91014	10.1371/journal.pone.0091014	http://dx.doi.org/10.1371/journal.pone.0091014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646732	Green Published, gold			2022-12-27	WOS:000333348500020
J	Andreassen, KV; Hjuler, ST; Furness, SG; Sexton, PM; Christopoulos, A; Nosjean, O; Karsdal, MA; Henriksen, K				Andreassen, Kim Vietz; Hjuler, Sara Toftegaard; Furness, Sebastian G.; Sexton, Patrick M.; Christopoulos, Arthur; Nosjean, Olivier; Karsdal, Morten Asser; Henriksen, Kim			Prolonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ADENYLATE-CYCLASE; REGIONAL-DISTRIBUTION; RAT OSTEOCLASTS; BINDING-SITES; KINASE-C; ACTIVATION; INTERNALIZATION; CELLS; PHARMACOLOGY	Salmon calcitonin (sCT) and human calcitonin (hCT) are pharmacologically distinct. However, the reason for the differences is unclear. Here we analyze the differences between sCT and hCT on the human calcitonin receptor (CT(a)R) with respect to activation of cAMP signaling, beta-arrestin recruitment, ligand binding kinetics and internalization. The study was conducted using mammalian cell lines heterologously expressing the human CT(a) receptor. CT(a)R downstream signaling was investigated with dose response profiles for cAMP production and beta-arrestin recruitment for sCT and hCT during short term (<2 hours) and prolonged (up to 72 hours) stimulation. CT(a)R kinetics and internalization was investigated with radio-labeled sCT and hCT ligands on cultured cells and isolated membrane preparations from the same cell line. We found that sCT and hCT are equipotent during short-term stimulations with differences manifesting themselves only during long-term stimulation with sCT inducing a prolonged activation up to 72 hours, while hCT loses activity markedly earlier. The prolonged sCT stimulation of both cAMP accumulation and beta-arrestin recruitment was attenuated, but not abrogated by acid wash, suggesting a role for sCT activated internalized receptors. We have demonstrated a novel phenomenon, namely that two distinct CT(a)R downstream signaling activation patterns are activated by two related ligands, thereby highlighting qualitatively different signaling responses in vitro that could have implications for sCT use in vivo.	[Andreassen, Kim Vietz; Hjuler, Sara Toftegaard; Karsdal, Morten Asser; Henriksen, Kim] Nord Biosci AS, Herlev, Denmark; [Furness, Sebastian G.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Clayton, Vic 3800, Australia; [Furness, Sebastian G.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Clayton, Vic 3800, Australia; [Nosjean, Olivier] Inst Rech Servier, Croissy Sur Seine, France	Nordic Bioscience; Monash University; Monash University; Servier; Institut de Recherches Internationales Servier	Andreassen, KV (corresponding author), Nord Biosci AS, Herlev, Denmark.	kan@nordicbioscience.com	Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008; Furness, Sebastian/Q-9068-2018	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Furness, Sebastian/0000-0001-8655-8221; Karsdal, Morten/0000-0001-5026-8740	Danish Research Foundation; Danish Ministry for Science, Technology and Education	Danish Research Foundation; Danish Ministry for Science, Technology and Education	Partly funded by Danish Research Foundation and the Danish Ministry for Science, Technology and Education. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARVINTE T, 1993, J BIOL CHEM, V268, P6415; Azria M, 1989, CALCITONINS; CHAKRABORTY M, 1994, P NATL ACAD SCI USA, V91, P2115, DOI 10.1073/pnas.91.6.2115; CHAKRABORTY M, 1991, SCIENCE, V251, P1078, DOI 10.1126/science.1847755; CHAMBERS TJ, 1986, J CLIN ENDOCR METAB, V63, P1080, DOI 10.1210/jcem-63-5-1080; Chen Y, 1998, J BIOL CHEM, V273, P19809, DOI 10.1074/jbc.273.31.19809; Degorce Francois, 2009, Curr Chem Genomics, V3, P22, DOI 10.2174/1875397300903010022; DEL FA, 2008, ARCH BIOCHEM BIOPHYS, V473, P147; Dong MQ, 2004, J BIOL CHEM, V279, P31177, DOI 10.1074/jbc.M404113200; Dong MQ, 2004, J BIOL CHEM, V279, P1167, DOI 10.1074/jbc.M305719200; Feigh M, 2012, BRIT J PHARMACOL, V167, P151, DOI 10.1111/j.1476-5381.2012.01979.x; Feigh M, 2011, DIABETES OBES METAB, V13, P911, DOI 10.1111/j.1463-1326.2011.01425.x; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; FINDLAY DM, 1984, ENDOCRINOLOGY, V115, P78, DOI 10.1210/endo-115-1-78; FISCHER JA, 1981, P NATL ACAD SCI-BIOL, V78, P7801, DOI 10.1073/pnas.78.12.7801; FISCHER JA, 1981, LIFE SCI, V29, P663, DOI 10.1016/0024-3205(81)90018-7; Henriksen K, 2010, EXPERT OPIN BIOL TH, V10, P1617, DOI 10.1517/14712598.2010.526104; Henriksen K, 2009, BIOCHEM BIOPH RES CO, V378, P804, DOI 10.1016/j.bbrc.2008.11.145; Hilton JM, 2000, J ENDOCRINOL, V166, P213, DOI 10.1677/joe.0.1660213; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; HOUSSAMI S, 1995, MOL PHARMACOL, V47, P798; Huang R, 2012, J MOL BIOL, V416, P108, DOI 10.1016/j.jmb.2011.12.023; KUESTNER RE, 1994, MOL PHARMACOL, V46, P246; Mack CM, 2011, DIABETES OBES METAB, V13, P1105, DOI 10.1111/j.1463-1326.2011.01465.x; MICHELANGELI VP, 1983, J CYCLIC NUCL PROT, V9, P129; NICHOLSON GC, 1987, ENDOCRINOLOGY, V120, P1902, DOI 10.1210/endo-120-5-1902; Pham V, 2005, J BIOL CHEM, V280, P28610, DOI 10.1074/jbc.M503272200; Pham VI, 2004, J PEPT SCI, V10, P179, DOI 10.1002/psc.541; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; SCHNEIDER HG, 1990, ACTA ENDOCRINOL-COP, V122, P255, DOI 10.1530/acta.0.1220255; SCHNEIDER HG, 1988, MOL CELL ENDOCRINOL, V58, P9, DOI 10.1016/0303-7207(88)90048-2; Sexton PM, 1999, CURR MED CHEM, V6, P1067; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; SU YJ, 1992, ENDOCRINOLOGY, V131, P1497, DOI 10.1210/en.131.3.1497; Yan YX, 2002, J BIOMOL SCREEN, V7, P451, DOI 10.1177/108705702237677; Young Andrew, 2005, Adv Pharmacol, V52, P47, DOI 10.1016/S1054-3589(05)52003-9; Zaidi M, 2002, BONE, V30, P655, DOI 10.1016/S8756-3282(02)00688-9	37	56	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92042	10.1371/journal.pone.0092042	http://dx.doi.org/10.1371/journal.pone.0092042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643196	Green Published, gold			2022-12-27	WOS:000333259900070
J	Scholer, J; Krischik, V				Scholer, Jamison; Krischik, Vera			Chronic Exposure of Imidacloprid and Clothianidin Reduce Queen Survival, Foraging, and Nectar Storing in Colonies of Bombus impatiens	PLOS ONE			English	Article							COORDINATED AGRICULTURAL PROJECT; HONEY-BEE; NEONICOTINOID INSECTICIDES; TERRESTRIS HYMENOPTERA; PESTICIDE EXPOSURE; NATIONAL RESEARCH; NOSEMA-CERANAE; TOXICITY; APIDAE; RISK	In an 11-week greenhouse study, caged queenright colonies of Bombus impatiens Cresson, were fed treatments of 0 (0 ppb actual residue I, imidacloprid; C, clothianidin), 10 (14 I, 9 C), 20 (16 I, 17 C), 50 (71 I, 39 C) and 100 (127 I, 76 C) ppb imidacloprid or clothianidin in sugar syrup (50%). These treatments overlapped the residue levels found in pollen and nectar of many crops and landscape plants, which have higher residue levels than seed-treated crops (less than 10 ppb, corn, canola and sunflower). At 6 weeks, queen mortality was significantly higher in 50 ppb and 100 ppb and by 11 weeks in 20 ppb-100 ppb neonicotinyl-treated colonies. The largest impact for both neonicotinyls starting at 20 (16 I, 17 C) ppb was the statistically significant reduction in queen survival (37% I, 56% C) ppb, worker movement, colony consumption, and colony weight compared to 0 ppb treatments. Bees at feeders flew back to the nest box so it appears that only a few workers were collecting syrup in the flight box and returning the syrup to the nest. The majority of the workers sat immobilized for weeks on the floor of the flight box without moving to fed at sugar syrup feeders. Neonicotinyl residues were lower in wax pots in the nest than in the sugar syrup that was provided. At 10 (14) ppb I and 50 (39) ppb C, fewer males were produced by the workers, but queens continued to invest in queen production which was similar among treatments. Feeding on imidacloprid and clothianidin can cause changes in behavior (reduced worker movement, consumption, wax pot production, and nectar storage) that result in detrimental effects on colonies (queen survival and colony weight). Wild bumblebees depending on foraging workers can be negatively impacted by chronic neonicotinyl exposure at 20 ppb.	[Scholer, Jamison; Krischik, Vera] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Krischik, V (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	krisc001@umn.edu			USDA SARE [00015590]; grant "Mitigating pollinator decline" [MN LCCMR 221G]; University of Minnesota Experiment Station (MAES) project [MN 17-027]	USDA SARE(United States Department of Agriculture (USDA)); grant "Mitigating pollinator decline"; University of Minnesota Experiment Station (MAES) project	Research was supported by a USDA SARE (00015590) grant "The role of imidacloprid systemic insecticide on colony collapse disorder of honey bees and decline of bumblebee pollinators", 2010 MN LCCMR 221G grant "Mitigating pollinator decline", and University of Minnesota Experiment Station (MAES) project MN 17-027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; Averill AL, 2011, AM BEE J, V151, P1187; Baldwin J, 2003, DELTA FARM PRES 1211; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Bonmatin JM, 2005, ENVIRONMENTAL CHEMISTRY: GREEN CHEMISTRY AND POLLUTANTS IN ECOSYSTEMS, P483; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cnaani J, 2002, INSECT SOC, V49, P164, DOI 10.1007/s00040-002-8297-8; Colin ME, 2004, ARCH ENVIRON CON TOX, V47, P387, DOI 10.1007/s00244-004-3052-y; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; EFSA Panel on Biological Hazards, 2012, EFSA Journal, V10, P2724; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; Elston C, 2013, APIDOLOGIE, V44, P563, DOI 10.1007/s13592-013-0206-9; Fischer DL, 2007, BAYER CROPSCIENCE; Frazier J, 2011, AM BEE J, V151, P779; Frazier M, 2008, AM BEE J, V148, P521; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gauthier M, 2010, ADV EXP MED BIOL, V683, P97; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gradish AE, 2010, PEST MANAG SCI, V66, P142, DOI 10.1002/ps.1846; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Incerti Francesca, 2003, Bulletin of Insectology, V56, P159; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Lambin M, 2001, ARCH INSECT BIOCHEM, V48, P129, DOI 10.1002/arch.1065; Larson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066375; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; Minnesota Department of Agriculture, 2013, PEST SAL DAT 2009; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Morandin LA, 2003, ENVIRON ENTOMOL, V32, P555, DOI 10.1603/0046-225X-32.3.555; MORSE RA, 2003, BEECULTURE, V128, P1; Paine TD, 2011, BIOL CONTROL, V56, P175, DOI 10.1016/j.biocontrol.2010.08.007; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pilatic H, 2012, WIDELY USED PESTICID; Prichard AM, 2009, NOT DEC IN REEV CHEM; Rossler W., 2012, HONEYBEE NEUROBIOLOG, P141, DOI [DOI 10.1007/978-94-007-2099-2, 10.1007/978-94-007-2099-2]; SAS, 2010, SAS ENT GUID 4 3; SAS, 2010, JMP PRO 9 0 2; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Scott-Dupree CD, 2001, IMPACT GAUCHO TI 435; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Suchail S, 2004, PEST MANAG SCI, V60, P1056, DOI 10.1002/ps.895; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Tasei JN, 2000, PEST MANAG SCI, V56, P784, DOI 10.1002/1526-4998(200009)56:9<784::AID-PS208>3.0.CO;2-T; Tasei JN, 2001, J ECON ENTOMOL, V94, P623, DOI 10.1603/0022-0493-94.3.623; Tome HVV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038406; USDA APHIS, 2003, AS LONGH BEETL COOP; USDA ARS, 2011, COL COLL DIS PROGR R; van der Sluijs JP, 2013, CURR OPIN ENV SUST, V5, P293, DOI 10.1016/j.cosust.2013.05.007; van der Steen JJM, 2008, APIDOLOGIE, V39, P273, DOI 10.1051/apido:2008006; vanEngelsdorp D, 2013, PREV VET MED, V108, P225, DOI 10.1016/j.prevetmed.2012.08.004; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vaughan M, 2006, 35 USDA NAT AGR CTR; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Winter K, 2006, IMPORTATION NONNATIV	73	51	51	3	177	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e91573	10.1371/journal.pone.0091573	http://dx.doi.org/10.1371/journal.pone.0091573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643057	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900027
J	Liu, CF; Liu, SY; Min, XY; Ji, YY; Wang, N; Liu, D; Ma, N; Li, ZF; Li, K				Liu, Cheng-Fei; Liu, Shu-Yan; Min, Xiao-Yun; Ji, Yuan-Yuan; Wang, Na; Liu, Dan; Ma, Ning; Li, Zong-Fang; Li, Ke			The Prognostic Value of CXCR4 in Ovarian Cancer: A Meta-Analysis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; EXPRESSION; CXCL12; CARCINOMA; SURVIVAL; MARKER; CHEMOTHERAPY; BLOCKADE; CELLS; BIAS	Objective: Recent reports have shown that C-X-C chemokine receptor 4 (CXCR4) is expressed in ovarian cancer and plays an important role in metastasis. However, the prognostic value of CXCR4 in ovarian cancer remains controversial and has not been emphasized. The aim of this study is to evaluate the prognostic significance of CXCR4 in ovarian cancer by performing a meta-analysis. Methods: We systematically searched for studies evaluating the relationship between CXCR4 expression and the outcome of ovarian cancer patients. Only articles in which CXCR4 expression was detected by immunohistochemical staining were included. Hazard ratios (HRs) and relative risk (RR) with 95% confidence intervals (CIs) were pooled as effect size (ES) across studies for overall survival (OS) and progression-free survival (PFS). Results: A total of 729 patients from 7 studies (6 articles) were included in this meta-analysis. Our results showed that high CXCR4 expression was significantly associated with poor prognosis in terms of OS (ES, 2.81; 95% CI, 1.16-6.80; p = 0.022) and PFS (ES, 8.48; 95% CI, 2.13-33.70; p = 0.002) in ovarian cancer patients. The association between high CXCR4 expression and poor ovarian cancer prognosis in OS was also statistically significant in subgroups of Asian and III-IV patients constituting 70%. Conclusions: The present meta-analysis indicated that high CXCR4 expression was associated with poor prognosis in ovarian cancer. More studies, especially larger scale and well-matched researches, are warranted to clarify the prognostic effect of CXCR4 on the outcome of ovarian cancer.	[Liu, Cheng-Fei; Liu, Shu-Yan; Min, Xiao-Yun; Ji, Yuan-Yuan; Wang, Na; Liu, Dan; Ma, Ning; Li, Ke] Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Core Res Lab, Xian 710049, Peoples R China; [Liu, Shu-Yan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Reprod Med, Xian 710049, Peoples R China; [Liu, Dan] Fifth Hosp Xian, Inst Rheumatol, Dept Rheumatol & Immunol, Xian 710049, Peoples R China; [Li, Zong-Fang] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Gen Surg, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Li, K (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Core Res Lab, Xian 710049, Peoples R China.	ke.li@mail.xjtu.edu.cn	Li, Ke/O-6291-2014		Fundamental Research Funds for the Central Universities of China [2010jdgz09]; Research Fund for the Doctoral Program of Higher Education [SRFDP 20120201110059]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by the Fundamental Research Funds for the Central Universities of China (No. 2010jdgz09), and the specialized Research Fund for the Doctoral Program of Higher Education (SRFDP 20120201110059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolome RA, 2009, AM J PATHOL, V174, P602, DOI 10.2353/ajpath.2009.080636; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chiang YC, 2013, J GYNECOL ONCOL, V24, P342, DOI 10.3802/jgo.2013.24.4.342; De Falco V, 2007, CANCER RES, V67, P11821, DOI 10.1158/0008-5472.CAN-07-0899; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Hassan S, 2011, INT J CANCER, V129, P225, DOI 10.1002/ijc.25665; Jiang YP, 2006, GYNECOL ONCOL, V103, P226, DOI 10.1016/j.ygyno.2006.02.036; Kucia M, 2004, J MOL HISTOL, V35, P233; Landrum LM, 2013, GYNECOL ONCOL, V130, P12, DOI 10.1016/j.ygyno.2013.04.001; Li J, 2013, BMB REP IN PRESS; Mhawech-Fauceglia P, 2012, HISTOPATHOLOGY, V60, P1019, DOI 10.1111/j.1365-2559.2011.04172.x; Monk BJ, 2014, GYNECOL ONCOL, V132, P176, DOI 10.1016/j.ygyno.2013.10.032; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Oda Y, 2007, CANCER SCI, V98, P1020, DOI 10.1111/j.1349-7006.2007.00492.x; Pils D, 2007, BRIT J CANCER, V96, P485, DOI 10.1038/sj.bjc.6603581; Popple A, 2012, BRIT J CANCER, V106, P1306, DOI 10.1038/bjc.2012.49; Salvucci O, 2006, BREAST CANCER RES TR, V97, P275, DOI 10.1007/s10549-005-9121-8; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; Scotton CJ, 2002, CANCER RES, V62, P5930; Sekiya R, 2012, HUM PATHOL, V43, P904, DOI 10.1016/j.humpath.2011.08.002; Shayegi N, 2014, BRIT J HAEMATOL, V164, P409, DOI 10.1111/bjh.12641; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skirnisdottir I, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-524; Spano JP, 2004, ANN ONCOL, V15, P613, DOI 10.1093/annonc/mdh136; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Warner LLM, 2013, INT J GYNECOL CANCER, V23, P1612, DOI 10.1097/01.IGC.0000436089.03581.6b; Yamada M, 2011, CELL MOL IMMUNOL, V8, P305, DOI 10.1038/cmi.2011.8; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	29	34	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92629	10.1371/journal.pone.0092629	http://dx.doi.org/10.1371/journal.pone.0092629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658065	Green Submitted, gold, Green Published			2022-12-27	WOS:000333355300108
J	Nordgreen, J; Tahamtani, FM; Janczak, AM; Horsberg, TE				Nordgreen, Janicke; Tahamtani, Fernanda M.; Janczak, Andrew M.; Horsberg, Tor Einar			Behavioural Effects of the Commonly Used Fish Anaesthetic Tricaine Methanesulfonate (MS-222) on Zebrafish (Danio rerio) and Its Relevance for the Acetic Acid Pain Test	PLOS ONE			English	Article							MORPHINE; NOCICEPTION; RESPONSES; SALMON; EUGENOL; STRESS	The pros and cons of using anaesthesia when handling fish in connection with experiments are debated. A widely adopted practice is to wait thirty minutes after anaesthesia before behavioural observations are initiated, but information about immediate effects of a treatment is then lost. This is pertinent for responses to acute stressors, such as acid injection in the acetic acid pain test. However, omission of anaesthetics in order to obtain data on immediate responses will compromise the welfare of fish and contribute to experimental noise due to stress. We therefore tested the effect of tricaine methanesulfonate on the behaviour of zebrafish. We predicted that tricaine (MS 222) would decrease swimming velocity and that the control fish would show an increased level of anxiety-and stress-related behaviours compared to the tricaine group. Following acclimatization to the test tank, baseline behaviour was recorded before immersion in either tricaine (168 mgl(-1), treatment group, N = 8) or tank water (control group, N = 7). Latencies to lose equilibrium and to lose response to touch were registered. The fish was then returned to the test tank, and the latency to regain equilibrium was registered in anaesthetized fish. When equilibrium was regained, and at five, thirty and sixty minutes after the fish had been returned to the test tank, behaviour was recorded. The tricaine fish showed the following responses (mean +/- sd): latency to lose equilibrium 22.6 s +/- 3.9; latency to lose response to touch 101.9 s +/- 26.8; latency to regain equilibrium 92.0 s +/- 54.4. Contrary to our predictions, neither treatment caused a change in any of the behaviours registered. This indicates that tricaine has no effect on several commonly used behavioural parameters, and that it may be unnecessary to postpone behavioural observations to 30 min after anaesthesia.	[Nordgreen, Janicke; Horsberg, Tor Einar] NMBU, Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway; [Tahamtani, Fernanda M.; Janczak, Andrew M.] NMBU, Sch Vet Sci, Dept Prod Anim Clin Sci, Anim Welf Res Grp, Oslo, Norway	Norwegian University of Life Sciences; Norwegian University of Life Sciences	Nordgreen, J (corresponding author), NMBU, Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway.	janicke.nordgreen@nmbu.no	Nordgreen, Janicke/H-9442-2017; Tahamtani, Fernanda/J-6339-2019; Janczak, Andrew M/B-4113-2013	Tahamtani, Fernanda/0000-0002-4439-9733; Janczak, Andrew M/0000-0002-1141-8272	Norwegian School of Veterinary Science	Norwegian School of Veterinary Science	This study was funded by the Norwegian School of Veterinary Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnolds DEW, 2002, BIOL BULL, V203, P188, DOI 10.2307/1543388; Ashley PJ, 2007, BRAIN RES, V1166, P47, DOI 10.1016/j.brainres.2007.07.011; Bakke MJ, 2010, AQUAT TOXICOL, V99, P1, DOI 10.1016/j.aquatox.2010.03.013; Brydges NM, 2009, APPL ANIM BEHAV SCI, V116, P295, DOI 10.1016/j.applanim.2008.09.003; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Correia AD, 2011, PHARMACEUTICALS, V4, P665, DOI 10.3390/ph4040665; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; FRAZIER DT, 1975, EUR J PHARMACOL, V33, P313, DOI 10.1016/0014-2999(75)90175-2; Godwin J., 2012, ZEBRAFISH PROTOCOLS, P181, DOI [10.1007/978-1-61779-597-8_13, 10.3389/fnbeh.2022.744533, DOI 10.3389/FNBEH.2022.744533]; HIKASA Y, 1986, JPN J VET SCI, V48, P341; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Lopez-Olmeda JF, 2012, FISH PHYSIOL BIOCHEM, V38, P143, DOI 10.1007/s10695-011-9523-y; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Newby NC, 2009, CAN J ZOOL, V87, P388, DOI 10.1139/Z09-023; Newby NC, 2007, T AM FISH SOC, V136, P341, DOI 10.1577/T06-110.1; Newby NC, 2009, APPL ANIMAL BEHAV SC, V116, P96; Nordgreen J, 2013, APPL ANIM BEHAV SCI, V145, P129, DOI 10.1016/j.applanim.2013.03.002; Nordgreen J, 2009, APPL ANIM BEHAV SCI, V119, P101, DOI 10.1016/j.applanim.2009.03.015; Palmer LM, 2004, J NEUROPHYSIOL, V92, P1034, DOI 10.1152/jn.01151.2003; Popovic NT, 2012, J APPL ICHTHYOL, V28, P553, DOI 10.1111/j.1439-0426.2012.01950.x; Raymond J, 2012, ZEBRAFISH PROTOCOLS, P273; Readman GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073773; Reilly SC, 2008, APPL ANIM BEHAV SCI, V114, P248, DOI 10.1016/j.applanim.2008.01.016; Sanchez-Vazquez FJ, 2011, CHRONOBIOL INT, V28, P109, DOI 10.3109/07420528.2010.538105; Sneddon LU, 2003, J PAIN, V4, P431, DOI 10.1067/S1526-5900(03)00717-X; Sneddon LU, 2003, APPL ANIM BEHAV SCI, V83, P153, DOI 10.1016/S0168-1591(03)00113-8; Sneddon LU, 2012, J EXOT PET MED, V21, P32, DOI 10.1053/j.jepm.2011.11.009; Sneddon LU, 2009, APPL ANIM BEHAV SCI, V116, P96, DOI 10.1016/j.applanim.2008.07.006; Summerfelt R.C., 1990, P213; TAYLOR PB, 1988, J FISH BIOL, V32, P161, DOI 10.1111/j.1095-8649.1988.tb05349.x; Vindas MA, 2012, ANIM COGN, V15, P903, DOI 10.1007/s10071-012-0517-7; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zahl IH, 2009, AQUACULTURE, V295, P52, DOI 10.1016/j.aquaculture.2009.06.019	33	34	34	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92116	10.1371/journal.pone.0092116	http://dx.doi.org/10.1371/journal.pone.0092116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658262	gold, Green Submitted, Green Published			2022-12-27	WOS:000333355300055
J	Vargas, LM; Leal, N; Estrada, LD; Gonzalez, A; Serrano, F; Araya, K; Gysling, K; Inestrosa, NC; Pasquale, EB; Alvarez, AR				Vargas, Lina M.; Leal, Nancy; Estrada, Lisbell D.; Gonzalez, Adrian; Serrano, Felipe; Araya, Katherine; Gysling, Katia; Inestrosa, Nibaldo C.; Pasquale, Elena B.; Alvarez, Alejandra R.			EphA4 Activation of c-Abl Mediates Synaptic Loss and LTP Blockade Caused by Amyloid-beta Oligomers	PLOS ONE			English	Article							DENDRITIC SPINE MORPHOLOGY; A-BETA; TYROSINE KINASE; MOLECULAR-BASIS; FAMILY KINASES; EPHRIN-BINDING; KEY ROLE; RECEPTORS; APOPTOSIS; PREVENTS	The early stages of Alzheimer's disease are characterised by impaired synaptic plasticity and synapse loss. Here, we show that amyloid-beta oligomers (A beta Os) activate the c-Abl kinase in dendritic spines of cultured hippocampal neurons and that c-Abl kinase activity is required for A beta Os-induced synaptic loss. We also show that the EphA4 receptor tyrosine kinase is upstream of c-Abl activation by A beta Os. EphA4 tyrosine phosphorylation (activation) is increased in cultured neurons and synaptoneurosomes exposed to A beta Os, and in Alzheimer-transgenic mice brain. We do not detect c-Abl activation in EphA4-knockout neurons exposed to A beta Os. More interestingly, we demonstrate EphA4/c-Abl activation is a key-signalling event that mediates the synaptic damage induced by A beta Os. According to this results, the EphA4 antagonistic peptide KYL and c-Abl inhibitor STI prevented i) dendritic spine reduction, ii) the blocking of LTP induction and iii) neuronal apoptosis caused by A beta Os. Moreover, EphA4-/- neurons or sh-EphA4-transfected neurons showed reduced synaptotoxicity by A beta Os. Our results are consistent with EphA4 being a novel receptor that mediates synaptic damage induced by A beta Os. EphA4/c-Abl signalling could be a relevant pathway involved in the early cognitive decline observed in Alzheimer's disease patients.	[Vargas, Lina M.; Leal, Nancy; Estrada, Lisbell D.; Gonzalez, Adrian; Alvarez, Alejandra R.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Lab Senalizac Celular, Santiago, Chile; [Araya, Katherine; Gysling, Katia] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Santiago, Chile; [Serrano, Felipe; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Envejecimiento & Regenerac CARE, Dept Biol Celular & Mol, Santiago, Chile; [Pasquale, Elena B.] Sanford Burnham Med Res Inst, La Jolla, CA USA	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Sanford Burnham Prebys Medical Discovery Institute	Alvarez, AR (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Lab Senalizac Celular, Alameda 340, Santiago, Chile.	aalvarez@bio.puc.cl	estrada, lisbell/S-8188-2019	estrada, lisbell/0000-0002-8594-4072; Alvarez Rojas, Alejandra/0000-0002-8129-9280; Serrano, Felipe/0000-0003-1362-8561	FONDECYT [3120015, 1120512, 11130561]; FONDEF [D10I1077]; National Institutes of Health [CA138390, HD025938]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA138390] Funding Source: NIH RePORTER	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDEF; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants from FONDECYT 3120015 (LV), FONDECYT 1120512 and FONDEF D10I1077 (AA), FONDECYT 11130561 (LE) and National Institutes of Health grants CA138390 and HD025938 (EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AR, 2008, FASEB J, V22, P3617, DOI 10.1096/fj.07-102715; Alvarez AR, 2004, NEUROBIOL DIS, V17, P326, DOI 10.1016/j.nbd.2004.06.007; Araya KA, 2007, EUR J PHARMACOL, V572, P32, DOI 10.1016/j.ejphar.2007.06.013; Arimon M, 2005, FASEB J, V19, P1344, DOI 10.1096/fj.04-3137fje; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Beazely MA, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-20; Bittner T, 2012, ACTA NEUROPATHOL, V124, P797, DOI 10.1007/s00401-012-1047-8; Bourgin C, 2007, J CELL BIOL, V178, P1295, DOI 10.1083/jcb.200610139; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cancino GI, 2008, BRAIN, V131, P2425, DOI 10.1093/brain/awn125; Cancino GI, 2011, NEUROBIOL AGING, V32, P1249, DOI 10.1016/j.neurobiolaging.2009.07.007; Carmona MA, 2009, P NATL ACAD SCI USA, V106, P12524, DOI 10.1073/pnas.0903328106; Cerpa W, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-3; Cesa R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019160; Chen Y, 2012, CELL SIGNAL, V24, P606, DOI 10.1016/j.cellsig.2011.11.016; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Clifford MA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-21; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Derkinderen P, 2005, J NEUROSCI, V25, P6584, DOI 10.1523/JNEUROSCI.1487-05.2005; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Estrada LD, 2011, CURR ALZHEIMER RES, V8, P643; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fu AKY, 2011, NAT NEUROSCI, V14, P181, DOI 10.1038/nn.2715; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Genua M, 2009, VITAM HORM, V80, P77, DOI 10.1016/S0083-6729(08)00604-3; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Gonfloni S, 2012, INT J CELL BIOL; Harbott LK, 2005, MOL CELL NEUROSCI, V30, P1, DOI 10.1016/j.mcn.2005.05.002; Ikonomovic MD, 1997, J NEUROPATH EXP NEUR, V56, P1018, DOI 10.1097/00005072-199709000-00007; Inoue E, 2009, J CELL BIOL, V185, P551, DOI 10.1083/jcb.200809151; Jing Z, 2009, J ALZHEIMERS DIS, V17, P409, DOI 10.3233/JAD-2009-1062; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lamberto I, 2012, BIOCHEM J, V445, P47, DOI 10.1042/BJ20120408; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li JG, 2012, NEUROSCI LETT, V518, P92, DOI 10.1016/j.neulet.2012.04.060; Simon AM, 2009, J ALZHEIMERS DIS, V17, P773, DOI 10.3233/JAD-2009-1096; Moresco EMY, 2003, CURR OPIN NEUROBIOL, V13, P535, DOI 10.1016/j.conb.2003.08.002; Moresco EMY, 2003, J NEUROPHYSIOL, V89, P1678, DOI 10.1152/jn.00892.2002; Munro KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055948; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Patel AN, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002134; Peng YR, 2013, NEUROPHARMACOLOGY, V65, P232, DOI 10.1016/j.neuropharm.2012.10.012; de Arce KP, 2010, J NEUROSCI, V30, P3728, DOI 10.1523/JNEUROSCI.2024-09.2010; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Schlatterer SD, 2011, J MOL NEUROSCI, V45, P445, DOI 10.1007/s12031-011-9588-1; Schlatterer SD, 2011, J ALZHEIMERS DIS, V25, P119, DOI 10.3233/JAD-2011-102025; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Spanevello MD, 2013, J NEUROTRAUM, V30, P1023, DOI 10.1089/neu.2012.2729; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Williams C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004936; Xu QL, 2000, PHILOS T ROY SOC B, V355, P993, DOI 10.1098/rstb.2000.0635; Yu HH, 2001, ONCOGENE, V20, P3995, DOI 10.1038/sj.onc.1204524; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182; Zhou L, 2007, J NEUROSCI, V27, P5127, DOI 10.1523/JNEUROSCI.1170-07.2007	71	56	57	8	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92309	10.1371/journal.pone.0092309	http://dx.doi.org/10.1371/journal.pone.0092309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658113	Green Submitted, Green Published, gold			2022-12-27	WOS:000333355300072
J	Wan, SW; Lu, YT; Huang, CH; Lin, CF; Anderson, R; Liu, HS; Yeh, TM; Yen, YT; Wu-Hsieh, BA; Lin, YS				Wan, Shu-Wen; Lu, Yi-Tien; Huang, Chia-Hui; Lin, Chiou-Feng; Anderson, Robert; Liu, Hsiao-Sheng; Yeh, Trai-Ming; Yen, Yu-Ting; Wu-Hsieh, Betty A.; Lin, Yee-Shin			Protection against Dengue Virus Infection in Mice by Administration of Antibodies against Modified Nonstructural Protein 1	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; C-TERMINAL REGION; DEPENDENT ENHANCEMENT; ENDOTHELIAL-CELLS; NS1 PROTEIN; ENCEPHALITIS; IMMUNIZATION; IMMUNITY; VACCINE; GLYCOPROTEIN	Background: Infection with dengue virus (DENV) may cause life-threatening disease with thrombocytopenia and vascular leakage which are related to dysfunction of platelets and endothelial cells. We previously showed that antibodies (Abs) against DENV nonstructural protein 1 (NS1) cross-react with human platelets and endothelial cells, leading to functional disturbances. Based on sequence homology analysis, the C-terminal region of DENV NS1 protein contains cross-reactive epitopes. For safety in vaccine development, the cross-reactive epitopes of DENV NS1 protein should be deleted or modified. Methodology/Principal Findings: We tested the protective effects of Abs against full-length DENV NS1, NS1 lacking the C-terminal amino acids (a.a.) 271-352 (designated DC NS1), and chimeric DJ NS1 consisting of N-terminal DENV NS1 (a.a. 1-270) and C-terminal Japanese encephalitis virus NS1 (a.a. 271-352). The anti-Delta C NS1 and anti-DJ NS1 Abs showed a lower binding activity to endothelial cells and platelets than that of anti-DENV NS1 Abs. Passive immunization with anti-Delta C NS1 and anti-DJ NS1 Abs reduced DENV-induced prolonged mouse tail bleeding time. Treatment with anti-DENV NS1, anti-Delta C NS1 and anti-DJ NS1 Abs reduced local skin hemorrhage, controlled the viral load of DENV infection in vivo, synergized with complement to inhibit viral replication in vitro, as well as abolished DENV-induced macrophage infiltration to the site of skin inoculation. Moreover, active immunization with modified NS1 protein, but not with unmodified DENV NS1 protein, reduced DENV-induced prolonged bleeding time, local skin hemorrhage, and viral load. Conclusions/Significance: These results support the idea that modified NS1 proteins may represent an improved strategy for safe and effective vaccine development against DENV infection.	[Wan, Shu-Wen; Lin, Chiou-Feng; Liu, Hsiao-Sheng; Yeh, Trai-Ming; Lin, Yee-Shin] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Lin, Chiou-Feng] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Lin, Chiou-Feng] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Anderson, Robert] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Yeh, Trai-Ming] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Yen, Yu-Ting; Wu-Hsieh, Betty A.] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Dalhousie University; National Cheng Kung University; National Taiwan University	Wu-Hsieh, BA (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan.	bwh@ntu.edu.tw; yslin1@mail.ncku.edu.tw	Yeh, Trai-Ming/C-7193-2011	Yeh, Trai-Ming/0000-0003-3172-7432; WU-HSIEH, BETTY AN-YE/0000-0003-1522-2055; Liu, Hsiao-Sheng/0000-0003-0576-7203	National Science Council, Taiwan [NSC101-2325-B-006-006, NSC101-2321-B-006-002, NSC101-2321-B-006-031, NSC 101-2321-B-002-062]; Multidisciplinary Center of Excellence for Clinical Trial and Research, Department of Health, Taiwan [DOH102-TD-B-111-002]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Multidisciplinary Center of Excellence for Clinical Trial and Research, Department of Health, Taiwan	This work was supported by Grants NSC101-2325-B-006-006, NSC101-2321-B-006-002, NSC101-2321-B-006-031 (to YSL), and NSC 101-2321-B-002-062 (to BAWH) from National Science Council, Taiwan; and DOH102-TD-B-111-002 from Multidisciplinary Center of Excellence for Clinical Trial and Research, Department of Health, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Amorim JH, 2012, VACCINE, V30, P837, DOI 10.1016/j.vaccine.2011.12.034; Anderson R, 1997, J VIROL, V71, P4226, DOI 10.1128/JVI.71.6.4226-4232.1997; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06; Chen MC, 2009, J IMMUNOL, V183, P1797, DOI 10.4049/jimmunol.0800672; Cheng HJ, 2009, MOL IMMUNOL, V47, P398, DOI 10.1016/j.molimm.2009.08.033; Cheng HJ, 2009, EXP BIOL MED, V234, P63, DOI 10.3181/0805-RM-147; Chuang YC, 2013, THROMB HAEMOSTASIS, V110, P358, DOI 10.1160/TH13-02-0149; Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006; Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07; Coller BAG, 2011, CURR OPIN IMMUNOL, V23, P391, DOI 10.1016/j.coi.2011.03.005; Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127; Falconar AKI, 2007, CLIN VACCINE IMMUNOL, V14, P493, DOI 10.1128/CVI.00371-06; FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Halstead SB, 2002, CURR OPIN INFECT DIS, V15, P471, DOI 10.1097/00001432-200210000-00003; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114; HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101; Henriques HR, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002330, 10.1371/journal.pntd.0002469]; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; Huang KJ, 2000, J GEN VIROL, V81, P2177, DOI 10.1099/0022-1317-81-9-2177; Kitai Y, 2010, CLIN VACCINE IMMUNOL, V17, P875, DOI 10.1128/CVI.00217-09; Krishna VD, 2009, J VIROL, V83, P4766, DOI 10.1128/JVI.01850-08; Li PC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001636; Lin CF, 2005, J IMMUNOL, V174, P395, DOI 10.4049/jimmunol.174.1.395; Lin CF, 2002, J IMMUNOL, V169, P657, DOI 10.4049/jimmunol.169.2.657; Lin CW, 2008, BIOTECHNOL LETT, V30, P205, DOI 10.1007/s10529-007-9529-9; Lin CF, 2008, AM J INFECT DIS, V4, P69, DOI 10.3844/ajidsp.2008.69.75; Lin YS, 2011, EXP BIOL MED, V236, P515, DOI 10.1258/ebm.2011.010339; Lin YL, 1998, J VIROL, V72, P191, DOI 10.1128/JVI.72.1.191-200.1998; Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008; Perng GC, 2011, WORLD J VACCIN, V1, P109; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015; SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853; SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805; Severin S, 2007, J CLIN INVEST, V117, P944, DOI 10.1172/JCI29967; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Swaminathan S, 2010, EXPERT OPIN THER PAT, V20, P819, DOI 10.1517/13543771003767476; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Thomas SJ, 2011, CURR OPIN INFECT DIS, V24, P442, DOI 10.1097/QCO.0b013e32834a1b0b; Wan SW, 2008, AM J INFECT DIS, V4, P85, DOI 10.3844/ajidsp.2008.85.91; Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4; Wu-Hsieh BA, 2009, ANN NY ACAD SCI, V1171, pE42, DOI 10.1111/j.1749-6632.2009.05053.x; Yauch LE, 2008, ANTIVIR RES, V80, P87, DOI 10.1016/j.antiviral.2008.06.010; Yen YT, 2008, J VIROL, V82, P12312, DOI 10.1128/JVI.00968-08	56	26	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92495	10.1371/journal.pone.0092495	http://dx.doi.org/10.1371/journal.pone.0092495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658118	Green Submitted, gold, Green Published			2022-12-27	WOS:000333355300090
J	Burk, D; Ingram, JN; Franklin, DW; Shadlen, MN; Wolpert, DM				Burk, Diana; Ingram, James N.; Franklin, David W.; Shadlen, Michael N.; Wolpert, Daniel M.			Motor Effort Alters Changes of Mind in Sensorimotor Decision Making	PLOS ONE			English	Article							DEVELOPING OCULOMOTOR COMMANDS; PERCEPTUAL DECISION; NEURAL BASIS; DISCRIMINATION; REPRESENTATION; TIME	After committing to an action, a decision-maker can change their mind to revise the action. Such changes of mind can even occur when the stream of information that led to the action is curtailed at movement onset. This is explained by the time delays in sensory processing and motor planning which lead to a component at the end of the sensory stream that can only be processed after initiation. Such post-initiation processing can explain the pattern of changes of mind by asserting an accumulation of additional evidence to a criterion level, termed change-of-mind bound. Here we test the hypothesis that physical effort associated with the movement required to change one's mind affects the level of the change-of-mind bound and the time for post-initiation deliberation. We varied the effort required to change from one choice target to another in a reaching movement by varying the geometry of the choice targets or by applying a force field between the targets. We show that there is a reduction in the frequency of change of mind when the separation of the choice targets would require a larger excursion of the hand from the initial to the opposite choice. The reduction is best explained by an increase in the evidence required for changes of mind and a reduced time period of integration after the initial decision. Thus the criteria to revise an initial choice is sensitive to energetic costs.	[Burk, Diana; Ingram, James N.; Franklin, David W.; Wolpert, Daniel M.] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England; [Burk, Diana] Howard Hughes Med Inst, Ashburn, VA USA; [Burk, Diana] NIDA, Intramural Res Program, Baltimore, MD USA; [Shadlen, Michael N.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst, New York, NY 10032 USA; [Shadlen, Michael N.] Columbia Univ, Zuckerman Mind Brain Behav Inst, Dept Neurosci, New York, NY USA	University of Cambridge; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Columbia University; Howard Hughes Medical Institute; Columbia University	Wolpert, DM (corresponding author), Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England.	wolpert@eng.cam.ac.uk	Shadlen, Michael Neil/AAL-1870-2020; Franklin, David/A-2371-2009	Franklin, David/0000-0001-9530-0820; Wolpert, Daniel/0000-0003-2011-2790	Human Frontiers Science Program; Wellcome Trust; Howard Hughes Medical Institute; NIH [R01EY11378]; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Human Frontiers Science Program, the Wellcome Trust, Howard Hughes Medical Institute and the NIH (R01EY11378). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Drugowitsch J, 2012, J NEUROSCI, V32, P3612, DOI 10.1523/JNEUROSCI.4010-11.2012; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Howard IS, 2009, J NEUROSCI METH, V181, P199, DOI 10.1016/j.jneumeth.2009.05.005; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Laming DR, 1968, INFORM THEORY CHOICE; LINK SW, 1975, J MATH PSYCHOL, V12, P114, DOI 10.1016/0022-2496(75)90053-X; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McCullagh P, 1989, GEN LINEAR MODELS; O'Sullivan I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000345; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Roitman JD, 2002, J NEUROSCI, V22, P9475; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Selen LPJ, 2012, J NEUROSCI, V32, P2276, DOI 10.1523/JNEUROSCI.5273-11.2012; Shadlen MN, 2013, NEURON, V80, P791, DOI 10.1016/j.neuron.2013.10.047; Shadlen MN, 2008, BETTER CONSCIOUS DEC, P71, DOI 10.7551/mitpress/9780262195805.003.0004; SMITH PL, 1988, J MATH PSYCHOL, V32, P135, DOI 10.1016/0022-2496(88)90043-0; Song JH, 2009, TRENDS COGN SCI, V13, P360, DOI 10.1016/j.tics.2009.04.009; Spivey MJ, 2005, P NATL ACAD SCI USA, V102, P10393, DOI 10.1073/pnas.0503903102; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963	26	45	45	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92681	10.1371/journal.pone.0092681	http://dx.doi.org/10.1371/journal.pone.0092681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651615	Green Published, gold			2022-12-27	WOS:000333352800141
J	Haward, SJ				Haward, Simon J.			Synovial Fluid Response to Extensional Flow: Effects of Dilution and Intermolecular Interactions	PLOS ONE			English	Article							SODIUM HYALURONATE; POLYMER-SOLUTIONS; VISCOSITY; SHEAR; BEHAVIOR; MACROMOLECULES; RHEOMETRY	In this study, a microfluidic cross-slot device is used to examine the extensional flow response of diluted porcine synovial fluid (PSF) samples using flow-induced birefringence (FIB) measurements. The PSF sample is diluted to 10x20x and 30x its original mass in a phosphate-buffered saline and its FIB response measured as a function of the strain rate at the stagnation point of the cross-slots. Equivalent experiments are also carried out using trypsin-treated PSF (t-PSF) in which the protein content is digested away using an enzyme. The results show that, at the synovial fluid concentrations tested, the protein content plays a negligible role in either the fluid's bulk shear or extensional flow behaviour. This helps support the validity of the analysis of synovial fluid HA content, either by microfluidic or by other techniques where the synovial fluid is first diluted, and suggests that the HA and protein content in synovial fluid must be higher than a certain minimum threshold concentration before HA-protein or protein-protein interactions become significant. However a systematic shift in the FIB response as the PSF and t-PSF samples are progressively diluted indicates that HA-HA interactions remain significant at the concentrations tested. These interactions influence FIB-derived macromolecular parameters such as the relaxation time and the molecular weight distribution and therefore must be minimized for the best validity of this method as an analytical technique, in which non-interaction between molecules is assumed.	Univ Porto, Ctr Estudos Fenomenos Transporte, Fac Engn, Dept Engn Quim, P-4100 Oporto, Portugal	Universidade do Porto	Haward, SJ (corresponding author), Univ Porto, Ctr Estudos Fenomenos Transporte, Fac Engn, Dept Engn Quim, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	shaward@fe.up.pt	Haward, Simon James/H-8700-2013	Haward, Simon James/0000-0002-1884-4100	Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme [298220]	Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme(European Commission)	This research was supported by a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme, FP7-PEOPLE-2011-IIF, grant 298220. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlAssaf S, 1996, BIORHEOLOGY, V33, P319, DOI 10.1016/0006-355X(96)00025-X; Arratia PE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.144502; Backus C, 2002, HYALURONAN, V1, P209, DOI DOI 10.1533/9781845693121.209; BALAZS EA, 1993, J RHEUMATOL, V20, P3; Bingol AO, 2010, BIORHEOLOGY, V47, P205, DOI 10.3233/BIR-2010-0572; Clasen C, 2006, J RHEOL, V50, P849, DOI 10.1122/1.2357595; DEGENNES PG, 1974, J CHEM PHYS, V60, P5030, DOI 10.1063/1.1681018; Elsaid KA, 2005, ARTHRITIS RHEUM-US, V52, P1746, DOI 10.1002/art.21038; FOUISSAC E, 1993, MACROMOLECULES, V26, P6945, DOI 10.1021/ma00077a036; GILSON MK, 1985, J MOL BIOL, V184, P503, DOI 10.1016/0022-2836(85)90297-9; Haward SJ, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4816708; Haward SJ, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4818151; Haward SJ, 2012, SOFT MATTER, V8, P536, DOI 10.1039/c1sm06494k; Haward SJ, 2014, BIOPOLYMERS, V101, P287, DOI 10.1002/bip.22357; Haward SJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.128301; Haward SJ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.031502; Haward SJ, 2011, SOFT MATTER, V7, P9908, DOI 10.1039/c1sm05493g; Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104; KELLER A, 1985, COLLOID POLYM SCI, V263, P181, DOI 10.1007/BF01415506; LARSON RG, 1989, MACROMOLECULES, V22, P3004, DOI 10.1021/ma00197a022; McCarty D. J., 1997, ARTHRITIS ALLIED CON, V1, P81; Mendichi R, 2003, BIOMACROMOLECULES, V4, P1805, DOI 10.1021/bm0342178; Meyer F, 2009, J RHEOL, V53, P799, DOI 10.1122/1.3122985; Moon YU, 2000, J SOLUTION CHEM, V29, P699, DOI 10.1023/A:1005112927213; Oates KMN, 2006, J R SOC INTERFACE, V3, P167, DOI 10.1098/rsif.2005.0086; Oates KMN, 2002, MATER RES SOC SYMP P, V711, P53; Odell JA, 2006, J NON-NEWTON FLUID, V137, P110, DOI 10.1016/j.jnnfm.2006.03.010; ODELL JA, 1989, ADV CHEM SER, P193; PALFREY AJ, 1968, J APPL PHYSIOL, V25, P672, DOI 10.1152/jappl.1968.25.6.672; Poole RJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.164503; RIDDIFORD CL, 1970, J PHYS D APPL PHYS, V3, P1314, DOI 10.1088/0022-3727/3/9/311; Sharma V, 2011, SOFT MATTER, V7, P5150, DOI 10.1039/c0sm01312a	32	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92867	10.1371/journal.pone.0092867	http://dx.doi.org/10.1371/journal.pone.0092867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651529	gold, Green Submitted, Green Published			2022-12-27	WOS:000333352800159
J	Pfortmueller, CA; Funk, GC; Leichtle, AB; Fiedler, GM; Schwarz, C; Exadaktylos, AK; Lindner, G				Pfortmueller, Carmen A.; Funk, Georg-Christian; Leichtle, Alexander B.; Fiedler, Georg M.; Schwarz, Christoph; Exadaktylos, Aristomenis K.; Lindner, Gregor			Electrolyte Disorders and In-Hospital Mortality during Prolonged Heat Periods: A Cross-Sectional Analysis	PLOS ONE			English	Article							HYPONATREMIA; DEHYDRATION; EXERCISE; HYPERNATREMIA; ADMISSION	Background: Heat periods during recent years were associated with excess hospitalization and mortality rates, especially in the elderly. We intended to study whether prolonged warmth/heat periods are associated with an increased prevalence of disorders of serum sodium and potassium and an increased hospital mortality. Methods: In this cross-sectional analysis all patients admitted to the Department of Emergency Medicine of a large tertiary care facility between January 2009 and December 2010 with measurements of serum sodium were included. Demographic data along with detailed data on diuretic medication, length of hospital stay and hospital mortality were obtained for all patients. Data on daily temperatures (maximum, mean, minimum) and humidity were retrieved by Meteo Swiss. Results: A total of 22.239 patients were included in the study. 5 periods with a temperature exceeding 25 degrees C for 3 to 5 days were noticed and 2 periods with temperatures exceeding 25 degrees C for more than 5 days were noted. Additionally, 2 periods with 3 to 5 days with daily temperatures exceeding 30 degrees C were noted during the study period. We found a significantly increased prevalence of hyponatremia during heat periods. However, in the Cox regression analysis, prolonged heat was not associated with the prevalence of disorders of serum sodium or potassium. Admission during a heat period was an independent predictor for hospital mortality. Conclusions: Although we found an increased prevalence of hyponatremia during heat periods, no convincing connection could be found for hypernatremia or disorders of serum potassium.	[Pfortmueller, Carmen A.; Exadaktylos, Aristomenis K.; Lindner, Gregor] Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen A.] Univ Hosp Bern, Inselspital, Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Funk, Georg-Christian] Otto Wagner Spital Vienna, Dept Resp & Crit Care Med, Vienna, Austria; [Funk, Georg-Christian] Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria; [Leichtle, Alexander B.; Fiedler, Georg M.] Univ Hosp Bern, Inselspital, Ctr Lab Med, CH-3010 Bern, Switzerland; [Schwarz, Christoph] Landeskrankenhaus Steyr, Dept Nephrol, Steyr, Austria	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Ludwig Boltzmann Institute; University of Bern; University Hospital of Bern	Lindner, G (corresponding author), Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland.	lindner.gregor@gmail.com	Fiedler, Georg Martin/C-8341-2011; Leichtle, Alexander/C-7262-2011; Lindner, Gregor/AAR-6761-2020	Fiedler, Georg Martin/0000-0001-5689-4574; Lindner, Gregor/0000-0001-5551-8227; Pfortmueller, Carmen/0000-0003-0326-2770				Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Almond CSD, 2005, NEW ENGL J MED, V352, P1550, DOI 10.1056/NEJMoa043901; Arampatzis S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-83; ARMSTRONG LE, 1993, MED SCI SPORT EXER, V25, P543; Flinn SD, 2000, PHYSICIAN SPORTSMED, V28, P61, DOI 10.3810/psm.2000.09.1207; Funk GC, 2010, INTENS CARE MED, V36, P304, DOI 10.1007/s00134-009-1692-0; Grandjean AC, 2007, J AM COLL NUTR, V26, p549S, DOI 10.1080/07315724.2007.10719657; Hawkins RC, 2003, CLIN CHIM ACTA, V337, P169, DOI 10.1016/j.cccn.2003.08.001; Hayes LD, 2010, EUR J APPL PHYSIOL, V108, P701, DOI 10.1007/s00421-009-1288-y; HIMMELSTEIN DU, 1983, J AM GERIATR SOC, V31, P466, DOI 10.1111/j.1532-5415.1983.tb05118.x; Knechtle B, 2011, CLIN J SPORT MED, V21, P226, DOI 10.1097/JSM.0b013e31820cb021; Lindner G, 2013, J CRIT CARE, V28, p[216, e211]; Nayha S, 2007, INT J CIRCUMPOL HEAL, V66, P418; O'Neill MS, 2009, J OCCUP ENVIRON MED, V51, P13, DOI 10.1097/JOM.0b013e318173e122; Palmisano P, 2013, INT J BIOMETEOROL; Rikkert MGMO, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2663; Robine J, 2003, REPORT EXCESS MORTAL; ROSE DB, 2001, CLIN PHYSL ACID BASE	18	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92150	10.1371/journal.pone.0092150	http://dx.doi.org/10.1371/journal.pone.0092150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651296	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800074
J	Zhang, DF; Song, XT; Lv, SZ; Yuan, F; Xu, F; Zhang, M; Li, W; Yan, S				Zhang, Dongfeng; Song, Xiantao; Lv, Shuzheng; Yuan, Fei; Xu, Feng; Zhang, Min; Li, Wei; Yan, Shuai			Culprit Vessel Only versus Multivessel Percutaneous Coronary Intervention in Patients Presenting with ST-Segment Elevation Myocardial Infarction and Multivessel Disease	PLOS ONE			English	Article							RANDOMIZED-TRIAL; FOLLOW-UP; REVASCULARIZATION; METAANALYSIS; REPERFUSION; EXPERIENCE; OUTCOMES; IMPACT; PCI	Background: The best strategy for ST-segment elevation myocardial infarction (STEMI) patients with multivessel disease (MVD), who underwent primary percutaneous coronary intervention (PCI) in the acute phase, is not well established. Objectives: Our goal was to conduct a meta-analysis comparing culprit vessel only percutaneous coronary intervention (culprit PCI) with multivessel percutaneous coronary intervention (MV-PCI) for treatment of patients with STEMI and MVD. Methods: Pubmed, Elsevier, Embase, and China National Knowledge Infrastructure (CNKI) databases were systematically searched for randomized and nonrandomized studies comparing culprit PCI and MV-PCI strategies during the index procedure. A meta-analysis was performed using Review Manager 5.1 (Cochrane Center, Denmark). Results: Four randomized and fourteen nonrandomized studies involving 39,390 patients were included. MV-PCI strategy is associated with an increased short-term mortality (OR: 0.50, 95% CI: 0.32 to 0.77, p = 0.002), long-term mortality (OR: 0.52, 95% CI: 0.36 to 0.74, p<0.001), and risk of renal dysfunction (OR: 0.77, 95% CI: 0.61 to 0.97, p = 0.03) compared with culprit PCI strategy, while it reduced the incidence of revascularization (OR: 2.65, 95% CI: 1.80 to 3.90, p<0.001). Conclusions: This meta-analysis supports current guidelines which indicate that the non-culprit vessel should not be treated during the index procedure.	[Zhang, Dongfeng; Song, Xiantao; Lv, Shuzheng; Yuan, Fei; Xu, Feng; Zhang, Min; Li, Wei; Yan, Shuai] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Cardiol, Beijing, Peoples R China	Capital Medical University	Song, XT (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Cardiol, Beijing, Peoples R China.	xiantao_song@163.com			State Science and Technology Support Program [2011BAI11B05]	State Science and Technology Support Program	State Science and Technology Support Program (No. 2011BAI11B05) http://program.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe D, 2013, HEART VESSELS; Bauer T, 2013, INT J CARDIOL, V166, P596, DOI 10.1016/j.ijcard.2011.11.024; Cavender MA, 2009, AM J CARDIOL, V104, P507, DOI 10.1016/j.amjcard.2009.04.016; Corpus RA, 2004, AM HEART J, V148, P493, DOI 10.1016/j.ahj.2004.03.051; Di Mario Carlo, 2004, Int J Cardiovasc Intervent, V6, P128; Dziewierz A, 2010, AM J CARDIOL, V106, P342, DOI 10.1016/j.amjcard.2010.03.029; Hannan EL, 2010, JACC-CARDIOVASC INTE, V3, P22, DOI 10.1016/j.jcin.2009.10.017; Jensen LO, 2012, EUROINTERVENTION, V8, P456, DOI 10.4244/EIJV8I4A72; Khattab AA, 2008, CLIN RES CARDIOL, V97, P32, DOI 10.1007/s00392-007-0570-4; Kornowski R, 2011, J AM COLL CARDIOL, V58, P704, DOI 10.1016/j.jacc.2011.02.071; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Mohamad T, 2011, AM J THER, V18, P92, DOI 10.1097/MJT.0b013e3181b809ee; Ochala Andrzej, 2004, J Invasive Cardiol, V16, P699; Politi L, 2010, HEART, V96, P662, DOI 10.1136/hrt.2009.177162; Qarawani D, 2008, INT J CARDIOL, V123, P288, DOI 10.1016/j.ijcard.2006.12.013; Roe MT, 2001, AM J CARDIOL, V88, P170, DOI 10.1016/S0002-9149(01)01615-0; Sorajja P, 2007, EUR HEART J, V28, P1709, DOI 10.1093/eurheartj/ehm184; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Toma M, 2010, EUR HEART J, V31, P1701, DOI 10.1093/eurheartj/ehq129; Varani E, 2008, CATHETER CARDIO INTE, V72, P927, DOI 10.1002/ccd.21722; Vlaar PJ, 2011, J AM COLL CARDIOL, V58, P692, DOI 10.1016/j.jacc.2011.03.046; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Widimsky P, 2011, EUR HEART J, V32, P396, DOI 10.1093/eurheartj/ehq410	24	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92316	10.1371/journal.pone.0092316	http://dx.doi.org/10.1371/journal.pone.0092316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651489	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800098
J	Kaucsar, T; Bodor, C; Godo, M; Szalay, C; Revesz, C; Nemeth, Z; Mozes, M; Szenasi, G; Rosivall, L; Soti, C; Hamar, P				Kaucsar, Tamas; Bodor, Csaba; Godo, Maria; Szalay, Csaba; Revesz, Csaba; Nemeth, Zalan; Mozes, Miklos; Szenasi, Gabor; Rosivall, Laszlo; Soti, Csaba; Hamar, Peter			LPS-Induced Delayed Preconditioning Is Mediated by Hsp90 and Involves the Heat Shock Response in Mouse Kidney	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; MOLECULAR CHAPERONES; EXPRESSION; PROTEINS; STRESS; INDUCTION; PROTECTS; CELLS; HSP70; INOS	Introduction: We and others demonstrated previously that preconditioning with endotoxin (LPS) protected from a subsequent lethal LPS challenge or from renal ischemia-reperfusion injury (IRI). LPS is effective in evoking the heat shock response, an ancient and essential cellular defense mechanism, which plays a role in resistance to, and recovery from diseases. Here, by using the pharmacological Hsp90 inhibitor novobiocin (NB), we investigated the role of Hsp90 and the heat shock response in LPS-induced delayed renal preconditioning. Methods: Male C57BL/6 mice were treated with preconditioning (P: 2 mg/kg, ip.) and subsequent lethal (L: 10 mg/kg, ip.) doses of LPS alone or in combination with NB (100 mg/kg, ip.). Controls received saline (C) or NB. Results: Preconditioning LPS conferred protection from a subsequent lethal LPS treatment. Importantly, the protective effect of LPS preconditioning was completely abolished by a concomitant treatment with NB. LPS induced a marked heat shock protein increase as demonstrated by Western blots of Hsp70 and Hsp90. NB alone also stimulated Hsp70 and Hsp90 mRNA but not protein expression. However, Hsp70 and Hsp90 protein induction in LPS-treated mice was abolished by a concomitant NB treatment, demonstrating a NB-induced impairment of the heat shock response to LPS preconditioning. Conclusion: LPS-induced heat shock protein induction and tolerance to a subsequent lethal LPS treatment was prevented by the Hsp90 inhibitor, novobiocin. Our findings demonstrate a critical role of Hsp90 in LPS signaling, and a potential involvement of the heat shock response in LPS-induced preconditioning.	[Kaucsar, Tamas; Bodor, Csaba; Godo, Maria; Szalay, Csaba; Revesz, Csaba; Nemeth, Zalan; Mozes, Miklos; Szenasi, Gabor; Rosivall, Laszlo; Hamar, Peter] Semmelweis Univ, Inst Pathophysiol, H-1085 Budapest, Hungary; [Soti, Csaba] Semmelweis Univ, Dept Med Chem, H-1085 Budapest, Hungary; [Rosivall, Laszlo] Semmelweis Univ, Hungarian Acad Sci, Nephrol Res Grp, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University	Soti, C (corresponding author), Semmelweis Univ, Dept Med Chem, H-1085 Budapest, Hungary.	csaba@med.semmelweis-univ.hu; hamar.peter@med.semmelweis-univ.hu	Szénási, Gábor/K-3136-2017; Szenasi, Gabor/ABH-2591-2021; Hamar, Peter/A-8996-2010; Kaucsár, Tamás/H-4904-2016; Revesz, Csaba/AAA-5722-2022; Sőti, Csaba/O-6070-2017	Szénási, Gábor/0000-0002-7350-6091; Hamar, Peter/0000-0002-1095-3564; Kaucsár, Tamás/0000-0003-4460-1265; Sőti, Csaba/0000-0002-4057-7678	Hungarian Research Fund [OTKA K 81972, NF69278, ETT 07-011/2009]; Bolyai Research Scholarship of the Hungarian Academy of Sciences; Merit Prize of the Semmelweis University	Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Merit Prize of the Semmelweis University	Support was provided to P. Hamar from the Hungarian Research Fund: OTKA K 81972, NF69278, ETT 07-011/2009. C. S. and P. H. acknowledge support from the Bolyai Research Scholarship of the Hungarian Academy of Sciences and the Merit Prize of the Semmelweis University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambade A, 2012, HEPATOLOGY, V55, P1585, DOI 10.1002/hep.24802; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Beck FX, 2000, AM J PHYSIOL-RENAL, V279, pF203, DOI 10.1152/ajprenal.2000.279.2.F203; BEESON PB, 1946, P SOC EXP BIOL MED, V61, P248; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Chatterjee A, 2008, AM J PHYSIOL-LUNG C, V294, pL755, DOI 10.1152/ajplung.00350.2007; Chowdhury P, 2006, CLIN EXP IMMUNOL, V145, P346, DOI 10.1111/j.1365-2249.2006.03116.x; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Ding XZ, 2010, PROSTAG OTH LIPID M, V92, P1, DOI 10.1016/j.prostaglandins.2009.12.006; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; Edelman DA, 2007, J SURG RES, V140, P171, DOI 10.1016/j.jss.2006.12.560; Elliott GT, 1998, J MOL CELL CARDIOL, V30, P3, DOI 10.1006/jmcc.1997.0586; Fintha A, 2013, AM J PATHOL, V182, P388, DOI 10.1016/j.ajpath.2012.10.009; Gupta A, 2007, AM J PHYSIOL-RENAL, V293, pF245, DOI 10.1152/ajprenal.00477.2006; Hamar P, 2004, P NATL ACAD SCI USA, V101, P14883, DOI 10.1073/pnas.0406421101; Harrison EM, 2008, AM J PHYSIOL-RENAL, V295, pF397, DOI 10.1152/ajprenal.00361.2007; Hausenloy DJ, 2012, HEART METAB, V54, P5; Hauser GJ, 1996, AM J PHYSIOL-HEART C, V271, pH2529, DOI 10.1152/ajpheart.1996.271.6.H2529; He K, 2013, KIDNEY INT; He X, 2013, LAB INVEST, V93, P168, DOI 10.1038/labinvest.2012.160; Heemann U, 2000, AM J PATHOL, V156, P287, DOI 10.1016/S0002-9440(10)64729-3; Imai J, 2003, EMBO J, V22, P3557, DOI 10.1093/emboj/cdg349; Kelly KJ, 2005, CONTRIB NEPHROL, V148, P86, DOI 10.1159/000086054; Kim MG, 2014, KIDNEY INT, V85, P62, DOI 10.1038/ki.2013.277; Lee J, 2013, HISTOL HISTOPATHOL, V28, P1223, DOI 10.14670/HH-28.1223; Lindquist SL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004507; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; MESELSON M, 1958, P NATL ACAD SCI USA, V44, P671, DOI 10.1073/pnas.44.7.671; Naito M, 2008, J AM SOC NEPHROL, V19, P1321, DOI 10.1681/ASN.2007121368; Nakada J, 2005, SHOCK, V24, P482, DOI 10.1097/01.shk.0000180980.63247.a9; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Njemini R, 2003, SCAND J IMMUNOL, V58, P664, DOI 10.1111/j.1365-3083.2003.01341.x; O'Neill S, 2012, EXPERT OPIN INV DRUG, V21, P1535, DOI 10.1517/13543784.2012.713939; Pare JM, 2013, MOL BIOL CELL, V24, P2303, DOI 10.1091/mbc.E12-12-0892; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Sharma D, 2009, PROTEIN PEPTIDE LETT, V16, P571, DOI 10.2174/092986609788490230; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Soti C, 2002, J BIOL CHEM, V277, P7066, DOI 10.1074/jbc.M105568200; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Suganuma T, 2002, J PHARMACOL EXP THER, V303, P656, DOI 10.1124/jpet.102.035758; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Toyoda T, 2000, J NEUROSURG, V92, P435, DOI 10.3171/jns.2000.92.3.0435; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Triantafilou M, 2008, NOVART FDN SYMP, V291, P79; Triantafilou M, 2008, NOVART FDN SYMP, V291, P137; Triantafilou Martha, 2008, Novartis Found Symp, V291, P74; Vladic N, 2011, AM J PHYSIOL-HEART C, V301, pH2130, DOI 10.1152/ajpheart.01078.2010; Yoshida K, 1996, MOL CELL BIOCHEM, V159, P73	53	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92004	10.1371/journal.pone.0092004	http://dx.doi.org/10.1371/journal.pone.0092004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646925	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500069
J	Mei, ZB; Zhang, ZJ; Liu, CY; Liu, Y; Cui, A; Liang, ZL; Wang, GH; Cui, L				Mei, Zu-Bing; Zhang, Zhi-Jiang; Liu, Chen-Ying; Liu, Yun; Cui, Ang; Liang, Zhong-Lin; Wang, Guang-Hui; Cui, Long			Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RISK; MELLITUS; COHORT; THIAZOLIDINEDIONES; MORTALITY; THERAPY	Background: Several studies suggest that metformin has the potential effect of reducing cancer risk. However, its survival benefit in patients with colorectal cancer (CRC) and diabetes is unknown. The aim of our study is to address the effect of metformin on outcomes for CRC based on a systematic review and meta-analysis. Methods and Findings: We searched EMBASE and MEDLINE databases from inception through August, 2013, using search terms related to metformin, diabetes, colorectal cancer, and prognostic outcome. The outcome measures were hazard ratios (HRs) with 95% CIs comparing CRC survival in diabetic patients using metformin and without using metformin. The primary end points were overall survival (OS) and CRC specific survival (CS). A total of six cohort studies including 2,461 patients met full eligibility criteria. The pooled HR favoring metformin users was 0.56 for OS (95% CI, 0.41 to 0.77) and 0.66 for CRC-specific survival (95% CI, 0.50 to 0.87). Thus metformin therapy reduced the risk of all cause of death by 44% and the risk of CRC specific death by 34% in CRC patients compared to those in non-users. However, evidence of heterogeneity and possible publication bias was noted for OS. Conclusions: Patients with CRC and diabetes treated with metformin appear to have an improved survival outcome. Prospective study should be warranted to examine the association between metformin exposure intensity as well as some other confounding variables and survival outcome in diabetic CRC patients.	[Mei, Zu-Bing; Liu, Chen-Ying; Liu, Yun; Cui, Ang; Liang, Zhong-Lin; Wang, Guang-Hui; Cui, Long] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Colorectal Surg, Shanghai 200030, Peoples R China; [Zhang, Zhi-Jiang] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol, Wuhan 430072, Peoples R China	Shanghai Jiao Tong University; Wuhan University	Cui, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Colorectal Surg, Shanghai 200030, Peoples R China.	longcuidr@126.com	Mei, Zubing/H-7879-2019		National Natural Science Foundation of China [81372636, 81302089]; National High Technology Research and Development Program of China (863 Program) [SQ2014SFOZD00314]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This research was supported by two National Natural Science Foundation of China (Grant No. 81372636 and No. 81302089) and the National High Technology Research and Development Program of China (863 Program) (Grant No. SQ2014SFOZD00314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1991, CANCER CAUSE CONTROL, V2, P307, DOI 10.1007/BF00051670; Bansal M, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.2608; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Boyd D Barry, 2003, Integr Cancer Ther, V2, P315, DOI 10.1177/1534735403259152; Cossor FI, 2013, CANC EPIDEMIOL; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Del Barco S, 2011, ONCOTARGET, V2, P896, DOI 10.18632/oncotarget.387; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Garrett CR, 2012, BRIT J CANCER, V106, P1374, DOI 10.1038/bjc.2012.71; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; He X, 2012, ANN ONCOL, V23, P1771, DOI 10.1093/annonc/mdr534; He XX, 2011, ANN ONCOL, V22, P2640, DOI 10.1093/annonc/mdr020; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; LAVECCHIA C, 1994, BRIT J CANCER, V70, P950, DOI 10.1038/bjc.1994.427; Lee GL, 2012, J CLIN ONCOL, V30; Lee JH, 2012, INT J CANCER, V131, P752, DOI 10.1002/ijc.26421; Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Rousseau MC, 2006, INT J CANCER, V118, P2105, DOI 10.1002/ijc.21600; Spillane SC, 2013, CANC EPIDEM BIOMAR; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Yang YX, 2005, CLIN GASTROENTEROL H, V3, P587, DOI 10.1016/S1542-3565(05)00152-7; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011; Zhang ZJ, 2011, DIABETES CARE, V34, P2323, DOI 10.2337/dc11-0512	31	68	78	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91818	10.1371/journal.pone.0091818	http://dx.doi.org/10.1371/journal.pone.0091818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647047	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500053
J	Robinson, J; Cinner, JE; Graham, NAJ				Robinson, Jan; Cinner, Joshua E.; Graham, Nicholas A. J.			The Influence of Fisher Knowledge on the Susceptibility of Reef Fish Aggregations to Fishing	PLOS ONE			English	Article							BROWN-MARBLED GROUPER; SPAWNING AGGREGATIONS; RESOURCE-MANAGEMENT; SITE FIDELITY; HOME-RANGE; ISLAND; VULNERABILITY; CONSERVATION; CATCHABILITY; RESIDENCY	Reef fishes that exhibit predictable aggregating behaviour are often considered vulnerable to overexploitation. However, fisher knowledge of this behaviour is often heterogeneous and, coupled with socioeconomic factors that constrain demand for or access to aggregated fish, will influence susceptibility to fishing. At two case study locations in Papua New Guinea, Ahus and Karkar islands, we conducted interview-based surveys to examine how local context influenced heterogeneity in knowledge of fish aggregations. We then explored the role of fisher knowledge in conferring susceptibility to fishing relative to socioeconomic drivers of fishing effort. Local heterogeneity in knowledge of aggregating behaviour differed between our case studies. At Ahus, variable access rights among fishers and genders to the main habitats were sources of heterogeneity in knowledge. By contrast, knowledge was more homogenous at Karkar and the sole source of variation was gear type. Differences between locations in the susceptibility of aggregations to fishing depended primarily on socioeconomic drivers of fishing effort rather than catchability. While Ahus fishers were knowledgeable of fish aggregations and used more selective gears, Karkar fishers were less constrained by tenure in their access to aggregation habitat. However, fishing effort was greater at Ahus and likely related to high dependency on fishing, greater access to provincial capital markets than Karkar and a weakening of customary management. Moreover, highly efficient fishing techniques have emerged at Ahus to exploit the non-reproductive aggregating behaviour of target species. Understanding how knowledge is structured within fishing communities and its relation to socioeconomic drivers of fishing effort is important if customary practices for conservation, such as tambu areas, are to be supported. The findings of this study call for a holistic approach to assessing the risks posed to reef fish aggregations by fishing, grounded in the principals of fisheries science and emerging social-ecological thinking.	[Robinson, Jan; Cinner, Joshua E.; Graham, Nicholas A. J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	James Cook University	Robinson, J (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	jan.robinson@my.jcu.edu.au	Cinner, Joshua e/E-8966-2011; Graham, Nicholas AJ/C-8360-2014; Cinner, Joshua/AAA-6823-2021	Cinner, Joshua e/0000-0003-2675-9317; Graham, Nicholas AJ/0000-0002-0304-7467; 	Australian Research Council	Australian Research Council(Australian Research Council)	This study was funded by the Australian Research Council (www.coralcoe.org.au). The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Aguilar-Perera A, 2006, MAR ECOL PROG SER, V327, P289, DOI 10.3354/meps327289; ArreguinSanchez F, 1996, REV FISH BIOL FISHER, V6, P221; Aswani S, 1998, OCEAN COAST MANAGE, V40, P207, DOI 10.1016/S0964-5691(98)00047-7; Aswani S, 2008, HUM ECOL, V36, P325, DOI 10.1007/s10745-007-9159-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bijoux JP, 2013, MAR ECOL PROG SER, V475, P233, DOI 10.3354/meps10113; Carrier James, 1987, QUESTION COMMONS CUL, P143; CARRIER JG, 1982, ANTHROPOS, V77, P904; Choat JH, 2012, FISH FISH SER, V35, P85, DOI 10.1007/978-94-007-1980-4_4; Christie P, 1997, COAST MANAGE, V25, P155, DOI 10.1080/08920759709362316; Cinner JE, 2007, CORAL REEFS, V26, P1035, DOI 10.1007/s00338-007-0213-2; Cinner JE, 2005, CONSERV BIOL, V19, P1714, DOI 10.1111/j.1523-1739.2005.00209.x-i1; Cinner J, 2006, ECOL SOC, V11; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Claro R, 2009, FISH RES, V99, P7, DOI 10.1016/j.fishres.2009.04.004; Claydon J, 2004, OCEANOGR MAR BIOL, V42, P265; Colding J, 2001, ECOL APPL, V11, P584; Connell SD, 1998, CORAL REEFS, V17, P49, DOI 10.1007/s003380050094; Corpuz VT, 1985, ICLARM Q, V8, P12; Crona BI, 2006, ECOL SOC, V11; Davis A, 2003, HUM ECOL, V31, P463, DOI 10.1023/A:1025075923297; Daw TM, 2011, ENVIRON CONSERV, V38, P75, DOI 10.1017/S0376892910000901; De Mitcheson YS, 2008, CONSERV BIOL, V22, P1233, DOI 10.1111/j.1523-1739.2008.01020.x; Domeier ML, 1997, B MAR SCI, V60, P698; Ebisawa A, 2006, ICHTHYOL RES, V53, P269, DOI 10.1007/s10228-006-0345-3; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; Froese R, 2013, FISHBASE; Grandcourt EM, 2006, FISH RES, V78, P203, DOI 10.1016/j.fishres.2005.11.021; Hamilton RJ, 2011, BIOL CONSERV, V144, P1850, DOI 10.1016/j.biocon.2011.03.024; Hamilton R.J., 2004, 404 TNC PAC ISL COUN; Heyman WD, 2008, B MAR SCI, V83, P531; Hitt S, 2011, ENVIRON BIOL FISH, V92, P525, DOI 10.1007/s10641-011-9875-2; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Jacquet J, 2008, CONSERV BIOL, V22, P832, DOI 10.1111/j.1523-1739.2008.00978.x; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Johannes R. E., 2000, SPC TRADITIONAL MARI, P22; Johannes R.E., 1981, WORDS LAGOON FISHING; JOHANNES RE, 1978, ANNU REV ECOL SYST, V9, P349, DOI 10.1146/annurev.es.09.110178.002025; Kaunda-Arara B, 2004, ENVIRON BIOL FISH, V70, P363, DOI 10.1023/B:EBFI.0000035428.59802.af; Legendre P., 2012, NUMERICAL ECOLOGY; Mangi SC, 2006, MAR POLLUT BULL, V52, P1646, DOI 10.1016/j.marpolbul.2006.06.006; Matlin M., 2005, COGNITION, V6th ed.; Matos-Caraballo D, 2006, B MAR SCI, V79, P1; McClanahan TR, 2008, AQUAT CONSERV, V18, P493, DOI 10.1002/aqc.874; Meyer CG, 2005, ENVIRON BIOL FISH, V73, P201, DOI 10.1007/s10641-005-0559-7; de Mitcheson YS, 2013, FISH FISH, V14, P119, DOI 10.1111/j.1467-2979.2011.00455.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Nanami A, 2009, FISHERIES SCI, V75, P1109, DOI 10.1007/s12562-009-0136-7; Newman SJ, 2001, MAR FRESHWATER RES, V52, P843, DOI 10.1071/MF99131; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Parish J.D., 1987, P405; Parrish JK, 1999, ENVIRON BIOL FISH, V55, P157, DOI 10.1023/A:1007472602017; Patrick WS, 2010, FISH B-NOAA, V108, P305; Pitcher TJ., 2001, ENCY OCEAN SCI, P975, DOI DOI 10.1006/RWOS.2001.0022; Rhodes KL, 2012, CORAL REEFS, V31, P443, DOI 10.1007/s00338-012-0875-2; Rhodes KL, 2008, FISH B-NOAA, V106, P194; Robinson J, 2008, B MAR SCI, V83, P415; Sadovy Y, 2005, CORAL REEFS, V24, P254, DOI 10.1007/s00338-005-0474-6; Samoilys MA, 2006, P 10 INT COR REEF S, V1, P1335; Wilberg MJ, 2010, REV FISH SCI, V18, P7, DOI 10.1080/10641260903294647	61	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91296	10.1371/journal.pone.0091296	http://dx.doi.org/10.1371/journal.pone.0091296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646910	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500028
J	Verhagen, M; van Roekel, E; Engels, RCME				Verhagen, Maaike; van Roekel, Eeske; Engels, Rutger C. M. E.			Involvement of the BDNF Gene in Loneliness in Adolescence: A Report of Opposite Gene Effects in Boys and Girls	PLOS ONE			English	Article							FACTOR VAL66MET POLYMORPHISM; FACTOR VAL(66)MET POLYMORPHISM; REDUCED HIPPOCAMPAL VOLUMES; RECEPTOR GENE; ENVIRONMENT INTERACTIONS; INDIVIDUAL-DIFFERENCES; MAJOR DEPRESSION; PARENTAL SUPPORT; SOCIAL-ISOLATION; HEALTHY-SUBJECTS	Previous research has shown that loneliness has a heritable component and that genes within the serotonin-, dopamine-, and oxytocin systems are related to loneliness in adolescence. In the present study, the relation between the BDNF Val66Met polymorphism and loneliness in adolescent boys and girls was examined in a longitudinal study spanning five annual waves (N = 305). Latent growth curve modeling (LGCM) was used to examine the baseline level and the change in loneliness over time. The main finding was that the BDNF gene was not related to loneliness in the total sample. A BDNF by sex interaction was found, in that Met carrying girls had the highest levels of loneliness at baseline, whereas in boys the ValVal genotype was related to higher levels of loneliness. Our results underline the importance of sex-stratified analyses when examining effects of the BDNF genotype and the necessity of conducting gene studies to intermediate phenotypes of loneliness.	[Verhagen, Maaike; van Roekel, Eeske; Engels, Rutger C. M. E.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [van Roekel, Eeske] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands	Radboud University Nijmegen; University of Groningen	Verhagen, M (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	m.verhagen@bsi.ru.nl	van Roekel, Eeske/E-7889-2012	van Roekel, Eeske/0000-0002-0829-8089; Engels, Rutger/0000-0003-1944-9126				Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; Barrientos RM, 2003, NEUROSCIENCE, V121, P847, DOI 10.1016/S0306-4522(03)00564-5; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005; Cacioppo JT, 2009, J COGNITIVE NEUROSCI, V21, P83, DOI 10.1162/jocn.2009.21007; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Chou KL, 2014, AM J GERIAT PSYCHIAT, V22, P510, DOI 10.1016/j.jagp.2012.11.002; Cicchetti D, 1996, DEV PSYCHOPATHOL, V8, P597, DOI 10.1017/S0954579400007318; de Geus E, 2008, BIOL PSYCHOL, V79, P1, DOI 10.1016/j.biopsycho.2008.04.002; Doane LD, 2010, PSYCHONEUROENDOCRINO, V35, P430, DOI 10.1016/j.psyneuen.2009.08.005; Duman RS, 2004, NEUROMOL MED, V5, P11, DOI 10.1385/NMM:5:1:011; Duncan T, 2006, INTRO LATENT VARIABL; Dunn EC, 2014, J AFFECT DISORDERS, V152, P243, DOI 10.1016/j.jad.2013.09.018; Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410; Gardner WL, 2005, PERS SOC PSYCHOL B, V31, P1549, DOI 10.1177/0146167205277208; Gasic GP, 2009, AM J MED GENET B, V150B, P762, DOI 10.1002/ajmg.b.30944; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Hajek T, 2012, WORLD J BIOL PSYCHIA, V13, P178, DOI 10.3109/15622975.2011.580005; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Heinrich LA, 2006, CLIN PSYCHOL REV, V26, P695, DOI 10.1016/j.cpr.2006.04.002; Hilt LM, 2007, NEUROSCI LETT, V429, P12, DOI 10.1016/j.neulet.2007.09.053; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Lang UE, 2005, PSYCHOPHARMACOLOGY, V180, P95, DOI 10.1007/s00213-004-2137-7; Lau JYF, 2010, NEUROIMAGE, V53, P952, DOI 10.1016/j.neuroimage.2009.11.026; Lucht MJ, 2009, PROG NEURO-PSYCHOPH, V33, P860, DOI 10.1016/j.pnpbp.2009.04.004; MARCOEN A, 1987, J YOUTH ADOLESCENCE, V16, P561, DOI 10.1007/BF02138821; Marcoen A., 1993, ADOLESCENCE ITS SOCI, P197; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Meltser I, 2008, J CLIN INVEST, V118, P1563, DOI 10.1172/JCI32796; Molendijk ML, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.72; Montag C, 2009, PSYCHOL MED, V39, P1831, DOI 10.1017/S0033291709005509; Montag C, 2008, NEUROIMAGE, V42, P1554, DOI 10.1016/j.neuroimage.2008.06.008; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Mueller SC, 2013, J AM ACAD CHILD PSY, V52, P184, DOI 10.1016/j.jaac.2012.11.016; Mukherjee P, 2011, PSYCHIAT RES-NEUROIM, V191, P182, DOI 10.1016/j.pscychresns.2010.10.001; Muthen B., 2010, MPLUS USERS GUIDE; Muthen BO, 1997, PSYCHOL METHODS, V2, P371, DOI 10.1037/1082-989X.2.4.371; Outhred T, 2012, BRAIN BEHAV, V2, P778, DOI 10.1002/brb3.99; Perlman D., 1981, PARKINSONISM RELATED, VVol. 3, P31; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Pressman SD, 2005, HEALTH PSYCHOL, V24, P297, DOI 10.1037/0278-6133.24.3.297; Qualter P, 2013, J ABNORM CHILD PSYCH, V41, P325, DOI 10.1007/s10802-012-9676-x; Rotenberg KJ, 2010, PERS SOC PSYCHOL B, V36, P1086, DOI 10.1177/0146167210374957; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Sasahara K, 2007, J NEUROSCI, V27, P7408, DOI 10.1523/JNEUROSCI.0710-07.2007; Scharfman HE, 2005, TRENDS NEUROSCI, V28, P79, DOI 10.1016/j.tins.2004.12.005; Schumacher J, 2005, BIOL PSYCHIAT, V58, P307, DOI 10.1016/j.biopsych.2005.04.006; Sen S, 2003, NEUROPSYCHOPHARMACOL, V28, P397, DOI 10.1038/sj.npp.1300053; Shalev I, 2009, PSYCHONEUROENDOCRINO, V34, P382, DOI 10.1016/j.psyneuen.2008.09.017; Sublette ME, 2008, PROG NEURO-PSYCHOPH, V32, P1652, DOI 10.1016/j.pnpbp.2008.06.009; Unternaehrer E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.77; van der Vorst H, 2005, ADDICTION, V100, P1464, DOI 10.1111/j.1360-0443.2005.01193.x; van Oostrom I, 2012, BIOL PSYCHOL, V89, P214, DOI 10.1016/j.biopsycho.2011.10.012; van Roekel E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077689; van Roekel E, 2013, PSYCHIAT GENET, V23, P204, DOI 10.1097/YPG.0b013e328363f631; van Roekel E, 2011, J CHILD PSYCHOL PSYC, V52, P1044, DOI 10.1111/j.1469-7610.2011.02424.x; van Roekel E, 2010, J CHILD PSYCHOL PSYC, V51, P747, DOI 10.1111/j.1469-7610.2010.02225.x; van Wingen G, 2010, NEUROIMAGE, V50, P1212, DOI 10.1016/j.neuroimage.2010.01.058; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Webster MJ, 2002, DEV BRAIN RES, V139, P139, DOI 10.1016/S0165-3806(02)00540-0; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Wong MY, 2003, INT J EPIDEMIOL, V32, P51, DOI 10.1093/ije/dyg002	65	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92768	10.1371/journal.pone.0092768	http://dx.doi.org/10.1371/journal.pone.0092768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647525	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500155
J	Wu, HJ; Yiu, WH; Li, RX; Wong, DWL; Leung, JCK; Chan, LYY; Zhang, Y; Lian, QZ; Lin, M; Tse, HF; Lai, KN; Tang, SCW				Wu, Hao Jia; Yiu, Wai Han; Li, Rui Xi; Wong, Dickson W. L.; Leung, Joseph C. K.; Chan, Loretta Y. Y.; Zhang, Yuelin; Lian, Qizhou; Lin, Miao; Tse, Hung Fat; Lai, Kar Neng; Tang, Sydney C. W.			Mesenchymal Stem Cells Modulate Albumin-Induced Renal Tubular Inflammation and Fibrosis	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; ANTIINFLAMMATORY PROTEIN TSG-6; CHRONIC KIDNEY-DISEASE; RAT REMNANT KIDNEY; EPITHELIAL-CELLS; DIABETIC-NEPHROPATHY; STROMAL CELLS; TNF-ALPHA; INTERSTITIAL FIBROSIS; IGA NEPHROPATHY	Bone marrow-derived mesenchymal stem cells (BM-MSCs) have recently shown promise as a therapeutic tool in various types of chronic kidney disease (CKD) models. However, the mechanism of action is incompletely understood. As renal prognosis in CKD is largely determined by the degree of renal tubular injury that correlates with residual proteinuria, we hypothesized that BM-MSCs may exert modulatory effects on renal tubular inflammation and epithelial-to-mesenchymal transition (EMT) under a protein-overloaded milieu. Using a co-culture model of human proximal tubular epithelial cells (PTECs) and BM-MSCs, we showed that concomitant stimulation of BM-MSCs by albumin excess was a prerequisite for them to attenuate albumin-induced IL-6, IL-8, TNF-alpha, CCL-2, CCL-5 overexpression in PTECs, which was partly mediated via deactivation of tubular NF-kappa B signaling. In addition, albumin induced tubular EMT, as shown by E-cadherin loss and alpha-SMA, FN and collagen IV overexpression, was also prevented by BM-MSC co-culture. Albumin-overloaded BM-MSCs per se retained their tri-lineage differentiation capacity and overexpressed hepatocyte growth factor (HGF) and TNF alpha-stimulating gene (TSG)-6 via P38 and NF-kappa B signaling. Albumin-induced tubular CCL-2, CCL-5 and TNF-alpha overexpression were suppressed by recombinant HGF treatment, while the upregulation of alpha-SMA, FN and collagen IV was attenuated by recombinant TSG-6. Neutralizing HGF and TSG-6 abolished the anti-inflammatory and anti-EMT effects of BM-MSC co-culture in albumin-induced PTECs, respectively. In vivo, albumin-overloaded mice treated with mouse BM-MSCs had markedly reduced BUN, tubular CCL-2 and CCL-5 expression, alpha-SMA and collagen IV accumulation independent of changes in proteinuria. These data suggest anti-inflammatory and anti-fibrotic roles of BM-MSCs on renal tubular cells under a protein overloaded condition, probably mediated via the paracrine action of HGF and TSG-6.	[Wu, Hao Jia; Yiu, Wai Han; Li, Rui Xi; Wong, Dickson W. L.; Leung, Joseph C. K.; Chan, Loretta Y. Y.; Lin, Miao; Lai, Kar Neng; Tang, Sydney C. W.] Univ Hong Kong, Queen Mary Hosp, Div Nephrol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Yuelin; Lian, Qizhou; Tse, Hung Fat] Univ Hong Kong, Queen Mary Hosp, Div Cardiol, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Lian, Qizhou] Univ Hong Kong, Queen Mary Hosp, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Tang, SCW (corresponding author), Univ Hong Kong, Queen Mary Hosp, Div Nephrol, Hong Kong, Hong Kong, Peoples R China.	scwtang@hku.hk	Lian, Qizhou/Y-1613-2019; Tse, Hung-Fat/C-4426-2009; Tang, Sydney Chi Wai/C-4411-2009; Wong, Dickson/F-8855-2013	Tse, Hung-Fat/0000-0002-9578-7808; Tang, Sydney Chi Wai/0000-0002-6862-1941; Wong, Dickson/0000-0002-4798-2908; Wu, Haojia/0000-0002-7866-2544; Lian, Qizhou/0000-0001-8189-7160; Tse, Hung Fat/0000-0003-4665-7887	Research Grants Council of Hong Kong [HKU 778212]; National Basic Research Program of China 973 program [2012CB517600, 2012CB517606]; HKU Seed Funding for Basic Research; Hong Kong Society of Nephrology Research; Endowment Fund; Hong Kong Concrete and the Continental Cement and Gypsum Co. Ltd.	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Basic Research Program of China 973 program(National Basic Research Program of China); HKU Seed Funding for Basic Research(University of Hong Kong); Hong Kong Society of Nephrology Research; Endowment Fund; Hong Kong Concrete and the Continental Cement and Gypsum Co. Ltd.	General Research Fund of the Research Grants Council (Grant number: HKU 778212) of Hong Kong, the National Basic Research Program of China 973 program no. 2012CB517600 (no. 2012CB517606), HKU Seed Funding for Basic Research, and the Hong Kong Society of Nephrology Research Grant 2010; W.H.Y. is partially supported by an Endowment Fund established for the "Yu Professorship in Nephrology" awarded to S.C.W.T. and the Hong Kong Concrete and the Continental Cement and Gypsum Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Part of the results from this study was presented in abstract form at the American Society of Nephrology Renal Week, Nov 10-13, 2011, Philadelphia, PA, USA.	Abbate M, 2008, J AM SOC NEPHROL, V19, P1158, DOI 10.1681/ASN.2007060686; Asanuma H, 2011, J SURG RES, V168, pE51, DOI 10.1016/j.jss.2010.06.022; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Cai L, 2007, STEM CELLS, V25, P3234, DOI 10.1634/stemcells.2007-0388; Chan LYY, 2005, KIDNEY INT, V67, P602, DOI 10.1111/j.1523-1755.2005.67116.x; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Donadelli R, 2003, J AM SOC NEPHROL, V14, P2436, DOI 10.1097/01.ASN.0000089564.55411.7F; Duan HF, 2003, MOL THER, V8, P467, DOI 10.1016/S1525-0016(03)00186-2; Eddy AA, 2000, KIDNEY INT, V58, P618, DOI 10.1046/j.1523-1755.2000.00208.x; Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; Gong RJ, 2004, J AM SOC NEPHROL, V15, P2868, DOI 10.1097/01.ASN.0000141962.44300.3A; Imberti B, 2007, J AM SOC NEPHROL, V18, P2921, DOI 10.1681/ASN.2006121318; Lai KN, 2007, KIDNEY INT, V71, P526, DOI 10.1038/sj.ki.5002091; Lai KN, 2006, NEPHROL DIAL TRANSPL, V21, P1188, DOI 10.1093/ndt/gfk085; Lee JH, 2013, AM J PHYSIOL-RENAL, V304, pF686, DOI 10.1152/ajprenal.00148.2012; Lee JY, 2011, AM J PHYSIOL-RENAL, V300, pF1214, DOI 10.1152/ajprenal.00710.2010; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Lin M, 2013, KIDNEY INT, V83, P887, DOI 10.1038/ki.2013.11; Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Molitoris BA, 1996, KIDNEY INT, V49, P1592, DOI 10.1038/ki.1996.231; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405; Ninichuk V, 2006, KIDNEY INT, V70, P121, DOI 10.1038/sj.ki.5001521; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Ruggenenti P, 1998, KIDNEY INT, V53, P1209, DOI 10.1046/j.1523-1755.1998.00874.x; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; Tang S, 1999, J AM SOC NEPHROL, V10, P69; Tang S, 2003, J CLIN INVEST, V111, P515, DOI [10.1172/JCI16079, 10.1172/JCI200316079]; Tang S, 2002, KIDNEY INT, V61, P1655, DOI 10.1046/j.1523-1755.2002.00301.x; Tang S, 2001, AM J KIDNEY DIS, V37, P94, DOI 10.1053/ajkd.2001.20593; Tang SCW, 2006, J AM SOC NEPHROL, V17, P1633, DOI 10.1681/ASN.2005101113; Tang SCW, 2010, KIDNEY INT, V77, P543, DOI 10.1038/ki.2009.499; Tang SCW, 2010, NEPHROL DIAL TRANSPL, V25, P698, DOI 10.1093/ndt/gfp599; Togel F, 2009, J CELL MOL MED, V13, P2109, DOI 10.1111/j.1582-4934.2008.00641.x; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043768; Zhang YL, 2012, CELL TRANSPLANT, V21, P2225, DOI 10.3727/096368912X653020	42	54	61	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e90883	10.1371/journal.pone.0090883	http://dx.doi.org/10.1371/journal.pone.0090883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646687	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500019
J	Nickerson, A; Priebe, S; Bryant, RA; Morina, N				Nickerson, Angela; Priebe, Stefan; Bryant, Richard A.; Morina, Nexhmedin			Mechanisms of Psychological Distress following War in the Former Yugoslavia: The Role of Interpersonal Sensitivity	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ENDURING PERSONALITY-CHANGE; DOSE-EFFECT RELATIONSHIPS; MENTAL-HEALTH; ORGANIZED VIOLENCE; TRAUMA; TORTURE; PTSD; ANGER; SURVIVORS	While high prevalence rates of psychological symptoms have been documented in civilian survivors of war, little is known about the mechanisms by which trauma exposure might lead to poor psychological outcomes in these populations. One potential mechanism that may underpin the association between war-related traumatic experiences and psychopathology is interpersonal sensitivity. In the current study, we applied structural equation modeling to investigate the impact of interpersonal sensitivity on posttraumatic stress disorder (PTSD) symptoms, depression symptoms, and anger responses following exposure to war trauma. 3313 survivors of the war in the former Yugoslavia were identified and selected using a multistage, probabilistic sampling frame and random walk technique. Participants were interviewed regarding trauma exposure, interpersonal sensitivity, and PTSD symptoms, depression symptoms, and anger responses. Structural equation modeling analyses revealed that the relationship between trauma and PTSD symptoms and depression symptoms was partly statistically mediated by interpersonal sensitivity. Further, findings indicated that the relationship between trauma and anger responses was fully statistically mediated by interpersonal sensitivity. These results suggest that interpersonal sensitivity may function as a key mechanism that contributes to psychopathology following trauma.	[Nickerson, Angela; Bryant, Richard A.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Priebe, Stefan] Queen Mary Univ London, Barts & London Sch Med & Dent, Unit Social & Community Psychiat, London, England; [Morina, Nexhmedin] Univ Amsterdam, Dept Clin Psychol, NL-1012 WX Amsterdam, Netherlands	University of New South Wales Sydney; University of London; Queen Mary University London; University of Amsterdam	Nickerson, A (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	anickerson@psy.unsw.edu.au	Morina, Nexhmedin/D-4976-2012; Morina, Nexhmedin/AAK-7071-2021; Bryant, Richard/AAA-6479-2019	Morina, Nexhmedin/0000-0002-2331-9140; Bryant, Richard/0000-0002-9607-819X; Priebe, Stefan/0000-0001-9864-3394; Nickerson, Angela/0000-0001-9171-4209	European Commission [INCO-CT-2004-509176]; National Health and Medical Research Council (NH&MRC) of Australia [113295, 1042882]	European Commission(European CommissionEuropean Commission Joint Research Centre); National Health and Medical Research Council (NH&MRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by a grant from the European Commission, contract number INCO-CT-2004-509176. AN was supported by a Clinical Early Career Research Fellowship (113295) and a Project Grant (1042882) from the National Health and Medical Research Council (NH&MRC) of Australia. The views expressed are those of the authors and not necessarily those of the European Commission or the NH&MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JG, 1998, PSYCHOL REP, V83, P499, DOI 10.2466/PR0.83.6.499-513; Amar AF, 2005, NURS RES, V54, P235; [Anonymous], 2004, BEGINNERS GUIDE STRU; Basoglu M, 2005, JAMA-J AM MED ASSOC, V294, P580, DOI 10.1001/jama.294.5.580; Beltran RO, 2008, COMPR PSYCHIAT, V49, P593, DOI 10.1016/j.comppsych.2008.04.006; BOYCE P, 1989, AUST NZ J PSYCHIAT, V23, P341; Brooks R, 2011, J AFFECT DISORDERS, V131, P268, DOI 10.1016/j.jad.2010.12.020; Bychowski G, 1968, MASSIVE PSYCHIC TRAU; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Cardozo BL, 2003, J TRAUMA STRESS, V16, P351, DOI 10.1023/A:1024413918346; Charuvastra A, 2008, ANNU REV PSYCHOL, V59, P301, DOI 10.1146/annurev.psych.58.110405.085650; Cloitre M, 2008, J TRAUMA STRESS, V21, P282, DOI 10.1002/jts.20339; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; DOERRZEGERS O, 1992, PSYCHIATRY, V55, P177; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; FOA EB, 1992, PSYCHOL BULL, V112, P218, DOI 10.1037/0033-2909.112.2.218; Gorst-Unsworth C, 1998, BRIT J PSYCHIAT, V172, P90, DOI 10.1192/bjp.172.1.90; GORSTUNSWORTH C, 1993, J NERV MENT DIS, V181, P263, DOI 10.1097/00005053-199304000-00008; Hagenaars MA, 2011, J AFFECT DISORDERS, V132, P192, DOI 10.1016/j.jad.2011.02.017; HAUFF E, 1994, J NERV MENT DIS, V182, P85, DOI 10.1097/00005053-199402000-00004; Hinton D, 2003, BEHAV RES THER, V41, P647, DOI 10.1016/S0005-7967(02)00035-9; Hinton DE, 2009, SOC SCI MED, V69, P1387, DOI 10.1016/j.socscimed.2009.08.018; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huang GP, 2006, COMPR PSYCHIAT, V47, P20, DOI 10.1016/j.comppsych.2005.04.004; Johnson H, 2008, CLIN PSYCHOL REV, V28, P36, DOI 10.1016/j.cpr.2007.01.017; Karam E, 2003, CURR OPIN PSYCHIATR, V16, P413, DOI 10.1097/01.yco.0000079211.36371.1b; Kennedy BL, 2001, PSYCHIAT QUART, V72, P277, DOI 10.1023/A:1010357216925; Krysinska K, 2010, PSYCHOPATHOLOGY, V43, P205, DOI 10.1159/000304177; Mollica RF, 1998, J NERV MENT DIS, V186, P543, DOI 10.1097/00005053-199809000-00005; Mollica RF, 1998, BRIT J PSYCHIAT, V173, P482, DOI 10.1192/bjp.173.6.482; Mollica RF, 2007, J NERV MENT DIS, V195, P572, DOI 10.1097/NMD.0b013e318093ed2c; Murphy SM, 1988, J INTERP VIOL; Muthen B O, 1998, MPLUS VERSION 7; Newman E, 1997, J TRAUMA STRESS, V10, P197, DOI 10.1002/jts.2490100204; Nickerson A, 2013, CLIN PSYCHOL SCI PRA; Nickerson A, 2011, CULT MED PSYCHIAT, V35, P396, DOI 10.1007/s11013-011-9218-y; Novaco RW, 2002, J TRAUMA STRESS, V15, P123, DOI 10.1023/A:1014855924072; Orth U, 2006, J CONSULT CLIN PSYCH, V74, P698, DOI 10.1037/0022-006X.74.4.698; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; Priebe S, 2010, ARCH GEN PSYCHIAT, V67, P518, DOI 10.1001/archgenpsychiatry.2010.37; ROSENBERG ML, 1992, JAMA-J AM MED ASSOC, V267, P3071; Ryan G, 2005, J INTERPERS VIOLENCE, V20, P132, DOI 10.1177/0886260504268605; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Silove D, 2009, SOC SCI MED, V69, P670, DOI 10.1016/j.socscimed.2009.06.030; Solomon Z, 1997, J APPL SOC PSYCHOL, V27, P1785, DOI 10.1111/j.1559-1816.1997.tb01625.x; Steel Z, 2006, BRIT J PSYCHIAT, V188, P58, DOI 10.1192/bjp.bp.104.007864; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Vidyanidhi K, 2009, ASIAN J PSYCHIATR, V2, P25, DOI 10.1016/j.ajp.2008.12.001; Weiss DF, 1997, ASSESSING PSYCHOL TR, P192; Wilhelm K, 2004, J AFFECT DISORDERS, V79, P33, DOI 10.1016/S0165-0327(02)00069-1; Wolfe Jessica, 1997, P192	51	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e90503	10.1371/journal.pone.0090503	http://dx.doi.org/10.1371/journal.pone.0090503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6GL	24658334	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300018
J	Zhao, JL; Chen, L; Shu, B; Tang, JM; Zhang, LJ; Xie, JL; Qi, SH; Xu, YB				Zhao, Jingling; Chen, Lei; Shu, Bin; Tang, Jinming; Zhang, Lijun; Xie, Julin; Qi, Shaohai; Xu, Yingbin			Granulocyte/Macrophage Colony-Stimulating Factor Influences Angiogenesis by Regulating the Coordinated Expression of VEGF and the Ang/Tie System	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; BLOOD-VESSEL MATURATION; NON-HODGKINS-LYMPHOMA; ENDOTHELIAL-CELLS; GROWTH-FACTOR; TUMOR ANGIOGENESIS; WOUND REPAIR; LEG ULCERS; GM-CSF; ANGIOPOIETIN-1	Granulocyte/macrophage colony-stimulating factor (GM-CSF) can accelerate wound healing by promoting angiogenesis. The biological effects of GM-CSF in angiogenesis and the corresponding underlying molecular mechanisms, including in the early stages of primitive endothelial tubule formation and the later stages of new vessel maturation, have only been partially clarified. This study aimed to investigate the effects of GM-CSF on angiogenesis and its regulatory mechanisms. Employing a self-controlled model (Sprague-Dawley rats with deep partial-thickness burn wounds), we determined that GMCSF can increase VEGF expression and decrease the expression ratio of Ang-1/Ang-2 and the phosphorylation of Tie-2 in the early stages of the wound healing process, which promotes the degradation of the basement membrane and the proliferation of endothelial cells. At later stages of wound healing, GM-CSF can increase the expression ratio of Ang-1/Ang-2 and the phosphorylation of Tie-2 and maintain a high VEGF expression level. Consequently, pericyte coverages were higher, and the basement membrane became more integrated in new blood vessels, which enhanced the barrier function of blood vessels. In summary, we report here that increased angiogenesis is associated with GM-CSF treatment, and we indicate that VEGF and the Ang/Tie system may act as angiogenic mediators of the healing effect of GM-CSF on burn wounds.	[Zhao, Jingling; Chen, Lei; Shu, Bin; Tang, Jinming; Zhang, Lijun; Xie, Julin; Qi, Shaohai; Xu, Yingbin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Burns, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xu, YB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Burns, Guangzhou 510275, Guangdong, Peoples R China.	79951927@qq.com	Chen, Lei/AAF-8797-2020; Qi, Shaohai/AAF-7703-2020	Chen, Lei/0000-0001-7146-4636; Qi, Shaohai/0000-0002-6945-4137	National Natural Science Foundation [81272153]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The research was funded by the National Natural Science Foundation (81272153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Benest AV, 2006, MICROCIRCULATION, V13, P423, DOI 10.1080/10739680600775940; Benest AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070459; Bhushan M, 2002, BRIT J DERMATOL, V147, P418, DOI 10.1046/j.1365-2133.2002.05003.x; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; BUSSOLINO F, 1989, NATURE, V337, P471, DOI 10.1038/337471a0; BUSSOLINO F, 1991, BLOOD, V78, P2475; Canturk NZ, 1999, ENDOCR RES, V25, P105, DOI 10.3109/07435809909066133; Cianfarani F, 2006, BRIT J DERMATOL, V154, P34, DOI 10.1111/j.1365-2133.2005.06925.x; Davidson JM, 1998, ARCH DERMATOL RES, V290, pS1, DOI 10.1007/PL00007448; Eberhard A, 2000, CANCER RES, V60, P1388; Etoh T, 2001, CANCER RES, V61, P2145; Fang Y, 2007, BRIT J DERMATOL, V157, P458, DOI 10.1111/j.1365-2133.2007.07979.x; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Goede V, 1998, LAB INVEST, V78, P1385; GORIN NC, 1992, BLOOD, V80, P1149; Groves R W, 2000, Adv Skin Wound Care, V13, P107; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Holash J, 1999, ONCOGENE, V18, P5356, DOI 10.1038/sj.onc.1203035; Imokawa G, 1996, BIOCHEM J, V313, P625, DOI 10.1042/bj3130625; Jeon BH, 2003, CIRC RES, V92, P586, DOI 10.1161/01.RES.0000066881.04116.45; KAPLAN G, 1992, J EXP MED, V175, P1717, DOI 10.1084/jem.175.6.1717; Karagiannis ED, 2006, J THEOR BIOL, V238, P124, DOI 10.1016/j.jtbi.2005.05.020; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kutcher ME, 2009, MICROVASC RES, V77, P235, DOI 10.1016/j.mvr.2009.01.007; Lee HJ, 2004, FASEB J, V18, P1200, DOI 10.1096/fj.03-1466com; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mann A, 2001, J INVEST DERMATOL, V117, P1382, DOI 10.1046/j.0022-202x.2001.01600.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mery L, 2004, DERMATOLOGY, V208, P135, DOI 10.1159/000076487; Reiss Y, 2007, CIRC RES, V101, P88, DOI 10.1161/CIRCRESAHA.106.143594; SCHRIBER JR, 1993, LEUKEMIA, V7, P1491; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Somerville RPT, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-216; Staton CA, 2010, BRIT J DERMATOL, V163, P920, DOI 10.1111/j.1365-2133.2010.09940.x; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Ure I, 1998, BRIT J DERMATOL, V138, P277; Valenzuela DM, 1999, P NATL ACAD SCI USA, V96, P1904, DOI 10.1073/pnas.96.5.1904; VISANI G, 1990, HAEMATOLOGICA, V75, P551; Voskaridou E, 1999, BLOOD, V93, P3568; WAKUI S, 1993, MICROVASC RES, V46, P19, DOI 10.1006/mvre.1993.1032; Weidner N, 1998, J PATHOL, V184, P119, DOI 10.1002/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO;2-D; Yan H, 2012, BURNS, V38, P877, DOI 10.1016/j.burns.2012.02.001; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zhang SX, 2004, DIABETOLOGIA, V47, P124, DOI 10.1007/s00125-003-1276-4	48	43	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92691	10.1371/journal.pone.0092691	http://dx.doi.org/10.1371/journal.pone.0092691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658178	gold, Green Submitted, Green Published			2022-12-27	WOS:000333355300115
J	Das, M; Isaakidis, P; Armstrong, E; Gundipudi, NR; Babu, RB; Qureshi, IA; Claes, A; Mudimanchi, AK; Prasad, N; Mansoor, H; Abraham, S				Das, Mrinalini; Isaakidis, Petros; Armstrong, Edward; Gundipudi, Nirmala Rani; Babu, Ramesh B.; Qureshi, Ihtesham A.; Claes, Andrea; Mudimanchi, Anil Kumar; Prasad, Nagendra; Mansoor, Homa; Abraham, Sunita			Directly-Observed and Self-Administered Tuberculosis Treatment in a Chronic, Low-Intensity Conflict Setting in India	PLOS ONE			English	Article							OUTCOMES	Background: Limited data are available about tuberculosis treatment models of care for internally displaced populations in chronic, low-intensity conflict zones. This study aimed to detail experiences of a Medecins Sans Frontieres tuberculosis programme in Andhra Pradesh-Chhattisgarh border area, India, from January to December 2012. Methods: The study was a description of two retrospective, observational cohorts receiving category I tuberculosis treatment, either intermittent directly observed treatment (DOT) or daily self-administered therapy (SAT) depending on the security of the area and access to health care services. Results: A total of 55 and 17 new tuberculosis patients under DOT and SAT respectively, with complete outcomes were included in the study. Most patients registered were new cases suffering from pulmonary, smear-positive tuberculosis. More than half of the patients in both cohorts were cured or completed treatment: 38/55 (69%) patients were successfully treated under DOT compared to 9/17 (53%) under SAT. Of the patients with adverse outcomes, the ratios of loss to follow up: failure: died were 10: 4: 3 under DOT and 7: 0: 1 under SAT. A much smaller proportion of patients under DOT (18%) were lost to follow up than under SAT (41%). Discussion: Maximum efforts are required to implement successful tuberculosis control programmes for internally displaced populations in conflict zones. Our study suggests that complete tuberculosis treatment can be given to patients using either intermittent DOT or daily SAT, depending on security and access to health services. National TB programmes should include SAT strategies for tuberculosis treatment as these may be an alternative feasible option in conflict settings.	[Das, Mrinalini; Isaakidis, Petros; Armstrong, Edward; Gundipudi, Nirmala Rani; Qureshi, Ihtesham A.; Claes, Andrea; Mudimanchi, Anil Kumar; Prasad, Nagendra; Mansoor, Homa; Abraham, Sunita] Med Sans Frontieres, Delhi, India; [Babu, Ramesh B.] RNTCP, Dist TB Control Off, Hyderabad, Andhra Pradesh, India		Isaakidis, P (corresponding author), Med Sans Frontieres, Delhi, India.	msfocb-asia-epidemio@brussels.msf.org		Isaakidis, Petros/0000-0002-7881-1554				Albanna AS, 2013, EUR RESPIR J, V42, P721, DOI 10.1183/09031936.00180612; Balasubramanian VN, 2000, INT J TUBERC LUNG D, V4, P409; Bartacek A, 2009, INT J TUBERC LUNG D, V13, P760; Central TB Division, 2005, TECHN OP GUID TUB CO; Central TB Division, 2010, UN ACC TB CAR PRACT; Central TB Division, 2013, TB IND 2013 RNTCP AN; Guha R., 2012, ECON POLIT WEEKLY, V42, P3305; Jain Y, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6769; Karumbi J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub4; Liddle KF, 2013, T ROY SOC TROP MED H, V107, P690, DOI 10.1093/trstmh/trt090; Mandal PK, 2013, J CLIN DIAGN RES, V7, P292, DOI [10.7860/JCDR/2013/5122.2750, 10.7860/JCDR/2013/6122.2750]; Medecins Sans Frontieres, 2010, TUB PRACT GUID CLIN; Murali Madhav S, 2004, INDIAN J COMMUNITY M, V29, P1; Nackers F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032140; Sachdeva KS, 2012, INDIAN J MED RES, V135, P690; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Tripathy JP, 2013, PHA, V3, DOI DOI 10.5588/PHA.13.0044); Verma R, 2009, INTERNET J EPIDEMIOL, V8, P1; [No title captured]	19	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92131	10.1371/journal.pone.0092131	http://dx.doi.org/10.1371/journal.pone.0092131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651176	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800072
J	Hiz, MC; Canher, B; Niron, H; Turet, M				Hiz, Mahmut Can; Canher, Balkan; Niron, Harun; Turet, Muge			Transcriptome Analysis of Salt Tolerant Common Bean (Phaseolus vulgaris L.) under Saline Conditions	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; GENE-EXPRESSION; ABIOTIC STRESS; ARABIDOPSIS-THALIANA; FUNCTIONAL GENOMICS; GLYCINE-MAX; SHORT READS; WEB TOOL; RNA-SEQ; DROUGHT	Salinity is one of the important abiotic stress factors that limit crop production. Common bean, Phaseolus vulgaris L., a major protein source in developing countries, is highly affected by soil salinity and the information on genes that play a role in salt tolerance is scarce. We aimed to identify differentially expressed genes (DEGs) and related pathways by comprehensive analysis of transcriptomes of both root and leaf tissues of the tolerant genotype grown under saline and control conditions in hydroponic system. We have generated a total of 158 million high-quality reads which were assembled into 83,774 all-unigenes with a mean length of 813 bp and N50 of 1,449 bp. Among the all-unigenes, 58,171 were assigned with Nr annotations after homology analyses. It was revealed that 6,422 and 4,555 all-unigenes were differentially expressed upon salt stress in leaf and root tissues respectively. Validation of the RNA-seq quantifications (RPKM values) was performed by qRT-PCR (Quantitative Reverse Transcription PCR) analyses. Enrichment analyses of DEGs based on GO and KEGG databases have shown that both leaf and root tissues regulate energy metabolism, transmembrane transport activity, and secondary metabolites to cope with salinity. A total of 2,678 putative common bean transcription factors were identified and classified under 59 transcription factor families; among them 441 were salt responsive. The data generated in this study will help in understanding the fundamentals of salt tolerance in common bean and will provide resources for functional genomic studies.	[Hiz, Mahmut Can; Canher, Balkan; Niron, Harun; Turet, Muge] Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey	Bogazici University	Hiz, MC (corresponding author), Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey.	mcanhiz@boun.edu.tr	türet, müge/AAM-1132-2020	türet, müge/0000-0003-1927-7918; Niron, Harun/0000-0001-5303-7024	Scientific and Technological Research Council of Turkey [TUBITAK 110T922]; Bogazici University [BAP 6674]	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Bogazici University(Bogazici University)	This work was financially supported by The Scientific and Technological Research Council of Turkey (TUBITAK 110T922) and Bogazici University Research Funds (BAP 6674). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aydi S, 2008, PLANT SOIL, V312, P59, DOI 10.1007/s11104-008-9656-7; Benjamini Y, 2001, ANN STAT, V29, P1165; Borges A, 2012, PLANT CELL REP, V31, P827, DOI 10.1007/s00299-011-1204-x; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Carillo P, 2011, ABIOTIC STRESS IN PLANTS - MECHANISMS AND ADAPTATIONS, P21; Chen Y, 2013, J PLANT PHYSIOL, V170, P93, DOI 10.1016/j.jplph.2012.08.019; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Dasgan HY, 2009, J FOOD AGRIC ENVIRON, V7, P363; Campos Mariana Lins de Oliveira, 2012, Braz. J. Plant Physiol., V24, P55, DOI 10.1590/S1677-04202012000100008; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Everett MV, 2011, MOL ECOL RESOUR, V11, P93, DOI 10.1111/j.1755-0998.2010.02969.x; Faical B, 2012, ISRN MOL BIOL, V2012; Fan XD, 2013, GENE, V512, P392, DOI 10.1016/j.gene.2012.09.100; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; Gama PBS, 2007, AFR J BIOTECHNOL, V6, P79; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Ge Y, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-153; Ghosh D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00006; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gulduren S., 2012, Ziraat Fakultesi Dergisi, Ataturk Universitesi, V43, P29; Guo KM, 2008, PHYSIOL PLANTARUM, V134, P499, DOI 10.1111/j.1399-3054.2008.01157.x; HIDE J, 1954, DIAGNOSIS IMPROVEMEN; Hiremath PJ, 2011, PLANT BIOTECHNOL J, V9, P922, DOI 10.1111/j.1467-7652.2011.00625.x; Horie T, 2012, RICE, V5, DOI 10.1186/1939-8433-5-11; Huang JZ, 2012, DNA RES, V19, P195, DOI 10.1093/dnares/dss004; Huang L, 2003, J BIOL CHEM, V278, P51085, DOI 10.1074/jbc.M308321200; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jacoby RP, 2011, TRENDS PLANT SCI, V16, P614, DOI 10.1016/j.tplants.2011.08.002; Jiang YQ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-25; Jiang YQ, 2009, MOL GENET GENOMICS, V282, P503, DOI 10.1007/s00438-009-0481-3; Kalavacharla V, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-135; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Leng Q, 2002, PLANT PHYSIOL, V128, P400, DOI 10.1104/pp.010832; Li HM, 2007, PLANT MOL BIOL, V65, P655, DOI 10.1007/s11103-007-9230-3; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li-Chao Z, 2009, ACTA AGRON SIN, V35, P1181; Liao D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00060; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Liu ZJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-42; Madakbas SY, 2005, HASAD BITKISEL URETI, V21, P80; Magnan F, 2008, PLANT J, V56, P575, DOI 10.1111/j.1365-313X.2008.03622.x; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Melotto M, 2005, GENOME, V48, P562, DOI 10.1139/G05-010; Mochida K, 2010, BIOINFORMATICS, V26, P290, DOI 10.1093/bioinformatics/btp645; Mochida K, 2009, DNA RES, V16, P353, DOI 10.1093/dnares/dsp023; Moe KT, 2011, J INTEGR PLANT BIOL, V53, P63, DOI 10.1111/j.1744-7909.2010.01012.x; Molina C, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-31; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Muzna Zahur, 2013, Advances in Bioscience and Biotechnology, V4, P15; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Ni YX, 2008, ACTA BIOCH BIOPH SIN, V40, P78, DOI 10.1111/j.1745-7270.2008.00371.x; Pang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-488; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Parra-Gonzalez LB, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-425; Postnikova OA, 2013, PLANT CELL PHYSIOL, V54, P1041, DOI 10.1093/pcp/pct056; Qin YX, 2012, MOL BIOL REP, V39, P7183, DOI 10.1007/s11033-012-1550-y; Qing DJ, 2009, PLANT CELL PHYSIOL, V50, P889, DOI 10.1093/pcp/pcp038; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Ramirez M, 2005, PLANT PHYSIOL, V137, P1211, DOI 10.1104/pp.104.054999; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Sanchez DH, 2008, PLANT J, V53, P973, DOI 10.1111/j.1365-313X.2007.03381.x; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shavrukov Y, 2013, J EXP BOT, V64, P119, DOI 10.1093/jxb/ers316; Silva P, 2009, PLANT SIGNAL BEHAV, V4, P718, DOI 10.4161/psb.4.8.9236; Skowyra D, 2001, J BIOL CHEM, V276, P8734, DOI 10.1074/jbc.M007664200; Sun JQ, 2007, PLANT CELL PHYSIOL, V48, P1148, DOI 10.1093/pcp/pcm088; Teakle NL, 2007, J EXP BOT, V58, P2169, DOI 10.1093/jxb/erm102; Teakle NL, 2010, PLANT CELL ENVIRON, V33, P566, DOI 10.1111/j.1365-3040.2009.02060.x; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Touchette BW, 2009, ESTUAR COAST, V32, P917, DOI 10.1007/s12237-009-9178-4; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Walia H, 2007, PLANT MOL BIOL, V63, P609, DOI 10.1007/s11103-006-9112-0; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039856; Wang H, 2003, PLANT MOL BIOL, V52, P873, DOI 10.1023/A:1025029026375; Wang HH, 2009, PLANTA, V230, P293, DOI 10.1007/s00425-009-0946-y; Wei W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007209; Wu N, 2013, THEOR APPL GENET, V126, P1145, DOI 10.1007/s00122-013-2042-8; Xu P, 2009, PLANT PHYSIOL, V149, P760, DOI 10.1104/pp.108.132217; Xu P, 2013, GENE, V525, P26, DOI 10.1016/j.gene.2013.04.066; YAMAGUCHISHINOZAKI K, 1992, PLANT CELL PHYSIOL, V33, P217, DOI 10.1093/oxfordjournals.pcp.a078243; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yochum GS, 2001, MOL CELL BIOL, V21, P4110, DOI 10.1128/MCB.21.13.4110-4118.2001; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Yuen CYL, 2010, SIGNAL COMMUN PLANTS, P137, DOI 10.1007/978-3-642-10494-7_7; Zahaf O, 2012, MOL PLANT, V5, P1068, DOI 10.1093/mp/sss009; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90	102	72	74	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92598	10.1371/journal.pone.0092598	http://dx.doi.org/10.1371/journal.pone.0092598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651267	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800131
J	Snapp-Childs, W; Flatters, I; Fath, A; Mon-Williams, M; Bingham, GP				Snapp-Childs, Winona; Flatters, Ian; Fath, Aaron; Mon-Williams, Mark; Bingham, Geoffrey P.			Training Compliance Control Yields Improvements in Drawing as a Function of Beery Scores	PLOS ONE			English	Article							DEVELOPMENTAL COORDINATION DISORDER; VISUAL-MOTOR INTEGRATION; ROBOT-ASSISTED THERAPY; CHILDREN; VARIABILITY; MOVEMENT; PERFORMANCE; STRATEGIES; FORCE; NOISE	Many children have difficulty producing movements well enough to improve in sensori-motor learning. Previously, we developed a training method that supports active movement generation to allow improvement at a 3D tracing task requiring good compliance control. Here, we tested 7-8 year old children from several 2nd grade classrooms to determine whether 3D tracing performance could be predicted using the Beery VMI. We also examined whether 3D tracing training lead to improvements in drawing. Baseline testing included Beery, a drawing task on a tablet computer, and 3D tracing. We found that baseline performance in 3D tracing and drawing co-varied with the visual perception (VP) component of the Beery. Differences in 3D tracing between children scoring low versus high on the Beery VP replicated differences previously found between children with and without motor impairments, as did post-training performance that eliminated these differences. Drawing improved as a result of training in the 3D tracing task. The training method improved drawing and reduced differences predicted by Beery scores.	[Snapp-Childs, Winona; Fath, Aaron; Bingham, Geoffrey P.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Flatters, Ian; Mon-Williams, Mark] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [Flatters, Ian] Univ Leeds, Sch Mech Engn, Leeds, W Yorkshire, England	Indiana University System; Indiana University Bloomington; University of Leeds; University of Leeds	Snapp-Childs, W (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	wsnappch@indiana.edu		Snapp-Childs, Winona/0000-0003-4354-7092; Fath, Aaron J/0000-0003-3451-2306; Mon-Williams, Mark/0000-0001-7595-8545; Flatters, Ian John/0000-0002-3789-0487	NIH NIDCD [T32DC00012]; NIH NICHD [R01HD070832]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000012] Funding Source: NIH RePORTER	NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH NIDCD Training Grant T32DC00012 and NIH NICHD R01HD070832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bastin J, 2006, HUM MOVEMENT SCI, V25, P718, DOI 10.1016/j.humov.2006.04.001; Beets IAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037687; Ben-Pazi H, 2010, J CHILD NEUROL, V25, P674, DOI 10.1177/0883073809342592; Bo J, 2008, NEUROSCI LETT, V431, P215, DOI 10.1016/j.neulet.2007.11.040; Clark F.J., 1986, HDB PERCEPTION PERFO, V1, P1; Cornhill H, 1996, AM J OCCUP THER, V50, P732, DOI 10.5014/ajot.50.9.732; Culmer PR, 2009, J NEUROSCI METH, V184, P184, DOI 10.1016/j.jneumeth.2009.07.025; Daly CJ, 2003, AM J OCCUP THER, V57, P459, DOI 10.5014/ajot.57.4.459; Davidson PR, 2003, CURR OPIN NEUROBIOL, V13, P232, DOI 10.1016/S0959-4388(03)00038-2; Dessing JC, 2002, NEURAL NETWORKS, V15, P163, DOI 10.1016/S0893-6080(01)00136-8; Deutsch KM, 2001, J EXP CHILD PSYCHOL, V80, P392, DOI 10.1006/jecp.2001.2642; FELDMAN AG, 1966, BIOPHYS-USSR, V11, P565; GETCHELL N, 1989, DEV PSYCHOL, V25, P920, DOI 10.1037/0012-1649.25.6.920; Gonzalez C, 2011, EXP BRAIN RES, V208, P459, DOI 10.1007/s00221-010-2482-1; Goodwin G M, 1976, Exerc Sport Sci Rev, V4, P87; Kaiser ML, 2009, J OCC THER SCH EARLY, V2, P87, DOI 10.1080/19411240903146228; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Lee DN, 1993, ECOLOGICAL INTERPERS, P68; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; Marchal-Crespo L, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-20; MCCLOSKEY DI, 1978, PHYSIOL REV, V58, P763, DOI 10.1152/physrev.1978.58.4.763; McCloskey DI, 1980, SPINAL SUPRASPINAL M; Montagne G, 2005, INT J SPORT PSYCHOL, V36, P127; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; NELSON JK, 1986, RES Q EXERCISE SPORT, V57, P280, DOI 10.1080/02701367.1986.10608088; NEWELL KM, 1991, ANNU REV PSYCHOL, V42, P213, DOI 10.1146/annurev.ps.42.020191.001241; Reinkensmeyer DJ, 2009, EXERC SPORT SCI REV, V37, P43, DOI 10.1097/JES.0b013e3181912108; Rodger S., 2007, NZ J PHYSIOTHERAPY, V35, P99; Smits-Engelsman BCM, 2008, HUM MOVEMENT SCI, V27, P296, DOI 10.1016/j.humov.2008.02.005; Snapp-Childs W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077609; Snapp-Childs W, 2013, J CHILD NEUROL, V28, P204, DOI 10.1177/0883073812461945; Snapp-Childs W, 2009, EXP BRAIN RES, V198, P527, DOI 10.1007/s00221-009-1944-9; Studenka BE, 2013, J EXP PSYCHOL HUMAN, V39, P1557, DOI 10.1037/a0031744; Sugden D., 2006, LEEDS CONSENSUS STAT; Takahashi CD, 2003, J NEUROPHYSIOL, V90, P703, DOI 10.1152/jn.01173.2002; THELEN E, 1993, CHILD DEV, V64, P1058, DOI 10.2307/1131327; Turvey M. T., 1992, ECOL PSYCHOL, V4, P173, DOI [10.1207/s15326969eco0403_3, DOI 10.1207/S15326969EC00403_]; Van Waelvelde H, 2004, DEV MED CHILD NEUROL, V46, P661, DOI 10.1017/s0012162204001112; Volman MJM, 2006, AM J OCCUP THER, V60, P451, DOI 10.5014/ajot.60.4.451; VONHOFSTEN C, 1993, HUM DEV, V36, P253, DOI 10.1159/000278212; Wild MR, 1938, RES QUART, V9, P20, DOI 10.1080/23267429.1938.11802445; Wilson AD, 2010, J EXP PSYCHOL HUMAN, V36, P1508, DOI 10.1037/a0020412; Wilson BN, 2009, PHYS OCCUP THER PEDI, V29, P182, DOI 10.1080/01942630902784761; Wong JD, 2012, J NEUROPHYSIOL, V108, P3313, DOI 10.1152/jn.00122.2012	46	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92464	10.1371/journal.pone.0092464	http://dx.doi.org/10.1371/journal.pone.0092464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651280	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800113
J	Uitdehaag, JCM; de Roos, JADM; van Doornmalen, AM; Prinsen, MBW; de Man, J; Tanizawa, Y; Kawase, Y; Yoshino, K; Buijsman, RC; Zaman, GJR				Uitdehaag, Joost C. M.; de Roos, Jeroen A. D. M.; van Doornmalen, Antoon M.; Prinsen, Martine B. W.; de Man, Jos; Tanizawa, Yoshinori; Kawase, Yusuke; Yoshino, Kohichiro; Buijsman, Rogier C.; Zaman, Guido J. R.			Comparison of the Cancer Gene Targeting and Biochemical Selectivities of All Targeted Kinase Inhibitors Approved for Clinical Use	PLOS ONE			English	Article							BCR-ABL; C-ABL; IDENTIFICATION; DISCOVERY; RAS; PROLIFERATION; SENSITIVITY; ACTIVATION; EXPRESSION; LEUKEMIA	The anti-proliferative activities of all twenty-five targeted kinase inhibitor drugs that are in clinical use were measured in two large assay panels: (1) a panel of proliferation assays of forty-four human cancer cell lines from diverse tumour tissue origins; and (2) a panel of more than 300 kinase enzyme activity assays. This study provides a head-on comparison of all kinase inhibitor drugs in use (status Nov. 2013), and for six of these drugs, the first kinome profiling data in the public domain. Correlation of drug activities with cancer gene mutations revealed novel drug sensitivity markers, suggesting that cancers dependent on mutant CTNNB1 will respond to trametinib and other MEK inhibitors, and cancers dependent on SMAD4 to small molecule EGFR inhibitor drugs. Comparison of cellular targeting efficacies reveals the most targeted inhibitors for EGFR, ABL1 and BRAF(V600E)-driven cell growth, and demonstrates that the best targeted agents combine high biochemical potency with good selectivity. For ABL1 inhibitors, we computationally deduce optimized kinase profiles for use in a next generation of drugs. Our study shows the power of combining biochemical and cellular profiling data in the evaluation of kinase inhibitor drug action.	[Uitdehaag, Joost C. M.; de Roos, Jeroen A. D. M.; van Doornmalen, Antoon M.; Prinsen, Martine B. W.; de Man, Jos; Buijsman, Rogier C.; Zaman, Guido J. R.] Netherlands Translat Res Ctr BV, Oss, Netherlands; [Tanizawa, Yoshinori; Kawase, Yusuke; Yoshino, Kohichiro] Carna Biosci Inc, Kobe, Hyogo, Japan		Zaman, GJR (corresponding author), Netherlands Translat Res Ctr BV, Oss, Netherlands.	guido.zaman@ntrc.nl		Tanizawa, Yoshinori/0000-0002-5014-2483	Innovation Office (Agentschap NL) of the Ministry of Economic Affairs of the Netherlands [INT 111039]	Innovation Office (Agentschap NL) of the Ministry of Economic Affairs of the Netherlands	This work was supported by a grant from the Innovation Office (Agentschap NL) of the Ministry of Economic Affairs of the Netherlands (INT 111039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bamborough P, 2012, EXPERT OPIN DRUG DIS, V7, P1053, DOI 10.1517/17460441.2012.724056; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentzien F, 2013, THYROID; Bruix J, 2013, EUR J CANCER, V49, P3412, DOI 10.1016/j.ejca.2013.05.028; CHEN TR, 1995, CANCER GENET CYTOGEN, V81, P103, DOI 10.1016/0165-4608(94)00225-Z; Chou TC, 1998, P NATL ACAD SCI USA, V95, P8369, DOI 10.1073/pnas.95.14.8369; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Dan S, 2002, CANCER RES, V62, P1139; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Fabbro D, 2012, METHODS MOL BIOL, V795, P1, DOI 10.1007/978-1-61779-337-0_1; Fallahi-Sichani M, 2013, NAT CHEM BIOL, V9, P708, DOI [10.1038/nchembio.1337, 10.1038/NCHEMBIO.1337]; Ganguly SS, 2012, ONCOGENE, V31, P1804, DOI 10.1038/onc.2011.361; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gosens R, 2010, FASEB J, V24, P757, DOI 10.1096/fj.09-136325; Greshock J, 2010, CANCER RES, V70, P3677, DOI 10.1158/0008-5472.CAN-09-3788; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Gubler H, 2013, J BIOMOL SCREEN, V18, P1, DOI 10.1177/1087057112455219; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jeong WJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002242; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kalliokoski T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061007; King AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067583; Kitagawa D, 2013, GENES CELLS, V18, P110, DOI 10.1111/gtc.12022; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Koos B, 2010, CANCER-AM CANCER SOC, V116, P5075, DOI 10.1002/cncr.25420; Li JJ, 2009, ONCOGENE, V28, P1759, DOI 10.1038/onc.2009.15; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; McGahon AJ, 1997, CELL DEATH DIFFER, V4, P95, DOI 10.1038/sj.cdd.4400213; Metz JT, 2011, NAT CHEM BIOL, V7, P200, DOI 10.1038/NCHEMBIO.530; Mimori K, 2004, CLIN CANCER RES, V10, P8243, DOI 10.1158/1078-0432.CCR-04-0849; Morphy R, 2010, J MED CHEM, V53, P1413, DOI 10.1021/jm901132v; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P87, DOI 10.1038/nrd3946; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Patel MN, 2013, NAT REV DRUG DISCOV, V12, P35, DOI 10.1038/nrd3913; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; R Core Team, 2018, R LANG ENV STAT COMP; Sedrani R, 1998, TRANSPLANT P, V30, P2192, DOI 10.1016/S0041-1345(98)00587-9; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Simon R, 2013, NAT REV DRUG DISCOV, V12, P359, DOI 10.1038/nrd3979; Uitdehaag JCM, 2012, BRIT J PHARMACOL, V166, P858, DOI 10.1111/j.1476-5381.2012.01859.x; Uitdehaag JCM, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-94; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wilhelm S, 2002, CURR PHARM DESIGN, V8, P2255, DOI 10.2174/1381612023393026; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; Yoshida T, 2012, ONCOTARGET, V3, P1533; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhao SJ, 2010, INT J CANCER, V127, P2076, DOI 10.1002/ijc.25412	55	77	78	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92146	10.1371/journal.pone.0092146	http://dx.doi.org/10.1371/journal.pone.0092146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651269	gold, Green Published, Green Submitted			2022-12-27	WOS:000333352800073
J	Watanabe, H; Takayama, K; Inamura, M; Tachibana, M; Mimura, N; Katayama, K; Tashiro, K; Nagamoto, Y; Sakurai, F; Kawabata, K; Furue, MK; Mizuguchi, H				Watanabe, Hitoshi; Takayama, Kazuo; Inamura, Mitsuru; Tachibana, Masashi; Mimura, Natsumi; Katayama, Kazufumi; Tashiro, Katsuhisa; Nagamoto, Yasuhito; Sakurai, Fuminori; Kawabata, Kenji; Furue, Miho Kusuda; Mizuguchi, Hiroyuki			HHEX Promotes Hepatic-Lineage Specification through the Negative Regulation of Eomesodermin	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HOMEOBOX GENE HEX; HEMATOPOIETIC-CELLS; EFFICIENT DIFFERENTIATION; FUNCTIONAL HEPATOCYTES; DEFINITIVE ENDODERM; LIVER; TRANSCRIPTION; GENERATION; ORGANOGENESIS	Human embryonic stem cells (hESCs) could provide a major window into human developmental biology, because the differentiation methods from hESCs mimic human embryogenesis. We previously reported that the overexpression of hematopoietically expressed homeobox (HHEX) in the hESC-derived definitive endoderm (DE) cells markedly promotes hepatic specification. However, it remains unclear how HHEX functions in this process. To reveal the molecular mechanisms of hepatic specification by HHEX, we tried to identify the genes directly targeted by HHEX. We found that HHEX knockdown considerably enhanced the expression level of eomesodermin (EOMES). In addition, HHEX bound to the HHEX response element located in the first intron of EOMES. Loss-of-function assays of EOMES showed that the gene expression levels of hepatoblast markers were significantly upregulated, suggesting that EOMES has a negative role in hepatic specification from the DE cells. Furthermore, EOMES exerts its effects downstream of HHEX in hepatic specification from the DE cells. In conclusion, the present results suggest that HHEX promotes hepatic specification by repressing EOMES expression.	[Watanabe, Hitoshi; Takayama, Kazuo; Inamura, Mitsuru; Tachibana, Masashi; Katayama, Kazufumi; Nagamoto, Yasuhito; Sakurai, Fuminori; Mizuguchi, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Osaka, Japan; [Takayama, Kazuo; Mimura, Natsumi; Nagamoto, Yasuhito; Mizuguchi, Hiroyuki] Natl Inst Biomed Innovat, Lab Hepatocyte Differentiat, Osaka, Japan; [Takayama, Kazuo; Mizuguchi, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, iPS Cell Based Res Project Hepat Tox & Metab, Osaka, Japan; [Tashiro, Katsuhisa; Kawabata, Kenji] Natl Inst Biomed Innovat, Lab Stem Cell Regulat, Osaka, Japan; [Furue, Miho Kusuda] Natl Inst Biomed Innovat, Dept Dis Bioresources Res, Lab Embryon Stem Cell Cultures, Osaka, Japan; [Furue, Miho Kusuda] Kyoto Univ, Inst Frontier Med Sci, Field Stem Cell Res, Dept Embryon Stem Cell Res, Kyoto, Japan; [Mizuguchi, Hiroyuki] Osaka Univ, Ctr Adv Med Engn & Informat, Osaka, Japan	Osaka University; National Institute of Health Sciences - Japan; Osaka University; National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; Kyoto University; Osaka University	Mizuguchi, H (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Osaka, Japan.	mizuguch@phs.osaka-u.ac.jp	Takayama, Kazuo/U-2360-2019; TASHIRO, KOHJI/AAM-1198-2020	Furue, Miho/0000-0001-5032-9953; Tachibana, Masashi/0000-0002-0376-508X; Mizuguchi, Hiroyuki/0000-0003-0594-8178; Takayama, Kazuo/0000-0002-1132-2457	Ministry of Health Labor and Welfare of Japan; Uehara Memorial Foundation; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)	Ministry of Health Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation)	HM and MKF were supported by grants from the Ministry of Health Labor and Welfare of Japan. HM was also supported by The Uehara Memorial Foundation. FS were supported by Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). K. Takayama and YN are supported by a Grant-in-aid for the Japan Society for the Promotion of Science Fellows. The funders had no role in study design data collection and analysis decision to publish or preparation of the manuscript.	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Bogue CW, 2000, DEV DYNAM, V219, P84, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1028>3.0.CO;2-5; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Cong R, 2006, BIOCHEM BIOPH RES CO, V346, P535, DOI 10.1016/j.bbrc.2006.05.153; CROMPTON MR, 1992, NUCLEIC ACIDS RES, V20, P5661, DOI 10.1093/nar/20.21.5661; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Guiral M, 2001, J BIOL CHEM, V276, P2961, DOI 10.1074/jbc.M004948200; Inamura M, 2011, MOL THER, V19, P400, DOI 10.1038/mt.2010.241; Keng VW, 2000, BIOCHEM BIOPH RES CO, V276, P1155, DOI 10.1006/bbrc.2000.3548; Kubo A, 2010, HEPATOLOGY, V51, P633, DOI 10.1002/hep.23293; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Nagamoto Y, 2012, BIOMATERIALS, V33, P4526, DOI 10.1016/j.biomaterials.2012.03.011; Noy P, 2010, MOL CELL BIOL, V30, P2120, DOI 10.1128/MCB.01511-09; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Takayama K, 2013, STEM CELL REP, V1, P322, DOI 10.1016/j.stemcr.2013.08.006; Takayama K, 2014, DEVELOPMENT, V141, P91, DOI 10.1242/dev.103168; Takayama K, 2013, BIOMATERIALS, V34, P1781, DOI 10.1016/j.biomaterials.2012.11.029; Takayama K, 2012, J HEPATOL, V57, P628, DOI 10.1016/j.jhep.2012.04.038; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Takayama K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021780; Tanaka H, 2005, ARCH BIOCHEM BIOPHYS, V442, P117, DOI 10.1016/j.abb.2005.08.001; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431	28	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90791	10.1371/journal.pone.0090791	http://dx.doi.org/10.1371/journal.pone.0090791			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651531	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800024
J	Zhao, YJ; Selvaraj, JN; Xing, FG; Zhou, L; Wang, Y; Song, HM; Tan, XX; Sun, LC; Sangare, L; Folly, YME; Liu, Y				Zhao, Yueju; Selvaraj, Jonathan Nimal; Xing, Fuguo; Zhou, Lu; Wang, Yan; Song, Huimin; Tan, Xinxin; Sun, Lichao; Sangare, Lancine; Folly, Yawa Minnie Elodie; Liu, Yang			Antagonistic Action of Bacillus subtilis Strain SG6 on Fusarium graminearum	PLOS ONE			English	Article							HEAD BLIGHT; BIOLOGICAL-CONTROL; MYCOTOXIN DEOXYNIVALENOL; WHEAT GERMPLASM; GIBBERELLA-ZEAE; WINTER-WHEAT; BIOCONTROL; BACTERIA; ANTIBIOTICS; FENGYCIN	Fusarium graminearum causes Fusarium head blight (FHB), a devastating disease that leads to extensive yield and quality loss of wheat and barley. Bacteria isolated from wheat kernels and plant anthers were screened for antagonistic activity against F. graminearum. Based on its in vitro effectiveness, strain SG6 was selected for characterization and identified as Bacillus subtilis. B. subtilis SG6 exhibited a high antifungal effect on the mycelium growth, sporulation and DON production of F. graminearum with the inhibition rate of 87.9%, 95.6% and 100%, respectively. In order to gain insight into biological control effect in situ, we applied B. subtilis SG6 at anthesis through the soft dough stage of kernel development in field test. It was revealed that B. subtilis SG6 significantly reduced disease incidence (DI), FHB index and DON (P <= 0.05). Further, ultrastructural examination shows that B. subtilis SG6 strain induced stripping of F. graminearum hyphal surface by destroying the cellular structure. When hypha cell wall was damaged, the organelles and cytoplasm inside cell would exude, leading to cell death. The antifungal activity of SG6 could be associated with the coproduction of chitinase, fengycins and surfactins.	[Zhao, Yueju; Selvaraj, Jonathan Nimal; Xing, Fuguo; Zhou, Lu; Wang, Yan; Song, Huimin; Tan, Xinxin; Sun, Lichao; Sangare, Lancine; Folly, Yawa Minnie Elodie; Liu, Yang] Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Beijing 100193, Peoples R China; [Zhao, Yueju; Selvaraj, Jonathan Nimal; Xing, Fuguo; Zhou, Lu; Wang, Yan; Song, Huimin; Tan, Xinxin; Sun, Lichao; Sangare, Lancine; Folly, Yawa Minnie Elodie; Liu, Yang] Minist Agr, Key Lab Agroprod Proc, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Liu, Y (corresponding author), Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Beijing 100193, Peoples R China.	liuyang01@caas.cn	Xing, Fuguo/HGD-3209-2022		Ministry of Sciences and Technology of China (973 Program) [2013CB127805]; Ministry of Agriculture of China [201203037]; Ministry of Sciences and Technology of China [2013FY113400]	Ministry of Sciences and Technology of China (973 Program)(National Basic Research Program of China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Ministry of Sciences and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the Ministry of Sciences and Technology of China (973 Program, 2013CB127805), from the Ministry of Agriculture of China (Special Fund for Agro-scientific Research in the Public Interest, 201203037), from the Ministry of Sciences and Technology of China (National Program of China Basic Science and Technology Research, 2013FY113400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baysal O, 2008, PHYSIOL MOL PLANT P, V73, P25, DOI 10.1016/j.pmpp.2008.11.002; Bie XM, 2009, J MICROBIOL METH, V79, P272, DOI 10.1016/j.mimet.2009.09.013; Bleakley BH, 2012, TRIAL PERFORMANCE SE, P7; Bluhm BH, 2007, MOL PLANT MICROBE IN, V20, P627, DOI 10.1094/MPMI-20-6-0627; Chan YK, 2003, CAN J MICROBIOL, V49, P253, DOI 10.1139/W03-033; Cohen-Kupiec R, 1998, CURR OPIN BIOTECH, V9, P270, DOI 10.1016/S0958-1669(98)80058-X; Crane JM, 2013, PHYTOPATHOLOGY, V103, P146, DOI 10.1094/PHYTO-07-12-0154-R; Dihazi A, 2012, PLANT PHYSIOL BIOCH, V55, P7, DOI 10.1016/j.plaphy.2012.03.003; Dunlap CA, 2011, J MICROBIOL, V49, P603, DOI 10.1007/s12275-011-1044-y; Gajbhiye A, 2010, WORLD J MICROB BIOT, V26, P1187, DOI 10.1007/s11274-009-0287-9; Gonzalez-Sanchez MA, 2010, J APPL MICROBIOL, V109, P65, DOI 10.1111/j.1365-2672.2009.04628.x; Groth JV, 1999, PLANT DIS, V83, P1033, DOI 10.1094/PDIS.1999.83.11.1033; Hao CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046444; Hartnett DJ, 2002, J I BREWING, V108, P169, DOI 10.1002/j.2050-0416.2002.tb00537.x; He J, 2009, J APPL MICROBIOL, V106, P1805, DOI 10.1111/j.1365-2672.2009.04147.x; HIRAOKA H, 1992, J GEN APPL MICROBIOL, V38, P635, DOI 10.2323/jgam.38.635; Jochum CC, 2006, BIOL CONTROL, V39, P336, DOI 10.1016/j.biocontrol.2006.05.004; Joshi R, 2006, PHYTOPATHOLOGY, V96, P145, DOI 10.1094/PHYTO-96-0145; Kang ZS, 2000, MYCOL RES, V104, P1083, DOI 10.1017/S0953756200002495; Khan NI, 2004, BIOL CONTROL, V29, P245, DOI 10.1016/S1049-9644(03)00157-9; Khan NI, 2001, PLANT DIS, V85, P1253, DOI 10.1094/PDIS.2001.85.12.1253; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Leelasuphakul W, 2008, POSTHARVEST BIOL TEC, V48, P113, DOI 10.1016/j.postharvbio.2007.09.024; Li DQ, 2007, APPL MICROBIOL BIOT, V75, P1401, DOI 10.1007/s00253-007-0951-7; Liu SX, 2003, CROP SCI, V43, P760, DOI 10.2135/cropsci2003.0760; Liu Y, 2005, J AGR FOOD CHEM, V53, P6864, DOI 10.1021/jf050831u; Mannanov RN, 2001, CHEM NAT COMPD, V37, P117, DOI 10.1023/A:1012314516354; Maragos CM, 2002, J AGR FOOD CHEM, V50, P1827, DOI 10.1021/jf011487d; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Marten P, 2000, J APPL MICROBIOL, V89, P463, DOI 10.1046/j.1365-2672.2000.01136.x; Montesinos E, 2007, FEMS MICROBIOL LETT, V270, P1, DOI 10.1111/j.1574-6968.2007.00683.x; Mora I, 2011, INT MICROBIOL, V14, P213, DOI 10.2436/20.1501.01.151; MORSY E. M., 2009, EGYPTIAN J PHYTOPATH, V37, P47; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; Palazzinia JM, 2007, CROP PROT, V26, P1702, DOI 10.1016/j.cropro.2007.03.004; Ramarathnam R, 2007, CAN J MICROBIOL, V53, P901, DOI 10.1139/W07-049; Romanenko LA, 2008, MICROBIOL RES, V163, P633, DOI 10.1016/j.micres.2006.10.001; Romero D, 2007, MOL PLANT MICROBE IN, V20, P430, DOI 10.1094/MPMI-20-4-0430; Schisler DA, 2002, PLANT DIS, V86, P1350, DOI 10.1094/PDIS.2002.86.12.1350; Schisler DA, 2002, ADV EXP MED BIOL, V504, P53; Schisler DA, 2003, GOOGLE PATENTS; Siddiqui S, 2005, WORLD J MICROB BIOT, V21, P729, DOI 10.1007/s11274-004-4799-z; Snedecor G.W., 1989, AMES IOWA STATE U PR; Snijders C, 1995, BREEDING RESISTANCE; SNIJDERS CHA, 1990, NETH J PLANT PATHOL, V96, P187, DOI 10.1007/BF01974256; Starkey DE, 2007, FUNGAL GENET BIOL, V44, P1191, DOI 10.1016/j.fgb.2007.03.001; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Stein T, 2008, RAPID COMMUN MASS SP, V22, P1146, DOI 10.1002/rcm.3481; Stockwell CA, 2001, BIOL CONTROL FUSARIU, V1448, P91; TUITE J, 1990, PLANT DIS, V74, P959, DOI 10.1094/PD-74-0959; VANITTANAKOM N, 1986, J ANTIBIOT, V39, P888, DOI 10.7164/antibiotics.39.888; WITT MF, 1985, J AGR FOOD CHEM, V33, P745, DOI 10.1021/jf00064a046; Xue AG, 2009, CAN J PLANT PATHOL, V31, P169; Xue AG, 2009, WORLD MYCOTOXIN J, V2, P193, DOI 10.3920/WMJ2008.1121; Xue YF, 2006, INT J SYST EVOL MICR, V56, P1217, DOI 10.1099/ijs.0.64105-0; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104, DOI 10.1128/AEM.61.3.1104-1109.1995; Yu JB, 2008, CROP SCI, V48, P1090, DOI 10.2135/cropsci2007.10.0554; Zhou XH, 2011, J FOOD SCI, V76, pM254, DOI 10.1111/j.1750-3841.2011.02160.x	61	101	112	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92486	10.1371/journal.pone.0092486	http://dx.doi.org/10.1371/journal.pone.0092486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651513	gold, Green Submitted, Green Published			2022-12-27	WOS:000333352800119
J	Agunbiade, TA; Coates, BS; Datinon, B; Djouaka, R; Sun, WL; Tamo, M; Pittendrigh, BR				Agunbiade, Tolulope A.; Coates, Brad S.; Datinon, Benjamin; Djouaka, Rousseau; Sun, Weilin; Tamo, Manuele; Pittendrigh, Barry R.			Genetic Differentiation among Maruca vitrata F. (Lepidoptera: Crambidae) Populations on Cultivated Cowpea and Wild Host Plants: Implications for Insect Resistance Management and Biological Control Strategies	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; LEGUME POD BORER; AFRICAN ARMYWORM; MIGRATION; SOFTWARE; COTTON; SUSTAINABILITY; BUTTERFLIES; SPECIATION; NOCTUIDAE	Maruca vitrata Fabricius (Lepidoptera: Crambidae) is a polyphagous insect pest that feeds on a variety of leguminous plants in the tropics and subtropics. The contribution of host-associated genetic variation on population structure was investigated using analysis of mitochondrial cytochrome oxidase 1 (cox1) sequence and microsatellite marker data from M. vitrata collected from cultivated cowpea (Vigna unguiculata L. Walp.), and alternative host plants Pueraria phaseoloides (Roxb.) Benth. var. javanica (Benth.) Baker, Loncocarpus sericeus (Poir), and Tephrosia candida (Roxb.). Analyses of microsatellite data revealed a significant global FST estimate of 0.05 (P <= 0.001). The program STRUCTURE estimated 2 genotypic clusters (co-ancestries) on the four host plants across 3 geographic locations, but little geographic variation was predicted among genotypes from different geographic locations using analysis of molecular variance (AMOVA; among group variation -0.68%) or F-statistics (F-ST(Loc) = 20.01; P = 0.62). These results were corroborated by mitochondrial haplotype data (phi(Loc)(ST) = 0.05; P = 0.92). In contrast, genotypes obtained from different host plants showed low but significant levels of genetic variation (F-ST(Host) = 0.04; P = 0.01), which accounted for 4.08% of the total genetic variation, but was not congruent with mitochondrial haplotype analyses (phi(Host)(ST) = 0.06; P = 0.27). Variation among host plants at a location and host plants among locations showed no consistent evidence for M. vitrata population subdivision. These results suggest that host plants do not significantly influence the genetic structure of M. vitrata, and this has implications for biocontrol agent releases as well as insecticide resistance management (IRM) for M. vitrata in West Africa.	[Agunbiade, Tolulope A.; Sun, Weilin; Pittendrigh, Barry R.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Coates, Brad S.] ARS, USDA, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Datinon, Benjamin; Djouaka, Rousseau; Tamo, Manuele] Int Inst Trop Agr, Cotonou, Benin	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Agunbiade, TA (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.	agunbia1@illinois.edu		Tamo, Manuele/0000-0002-5863-7421; Coates, Brad/0000-0001-8908-1529	Howard Hughes Medical Institute; Legumes Innovation Lab; Bureau for Economic Growth, Agriculture, and Trade, US Agency for International Development [EDH-A-00-07-00005]; United States Department of Agriculture, Agricultural Research Service (USDA-ARS: CRIS Project) [3625-22000-017-00]; Iowa Agriculture 567 and Home Economics Experiment Station, Ames, IA [3543]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Legumes Innovation Lab; Bureau for Economic Growth, Agriculture, and Trade, US Agency for International Development(United States Agency for International Development (USAID)); United States Department of Agriculture, Agricultural Research Service (USDA-ARS: CRIS Project); Iowa Agriculture 567 and Home Economics Experiment Station, Ames, IA	This project has been made possible through the International Student Research Fellowship to Tolulope A. Agunbiade by the Howard Hughes Medical Institute. This project was also supported by the Legumes Innovation Lab, formerly known as the Dry Grains Pulses Collaborative Research Support Program (CRSP), by the Bureau for Economic Growth, Agriculture, and Trade, US Agency for International Development, under the terms of Grant No. EDH-A-00-07-00005. A portion of research data collection and analysis was supported by the United States Department of Agriculture, Agricultural Research Service (USDA-ARS: CRIS Project 3625-22000-017-00) and the Iowa Agriculture 567 and Home Economics Experiment Station, Ames, IA (Project 3543). The opinions expressed are those of the authors and do not necessarily reflect the views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney MR, 2007, J COTTON SCI, V11, P35; Agunbiade TA, 2012, B ENTOMOL RES, V102, P589, DOI 10.1017/S0007485312000156; ALSTAD DN, 1995, SCIENCE, V268, P1894, DOI 10.1126/science.268.5219.1894; Altieri M. A., 1982, Crop Protection, V1, P405, DOI 10.1016/0261-2194(82)90023-0; Altieri Miguel A., 1993, P257; Arodokoun D, 1996, THESIS U LAVAL QUEBE; Arodokoun D. Y., 2003, Insect Science and its Application, V23, P103; Ba Niango Malick, 2009, International Journal of Tropical Insect Science, V29, P109, DOI 10.1017/S174275840999021X; Benjamini Y, 2001, ANN STAT, V29, P1165; Bianchi FJJA, 2008, BIOL CONTROL, V46, P400, DOI 10.1016/j.biocontrol.2008.04.010; Bottenberg H., 1997, Advances in cowpea research, P271; Bourguet D, 2000, P ROY SOC B-BIOL SCI, V267, P117, DOI 10.1098/rspb.2000.0975; Calcagno V, 2007, J EVOLUTION BIOL, V20, P1720, DOI 10.1111/j.1420-9101.2007.01391.x; Chapuis MP, 2008, MOL ECOL, V17, P3640, DOI 10.1111/j.1365-294X.2008.03869.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Coates BS, 2010, J MOL EVOL, V70, P275, DOI 10.1007/s00239-010-9330-6; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DENBOER MH, 1978, J ZOOL, V185, P539; DeWoody JA, 2006, MOL ECOL NOTES, V6, P951, DOI 10.1111/j.1471-8286.2006.01449.x; Downham MCA, 2002, CHALLENGES OPPORTUNI, P124; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Fatokun CA, 2002, CHALLENGES OPPORTUNI, P81; Feder Jeffrey L., 1998, P408; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Funk DJ, 2002, GENETICA, V116, P251, DOI 10.1023/A:1021236510453; Futuyma D.J., 1983, P227; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gourdine JS, 2005, J ENTOMOL SCI, V40, P96, DOI 10.18474/0749-8004-40.1.96; Gurr G, 2005, PLANT PROVIDED FOOD, P267; Gurr GM, 1999, INT J PEST MANAGE, V45, P81, DOI 10.1080/096708799227851; Huesing Joseph, 2011, GM Crops, V2, P211, DOI 10.4161/gmcr.2.3.18689; Jackson RE, 2008, ENTOMOL EXP APPL, V126, P89, DOI 10.1111/j.1570-7458.2007.00653.x; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Lavandero B, 2006, BASIC APPL ECOL, V7, P236, DOI 10.1016/j.baae.2005.09.004; Lee JC, 2008, BIOCONTROL, V53, P289, DOI 10.1007/s10526-007-9070-8; Leumann C, 1994, THESIS ETH ZURICH SW; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; Lyons JI, 2012, MOL ECOL, V21, P3433, DOI 10.1111/j.1365-294X.2012.05613.x; Malausa T, 2005, SCIENCE, V308, P258, DOI 10.1126/science.1107577; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016444; MERRETT PJ, 1986, B ENTOMOL RES, V76, P247, DOI 10.1017/S0007485300014723; Mitter C., 1991, P35; Murdock LL, 2002, WORKSH GEN TRANSF CO; Nason JD, 2002, EVOLUTION, V56, P1475, DOI 10.1111/j.0014-3820.2002.tb01459.x; Olivieri I, 2008, EVOL APPL, V1, P112, DOI 10.1111/j.1752-4571.2007.00010.x; Onstad D. W., 2012, ENVIRON ENTOMOL, V41, P1045; Onstad DW, 2003, J ECON ENTOMOL, V96, P1872, DOI 10.1603/0022-0493-96.6.1872; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sharma HC, 1998, CROP PROT, V17, P373, DOI 10.1016/S0261-2194(98)00045-3; Showers WB, 1997, ANNU REV ENTOMOL, V42, P393, DOI 10.1146/annurev.ento.42.1.393; Strong D., 1984, INSECTS PLANTS COMMU; Sword GA, 2005, MOL ECOL, V14, P2197, DOI 10.1111/j.1365-294X.2005.02546.x; Tamo M., 1997, Advances in cowpea research, P259; Tamo M, 2003, BIOL CONTROL IPM SYS, P256; Tamo M, 2012, IMPR LIV COWP VAL CH, P249; Tan SJ, 2001, CHINESE SCI BULL, V46, P1804, DOI 10.1007/BF02900555; Taylor T.A., 1978, P193; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waage JK, 1991, P 1 WORKSH EC FDN SU; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059654; Weir B. S., 1996, GENETIC DATA ANAL; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wratten S. D., 1995, P117; Wu K, 2004, CROP PROT, V23, P523, DOI 10.1016/j.cropro.2003.10.009; Zhang TZ, 2000, CHINESE SCI BULL, V45, P119	75	17	17	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92072	10.1371/journal.pone.0092072	http://dx.doi.org/10.1371/journal.pone.0092072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647356	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500079
J	Black, G; Kononovas, K; Taylor, J; Raine, R				Black, Georgia; Kononovas, Kostas; Taylor, Jayne; Raine, Rosalind			Healthcare Planning for the Olympics in London: A Qualitative Evaluation	PLOS ONE			English	Article							GAMES	Background: Mass gatherings, such as the Olympic and Paralympic Games, represent an enormous logistical challenge for the host city. Health service planners must deliver routine and emergency services and, in recent Games, health legacy initiatives, for the local and visiting population. However there is little evidence to support their planning decisions. We therefore evaluated the strategic health planning programme for the London 2012 Olympic and Paralympic Games to identify generalisable information for future Games. Methods: We thematically analysed data from stakeholder interviews and documents. The data were prospectively collected in three phases, before, during and after the Games. Findings: We identified five key themes: (1) Systemic Improvement for example in communications, (2) Effective relationships led to efficiencies and permanent gains, such as new relationships with the private sector (3) Difficult relationships led to inefficiencies, for instance, duplication in testing and exercising emergency scenarios, (4) Tendency to over-estimate demand for care, particularly emergency medicine, and (5) Difficulties establishing a health legacy due to its deprioritisation and lack of vision by the programme team. Interpretation: Enduring improvements which are sustained after the Games are possible, such as the establishment of new and productive partnerships. Relationships must be established early on to avoid duplication, delay and unnecessary expense. There should be greater critical evaluation of the likely demand for health services to reduce the wasting of resources. Finally, if a health legacy is planned, then clear definitions and commitment to its measurement is essential.	[Black, Georgia; Kononovas, Kostas; Raine, Rosalind] UCL, Dept Appl Hlth Res, London, England; [Taylor, Jayne] London Deanery, London, England	University of London; University College London	Black, G (corresponding author), UCL, Dept Appl Hlth Res, London, England.	g.black@ucl.ac.uk		Raine, Rosalind/0000-0003-0904-749X; Black, Georgia/0000-0003-2676-5071	NHS London; UCL Partners; Health Innovation Education Cluster (HIEC) for North East London, North Central London and Essex (NECLES)	NHS London; UCL Partners; Health Innovation Education Cluster (HIEC) for North East London, North Central London and Essex (NECLES)	This project was jointly funded by NHS London, UCL Partners and the Health Innovation Education Cluster (HIEC) for North East London, North Central London and Essex (NECLES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri N, 2010, CAN MED ASSOC J, V182, pE229, DOI 10.1503/cmaj.109-3170; Bate P, 2002, QUALITATIVE HLTH RES, V12, P962; Bi-bo ZX-IP, 2009, CHINESE J NURSING, V1; Black G, 2013, NHS LONDON 2012 PROG; Boyd A, 2012, SCOPING STUDY EMERGE; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Dapeng J, 2010, HLTH LEGACY 2008 BEI; Davies LE, 2012, LEISURE STUD, V31, P309, DOI 10.1080/02614367.2011.649779; Enock KE, 2008, PUBLIC HEALTH, V122, P1229, DOI 10.1016/j.puhe.2008.04.016; Hebson G, 2003, WORK EMPLOY SOC, V17, P481, DOI 10.1177/09500170030173005; Jorm LR, 2003, J EPIDEMIOL COMMUN H, V57, P102, DOI 10.1136/jech.57.2.102; Leatherman S, 2010, INT J QUAL HEALTH C, V22, P237, DOI 10.1093/intqhc/mzq028; MacDonald MN, 2013, DISCOURSE SOC, V24, P66, DOI 10.1177/0957926512474148; McCartney G, 2010, BMJ BRIT MED J, V340; McConnell J, 2010, LANCET INFECT DIS, V10, P818, DOI 10.1016/S1473-3099(10)70260-7; Milsten Andrew M, 2002, Prehosp Disaster Med, V17, P151; NHS London, 2012, SUPP 2012 LOND OL PA; NHS London, 2012, GO LOND LEG BETT HLT; Pepe P, 2013, ANN UPDATE INTENSIVE, V2013, P37; Preuss H., 2007, Journal of Sport Tourism, V12, P207, DOI 10.1080/14775080701736957; Tam JS, 2012, LANCET INFECT DIS; Tsouros AD, 2004, MASS GATHERINGS PUBL; Weed M., 2009, SYSTEMATIC REV EVIDE; Wetterhall SF, 1998, JAMA-J AM MED ASSOC, V279, P1463, DOI 10.1001/jama.279.18.1463	24	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92338	10.1371/journal.pone.0092338	http://dx.doi.org/10.1371/journal.pone.0092338			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24647613	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500119
J	Ferguson, L; Grant, AD; Lewis, J; Kielmann, K; Watson-Jones, D; Vusha, S; Ong'ech, JO; Ross, DA				Ferguson, Laura; Grant, Alison D.; Lewis, James; Kielmann, Karina; Watson-Jones, Deborah; Vusha, Sophie; Ong'ech, John O.; Ross, David A.			Linking Women Who Test HIV-Positive in Pregnancy-Related Services to HIV Care and Treatment Services in Kenya: A Mixed Methods Prospective Cohort Study	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ACTIVE ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; FOLLOW-UP; ANTENATAL CARE; TREATMENT INITIATION; BEHAVIOR-CHANGE; PREVENTION; PROGRAM; ACCESS	Introduction: There has been insufficient attention to long-term care and treatment for pregnant women diagnosed with HIV. Objective and Methods: This prospective cohort study of 100 HIV-positive women recruited within pregnancy-related services in a district hospital in Kenya employed quantitative methods to assess attrition between women testing HIV-positive in pregnancy-related services and accessing long-term HIV care and treatment services. Qualitative methods were used to explore barriers and facilitators to navigating these services. Structured questionnaires were administered to cohort participants at enrolment and 90+ days later. Participants' medical records were monitored prospectively. Semi-structured qualitative interviews were carried out with a sub-set of 19 participants. Findings: Only 53/100 (53%) women registered at an HIV clinic within 90 days of HIV diagnosis, of whom 27/53 (51%) had a CD4 count result in their file. 11/27 (41%) women were eligible for immediate antiretroviral therapy (ART); only 6/11 (55%) started ART during study follow-up. In multivariable logistic regression analysis, factors associated with registration at the HIV clinic within 90 days of HIV diagnosis were: having cared for someone with HIV (aOR:3.67(95% CI:1.22, 11.09)), not having to pay for transport to the hospital (aOR: 2.73(95% CI: 1.09, 6.84)), and having received enough information to decide to have an HIV test (aOR: 3.61(95% CI: 0.83, 15.71)). Qualitative data revealed multiple factors underlying high patient drop-out related to women's social support networks (e.g. partner's attitude to HIV status), interactions with health workers (e.g. being given unclear/incorrect HIV-related information) and health services characteristics (e.g. restricted opening hours, long waiting times). Conclusion: HIV testing within pregnancy-related services is an important entry point to HIV care and treatment services, but few women successfully completed the steps needed for assessment of their treatment needs within three months of diagnosis. Programmatic recommendations include simplified pathways to care, better-tailored counselling, integration of ART into antenatal services, and facilitation of social support.	[Ferguson, Laura] Univ So Calif, Inst Global Hlth, Los Angeles, CA 90089 USA; [Ferguson, Laura; Lewis, James; Ross, David A.] Univ London London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Ferguson, Laura; Vusha, Sophie; Ong'ech, John O.] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [Grant, Alison D.; Watson-Jones, Deborah] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England; [Kielmann, Karina] Queen Margaret Univ, Inst Int Hlth & Dev, Edinburgh, Midlothian, Scotland; [Watson-Jones, Deborah] Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Ong'ech, John O.] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya	University of Southern California; University of London; London School of Hygiene & Tropical Medicine; University of Nairobi; University of London; London School of Hygiene & Tropical Medicine; Queen Margaret University; National Institute of Medical Research; University of Nairobi	Ferguson, L (corresponding author), Univ So Calif, Inst Global Hlth, Los Angeles, CA 90089 USA.	laurafer@usc.edu	Lewis, James/F-6333-2013; Ferguson, Laura/AAO-9694-2021	Ferguson, Laura/0000-0002-1340-793X	Economic and Social Research Council (UK)/Medical Research Council UK; UK Department for International Development-supported Evidence for Action on HIV Treatment and Care Systems Research Programme; Parkes Foundation; University of London Central Research Fund; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Economic and Social Research Council (UK)/Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development-supported Evidence for Action on HIV Treatment and Care Systems Research Programme; Parkes Foundation; University of London Central Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding to support this work came from the Economic and Social Research Council (UK)/Medical Research Council UK (www.esrc.ac.uk; www.mrc.ac.uk), the UK Department for International Development-supported Evidence for Action on HIV Treatment and Care Systems Research Programme (www.evidence4action.org), the Parkes Foundation (www.parkesfoundation.org.uk) and the University of London Central Research Fund (www.london.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams E, 2010, INT AIDS C VIENN AUS; Balira R, 2010, IMPLEMENTATION PREVE; Chen JY, 2010, JAIDS-J ACQ IMM DEF, V54, P102, DOI 10.1097/QAI.0b013e3181c080bf; Chi BH, 2007, JAIDS-J ACQ IMM DEF, V45, P125, DOI 10.1097/QAI.0b013e318050d28f; Chinkonde JR, 2009, REPROD HEALTH MATTER, V17, P143, DOI 10.1016/S0968-8080(09)33440-0; Clouse K, 2013, TROP MED INT HEALTH, V18, P451, DOI 10.1111/tmi.12072; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Ferguson L, 2012, JAIDS-J ACQ IMM DEF, V60, pE90, DOI 10.1097/QAI.0b013e318253258a; Ferguson L, 2012, TROP MED INT HEALTH, V17, P564, DOI 10.1111/j.1365-3156.2012.02958.x; Hensen B, 2012, TROP MED INT HEALTH, V17, P59, DOI 10.1111/j.1365-3156.2011.02893.x; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Killam WP, 2010, AIDS, V24, P85, DOI 10.1097/QAD.0b013e32833298be; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Larsson EC, 2012, HEALTH POLICY PLANN, V27, P69, DOI 10.1093/heapol/czr009; Levy JM, 2009, REPROD HEALTH MATTER, V17, P152, DOI 10.1016/S0968-8080(09)33436-9; Macintyre K, 2001, AIDS EDUC PREV, V13, P160, DOI 10.1521/aeap.13.2.160.19736; Mandala J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-314; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Ministry of Health Republic of Kenya, 2010, NAT REC PREV MOTH CH; Ministry of Health Republic of Kenya, 2009, NAT GUID PREV MOTH T; Mshana GH, 2006, AIDS PATIENT CARE ST, V20, P649, DOI 10.1089/apc.2006.20.649; Muchedzi A, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-38; Nachega JB, 2010, CURR OPIN HIV AIDS, V5, P70, DOI 10.1097/COH.0b013e328333ad61; Otieno PA, 2010, AIDS CARE, V22, P729, DOI 10.1080/09540120903373565; Painter TM, 2004, BMJ-BRIT MED J, V329, P543, DOI 10.1136/bmj.329.7465.543; Palekar R, 2008, AIDS BEHAV, V12, P903, DOI 10.1007/s10461-007-9325-5; Sprague C, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-10; Stinson K, 2010, TROP MED INT HEALTH, V15, P825, DOI 10.1111/j.1365-3156.2010.02538.x; Tonwe-Gold B, 2009, TROP MED INT HEALTH, V14, P204, DOI 10.1111/j.1365-3156.2008.02182.x; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Watson-Jones D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040091; Wettstein C, 2012, AIDS ACQUIRED IMMUNE; WHO, 2012, US ANT DRUGS TREAT P	36	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89764	10.1371/journal.pone.0089764	http://dx.doi.org/10.1371/journal.pone.0089764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24646492	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500009
J	Greshake, B; Bayer, PE; Rausch, H; Reda, J				Greshake, Bastian; Bayer, Philipp E.; Rausch, Helge; Reda, Julia			openSNP-A Crowdsourced Web Resource for Personal Genomics	PLOS ONE			English	Article							DATABASE; CANCER; ISSUES	Genome-Wide Association Studies are widely used to correlate phenotypic traits with genetic variants. These studies usually compare the genetic variation between two groups to single out certain Single Nucleotide Polymorphisms ( SNPs) that are linked to a phenotypic variation in one of the groups. However, it is necessary to have a large enough sample size to find statistically significant correlations. Direct-To-Consumer (DTC) genetic testing can supply additional data: DTC-companies offer the analysis of a large amount of SNPs for an individual at low cost without the need to consult a physician or geneticist. Over 100,000 people have already been genotyped through Direct-To-Consumer genetic testing companies. However, this data is not public for a variety of reasons and thus cannot be used in research. It seems reasonable to create a central open data repository for such data. Here we present the web platform openSNP, an open database which allows participants of Direct-To-Consumer genetic testing to publish their genetic data at no cost along with phenotypic information. Through this crowdsourced effort of collecting genetic and phenotypic information, openSNP has become a resource for a wide area of studies, including Genome-Wide Association Studies. openSNP is hosted at http://www.opensnp.org, and the code is released under MIT-license at http://github.com/gedankenstuecke/snpr.	[Greshake, Bastian] Biodivers & Climate Res Ctr, Mol Ecol Grp, Frankfurt, Germany; [Greshake, Bastian] Goethe Univ Frankfurt, Dept Appl Bioinformat, Inst Cell Biol & Neurosci, D-60054 Frankfurt, Germany; [Bayer, Philipp E.] Univ Queensland, Sch Land Crop & Food Sci, Brisbane, Qld, Australia; [Bayer, Philipp E.] Univ Queensland, Sch Agr & Food Sci, Australian Ctr Plant Funct Genom, Brisbane, Qld, Australia; [Rausch, Helge] Hsch Tech & Wirtschaft, Berlin, Germany; [Reda, Julia] Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany	Goethe University Frankfurt; University of Queensland; University of Queensland; Johannes Gutenberg University of Mainz	Greshake, B (corresponding author), Biodivers & Climate Res Ctr, Mol Ecol Grp, Frankfurt, Germany.	info@opensnp.org	Greshake, Bastian/ABF-7171-2020; Bayer, Philipp Emanuel/L-4481-2018	Greshake, Bastian/0000-0002-9925-9623; Bayer, Philipp Emanuel/0000-0001-8530-3067	German Wikimedia Foundation	German Wikimedia Foundation	The study was partially funded by 5000(sic) from the German Wikimedia Foundation (http://www.wikimedia.de/wiki/Hauptseite) in the context of their WissensWert contest, which funds projects for the use of open licenses to create a more open culture (2011) (http://de.wikipedia.org/wiki/Wikipedia:WissensWert). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	23andMe, 2011, 23ANDME 2011 STAT DA; Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; andMe, 2012, 23ANDME PRIV STAT; Ball MP, 2012, P NATL ACAD SCI USA, V109, P11920, DOI 10.1073/pnas.1201904109; Bove R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059707; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Cariaso M, 2011, NUCL ACIDS RES; Caulfield T, 2012, ANNU REV MED, V63, P23, DOI 10.1146/annurev-med-062110-123753; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Darst BF, 2013, HLTH COMMUN; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Dowell RD, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-7; Eiben CB, 2012, NAT BIOTECHNOL, V30, P190, DOI 10.1038/nbt.2109; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Gollust SE, 2012, PUBLIC HEALTH GENOM, V15, P22, DOI 10.1159/000327296; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Hauskeller C, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2317; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hogarth S, 2008, ANNU REV GENOM HUM G, V9, P161, DOI 10.1146/annurev.genom.9.081307.164319; Jenkinson AM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S8-S3; Joh EE, 2011, NATURE REV GENETICS, V12, P3113; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Joly Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-25; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lee SSJ, 2009, AM J BIOETHICS, V9, P35, DOI 10.1080/15265160902874452; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lintott CJ, 2008, MON NOT R ASTRON SOC, V389, P1179, DOI 10.1111/j.1365-2966.2008.13689.x; McGowan ML, 2010, NEW GENET SOC, V29, P261, DOI 10.1080/14636778.2010.507485; Mei H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031470; Molloy JC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001195; Njiaju UO, 2012, BREAST J, V18, P436, DOI 10.1111/j.1524-4741.2012.01274.x; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Pinkerton CR, 2002, EUR J CANCER, V38, P1051, DOI 10.1016/S0959-8049(02)00021-7; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sweeney L, 2013, CISC VIS NETW IND GL; Tanzi RE, 2012, COLD SPRING HARBOR P, V2; Wasson K, 2009, AM J BIOETHICS, V9, P56, DOI 10.1080/15265160902893965; Wicks P, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1549; Wolinsky H, 2005, EMBO REP, V6, P805, DOI 10.1038/sj.embor.7400508; Xu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030309	42	48	49	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89204	10.1371/journal.pone.0089204	http://dx.doi.org/10.1371/journal.pone.0089204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647222	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500004
J	Kang, KR; Chen, L; Zhao, X; Qin, CF; Zhan, ZW; Wang, JH; Li, WM; Dzakah, EE; Huang, WJ; Shu, YL; Jiang, T; Cao, WC; Xie, MQ; Luo, XC; Tang, SX				Kang, Keren; Chen, Li; Zhao, Xiang; Qin, Chengfeng; Zhan, Zanwu; Wang, Jihua; Li, Wenmei; Dzakah, Emmanuel E.; Huang, Weijuang; Shu, Yuelong; Jiang, Tao; Cao, Wuchun; Xie, Mingquan; Luo, Xiaochun; Tang, Shixing			Development of Rapid Immunochromatographic Test for Hemagglutinin Antigen of H7 Subtype in Patients Infected with Novel Avian Influenza A (H7N9) Virus	PLOS ONE			English	Article							TRANSMISSION; OUTBREAK	Background: Since human infection with the novel H7N9 avian influenza virus was identified in China in March 2013, the relatively high mortality rate and possibility of human-to-human transmission have highlighted the urgent need for sensitive and specific assays for diagnosis of H7N9 infection. Methodology/Principal Findings: We developed a rapid diagnostic test for the novel avian influenza A (H7N9) virus using anti-hemagglutinin (HA) monoclonal antibodies specifically targeting H7 in an immunochromatographic assay system. The assay limit of detection was 10 3.5 pfu/ml or 10 3 TCID50 of H7N9 virus. The assay specifically detected H7N9 viral isolates and recombinant HA proteins of H7 subtypes including H7N7 and H7N9, but did not react with non-H7 subtypes including H1N1, H3N2, H5N1, H5N9, and H9N2. The detection sensitivity was 59.4% (19/32) for H7N9 patients confirmed by RT-PCR. Moreover, the highest sensitivity of 61.5% (16/26) was obtained when testing H7N9 positive sputum samples while 35.7% (5/14) of nasopharyngeal swabs and 20% (2/10) of fecal samples tested positive. No false positive detection was found when testing 180 H7N9 negative samples. Conclusions/Significance: Our novel rapid assay can specifically detect H7 HA antigen, facilitating rapid diagnosis for prevention and control of the on-going H7N9 epidemic.	[Kang, Keren; Dzakah, Emmanuel E.; Xie, Mingquan; Luo, Xiaochun] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Kang, Keren; Chen, Li; Zhan, Zanwu; Wang, Jihua; Li, Wenmei; Tang, Shixing] Guangzhou Wondfo Biotech Co Ltd, Natl Engn Lab Point Of Care Tests, Guangzhou, Guangdong, Peoples R China; [Zhao, Xiang; Huang, Weijuang; Shu, Yuelong] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Qin, Chengfeng; Jiang, Tao; Cao, Wuchun] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China	South China University of Technology; Chinese Center for Disease Control & Prevention; Beijing Institute of Microbiology & Epidemiology	Tang, SX (corresponding author), Guangzhou Wondfo Biotech Co Ltd, Natl Engn Lab Point Of Care Tests, Guangzhou, Guangdong, Peoples R China.	tang.shixing@wondfo.com.cn	Qin, Cheng-Feng/I-6839-2019; Luo, Xiao-Chun/E-2377-2012	Qin, Cheng-Feng/0000-0002-0632-2807; Luo, Xiao-Chun/0000-0001-9554-370X; Dzakah, Emmanuel/0000-0002-7475-6420	National Major Science & Technology Projects for Infectious Disease Control and Prevention [2013ZX10004804]	National Major Science & Technology Projects for Infectious Disease Control and Prevention	This study was supported by the National Major Science & Technology Projects for Infectious Disease Control and Prevention (2013ZX10004804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas C, 2013, EURO SURVEILL, V18; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; China Food and Drug Administration, 2013, AUTH PCR KITS H7N9 C; Editorial team, 2007, EURO SURVEILL, V12; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; National Health and Family Planning Commission of the People's Republic of China, 2013, NEW CAS CHIN; Nguyen-Van-Tam JS, 2006, EUROSURVEILLANCE, V11; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; WHO, 2013, REAL TIM RT PCR PROT; WHO Global Alert and Response, 2013, HUM INF AV INFL A H7; Wulff Niels H, 2012, J Clin Bioinforma, V2, P5, DOI 10.1186/2043-9113-2-5	17	20	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92306	10.1371/journal.pone.0092306	http://dx.doi.org/10.1371/journal.pone.0092306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647358	gold, Green Published, Green Submitted			2022-12-27	WOS:000333348500112
J	Li, CW; Lu, HG; Chen, DH; Lin, ZB; Wang, DY; Li, TY				Li, Chun Wei; Lu, Han Gui; Chen, De Hua; Lin, Zhi Bin; Wang, De Yun; Li, Tian Ying			In Vivo and In Vitro Studies of Th17 Response to Specific Immunotherapy in House Dust Mite-Induced Allergic Rhinitis Patients	PLOS ONE			English	Article							T(H)17 CELLS; HEALTH; DIFFERENTIATION; IL-10	T helper (Th)17 cells have been implicated in the development of allergic rhinitis (AR), but their response to specific immunotherapy (SIT) remains unclear. We investigated the impact of SIT on Th17 response and Th1/Th2 changes in AR patients. Blood samples from AR patients (n = 20) who were monosensitized to house dust mite (HDM) were collected before the initiation of SIT (SIT-untreated) and after the end of 2-year SIT (SIT-treated) treatment. Twenty healthy volunteers were recruited as controls. In vitro HDM stimulation in peripheral blood mononuclear cells (PBMCs) was also performed. Expression levels of Th17 associated genes were determined in both PBMCs and plasma by PCR and ELISA, while Th17/Th1/Th2/IL10 producing cell proportions were evaluated in PBMCs by flow cytometry. The SIT effect was evaluated by assessing clinical symptoms. mRNA levels of Th17 specific genes (IL17 and RORC) were increased in SIT-untreated AR versus controls, and decreased following SIT treatment. SIT can change the production of Th17 associated genes (reduction of IL17, IL6, and IL23, but increase of IL27) in plasma from AR patients. Th2/Th1 ratio and proportions of Th17 cells were suppressed while IL10 producing CD4(+) T cells were elevated after SIT. In vitro HDM challenge presents concordant patterns with in vivo findings: 1) increase of Th2 and Th17 response in AR patients; 2) suppression of IL10 producing CD4(+) T cells in SIT-untreated AR but elevation in SIT-treated AR patients. Most importantly, a positive correlation between IL17 mRNA/protein levels and clinical symptom scores was observed. SIT significantly inhibits Th17 mediated inflammation in AR and IL17 may be a useful biomarker for both AR severity and SIT therapeutic effect.	[Li, Chun Wei; Wang, De Yun] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Otolaryngol, Singapore 117548, Singapore; [Lu, Han Gui; Chen, De Hua; Lin, Zhi Bin; Li, Tian Ying] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Han Gui] Sun Yat Sen Univ, Shantou Cent Hosp, Dept Otolaryngol Head & Neck Surg, Shantou, Peoples R China; [Chen, De Hua; Lin, Zhi Bin; Li, Tian Ying] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Allergy, Guangzhou 510275, Guangdong, Peoples R China	National University of Singapore; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wang, DY (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Dept Otolaryngol, Singapore 117548, Singapore.	entwdy@nus.edu.sg; litianying@yeah.net			Science and Technology Planning Project of Guangdong Province, China [99M04901G]	Science and Technology Planning Project of Guangdong Province, China	This study was supported by grant from Science and Technology Planning Project of Guangdong Province, China (No. 99M04901G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; [Anonymous], CELL, V126, P1121; Borish L, 2003, J ALLERGY CLIN IMMUN, V112, P1021, DOI 10.1016/j.jaci.2003.09.015; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Ciprandi G, 2009, ALLERGY, V64, P1375, DOI 10.1111/j.1398-9995.2009.02010.x; Ciprandi G, 2010, INT IMMUNOPHARMACOL, V10, P226, DOI 10.1016/j.intimp.2009.11.004; Ciprandi G, 2009, INT IMMUNOPHARMACOL, V9, P1247, DOI 10.1016/j.intimp.2009.07.004; Crome SQ, 2010, CLIN EXP IMMUNOL, V159, P109, DOI 10.1111/j.1365-2249.2009.04037.x; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Hansen I, 2004, CURR OPIN ALLERGY CL, V4, P159, DOI 10.1097/01.all.0000129444.81350.23; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; JUTEL M, 1995, J IMMUNOL, V154, P4187; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louten J, 2009, J ALLERGY CLIN IMMUN, V123, P1004, DOI 10.1016/j.jaci.2009.04.003; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; Park SJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-78; Pipe A, 2009, RESP MED, V103, P800, DOI 10.1016/j.rmed.2009.01.008; Qu Shen-hong, 2005, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V40, P908; Schmidt-Weber CB, 2007, J ALLERGY CLIN IMMUN, V120, P247, DOI 10.1016/j.jaci.2007.06.039; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001; Zuberbier T, 2010, ALLERGY, V65, P1525, DOI 10.1111/j.1398-9995.2010.02474.x	25	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91950	10.1371/journal.pone.0091950	http://dx.doi.org/10.1371/journal.pone.0091950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647473	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500063
J	Zhang, M; Guo, R; Shi, S; Miao, Y; Zhang, YF; Li, B				Zhang, Min; Guo, Rui; Shi, Shuo; Miao, Yin; Zhang, Yifan; Li, Biao			Baculovirus Vector-Mediated Transfer of Sodium Iodide Symporter and Plasminogen Kringle 5 Genes for Tumor Radioiodide Therapy	PLOS ONE			English	Article							IONIZING-RADIATION; ANGIOGENESIS INHIBITORS; PROSTATE-CANCER; IN-VIVO; EXPRESSION; CELLS; PROMOTER; RADIOTHERAPY; XENOGRAFTS; ACTIVATION	Background: Both tumor cells and their supporting endothelial cells should be considered for targeted cell killing when designing cancer treatments. Here we investigated the feasibility of combining radioiodide and antiangiogenic therapies after baculovirus-mediated transfer of genes encoding the sodium iodide symporter (NIS) and plasminogen kringle 5 (K5). Methods: A recombinant baculovirus containing the NIS gene under control of the human telomerase reverse transcriptase (hTERT) promoter and the K5 gene driven by the early growth response 1 (Egr1) promoter was developed. Dual-luciferase reporter assay was performed to confirm the activation of hTERT transcription. NIS and K5 gene expression were identified by Western blot and Real-Time PCR. Functional NIS activity in baculovirus-infected Hela cells was confirmed by the uptake of (125)vertical bar and cytotoxicity of (131)vertical bar. The apoptotic effect of (131)vertical bar-induced K5 on baculovirus-infected human umbilical vein endothelial cells (HUVECs) was analyzed by a flow cytometry-based assay. In vivo, NIS reporter gene imaging and therapeutic experiments with (131)vertical bar were performed. Finally, the microvessel density (MVD) in tumors after treatment was determined by CD31 immunostaining. Results: The activation of hTERT transcription was specifically up-regulated in tumor cells. NIS gene expression markedly increased in baculovirus-infected HeLa cells, but not in MRC5 cells. The Hela cells showed a significant increase of (125) vertical bar uptake, which was inhibited by NaClO4, and a notably decreased cell survival rate by (131)vertical bar treatment. Expression of the K5 gene induced by (131)vertical bar was elevated in a dose-and time-dependent manner and resulted in the apoptosis of HUVECs. Furthermore, (131)vertical bar SPECT imaging clearly showed cervical tumor xenografts infected with recombinant baculovirus. Following therapy, tumor growth was significantly retarded. CD31 immunostaining confirmed a significant decrease of MVD. Conclusion: The recombinant baculovirus supports a promising strategy of NIS-based raidoiodide therapy combined with K5-based antiangiogenic therapy by targeting both the tumor and its supporting vessels.	[Zhang, Min; Guo, Rui; Shi, Shuo; Miao, Yin; Zhang, Yifan; Li, Biao] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Li, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China.	lb10363@rjh.com.cn	Zhang, Yifan/AGT-8799-2022	Yifan, Zhang/0000-0001-6488-6232; Zhang, Min/0000-0001-5812-9518	National Natural Science Foundation of China [81071181]; Shanghai Outstanding Academic Leaders Project [11XD1403700]; Shanghai Health Bureau Youth Foundation [2010Y021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Outstanding Academic Leaders Project; Shanghai Health Bureau Youth Foundation	This work was supported by grants from the National Natural Science Foundation of China (No. 81071181,http://isisn.nsfc.gov.cn/egrantweb/), Shanghai Outstanding Academic Leaders Project (11XD1403700, http://www.stcsm.gov.cn/) and Shanghai Health Bureau Youth Foundation (2010Y021,http://www.smhb.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boland A, 2000, CANCER RES, V60, P3484; Camphausen K, 2002, EXPERT OPIN BIOL TH, V2, P477; Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; Cengic N, 2005, J CLIN ENDOCR METAB, V90, P4457, DOI 10.1210/jc.2004-2140; Condreay JP, 1999, P NATL ACAD SCI USA, V96, P127, DOI 10.1073/pnas.96.1.127; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; DATTA R, 1992, P NATL ACAD SCI USA, V89, P10149, DOI 10.1073/pnas.89.21.10149; Dwyer RM, 2005, MOL THER, V12, P835, DOI 10.1016/j.ymthe.2005.05.013; Dwyer RM, 2005, CLIN CANCER RES, V11, P1483, DOI 10.1158/1078-0432.CCR-04-1636; Gorski DH, 1999, CANCER RES, V59, P3374; Gorski DH, 1998, CANCER RES, V58, P5686; Guo R, 2010, NUCL MED COMMUN, V31, P916, DOI 10.1097/MNM.0b013e32833dedd7; Haberkorn U, 2001, J NUCL MED, V42, P317; Hu YC, 2008, CURR GENE THER, V8, P54, DOI 10.2174/156652308783688509; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jin GH, 2007, INT J CANCER, V121, P2539, DOI 10.1002/ijc.22708; Kaikkonen MU, 2006, GENE THER, V13, P304, DOI 10.1038/sj.gt.3302657; Kawashita Y, 2005, GENE THER, V12, P1633, DOI 10.1038/sj.gt.3302531; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kim SH, 2008, HUM GENE THER, V19, P951, DOI [10.1089/hum.2008.030, 10.1089/hgt.2008.030]; Koga S, 2000, HUM GENE THER, V11, P1397, DOI 10.1089/10430340050057477; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu H, 1999, BIOCHEM BIOPH RES CO, V258, P668, DOI 10.1006/bbrc.1999.0612; Minemura K, 2000, ENDOCRINOLOGY, V141, P1814, DOI 10.1210/en.141.5.1814; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; Scholz IV, 2005, GENE THER, V12, P272, DOI 10.1038/sj.gt.3302410; Shin JH, 2004, EUR J NUCL MED MOL I, V31, P425, DOI 10.1007/s00259-003-1394-8; Spitzweg C, 2000, CANCER RES, V60, P6526; Takahashi T, 1997, HUM GENE THER, V8, P827, DOI 10.1089/hum.1997.8.7-827; Takakura M, 1999, CANCER RES, V59, P551; WEICHSELBAUM RR, 1994, CANCER RES, V54, P4266; Zhu XP, 2010, MED PHYS, V37, P2974, DOI 10.1118/1.3431999	32	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92326	10.1371/journal.pone.0092326	http://dx.doi.org/10.1371/journal.pone.0092326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647588	Green Published, gold, Green Submitted			2022-12-27	WOS:000333348500118
J	Zhu, XM; Huang, SX; Zhang, LL; Wu, YM; Chen, YW; Tao, YX; Wang, YS; He, SG; Shen, SB; Wu, J; Li, BJ; Guo, XZ; He, L; Ma, G				Zhu, Xuming; Huang, Sixia; Zhang, Lingling; Wu, Yumei; Chen, Yingwei; Tao, Yixin; Wang, Yushu; He, Shigang; Shen, Sanbing; Wu, Ji; Li, Baojie; Guo, Xizhi; He, Lin; Ma, Gang			Constitutive Activation of Ectodermal beta-Catenin Induces Ectopic Outgrowths at Various Positions in Mouse Embryo and Affects Abdominal Ventral Body Wall Closure	PLOS ONE			English	Article							GENETIC INTERACTION; VERTEBRATE LIMB; MORPHOGENESIS; INITIATION; IDENTITY; SIGNALS; RIDGE; FGF10; TBX4; MICE	Vertebrate limbs originate from the lateral plate mesoderm (LPM) and the overlying ectoderm. While normal limb formation in defined regions has been well studied, the question of whether other positions retain limb-forming potential has not been fully investigated in mice. By ectopically activating beta-catenin in the ectoderm with Msx2-cre, we observed that local tissue outgrowths were induced, which either progressed into limb-like structure within the inter-limb flank or formed extra tissues in other parts of the mouse embryo. In the presumptive abdominal region of severely affected embryos, ectopic limb formation was coupled with impaired abdominal ventral body wall (AVBW) closure, which indicates the existence of a potential counterbalance of limb formation and AVBW closure. At the molecular level, constitutive beta-catenin activation was sufficient to trigger, but insufficient to maintain the ectopic expression of a putative limb-inducing factor, Fgf8, in the ectoderm. These findings provide new insight into the mechanism of limb formation and AVBW closure, and the crosstalk between the Wnt/beta-catenin pathway and Fgf signal.	[Zhu, Xuming; Huang, Sixia; Zhang, Lingling; Tao, Yixin; Wang, Yushu; He, Shigang; Shen, Sanbing; Wu, Ji; Li, Baojie; Guo, Xizhi; He, Lin; Ma, Gang] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Wu, Yumei; Chen, Yingwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Dermatol,Luwan Branch, Shanghai 200030, Peoples R China; [He, Shigang] Shanghai Jiao Tong Univ, Dept Biomed Engn, Shanghai 200030, Peoples R China; [Shen, Sanbing] Natl Univ Ireland Galway, Sch Med, Regenerat Med Inst, Galway, Ireland	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Ollscoil na Gaillimhe-University of Galway	Guo, XZ (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.	xzguo2005@gmail.com; helinhelin3@gmail.com; magang2004@gmail.com	Zhu, Xuming/ABC-6380-2021; Shen, Sanbing/E-3750-2015; zhang, lingling/HDM-2189-2022	Zhu, Xuming/0000-0003-1148-4162; Huang, Sixia/0000-0003-3591-1085; Zhang, Lingling/0000-0002-9390-8880; Shen, Sanbing/0000-0002-8217-9811; Guo, Xizhi/0000-0001-8047-6049	973 Programs [2013CB967401, 2011CBA00803, 2012CB966903, 2010CB529600]; National Key Technology RD Program [2012BAI01B09]; National Nature Science Foundation of China [91127047, 81121001]; Natural Science Foundation of Shanghai [13ZR1421100]; Shanghai Leading Academic Discipline Project [B205]	973 Programs(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the 973 Programs (2013CB967401, 2011CBA00803, 2012CB966903, 2010CB529600), the National Key Technology R&D Program (2012BAI01B09), the National Nature Science Foundation of China (91127047, 81121001), the Natural Science Foundation of Shanghai (13ZR1421100), and the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Brewer S, 2004, BIOESSAYS, V26, P1307, DOI 10.1002/bies.20137; Cohn MJ, 1997, NATURE, V387, P97, DOI 10.1038/387097a0; Cooper KL, 2011, SCIENCE, V332, P1083, DOI 10.1126/science.1199499; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Huang SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045904; Hunter AGW, 2011, AM J MED GENET A, V155A, P2045, DOI 10.1002/ajmg.a.34161; Kawakami Y, 2001, CELL, V104, P891, DOI 10.1016/S0092-8674(01)00285-9; Lin CX, 2008, DEVELOPMENT, V135, P2815, DOI 10.1242/dev.020586; Lin CX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003231; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; RANCOURT DE, 1995, GENE DEV, V9, P108, DOI 10.1101/gad.9.1.108; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Soshnikova N, 2003, GENE DEV, V17, P1963, DOI 10.1101/gad.263003; Sun J, 2007, BIOCHEM BIOPH RES CO, V360, P238, DOI 10.1016/j.bbrc.2007.06.049; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Takeuchi JK, 1999, NATURE, V398, P810, DOI 10.1038/19762; Tamura K, 2001, J ANAT, V199, P195, DOI 10.1017/S0021878201008081; Tanaka M, 2000, DEVELOPMENT, V127, P4011; Zhu XM, 2012, DEV BIOL, V365, P328, DOI 10.1016/j.ydbio.2012.02.019	22	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92092	10.1371/journal.pone.0092092	http://dx.doi.org/10.1371/journal.pone.0092092			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647475	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500082
J	Zou, B; Peng, F; Wan, N; Mamady, K; Wilson, GJ				Zou, Bin; Peng, Fen; Wan, Neng; Mamady, Keita; Wilson, Gaines J.			Spatial Cluster Detection of Air Pollution Exposure Inequities across the United States	PLOS ONE			English	Article							ENVIRONMENTAL INEQUALITY; HEALTH; MORTALITY; DISPARITIES; MODIFIERS; BENZENE; JUSTICE; CONTEXT; BURDEN; MODELS	Air quality is known to be a key factor in affecting the wellbeing and quality of life of the general populous and there is a large body of knowledge indicating that certain underrepresented groups may be overexposed to air pollution. Therefore, a more precise understanding of air pollution exposure as a driving cause of health disparities between and among ethnic and racial groups is necessary. Utilizing 52,613 urban census tracts across the United States, this study investigates age, racial, educational attainment and income differences in exposure to benzene pollution in 1999 as a case. The study examines spatial clustering patterns of these inequities using logistic regression modeling and spatial autocorrelation methods such as the Global Moran's I index and the Anselin Local Moran's I index. Results show that the age groups of 0 to 14 and those over 60 years old, individuals with less than 12 years of education, racial minorities including Blacks, American Indians, Asians, some other races, and those with low income were exposed to higher levels of benzene pollution in some census tracts. Clustering analyses stratified by age, education, and race revealed a clear case of disparities in spatial distribution of exposure to benzene pollution across the entire United States. For example, people aged less than 4 years from the western south and the Pacific coastal areas exhibit statistically significant clusters. The findings confirmed that there are geographical-location based disproportionate pattern of exposures to benzene air pollution by various socio-demographic factors across the United States and this type of disproportionate exposure pattern can be effectively detected by a spatial autocorrelation based cluster analysis method. It is suggested that there is a clear and present need for programs and services that will reduce inequities and ultimately improve environmental conditions for all underrepresented groups in the United States.	[Zou, Bin; Peng, Fen] Cent S Univ, Sch Geosci & Infophys, Changsha, Hunan, Peoples R China; [Wan, Neng] Univ Utah, Dept Geog, Salt Lake City, UT USA; [Mamady, Keita] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Wilson, Gaines J.] Huston Tillotson Univ, Dept Biol Sci, Austin, TX USA	Central South University; Utah System of Higher Education; University of Utah; Central South University; Huston-Tillotson University	Zou, B (corresponding author), Cent S Univ, Sch Geosci & Infophys, Changsha, Hunan, Peoples R China.	210010@csu.edu.cn	Wan, Neng/C-1577-2016	Wan, Neng/0000-0001-8214-9164	National Natural Science Foundation of China [41201384]; Hunan Provincial Natural Science Foundation of China [12JJ3034]; State Key Laboratory of Resources and Environmental Information System; Key Laboratory of Geo-informatics of State Bureau of Surveying and Mapping [201328]; NieYing Talent Program of Central South University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); State Key Laboratory of Resources and Environmental Information System; Key Laboratory of Geo-informatics of State Bureau of Surveying and Mapping; NieYing Talent Program of Central South University	The research reported in this paper was funded by the National Natural Science Foundation of China (Project No. 41201384, http://www.nsfc.gov.cn/Portal0/default152.htm), the Hunan Provincial Natural Science Foundation of China (Project No. 12JJ3034, http://www.hnst.gov.cn/zzjg/nsjg/hnszrkxjjwyhbgs/), the State Key Laboratory of Resources and Environmental Information System (http://www.lreis.ac.cn/sc/index.aspx). Bin Zou would also like to thank the grant from the Key Laboratory of Geo-informatics of State Bureau of Surveying and Mapping (Project No. 201328, http://www.casm.ac.cn/), as well as the NieYing Talent Program of Central South University (www.csu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, LANCET; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Bowen WM, 1995, ANN ASSOC AM GEOGR, V85, P641, DOI 10.1111/j.1467-8306.1995.tb01818.x; Briggs DJ, 2000, SCI TOTAL ENVIRON, V253, P151, DOI 10.1016/S0048-9697(00)00429-0; Buzzelli M, 2003, ANN ASSOC AM GEOGR, V93, P557, DOI 10.1111/1467-8306.9303003; Chakraborty J, 2012, INT J ENVIRON HEAL R, V22, P165, DOI 10.1080/09603123.2011.628643; Chakraborty J, 2011, GEOTECH ENVIRON, V4, P111, DOI 10.1007/978-94-007-0329-2_5; Cliff A, 1987, SPATIAL PROCESS MODE; Cole L, 1992, ECOLOGY LQ, V19, P634; Cubbin Catherine, 2001, Ethnicity and Disease, V11, P687; Toan DTT, 2013, GLOBAL HEALTH ACTION, V6, P7, DOI 10.3402/gha.v6i0.18632; Duarte-Davidson R, 2001, OCCUP ENVIRON MED, V58, P2, DOI 10.1136/oem.58.1.2; ESRI, ARCGIS DESKT HELP EB; Fernandez-Somoano A, 2014, J EPIDEMIOL COMMUN H, V68, P29, DOI 10.1136/jech-2013-202722; Fuller MM, 2012, ECOGRAPHY, V35, P510, DOI 10.1111/j.1600-0587.2011.06772.x; Gee GC, 2004, ENVIRON HEALTH PERSP, V112, P1645, DOI 10.1289/ehp.7074; Gee GC, 2004, SOC SCI MED, V59, P405, DOI 10.1016/j.socscimed.2003.10.027; Gwynn RC, 2001, ENVIRON HEALTH PERSP, V109, P501, DOI 10.2307/3454660; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Jerrett M, 2003, J TOXICOL ENV HEAL A, V66, P1735, DOI 10.1080/15287390306438; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Keppel K. G., 2002, HLTH PEOPLE STAT NOT, V23; Kleinbaum D.G., 2010, LOGISTIC REGRESSION, P1, DOI 10.1007/978-1-4419-1742-3_1; Lebel A, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-27; Marchetti F, 2012, ENVIRON HEALTH PERSP, V120, P229, DOI 10.1289/ehp.1103921; Margellos H, 2004, AM J PUBLIC HEALTH, V94, P116, DOI 10.2105/AJPH.94.1.116; Marshall JD, 2008, ATMOS ENVIRON, V42, P5499, DOI 10.1016/j.atmosenv.2008.02.005; Martin D, 2004, AREA, V36, P136, DOI 10.1111/j.0004-0894.2004.00210.x; Mennis J, 2003, PROF GEOGR, V55, P31; Morrens B, 2012, INT J HYG ENVIR HEAL, V215, P474, DOI 10.1016/j.ijheh.2011.10.008; O'Neill MS, 2003, ENVIRON HEALTH PERSP, V111, P1861, DOI 10.1289/ehp.6334; Ou CQ, 2008, ENVIRON RES, V107, P237, DOI 10.1016/j.envres.2008.02.002; Pastor M, 2005, J URBAN AFF, V27, P127, DOI 10.1111/j.0735-2166.2005.00228.x; Pellow DN, 2000, AM BEHAV SCI, V43, P581, DOI 10.1177/00027640021955441; Ponce NA, 2005, AM J EPIDEMIOL, V162, P140, DOI 10.1093/aje/kwi173; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Pulido L, 1996, ANTIPODE, V28, P142, DOI 10.1111/j.1467-8330.1996.tb00519.x; REITZE AW, 1999, HOUS L REV, V36, P679; Ringquist EJ, 2005, J POLICY ANAL MANAG, V24, P223, DOI 10.1002/pam.20088; Rogerson PA, 2012, GEOGR ANAL, V44, P121, DOI 10.1111/j.1538-4632.2012.00840.x; Schwartz J, 2000, EPIDEMIOLOGY, V11, P666, DOI 10.1097/00001648-200011000-00009; Smith MT, 2010, ANNU REV PUBL HEALTH, V31, P133, DOI 10.1146/annurev.publhealth.012809.103646; Tian N, 2010, HEALTH PLACE, V16, P209, DOI 10.1016/j.healthplace.2009.09.012; U.S. Bureau of the Census, 2001, CENS 2000 TIGER LIN; U.S. Environmental Protection Agency, 1999, 1999 NAT AIR TOX ASS; *US BUR CENS, 2001, CENS 2000 SUMM FIL 1; Wikipedia the free encyclopedia, LIST REG US; Zanobetti A, 2000, J OCCUP ENVIRON MED, V42, P469, DOI 10.1097/00043764-200005000-00002; Zeka A, 2006, AM J EPIDEMIOL, V163, P849, DOI 10.1093/aje/kwj116; Zou B, 2010, ENVIRON MONIT ASSESS, V166, P159, DOI 10.1007/s10661-009-0992-8	50	49	51	4	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91917	10.1371/journal.pone.0091917	http://dx.doi.org/10.1371/journal.pone.0091917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6ER	24647354	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500060
J	Li, C; Yu, DG; Williams, GR; Wang, ZH				Li, Chen; Yu, Deng-Guang; Williams, Gareth R.; Wang, Zhuan-Hua			Fast-Dissolving Core-Shell Composite Microparticles of Quercetin Fabricated Using a Coaxial Electrospray Process	PLOS ONE			English	Article							DUAL DRUG-RELEASE; SOLID DISPERSIONS; DELIVERY; ENHANCEMENT; ATOMIZATION; PARTICLES; SYSTEM	This study reports on novel fast-dissolving core-shell composite microparticles of quercetin fabricated using coaxial electrospraying. A PVC-coated concentric spinneret was developed to conduct the electrospray process. A series of analyses were undertaken to characterize the resultant particles in terms of their morphology, the physical form of their components, and their functional performance. Scanning and transmission electron microscopies revealed that the microparticles had spherical morphologies with clear core-shell structure visible. Differential scanning calorimetry and X-ray diffraction verified that the quercetin active ingredient in the core and sucralose and sodium dodecyl sulfate (SDS) excipients in the shell existed in the amorphous state. This is believed to be a result of second-order interactions between the components; these could be observed by Fourier transform infrared spectroscopy. In vitro dissolution and permeation studies showed that the microparticles rapidly released the incorporated quercetin within one minute, and had permeation rates across the sublingual mucosa around 10 times faster than raw quercetin.	[Li, Chen; Wang, Zhuan-Hua] Shanxi Univ, Inst Biotechnol, Taiyuan, Peoples R China; [Yu, Deng-Guang] Shanghai Univ Sci & Technol, Sch Mat & Engn, Shanghai 201800, Peoples R China; [Williams, Gareth R.] UCL Sch Pharm, London, England	Shanxi University; University of Shanghai for Science & Technology; University of London; University College London	Yu, DG (corresponding author), Shanghai Univ Sci & Technol, Sch Mat & Engn, Shanghai 201800, Peoples R China.	ydg017@gmail.com; zhwang@sxu.edu.cn	Williams, Gareth/A-5980-2013; Yu, Deng-Guang/W-1686-2019	Williams, Gareth/0000-0002-3066-2860; Yu, Deng-Guang/0000-0001-7825-4498	Natural Sciences Foundation of China [51373101, 30970611, 31171659]; Natural Science Foundation of Shanghai [13ZR1428900]; Shanghai Municipal Education Commission [13ZZ113]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by the Natural Sciences Foundation of China (Nos. 51373101, 30970611 and 31171659), the Natural Science Foundation of Shanghai (No. 13ZR1428900) and the Key Project of the Shanghai Municipal Education Commission (No. 13ZZ113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrendt JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050713; Beig A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068237; Bikiaris DN, 2011, EXPERT OPIN DRUG DEL, V8, P1501, DOI 10.1517/17425247.2011.618181; Chakraborty S, 2009, ADV DRUG DELIVER REV, V61, P1043, DOI 10.1016/j.addr.2009.07.013; Chaturvedi A, 2011, CURR DRUG DELIV, V8, P373, DOI 10.2174/156720111795768022; Chaudhuri RG, 2012, CHEM REV, V112, P2373, DOI 10.1021/cr100449n; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071265; Chuang CC, 2010, AM J CLIN NUTR, V92, P1511, DOI 10.3945/ajcn.2010.29807; Cui WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068771; Ding L, 2005, J CONTROL RELEASE, V102, P395, DOI 10.1016/j.jconrel.2004.10.011; Douroumis D, 2011, EXPERT OPIN DRUG DEL, V8, P665, DOI 10.1517/17425247.2011.566553; Enayati M, 2010, J R SOC INTERFACE, V7, P667, DOI 10.1098/rsif.2009.0348; George MC, 2009, ANGEW CHEM INT EDIT, V48, P8606, DOI 10.1002/anie.200904089; Grotz VL, 2009, REGUL TOXICOL PHARM, V55, P1, DOI 10.1016/j.yrtph.2009.05.011; Hong Y, 2011, BIOMATERIALS, V32, P3387, DOI 10.1016/j.biomaterials.2011.01.025; Li HL, 2009, J CONTROL RELEASE, V133, P238, DOI 10.1016/j.jconrel.2008.10.002; Li SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043328; Li WB, 2013, MATER LETT, V93, P125, DOI 10.1016/j.matlet.2012.11.064; Li XY, 2013, INT J MOL SCI, V14, P21647, DOI 10.3390/ijms141121647; Liang XL, 2012, ANGEW CHEM INT EDIT, V51, P8034, DOI 10.1002/anie.201203456; Loscertales IG, 2002, SCIENCE, V295, P1695, DOI 10.1126/science.1067595; Lu XF, 2011, PROG POLYM SCI, V36, P671, DOI 10.1016/j.progpolymsci.2010.07.010; Moghe AK, 2008, POLYM REV, V48, P353, DOI 10.1080/15583720802022257; Nagaraju T, 2013, CURR DRUG DELIV, V10, P96, DOI 10.2174/1567201811310010016; Nagy ZK, 2013, J PHARM SCI-US, V102, P508, DOI 10.1002/jps.23374; Nicolazzo JA, 2005, J CONTROL RELEASE, V105, P1, DOI 10.1016/j.jconrel.2005.01.024; Park CG, 2014, ACTA BIOMATER, V10, P77, DOI 10.1016/j.actbio.2013.08.026; Pongpeerapat A, 2006, PHARM RES, V23, P2566, DOI 10.1007/s11095-006-9089-z; Roh KH, 2005, NAT MATER, V4, P759, DOI 10.1038/nmat1486; Roscigno P, 2003, LANGMUIR, V19, P9638, DOI 10.1021/la034928r; Saigal N, 2008, EXPERT OPIN THER PAT, V18, P769, DOI 10.1517/13543776.18.7.769; Salata OV, 2005, CURR NANOSCI, V1, P25, DOI 10.2174/1573413052953192; Slater SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020802; Song BT, 2012, ACTA BIOMATER, V8, P1901, DOI 10.1016/j.actbio.2012.01.020; Webster TJ, 2006, INT J NANOMED, V1, P115, DOI 10.2147/nano.2006.1.2.115; Wu J, 2013, ACTA BIOMATER, V9, P7410, DOI 10.1016/j.actbio.2013.03.022; Wu YQ, 2008, J BIOMAT SCI-POLYM E, V19, P573, DOI 10.1163/156856208784089616; Xie JW, 2006, BIOMATERIALS, V27, P3321, DOI 10.1016/j.biomaterials.2006.01.034; Yu DG, 2013, ACTA BIOMATER, V9, P5665, DOI 10.1016/j.actbio.2012.10.021; Yu DG, 2013, RSC ADV, V3, P17775, DOI 10.1039/c3ra43222j; Yu DG, 2013, RSC ADV, V3, P4652, DOI 10.1039/c3ra40334c; Yu DG, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/10/105606; Yu DG, 2011, INT J NANOMED, V6, P3271, DOI 10.2147/IJN.S27468; Yu DG, 2010, INT J PHARMACEUT, V400, P158, DOI 10.1016/j.ijpharm.2010.08.010; Yu DG, 2009, DRUG DEV IND PHARM, V35, P1530, DOI 10.3109/03639040903059359; Yu DG, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/5/055104; Yu DG, 2009, J PHARM PHARMACOL, V61, P323, DOI 10.1211/jpp/61.03.0006	47	37	38	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92106	10.1371/journal.pone.0092106	http://dx.doi.org/10.1371/journal.pone.0092106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643072	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900087
J	Nandi, S; Chanda, S; Bagchi, P; Nayak, MK; Bhowmick, R; Chawla-Sarkar, M				Nandi, Satabdi; Chanda, Shampa; Bagchi, Parikshit; Nayak, Mukti Kant; Bhowmick, Rahul; Chawla-Sarkar, Mamta			MAVS Protein Is Attenuated by Rotavirus Nonstructural Protein 1	PLOS ONE			English	Article							ANTIVIRAL SIGNALING PROTEIN; INTERFERON-REGULATORY-FACTORS; INNATE IMMUNE-RESPONSES; NF-KAPPA-B; RIG-I; VIRAL EVASION; NSP1; INFECTION; RNA; DEGRADATION	Rotavirus is the single, most important agent of infantile gastroenteritis in many animal species, including humans. In developing countries, rotavirus infection attributes approximately 500,000 deaths annually. Like other viruses it establishes an intimate and complex interaction with the host cell to counteract the antiviral responses elicited by the cell. Among various pattern recognition receptors (PAMPs) of the host, the cytosolic RNA helicases interact with viral RNA to activate the Mitochondrial Antiviral Signaling protein (MAVS), which regulates cellular interferon response. With an aim to identify the role of different PAMPs in rotavirus infected cell, MAVS was found to degrade in a time dependent and strain independent manner. Rotavirus non-structural protein 1 (NSP1) which is a known IFN antagonist, interacted with MAVS and degraded it in a strain independent manner, resulting in a complete loss of RNA sensing machinery in the infected cell. To best of our knowledge, this is the first report on NSP1 functionality where a signaling protein is targeted unanimously in all strains. In addition NSP1 inhibited the formation of detergent resistant MAVS aggregates, thereby averting the antiviral signaling cascade. The present study highlights the multifunctional role of rotavirus NSP1 and reinforces the fact that the virus orchestrates the cellular antiviral response to its own benefit by various back up strategies.	[Nandi, Satabdi; Chanda, Shampa; Bagchi, Parikshit; Nayak, Mukti Kant; Bhowmick, Rahul; Chawla-Sarkar, Mamta] Natl Inst Cholera & Enter Dis, Div Virol, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Chawla-Sarkar, M (corresponding author), Natl Inst Cholera & Enter Dis, Div Virol, Kolkata, W Bengal, India.	chawlam70@gmail.com	Bhowmick, Rahul/AAD-4433-2022	Bhowmick, Rahul/0000-0002-5412-1209	Indian Council of Medical Research (ICMR), India; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science and Technology of Japan	Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR)); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science and Technology of Japan	The study was financially supported by Indian Council of Medical Research (ICMR), India and Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) of the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Arnold MM, 2013, J VIROL, V87, P9813, DOI 10.1128/JVI.01146-13; Arnold MM, 2011, J VIROL, V85, P1970, DOI 10.1128/JVI.01801-10; Bagchi P, 2013, VIROLOGY, V444, P41, DOI 10.1016/j.virol.2013.07.003; Bagchi P, 2013, J VIROL, V87, P2358, DOI 10.1128/JVI.02479-12; Bagchi P, 2010, J VIROL, V84, P6834, DOI 10.1128/JVI.00225-10; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Bhowmick R, 2013, J VIROL, V87, P6840, DOI 10.1128/JVI.00734-13; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Broquet AH, 2011, J IMMUNOL, V186, P1618, DOI 10.4049/jimmunol.1002862; ESTES MK, 2007, FIELDS VIROLOGY, V2, P1917; Feng N, 2009, J VIROL, V83, P6987, DOI 10.1128/JVI.00585-09; Graff JW, 2007, J GEN VIROL, V88, P613, DOI 10.1099/vir.0.82255-0; Graff JW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000280; Graff JW, 2002, J VIROL, V76, P9545, DOI 10.1128/JVI.76.18.9545-9550.2002; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hrincius ER, 2011, CELL MICROBIOL, V13, P1907, DOI 10.1111/j.1462-5822.2011.01680.x; HUA J, 1993, VIROLOGY, V196, P372, DOI 10.1006/viro.1993.1492; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Kumar M, 2011, J VIROL, V85, P987, DOI 10.1128/JVI.01825-10; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203; Qi BC, 2007, INT J BIOCHEM CELL B, V39, P287, DOI 10.1016/j.biocel.2006.08.016; Qin L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-526; Ramig RF, 2004, J VIROL, V78, P10213, DOI 10.1128/JVI.78.19.10213-10220.2004; Rojas M, 2010, J VIROL, V84, P10457, DOI 10.1128/JVI.00625-10; Rollo EE, 1999, J IMMUNOL, V163, P4442; Sen A, 2013, J VIROL; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Sen A, 2009, J VIROL, V83, P10322, DOI 10.1128/JVI.01186-09; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Varga ZT, 2012, J VIROL, V86, P8359, DOI 10.1128/JVI.01122-12; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Wei CW, 2010, J IMMUNOL, V185, P1158, DOI 10.4049/jimmunol.0903874; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014	43	27	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92126	10.1371/journal.pone.0092126	http://dx.doi.org/10.1371/journal.pone.0092126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643253	Green Submitted, Green Published, gold			2022-12-27	WOS:000333259900091
J	Hotson, JR				Hotson, John R.			Noninvasive Peroneal Sensory and Motor Nerve Conduction Recordings in the Rabbit Distal Hindlimb: Feasibility, Variability and Neuropathy Measure	PLOS ONE			English	Article							OXALIPLATIN-INDUCED NEUROTOXICITY; PERIPHERAL NEUROPATHY; PHYLOGENETIC ANALYSIS; AXONAL NEUROPATHY; FIBER DENSITY; ANIMAL-MODELS; VINCRISTINE; RELIABILITY; TRANSPORT; MEDICINE	The peroneal nerve anatomy of the rabbit distal hindlimb is similar to humans, but reports of distal peroneal nerve conduction studies were not identified with a literature search. Distal sensorimotor recordings may be useful for studying rabbit models of length-dependent peripheral neuropathy. Surface electrodes were adhered to the dorsal rabbit foot overlying the extensor digitorum brevis muscle and the superficial peroneal nerve. The deep and superficial peroneal nerves were stimulated above the ankle and the common peroneal nerve was stimulated at the knee. The nerve conduction studies were repeated twice with a one-week intertest interval to determine measurement variability. Intravenous vincristine was used to produce a peripheral neuropathy. Repeat recordings measured the response to vincristine. A compound muscle action potential and a sensory nerve action potential were evoked in all rabbits. The compound muscle action potential mean amplitude was 0.29 mV (SD +/- 0.12) and the fibula head to ankle mean motor conduction velocity was 46.5 m/s (SD +/- 2.9). The sensory nerve action potential mean amplitude was 22.8 mu V (SD +/- 2.8) and the distal sensory conduction velocity was 38.8 m/s (SD +/- 2.2). Sensorimotor latencies and velocities were least variable between two test sessions (coefficient of variation = 2.6-5.9%), sensory potential amplitudes were intermediate (coefficient of variation = 11.1%) and compound potential amplitudes were the most variable (coefficient of variation = 19.3%). Vincristine abolished compound muscle action potentials and reduced sensory nerve action potential amplitudes by 42-57% while having little effect on velocity. Rabbit distal hindlimb nerve conduction studies are feasible with surface recordings and stimulation. The evoked distal sensory potentials have amplitudes, configurations and recording techniques that are similar to humans and may be valuable for measuring large sensory fiber function in chronic models of peripheral neuropathies.	[Hotson, John R.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Hotson, John R.] Calif Inst Med Res, San Jose, CA 95128 USA	Stanford University	Hotson, JR (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	hotson@stanford.edu			California Institute for Medical Research	California Institute for Medical Research	The study was supported by internal funds of the California Institute for Medical Research, (http://www.cimr.org). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albers JW, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005228.pub3; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; BABA M, 1983, J NEUROL SCI, V60, P235, DOI 10.1016/0022-510X(83)90065-5; BABA M, 1982, J NEUROL SCI, V54, P197, DOI 10.1016/0022-510X(82)90182-4; BRADLEY WG, 1970, J NEUROL SCI, V10, P107, DOI 10.1016/0022-510X(70)90013-4; Brigo F, 2012, J CHILD NEUROL, V27, P867, DOI 10.1177/0883073811428379; CASEY EB, 1973, BRAIN, V96, P69, DOI 10.1093/brain/96.1.69; David WS, 2010, MUSCLE NERVE, V41, P794, DOI 10.1002/mus.21590; Devigili G, 2008, BRAIN, V131, P1912, DOI 10.1093/brain/awn093; Duranthon V, 2012, TRANSGENIC RES, V21, P699, DOI 10.1007/s11248-012-9599-x; England JD, 2005, NEUROLOGY, V64, P199, DOI 10.1212/01.WNL.0000149522.32823.EA; FIORI MG, 1995, TOXICOL PATHOL, V23, P248, DOI 10.1177/019262339502300302; Gomber S, 2010, INDIAN J PEDIATR, V77, P97, DOI 10.1007/s12098-009-0254-3; Graur D, 1996, NATURE, V379, P333, DOI 10.1038/379333a0; Hoke A, 2013, J PERIPHER NERV SYST, V18, P1, DOI 10.1111/jns5.12000; Hoke A, 2012, NEUROTHERAPEUTICS, V9, P262, DOI 10.1007/s13311-012-0116-y; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hotson JR, 2013, J PERIPHER NERV SYST, V18, P48; JOHNSTONE EM, 1991, MOL BRAIN RES, V10, P299, DOI 10.1016/0169-328X(91)90088-F; Kimura J, 2001, ELECTRODIAGNOSIS DIS; Krishnan AV, 2005, MUSCLE NERVE, V32, P51, DOI 10.1002/mus.20340; Kurokawa K, 2004, CLIN NEUROPHYSIOL, V115, P1677, DOI 10.1016/j.clinph.2004.02.007; Lauria G, 2005, J PERIPHER NERV SYST, V10, P202, DOI 10.1111/j.1085-9489.2005.0010210.x; Leandri M, 2012, J NEUROSCI METH, V209, P403, DOI 10.1016/j.jneumeth.2012.07.005; Lehky RJ, 2004, MUSCLE NERVE, V29, P387, DOI 10.1002/mus.10559; LOUIS AA, 1986, ELECTROEN CLIN NEURO, V63, P371, DOI 10.1016/0013-4694(86)90022-2; Misawa K, 2003, MOL PHYLOGENET EVOL, V28, P320, DOI 10.1016/S1055-7903(03)00079-4; Nishimoto Y, 2004, NEUROLOGY, V62, P1939, DOI 10.1212/01.WNL.0000129917.28461.0C; NORIDO F, 1988, TOXICOL APPL PHARM, V93, P433, DOI 10.1016/0041-008X(88)90046-4; Ogawa T, 2000, NEUROTOXICOLOGY, V21, P501; Park SB, 2009, BRAIN, V132, P2712, DOI 10.1093/brain/awp219; POPESKO P, 2003, COLOUR ATLAS ANATOMY; SANDLER SG, 1969, NEUROLOGY, V19, P367, DOI 10.1212/WNL.19.4.367; Shevalye H, 2012, DIABETES, V61, P2126, DOI 10.2337/db11-1524; Sprowl JA, 2013, P NATL ACAD SCI USA, V110, P11199, DOI 10.1073/pnas.1305321110; Staff NP, 2013, NEUROTOXICOLOGY, V39, P124, DOI 10.1016/j.neuro.2013.09.001; STOKES M, 1985, Physiotherapy Practice, V1, P71; Susuki K, 2003, ANN NEUROL, V54, P383, DOI 10.1002/ana.33333; VALENSI P, 1993, DIABETIC MED, V10, P933, DOI 10.1111/j.1464-5491.1993.tb00009.x; Vuillaumier S, 1997, MOL BIOL EVOL, V14, P372, DOI 10.1093/oxfordjournals.molbev.a025773; Woodruff-Pak DS, 2008, J ALZHEIMERS DIS, V15, P507; Zhu J, 2013, ANN NEUROL, V74, P893, DOI 10.1002/ana.24004	42	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92694	10.1371/journal.pone.0092694	http://dx.doi.org/10.1371/journal.pone.0092694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658286	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300116
J	Kang, YG; Shin, JW; Park, SH; Oh, MJ; Park, HS; Shin, JW; Kim, SH				Kang, Yun Gyeong; Shin, Ji Won; Park, So Hee; Oh, Min-Jae; Park, Hyo Soon; Shin, Jung-Woog; Kim, Su-Hyang			Effects of Flow-Induced Shear Stress on Limbal Epithelial Stem Cell Growth and Enrichment	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; IN-VITRO; DIFFERENTIATION; CORNEA; EXPRESSION; PHENOTYPE; ABSENCE; MATRIX; LINES	The roles of limbal epithelial stem cells (LESCs) are widely recognized, but for these cells to be utilized in basic research and potential clinical applications, researchers must be able to efficiently isolate them and subsequently maintain their stemness in vitro. We aimed to develop a biomimetic environment for LESCs involving cells from their in vivo niche and the principle of flow-induced shear stress, and to subsequently demonstrate the potential of this novel paradigm. LESCs, together with neighboring cells, were isolated from the minced limbal tissues of rabbits. At days 8 and 9 of culture, the cells were exposed to a steady flow or intermittent flow for 2 h per day in a custom-designed bioreactor. The responses of LESCs and epithelial cells were assessed at days 12 and 14. LESCs and epithelial cells responded to both types of flow. Proliferation of LESCs, as assessed using a BrdU assay, was increased to a greater extent under steady flow conditions. Holoclones were found under intermittent flow, indicating that differentiation into transient amplifying cells had occurred. Immunofluorescent staining of Bmi-1 suggested that steady flow has a positive effect on the maintenance of stemness. This finding was confirmed by real-time PCR. Notch-1 and p63 were more sensitive to intermittent flow, but this effect was transient. K3 and K12 expression, indicative of differentiation of LESCs into epithelial cells, was induced by flow and lasted longer under intermittent flow conditions. In summary, culture of LESCs in a bioreactor under a steady flow paradigm, rather than one of intermittent flow, is beneficial for both increasing proliferation and maintaining stemness. Conversely, intermittent flow appears to induce differentiation of LESCs. This novel experimental method introduces micro-mechanical stimuli to traditional culture techniques, and has potential for regulating the proliferation and differentiation of LESCs in vitro, thereby facilitating research in this field.	[Kang, Yun Gyeong; Park, So Hee; Oh, Min-Jae; Shin, Jung-Woog; Kim, Su-Hyang] Inje Univ, Dept Biomed Engn, Gyeongnam, South Korea; [Shin, Ji Won; Shin, Jung-Woog] Inje Univ, Cardiovasc & Metab Dis Ctr, Pusan, South Korea; [Park, Hyo Soon] Nunevit Eye Clin, Pusan, South Korea; [Shin, Jung-Woog] Inje Univ, UHRC, Inst Aged Life Redesign, Dept Hlth Sci & Technol, Gyeongnam, South Korea	Inje University; Inje University; Inje University	Shin, JW (corresponding author), Inje Univ, Dept Biomed Engn, Gyeongnam, South Korea.	biomechshin@gmail.com; jacky1231@paran.com			Bio & Medical Technology Development Program of the National Research Foundation (NRF); Ministry of Science [NRF-2012M3A9C6050370]; Korea Healthcare technology R&D Projects, Ministry for Health, Welfare & Family, Republic of Korea [A091807]; Nunevit Eye Clinic	Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea Healthcare technology R&D Projects, Ministry for Health, Welfare & Family, Republic of Korea; Nunevit Eye Clinic	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science (NRF-2012M3A9C6050370) and a grant of the Korea Healthcare technology R&D Projects, Ministry for Health, Welfare & Family, Republic of Korea (A091807). Nunevit Eye Clinic provided support in the form of a salary for author HSP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647; Chee KYH, 2006, CLIN EXP OPHTHALMOL, V34, P64, DOI 10.1111/j.1442-9071.2006.01147.x; Chen SY, 2011, TISSUE ENG PART C-ME, V17, P537, DOI [10.1089/ten.TEC.2010.0609, 10.1089/ten.tec.2010.0609]; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; Grueterich M, 2002, INVEST OPHTH VIS SCI, V43, P63; HUANG AJW, 1991, INVEST OPHTH VIS SCI, V32, P96; Jang JY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/860652; Jones MB, 2008, B MATH BIOL, V70, P323, DOI 10.1007/s11538-007-9252-7; Kisiday JD, 2009, TISSUE ENG PT A, V15, P2817, DOI [10.1089/ten.tea.2008.0357, 10.1089/ten.TEA.2008.0357]; Knippenberg M, 2005, TISSUE ENG, V11, P1780, DOI 10.1089/ten.2005.11.1780; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; Lee SW, 2010, TISSUE ENG REGEN MED, V7, P255; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Mathers WD, 1996, OPHTHALMOLOGY, V103, P664, DOI 10.1016/S0161-6420(96)30637-4; Meyer-Blazejewska EA, 2010, INVEST OPHTH VIS SCI, V51, P765, DOI 10.1167/iovs.09-4109; Park KS, 2006, INVEST OPHTH VIS SCI, V47, P892, DOI 10.1167/iovs.05-1006; Sato M, 2000, J BIOMECH, V33, P127, DOI 10.1016/S0021-9290(99)00178-5; Sumanasinghe RD, 2009, J BIOMED MATER RES A, V88A, P778, DOI 10.1002/jbm.a.31913; Thorpe SD, 2010, ANN BIOMED ENG, V38, P2896, DOI 10.1007/s10439-010-0059-6; Wray LS, 2009, TISSUE ENG PT A, V15, P1463, DOI 10.1089/ten.tea.2008.0239; Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004	25	19	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e93023	10.1371/journal.pone.0093023	http://dx.doi.org/10.1371/journal.pone.0093023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658122	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300151
J	Ma, JY; Chen, J; Ming, DL; Tian, JW				Ma, Jiayi; Chen, Jun; Ming, Delie; Tian, Jinwen			A Mixture Model for Robust Point Matching under Multi-Layer Motion	PLOS ONE			English	Article							VECTOR; APPROXIMATION	This paper proposes an efficient mixture model for establishing robust point correspondences between two sets of points under multi-layer motion. Our algorithm starts by creating a set of putative correspondences which can contain a number of false correspondences, or outliers, in addition to the true correspondences (inliers). Next we solve for correspondence by interpolating a set of spatial transformations on the putative correspondence set based on a mixture model, which involves estimating a consensus of inlier points whose matching follows a non-parametric geometrical constraint. We formulate this as a maximum a posteriori (MAP) estimation of a Bayesian model with hidden/latent variables indicating whether matches in the putative set are outliers or inliers. We impose non-parametric geometrical constraints on the correspondence, as a prior distribution, in a reproducing kernel Hilbert space (RKHS). MAP estimation is performed by the EM algorithm which by also estimating the variance of the prior model (initialized to a large value) is able to obtain good estimates very quickly (e. g., avoiding many of the local minima inherent in this formulation). We further provide a fast implementation based on sparse approximation which can achieve a significant speed-up without much performance degradation. We illustrate the proposed method on 2D and 3D real images for sparse feature correspondence, as well as a public available dataset for shape matching. The quantitative results demonstrate that our method is robust to non-rigid deformation and multi-layer/large discontinuous motion.	[Ma, Jiayi; Ming, Delie; Tian, Jinwen] Huazhong Univ Sci & Technol, Sch Automat, Natl Key Lab Sci & Technol Multispectral Informat, Wuhan 430074, Hubei, Peoples R China; [Chen, Jun] Huazhong Univ Sci & Technol, Elect & Informat Engn Dept, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Ming, DL (corresponding author), Huazhong Univ Sci & Technol, Sch Automat, Natl Key Lab Sci & Technol Multispectral Informat, Wuhan 430074, Hubei, Peoples R China.	mingdelie@hust.edu.cn	Ma, Jiayi/Y-2470-2019	Ma, Jiayi/0000-0003-3264-3265	National Natural Science Foundation of China [61273279, 61273241]; China Scholarship Council [201206160008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work is supported by the National Natural Science Foundation of China (Nos. 61273279 and 61273241, http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) and China Scholarship Council (No. 201206160008, http://en.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSZAJN N, 1950, T AM MATH SOC, V68, P337, DOI 10.1090/s0002-9947-1950-0051437-7; Baldassarre L, 2011, TECHNICAL REPORT; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bishop C. M, 2006, PATTERN RECOGNITION; Carmeli C, 2006, ANAL APPL, V4, P377, DOI 10.1142/S0219530506000838; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Chum O, 2005, PROC CVPR IEEE, P772; Chum O, 2005, PROC CVPR IEEE, P220, DOI 10.1109/cvpr.2005.221; Chum O, 2003, LECT NOTES COMPUT SC, V2781, P236; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Gold S, 1998, PATTERN RECOGN, V31, P1019, DOI 10.1016/S0031-3203(98)80010-1; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; Horaud R, 2011, IEEE T PATTERN ANAL, V33, P587, DOI 10.1109/TPAMI.2010.94; Huber P. H., 1981, ROBUST STAT; Jian B, 2011, IEEE T PATTERN ANAL, V33, P1633, DOI 10.1109/TPAMI.2010.223; Kim VG, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1964921.1964974; Leordeanu M., 2005, P INT C COMP VIS; Li XR, 2010, INT J COMPUT VISION, V89, P1, DOI 10.1007/s11263-010-0318-x; Liu C., 2011, IEEE T PATTERN ANAL, V33; Liu H., 2010, ICML, P671; Liu HR, 2010, PROC CVPR IEEE, P1609, DOI 10.1109/CVPR.2010.5539780; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Ma JY, 2014, IEEE T IMAGE PROCESS, V23, P1706, DOI 10.1109/TIP.2014.2307478; Ma JY, 2013, PROC CVPR IEEE, P2147, DOI 10.1109/CVPR.2013.279; Ma JY, 2013, PATTERN RECOGN, V46, P3519, DOI 10.1016/j.patcog.2013.05.017; Ma JY, 2012, IEEE IMAGE PROC, P1, DOI 10.1109/ICIP.2012.6466780; Micchelli CA, 2005, NEURAL COMPUT, V17, P177, DOI 10.1162/0899766052530802; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; POGGIO T, 1990, P IEEE, V78, P1481, DOI 10.1109/5.58326; Raguram R, 2008, LECT NOTES COMPUT SC, V5303, P500, DOI 10.1007/978-3-540-88688-4_37; Rangarajan A, 1997, LECT NOTES COMPUT SC, V1230, P29; Rousseeuw P. J., 1987, ROBUST REGRESSION OU; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Torr PHS, 2000, COMPUT VIS IMAGE UND, V78, P138, DOI 10.1006/cviu.1999.0832; Torresani L, 2008, LECT NOTES COMPUT SC, V5303, P596, DOI 10.1007/978-3-540-88688-4_44; Tsin Y, 2004, LECT NOTES COMPUT SC, V3023, P558; Tuytelaars T, 2004, INT J COMPUT VISION, V59, P61, DOI 10.1023/B:VISI.0000020671.28016.e8; Ullman S., 1979, INTERPRETATION VISUA, V28; YUILLE AL, 1988, NATURE, V333, P71, DOI 10.1038/333071a0; YUILLE AL, 1989, INT J COMPUT VISION, V3, P155, DOI 10.1007/BF00126430; Zaharescu A, 2009, PROC CVPR IEEE, P373, DOI 10.1109/CVPRW.2009.5206748; Zhao J, 2011, PROC CVPR IEEE, P2977, DOI 10.1109/CVPR.2011.5995336	44	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92282	10.1371/journal.pone.0092282	http://dx.doi.org/10.1371/journal.pone.0092282			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658087	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300069
J	Romeo, R; Foglieni, B; Casazza, G; Spreafico, M; Colombo, M; Prati, D				Romeo, Raffaella; Foglieni, Barbara; Casazza, Giovanni; Spreafico, Marta; Colombo, Massimo; Prati, Daniele			High Serum Levels of HDV RNA Are Predictors of Cirrhosis and Liver Cancer in Patients with Chronic Hepatitis Delta	PLOS ONE			English	Article							B-VIRUS; HEPATOCELLULAR-CARCINOMA; VANISHING DISEASE; INFECTION; MANAGEMENT	Chronic infection with the hepatitis delta virus (HDV) is a risk factor for cirrhosis and hepatocellular carcinoma (HCC), but little is known whether the outcome of hepatitis is predicted by serum markers of HDV and hepatitis B virus (HBV) infection. The aim of the study was to investigate these correlations in 193 patients with chronic HDV infection who had been followed up for a median of 9.5 years (4.8-19.3). HDV-RNA was first measured by qualitative in-house nested RT-PCR and quantified by in-house real-time PCR. HDV RNA levels only appeared significantly associated to HCC (univariate analysis: OR 1.32, 95% CI 1.02-1.71; p = 0.037; multivariate analysis: OR 1.42, 95% CI 1.04-1.95; p = 0.03). In non-cirrhotics at first presentation (n = 105), HDV RNA levels were associated with progression to cirrhosis (univariate analysis: OR = 1.57, 95% CI 1.20-2.05, p<0.001; multivariate analysis: OR = 1.60, 95% CI 1.20-2.12, p = 0.007) and development of HCC (univariate analysis: OR = 1.66, 95% CI 1.04-2.65, p = 0.033; multivariate analysis: OR = 1.88, 95% CI 1.11-3.19, p = 0.019). ROC analysis showed that approximately 600,000 HDV RNA copies/mL was the optimal cut-off value in our cohort of patients for discriminating the development of cirrhosis. High levels of HDV viremia in non-cirrhotic patients are associated with a considerable likelihood of progression to cirrhosis and the development of HCC. Once cirrhosis has developed, the role of HDV replication as a predictor of a negative outcome lessens.	[Romeo, Raffaella; Colombo, Massimo] Univ Milan, IRCCS, Fdn Ca Granda Osped Maggiore Policlin, AM & A Migliavacca Ctr Liver Dis,Div Gastroentero, Milan, Italy; [Foglieni, Barbara; Spreafico, Marta; Prati, Daniele] Osped A Manzoni, Dept Transfus Med & Hematol, Lecce, Italy; [Casazza, Giovanni] Univ Milan, Dipartimento Sci Biomed Clin L Sacco, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan	Romeo, R (corresponding author), Univ Milan, IRCCS, Fdn Ca Granda Osped Maggiore Policlin, AM & A Migliavacca Ctr Liver Dis,Div Gastroentero, Milan, Italy.	raffaella.romeo@policlinico.mi.it	Casazza, Giovanni/G-3661-2012; Prati, Daniele/P-8215-2019; Spreafico, Marta/C-5945-2014	Casazza, Giovanni/0000-0003-3718-1784; Prati, Daniele/0000-0002-2281-7498; Spreafico, Marta/0000-0003-3378-5513	Merck; Roche; BMS; Novartis; Bayer; Tibotec; Vertex; Janssen Cilag; Achillion; Lundbeck; Abbott; Boehringer Ingelheim; GSK; GenSpera; AbbVie Speaking and teaching	Merck(Merck & Company); Roche(Roche Holding); BMS(Bristol-Myers Squibb); Novartis(Novartis); Bayer(Bayer AG); Tibotec; Vertex(Vertex Pharmaceuticals); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Achillion; Lundbeck(Lundbeck Corporation); Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); GSK(GlaxoSmithKline); GenSpera; AbbVie Speaking and teaching(AbbVie)	MC has the following interests: Grant and research support: Merck, Roche, BMS, Gilead Science Advisory committees: Merck, Roche, Novartis, Bayer, BMS, Gilead Science, Tibotec, Vertex, Janssen Cilag, Achillion, Lundbeck, Abbott, Boehringer Ingelheim, GSK, GenSpera, AbbVie Speaking and teaching: Tibotec, Roche, Novartis, Bayer, BMS, Gilead Science, Vertex. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aslan N, 2003, J HEPATOL, V38, P15, DOI 10.1016/S0168-8278(03)80457-9; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; COLOMBO M, 1983, GASTROENTEROLOGY, V85, P235; COLOMBO M, 1991, NEW ENGL J MED, V325, P675, DOI 10.1056/NEJM199109053251002; Cross TJS, 2008, J MED VIROL, V80, P277, DOI 10.1002/jmv.21078; De Franchis R, 2001, P 3 BAV INT CONS WOR; Erhardt A, 2003, Z GASTROENTEROL, V41, P523, DOI 10.1055/s-2003-39648; Farci P, 2003, J HEPATOL, V39, pS212, DOI 10.1016/S0168-8278(03)00331-3; Gaeta GB, 2000, HEPATOLOGY, V32, P824, DOI 10.1053/jhep.2000.17711; Hadziyannis SJ, 1997, J GASTROEN HEPATOL, V12, P289, DOI 10.1111/j.1440-1746.1997.tb00424.x; HADZIYANNIS SJ, 1985, HEPATOLOGY, V5, P544, DOI 10.1002/hep.1840050404; Heidrich B, 2012, LIVER INT; Huang YH, 2004, J GEN VIROL, V85, P3089, DOI 10.1099/vir.0.80183-0; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Kodani M, 2013, J VIROL METHODS, V193, P531, DOI 10.1016/j.jviromet.2013.07.033; Niro GA, 1997, HEPATOLOGY, V25, P728, DOI 10.1002/hep.510250339; OTTOBRELLI A, 1991, GASTROENTEROLOGY, V101, P1649, DOI 10.1016/0016-5085(91)90404-9; Peters RL, 1976, HEPATOCELLULAR CARCI; Pollicino T, 2011, J VIROL, V85, P432, DOI 10.1128/JVI.01609-10; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; RIZZETTO M, 1983, HEPATOLOGY, V3, P729; Romeo R, 2009, GASTROENTEROLOGY, V136, P1629, DOI 10.1053/j.gastro.2009.01.052; Sakugawa H, 2001, J MED VIROL, V65, P478, DOI 10.1002/jmv.2061; Salerno F, 1999, ITAL J GASTROENTEROL, V31, P626; Schaper M, 2010, J HEPATOL, V52, P658, DOI 10.1016/j.jhep.2009.10.036; Taylor JM, 2006, VIROLOGY, V344, P71, DOI 10.1016/j.virol.2005.09.033; Wedemeyer H, 2007, HEPATOLOGY, V45, P1331, DOI 10.1002/hep.21590; Williams V, 2009, J GEN VIROL, V90, P2759, DOI 10.1099/vir.0.011239-0; WU JC, 1995, GASTROENTEROLOGY, V108, P796, DOI 10.1016/0016-5085(95)90453-0; Zachou K, 2010, LIVER INT, V30, P430, DOI 10.1111/j.1478-3231.2009.02140.x	31	50	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e92062	10.1371/journal.pone.0092062	http://dx.doi.org/10.1371/journal.pone.0092062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24658127	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300052
J	Erb, CD; Sobel, DM				Erb, Christopher D.; Sobel, David M.			The Development of Diagnostic Reasoning about Uncertain Events between Ages 4-7	PLOS ONE			English	Article							YOUNG-CHILDREN; EXPLORATORY PLAY; CAUSAL; PRESCHOOLERS; KNOWLEDGE; SCIENCE; PROBABILITY; ACQUISITION; EXPLANATION; INFERENCES	The present investigation examines the development of children's diagnostic reasoning abilities when such inferences involve belief revision about uncertain potential causes. Four-to 7-year-olds observed an event occur that was due to one of four potential causes. Some of those potential causes were revealed to be efficacious; others were revealed to be inefficacious, but there was always one potential cause presented with unknown efficacy. While all children could make appropriate predictive inferences about this situation, 4- and 5-year-olds were less capable of making correct diagnostic inferences about the cause of the event under these circumstances than older children. We discuss possible mechanisms for this development, as well as speculate on the relation between these findings and literature in children's scientific reasoning.	[Erb, Christopher D.; Sobel, David M.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA	Brown University	Sobel, DM (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA.	Dave_Sobel@brown.edu	Erb, Christopher/I-8241-2019	Erb, Christopher/0000-0002-1649-2324	National Science Foundation [1223777]	National Science Foundation(National Science Foundation (NSF))	This research was funded by National Science Foundation 1223777 to DMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck SR, 2006, CHILD DEV, V77, P413, DOI 10.1111/j.1467-8624.2006.00879.x; BINDRA D, 1980, J EXP PSYCHOL GEN, V109, P422, DOI 10.1037/0096-3445.109.4.422; Bullock M., 1982, DEV PSYCHOL TIME, P209; Chen Z, 1999, CHILD DEV, V70, P1098, DOI 10.1111/1467-8624.00081; Cook C, 2011, COGNITION, V120, P341, DOI 10.1016/j.cognition.2011.03.003; Fernbach PM, 2012, COGNITIVE DEV, V27, P39, DOI 10.1016/j.cogdev.2011.10.002; Fischbein E., 1975, INTUITIVE SOURCES PR; Gopnik A, 2000, CHILD DEV, V71, P1205, DOI 10.1111/1467-8624.00224; Gopnik A, 2001, DEV PSYCHOL, V37, P620, DOI 10.1037//0012-1649.37.5.620; HARMAN GH, 1965, PHILOS REV, V74, P88, DOI 10.2307/2183532; HOEMANN HW, 1971, CHILD DEV, V42, P221, DOI 10.1111/j.1467-8624.1971.tb03631.x; Klahr D, 2004, PSYCHOL SCI, V15, P661, DOI 10.1111/j.0956-7976.2004.00737.x; Kuhn D, 1995, MONOGR SOC RES CHILD, V60, P1; Kuhn D, 2009, J EXP CHILD PSYCHOL, V103, P268, DOI 10.1016/j.jecp.2009.01.009; Legare CH, 2012, CHILD DEV, V83, P173, DOI 10.1111/j.1467-8624.2011.01691.x; Lehrer R, 2000, J APPL DEV PSYCHOL, V21, P39, DOI 10.1016/S0193-3973(99)00049-0; Muentener P, 2010, COGNITIVE PSYCHOL, V61, P63, DOI 10.1016/j.cogpsych.2010.02.001; PERNER J, 1979, CHILD DEV, V50, P1121; Piaget J., 1975, ORIGIN IDEA CHANCE C; RUFFMAN T, 1993, CHILD DEV, V64, P1617, DOI 10.2307/1131459; Saxe R, 2005, PSYCHOL SCI, V16, P995, DOI 10.1111/j.1467-9280.2005.01649.x; Schauble L, 1996, DEV PSYCHOL, V32, P102, DOI 10.1037/0012-1649.32.1.102; Schulz LE, 2007, DEV PSYCHOL, V43, P1045, DOI 10.1037/0012-1649.43.4.1045; Schulz LE, 2007, DEVELOPMENTAL SCI, V10, P322, DOI 10.1111/j.1467-7687.2007.00587.x; Sobel DM, 2007, DEVELOPMENTAL SCI, V10, P298, DOI 10.1111/j.1467-7687.2007.00589.x; Sobel DM, 2009, DEV PSYCHOL, V45, P511, DOI 10.1037/a0014944; Sobel DM, 2004, COGNITIVE SCI, V28, P303, DOI 10.1016/j.cogsci.2003.11.001; SODIAN B, 1991, CHILD DEV, V62, P753, DOI 10.2307/1131175	28	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e92285	10.1371/journal.pone.0092285	http://dx.doi.org/10.1371/journal.pone.0092285			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651366	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800094
J	Kleisner, K; Chvatalova, V; Flegr, J				Kleisner, Karel; Chvatalova, Veronika; Flegr, Jaroslav			Perceived Intelligence Is Associated with Measured Intelligence in Men but Not Women	PLOS ONE			English	Article							4TH DIGIT RATIO; MATING SUCCESS; TESTOSTERONE; PERSONALITY; BEAUTY; CUES; ATTRACTIVENESS; IMPRESSIONS; SCHIZOTYPY; ACCURACY	Background: The ability to accurately assess the intelligence of other persons finds its place in everyday social interaction and should have important evolutionary consequences. Methodology/Principal Findings: We used static facial photographs of 40 men and 40 women to test the relationship between measured IQ, perceived intelligence, and facial shape. Both men and women were able to accurately evaluate the intelligence of men by viewing facial photographs. In addition to general intelligence, figural and fluid intelligence showed a significant relationship with perceived intelligence, but again, only in men. No relationship between perceived intelligence and IQ was found for women. We used geometric morphometrics to determine which facial traits are associated with the perception of intelligence, as well as with intelligence as measured by IQ testing. Faces that are perceived as highly intelligent are rather prolonged with a broader distance between the eyes, a larger nose, a slight upturn to the corners of the mouth, and a sharper, pointing, less rounded chin. By contrast, the perception of lower intelligence is associated with broader, more rounded faces with eyes closer to each other, a shorter nose, declining corners of the mouth, and a rounded and massive chin. By contrast, we found no correlation between morphological traits and real intelligence measured with IQ test, either in men or women. Conclusions: These results suggest that a perceiver can accurately gauge the real intelligence of men, but not women, by viewing their faces in photographs; however, this estimation is possibly not based on facial shape. Our study revealed no relation between intelligence and either attractiveness or face shape.	[Kleisner, Karel; Chvatalova, Veronika; Flegr, Jaroslav] Charles Univ Prague, Dept Philosophy & Hist Sci, Fac Sci, Prague, Czech Republic	Charles University Prague	Kleisner, K (corresponding author), Charles Univ Prague, Dept Philosophy & Hist Sci, Fac Sci, Prague, Czech Republic.	karel.kleisner@natur.cuni.cz	Kleisner, Karel/M-2718-2017; Flegr, Jaroslav/AAG-7568-2021; Chvatalova, Veronika/Z-4109-2019; Flegr, Jaroslav/A-1564-2008	Kleisner, Karel/0000-0002-3277-8365; Flegr, Jaroslav/0000-0002-0822-0126; Chvatalova, Veronika/0000-0002-9601-492X; Flegr, Jaroslav/0000-0002-0822-0126	Czech Grant Agency [GACR P407/11/1464]; Charles University in Prague [UNCE 204004]	Czech Grant Agency(Grant Agency of the Czech Republic); Charles University in Prague	This research was supported by Czech Grant Agency project GACR P407/11/1464 (www.gacr.cz) and by Charles University in Prague project UNCE 204004 (www.cuni.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amthauer R, 2001, INTELLIGENZ STRUKTUR; Anderson LD, 1921, J APPL PSYCHOL, V5, P152, DOI 10.1037/h0075189; BORKENAU P, 1995, J PERS, V63, P1, DOI 10.1111/j.1467-6494.1995.tb00799.x; BORKENAU P, 1993, J PERS SOC PSYCHOL, V65, P546, DOI 10.1037/0022-3514.65.3.546; Borkenau P, 2004, J PERS SOC PSYCHOL, V86, P599, DOI 10.1037/0022-3514.86.4.599; Brand A, 2012, J GEN PSYCHOL, V139, P260, DOI 10.1080/00221309.2012.703711; Burke D, 2010, EVOL PSYCHOL-US, V8, P573, DOI 10.1177/147470491000800404; Burrows AM, 2008, BIOESSAYS, V30, P212, DOI 10.1002/bies.20719; Cattell R. B., 1971, ABILITIES THEIR STRU; Denny K, 2008, INTELLIGENCE, V36, P616, DOI 10.1016/j.intell.2008.01.003; DeYoung CG, 2012, J RES PERS, V46, P63, DOI 10.1016/j.jrp.2011.12.003; FEINGOLD A, 1992, PSYCHOL BULL, V111, P304, DOI 10.1037/0033-2909.111.2.304; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Gelman A, 2009, AM SCI, V97, P310, DOI 10.1511/2009.79.310; Greengross G, 2011, INTELLIGENCE, V39, P188, DOI 10.1016/j.intell.2011.03.006; Haselton MG, 2006, HUM NATURE-INT BIOS, V17, P50, DOI 10.1007/s12110-006-1020-0; Havlicek J, 2005, BIOL LETTERS, V1, P256, DOI 10.1098/rsbl.2005.0332; Kanazawa S, 2004, INTELLIGENCE, V32, P227, DOI 10.1016/j.intell.2004.03.003; Kanazawa S, 2011, INTELLIGENCE, V39, P7, DOI 10.1016/j.intell.2010.11.003; Kleisner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053285; Kleisner K, 2010, PERS INDIV DIFFER, V49, P59, DOI 10.1016/j.paid.2010.03.011; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Miller G, 2000, Novartis Found Symp, V233, P260; Miller G, 2000, ANN NY ACAD SCI, V907, P62; Miller G., 2011, MATING MIND SEXUAL C; Miller GF, 1998, TRENDS COGN SCI, V2, P190, DOI 10.1016/S1364-6613(98)01169-3; Moore F. R., 2011, J EVOLUTIONARY PSYCH, V9, P205, DOI [10.1556/JEP.9.2011.3.2, DOI 10.1556/JEP.9.2011.3.2]; Murphy NA, 2003, J PERS, V71, P465, DOI 10.1111/1467-6494.7103008; Murphy NA, 2007, PERS SOC PSYCHOL B, V33, P325, DOI 10.1177/0146167206294871; Murphy NA, 2011, INTELLIGENCE, V39, P54, DOI 10.1016/j.intell.2010.10.001; Neave N, 2003, P ROY SOC B-BIOL SCI, V270, P2167, DOI 10.1098/rspb.2003.2502; Nettle D, 2006, P ROY SOC B-BIOL SCI, V273, P611, DOI 10.1098/rspb.2005.3349; Nettle D, 2006, J RES PERS, V40, P876, DOI 10.1016/j.jrp.2005.09.004; Olivola CY, 2010, J EXP SOC PSYCHOL, V46, P315, DOI 10.1016/j.jesp.2009.12.002; Oosterhof NN, 2009, EMOTION, V9, P128, DOI 10.1037/a0014520; Penke L, 2011, EVOLUTIONARY PSYCHOL; Plhakova A., 2005, TEST STRUKTURY INTEL; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Prokosch MD, 2005, INTELLIGENCE, V33, P203, DOI 10.1016/j.intell.2004.07.007; Reynolds DJ, 2001, PERS SOC PSYCHOL B, V27, P187, DOI 10.1177/0146167201272005; Rohlf J., 2008, TPSRELW VERSION 1 46; Rohlf J.F., 2004, TPSSUPER VERSION 1 1; Rohlf J. F., 2009, TPSREGR VERSION 1 36; Roney JR, 2006, P ROY SOC B-BIOL SCI, V273, P2169, DOI 10.1098/rspb.2006.3569; Rule NO, 2010, PLOS ONE, V5; Samochowiec J, 2010, SOC PSYCHOL PERS SCI, V1, P206, DOI 10.1177/1948550610372145; SCHAEFER K, 2006, PSYCHOL SCI, V48, P178; Stephen ID, 2011, EVOL HUM BEHAV, V32, P216, DOI 10.1016/j.evolhumbehav.2010.09.003; Todorov A., 2011, OXFORD HDB FACE PERC, P631, DOI 10.1093/oxfordhb/9780199559053.013.0032; Zebrowitz L. A., 1997, READING FACES WINDOW; Zebrowitz LA, 2004, J NONVERBAL BEHAV, V28, P167, DOI 10.1023/B:JONB.0000039648.30935.1b; Zebrowitz LA, 2002, PERS SOC PSYCHOL B, V28, P238, DOI 10.1177/0146167202282009	52	50	53	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e81237	10.1371/journal.pone.0081237	http://dx.doi.org/10.1371/journal.pone.0081237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6FV	24651120	Green Published, gold, Green Submitted			2022-12-27	WOS:000333352800001
J	Barta, ML; Hickey, JM; Anbanandam, A; Dyer, K; Hammel, M; Hefty, PS				Barta, Michael L.; Hickey, John M.; Anbanandam, Asokan; Dyer, Kevin; Hammel, Michal; Hefty, P. Scott			Atypical Response Regulator ChxR from Chlamydia trachomatis Is Structurally Poised for DNA Binding	PLOS ONE			English	Article							X-RAY-SCATTERING; 2-COMPONENT SIGNAL-TRANSDUCTION; RNA-POLYMERASE INTERACTION; SMALL-ANGLE SCATTERING; MYCOBACTERIUM-TUBERCULOSIS; BIOLOGICAL MACROMOLECULES; TRANSCRIPTIONAL ACTIVATOR; OMPR/PHOB-SUBFAMILY; HELICOBACTER-PYLORI; ESCHERICHIA-COLI	ChxR is an atypical two-component signal transduction response regulator (RR) of the OmpR/PhoB subfamily encoded by the obligate intracellular bacterial pathogen Chlamydia trachomatis. Despite structural homology within both receiver and effector domains to prototypical subfamily members, ChxR does not require phosphorylation for dimer formation, DNA binding or transcriptional activation. Thus, we hypothesized that ChxR is in a conformation optimal for DNA binding with limited interdomain interactions. To address this hypothesis, the NMR solution structure of the ChxR effector domain was determined and used in combination with the previously reported ChxR receiver domain structure to generate a full-length dimer model based upon SAXS analysis. Small-angle scattering of ChxR supported a dimer with minimal interdomain interactions and effector domains in a conformation that appears to require only subtle reorientation for optimal major/minor groove DNA interactions. SAXS modeling also supported that the effector domains were in a head-to-tail conformation, consistent with ChxR recognizing tandem DNA repeats. The effector domain structure was leveraged to identify key residues that were critical for maintaining protein - nucleic acid interactions. In combination with prior analysis of the essential location of specific nucleotides for ChxR recognition of DNA, a model of the full-length ChxR dimer bound to its cognate cis-acting element was generated.	[Barta, Michael L.; Hefty, P. Scott] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Hickey, John M.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA; [Anbanandam, Asokan] Univ Kansas, Del Shankel Struct Biol Ctr, Lawrence, KS 66045 USA; [Dyer, Kevin; Hammel, Michal] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of Kansas; University of Kansas; University of Kansas; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hefty, PS (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	pshefty@ku.edu		Hammel, Michal/0000-0002-5610-9289	NIH [AIR01079083]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079083, R03AI078179] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH AIR01079083. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Barbieri CM, 2010, J BIOL CHEM, V285, P32325, DOI 10.1074/jbc.M110.157164; Bauler LD, 2014, J BACTERIOL; Bernado Pau, 2012, Methods Mol Biol, V896, P107, DOI 10.1007/978-1-4614-3704-8_7; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI 10.1039/c1mb05275f; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Biersmith BH, 2011, J MOL BIOL, V408, P616, DOI 10.1016/j.jmb.2011.03.013; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Blanco AG, 2011, EMBO J, V30, P3776, DOI 10.1038/emboj.2011.271; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Chen YH, 2004, J BACTERIOL, V186, P1493, DOI 10.1128/JB.186.5.1493-1502.2004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delano WL., 2002, PYMOL MOL GRAPHICS S; Delany I, 2002, J BACTERIOL, V184, P4800, DOI 10.1128/JB.184.17.4800-4810.2002; Duda DM, 2012, MOL CELL, V47, P371, DOI 10.1016/j.molcel.2012.05.044; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fraser JS, 2007, MOL MICROBIOL, V65, P319, DOI 10.1111/j.1365-2958.2007.05785.x; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Goddard D., 2008, SPARKY 3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gupta SS, 2009, J BIOL CHEM, V284, P6536, DOI 10.1074/jbc.M804592200; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; Hickey JM, 2011, J BIOL CHEM, V286, P32606, DOI 10.1074/jbc.M111.220574; Hickey JM, 2011, J BACTERIOL, V193, P389, DOI 10.1128/JB.00833-10; Hickey JM, 2009, ACTA CRYSTALLOGR F, V65, P791, DOI 10.1107/S1744309109025184; Hong E, 2007, J BIOL CHEM, V282, P20667, DOI 10.1074/jbc.M609104200; Hura GL, 2013, NAT METHODS, V10, P453, DOI 10.1038/nmeth.2453; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Johnson CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083989; Kari L, 2011, P NATL ACAD SCI USA, V108, P7189, DOI 10.1073/pnas.1102229108; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kenney LJ, 2002, CURR OPIN MICROBIOL, V5, P135, DOI 10.1016/S1369-5274(02)00310-7; King-Scott J, 2007, J BIOL CHEM, V282, P37717, DOI 10.1074/jbc.M705081200; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Kondo H, 1997, NAT STRUCT BIOL, V4, P28, DOI 10.1038/nsb0197-28; Koo IC, 2006, P NATL ACAD SCI USA, V103, P750, DOI 10.1073/pnas.0509690103; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu X, 2013, P NATL ACAD SCI US; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MAKINO K, 1993, GENE DEV, V7, P149, DOI 10.1101/gad.7.1.149; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; MartinezHackert E, 1997, STRUCTURE, V5, P109, DOI 10.1016/S0969-2126(97)00170-6; Menon S, 2011, BIOCHEMISTRY-US, V50, P5948, DOI 10.1021/bi2005575; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Narayanan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030102; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; Okamura H, 2000, J MOL BIOL, V295, P1225, DOI 10.1006/jmbi.1999.3379; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rhee JE, 2008, J BIOL CHEM, V283, P8664, DOI 10.1074/jbc.M705550200; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Ruiz D, 2008, MICROBIOL-SGM, V154, P3002, DOI 10.1099/mic.0.2008/020677-0; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schar J, 2005, J BACTERIOL, V187, P3100, DOI 10.1128/JB.187.9.3100-3109.2005; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805; Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059; TSUNG K, 1990, P NATL ACAD SCI USA, V87, P5940, DOI 10.1073/pnas.87.15.5940; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Wickstrum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076743; WING R, 1980, NATURE, V287, P755, DOI 10.1038/287755a0; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571	80	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91760	10.1371/journal.pone.0091760	http://dx.doi.org/10.1371/journal.pone.0091760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646934	gold, Green Submitted, Green Published			2022-12-27	WOS:000333348500050
J	Deboeck, G; Taboada, D; Hagan, G; Treacy, C; Page, K; Sheares, K; Naeije, R; Pepke-Zaba, J				Deboeck, Gael; Taboada, Dolores; Hagan, Guy; Treacy, Carmen; Page, Kathy; Sheares, Karen; Naeije, Robert; Pepke-Zaba, Joanna			Maximal Cardiac Output Determines 6 Minutes Walking Distance in Pulmonary Hypertension	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; ARTERIAL-HYPERTENSION; NONINVASIVE MEASUREMENT; EXERCISE; SURVIVAL; HEMODYNAMICS; GUIDELINES; DIAGNOSIS; REST	Purpose: The 6 minutes walk test (6MWT) is often shown to be the best predictor of mortality in pulmonary hypertension (PH) probably because it challenges the failing heart to deliver adequate cardiac output. We hypothesised that the 6MWT elicits maximal cardiac output as measured during a maximal cardiopulmonary exercise testing (CPET). Methods: 18 patients with chronic thromboembolic pulmonary hypertension (n = 12) or pulmonary arterial hypertension (n = 6) and 10 healthy subjects performed a 6MWT and CPET with measurements of cardiac output (non invasive rebreathing device) before and directly after exercise. Heart rate was measured during 6MWT with a cardiofrequence meter. Results: Cardiac output and heart rate measured at the end of the 6MWT were linearly related to 6MW distance (mean +/- SD: 490 +/- 87 m). Patients with a high NT-pro-BNP achieve a maximum cardiac output during the 6MWT, while in normal subjects and in patients with a low-normal NT-proBNP, cardiac output at the end of a 6MWT was lower than achieved at maximum exercise during a CPET. In both cases, heart rate is the major determinant of exercise-induced increase in cardiac output. However, stroke volume increased during CPET in healthy subjects, not in PH patients. Conclusion: Maximal cardiac output is elicited by 6MWT in PH patients with failing right ventricle. Cardiac output increase is dependent on chronotropic response in patients with PH.	[Deboeck, Gael] Univ Libre Bruxelles, Dept Cardiol, Erasmus Univ Hosp, Brussels, Belgium; [Taboada, Dolores; Hagan, Guy; Treacy, Carmen; Page, Kathy; Sheares, Karen; Pepke-Zaba, Joanna] Papworth Hosp, Pulm Vasc Dis Unit, Cambridge, England; [Naeije, Robert] Univ Libre Bruxelles, Fac Med, Dept Physiol, Brussels, Belgium	Universite Libre de Bruxelles; Papworth Hospital; Universite Libre de Bruxelles	Deboeck, G (corresponding author), Univ Libre Bruxelles, Dept Cardiol, Erasmus Univ Hosp, Brussels, Belgium.	gael.deboeck@ulb.ac.be	Pepke-Zaba, Joanna/AGW-3073-2022		European Respiratory Society [LTRF21-2010]; Cambridge biomedical centre	European Respiratory Society; Cambridge biomedical centre	Dr Gael Deboeck is the recipient of a European Respiratory Society Fellowship (LTRF21-2010). The authors acknowledge the support of the Cambridge biomedical centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni P, 2005, J AM COLL CARDIOL, V46, P1779, DOI 10.1016/j.jacc.2005.08.005; Champion HC, 2009, CIRCULATION, V120, P992, DOI 10.1161/CIRCULATIONAHA.106.674028; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Deboeck G, 2005, EUR RESPIR J, V26, P667, DOI 10.1183/09031936.05.00031505; Deboeck G, 2004, EUR RESPIR J, V23, P747, DOI 10.1183/09031936.04.00111904; Deboeck G, 2013, EUR J PREV CARD 0319, V19; Deboeck G, 2012, EUR RESPIR J, V40, P1410, DOI 10.1183/09031936.00217911; Farina S, 2014, AM J CARDIOL, V113, P546, DOI 10.1016/j.amjcard.2013.10.017; Fijalkowska A, 2006, CHEST, V129, P1313, DOI 10.1378/chest.129.5.1313; Frantz RP, 2012, J HEART LUNG TRANSPL, V31, P811, DOI 10.1016/j.healun.2012.04.005; Frost AE, 2005, VASC PHARMACOL, V43, P36, DOI 10.1016/j.vph.2005.03.003; Groepenhoff H, 2008, MED SCI SPORT EXER, V40, P1725, DOI 10.1249/MSS.0b013e31817c92c0; Hall JE., 2011, TXB MED PHYSL; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Lang CC, 2007, AM J CARDIOL, V99, P404, DOI 10.1016/j.amjcard.2006.08.047; LASKEY WK, 1993, J AM COLL CARDIOL, V21, P406, DOI 10.1016/0735-1097(93)90682-Q; Lee WTN, 2011, THORAX, V66, P810, DOI 10.1136/thx.2011.159228; LIPKIN DP, 1986, BRIT MED J, V292, P653, DOI 10.1136/bmj.292.6521.653; Mainguy V, 2013, EUR RESPIR J, V42, P425, DOI 10.1183/09031936.00107012; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Naeije R, 2010, CHEST, V137, P1258, DOI 10.1378/chest.10-0351; NOOTENS M, 1995, AM J CARDIOL, V75, P374, DOI 10.1016/S0002-9149(99)80557-8; Palange P, 2007, EUR RESPIR J, V29, P185, DOI 10.1183/09031936.00046906; Provencher S, 2006, EUR RESPIR J, V27, P114, DOI 10.1183/09031936.06.00042705; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Stringer WW, 1997, J APPL PHYSIOL, V82, P908, DOI 10.1152/jappl.1997.82.3.908; Sun XG, 2002, CIRCULATION, V105, P54, DOI 10.1161/hc0102.101509; Vella CA, 2005, BRIT J SPORT MED, V39, P190, DOI 10.1136/bjsm.2004.013037; Wensel R, 2002, CIRCULATION, V106, P319, DOI 10.1161/01.CIR.0000022687.18568.2A; Wensel R, 2013, INT J CARDIOL, V167, P1193, DOI 10.1016/j.ijcard.2012.03.135	30	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e92324	10.1371/journal.pone.0092324	http://dx.doi.org/10.1371/journal.pone.0092324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24647561	Green Submitted, Green Published, gold			2022-12-27	WOS:000333348500117
J	Kim, JA; Choi, HJ; Kwon, YK; Ryu, DH; Kwon, TH; Hwang, GS				Kim, Ju-Ae; Choi, Hyo-Jung; Kwon, Yong-Kook; Ryu, Do Hyun; Kwon, Tae-Hwan; Hwang, Geum-Sook			H-1 NMR-Based Metabolite Profiling of Plasma in a Rat Model of Chronic Kidney Disease	PLOS ONE			English	Article							EXPERIMENTAL CHRONIC UREMIA; AMINO-ACID-METABOLISM; SKELETAL-MUSCLE; GLUTAMINE FORMATION; SERUM METABOLITES; PROXIMAL TUBULE; PROTEIN; ALANINE; CITRATE; COTRANSPORTER	Chronic kidney disease (CKD) is characterized by the gradual loss of the kidney function to excrete wastes and fluids from the blood. H-1 NMR-based metabolomics was exploited to investigate the altered metabolic pattern in rats with CKD induced by surgical reduction of the renal mass (i.e., 5/6 nephrectomy (5/6 Nx)), particularly for identifying specific metabolic biomarkers associated with early of CKD. Plasma metabolite profiling was performed in CKD rats (at 4- or 8-weeks after 5/6 Nx) compared to sham-operated rats. Principle components analysis (PCA), partial least squares-discriminant analysis (PLS-DA) and orthogonal partial least squares-discriminant analysis (OPLS-DA) score plots showed a significant separation between the groups. The resulting metabolic profiles demonstrated significantly increased plasma levels of organic anions, including citrate, beta-hydroxybutyrate, lactate, acetate, acetoacetate, and formate in CKD. Moreover, levels of alanine, glutamine, and glutamate were significantly higher. These changes were likely to be associated with complicated metabolic acidosis in CKD for counteracting systemic metabolic acidosis or increased protein catabolism from muscle. In contrast, levels of VLDL/LDL (CH2)(n) and N-acetylglycoproteins were decreased. Taken together, the observed changes of plasma metabolite profiles in CKD rats provide insights into the disturbed metabolism in early phase of CKD, in particular for the altered metabolism of acid-base and/or amino acids.	[Kim, Ju-Ae; Kwon, Yong-Kook; Hwang, Geum-Sook] Korea Basic Sci Inst, Integrated Metabol Res Grp, Seoul Ctr, Seoul, South Korea; [Kim, Ju-Ae; Ryu, Do Hyun] Sungkyunkwan Univ, Dept Chem, Suwon, South Korea; [Choi, Hyo-Jung; Kwon, Tae-Hwan] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu 702701, South Korea; [Kwon, Yong-Kook; Hwang, Geum-Sook] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon, South Korea	Korea Basic Science Institute (KBSI); Sungkyunkwan University (SKKU); Kyungpook National University; Chungnam National University	Kwon, TH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu 702701, South Korea.	thkwon@knu.ac.kr; gshwang@kbsi.re.kr	Ryu, Do Hyun/ADI-9819-2022; Kwon, Tae-Hwan/ABA-1981-2020		National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning, Korea [2010-0019393, 2010-0019394, 2013R1A1A2007266, 2013M3A9B6046418]; Korea Healthcare Technology R&D Project, Ministry of Health Welfare, Korea [A111345]; Korea Basic Science Institute [T33409]; Creative Allied Project (CAP); Kyungpook National University Research Fund	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning, Korea; Korea Healthcare Technology R&D Project, Ministry of Health Welfare, Korea; Korea Basic Science Institute; Creative Allied Project (CAP); Kyungpook National University Research Fund	This study was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning, Korea (2010-0019393, 2010-0019394, 2013R1A1A2007266, and 2013M3A9B6046418); the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Korea (A111345), Korea Basic Science Institute (T33409), the Creative Allied Project (CAP), and Kyungpook National University Research Fund, 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A RJ, 2000, KIDNEY, P455; Adeva MM, 2011, CLIN NUTR, V30, P416, DOI 10.1016/j.clnu.2011.03.008; ALPERN RJ, 1990, PHYSIOL REV, V70, P79, DOI 10.1152/physrev.1990.70.1.79; ALPERN RJ, 1995, KIDNEY INT, V47, P1205, DOI 10.1038/ki.1995.171; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; BORON WF, 1983, J GEN PHYSIOL, V81, P53, DOI 10.1085/jgp.81.1.53; BOUBY N, 1993, KIDNEY INT, V44, P676, DOI 10.1038/ki.1993.300; BRENNAN S, 1988, AM J PHYSIOL, V255, pF301, DOI 10.1152/ajprenal.1988.255.2.F301; CHARLES J.C., 2005, HOSP PHYS, V1, P37; Choi HJ, 2012, J PROTEOME RES, V11, P3816, DOI 10.1021/pr300309d; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Choi JY, 2011, NEPHROL DIAL TRANSPL, V26, P1304, DOI 10.1093/ndt/gfq554; CONDON JR, 1971, CLIN CHIM ACTA, V32, P333, DOI 10.1016/0009-8981(71)90433-5; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; FARBER MO, 1976, CLIN SCI MOL MED, V50, P165, DOI 10.1042/cs0500165; GARBER AJ, 1976, J BIOL CHEM, V251, P826; GARBER AJ, 1978, J CLIN INVEST, V62, P633, DOI 10.1172/JCI109170; GARBER AJ, 1978, J CLIN INVEST, V62, P623, DOI 10.1172/JCI109169; HAMM LL, 1990, KIDNEY INT, V38, P728, DOI 10.1038/ki.1990.265; Hong YS, 2010, ARCH PHARM RES, V33, P1091, DOI 10.1007/s12272-010-0716-1; Hwang GS, 2010, AM J PHYSIOL-RENAL, V298, pF461, DOI 10.1152/ajprenal.00389.2009; Jang ZH, 2012, MOL BIOSYST, V8, P2001, DOI 10.1039/c2mb25073j; JENKINS AD, 1985, AM J PHYSIOL, V249, pF590, DOI 10.1152/ajprenal.1985.249.4.F590; Jung JY, 2011, STROKE, V42, P1282, DOI 10.1161/STROKEAHA.110.598789; Kim CD, 2010, TRANSPLANTATION, V90, P748, DOI 10.1097/TP.0b013e3181edd69a; Kirschenlohr HL, 2006, NAT MED, V12, P705, DOI 10.1038/nm1432; Kovesdy CP, 2009, NEPHROL DIAL TRANSPL, V24, P1232, DOI 10.1093/ndt/gfn633; Kraut JA, 2005, AM J KIDNEY DIS, V45, P978, DOI 10.1053/j.ajkd.2005.03.003; Kwon TH, 2002, AM J PHYSIOL-RENAL, V282, pF341, DOI 10.1152/ajprenal.00104.2001; Kwon TH, 1998, AM J PHYSIOL-RENAL, V275, pF724, DOI 10.1152/ajprenal.1998.275.5.F724; Kwon TH, 1999, AM J PHYSIOL-RENAL, V277, pF257, DOI 10.1152/ajprenal.1999.277.2.F257; Laing CM, 2005, INT J BIOCHEM CELL B, V37, P1151, DOI 10.1016/j.biocel.2005.01.002; MADDOX DA, 1986, J CLIN INVEST, V77, P1639, DOI 10.1172/JCI112481; MAY RC, 1987, J CLIN INVEST, V79, P1099, DOI 10.1172/JCI112924; MAY RC, 1986, J CLIN INVEST, V77, P614, DOI 10.1172/JCI112344; Roderick PJ, 2007, COCHRANE DB SYST REV, V1; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Schicho R, 2012, J PROTEOME RES, V11, P3344, DOI 10.1021/pr300139q; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Somashekar BS, 2012, J PROTEOME RES, V11, P4873, DOI 10.1021/pr300345x; Tanner GA, 2000, KIDNEY INT, V58, P1859, DOI 10.1046/j.1523-1755.2000.00357.x; Vorum H, 2000, AM J PHYSIOL-RENAL, V279, pF901, DOI 10.1152/ajprenal.2000.279.5.F901; Weiner ID, 2011, CORE CONCEPTS DISORD, P203; Zhao YY, 2012, CLIN CHIM ACTA, V413, P642, DOI 10.1016/j.cca.2011.12.014	46	89	100	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85445	10.1371/journal.pone.0085445	http://dx.doi.org/10.1371/journal.pone.0085445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24647444	Green Submitted, Green Published, gold			2022-12-27	WOS:000330240500046
J	Johnson, SN; Lopaticki, G; Hartley, SE				Johnson, Scott N.; Lopaticki, Goran; Hartley, Susan E.			Elevated Atmospheric CO2 Triggers Compensatory Feeding by Root Herbivores on a C-3 but Not a C-4 Grass	PLOS ONE			English	Article							RISING CO2; CARBON; PERFORMANCE; NITROGEN; GROWTH	Predicted increases in atmospheric carbon dioxide (CO2) concentrations often reduce nutritional quality for herbivores by increasing the C:N ratio of plant tissue. This frequently triggers compensatory feeding by aboveground herbivores, whereby they consume more shoot material in an attempt to meet their nutritional needs. Little, however, is known about how root herbivores respond to such changes. Grasslands are particularly vulnerable to root herbivores, which can collectively exceed the mass of mammals grazing aboveground. Here we provide novel evidence for compensatory feeding by a grass root herbivore, Sericesthis nigrolineata, under elevated atmospheric CO2 (600 mmol mol(-1)) on a C-3 (Microlaena stipoides) but not a C-4 (Cymbopogon refractus) grass species. At ambient CO2 (400 mu mol mol(-1)) M. stipoides roots were 44% higher in nitrogen (N) and 7% lower in carbon (C) concentrations than C. refractus, with insects performing better on M. stipoides. Elevated CO2 decreased N and increased C: N in M. stipoides roots, but had no impact on C. refractus roots. Root-feeders displayed compensatory feeding on M. stipoides at elevated CO2, consuming 118% more tissue than at ambient atmospheric CO2. Despite this, root feeder biomass remained depressed by 24%. These results suggest that compensatory feeding under elevated atmospheric CO2 may make some grass species particularly vulnerable to attack, potentially leading to future shifts in the community composition of grasslands.	[Johnson, Scott N.; Lopaticki, Goran] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia; [Hartley, Susan E.] Univ York, Dept Biol, York Environm Sustainabil Inst, York YO10 5DD, N Yorkshire, England	Western Sydney University; University of York - UK	Johnson, SN (corresponding author), Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia.	Scott.Johnson@uws.edu.au	Johnson, Scott/HDN-6310-2022; Johnson, Scott N/B-2268-2012; Gemmell, Neil/C-6774-2009	Johnson, Scott/0000-0002-8388-8345; Rosengrave, Patrice/0000-0001-8421-3094; Gemmell, Neil/0000-0003-0671-3637; Carne, Alan/0000-0003-3665-1940; Hartley, Sue/0000-0002-5117-687X; Kleffmann, Torsten/0000-0001-9305-5980	Hawkesbury Institute for the Environment	Hawkesbury Institute for the Environment	The authors are grateful to the Hawkesbury Institute for the Environment for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Barbehenn RV, 2004, GLOBAL CHANGE BIOL, V10, P1565, DOI 10.1111/j.1365-2486.2004.00833.x; Barbehenn RV, 2004, OECOLOGIA, V140, P86, DOI 10.1007/s00442-004-1572-9; Barbehenn RV, 2004, OECOLOGIA, V140, P96, DOI 10.1007/s00442-004-1555-x; Barnett K, 2013, ADV INSECT PHYSIOL, V45, P1, DOI 10.1016/B978-0-12-417165-7.00001-5; Barton CVM, 2010, AGR FOREST METEOROL, V150, P941, DOI 10.1016/j.agrformet.2010.03.001; Blossey B, 2003, ANNU REV ENTOMOL, V48, P521, DOI 10.1146/annurev.ento.48.091801.112700; BRITTON EB, 1978, AUST J ZOOL, P1; CASWELL H, 1973, AM NAT, V107, P465, DOI 10.1086/282851; Dawson LA, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P3, DOI 10.1079/9781845934613.0003; DeLucia EH, 2012, PLANT PHYSIOL, V160, P1677, DOI 10.1104/pp.112.204750; Frew A, 2013, FOREST ECOL MANAG, V306, P275, DOI 10.1016/j.foreco.2013.06.051; Hovenden MJ, 2010, AUSTRAL ECOL, V35, P665, DOI 10.1111/j.1442-9993.2009.02074.x; Johnson SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079479; Johnson SN, 2012, ECOLOGY, V93, P2208, DOI 10.1890/11-2272.1; Johnson SN, 2011, GLOBAL CHANGE BIOL, V17, P688, DOI 10.1111/j.1365-2486.2010.02264.x; Johnson SN, 2010, OECOLOGIA, V162, P209, DOI 10.1007/s00442-009-1428-4; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; MURRAY PJ, 1992, ANN APPL BIOL, V121, P715, DOI 10.1111/j.1744-7348.1992.tb03480.x; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Salt DT, 1996, OIKOS, V77, P326, DOI 10.2307/3546072; Scheirs J, 2001, ECOLOGY, V82, P410, DOI 10.1890/0012-9658(2001)082[0410:ATOTCC]2.0.CO;2; Seastedt TR, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P54, DOI 10.1079/9781845934613.0054; Simpson S.J., 1990, P111; Staley JT, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P192, DOI 10.1079/9781845934613.0192; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Trumper K, 2009, UNEP RAPID RESPONSE; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; WILLIAMS RE, 1968, J RANGE MANAGE, V21, P355, DOI 10.2307/3896081	30	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90251	10.1371/journal.pone.0090251	http://dx.doi.org/10.1371/journal.pone.0090251			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651855	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800012
J	Knowles, SE; Toms, G; Sanders, C; Bee, P; Lovell, K; Rennick-Egglestone, S; Coyle, D; Kennedy, CM; Littlewood, E; Kessler, D; Gilbody, S; Bower, P				Knowles, Sarah E.; Toms, Gill; Sanders, Caroline; Bee, Penny; Lovell, Karina; Rennick-Egglestone, Stefan; Coyle, David; Kennedy, Catriona M.; Littlewood, Elizabeth; Kessler, David; Gilbody, Simon; Bower, Peter			Qualitative Meta-Synthesis of User Experience of Computerised Therapy for Depression and Anxiety	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; STEPPED CARE; SELF-HELP; ACCEPTABILITY; ETHNOGRAPHY; MANAGEMENT; BARRIERS; SYSTEM; AGENTS	Objective: Computerised therapies play an integral role in efforts to improve access to psychological treatment for patients with depression and anxiety. However, despite recognised problems with uptake, there has been a lack of investigation into the barriers and facilitators of engagement. We aimed to systematically review and synthesise findings from qualitative studies of computerised therapies, in order to identify factors impacting on engagement. Method: Systematic review and meta-synthesis of qualitative studies of user experiences of computer delivered therapy for depression and/or anxiety. Results: 8 studies were included in the review. All except one were of desktop based cognitive behavioural treatments. Black and minority ethnic and older participants were underrepresented, and only one study addressed users with a comorbid physical health problem. Through synthesis, we identified two key overarching concepts, regarding the need for treatments to be sensitive to the individual, and the dialectal nature of user experience, with different degrees of support and anonymity experienced as both positive and negative. We propose that these factors can be conceptually understood as the 'non-specific' or 'common' factors of computerised therapy, analogous to but distinct from the common factors of traditional face-to-face therapies. Conclusion: Experience of computerised therapy could be improved through personalisation and sensitisation of content to individual users, recognising the need for users to experience a sense of 'self' in the treatment which is currently absent. Exploiting the common factors of computerised therapy, through enhancing perceived connection and collaboration, could offer a way of reconciling tensions due to the dialectal nature of user experience. Future research should explore whether the findings are generalisable to other patient groups, to other delivery formats (such as mobile technology) and other treatment modalities beyond cognitive behaviour therapy. The proposed model could aid the development of enhancements to current packages to improve uptake and support engagement.	[Knowles, Sarah E.; Toms, Gill; Sanders, Caroline; Bower, Peter] Univ Manchester, NIHR Sch Primary Care Res, Ctr Primary Care, Manchester, Lancs, England; [Bee, Penny; Lovell, Karina] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Rennick-Egglestone, Stefan] Univ Nottingham, Mixed Real Lab, Sch Comp Sci, Nottingham NG7 2RD, England; [Coyle, David] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Kennedy, Catriona M.] Univ Birmingham, Sch Comp Sci, Birmingham B15 2TT, W Midlands, England; [Littlewood, Elizabeth; Gilbody, Simon] Univ York, Mental Hlth & Addict Res Grp, York YO10 5DD, N Yorkshire, England; [Kessler, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Manchester; University of Manchester; University of Nottingham; University of Bristol; University of Birmingham; University of York - UK; University of Bristol	Knowles, SE (corresponding author), Univ Manchester, NIHR Sch Primary Care Res, Ctr Primary Care, Manchester, Lancs, England.	sarah.knowles@manchester.ac.uk	Coyle, David/P-3920-2019; Sanders, Caroline/G-8021-2014; Kessler, david/ABB-6489-2021; Bower, Peter/A-1508-2011; Bee, Penny E/O-8822-2014; Lonsdale, Chris/T-8710-2017; Gilbody, Simon/AAY-3720-2021; Sanders, Taren/N-9511-2018; Lovell, Karina S E/E-6410-2012	Coyle, David/0000-0002-5103-0379; Sanders, Caroline/0000-0002-0539-928X; Bower, Peter/0000-0001-9558-3349; Bee, Penny E/0000-0002-5600-0400; Lonsdale, Chris/0000-0002-2523-5565; Gilbody, Simon/0000-0002-8236-6983; Sanders, Taren/0000-0002-4504-6008; Lovell, Karina S E/0000-0001-8821-895X; Knowles, Sarah/0000-0002-0863-5866; Rennick-Egglestone, Stefan/0000-0003-4187-011X; Kennedy, Catriona/0000-0003-3510-9113; Cliff, Dylan/0000-0001-6863-3996	UK National Institute of Health Research (NIHR) School for Primary Care Research; Medical Research Council [G0401181] Funding Source: researchfish; National Institute for Health Research [SPCR-040, 06/43/05, 06/43/504] Funding Source: researchfish	UK National Institute of Health Research (NIHR) School for Primary Care Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded as part of the UK National Institute of Health Research (NIHR) School for Primary Care Research. The research team were independent from the funding agency. The views expressed in this publication are those of the authors and not necessarily those of the NHS, NIHR, or Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advocat J, 2010, SOC SCI MED, V70, P485, DOI 10.1016/j.socscimed.2009.10.051; [Anonymous], 1994, QUAL HEALTH RES, DOI [10.1177/104973239400400102, DOI 10.1177/104973239400400102]; Atkins S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-21; Bate P., 2007, J APPL BEHAV SCI, V43, P41, DOI [10.1177/0021886306297014, DOI 10.1177/0021886306297014]; Bickmore T, 2010, HARVARD REV PSYCHIAT, V18, P119, DOI 10.3109/10673221003707538; Bower P, 2005, BRIT J PSYCHIAT, V186, P11, DOI 10.1192/bjp.186.1.11; Bradley KL., 2012, INT J MENT HEALTH PR, V14, P23, DOI [10.1080/14623730.2012.665337, DOI 10.1080/14623730.2012.665337]; Carlbring P, 2011, BEHAV RES THER, V49, P18, DOI 10.1016/j.brat.2010.10.002; Cavanagh Kate, 2009, Cognitive Behaviour Therapy, V38, P235, DOI 10.1080/16506070802561256; Chambers DA, 2013, GEN HOSP PSYCHIAT, V35, P329, DOI 10.1016/j.genhosppsych.2013.03.006; Coyle D, 2007, INTERACT COMPUT, V19, P545, DOI 10.1016/j.intcom.2007.02.001; Coyle D, 2008, ONTORACT 2008: FIRST INTERNATIONAL WORKSHOP ON ONTOLOGIES IN INTERACTIVE SYSTEMS, PROCEEDINGS, P18, DOI 10.1109/ONTORACT.2008.12; Dehn DM, 2000, INT J HUM-COMPUT ST, V52, P1, DOI 10.1006/ijhc.1999.0325; Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35; Doherty G., 2012, P 2012 ACM ANN C HUM, P1421, DOI DOI 10.1145/2207676.2208602; Farzanfar R, 2007, COMPUT HUM BEHAV, V23, P1167, DOI 10.1016/j.chb.2004.11.015; Gerhards SAH, 2011, J AFFECT DISORDERS, V129, P117, DOI 10.1016/j.jad.2010.09.012; Green KE, 2009, PROF PSYCHOL-RES PR, V40, P96, DOI 10.1037/a0012847; Helgadottir FD, 2009, BEHAV CHANGE, V26, P245, DOI 10.1375/bech.26.4.245; Hind D, 2010, PSYCHOL HEALTH, V25, P699, DOI 10.1080/08870440902842739; Iloabachie C, 2011, GEN HOSP PSYCHIAT, V33, P543, DOI 10.1016/j.genhosppsych.2011.08.004; Kaltenthaler E, 2008, PSYCHOL MED, V38, P1521, DOI 10.1017/S0033291707002607; Klein B, 2008, J APPL PSYCHOL, V4; Knowles SE, 2012, 2012 C PRIM CAR MENT; Lambert MJ, 2005, J CLIN PSYCHOL, V61, P855, DOI 10.1002/jclp.20130; Layard R, 2006, DEPRESSION REPORT; Malpass A, 2009, SOC SCI MED, V68, P154, DOI 10.1016/j.socscimed.2008.09.068; Marks I, 2009, ANNU REV CLIN PSYCHO, V5, P121, DOI 10.1146/annurev.clinpsy.032408.153538; Mitchell J., 2005, PRIMARY CARE MENTAL, V3, P27; Mitchell N, 2007, COUNS PSYCHOTHER RES, V7, P144, DOI 10.1080/14733140701565987; NHS Confederation Mental Health Network, 2013, E MENT HLTH WHATS AL; NICE, 2009, DEPR AD UPD NICE CLI; Noblit G. W., 1988, METAETHNOGRAPHY SYNT; Peck DF, 2010, CLIN PSYCHOL PSYCHOT, V17, P147, DOI 10.1002/cpp.669; Pilgrim D, 2009, HEALTH-LONDON, V13, P235, DOI 10.1177/1363459308099686; Prevost S., 2000, EMBODIED CONVERSATIO, DOI DOI 10.7551/MITPRESS/2697.001.0001; Reeves B, 1996, CSLI PUBLICATIONS ST; Richards DA, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-3; Rosser BA, 2009, J TELEMED TELECARE, V15, P327, DOI 10.1258/jtt.2009.090116; Ryan RM, 2011, COUNS PSYCHOL, V39, P193, DOI 10.1177/0011000009359313; Sanders C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-220; Schneider J, 2012, COMPUTERISED CBT COM; Simon GE, 2009, LANCET, V374, P594, DOI 10.1016/S0140-6736(09)61415-X; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; STRUPP H, 1978, HDB PSYCHOTHERAPY BE; The King's Fund, 2011, PAT CTR CAR KINGS FU; Timmermans S, 2003, SOCIOL HEALTH ILL, V25, P97, DOI 10.1111/1467-9566.00342; Titov N, 2010, COMPUTER DELIVERED C; Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181; Waller R, 2009, PSYCHOL MED, V39, P705, DOI 10.1017/S0033291708004224; Watkins DC, 2011, J TELEMED TELECARE, V17, P378, DOI 10.1258/jtt.2011.110105	51	143	148	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84323	10.1371/journal.pone.0084323	http://dx.doi.org/10.1371/journal.pone.0084323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297EA	24643129	Green Submitted, Green Published, gold			2022-12-27	WOS:000330237000012
J	Xie, JF; Ma, XD; Huang, YZ; Mo, M; Guo, FM; Yang, Y; Qiu, HB				Xie, Jianfeng; Ma, Xudong; Huang, Yingzi; Mo, Min; Guo, Fengmei; Yang, Yi; Qiu, Haibo			Value of American Thoracic Society Guidelines in Predicting Infection or Colonization with Multidrug-Resistant Organisms in Critically III Patients	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE UNITS; RISK-FACTORS; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; SEVERE SEPSIS; IMPACT; BACTERIA; CHINA; EPIDEMIOLOGY	Background: The incidence rate of infection by multidrug-resistant organisms (MDROs) can affect the accuracy of etiological diagnosis when using American Thoracic Society (ATS) guidelines. We determined the accuracy of the ATS guidelines in predicting infection or colonization by MDROs over 18 months at a single ICU in eastern China. Methods: This prospective observational study examined consecutive patients who were admitted to an intensive care unit (ICU) in Nanjing, China. MDROs were defined as bacteria that were resistant to at least three antimicrobial classes, such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), Pseudomonas aeruginosa, Acinetobacter baumannii. Screening for MDROs was performed at ICU admission and discharge. Risk factors for infection or colonization with MDROs were recorded, and the accuracy of the ATS guidelines in predicting infection or colonization with MDROs was documented. Results: There were 610 patients, 225 (37%) of whom were colonized or infected with MDROs at ICU admission, and this increased to 311 (51%) at discharge. At admission, the sensitivity (70.0%), specificity (31.6%), positive predictive value (38.2%), and negative predictive value (63.5%), all based on ATS guidelines for infection or colonization with MDROs were low. The negative predictive value was greater in patients from departments with MDRO infection rates of 31-40% than in patients from departments with MDRO infection rates of 30% or less and from departments with MDRO infection rates more than 40%. Conclusion: ATS criteria were not reliable in predicting infection or colonization with MDROs in our ICU. The negative predictive value was greater in patients from departments with intermediate rates of MDRO infection than in patients from departments with low or high rates of MDRO infection.	[Xie, Jianfeng; Huang, Yingzi; Mo, Min; Guo, Fengmei; Yang, Yi; Qiu, Haibo] Southeast Univ, Dept Crit Care Med, Zhong Da Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China; [Ma, Xudong] Huazhong Univ Sci & Technol, Sch Med & Hlth Management, Tongji Med Coll, Wuhan 430074, Peoples R China	Southeast University - China; Huazhong University of Science & Technology	Qiu, HB (corresponding author), Southeast Univ, Dept Crit Care Med, Zhong Da Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China.	haiboq2000@gmail.com	Lang, Ming/HIK-0758-2022; yang, yang/HGT-7999-2022; yang, yang/GVT-5210-2022; Qiu, Haibo/AAS-9047-2021; Odle, Jack/K-9660-2017	Qiu, Haibo/0000-0001-8589-4717; Odle, Jack/0000-0003-4965-2096; Ma, Xudong/0000-0002-5943-0879; Xi, Lin/0000-0003-3911-9677	Major Special Projects of Ministry of Health of China [201202011]; Fund of the Key Discipline of Jiangsu Province [KJXW11.3]	Major Special Projects of Ministry of Health of China; Fund of the Key Discipline of Jiangsu Province	This research was supported by the Major Special Projects of Ministry of Health of China (grant number: 201202011), and the Fund of the Key Discipline of Jiangsu Province (grant number KJXW11.3.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Bertrand X, 2012, CLIN THER, V34, P124, DOI 10.1016/j.clinthera.2011.11.023; Cao B, 2010, CLIN INFECT DIS, V51, P189, DOI 10.1086/653535; Chastre J, 2008, CLIN MICROBIOL INFEC, V14, P3, DOI 10.1111/j.1469-0691.2008.01958.x; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dong LF, 2008, J ANTIMICROB CHEMOTH, V62, P410, DOI 10.1093/jac/dkn153; Ewig S, 2010, LANCET INFECT DIS, V10, P279, DOI 10.1016/S1473-3099(10)70032-3; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Harris AD, 2007, EMERG INFECT DIS, V13, P1144, DOI 10.3201/eid1308.070071; Heddini A, 2009, LANCET, V373, P30, DOI 10.1016/S0140-6736(08)61956-X; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hoo GWS, 2005, CHEST, V128, P2778, DOI 10.1378/chest.128.4.2778; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Liang XY, 2011, INT J CLIN PHARM-NET, V33, P750, DOI 10.1007/s11096-011-9535-9; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Maragakis LL, 2010, CRIT CARE MED, V38, pS345, DOI 10.1097/CCM.0b013e3181e6cbc5; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Nachtigall I, 2009, CRIT CARE MED, V37, P159, DOI 10.1097/CCM.0b013e3181934f1b; Nseir S, 2010, CLIN MICROBIOL INFEC, V16, P902, DOI 10.1111/j.1469-0691.2009.03027.x; Nseir S, 2008, J INFECTION, V56, P319, DOI 10.1016/j.jinf.2008.02.012; Parker CM, 2008, J CRIT CARE, V23, P18, DOI 10.1016/j.jcrc.2008.02.001; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Reynolds L, 2009, HEALTH POLICY, V90, P32, DOI 10.1016/j.healthpol.2008.09.002; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Teixeira PJZ, 2007, J HOSP INFECT, V65, P361, DOI 10.1016/j.jhin.2006.12.019; Thomson T, 2011, INFECT CONT HOSP EP, V32, P626, DOI 10.1086/660199; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Warren DK, 2007, CRIT CARE MED, V35, P430, DOI 10.1097/01.CCM.0000253813.98431.28; Zhang RF, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-6	34	41	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e89687	10.1371/journal.pone.0089687	http://dx.doi.org/10.1371/journal.pone.0089687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	25072282	Green Published, Green Submitted, gold			2022-12-27	WOS:000333348500008
J	Rhodes, JR; Lunney, D; Callaghan, J; McAlpine, CA				Rhodes, Jonathan R.; Lunney, Daniel; Callaghan, John; McAlpine, Clive A.			A Few Large Roads or Many Small Ones? How to Accommodate Growth in Vehicle Numbers to Minimise Impacts on Wildlife	PLOS ONE			English	Article							NEW-SOUTH-WALES; OF-FIT TESTS; PHASCOLARCTOS-CINEREUS; PORT STEPHENS; HOME-RANGE; MORTALITY; CONSERVATION; POPULATION; KOALAS; MODELS	Roads and vehicular traffic are among the most pervasive of threats to biodiversity because they fragmenting habitat, increasing mortality and opening up new areas for the exploitation of natural resources. However, the number of vehicles on roads is increasing rapidly and this is likely to continue into the future, putting increased pressure on wildlife populations. Consequently, a major challenge is the planning of road networks to accommodate increased numbers of vehicles, while minimising impacts on wildlife. Nonetheless, we currently have few principles for guiding decisions on road network planning to reduce impacts on wildlife in real landscapes. We addressed this issue by developing an approach for quantifying the impact on wildlife mortality of two alternative mechanisms for accommodating growth in vehicle numbers: (1) increasing the number of roads, and (2) increasing traffic volumes on existing roads. We applied this approach to a koala (Phascolarctos cinereus) population in eastern Australia and quantified the relative impact of each strategy on mortality. We show that, in most cases, accommodating growth in traffic through increases in volumes on existing roads has a lower impact than building new roads. An exception is where the existing road network has very low road density, but very high traffic volumes on each road. These findings have important implications for how we design road networks to reduce their impacts on biodiversity.	[Rhodes, Jonathan R.; McAlpine, Clive A.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia; [Rhodes, Jonathan R.] Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Rhodes, Jonathan R.; McAlpine, Clive A.] Univ Queensland, NERP Environm Decis Hub, Brisbane, Qld, Australia; [Lunney, Daniel] Off Environm & Heritage New South Wales, Hurstville, NSW, Australia; [Lunney, Daniel] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Callaghan, John] Australian Koala Fdn, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; Office of Environment & Heritage - New South Wales; University of Sydney	Rhodes, JR (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia.	j.rhodes@uq.edu.au	Rhodes, Jonathan/C-4841-2008	Rhodes, Jonathan/0000-0001-6746-7412; Beale, Mathew/0000-0002-4740-3187; Fisher, Matthew/0000-0002-1862-6402; Rhodes, Johanna/0000-0002-1338-7860; McAlpine, Clive/0000-0003-0457-8144; Lunney, Dan/0000-0002-5771-0746	Australian Research Council [C00107594]	Australian Research Council(Australian Research Council)	This work was supported by funding from: An Australian Research Council Linkage Project with contributions from the Australian Koala Foundation and New South Wales Government (project number: C00107594, www.arc.gov.au). The Australian Research Council Centre of Excellence for Environmental Decisions (www.arc.gov.au). The National Environmental Research Program Environmental Decisions Hub (http://www.environment.gov.au/topics/science-and-research/national-environmental-research-program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Hosking C, 2012, DIVERS DISTRIB, V18, P847, DOI 10.1111/j.1472-4642.2012.00881.x; Bautista LM, 2004, CONSERV BIOL, V18, P726, DOI 10.1111/j.1523-1739.2004.00499.x; Callaghan J, 2011, WILDLIFE RES, V38, P89, DOI 10.1071/WR07177; Caswell, 2000, MATRIX POPULATION MO; Clarke GP, 1998, BIOL CONSERV, V86, P117, DOI 10.1016/S0006-3207(98)00018-4; Cork SJ, 2000, CONSERV BIOL, V14, P660, DOI 10.1046/j.1523-1739.2000.99389.x; DECC, 2008, NSW 2008 KOAL REC PL; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; Dovers SR, 1996, BIODIVERS CONSERV, V5, P1143, DOI 10.1007/BF00051569; Dudaniec RY, 2013, MOL ECOL, V22, P3752, DOI 10.1111/mec.12359; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ellis WAH, 2002, WILDLIFE RES, V29, P303, DOI 10.1071/WR00111; FAHRIG L, 1995, BIOL CONSERV, V73, P177, DOI 10.1016/0006-3207(94)00102-V; FAHRIG L, 2009, ECOL SOC, V14; Fields G, 2009, INT J SUSTAIN TRANSP, V3, P360, DOI 10.1080/15568310802260013; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Frair JL, 2008, J APPL ECOL, V45, P1504, DOI 10.1111/j.1365-2664.2008.01526.x; Gibbs JP, 2002, CONSERV BIOL, V16, P1647, DOI 10.1046/j.1523-1739.2002.01215.x; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; Goosem Miriam, 1997, P241; Grosman PD, 2011, ECOL MODEL, V222, P1423, DOI 10.1016/j.ecolmodel.2011.01.022; Hels T, 2001, BIOL CONSERV, V99, P331, DOI 10.1016/S0006-3207(00)00215-9; HINDELL MA, 1985, AUST WILDLIFE RES, V12, P137; HINDELL MA, 1987, AUST WILDLIFE RES, V14, P349, DOI 10.1071/WR9870349; Hosmer DW, 1997, STAT MED, V16, P965; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; International Road Federation, 2011, WORLD ROAD STAT 2011; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; Jaeger Jochen A.G., 2006, P151; Jones ME, 2000, WILDLIFE RES, V27, P289, DOI 10.1071/WR98069; Knott Tiffany, 1998, Pacific Conservation Biology, V4, P354; Lesbarreres D, 2012, TRENDS ECOL EVOL, V27, P374, DOI 10.1016/j.tree.2012.01.015; Lunney D, 2000, CONSERV BIOL, V14, P669, DOI 10.1046/j.1523-1739.2000.99386.x; Lunney D, 2010, NATURAL HIST SYDNEY; Lunney D, PAC CONSERV IN PRESS; Lunney Daniel, 1998, Pacific Conservation Biology, V4, P186; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Melzer A, 1995, ASPECTS ECOLOGY KOAL; Mitchell P., 1990, P171; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Natural Resource Management Ministerial Council, 2009, NAT KOAL CONS MAN ST; OSIUS G, 1992, J AM STAT ASSOC, V87, P1145, DOI 10.2307/2290653; Phillips S, 2000, WILDLIFE RES, V27, P1, DOI 10.1071/WR98054; Pittman J, 1993, PROBABILITY; Polak T, J APPL ECOL IN PRESS; Port Stephens Council, 2001, PORT STEPH COUNC C 1; Ramp D, 2005, BIOL CONSERV, V126, P474, DOI 10.1016/j.biocon.2005.07.001; Ramp D, 2006, J WILDLIFE MANAGE, V70, P1615, DOI 10.2193/0022-541X(2006)70[1615:TEORFO]2.0.CO;2; Reed P.C., 1990, P55; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Rhodes JR, 2006, CONSERV BIOL, V20, P449, DOI 10.1111/j.1523-1739.2006.00330.x; Rhodes JR, 2005, ECOLOGY, V86, P1199, DOI 10.1890/04-0912; Roger E, 2011, POPUL ECOL, V53, P215, DOI 10.1007/s10144-010-0209-6; Rondinini C, 2002, FUNCT ECOL, V16, P504, DOI 10.1046/j.1365-2435.2002.00651.x; Seabrook L, 2011, WILDLIFE RES, V38, P509, DOI 10.1071/WR11064; Slooten E, 2000, CONSERV BIOL, V14, P1264, DOI 10.1046/j.1523-1739.2000.00099-411.x; Spellerberg IF, 2002, ECOLOGICAL EFFECTS R, DOI DOI 10.1201/9781482279931; Stewart-Oaten Allan, 1996, P17, DOI 10.1016/B978-012627255-0/50004-5; Sushinsky JR, 2013, GLOBAL CHANGE BIOL, V19, P401, DOI 10.1111/gcb.12055; Taylor BD, 2003, WILDLIFE RES, V30, P529, DOI 10.1071/WR01062; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; van Langevelde F, 2004, LANDSCAPE ECOL, V19, P895, DOI 10.1007/s10980-004-0464-z; van Langevelde F, 1997, HABITAT FRAGMENTATIO, P171; van Langevelde F, 2009, ECOL SOC, V14; Wade PR, 2000, CONSERV BIOL, V14, P1308, DOI 10.1046/j.1523-1739.2000.99415.x; Wade PR, 2002, POPULATION VIABILITY ANALYSIS, P213; White NA, 1999, WILDLIFE RES, V26, P731, DOI 10.1071/WR98002; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zar J. H., 1996, BIOSTATISTICAL ANAL; [No title captured], DOI DOI 10.1016/j.jenvman.2010.11.027	74	56	58	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2014	9	3							e91093	10.1371/journal.pone.0091093	http://dx.doi.org/10.1371/journal.pone.0091093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6ER	24646891	Green Published, gold			2022-12-27	WOS:000333348500024
J	Sanders, T; Cliff, DP; Lonsdale, C				Sanders, Taren; Cliff, Dylan P.; Lonsdale, Chris			Measuring Adolescent Boys' Physical Activity: Bout Length and the Influence of Accelerometer Epoch Length	PLOS ONE			English	Article							ACTIVITY PATTERNS; CHILDREN; HEALTH; LEVEL	Objectives: Accurate, objective measurement is important for understanding adolescents' physical activity (PA) behaviour. When using accelerometry to objectively measure PA, a decision must be made regarding how frequently data is recorded (i.e., epoch length). The purpose of this study was to examine i) PA bout length, and ii) the effect of variations in accelerometer epoch length on PA estimates during physical education (PE) and leisure time in adolescent boys. Design: Cross-sectional study. Methods: Year 9 boys (N = 133; mean age +/- SD = 14.36 +/- 0.48 years) wore accelerometers during two PE lessons, and for a period of seven consecutive days. Data were reintegrated from 1s into longer periods of 2, 5, 10, 30, and 60 seconds. ANOVAs were used to test for differences in PA estimates between epochs in leisure time and PE. Results: The mean length of vigorous PA (VPA) bouts was 3.5 +/- 2.0 seconds for PE and 2.5 +/- 1.7 seconds for leisure time, and mean length of moderate PA (MPA) bouts was 2.3 +/- 0.5 seconds for PE and 2.9 +/- 0.5 seconds for leisure time. During PE, estimates of MVPA, MPA, and light PA (LPA) increased as epoch increased from 1 second to 60 seconds, while VPA and sedentary behaviour estimates decreased. During leisure time, estimates of all PA intensities decreased as epoch increased from 1 second to 60 seconds, with the exception of sedentary behaviour, which increased as epoch length increased. Conclusion: The context in which PA occurs can influence PA bout length measurement and the effect of variations in epoch length on PA estimates. Researchers measuring PA with accelerometry should be conscious of the possible influence of context on PA estimates.	[Sanders, Taren; Lonsdale, Chris] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia; [Cliff, Dylan P.] Univ Wollongong, Interdisciplinary Educ Res Inst, Sch Educ, Wollongong, NSW, Australia	Western Sydney University; University of Wollongong	Lonsdale, C (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia.	c.lonsdale@uws.edu.au	Coyle, David/P-3920-2019; Sanders, Caroline/G-8021-2014; Kessler, david/ABB-6489-2021; Bower, Peter/A-1508-2011; Bee, Penny E/O-8822-2014; Lonsdale, Chris/T-8710-2017; Gilbody, Simon/AAY-3720-2021; Sanders, Taren/N-9511-2018; Lovell, Karina S E/E-6410-2012	Coyle, David/0000-0002-5103-0379; Sanders, Caroline/0000-0002-0539-928X; Bower, Peter/0000-0001-9558-3349; Bee, Penny E/0000-0002-5600-0400; Lonsdale, Chris/0000-0002-2523-5565; Gilbody, Simon/0000-0002-8236-6983; Sanders, Taren/0000-0002-4504-6008; Lovell, Karina S E/0000-0001-8821-895X; Knowles, Sarah/0000-0002-0863-5866; Rennick-Egglestone, Stefan/0000-0003-4187-011X; Kennedy, Catriona/0000-0003-3510-9113; Cliff, Dylan/0000-0001-6863-3996	University of Western Sydney; National Heart Foundation of Australia [PH 11S 6025]; Medical Research Council [G0401181] Funding Source: researchfish; National Institute for Health Research [SPCR-040, 06/43/05, 06/43/504] Funding Source: researchfish	University of Western Sydney; National Heart Foundation of Australia(National Heart Foundation of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the University of Western Sydney's support for Bachelor of Health Science (Honours) research projects. Dylan Cliff is funded by a National Heart Foundation of Australia Postdoctoral Research Fellowship (PH 11S 6025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ActiGraph Software Department, 2012, ACT 6 US MAN; Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; Baquet G, 2007, PREV MED, V44, P143, DOI 10.1016/j.ypmed.2006.10.004; Berman N, 1998, AM J HUM BIOL, V10, P289, DOI 10.1002/(SICI)1520-6300(1998)10:3<289::AID-AJHB4>3.0.CO;2-E; Blaes A, 2011, AM J HUM BIOL, V23, P353, DOI 10.1002/ajhb.21142; Carson V, 2014, INT J OBESITY, V38, P16, DOI 10.1038/ijo.2013.135; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dencker M, 2012, J SPORT MED PHYS FIT, V52, P115; Edwardson CL, 2010, MED SCI SPORT EXER, V42, P928, DOI 10.1249/MSS.0b013e3181c301f5; Esliger DW, 2005, J PHYS ACTIVITY HLTH, V3, P366, DOI DOI 10.1186/1479-5868-8-62; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson P.S., 1997, MED SCI SPORT EXER S, V29, P45, DOI DOI 10.1097/00005768-199705001-00256; Freedson PS, 2000, RES Q EXERCISE SPORT, V71, pS21, DOI 10.1080/02701367.2000.11082782; Gabriel KP, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-53; Gutin B, 2008, OBESITY, V16, P2193, DOI 10.1038/oby.2008.348; Holman RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025733; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Mcclain JJ, 2008, MED SCI SPORT EXER, V40, P2080, DOI 10.1249/MSS.0b013e3181824d98; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Nilsson A, 2002, PEDIATR EXERC SCI, V14, P87, DOI 10.1123/pes.14.1.87; Obeid J, 2011, APPL PHYSIOL NUTR ME, V36, P291, DOI [10.1139/h11-002, 10.1139/H11-002]; Rowls AV., 2006, CITESEER, V4, P52; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sayers A, 2011, J CLIN ENDOCR METAB, V96, pE793, DOI 10.1210/jc.2010-2550; Sirard JR, 2009, J PHYS ACT HEALTH, V6, pS148, DOI 10.1123/jpah.6.s1.s148; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Trost SG, 2007, AM J LIFESTYLE MED, V1, P299, DOI 10.1177/1559827607301686; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Vale S, 2009, PEDIATR EXERC SCI, V21, P413, DOI 10.1123/pes.21.4.413; Vanhelst J, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-26; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788	37	143	148	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2014	9	3							e92040	10.1371/journal.pone.0092040	http://dx.doi.org/10.1371/journal.pone.0092040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4ZE	24643129	Green Published, Green Submitted, gold			2022-12-27	WOS:000333259900069
J	Wang, ZT; Akamatsu, T; Wang, KX; Wang, D				Wang, Zhitao; Akamatsu, Tomonari; Wang, Kexiong; Wang, Ding			The Diel Rhythms of Biosonar Behavior in the Yangtze Finless Porpoise (Neophocaena asiaeorientalis asiaeorientalis) in the Port of the Yangtze River: The Correlation between Prey Availability and Boat Traffic	PLOS ONE			English	Article							PANTROPICAL SPOTTED DOLPHINS; PHOCAENOIDES-ASIAEORIENTALIS; ECHOLOCATION BEHAVIOR; TEMPORAL PATTERNS; BEAKED-WHALES; FOOD-HABITS; CONSERVATION; SIGNALS; SONAR; MOVEMENTS	Information on the habitat use of the critically endangered Yangtze finless porpoise (Neophocaena asiaeorientalis asiaeorientalis) is critical for its conservation. The diel biosonar behavior of the porpoise in the port areas of the Yangtze River was examined along with simultaneous observations of fish density and boat traffic. Biosonar pulses from the porpoises were detected for 1233 min (5.77%) over a 21,380 min duration of effective observations. In total, 190 (5.63%) buzzes (an indication of prey capture attempts) were recorded among the 3372 identified click trains. Of the 168 echolocation encounters (bouts of click trains less than eight min apart), 150 (89.3%) involved single animals, indicating that solitary porpoises were frequently present and feeding in the port areas. Significant diel patterns were evident involving the biosonar behavior of the porpoises (including click trains and buzzes), fish density and boat traffic. The frequencies of the click trains and buzzes were significantly lower during the day than in the evening and at night, which suggests that porpoises in this region are primarily engaged in crepuscular and nocturnal foraging. The lack of a significant diel pattern in the echolocation encounters indicates the importance of the port in porpoise conservation. A forced feeding schedule may be associated with the lack of a significant correlation between porpoise acoustics and boat traffic. Overall, prey availability appears to be the primary factor that attracts porpoises. Additionally, porpoises tend to migrate or remain downstream in the morning and migrate or remain upstream in the evening, most likely to follow their prey. The findings of this study can be used to improve the conservation of the Yangtze finless porpoise.	[Wang, Zhitao; Wang, Kexiong; Wang, Ding] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Wang, Zhitao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Akamatsu, Tomonari] Natl Res Inst Fisheries Engn, Fisheries Res Agcy, Ibaraki, Japan	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Japan Fisheries Research & Education Agency (FRA)	Wang, KX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	wangk@ihb.ac.cn; wangd@ihb.ac.cn	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-4]; National Natural Science Foundation of China [31170501, 31070347]; Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China [201203086]; Ministry of Science and Technology of China [2011BAG07B05-3]; State Oceanic Administration of China [201105011-3]; CREST, Japan Science and Technology Agency; Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Oceanic Administration of China; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-4), the National Natural Science Foundation of China (31170501 and 31070347), the Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China (201203086), Ministry of Science and Technology of China (2011BAG07B05-3), State Oceanic Administration of China (201105011-3), CREST, Japan Science and Technology Agency and the Ocean Park Conservation Foundation, Hong Kong (There is no grant code). The funders had no roles in designing the study, collecting and analyzing data or preparing and deciding where to publish the manuscript.	Akamatsu T, 2008, J ACOUST SOC AM, V123, P4403, DOI 10.1121/1.2912449; Akamatsu T, 2000, J ACOUST SOC AM, V108, P1353, DOI 10.1121/1.1287841; Akamatsu T, 2005, MAR TECHNOL SOC J, V39, P3, DOI 10.4031/002533205787443980; Akamatsu T, 2005, J ACOUST SOC AM, V117, P3325, DOI 10.1121/1.1893325; Akamatsu T, 2010, J EXP BIOL, V213, P146, DOI 10.1242/jeb.037655; Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Au W.W, 2008, PRINCIPLES MARINE BI; Au WWL, 2013, J ACOUST SOC AM, V133, P3119, DOI 10.1121/1.4798360; Baird RW, 2001, CAN J ZOOL, V79, P988, DOI 10.1139/cjz-79-6-988; Barros NB, 2002, RAFFLES B ZOOL, P115; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Carlstrom J, 2005, MAR MAMMAL SCI, V21, P1, DOI 10.1111/j.1748-7692.2005.tb01204.x; Dawson S, 2013, ENDANGER SPECIES RES, V21, P45, DOI 10.3354/esr00508; Dong Shou-Yue, 2012, Acta Hydrobiologica Sinica, V36, P246; Evans W.E., 1974, P385; Fabi G, 2002, ICES J MAR SCI, V59, pS309, DOI 10.1006/jmsc.2002.1194; FOOTE KG, 1987, J ACOUST SOC AM, V82, P981, DOI 10.1121/1.395298; Gannier Alexandre, 1999, Aquatic Mammals, V25, P123; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Henderson EE, 2012, MAR MAMMAL SCI, V28, P439, DOI 10.1111/j.1748-7692.2011.00498.x; Johnston DW, 2008, BIOL LETTERS, V4, P208, DOI 10.1098/rsbl.2007.0614; Kajimura H., 1981, FISH B-NOAA, V78, P951; Keenan SE, 2003, AM FISH S S, V36, P167; Kimura S, 2013, J ACOUST SOC AM, V133, P3128, DOI 10.1121/1.4796129; Kimura S, 2012, MAR MAMMAL SCI, V28, P308, DOI 10.1111/j.1748-7692.2011.00490.x; Kimura S, 2009, J ACOUST SOC AM, V125, P547, DOI 10.1121/1.3021302; Leeney RH, 2011, AQUAT MAMM, V37, P151, DOI 10.1578/AM.37.2.2011.151; Li S., 2008, BIOACOUSTICS, V17, P174, DOI [10.1080/09524622.2008.9753806, DOI 10.1080/09524622.2008.9753806]; Li SH, 2006, J ACOUST SOC AM, V120, P1803, DOI 10.1121/1.2335674; Li SH, 2010, WILDL PROT DESTR EXT, P343; Lin PC, 2013, J APPL ICHTHYOL, V29, P1402, DOI 10.1111/jai.12342; Linnenschmidt M, 2013, MAR MAMMAL SCI, V29, pE77, DOI 10.1111/j.1748-7692.2012.00592.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Payne NL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2363; Pilleri G., 1970, P27; Rasmussen MH, 2013, DEEP-SEA RES PT II, V88-89, P97, DOI 10.1016/j.dsr2.2012.07.011; Reubens JT, 2014, J SEA RES, V85, P214, DOI 10.1016/j.seares.2013.05.005; Richard S, 2010, SCIENCE, V329, P378; Robertson KM, 1997, FISH B-NOAA, V95, P334; Sasaki-Yamamoto Y, 2013, MAR MAMMAL SCI, V29, P589, DOI 10.1111/j.1748-7692.2012.00590.x; Scott MD, 2009, MAR MAMMAL SCI, V25, P137, DOI 10.1111/j.1748-7692.2008.00241.x; Shirakihara M, 2008, J MAMMAL, V89, P1248, DOI 10.1644/07-MAMM-A-264.1; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Wang D., 2013, NEOPHOCAENA ASIAEORI, V2013, DOI DOI 10.2305/IUCN.UK.2013-1.RLTS.T43205774A45893487.EN; Wang D, 2009, CHINESE SCI BULL, V54, P3473, DOI 10.1007/s11434-009-0522-7; Wang KX, 2005, J ACOUST SOC AM, V118, P1180, DOI 10.1121/1.1945487; Wang ZT, 2014, INTEGRATIVE ZOOLOGY, V9; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Wei Zhou, 2003, Acta Zoologica Sinica, V49, P163; Xiao JQ, 2005, ZOO BIOL, V24, P531, DOI 10.1002/zoo.20070; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhao XJ, 2008, BIOL CONSERV, V141, P3006, DOI 10.1016/j.biocon.2008.09.005; Zimmer WM., 2011, PASSIVE ACOUSTIC MON, DOI 10.1017/CBO9780511977107	59	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97907	10.1371/journal.pone.0097907	http://dx.doi.org/10.1371/journal.pone.0097907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	25116432	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200137
J	Wang, ZL; Luo, XF; Li, MT; Xu, D; Zhou, S; Chen, HZ; Gao, N; Chen, Z; Zhang, LL; Zeng, XF				Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Chen, Hou-Zao; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng			Resveratrol Possesses Protective Effects in a Pristane-Induced Lupus Mouse Model	PLOS ONE			English	Article							INDUCED APOPTOSIS; BALB/C MICE; AUTOANTIBODIES; MECHANISMS; DIFFERENTIATION; DISEASE; CELLS; SIRT1	Background: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterized by the production of autoantibodies. To date, no therapy has been found to satisfactorily treat SLE. SIRT1 deficiency results in the development of an autoimmune syndrome in mice, including a high titer of anti-nuclear antibody in serum, immunoglobulin deposition in the kidney, and immune complex glomerulonephritis. Resveratrol is an activator of SIRT1 and possesses anti-inflammation and immune-regulatory properties. Objective: To evaluate the preventative effects of resveratrol on a pristane-induced lupus animal model and assess its putative immune modulation effects. Methods: BALB/c mice received a single intraperitoneal injection of 0.5 ml of pristane on day 1 and then various doses of resveratrol were given to the mice daily starting on day 2 and continuing for seven months. The autoantibodies in serum and supernatants were measured. Single cells isolated from spleen, isolated CD4+ T cells, and CD19+ B cells were cultured with or without resveratrol in vitro and assessed by flow cytometry. Results: Resveratrol attenuated proteinuria, immunoglobuin depositon in kidney, and glomerulonephritis as well as IgG1 and IgG2a in serum in pristane-induced lupus mice. Resveratrol also suppressed CD69 and CD71 expression on CD4+ T cells as well as CD4+ T cell proliferation, induced CD4+ T cell apoptosis, and decreased CD4 IFN gamma(+) Th1 cells and the ratio of Th1/Th2 cells in vitro. In vitro antibody production and proliferation of B cells were also inhibited. Conclusion: Resveratrol possesses protective effects in pristane-induced lupus mice and may represent a novel approach for the management of SLE.	[Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China; [Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Chinese Acad Med Sci, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing 100730, Peoples R China; [Chen, Hou-Zao] Peking Union Med Coll, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100021, Peoples R China; [Chen, Hou-Zao] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College	Zeng, XF (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China.	zengxfpumc@gmail.com	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Chinese National Key Technology R&D Program, Ministry of Science and Technology [2008BAI59B02]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2012AA02A513]; Young Investigator Project, Peking Union Medical College Hospital [I457200]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Chinese National Key Technology R&D Program, Ministry of Science and Technology; Chinese National High Technology Research and Development Program, Ministry of Science and Technology(National High Technology Research and Development Program of China); Young Investigator Project, Peking Union Medical College Hospital; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Chinese National Key Technology R&D Program, Ministry of Science and Technology (2008BAI59B02); the Chinese National High Technology Research and Development Program, Ministry of Science and Technology (2012AA02A513) and the Young Investigator Project, Peking Union Medical College Hospital (I457200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; Cui XL, 2010, CANCER PREV RES, V3, P549, DOI 10.1158/1940-6207.CAPR-09-0117; Danila MI, 2009, RHEUMATOLOGY, V48, P542, DOI 10.1093/rheumatology/kep012; Dorrie J, 2001, CANCER RES, V61, P4731; Gao XZ, 2012, ANN RHEUM DIS, V71, P129, DOI 10.1136/ard.2011.149831; He MX, 2013, CELL DEATH DIFFER, V20, P188, DOI 10.1038/cdd.2012.148; Hoffman RW, 2004, CLIN IMMUNOL, V113, P4, DOI 10.1016/j.clim.2004.05.001; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Izawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048798; Ko YC, 2011, CANCER LETT, V309, P46, DOI 10.1016/j.canlet.2011.05.014; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Miyake K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/980286; Monneaux F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2711; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Richards HB, 1999, CLIN EXP IMMUNOL, V115, P547; Roman V, 2002, BRIT J HAEMATOL, V117, P842, DOI 10.1046/j.1365-2141.2002.03520.x; SATOH M, 1995, P NATL ACAD SCI USA, V92, P10934, DOI 10.1073/pnas.92.24.10934; SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341; Savarese E, 2008, ARTHRITIS RHEUM, V58, P1107, DOI 10.1002/art.23407; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Sestak AL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2176; Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Svajger U, 2010, IMMUNOLOGY, V129, P525, DOI 10.1111/j.1365-2567.2009.03205.x; Takahashi S, 1996, J CLIN INVEST, V97, P1597, DOI 10.1172/JCI118584; Wallace DJ, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-77; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]; Zou T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075139; Zunino SJ, 2009, J NUTR, V139, P1603, DOI 10.3945/jn.109.105064	39	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114792	10.1371/journal.pone.0114792	http://dx.doi.org/10.1371/journal.pone.0114792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25116432	Green Submitted, gold, Green Published			2022-12-27	WOS:000347146700054
J	Wang, Z; Li, Y; Childress, AR; Detre, JA				Wang, Ze; Li, Yin; Childress, Anna Rose; Detre, John A.			Brain Entropy Mapping Using fMRI	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; APPROXIMATE ENTROPY; COMPLEXITY ANALYSIS; SAMPLE ENTROPY; FUNCTIONAL MRI; DEFAULT MODE; NETWORKS; DISEASE; NOVELTY	Entropy is an important trait for life as well as the human brain. Characterizing brain entropy (BEN) may provide an informative tool to assess brain states and brain functions. Yet little is known about the distribution and regional organization of BEN in normal brain. The purpose of this study was to examine the whole brain entropy patterns using a large cohort of normal subjects. A series of experiments were first performed to validate an approximate entropy measure regarding its sensitivity, specificity, and reliability using synthetic data and fMRI data. Resting state fMRI data from a large cohort of normal subjects (n = 1049) from multi-sites were then used to derive a 3-dimensional BEN map, showing a sharp low-high entropy contrast between the neocortex and the rest of brain. The spatial heterogeneity of resting BEN was further studied using a data-driven clustering method, and the entire brain was found to be organized into 7 hierarchical regional BEN networks that are consistent with known structural and functional brain parcellations. These findings suggest BEN mapping as a physiologically and functionally meaningful measure for studying brain functions.	[Wang, Ze; Li, Yin; Childress, Anna Rose] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Wang, Ze; Detre, John A.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wang, Z (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	zewang@mail.med.upenn.edu	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	National Institutes of Health [R21DC011074, 8P41-EB015893, 5R33DA026114-04]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants: R21DC011074, and 8P41-EB015893, and 5R33DA026114-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2008, HUM BRAIN MAP POSTER, P496; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Baumgartner R, 2000, MAGN RESON IMAGING, V18, P845, DOI 10.1016/S0730-725X(00)00171-5; BERGSTROM R M, 1969, Developmental Psychobiology, V2, P139, DOI 10.1002/dev.420020304; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bruna R, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036007; Buxton R., 2002, INTRO FUNCTIONAL MAG; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Chen X, 2005, P ANN INT IEEE EMBS, P4212; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Araujo DB, 2003, NEUROIMAGE, V20, P311, DOI 10.1016/S1053-8119(03)00306-9; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fernandez A, 2010, ALZ DIS ASSOC DIS, V24, P182, DOI 10.1097/WAD.0b013e3181c727f7; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; HITCHCOCK DR, 1967, ICARUS, V7, P149, DOI 10.1016/0019-1035(67)90059-0; Hu ZH, 2006, IEEE IMAGE PROC, P2861, DOI 10.1109/ICIP.2006.313026; Hyvarinen A, 1998, ADV NEUR IN, V10, P273; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kolmogorov AN, 1998, THEOR COMPUT SCI, V207, P387, DOI 10.1016/S0304-3975(98)00075-9; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Li Z, 2012, JMRI; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Liu CY, 2013, J MAGN RESON IMAGING, V38, P36, DOI 10.1002/jmri.23961; Lovelock James, 1979, GAIA NEW LOOK LIFE E; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Palazzolo JA, 1998, AM J PHYSIOL-HEART C, V274, pH1099, DOI 10.1152/ajpheart.1998.274.4.H1099; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pinker S., 1997, MIND WORKS; Poza J, 2008, ANN BIOMED ENG, V36, P141, DOI 10.1007/s10439-007-9402-y; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rezek IA, 1998, IEEE T BIO-MED ENG, V45, P1186, DOI 10.1109/10.709563; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sandler S.I, 2006, CHEM ENG THERMODYNAM; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Singer W, 2009, EUR REV, V17, P321, DOI 10.1017/S1062798709000751; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Sokunbi MO, 2011, IEEE T BIO-MED ENG, V58, P3206, DOI 10.1109/TBME.2011.2164793; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang Z., 2012, 3 BIENN C REST STAT, P208; Wang Z, 2012, 2012 ANN M ORG HUM B; Wang Z, 2007, NEUROIMAGE, V36, P1139, DOI 10.1016/j.neuroimage.2007.03.072; Wang Z, 2009, NEUROIMAGE, V46, P608, DOI 10.1016/j.neuroimage.2009.03.016; Yang AC, 2013, NEUROBIOL AGING, V34, P428, DOI 10.1016/j.neurobiolaging.2012.05.004; Ze Wang A.M., 2013, 2013 ANN M INT SOC M, P4861; Ze Wang JS, 2013, 2013 ANN M SOC NEUR, P7491; Zhu HT, 2006, 9 INT C CONTR AUT RO, P1	57	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e89948	10.1371/journal.pone.0089948	http://dx.doi.org/10.1371/journal.pone.0089948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	25116432	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300008
